Uniprot,Gene names,Protein names,Number of razor/unique peptides,Unique/razor sequence coverage,EOC 1,EOC 2,EOC 3,EOC 4,FTE 13,FTE 14,FTE 15,FTE 16,FTE 17,OSE 26,OSE 27,OSE 28,OSE 29,AvgExp,EOC 1 mean normalized,EOC 2  mean normalized,EOC 3  mean normalized,EOC 4  mean normalized,FTE 13  mean normalized,FTE 14  mean normalized,FTE 15  mean normalized,FTE 16  mean normalized,FTE 17  mean normalized,OSE 26  mean normalized,OSE 27  mean normalized,OSE 28  mean normalized,OSE 29  mean normalized,GOBP ,GOCC ,Tf domains,Kinases,Phosphatases,Adaptors,p value,adj p value,EOC vs FTE p value,EOC vs OSE_ p value,FTE vs OSE p value,cluster
P80404,ABAT,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",16,42,26.19,27.2,27.98,28.55,,27.65,26.13,24.59,25.83,,30.25,30.59,30.3,27.75,-1.56,-0.55,0.23,0.8, ,-0.1,-1.62,-3.16,-1.92, ,2.5,2.83,2.55,amine metabolic process;behavior;biological regulation;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;metabolic process;multicellular organismal process;multi-organism process;neurotransmitter metabolic process;neurotransmitter transport;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to stimulus;response to stress;secretion;small molecule metabolic process;transport,cell part;cell projection;macromolecular complex;neuron projection;protein complex,,,,,2.17E-04,3.93E-02,5.35E-02,1.80E-03,7.18E-05,4
Q96S19,C16orf13,UPF0585 protein C16orf13,4,27.5,27.5,28.47,27.18,27.51,27.14,27.13,27.72,27.99,27.96,,24.18,,,27.28,0.22,1.19,-0.1,0.23,-0.14,-0.15,0.44,0.71,0.68, ,-3.1, , ,,,,,,,4.89E-04,4.82E-02,8.59E-01,3.83E-04,3.86E-04,2
Q13951,CBFB,Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit),7,34.8,25.53,26.17,26.27,26.28,21.14,21.24,24.34,22.15,21.88,,26.36,,,24.14,1.39,2.03,2.13,2.14,-2.99,-2.89,0.2,-1.99,-2.25, ,2.23, , ,anatomical structure development;biological regulation;biosynthetic process;cell activation;cell differentiation;cell maturation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental maturation;developmental process;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,3.65E-04,4.50E-02,8.23E-05,7.79E-01,1.96E-03,1
P51946,CCNH,Cyclin-H (MO15-associated protein) (p34) (p37),3,19.7,24.81,25.32,,24.68,28.05,27.79,27.64,27.98,28.41,28.42,,,28.57,27.17,-2.35,-1.84, ,-2.49,0.88,0.62,0.47,0.81,1.24,1.25, , ,1.4,"biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,,,,,1.19E-05,1.38E-02,7.99E-06,1.45E-05,2.55E-01,3
Q96HQ2,CDKN2AIPNL,CDKN2AIP N-terminal-like protein (CDKN2A-interacting protein N-terminal-like protein),3,40.5,27.62,26.54,25.16,27.66,27.92,28.82,27.62,27.19,27.3,25.39,25.34,24.08,23.75,26.49,1.13,0.05,-1.33,1.17,1.43,2.32,1.13,0.69,0.81,-1.1,-1.15,-2.41,-2.74,,,,,,,4.16E-04,4.50E-02,1.02E-01,4.29E-03,1.13E-04,2
P27658,COL8A1,Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin],4,6.9,22.12,,,26.48,29.79,29.4,29.47,29.74,30.35,26.92,29.28,28.4,29.29,28.3,-6.17, , ,-1.81,1.5,1.1,1.18,1.44,2.06,-1.37,0.99,0.1,1,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell proliferation;cellular component disassembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;metabolic process;multicellular organismal process,cell part,,,,,4.12E-04,4.50E-02,1.56E-04,1.67E-03,1.34E-01,3
Q96PD2,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1) (Endothelial and smooth muscle cell-derived neuropilin-like protein)",12,27.5,27.37,25.79,27.77,27.33,30.1,29.66,30.47,29.66,30.42,30.57,30.59,29.2,30.9,29.22,-1.85,-3.42,-1.45,-1.89,0.88,0.44,1.26,0.45,1.2,1.35,1.37,-0.01,1.68,biological adhesion;biological regulation;cell adhesion;cellular process;response to stimulus;response to stress;signal transduction,cell part;cell surface,,,,,2.04E-05,1.57E-02,2.34E-05,1.75E-05,6.06E-01,3
Q92466,DDB2,DNA damage-binding protein 2 (DDB p48 subunit) (DDBb) (Damage-specific DNA-binding protein 2) (UV-damaged DNA-binding protein 2) (UV-DDB 2),11,22.2,,,,24.62,29.36,28.31,28.89,27.93,28.91,25.04,24.24,,26.09,27.04, , , ,-2.43,2.31,1.26,1.85,0.89,1.87,-2.01,-2.81, ,-0.95,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;macromolecular complex;nucleoplasm;protein complex,,,,,2.16E-04,3.93E-02,6.12E-04,5.68E-01,7.81E-05,3
O94830,DDHD2,"Phospholipase DDHD2 (EC 3.1.1.-) (DDHD domain-containing protein 2) (KIAA0725p) (SAM, WWE and DDHD domain-containing protein 1)",2,9.8,23.54,24.21,,23.35,,26.33,26.89,26.05,25.07,25.92,27.05,27.39,27.11,25.72,-2.17,-1.51, ,-2.37, ,0.61,1.17,0.33,-0.65,0.2,1.33,1.67,1.4,catabolic process;lipid metabolic process;metabolic process;primary metabolic process,cell part;centrosome;cytoplasm;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle,,,,,2.46E-04,3.93E-02,8.54E-04,8.18E-05,1.39E-01,3
O95661,DIRAS3,GTP-binding protein Di-Ras3 (Distinct subgroup of the Ras family member 3) (Rho-related GTP-binding protein RhoI),3,12.7,23.38,24.52,25.24,24.76,28.48,27.99,27.9,28.39,27.39,,27.58,25.96,28.01,26.63,-3.25,-2.11,-1.39,-1.87,1.85,1.36,1.27,1.75,0.76, ,0.94,-0.67,1.38,"biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of gene expression, epigenetic;regulation of protein modification process;response to stimulus;signal transduction",cell part;membrane;plasma membrane,,,,,4.81E-05,2.02E-02,1.16E-05,4.72E-04,1.51E-01,3
P09104,ENO2,Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE),14,53.7,30.77,32.08,28.61,30.16,27.05,26.64,26.43,26.84,26.12,25.44,28.8,26.08,26.58,27.82,2.96,4.27,0.79,2.34,-0.77,-1.18,-1.38,-0.97,-1.69,-2.38,0.98,-1.73,-1.24,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;macromolecular complex;membrane;photoreceptor inner segment;plasma membrane;protein complex,,,,,2.03E-04,3.93E-02,1.28E-04,2.69E-04,8.82E-01,1
P32455,GBP1,Interferon-induced guanylate-binding protein 1 (GTP-binding protein 1) (GBP-1) (HuGBP-1) (Guanine nucleotide-binding protein 1),22,36.7,30.62,29.76,32.04,30.72,26.41,22.32,24.34,27.48,24.24,27.07,27.25,26.29,25.43,27.23,3.39,2.53,4.81,3.49,-0.82,-4.91,-2.89,0.25,-2.99,-0.16,0.02,-0.94,-1.8,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;immune system process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cytosol;extracellular region;membrane,,,,,4.78E-05,2.02E-02,1.40E-05,4.49E-04,1.01E-01,1
Q4V328,GRIPAP1,GRIP1-associated protein 1 (GRASP-1),7,14,26.24,27.05,27.94,26.75,23.06,23.51,22.28,22.2,25.3,25.17,24.87,24.76,23.35,24.81,1.43,2.24,3.13,1.94,-1.74,-1.3,-2.53,-2.61,0.5,0.37,0.07,-0.05,-1.46,,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,1.82E-04,3.93E-02,4.77E-05,2.67E-03,6.63E-02,1
P07305,H1F0,"Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed]",8,31.4,30.31,30.25,31.17,30.2,28.75,29.08,27.89,29.17,30.45,28.5,27.57,26.5,26.51,28.95,1.36,1.3,2.22,1.25,-0.2,0.13,-1.06,0.22,1.5,-0.45,-1.38,-2.45,-2.44,catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;DNA metabolic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleosome;organelle,,,,,3.15E-04,4.40E-02,2.21E-02,8.03E-05,5.74E-03,2
Q92522,H1FX,Histone H1x,9,37.6,28.71,30.04,29.37,29.92,30.48,30.58,29.89,29.83,30.81,27.89,26.96,27.9,28.7,29.31,-0.6,0.73,0.05,0.61,1.17,1.26,0.57,0.52,1.5,-1.42,-2.36,-1.41,-0.62,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,2.42E-04,3.93E-02,8.34E-02,2.94E-03,6.48E-05,2
Q02539,HIST1H1A,Histone H1.1 (Histone H1a),3,24.2,25.67,,,26.68,28.53,30.07,28.87,29.04,29.22,27.51,,27.03,27.08,27.97,-2.3, , ,-1.29,0.56,2.1,0.9,1.07,1.25,-0.46, ,-0.94,-0.89,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;multicellular organismal process;organelle organization,cell part;macromolecular complex;nucleosome,,,,,3.98E-04,4.50E-02,1.82E-04,1.01E-01,1.63E-03,3
Q8SNC9,HLA-B,MHC class I antigen (Fragment),3,8.1,26.84,,,25.52,20.04,19.55,20.97,20.38,21.72,20.58,,,,21.95,4.89, , ,3.57,-1.91,-2.4,-0.98,-1.57,-0.23,-1.37, , , ,immune system process;response to stimulus,cell part;macromolecular complex;MHC protein complex;protein complex,,,,,1.24E-04,3.58E-02,2.82E-05,4.74E-04,9.56E-01,1
P26583,HMGB2,High mobility group protein B2 (High mobility group protein 2) (HMG-2),10,36.8,26.37,25.88,26.25,25.23,29.19,28.65,28.75,28.95,28.62,27.82,26.23,27.94,27.67,27.5,-1.14,-1.62,-1.26,-2.27,1.69,1.15,1.25,1.45,1.12,0.31,-1.27,0.43,0.17,anatomical structure development;biological regulation;catabolic process;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;developmental process;DNA ligation;DNA metabolic process;DNA recombination;immune system process;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleus organization;organelle organization;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;chromosome;extracellular space;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,HMG-box,,,,3.01E-05,1.99E-02,7.22E-06,4.44E-03,4.13E-03,3
P05204,HMGN2,Non-histone chromosomal protein HMG-17 (High mobility group nucleosome-binding domain-containing protein 2),9,53.3,28.58,27.05,26.59,28.31,28.11,27.49,27.49,28.55,27.86,26.81,22.79,20.44,19,26.08,2.5,0.97,0.5,2.22,2.03,1.4,1.41,2.47,1.77,0.73,-3.29,-5.65,-7.08,biological regulation;cellular component organization;cellular process;chromatin organization;chromosome organization;organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,5.14E-04,4.94E-02,8.21E-01,6.97E-04,2.93E-04,2
P20839,IMPDH1,Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I),8,24.3,29.36,28.61,28.14,29.16,25.93,26.6,27.4,27.51,26.26,27.04,25.87,26.25,25.8,27.23,2.14,1.38,0.92,1.93,-1.3,-0.62,0.17,0.29,-0.97,-0.18,-1.36,-0.98,-1.42,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,2.03E-04,3.93E-02,4.21E-04,9.61E-05,2.85E-01,2
Q96CX2,KCTD12,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),20,60.6,32.15,30.87,30.77,29.59,26.27,27.76,24.21,28.23,27.85,,24.45,,23.79,27.81,4.34,3.06,2.96,1.78,-1.54,-0.06,-3.6,0.42,0.04, ,-3.36, ,-4.03,biological regulation;cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;macromolecular complex;membrane;plasma membrane;protein complex;receptor complex,,,,,8.78E-05,2.76E-02,4.01E-04,3.95E-05,1.93E-02,2
Q8TDW0,LRRC8C,Leucine-rich repeat-containing protein 8C (Factor for adipocyte differentiation 158),5,7.5,24.26,23.94,24.21,23.74,26.54,25.13,26.33,25.41,26.54,24.45,23.53,24.44,23.77,24.79,-0.53,-0.85,-0.58,-1.05,1.75,0.34,1.54,0.62,1.75,-0.34,-1.26,-0.35,-1.03,,cell part;membrane,,,,,2.43E-04,3.93E-02,2.70E-04,9.86E-01,2.80E-04,3
Q8WUT4,LRRN4,Leucine-rich repeat neuronal protein 4 (Neuronal leucine-rich repeat protein 4) (NLRR-4),8,15.5,27.81,28.2,25.34,27.36,30.68,31.23,30.97,31.06,29.66,29.89,30.54,31.54,31.24,29.66,-1.84,-1.45,-4.32,-2.3,1.02,1.58,1.32,1.4,0,0.23,0.89,1.88,1.59,,cell part,,,,,4.20E-05,2.02E-02,3.49E-05,4.69E-05,8.90E-01,3
P48449,LSS,"Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC)",30,43.7,29.32,30.73,29.72,31.54,32.32,32.59,32.74,32.75,33.01,32.66,32.31,31.77,32.99,31.88,-2.56,-1.16,-2.16,-0.34,0.44,0.71,0.86,0.87,1.13,0.78,0.43,-0.11,1.1,alcohol metabolic process;biosynthetic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;lipid particle;membrane,,,,,3.56E-04,4.50E-02,1.67E-04,7.00E-04,5.95E-01,3
O95372,LYPLA2,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase II) (LPL-II) (LysoPLA II),5,33.8,28.56,28.36,28.57,27.97,24.88,25.37,27.06,25.1,25.16,26.29,28.72,27.41,26.7,26.93,1.63,1.43,1.64,1.03,-2.06,-1.56,0.12,-1.84,-1.77,-0.65,1.79,0.48,-0.23,cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,4.90E-04,4.82E-02,1.47E-04,8.17E-02,6.25E-03,1
Q9NVC6,MED17,Mediator of RNA polymerase II transcription subunit 17 (Activator-recruited cofactor 77 kDa component) (ARC77) (Cofactor required for Sp1 transcriptional activation subunit 6) (CRSP complex subunit 6) (Mediator complex subunit 17) (Thyroid hormone receptor-associated protein complex 80 kDa component) (Trap80) (Transcriptional coactivator CRSP77) (Vitamin D3 receptor-interacting protein complex 80 kDa component) (DRIP80),5,6.9,27.49,26.11,28.08,26.38,,23.22,23.23,22.49,23.67,25.37,23.99,25.36,26.94,25.19,2.3,0.92,2.88,1.18, ,-1.98,-1.96,-2.7,-1.52,0.17,-1.21,0.17,1.74,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,,,,,1.41E-04,3.79E-02,4.16E-05,2.47E-02,3.45E-03,1
Q7RTP6,MICAL3,Protein-methionine sulfoxide oxidase MICAL3 (EC 1.14.13.-) (Molecule interacting with CasL protein 3) (MICAL-3),10,6.7,26.12,27.08,27.04,26.56,23.9,22.89,23.88,,,,25.12,24.96,,25.28,0.83,1.8,1.76,1.28,-1.39,-2.39,-1.4, , , ,-0.16,-0.32, ,cellular component disassembly;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;exocytosis;organelle organization;protein depolymerization;secretion;transport;vesicle-mediated transport,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,3.03E-04,4.38E-02,6.16E-05,1.07E-02,2.39E-02,1
Q92552,MRPS27,"28S ribosomal protein S27, mitochondrial (MRP-S27) (S27mt)",13,39.9,27.95,28.71,28.8,29.04,30.39,30.76,30.31,30.14,30.22,31.17,30.15,30.46,30.77,29.91,-1.96,-1.21,-1.12,-0.88,0.48,0.84,0.4,0.23,0.31,1.26,0.24,0.55,0.86,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,1.50E-04,3.79E-02,2.18E-04,9.13E-05,4.45E-01,3
Q8WXI7,MUC16* ,Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125),132,24.3,28.1,28.06,24.74,,,,25.14,,,24.19,,,,26.04,2.05,2.01,-1.3, , , ,-0.9, , ,-1.86, , , ,,,,,,,,,,,,1
O94832,MYO1D,Unconventional myosin-Id,25,28.6,27.12,27.59,26.73,27.1,28.76,29.1,29.53,29.25,30.91,30.8,30.06,28.46,30.11,28.89,-1.76,-1.29,-2.16,-1.79,-0.12,0.21,0.64,0.37,2.02,1.91,1.18,-0.43,1.22,biological regulation,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,4.11E-04,4.50E-02,5.20E-04,2.52E-04,5.21E-01,3
Q9BPX3,NCAPG,Condensin complex subunit 3 (Chromosome-associated protein G) (Condensin subunit CAP-G) (hCAP-G) (Melanoma antigen NY-MEL-3) (Non-SMC condensin I complex subunit G) (XCAP-G homolog),11,15.1,25.83,25.82,23.92,27.3,29.55,28.71,29.04,29.31,28.58,27.34,28.21,28,28.56,27.71,-1.87,-1.88,-3.79,-0.4,1.84,1,1.33,1.6,0.88,-0.36,0.5,0.3,0.85,cell cycle;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA packaging;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;centrosome;condensin complex;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex,,,,,1.56E-04,3.79E-02,4.31E-05,1.66E-03,9.40E-02,3
Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),19,64.3,34.58,32.53,31.84,31.11,25.69,25.49,28.55,27.77,27.82,29.57,30.2,26.28,25.67,29.01,5.57,3.52,2.83,2.1,-3.31,-3.52,-0.46,-1.24,-1.18,0.56,1.2,-2.73,-3.34,biological regulation;cell activation;cellular component organization;cellular membrane organization;cellular process;immune system process;membrane organization;plasma membrane organization;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;nucleus;organelle;plasma membrane;protein complex,,,,,3.50E-04,4.50E-02,1.38E-04,9.76E-04,4.19E-01,1
Q13287,NMI,N-myc-interactor (Nmi) (N-myc and STAT interactor),8,28,28.23,28.19,29.31,29.21,26.63,24.97,27,25.87,,25.28,25.75,26.43,,26.99,1.24,1.21,2.33,2.22,-0.36,-2.02,0.01,-1.12, ,-1.71,-1.23,-0.56, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,4.02E-04,4.50E-02,3.73E-04,2.93E-04,6.15E-01,1
Q92823,NrCAM,Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related),19,24.4,27.08,25.95,27.39,26.14,29.81,30.31,29.79,29.13,31.1,30.19,29.58,,30.72,28.93,-1.85,-2.99,-1.54,-2.79,0.87,1.37,0.86,0.2,2.17,1.26,0.65, ,1.79,anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell motility;cell recognition;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular process;developmental process;localization;locomotion;membrane organization;multicellular organismal process;neurological system process;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;synapse,,,,,1.80E-05,1.57E-02,1.11E-05,2.75E-05,8.02E-01,3
O43175,PHGDH,D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95),20,42.8,33.36,32.13,31.14,32.67,30.73,30.48,31.15,31.55,30.2,27.26,28.67,29.76,26.66,30.44,2.91,1.69,0.69,2.23,0.29,0.04,0.7,1.11,-0.24,-3.18,-1.77,-0.69,-3.78,amine metabolic process;anatomical structure development;biological regulation;biosynthetic process;cell development;cellular amino acid metabolic process;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol,,,,,6.91E-05,2.46E-02,3.17E-02,1.96E-05,7.17E-04,2
O00443,PIK3C2A,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha),25,18.4,24.68,25.67,24.61,27.96,28.79,28.19,29.44,29.5,28.49,28.77,30.23,28.12,30.57,28.08,-3.4,-2.41,-3.47,-0.11,0.71,0.11,1.36,1.42,0.41,0.69,2.15,0.04,2.49,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular process;circulatory system process;endocytosis;establishment of localization;exocytosis;macromolecular complex assembly;membrane invagination;membrane organization;metabolic process;multicellular organismal process;muscle contraction;organelle organization;protein complex assembly;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;signal transduction;small molecule metabolic process;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;phosphatidylinositol 3-kinase complex;plasma membrane;protein complex;vesicle,,,,,4.18E-04,4.50E-02,5.92E-04,2.37E-04,4.58E-01,3
P54619,PRKAG1,5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg),9,39.6,29.04,28.31,28.07,27.35,,24.71,24.29,24.42,,27.91,26.81,26.51,25.33,26.61,2.42,1.69,1.46,0.74, ,-1.9,-2.32,-2.19, ,1.29,0.19,-0.1,-1.28,biological regulation;biosynthetic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular process;lipid metabolic process;membrane organization;metabolic process;multicellular organismal process;organic acid metabolic process;primary metabolic process;regulation of cell cycle;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytosol;macromolecular complex;protein complex,,,,,1.76E-04,3.93E-02,5.67E-05,1.68E-02,3.90E-03,1
Q16651,PRSS8*,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],3,16.3,29.07,27.22,27.54,24.1,,24.97,,,,28.98,,,,26.98,2.09,0.24,0.56,-2.88, ,-2.01, , , ,2, , , ,,,,,,,,,,,,1
P23219,PTGS1,Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1),19,41.3,32.44,33.65,30.26,31.75,26.53,27.34,25.37,24.96,24.7,26.14,27.51,28.13,26.79,28.12,4.32,5.53,2.14,3.63,-1.59,-0.78,-2.75,-3.16,-3.42,-1.98,-0.61,0.01,-1.33,biological regulation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;xenobiotic metabolic process,cell part;cell projection;cilium;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,2.05E-06,9.49E-03,6.71E-07,1.81E-05,7.90E-02,1
P06454,PTMA,"Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed;Thymosin alpha-1]",11,92.7,34.52,32.72,33.87,32.21,29.92,30.28,29.7,30.31,28.95,27.31,29.39,31.94,28.26,30.72,3.8,2,3.15,1.49,-0.8,-0.44,-1.02,-0.41,-1.77,-3.41,-1.33,1.21,-2.46,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,4.42E-04,4.64E-02,6.28E-04,2.48E-04,4.55E-01,1
P20962,PTMS,Parathymosin,7,28.4,28.19,26.06,27.58,26.77,24.66,24.42,25.2,25,25.37,22.74,22.15,23.9,21.73,24.91,3.28,1.15,2.67,1.86,-0.24,-0.48,0.29,0.09,0.47,-2.16,-2.76,-1,-3.17,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,5.24E-06,1.21E-02,8.30E-04,1.21E-06,6.14E-04,2
O00194,RAB27B,Ras-related protein Rab-27B (C25KG),11,54.1,24.63,26.25,28.63,26.12,27.22,27.56,26.81,27.39,26.05,,31.02,31.81,31.01,27.88,-3.25,-1.63,0.75,-1.75,-0.65,-0.31,-1.07,-0.48,-1.82, ,3.14,3.94,3.13,biological regulation;cellular process;establishment of localization;protein transport;regulation of transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,4.24E-05,2.02E-02,3.84E-01,2.68E-05,6.15E-05,4
P51151,RAB9A,Ras-related protein Rab-9A,7,45.3,27.99,27.65,26.84,27.55,27.41,26.62,27.45,27.41,27.63,29.74,29.68,29.07,29.46,28.04,-0.05,-0.39,-1.2,-0.48,-0.63,-1.42,-0.59,-0.63,-0.41,1.7,1.64,1.03,1.42,biological regulation;cellular process;establishment of localization;protein transport;regulation of transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole;vesicle,,,,,5.93E-05,2.28E-02,5.81E-01,1.28E-04,2.99E-05,4
O15541,RNF113A,RING finger protein 113A (Zinc finger protein 183),4,22.4,,,22.06,20.82,25.44,26.37,24.4,,24.51,,25.24,25.67,24.82,24.37, , ,-2.31,-3.55,1.07,2,0.03, ,0.14, ,0.87,1.3,0.45,,,,,,,4.70E-04,4.82E-02,3.16E-04,4.14E-04,9.21E-01,3
Q9Y3Z3,SAMHD1,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1),50,76.8,33.03,32.96,34.13,32.43,31.71,30.32,31.46,31.84,31.59,30.13,29.14,29.59,28.85,31.32,1.71,1.64,2.81,1.11,0.38,-1,0.14,0.52,0.27,-1.2,-2.18,-1.73,-2.47,biological regulation;immune system process;metabolic process;multi-organism process;response to biotic stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,1.03E-05,1.38E-02,1.78E-03,2.40E-06,7.61E-04,2
Q9UPQ9,TNRC6B,Trinucleotide repeat-containing gene 6B protein,6,5,24.65,25.9,25.31,25.51,,20.99,21.74,21.4,23.22,23.83,23.75,24.77,22.01,23.59,1.06,2.31,1.72,1.92, ,-2.6,-1.85,-2.19,-0.37,0.24,0.16,1.18,-1.59,biological regulation;cellular process;gene silencing;immune system process;macromolecule metabolic process;metabolic process;regulation of translation;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex,,,,,3.71E-04,4.50E-02,1.03E-04,1.56E-02,1.60E-02,1
P19971,TYMP,Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase),28,58.7,30.58,32.71,34.04,31.78,28.66,28,26.91,30.15,26.67,28.03,28.06,29.96,26.17,29.36,1.21,3.34,4.68,2.42,-0.7,-1.36,-2.45,0.79,-2.7,-1.33,-1.3,0.6,-3.19,anatomical structure formation involved in morphogenesis;biosynthetic process;catabolic process;cell differentiation;cellular aromatic compound metabolic process;cellular component organization;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA replication;heterocycle metabolic process;locomotion;macromolecule metabolic process;metabolic process;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;pyrimidine-containing compound salvage;response to chemical stimulus;response to external stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol,,,,,5.30E-04,5.00E-02,3.68E-04,5.56E-04,9.83E-01,1
O94888,UBXN7,UBX domain-containing protein 7,9,22.9,29.45,27.97,27.45,27.31,26.22,26.6,26.57,25.4,27.7,25.3,24.97,25,24.64,26.51,2.95,1.46,0.95,0.8,-0.28,0.09,0.06,-1.11,1.2,-1.21,-1.54,-1.51,-1.86,,cell part;macromolecular complex;protein complex,,,,,2.91E-04,4.33E-02,1.01E-02,7.21E-05,1.12E-02,2
Q96GC9,VMP1,Vacuole membrane protein 1 (Transmembrane protein 49),3,13.4,26.34,26.67,24.74,26.1,27.82,28.57,28.05,27.28,28.38,28.18,29.4,28.94,29.71,27.7,-1.36,-1.03,-2.97,-1.61,0.11,0.86,0.34,-0.43,0.67,0.48,1.7,1.24,2,autophagy;biological adhesion;biological regulation;catabolic process;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,8.95E-05,2.76E-02,7.26E-04,2.66E-05,4.53E-02,3
Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),23,24.6,22.52,24.87,24.07,25.85,26.41,26.96,28,25.92,27.68,27.59,28.16,29.06,27.51,26.51,-3.98,-1.64,-2.44,-0.66,-0.09,0.45,1.49,-0.59,1.17,1.08,1.65,2.55,1,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,2.72E-04,4.19E-02,1.15E-03,9.28E-05,1.18E-01,3
Q9NRG9,AAAS,Aladin (Adracalin),12,29.3,29.83,29.03,26.32,29.1,30.84,29.67,29.74,29.87,29.91,28.88,28.03,29.7,29.94,29.3,0.54,-0.27,-2.98,-0.2,1.54,0.38,0.44,0.57,0.62,-0.42,-1.26,0.4,0.64,behavior;biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;multicellular organismal process;neurological system process;nuclear transport;nucleocytoplasmic transport;primary metabolic process;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;centrosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;nuclear pore;organelle;protein complex,,,,,,,,,,
Q86V21,AACS,Acetoacetyl-CoA synthetase (EC 6.2.1.16) (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog),6,7.9,25.84,26.26,26.18,28.91,27.69,25.45,28.94,29.25,24.87,25.54,27.59,29.16,25.25,27,-1.16,-0.74,-0.82,1.92,0.7,-1.54,1.95,2.26,-2.12,-1.46,0.59,2.17,-1.74,anatomical structure development;biological regulation;cell differentiation;cellular homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;homeostatic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P22760,AADAC,Arylacetamide deacetylase (EC 3.1.1.3),5,18.3,,27.44,27.47,26.33,25.31,,23.89,27.52,24.08,,26.98,27.51,24.74,26.13, ,1.32,1.35,0.2,-0.81, ,-2.24,1.39,-2.05, ,0.85,1.38,-1.39,biological regulation,cell part;membrane,,,,,,,,,,
Q2M2I8,AAK1,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),15,22.6,29.04,27.96,28,27.26,25.52,27.38,28.36,27.51,27.59,,28.61,27.43,27.48,27.68,1.37,0.28,0.32,-0.41,-2.16,-0.3,0.68,-0.17,-0.09, ,0.93,-0.25,-0.2,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;establishment of localization;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein stability;regulation of transport;transport;vesicle-mediated transport,cell leading edge;cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,+,,,,,,,,
P49588,AARS,"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)",27,36.9,32.03,31.57,30.49,31.85,30.38,29.97,30.92,30.87,29.45,27.95,30.67,30.61,27.45,30.32,1.7,1.25,0.16,1.53,0.06,-0.35,0.59,0.55,-0.88,-2.38,0.34,0.29,-2.87,amine metabolic process;anatomical structure development;biological regulation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;molting cycle;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;protein folding;protein metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;RNA modification;RNA processing;signal transduction;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process;tRNA processing,cell part;cytosol,,,,,,,,,,
Q5JTZ9,AARS2,"Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)",13,13.8,26.58,27.34,26.15,27.37,28.79,28.61,27.91,27.46,28.81,28.16,27.26,26.01,28.52,27.61,-1.03,-0.27,-1.46,-0.24,1.18,0.99,0.3,-0.15,1.2,0.55,-0.36,-1.6,0.91,amine metabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9BTE6,AARSD1,Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1),3,10.9,24.74,,,26.2,25.01,24.66,24.15,24.58,22.38,,26.27,27.48,,25.05,-0.31, , ,1.14,-0.04,-0.39,-0.91,-0.47,-2.67, ,1.22,2.43, ,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytoplasm,,,,,,,,,,
Q9NRN7,AASDHPPT,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.-) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT) (LYS5 ortholog),8,21.7,25.92,27.32,24.91,27.67,27.76,24.51,27.98,26.99,25.52,,27.5,27.7,24.53,26.53,-0.61,0.79,-1.61,1.14,1.24,-2.01,1.45,0.46,-1.01, ,0.98,1.18,-2,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
Q9UDR5,AASS,"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8);Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]",10,13.1,23.65,28.11,25.17,29.23,27.59,29.41,28.16,28.31,28.87,27.04,25.27,26.44,27.44,27.28,-3.64,0.83,-2.11,1.94,0.3,2.12,0.88,1.03,1.59,-0.25,-2.01,-0.85,0.16,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part,,,,,,,,,,
Q9NY61,AATF,Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1),9,33.6,28.25,26.74,,28.02,28.3,26.85,27.35,25.91,28.29,27.5,23.87,24,27.49,26.88,1.37,-0.14, ,1.14,1.42,-0.03,0.47,-0.97,1.41,0.62,-3.01,-2.89,0.61,biological adhesion;biological regulation;cell adhesion;cell division;cellular process;regulation of cell cycle;regulation of mitotic cell cycle;response to DNA damage stimulus;response to stimulus;response to stress;ribosome biogenesis;signal transduction,cell part;centrosome;cytoplasm;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleolus;organelle,,,,,,,,,,
Q9NRK6,ABCB10,"ATP-binding cassette sub-family B member 10, mitochondrial (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)",6,9.2,23.14,,,24.4,27.27,26.54,,26.6,23.41,26.59,,,25,25.37,-2.23, , ,-0.96,1.9,1.17, ,1.23,-1.96,1.22, , ,-0.37,,cell part;membrane,,,,,,,,,,
Q9NP58,ABCB6,"ATP-binding cassette sub-family B member 6, mitochondrial (Mitochondrial ABC transporter 3) (Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter)",7,17,25.48,26.96,,26.05,25.87,27.79,26.26,24.43,23.62,25.68,21.94,,,25.41,0.07,1.55, ,0.64,0.46,2.38,0.85,-0.97,-1.79,0.27,-3.47, , ,anatomical structure development;biological regulation;biosynthetic process;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;establishment of localization;heterocycle metabolic process;homeostatic process;ion transport;metabolic process;nitrogen compound metabolic process;response to chemical stimulus;response to stimulus;transmembrane transport;transport,ATP-binding cassette (ABC) transporter complex;cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
O75027,ABCB7,"ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein)",7,12.2,27.13,28.23,27.47,27.22,27.74,28.06,27.71,26.55,28.65,28.29,27.45,23.72,28.7,27.46,-0.32,0.78,0.02,-0.24,0.29,0.6,0.26,-0.9,1.2,0.83,-0.01,-3.74,1.24,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;homeostatic process,cell part;membrane,,,,,,,,,,
P33527,ABCC1,Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter),26,20.7,30.06,30.19,28.09,29.88,29.16,29.23,28.93,28.74,29.59,30.41,29.31,28.5,29.84,29.38,0.68,0.81,-1.29,0.5,-0.22,-0.14,-0.45,-0.64,0.21,1.03,-0.07,-0.88,0.47,cellular alkene metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O15439,ABCC4,Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B),17,13.7,26.52,25.91,25.32,25.95,27.63,29.18,27.81,26.12,28.78,27.81,27.42,27.65,28.34,27.26,-0.74,-1.36,-1.95,-1.32,0.37,1.92,0.55,-1.14,1.51,0.54,0.15,0.39,1.07,catabolic process;cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;exocytosis;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;secretion;small molecule metabolic process;transmembrane transport;transport;vesicle-mediated transport,cell part;membrane;plasma membrane,,,,,,,,,,
O15440,ABCC5,Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11),8,8,27.1,24.11,24.76,,24.92,,,,24.27,24.6,23.96,,24.85,24.82,2.28,-0.71,-0.06, ,0.1, , , ,-0.55,-0.22,-0.86, ,0.03,amine metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P33897,ABCD1,ATP-binding cassette sub-family D member 1 (Adrenoleukodystrophy protein) (ALDP),9,19.1,23.27,28.71,27.66,27.4,24.97,24.57,26.42,24.38,27.5,27.83,,,,26.27,-3,2.43,1.39,1.13,-1.3,-1.7,0.15,-1.89,1.23,1.56, , , ,catabolic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;lipid metabolic process;metabolic process;organelle organization;organic acid metabolic process;peroxisome organization;primary metabolic process;small molecule metabolic process;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P28288,ABCD3,ATP-binding cassette sub-family D member 3 (70 kDa peroxisomal membrane protein) (PMP70),21,41.8,31.38,31.14,29.71,31.02,30.36,31.31,31.28,30.44,31.61,31.41,31.46,31.6,31.9,31.13,0.26,0.01,-1.41,-0.11,-0.77,0.19,0.15,-0.68,0.48,0.29,0.33,0.47,0.78,catabolic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;lipid metabolic process;metabolic process;organelle organization;organic acid metabolic process;peroxisome organization;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle,,,,,,,,,,
P61221,ABCE1,ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I),23,50.4,30.45,30.57,29.84,31.32,30.67,30.01,31.55,31.63,29.92,29.89,30.92,31.06,29.25,30.54,-0.09,0.02,-0.71,0.77,0.13,-0.54,1,1.09,-0.62,-0.65,0.37,0.52,-1.3,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),36,41.4,31.78,30.97,31.28,30.91,30.73,29.81,30.82,30.73,30.12,30.14,30.35,30.56,29.5,30.59,1.19,0.38,0.69,0.31,0.14,-0.78,0.23,0.14,-0.47,-0.45,-0.24,-0.03,-1.09,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to stimulus;response to stress;small molecule metabolic process;translational initiation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear envelope;nucleoplasm;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9UG63,ABCF2,ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2),13,17.2,29.39,28.08,29.67,30.41,29.68,28.36,30.07,30.15,28.78,28.89,29.32,30.21,28.71,29.36,0.02,-1.29,0.31,1.05,0.32,-1,0.71,0.79,-0.59,-0.48,-0.04,0.85,-0.65,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,ATP-binding cassette (ABC) transporter complex;cell part;macromolecular complex;mitochondrial envelope;protein complex,,,,,,,,,,
Q9NUQ8,ABCF3,ATP-binding cassette sub-family F member 3,9,17.5,29.01,26.23,27.85,27.73,26.11,25.43,26.16,27.85,,25.25,28.13,28.08,25.21,26.92,2.09,-0.69,0.93,0.81,-0.81,-1.49,-0.76,0.93, ,-1.67,1.21,1.16,-1.71,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;immune system process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;response to stress;small molecule metabolic process,,,,,,,,,,,
Q9NUJ1,ABHD10,"Mycophenolic acid acyl-glucuronide esterase, mitochondrial (EC 3.1.1.93) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10)",11,52,29.71,30.32,29.19,29.23,29.67,30.18,29.32,29.02,29.88,29.73,28.99,28.81,29.47,29.5,0.21,0.82,-0.31,-0.27,0.17,0.68,-0.18,-0.49,0.38,0.23,-0.52,-0.7,-0.03,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8NFV4,ABHD11,Alpha/beta hydrolase domain-containing protein 11 (Abhydrolase domain-containing protein 11) (EC 3.-.-.-) (Williams-Beuren syndrome chromosomal region 21 protein),14,62.9,31.71,31.81,31.1,30.7,30.63,30.34,28.28,29.65,30.61,32.65,29.04,28.94,30.07,30.43,1.28,1.39,0.67,0.28,0.21,-0.09,-2.15,-0.77,0.19,2.23,-1.38,-1.48,-0.36,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8N2K0,ABHD12,Monoacylglycerol lipase ABHD12 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 12),15,44,29.41,30.19,29.51,29.61,29.22,29.52,29.04,28.95,29.68,29.07,29.42,28.57,30.31,29.42,-0.01,0.76,0.09,0.19,-0.21,0.1,-0.38,-0.47,0.25,-0.36,-0.01,-0.85,0.89,,cell part,,,,,,,,,,
Q96IU4,ABHD14B,Alpha/beta hydrolase domain-containing protein 14B (Abhydrolase domain-containing protein 14B) (EC 3.-.-.-) (CCG1-interacting factor B),3,24.9,28.11,29.12,28.3,28.8,26.69,25.76,28.41,28.33,26.95,26.96,27.96,29.36,25.55,27.72,0.39,1.4,0.59,1.08,-1.02,-1.95,0.69,0.61,-0.76,-0.76,0.24,1.64,-2.16,,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O95870,ABHD16A,Abhydrolase domain-containing protein 16A (EC 3.-.-.-) (HLA-B-associated transcript 5) (Protein G5),13,23.7,29.48,29.74,29.82,28.57,28.84,28.1,28.05,28.19,28.12,28.69,28.2,27.91,29.95,28.74,0.73,0.99,1.07,-0.17,0.1,-0.64,-0.69,-0.55,-0.62,-0.05,-0.54,-0.84,1.2,,cell part,,,,,,,,,,
Q8WTS1,ABHD5,1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (EC 2.3.1.51) (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58),2,8.9,24.4,24.24,25.66,23.87,23.96,23.55,22.84,22.59,21.3,23.15,22.81,24.65,23.99,23.62,0.78,0.63,2.04,0.25,0.34,-0.06,-0.78,-1.03,-2.31,-0.46,-0.81,1.03,0.37,biological regulation;biosynthetic process;catabolic process;cell differentiation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;lipid particle,,,,,,,,,,
Q8IZP0,ABI1,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1),8,26.3,29.05,28.74,29.47,28.35,28.17,27.99,28.51,28.63,28.41,28.86,28.86,23.03,28.7,28.21,0.84,0.52,1.26,0.14,-0.04,-0.23,0.3,0.42,0.2,0.65,0.64,-5.18,0.49,anatomical structure formation involved in morphogenesis;biological regulation;cellular component movement;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;response to stimulus;response to stress;signal transduction,cell part;cell projection;cytoskeleton;cytosol;endoplasmic reticulum;filopodium;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle;site of polarized growth;synapse,,,,,,,,,,
Q12979,ABR,Active breakpoint cluster region-related protein,4,6.6,24.28,26.83,27.4,26.59,26.1,21.75,27.19,26.5,25.85,25.65,26.18,26.91,25.2,25.88,-1.6,0.95,1.52,0.71,0.22,-4.13,1.31,0.62,-0.03,-0.23,0.3,1.03,-0.68,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular component organization;cellular process;cytoskeleton organization;developmental process;multicellular organismal process;neurological system process;organelle organization;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q9P1F3,ABRACL,Costars family protein ABRACL (ABRA C-terminal-like protein),6,81.5,31.54,29.53,30.7,29.49,28.01,26.79,29.65,29.68,27.53,27.63,27.75,29.48,26.86,28.82,2.72,0.72,1.88,0.67,-0.81,-2.03,0.84,0.86,-1.29,-1.19,-1.07,0.66,-1.95,,,,,,,,,,,,
P09110,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase)",14,47.6,30.87,30.83,31.7,30.42,29.64,30.52,30.21,30.89,31.31,31.62,31.78,31.5,31.39,30.98,-0.1,-0.14,0.73,-0.55,-1.34,-0.46,-0.77,-0.08,0.34,0.64,0.81,0.53,0.41,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P42765,ACAA2,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)",22,74.1,31.58,32.31,33.22,31.01,29.97,30.83,31.32,30.52,31.51,29.66,31.83,30.83,31.52,31.24,0.34,1.07,1.99,-0.23,-1.27,-0.41,0.08,-0.72,0.27,-1.58,0.6,-0.41,0.28,alcohol metabolic process;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q13085,ACACA,Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)],54,32.4,29.3,29.82,27.92,31.11,30.58,29.65,31.52,31.84,28.16,29.27,31.05,31.87,29.48,30.12,-0.82,-0.3,-2.2,0.99,0.46,-0.47,1.4,1.72,-1.96,-0.85,0.93,1.75,-0.64,amine transport;amino acid transport;biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;energy reserve metabolic process;establishment of localization;generation of precursor metabolites and energy;glycerol ether metabolic process;homeostatic process;ion transport;lipid metabolic process;lipid transport;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;organic acid metabolic process;organic acid transport;primary metabolic process;protein complex assembly;protein metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9UKU7,ACAD8,"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.99.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)",6,14.9,27.81,26.79,23.75,24.74,,26.4,,,,25.58,26.72,22.79,25.44,25.56,2.25,1.23,-1.81,-0.81, ,0.84, , , ,0.02,1.16,-2.76,-0.11,amine metabolic process;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q9H845,ACAD9,"Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-)",24,41.7,31.3,30.62,30.52,30.08,30.14,30.7,30.8,30.05,31.3,30.62,30.85,30.4,30.59,30.61,0.69,0.01,-0.1,-0.54,-0.47,0.09,0.19,-0.57,0.68,0.01,0.24,-0.21,-0.02,,cell part;cell projection;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;neuron projection;nucleus;organelle,,,,,,,,,,
P11310,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7)",13,35.3,28.94,30.78,31.67,29.35,31.04,31.49,30.64,31.04,31.11,31.35,30.1,29.99,29.53,30.54,-1.6,0.24,1.13,-1.19,0.5,0.95,0.1,0.5,0.57,0.81,-0.44,-0.55,-1.02,amine metabolic process;anatomical structure development;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell differentiation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;polysaccharide metabolic process;post-embryonic development;primary metabolic process;response to abiotic stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;cell projection;neuron projection,,,,,,,,,,
P45954,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)",14,40.5,30.87,28.87,27.41,28.07,29.18,29.05,29.33,29.9,29.72,29.68,28.52,28.88,29.32,29.14,1.73,-0.26,-1.73,-1.07,0.04,-0.09,0.19,0.76,0.58,0.54,-0.62,-0.26,0.18,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P49748,ACADVL,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",39,57.4,33.35,34,33.51,32.03,32.37,32.96,32.77,32.65,32.98,34.08,33.35,32.9,33.28,33.1,0.26,0.9,0.41,-1.06,-0.72,-0.14,-0.32,-0.44,-0.11,0.99,0.25,-0.2,0.19,biological regulation;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;homeostatic process;lipid metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;organic acid metabolic process;primary metabolic process;protein metabolic process;regulation of protein modification process;small molecule metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P24752,ACAT1,"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)",27,70,31.26,33.04,31.89,32.23,32.83,33.1,32.22,32.44,32.8,33.18,32.67,32.57,33.44,32.59,-1.33,0.45,-0.7,-0.36,0.24,0.51,-0.37,-0.15,0.21,0.59,0.08,-0.02,0.85,amine metabolic process;anatomical structure development;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone body metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;lipid metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9BWD1,ACAT2,"Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)",17,65.2,29.92,29.81,29.48,31.66,30.92,30.42,32.16,31.82,30.45,30.66,29.58,31.73,28.12,30.52,-0.6,-0.71,-1.04,1.14,0.4,-0.1,1.64,1.3,-0.07,0.14,-0.94,1.21,-2.4,lipid metabolic process;metabolic process;primary metabolic process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
Q9H3P7,ACBD3,Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7),15,37.9,29.8,31.34,30.22,31,30.34,30.75,29.96,30.06,31.32,30.43,30.58,29.98,30.35,30.47,-0.67,0.86,-0.25,0.53,-0.13,0.28,-0.51,-0.41,0.85,-0.05,0.11,-0.5,-0.12,biosynthetic process;establishment of localization;lipid metabolic process;metabolic process;primary metabolic process;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q5T8D3,ACBD5,Acyl-CoA-binding domain-containing protein 5,11,24.9,28.67,27.77,28.45,27.61,27.22,28.03,27.15,28.06,28.05,29.33,27.77,25.8,28.29,27.86,0.81,-0.09,0.59,-0.25,-0.64,0.17,-0.71,0.2,0.19,1.47,-0.09,-2.06,0.43,establishment of localization;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle,,,,,,,,,,
P53396,ACLY,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme),71,55.3,32.5,33.71,33.04,34.85,34.19,33.7,34.77,34.66,33.28,33.16,34.16,34.51,32.94,33.8,-1.3,-0.1,-0.77,1.05,0.38,-0.1,0.96,0.85,-0.53,-0.65,0.36,0.7,-0.86,biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;energy reserve metabolic process;generation of precursor metabolites and energy;glycerol ether metabolic process;heterocycle metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
P21399,ACO1,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),23,33,29.26,30.51,30.13,30.28,28.63,29.4,29.73,29.88,29.12,29.42,29.6,29.57,25.02,29.27,-0.02,1.24,0.86,1.01,-0.65,0.13,0.45,0.6,-0.15,0.15,0.33,0.3,-4.25,biological regulation;catabolic process;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;developmental process;homeostatic process;metabolic process;multicellular organismal process;organic acid metabolic process;post-embryonic development;regulation of translation;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q99798,ACO2,"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)",55,68.1,32.92,33.06,33.74,32.85,32.79,33.13,33.6,33.19,33.92,33.96,33.9,33.63,33.98,33.44,-0.52,-0.37,0.31,-0.58,-0.65,-0.31,0.16,-0.25,0.48,0.53,0.47,0.2,0.54,catabolic process;cell death;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;death;metabolic process;organic acid metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NPJ3,ACOT13,Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Thioesterase superfamily member 2),4,33.6,27.36,28.57,29.41,25.85,27.77,28.93,27.86,27.65,29.13,29.5,28.68,26.45,28.69,28.14,-0.78,0.42,1.27,-2.29,-0.37,0.79,-0.28,-0.49,0.99,1.36,0.54,-1.7,0.55,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O00154,ACOT7,Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (CTE-IIa) (CTE-II) (Long chain acyl-CoA thioester hydrolase),13,45.9,30.01,29.26,28.5,30.93,31.44,30.5,31.14,31.51,31.22,27.66,30.56,31.66,31.04,30.42,-0.41,-1.16,-1.92,0.52,1.02,0.08,0.72,1.09,0.8,-2.76,0.14,1.24,0.62,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell body;cell part;cell projection;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;neuron projection;organelle,,,,,,,,,,
O14734,ACOT8,Acyl-coenzyme A thioesterase 8 (Acyl-CoA thioesterase 8) (EC 3.1.2.27) (Choloyl-coenzyme A thioesterase) (HIV-Nef-associated acyl-CoA thioesterase) (PTE-2) (Peroxisomal acyl-coenzyme A thioester hydrolase 1) (PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1) (Thioesterase II) (hACTE-III) (hACTEIII) (hTE),3,23,26.71,26.33,27.53,26.6,27.09,27.01,27.91,24.99,28.4,27.78,28.14,27.99,27.71,27.24,-0.54,-0.92,0.28,-0.64,-0.16,-0.24,0.66,-2.25,1.16,0.53,0.89,0.75,0.47,biosynthetic process;catabolic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;interspecies interaction between organisms;lipid metabolic process;metabolic process;multi-organism process;organelle fission;organelle organization;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9Y305,ACOT9,"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)",24,52.6,31.19,31.47,31.97,31.71,31.37,31.91,31.84,31.54,32.33,32.17,32.26,31.08,32.48,31.79,-0.6,-0.33,0.17,-0.09,-0.43,0.12,0.05,-0.25,0.53,0.38,0.46,-0.71,0.69,cellular metabolic process;cellular process;cofactor metabolic process;metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q15067,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX),22,46.7,28.88,29.71,28.86,29.5,29.59,30.03,29.45,29.71,30.32,30.81,29.52,29.41,30.09,29.68,-0.8,0.03,-0.83,-0.19,-0.09,0.34,-0.23,0.03,0.64,1.13,-0.16,-0.27,0.41,biological regulation;catabolic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;homeostatic process;lipid metabolic process;metabolic process;multicellular organismal process;organelle fission;organelle organization;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;organelle,,,,,,,,,,
O15254,ACOX3,Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase),12,23.9,26.75,28.72,27.04,28.39,27.23,28.4,27.1,27.08,28.44,28.43,27.45,28.14,28.46,27.82,-1.07,0.91,-0.78,0.57,-0.59,0.58,-0.72,-0.74,0.63,0.62,-0.37,0.32,0.64,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P24666,ACP1,Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1),7,46.8,29.33,28.6,28.79,28.55,27.97,27.1,27.7,28.49,24.95,29.65,28.63,27.47,,28.1,1.23,0.5,0.69,0.44,-0.13,-1,-0.41,0.39,-3.15,1.55,0.53,-0.63, ,cell communication;cell-cell signaling;cellular process;signaling,cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;nucleus;organelle,,,+,,,,,,,
P11117,ACP2,Lysosomal acid phosphatase (LAP) (EC 3.1.3.2),9,23.9,28.99,31.23,29.04,28.86,28.71,29.75,28.65,29.39,28.53,29.5,30.26,29.24,30.53,29.44,-0.45,1.79,-0.4,-0.58,-0.73,0.32,-0.79,-0.05,-0.9,0.06,0.82,-0.19,1.09,anatomical structure development;cellular component organization;cellular process;developmental process;organelle organization;vacuole organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole,,,+,,,,,,,
Q96CM8,ACSF2,"Acyl-CoA synthetase family member 2, mitochondrial (EC 6.2.1.-)",16,31.7,30.44,29.54,30.91,28.44,27.38,30.46,28.45,29.56,28.6,30.65,30.09,28.43,30.43,29.49,0.94,0.04,1.42,-1.05,-2.11,0.97,-1.04,0.07,-0.89,1.16,0.6,-1.06,0.94,cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q4G176,ACSF3,"Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-)",6,26,25.31,26.85,,26.48,27.29,28.15,27.22,27.67,27.27,27.9,27.66,27.32,27.51,27.22,-1.91,-0.37, ,-0.74,0.07,0.93,0,0.45,0.05,0.68,0.44,0.1,0.29,biosynthetic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P33121,ACSL1,Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2),34,46.5,30.42,32.24,31.91,31.27,31.64,32.43,30.87,31.96,33,31.7,31.14,30.06,32.74,31.64,-1.23,0.6,0.26,-0.37,0,0.79,-0.77,0.31,1.35,0.05,-0.5,-1.59,1.09,biological regulation;biosynthetic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;regulation of protein modification process;response to chemical stimulus;response to drug;response to external stimulus;response to extracellular stimulus;response to stimulus;signal transduction;small molecule metabolic process;xenobiotic metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle;plasma membrane,,,,,,,,,,
O60488,ACSL4,Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4),41,58.5,30.37,32.08,31.79,32.5,32.71,32.4,32.59,32.53,32.31,32.33,32.54,33.42,32.96,32.35,-1.98,-0.27,-0.56,0.15,0.36,0.05,0.24,0.18,-0.04,-0.02,0.19,1.07,0.61,anatomical structure development;biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;developmental process;establishment of localization;glycerol ether metabolic process;lipid metabolic process;lipid transport;metabolic process;multicellular organismal process;organic acid transport;primary metabolic process;regulation of transport;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;small molecule metabolic process;transport,cell body;cell part;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;membrane;microbody;neuronal cell body;organelle,,,,,,,,,,
Q9ULC5,ACSL5,Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 5) (LACS 5),18,34,31.33,26.49,28.88,25.98,27.53,27.59,26.17,,26.34,31.11,26.16,27.18,27.5,27.69,3.65,-1.2,1.19,-1.71,-0.16,-0.1,-1.52, ,-1.35,3.42,-1.53,-0.5,-0.19,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9NUB1,ACSS1,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1)",5,14.4,26.7,24.57,28.41,,23.4,23.79,23.19,23.49,26.85,24.32,22.85,22.41,24.17,24.51,2.18,0.06,3.9, ,-1.11,-0.72,-1.32,-1.02,2.34,-0.19,-1.67,-2.11,-0.34,alcohol metabolic process;biosynthetic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;organic acid metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part,,,,,,,,,,
Q9NR19,ACSS2,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme)",13,21.7,29.43,28.18,26.51,29.49,27.95,27.29,29.34,29.26,27.35,28.59,28.56,27.61,26.49,28.16,1.27,0.02,-1.65,1.33,-0.2,-0.87,1.18,1.1,-0.81,0.44,0.4,-0.55,-1.66,alcohol metabolic process;biosynthetic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H6R3,ACSS3,"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acyl-CoA synthetase short-chain family member 3)",7,14.1,25.2,28.09,26.22,24.89,25.63,25.19,,27.23,24.94,28.94,28.63,,,26.5,-1.3,1.59,-0.28,-1.6,-0.86,-1.3, ,0.74,-1.56,2.44,2.14, , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q562R1,ACTBL2,Beta-actin-like protein 2 (Kappa-actin),6,28.2,,24.46,27.8,27.87,30.02,30.98,29.55,29.03,30.9,26.59,30.33,28.81,31.04,28.95, ,-4.49,-1.15,-1.08,1.07,2.03,0.6,0.08,1.95,-2.36,1.38,-0.14,2.09,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P68032,ACTC1,"Actin, alpha cardiac muscle 1 (Alpha-cardiac actin)",8,30,34.79,34.96,35.18,35.12,35.88,35.5,35.12,35.54,35.28,35.32,35.55,35.69,35.62,35.35,-0.56,-0.39,-0.17,-0.23,0.53,0.15,-0.23,0.19,-0.07,-0.03,0.2,0.34,0.27,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;cell death;cellular component assembly;cellular component movement;cellular component organization;cellular process;circulatory system process;cytoskeleton organization;death;developmental process;multicellular organismal process;muscle contraction;organelle organization;response to chemical stimulus;response to drug;response to stimulus,cell part;cytosol;extracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P63261,ACTG1,"Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed]",55,92.8,38.16,38.44,38.44,38.44,38.44,38.44,38.44,38.44,38.44,38.44,38.14,38.44,38.13,38.37,-0.21,0.07,0.07,0.07,0.07,0.07,0.07,0.07,0.07,0.07,-0.23,0.07,-0.25,cell junction organization;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;immune system process;locomotion;membrane organization;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;extracellular organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
O96019,ACTL6A,Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K),16,46.4,31.67,30.18,30.49,30.72,30.78,30.85,30.29,30.54,30.71,30,29.18,30.17,30.29,30.45,1.22,-0.27,0.04,0.27,0.33,0.39,-0.16,0.09,0.26,-0.45,-1.27,-0.28,-0.17,anatomical structure development;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA recombination;DNA repair;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;chromatin remodeling complex;DNA helicase complex;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P12814,ACTN1,Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1),53,65.8,33.33,34.33,33.54,35.15,34.73,34.37,34.72,34.74,35.47,34.13,34.95,34.85,34.82,34.55,-1.21,-0.22,-1.01,0.6,0.18,-0.18,0.17,0.19,0.92,-0.42,0.41,0.3,0.27,biological regulation;cell activation;cell junction organization;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;exocytosis;organelle organization;secretion;transport;vesicle-mediated transport,cell part;cell projection;cytoskeleton;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;neuron projection;nucleus;organelle;plasma membrane;pseudopodium;vesicle,,,,,,,,,,
O43707,ACTN4,Alpha-actinin-4 (F-actin cross-linking protein) (Non-muscle alpha-actinin 4),94,82.4,37.18,35.77,36.1,36.09,36.11,36.18,36.61,36.29,36.82,36.87,36.51,36.54,36.01,36.39,0.79,-0.62,-0.29,-0.3,-0.28,-0.21,0.22,-0.1,0.43,0.48,0.12,0.15,-0.38,biological regulation;cell activation;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;exocytosis;organelle organization;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;cell projection;cytoskeleton;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;pseudopodium;ribonucleoprotein complex;vesicle,,,,,,,,,,
Q9NZ32,ACTR10,Actin-related protein 10 (Actin-related protein 11) (hARP11),8,28.8,26.21,27.15,25.31,27.69,27.07,26.89,27.55,28.12,27.49,24.97,28.44,28.55,26.63,27.08,-0.87,0.07,-1.77,0.6,-0.01,-0.2,0.47,1.04,0.41,-2.11,1.36,1.47,-0.45,cellular component movement;cellular process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
P61163,ACTR1A,Alpha-centractin (Centractin) (ARP1) (Actin-RPV) (Centrosome-associated actin homolog),23,64.6,30.45,31.78,31.66,32.27,31.75,31.54,32.59,32.83,31.6,31.5,32.51,32.23,31.85,31.89,-1.44,-0.11,-0.23,0.38,-0.14,-0.35,0.7,0.94,-0.29,-0.39,0.62,0.34,-0.04,cellular process;establishment of localization;immune system process;transport;vesicle-mediated transport,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P42025,ACTR1B,Beta-centractin (Actin-related protein 1B) (ARP1B),5,24.7,27.26,28.47,27.77,27.67,21.59,,25.84,26.46,26.59,27.32,26.53,23.42,20.33,25.77,1.48,2.7,2,1.9,-4.18, ,0.07,0.69,0.82,1.55,0.75,-2.35,-5.44,immune system process,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P61160,ACTR2,Actin-related protein 2 (Actin-like protein 2),33,78.7,32.53,32.76,33.4,33.01,32.4,32.41,32.69,32.72,32.31,32.28,32.94,32.92,32.47,32.68,-0.15,0.08,0.72,0.33,-0.28,-0.27,0.01,0.04,-0.37,-0.4,0.27,0.24,-0.21,biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;immune system process;organelle organization;regulation of organelle organization;response to stimulus;response to stress,cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P61158,ACTR3,Actin-related protein 3 (Actin-like protein 3),29,72.2,32.95,33.43,33.45,33.54,32.94,32.93,33.03,33.16,32.63,32.4,33.21,33.43,32.67,33.06,-0.11,0.37,0.39,0.48,-0.12,-0.13,-0.03,0.1,-0.42,-0.66,0.15,0.37,-0.39,anatomical structure morphogenesis;biological regulation;cell cycle;cell division;cellular component morphogenesis;cellular component movement;cellular component organization;cellular localization;cellular process;cytokinesis;cytoskeleton organization;developmental process;establishment or maintenance of cell polarity;immune system process;localization;meiotic cell cycle;organelle localization;organelle organization;regulation of organelle organization;response to chemical stimulus;response to stimulus;response to stress,cell part;cell projection;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;synapse,,,,,,,,,,
Q03154,ACY1,Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),6,28.9,27.26,27.15,26.82,26.75,24.45,23.9,,26.35,26.02,,25.69,24.91,23.22,25.68,1.57,1.47,1.14,1.07,-1.23,-1.79, ,0.67,0.34, ,0.01,-0.78,-2.46,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P00813,ADA,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),5,19,28.07,27.94,27.5,27.04,26.24,24.73,29.49,28.3,28.48,29.49,26.67,,,27.63,0.44,0.31,-0.13,-0.59,-1.4,-2.91,1.86,0.66,0.85,1.86,-0.96, , ,aging;amine transport;anatomical structure development;behavior;biological adhesion;biological regulation;biosynthetic process;catabolic process;cell activation;cell adhesion;cell differentiation;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;heterocycle metabolic process;immune system process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;pigment metabolic process;primary metabolic process;purine-containing compound salvage;regulation of transport;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;rhythmic process;secretion;small molecule metabolic process;transport,cell body;cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;lysosome;neuronal cell body;organelle;vacuole,,,,,,,,,,
O14672,ADAM10,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),18,27.7,29.79,29.78,28.39,30.47,30.58,31.31,30.46,29.52,30.67,30.64,29.64,28.26,30.96,30.04,-0.25,-0.26,-1.65,0.43,0.54,1.27,0.43,-0.51,0.63,0.61,-0.4,-1.78,0.93,biological regulation;cell activation;cell communication;cell-cell signaling;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;developmental process;embryo development;extracellular matrix organization;extracellular structure organization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;proteolysis;response to chemical stimulus;response to stimulus;signal transduction;signaling,cell part;cell surface;cytoplasmic membrane-bounded vesicle;endomembrane system;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
P78536,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b),7,10.7,27.26,27,26.79,27.26,25.32,27.33,26.19,25.58,26.64,27.44,27.82,26.91,27.49,26.85,0.41,0.15,-0.06,0.41,-1.53,0.48,-0.66,-1.26,-0.21,0.59,0.97,0.06,0.64,anatomical structure development;biological adhesion;biological regulation;cell activation;cell adhesion;cell differentiation;cell motility;cellular component disassembly;cellular component movement;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;proteolysis;regulation of cell cycle;regulation of protein modification process;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cell surface;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q13443,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),7,11,24.85,25.67,26.74,26.81,27.37,27.5,26.77,26.81,27.02,27.08,,23.62,25.72,26.33,-1.48,-0.66,0.41,0.48,1.04,1.17,0.44,0.48,0.69,0.75, ,-2.71,-0.61,biological adhesion;biological regulation;cell activation;cell adhesion;cell differentiation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;proteolysis;regulation of protein modification process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction,cell part;cytoplasm;extracellular space,,,,,,,,,,
P78563,ADARB1,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),14,25.9,24.79,30.12,,28.71,25.51,25.38,,,25.72,,25.52,,,26.54,-1.74,3.58, ,2.18,-1.02,-1.16, , ,-0.82, ,-1.01, , ,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;response to biotic stimulus;response to stimulus;response to stress;RNA metabolic process;RNA modification;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;nucleus;organelle,,,,,,,,,,
Q96D53,ADCK4,Uncharacterized aarF domain-containing protein kinase 4 (EC 2.7.11.-),4,13.1,27.7,26.15,23.03,26.64,27.06,27.87,26.68,27.1,24.99,25.5,27.12,27.06,27.31,26.48,1.22,-0.33,-3.45,0.16,0.58,1.39,0.21,0.62,-1.49,-0.98,0.64,0.59,0.84,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,+,,,,,,,,
P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),30,52,29.35,29.66,28.49,29.79,30.16,30.52,30.38,29.64,30.28,29.37,30.06,29.06,30.33,29.78,-0.42,-0.11,-1.29,0.02,0.38,0.74,0.6,-0.14,0.51,-0.4,0.28,-0.71,0.56,anatomical structure morphogenesis;biological regulation;cell communication;cell differentiation;cell morphogenesis;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component organization;cellular homeostasis;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;embryo development;growth;homeostatic process;macromolecule metabolic process;metabolic process;multicellular organismal process;organelle organization;primary metabolic process;protein metabolic process;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus,cell part;cytosol;F-actin capping protein complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9UEY8,ADD3,Gamma-adducin (Adducin-like protein 70),25,39.4,29.77,29.76,30.66,29.09,30.06,30.42,30.5,29.75,30.06,30.59,29.89,30.75,30.09,30.11,-0.34,-0.35,0.56,-1.01,-0.05,0.31,0.39,-0.36,-0.05,0.48,-0.21,0.64,-0.02,,cell cortex;cell part;chromosome;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nuclear chromosome;organelle;plasma membrane,,,,,,,,,,
P11766,ADH5,Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284),17,43.9,30.97,31.69,31.78,31.78,29.68,30.19,31.34,30.78,30.12,30.41,31.42,32.72,29.05,30.92,0.05,0.77,0.86,0.86,-1.24,-0.73,0.42,-0.14,-0.8,-0.51,0.51,1.8,-1.86,aging;alcohol metabolic process;biological regulation;catabolic process;cellular aldehyde metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9BV57,ADI1,"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD) (Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1) (MTCBP-1) (Submergence-induced protein-like factor) (Sip-L)",5,38.5,27.64,28.38,28.43,30.06,28.56,27.82,29.39,29.09,27.78,27.98,29.17,30.6,26.46,28.56,-0.93,-0.19,-0.14,1.49,0,-0.75,0.83,0.52,-0.78,-0.58,0.6,2.03,-2.1,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q15847,ADIRF,Adipogenesis regulatory factor (Adipogenesis factor rich in obesity) (Adipose most abundant gene transcript 2 protein) (Adipose-specific protein 2) (apM-2),6,88.2,31.63,23.2,,26.17,28.87,27.81,29.32,29.77,27.75,,29.48,27.06,27.54,28.05,3.57,-4.85, ,-1.89,0.82,-0.25,1.27,1.71,-0.31, ,1.43,-0.99,-0.51,biological regulation;biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to stimulus;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P55263,ADK,Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase),8,28.9,29.87,28.7,28.71,31.12,26.59,27.77,28.63,28.69,27.75,27.81,29.13,27.25,26.49,28.35,1.52,0.35,0.37,2.78,-1.76,-0.57,0.28,0.34,-0.6,-0.54,0.78,-1.1,-1.85,biological regulation;biosynthetic process;cell proliferation;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;purine-containing compound salvage;rhythmic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H2P0,ADNP,Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein),14,17.5,29.2,26.18,29.06,27.14,26.47,26.94,27.45,25.58,26.85,27.33,24.5,25.87,24.73,26.72,2.48,-0.53,2.34,0.43,-0.25,0.22,0.73,-1.14,0.13,0.62,-2.21,-0.84,-1.99,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
Q9BRR6,ADPGK,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147) (RbBP-35),14,38.1,26.78,30.64,29.83,30.47,30.38,30.3,30.04,29.77,30.76,30.16,30.59,30.47,31.13,30.1,-3.32,0.54,-0.27,0.37,0.28,0.19,-0.06,-0.33,0.66,0.06,0.49,0.37,1.03,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,extracellular region,,,,,,,,,,
Q9NX46,ADPRHL2,Poly(ADP-ribose) glycohydrolase ARH3 (EC 3.2.1.143) (ADP-ribosylhydrolase 3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2),7,27.3,30.08,29.97,28.37,28.26,25.66,26.24,27.14,26.75,27.76,26.93,28.68,28.29,26.68,27.75,2.33,2.22,0.61,0.5,-2.1,-1.51,-0.62,-1,0,-0.82,0.92,0.53,-1.08,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q16186,ADRM1,Proteasomal ubiquitin receptor ADRM1 (110 kDa cell membrane glycoprotein) (Gp110) (Adhesion-regulating molecule 1) (ARM-1) (Proteasome regulatory particle non-ATPase 13) (hRpn13) (Rpn13 homolog),9,20.9,29.2,29.6,29.96,29.61,29.39,29.74,29.55,29.76,28.85,29.08,29.6,30.36,29.12,29.52,-0.33,0.08,0.43,0.09,-0.14,0.21,0.03,0.24,-0.68,-0.44,0.07,0.84,-0.41,"biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;transcription elongation, DNA-dependent",cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;proteasome complex;protein complex,,,,,,,,,,
P30566,ADSL,Adenylosuccinate lyase (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase),14,35.3,28.62,28.98,28.43,30.2,28.6,27.84,29.43,30.1,27.74,27.26,28.12,30.51,26.27,28.62,-0.01,0.36,-0.19,1.58,-0.02,-0.79,0.8,1.48,-0.89,-1.36,-0.5,1.89,-2.36,biosynthetic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P30520,ADSS,"Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)",14,36.4,30.79,29.69,30.28,30.87,28.8,28.04,30.07,30.13,28.73,28.82,29.43,30.55,25.84,29.39,1.41,0.3,0.89,1.48,-0.59,-1.35,0.68,0.75,-0.65,-0.57,0.04,1.16,-3.55,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;immune system process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q8N556,AFAP1,Actin filament-associated protein 1 (110 kDa actin filament-associated protein) (AFAP-110),12,19.7,26.61,28.85,26.28,29.04,29.4,28.83,29.13,28.68,29.76,26.76,28.47,29.49,29.07,28.49,-1.88,0.36,-2.21,0.55,0.9,0.34,0.64,0.19,1.27,-1.73,-0.02,1,0.58,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9UHB7,AFF4,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),8,8.1,25.53,25.19,,24.63,25.15,25.6,24.72,,25.12,24.6,24.11,,24.92,24.96,0.58,0.24, ,-0.32,0.19,0.64,-0.24, ,0.16,-0.35,-0.85, ,-0.04,anatomical structure development;biosynthetic process;cell development;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
Q9Y4W6,AFG3L2,AFG3-like protein 2 (EC 3.4.24.-) (Paraplegin-like protein),28,36.8,31.31,31.42,30.67,30.06,30.57,30.82,30.82,30.14,30.88,31.26,31.04,30.78,31.09,30.84,0.47,0.59,-0.17,-0.78,-0.27,-0.01,-0.02,-0.69,0.04,0.43,0.21,-0.05,0.26,anatomical structure development;anatomical structure morphogenesis;biological regulation;catabolic process;cell death;cellular component morphogenesis;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;death;developmental process;macromolecule metabolic process;membrane fusion;membrane organization;metabolic process;mitochondrion organization;organelle fusion;organelle organization;primary metabolic process;protein catabolic process;protein maturation;protein metabolic process;proteolysis;response to external stimulus;response to stimulus,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
P52594,AGFG1,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),7,19.6,28.96,28.56,30.13,28.95,28.1,27.36,28.61,28.99,28.57,28.49,27.71,28.61,,28.59,0.37,-0.02,1.54,0.36,-0.49,-1.22,0.02,0.4,-0.02,-0.09,-0.88,0.03, ,biological regulation;cell differentiation;cellular process;developmental process;establishment of localization;multicellular organismal development;multicellular organismal process;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;organelle;protein complex;vesicle,,,,,,,,,,
O95081,AGFG2,Arf-GAP domain and FG repeat-containing protein 2 (HIV-1 Rev-binding protein-like protein) (Rev/Rex activation domain-binding protein related) (RAB-R),2,17.3,25.2,23.51,23.51,25.36,23.91,,,25.89,,,24.81,26.28,,24.81,0.39,-1.3,-1.3,0.55,-0.9, , ,1.08, , ,0,1.47, ,biological regulation,,,,,,,,,,,
Q53H12,AGK,"Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase)",9,33.5,30.52,30.48,30.18,29.77,27.8,29.39,30.52,28.34,30.86,30.93,29.97,30.29,30.55,29.97,0.55,0.51,0.21,-0.2,-2.17,-0.58,0.55,-1.63,0.89,0.96,0,0.32,0.58,biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;regulation of protein modification process;response to stimulus;signal transduction,cell part;membrane,,,,,,,,,,
P35573,AGL,"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase);Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]",14,12.5,27.98,29.45,26.34,28.87,24.82,24.95,27.45,27.43,,26.82,27.93,27.5,25.54,27.09,0.89,2.36,-0.75,1.78,-2.27,-2.14,0.36,0.34, ,-0.27,0.84,0.41,-1.55,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;isoamylase complex;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9UKV8,AGO2,Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer),12,23,29.24,26.1,27.45,27.24,26.73,26.55,25.81,26.9,26.84,27.36,27.29,25.11,25.99,26.82,2.42,-0.72,0.64,0.42,-0.08,-0.27,-1,0.08,0.03,0.54,0.48,-1.71,-0.83,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;post-embryonic development;primary metabolic process;regulation of translation;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;polysome;protein complex;ribonucleoprotein complex;RNAi effector complex,,,,,,,,,,
Q9HBM8,AGPAT1,"1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (cDNA, FLJ78849, highly similar to 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51))",4,31,26.35,27.88,25.78,24.93,24.06,27.01,,26.48,26.1,,26.67,27.04,26.88,26.29,0.06,1.59,-0.51,-1.36,-2.23,0.72, ,0.19,-0.19, ,0.38,0.75,0.59,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q9NRZ7,AGPAT3,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma),6,17.8,28.56,29.09,29.13,28.09,27.14,27.94,28.48,27.84,28.58,28.78,28.71,27.07,28.96,28.34,0.22,0.75,0.79,-0.24,-1.2,-0.4,0.15,-0.5,0.24,0.45,0.37,-1.26,0.62,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane;nuclear envelope;plasma membrane,,,,,,,,,,
Q9NRZ5,AGPAT4,1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta),3,8.7,24.33,24.26,25.43,,,26.52,25.95,26.28,25.71,24.62,26.1,24.12,,25.33,-1,-1.08,0.09, , ,1.18,0.62,0.95,0.38,-0.71,0.77,-1.21, ,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9NUQ2,AGPAT5,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),4,12.1,26.28,28.42,26.54,24.86,26.07,24.75,31.22,23.67,27.43,27.87,,,,26.71,-0.43,1.71,-0.17,-1.86,-0.64,-1.96,4.51,-3.04,0.72,1.16, , , ,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane;nuclear envelope,,,,,,,,,,
Q86UL3,AGPAT6,Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta),5,12.7,23.97,24.91,24.75,26.06,27.66,26.56,23.52,26.84,25.65,26.67,27.15,27.34,27.87,26.07,-2.1,-1.16,-1.32,-0.01,1.59,0.49,-2.55,0.77,-0.42,0.59,1.08,1.26,1.8,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;cell maturation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental maturation;developmental process;establishment of localization;glycerol ether metabolic process;lipid metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of body fluid levels;secretion;small molecule metabolic process;transport,cell part;membrane,,,,,,,,,,
O00116,AGPS,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",27,47.1,29.93,29.52,31.28,30.58,31.63,31.61,31.05,30.79,31.23,31.94,30.66,30.73,31.38,30.95,-1.01,-1.43,0.33,-0.37,0.68,0.66,0.1,-0.16,0.28,0.99,-0.29,-0.22,0.43,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;organelle,,,,,,,,,,
O95994,AGR2,Anterior gradient protein 2 homolog (AG-2) (hAG-2) (HPC8) (Secreted cement gland protein XAG-2 homolog),7,34.9,29.6,28.94,28.27,24.09,28.68,27,25.39,26.22,25.23,32.67,,,25.85,27.45,2.15,1.49,0.82,-3.36,1.23,-0.45,-2.06,-1.23,-2.22,5.22, , ,-1.6,biological regulation;establishment of localization;multicellular organismal process;regulation of body fluid levels;secretion;transport,cell part;endoplasmic reticulum;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O00468,AGRN,Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit;Agrin C-terminal 110 kDa subunit;Agrin C-terminal 90 kDa fragment (C90);Agrin C-terminal 22 kDa fragment (C22)],28,15.5,30.73,29.59,29.74,30.2,30.93,31.24,30.8,30.78,31.19,31.92,29.48,30.6,31.53,30.67,0.06,-1.08,-0.93,-0.47,0.26,0.57,0.13,0.11,0.52,1.25,-1.19,-0.07,0.86,amine metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular component organization;cellular lipid metabolic process;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;detection of stimulus;lipid metabolic process;localization;locomotion;macromolecule metabolic process;membrane organization;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;sulfur compound metabolic process,cell part;membrane;plasma membrane;synapse,,,,,,,,,,
Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),31,16.5,29.19,27.49,29.08,28.43,29.05,28.54,28.82,28.3,28.86,29.05,26.85,25.64,27.28,28.2,0.99,-0.71,0.88,0.24,0.85,0.34,0.62,0.11,0.66,0.85,-1.35,-2.56,-0.92,cell cycle;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;cytokinesis;establishment of localization;macromolecular complex assembly;mitotic cell cycle;nucleobase-containing compound transport;nucleus organization;organelle organization;protein complex assembly;protein transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;nuclear pore;nucleoplasm;organelle;protein complex,,,,,,,,,,
P23526,AHCY,Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase),23,43.8,33.41,32.63,32.56,32.62,32.2,31.95,32.83,32.98,31.22,31.64,33.11,31.76,31.02,32.3,1.11,0.33,0.26,0.32,-0.1,-0.35,0.52,0.68,-1.09,-0.66,0.8,-0.54,-1.28,amine metabolic process;behavior;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;metabolic process;nitrogen compound metabolic process;one-carbon metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;rhythmic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;nucleus;organelle;vesicle,,,,,,,,,,
O43865,AHCYL1,Putative adenosylhomocysteinase 2 (AdoHcyase 2) (EC 3.3.1.1) (DC-expressed AHCY-like molecule) (S-adenosyl-L-homocysteine hydrolase 2) (S-adenosylhomocysteine hydrolase-like protein 1),17,33.6,30.12,30.35,29.6,30.65,29.64,30.49,30.01,30.07,28.67,30.22,30.89,29.66,29.22,29.97,0.15,0.38,-0.37,0.68,-0.32,0.52,0.04,0.1,-1.3,0.25,0.92,-0.31,-0.74,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;one-carbon metabolic process;primary metabolic process;protein targeting;protein transport;regulation of transport;RNA metabolic process;RNA processing;small molecule metabolic process;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q8IVF2,AHNAK2,Protein AHNAK2,93,38.2,32.04,28.98,28.83,27.87,30.63,28.85,31.09,30.53,30.67,29.41,32.67,29.47,32.24,30.25,1.79,-1.27,-1.42,-2.38,0.38,-1.41,0.84,0.28,0.42,-0.84,2.42,-0.79,1.98,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O95433,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38),13,43.5,30.78,30.32,29.19,31.23,30.2,29.9,30.89,31,29.56,28.44,30.11,32.09,28.78,30.19,0.59,0.13,-1,1.04,0.01,-0.29,0.7,0.81,-0.64,-1.75,-0.08,1.9,-1.41,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to stimulus;response to stress,cell part;cytoplasm;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q96BJ3,AIDA,"Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)",4,17.5,27.04,27.21,26.71,27.09,26.52,27.17,27.26,27.68,27.71,,25.4,26.93,24.91,26.8,0.24,0.41,-0.09,0.29,-0.28,0.36,0.45,0.87,0.91, ,-1.4,0.12,-1.9,biological regulation;developmental process;regulation of protein modification process,,,,,,,,,,,
O95831,AIFM1,"Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8)",37,61.4,31.84,33.59,32.74,31.32,31.97,32.36,31.87,31.65,32.22,33.06,31.93,31.53,32.27,32.18,-0.34,1.41,0.56,-0.86,-0.22,0.18,-0.31,-0.53,0.04,0.88,-0.25,-0.65,0.09,biological regulation;catabolic process;cell death;cell differentiation;cellular component assembly;cellular component organization;cellular homeostasis;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;DNA metabolic process;homeostatic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein complex biogenesis,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),27,24.8,30.39,29.13,26.54,28.06,24.85,27.07,29.41,25.13,29.85,29.96,28.94,28.78,27.82,28.15,2.24,0.99,-1.61,-0.09,-3.3,-1.07,1.26,-3.02,1.7,1.81,0.79,0.63,-0.33,,,,,,,,,,,,
Q12904,AIMP1,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)],18,68.3,30.99,31.02,30.83,30.9,31,30.92,31.48,31.19,30.81,31.44,31.39,31.11,31.09,31.09,-0.1,-0.07,-0.26,-0.19,-0.09,-0.17,0.39,0.1,-0.28,0.35,0.3,0.02,0,alcohol metabolic process;amine metabolic process;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;carbohydrate metabolic process;cell adhesion;cell communication;cell death;cell motility;cell-cell signaling;cellular amino acid metabolic process;cellular component movement;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;signaling;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;endoplasmic reticulum;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;vesicle,,,,,,,,,,
Q13155,AIMP2,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1),9,36.9,29.75,29.98,29.68,30.26,29.8,29.9,30.08,30.38,29.68,30.05,29.73,30.46,29.78,29.96,-0.21,0.02,-0.29,0.3,-0.16,-0.07,0.12,0.41,-0.28,0.09,-0.24,0.49,-0.19,amine metabolic process;biological regulation;cell death;cell differentiation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of protein modification process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O00170,AIP,AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9),11,45.3,29.09,28.72,28.24,29.22,27.92,27.5,28.99,28.54,27.81,27.21,26.8,26.86,26.43,27.95,1.15,0.77,0.3,1.27,-0.03,-0.45,1.04,0.59,-0.14,-0.74,-1.15,-1.09,-1.52,biological regulation;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein maturation;protein metabolic process;protein targeting;protein transport;transport;xenobiotic metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
P00568,AK1,Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase),10,60.8,31.05,30.38,30.25,30.44,28.71,28.88,31.4,29.95,27.48,28.93,30.51,32.3,27.03,29.79,1.25,0.58,0.46,0.65,-1.09,-0.91,1.6,0.16,-2.31,-0.86,0.71,2.5,-2.77,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;regulation of cell cycle;small molecule metabolic process,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
P54819,AK2,"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]",34,89.7,32.6,33.27,33,31.8,32.75,33.14,32.55,32.1,33.12,32.84,31.54,32.09,33.04,32.6,0,0.66,0.4,-0.8,0.15,0.53,-0.05,-0.51,0.52,0.23,-1.06,-0.51,0.44,anatomical structure development;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;generation of precursor metabolites and energy;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;membrane,,,,,,,,,,
Q9UIJ7,AK3,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)",19,75.8,30.11,31.41,32.28,30.85,30.99,30.94,30.83,31.07,31.4,32.43,32.15,29.39,32.46,31.25,-1.15,0.16,1.03,-0.4,-0.26,-0.31,-0.42,-0.19,0.14,1.18,0.9,-1.87,1.2,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;heterocycle metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;regulation of body fluid levels;small molecule metabolic process,cell part,,,,,,,,,,
P27144,AK4,"GTP:AMP phosphotransferase AK4, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3-like) (Adenylate kinase isoenzyme 4) (AK 4)",16,69.1,31.75,32.16,31.52,31.08,30.38,31.07,30.21,31.1,31.56,31.67,31.01,30.76,31.51,31.22,0.53,0.95,0.3,-0.14,-0.83,-0.14,-1,-0.11,0.35,0.46,-0.2,-0.45,0.3,anatomical structure development;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;drug metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process;xenobiotic metabolic process,cell part,,,,,,,,,,
Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),85,62.9,31.7,29.14,31.39,27.69,32.22,31.38,32.1,32.24,31.37,33.14,33.56,27.66,31.05,31.13,0.58,-1.99,0.26,-3.44,1.09,0.25,0.97,1.12,0.24,2.01,2.44,-3.46,-0.07,biological regulation;cellular process;establishment of localization;protein targeting;protein transport;response to stimulus;signal transduction;transport,cell cortex;cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),24,11.7,26.21,26.68,26.3,26.51,26.3,25.15,26.66,27.68,26.13,27.16,28.76,27.84,26.85,26.79,-0.58,-0.11,-0.48,-0.28,-0.49,-1.64,-0.13,0.89,-0.65,0.37,1.97,1.05,0.06,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q02040,AKAP17A,"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)",6,6.9,23.98,,23.76,25.32,,25.75,,,26.15,24.45,24.76,24.59,24.36,24.79,-0.81, ,-1.03,0.53, ,0.96, , ,1.36,-0.34,-0.03,-0.2,-0.43,biological regulation;cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),26,39.6,23.66,29.91,29.38,30.51,28.77,29.16,28.97,28.47,29.35,29.56,31.29,30.15,30.91,29.24,-5.58,0.67,0.14,1.28,-0.47,-0.08,-0.26,-0.77,0.11,0.32,2.06,0.91,1.67,,,,,,,,,,,,
O43823,AKAP8,A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95),14,25.6,29.62,26.53,29.07,27.2,26.6,26.15,27.89,24.02,28.61,29.59,27.94,28.59,26.59,27.57,2.05,-1.04,1.5,-0.37,-0.97,-1.42,0.32,-3.55,1.04,2.02,0.37,1.02,-0.97,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA packaging;macromolecule metabolic process;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;response to stimulus;signal transduction,cell part;chromosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9ULX6,AKAP8L,A-kinase anchor protein 8-like (AKAP8-like protein) (Helicase A-binding protein 95) (HAP95) (Homologous to AKAP95 protein) (HA95) (Neighbor of A-kinase-anchoring protein 95) (Neighbor of AKAP95),10,19.3,28.43,26.49,27.97,26.4,27.13,27.09,26.12,27.2,28.26,28.17,26.89,26.9,28,27.31,1.12,-0.82,0.66,-0.91,-0.19,-0.22,-1.19,-0.11,0.95,0.85,-0.42,-0.41,0.69,,cell part;cytoplasm,,,,,,,,,,
P14550,AKR1A1,Alcohol dehydrogenase [NADP(+)] (EC 1.1.1.2) (Aldehyde reductase) (Aldo-keto reductase family 1 member A1),19,60,32.19,32.27,31.92,31.34,30.82,30.11,31.05,31.22,30.74,29.86,31.8,31.14,29.69,31.09,1.11,1.18,0.83,0.25,-0.27,-0.98,-0.04,0.13,-0.35,-1.22,0.71,0.05,-1.4,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular aldehyde metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
P15121,AKR1B1,Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1),26,76.6,30.92,32.65,31.13,32.95,30.67,31.29,31.47,32.23,31.97,32.68,34.55,32.84,31.02,32.03,-1.11,0.62,-0.9,0.92,-1.36,-0.74,-0.56,0.2,-0.06,0.66,2.52,0.81,-1.01,biological regulation;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P42330,AKR1C3,"Aldo-keto reductase family 1 member C3 (EC 1.-.-.-) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.213) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Indanol dehydrogenase) (EC 1.1.1.112) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239) (EC 1.1.1.64) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20)",12,56,31,28.41,26.09,28.57,,,,24.17,,26.14,27.74,21.1,20.1,25.93,5.08,2.49,0.16,2.65, , , ,-1.76, ,0.21,1.81,-4.82,-5.82,alcohol metabolic process;anatomical structure development;biological regulation;biosynthetic process;catabolic process;cell communication;cell differentiation;cellular aldehyde metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;developmental process;establishment of localization;hormone metabolic process;lipid metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;organic acid metabolic process;primary metabolic process;protein transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to starvation;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transport;vitamin metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43488,AKR7A2,Aflatoxin B1 aldehyde reductase member 2 (EC 1.1.1.n11) (AFB1 aldehyde reductase 1) (AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase) (SSA reductase),9,34,30.62,30.82,29.46,29.84,28.4,28.89,29.4,29.77,28.59,28.77,29.39,29.38,27.95,29.33,1.29,1.49,0.13,0.51,-0.93,-0.44,0.07,0.44,-0.74,-0.55,0.06,0.05,-1.38,carbohydrate metabolic process;cellular aldehyde metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P31749,AKT1,RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha),8,19.6,25.99,26.82,27.11,27.63,24.05,,24.94,26.72,,25.29,26.07,,,26.07,-0.08,0.75,1.04,1.56,-2.02, ,-1.13,0.65, ,-0.78,0, , ,aging;alcohol metabolic process;anatomical structure development;biological regulation;biosynthetic process;carbohydrate metabolic process;carbohydrate transport;catabolic process;cell activation;cell death;cell development;cell differentiation;cell proliferation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;energy reserve metabolic process;establishment of localization;generation of precursor metabolites and energy;growth;homeostatic process;immune system process;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;mitochondrion organization;molting cycle;mRNA metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;plasma membrane organization;polysaccharide metabolic process;primary metabolic process;protein catabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein phosphorylation;protein transport;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of translation;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to heat;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;translation;transport,cell part;cell projection;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleoplasm;organelle;plasma membrane,,+,,,,,,,,
P31751,AKT2,RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta),5,10.6,25.97,24.92,26.27,26.46,26.06,24.91,26.96,27.03,23.85,,24.52,26.27,,25.75,0.22,-0.83,0.52,0.71,0.32,-0.84,1.22,1.28,-1.89, ,-1.23,0.52, ,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;carbohydrate transport;cell death;cell differentiation;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;death;developmental process;energy reserve metabolic process;establishment of localization;generation of precursor metabolites and energy;localization;macromolecule metabolic process;membrane organization;metabolic process;plasma membrane organization;polysaccharide metabolic process;primary metabolic process;protein transport;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of translation;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell cortex;cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
P13716,ALAD,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),13,43.1,27.15,27.61,28.02,28.75,26.77,27.35,29.49,29.33,26.2,26.68,30.54,30.58,25.56,28,-0.85,-0.39,0.02,0.75,-1.23,-0.65,1.49,1.33,-1.8,-1.32,2.54,2.58,-2.44,biosynthetic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;pigment metabolic process;protein complex assembly;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q13740,ALCAM,CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166),20,44,28.98,27.79,30.27,30.39,31.54,31.81,30.9,30.7,32.5,33,29.25,28.64,31.07,30.53,-1.54,-2.74,-0.25,-0.14,1.01,1.28,0.38,0.17,1.98,2.47,-1.27,-1.89,0.55,biological adhesion;biological regulation;cell adhesion;cellular process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell body;cell part;cell projection;neuron projection;neuronal cell body,,,,,,,,,,
F8WBH3,ALDH16A1,Aldehyde dehydrogenase family 16 member A1,6,13.3,29.14,28.82,27.45,28.69,29.52,28.36,29.23,29.89,26.26,28.39,26.87,24.9,,28.13,1.01,0.69,-0.67,0.56,1.39,0.23,1.1,1.76,-1.86,0.27,-1.26,-3.23, ,,,,,,,,,,,,
P54886,ALDH18A1,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase);Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],44,53.6,31.27,33.3,31.72,32.97,33,33.28,32.79,32.58,34.26,33.36,32.34,32.16,33.02,32.77,-1.51,0.53,-1.06,0.2,0.22,0.51,0.02,-0.2,1.48,0.59,-0.44,-0.61,0.25,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P00352,ALDH1A1,"Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic)",19,49.3,25.45,30.44,32.25,29.5,26.66,25.15,25.34,,,32.58,26.79,24.88,27.72,27.89,-2.44,2.55,4.36,1.61,-1.23,-2.74,-2.55, , ,4.69,-1.09,-3,-0.17,alcohol metabolic process;biological regulation;cellular aldehyde metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
O94788,ALDH1A2,Retinal dehydrogenase 2 (RALDH 2) (RalDH2) (EC 1.2.1.36) (Aldehyde dehydrogenase family 1 member A2) (Retinaldehyde-specific dehydrogenase type 2) (RALDH(II)),30,64.9,26.93,28.95,30.44,29.63,30.6,29.21,32.07,31.99,29.46,27.58,31.78,33.58,30.55,30.21,-3.28,-1.27,0.22,-0.58,0.38,-1,1.86,1.78,-0.75,-2.63,1.57,3.37,0.34,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell communication;cell development;cell differentiation;cellular aldehyde metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental maturation;developmental process;hormone metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;signal transduction;small molecule metabolic process;vitamin metabolic process,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P47895,ALDH1A3,Aldehyde dehydrogenase family 1 member A3 (EC 1.2.1.5) (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3) (RALDH-3) (RalDH3),45,71.3,30.98,34.39,34.29,32.9,33.6,33.25,35.36,35.15,31.96,33.57,35.51,35.29,32.65,33.76,-2.78,0.62,0.53,-0.86,-0.17,-0.51,1.6,1.39,-1.8,-0.2,1.75,1.53,-1.11,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular aldehyde metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;hormone metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytoplasm,,,,,,,,,,
P30837,ALDH1B1,"Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)",23,42.9,29.29,31.43,32.38,31,29.87,31.28,30.94,31.52,32.16,30.92,31.21,32.27,32.48,31.29,-2,0.14,1.09,-0.29,-1.41,-0.01,-0.35,0.23,0.87,-0.37,-0.07,0.98,1.19,alcohol metabolic process;carbohydrate metabolic process;catabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P05091,ALDH2,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)",37,65.4,32.79,33.62,32.61,32.48,32.26,33.8,32.14,32.37,32.74,33.27,32.48,32.64,32.68,32.76,0.03,0.86,-0.15,-0.28,-0.5,1.04,-0.62,-0.39,-0.02,0.51,-0.28,-0.12,-0.08,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;metabolic process;neurotransmitter metabolic process;primary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part,,,,,,,,,,
P51648,ALDH3A2,Fatty aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase 10) (Aldehyde dehydrogenase family 3 member A2) (Microsomal aldehyde dehydrogenase),15,29.1,31.43,29.94,30.73,29.07,29.47,29.71,30.26,29.39,29,28.76,30.31,29.72,30.14,29.84,1.58,0.1,0.89,-0.77,-0.37,-0.13,0.42,-0.46,-0.84,-1.08,0.47,-0.12,0.3,alcohol metabolic process;anatomical structure development;cellular aldehyde metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle;peroxisome,,,,,,,,,,
P30038,ALDH4A1,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.5.1.12) (Aldehyde dehydrogenase family 4 member A1)",9,18.6,29.24,28.71,29.88,27.46,28.27,30.33,28.4,29.62,28.79,30.09,29.05,29.58,29.56,29.15,0.09,-0.45,0.72,-1.69,-0.88,1.17,-0.75,0.46,-0.36,0.94,-0.1,0.43,0.41,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P51649,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",12,26.7,29.45,30.73,28.32,27.73,26.49,26.94,27.77,27.25,,,28.26,29.18,29.11,28.29,1.16,2.44,0.02,-0.57,-1.81,-1.35,-0.53,-1.04, , ,-0.03,0.89,0.82,alcohol metabolic process;amine metabolic process;anatomical structure development;biological regulation;carbohydrate metabolic process;catabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;generation of precursor metabolites and energy;lipid metabolic process;macromolecular complex assembly;metabolic process;neurotransmitter metabolic process;neurotransmitter transport;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;post-embryonic development;primary metabolic process;protein complex assembly;secretion;small molecule metabolic process;sulfur compound metabolic process;transport,cell part,,,,,,,,,,
Q02252,ALDH6A1,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)",24,50.8,31.11,30.86,30.7,29.67,30.82,32.16,30.33,30.67,31.48,32.69,30.71,29.45,31.7,30.95,0.16,-0.09,-0.25,-1.28,-0.13,1.21,-0.62,-0.28,0.53,1.74,-0.24,-1.5,0.75,amine metabolic process;catabolic process;cell differentiation;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P49419,ALDH7A1,Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase),26,62.2,32.84,32.09,32.47,32.18,31.52,31.59,31.17,31.6,31.87,32.48,31.61,31.56,31.55,31.89,0.95,0.21,0.58,0.3,-0.37,-0.3,-0.72,-0.29,-0.02,0.59,-0.28,-0.33,-0.33,alcohol metabolic process;amine metabolic process;biosynthetic process;catabolic process;cellular aldehyde metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P49189,ALDH9A1,4-trimethylaminobutyraldehyde dehydrogenase (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase) (EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase),26,42.1,31.23,31.72,32.16,31.54,30.42,30,30.75,31.69,30.79,30.68,31.3,29.2,30.79,30.94,0.28,0.78,1.22,0.6,-0.53,-0.94,-0.2,0.75,-0.16,-0.26,0.36,-1.74,-0.15,amine metabolic process;biological regulation;biosynthetic process;cellular aldehyde metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;hormone metabolic process;metabolic process;neurotransmitter metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
P04075,ALDOA,Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase),47,95.9,35.89,35.36,35.28,35.36,34.5,33.7,34.89,35.04,33.34,33.43,34.61,35.46,32.98,34.6,1.29,0.75,0.67,0.76,-0.11,-0.91,0.29,0.44,-1.26,-1.17,0,0.86,-1.63,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell activation;cellular component assembly;cellular component organization;cellular homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;establishment of localization;exocytosis;generation of precursor metabolites and energy;heterocycle metabolic process;homeostatic process;macromolecular complex assembly;metabolic process;multicellular organismal process;muscle contraction;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;protein complex assembly;secretion;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cytoskeleton;cytosol;extracellular organelle;intracellular non-membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P09972,ALDOC,Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase),17,50.8,31.47,31.45,29.9,31.08,28.35,29.09,29.49,30.34,29.76,27.28,30.98,31.9,29.38,30.04,1.44,1.41,-0.14,1.04,-1.68,-0.94,-0.54,0.3,-0.27,-2.75,0.94,1.86,-0.66,aging;alcohol metabolic process;anatomical structure morphogenesis;biosynthetic process;carbohydrate metabolic process;catabolic process;cell death;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;death;developmental process;generation of precursor metabolites and energy;macromolecular complex assembly;metabolic process;primary metabolic process;protein complex assembly;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;small molecule metabolic process,cell part;cell projection;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;neuron projection;organelle,,,,,,,,,,
Q9BT22,ALG1,"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)",5,13.6,26.13,26.79,27.18,26.45,26.71,28.02,,26.85,29.09,27.57,26.97,,27.26,27.18,-1.06,-0.4,0,-0.74,-0.47,0.84, ,-0.33,1.9,0.39,-0.22, ,0.08,biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;polysaccharide metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q2TAA5,ALG11,"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (EC 2.4.1.131) (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)",4,10.4,26.5,27.85,27.02,28.06,26.89,28.55,27.51,26.36,28.06,27.53,28.34,28.3,29.16,27.7,-1.2,0.14,-0.68,0.35,-0.81,0.85,-0.19,-1.34,0.36,-0.18,0.64,0.6,1.45,biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q9H553,ALG2,"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)",12,30,26.86,29.85,26.74,29.6,28.64,29.07,28.67,27.97,29.71,28.35,28.84,29.59,29.85,28.75,-1.89,1.1,-2.01,0.85,-0.11,0.32,-0.08,-0.78,0.96,-0.4,0.09,0.83,1.1,biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;response to chemical stimulus;response to stimulus,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9Y673,ALG5,Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog),7,37,27.91,29.39,29.59,29.67,29.14,29.65,29.21,29.15,29.75,28.58,27.63,28.36,29.94,29.07,-1.17,0.32,0.51,0.59,0.07,0.58,0.14,0.07,0.67,-0.5,-1.45,-0.71,0.86,biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q9H6U8,ALG9,"Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)",5,11,23.44,25.15,,24.62,23.64,22.3,24.88,23.84,25.07,27.02,24.2,23.92,26.08,24.51,-1.08,0.63, ,0.1,-0.87,-2.22,0.37,-0.67,0.56,2.51,-0.31,-0.59,1.57,biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein lipidation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q6P6C2,ALKBH5,RNA demethylase ALKBH5 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),3,10.9,25.69,26.19,26.6,25.7,26.14,25.9,25.39,25.98,25.24,24.43,24.6,24.69,,25.55,0.15,0.64,1.05,0.15,0.6,0.35,-0.15,0.44,-0.31,-1.12,-0.95,-0.85, ,cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;one-carbon metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;RNA modification;RNA processing;small molecule metabolic process;transport,cell part,,,,,,,,,,
P05187,ALPP,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)",28,62.4,34.59,30.27,30.35,26.03,25.8,,,,,25.98,,25.19,,28.31,6.27,1.95,2.04,-2.28,-2.52, , , , ,-2.34, ,-3.13, ,,cell part;cell surface;membrane;plasma membrane,,,+,,,,,,,
Q86V81,ALYREF,THO complex subunit 4 (Tho4) (Ally of AML-1 and LEF-1) (Aly/REF export factor) (Transcriptional coactivator Aly/REF) (bZIP-enhancing factor BEF),15,56.4,31.32,31.34,31.39,31.65,32.52,32.59,31.72,31.67,32.54,32.06,30.49,30.64,31.56,31.65,-0.33,-0.31,-0.26,-0.01,0.86,0.94,0.06,0.02,0.89,0.41,-1.17,-1.01,-0.09,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ribonucleoprotein complex;spliceosomal complex;transcription export complex,,,,,,,,,,
Q01433,AMPD2,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),22,23.7,28.44,29.31,27.95,29.08,28.1,26.62,27.92,28.94,25.86,23.65,28.73,30.37,25.57,27.73,0.7,1.57,0.22,1.35,0.36,-1.12,0.18,1.21,-1.87,-4.08,1,2.64,-2.16,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;purine-containing compound salvage;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P04745,AMY1A,"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase)",14,37.8,28.5,26.87,30.4,25.12,25.96,26.53,26.07,26.11,,,23.24,,,26.53,1.97,0.34,3.87,-1.42,-0.58,-0.01,-0.46,-0.42, , ,-3.29, , ,carbohydrate metabolic process;digestion;metabolic process;multicellular organismal process;primary metabolic process,extracellular region,,,,,,,,,,
Q9H1A4,ANAPC1,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),8,5.8,28.57,25.55,28.38,26.12,26.23,24.92,24.99,25.36,,29.11,25.15,25.83,24.78,26.25,2.32,-0.7,2.13,-0.13,-0.02,-1.33,-1.26,-0.89, ,2.86,-1.1,-0.42,-1.47,biological regulation;catabolic process;cell division;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q9UJX3,ANAPC7,Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7),8,18.7,27.15,24.66,28.39,27.02,27.09,27.8,27.89,28.04,,25.94,26.47,27.87,28.86,27.27,-0.12,-2.6,1.12,-0.24,-0.17,0.54,0.62,0.78, ,-1.32,-0.79,0.6,1.6,biological regulation;catabolic process;cell division;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q12955,ANK3,Ankyrin-3 (ANK-3) (Ankyrin-G),16,5.1,28.79,24.35,26.02,24.01,27.63,27.38,,28.3,24.79,25.88,,,24.29,26.14,2.64,-1.8,-0.12,-2.13,1.48,1.24, ,2.16,-1.35,-0.27, , ,-1.85,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular process;cytokinesis;developmental process;establishment of localization;Golgi vesicle transport;homeostatic process;locomotion;membrane organization;protein targeting;protein transport;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cell surface;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole,,,,,,,,,,
Q9P2R3,ANKFY1,Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif),16,19.8,26.32,29.19,29.35,29.45,28.06,28.18,29.17,29.29,28.81,27.54,28.64,29.38,28.3,28.59,-2.27,0.6,0.76,0.86,-0.53,-0.41,0.58,0.7,0.22,-1.05,0.05,0.79,-0.29,,cell part;membrane,,,,,,,,,,
Q8IWZ3,ANKHD1,Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK),11,6.8,27.69,26.41,,26.52,27.04,26.87,28,27.39,24.32,23.91,26.56,27.75,26.62,26.59,1.1,-0.19, ,-0.07,0.45,0.28,1.41,0.8,-2.27,-2.68,-0.04,1.16,0.03,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q86XL3,ANKLE2,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),19,28.7,27.83,27,27.81,29.31,28.62,28.59,29.05,27.85,29.01,28.43,28.1,28.54,28.88,28.39,-0.56,-1.38,-0.57,0.92,0.24,0.2,0.66,-0.54,0.62,0.05,-0.29,0.15,0.49,biological regulation;cell division;cellular component organization;cellular membrane organization;cellular process;membrane organization;mitosis;nuclear division;organelle fission;organelle organization;regulation of protein modification process,cell part,,,,,,,,,,
Q8IZ07,ANKRD13A,Ankyrin repeat domain-containing protein 13A (Protein KE03),4,7.5,27.64,25.68,26.22,25.34,,,24.69,25.43,,24.04,25.99,26.13,23.02,25.42,2.22,0.26,0.8,-0.08, , ,-0.73,0.01, ,-1.38,0.57,0.71,-2.4,,,,,,,,,,,,
Q6AI12,ANKRD40,Ankyrin repeat domain-containing protein 40,2,18,,,,,25.86,25.47,24.57,24.34,23.21,27.01,25.19,26.17,,25.23, , , , ,0.63,0.24,-0.66,-0.89,-2.02,1.78,-0.04,0.95, ,,,,,,,,,,,,
Q9H8Y5,ANKZF1,Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744),6,14.7,25.96,25.05,,25.82,24.8,,24.59,,24.8,,24.03,25.03,,25.01,0.95,0.04, ,0.81,-0.21, ,-0.42, ,-0.21, ,-0.98,0.02, ,,,C2H2-type,,,,,,,,,
Q9NQW6,ANLN,Actin-binding protein anillin,15,17.8,27.65,,28.02,22.81,27.47,24.34,26.7,26.13,25.36,25.44,,25.61,24.69,25.84,1.81, ,2.18,-3.03,1.63,-1.5,0.86,0.29,-0.48,-0.39, ,-0.23,-1.15,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;cytokinesis;macromolecular complex assembly;mitosis;nuclear division;organelle fission;organelle organization;protein complex assembly;regulation of cell cycle;regulation of mitotic cell cycle,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NW15,ANO10,Anoctamin-10 (Transmembrane protein 16K),9,18.2,26.79,25.9,27.15,28.11,25.1,27.66,26.16,25.53,28.43,27.96,29.12,27.84,29.29,27.31,-0.52,-1.41,-0.16,0.79,-2.21,0.35,-1.15,-1.78,1.12,0.65,1.81,0.53,1.98,cell death;cellular process;death;establishment of localization;ion transport;transmembrane transport;transport,cell part;intracellular;membrane;plasma membrane,,,,,,,,,,
Q4KMQ2,ANO6,Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F),7,10.5,23.81,27.77,25.71,27.32,25,26.63,26.84,26.48,27.93,27.27,26.12,26.84,27.49,26.55,-2.75,1.22,-0.84,0.77,-1.56,0.08,0.29,-0.08,1.37,0.71,-0.43,0.29,0.94,biological regulation;cellular component organization;cellular membrane organization;cellular process;coagulation;membrane organization;multicellular organismal process;plasma membrane organization;regulation of body fluid levels,cell part;intracellular;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P39687,ANP32A,Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32) (Leucine-rich acidic nuclear protein) (LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I) (PHAPI),17,49.4,33.32,32.56,32.04,31.35,30.56,30.99,31.81,30.42,31.68,30.43,30.22,31.67,30.46,31.35,1.97,1.22,0.69,0,-0.79,-0.36,0.47,-0.93,0.33,-0.91,-1.12,0.32,-0.89,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
Q92688,ANP32B,Acidic leucine-rich nuclear phosphoprotein 32 family member B (Acidic protein rich in leucines) (Putative HLA-DR-associated protein I-2) (PHAPI2) (Silver-stainable protein SSP29),8,36.9,30.32,31.3,30.97,31.38,31.58,31.08,30.65,30.86,30.97,29.74,29.99,30.97,30.66,30.8,-0.48,0.49,0.16,0.57,0.77,0.27,-0.15,0.06,0.16,-1.06,-0.82,0.16,-0.14,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BTT0,ANP32E,Acidic leucine-rich nuclear phosphoprotein 32 family member E (LANP-like protein) (LANP-L),12,43.2,30.16,28.77,30.18,28.97,30.04,29.88,29.69,29.93,30.4,29.62,28.37,30.19,29.36,29.66,0.5,-0.89,0.52,-0.69,0.38,0.22,0.03,0.27,0.74,-0.03,-1.29,0.53,-0.3,,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;vesicle,,,,,,,,,,
P15144,ANPEP,Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13),41,41.8,31.95,33.93,31.03,30.95,28.55,30.16,27.13,27.47,32.03,33.58,28.66,27.49,28.92,30.14,1.81,3.79,0.89,0.81,-1.59,0.02,-3.01,-2.67,1.89,3.43,-1.48,-2.65,-1.22,anatomical structure formation involved in morphogenesis;biological regulation;cell differentiation;cellular metabolic process;cellular process;developmental process;hormone metabolic process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein maturation;protein metabolic process;proteolysis,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9H6X2,ANTXR1,Anthrax toxin receptor 1 (Tumor endothelial marker 8),9,21.5,,26.95,,27.8,,28.36,27.04,26.64,27.63,,23.41,25.43,26.45,26.63, ,0.32, ,1.16, ,1.72,0.41,0.01,1, ,-3.22,-1.21,-0.19,anatomical structure morphogenesis;biological adhesion;cell adhesion;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization,cell part,,,,,,,,,,
P58335,ANTXR2,Anthrax toxin receptor 2 (Capillary morphogenesis gene 2 protein) (CMG-2),7,15.5,,23.79,,25.87,28.6,29.3,29.37,25.64,29.36,,28.8,,27.08,27.53, ,-3.74, ,-1.66,1.06,1.76,1.83,-1.89,1.82, ,1.26, ,-0.46,,cell part;extracellular region;membrane;plasma membrane,,,,,,,,,,
P04083,ANXA1,Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35),42,83.5,35.05,34.38,35.46,35.19,34.32,33.78,34.87,34.71,33.23,33.88,35.28,35.91,33.7,34.6,0.45,-0.21,0.86,0.6,-0.28,-0.82,0.27,0.11,-1.37,-0.71,0.68,1.31,-0.89,anatomical structure development;biological regulation;cell activation;cell cycle;cell differentiation;cellular component movement;cellular metabolic process;cellular process;developmental process;establishment of localization;hormone transport;immune system process;lipid transport;macromolecule metabolic process;macromolecule modification;metabolic process;organic acid transport;peptide transport;primary metabolic process;protein metabolic process;protein modification process;regulation of organelle organization;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;rhythmic process;secretion;signal transduction;transport,cell part;cell projection;cilium;cytoplasm;cytoskeleton;extracellular organelle;extracellular space;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
P50995,ANXA11,Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50),23,50.9,32.63,32.2,32.11,31.87,31.51,30.46,32.21,32.55,30.75,31.67,32.32,32.5,30.84,31.82,0.81,0.39,0.29,0.06,-0.3,-1.36,0.39,0.74,-1.07,-0.14,0.5,0.68,-0.98,cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;response to chemical stimulus;response to stimulus;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;lysosome;midbody;nuclear envelope;nucleoplasm;organelle;vacuole;vesicle,,,,,,,,,,
P07355,ANXA2,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),66,94.1,36.08,36.67,36.83,36.35,36.94,36.58,37.16,37.22,37.15,36.79,37.21,36.47,36.89,36.8,-0.72,-0.13,0.03,-0.45,0.15,-0.21,0.37,0.42,0.36,-0.01,0.42,-0.33,0.1,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;cellular component organization;cellular process;developmental process;establishment of localization;extracellular matrix organization;extracellular structure organization;multicellular organismal process;regulation of body fluid levels;regulation of organelle organization;regulation of transport;response to chemical stimulus;response to stimulus;secretion;transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;extracellular organelle;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;macromolecular complex;membrane;midbody;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
P12429,ANXA3,"Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)",36,86.4,33.02,32.56,32.94,30.94,33.58,32.51,34.15,34.41,32.23,33.04,33.07,33.92,32.13,32.96,0.06,-0.4,-0.02,-2.02,0.62,-0.45,1.19,1.44,-0.73,0.08,0.11,0.96,-0.83,biological regulation;cell activation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;exocytosis;immune system process;membrane invagination;membrane organization;multi-organism process;response to biotic stimulus;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
P09525,ANXA4,Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II),31,79.6,33.35,32.22,32.94,31.09,31.77,31.41,33.07,32.93,29.88,32.59,32.85,31.93,30.71,32.06,1.3,0.16,0.88,-0.97,-0.28,-0.64,1.01,0.87,-2.18,0.54,0.79,-0.12,-1.34,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm,,,,,,,,,,
P08758,ANXA5,Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha),45,89.7,34.04,35.13,35.53,34.97,34.15,33.91,35.08,35.28,33.61,33.33,35.33,35.35,33.49,34.55,-0.52,0.57,0.98,0.42,-0.4,-0.64,0.52,0.72,-0.94,-1.22,0.78,0.8,-1.06,biological regulation;cellular process;coagulation;multicellular organismal process;regulation of body fluid levels;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoplasm;extracellular organelle;organelle;vesicle,,,,,,,,,,
P08133,ANXA6,Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70),55,68.7,30.44,33.68,32.81,33.6,33.08,32.25,32.24,33.05,32.66,28.98,33.18,33.2,31.51,32.36,-1.92,1.32,0.45,1.24,0.72,-0.11,-0.12,0.69,0.3,-3.38,0.82,0.84,-0.85,biological regulation;establishment of localization;ion transport;transport,cell part;cytoplasmic membrane-bounded vesicle;extracellular organelle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P20073,ANXA7,Annexin A7 (Annexin VII) (Annexin-7) (Synexin),17,56,30.91,30.4,30.63,30.83,30.41,29.83,30.81,30.58,29.65,29.82,30.02,31.42,27.78,30.24,0.68,0.16,0.39,0.59,0.17,-0.4,0.57,0.34,-0.59,-0.42,-0.22,1.18,-2.46,behavior;behavioral interaction between organisms;biological regulation;cell proliferation;cellular homeostasis;cellular ion homeostasis;cellular process;homeostatic process;multicellular organismal process;multi-organism process;regulation of body fluid levels;response to abiotic stimulus;response to osmotic stress;response to stimulus;response to stress,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nuclear envelope;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
P13928,ANXA8,Annexin A8 (Annexin VIII) (Annexin-8) (Vascular anticoagulant-beta) (VAC-beta),17,53.2,,28.84,30.98,31.09,29.45,29.54,31.91,31.97,25.55,27.3,31.46,33.53,29.14,30.07, ,-1.23,0.92,1.03,-0.61,-0.52,1.84,1.9,-4.51,-2.76,1.4,3.47,-0.92,biological regulation;coagulation;multicellular organismal process;regulation of body fluid levels,,,,,,,,,,,
Q06278,AOX1,Aldehyde oxidase (EC 1.2.3.1),16,16.5,,27.93,27.65,28.56,26.65,24.07,27.77,27.95,,,26.79,30.01,24.61,27.2, ,0.73,0.46,1.36,-0.55,-3.13,0.57,0.75, , ,-0.41,2.81,-2.59,cellular metabolic process;cellular process;metabolic process;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
Q10567,AP1B1,AP-1 complex subunit beta-1 (Adapter-related protein complex 1 subunit beta-1) (Adaptor protein complex AP-1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit),21,29.6,30.59,30.96,31.7,31.19,30.47,31.09,31.54,31.16,30.63,31.41,31.51,30.97,31.03,31.1,-0.5,-0.13,0.6,0.1,-0.63,-0.01,0.45,0.06,-0.47,0.32,0.42,-0.13,-0.07,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;Golgi vesicle transport;immune system process;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
O43747,AP1G1,AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1),18,24.1,29.46,29.82,30.15,30.25,29.75,30.09,30.33,30.49,29.89,30.87,30.9,31.01,30.63,30.28,-0.82,-0.46,-0.13,-0.03,-0.54,-0.19,0.05,0.2,-0.39,0.59,0.62,0.73,0.35,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;Golgi vesicle transport;immune system process;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9BXS5,AP1M1,AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 mu-1 subunit) (Adaptor-related protein complex 1 mu-1 subunit) (Clathrin assembly protein complex 1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin),21,54.8,29.36,30.51,30.45,30.64,30.26,30.09,31.49,31.02,30.44,30.09,31.56,31.07,30.89,30.61,-1.24,-0.09,-0.16,0.03,-0.35,-0.51,0.88,0.41,-0.16,-0.52,0.95,0.46,0.29,biological regulation;cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;Golgi vesicle transport;immune system process;interspecies interaction between organisms;membrane organization;multi-organism process;organelle organization;pigment granule organization;protein transport;transport;vesicle organization;vesicle-mediated transport;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
P61966,AP1S1,AP-1 complex subunit sigma-1A (Adapter-related protein complex 1 sigma-1A subunit) (Adaptor protein complex AP-1 sigma-1A subunit) (Clathrin assembly protein complex 1 sigma-1A small chain) (Clathrin coat assembly protein AP19) (Golgi adaptor HA1/AP1 adaptin sigma-1A subunit) (HA1 19 kDa subunit) (Sigma 1a subunit of AP-1 clathrin) (Sigma-adaptin 1A) (Sigma1A-adaptin),4,24.7,26.85,27.22,24.71,28.32,26.81,27.78,28.1,27.51,27.38,27.09,28.55,26.81,27.67,27.29,-0.44,-0.08,-2.59,1.03,-0.48,0.49,0.81,0.21,0.09,-0.2,1.25,-0.48,0.38,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;Golgi vesicle transport;immune system process;membrane invagination;membrane organization;multi-organism process;protein transport;response to biotic stimulus;response to stimulus;transport;vesicle-mediated transport;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
O95782,AP2A1,AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 alpha-1 subunit) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit),43,58.3,31.74,32.26,32.28,32.66,31.8,32.87,32.42,31.95,32.76,31.77,32.72,32.42,32.92,32.35,-0.61,-0.09,-0.08,0.31,-0.55,0.51,0.07,-0.4,0.41,-0.58,0.36,0.07,0.57,biological regulation;cell communication;cell-cell signaling;cellular component organization;cellular membrane organization;cellular process;endocytosis;endosome transport;establishment of localization;Golgi vesicle transport;immune system process;locomotion;membrane invagination;membrane organization;protein transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling;transport;vesicle-mediated transport;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
O94973,AP2A2,AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adapter-related protein complex 2 alpha-2 subunit) (Adaptor protein complex AP-2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9) (HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit),23,33.4,29.95,31.29,31.36,30.77,30.06,30.9,31.19,30.54,31.58,31.14,31.56,31.38,31.41,31.01,-1.06,0.28,0.35,-0.24,-0.95,-0.11,0.18,-0.47,0.57,0.12,0.55,0.37,0.4,biological regulation;cell communication;cell-cell signaling;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;immune system process;locomotion;membrane invagination;membrane organization;protein transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling;transport;vesicle-mediated transport;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P63010,AP2B1,AP-2 complex subunit beta (AP105B) (Adapter-related protein complex 2 beta subunit) (Adaptor protein complex AP-2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit),50,54.5,32.54,33.4,33.33,33.38,33.48,33.66,33.5,33.4,33.52,33.53,33.74,33.34,33.9,33.44,-0.9,-0.04,-0.11,-0.06,0.04,0.22,0.06,-0.04,0.08,0.09,0.3,-0.1,0.46,biological regulation;cell communication;cell-cell signaling;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;immune system process;locomotion;macromolecular complex assembly;organelle organization;protein complex assembly;protein transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling;transport;vesicle organization;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q96CW1,AP2M1,AP-2 complex subunit mu (AP-2 mu chain) (Adapter-related protein complex 2 mu subunit) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Clathrin assembly protein complex 2 medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein),23,49.9,29.88,31.21,31.6,31.28,31.25,31.17,31.34,31.35,31.29,31.47,31.64,30.86,31.34,31.21,-1.33,0,0.39,0.07,0.04,-0.04,0.14,0.15,0.08,0.27,0.44,-0.34,0.13,biological regulation;cell communication;cell-cell signaling;cellular component organization;cellular membrane organization;cellular process;establishment of localization;immune system process;locomotion;membrane organization;protein transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling;transport;vesicle-mediated transport;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;plasma membrane;protein complex,,,,,,,,,,
P53680,AP2S1,AP-2 complex subunit sigma (Adapter-related protein complex 2 sigma subunit) (Adaptor protein complex AP-2 subunit sigma) (Clathrin assembly protein 2 small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (HA2 17 kDa subunit) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin),4,23.9,27.73,29.52,28.52,29.29,29.29,29.95,29.94,29.81,30,29.75,30.03,28.52,30.49,29.45,-1.72,0.07,-0.93,-0.16,-0.15,0.5,0.49,0.36,0.55,0.3,0.58,-0.93,1.04,biological regulation;cell communication;cell-cell signaling;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;immune system process;locomotion;macromolecular complex assembly;organelle organization;protein complex assembly;protein transport;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling;transport;vesicle organization;viral reproduction,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
O00203,AP3B1,AP-3 complex subunit beta-1 (Adapter-related protein complex 3 subunit beta-1) (Adaptor protein complex AP-3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain),28,26.7,29.93,30.72,30.46,31.01,30.28,30.76,30.77,30.53,29.7,29.71,31.42,30.49,31.12,30.53,-0.6,0.19,-0.07,0.48,-0.25,0.23,0.24,0,-0.83,-0.82,0.89,-0.04,0.58,biological regulation;cellular component movement;cellular component organization;cellular membrane organization;cellular process;coagulation;cytoskeleton-dependent intracellular transport;endocytosis;establishment of localization;immune system process;membrane invagination;membrane organization;multicellular organismal process;organelle organization;pigment granule organization;protein targeting;protein transport;regulation of body fluid levels;transport;vacuolar transport;vesicle organization;vesicle-mediated transport,AP-type membrane coat adaptor complex;cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
O14617,AP3D1,AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adapter-related protein complex 3 subunit delta-1) (Delta-adaptin),29,28.7,29.32,30.48,30.71,30.58,28.72,30.21,30.8,30.36,29.76,29.63,30.63,31.85,29.37,30.19,-0.86,0.3,0.52,0.39,-1.46,0.03,0.61,0.17,-0.43,-0.55,0.44,1.66,-0.81,biological regulation;biosynthetic process;cellular component movement;cellular component organization;cellular localization;cellular membrane organization;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;immune system process;localization;membrane organization;metabolic process;pigment metabolic process;protein transport;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9Y2T2,AP3M1,AP-3 complex subunit mu-1 (AP-3 adapter complex mu3A subunit) (Adapter-related protein complex 3 mu-1 subunit) (Mu-adaptin 3A) (Mu3A-adaptin),12,43.1,28.42,29.61,29.63,30.06,29.29,29.31,29.15,29.6,28.74,28.68,29.91,30.44,29.08,29.38,-0.96,0.23,0.25,0.68,-0.09,-0.07,-0.23,0.22,-0.64,-0.69,0.53,1.06,-0.29,cellular component movement;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;protein targeting;protein transport;transport;vacuolar transport;vesicle-mediated transport,AP-type membrane coat adaptor complex;cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;organelle;protein complex;vacuole,,,,,,,,,,
Q92572,AP3S1,"AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 sigma-1 subunit) (Clathrin-associated/assembly/adapter protein, small 3) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a)",8,37.8,26.75,27.32,27.36,28.19,27.08,26.29,28.2,27.3,27.07,26.57,28.47,28.34,26.51,27.34,-0.6,-0.02,0.02,0.85,-0.26,-1.05,0.85,-0.04,-0.28,-0.77,1.13,1,-0.83,biological regulation;cellular component movement;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transport;vesicle-mediated transport,AP-type membrane coat adaptor complex;cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
P13798,APEH,Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH),14,19.4,29.18,30.64,30.78,30.4,30.23,29.57,31.39,31.54,29.49,29.95,31.82,31.26,29.54,30.45,-1.27,0.2,0.34,-0.05,-0.22,-0.88,0.94,1.1,-0.95,-0.5,1.37,0.82,-0.9,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;membrane,,,,,,,,,,
P27695,APEX1,"DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial]",20,71.7,33.18,32.25,31.68,31.27,31.35,31.07,31.58,31.12,31.74,31.41,30.45,31.21,29.88,31.4,1.78,0.85,0.28,-0.12,-0.05,-0.33,0.18,-0.28,0.34,0.01,-0.94,-0.19,-1.52,"aging;biological regulation;biosynthetic process;cellular homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA modification;DNA recombination;DNA repair;homeostatic process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;regulation of DNA metabolic process;regulation of gene expression, epigenetic;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;small molecule metabolic process",cell part;centrosome;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;mitochondrion;nucleolus;organelle;protein complex;ribonucleoprotein complex;ribosome;transcription factor complex,Other TF domain,,,,,,,,,
Q9BZZ5,API5,Apoptosis inhibitor 5 (API-5) (Antiapoptosis clone 11 protein) (AAC-11) (Cell migration-inducing gene 8 protein) (Fibroblast growth factor 2-interacting factor) (FIF) (Protein XAGL),24,49.6,31.62,31.16,30.49,31,31.7,31.49,31.63,31.17,31.88,31.2,30.37,30.85,31.28,31.22,0.41,-0.06,-0.73,-0.22,0.48,0.27,0.41,-0.05,0.66,-0.02,-0.84,-0.37,0.06,biological regulation;cell death;cellular process;death,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q06481,APLP2,Amyloid-like protein 2 (APLP-2) (APPH) (Amyloid protein homolog) (CDEI box-binding protein) (CDEBP),10,18.7,28.5,27.45,,27.02,,,25.87,,27.11,26.58,23.99,23.43,27.42,26.37,2.13,1.07, ,0.65, , ,-0.5, ,0.73,0.2,-2.38,-2.94,1.05,alcohol metabolic process;anatomical structure development;behavior;behavioral interaction between organisms;biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;embryo development;extracellular matrix organization;extracellular structure organization;homeostatic process;lipid metabolic process;metabolic process;multicellular organismal process;multi-organism process;neurological system process;primary metabolic process;regulation of protein modification process;response to stimulus;signal transduction;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9HDC9,APMAP,Adipocyte plasma membrane-associated protein (Protein BSCv),21,57,33.22,33.35,32.8,32.54,32.66,33.39,32.81,32.75,33.41,32.79,33.63,32.38,33.95,33.05,0.17,0.29,-0.26,-0.52,-0.39,0.34,-0.24,-0.3,0.36,-0.27,0.58,-0.67,0.9,biosynthetic process;metabolic process,cell part;cell surface;membrane,,,,,,,,,,
Q8NCW5,APOA1BP,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase) (YjeF N-terminal domain-containing protein 1) (YjeF_N1),10,64.9,31.01,30.65,30.57,29.68,29.71,30.15,30.71,31.08,29.3,29.23,31.41,32.21,29.85,30.43,0.58,0.22,0.14,-0.75,-0.71,-0.27,0.28,0.65,-1.13,-1.2,0.99,1.78,-0.58,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell body;cell part;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NRW3,APOBEC3C,DNA dC->dU-editing enzyme APOBEC-3C (A3C) (EC 3.5.4.-) (APOBEC1-like) (Phorbolin I),6,41.6,24.08,25.88,27.26,28.51,28.88,27.78,28.99,28.72,28.83,26.32,28.41,28.62,26.99,27.64,-3.55,-1.76,-0.38,0.88,1.25,0.15,1.35,1.09,1.19,-1.32,0.77,0.99,-0.64,"biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA modification;heterocycle metabolic process;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;one-carbon metabolic process;primary metabolic process;regulation of gene expression, epigenetic;response to biotic stimulus;response to stimulus;response to stress;small molecule metabolic process",cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BQE5,APOL2,Apolipoprotein L2 (Apolipoprotein L-II) (ApoL-II),16,33.2,29.79,29.16,31.77,31.44,31.23,30.91,30.49,31.67,30.85,32.26,31.45,27.33,30.45,30.68,-0.89,-1.51,1.09,0.76,0.55,0.24,-0.19,0.99,0.17,1.59,0.77,-3.35,-0.23,alcohol metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;lipid metabolic process;lipid transport;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;primary metabolic process;response to stimulus;response to stress;small molecule metabolic process;transport,cell part;extracellular region;membrane,,,,,,,,,,
Q9BUR5,APOO,Apolipoprotein O (Protein FAM121B),5,26.4,28.77,28.77,27.73,28.11,28.48,29,26.19,28.36,28.56,28.2,29.28,28.09,29.28,28.37,0.4,0.4,-0.64,-0.26,0.11,0.63,-2.18,-0.01,0.19,-0.17,0.91,-0.28,0.91,establishment of localization;lipid transport;transport,cell part;extracellular space;macromolecular complex,,,,,,,,,,
Q6UXV4,APOOL,Apolipoprotein O-like (Protein FAM121A),7,39.6,27.94,28.79,28.72,27.92,26.8,28.03,27.6,27.2,28.96,29.31,28.58,26.84,28.75,28.11,-0.17,0.68,0.61,-0.19,-1.31,-0.08,-0.51,-0.91,0.85,1.2,0.47,-1.27,0.64,,cell part;extracellular region;membrane,,,,,,,,,,
P05067,APP,Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP;Soluble APP-alpha (S-APP-alpha);Soluble APP-beta (S-APP-beta);C99;Beta-amyloid protein 42 (Beta-APP42);Beta-amyloid protein 40 (Beta-APP40);C83;P3(42);P3(40);C80;Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59));Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57));Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50));C31],15,26.5,30.17,28.88,28.88,28.29,26.62,28.1,28.26,27.3,28.77,30.84,28.94,26.22,28.84,28.47,1.7,0.41,0.41,-0.18,-1.85,-0.37,-0.21,-1.17,0.3,2.37,0.47,-2.25,0.37,alcohol metabolic process;anatomical structure development;behavior;behavioral interaction between organisms;biological adhesion;biological regulation;cell activation;cell adhesion;cell death;cell growth;cell maturation;cell recognition;cellular component assembly;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton-dependent intracellular transport;death;developmental maturation;developmental process;endocytosis;establishment of localization;exocytosis;extracellular matrix organization;extracellular structure organization;growth;homeostatic process;immune system process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal process;multi-organism process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of mitotic cell cycle;regulation of protein modification process;regulation of translation;response to abiotic stimulus;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;RNA processing;secretion;signal transduction;small molecule metabolic process;transport;vesicle-mediated transport,apical part of cell;cell part;cell projection;cell surface;cytosol;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;organelle;synapse,,,,,,,,,,
Q9UKG1,APPL1,"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)",7,14.1,26.73,27.63,27.17,27,27.61,26.88,27.17,28.28,27.71,27.99,26.37,27.47,27.96,27.38,-0.65,0.25,-0.21,-0.38,0.23,-0.5,-0.21,0.9,0.33,0.61,-1.01,0.09,0.58,biological regulation;cell cycle;cell death;cell proliferation;cellular process;death;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q8NEU8,APPL2,"DCC-interacting protein 13-beta (Dip13-beta) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 2)",6,14,25.91,26.59,26.61,26.06,25.57,25.85,26.66,27.09,27.92,27.11,28.05,27.25,25.1,26.6,-0.69,-0.01,0.01,-0.54,-1.02,-0.75,0.07,0.5,1.32,0.51,1.45,0.65,-1.5,biological regulation;cell cycle;cell proliferation;cellular process;response to stimulus;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
P07741,APRT,Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7),11,54.4,29.84,31,29.74,31.08,29.58,29.24,30.09,30.64,28.15,29.19,30.08,31.29,27.76,29.82,0.02,1.18,-0.09,1.25,-0.24,-0.58,0.27,0.81,-1.67,-0.63,0.26,1.47,-2.06,behavior;biological regulation;biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;heterocycle metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;pigment metabolic process;primary metabolic process;purine-containing compound salvage;regulation of body fluid levels;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;small molecule metabolic process;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q7Z2E3,APTX,Aprataxin (EC 3.-.-.-) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT),3,20.7,24.83,25.29,25.99,26.68,24.96,24.14,,,24.87,,,,,25.25,-0.42,0.04,0.74,1.43,-0.29,-1.11, , ,-0.38, , , , ,biological regulation;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;DNA ligation;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein stability;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,C2H2-type,,+,,,,,,,
O60306,AQR,Intron-binding protein aquarius (Intron-binding protein of 160 kDa) (IBP160),12,10.4,29.05,27.98,29.12,28.44,28.31,28.32,28.31,28,28.09,28.8,26.44,27.81,27.62,28.18,0.88,-0.2,0.95,0.26,0.14,0.15,0.13,-0.18,-0.09,0.62,-1.74,-0.36,-0.56,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P10398,ARAF,Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks),3,6.1,21.55,22.65,,22.71,23.01,21.94,25.43,22.87,22.53,24.24,27.03,23.67,24.81,23.54,-1.98,-0.89, ,-0.82,-0.52,-1.6,1.89,-0.67,-1,0.7,3.49,0.13,1.27,biological regulation;regulation of protein modification process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,+,,,,,,,,
Q96P48,ARAP1,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2)",6,6.7,24.66,26.75,25.92,27.38,26.55,27.22,27.2,26.24,25.26,,,26.66,,26.38,-1.72,0.36,-0.46,0.99,0.17,0.83,0.81,-0.15,-1.13, , ,0.28, ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization;response to stimulus;signal transduction,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P48444,ARCN1,Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP),32,51.1,31.39,31.75,31.46,32.1,32.22,31.58,31.78,32.28,31.36,30.95,32.03,31.44,30.99,31.64,-0.25,0.11,-0.18,0.46,0.58,-0.06,0.14,0.64,-0.28,-0.69,0.39,-0.2,-0.65,cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,AP-type membrane coat adaptor complex;cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P84077,ARF1,ADP-ribosylation factor 1,18,75.7,33.14,33.05,32.93,32.75,32.58,32.81,33.31,32.27,33.23,33.26,33.65,33.99,32.44,33.03,0.1,0.02,-0.1,-0.28,-0.45,-0.22,0.28,-0.76,0.2,0.23,0.62,0.95,-0.59,biological regulation;biosynthetic process;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;homeostatic process;immune system process;lipid metabolic process;metabolic process;organelle organization;primary metabolic process;protein transport;response to stimulus;signal transduction;transport;vesicle organization;vesicle-mediated transport;viral reproduction,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
P18085,ARF4,ADP-ribosylation factor 4,8,35.6,31.72,32.26,32.03,32.51,30.97,31.36,31.99,31.68,31.93,31.62,32.61,32.54,31.6,31.91,-0.19,0.35,0.12,0.6,-0.94,-0.55,0.08,-0.23,0.02,-0.29,0.7,0.63,-0.31,anatomical structure development;biological regulation;cellular process;developmental process;establishment of localization;protein transport;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P84085,ARF5,ADP-ribosylation factor 5,5,30,28.54,28.65,28.21,28.54,26.05,27.46,28.22,24.88,28.16,28.36,27.86,28.89,27.22,27.77,0.77,0.88,0.44,0.77,-1.72,-0.31,0.45,-2.89,0.38,0.59,0.09,1.11,-0.55,biological regulation;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P62330,ARF6,ADP-ribosylation factor 6,7,44.6,30.5,30.15,30.03,30.09,29.16,29.89,30,29.16,30.63,30.82,29.55,29.72,30.12,29.98,0.51,0.16,0.04,0.1,-0.83,-0.1,0.01,-0.82,0.65,0.83,-0.44,-0.26,0.13,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cell death;cellular component movement;cellular component organization;cellular localization;cellular process;cytoskeleton organization;death;developmental process;establishment of localization;establishment or maintenance of cell polarity;localization;organelle organization;protein transport;regulation of organelle organization;regulation of transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell cortex;cell part;cell projection;cytoplasmic membrane-bounded vesicle;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q8N6T3,ARFGAP1,ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein),7,46.5,27.7,27.12,27.83,29.03,26.73,,27.82,29.33,28.33,,27.11,28.48,25.51,27.73,-0.02,-0.61,0.11,1.31,-0.99, ,0.09,1.6,0.61, ,-0.62,0.75,-2.22,biological regulation;cellular component organization;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein transport;regulation of protein modification process;transport;vesicle organization;vesicle-mediated transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;synapse,,,,,,,,,,
Q8N6H7,ARFGAP2,ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289),8,26,26.8,25.11,,26.79,28.33,27.67,28.22,29.04,26.23,,28.27,27.54,25.96,27.27,-0.47,-2.16, ,-0.48,1.06,0.4,0.95,1.77,-1.04, ,1,0.27,-1.31,biological regulation;cellular process;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q9Y6D6,ARFGEF1,Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1),13,9,28.15,25.58,26.94,25.87,24.22,26.98,26,25.09,25.21,27.83,27.51,26.73,27.15,26.4,1.74,-0.83,0.54,-0.53,-2.19,0.58,-0.41,-1.32,-1.19,1.43,1.11,0.33,0.75,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;exocytosis;Golgi organization;membrane organization;organelle organization;protein transport;regulation of organelle organization;regulation of protein modification process;secretion;transport;vesicle-mediated transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;ribonucleoprotein complex;small nuclear ribonucleoprotein complex,,,,,,,,,,
Q9Y6D5,ARFGEF2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),21,15.5,28.97,27.93,28.57,28.4,28.64,28.08,28.45,28.71,27.13,28.85,28.63,28.51,28.39,28.41,0.57,-0.47,0.17,0,0.23,-0.32,0.04,0.3,-1.27,0.45,0.22,0.11,-0.01,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endosome organization;establishment of localization;exocytosis;Golgi vesicle transport;macromolecule metabolic process;membrane organization;metabolic process;organelle organization;protein transport;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;neuron projection;organelle;protein complex;synapse;vesicle,,,,,,,,,,
P53367,ARFIP1,Arfaptin-1 (ADP-ribosylation factor-interacting protein 1),13,44.2,30.19,28.87,29.45,28.83,28.65,28.35,29.47,29.59,29.06,30.04,29.96,29.83,29.27,29.35,0.84,-0.48,0.1,-0.52,-0.7,-1,0.12,0.24,-0.29,0.69,0.61,0.48,-0.08,biological regulation;establishment of localization;protein transport;regulation of transport;transport,cell part;cytosol;membrane,,,,,,,,,,
P53365,ARFIP2,Arfaptin-2 (ADP-ribosylation factor-interacting protein 2) (Partner of RAC1) (Protein POR1),5,19.1,25.92,,,27.1,28.06,26.49,26.35,27.1,26.92,26.36,26.38,,25.82,26.65,-0.73, , ,0.45,1.41,-0.16,-0.3,0.45,0.27,-0.3,-0.27, ,-0.83,biological regulation;cellular component assembly;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;organelle organization;response to stimulus;signal transduction,cell cortex;cell part;cell projection;membrane;plasma membrane,,,,,,,,,,
Q13795,ARFRP1,ADP-ribosylation factor-related protein 1 (ARF-related protein 1) (ARP),2,16.2,25.47,26.48,24.79,25.94,25.94,26.19,,23.83,25.47,26.36,,,,25.61,-0.14,0.87,-0.82,0.33,0.33,0.58, ,-1.78,-0.13,0.75, , , ,anatomical structure morphogenesis;biological regulation;cellular localization;cellular process;developmental process;endosome transport;establishment of localization;Golgi vesicle transport;localization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9NWB6,ARGLU1,Arginine and glutamate-rich protein 1,14,34.8,27.2,27.04,29.03,27.37,26.26,28.01,27.92,27.07,28.65,28.68,,27.08,25.17,27.46,-0.25,-0.41,1.57,-0.08,-1.19,0.55,0.46,-0.39,1.19,1.22, ,-0.38,-2.29,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q07960,ARHGAP1,Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoOGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP),25,69.7,32.18,31.38,31.14,31.62,30.03,28.55,31.02,30.97,29.53,29.78,31.41,30.7,29.07,30.57,1.62,0.82,0.57,1.05,-0.54,-2.01,0.46,0.4,-1.04,-0.79,0.84,0.13,-1.5,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,+,,,,,,
Q68EM7,ARHGAP17,Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1),9,16.5,27.29,27.82,27.8,26.82,25.82,,28.3,28.09,,26.56,28.75,28.53,,27.58,-0.29,0.25,0.22,-0.76,-1.76, ,0.72,0.51, ,-1.02,1.17,0.95, ,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytosol;membrane,,,,,,,,,,
Q8N392,ARHGAP18,Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18),8,14.2,,27.28,26.65,26.03,,24.83,26.2,24.98,25.93,25.46,27.86,28.42,24.07,26.16, ,1.13,0.5,-0.12, ,-1.32,0.05,-1.17,-0.23,-0.7,1.7,2.26,-2.09,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q52LW3,ARHGAP29,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),27,23.5,25.33,24.18,,,26.57,24.03,29.1,27.59,26.99,27.48,27.68,,26.39,26.53,-1.2,-2.35, , ,0.04,-2.51,2.56,1.06,0.46,0.95,1.14, ,-0.15,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q9NRY4,ARHGAP35,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),13,8.4,25.98,24.52,26.53,26.62,27.1,26.36,26.47,26.86,27.45,26.67,25.26,,,26.35,-0.36,-1.83,0.18,0.27,0.76,0.01,0.12,0.52,1.1,0.32,-1.09, , ,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;developmental process;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to external stimulus;response to stimulus;RNA metabolic process;signal transduction,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q13017,ARHGAP5,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),12,10.4,24.73,27.31,27.4,26.92,27.71,26.83,28.01,28.84,25.58,26.07,26.33,,26.87,26.88,-2.15,0.43,0.52,0.04,0.82,-0.06,1.13,1.96,-1.3,-0.81,-0.55, ,-0.01,biological adhesion;biological regulation;cell adhesion;cellular component organization;cellular process;response to stimulus;signal transduction,cell part;cytosol;membrane,,,,,,,,,,
P52565,ARHGDIA,Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha),12,47.5,30.74,32.32,32.31,32.38,31.73,30.55,32.46,32.67,30.95,30.4,32.28,32.11,29.62,31.58,-0.84,0.74,0.74,0.8,0.15,-1.02,0.88,1.09,-0.63,-1.18,0.7,0.53,-1.96,biological regulation;cellular component movement;cellular process;response to stimulus;signal transduction,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P52566,ARHGDIB,Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Ly-GDI) (Rho-GDI beta),11,60.2,30.66,31.03,32.72,28.53,29.79,28.83,30.37,30.38,29,25.73,32.41,29.91,28.45,29.83,0.83,1.2,2.88,-1.3,-0.04,-1,0.53,0.55,-0.83,-4.1,2.58,0.08,-1.38,biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;immune system process;multicellular organismal development;multicellular organismal process;organelle organization;response to stimulus;signal transduction,cell part;cytoplasmic membrane-bounded vesicle;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q92888,ARHGEF1,Rho guanine nucleotide exchange factor 1 (115 kDa guanine nucleotide exchange factor) (p115-RhoGEF) (p115RhoGEF) (Sub1.5),16,23.6,29.33,28.94,28.29,29.09,28.03,27.17,28.93,29.38,27.8,25.93,27.93,28.33,26.91,28.16,1.18,0.78,0.14,0.93,-0.13,-0.99,0.77,1.22,-0.36,-2.23,-0.23,0.17,-1.24,biological regulation;cell proliferation;cellular process;response to stimulus;signal transduction,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q9NZN5,ARHGEF12,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),12,10.6,27.02,23.79,23.4,24.55,25.78,27.32,27.15,23.85,23.49,25.16,29.23,,28.22,25.75,1.27,-1.95,-2.35,-1.2,0.04,1.57,1.4,-1.9,-2.26,-0.59,3.48, ,2.48,biological regulation;cellular process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytosol;membrane,,,,,,,,,,
Q5VV41,ARHGEF16,Rho guanine nucleotide exchange factor 16 (Ephexin-4),5,11.8,27.2,27.42,26.61,27.41,28.75,28.39,28.8,28.11,27.49,27.3,28.89,23.22,27.26,27.45,-0.25,-0.03,-0.84,-0.04,1.3,0.94,1.35,0.66,0.04,-0.15,1.44,-4.23,-0.19,biological regulation;cell motility;cellular component movement;cellular process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q96PE2,ARHGEF17,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),11,7.7,24.48,,25.66,25.59,,,24.29,26.78,24.95,24.78,24.72,25.09,,25.15,-0.67, ,0.51,0.44, , ,-0.86,1.63,-0.19,-0.37,-0.43,-0.06, ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q6ZSZ5,ARHGEF18,Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF),5,5.6,24.28,27.05,,,25.29,25.51,,24.81,,23.49,22.83,,,24.75,-0.48,2.3, , ,0.54,0.76, ,0.06, ,-1.26,-1.92, , ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;response to stimulus;signal transduction,apical part of cell;cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),40,46.1,30.76,29.83,29.62,29.83,29.37,29.34,30.17,29.72,28.92,28.33,29.59,29.83,29.41,29.59,1.16,0.23,0.03,0.24,-0.22,-0.26,0.57,0.13,-0.67,-1.26,0,0.23,-0.18,anatomical structure morphogenesis;biological regulation;cell division;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment of localization;mitosis;nuclear division;organelle fission;organelle organization;protein transport;regulation of organelle organization;response to abiotic stimulus;response to chemical stimulus;response to osmotic stress;response to stimulus;response to stress;signal transduction;transport,cell body;cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuronal cell body;organelle;protein complex,,,,,,,,,,
Q12774,ARHGEF5,Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM),11,9.1,26.31,24.83,25.05,24.41,26.76,25.91,27.32,27.08,26.67,26.5,27.12,27,26.43,26.26,0.05,-1.43,-1.21,-1.85,0.5,-0.35,1.06,0.82,0.41,0.24,0.86,0.74,0.17,biological regulation;cell motility;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;immune system process;locomotion;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q14155,ARHGEF7,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),16,26,27.95,28.84,28.81,28.4,27.59,27.03,28.26,28.23,27.44,27.85,29.46,26.87,28.51,28.1,-0.14,0.74,0.71,0.3,-0.5,-1.06,0.16,0.14,-0.66,-0.24,1.36,-1.23,0.42,anatomical structure development;biological regulation;cellular component assembly;cellular component organization;cellular process;developmental process;response to stimulus;signal transduction,cell body;cell cortex;cell part;cell projection;cytosol;macromolecular complex;neuron projection;neuronal cell body;protein complex,,,,,,,,,,
O14497,ARID1A,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",14,9.4,28.21,27.6,26.35,27.99,28.94,28.8,27.16,28.18,28.24,28.09,24.32,26.15,27.29,27.49,0.72,0.11,-1.13,0.5,1.45,1.32,-0.33,0.69,0.76,0.61,-3.17,-1.34,-0.19,"anatomical structure development;biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of gene expression, epigenetic;response to stimulus;RNA metabolic process;signal transduction",cell part;chromatin remodeling complex;macromolecular complex;protein complex,ARID domain,,,,,,,,,
Q68CP9,ARID2,AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200),6,6.2,26.75,25.55,24.41,24.11,24.39,24.61,23.09,24.75,25.82,25.37,21.64,24.7,22.8,24.46,2.29,1.09,-0.05,-0.35,-0.07,0.15,-1.37,0.29,1.36,0.91,-2.82,0.24,-1.66,biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
P29374,ARID4A,AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1),5,5.6,25.58,24.06,25.88,23.59,,,,,23.6,24.65,,24.01,,24.48,1.1,-0.42,1.4,-0.89, , , , ,-0.88,0.17, ,-0.47, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;macromolecular complex;protein complex;transcriptional repressor complex,,,,,,,,,,
Q9Y4X5,ARIH1,E3 ubiquitin-protein ligase ARIH1 (EC 6.3.2.-) (H7-AP2) (HHARI) (Monocyte protein 6) (MOP-6) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein) (Ubiquitin-conjugating enzyme E2-binding protein 1),3,6.3,23.81,27.16,25.8,26.13,24.01,23.7,26.16,26.67,22.79,25.57,26.22,26.72,22.51,25.17,-1.36,1.99,0.63,0.96,-1.17,-1.48,0.99,1.5,-2.38,0.4,1.04,1.54,-2.66,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytosol;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
P40616,ARL1,ADP-ribosylation factor-like protein 1,6,54.3,30.59,30.56,30.4,30.51,30.14,30.73,30.72,30.44,30.91,30.37,30.49,31.74,30.87,30.65,-0.06,-0.09,-0.25,-0.14,-0.52,0.08,0.07,-0.21,0.26,-0.28,-0.16,1.09,0.22,biological regulation;cellular component organization;cellular localization;cellular metabolic process;cellular process;endosome transport;establishment of localization;Golgi organization;Golgi vesicle transport;localization;metabolic process;organelle organization;response to stimulus;secondary metabolic process;signal transduction;toxin metabolic process;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P36404,ARL2,ADP-ribosylation factor-like protein 2,5,33.2,25.42,24.42,25.32,25.21,26.26,27.25,25.03,,25.48,25.85,26.53,26.45,25.21,25.7,-0.28,-1.28,-0.38,-0.49,0.56,1.55,-0.67, ,-0.23,0.15,0.83,0.75,-0.5,biological regulation;cell cycle;cell junction organization;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;microtubule organizing center organization;organelle organization;protein complex assembly;regulation of organelle organization;response to stimulus;signal transduction,cell part;centrosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
P36405,ARL3,ADP-ribosylation factor-like protein 3,8,51.6,28.14,28.35,28.39,30.32,27.95,27.53,28.7,29.41,28.11,27.33,28.35,30.21,27.1,28.45,-0.31,-0.11,-0.06,1.86,-0.5,-0.93,0.25,0.96,-0.34,-1.12,-0.1,1.75,-1.35,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell development;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;cytokinesis;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;protein transport;response to stimulus;signal transduction;transport,cell part;cell projection;centrosome;cilium;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;midbody;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
H7BZV4,ARL6IP4,ADP-ribosylation factor-like protein 6-interacting protein 4 (Fragment),4,29.2,27.53,26.59,26.39,26.82,26.06,,25.58,25.72,27.42,26.5,,26.77,,26.54,0.99,0.05,-0.15,0.28,-0.48, ,-0.96,-0.82,0.88,-0.04, ,0.23, ,,,,,,,,,,,,
O75915,ARL6IP5,PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27),12,39.4,31.2,30.96,30.5,30.43,30.15,30.79,30,30.08,31.01,30.58,31.86,30.25,31.88,30.75,0.46,0.21,-0.25,-0.32,-0.6,0.04,-0.75,-0.66,0.27,-0.17,1.12,-0.5,1.14,amine transport;amino acid transport;biological regulation;establishment of localization;ion transport;organic acid transport;regulation of transport;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q96BM9,ARL8A,ADP-ribosylation factor-like protein 8A (ADP-ribosylation factor-like protein 10B) (Novel small G protein indispensable for equal chromosome segregation 2),14,60.2,29.24,31.32,30.6,30.48,30.55,30.88,31.11,30.41,30.37,30.9,31.43,30.52,31.39,30.71,-1.47,0.61,-0.11,-0.23,-0.16,0.17,0.4,-0.29,-0.34,0.19,0.72,-0.19,0.68,biological regulation;cell division;cellular component organization;cellular process;chromosome segregation;mitosis;nuclear division;organelle fission;organelle organization;response to stimulus;signal transduction,cell part;cytoplasm;membrane;midbody,,,,,,,,,,
Q9NVJ2,ARL8B,ADP-ribosylation factor-like protein 8B (ADP-ribosylation factor-like protein 10C) (Novel small G protein indispensable for equal chromosome segregation 1),5,33.3,28.22,29.14,29.31,29.58,28.67,29.7,28.69,28.84,28.67,29.42,27.68,30.03,30.1,29.08,-0.86,0.06,0.23,0.5,-0.41,0.62,-0.39,-0.24,-0.41,0.34,-1.4,0.95,1.02,biological regulation;cell cycle;cell division;cellular process;chromosome segregation;response to stimulus;signal transduction,cell part;cytoplasm;membrane;midbody,,,,,,,,,,
Q9NVT9,ARMC1,Armadillo repeat-containing protein 1,4,26.6,27.31,27.26,27.7,26.34,27.85,25.52,26.75,27.85,28.56,27.45,,28.92,25.96,27.29,0.02,-0.03,0.41,-0.95,0.56,-1.77,-0.54,0.56,1.27,0.16, ,1.63,-1.33,establishment of localization;ion transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8N2F6,ARMC10,Armadillo repeat-containing protein 10 (Splicing variant involved in hepatocarcinogenesis protein),8,44.6,,23.02,23.23,,25.05,,,,,,,25.98,,24.32, ,-1.3,-1.09, ,0.73, , , , , , ,1.66, ,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q8IUR7,ARMC8,Armadillo repeat-containing protein 8,3,5.8,26.8,26.21,27.07,26.76,27.13,27.1,26.87,26.36,26.01,25,26.45,27.35,27.1,26.63,0.17,-0.42,0.44,0.13,0.5,0.47,0.24,-0.27,-0.62,-1.63,-0.18,0.71,0.47,,,,,,,,,,,,
Q7Z3E5,ARMC9,LisH domain-containing protein ARMC9 (Melanoma/melanocyte-specific tumor antigen KU-MEL-1) (NS21),3,5.3,23.64,25.09,24.67,25.61,22.61,,23.92,,,24.61,22.02,25.22,,24.15,-0.51,0.94,0.51,1.46,-1.54, ,-0.24, , ,0.45,-2.13,1.06, ,,,,,,,,,,,,
Q9P291,ARMCX1,Armadillo repeat-containing X-linked protein 1 (ARM protein lost in epithelial cancers on chromosome X 1) (Protein ALEX1),5,13.5,,,21.87,25.28,22.34,27.27,25.63,23.85,26.21,24.58,27.25,25.48,27.09,25.17, , ,-3.3,0.11,-2.82,2.1,0.46,-1.31,1.04,-0.59,2.08,0.31,1.92,,cell part,,,,,,,,,,
Q7L311,ARMCX2,Armadillo repeat-containing X-linked protein 2 (ARM protein lost in epithelial cancers on chromosome X 2) (Protein ALEX2),7,17.4,26.5,26.1,27.11,27.19,26.98,28.96,27.69,27.78,27.69,27.54,28.62,27.17,29.39,27.59,-1.09,-1.5,-0.49,-0.41,-0.61,1.37,0.1,0.19,0.1,-0.06,1.03,-0.43,1.8,,cell part,,,,,,,,,,
Q9UH62,ARMCX3,Armadillo repeat-containing X-linked protein 3 (ARM protein lost in epithelial cancers on chromosome X 3) (Protein ALEX3),17,54.4,28.14,27.87,28.29,28.71,29.86,30.78,29.27,29.29,29.32,30.49,31.1,28.5,31.32,29.46,-1.32,-1.58,-1.17,-0.75,0.4,1.32,-0.18,-0.17,-0.14,1.03,1.64,-0.95,1.86,biological regulation;cellular localization;cellular process;localization,cell part,,,,,,,,,,
Q92747,ARPC1A,Actin-related protein 2/3 complex subunit 1A (SOP2-like protein),6,19.2,28.46,29.08,29.85,30.63,29.65,29.37,29.84,30.14,28.65,29.95,29.65,30.68,29.48,29.65,-1.19,-0.57,0.2,0.98,0,-0.28,0.19,0.49,-1,0.3,0,1.04,-0.17,biological regulation;cellular component organization;cellular process;cytoskeleton organization;immune system process;organelle organization;regulation of organelle organization;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O15143,ARPC1B,Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC),20,58.1,32.45,32.81,32.82,32.68,32.73,32.12,33.09,32.96,32.89,32.5,32.92,32.5,32.29,32.67,-0.22,0.13,0.14,0.01,0.06,-0.55,0.42,0.29,0.21,-0.17,0.25,-0.17,-0.38,biological regulation;cellular component movement;cellular component organization;cellular process;regulation of organelle organization,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
O15144,ARPC2,Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC),25,81.3,33.08,33.46,33.81,33.38,32.5,32.62,33.13,32.79,32.64,32.6,33.8,32.78,32.99,33.05,0.04,0.42,0.76,0.33,-0.55,-0.42,0.08,-0.26,-0.4,-0.45,0.76,-0.26,-0.05,biological regulation;cellular component movement;cellular component organization;cellular process;immune system process;regulation of organelle organization;response to stimulus;response to stress,cell leading edge;cell part;cell projection;cytosol;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
O15145,ARPC3,Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC),14,68,31.42,31.9,32.8,32.15,31.66,31.44,31.7,31.78,31.53,31.52,31.94,32.24,31.3,31.8,-0.37,0.1,1,0.35,-0.14,-0.36,-0.1,-0.01,-0.27,-0.28,0.14,0.44,-0.5,biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;immune system process;organelle organization;regulation of organelle organization;response to stimulus;response to stress,cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P59998,ARPC4,Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC),13,66.1,32.46,32.77,32.65,32.92,33.01,32.61,32.98,33.13,32.32,32.45,32.86,33.42,32.7,32.79,-0.33,-0.02,-0.14,0.13,0.22,-0.18,0.19,0.34,-0.47,-0.34,0.07,0.63,-0.09,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;cytoskeleton organization;immune system process;macromolecular complex assembly;organelle organization;protein complex assembly;protein polymerization;regulation of organelle organization;response to stimulus;response to stress,cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
O15511,ARPC5,Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC),13,80.8,31.35,31.77,32.87,32.2,31.38,32.48,32,31.82,31.26,31,32.6,32.62,31.68,31.93,-0.58,-0.16,0.95,0.27,-0.55,0.56,0.07,-0.11,-0.66,-0.92,0.67,0.69,-0.24,biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;immune system process;organelle organization;regulation of organelle organization;response to stimulus;response to stress,cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q9BPX5,ARPC5L,Actin-related protein 2/3 complex subunit 5-like protein (Arp2/3 complex 16 kDa subunit 2) (ARC16-2),6,30.1,29.14,29.68,29.38,29.93,30.24,28.93,28.88,29.19,29.02,30.03,29.65,30.23,29.46,29.52,-0.38,0.16,-0.14,0.41,0.72,-0.59,-0.64,-0.33,-0.5,0.51,0.13,0.71,-0.06,biological regulation;cellular component organization;regulation of organelle organization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P49407,ARRB1,Beta-arrestin-1 (Arrestin beta-1),4,11.7,25.97,28.06,25.19,26.64,23.52,,25.06,24.64,25.68,,26.94,,,25.75,0.22,2.31,-0.55,0.9,-2.22, ,-0.69,-1.11,-0.06, ,1.2, , ,biological regulation;biosynthetic process;catabolic process;cell activation;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;detection of stimulus;endocytosis;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to external stimulus;response to stimulus;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter;transport;vesicle-mediated transport,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;pseudopodium,,,,,,,,,,
P15289,ARSA,Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) [Cleaved into: Arylsulfatase A component B;Arylsulfatase A component C],8,21.9,28.96,30.32,,28.65,28.89,29.38,28.93,27.55,28.84,29.4,29.8,29.33,30.3,29.2,-0.24,1.12, ,-0.55,-0.3,0.19,-0.26,-1.65,-0.36,0.2,0.6,0.13,1.1,cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;small molecule metabolic process,cell part,,,,,,,,,,
P15848,ARSB,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),6,12.9,,26.95,25.59,26.41,25.56,27.07,28.63,27.28,27.1,28.8,27.13,26.49,27.98,27.08, ,-0.13,-1.49,-0.67,-1.52,-0.01,1.54,0.2,0.02,1.72,0.05,-0.59,0.9,amine metabolic process;anatomical structure development;autophagy;carbohydrate metabolic process;catabolic process;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organelle organization;polysaccharide metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;sulfur compound metabolic process;transport;vacuolar transport;vacuole organization,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9HBK9,AS3MT,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),5,15,,25.16,,25.62,23.84,23.26,,22.32,,,25.77,29.86,,25.12, ,0.04, ,0.5,-1.27,-1.86, ,-2.8, , ,0.65,4.74, ,cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;secondary metabolic process;small molecule metabolic process;toxin metabolic process;xenobiotic metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q13510,ASAH1,Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein) (PHP32) [Cleaved into: Acid ceramidase subunit alpha;Acid ceramidase subunit beta],2,6.8,26.33,28.5,27.85,,,,25.09,,24.47,25.75,,,25.13,26.16,0.17,2.34,1.69, , , ,-1.07, ,-1.69,-0.41, , ,-1.03,anatomical structure development;cell death;cellular lipid metabolic process;cellular metabolic process;cellular process;death;developmental process;lipid metabolic process;metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part,,,,,,,,,,
Q9ULH1,ASAP1,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",12,13.2,27.05,25.86,24.31,28.36,25.59,24.91,25.53,26.82,25.06,,26.68,27.28,,26.13,0.91,-0.27,-1.82,2.22,-0.55,-1.22,-0.6,0.69,-1.07, ,0.55,1.15, ,anatomical structure morphogenesis;biological regulation;cellular component morphogenesis;cellular component organization;cellular process;developmental process,cell part;cytoplasm;membrane,,,,,,,,,,
Q8N9N2,ASCC1,Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50),4,11.8,27.37,26.42,,27.69,28.15,27.34,27.36,26.94,26.98,27.15,27.91,27.56,27.07,27.33,0.05,-0.9, ,0.36,0.82,0.01,0.04,-0.39,-0.35,-0.18,0.58,0.23,-0.26,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q9H1I8,ASCC2,Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100),6,18.5,24.22,23.86,,26.45,27.46,25.24,26.56,27.29,24.03,24.83,28.45,27.02,26.81,26.02,-1.8,-2.15, ,0.44,1.44,-0.78,0.54,1.27,-1.99,-1.19,2.43,1,0.79,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,,,,,,,,,,,
Q8N3C0,ASCC3,"Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)",17,9.9,28.8,29.18,28.25,29.09,28.71,28.62,29.42,29.53,28.39,28.15,29.42,29.63,28.85,28.93,-0.12,0.25,-0.67,0.16,-0.21,-0.31,0.49,0.6,-0.54,-0.78,0.49,0.7,-0.07,biological regulation;biosynthetic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UBL3,ASH2L,Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein),7,14.3,27.48,26.02,27.79,26.19,26.28,26.85,25.86,26,27.31,27.36,,24.31,25.58,26.42,1.06,-0.4,1.37,-0.23,-0.14,0.43,-0.56,-0.42,0.89,0.94, ,-2.11,-0.84,anatomical structure development;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;small molecule metabolic process;transcription from RNA polymerase II promoter,cell part;chromatin remodeling complex;histone methyltransferase complex;macromolecular complex;protein complex,DNA binding region,,,,,,,,,
P04424,ASL,Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase),6,12.8,28.18,28.43,25.64,27.53,26.85,24.09,27.36,27.16,26.37,26.28,26.07,26.6,,26.71,1.47,1.72,-1.07,0.82,0.14,-2.62,0.64,0.45,-0.35,-0.43,-0.65,-0.11, ,amine metabolic process;behavior;biosynthetic process;catabolic process;cellular amide metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nitrogen cycle metabolic process;organic acid metabolic process;post-embryonic development;primary metabolic process;protein acylation;protein metabolic process;protein modification process;response to stimulus;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
O95671,ASMTL,N-acetylserotonin O-methyltransferase-like protein (ASMTL),4,10.6,25.11,27.2,25.24,27.2,,,,,25.22,,23.34,23.11,,25.2,-0.09,2,0.04,1.99, , , , ,0.02, ,-1.86,-2.09, ,,cell part;cytoplasm,,,,,,,,,,
O43681,ASNA1,ATPase ASNA1 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I),16,54.6,31.26,30.87,31.16,30.37,30,30.08,31.14,30.53,30.44,30.46,30.58,31.5,30.4,30.68,0.59,0.19,0.49,-0.31,-0.68,-0.59,0.47,-0.15,-0.24,-0.22,-0.1,0.82,-0.27,catabolic process;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;localization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P08243,ASNS,Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase),12,28.1,30.54,29.65,28.04,30.38,24.86,26.4,27.02,27.79,25.71,27.27,23.04,26.43,,27.26,3.28,2.39,0.78,3.12,-2.4,-0.86,-0.24,0.53,-1.55,0.01,-4.22,-0.83, ,amine metabolic process;anatomical structure development;biological regulation;biosynthetic process;cell communication;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q12797,ASPH,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),33,44.5,31.44,32.19,31.38,31.8,31.95,32.17,31.69,31.28,33.13,32.86,32.07,32.79,32.4,32.09,-0.65,0.1,-0.71,-0.29,-0.14,0.08,-0.4,-0.81,1.04,0.77,-0.02,0.7,0.31,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular metabolic process;cellular process;detection of stimulus;developmental process;establishment of localization;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;muscle contraction;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P00966,ASS1,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),30,62.9,33.91,32.79,32.2,30.16,,27.33,26.7,29.06,22.06,28.97,30.06,27.26,,29.14,4.77,3.65,3.06,1.02, ,-1.8,-2.44,-0.07,-7.08,-0.16,0.93,-1.88, ,amine metabolic process;biosynthetic process;cellular amide metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nitrogen cycle metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9NVM9,ASUN,Protein asunder homolog (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Sarcoma antigen NY-SAR-95),12,19.1,28.66,25.68,26.98,26.56,26.86,26.13,24.01,26.02,26.4,25.49,23.5,23.91,,25.85,2.81,-0.17,1.13,0.71,1.01,0.28,-1.84,0.17,0.55,-0.36,-2.35,-1.94, ,biological regulation;cell division;cell motility;cellular component movement;cellular component organization;cellular process;locomotion;mitosis;nuclear division;organelle fission;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8NBU5,ATAD1,ATPase family AAA domain-containing protein 1 (EC 3.6.1.3) (Thorase),11,37.4,29.47,30.2,27.98,29.54,28.97,29.77,29.53,29.03,29.66,31.02,29.77,29.56,30.39,29.61,-0.14,0.59,-1.63,-0.07,-0.63,0.16,-0.08,-0.57,0.05,1.42,0.16,-0.05,0.78,behavior;biological regulation;multicellular organismal process;neurological system process;regulation of transport;response to stimulus,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;organelle;plasma membrane,,,,,,,,,,
Q6PL18,ATAD2,ATPase family AAA domain-containing protein 2 (EC 3.6.1.3) (AAA nuclear coregulator cancer-associated protein) (ANCCA),10,10.1,28.56,22.15,24.47,25.27,,,25.16,22.9,23.44,23.25,,,,24.4,4.17,-2.25,0.07,0.87, , ,0.76,-1.5,-0.96,-1.15, , , ,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NVI7,ATAD3A,ATPase family AAA domain-containing protein 3A,47,63.3,30.93,31.44,31.51,31.98,32.7,32.98,32.55,31.86,33.29,33.1,32.13,31.73,32.75,32.23,-1.3,-0.78,-0.72,-0.25,0.47,0.75,0.32,-0.37,1.06,0.87,-0.1,-0.49,0.52,biological regulation;cell growth;cellular process;growth,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q5T9A4,ATAD3B,ATPase family AAA domain-containing protein 3B (AAA-TOB3),3,6.3,,24.09,24.54,27.94,28.39,28.52,26.76,27.72,26.74,27.99,26.82,27.11,26.47,26.92, ,-2.83,-2.39,1.02,1.46,1.59,-0.16,0.8,-0.19,1.06,-0.1,0.18,-0.46,,cell part;membrane,,,,,,,,,,
O95260,ATE1,Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1),3,7.8,26.12,25.76,24.22,25.36,,,25,26.71,23.79,23.92,26,25.71,,25.26,0.86,0.5,-1.04,0.1, , ,-0.26,1.45,-1.47,-1.34,0.75,0.45, ,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P18850,ATF6,Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha],2,5.9,24.39,,24.63,23.93,24.25,23.85,,,,23.74,,,23.63,24.06,0.33, ,0.57,-0.13,0.19,-0.21, , , ,-0.32, , ,-0.43,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process;RNA metabolic process,cell part;membrane;nuclear envelope;nucleoplasm,bZIP,,,,,,,,,
Q9NT62,ATG3,Ubiquitin-like-conjugating enzyme ATG3 (EC 6.3.2.-) (Autophagy-related protein 3) (APG3-like) (hApg3) (Protein PC3-96),7,26.1,28.68,28.72,28.98,29.03,28.02,26.67,28.59,28.48,,25.75,28.54,29.88,24.8,28.01,0.67,0.71,0.97,1.02,0.01,-1.34,0.57,0.47, ,-2.26,0.53,1.87,-3.21,cellular component assembly;cellular component organization;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;mitochondrion organization;organelle assembly;organelle fission;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein targeting;protein transport;transport;vacuole organization,cell part;cytosol;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q9Y4P1,ATG4B,Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B),7,24.2,22.06,26.24,25.5,25.62,26.68,24.53,27.54,26.95,,,25.44,27.35,,25.79,-3.73,0.45,-0.29,-0.17,0.89,-1.26,1.75,1.16, , ,-0.35,1.56, ,biological regulation;cellular component assembly;cellular component organization;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;organelle assembly;organelle organization;primary metabolic process;protein metabolic process;protein transport;proteolysis;transport;vacuole organization,cell part;cytoplasm,,,,,,,,,,
Q9H1Y0,ATG5,Autophagy protein 5 (APG5-like) (Apoptosis-specific protein),3,14.9,26.09,27.51,27.31,27.45,,,27.74,26.69,27.14,26.76,27.27,28.21,,27.22,-1.13,0.29,0.09,0.24, , ,0.52,-0.53,-0.08,-0.46,0.05,0.99, ,anatomical structure development;biological regulation;cell death;cell development;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;circulatory system process;death;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;organelle assembly;organelle organization;primary metabolic process;protein metabolic process;protein modification process;regulation of protein modification process;response to chemical stimulus;response to drug;response to stimulus;response to stress;tissue remodeling;vacuole organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vacuole,,,,,,,,,,
O95352,ATG7,Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein),7,14,26.27,27.88,27.03,27.15,26.66,24.18,28.16,28.17,24.47,,26.12,28.48,,26.78,-0.51,1.11,0.25,0.38,-0.12,-2.6,1.38,1.39,-2.31, ,-0.66,1.7, ,amine metabolic process;anatomical structure development;anatomical structure morphogenesis;autophagy;behavior;biological regulation;catabolic process;cell development;cellular amino acid metabolic process;cellular component morphogenesis;cellular component organization;cellular ketone metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;macromolecule modification;membrane fusion;membrane organization;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;organelle organization;organic acid metabolic process;post-embryonic development;primary metabolic process;protein catabolic process;protein lipidation;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein transport;regulation of protein modification process;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process;transport,cell part;cytoplasm,,,,,,,,,,
Q7Z3C6,ATG9A,Autophagy-related protein 9A (APG9-like 1) (mATG9),8,13.6,27.08,25.57,,24.93,23.21,,23.85,23.85,23.2,,,,,24.53,2.55,1.05, ,0.4,-1.32, ,-0.68,-0.68,-1.33, , , , ,cellular component assembly;cellular component organization;cellular localization;cellular process;establishment of localization;immune system process;localization;organelle assembly;organelle organization;protein transport;response to stimulus;response to stress;transport;vacuole organization,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
P31939,ATIC,Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase);IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)],36,69.6,32.66,32.33,32.92,32.91,32.25,31.64,32.36,32.66,31.32,31.58,32.27,32.63,30.66,32.17,0.5,0.16,0.75,0.74,0.08,-0.52,0.19,0.49,-0.85,-0.58,0.1,0.46,-1.51,anatomical structure development;anatomical structure morphogenesis;biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8WXF7,ATL1,Atlastin-1 (EC 3.6.5.-) (Brain-specific GTP-binding protein) (GTP-binding protein 3) (GBP-3) (hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A),7,15.6,22.82,26.13,26.33,26.15,21.32,23.01,26.48,25.19,23.46,,29.6,29.4,28.35,25.69,-2.86,0.45,0.64,0.46,-4.36,-2.68,0.79,-0.5,-2.22, ,3.91,3.72,2.67,anatomical structure morphogenesis;cell death;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;death;developmental process;endoplasmic reticulum organization;macromolecular complex assembly;organelle organization;protein complex assembly,cell part;cell projection;membrane;neuron projection,,,,,,,,,,
Q8NHH9,ATL2,Atlastin-2 (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) (ARL-6-interacting protein 2) (Aip-2),10,20.6,28.45,27.51,28.36,27.27,27.97,27.09,27.27,27.31,27.22,28.06,27.07,27.05,28.02,27.59,0.86,-0.08,0.77,-0.32,0.38,-0.5,-0.32,-0.28,-0.37,0.48,-0.52,-0.54,0.43,cellular component assembly;cellular component organization;cellular process;endoplasmic reticulum organization;Golgi organization;macromolecular complex assembly;organelle organization;protein complex assembly,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q6DD88,ATL3,Atlastin-3 (EC 3.6.5.-),26,47.7,32.21,33.08,32.32,32.51,31.57,32.56,32.69,32.09,33.29,32.93,33.16,33.34,33.34,32.7,-0.49,0.38,-0.38,-0.19,-1.13,-0.14,-0.01,-0.61,0.59,0.23,0.46,0.65,0.64,cellular component assembly;cellular component organization;cellular process;endoplasmic reticulum organization;Golgi organization;macromolecular complex assembly;organelle organization;protein complex assembly,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P54259,ATN1,Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein),5,6.1,,,,,24.48,24.23,23.33,23.86,22.21,,23.93,,24.05,23.73, , , , ,0.75,0.5,-0.4,0.14,-1.52, ,0.2, ,0.32,anatomical structure development;biological regulation;biosynthetic process;cell death;cell motility;cellular component movement;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;establishment or maintenance of cell polarity;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;secondary metabolic process;toxin metabolic process,cell part;cytoplasm,,,,,,,,,,
O00244,ATOX1,Copper transport protein ATOX1 (Metal transport protein ATX1),6,67.8,29.72,28.31,29.93,29.97,27.03,25.88,27.95,27.83,25.51,27.09,27.98,28.61,,27.98,1.74,0.33,1.95,1.98,-0.95,-2.1,-0.04,-0.15,-2.48,-0.9,-0.01,0.62, ,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;transport,cell part;cytosol,,,,,,,,,,
Q6PJ25,ATP11A,ATP11A protein (Fragment),5,7.4,22.4,25.99,27.4,26.9,25.08,,26.69,23.87,25.78,27.03,27.92,26.11,27.49,26.05,-3.66,-0.06,1.34,0.85,-0.97, ,0.63,-2.18,-0.28,0.97,1.86,0.06,1.44,,cell part,,,,,,,,,,
Q8NB49,ATP11C,Probable phospholipid-transporting ATPase IG (EC 3.6.3.1) (ATPase IQ) (ATPase class VI type 11C),8,8,25.51,27.29,,26.8,25.71,27.18,27.18,25.9,28.2,27.46,27.23,27.44,27.41,26.94,-1.44,0.35, ,-0.14,-1.23,0.24,0.24,-1.05,1.26,0.51,0.29,0.5,0.47,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;ion transport;lipid transport;membrane organization;transmembrane transport;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9HD20,ATP13A1,Probable cation-transporting ATPase 13A1 (EC 3.6.3.-),35,38.3,31.21,31.08,30.7,30.68,29.64,31.12,30.95,30.46,31.15,31.47,31.13,30.9,31.65,30.93,0.28,0.14,-0.23,-0.26,-1.3,0.19,0.02,-0.47,0.21,0.53,0.2,-0.03,0.72,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q9H7F0,ATP13A3,Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1),8,8.9,27.53,25.58,24.11,23.34,26.18,25.51,26.93,25.66,25.68,26.28,27.88,25.39,28.15,26.02,1.51,-0.43,-1.91,-2.67,0.16,-0.51,0.92,-0.36,-0.34,0.27,1.86,-0.62,2.13,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
F5H3A1,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,57,46.9,34.53,33.68,33.75,33.58,33.77,34.25,33.73,33.36,34.01,34.95,33.79,33.4,34.42,33.94,0.59,-0.26,-0.19,-0.36,-0.17,0.31,-0.21,-0.58,0.07,1.01,-0.15,-0.54,0.48,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;regulation of transport;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P05026,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1),14,46.5,31.48,30.6,30.95,30.42,28.98,29.33,30.16,29.37,29.24,33.01,29.75,29.87,30.37,30.27,1.21,0.32,0.68,0.15,-1.29,-0.94,-0.12,-0.9,-1.03,2.73,-0.52,-0.4,0.1,biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular process;coagulation;immune system process;locomotion;multicellular organismal process;regulation of body fluid levels;response to chemical stimulus;response to stimulus;response to stress,cell part;macromolecular complex;protein complex,,,,,,,,,,
P54709,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3) (ATPB-3) (CD antigen CD298),16,45.5,32.92,31.75,31.73,32.07,32.04,32.26,32.35,31.29,32.67,31.79,31.72,31.21,32.89,32.05,0.87,-0.3,-0.32,0.01,-0.02,0.21,0.3,-0.77,0.62,-0.26,-0.34,-0.84,0.84,biological regulation;cell motility;cellular component movement;cellular process;coagulation;immune system process;locomotion;multicellular organismal process;regulation of body fluid levels,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P16615,ATP2A2,"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)",55,47.5,33.93,34.14,33.59,33.5,32.91,33.33,33.25,32.84,33.79,34.15,33.33,32.84,33.69,33.48,0.45,0.65,0.1,0.01,-0.58,-0.15,-0.24,-0.64,0.3,0.67,-0.15,-0.64,0.21,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cellular homeostasis;cellular ion homeostasis;cellular process;coagulation;developmental process;establishment of localization;homeostatic process;ion transport;multicellular organismal process;regulation of body fluid levels;response to stimulus;signal transduction;transport,cell part;membrane,,,,,,,,,,
P20020,ATP2B1,Plasma membrane calcium-transporting ATPase 1 (PMCA1) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 1) (Plasma membrane calcium pump isoform 1),19,18.8,29.64,29.14,27.86,28.3,26.77,28.24,27.02,25.3,26.72,27.55,28.4,26.19,28.84,27.69,1.95,1.45,0.17,0.61,-0.92,0.55,-0.67,-2.39,-0.97,-0.14,0.71,-1.5,1.15,biological regulation;coagulation;multicellular organismal process;regulation of body fluid levels,cell part,,,,,,,,,,
P23634,ATP2B4,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 3.6.3.8) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),29,27.5,31.18,31.77,31.62,31.35,29.46,31.7,30.28,29.61,31.06,29.65,31.18,31.79,30.95,30.89,0.29,0.88,0.73,0.45,-1.43,0.81,-0.61,-1.28,0.16,-1.24,0.29,0.9,0.06,biological regulation;coagulation;multicellular organismal process;regulation of body fluid levels,cell part,,,,,,,,,,
P98194,ATP2C1,Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 3.6.3.8) (ATP-dependent Ca(2+) pump PMR1),12,21.2,29.49,28.56,27.87,28.11,29,29.93,29.24,28.4,29.48,29.15,29.37,30.07,29.83,29.11,0.37,-0.55,-1.25,-1.01,-0.12,0.81,0.12,-0.72,0.37,0.04,0.25,0.96,0.72,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;cytoskeleton organization;developmental process;establishment of localization;homeostatic process;ion transport;organelle organization;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P25705,ATP5A1,"ATP synthase subunit alpha, mitochondrial",57,70.9,35.49,35.47,35.57,35.33,35.79,36,35.33,35.43,35.78,35.92,36.06,35.62,36.21,35.69,-0.2,-0.22,-0.13,-0.36,0.1,0.31,-0.36,-0.26,0.08,0.23,0.37,-0.08,0.51,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;plasma membrane;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
P06576,ATP5B,"ATP synthase subunit beta, mitochondrial (EC 3.6.3.14)",45,80.3,36.2,36.19,35.83,35.78,36.23,36.46,35.74,35.81,36.25,36.46,36.32,36.33,36.65,36.17,0.02,0.02,-0.34,-0.39,0.06,0.29,-0.44,-0.36,0.08,0.29,0.14,0.16,0.48,anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;homeostatic process;hydrogen transport;ion transport;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;cell surface;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
P36542,ATP5C1,"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)",18,49.8,32.56,32.82,33.05,32.29,32.43,32.63,32.3,31.56,32.55,33.42,33.25,31.02,33.48,32.57,-0.01,0.26,0.49,-0.27,-0.14,0.06,-0.26,-1.01,-0.02,0.86,0.68,-1.55,0.92,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
P30049,ATP5D,"ATP synthase subunit delta, mitochondrial (F-ATPase delta subunit)",3,37.5,30.62,31.35,30.21,30.29,30.64,31.38,30.41,30.49,30.51,31.05,31.4,30.81,31.33,30.81,-0.19,0.54,-0.59,-0.52,-0.16,0.57,-0.4,-0.31,-0.29,0.24,0.59,0,0.53,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
P56381,ATP5E,"ATP synthase subunit epsilon, mitochondrial (ATPase subunit epsilon)",4,54.9,23.83,25.92,25.57,25.64,29.15,26.92,25.1,27.04,25.53,24.99,25.93,,,25.97,-2.13,-0.04,-0.4,-0.33,3.18,0.95,-0.87,1.07,-0.43,-0.98,-0.03, , ,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
O75947,ATP5H,"ATP synthase subunit d, mitochondrial (ATPase subunit d)",18,77.6,31.89,34.01,32.22,33.3,32.18,32.31,32.12,32.78,32.2,32.5,34.15,31.83,32.66,32.63,-0.74,1.38,-0.4,0.67,-0.45,-0.31,-0.5,0.16,-0.43,-0.13,1.53,-0.8,0.03,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
P56385,ATP5I,"ATP synthase subunit e, mitochondrial (ATPase subunit e)",8,85.5,29.92,31.08,30.67,29.54,31.32,31.13,30.36,30.83,30.58,30.99,30.8,29.94,30.9,30.62,-0.7,0.46,0.05,-1.08,0.7,0.51,-0.26,0.22,-0.04,0.37,0.18,-0.68,0.28,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
P18859,ATP5J,"ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6)",11,62,30.98,31.56,31.68,31.07,31.34,31.44,31.04,30.44,31.7,32.56,32.14,31.62,31.57,31.47,-0.49,0.08,0.2,-0.4,-0.13,-0.03,-0.44,-1.04,0.23,1.09,0.67,0.15,0.1,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
P56134,ATP5J2,"ATP synthase subunit f, mitochondrial",4,43.6,30.93,31.18,30.62,31.26,31.51,31.39,30.96,31.47,31.55,31.61,31.42,31.82,31.52,31.33,-0.4,-0.15,-0.7,-0.06,0.18,0.06,-0.36,0.15,0.23,0.28,0.09,0.5,0.2,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
O75964,ATP5L,"ATP synthase subunit g, mitochondrial (ATPase subunit g)",12,70.9,31.16,31.94,32.34,31.19,32.12,31.99,30.86,31.01,32.19,32.05,30.66,32.08,32.01,31.66,-0.5,0.28,0.68,-0.47,0.46,0.33,-0.8,-0.65,0.53,0.39,-1.01,0.42,0.35,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
P48047,ATP5O,"ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)",19,76.5,32.94,33.2,33.16,32.95,33.42,33.53,33.04,33.01,33.22,33.5,33.52,32.83,33.82,33.24,-0.3,-0.04,-0.09,-0.3,0.18,0.29,-0.2,-0.23,-0.03,0.26,0.28,-0.41,0.57,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;plasma membrane;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
Q99766,ATP5S,"ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Mitochondrial ATP synthase regulatory component factor B)",3,10.2,27.41,26.35,26.3,26.12,25.19,25.53,24.98,24.81,26.34,26.56,25.69,24.54,25.45,25.79,1.62,0.55,0.51,0.33,-0.6,-0.26,-0.81,-0.98,0.55,0.77,-0.1,-1.25,-0.34,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
O75787,ATP6AP2,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adaptor) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit),5,23.6,28.2,29.07,26.74,28.15,28.12,28.1,27.27,27.87,27.57,28.3,28.01,26.21,27.91,27.81,0.39,1.26,-1.07,0.34,0.31,0.29,-0.54,0.06,-0.24,0.49,0.2,-1.6,0.1,biological regulation;cellular metabolic process;cellular process;hormone metabolic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein maturation;protein metabolic process,cell body;cell part;cell projection;neuron projection,,,,,,,,,,
Q93050,ATP6V0A1,V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),15,19,25.31,28.38,27.89,28.08,28.93,29.36,28.28,29,28.91,30.74,30.4,29.36,30.5,28.86,-3.55,-0.48,-0.97,-0.78,0.08,0.5,-0.58,0.14,0.05,1.88,1.54,0.51,1.65,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
Q9Y487,ATP6V0A2,V-type proton ATPase 116 kDa subunit a isoform 2 (V-ATPase 116 kDa isoform a2) (Lysosomal H(+)-transporting ATPase V0 subunit a2) (TJ6) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2),5,8.9,26.59,26.16,27.96,24.85,26.04,25.92,25.01,25.45,26.4,26.49,24.62,26.2,25.24,25.92,0.67,0.24,2.04,-1.06,0.12,0,-0.9,-0.46,0.48,0.57,-1.3,0.28,-0.67,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;immune system process;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
P61421,ATP6V0D1,V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (32 kDa accessory protein) (V-ATPase 40 kDa accessory protein) (V-ATPase AC39 subunit) (p39) (Vacuolar proton pump subunit d 1),14,41.3,28.69,30.63,30.44,30.4,31.46,31.69,31.06,31.15,30.88,31.88,31.77,30.84,31.8,30.98,-2.28,-0.35,-0.54,-0.58,0.49,0.71,0.08,0.18,-0.09,0.9,0.79,-0.14,0.82,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;macromolecule metabolic process;metabolic process;multi-organism process;organelle organization;primary metabolic process;protein metabolic process;protein transport;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;proton-transporting two-sector ATPase complex;vesicle,,,,,,,,,,
P38606,ATP6V1A,V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha),35,48.6,32.69,32.42,32.46,31.93,32.1,31.69,31.51,31.7,31.54,32.35,32.31,31.73,31.82,32.02,0.67,0.41,0.44,-0.09,0.08,-0.33,-0.51,-0.32,-0.48,0.33,0.29,-0.29,-0.19,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microvillus;mitochondrion;organelle;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
P21281,ATP6V1B2,"V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)",24,46,31.37,31.79,31.71,31.36,31.17,31.15,31.22,31.35,31.26,32.09,31.92,31.69,31.21,31.48,-0.12,0.31,0.22,-0.13,-0.31,-0.33,-0.27,-0.13,-0.23,0.61,0.44,0.21,-0.27,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;endomembrane system;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microvillus;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
P21283,ATP6V1C1,V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1),15,42.4,29.79,30.02,30.48,29.36,27.58,29.08,29.31,28.55,29.85,30.3,30.26,29.27,29.06,29.45,0.33,0.56,1.02,-0.1,-1.87,-0.38,-0.14,-0.9,0.4,0.85,0.8,-0.18,-0.4,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,apical part of cell;cell part;cytosol;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;proton-transporting two-sector ATPase complex;vesicle,,,,,,,,,,
Q9Y5K8,ATP6V1D,V-type proton ATPase subunit D (V-ATPase subunit D) (V-ATPase 28 kDa accessory protein) (Vacuolar proton pump subunit D),11,45.3,28.76,29.17,29.44,29.2,28.57,28.64,29.59,29.37,29.5,30.58,29.16,29.84,27.99,29.22,-0.46,-0.04,0.23,-0.02,-0.65,-0.58,0.37,0.15,0.29,1.36,-0.06,0.62,-1.22,anatomical structure formation involved in morphogenesis;biological regulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cytosol;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
P36543,ATP6V1E1,V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1),12,47.3,30.57,31.22,30.59,30.4,30.73,29.59,29.99,30.45,30.31,30.56,30.91,28.77,29.87,30.3,0.26,0.91,0.29,0.1,0.42,-0.72,-0.31,0.15,0.01,0.25,0.6,-1.54,-0.43,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cell projection;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microvillus;mitochondrion;organelle;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
Q16864,ATP6V1F,V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F),4,42.9,28.31,28.7,27.74,27.17,27.69,26.08,26.36,26.9,26.75,28.08,27.99,27.16,26.98,27.38,0.93,1.33,0.36,-0.21,0.31,-1.3,-1.02,-0.47,-0.62,0.7,0.61,-0.22,-0.4,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cytosol;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
O75348,ATP6V1G1,V-type proton ATPase subunit G 1 (V-ATPase subunit G 1) (V-ATPase 13 kDa subunit 1) (Vacuolar proton pump subunit G 1) (Vacuolar proton pump subunit M16),6,48.3,30.04,30.34,30.16,30.36,29.49,28.49,29.43,28.27,30,30.99,30.52,29.17,29.72,29.77,0.27,0.57,0.4,0.59,-0.28,-1.28,-0.33,-1.5,0.23,1.23,0.75,-0.6,-0.05,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
Q9UI12,ATP6V1H,V-type proton ATPase subunit H (V-ATPase subunit H) (Nef-binding protein 1) (NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD),14,33.3,29.56,30.07,29.67,29.8,29.26,29.61,29.51,29.44,29.11,30.08,30.05,29.91,29.13,29.63,-0.07,0.43,0.04,0.17,-0.37,-0.02,-0.12,-0.19,-0.52,0.45,0.42,0.28,-0.5,biological regulation;catabolic process;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;endocytosis;establishment of localization;heterocycle metabolic process;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;membrane invagination;membrane organization;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport;vesicle-mediated transport;viral reproduction,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
O75110,ATP9A,Probable phospholipid-transporting ATPase IIA (EC 3.6.3.1) (ATPase class II type 9A),4,6.3,26.05,23.39,,,24.99,25.85,24.3,,25.27,,25.18,,26.22,25.16,0.89,-1.77, , ,-0.17,0.69,-0.86, ,0.12, ,0.02, ,1.07,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;lipid transport;membrane organization;transport,cell part;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q5TC12,ATPAF1,ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog),4,17.5,24.9,26.07,25.37,25.4,,24.55,25.12,,26.76,26.73,24.33,26.32,25.43,25.54,-0.64,0.52,-0.17,-0.14, ,-0.99,-0.42, ,1.22,1.19,-1.22,0.78,-0.12,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8N5M1,ATPAF2,ATP synthase mitochondrial F1 complex assembly factor 2 (ATP12 homolog),3,12.1,27.02,26.79,24.25,25.81,,25.94,,,25.02,,25.85,,23.98,25.58,1.44,1.21,-1.33,0.23, ,0.36, , ,-0.57, ,0.26, ,-1.6,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9UII2,ATPIF1,"ATPase inhibitor, mitochondrial (Inhibitor of F(1)F(o)-ATPase) (IF(1)) (IF1)",10,46.2,26.08,27.95,28.23,28.61,29.6,29.43,28.65,29.36,29.7,29.73,29.39,,22.69,28.29,-2.2,-0.33,-0.06,0.32,1.32,1.14,0.37,1.07,1.41,1.45,1.1, ,-5.6,anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cell differentiation;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;generation of precursor metabolites and energy;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;pigment metabolic process;protein complex assembly,cell part;cell surface;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),17,8.8,26.62,26.63,26.22,27.17,27.28,27.15,26.82,26.41,26.84,27.21,26.41,27.02,25.79,26.74,-0.12,-0.1,-0.51,0.44,0.54,0.41,0.08,-0.32,0.11,0.47,-0.33,0.28,-0.94,"anatomical structure development;biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA modification;DNA recombination;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;regulation of gene expression, epigenetic;response to DNA damage stimulus;response to stimulus;response to stress;small molecule metabolic process",cell part,,,,,,,,,,
Q9UBB4,ATXN10,Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein),15,35.2,28.71,28.79,28.41,30.06,30.03,28.77,30.28,30.44,28.13,27.48,29.8,30.57,28.8,29.25,-0.54,-0.46,-0.84,0.81,0.78,-0.48,1.03,1.18,-1.12,-1.77,0.55,1.32,-0.46,cell death;cellular component organization;cellular process;death,cell body;cell part;cell projection;cytosol;neuron projection;neuronal cell body,,,,,,,,,,
Q99700,ATXN2,Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein),13,16.9,26.34,25.85,,27.63,26.29,26.29,27.21,27.79,26.29,,27.6,27.32,27.79,26.94,-0.6,-1.09, ,0.69,-0.66,-0.66,0.26,0.84,-0.65, ,0.65,0.37,0.84,anatomical structure morphogenesis;biological regulation;cell death;cell differentiation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;establishment of localization;homeostatic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;primary metabolic process;regulation of translation;regulation of transport;ribonucleoprotein complex assembly;RNA metabolic process;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;polysome;ribonucleoprotein complex,,,,,,,,,,
Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),26,32.1,30.64,29.67,29.96,29.69,30.05,29.65,29.52,29.97,29.33,29.61,29.05,27.18,28.91,29.48,1.16,0.19,0.48,0.21,0.57,0.17,0.04,0.5,-0.15,0.14,-0.43,-2.3,-0.57,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;ribonucleoprotein complex,,,,,,,,,,
D3VVB8,ATXN3,Ataxin 3 variant r,2,16.2,28.09,28.53,,28.53,25.56,25.44,25.52,26.58,28.26,,25.34,27.36,,26.92,1.17,1.61, ,1.61,-1.36,-1.48,-1.4,-0.34,1.34, ,-1.58,0.44, ,,,,,,,,,,,,
Q96GX2,ATXN7L3B,Putative ataxin-7-like protein 3B,3,44.3,24.95,22.45,,24.79,23.19,24.04,,,23.25,23.03,22.84,27.54,,24.01,0.94,-1.56, ,0.78,-0.82,0.03, , ,-0.76,-0.98,-1.17,3.53, ,,,,,,,,,,,,
Q9Y679,AUP1,Ancient ubiquitous protein 1,9,23.4,29.18,29.09,28.31,29.27,27.63,28.81,30,29.28,29.66,29.16,29.62,29.95,29.7,29.2,-0.02,-0.12,-0.89,0.07,-1.58,-0.39,0.79,0.07,0.46,-0.05,0.41,0.74,0.5,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9NQS1,AVEN,Cell death regulator Aven,3,19.9,,22.42,22.93,24.28,23.49,,23.39,,21.62,23.31,23.9,25.2,,23.39, ,-0.98,-0.47,0.89,0.09, ,-0.01, ,-1.77,-0.08,0.51,1.8, ,biological regulation;cell death;cellular process;death,cell part;endomembrane system;intracellular;membrane,,,,,,,,,,
Q8NBF6,AVL9,Late secretory pathway protein AVL9 homolog,3,6.2,26.06,25.8,26.51,25.9,,26.22,25.93,26.17,24.76,25.96,25.54,,,25.89,0.18,-0.09,0.63,0.02, ,0.33,0.05,0.29,-1.13,0.07,-0.35, , ,cell motility;cellular component movement;cellular process;locomotion,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P61769,B2M,Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3],9,57.1,30.82,31.46,33.19,31.28,31.06,30.36,29.9,30.97,30.57,31.67,30,29.55,,30.9,-0.08,0.56,2.29,0.38,0.16,-0.54,-1,0.07,-0.34,0.77,-0.91,-1.35, ,biological regulation;cell activation;cell differentiation;cellular metabolic process;cellular process;developmental process;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to biotic stimulus;response to chemical stimulus;response to drug;response to stimulus;signal transduction;viral reproduction,cell part;extracellular region;extracellular space;macromolecular complex;membrane;MHC protein complex;plasma membrane;protein complex,,,,,,,,,,
Q6Y288,B3GALTL,"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta-3-glycosyltransferase-like)",4,12.4,,25.16,24.1,26.07,26.92,27.64,26.93,26.33,27.69,26.53,25.68,25.28,25.58,26.16, ,-1,-2.06,-0.09,0.76,1.49,0.77,0.17,1.53,0.37,-0.48,-0.88,-0.58,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
B7ZAB3,B3GAT3,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (cDNA, FLJ79127, highly similar to Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135))",3,12.4,25.57,25.88,23.73,26.07,25.74,27,25.23,26.4,25.65,25.7,25.09,25.4,25.77,25.63,-0.06,0.25,-1.9,0.44,0.11,1.36,-0.4,0.77,0.01,0.06,-0.54,-0.23,0.14,,cell part;membrane,,,,,,,,,,
P15291,B4GALT1,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22);N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase);Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38);Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)]",6,23.9,29.14,29.2,28.8,29.44,28.52,28.9,27.56,27.86,28.02,28.95,28.85,28.65,28.95,28.68,0.46,0.52,0.12,0.76,-0.16,0.23,-1.12,-0.82,-0.66,0.27,0.17,-0.03,0.27,alcohol metabolic process;amine metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;biosynthetic process;carbohydrate metabolic process;cell adhesion;cell development;cell motility;cell recognition;cellular component movement;cellular component organization;cellular metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;nitrogen compound metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;polysaccharide metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;regulation of transport;response to stimulus;response to stress;signal transduction;small molecule metabolic process;sulfur compound metabolic process,cell part;external encapsulating structure;extracellular region;glycocalyx;membrane,,,,,,,,,,
C9J3R8,B4GALT4,N-acetyllactosamine synthase,3,16.6,27.53,26.98,29.29,28.45,26.78,27.08,27.34,,27.2,26.85,26.15,28.17,28.32,27.51,0.01,-0.53,1.78,0.94,-0.73,-0.43,-0.17, ,-0.31,-0.66,-1.36,0.66,0.81,carbohydrate metabolic process;metabolic process;primary metabolic process,,,,,,,,,,,
Q9UBV7,B4GALT7,"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) [Includes: Xylosylprotein 4-beta-galactosyltransferase (EC 2.4.1.133) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein beta-1,4-galactosyltransferase)]",2,26,23.69,26.72,,25.67,23.95,25.2,24.09,25.19,25.8,,24.79,,26.18,25.13,-1.44,1.59, ,0.54,-1.17,0.07,-1.04,0.06,0.67, ,-0.34, ,1.05,amine metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;sulfur compound metabolic process,cell part;membrane,,,,,,,,,,
Q9NWV8,BABAM1,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),7,41.5,27.48,28.2,23.97,28.45,20.53,24.91,26.02,26.35,25.03,21.85,25.53,,,25.3,2.18,2.9,-1.34,3.15,-4.78,-0.4,0.72,1.05,-0.27,-3.45,0.23, , ,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of cell cycle;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q92934,BAD,Bcl2 antagonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-XL/Bcl-2-associated death promoter),5,43.6,23.29,23.72,,23.1,23.55,24.21,22.34,23.01,,,25.07,,,23.54,-0.24,0.18, ,-0.44,0.02,0.67,-1.19,-0.53, , ,1.54, , ,alcohol metabolic process;biological regulation;carbohydrate metabolic process;catabolic process;cell proliferation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;homeostatic process;immune system process;membrane organization;metabolic process;mitochondrion organization;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of organelle organization;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cytosol;membrane,,,,,,,,,,
O95816,BAG2,BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2),12,62.6,,27.92,27.98,29.26,29.7,30.12,30.22,30.19,29.91,29.64,29.61,30.94,29.65,29.6, ,-1.67,-1.62,-0.33,0.1,0.52,0.62,0.59,0.31,0.05,0.02,1.34,0.05,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,,,,,,,,,,,
O95817,BAG3,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),20,61.4,29.9,29.1,28.76,30.22,28.95,28.61,30.79,30.35,28.16,27.43,31.14,30.96,29.55,29.53,0.37,-0.44,-0.77,0.69,-0.58,-0.92,1.26,0.82,-1.37,-2.11,1.61,1.43,0.01,anatomical structure development;biological regulation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cell projection;cytosol;membrane;neuron projection;plasma membrane,,,,,,,,,,
O95429,BAG4,BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains),3,10,23.69,23.3,,25.06,22.19,24.98,25.27,,25.25,,21.7,25,24.38,24.08,-0.39,-0.78, ,0.98,-1.89,0.9,1.19, ,1.16, ,-2.39,0.92,0.3,biological regulation;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;localization;macromolecule metabolic process;membrane organization;metabolic process;plasma membrane organization;primary metabolic process;protein folding;protein metabolic process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9UL15,BAG5,BAG family molecular chaperone regulator 5 (BAG-5) (Bcl-2-associated athanogene 5),6,18.3,27.66,25.69,25.03,26.33,,,25.53,23.73,24.81,25.87,25.62,27.02,,25.73,1.93,-0.04,-0.7,0.6, , ,-0.2,-2,-0.92,0.15,-0.11,1.29, ,biological regulation;cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process,cell part,,,,,,,,,,
P46379,BAG6,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (BAG6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),15,20.4,28.85,29.04,28.05,29.59,29.93,28.95,28.83,29.83,28.32,28.81,29.67,29.58,29.43,29.15,-0.29,-0.11,-1.09,0.45,0.78,-0.19,-0.32,0.69,-0.83,-0.33,0.52,0.43,0.28,anatomical structure development;biological regulation;catabolic process;cell death;cell differentiation;cellular component assembly;cellular component organization;cellular localization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;death;developmental process;embryo development;establishment of localization;localization;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein stability;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9UQB8,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),27,62.4,29.66,28.97,29.68,30.12,29.5,27.99,30.25,29.9,29.42,31.04,29.94,30.67,29.4,29.74,-0.07,-0.76,-0.06,0.39,-0.24,-1.75,0.52,0.17,-0.32,1.3,0.21,0.94,-0.33,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;immune system process;multi-organism process;organelle organization;regulation of organelle organization;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cell projection;cytoskeleton;cytosol;filopodium;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;neuron projection;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9UHR4,BAIAP2L1,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate),12,33.1,28.81,26.37,28.68,26.43,26.88,25.29,27.3,26.78,27.21,27.67,27.3,28.19,28.31,27.32,1.49,-0.96,1.36,-0.9,-0.44,-2.03,-0.03,-0.55,-0.11,0.35,-0.02,0.86,0.98,biological regulation;cellular component assembly;cellular component organization;cellular process;multi-organism process;regulation of organelle organization;response to biotic stimulus;response to stimulus;signal transduction,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O75531,BANF1,"Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed]",11,62.9,32.41,31.47,31.68,31.45,31.21,31.89,31.43,31.4,32.1,32.59,30.12,31.13,31.13,31.54,0.87,-0.07,0.14,-0.08,-0.33,0.35,-0.11,-0.14,0.56,1.05,-1.42,-0.41,-0.41,cellular component disassembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA integration;DNA metabolic process;macromolecule metabolic process;membrane organization;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus,cell part;chromosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
Q8IXM2,BAP18,Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa),9,79.7,29.42,28.53,28.28,26.68,27.4,27.57,26.44,,27.9,27.04,,25.68,27.48,27.49,1.92,1.03,0.78,-0.81,-0.09,0.08,-1.05, ,0.41,-0.45, ,-1.82,-0.01,cellular component organization;cellular process;chromatin modification;chromatin organization;chromosome organization;organelle organization,cell part;chromatin remodeling complex;histone methyltransferase complex;macromolecular complex;protein complex,,,,,,,,,,
P80723,BASP1,Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22),17,79.3,29.79,31.07,31.67,31.06,30.93,30.89,31.21,30.63,31.82,32.17,31.68,27.82,30.03,30.83,-1.03,0.24,0.84,0.23,0.1,0.06,0.39,-0.2,0.99,1.34,0.86,-3.01,-0.8,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell differentiation;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular process;developmental process,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;site of polarized growth,,,,,,,,,,
Q07812,BAX,Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4),8,51.2,28.48,28.96,27.72,28.79,28.56,28.7,29.51,29.48,29.25,29.05,28.61,28.47,27.58,28.7,-0.22,0.26,-0.98,0.08,-0.15,-0.01,0.81,0.78,0.55,0.34,-0.1,-0.23,-1.13,anatomical structure development;anatomical structure morphogenesis;biological regulation;catabolic process;cell activation;cell death;cell development;cell differentiation;cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular lipid metabolic process;cellular localization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;DNA metabolic process;establishment of localization;homeostatic process;immune system process;interspecies interaction between organisms;ion transport;lipid metabolic process;localization;locomotion;macromolecular complex assembly;macromolecule metabolic process;membrane fusion;membrane organization;metabolic process;mitochondrion organization;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle fission;organelle fusion;organelle organization;primary metabolic process;protein complex assembly;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to osmotic stress;response to stimulus;response to stress;rhythmic process;tissue remodeling;transmembrane transport;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
Q9NRL2,BAZ1A,Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1),7,7.5,26.38,24.41,25.6,26.48,27.94,25.22,27.32,26.13,25.92,27.93,24.77,25.96,25.37,26.11,0.27,-1.7,-0.52,0.37,1.83,-0.89,1.21,0.02,-0.19,1.82,-1.34,-0.15,-0.74,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;chromatin remodeling complex;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear chromosome;organelle;protein complex,,,,,,,,,,
Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),23,17.9,29.2,27.52,28.67,29.11,27.63,29.07,29.29,28.57,29.33,29.04,26.75,29.17,27.64,28.54,0.66,-1.01,0.13,0.57,-0.9,0.53,0.76,0.03,0.79,0.5,-1.79,0.64,-0.9,"anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of gene expression, epigenetic;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process",cell part;chromatin remodeling complex;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),13,8.8,26.94,25.02,,25.17,,23.08,25.64,,25.35,25.15,,,,25.19,1.75,-0.17, ,-0.02, ,-2.11,0.45, ,0.16,-0.05, , , ,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA modification;gene silencing;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;regulation of gene expression, epigenetic;RNA metabolic process;small molecule metabolic process",cell part;chromatin remodeling complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,Other TF domain,,,,,,,,,
P50895,BCAM,Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239),17,35.4,31.8,29.1,29.45,29.19,27.94,29.51,28.48,26.57,28.47,27.3,,26.14,27.65,28.47,3.34,0.63,0.98,0.72,-0.52,1.05,0.01,-1.9,0,-1.17, ,-2.33,-0.81,biological adhesion;cell adhesion;cellular process,cell part,,,,,,,,,,
Q9UHQ4,BCAP29,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),6,22.9,25.48,24.16,27.07,23.35,26.4,26.09,26.2,26.18,28.2,27.75,26.21,,,26.1,-0.62,-1.94,0.97,-2.75,0.31,-0.01,0.1,0.08,2.1,1.65,0.11, , ,cell death;cellular process;death;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
P51572,BCAP31,B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28),19,44.7,31.55,32.77,32.71,31.7,31.73,32.32,31.82,31.42,32.51,32.93,32.4,25.51,32.63,31.69,-0.14,1.07,1.02,0.01,0.04,0.63,0.12,-0.27,0.82,1.24,0.71,-6.18,0.94,biological regulation;cellular component disassembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;immune system process;multicellular organismal process;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;lipid particle;membrane,,,,,,,,,,
O75815,BCAR3,Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B),4,7.6,25.12,,,25,23.1,,,24.37,,,25.84,24.98,24.49,24.7,0.42, , ,0.3,-1.6, , ,-0.33, , ,1.14,0.28,-0.2,biological regulation;cellular process;response to chemical stimulus;response to drug;response to stimulus;signal transduction,cell part;intracellular,,,,,,,,,,
O75934,BCAS2,Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2) (DNA amplified in mammary carcinoma 1 protein) (Spliceosome-associated protein SPF 27),9,51.6,30.16,29.32,29.79,29.76,30.07,29.5,29.87,29.37,30.08,28.74,28.39,27.27,29.75,29.39,0.77,-0.07,0.4,0.37,0.68,0.11,0.48,-0.02,0.69,-0.65,-1,-2.12,0.36,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P54687,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)",14,40.5,,31.01,30.2,30.92,28.16,27.81,28.17,28.56,27.25,22.77,27.27,30.2,26.63,28.24, ,2.77,1.95,2.67,-0.09,-0.43,-0.08,0.31,-1,-5.47,-0.98,1.96,-1.62,amine metabolic process;biosynthetic process;catabolic process;cell proliferation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
O15382,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42) (Placental protein 18) (PP18)",18,55.6,30.55,29.27,29.48,28.5,29.36,30.47,29.72,29.77,30.66,29.82,31.46,30.14,31,30.02,0.53,-0.75,-0.53,-1.52,-0.66,0.46,-0.3,-0.24,0.65,-0.2,1.45,0.12,0.99,amine metabolic process;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q9P287,BCCIP,BRCA2 and CDKN1A-interacting protein (P21- and CDK-associated protein 1) (Protein TOK-1),6,29.6,30.12,28.27,28.91,29.61,29.65,29.03,29.8,30.17,29.22,28.35,27.8,28.17,28.45,29.04,1.08,-0.77,-0.13,0.56,0.61,-0.01,0.76,1.13,0.17,-0.69,-1.25,-0.87,-0.59,biological regulation;cell cycle;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cyclin-dependent protein kinase holoenzyme complex;macromolecular complex;protein complex,,,,,,,,,,
P06276,BCHE,Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase),3,7.1,,,,25.92,26,26.96,24.78,24.03,,,25.27,24.2,27.21,25.55, , , ,0.37,0.45,1.41,-0.77,-1.51, , ,-0.27,-1.34,1.66,alcohol metabolic process;amine metabolic process;cell communication;cell-cell signaling;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;drug metabolic process;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;protein metabolic process;signaling;small molecule metabolic process,cell part;extracellular space;membrane,,,,,,,,,,
P12694,BCKDHA,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)",14,45.2,29.94,29.07,27.42,28.77,25.69,28.11,28.69,28.05,29.19,29.81,28.8,28.59,27.6,28.44,1.5,0.63,-1.02,0.33,-2.75,-0.34,0.25,-0.4,0.75,1.37,0.35,0.15,-0.84,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;tricarboxylic acid cycle enzyme complex,,,,,,,,,,
O14874,BCKDK,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)",10,33.5,29.11,29.68,29.09,28.12,27.95,28.78,27.72,27.92,29.39,28.8,27.98,27.87,28.81,28.55,0.56,1.12,0.53,-0.44,-0.61,0.23,-0.84,-0.63,0.84,0.24,-0.57,-0.69,0.25,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;tricarboxylic acid cycle enzyme complex,,+,,,,,,,,
O95999,BCL10,B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10) (Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein) (hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator) (CIPER) (Cellular homolog of vCARMEN) (cCARMEN) (Cellular-E10) (c-E10) (Mammalian CARD-containing adapter molecule E10) (mE10),3,24.8,27.22,25.69,24.55,25.95,26.27,,27.65,24.79,,26.19,26.19,27.1,,26.16,1.06,-0.47,-1.61,-0.21,0.11, ,1.49,-1.37, ,0.03,0.03,0.94, ,anatomical structure formation involved in morphogenesis;biological regulation;cellular component assembly;cellular component disassembly;cellular component organization;cellular process;developmental process;immune system process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein complex assembly;protein metabolic process;regulation of protein modification process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;vacuole,,,,,,,,,,
Q07817,BCL2L1,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),4,19.4,27.1,27.76,27.55,25.37,27.4,25.65,27.05,27.81,26.21,28.18,26.39,,26.12,26.88,0.22,0.88,0.66,-1.51,0.52,-1.24,0.17,0.93,-0.68,1.29,-0.49, ,-0.76,anatomical structure development;biological regulation;cell development;cell proliferation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular process;cytokinesis;developmental process;embryo development;growth;homeostatic process;immune system process;membrane organization;mitochondrion organization;multicellular organismal process;multi-organism process;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;rhythmic process;signal transduction,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;organelle;protein complex,,,,,,,,,,
Q9BXK5,BCL2L13,Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1),17,53.4,27.92,28.52,29.09,29.84,29.55,29.94,29.64,29.56,30.31,30.24,31.24,30.08,30.68,29.74,-1.82,-1.22,-0.65,0.1,-0.19,0.2,-0.1,-0.18,0.57,0.5,1.5,0.34,0.94,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),63,50.5,31.18,30.06,31.72,30.63,31.32,31.34,31.09,30.66,31.07,31.58,30.57,30.77,30.93,30.99,0.19,-0.93,0.72,-0.37,0.32,0.35,0.1,-0.33,0.07,0.58,-0.42,-0.23,-0.07,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;response to stress;RNA metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,Other TF domain,,,,,,,,,
Q9Y276,BCS1L,Mitochondrial chaperone BCS1 (h-BCS1) (BCS1-like protein),11,36,28.7,28.66,25.94,28.28,28.84,28.08,27.85,28.34,28.2,28.5,28.78,27.97,28.03,28.17,0.53,0.49,-2.22,0.11,0.67,-0.09,-0.32,0.17,0.03,0.34,0.61,-0.2,-0.14,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein complex biogenesis,cell part;macromolecular complex;protein complex;respiratory chain complex III,,,,,,,,,,
Q02338,BDH1,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (BDH) (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase)",13,37.3,30.1,30.15,26.72,26.63,24.5,25.81,25.81,25.61,24.27,27.65,24.61,26.29,25.46,26.43,3.67,3.72,0.29,0.2,-1.93,-0.62,-0.62,-0.82,-2.16,1.22,-1.82,-0.14,-0.98,anatomical structure development;biosynthetic process;catabolic process;cellular ketone body metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9BUT1,BDH2,3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (Dehydrogenase/reductase SDR family member 6) (Oxidoreductase UCPA) (R-beta-hydroxybutyrate dehydrogenase),3,15.1,26.92,27.38,28.01,27.04,,,27.43,27.41,26.48,25.92,27.6,28.45,26.14,27.16,-0.24,0.22,0.84,-0.12, , ,0.27,0.25,-0.68,-1.24,0.44,1.28,-1.02,biological regulation;biosynthetic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;homeostatic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;pigment metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q14457,BECN1,Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197),2,22.7,24.18,23.11,25.06,23.03,25.76,23.62,24.39,23.2,24.92,,25.17,25.85,,24.39,-0.21,-1.28,0.67,-1.36,1.37,-0.77,0,-1.19,0.53, ,0.78,1.46, ,anatomical structure development;biological regulation;cell development;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;cytokinesis;developmental process;immune system process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;organelle assembly;organelle organization;response to biotic stimulus;response to chemical stimulus;response to drug;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;vacuole organization,cell part;cell projection;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;nucleus;organelle;protein complex;vesicle,,,,,,,,,,
Q9NYM9,BET1L,BET1-like protein (Golgi SNARE with a size of 15 kDa) (GOS-15) (GS15) (Vesicle transport protein GOS15),4,63.8,,22.83,,21.4,22.44,23.11,20.71,,21.24,,22.9,23.17,21.82,22.18, ,0.65, ,-0.78,0.26,0.93,-1.47, ,-0.94, ,0.72,0.99,-0.36,cellular process;endosome transport;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
O14503,BHLHE40,Class E basic helix-loop-helix protein 40 (bHLHe40) (Class B basic helix-loop-helix protein 2) (bHLHb2) (Differentially expressed in chondrocytes protein 1) (DEC1) (Enhancer-of-split and hairy-related protein 2) (SHARP-2) (Stimulated by retinoic acid gene 13 protein),2,5.6,23.23,21.65,19.92,23.27,20.89,21.46,,,,20.99,,,,21.63,1.6,0.02,-1.71,1.64,-0.74,-0.17, , , ,-0.64, , , ,biological regulation;response to abiotic stimulus;response to external stimulus;response to stimulus;rhythmic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,bHLH,,,,,,,,,
P55957,BID,BH3-interacting domain death agonist (p22 BID) (BID) [Cleaved into: BH3-interacting domain death agonist p15 (p15 BID);BH3-interacting domain death agonist p13 (p13 BID);BH3-interacting domain death agonist p11 (p11 BID)],6,49.7,28.9,29.14,27.6,29.02,27.29,,24.87,27.72,23.69,25.77,26.83,26.98,24.79,26.88,2.02,2.26,0.71,2.14,0.4, ,-2.01,0.84,-3.2,-1.11,-0.06,0.1,-2.09,anatomical structure development;biological regulation;cell death;cellular component assembly;cellular component organization;cellular membrane organization;cellular process;death;developmental process;establishment of localization;macromolecular complex assembly;membrane organization;mitochondrion organization;organelle organization;protein complex assembly;protein targeting;protein transport;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;response to chemical stimulus;response to endogenous stimulus;response to stimulus;transport,cell part;cytosol;membrane,,,,,,,,,,
O00499,BIN1,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),10,29.9,27.15,28.4,28.2,28.55,28.65,28.23,28.49,28.66,27.09,27.63,28.75,27.76,26.17,27.98,-0.83,0.42,0.23,0.58,0.67,0.25,0.51,0.68,-0.89,-0.35,0.77,-0.22,-1.81,biological regulation;cell differentiation;cell proliferation;cellular component organization;cellular membrane organization;cellular process;developmental process;endocytosis;establishment of localization;interspecies interaction between organisms;membrane invagination;membrane organization;multicellular organismal development;multicellular organismal process;multi-organism process;regulation of transport;transport;vesicle-mediated transport,cell part;cell projection;cytoplasm;cytoplasmic membrane-bounded vesicle;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;nucleus;organelle;vesicle,,,,,,,,,,
Q13867,BLMH,Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40),6,17.6,27.97,29.49,28.22,29.36,28.65,28.1,28.96,28.95,27.67,27.94,28.53,28.29,26.67,28.37,-0.4,1.12,-0.15,0.99,0.28,-0.27,0.59,0.59,-0.7,-0.43,0.16,-0.08,-1.7,cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;response to chemical stimulus;response to drug;response to stimulus,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P53004,BLVRA,Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase),11,44.3,27.93,30.58,30.64,30.04,29.14,28.86,29.44,29.4,28.41,27.28,29.99,29.75,27.7,29.17,-1.24,1.42,1.47,0.87,-0.02,-0.31,0.27,0.24,-0.76,-1.89,0.82,0.59,-1.46,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;pigment metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P30043,BLVRB,Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR),13,63.6,31.47,31.44,32.2,29.5,27.17,25.3,28.14,28.37,26.45,24.79,29.08,29.54,26.92,28.49,2.98,2.95,3.71,1.01,-1.32,-3.19,-0.35,-0.12,-2.04,-3.7,0.59,1.05,-1.57,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;pigment metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9NSY1,BMP2K,BMP-2-inducible protein kinase (BIKe) (EC 2.7.11.1),4,5.5,25.08,26.25,27.49,26.04,,22.48,26.79,22.18,26.46,22.9,23.21,26.91,24.89,25.06,0.02,1.19,2.43,0.98, ,-2.57,1.73,-2.87,1.4,-2.16,-1.85,1.85,-0.16,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q14692,BMS1,Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog),20,20.5,29.33,28.03,30.7,29.67,28.86,28.84,29.24,27.24,28.8,29.41,27.46,28.72,29.04,28.87,0.45,-0.84,1.83,0.79,-0.02,-0.03,0.37,-1.64,-0.07,0.54,-1.41,-0.15,0.17,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;organelle assembly;ribonucleoprotein complex assembly;ribosome assembly,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q12981,BNIP1,Vesicle transport protein SEC20 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 1) (Transformation-related gene 8 protein) (TRG-8),5,17.1,27.01,27.72,25.54,26.09,24.66,27.31,27.47,26.81,28.05,28.45,28.22,26.49,27.14,27,0.01,0.72,-1.46,-0.91,-2.34,0.31,0.48,-0.19,1.05,1.45,1.22,-0.5,0.15,autophagy;biological regulation;catabolic process;cell death;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;death;endoplasmic reticulum organization;establishment of localization;membrane fusion;membrane organization;metabolic process;organelle fusion;organelle organization;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nuclear envelope;organelle;protein complex,,,,,,,,,,
Q12982,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,3,8,24.27,24.76,,24.85,,24.47,25.57,25.35,25.67,,25.23,25.58,24.59,25.03,-0.76,-0.28, ,-0.19, ,-0.56,0.53,0.31,0.64, ,0.19,0.55,-0.44,biological regulation;cell death;cell differentiation;cellular process;death;developmental process,cell part;cytosol;nuclear envelope,,,,,,,,,,
Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),19,8.2,25.17,24.15,25.26,24.62,19.56,,25.36,19.13,25.46,24.71,23.12,27.25,23.85,23.97,1.2,0.18,1.29,0.65,-4.41, ,1.39,-4.84,1.49,0.74,-0.85,3.28,-0.12,,,,,,,,,,,,
Q9H3K6,BOLA2,BolA-like protein 2,6,72.1,28.85,30.08,27.73,29.5,27.73,25.15,28.66,28.58,23.92,27.99,28.49,29.15,24.37,27.71,1.14,2.37,0.02,1.79,0.02,-2.55,0.96,0.87,-3.79,0.28,0.78,1.45,-3.34,,,,,,,,,,,,
Q14137,BOP1,Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein),15,28.2,28.06,27.39,27.5,28.3,29.12,29.48,28.59,27.61,28.85,29.23,27.26,27.76,29.15,28.33,-0.27,-0.94,-0.83,-0.03,0.79,1.14,0.26,-0.72,0.52,0.9,-1.07,-0.57,0.82,biological regulation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;RNA metabolic process;RNA processing;rRNA processing,cell part;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P17213,BPI,Bactericidal permeability-increasing protein (BPI) (CAP 57),4,8.2,25.79,26.26,27.29,,24.92,26.53,24.79,25.39,26.92,26.14,,26.52,26.35,26.08,-0.29,0.18,1.21, ,-1.16,0.45,-1.29,-0.69,0.84,0.06, ,0.44,0.27,biological regulation;immune system process;multi-organism process;response to biotic stimulus;response to stimulus;response to stress,cell part;cytoplasm;extracellular region,,,,,,,,,,
O95861,BPNT1,"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)",13,54.9,29.43,29.67,30.86,29.65,29.12,28.63,29.56,29.55,28.66,29.33,30.05,29.48,27.56,29.35,0.08,0.32,1.51,0.3,-0.23,-0.72,0.21,0.2,-0.69,-0.02,0.7,0.13,-1.79,anatomical structure development;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;phosphorus metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,+,,,,,,,
Q12830,BPTF,Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen),11,5.9,25.38,24.59,26.14,24.29,25.8,25.77,25.33,22.48,25,25.78,26.09,25.97,26.33,25.3,0.08,-0.71,0.84,-1.02,0.5,0.47,0.02,-2.82,-0.3,0.48,0.78,0.67,1.02,anatomical structure development;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;chromatin remodeling complex;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q7Z569,BRAP,BRCA1-associated protein (EC 6.3.2.-) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (Renal carcinoma antigen NY-REN-63),3,6.2,25.91,27.24,27.34,25.55,20.75,26.76,23.17,23.17,,24.82,25.47,23.51,21.66,24.61,1.3,2.63,2.73,0.94,-3.86,2.14,-1.44,-1.44, ,0.21,0.85,-1.1,-2.96,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
P46736,BRCC3,Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36),6,34,27.5,28.35,28.81,28.42,26.96,26.86,28.33,27.1,27.15,27.65,24.79,29,25.53,27.42,0.08,0.93,1.39,1,-0.46,-0.56,0.91,-0.32,-0.27,0.23,-2.63,1.58,-1.89,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA repair;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;regulation of cell cycle;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
P25440,BRD2,Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein),5,13.1,27.33,25.99,25.5,25.36,25.83,24.71,,,,,,,26.38,25.87,1.46,0.12,-0.37,-0.51,-0.04,-1.16, , , , , , ,0.51,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q15059,BRD3,Bromodomain-containing protein 3 (RING3-like protein),6,10.2,28.03,27.86,28.96,26.92,,,29.33,,28.62,28.92,29.9,,,28.57,-0.53,-0.71,0.39,-1.65, , ,0.77, ,0.05,0.35,1.33, , ,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
O60885,BRD4,Bromodomain-containing protein 4 (Protein HUNK1),12,12,30.18,27.33,28.28,27.81,27.57,28.42,27.78,,28.48,27.7,26.7,25.14,28.29,27.81,2.38,-0.48,0.47,0.01,-0.24,0.61,-0.03, ,0.67,-0.11,-1.11,-2.67,0.49,biological regulation;cell proliferation;cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;chromosome segregation;histone modification;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein acylation;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of mitotic cell cycle,cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nuclear chromosome;organelle,,+,,,,,,,,
Q9NXR7,BRE,BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein),4,14.1,27.56,27.15,26.33,27.15,25.6,26.47,26.42,27.6,25.58,26.89,27.62,27.69,26.17,26.79,0.77,0.36,-0.45,0.36,-1.19,-0.31,-0.37,0.82,-1.2,0.1,0.83,0.9,-0.62,biological regulation;cell death;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;death;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoplasm;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q8WY22,BRI3BP,BRI3-binding protein (I3-binding protein) (Cervical cancer 1 proto-oncogene-binding protein KG19) (HCCRBP-1),3,21.5,25.4,27.27,25.69,26.08,27.92,27.22,26.5,26.47,25.89,27.11,,,25.9,26.5,-1.1,0.78,-0.81,-0.42,1.42,0.73,0,-0.03,-0.6,0.62, , ,-0.59,,cell part;membrane,,,,,,,,,,
Q8TDN6,BRIX1,Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2),13,51.3,30.58,29.51,29.3,30.53,30.99,31.09,30.52,30.56,31.13,30.99,29.45,30.7,30.29,30.43,0.14,-0.92,-1.13,0.1,0.55,0.65,0.09,0.13,0.7,0.55,-0.98,0.27,-0.14,cellular process;ribosome biogenesis,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8WUW1,BRK1,Protein BRICK1 (BRK1),2,28,26.71,27.51,26.1,28.06,25.42,25.52,27.7,26.26,27.29,27.16,27.08,27.47,25.32,26.74,-0.02,0.77,-0.64,1.32,-1.32,-1.21,0.96,-0.48,0.55,0.42,0.34,0.73,-1.42,biological regulation;cell motility;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;embryo development;immune system process;locomotion;organelle organization;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q5VW32,BROX,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),4,17.4,28.07,27.07,28.85,27.46,27.49,26.41,27.83,28.57,26.71,25.39,27,29.03,26.01,27.37,0.69,-0.31,1.48,0.08,0.11,-0.96,0.45,1.2,-0.67,-1.99,-0.38,1.65,-1.37,,cell part;membrane,,,,,,,,,,
P35613,BSG,Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147),10,46.5,29.38,31.81,30.53,31.33,31.86,32.09,31.38,31.11,31.64,31.11,31.06,30.71,32.17,31.24,-1.87,0.56,-0.72,0.09,0.62,0.85,0.13,-0.13,0.4,-0.14,-0.19,-0.53,0.93,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell motility;cellular component movement;cellular ketone metabolic process;cellular metabolic process;cellular process;coagulation;developmental process;immune system process;locomotion;metabolic process;multicellular organismal process;organic acid metabolic process;regulation of body fluid levels;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane;vesicle,,,,,,,,,,
Q10588,BST1,ADP-ribosyl cyclase 2 (EC 3.2.2.5) (Bone marrow stromal antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPr hydrolase 2) (CD antigen CD157),6,26.5,24.74,28.95,28.28,28.23,28.25,28.13,26.75,27.49,28.78,24.97,28.15,29.19,28.46,27.72,-2.98,1.23,0.56,0.5,0.53,0.41,-0.98,-0.23,1.06,-2.75,0.43,1.47,0.74,developmental process;immune system process;multicellular organismal development;multicellular organismal process;response to stimulus,cell part;membrane;plasma membrane,,,,,,,,,,
Q10589,BST2,Bone marrow stromal antigen 2 (BST-2) (HM1.24 antigen) (Tetherin) (CD antigen CD317),5,35.6,,28.98,30.24,30.09,28.52,21.49,28.66,20.45,,28.12,24.41,21.4,24.75,26.1, ,2.88,4.14,3.99,2.42,-4.61,2.56,-5.65, ,2.01,-1.69,-4.7,-1.35,biological regulation;cell activation;cell communication;cell proliferation;cell-cell signaling;cellular process;developmental process;immune system process;multicellular organismal development;multicellular organismal process;multi-organism process;regulation of organelle organization;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signaling,cell part;cell surface;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O14981,BTAF1,TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172),7,5.2,27.07,25.37,22.94,25.01,28.46,27.81,26.67,26.85,26.57,26.67,26.37,27.76,26.14,26.44,0.63,-1.07,-3.49,-1.43,2.02,1.37,0.23,0.41,0.13,0.24,-0.06,1.32,-0.29,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P20290,BTF3,Transcription factor BTF3 (RNA polymerase B transcription factor 3),13,67,29.23,29.42,30.36,30.67,33.03,31.24,32.64,32.45,30.24,32.21,32.81,34,31.71,31.54,-2.3,-2.12,-1.17,-0.87,1.49,-0.3,1.1,0.92,-1.3,0.67,1.27,2.46,0.17,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96K17,BTF3L4,Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4),8,47.1,30.09,29.76,30.78,28.96,30.49,28.59,30.13,30.21,29.03,29.89,30.14,32.03,28.32,29.88,0.21,-0.12,0.9,-0.92,0.62,-1.29,0.25,0.33,-0.85,0.01,0.26,2.15,-1.56,,,,,,,,,,,,
Q7KYR7,BTN2A1,Butyrophilin subfamily 2 member A1,3,9.6,27.14,26.32,27.57,26.81,27.13,26.82,25.3,24.82,26.89,27.44,25.59,25.48,26.76,26.47,0.67,-0.15,1.11,0.34,0.66,0.35,-1.17,-1.64,0.42,0.97,-0.87,-0.99,0.3,lipid metabolic process;metabolic process;primary metabolic process,cell part,,,,,,,,,,
O00478,BTN3A3,Butyrophilin subfamily 3 member A3,2,5.2,25.75,26.39,24.5,24.43,,25.09,,,26.41,24.08,,25.74,,25.3,0.45,1.09,-0.8,-0.87, ,-0.21, , ,1.11,-1.22, ,0.44, ,immune system process;response to stimulus,cell part;membrane;plasma membrane,,,,,,,,,,
O43684,BUB3,Mitotic checkpoint protein BUB3,14,48.2,31.11,30.24,30.3,30.8,31.41,31.4,30.96,30.75,30.8,30.16,30.09,28.39,30.9,30.56,0.54,-0.32,-0.26,0.24,0.85,0.83,0.39,0.19,0.24,-0.4,-0.48,-2.17,0.34,biological regulation;catabolic process;cell division;cellular component organization;cellular metabolic process;cellular process;chromosome organization;chromosome segregation;cytoskeleton organization;macromolecule metabolic process;meiosis;metabolic process;organelle organization;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P41223,BUD31,Protein BUD31 homolog (Protein EDG-2) (Protein G10 homolog),6,44.4,27.71,26.02,27.49,25.39,27.24,27.52,25.81,26.32,26.36,26.61,25.43,26.71,25.53,26.47,1.23,-0.45,1.02,-1.08,0.77,1.05,-0.66,-0.15,-0.11,0.14,-1.04,0.24,-0.94,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q13895,BYSL,Bystin,10,28.1,27.94,26.81,27.13,28.52,27.89,27.9,28.44,28.26,28.51,27.69,26.49,27.45,27.5,27.73,0.2,-0.92,-0.6,0.79,0.16,0.17,0.71,0.52,0.77,-0.04,-1.24,-0.29,-0.23,biological adhesion;cell adhesion;cellular process;multi-organism process;ribosome biogenesis,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q7L1Q6,BZW1,Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf),20,39.7,30.58,30.58,31.52,30.93,31.09,30.79,30.98,31.75,29.6,30.18,30.92,31.29,30.65,30.84,-0.25,-0.25,0.68,0.09,0.26,-0.04,0.15,0.91,-1.24,-0.66,0.09,0.45,-0.19,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm,,,,,,,,,,
Q9H0W9,C11orf54,Ester hydrolase C11orf54 (EC 3.1.-.-),9,26,30.15,28.15,28.7,25.31,,,23.71,25.36,,23.49,,25.97,,26.35,3.79,1.8,2.34,-1.04, , ,-2.65,-1, ,-2.87, ,-0.38, ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H3H3,C11orf68,UPF0696 protein C11orf68 (Basophilic leukemia-expressed protein Bles03) (Protein p5326),4,17.9,25.63,27.32,,25.94,,,26.03,26.29,25.73,,,25.88,,26.12,-0.49,1.2, ,-0.18, , ,-0.08,0.17,-0.39, , ,-0.23, ,,,,,,,,,,,,
Q9HB07,C12orf10,"UPF0160 protein MYG1, mitochondrial",11,33.8,30.64,28.67,27.34,28.76,28.48,29.04,29.87,28.7,28.35,26.47,28.28,29.57,28.25,28.65,1.99,0.02,-1.31,0.11,-0.16,0.39,1.22,0.05,-0.29,-2.18,-0.37,0.92,-0.4,pigmentation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q8WUH6,C12orf23,UPF0444 transmembrane protein C12orf23,4,60.3,28.38,28.27,28.39,29.06,28.97,28.36,28.42,29.1,29.12,,29,29.32,28.12,28.71,-0.33,-0.44,-0.32,0.36,0.26,-0.35,-0.29,0.39,0.41, ,0.29,0.62,-0.59,,cell part,,,,,,,,,,
Q9UKR5,C14orf1,Probable ergosterol biosynthetic protein 28,2,16.5,26.32,27.1,25.42,28.03,27.02,27.63,26.13,,27.36,27.37,27.99,,28.99,27.21,-0.89,-0.11,-1.79,0.81,-0.2,0.41,-1.09, ,0.15,0.15,0.78, ,1.78,alcohol metabolic process;biosynthetic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q9BXV9,C14orf142,Uncharacterized protein C14orf142,4,69,29.4,27.92,27.14,27.48,29.02,29.05,28.26,28.11,26.09,27.15,29.01,29.24,27.91,28.14,1.27,-0.22,-1,-0.66,0.89,0.91,0.12,-0.03,-2.04,-0.99,0.87,1.11,-0.23,,,,,,,,,,,,
Q7Z3D6,C14orf159,"UPF0317 protein C14orf159, mitochondrial",6,14.2,27.22,27.69,28.5,24.94,28.28,18.96,24.41,27.96,28.32,29.86,25.48,26.13,,26.48,0.74,1.21,2.03,-1.54,1.8,-7.52,-2.07,1.48,1.84,3.38,-0.99,-0.35, ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9Y224,C14orf166,UPF0568 protein C14orf166 (CLE7 homolog) (CLE),17,71.3,31.35,31.49,30.6,31.52,31.82,31.82,31.71,31.68,31.79,30.89,31.48,30.49,31.78,31.42,-0.07,0.07,-0.81,0.11,0.4,0.4,0.29,0.27,0.38,-0.53,0.07,-0.93,0.37,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex,,,,,,,,,,
Q6ZUT6,C15orf52,Uncharacterized protein C15orf52,6,15.5,29.09,30.93,29.63,30.04,29.75,29.39,29.1,29.05,29.82,29.37,29.18,,20.39,28.81,0.28,2.12,0.82,1.23,0.94,0.58,0.28,0.24,1.01,0.56,0.37, ,-8.42,,,,,,,,,,,,
Q96GQ5,C16orf58,UPF0420 protein C16orf58,6,15.5,28.12,28.15,,26.36,,25.22,24.78,,27.23,23.66,25.67,,27.23,26.27,1.85,1.88, ,0.09, ,-1.05,-1.49, ,0.96,-2.6,-0.6, ,0.96,,cell part,,,,,,,,,,
Q7Z3J2,C16orf62,UPF0505 protein C16orf62 (Esophageal cancer-associated protein),14,18.9,25.28,28.7,28.92,28.65,27.25,26.08,28.2,28.43,26.31,26.83,28.91,28.86,26.55,27.61,-2.33,1.08,1.31,1.04,-0.36,-1.53,0.59,0.82,-1.3,-0.78,1.3,1.24,-1.06,,cell part,,,,,,,,,,
J3KTF4,C17orf62,Uncharacterized protein C17orf62 (Fragment),5,60.2,25.4,27.59,27.37,26.32,19.3,25.38,26.05,19.83,26.1,26.76,27.58,21.88,27.6,25.17,0.23,2.42,2.21,1.15,-5.86,0.22,0.88,-5.33,0.93,1.59,2.41,-3.28,2.43,,,,,,,,,,,,
Q9HAS0,C17orf75,Protein Njmu-R1,4,9.3,24.19,24.44,22.16,21.66,25.61,22.28,25.69,25.04,25.28,,25.57,25.41,24.7,24.34,-0.14,0.11,-2.18,-2.68,1.28,-2.05,1.36,0.7,0.95, ,1.23,1.07,0.36,multicellular organismal process,,,,,,,,,,,
Q969H8,C19orf10,UPF0556 protein C19orf10 (Interleukin-25) (IL-25) (Stromal cell-derived growth factor SF20),9,32.4,30.07,31.52,31.88,31.46,32.54,32.53,31.72,31.96,32.58,32.86,31.64,30.55,33.07,31.88,-1.81,-0.36,0,-0.42,0.67,0.65,-0.15,0.09,0.7,0.99,-0.24,-1.32,1.19,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;regulation of protein modification process,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9UFG5,C19orf25,UPF0449 protein C19orf25,3,42.4,24.83,25.56,22.57,25.98,25.66,24.68,26.45,27.22,27.77,25.83,27.53,26.49,26.32,25.92,-1.09,-0.35,-3.35,0.07,-0.25,-1.23,0.53,1.3,1.86,-0.08,1.61,0.58,0.41,,,,,,,,,,,,
Q9BQ61,C19orf43,Uncharacterized protein C19orf43,5,54,27.49,25.14,26.2,26.48,26.34,25.98,25.92,26.18,27.29,24.72,24.56,,,26.03,1.47,-0.89,0.17,0.45,0.32,-0.05,-0.11,0.15,1.26,-1.31,-1.47, , ,,,,,,,,,,,,
Q9UNZ5,C19orf53,Leydig cell tumor 10 kDa protein homolog,2,8.1,28.37,25.23,27.73,26.64,22.81,23.68,25.46,25.71,25.86,25.07,,,,25.66,2.71,-0.43,2.08,0.99,-2.84,-1.97,-0.19,0.05,0.2,-0.59, , , ,,,,,,,,,,,,
Q9NUL5,C19orf66,UPF0515 protein C19orf66,3,18,26.06,26.17,29.03,25.75,25.31,23.04,26.19,,25.37,27.18,26.64,28.71,22.49,25.99,0.07,0.17,3.04,-0.25,-0.69,-2.96,0.2, ,-0.62,1.19,0.65,2.71,-3.51,,,,,,,,,,,,
Q9NS00,C1GALT1,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)",2,8.4,22.87,24.99,26.31,25.02,,22.17,24.07,22.38,22.95,26.21,25.41,27.75,23.73,24.49,-1.62,0.5,1.82,0.54, ,-2.32,-0.41,-2.11,-1.54,1.72,0.92,3.26,-0.76,anatomical structure development;anatomical structure formation involved in morphogenesis;carbohydrate metabolic process;cell differentiation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q96EU7,C1GALT1C1,"C1GALT1-specific chaperone 1 (C38H2-like protein 1) (C38H2-L1) (Core 1 beta1,3-galactosyltransferase 2) (C1Gal-T2) (C1GalT2) (Core 1 beta3-Gal-T2) (Core 1 beta3-galactosyltransferase-specific molecular chaperone)",2,7.9,,23.44,23.96,23.86,,,24.61,,22.1,22.02,23.42,,23.81,23.4, ,0.03,0.56,0.46, , ,1.21, ,-1.3,-1.38,0.02, ,0.41,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q9NWV4,C1orf123,UPF0587 protein C1orf123,4,40,27.86,28.54,27.23,28.29,22.4,26.47,26.58,28.24,26.24,25.22,26.96,28.6,24.66,26.71,1.15,1.82,0.52,1.57,-4.31,-0.24,-0.14,1.53,-0.47,-1.49,0.25,1.89,-2.06,,,,,,,,,,,,
P02746,C1QB,Complement C1q subcomponent subunit B,3,16.2,,28.37,27.36,,24.75,25.52,,23.64,,25.38,,,25.55,25.8, ,2.58,1.57, ,-1.04,-0.28, ,-2.16, ,-0.42, , ,-0.25,anatomical structure development;biological regulation;developmental process;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;response to stimulus;response to stress,macromolecular complex;protein complex,,,,,,,,,,
Q07021,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33)",10,53.9,31.5,33.01,32.06,32.44,32.29,32.7,32.44,32.31,32.79,32.83,32.08,32.59,32.54,32.43,-0.93,0.58,-0.37,0.01,-0.14,0.27,0.01,-0.11,0.36,0.4,-0.35,0.17,0.11,biological regulation;biosynthetic process;cell death;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle assembly;primary metabolic process;protein metabolic process;regulation of organelle organization;regulation of translation;response to stimulus;response to stress;ribonucleoprotein complex assembly;ribosome assembly;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;cell surface;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleolus;nucleus;organelle;plasma membrane,,,,,,,,,,
Q96MY1,C20orf112,Uncharacterized protein C20orf112,7,23.9,25.38,24.37,25.08,24.78,27.09,26.9,22.76,25.48,26.64,24.74,25.21,25.17,26.07,25.36,0.02,-0.99,-0.28,-0.58,1.73,1.54,-2.6,0.12,1.28,-0.62,-0.15,-0.19,0.71,,,,,,,,,,,,
Q9BUV8,C20orf24,Uncharacterized protein C20orf24 (Rab5-interacting protein) (RIP5),3,31,25.73,27.14,27.99,26.62,27.21,27.12,25.67,27.38,27.19,27.47,27.92,,,27.04,-1.31,0.1,0.95,-0.42,0.17,0.08,-1.37,0.34,0.15,0.43,0.88, , ,,,,,,,,,,,,
P30042,C21orf33,"ES1 protein homolog, mitochondrial (Protein GT335) (Protein KNP-I)",16,63.8,31.16,32.38,31.2,30.13,29.45,30.87,30.4,30.11,31.25,31.19,31.21,31.11,31.3,30.91,0.26,1.47,0.3,-0.78,-1.45,-0.03,-0.5,-0.79,0.35,0.28,0.3,0.21,0.4,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O14523,C2CD2L,C2 domain-containing protein 2-like (Transmembrane protein 24),5,8.9,24.73,23.99,25.03,23.31,23.7,23.83,23.14,23.76,24.09,23.39,,24.15,23.94,23.92,0.81,0.06,1.11,-0.61,-0.22,-0.09,-0.78,-0.16,0.17,-0.53, ,0.23,0.02,,cell part,,,,,,,,,,
Q9H6V9,C2orf43,UPF0554 protein C2orf43,2,7.4,,25.45,25.65,24.86,25.79,27.21,,,,28.2,27.3,,27.04,26.44, ,-0.99,-0.78,-1.58,-0.65,0.78, , , ,1.76,0.86, ,0.6,,,,,,,,,,,,
Q8WWC4,C2orf47,"Uncharacterized protein C2orf47, mitochondrial",6,24.1,28.69,28.88,28.85,28.36,29.1,28.87,28.52,28.38,28.22,28.99,28.48,28.18,28.57,28.62,0.07,0.26,0.22,-0.26,0.47,0.25,-0.1,-0.24,-0.4,0.36,-0.14,-0.45,-0.05,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9BVC5,C2orf49,Ashwin,4,21.6,26.1,,26.99,26.53,,24.29,25.59,,27.06,26.87,,24.42,,25.98,0.12, ,1.01,0.55, ,-1.69,-0.4, ,1.08,0.89, ,-1.56, ,,cell part;macromolecular complex;protein complex,,,,,,,,,,
P01024,C3,Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain;Complement C3 alpha chain;C3a anaphylatoxin;Acylation stimulating protein (ASP) (C3adesArg);Complement C3b alpha' chain;Complement C3c alpha' chain fragment 1;Complement C3dg fragment;Complement C3g fragment;Complement C3d fragment;Complement C3f fragment;Complement C3c alpha' chain fragment 2],64,44.7,33.61,32.67,31.21,31.44,31.7,32.76,30.67,31.82,32.37,32.64,32.15,31.23,32.82,32.08,1.53,0.59,-0.87,-0.65,-0.38,0.67,-1.42,-0.26,0.29,0.55,0.07,-0.85,0.74,biological regulation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;immune system process;lipid metabolic process;macromolecule metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;regulation of protein modification process;regulation of transport;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;extracellular organelle;extracellular space;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9NWY4,C4orf27,UPF0609 protein C4orf27,2,8.4,23.07,24.21,24.48,24.55,25.58,,26.56,24.7,24.9,,,,,24.76,-1.69,-0.55,-0.27,-0.21,0.83, ,1.81,-0.06,0.14, , , , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8WVX3,C4orf3,Uncharacterized protein C4orf3 (Hepatitis C virus F protein-transactivated protein 1) (HCV F-transactivated protein 1),3,25.8,,24.85,,,22.47,22.12,24.54,,21.82,28.52,,26.35,22.08,24.09, ,0.76, , ,-1.63,-1.97,0.45, ,-2.28,4.43, ,2.26,-2.01,,cell part,,,,,,,,,,
Q49AR2,C5orf22,UPF0489 protein C5orf22,2,6.1,25.34,25.48,25.41,24.11,25.15,26.46,26.08,25.84,25.89,,,24.72,25.72,25.47,-0.14,0.01,-0.06,-1.36,-0.32,0.99,0.61,0.37,0.42, , ,-0.76,0.25,,,,,,,,,,,,
Q5T0Z8,C6orf132,Uncharacterized protein C6orf132,17,22.1,28.63,25.56,29.44,,26.19,,26.1,25.06,,28.91,27.29,,26.73,27.1,1.53,-1.55,2.34, ,-0.91, ,-1,-2.04, ,1.81,0.19, ,-0.37,,,,,,,,,,,,
Q9P0P8,C6orf203,Uncharacterized protein C6orf203,3,21.7,24.94,24.68,25.56,20.21,26.52,25.46,22.05,21.35,23.03,23.64,25.5,23,26.75,24.05,0.89,0.63,1.5,-3.84,2.46,1.4,-2,-2.71,-1.02,-0.41,1.45,-1.06,2.7,,,,,,,,,,,,
Q9H993,C6orf211,UPF0364 protein C6orf211,11,31.3,29.44,28.24,29.28,29.04,28.17,27.8,29.23,29.72,25.86,26.71,28.37,29.05,26.84,28.29,1.15,-0.05,0.99,0.75,-0.12,-0.49,0.94,1.43,-2.43,-1.58,0.08,0.76,-1.45,,,,,,,,,,,,
Q9BRJ6,C7orf50,Uncharacterized protein C7orf50,6,40.6,24.91,23.85,,26.09,,27.29,26.39,,26.36,26.81,,,,25.96,-1.05,-2.1, ,0.13, ,1.33,0.43, ,0.4,0.85, , , ,,,,,,,,,,,,
Q6P1X6,C8orf82,UPF0598 protein C8orf82,3,22.1,27.33,27.05,25.1,26.68,,26.89,,,25.09,25.11,24.92,,,26.02,1.31,1.03,-0.92,0.65, ,0.87, , ,-0.93,-0.91,-1.1, , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96LW7,C9orf89,Bcl10-interacting CARD protein (BinCARD),5,26.8,27.55,27.4,26.31,26.5,27.54,27.71,27,26.22,28.96,25.52,26.58,27.16,27.74,27.09,0.46,0.31,-0.78,-0.59,0.45,0.62,-0.09,-0.87,1.87,-1.57,-0.51,0.07,0.65,biological regulation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43570,CA12,Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3),7,32.9,29.15,30.49,28.9,27.71,,28.22,25.16,25.32,29.18,,26.64,28.9,27.39,27.91,1.23,2.57,0.99,-0.21, ,0.3,-2.76,-2.59,1.27, ,-1.27,0.98,-0.52,cellular metabolic process;cellular process;establishment of localization;ion transport;metabolic process;one-carbon metabolic process;small molecule metabolic process;transport,cell part;membrane;plasma membrane,,,,,,,,,,
P00918,CA2,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II),12,59.6,27.95,27.91,25.96,24.57,31.38,30.38,31.24,31.9,31.07,32.01,30.89,26.22,29.17,29.28,-1.33,-1.37,-3.32,-4.71,2.1,1.1,1.96,2.62,1.79,2.73,1.61,-3.06,-0.11,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular metabolic process;cellular process;developmental process;establishment of localization;gas transport;ion transport;metabolic process;one-carbon metabolic process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;secretion;small molecule metabolic process;transport,apical part of cell;cell part;cell projection;cytosol;extracellular space;microvillus;neuron projection,,,,,,,,,,
Q16790,CA9,Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1),13,51.9,24.35,31.26,25.95,26.14,25.35,,,,26.44,,,26.79,,26.61,-2.26,4.65,-0.66,-0.47,-1.26, , , ,-0.17, , ,0.17, ,anatomical structure morphogenesis;cellular metabolic process;cellular process;developmental process;establishment of localization;ion transport;metabolic process;one-carbon metabolic process;secretion;small molecule metabolic process;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle;plasma membrane,,,,,,,,,,
Q9H8G2,CAAP1,Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein) (CAAP),5,17.7,24.44,25.48,,24.91,25.08,25.53,,,25.36,25.72,24.42,,25.33,25.14,-0.7,0.34, ,-0.23,-0.06,0.39, , ,0.22,0.58,-0.72, ,0.19,cell death;cellular process;death,,,,,,,,,,,
Q9Y376,CAB39,Calcium-binding protein 39 (MO25alpha) (Protein Mo25),14,32.3,29.73,28.99,29.76,29.5,29.43,28.07,29.06,29.19,27.6,29.3,29.03,29.96,26.85,28.96,0.77,0.03,0.81,0.54,0.47,-0.89,0.1,0.24,-1.36,0.34,0.07,1,-2.11,biological regulation;cellular process;regulation of cell cycle;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
P54289,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1;Voltage-dependent calcium channel subunit delta-1],13,17.1,,29.26,24.5,28.4,28.24,28.87,28.94,27.03,27.73,,28.83,27.15,28.37,27.94, ,1.33,-3.44,0.46,0.3,0.93,1,-0.91,-0.21, ,0.89,-0.79,0.43,biological regulation;regulation of transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;voltage-gated calcium channel complex,,,,,,,,,,
Q9HB71,CACYBP,Calcyclin-binding protein (CacyBP) (hCacyBP) (S100A6-binding protein) (Siah-interacting protein),24,80.3,32.16,31.42,33.26,32.1,32.35,30.44,32.28,31.88,33.36,30.32,31.55,32.01,29.52,31.74,0.42,-0.32,1.52,0.36,0.6,-1.3,0.54,0.14,1.62,-1.42,-0.19,0.27,-2.23,aging;biological regulation;cell differentiation;cellular process;developmental process;regulation of DNA metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell body;cell part;cell projection;macromolecular complex;neuron projection;protein complex,,,,,,,,,,
P27708,CAD,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5);Aspartate carbamoyltransferase (EC 2.1.3.2);Dihydroorotase (EC 3.5.2.3)],40,26,30.85,30.46,29.92,31.05,31.19,29.76,31.54,31.95,29.6,29.56,30.45,31.48,29.61,30.57,0.28,-0.11,-0.65,0.48,0.62,-0.81,0.97,1.39,-0.97,-1,-0.12,0.91,-0.96,amine metabolic process;anatomical structure morphogenesis;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;drug metabolic process;embryo development;establishment of localization;heterocycle metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;secretion;small molecule metabolic process;transport,cell body;cell part;cytosol;macromolecular complex;neuronal cell body;protein complex,,,,,,,,,,
Q9BY67,CADM1,Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1),4,11.4,27.61,24.45,,,,24.85,26.12,25.77,27.79,,,22.48,,25.58,2.03,-1.13, , , ,-0.73,0.54,0.19,2.2, , ,-3.11, ,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell death;cell differentiation;cell growth;cell junction organization;cell morphogenesis;cell recognition;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;death;detection of stimulus;developmental process;growth;multicellular organismal process;regulation of transport;response to stimulus,cell part;cell projection;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;organelle;vesicle,,,,,,,,,,
Q8N126,CADM3,Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1),11,42.5,25.43,28.76,22.87,31.55,25.95,28.58,28.61,25.55,25.23,,28.62,,28.07,27.2,-1.77,1.55,-4.33,4.35,-1.25,1.38,1.4,-1.65,-1.97, ,1.42, ,0.87,biological adhesion;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process;localization,cell part;membrane;plasma membrane,,,,,,,,,,
P05937,CALB1,"Calbindin (Calbindin D28) (D-28K) (Vitamin D-dependent calcium-binding protein, avian-type)",2,9.6,26.11,26,26.36,26.14,,,26.32,24.77,27.33,27.19,26.38,26.69,26.73,26.37,-0.26,-0.37,0,-0.23, , ,-0.05,-1.6,0.97,0.83,0.02,0.33,0.36,anatomical structure development;anatomical structure formation involved in morphogenesis;behavior;biological regulation;cellular process;developmental process;multicellular organismal process;neurological system process;response to chemical stimulus;response to stimulus,cell body;cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;neuronal cell body;nucleus;organelle,,,,,,,,,,
P22676,CALB2,Calretinin (CR) (29 kDa calbindin),15,54.6,26.09,30.48,32.79,30.92,28.91,28.21,30.15,28.96,27.51,28.57,31.63,33.89,28.6,29.75,-3.66,0.73,3.04,1.17,-0.84,-1.54,0.4,-0.79,-2.23,-1.17,1.88,4.14,-1.14,,cell part;cytoplasm,,,,,,,,,,
Q13137,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2 (Antigen nuclear dot 52 kDa protein) (Nuclear domain 10 protein NDP52) (Nuclear domain 10 protein 52) (Nuclear dot protein 52),3,5.3,,,27.93,25.35,26.65,,26.54,25.16,,27.08,,25,25.65,26.17, , ,1.76,-0.82,0.48, ,0.37,-1.01, ,0.91, ,-1.17,-0.52,response to chemical stimulus;response to stimulus;viral reproduction,cell part;cytoskeleton;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q05682,CALD1,Caldesmon (CDM),62,75.3,25.43,24.51,,27.12,,,,,,,25.84,28.03,,26.19,-0.75,-1.67, ,0.93, , , , , , ,-0.35,1.85, ,cellular component movement;cellular process;multicellular organismal process;muscle contraction,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P62158,CALM1,Calmodulin (CaM),17,85.9,34.01,34.19,33.98,34.24,33.54,34.14,33.94,33.8,33.91,33.52,34.44,34.66,34.15,34.04,-0.03,0.15,-0.06,0.2,-0.5,0.1,-0.1,-0.24,-0.13,-0.52,0.4,0.62,0.11,alcohol metabolic process;biological regulation;carbohydrate metabolic process;catabolic process;cell activation;cell communication;cell-cell signaling;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;detection of stimulus;energy reserve metabolic process;establishment of localization;exocytosis;generation of precursor metabolites and energy;immune system process;macromolecule metabolic process;membrane organization;metabolic process;multicellular organismal process;muscle contraction;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;secretion;signal transduction;signaling;small molecule metabolic process;transport;vesicle-mediated transport,cell part;centrosome;cytosol;extracellular region;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;nucleoplasm;organelle;plasma membrane;protein complex,,,,,,,,,,
P27797,CALR,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60),53,91.6,36.36,36.23,37.23,35.76,35.45,35.71,35.47,34.98,35.97,35.89,35.59,35.78,35.06,35.81,0.55,0.42,1.42,-0.05,-0.36,-0.1,-0.34,-0.83,0.17,0.08,-0.21,-0.02,-0.74,aging;biological regulation;carbohydrate metabolic process;cell differentiation;cellular component assembly;cellular component organization;cellular localization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;establishment of localization;immune system process;localization;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;nuclear transport;nucleocytoplasmic transport;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein complex assembly;protein folding;protein glycosylation;protein maturation;protein metabolic process;protein modification process;protein targeting;protein transport;regulation of cell cycle;regulation of DNA metabolic process;regulation of protein modification process;regulation of protein stability;regulation of translation;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;extracellular matrix;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;MHC class I peptide loading complex;nucleus;organelle;polysome;protein complex;proteinaceous extracellular matrix;ribonucleoprotein complex;vesicle,,,,,,,,,,
O43852,CALU,Calumenin (Crocalbin) (IEF SSP 9302),5,7.6,33.44,34.78,33.62,34.64,34.04,35.04,34.56,34.01,35.54,34.06,34.93,34.78,35.29,34.52,-1.07,0.26,-0.9,0.12,-0.48,0.52,0.04,-0.51,1.03,-0.46,0.42,0.27,0.77,cell activation;cellular process;establishment of localization;exocytosis;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
O43852,CALU,Calumenin (Crocalbin) (IEF SSP 9302),5,7.6,33.44,34.78,33.62,34.64,34.04,35.04,34.56,34.01,35.54,34.06,34.93,34.78,35.29,34.52,-1.07,0.26,-0.9,0.12,-0.48,0.52,0.04,-0.51,1.03,-0.46,0.42,0.27,0.77,cell activation;cellular process;establishment of localization;exocytosis;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q13557,CAMK2D,Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17),8,18.4,27.73,27.91,30.09,28.1,27.31,24.79,28.66,26.3,27.81,26.75,27.11,28.61,25.03,27.4,0.33,0.51,2.69,0.7,-0.09,-2.61,1.26,-1.1,0.41,-0.65,-0.29,1.21,-2.37,biological regulation;cell communication;cell-cell signaling;cellular metabolic process;cellular process;establishment of localization;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;muscle contraction;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;signaling;transport,cell body;cell part;cytosol;macromolecular complex;membrane;neuronal cell body;nucleoplasm;plasma membrane;protein complex;synapse,,+,,,,,,,,
Q13555,CAMK2G,Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17),5,9.7,26.01,26.37,26.28,26.89,26.64,26.01,26.28,26.73,27.23,25.63,26.36,26.48,25.01,26.3,-0.29,0.07,-0.02,0.58,0.34,-0.29,-0.02,0.43,0.93,-0.67,0.06,0.18,-1.29,anatomical structure development;biological regulation;cell communication;cell differentiation;cell-cell signaling;cellular metabolic process;cellular process;developmental process;establishment of localization;hormone transport;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;peptide transport;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of transport;response to chemical stimulus;response to stimulus;secretion;signal transduction;signaling;transport,cell part;cytosol;macromolecular complex;membrane;nucleoplasm;plasma membrane;protein complex,,+,+,,,,,,,
P49069,CAMLG,Calcium signal-modulating cyclophilin ligand (CAML),2,14.2,,,,,23.88,25.11,24.65,,24.47,26.14,25.64,25.38,27.27,25.32, , , , ,-1.44,-0.21,-0.67, ,-0.85,0.82,0.32,0.07,1.95,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;response to stimulus;response to stress;signal transduction,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q08AD1,CAMSAP2,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),10,7.9,24.51,26.08,20.72,24.96,25.87,25.49,25.36,26.52,22.82,23.81,25.59,25.82,25.21,24.83,-0.32,1.25,-4.11,0.13,1.05,0.66,0.53,1.69,-2,-1.02,0.76,1,0.38,,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9P1Y5,CAMSAP3,Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha),9,10.2,27.23,26.47,27.14,,,23.46,24.02,25.8,23.15,21.24,,,,24.81,2.41,1.65,2.33, , ,-1.36,-0.79,0.99,-1.67,-3.57, , , ,biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q86VP6,CAND1,Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1),55,47.4,34.34,33.56,33.29,33.09,32.63,32.72,33.12,33.21,32.53,32.16,32.64,33.18,32.11,32.97,1.37,0.59,0.32,0.12,-0.34,-0.25,0.15,0.24,-0.44,-0.8,-0.33,0.22,-0.85,biological regulation;cell differentiation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;developmental process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q8WVQ1,CANT1,Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107),3,15.7,26.47,26.71,26.91,27.19,,27.41,24.83,26.7,27.33,26.67,26.67,,24.86,26.52,-0.05,0.19,0.39,0.66, ,0.89,-1.69,0.17,0.81,0.15,0.15, ,-1.67,biological regulation;biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process,cell part;membrane,,,,,,,,,,
P27824,CANX,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),60,71.3,35.49,35.47,34.8,34.89,34.24,34.93,34.79,34.14,35.04,35.18,34.72,34.64,35.14,34.88,0.61,0.58,-0.08,0.01,-0.65,0.05,-0.1,-0.74,0.16,0.3,-0.16,-0.24,0.26,aging;carbohydrate metabolic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;endocytosis;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process;protein transport;secretion;transport;vesicle-mediated transport,cell body;cell part;cell projection;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;neuronal cell body;organelle;ribonucleoprotein complex;ribosome;vesicle,,,,,,,,,,
Q01518,CAP1,Adenylyl cyclase-associated protein 1 (CAP 1),49,85.7,33.66,34.28,34.44,34.55,33.74,33.76,34.61,34.77,33.43,33.11,35.01,34.46,33.55,34.11,-0.44,0.18,0.34,0.44,-0.37,-0.34,0.51,0.67,-0.68,-1,0.9,0.35,-0.56,biological regulation;cell activation;cell motility;cellular component movement;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;endocytosis;establishment of localization;establishment or maintenance of cell polarity;exocytosis;locomotion;membrane invagination;membrane organization;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P40123,CAP2,Adenylyl cyclase-associated protein 2 (CAP 2),8,28.5,26.51,26.98,27.45,27.36,,,26.24,26.95,25.92,,27.51,29.09,,27.11,-0.6,-0.13,0.33,0.25, , ,-0.88,-0.16,-1.19, ,0.4,1.98, ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;establishment or maintenance of cell polarity;locomotion;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;membrane;plasma membrane,,,,,,,,,,
P40121,CAPG,Macrophage-capping protein (Actin regulatory protein CAP-G),18,58,33.39,32.58,32.91,30.27,30.06,29.46,31.84,32.3,30.92,30.62,32.63,31.4,28.98,31.33,2.05,1.25,1.58,-1.07,-1.28,-1.87,0.5,0.96,-0.42,-0.72,1.29,0.07,-2.35,biological regulation;cellular component assembly;cellular component organization;cellular process;macromolecular complex assembly;protein complex assembly;regulation of organelle organization,cell part;cytoplasm;cytoplasmic membrane-bounded vesicle;F-actin capping protein complex;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;protein complex;vesicle,,,,,,,,,,
P07384,CAPN1,Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP),40,46.5,33.38,32,32.11,32.14,31.25,31.07,32.56,32.38,30.21,31.74,32.99,32.75,30.47,31.93,1.45,0.07,0.19,0.22,-0.68,-0.85,0.63,0.46,-1.72,-0.19,1.07,0.82,-1.45,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
P17655,CAPN2,Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain),29,44.9,30.99,31.3,31.44,32.02,31.65,30.87,32.57,32.68,31.4,29.8,33.01,32.98,30.23,31.61,-0.62,-0.31,-0.17,0.41,0.04,-0.74,0.96,1.07,-0.21,-1.81,1.4,1.37,-1.38,anatomical structure development;anatomical structure formation involved in morphogenesis;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis;response to chemical stimulus;response to stimulus;response to stress;syncytium formation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O15484,CAPN5,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),6,13.1,29.07,26.78,,26.15,26.61,27.36,25.97,26.34,27,25.96,28.39,29.23,27.11,27.17,1.91,-0.39, ,-1.01,-0.56,0.19,-1.19,-0.83,-0.16,-1.21,1.23,2.07,-0.05,biological regulation;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to stimulus;signal transduction,cell part;cell surface;intracellular,,,,,,,,,,
P04632,CAPNS1,Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit),19,68.7,32.47,32,31.61,32.47,30.98,30.77,32.37,32.29,31.17,30.44,32.55,31.14,30.34,31.59,0.89,0.42,0.03,0.89,-0.6,-0.82,0.78,0.71,-0.42,-1.15,0.96,-0.44,-1.24,biological regulation,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q14444,CAPRIN1,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),22,33.4,31.14,30.26,31.05,31.76,32.18,31.51,32.09,31.85,31.38,31.76,31.75,30.74,31.03,31.42,-0.28,-1.17,-0.37,0.34,0.76,0.09,0.67,0.43,-0.04,0.33,0.33,-0.68,-0.39,biological regulation;regulation of translation,cell part;cell projection;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;organelle;ribonucleoprotein complex,,,,,,,,,,
P52907,CAPZA1,F-actin-capping protein subunit alpha-1 (CapZ alpha-1),27,89.5,33.06,33.21,33.11,33.23,33.14,32.84,33.08,33.46,33.02,32.3,33.1,33.74,33.1,33.11,-0.05,0.1,0.01,0.12,0.03,-0.27,-0.02,0.35,-0.09,-0.81,-0.01,0.63,0,biological regulation;cellular component assembly;cellular component movement;cellular component organization;cellular process;coagulation;cytoskeleton organization;immune system process;macromolecular complex assembly;multicellular organismal process;organelle organization;protein complex assembly;regulation of body fluid levels;regulation of organelle organization;response to stimulus;response to stress,cell part;cytosol;extracellular region;F-actin capping protein complex;macromolecular complex;protein complex,,,,,,,,,,
P47756,CAPZB,F-actin-capping protein subunit beta (CapZ beta),31,77.9,33.21,33.4,33.7,33.27,33.27,33.06,33.34,33.32,33.26,32.95,33.24,32.52,32.25,33.14,0.07,0.26,0.56,0.13,0.14,-0.08,0.21,0.19,0.12,-0.19,0.11,-0.62,-0.89,biological regulation;cellular component assembly;cellular component movement;cellular component organization;cellular process;coagulation;cytoskeleton organization;multicellular organismal process;organelle organization;regulation of body fluid levels;regulation of organelle organization,cell part;cell projection;cytoskeleton;cytosol;F-actin capping protein complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9Y2V2,CARHSP1,Calcium-regulated heat stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),11,80.3,29.66,29.65,28.62,30.28,26.69,26.21,28.97,28.53,27.81,26.31,28.97,30.3,26.04,28.31,1.35,1.34,0.31,1.97,-1.62,-2.1,0.66,0.22,-0.5,-2,0.66,1.99,-2.27,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex,,,,,,,,,,
Q8IW45,CARKD,ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein),3,25.9,27.35,27.49,25.51,26.28,,25.41,26.5,26.95,25.31,25.38,26.9,27.36,,26.4,0.95,1.09,-0.9,-0.13, ,-0.99,0.1,0.55,-1.09,-1.02,0.5,0.96, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q86X55,CARM1,Histone-arginine methyltransferase CARM1 (EC 2.1.1.-) (EC 2.1.1.125) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4),8,22.4,30.03,28.88,28.85,29.15,29.86,29.55,29.75,29.64,29.03,28.46,29.54,30.29,29.28,29.41,0.62,-0.53,-0.56,-0.26,0.45,0.14,0.34,0.23,-0.37,-0.95,0.14,0.88,-0.13,anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;interspecies interaction between organisms;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;pathogenesis;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;response to chemical stimulus;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;cytosol;nucleoplasm,,,,,,,,,,
P49589,CARS,"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)",23,35.6,30.41,30.39,30.29,30.97,28.98,28.98,30.02,30.11,29.5,29.34,31.06,30.29,29.1,29.96,0.45,0.43,0.33,1.02,-0.97,-0.98,0.06,0.16,-0.46,-0.62,1.1,0.33,-0.86,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytoplasm;cytosol,,,,,,,,,,
Q9HA77,CARS2,"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)",15,29.1,28.62,29.61,28.8,28.57,29.89,29.87,29.36,30.01,29.29,29.52,30.86,30.97,31.08,29.73,-1.11,-0.12,-0.93,-1.16,0.17,0.15,-0.36,0.28,-0.44,-0.21,1.14,1.24,1.35,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
Q6P4E1,CASC4,Protein CASC4 (Cancer susceptibility candidate gene 4 protein),6,21.2,25.96,26.33,26.23,27.2,,26.91,26.11,25.73,26.82,27.42,25.89,22.03,26.9,26.13,-0.17,0.2,0.11,1.07, ,0.78,-0.02,-0.4,0.69,1.29,-0.24,-4.1,0.77,,cell part,,,,,,,,,,
O14936,CASK,Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog),15,19.7,27.58,28.31,27.06,28.46,27.5,29.14,27.72,26.49,28.34,30.71,28.85,27.7,27.96,28.14,-0.56,0.17,-1.08,0.32,-0.64,1,-0.42,-1.65,0.2,2.57,0.71,-0.44,-0.18,biological adhesion;biological regulation;cell adhesion;cellular process;establishment of localization;ion transport;regulation of transport;transmembrane transport;transport,cell part;cytoplasm;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,+,,,,,,,,
P29466,CASP1,Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20;Caspase-1 subunit p10],9,28.6,27.18,27.87,29.75,27.63,24.67,,24.71,25.34,23.93,,,26.9,,26.44,0.74,1.43,3.3,1.19,-1.77, ,-1.74,-1.1,-2.51, , ,0.46, ,biological regulation;cellular process;cytokine production;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein maturation;protein metabolic process;proteolysis;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;extracellular region;macromolecular complex;protein complex,,,,,,,,,,
P42574,CASP3,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17;Caspase-3 subunit p12],3,12.3,27.15,27.32,25.28,27.61,,,27.76,26.23,26.35,24.52,27.44,27.75,,26.74,0.41,0.58,-1.46,0.87, , ,1.02,-0.51,-0.39,-2.22,0.7,1.01, ,anatomical structure development;biological regulation;catabolic process;cell death;cell differentiation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;DNA metabolic process;homeostatic process;immune system process;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein maturation;protein metabolic process;proteolysis;regulation of cell cycle;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleoplasm;organelle;plasma membrane,,,,,,,,,,
P55212,CASP6,Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18;Caspase-6 subunit p11],2,14.7,26.24,26.65,26.27,25.57,24.91,,27.03,25.51,25.03,26.06,26.24,27.98,,26.14,0.11,0.52,0.14,-0.56,-1.23, ,0.89,-0.62,-1.11,-0.08,0.1,1.84, ,biological regulation;cellular component disassembly;cellular component organization;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytosol;nucleoplasm,,,,,,,,,,
P55210,CASP7,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20;Caspase-7 subunit p11],5,22.1,28.12,24.11,25.51,25.97,26.11,25.39,26.33,26.08,23.05,,26.51,27.17,24.27,25.72,2.4,-1.61,-0.21,0.25,0.39,-0.33,0.61,0.36,-2.66, ,0.79,1.45,-1.45,anatomical structure development;biological regulation;cellular component disassembly;cellular component organization;cellular process;developmental process;macromolecule metabolic process;metabolic process;mitochondrion organization;organelle organization;primary metabolic process;protein maturation;protein metabolic process;proteolysis;response to abiotic stimulus;response to stimulus,cell part;cytosol;nucleoplasm,,,,,,,,,,
P20810,CAST,Calpastatin (Calpain inhibitor) (Sperm BS-17 component),30,50.9,31.3,30.68,31.91,30.43,29.58,29.75,31.7,31.14,30.35,31.31,32.01,32.57,30.61,31.03,0.27,-0.34,0.88,-0.6,-1.44,-1.27,0.67,0.12,-0.68,0.28,0.98,1.55,-0.42,biological regulation,,,,,,,,,,,
P04040,CAT,Catalase (EC 1.11.1.6),23,49.3,31.15,31.63,31.69,31.24,30.29,31.59,30.33,30.61,31.59,31.24,30.79,29.69,31.56,31.03,0.12,0.6,0.66,0.21,-0.74,0.56,-0.7,-0.42,0.55,0.21,-0.24,-1.34,0.53,alcohol metabolic process;anatomical structure development;biological regulation;catabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cellular respiration;developmental process;generation of precursor metabolites and energy;glycerol ether metabolic process;heterocycle metabolic process;lipid metabolic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;rhythmic process;small molecule metabolic process,cell part;cytosol;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;microbody;organelle;plasma membrane;vacuole,,,,,,,,,,
Q03135,CAV1,Caveolin-1,12,51.1,25.55,31.85,27.94,31.85,30.75,30.64,31.29,30.8,31.24,30.55,29.93,26.51,30.11,29.92,-4.37,1.93,-1.98,1.92,0.83,0.72,1.37,0.88,1.31,0.62,0,-3.42,0.19,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;cell communication;cell differentiation;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular process;circulatory system process;coagulation;developmental process;endocytosis;establishment of localization;glycerol ether metabolic process;homeostatic process;immune system process;interspecies interaction between organisms;ion transport;lipid metabolic process;lipid transport;localization;locomotion;macromolecular complex assembly;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;organelle organization;primary metabolic process;protein complex assembly;regulation of body fluid levels;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;secretion;signal transduction;small molecule metabolic process;tissue remodeling;transport;vesicle organization;vesicle-mediated transport,cell cortex;cell part;endoplasmic reticulum;endosome;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
P51636,CAV2,Caveolin-2,3,36.9,23.02,26.92,26.3,26.75,24.14,26.74,27.57,26.54,27.37,25.28,26.92,25.83,,26.12,-3.1,0.81,0.19,0.63,-1.98,0.62,1.46,0.43,1.26,-0.83,0.81,-0.29, ,anatomical structure development;biological regulation;cell communication;cell development;cell-cell signaling;cellular component assembly;cellular component organization;cellular membrane organization;cellular process;developmental process;endoplasmic reticulum organization;macromolecular complex assembly;membrane docking;membrane fusion;membrane organization;mitochondrion organization;organelle fusion;organelle organization;protein complex assembly;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;signaling;vesicle organization,cell part;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;macromolecular complex;membrane;nucleus;organelle;protein complex;vesicle,,,,,,,,,,
P16152,CBR1,Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189),23,83.4,31.35,32.34,31.96,31.57,30.66,30.59,31.9,31.91,29.56,30.33,31.82,32.86,29.38,31.25,0.1,1.09,0.71,0.33,-0.59,-0.66,0.65,0.66,-1.69,-0.92,0.57,1.62,-1.87,cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;drug metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
P35520,CBS,Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase),7,11.8,28.23,24.57,25.45,28.4,27.29,25.98,28.03,28.44,25.77,25.52,,23.7,,26.49,1.75,-1.92,-1.04,1.92,0.8,-0.51,1.54,1.95,-0.72,-0.97, ,-2.79, ,amine metabolic process;anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;developmental process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process;tissue remodeling,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P83916,CBX1,Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta),5,37.4,27.9,26.05,,26.5,26.2,27.95,,26.98,,,24.35,,26.28,26.53,1.38,-0.48, ,-0.02,-0.33,1.42, ,0.46, , ,-2.17, ,-0.25,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;nucleus;organelle,,,,,,,,,,
Q13185,CBX3,Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein),14,54.1,31.93,30.81,32.07,30.64,31.55,31.78,31.12,30.8,31.92,31.34,31.12,28.11,31.34,31.12,0.81,-0.3,0.95,-0.48,0.43,0.66,0,-0.32,0.8,0.22,0,-3.01,0.22,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P45973,CBX5,Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha),12,59.7,31.43,28.63,29.99,28.92,29.28,29.67,29.66,29.52,30,30.71,28.2,27.08,29.53,29.43,2,-0.8,0.56,-0.51,-0.15,0.23,0.23,0.09,0.57,1.27,-1.24,-2.35,0.1,biological regulation;coagulation;interspecies interaction between organisms;multicellular organismal process;multi-organism process;regulation of body fluid levels,cell part;chromatin remodeling complex;cytoplasm;histone methyltransferase complex;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nuclear envelope;nucleolus;organelle;protein complex;transcriptional repressor complex,,,,,,,,,,
Q6P1N0,CC2D1A,Coiled-coil and C2 domain-containing protein 1A (Akt kinase-interacting protein 1) (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1) (Putative NF-kappa-B-activating protein 023N),14,19.1,28.47,26.23,25.74,25.77,26.17,26.38,26.92,27.05,26.81,23.09,26.6,24.63,26.82,26.21,2.26,0.02,-0.47,-0.44,-0.04,0.17,0.72,0.85,0.6,-3.12,0.4,-1.57,0.61,biological regulation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,Other TF domain,,,,,,,,,
Q5T0F9,CC2D1B,Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2) (FRE under dual repression-binding protein 2) (Freud-2),3,7.3,24.44,,25.34,24.85,20.6,21.87,22.77,23.45,22.08,21.08,,26.28,,23.28,1.16, ,2.06,1.57,-2.68,-1.4,-0.51,0.18,-1.19,-2.19, ,3, ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8IX12,CCAR1,Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain),28,30,30.49,30.25,29.51,30.31,30.24,30.75,30.02,29.82,30.55,30.65,29.19,29.42,30.1,30.1,0.39,0.15,-0.59,0.2,0.14,0.64,-0.08,-0.28,0.45,0.55,-0.91,-0.68,0,biological regulation;biosynthetic process;cell cycle;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;nucleoplasm,SAP-domain,,,,,,,,,
Q6YP21,CCBL2,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),8,24.5,27.51,30.41,28.89,29.82,28.96,30.34,29.15,30.02,29.7,29.72,30.43,29.79,30.05,29.6,-2.09,0.81,-0.71,0.22,-0.64,0.74,-0.45,0.42,0.1,0.12,0.83,0.19,0.45,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NWR8,CCDC109B,Coiled-coil domain-containing protein 109B,2,6.2,23.08,24.19,,24.26,,25.54,,,,25.99,,24.96,25.55,24.8,-1.72,-0.61, ,-0.53, ,0.74, , , ,1.19, ,0.17,0.75,,cell part,,,,,,,,,,
Q96NT0,CCDC115,Coiled-coil domain-containing protein 115,2,13.9,26.61,25.42,24.4,25.13,25.67,,,24.98,25.87,,,,,25.44,1.17,-0.02,-1.04,-0.31,0.23, , ,-0.46,0.43, , , , ,,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q8WUD4,CCDC12,Coiled-coil domain-containing protein 12,4,31.3,26.74,23.82,26.82,24.04,27.57,27.33,26.85,27.25,27.52,26.9,18.03,25.55,17.4,25.06,1.68,-1.24,1.76,-1.02,2.5,2.26,1.78,2.19,2.46,1.83,-7.03,0.48,-7.66,,,,,,,,,,,,
Q96CT7,CCDC124,Coiled-coil domain-containing protein 124,10,44.4,28.95,27.19,28.18,28.71,29.37,27.97,29.64,29.22,28.16,27.71,28.1,29.11,28.01,28.49,0.46,-1.3,-0.3,0.22,0.89,-0.52,1.15,0.73,-0.32,-0.78,-0.38,0.62,-0.48,,,,,,,,,,,,
F5H5U7,CCDC132,Coiled-coil domain-containing protein 132,7,8,23.88,24.96,27.21,,24.41,,,,25.09,,,25.92,23.5,25,-1.12,-0.04,2.22, ,-0.59, , , ,0.09, , ,0.93,-1.49,,,,,,,,,,,,
Q9H6E4,CCDC134,Coiled-coil domain-containing protein 134,6,31.4,28.61,27.54,26.57,27.46,28.78,28.76,28.49,,28.79,30.11,27.77,28.08,28.59,28.3,0.32,-0.76,-1.73,-0.83,0.49,0.47,0.19, ,0.49,1.81,-0.53,-0.21,0.3,,extracellular region,,,,,,,,,,
O60826,CCDC22,Coiled-coil domain-containing protein 22,11,22.6,26.26,27.85,26.64,27.45,26.75,25.2,27.67,28.02,27.09,,28.46,27.59,26.39,27.11,-0.86,0.74,-0.48,0.33,-0.36,-1.91,0.55,0.9,-0.02, ,1.35,0.47,-0.72,,,,,,,,,,,,
Q86WR0,CCDC25,Coiled-coil domain-containing protein 25,2,21.4,24.85,25.67,,25.43,,,25.24,25.52,,24.4,24.98,,,25.16,-0.31,0.52, ,0.28, , ,0.08,0.36, ,-0.75,-0.18, , ,,,,,,,,,,,,
Q96MW1,CCDC43,Coiled-coil domain-containing protein 43,4,20.1,26.52,25.09,26.31,25.76,21.48,,23.32,,,,24.37,25.24,,24.76,1.75,0.33,1.55,1,-3.28, ,-1.44, , , ,-0.39,0.48, ,,,,,,,,,,,,
Q96A33,CCDC47,Coiled-coil domain-containing protein 47,18,48.4,30.97,31.29,31.01,31.15,30.44,31.18,30.79,30.02,31.37,31.49,31.07,30.25,31.67,30.98,0,0.31,0.03,0.17,-0.54,0.21,-0.18,-0.96,0.4,0.51,0.09,-0.73,0.69,biological regulation;cellular process;developmental process;embryo development;homeostatic process;post-embryonic development;response to biotic stimulus;response to stimulus;response to stress;signal transduction,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q8IVM0,CCDC50,Coiled-coil domain-containing protein 50 (Protein Ymer),2,9.2,24.11,22.78,24.26,24.12,23.7,24.33,26.28,24.45,24.49,25.33,26.33,27.31,,24.79,-0.68,-2.01,-0.53,-0.67,-1.09,-0.46,1.49,-0.34,-0.31,0.54,1.53,2.52, ,,cell part;cytoplasm,,,,,,,,,,
Q96ER9,CCDC51,Coiled-coil domain-containing protein 51,4,17.5,24.28,25.55,26.99,24.59,27.06,27.71,,25.8,26.96,26.77,25.63,,26.6,26.18,-1.9,-0.63,0.81,-1.59,0.88,1.54, ,-0.38,0.78,0.6,-0.54, ,0.43,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9Y3C0,CCDC53,WASH complex subunit CCDC53 (Coiled-coil domain-containing protein 53),3,26.4,25.84,26.18,24.3,27.24,25.17,23,26.2,26.46,,24.82,27.95,28.14,,25.94,-0.09,0.24,-1.64,1.3,-0.76,-2.94,0.26,0.52, ,-1.11,2.01,2.2, ,,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q4VC31,CCDC58,Coiled-coil domain-containing protein 58,7,56.2,30.77,30.83,30.44,29.46,30.07,29.62,29.68,28.86,30.27,29.39,28.67,29.08,29.33,29.73,1.05,1.1,0.71,-0.26,0.34,-0.11,-0.05,-0.87,0.54,-0.34,-1.06,-0.65,-0.4,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q16204,CCDC6,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),23,48.1,31.1,29.34,29.78,29.63,28.02,28.16,29.07,29.75,27.83,27.29,30.6,28.56,,29.09,2,0.24,0.69,0.54,-1.07,-0.93,-0.03,0.66,-1.26,-1.81,1.51,-0.54, ,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9H0W5,CCDC8,Coiled-coil domain-containing protein 8,2,8.9,,,,23.26,25.98,25.74,24.11,24.6,23.31,24.87,24.36,26.1,24.18,24.65, , , ,-1.39,1.33,1.09,-0.54,-0.05,-1.34,0.22,-0.29,1.45,-0.47,biological regulation,cell part;membrane;plasma membrane,,,,,,,,,,
Q76M96,CCDC80,Coiled-coil domain-containing protein 80 (Down-regulated by oncogenes protein 1) (Up-regulated in BRS-3 deficient mouse homolog),11,12.9,,29.64,24.56,28.58,22.46,23.75,,,25.15,26.16,22.97,24.76,27.71,25.57, ,4.07,-1.02,3,-3.12,-1.83, , ,-0.43,0.59,-2.6,-0.81,2.14,biological regulation;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization,extracellular matrix;proteinaceous extracellular matrix,,,,,,,,,,
Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),11,42.8,26.43,25.44,26.09,25.87,,,26.33,,27.04,27.05,25.17,22.14,,25.73,0.7,-0.29,0.37,0.14, , ,0.6, ,1.31,1.32,-0.56,-3.59, ,interspecies interaction between organisms;multi-organism process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q3V6T2,CCDC88A,Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1),8,6,23.89,26.08,26.83,25.8,24.73,23.92,25.25,24.55,24.42,24.56,24.26,25.72,19.63,24.59,-0.7,1.5,2.25,1.21,0.14,-0.67,0.66,-0.04,-0.16,-0.03,-0.33,1.13,-4.96,biological regulation;biosynthetic process;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;DNA metabolic process;DNA replication;locomotion;macromolecule metabolic process;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of DNA metabolic process;regulation of organelle organization;regulation of protein modification process;response to stimulus;signal transduction,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9Y3X0,CCDC9,Coiled-coil domain-containing protein 9,2,5.5,19.77,17.4,,19.26,,20.33,21.31,22.92,21.08,19.13,,,,20.15,-0.38,-2.75, ,-0.89, ,0.18,1.16,2.77,0.93,-1.02, , , ,,,,,,,,,,,,
Q9GZT6,CCDC90B,"Coiled-coil domain-containing protein 90B, mitochondrial",3,24.9,27.07,25.31,26.53,24.75,25.26,,24.62,25.88,26.88,27.46,25.79,22.75,23.15,25.45,1.61,-0.14,1.07,-0.71,-0.19, ,-0.83,0.42,1.42,2.01,0.33,-2.71,-2.3,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q567U6,CCDC93,Coiled-coil domain-containing protein 93,8,14,23.11,25.35,25.31,24.24,25.2,25.73,25.83,26.81,23.06,,26.7,25.45,25.64,25.2,-2.1,0.15,0.11,-0.96,-0.01,0.53,0.63,1.6,-2.14, ,1.5,0.25,0.44,,,,,,,,,,,,
O75909,CCNK,Cyclin-K,9,28.9,27.39,26.08,27.46,26.45,28.59,28.22,27.48,26.38,27.83,27.49,25.52,26.33,26.23,27.03,0.36,-0.96,0.43,-0.59,1.56,1.18,0.44,-0.65,0.8,0.46,-1.52,-0.7,-0.81,biological regulation;biosynthetic process;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transcription from RNA polymerase II promoter,,,,,,,,,,,
Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),8,17.3,25.85,,24.49,,,25.5,24.85,24.29,25.19,25.55,,,24.93,25.08,0.77, ,-0.59, , ,0.42,-0.23,-0.8,0.1,0.47, , ,-0.15,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of protein modification process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8ND76,CCNY,Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X),6,24.1,26.48,26.64,25.82,26.36,26.09,26.84,25.68,,26.83,25.87,25.9,25.57,26.36,26.2,0.27,0.43,-0.38,0.16,-0.11,0.64,-0.53, ,0.63,-0.33,-0.31,-0.63,0.16,biological regulation;cell division;cellular process;regulation of cell cycle;regulation of protein modification process;response to stimulus;signal transduction,cell part;cyclin-dependent protein kinase holoenzyme complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9ULG6,CCPG1,Cell cycle progression protein 1 (Cell cycle progression restoration protein 8),5,11.6,22.12,26.28,28.63,25.71,,26.29,26.62,25.69,26.56,24.79,26.13,27.91,28.21,26.24,-4.13,0.04,2.39,-0.54, ,0.05,0.37,-0.55,0.32,-1.45,-0.12,1.66,1.96,biological regulation;cell cycle;cellular process,cell part,,,,,,,,,,
O14618,CCS,Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone),4,13.7,27.19,26.49,27.15,26.49,24.81,26.61,26.91,27.66,26.83,26.91,24.73,20.89,27.02,26.13,1.06,0.36,1.03,0.36,-1.32,0.48,0.78,1.53,0.7,0.78,-1.4,-5.24,0.89,biological regulation;cellular metabolic process;cellular process;establishment of localization;ion transport;metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
P78371,CCT2,T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta),43,67.1,33.13,33.16,32.77,33.92,33.74,33.23,33.81,33.96,32.61,33.55,33.53,33.12,33,33.35,-0.22,-0.19,-0.57,0.57,0.4,-0.12,0.46,0.62,-0.74,0.2,0.18,-0.23,-0.35,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P49368,CCT3,T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5),46,75.7,33.5,33.37,33.12,33.95,33.53,33.46,34.22,34.3,32.67,33.7,33.98,34.05,33.18,33.62,-0.12,-0.25,-0.5,0.33,-0.09,-0.16,0.6,0.68,-0.95,0.08,0.36,0.43,-0.43,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P50991,CCT4,T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding),42,73.8,33.19,33.26,33.03,33.74,33.67,33.06,34.01,33.99,32.99,33.46,33.62,33.97,33.05,33.46,-0.28,-0.2,-0.43,0.28,0.21,-0.4,0.54,0.52,-0.47,-0.01,0.16,0.5,-0.42,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;centrosome;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex;vesicle,,,,,,,,,,
P48643,CCT5,T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon),48,80.2,33.02,32.94,33.27,33.71,33.12,33.13,33.73,33.38,32.48,33.39,33.68,33.66,32.88,33.26,-0.24,-0.32,0.01,0.45,-0.14,-0.13,0.47,0.12,-0.78,0.13,0.42,0.4,-0.38,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein folding;protein metabolic process;response to biotic stimulus;response to stimulus,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleolus;organelle;protein complex,,,,,,,,,,
P40227,CCT6A,T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20),32,50.5,32.67,32.96,33.01,33.61,33.35,32.99,33.83,33.78,32.89,33.67,33.79,33.55,33.05,33.32,-0.64,-0.36,-0.31,0.29,0.03,-0.33,0.51,0.46,-0.43,0.35,0.48,0.23,-0.27,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q99832,CCT7,T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein),36,64.6,32.61,32.75,32.58,33.32,33.25,32.77,33.15,33.39,32.34,33,33.27,32.69,32.59,32.9,-0.29,-0.15,-0.32,0.42,0.35,-0.13,0.25,0.49,-0.56,0.1,0.37,-0.21,-0.31,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
P50990,CCT8,T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Renal carcinoma antigen NY-REN-15),49,75.9,33.69,33.66,33.6,34.3,34.21,33.85,34.55,34.56,33.36,33.97,34.38,34.34,33.53,34,-0.31,-0.34,-0.4,0.3,0.21,-0.15,0.55,0.56,-0.64,-0.03,0.38,0.34,-0.47,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;centrosome;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P86791,CCZ1,Vacuolar fusion protein CCZ1 homolog,2,6.8,,,,,26.48,26.07,26.11,25.98,22.43,,24.87,25.24,23.88,25.13, , , , ,1.34,0.94,0.98,0.85,-2.7, ,-0.27,0.11,-1.26,,cell part;membrane,,,,,,,,,,
Q6YHK3,CD109,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),16,15.7,28.15,27.44,27.92,28.25,27.61,29.52,28.35,29.42,30.4,28.57,28.53,26.2,29.49,28.45,-0.3,-1.01,-0.53,-0.2,-0.84,1.07,-0.1,0.97,1.95,0.12,0.08,-2.25,1.04,biological regulation,cell part;extracellular space;membrane;plasma membrane,,,,,,,,,,
P08571,CD14,"Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form;Monocyte differentiation antigen CD14, membrane-bound form]",15,48,27.03,31.53,30.63,27.02,27.11,24.86,25.06,26.52,26.59,24.54,28.66,24.64,25.57,26.91,0.12,4.62,3.72,0.11,0.21,-2.04,-1.84,-0.38,-0.31,-2.36,1.76,-2.26,-1.34,biological regulation;cell death;cellular component organization;cellular membrane organization;cellular process;death;endocytosis;establishment of localization;immune system process;membrane invagination;membrane organization;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to heat;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;cell surface;extracellular region;extracellular space;membrane;plasma membrane,,,,,,,,,,
P48509,CD151,CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151),3,24,23.64,24.77,25.48,26.43,26.4,25.45,25.83,25.92,27.12,28.45,,,25.9,25.94,-2.31,-1.18,-0.46,0.48,0.45,-0.49,-0.12,-0.02,1.18,2.51, , ,-0.05,biological adhesion;cell activation;cell adhesion;cell junction organization;cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization;immune system process;locomotion,cell part;cytosol,,,,,,,,,,
P41217,CD200,OX-2 membrane glycoprotein (CD antigen CD200),3,17.5,23.94,28.89,,27.12,24.46,26.45,23.85,,28.29,,27.54,28.21,27.29,26.6,-2.67,2.29, ,0.52,-2.15,-0.15,-2.75, ,1.68, ,0.93,1.61,0.68,biological regulation,cell part,,,,,,,,,,
Q5ZPR3,CD276,CD276 antigen (4Ig-B7-H3) (B7 homolog 3) (B7-H3) (Costimulatory molecule) (CD antigen CD276),2,12.6,24.36,25,,26.42,,27.31,27.26,24.72,26.93,27.57,26.43,,26.96,26.3,-1.94,-1.29, ,0.12, ,1.02,0.96,-1.58,0.64,1.28,0.13, ,0.66,biological regulation;cell activation;cell proliferation;cellular process;immune system process;response to stimulus,cell part,,,,,,,,,,
Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),27,52.6,31.52,28.72,31.18,29.04,29.34,27.97,29.26,30.47,27.76,30.31,29.31,30.1,27.9,29.45,2.07,-0.73,1.73,-0.42,-0.12,-1.48,-0.19,1.02,-1.69,0.85,-0.15,0.64,-1.55,biological regulation;cell division;cellular component assembly;cellular component organization;cellular process;macromolecular complex assembly;mitosis;nuclear division;organelle fission;organelle organization;protein complex assembly;response to stimulus;signal transduction,cell part;cell projection;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;plasma membrane;protein complex,,,,,,,,,,
O95400,CD2BP2,CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K),6,17.3,25.35,24.75,25.72,25.48,27.17,,,25.48,25.93,26.2,,23.6,24.68,25.44,-0.09,-0.68,0.28,0.04,1.73, , ,0.04,0.5,0.77, ,-1.83,-0.76,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;cytoplasm;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex,,,,,,,,,,
P15529,CD46,Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD antigen CD46),3,10.1,26.1,26.9,27.79,26.22,26.22,27.11,28.33,25.09,27.12,27.77,25.72,23.71,26.24,26.49,-0.39,0.42,1.3,-0.27,-0.27,0.62,1.85,-1.39,0.63,1.28,-0.77,-2.78,-0.24,biological regulation;immune system process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;proteolysis;response to stimulus;response to stress,cell part;cell surface;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q08722,CD47,Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47),6,12.7,31.46,30.46,32.17,29.69,28.9,29.34,28.31,29.12,30.65,32.07,28.48,29.28,28.5,29.88,1.58,0.59,2.29,-0.19,-0.98,-0.54,-1.57,-0.76,0.77,2.19,-1.4,-0.6,-1.38,biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular process;coagulation;immune system process;locomotion;multicellular organismal process;multi-organism process;regulation of body fluid levels;regulation of transport;response to biotic stimulus;response to stimulus;signal transduction,cell part;extracellular organelle;organelle;vesicle,,,,,,,,,,
P19256,CD58,Lymphocyte function-associated antigen 3 (Ag3) (Surface glycoprotein LFA-3) (CD antigen CD58),2,13.4,25.75,26.48,27.08,26.25,,27.28,,,27.72,26.4,27.15,,26.23,26.7,-0.96,-0.23,0.38,-0.45, ,0.58, , ,1.02,-0.31,0.45, ,-0.47,biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular process;coagulation;immune system process;locomotion;multicellular organismal process;regulation of body fluid levels,cell part,,,,,,,,,,
P13987,CD59,CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59),6,30.6,30.64,32.1,31.54,31.77,30.78,31.38,32.31,30.65,32.71,33.11,32.22,23.85,28.83,30.91,-0.28,1.19,0.63,0.86,-0.14,0.46,1.39,-0.27,1.8,2.2,1.3,-7.06,-2.09,biological regulation;cellular process;coagulation;multicellular organismal process;regulation of body fluid levels;response to stimulus;signal transduction,cell part;extracellular space;membrane;plasma membrane,,,,,,,,,,
P08962,CD63,CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63),4,16.6,29.64,30.52,29.59,30.89,31.24,30.57,30.65,28.98,30.61,30.13,31.01,26.89,30.63,30.1,-0.46,0.42,-0.51,0.79,1.13,0.46,0.54,-1.12,0.51,0.03,0.9,-3.21,0.53,biological regulation;cell activation;cellular localization;cellular process;establishment of localization;exocytosis;localization;regulation of transport;secretion;transport;vesicle-mediated transport,cell part;cell surface;membrane,,,,,,,,,,
P04233,CD74,HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (p33) (CD antigen CD74),5,28.4,30.69,28.19,29.63,25.83,,,,,,28.83,,25.03,26.95,27.88,2.81,0.31,1.75,-2.05, , , , , ,0.95, ,-2.85,-0.93,biological regulation;biosynthetic process;cell proliferation;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;immune system process;lipid metabolic process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein modification process;protein phosphorylation;protein transport;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transport,cell part;cell surface;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;MHC protein complex;organelle;plasma membrane;protein complex;receptor complex,,,,,,,,,,
P60033,CD81,CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81),3,35.8,29.75,31.26,31.01,30.56,31.76,31.32,30.27,30.13,31.01,30.8,30.7,31.84,30.77,30.86,-1.11,0.4,0.15,-0.3,0.9,0.46,-0.59,-0.73,0.14,-0.06,-0.16,0.98,-0.09,biological regulation;biosynthetic process;cell proliferation;cellular lipid metabolic process;cellular metabolic process;cellular process;interspecies interaction between organisms;lipid metabolic process;localization;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process,cell part,,,,,,,,,,
P27701,CD82,CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82),3,9,27.01,26.1,,27.11,24.97,28.74,,,,,27.45,27.56,26.59,26.94,0.07,-0.84, ,0.17,-1.97,1.8, , , , ,0.51,0.61,-0.35,,cell part,,,,,,,,,,
P21926,CD9,CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9),7,41.1,31.5,30.89,29.41,28.88,31.96,32.06,32.19,31.5,31.68,30.94,32.37,28.93,33.24,31.2,0.3,-0.3,-1.79,-2.31,0.76,0.86,0.99,0.3,0.48,-0.26,1.18,-2.26,2.04,anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell development;cell junction organization;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular process;developmental process;establishment of localization;exocytosis;membrane fusion;membrane organization;response to abiotic stimulus;response to chemical stimulus;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
P48960,CD97,CD97 antigen (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: CD97 antigen subunit alpha;CD97 antigen subunit beta],6,14.1,28.28,27.27,,27.15,25.72,26.65,,,23.93,26.41,24.39,26.84,25.2,26.18,2.09,1.09, ,0.97,-0.47,0.46, , ,-2.25,0.23,-1.79,0.65,-0.98,biological adhesion;biological regulation;cell adhesion;cell communication;cell-cell signaling;cellular component movement;cellular process;immune system process;response to stimulus;response to stress;signal transduction;signaling,cell part;extracellular space,,,,,,,,,,
P14209,CD99,CD99 antigen (12E7) (E2 antigen) (Protein MIC2) (T-cell surface glycoprotein E2) (CD antigen CD99),5,48.1,25.91,29.36,24.18,29.64,25.99,28.1,28.55,26.98,30.39,26.78,29.07,30.06,25.03,27.69,-1.79,1.66,-3.52,1.94,-1.71,0.41,0.86,-0.71,2.7,-0.92,1.37,2.37,-2.67,biological adhesion;cell adhesion;cellular process,cell part;cytoplasm,,,,,,,,,,
Q13042,CDC16,Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6),4,9.3,23.84,25.66,26.49,25.65,27.29,25.07,28.23,28.2,27.41,27.4,24.66,26.19,,26.34,-2.5,-0.68,0.15,-0.69,0.94,-1.27,1.89,1.86,1.07,1.06,-1.68,-0.15, ,biological regulation;catabolic process;cell division;cell proliferation;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleoplasm;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q9UJX2,CDC23,Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8),9,15.9,26.27,25,24.8,25.82,26.78,25.83,27.07,26.75,23.77,25.36,26.28,25.98,25.86,25.81,0.45,-0.81,-1.01,0.01,0.97,0.02,1.26,0.93,-2.04,-0.46,0.47,0.17,0.04,biological regulation;catabolic process;cell division;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
P30260,CDC27,Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC),6,10,25.76,25.45,28.31,27.38,27.68,27.08,28.14,26.55,26.94,27.76,26.51,27.31,26.65,27.04,-1.28,-1.59,1.27,0.34,0.64,0.04,1.1,-0.49,-0.1,0.72,-0.54,0.27,-0.39,biological regulation;catabolic process;cell proliferation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleoplasm;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q16543,CDC37,"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]",22,53.4,31.27,30.91,31.98,31.68,30.31,29.89,31.38,31.36,30.28,30.61,30.64,32.22,30.46,31,0.27,-0.08,0.98,0.68,-0.69,-1.1,0.38,0.36,-0.72,-0.39,-0.36,1.22,-0.54,biological regulation;establishment of localization;protein targeting;protein transport;regulation of cell cycle;regulation of protein modification process;transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
O60508,CDC40,Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17),8,16.9,27.64,25.55,25.23,26.15,26.97,27.77,26.54,26.52,26.67,26.94,,25.76,26.43,26.51,1.13,-0.97,-1.28,-0.36,0.46,1.25,0.03,0,0.16,0.43, ,-0.75,-0.08,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P60953,CDC42,Cell division control protein 42 homolog (G25K GTP-binding protein),9,42.9,31.04,30.99,31.49,31.16,29.96,30.4,30.84,30.41,30.3,31.05,30.96,30.94,30.15,30.74,0.29,0.25,0.75,0.42,-0.79,-0.34,0.09,-0.34,-0.44,0.3,0.21,0.2,-0.6,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell communication;cell development;cell differentiation;cell junction organization;cell-cell signaling;cellular component assembly;cellular component movement;cellular component organization;cellular localization;cellular process;circulatory system process;coagulation;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;establishment or maintenance of cell polarity;Golgi organization;growth;immune system process;localization;locomotion;molting cycle;multicellular organismal process;organelle organization;regulation of body fluid levels;regulation of cell cycle;regulation of DNA metabolic process;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of protein stability;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;signaling;transport,apical part of cell;cell body;cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;filopodium;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;midbody;neuron projection;neuronal cell body;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9Y5S2,CDC42BPB,Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta),24,19.7,28.58,27.79,28.12,28.79,28.9,28.71,28.93,28.64,28.25,29.28,29.9,29.67,29.21,28.83,-0.24,-1.03,-0.71,-0.04,0.07,-0.12,0.1,-0.19,-0.58,0.45,1.07,0.84,0.38,biological regulation;cell motility;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;establishment or maintenance of cell polarity;locomotion;organelle organization;response to stimulus;signal transduction,cell leading edge;cell part;cytoplasm;membrane;plasma membrane,,+,,,,,,,,
Q00587,CDC42EP1,Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55),7,24.2,24.09,24.44,,27.81,27.66,,27.25,26.03,25.95,,25.76,28.47,26.27,26.37,-2.28,-1.93, ,1.44,1.28, ,0.88,-0.34,-0.43, ,-0.61,2.1,-0.11,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoskeleton;endomembrane system;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),16,55.1,28.23,24.04,26.47,26.05,28.04,27.71,27.56,28.25,26.49,27.51,28.46,29.7,26.81,27.33,0.9,-3.29,-0.86,-1.28,0.71,0.38,0.22,0.92,-0.84,0.18,1.12,2.37,-0.53,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm;cytoskeleton;endomembrane system;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q99459,CDC5L,Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein),32,46.3,31.03,30,30.86,30.55,30.87,30.71,30.48,29.63,31.05,30.59,29.08,29.72,29.52,30.32,0.72,-0.32,0.55,0.23,0.56,0.4,0.17,-0.69,0.74,0.28,-1.23,-0.6,-0.79,biological regulation;biosynthetic process;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
Q6P1J9,CDC73,Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein),11,22.6,27.91,26.4,28.81,27.85,27.47,27.68,27.05,27.21,28.43,28.09,26.78,26.64,27.86,27.55,0.36,-1.15,1.26,0.3,-0.08,0.13,-0.51,-0.34,0.88,0.53,-0.77,-0.91,0.31,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of protein stability;response to biotic stimulus;response to chemical stimulus;response to stimulus;RNA metabolic process;RNA processing;signal transduction,cell part;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
Q9H5V8,CDCP1,CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein) (SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318),17,24.6,29,28.72,29.12,26.74,28.19,28,29.25,28.32,29.99,30.57,27.36,29.24,27.75,28.63,0.36,0.09,0.48,-1.89,-0.45,-0.63,0.61,-0.31,1.35,1.94,-1.28,0.6,-0.88,,cell part;extracellular region;membrane;plasma membrane,,,,,,,,,,
P12830,CDH1,Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1;E-Cad/CTF2;E-Cad/CTF3],13,15.4,31.44,29.96,30.06,26.32,24.09,,,23.41,,30.99,,22.92,,27.4,4.04,2.56,2.66,-1.08,-3.31, , ,-3.99, ,3.59, ,-4.48, ,anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell differentiation;cell junction organization;cellular component assembly;cellular component disassembly;cellular component organization;cellular localization;cellular membrane organization;cellular process;developmental process;homeostatic process;localization;macromolecular complex assembly;macromolecule metabolic process;membrane organization;metabolic process;multicellular organismal process;neurological system process;plasma membrane organization;primary metabolic process;protein complex assembly;protein metabolic process;regulation of body fluid levels;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus,apical part of cell;cell part;cell surface;cytoskeleton;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
P55290,CDH13,Cadherin-13 (Heart cadherin) (H-cadherin) (P105) (Truncated cadherin) (T-cad) (T-cadherin),12,22.6,,30.14,,26.23,27.11,29.31,27.84,24.65,29.73,28.05,,,27.79,27.87, ,2.27, ,-1.65,-0.76,1.44,-0.04,-3.22,1.86,0.17, , ,-0.08,anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular localization;cellular process;developmental process;localization;locomotion;regulation of transport;response to stimulus;signal transduction,cell part;cell projection;cytoplasm;extracellular space;neuron projection,,,,,,,,,,
P19022,CDH2,Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325),13,22.9,,28.08,26.05,30.33,30.64,30.52,30.8,30.14,30.49,29.52,29.34,30.59,30.33,29.74, ,-1.66,-3.68,0.59,0.91,0.78,1.06,0.4,0.76,-0.22,-0.39,0.85,0.6,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell differentiation;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;developmental process;locomotion,cell part;cell projection;macromolecular complex;protein complex;synapse,,,,,,,,,,
P55285,CDH6,Cadherin-6 (Kidney cadherin) (K-cadherin),17,26.8,27.51,26.76,26.99,25.4,28.5,29.96,27.98,27.62,29.58,30.3,28.08,,28.49,28.1,-0.59,-1.33,-1.11,-2.7,0.4,1.86,-0.12,-0.48,1.48,2.2,-0.02, ,0.39,biological adhesion;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O14735,CDIPT,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase),4,26.8,27.84,29.05,25.49,27.75,26.97,28.05,26.27,27.02,27.5,27.49,27.16,28.07,27.7,27.41,0.43,1.64,-1.92,0.34,-0.44,0.64,-1.15,-0.39,0.09,0.08,-0.25,0.66,0.29,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane;plasma membrane,,,,,,,,,,
P06493,CDK1,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),14,52.9,29.61,24.77,28.51,29.2,29.78,28.27,30.44,30.56,26.14,27.18,,29.19,27.11,28.4,1.21,-3.63,0.11,0.81,1.39,-0.12,2.04,2.16,-2.26,-1.22, ,0.79,-1.29,aging;anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;catabolic process;cell death;cell development;cell division;cell motility;cellular component assembly;cellular component disassembly;cellular component movement;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;death;developmental process;DNA metabolic process;DNA packaging;DNA repair;DNA replication;immune system process;localization;locomotion;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;microtubule organizing center organization;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle fusion;organelle organization;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of DNA metabolic process;regulation of mitotic cell cycle;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;midbody;mitochondrion;nucleoplasm;organelle;protein complex,,+,,,,,,,,
Q9UQ88,CDK11A,Cyclin-dependent kinase 11A (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2),27,34.3,29.6,29.31,29.71,28.78,29.61,28.55,29.08,29.45,29.73,29.28,27.85,28.58,28.62,29.09,0.51,0.22,0.62,-0.3,0.52,-0.54,-0.01,0.37,0.64,0.19,-1.24,-0.51,-0.46,biological regulation;cell death;cellular component organization;cellular process;death;mitosis;nuclear division;organelle fission;organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",18,13.3,29.17,28.48,29.18,29,28.21,27.97,29.5,27.97,29.32,25.69,29.37,26.98,27.22,28.31,0.85,0.17,0.87,0.69,-0.1,-0.35,1.19,-0.35,1.01,-2.63,1.06,-1.33,-1.09,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;RNA metabolic process;RNA processing;RNA splicing,cell part;cyclin-dependent protein kinase holoenzyme complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,+,,,,,,,,
O94921,CDK14,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1),4,7.5,,21.54,21.75,22.76,,22.72,23.24,21.83,21.43,,22.37,24.62,22.32,22.46, ,-0.92,-0.71,0.31, ,0.27,0.78,-0.62,-1.03, ,-0.09,2.16,-0.14,biological regulation;cell division;cellular process;response to stimulus;signal transduction,cell part;cyclin-dependent protein kinase holoenzyme complex;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,+,,,,,,,,
Q00537,CDK17,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),6,15.5,22.6,25.71,22.77,25.29,26.89,26.32,26.27,26.49,26.85,23.66,24.74,24.69,26.9,25.32,-2.72,0.39,-2.55,-0.03,1.57,1,0.95,1.16,1.53,-1.66,-0.58,-0.63,1.58,,,,+,,,,,,,,
Q07002,CDK18,Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3),7,19.7,25,25.6,26.2,24.41,25.02,26.08,,25.25,,26.16,28.19,26.36,26.85,25.92,-0.92,-0.31,0.28,-1.51,-0.9,0.16, ,-0.67, ,0.24,2.27,0.44,0.93,,,,+,,,,,,,,
P24941,CDK2,Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase),6,35.6,28.21,25.71,26.93,27.15,25.59,26.14,27.47,28.18,27.05,27.43,25.45,24.51,26.63,26.65,1.56,-0.94,0.28,0.5,-1.06,-0.51,0.82,1.53,0.4,0.78,-1.2,-2.14,-0.02,biological regulation;biosynthetic process;catabolic process;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;coagulation;DNA metabolic process;DNA repair;DNA replication;establishment of localization;histone modification;ion transport;macromolecule metabolic process;macromolecule modification;meiosis;metabolic process;microtubule organizing center organization;mitosis;multicellular organismal process;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of body fluid levels;regulation of cell cycle;regulation of DNA metabolic process;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;centrosome;chromosome;cyclin-dependent protein kinase holoenzyme complex;cytosol;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex;transcription factor complex,,+,,,,,,,,
Q00535,CDK5,Cyclin-dependent kinase 5 (EC 2.7.11.22) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit),8,31.2,27.33,27.76,27.03,27.05,26.07,25.66,27.27,26.89,24.87,24.57,27.4,27.32,26.12,26.56,0.77,1.19,0.47,0.48,-0.5,-0.9,0.71,0.33,-1.7,-1.99,0.83,0.76,-0.44,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;behavior;biological adhesion;biological regulation;catabolic process;cell adhesion;cell communication;cell death;cell development;cell differentiation;cell division;cell growth;cell motility;cell proliferation;cell-cell signaling;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;coagulation;cytoskeleton organization;death;developmental process;embryo development;endocytosis;establishment of localization;exocytosis;growth;homeostatic process;ion transport;localization;locomotion;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;neurological system process;nuclear transport;nucleocytoplasmic transport;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein transport;regulation of body fluid levels;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;secretion;signaling;transmembrane transport;transport;vesicle-mediated transport,cell body;cell part;cell projection;cyclin-dependent protein kinase holoenzyme complex;cytosol;filopodium;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;neuronal cell body;nucleus;organelle;plasma membrane;protein complex;site of polarized growth;synapse,,+,,,,,,,,
Q96JB5,CDK5RAP3,CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (Protein HSF-27),17,35.8,31.01,30.6,31.02,29.82,30.55,31.21,29.62,29.51,30.6,31.03,30.12,30.02,30.6,30.44,0.57,0.16,0.58,-0.62,0.11,0.77,-0.82,-0.93,0.17,0.59,-0.32,-0.42,0.16,anatomical structure development;biological regulation;developmental process;regulation of cell cycle;regulation of protein modification process,,,,,,,,,,,
Q00534,CDK6,Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),6,25.2,28.07,25.85,24.37,26.37,26.05,,27.51,25.66,24.53,26.52,,26.79,,26.17,1.9,-0.32,-1.81,0.2,-0.13, ,1.34,-0.51,-1.64,0.35, ,0.62, ,anatomical structure development;biological regulation;cell development;cell differentiation;cell division;cellular process;developmental process;multi-organism process;regulation of cell cycle;response to biotic stimulus;response to stimulus,cell part;cell projection;cyclin-dependent protein kinase holoenzyme complex;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,+,,,,,,,,
P50613,CDK7,Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit),4,16.5,25.13,24.92,,25.57,26.91,26.83,26.61,26.2,26.08,25.71,25.44,26.47,27.35,26.1,-0.97,-1.18, ,-0.53,0.81,0.73,0.51,0.1,-0.02,-0.39,-0.66,0.37,1.25,"biological regulation;biosynthetic process;catabolic process;cell division;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;signal transduction;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex;transcription factor complex,,+,,,,,,,,
P50750,CDK9,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit),6,18.5,28.23,28.07,25.13,27.56,25.33,27.59,27.86,25.67,28.33,26.79,25.53,25.47,26.65,26.78,1.44,1.28,-1.65,0.77,-1.45,0.8,1.07,-1.12,1.54,0.01,-1.25,-1.31,-0.13,"biological regulation;biosynthetic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;cytoplasm;macromolecular complex;protein complex;transcription elongation factor complex,,+,,,,,,,,
Q5VV42,CDKAL1,Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase),9,25.4,27.26,27.01,25.81,26.97,28.01,26.82,28.02,26.55,29.14,29.34,25.09,26.75,29.42,27.4,-0.14,-0.4,-1.59,-0.43,0.61,-0.58,0.62,-0.85,1.74,1.94,-2.31,-0.65,2.02,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;tRNA metabolic process;tRNA processing,cell part;membrane,,,,,,,,,,
E7ES52,CDKN1B,Cyclin-dependent kinase inhibitor 1B,2,7.8,23.97,26.22,25.85,26.28,25.14,24.84,25.18,26.11,24.37,,25.93,,24.95,25.35,-1.38,0.87,0.5,0.93,-0.21,-0.51,-0.16,0.76,-0.98, ,0.58, ,-0.4,biological regulation;cellular process;regulation of cell cycle,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NXV6,CDKN2AIP,CDKN2A-interacting protein (Collaborator of ARF),13,32.8,29.36,27.42,29,27.22,27.85,28.54,28.22,27.67,28.66,30.14,26.58,25.57,27.81,28,1.35,-0.58,1,-0.78,-0.16,0.53,0.22,-0.33,0.66,2.14,-1.43,-2.43,-0.19,biological regulation;regulation of protein stability,cell part;nucleoplasm,,,,,,,,,,
Q86X02,CDR2L,Cerebellar degeneration-related protein 2-like (Paraneoplastic 62 kDa antigen),3,8.8,,,,,24.8,23.35,24.63,25.9,23.86,24.03,26.56,,,24.73, , , , ,0.06,-1.38,-0.1,1.17,-0.87,-0.7,1.82, , ,,,,,,,,,,,,
O95674,CDS2,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),7,18.2,27.98,28.79,28.93,28.25,27.84,28,27.71,27.65,28.23,28.62,28.42,27.96,28.39,28.21,-0.24,0.58,0.71,0.04,-0.37,-0.21,-0.51,-0.56,0.02,0.4,0.21,-0.25,0.18,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9UKY7,CDV3,Protein CDV3 homolog,15,71.3,31.53,29.77,31,30.78,29.56,28.54,30.59,30.5,29.12,29.18,30.87,31.08,27.36,29.99,1.54,-0.22,1.01,0.79,-0.43,-1.45,0.6,0.51,-0.87,-0.82,0.88,1.09,-2.63,cell proliferation,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9Y232,CDYL,Chromodomain Y-like protein (CDY-like) (EC 2.3.1.48),12,25,27.92,26.22,24.78,24.82,26.38,25.32,,24.77,24.66,24.2,,,22.34,25.14,2.77,1.08,-0.36,-0.32,1.24,0.18, ,-0.37,-0.48,-0.94, , ,-2.8,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P17676,CEBPB,CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5),3,39.4,28.65,27.59,26.85,27.44,26.53,28.05,26.3,26.68,26.82,,26.28,,26.73,27.08,1.57,0.51,-0.23,0.36,-0.56,0.97,-0.78,-0.41,-0.27, ,-0.8, ,-0.36,anatomical structure development;biological regulation;cell differentiation;cell proliferation;cellular process;developmental process;immune system process;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,bZIP,,,,,,,,,
P49716,CEBPD,CCAAT/enhancer-binding protein delta (C/EBP delta) (Nuclear factor NF-IL6-beta) (NF-IL6-beta),4,23.8,27.92,27.35,26.21,26.94,24.85,23.88,24.99,,26.7,25.02,,,21.58,25.54,2.38,1.8,0.67,1.39,-0.7,-1.66,-0.56, ,1.15,-0.52, , ,-3.96,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,bZIP,,,,,,,,,
Q9BXW7,CECR5,Cat eye syndrome critical region protein 5,6,21.4,26.14,26.94,26.9,28.14,27.02,28.42,27.26,26.08,26.88,28.55,27.12,27.55,26.04,27.16,-1.02,-0.22,-0.25,0.99,-0.14,1.26,0.11,-1.08,-0.27,1.39,-0.04,0.39,-1.12,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q92879,CELF1,CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2),5,13.3,30.06,29.9,28.93,28.85,28.89,29.51,28.83,27.86,29.14,29.32,27.35,26.3,29.19,28.78,1.28,1.12,0.15,0.07,0.11,0.73,0.05,-0.92,0.36,0.54,-1.43,-2.48,0.41,"anatomical structure development;biological regulation;cell development;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;developmental process;embryo development;gene silencing;macromolecular complex assembly;regulation of gene expression, epigenetic;ribonucleoprotein complex assembly",cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
O95319,CELF2,CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3),11,20.3,27.85,29.74,29.82,28.4,29.52,28.68,30.01,29.21,29.67,30.6,29.06,29.04,29.22,29.29,-1.44,0.44,0.53,-0.9,0.23,-0.61,0.71,-0.09,0.38,1.3,-0.23,-0.25,-0.07,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q03188,CENPC,Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Interphase centromere complex protein 7),4,8.1,24.3,23.78,26.01,23.2,,,20.42,,,21.31,19.46,22.43,20.02,22.32,1.98,1.45,3.69,0.88, , ,-1.91, , ,-1.02,-2.87,0.11,-2.31,cell cycle;cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromosome organization;chromosome segregation;macromolecular complex assembly;mitosis;mitotic cell cycle;nuclear division;organelle assembly;organelle fission;organelle organization;protein complex assembly,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q7Z7K6,CENPV,Centromere protein V (CENP-V) (Nuclear protein p30) (Proline-rich protein 6),3,16.9,,25.9,,25.79,27.22,26.72,26.46,25.73,26.63,26.88,25.04,25.75,25.28,26.13, ,-0.22, ,-0.34,1.09,0.59,0.33,-0.4,0.5,0.76,-1.09,-0.38,-0.85,biological regulation;cell division;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;chromatin modification;chromatin organization;chromosome organization;locomotion;mitosis;nuclear division;organelle fission;organelle organization;regulation of organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),34,25.7,26.26,28.36,26.78,29.87,28.55,28.24,29.79,28.97,28.4,27.16,29.32,27.66,28.31,28.28,-2.02,0.08,-1.5,1.59,0.27,-0.04,1.51,0.69,0.12,-1.12,1.04,-0.63,0.03,,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),12,12.5,24.65,22.96,,22.91,,22.62,22.73,23.48,,,24.41,24.2,23.21,23.46,1.18,-0.51, ,-0.55, ,-0.84,-0.73,0.01, , ,0.94,0.74,-0.25,,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q96G23,CERS2,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein),8,19.5,28.06,29.02,28.78,28.28,27.45,29.73,29.07,28.16,27.87,31.09,29.08,29.55,29.88,28.92,-0.86,0.09,-0.14,-0.65,-1.47,0.8,0.14,-0.77,-1.05,2.17,0.15,0.63,0.95,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,Homeobox,,,,,,,,,
O00748,CES2,Cocaine esterase (EC 3.1.1.84) (Carboxylesterase 2) (CE-2) (hCE-2) (EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56),12,27.2,29.89,27.03,24.41,25.57,28.28,24.51,27.4,27.56,24.74,29.45,28.44,,29.22,27.21,2.68,-0.18,-2.8,-1.63,1.07,-2.7,0.2,0.35,-2.47,2.25,1.23, ,2.01,catabolic process;metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P41208,CETN2,Centrin-2 (Caltractin isoform 1),4,39.5,24.04,24.94,26.25,23.95,26.02,25.4,25.62,25.12,23.4,24.09,23.09,27.71,,24.97,-0.93,-0.02,1.28,-1.02,1.05,0.43,0.65,0.15,-1.57,-0.88,-1.87,2.74, ,biological regulation;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mitosis;multicellular organismal process;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cell projection;cilium;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleotide-excision repair complex;organelle;protein complex,,,,,,,,,,
Q9UEE9,CFDP1,Craniofacial development protein 1 (Bucentaur),3,10.4,26.43,25.31,25.46,26.07,,,22.79,,25.43,,24.84,24.92,19.19,24.49,1.93,0.82,0.96,1.58, , ,-1.7, ,0.94, ,0.35,0.43,-5.3,biological adhesion;biological regulation;cell adhesion;cellular process;developmental process;multicellular organismal development;multicellular organismal process,,,,,,,,,,,
P23528,CFL1,"Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)",25,89.2,34.36,34.13,34.43,34.73,33.58,33.5,34.12,34.37,33.35,33.09,34.09,34.16,32.65,33.89,0.47,0.25,0.54,0.84,-0.3,-0.39,0.23,0.48,-0.54,-0.8,0.2,0.27,-1.24,anatomical structure morphogenesis;biological regulation;cell activation;cell motility;cellular component disassembly;cellular component movement;cellular component organization;cellular metabolic process;cellular process;cytokinesis;cytoskeleton organization;developmental process;establishment of localization;establishment or maintenance of cell polarity;exocytosis;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;organelle organization;phosphorus metabolic process;primary metabolic process;protein depolymerization;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y281,CFL2,"Cofilin-2 (Cofilin, muscle isoform)",8,54.8,27.43,29.22,28.96,30.12,28.16,27.09,28.97,28.58,28.33,27.67,29.55,29.93,26.78,28.52,-1.09,0.7,0.44,1.6,-0.37,-1.43,0.45,0.05,-0.19,-0.85,1.03,1.41,-1.74,cellular component disassembly;cellular component organization;cellular process;cytoskeleton organization;organelle organization;protein depolymerization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9P2M7,CGN,Cingulin,23,23.7,28.89,24.2,29.04,,,,24.56,26.88,,29.22,26.2,27.73,,27.09,1.8,-2.89,1.95, , , ,-2.53,-0.21, ,2.13,-0.89,0.64, ,biological regulation;cellular process;response to stimulus;signal transduction,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),23,29.3,26.45,26.98,27.04,26.25,27.72,27.06,26.92,26.07,27.82,26.55,22.86,24.83,27.18,26.44,0.01,0.54,0.6,-0.19,1.28,0.62,0.48,-0.37,1.38,0.11,-3.58,-1.61,0.74,biological regulation;cellular component organization;cellular localization;cellular process;cytoskeleton organization;localization;organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nucleus;organelle;protein complex,C2H2-type,,,,,,,,,
Q96BP2,CHCHD1,Coiled-coil-helix-coiled-coil-helix domain-containing protein 1 (Nuclear protein C2360),3,25.4,24.75,26.78,,27.25,27.74,26.52,26.05,,,,26,,26.12,26.4,-1.65,0.37, ,0.85,1.33,0.12,-0.35, , , ,-0.4, ,-0.28,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
Q9Y6H1,CHCHD2,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 2, mitochondrial (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein) (NS2TP)",3,33.8,29.11,30.21,28.84,29.49,27.51,28.83,28.86,28.71,29.55,29.94,29.21,28.89,29.94,29.16,-0.05,1.05,-0.32,0.33,-1.65,-0.34,-0.3,-0.45,0.39,0.78,0.05,-0.27,0.78,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NX63,CHCHD3,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial",17,54.2,29.7,30.46,31.53,30,29.69,29.66,29.71,29.75,30.55,31.52,29.57,,26.54,29.89,-0.19,0.57,1.64,0.11,-0.2,-0.23,-0.18,-0.14,0.66,1.63,-0.32, ,-3.35,cellular component organization;cellular membrane organization;cellular process;membrane fusion;membrane organization;mitochondrion organization;organelle fusion;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q8N4Q1,CHCHD4,Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4),6,45.1,26.26,29.11,28.52,27.52,23.3,26.18,27.99,23.6,28.4,29.27,28.36,28.12,27.16,27.21,-0.96,1.9,1.31,0.3,-3.91,-1.03,0.78,-3.62,1.18,2.05,1.15,0.91,-0.05,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein maturation;protein metabolic process;protein targeting;protein transport;transmembrane transport;transport,cell part,,,,,,,,,,
J3QTB2,CHCHD6,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 6, mitochondrial",2,20,24.21,25.72,23.06,23.3,22.21,25.24,25.29,21.21,25.77,26.24,,,,24.23,-0.02,1.49,-1.16,-0.92,-2.01,1.02,1.06,-3.01,1.54,2.02, , , ,,,,,,,,,,,,
Q86WJ1,CHD1L,Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.12) (Amplified in liver cancer protein 1),4,6.3,,23.85,,23.54,25.33,25.8,25.17,26,26.74,24.08,22.94,25.42,25.27,24.92, ,-1.08, ,-1.38,0.41,0.88,0.25,1.07,1.82,-0.84,-1.98,0.5,0.35,cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O14647,CHD2,Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2),13,8.6,28.45,27.88,26.46,28.18,26.32,27.92,27.47,27.36,28.42,28.44,27.46,29.08,28.34,27.83,0.62,0.05,-1.37,0.35,-1.51,0.09,-0.36,-0.47,0.59,0.61,-0.37,1.26,0.51,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q12873,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),11,7,27.45,24.56,26.09,26.06,,,25.54,,25.57,25.93,22.12,25.38,,25.41,2.04,-0.85,0.68,0.65, , ,0.13, ,0.16,0.51,-3.29,-0.04, ,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;cytoskeleton organization;macromolecule metabolic process;metabolic process;microtubule organizing center organization;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;centrosome;chromatin remodeling complex;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleolus;organelle;protein complex;transcriptional repressor complex,Other TF domain,,,,,,,,,
Q14839,CHD4,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),66,39.9,32.64,30.57,31.82,31.04,31.77,31.59,31.37,30.32,31.34,31.49,29.75,30.65,30.56,31.15,1.49,-0.58,0.67,-0.11,0.62,0.45,0.23,-0.83,0.19,0.35,-1.4,-0.5,-0.58,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;centrosome;chromatin remodeling complex;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex;transcriptional repressor complex,Other TF domain,,,,,,,,,
Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),9,5.7,26.72,22.67,24.89,23.88,28.04,28.26,27.41,28.69,26.73,26.4,27.45,26.03,26.45,26.43,0.28,-3.76,-1.54,-2.56,1.61,1.83,0.98,2.25,0.3,-0.04,1.02,-0.4,0.02,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;embryo development;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction,cell part;histone methyltransferase complex;macromolecular complex;protein complex,Other TF domain,,,,,,,,,
Q8IWX8,CHERP,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),12,16.4,28.92,28.32,27.6,28.75,28.79,28.6,28.37,28.05,28.96,26.97,26.38,25.08,28.57,27.95,0.97,0.37,-0.35,0.8,0.84,0.65,0.42,0.1,1.01,-0.98,-1.57,-2.87,0.62,anatomical structure development;biological regulation;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;ion transport;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of transport;RNA metabolic process;RNA processing;transport,cell part;membrane,,,,,,,,,,
Q9BWS9,CHID1,Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein) (SI-CLP),7,25.1,28.26,29.88,28.74,28.61,28.58,28.6,28.81,27.5,28.69,28.63,28.49,28.44,28.99,28.63,-0.37,1.25,0.11,-0.02,-0.05,-0.03,0.18,-1.14,0.06,-0.01,-0.14,-0.19,0.36,amine metabolic process;carbohydrate metabolic process;catabolic process;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;response to stimulus;response to stress,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
B4DRL9,CHM,"Rab proteins geranylgeranyltransferase component A 1 (cDNA FLJ58404, highly similar to Rab proteins geranylgeranyltransferase component A 1)",2,6.3,22.68,23.72,24.85,24.21,24.28,23.94,24.88,24.34,,23.93,25.53,27.04,23.7,24.43,-1.75,-0.7,0.43,-0.21,-0.14,-0.49,0.45,-0.08, ,-0.49,1.1,2.61,-0.72,anatomical structure development;developmental process;establishment of localization;protein transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q7LBR1,CHMP1B,Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b) (CHMP1b) (Vacuolar protein sorting-associated protein 46-2) (Vps46-2) (hVps46-2),5,21.4,28.61,27.43,29.05,26.78,24.98,25.44,26.64,24.54,26.16,27.72,27.34,,,26.79,1.82,0.64,2.26,-0.01,-1.81,-1.35,-0.15,-2.25,-0.63,0.93,0.55, , ,cellular process;cytokinesis;establishment of localization;protein transport;transport,cell part;cytosol;membrane,,,,,,,,,,
O43633,CHMP2A,Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1),4,19.4,27.95,26.6,26.92,27.29,27.81,25.78,27.11,27.59,26.7,25.75,26.59,25.6,24.46,26.63,1.32,-0.02,0.29,0.66,1.19,-0.84,0.48,0.96,0.07,-0.88,-0.04,-1.02,-2.17,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;membrane,,,,,,,,,,
Q9Y3E7,CHMP3,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24),5,34.6,28.08,27.28,27.01,27.66,,,27.4,26.79,26.39,,26.15,23.63,27.19,26.76,1.32,0.52,0.26,0.9, , ,0.64,0.04,-0.37, ,-0.61,-3.13,0.43,biological regulation;cell death;cellular component organization;cellular membrane organization;cellular process;cytokinesis;death;endosome transport;establishment of localization;membrane organization;protein transport;transport;vacuolar transport;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;midbody;organelle,,,,,,,,,,
Q9BY43,CHMP4A,Charged multivesicular body protein 4a (Chromatin-modifying protein 4a) (CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1) (hSnf-1) (Vacuolar protein sorting-associated protein 32-1) (Vps32-1) (hVps32-1),2,12.2,27.24,26.15,25.96,27,24.04,,25.5,,,22.13,,22.6,,25.08,2.16,1.07,0.88,1.92,-1.04, ,0.42, , ,-2.94, ,-2.48, ,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;membrane;midbody,,,,,,,,,,
Q9H444,CHMP4B,Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2),10,51.3,31.13,29.22,29.82,29.66,26.59,28.29,28.71,29.23,27.67,27.7,28.65,28.72,28,28.72,2.41,0.5,1.09,0.94,-2.13,-0.43,-0.01,0.51,-1.05,-1.03,-0.07,-0.01,-0.73,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;membrane;midbody,,,,,,,,,,
Q9NZZ3,CHMP5,Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2) (Vacuolar protein sorting-associated protein 60) (Vps60) (hVps60),6,40.6,27.1,25.07,29,26.62,27.52,26.08,27.06,28.24,26.66,20.33,25.75,29.44,26.52,26.57,0.53,-1.5,2.44,0.06,0.95,-0.49,0.49,1.67,0.09,-6.24,-0.82,2.87,-0.05,biological regulation;cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;organelle organization;protein transport;transport;vacuolar transport;vacuole organization;vesicle-mediated transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q96FZ7,CHMP6,Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20) (Vps20) (hVps20),4,21.9,26.23,27.18,,26.51,27.09,,26.4,,27.07,27.07,26.7,26.95,,26.8,-0.57,0.38, ,-0.29,0.29, ,-0.4, ,0.27,0.27,-0.1,0.15, ,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;endomembrane system;membrane,,,,,,,,,,
Q9UHD1,CHORDC1,Cysteine and histidine-rich domain-containing protein 1 (CHORD domain-containing protein 1) (CHORD-containing protein 1) (CHP-1) (Protein morgana),9,41.6,29.73,28.55,29.77,29.72,27.55,27.64,29.65,29.3,28.67,27.79,28.83,28.22,24.73,28.47,1.26,0.07,1.3,1.25,-0.93,-0.83,1.17,0.82,0.2,-0.68,0.36,-0.26,-3.74,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;response to stimulus;response to stress,,,,,,,,,,,
Q99653,CHP1,Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22),13,69.2,28.79,29.15,28.69,29.65,29.73,29.92,29.46,29.53,29.75,29.47,30.49,28.96,30.49,29.55,-0.76,-0.39,-0.85,0.1,0.19,0.38,-0.09,-0.02,0.21,-0.07,0.95,-0.59,0.94,biological regulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;cytoskeleton organization;establishment of localization;exocytosis;homeostatic process;ion transport;macromolecular complex assembly;membrane docking;membrane fusion;membrane organization;nuclear transport;nucleocytoplasmic transport;organelle organization;protein complex assembly;protein targeting;protein transport;regulation of protein modification process;regulation of protein stability;regulation of transport;response to abiotic stimulus;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytoskeleton;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9P2E5,CHPF2,Chondroitin sulfate glucuronyltransferase (EC 2.4.1.226) (CSGlcA-T) (Chondroitin glucuronyltransferase) (Chondroitin polymerizing factor 2) (ChPF-2) (Chondroitin synthase 3) (ChSy-3) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase),4,10.8,24.83,25.39,,25.36,25.18,27.08,25.05,24.64,27.44,24.03,25.02,24.14,26.64,25.4,-0.57,-0.01, ,-0.04,-0.22,1.68,-0.35,-0.76,2.04,-1.37,-0.37,-1.26,1.24,amine metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;sulfur compound metabolic process,cell part;membrane,,,,,,,,,,
Q9NRG0,CHRAC1,Chromatin accessibility complex protein 1 (CHRAC-1) (Chromatin accessibility complex 15 kDa protein) (CHRAC-15) (HuCHRAC15) (DNA polymerase epsilon subunit p15),3,23.7,25.73,25.06,25.01,25.34,26.08,25.37,,25.63,,25.31,23.36,,25.46,25.23,0.49,-0.18,-0.23,0.1,0.84,0.14, ,0.4, ,0.08,-1.87, ,0.22,cellular component organization;cellular process;chromatin modification;chromatin organization;chromosome organization;organelle organization,cell part;chromatin remodeling complex;DNA polymerase complex;macromolecular complex;protein complex,,,,,,,,,,
Q9Y3Y2,CHTOP,Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG),5,31.7,30.37,29.14,30.15,29.71,29.05,30.02,28.96,29.67,30.47,30.45,28.99,28.45,28.92,29.57,0.8,-0.43,0.59,0.14,-0.52,0.46,-0.6,0.11,0.9,0.88,-0.57,-1.12,-0.65,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleoplasm;nucleus;organelle,,,,,,,,,,
O76071,CIAO1,Probable cytosolic iron-sulfur protein assembly protein CIAO1 (WD repeat-containing protein 39),3,9.4,26.15,26.72,27.56,27.06,24.46,,27.54,26.53,25.02,25.82,26.58,26.32,,26.34,-0.2,0.38,1.22,0.72,-1.88, ,1.2,0.19,-1.32,-0.52,0.24,-0.02, ,biological regulation;biosynthetic process;cellular metabolic process;cellular process;chromosome segregation;cofactor metabolic process;metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q6FI81,CIAPIN1,Anamorsin (Cytokine-induced apoptosis inhibitor 1) (Fe-S cluster assembly protein DRE2 homolog),8,32.1,28.39,27.37,29.14,28.82,28.78,28.08,28.43,28.76,26.06,27.73,29.2,28.56,26.79,28.16,0.23,-0.79,0.98,0.66,0.61,-0.08,0.27,0.6,-2.1,-0.43,1.03,0.39,-1.37,anatomical structure development;biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular process;cofactor metabolic process;death;developmental process;metabolic process;small molecule metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q86X95,CIR1,Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin),2,8.9,20.25,19.4,18.02,19.35,18.03,18.43,19.27,19.44,20.67,19.69,,,,19.25,0.99,0.15,-1.24,0.09,-1.22,-0.82,0.01,0.19,1.41,0.44, , , ,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
Q14011,CIRBP,Cold-inducible RNA-binding protein (A18 hnRNP) (Glycine-rich RNA-binding protein CIRP),5,30.2,29.23,28.38,28.98,28.96,29.9,29.75,29.32,29.46,29.64,28.88,28.1,28.41,28.87,29.07,0.16,-0.69,-0.09,-0.1,0.83,0.69,0.26,0.39,0.57,-0.19,-0.97,-0.66,-0.2,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to abiotic stimulus;response to stimulus;response to stress;ribonucleoprotein complex assembly;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q969X6,CIRH1A,Cirhin,10,19.8,28.39,26.31,27.44,27.27,28.49,27.86,27.04,27.37,27.76,27.39,,25.75,26.83,27.32,1.07,-1.02,0.12,-0.06,1.16,0.53,-0.28,0.05,0.43,0.06, ,-1.58,-0.5,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9NZ45,CISD1,CDGSH iron-sulfur domain-containing protein 1 (MitoNEET),4,44.4,29.64,30.55,31.07,29.64,28.34,29.45,29.67,29.54,30.49,30.06,30.27,29.42,29.87,29.85,-0.21,0.7,1.22,-0.2,-1.5,-0.39,-0.18,-0.31,0.64,0.21,0.43,-0.42,0.02,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q8N5K1,CISD2,CDGSH iron-sulfur domain-containing protein 2 (Endoplasmic reticulum intermembrane small protein) (MitoNEET-related 1 protein) (Miner1) (Nutrient-deprivation autophagy factor-1) (NAF-1),7,47.4,29.35,30.33,30.11,29.59,28.82,30.3,29.98,30.11,30.09,30.15,30.18,30.17,29.97,29.94,-0.59,0.4,0.17,-0.35,-1.11,0.37,0.04,0.17,0.16,0.22,0.25,0.23,0.04,aging;autophagy;biological regulation;catabolic process;cellular metabolic process;cellular process;developmental process;metabolic process,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q07065,CKAP4,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),78,79.9,33.25,35.34,33.66,35.46,34.86,35.61,33.98,34.16,35.65,33.6,34.48,33.83,35.66,34.58,-1.33,0.75,-0.92,0.88,0.28,1.03,-0.6,-0.42,1.07,-0.98,-0.1,-0.75,1.08,,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;lipid particle;membrane;organelle;plasma membrane,,,,,,,,,,
Q14008,CKAP5,Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG),53,34.3,30.69,30.19,30.36,31,31.25,30.86,31.45,31.35,30.68,30.24,30.98,31.43,30.85,30.87,-0.18,-0.68,-0.52,0.13,0.37,-0.01,0.58,0.48,-0.19,-0.63,0.11,0.56,-0.02,cell division;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;establishment or maintenance of cell polarity;microtubule organizing center organization;mitosis;nuclear division;nucleobase-containing compound transport;organelle fission;organelle organization;transport,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle,,,,,,,,,,
P12277,CKB,Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain),17,58.5,32.66,30.09,30.07,26.5,28.74,22.34,25.31,26.16,,27.68,26.11,26.36,26.02,27.34,5.32,2.75,2.73,-0.84,1.41,-5,-2.02,-1.18, ,0.34,-1.22,-0.98,-1.32,amine metabolic process;anatomical structure development;biological regulation;cellular amino acid metabolic process;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;homeostatic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P12532,CKMT1A,"Creatine kinase U-type, mitochondrial (EC 2.7.3.2) (Acidic-type mitochondrial creatine kinase) (Mia-CK) (Ubiquitous mitochondrial creatine kinase) (U-MtCK)",10,32.4,29.85,27,26.92,27.57,,,,,25.95,27.34,28.32,24.78,25.43,27.02,2.84,-0.02,-0.1,0.55, , , , ,-1.07,0.32,1.31,-2.24,-1.58,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q7Z460,CLASP1,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),20,16.8,28.58,26.88,27.99,28.73,27.83,28.06,27.74,28.15,26.86,27.95,27.85,27.88,27.31,27.83,0.75,-0.95,0.16,0.9,0,0.23,-0.09,0.32,-0.97,0.12,0.02,0.05,-0.52,biological regulation;cell division;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;locomotion;microtubule organizing center organization;organelle organization;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cytoskeleton;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;organelle;protein complex,,,,,,,,,,
F5H604,CLASP2,CLIP-associating protein 2,9,7.7,23.91,23.41,23.66,24.83,25.22,23.13,25.39,24.33,23.32,23.07,24.45,25.71,23.68,24.16,-0.25,-0.76,-0.51,0.67,1.06,-1.04,1.23,0.17,-0.84,-1.09,0.28,1.55,-0.48,,,,,,,,,,,,
Q96S66,CLCC1,Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1),6,22.4,26.65,26.04,25.82,26.82,27.39,27.1,23.34,27.93,22.99,22.7,27.24,24.78,26.38,25.78,0.87,0.25,0.03,1.04,1.61,1.32,-2.44,2.14,-2.79,-3.08,1.46,-1.01,0.6,,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P51798,CLCN7,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),8,14.1,25.66,25.56,25.76,26.43,24.24,27.13,24.01,24.98,25.64,26.59,26.56,25.24,25.87,25.67,-0.01,-0.11,0.09,0.76,-1.42,1.47,-1.66,-0.69,-0.03,0.93,0.9,-0.43,0.2,response to abiotic stimulus;response to stimulus,cell part;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
O14967,CLGN,Calmegin,20,47,28.16,28.67,29.09,25.63,29.72,31.02,30.69,29.62,31.65,30.18,30.21,27.64,31.67,29.53,-1.37,-0.86,-0.45,-3.9,0.19,1.48,1.15,0.08,2.12,0.65,0.67,-1.89,2.13,cell recognition;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nuclear envelope;organelle,,,,,,,,,,
O00299,CLIC1,Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC),21,87.1,33.95,33.62,34.37,33.29,33.17,32.33,33.28,33.22,32.26,32.36,33.48,34.2,31.36,33.15,0.81,0.48,1.23,0.15,0.03,-0.82,0.14,0.07,-0.88,-0.79,0.33,1.05,-1.79,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;homeostatic process;response to stimulus;signal transduction,brush border;cell part;cell projection;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nuclear envelope;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9Y696,CLIC4,Chloride intracellular channel protein 4 (Intracellular chloride ion channel protein p64H1),30,91.3,31.82,32.39,32.66,32.92,32.76,32.2,33.62,34.02,33.07,31.13,34.34,34.31,32.19,32.88,-1.06,-0.49,-0.22,0.04,-0.12,-0.68,0.74,1.14,0.19,-1.75,1.46,1.43,-0.69,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell differentiation;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;establishment or maintenance of cell polarity;growth;homeostatic process;multicellular organismal process;regulation of organelle organization;response to chemical stimulus;response to stimulus,apical part of cell;cell part;cell projection;cell surface;centrosome;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;microvillus;midbody;mitochondrion;organelle;plasma membrane;protein complex;vacuole,,,,,,,,,,
Q9NZA1,CLIC5,Chloride intracellular channel protein 5,9,57,29.31,26.92,29.72,25.56,31.04,26.23,,,25.22,29.32,25.1,,,27.6,1.71,-0.68,2.12,-2.04,3.44,-1.37, , ,-2.38,1.72,-2.5, , ,biological regulation;cellular component organization;cellular process;establishment of localization;ion transport;localization;multicellular organismal process;multi-organism process;neurological system process;transport,cell cortex;cell part;cell projection;cytoskeleton;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;microvillus;organelle;protein complex,,,,,,,,,,
Q14677,CLINT1,Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR),23,41.5,31.38,30.04,30.99,30.5,30.59,29.47,31.04,30.35,30.72,30.87,30.52,28.35,29.27,30.32,1.06,-0.27,0.68,0.19,0.28,-0.84,0.73,0.04,0.41,0.55,0.2,-1.96,-1.04,cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;Golgi vesicle transport;membrane invagination;membrane organization;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
P30622,CLIP1,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),24,18.8,28.39,28.12,28.02,28.35,27.4,27.3,27.75,28.22,27.41,27.95,27.71,29.26,26.55,27.88,0.51,0.24,0.14,0.47,-0.48,-0.58,-0.13,0.34,-0.47,0.07,-0.17,1.38,-1.33,biological regulation;cell cycle;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;mitosis;mitotic cell cycle;nuclear division;organelle fission;organelle organization;regulation of organelle organization;transport,cell part;cell projection;centrosome;cytosol;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;microtubule organizing center;organelle;protein complex,,,,,,,,,,
Q9UDT6,CLIP2,CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein),7,7.3,28.98,27.5,24.75,27.7,28.81,29.32,29.54,25.42,27.98,21.97,27.04,26.88,30.66,27.43,1.55,0.08,-2.68,0.28,1.38,1.89,2.11,-2,0.55,-5.45,-0.39,-0.55,3.23,,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q13286,CLN3,Battenin (Batten disease protein) (Protein CLN3),4,17.1,25.72,25.04,25.61,25.4,25.96,26.58,26.31,24.28,25.43,26.25,25.41,26.84,24.83,25.67,0.06,-0.63,-0.05,-0.26,0.29,0.92,0.64,-1.39,-0.23,0.58,-0.25,1.18,-0.84,amine metabolic process;amine transport;amino acid transport;behavior;biological regulation;catabolic process;cell death;cellular amino acid metabolic process;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular localization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton-dependent intracellular transport;death;endocytosis;establishment of localization;homeostatic process;lipid metabolic process;localization;macromolecule metabolic process;membrane fusion;membrane invagination;membrane organization;metabolic process;multicellular organismal process;neurological system process;neurotransmitter metabolic process;nitrogen compound metabolic process;organelle fusion;organelle localization;organelle organization;organic acid metabolic process;organic acid transport;primary metabolic process;protein catabolic process;protein folding;protein maturation;protein metabolic process;response to stimulus;signal transduction;small molecule metabolic process;transport;vacuolar transport;vesicle-mediated transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;neuron projection;nucleus;organelle;vacuole;vesicle,,,,,,,,,,
P54105,CLNS1A,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) (Chloride ion current inducer protein) (ClCI) (Reticulocyte pICln)",5,30.4,28.27,27.14,27.65,26.97,28.23,27.04,27.29,27.78,25.91,26.65,27.99,28.95,26.03,27.38,0.89,-0.24,0.27,-0.4,0.86,-0.33,-0.09,0.4,-1.47,-0.73,0.62,1.57,-1.35,biological regulation;blood circulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;establishment of localization;homeostatic process;ion transport;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;transport,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9H078,CLPB,Caseinolytic peptidase B protein homolog (Suppressor of potassium transport defect 3),14,23.3,28.25,29.8,27.78,28.16,29.26,29.67,26.68,28.16,29,28.81,28.69,25.91,29.15,28.41,-0.15,1.4,-0.63,-0.25,0.85,1.26,-1.73,-0.25,0.59,0.4,0.28,-2.5,0.74,cellular process;response to abiotic stimulus;response to heat;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q16740,CLPP,"Putative ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)",9,31,28.61,29.68,28.21,28.79,29.67,30.19,29.33,28.76,29.65,29.5,29.41,28.37,29.78,29.23,-0.62,0.45,-1.02,-0.43,0.45,0.96,0.1,-0.47,0.42,0.28,0.18,-0.86,0.55,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O96005,CLPTM1,Cleft lip and palate transmembrane protein 1,8,19.9,29.16,27.72,29.15,29.5,27.55,29.73,29.16,27.97,29.69,29.79,29.66,29.15,30.14,29.11,0.06,-1.39,0.04,0.39,-1.56,0.62,0.06,-1.13,0.59,0.69,0.55,0.04,1.03,biological regulation;cell differentiation;cellular process;developmental process;multicellular organismal development;multicellular organismal process,cell part,,,,,,,,,,
Q96KA5,CLPTM1L,Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein) (Cisplatin resistance-related protein 9) (CRR9p),9,23.7,28.27,28.55,26.89,28.65,28.46,28.88,28.47,28.45,29.23,28.46,29.23,27.72,28.94,28.48,-0.21,0.07,-1.58,0.17,-0.02,0.41,-0.01,-0.03,0.75,-0.02,0.75,-0.75,0.46,cell death;cellular process;death,cell part,,,,,,,,,,
O76031,CLPX,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",22,40.3,30.02,28.67,29.95,29.07,30.59,30.93,29.99,29.85,30.1,30.96,30.34,29.63,30.72,30.06,-0.04,-1.39,-0.11,-0.99,0.52,0.87,-0.08,-0.21,0.04,0.89,0.28,-0.43,0.66,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;endopeptidase Clp complex;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
P09496,CLTA,Clathrin light chain A (Lca),16,44,29.1,30.07,30.55,30.51,30.54,29.96,29.82,30.43,29.93,29.85,30.23,26.55,30.24,29.83,-0.73,0.24,0.72,0.68,0.71,0.13,-0.01,0.6,0.1,0.02,0.4,-3.28,0.41,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;Golgi vesicle transport;immune system process;locomotion;membrane invagination;membrane organization;protein transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P09497,CLTB,Clathrin light chain B (Lcb),10,38.4,29.71,29.96,31.16,29.09,28.81,29.56,29.32,28.35,28.71,30.05,30.1,28.08,29.46,29.41,0.3,0.54,1.75,-0.32,-0.6,0.15,-0.1,-1.07,-0.7,0.64,0.68,-1.33,0.05,cellular process;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q00610,CLTC,Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17),120,67.3,35.63,35.68,35.67,35.87,35.76,35.77,35.77,35.92,35.93,35.64,36.03,36.03,36.05,35.83,-0.2,-0.14,-0.16,0.04,-0.07,-0.06,-0.06,0.1,0.1,-0.18,0.2,0.2,0.22,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;establishment of localization;Golgi vesicle transport;immune system process;ion transport;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;protein transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;protein complex;vesicle,,,,,,,,,,
P10909,CLU,"Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Testosterone-repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain);Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)]",14,35.6,31.62,29.87,29.23,24.01,26.5,28.92,27.54,27.83,27.95,27.25,26.75,24.58,25.85,27.53,4.09,2.34,1.7,-3.52,-1.03,1.39,0.01,0.3,0.42,-0.28,-0.78,-2.95,-1.68,biological regulation;cell activation;cellular component organization;cellular metabolic process;cellular process;establishment of localization;exocytosis;immune system process;lipid metabolic process;lipid transport;macromolecule metabolic process;metabolic process;mitochondrion organization;multi-organism process;organelle organization;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process;regulation of protein stability;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleus;organelle;vesicle,,,,,,,,,,
O75153,CLUH,Clustered mitochondria protein homolog,16,17.9,28.97,27.12,27.78,28.92,28.39,25.97,28.32,29.69,25.82,26.79,28.19,27.94,26.62,27.73,1.24,-0.61,0.05,1.18,0.66,-1.76,0.58,1.96,-1.91,-0.94,0.46,0.2,-1.11,cellular component organization;cellular localization;cellular process;localization;mitochondrion organization;organelle localization;organelle organization,cell part;cytoplasm,,,,,,,,,,
Q8NFW8,CMAS,N-acylneuraminate cytidylyltransferase (EC 2.7.7.43) (CMP-N-acetylneuraminic acid synthase) (CMP-NeuNAc synthase),18,40.8,31.57,29.18,29.78,28.59,28.68,30.29,28.45,28.22,29.54,29.09,28.99,28.42,30.44,29.33,2.25,-0.15,0.45,-0.73,-0.64,0.97,-0.87,-1.11,0.21,-0.24,-0.34,-0.91,1.11,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;organic acid metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P30085,CMPK1,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),15,61.2,30.71,30.07,29.89,30.19,29.46,27.79,30.19,30.49,29.37,28.55,30.53,30.64,27.33,29.63,1.08,0.44,0.26,0.56,-0.17,-1.84,0.56,0.86,-0.26,-1.08,0.9,1.01,-2.3,biosynthetic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;rhythmic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
C9J384,CMSS1,Protein CMSS1 (Fragment),3,16,28.19,24.68,27.69,25.06,26.54,25.91,25.36,,26.24,26.1,,21.43,,25.72,2.47,-1.04,1.97,-0.66,0.82,0.19,-0.36, ,0.52,0.38, ,-4.29, ,,,,,,,,,,,,
Q8IZR5,CMTM4,CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4),2,12.3,,22.75,,,23.17,23.73,22.44,,22.73,24.48,24.46,24.32,23.69,23.53, ,-0.79, , ,-0.36,0.2,-1.1, ,-0.8,0.95,0.93,0.79,0.16,locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;extracellular space,,,,,,,,,,
Q9NX76,CMTM6,CKLF-like MARVEL transmembrane domain-containing protein 6 (Chemokine-like factor superfamily member 6),3,17.5,25.28,25.01,27.37,25.18,27.41,26.41,25.76,26.09,27.99,29.29,24.42,,27.27,26.46,-1.18,-1.45,0.92,-1.28,0.95,-0.05,-0.7,-0.36,1.53,2.84,-2.03, ,0.82,locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;extracellular space,,,,,,,,,,
P62633,CNBP,Cellular nucleic acid-binding protein (CNBP) (Zinc finger protein 9),3,21.2,29.26,26.17,27.34,28.25,26.36,24.1,27.44,25.48,25.71,26.5,27.23,28.13,,26.83,2.43,-0.66,0.51,1.42,-0.47,-2.73,0.61,-1.35,-1.12,-0.33,0.4,1.3, ,alcohol metabolic process;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q96KP4,CNDP2,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A),41,82.9,35.17,32.63,34.18,31.66,30.62,30.03,31.15,31.93,29.57,32.23,31.74,31.99,28.51,31.65,3.53,0.98,2.53,0.01,-1.02,-1.61,-0.49,0.29,-2.08,0.58,0.09,0.34,-3.14,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q99439,CNN2,"Calponin-2 (Calponin H2, smooth muscle) (Neutral calponin)",16,52.3,30.83,30.38,31.41,32.15,32.39,31.86,31.95,31.97,32.05,31.57,32,32.67,32.26,31.81,-0.98,-1.43,-0.39,0.34,0.58,0.05,0.15,0.17,0.25,-0.23,0.19,0.86,0.45,anatomical structure development;biological regulation;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization;regulation of transport;response to abiotic stimulus;response to external stimulus;response to stimulus;response to stress,cell part,,,,,,,,,,
Q15417,CNN3,"Calponin-3 (Calponin, acidic isoform)",11,39.2,30.54,29.31,29.82,30.19,30.38,30.27,30.15,31.16,30.54,29.28,30.55,29.99,29.77,30.15,0.39,-0.84,-0.33,0.04,0.23,0.12,0,1.01,0.39,-0.87,0.4,-0.16,-0.38,cellular component organization;cellular process;cytoskeleton organization;multicellular organismal process;muscle contraction;organelle organization,,,,,,,,,,,
A5YKK6,CNOT1,CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1),35,19.7,30.48,29.09,28.72,30.19,30,29.69,29.92,29.66,29.08,29.25,29.81,29.43,30.61,29.69,0.79,-0.6,-0.97,0.51,0.32,0.01,0.23,-0.03,-0.61,-0.44,0.12,-0.26,0.92,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;gene silencing;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process;RNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microbody;nucleus;organelle;protein complex;ribonucleoprotein complex;transcription factor complex,,,,,,,,,,
Q9H9A5,CNOT10,CCR4-NOT transcription complex subunit 10,5,7.9,27.36,27.26,26.51,25.94,26.28,26.01,28.1,26.56,26.71,24.56,25.86,26.27,25.96,26.41,0.94,0.84,0.1,-0.47,-0.13,-0.4,1.69,0.14,0.29,-1.85,-0.56,-0.14,-0.45,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;gene silencing;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process;RNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;transcription factor complex,,,,,,,,,,
Q9UKZ1,CNOT11,CCR4-NOT transcription complex subunit 11,4,10,26.51,24.26,25.95,25.21,,,25.42,,26.33,24.11,,24.13,28.25,25.58,0.93,-1.31,0.38,-0.36, , ,-0.15, ,0.75,-1.47, ,-1.44,2.67,biological regulation;biosynthetic process;catabolic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;gene silencing;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process;RNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;transcription factor complex,,,,,,,,,,
Q9NZN8,CNOT2,CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2),4,15.1,27.39,25.41,,27.51,26.57,25.38,25.41,26.55,26.6,,25.51,25.51,25.98,26.17,1.23,-0.76, ,1.34,0.4,-0.79,-0.75,0.38,0.44, ,-0.65,-0.65,-0.19,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;gene silencing;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process;RNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;transcription factor complex,,,,,,,,,,
O75175,CNOT3,CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2),5,10.2,27.9,26.16,27.42,26.89,26.05,25.97,28.09,24.46,26.03,26.85,26.53,26.39,26.02,26.52,1.38,-0.36,0.9,0.37,-0.47,-0.55,1.57,-2.06,-0.49,0.33,0.01,-0.13,-0.5,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;gene silencing;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process;RNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ribonucleoprotein complex;transcription factor complex,,,,,,,,,,
H0Y9C1,CNOT6L,CCR4-NOT transcription complex subunit 6-like (Fragment),3,7.5,25.12,25.2,,25.34,25.06,25.25,25.93,26.57,26.05,24.86,24.67,24.84,24.47,25.28,-0.16,-0.08, ,0.06,-0.22,-0.03,0.65,1.29,0.77,-0.42,-0.61,-0.44,-0.81,,,,,,,,,,,,
Q9UIV1,CNOT7,CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (BTG1-binding factor 1) (CCR4-associated factor 1) (CAF-1) (Caf1a),4,27,26.51,25.51,,26.34,27.62,25.74,25.13,27.12,25.17,24.91,24.93,25.7,25.35,25.84,0.68,-0.33, ,0.51,1.78,-0.1,-0.71,1.28,-0.67,-0.92,-0.91,-0.14,-0.48,"biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;gene silencing;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of gene expression, epigenetic;regulation of translation;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process;RNA processing",cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ribonucleoprotein complex;transcription factor complex,,,,,,,,,,
P09543,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",18,41.4,30.51,30.95,32.06,31.14,30.57,31.57,30.97,31.05,30.87,31.36,30.79,28.87,30.98,30.9,-0.39,0.05,1.16,0.24,-0.33,0.67,0.07,0.15,-0.03,0.46,-0.11,-2.03,0.08,aging;anatomical structure development;anatomical structure morphogenesis;behavior;biological regulation;catabolic process;cell communication;cell-cell signaling;cellular component morphogenesis;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;developmental process;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;RNA metabolic process;signaling;small molecule metabolic process,cell part;cell projection;cytoplasm;cytoplasmic membrane-bounded vesicle;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microvillus;organelle;plasma membrane;protein complex;pseudopodium;vesicle,,,,,,,,,,
Q9Y2B0,CNPY2,Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4),11,39.2,30.86,31.57,29.84,30.68,30.85,31.46,30.69,30.77,31.16,30.6,30.81,29.49,31.38,30.78,0.07,0.78,-0.94,-0.11,0.07,0.68,-0.09,-0.01,0.38,-0.18,0.02,-1.29,0.6,biological regulation,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9BT09,CNPY3,Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein),8,32.7,28.91,29.05,30.51,27.99,28.8,29.01,27.99,28.38,28.43,28.64,28.38,28.55,28.12,28.67,0.23,0.38,1.84,-0.68,0.12,0.34,-0.69,-0.29,-0.24,-0.03,-0.3,-0.12,-0.56,biological regulation;cellular process;immune system process;response to stimulus;response to stress;signal transduction,cell part,,,,,,,,,,
Q8N129,CNPY4,Protein canopy homolog 4,7,35.5,24.22,28.64,28.52,27.81,25.98,28.62,27.29,27.23,28.71,27.98,28.89,28.98,29.11,27.85,-3.63,0.79,0.68,-0.04,-1.86,0.78,-0.55,-0.62,0.86,0.14,1.05,1.14,1.27,,extracellular region,,,,,,,,,,
P78357,CNTNAP1,Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190),7,5.6,,27.74,21.23,28.03,,24.44,,22.28,24.48,,26.05,26.42,27.05,25.3, ,2.44,-4.08,2.73, ,-0.86, ,-3.02,-0.82, ,0.74,1.12,1.75,anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component assembly;cellular component movement;cellular component organization;cellular localization;cellular process;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;localization;locomotion;multicellular organismal process;neurological system process;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;transport,cell part;macromolecular complex;protein complex,,,,+,,,,,,
Q9Y2R0,COA3,"Cytochrome c oxidase assembly protein 3 homolog, mitochondrial (Coiled-coil domain-containing protein 56) (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa)",4,38.7,25.51,27.76,23.46,26.93,29.38,29.11,27.33,28.5,27.57,28.28,28.6,27.97,28.13,27.58,-2.07,0.18,-4.12,-0.65,1.8,1.53,-0.25,0.93,-0.01,0.7,1.02,0.39,0.55,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein complex biogenesis;regulation of organelle organization;regulation of translation,cell part,,,,,,,,,,
Q9NYJ1,COA4,"Cytochrome c oxidase assembly factor 4 homolog, mitochondrial (Coiled-coil-helix-coiled-coil-helix domain-containing protein 8) (E2-induced gene 2 protein)",4,34.5,26.92,28.22,28.3,27.46,28.31,28.59,28.12,28.03,27.75,28.94,27.88,27.63,28.17,28.02,-1.11,0.19,0.27,-0.56,0.28,0.57,0.1,0,-0.27,0.92,-0.15,-0.39,0.15,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q5JTJ3,COA6,Cytochrome c oxidase assembly factor 6 homolog,2,19,25.13,27.36,28.42,26.21,,27.07,27.18,25.94,27.67,27.95,27.34,20.58,26.48,26.44,-1.31,0.92,1.97,-0.23, ,0.63,0.74,-0.51,1.22,1.51,0.89,-5.87,0.04,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q13057,COASY,Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT);Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)],6,15.4,28.58,28.51,26.73,27.42,26.55,26.49,26.63,27.5,26.38,26.82,26.06,25.44,24.82,26.76,1.81,1.75,-0.04,0.66,-0.21,-0.28,-0.14,0.74,-0.38,0.06,-0.71,-1.32,-1.94,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q53SF7,COBLL1,Cordon-bleu protein-like 1,12,16.8,25.63,25.61,22.34,26.27,,,26.03,21.38,24.75,26.56,25.39,27.5,24.95,25.13,0.5,0.49,-2.79,1.14, , ,0.9,-3.75,-0.37,1.43,0.27,2.37,-0.18,,,,,,,,,,,,
Q8WTW3,COG1,Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1),10,13.5,26.75,27.48,27.23,27.34,27.7,27.84,27.66,27.87,27.52,28.1,27.89,27.69,27.91,27.61,-0.87,-0.13,-0.38,-0.27,0.08,0.22,0.04,0.26,-0.09,0.49,0.28,0.08,0.29,cellular component organization;cellular process;establishment of localization;Golgi organization;Golgi vesicle transport;organelle organization;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q14746,COG2,Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein),8,15.5,27.7,27.28,28.34,27.54,,25.57,27.49,26.84,28.52,27.21,27.76,27.56,25.94,27.31,0.39,-0.04,1.03,0.22, ,-1.74,0.18,-0.47,1.21,-0.1,0.45,0.25,-1.37,biosynthetic process;carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;Golgi organization;Golgi vesicle transport;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;organelle organization;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q96JB2,COG3,Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94),16,22.7,27.53,27.82,28.76,26.94,27.91,27.85,27.53,27.02,28.24,27.47,27.15,27.68,27.66,27.66,-0.12,0.17,1.11,-0.72,0.25,0.19,-0.13,-0.64,0.58,-0.19,-0.51,0.02,0.01,biological regulation;carbohydrate metabolic process;cellular localization;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;localization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;regulation of protein stability;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9H9E3,COG4,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),8,13.8,26.6,25.55,26.65,24,27.82,22.87,,25.35,,,25.64,,,25.56,1.04,-0.01,1.09,-1.56,2.26,-2.69, ,-0.21, , ,0.08, , ,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;Golgi organization;Golgi vesicle transport;macromolecular complex assembly;organelle organization;protein complex assembly;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9Y2V7,COG6,Conserved oligomeric Golgi complex subunit 6 (COG complex subunit 6) (Component of oligomeric Golgi complex 6),6,12,26.92,26.42,25.59,26.41,26.79,26.89,27.14,26.25,27.6,25.91,27.5,26.89,27.65,26.77,0.15,-0.35,-1.18,-0.36,0.02,0.12,0.37,-0.51,0.83,-0.85,0.73,0.12,0.88,carbohydrate metabolic process;cellular process;establishment of localization;Golgi vesicle transport;metabolic process;primary metabolic process;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
P83436,COG7,Conserved oligomeric Golgi complex subunit 7 (COG complex subunit 7) (Component of oligomeric Golgi complex 7),10,20.6,27.68,27.63,27.72,27.04,28.78,28.57,27.81,28.38,29.23,28.6,27.2,28.67,28.46,28.14,-0.45,-0.51,-0.42,-1.1,0.64,0.43,-0.33,0.24,1.09,0.47,-0.94,0.54,0.32,biological regulation;carbohydrate metabolic process;cellular localization;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;localization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;regulation of protein stability;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
P38432,COIL,Coilin (p80),3,6.2,25.42,24.29,,24.31,25.9,25.74,25.28,25.37,,24.53,,24.47,,25.03,0.39,-0.74, ,-0.73,0.86,0.7,0.24,0.33, ,-0.5, ,-0.56, ,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,,,,,,,,,,
Q99715,COL12A1,Collagen alpha-1(XII) chain,49,22.9,29.39,29.36,27.63,31.96,27.18,29.05,25.85,26.98,29.96,27.76,26.73,27.54,28.81,28.32,1.07,1.04,-0.69,3.64,-1.14,0.73,-2.48,-1.34,1.64,-0.57,-1.59,-0.79,0.49,anatomical structure development;biological adhesion;cell adhesion;cellular component disassembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;metabolic process;multicellular organismal process,cell part;extracellular organelle;extracellular space;organelle;vesicle,,,,,,,,,,
P39060,COL18A1,Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin],16,15.3,29.75,29.01,,27.63,30.62,29.82,28.87,29.07,30.38,31.45,29.35,27,30.45,29.45,0.3,-0.43, ,-1.82,1.17,0.37,-0.58,-0.38,0.93,2,-0.09,-2.45,1,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell morphogenesis;cellular component disassembly;cellular component morphogenesis;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process,cell part;extracellular space,,,,,,,,,,
P02452,COL1A1,Collagen alpha-1(I) chain (Alpha-1 type I collagen),54,57.3,25.95,30.82,27.34,34.41,28.13,29.91,28.54,28.48,25.45,27.22,24.3,28.51,26.51,28.12,-2.17,2.7,-0.78,6.29,0.01,1.79,0.42,0.36,-2.67,-0.9,-3.82,0.39,-1.62,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell activation;cell communication;cell differentiation;cell motility;cellular component assembly;cellular component disassembly;cellular component movement;cellular component organization;cellular localization;cellular process;developmental process;establishment of localization;extracellular matrix organization;extracellular structure organization;immune system process;localization;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;protein complex assembly;protein transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;transport,cell part;extracellular space,,,,,,,,,,
P08123,COL1A2,Collagen alpha-2(I) chain (Alpha-2 type I collagen),37,41,25.94,31.09,27.17,33.19,25.72,26.33,25.48,24.25,28.01,26.58,28.51,25.89,25.6,27.21,-1.27,3.88,-0.05,5.98,-1.49,-0.88,-1.74,-2.96,0.8,-0.63,1.3,-1.33,-1.61,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell activation;cell motility;cellular component assembly;cellular component disassembly;cellular component movement;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;protein complex assembly;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell part;extracellular organelle;extracellular space;organelle;vesicle,,,,,,,,,,
P02461,COL3A1,Collagen alpha-1(III) chain,44,44.2,25.09,33.95,29.55,34.81,27.12,30.05,27.12,24.31,25.54,27.16,25.38,30.63,29.03,28.44,-3.35,5.51,1.11,6.37,-1.32,1.61,-1.32,-4.13,-2.91,-1.28,-3.06,2.19,0.59,anatomical structure development;biological adhesion;biological regulation;biosynthetic process;cell activation;cell adhesion;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;protein modification process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;extracellular space,,,,,,,,,,
P02462,COL4A1,Collagen alpha-1(IV) chain [Cleaved into: Arresten],9,10,,23.19,,27.76,25.01,28.69,26.49,26.07,28.46,28.63,27,,28.18,26.95, ,-3.76, ,0.81,-1.94,1.74,-0.45,-0.88,1.51,1.68,0.05, ,1.23,anatomical structure formation involved in morphogenesis;cellular component disassembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus,cell part;extracellular region,,,,,,,,,,
P08572,COL4A2,Collagen alpha-2(IV) chain [Cleaved into: Canstatin],6,11.7,25.27,26.43,,26.3,27.79,29.74,26.51,26.59,30.01,28.27,27.48,25.98,28.9,27.44,-2.17,-1, ,-1.14,0.36,2.31,-0.93,-0.85,2.57,0.83,0.04,-1.46,1.46,anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;RNA metabolic process,cell part,,,,,,,,,,
Q9Y5P4,COL4A3BP,Collagen type IV alpha-3-binding protein (Ceramide transfer protein) (hCERT) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11),6,11.7,26,27.45,26.71,26.85,26.28,27.58,27.41,26.79,24.32,26.96,27.98,27.24,26.14,26.75,-0.74,0.7,-0.03,0.1,-0.47,0.83,0.67,0.04,-2.43,0.21,1.23,0.49,-0.61,anatomical structure morphogenesis;biological regulation;biosynthetic process;cell morphogenesis;cell proliferation;cellular component morphogenesis;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;embryo development;endoplasmic reticulum organization;establishment of localization;homeostatic process;immune system process;lipid metabolic process;lipid transport;metabolic process;mitochondrion organization;multicellular organismal process;muscle contraction;organelle organization;primary metabolic process;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transport,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
P20908,COL5A1,Collagen alpha-1(V) chain,16,15.8,25.2,30.76,27.3,32.05,28.44,29.32,26.52,27.51,28.12,25.12,24.8,28.26,27.11,27.73,-2.53,3.03,-0.43,4.32,0.71,1.59,-1.21,-0.22,0.39,-2.61,-2.93,0.53,-0.62,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;biosynthetic process;cell adhesion;cell motility;cellular component disassembly;cellular component movement;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;response to chemical stimulus;response to external stimulus;response to stimulus,cell part,,,,,,,,,,
P05997,COL5A2,Collagen alpha-2(V) chain,12,14.7,26.44,30.45,26.87,30.9,25.03,28.47,26.4,,28.15,26.51,,27.17,27.87,27.66,-1.22,2.79,-0.79,3.24,-2.63,0.81,-1.26, ,0.49,-1.15, ,-0.49,0.21,anatomical structure development;anatomical structure morphogenesis;cellular component disassembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus,cell part,,,,,,,,,,
P12109,COL6A1,Collagen alpha-1(VI) chain,37,42.6,30.8,31.88,30.11,32.36,31.82,32.11,29.84,30.54,33.85,28.37,29.47,28.56,31.65,30.87,-0.07,1,-0.77,1.48,0.95,1.24,-1.03,-0.34,2.98,-2.5,-1.41,-2.31,0.77,biological adhesion;cell adhesion;cellular component assembly;cellular component disassembly;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;protein complex assembly;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P12110,COL6A2,Collagen alpha-2(VI) chain,15,16.4,27.65,29.73,25.78,30.17,29.4,30.23,27.39,28.26,31.48,25.8,27.21,25.87,29.96,28.38,-0.73,1.35,-2.59,1.79,1.03,1.85,-0.99,-0.12,3.1,-2.58,-1.17,-2.51,1.58,biological adhesion;cell adhesion;cellular component assembly;cellular component disassembly;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;protein complex assembly;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;extracellular matrix;extracellular space;macromolecular complex;membrane;plasma membrane;protein complex;proteinaceous extracellular matrix,,,,,,,,,,
P12111,COL6A3,Collagen alpha-3(VI) chain,31,15,26.87,28.91,27.15,31.02,29.09,28.41,,25.6,30.1,,23.06,25.56,30.21,27.82,-0.95,1.09,-0.66,3.21,1.27,0.6, ,-2.21,2.28, ,-4.75,-2.26,2.39,anatomical structure development;biological adhesion;cell adhesion;cellular component disassembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;extracellular space;membrane;plasma membrane,,,,,,,,,,
Q8NBJ5,COLGALT1,Procollagen galactosyltransferase 1 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1),36,55.3,31.37,32.78,31.3,33.27,32.36,32.41,31.14,31.62,32.81,31.9,32.55,31.57,32.46,32.12,-0.75,0.67,-0.81,1.15,0.24,0.3,-0.98,-0.5,0.69,-0.22,0.43,-0.55,0.34,biosynthetic process;carbohydrate metabolic process;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;lipid metabolic process;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process,cell part,,,,,,,,,,
Q9Y6G5,COMMD10,COMM domain-containing protein 10,3,25.9,23.99,26.89,27.76,25.3,24.57,23.58,25.36,24.79,23.73,25.14,27.3,26.8,24.06,25.33,-1.34,1.57,2.43,-0.03,-0.76,-1.75,0.03,-0.54,-1.6,-0.19,1.97,1.47,-1.27,,,,,,,,,,,,
Q561V4,COMMD2,COMMD2 protein,4,34.3,27.02,27.92,25.47,27.47,26.98,27.84,27.76,27.35,25.96,27.1,26.29,28.3,27.12,27.12,-0.11,0.8,-1.65,0.35,-0.14,0.72,0.64,0.23,-1.16,-0.02,-0.83,1.18,0,,,,,,,,,,,,
Q9UBI1,COMMD3,COMM domain-containing protein 3 (Protein Bup) (Protein PIL),4,29.2,25.77,26.73,27.11,27.43,24.37,,27.36,26.12,25.89,,25.25,27.97,,26.4,-0.63,0.33,0.72,1.03,-2.03, ,0.96,-0.28,-0.51, ,-1.15,1.57, ,,,,,,,,,,,,
Q9H0A8,COMMD4,COMM domain-containing protein 4,5,41.2,26.1,27.06,25.97,27.93,26.12,25.04,28.02,25.29,26.92,26.04,27.09,28.23,24.72,26.5,-0.4,0.56,-0.53,1.43,-0.38,-1.46,1.52,-1.22,0.42,-0.47,0.59,1.73,-1.78,,cell part;cytoplasm,,,,,,,,,,
Q86VX2,COMMD7,COMM domain-containing protein 7,3,16.1,24.94,25.94,26.4,26.16,24.74,26.24,26.58,26.5,24.01,24.01,27.17,26.43,,25.76,-0.82,0.18,0.64,0.4,-1.02,0.48,0.82,0.74,-1.75,-1.75,1.41,0.67, ,biological regulation;cellular process;response to chemical stimulus;response to stimulus;signal transduction,,,,,,,,,,,
Q9NX08,COMMD8,COMM domain-containing protein 8,2,19.7,25,26.27,27.79,27.12,,25.55,26.13,27.33,24.93,26.05,26.3,29.33,27.01,26.57,-1.57,-0.29,1.23,0.55, ,-1.02,-0.44,0.77,-1.64,-0.51,-0.27,2.76,0.44,,,,,,,,,,,,
Q9P000,COMMD9,COMM domain-containing protein 9,5,38.5,25.81,26.46,26.45,25.76,,22.14,26.55,26.37,,25.73,25.5,,,25.64,0.17,0.82,0.81,0.12, ,-3.5,0.91,0.73, ,0.09,-0.14, , ,,,,,,,,,,,,
P21964,COMT,Catechol O-methyltransferase (EC 2.1.1.6),21,94.6,30.49,31.41,30.98,31.35,29.35,30.45,30.25,29.4,31.94,30.66,30.94,31.58,31.14,30.76,-0.27,0.65,0.22,0.59,-1.42,-0.31,-0.51,-1.37,1.18,-0.1,0.17,0.81,0.37,alcohol metabolic process;amine metabolic process;behavior;biological regulation;biosynthetic process;catabolic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;hormone metabolic process;lipid metabolic process;metabolic process;multicellular organismal process;multi-organism process;neurological system process;neurotransmitter metabolic process;nitrogen compound metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to drug;response to stimulus;response to stress;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
P53621,COPA,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide);Proxenin],85,64.6,33.16,33.51,33.35,33.64,33.78,33.63,34.27,34.1,33.58,33.22,33.75,33.55,33.07,33.59,-0.43,-0.07,-0.24,0.05,0.2,0.04,0.68,0.51,0,-0.36,0.17,-0.03,-0.51,biological regulation;cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;multicellular organismal process;organelle organization;protein transport;regulation of body fluid levels;secretion;transport;vesicle organization;vesicle-mediated transport,cell part;cytosol;extracellular space;macromolecular complex;protein complex,,,,,,,,,,
P53618,COPB1,Coatomer subunit beta (Beta-coat protein) (Beta-COP),53,54.1,32.8,33.22,32.9,33.29,32.77,33.07,33.48,33.53,32.95,32.35,33.55,33.44,33.01,33.11,-0.3,0.11,-0.2,0.19,-0.34,-0.03,0.38,0.43,-0.15,-0.75,0.45,0.33,-0.1,cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;interspecies interaction between organisms;multi-organism process;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
P35606,COPB2,Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102),54,61.1,32.57,32.96,32.84,32.86,33.36,33.16,33.48,33.7,32.87,32.45,33.36,32.97,32.63,33.02,-0.45,-0.06,-0.17,-0.16,0.34,0.14,0.46,0.69,-0.15,-0.57,0.34,-0.04,-0.39,cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
O14579,COPE,Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP),23,77.9,31.34,31.57,30.8,32.14,31.6,31.82,32.32,32.35,31.75,31.29,32.12,32.33,31.54,31.77,-0.42,-0.2,-0.97,0.37,-0.17,0.06,0.56,0.58,-0.02,-0.48,0.35,0.57,-0.23,cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q9Y678,COPG1,Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP),48,63.6,32.56,33.2,32.6,33.2,33.05,33.22,33.5,33.44,33.1,32.37,33.54,33.31,32.73,33.06,-0.5,0.14,-0.46,0.13,-0.01,0.16,0.43,0.38,0.04,-0.7,0.48,0.25,-0.33,cellular component movement;cellular component organization;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;Golgi vesicle transport;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9UBF2,COPG2,Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP),9,15.6,28.83,28.37,28.13,28.34,28.4,27.17,28.95,27.91,26.71,25.75,27.65,28.21,27.97,27.88,0.95,0.5,0.26,0.46,0.53,-0.71,1.07,0.03,-1.17,-2.12,-0.23,0.34,0.1,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9NQ92,COPRS,Coordinator of PRMT5 and differentiation stimulator (Cooperator of PRMT5) (Protein TTP1),2,19.8,22.79,21.37,24.85,23.73,25.12,24.27,24.12,25.23,22.35,23.6,25.66,27.33,24.34,24.21,-1.43,-2.85,0.64,-0.48,0.91,0.06,-0.09,1.02,-1.86,-0.62,1.45,3.12,0.12,anatomical structure development;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;RNA metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P61201,COPS2,COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15),18,46.7,29.55,30.43,29.53,30.56,31.28,30.81,31,31.08,30.13,29.56,30.81,30.96,30.09,30.44,-0.9,-0.01,-0.92,0.11,0.83,0.37,0.56,0.63,-0.31,-0.89,0.37,0.51,-0.36,biological regulation;biosynthetic process;cell differentiation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9UNS2,COPS3,COP9 signalosome complex subunit 3 (SGN3) (Signalosome subunit 3) (JAB1-containing signalosome subunit 3),10,34.3,28.86,29.58,28.61,30.09,29.15,29.33,29.75,29.73,29.3,29.58,28.74,29.46,27.75,29.23,-0.36,0.35,-0.61,0.87,-0.08,0.1,0.53,0.5,0.08,0.35,-0.48,0.23,-1.48,biological regulation;cellular metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to abiotic stimulus;response to stimulus;signal transduction,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9BT78,COPS4,COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4),24,69.5,29.19,30.14,30.97,30.19,30.85,30.97,31.01,31.3,29.86,30.39,30.82,31.01,29.9,30.51,-1.32,-0.37,0.47,-0.32,0.34,0.46,0.5,0.8,-0.65,-0.11,0.31,0.5,-0.61,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q92905,COPS5,COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (EC 3.4.-.-) (Jun activation domain-binding protein 1),8,24.6,28.89,29.47,31.08,28.82,29.17,29.79,29.64,29.19,29.1,29.39,29.81,31.16,30.2,29.67,-0.78,-0.2,1.41,-0.84,-0.5,0.12,-0.03,-0.48,-0.57,-0.28,0.14,1.49,0.53,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;regulation of cell cycle;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q7L5N1,COPS6,COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) (JAB1-containing signalosome subunit 6) (MOV34 homolog) (Vpr-interacting protein) (hVIP),7,36.7,28.92,29.77,29.39,29.45,29.84,29.36,30.2,30.4,29.78,28.83,29.89,29.57,29.39,29.6,-0.68,0.17,-0.21,-0.15,0.24,-0.24,0.6,0.8,0.18,-0.77,0.29,-0.03,-0.21,cellular metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9UBW8,COPS7A,COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a),5,30.2,26.54,28.28,28.41,29.08,25.93,28.14,27.12,27.49,26.63,27.91,28.3,28.07,27.3,27.63,-1.1,0.65,0.78,1.45,-1.71,0.51,-0.51,-0.14,-1,0.27,0.67,0.44,-0.33,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9H9Q2,COPS7B,COP9 signalosome complex subunit 7b (SGN7b) (Signalosome subunit 7b) (JAB1-containing signalosome subunit 7b),3,15.5,28,27.84,26.5,26.73,27.56,26.17,28.38,26.48,,,28.08,27.55,25.42,27.16,0.85,0.68,-0.65,-0.42,0.41,-0.99,1.22,-0.68, , ,0.93,0.4,-1.74,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q99627,COPS8,COP9 signalosome complex subunit 8 (SGN8) (Signalosome subunit 8) (COP9 homolog) (hCOP9) (JAB1-containing signalosome subunit 8),4,39.4,27.37,28.15,26.6,28.48,29.31,29,29,29.14,28.13,28.42,29.4,27.46,28.89,28.41,-1.04,-0.26,-1.81,0.07,0.9,0.59,0.58,0.73,-0.28,0.01,0.99,-0.96,0.48,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
P61923,COPZ1,Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP),8,39,31.24,30.85,30.02,31.44,31.49,30.86,31.82,31.55,31.36,30.83,31.62,31.48,30.73,31.18,0.07,-0.32,-1.16,0.26,0.32,-0.32,0.64,0.37,0.18,-0.35,0.44,0.3,-0.44,cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q9Y2Z9,COQ6,Ubiquinone biosynthesis monooxygenase COQ6 (EC 1.14.13.-) (Coenzyme Q10 monooxygenase 6),4,13.5,28.79,28.78,28.55,27.58,25.85,28.34,28.61,28.07,29.16,29.06,28.06,,25.48,28.03,0.76,0.76,0.52,-0.45,-2.18,0.31,0.58,0.05,1.13,1.03,0.03, ,-2.55,biosynthetic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;small molecule metabolic process,cell part;cell projection;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O75208,COQ9,"Ubiquinone biosynthesis protein COQ9, mitochondrial",2,12.2,26.26,27.21,,27.16,27.23,27,27.91,27.93,26.89,25.88,27.16,27.69,26.7,27.08,-0.82,0.13, ,0.07,0.15,-0.08,0.82,0.85,-0.2,-1.2,0.08,0.6,-0.39,biosynthetic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P31146,CORO1A,Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO),14,28.9,24.94,30.12,32.44,26.69,19.14,25.98,26.62,25.18,19.12,24.13,27.05,,,25.58,-0.64,4.54,6.85,1.11,-6.44,0.4,1.03,-0.4,-6.46,-1.45,1.47, , ,biological adhesion;biological regulation;cell adhesion;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;establishment of localization;homeostatic process;immune system process;ion transport;locomotion;membrane fusion;membrane organization;organelle assembly;organelle fusion;organelle organization;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;transport;vesicle organization,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
Q9BR76,CORO1B,Coronin-1B (Coronin-2),22,44.2,31.11,31.39,31.07,31,30.92,30.62,31.06,31.38,30.51,31.06,31.91,31.28,30.95,31.1,0.01,0.3,-0.03,-0.1,-0.18,-0.47,-0.04,0.28,-0.59,-0.03,0.81,0.19,-0.15,cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9ULV4,CORO1C,Coronin-1C (Coronin-3) (hCRNN4),26,46.8,30.05,32.15,31.23,32.68,32.32,32.46,32.43,32.15,32.68,32.3,32.8,32.42,33.12,32.21,-2.17,-0.07,-0.98,0.47,0.11,0.24,0.22,-0.06,0.47,0.08,0.59,0.2,0.91,biological regulation;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;endocytosis;establishment of localization;membrane invagination;membrane organization;organelle organization;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q92828,CORO2A,Coronin-2A (IR10) (WD repeat-containing protein 2),3,5.9,24.47,24.16,26.64,25.45,22.92,23.93,25.13,26.31,27.31,26.87,,27.59,26.26,25.59,-1.11,-1.43,1.06,-0.14,-2.67,-1.65,-0.45,0.72,1.72,1.28, ,2,0.67,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;response to stimulus;signal transduction,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;transcriptional repressor complex,,,,,,,,,,
Q9UQ03,CORO2B,Coronin-2B (Coronin-like protein C) (Clipin-C) (Protein FC96),2,5.3,,23.94,24.53,,26.02,26.13,25.37,26.86,27.44,25.39,26.91,24.66,26.11,25.76, ,-1.82,-1.24, ,0.26,0.37,-0.39,1.1,1.68,-0.37,1.15,-1.1,0.35,cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P57737,CORO7,Coronin-7 (Crn7) (70 kDa WD repeat tumor rejection antigen homolog),10,13.8,27.88,29.24,26.79,27.64,27.84,27.25,26.91,27.77,27.8,27.01,27.35,27.45,27.36,27.56,0.32,1.68,-0.77,0.08,0.28,-0.31,-0.65,0.21,0.24,-0.55,-0.21,-0.11,-0.2,,cell part;cytoplasmic membrane-bounded vesicle;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q14019,COTL1,Coactosin-like protein,11,69,28.88,31.27,32.23,31.18,29.07,28.61,30.12,30.22,28.7,29.62,31.32,31.58,27.03,29.99,-1.11,1.28,2.24,1.19,-0.92,-1.37,0.13,0.23,-1.29,-0.37,1.33,1.59,-2.96,multi-organism process;response to biotic stimulus;response to stimulus;response to stress,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q14061,COX17,Cytochrome c oxidase copper chaperone,3,66.7,28.67,28.97,30.64,27.97,28.22,28.66,28.21,28.04,28.36,28.92,27.61,23.31,27.01,28.04,0.63,0.92,2.59,-0.08,0.17,0.62,0.17,-0.01,0.31,0.87,-0.43,-4.73,-1.04,anatomical structure development;cellular metabolic process;cellular process;developmental process;establishment of localization;generation of precursor metabolites and energy;ion transport;metabolic process;transport,cell part;cytoplasm,,,,,,,,,,
Q5RI15,COX20,Cytochrome c oxidase protein 20 homolog,5,33.9,28.39,27.48,28.54,29.73,28.96,29.92,29.32,29.08,28.88,26.99,28.47,26.77,26.79,28.41,-0.02,-0.93,0.13,1.32,0.55,1.51,0.91,0.67,0.47,-1.41,0.06,-1.63,-1.62,,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
P13073,COX4I1,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)",12,50.9,30.93,32,31.44,31.53,31.79,32.69,32.11,32.11,32.57,32.91,31.55,30.48,32.24,31.87,-0.95,0.12,-0.44,-0.35,-0.08,0.82,0.24,0.24,0.7,1.04,-0.33,-1.39,0.37,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
P20674,COX5A,"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)",9,58,31.19,32.53,31.42,31.79,32.57,32.39,31.84,31.97,32.25,32.12,31.81,30.87,31.97,31.9,-0.71,0.62,-0.48,-0.11,0.67,0.49,-0.06,0.07,0.35,0.22,-0.09,-1.04,0.07,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P10606,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)",7,35.7,30.31,31.45,31.53,31.08,31.66,32.09,31.55,31.41,31.69,31.87,30.47,31.61,31.71,31.42,-1.11,0.04,0.11,-0.34,0.24,0.67,0.14,0,0.27,0.45,-0.95,0.19,0.29,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;multicellular organismal process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P14854,COX6B1,Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1) (COX VIb-1),6,75.6,29.88,30.94,31.16,30.6,30.9,31.26,31.03,30.81,31.41,31.39,30.07,30.49,30.86,30.83,-0.95,0.11,0.33,-0.23,0.07,0.43,0.19,-0.02,0.58,0.56,-0.76,-0.34,0.03,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P09669,COX6C,Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide VIc),8,50.7,28.47,29.38,29.51,29.25,30.6,30.77,29.13,30.3,29.21,30.48,28.9,,29.73,29.64,-1.18,-0.26,-0.14,-0.39,0.96,1.12,-0.51,0.65,-0.44,0.84,-0.75, ,0.09,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P14406,COX7A2,"Cytochrome c oxidase subunit 7A2, mitochondrial (Cytochrome c oxidase subunit VIIa-liver/heart) (Cytochrome c oxidase subunit VIIa-L) (Cytochrome c oxidase subunit VIIaL)",3,30.1,29.17,30.22,30.42,30.02,30.48,32.15,29.96,30.39,30.54,30.63,29.8,30.18,31.53,30.42,-1.25,-0.2,0,-0.4,0.05,1.73,-0.47,-0.04,0.12,0.21,-0.62,-0.24,1.11,,cell part,,,,,,,,,,
E5RJZ1,COX7A2L,"Cytochrome c oxidase subunit 7A-related protein, mitochondrial",3,58.2,25.99,27.26,28.32,27.7,27.67,28.58,26.23,26.86,26.97,28.77,27.62,26.36,27.97,27.41,-1.42,-0.14,0.91,0.3,0.26,1.17,-1.17,-0.55,-0.44,1.36,0.22,-1.05,0.56,,cell part,,,,,,,,,,
P15954,COX7C,"Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc)",3,42.9,27.73,29.08,29.61,28.83,29.3,30.25,28.72,28.55,29.45,29.66,28.66,26.13,,28.83,-1.1,0.25,0.78,0,0.47,1.42,-0.11,-0.28,0.62,0.83,-0.17,-2.7, ,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
O75976,CPD,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),35,28.6,30.28,28.72,28.6,30.05,31.17,30.71,29.86,29.46,31.16,31.98,29.83,29.47,30.36,30.13,0.15,-1.41,-1.52,-0.07,1.04,0.58,-0.26,-0.67,1.03,1.86,-0.3,-0.66,0.23,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;membrane,,,,,,,,,,
P14384,CPM,Carboxypeptidase M (CPM) (EC 3.4.17.12),12,29.3,30.55,30.26,29.39,30.43,27.36,28.3,28,26.79,,29.22,29.38,24.98,30.2,28.74,1.81,1.52,0.65,1.69,-1.38,-0.43,-0.74,-1.95, ,0.48,0.64,-3.76,1.46,anatomical structure morphogenesis;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q99829,CPNE1,Copine-1 (Copine I),11,18.9,30.56,29.3,30.52,29.28,28.36,27.78,29.61,29.96,27.45,28.55,29.83,29.84,28.87,29.22,1.33,0.07,1.29,0.05,-0.86,-1.44,0.39,0.73,-1.77,-0.68,0.61,0.62,-0.35,cellular process;establishment of localization;lipid metabolic process;metabolic process;primary metabolic process;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96FN4,CPNE2,Copine-2 (Copine II),3,9.6,,,26.41,26.21,26.56,25.05,25,26.39,24.85,,,26.31,,25.85, , ,0.56,0.37,0.71,-0.79,-0.84,0.54,-1, , ,0.46, ,,,,,,,,,,,,
O75131,CPNE3,Copine-3 (Copine III),14,27.4,31.36,30.2,29.67,30.11,29.51,29.69,30.91,31.39,29.53,29.35,30.64,30.84,28.91,30.16,1.2,0.04,-0.49,-0.05,-0.65,-0.47,0.74,1.22,-0.63,-0.81,0.48,0.67,-1.25,cellular process;establishment of localization;lipid metabolic process;metabolic process;primary metabolic process;transport;vesicle-mediated transport,cell part;cytosol,,,,,,,,,,
Q86YQ8,CPNE8,Copine-8 (Copine VIII),2,13.7,,20.89,,21.25,,23.6,22.69,23.03,22.7,23.22,23.73,25.16,26.37,23.26, ,-2.37, ,-2.02, ,0.33,-0.57,-0.23,-0.57,-0.04,0.46,1.9,3.1,,,,,,,,,,,,
P36551,CPOX,"Coproporphyrinogen-III oxidase, mitochondrial (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3)",24,54.4,31.31,31.6,31.08,30.83,31.1,31.67,31.26,30.41,31.09,31.21,30.83,30.54,31.64,31.12,0.19,0.48,-0.04,-0.29,-0.02,0.55,0.14,-0.71,-0.03,0.09,-0.29,-0.58,0.52,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;pigment metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9BRF8,CPPED1,Calcineurin-like phosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Complete S-transactivated protein 1),13,51.6,30.11,30.27,29.29,29.42,27.78,27.96,28.47,28.87,27.99,27.52,30.33,27.8,28.89,28.82,1.28,1.45,0.47,0.59,-1.04,-0.86,-0.35,0.05,-0.83,-1.3,1.5,-1.03,0.07,,,,,,,,,,,,
Q9Y646,CPQ,Carboxypeptidase Q (EC 3.4.17.-) (Lysosomal dipeptidase) (Plasma glutamate carboxypeptidase),3,6.4,28.11,28,28.3,26.53,25.36,26.79,24.07,25.7,28.22,25.47,24.52,24.49,27.53,26.39,1.72,1.61,1.91,0.14,-1.04,0.4,-2.32,-0.69,1.83,-0.92,-1.87,-1.9,1.14,alcohol metabolic process;amine metabolic process;anatomical structure development;anatomical structure morphogenesis;biological regulation;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;growth;hormone metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process,cell part;endoplasmic reticulum;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q10570,CPSF1,Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit),19,18.6,29.22,28.54,27.29,28.48,28.81,28.7,29.06,27.87,29.61,28.65,27.5,27.25,27.03,28.31,0.91,0.23,-1.02,0.17,0.5,0.39,0.75,-0.44,1.3,0.34,-0.81,-1.06,-1.28,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;macromolecular complex;mRNA cleavage factor complex;protein complex,,,,,,,,,,
Q9P2I0,CPSF2,Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit),12,24.4,28.94,28.11,29.56,28.77,28.29,29.65,29.6,29.74,29.22,29.73,29.87,27.68,29.1,29.1,-0.16,-0.98,0.46,-0.33,-0.81,0.56,0.51,0.64,0.12,0.63,0.77,-1.41,0,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;macromolecular complex;mRNA cleavage factor complex;protein complex,,,,,,,,,,
Q9UKF6,CPSF3,Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73),13,23.1,29.31,28.29,28.56,28.94,29.47,29.38,29.02,29.17,29.52,29.11,26.11,28.41,28.56,28.76,0.56,-0.47,-0.2,0.19,0.71,0.62,0.26,0.41,0.76,0.36,-2.64,-0.35,-0.2,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;macromolecular complex;mRNA cleavage factor complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q5TA45,CPSF3L,Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein) (Protein related to CPSF subunits of 68 kDa) (RC-68),3,9,26.2,25.08,24.39,27.32,27.26,25.9,26.65,25.99,25.63,26.29,25.57,26.97,25.31,26.04,0.16,-0.96,-1.65,1.27,1.22,-0.14,0.61,-0.05,-0.41,0.25,-0.47,0.92,-0.74,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O95639,CPSF4,Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog),4,23.4,27.13,27.33,27.38,27.17,,28.2,,,27.91,27.93,,,,27.58,-0.45,-0.25,-0.2,-0.41, ,0.62, , ,0.33,0.35, , , ,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;mRNA cleavage factor complex;organelle;protein complex,,,,,,,,,,
Q16630,CPSF6,Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit) (CFIm68) (CPSF 68 kDa subunit) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7),14,33.3,30.94,30.09,29.96,30.23,30.55,31.06,29.65,30.05,30.31,29.84,29.84,30.06,30.7,30.25,0.69,-0.16,-0.3,-0.02,0.3,0.81,-0.6,-0.2,0.05,-0.42,-0.41,-0.2,0.45,cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;RNA processing,cell part;macromolecular complex;mRNA cleavage factor complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q8N684,CPSF7,Cleavage and polyadenylation specificity factor subunit 7 (Cleavage and polyadenylation specificity factor 59 kDa subunit) (CFIm59) (CPSF 59 kDa subunit) (Pre-mRNA cleavage factor Im 59 kDa subunit),9,32.9,29.19,29.52,29.01,28.99,29.75,29.44,28.74,28.7,29.54,29.39,28.19,28.43,28.96,29.07,0.13,0.45,-0.05,-0.08,0.68,0.37,-0.33,-0.37,0.47,0.33,-0.87,-0.63,-0.1,"biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent",cell part;macromolecular complex;mRNA cleavage factor complex;protein complex,,,,,,,,,,
P50416,CPT1A,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)",20,29,31.84,29.69,30.92,27.42,29.53,28.02,29.29,29.86,28.68,29.64,29.46,28.55,30.54,29.5,2.35,0.2,1.42,-2.07,0.03,-1.48,-0.21,0.36,-0.81,0.14,-0.03,-0.95,1.05,alcohol metabolic process;amine metabolic process;amine transport;amino acid transport;behavior;biological regulation;carbohydrate metabolic process;catabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;glycerol ether metabolic process;ion transport;lipid metabolic process;lipid transport;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;organic acid transport;primary metabolic process;protein complex assembly;regulation of transport;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
P23786,CPT2,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)",19,31.3,30.1,31.02,29.13,30.28,30.18,29.78,29.39,29.61,29.28,30.56,29.15,29.22,30.13,29.83,0.27,1.18,-0.71,0.45,0.35,-0.06,-0.44,-0.23,-0.55,0.73,-0.69,-0.61,0.3,amine transport;amino acid transport;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;ion transport;lipid metabolic process;lipid transport;metabolic process;organic acid metabolic process;organic acid transport;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q9H3G5,CPVL,"Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP)",11,22.9,29.19,30.98,30.14,,25.06,25.84,24.31,27.82,,29.25,,,25.75,27.59,1.6,3.39,2.55, ,-2.54,-1.76,-3.29,0.23, ,1.66, , ,-1.85,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,,,,,,,,,,,
P29373,CRABP2,Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II),12,55.1,33.02,29.31,26.97,25.15,22.04,22.03,22.01,,22.43,,18.74,26.14,,24.78,8.24,4.53,2.18,0.37,-2.75,-2.76,-2.78, ,-2.36, ,-6.04,1.36, ,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;hormone metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process;vitamin metabolic process,cell part;cytoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P43155,CRAT,Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT),10,22,,29.06,26.5,27.4,26.69,28.78,27.35,26.65,28.7,29.42,29.24,27.2,28.98,28, ,1.06,-1.5,-0.6,-1.3,0.78,-0.65,-1.34,0.71,1.43,1.24,-0.8,0.98,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q5IJ48,CRB2,Protein crumbs homolog 2 (Crumbs-like protein 2),10,11.1,,24.87,,,25.71,27.69,27.7,26.96,,,26.52,30.47,27.47,27.17, ,-2.31, , ,-1.46,0.52,0.53,-0.21, , ,-0.65,3.3,0.29,,cell part;extracellular region;membrane;plasma membrane,,,,,,,,,,
P16220,CREB1,Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1),4,16.8,27.75,26.48,27.84,26.23,27.94,27.21,,26.52,26.27,27.28,,22.83,26.6,26.63,1.12,-0.16,1.21,-0.4,1.31,0.58, ,-0.11,-0.36,0.65, ,-3.8,-0.03,anatomical structure development;biological regulation;cell communication;cell-cell signaling;cellular component organization;cellular metabolic process;cellular process;developmental process;establishment of localization;immune system process;interspecies interaction between organisms;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;regulation of protein stability;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;secretion;signal transduction;signaling;transport,cell part;macromolecular complex;nucleoplasm;protein complex;transcription factor complex,bZIP,,,,,,,,,
O75629,CREG1,Protein CREG1 (Cellular repressor of E1A-stimulated genes 1),3,20,25.13,27.83,28.1,26.36,27.25,27.88,24.45,27.92,25.76,25.48,25.76,,26.5,26.54,-1.4,1.29,1.57,-0.18,0.71,1.34,-2.08,1.39,-0.77,-1.06,-0.78, ,-0.03,biological regulation;cell proliferation;developmental process;multicellular organismal development;multicellular organismal process,cell part;extracellular region;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q96HD1,CRELD1,Cysteine-rich with EGF-like domain protein 1,4,11.2,24.59,25.77,25.87,22.28,,27.53,25.46,25.87,25.98,27.66,27.13,26.06,27.51,25.98,-1.38,-0.21,-0.11,-3.69, ,1.55,-0.51,-0.11,0,1.69,1.16,0.08,1.53,anatomical structure development;developmental process,cell part,,,,,,,,,,
Q6UXH1,CRELD2,Cysteine-rich with EGF-like domain protein 2,3,10,25.4,26.46,27.46,26.12,26.61,27.17,26.58,25.85,27.5,26.96,26.69,,26.97,26.65,-1.24,-0.19,0.81,-0.52,-0.04,0.53,-0.07,-0.8,0.86,0.31,0.04, ,0.33,,cell part;endoplasmic reticulum;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P52943,CRIP2,Cysteine-rich protein 2 (CRP-2) (Protein ESP1),15,71.6,33.09,29.05,31.3,29.39,28.5,29.13,31.11,29.67,30.52,29.22,30,28.98,28.64,29.89,3.2,-0.84,1.41,-0.5,-1.4,-0.76,1.22,-0.22,0.63,-0.67,0.11,-0.91,-1.25,anatomical structure development;biological regulation;developmental process,cell cortex;cell part,,,,,,,,,,
P46108,CRK,Adapter molecule crk (Proto-oncogene c-Crk) (p38),12,43.4,29.06,29.44,29.14,29.29,29.07,28.43,29.75,29.62,28.36,28.5,29.99,31.04,27.36,29.16,-0.1,0.28,-0.02,0.14,-0.09,-0.73,0.59,0.46,-0.79,-0.66,0.84,1.88,-1.8,biological regulation;cell activation;cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P46109,CRKL,Crk-like protein,10,42.2,29.27,29.15,29.19,29.26,29.2,27.64,28.58,28.85,27.05,27.14,29.74,30.89,26.57,28.66,0.61,0.49,0.53,0.61,0.55,-1.02,-0.08,0.19,-1.61,-1.52,1.08,2.23,-2.08,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to stimulus;response to stress;signal transduction,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,+,,,,,,
Q9BZJ0,CRNKL1,Crooked neck-like protein 1 (Crooked neck homolog) (hCrn),12,18,29.06,27.77,30.05,27.82,28.98,28.72,28.32,28.26,28.48,28.62,27.17,28.83,27.79,28.45,0.61,-0.68,1.59,-0.63,0.52,0.26,-0.13,-0.19,0.03,0.17,-1.28,0.38,-0.66,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P02511,CRYAB,Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component),19,92,34.75,31.65,32.44,28.2,27.96,27.03,28.32,29.06,,29.47,33.49,,28.14,30.05,4.7,1.61,2.39,-1.85,-2.08,-3.02,-1.73,-0.99, ,-0.57,3.44, ,-1.9,aging;alcohol metabolic process;anatomical structure development;biological regulation;carbohydrate metabolic process;cell death;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cytoskeleton organization;death;developmental process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;muscle contraction;organelle organization;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cell surface;cytoplasm;cytoskeleton;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9Y2S2,CRYL1,Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH),3,11.1,25.18,28.18,26.53,,,,25.28,25.54,,24.28,26.03,24.43,,25.68,-0.5,2.5,0.85, , , ,-0.4,-0.14, ,-1.41,0.35,-1.26, ,cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q08257,CRYZ,Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin),23,78.7,30.94,31.2,31.4,31.48,30.87,31.68,30.13,31.97,31.47,33.48,31.37,31.68,30.25,31.38,-0.44,-0.18,0.02,0.1,-0.51,0.3,-1.25,0.59,0.09,2.1,-0.01,0.3,-1.12,catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecular complex assembly;metabolic process;multicellular organismal process;neurological system process;protein complex assembly;xenobiotic metabolic process,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O95825,CRYZL1,Quinone oxidoreductase-like protein 1 (EC 1.-.-.-) (Protein 4P11) (Quinone oxidoreductase homolog 1) (QOH-1) (Zeta-crystallin homolog),2,9.3,25.99,25.63,26.19,26.35,25.97,,26.54,26.14,25.71,26.07,,,,26.07,-0.07,-0.44,0.12,0.29,-0.1, ,0.48,0.08,-0.35,0, , , ,cellular metabolic process;cellular process;cofactor metabolic process;metabolic process,cell part;cytosol,,,,,,,,,,
O75390,CS,"Citrate synthase, mitochondrial (EC 2.3.3.1)",24,53,33.79,33.66,33.05,32.94,33.52,34.08,33.2,33.29,33.86,34.14,33.73,33.26,34.13,33.59,0.2,0.07,-0.54,-0.65,-0.07,0.5,-0.39,-0.3,0.27,0.55,0.14,-0.33,0.54,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q9UK43,CSA2,Chondrosarcoma-associated protein 2,7,14.9,28.35,27.69,29.13,28.12,29.31,28.17,28.09,27.64,28.67,28.52,26.47,27.14,27.8,28.09,0.26,-0.4,1.05,0.03,1.23,0.08,0.01,-0.44,0.58,0.43,-1.61,-0.95,-0.29,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75534,CSDE1,Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR),29,42.5,31.15,29.68,30.94,31.45,30.75,30.1,31.54,31.46,30.03,30.68,31.29,31.53,30.54,30.86,0.3,-1.18,0.09,0.6,-0.11,-0.76,0.68,0.6,-0.83,-0.18,0.43,0.67,-0.31,anatomical structure development;biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P55060,CSE1L,Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter),38,47.6,32.58,32.02,32.08,32.77,32.27,31.48,34.7,32.7,31.24,30.55,31.5,32.87,30.38,32.09,0.49,-0.06,-0.01,0.68,0.18,-0.6,2.62,0.61,-0.84,-1.54,-0.59,0.78,-1.71,cell death;cell proliferation;cellular process;death,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;nucleus;organelle;protein complex,,,,,,,,,,
P41240,CSK,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),6,17.1,25.54,27.86,28.6,27.07,25.93,24.6,26.9,27,24.68,24.09,25.96,25.76,23.69,25.97,-0.43,1.88,2.62,1.09,-0.04,-1.38,0.93,1.03,-1.3,-1.88,-0.02,-0.22,-2.29,anatomical structure development;biological regulation;cell activation;cell differentiation;cell junction organization;cellular component organization;cellular metabolic process;cellular process;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell part;centrosome;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;organelle;plasma membrane,,+,,,,,,,,
P48729,CSNK1A1,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),10,36.6,29.19,27.91,27.94,28.15,29.73,29.44,30.19,30.17,28.4,29.25,29.28,28.4,29.51,29.04,0.15,-1.13,-1.11,-0.89,0.69,0.4,1.15,1.13,-0.64,0.2,0.24,-0.65,0.47,biological regulation;cell division;cellular component organization;cellular process;mitosis;nuclear division;organelle fission;organelle organization;response to stimulus;signal transduction,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;microtubule organizing center;organelle;protein complex,,+,,,,,,,,
Q5U045,CSNK1E,"Casein kinase 1 epsilon (Casein kinase 1, epsilon) (HCG2014051, isoform CRA_a)",4,11.8,25.88,,,26.91,27.69,24.48,26.58,26.36,25.96,26.4,26.55,25.81,26.88,26.32,-0.44, , ,0.59,1.37,-1.84,0.26,0.04,-0.36,0.09,0.23,-0.51,0.56,biological regulation;cellular localization;cellular process;localization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
P68400,CSNK2A1,Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1),26,63.1,31.41,30.64,31.27,31.08,31.48,31.39,31.65,31.66,30.83,31.99,31.13,31.49,31.59,31.35,0.06,-0.71,-0.08,-0.27,0.12,0.03,0.29,0.31,-0.53,0.64,-0.23,0.13,0.23,biological regulation;biosynthetic process;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;locomotion;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to chemical stimulus;response to external stimulus;response to stimulus;RNA metabolic process;signal transduction,cell part;chromatin remodeling complex;cytosol;macromolecular complex;membrane;plasma membrane;protein complex;transcriptional repressor complex,,+,,,,,,,,
P19784,CSNK2A2,Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1),10,34.6,29.75,29.3,27.03,30.09,29.5,29.47,30.09,30.24,29.79,28.31,29.56,29.04,27.87,29.23,0.51,0.06,-2.2,0.86,0.27,0.24,0.85,1.01,0.55,-0.92,0.33,-0.19,-1.37,biological regulation;biosynthetic process;cell cycle;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;locomotion;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to chemical stimulus;response to external stimulus;response to stimulus;RNA metabolic process;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
P67870,CSNK2B,Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a),8,48.4,30.15,29.66,29.26,30.38,27.7,30.01,30.23,30.46,29.83,30.78,29.72,30.03,29.59,29.83,0.32,-0.17,-0.58,0.55,-2.13,0.18,0.4,0.63,0,0.95,-0.11,0.2,-0.24,anatomical structure morphogenesis;biological regulation;cell cycle;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;developmental process;locomotion;macromolecular complex assembly;mitotic cell cycle;protein complex assembly;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P21291,CSRP1,Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1),11,66.3,30.62,26.93,27.89,29.5,26.2,26.79,29.06,27.88,27.46,25.64,28.56,30.04,26.04,27.89,2.73,-0.96,0,1.61,-1.7,-1.11,1.17,-0.01,-0.43,-2.25,0.66,2.14,-1.86,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P04080,CSTB,Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B),10,91.8,33.49,32.9,32.96,32.33,31.31,30.73,31.83,31.86,30.27,31.36,32.64,31.96,30.28,31.84,1.65,1.06,1.12,0.49,-0.53,-1.11,-0.01,0.02,-1.57,-0.48,0.8,0.12,-1.56,behavior;biological regulation;multicellular organismal process;response to stimulus,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q05048,CSTF1,Cleavage stimulation factor subunit 1 (CF-1 50 kDa subunit) (Cleavage stimulation factor 50 kDa subunit) (CSTF 50 kDa subunit) (CstF-50),9,32.3,29.52,29.31,28.69,29.9,29.37,29.79,29.01,28.96,29.84,29.49,28.54,23.93,29.46,28.91,0.61,0.41,-0.22,0.99,0.46,0.89,0.1,0.05,0.93,0.58,-0.37,-4.98,0.55,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent",cell part;nucleoplasm,,,,,,,,,,
P33240,CSTF2,Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64),13,36.3,30.3,29.59,29.03,29.83,30.05,30.5,30.1,30,30.5,30.08,29.56,28.89,30.75,29.94,0.36,-0.35,-0.91,-0.1,0.12,0.56,0.16,0.06,0.56,0.14,-0.37,-1.05,0.82,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent",cell part;macromolecular complex;mRNA cleavage factor complex;protein complex,,,,,,,,,,
Q12996,CSTF3,Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77),19,34,29.86,29.02,29.64,29.47,29.92,29.75,29.68,29.63,30.32,30.29,28.07,27.89,29.16,29.44,0.42,-0.41,0.2,0.03,0.48,0.31,0.24,0.19,0.88,0.85,-1.37,-1.55,-0.28,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent",cell part;nucleoplasm,,,,,,,,,,
O15320,CTAGE5,cTAGE family member 5 (Protein cTAGE-5) (Meningioma-expressed antigen 6/11),14,21.4,27.37,27.36,28.42,27.38,27.88,28.5,27.43,27.75,28.31,28.41,28,28.24,28.67,27.98,-0.6,-0.62,0.44,-0.6,-0.1,0.53,-0.55,-0.23,0.33,0.43,0.02,0.26,0.69,,,,,,,,,,,,
Q13363,CTBP1,C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-),8,22.1,29.66,29.32,28.9,28.54,29.69,29.92,28.83,28.59,29.63,29.4,27.94,28.96,28.63,29.08,0.58,0.24,-0.18,-0.54,0.62,0.84,-0.25,-0.49,0.55,0.32,-1.14,-0.11,-0.45,biological regulation;cell differentiation;cellular component organization;cellular metabolic process;cellular process;chromatin organization;chromosome organization;developmental process;Golgi organization;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;cytosol;macromolecular complex;protein complex;transcription factor complex;transcriptional repressor complex,,,,,,,,,,
P56545,CTBP2,C-terminal-binding protein 2 (CtBP2),16,50.8,31.4,29.35,29.75,29.54,30.38,30.06,29.7,30.13,30.53,31.11,27.19,28.54,29.79,29.81,1.6,-0.45,-0.06,-0.27,0.58,0.26,-0.1,0.32,0.72,1.31,-2.62,-1.27,-0.01,biological regulation;biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;macromolecular complex;protein complex;synapse;transcriptional repressor complex,,,,,,,,,,
Q9Y5B0,CTDP1,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),5,6.3,25.3,25.54,24.81,24.65,25.45,25.18,24.58,24.52,24.5,25.54,,26.01,25.41,25.12,0.18,0.41,-0.32,-0.47,0.33,0.06,-0.55,-0.61,-0.62,0.42, ,0.89,0.29,"biological regulation;biosynthetic process;cell division;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;centrosome;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;midbody;nucleoplasm;organelle,,,+,,,,,,,
H7C270,CTDSP1,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (Fragment),2,6.7,26.44,26.44,23.84,26.24,,25.07,,22.63,26.13,21.63,24.64,,,24.78,1.65,1.66,-0.94,1.46, ,0.28, ,-2.15,1.35,-3.16,-0.14, , ,cellular metabolic process;cellular process;metabolic process;phosphorus metabolic process,,,,,,,,,,,
P29279,CTGF,Connective tissue growth factor (CCN family member 2) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8) (IBP-8) (IGF-binding protein 8) (IGFBP-8),5,15.9,,25.96,,28.2,27.7,27.41,27.94,26.32,28.98,25.05,,,28.67,27.36, ,-1.4, ,0.84,0.34,0.05,0.59,-1.04,1.62,-2.31, , ,1.31,"aging;anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;biosynthetic process;cell adhesion;cell differentiation;cell motility;cell proliferation;cellular component movement;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA replication;establishment of localization;ion transport;lipid metabolic process;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;secretion;signal transduction;small molecule metabolic process;transcription initiation, DNA-dependent;transport",cell cortex;cell part;cytosol;extracellular matrix;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;proteinaceous extracellular matrix,,,,,,,,,,
Q96CG8,CTHRC1,Collagen triple helix repeat-containing protein 1 (Protein NMTC1),3,15.3,24.67,27.91,,28.15,24.75,25.82,,,26.54,26.43,,,,26.32,-1.66,1.59, ,1.83,-1.57,-0.5, , ,0.21,0.11, , , ,anatomical structure morphogenesis;biological regulation;cell motility;cellular component movement;cellular component organization;cellular process;developmental process;locomotion;multicellular organismal process;response to stimulus;signal transduction,cell part;cytoplasm;extracellular space,,,,,,,,,,
P35221,CTNNA1,Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13),60,75.5,33.58,32.4,32.33,33.23,33.31,33.79,32.94,32.59,33.65,33.79,32.32,32.21,33.01,33.01,0.57,-0.61,-0.68,0.22,0.29,0.77,-0.07,-0.42,0.64,0.78,-0.69,-0.8,0,aging;anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell differentiation;cell junction organization;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;developmental process;establishment or maintenance of cell polarity;macromolecular complex assembly;protein complex assembly;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;rhythmic process,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P35222,CTNNB1,Catenin beta-1 (Beta-catenin),27,45.6,32.34,31.12,30.65,32.09,31.53,31.85,31.36,31.22,31.91,31.09,30.49,30.71,31.25,31.35,0.98,-0.23,-0.71,0.73,0.18,0.49,0,-0.13,0.56,-0.27,-0.86,-0.64,-0.1,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;biosynthetic process;cell activation;cell adhesion;cell communication;cell development;cell differentiation;cell junction organization;cell maturation;cell morphogenesis;cell motility;cell proliferation;cell-cell signaling;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;developmental maturation;developmental process;embryo development;establishment of localization;homeostatic process;immune system process;localization;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;molting cycle;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein complex assembly;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;RNA metabolic process;signal transduction;signaling;transport;vesicle-mediated transport,apical part of cell;cell cortex;cell part;cell projection;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex;synapse;transcription factor complex,,,,,,,,,,
Q8WYA6,CTNNBL1,Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19),19,28.4,29.59,28.27,30.27,28.68,28.92,29.65,29.22,28.19,29.92,29.26,28.1,29.55,28.75,29.11,0.48,-0.83,1.17,-0.43,-0.18,0.54,0.11,-0.91,0.82,0.15,-1.01,0.45,-0.36,biological regulation;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;protein complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),54,62.8,32.8,31.48,31.22,31.97,32,31.9,31.68,30.75,32.4,32.49,30.9,30.73,31.16,31.65,1.15,-0.17,-0.44,0.32,0.35,0.24,0.03,-0.91,0.75,0.84,-0.75,-0.92,-0.5,anatomical structure morphogenesis;biological adhesion;biological regulation;biosynthetic process;cell adhesion;cell differentiation;cell junction organization;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;midbody;nucleus;organelle;plasma membrane,,,,,,,,,,
P17812,CTPS1,CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1),23,48.9,29.19,30.04,29.58,31.1,29.76,28.42,30.22,30.45,29.09,29.57,30.28,29.89,27.21,29.6,-0.41,0.44,-0.02,1.5,0.16,-1.18,0.62,0.85,-0.51,-0.03,0.68,0.29,-2.39,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9NRF8,CTPS2,CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2),6,14.5,26.64,26.87,27.13,27.35,25.6,25.75,27.48,26.54,25.09,28.06,26.02,27.83,,26.7,-0.06,0.17,0.44,0.65,-1.1,-0.95,0.78,-0.16,-1.61,1.37,-0.68,1.14, ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6PD62,CTR9,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),17,18.5,29.32,28.25,27.33,27.44,28.38,29.47,28.17,29.55,29.86,29.95,28.88,27.19,26.89,28.51,0.81,-0.26,-1.19,-1.07,-0.14,0.95,-0.35,1.04,1.35,1.44,0.37,-1.32,-1.63,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of organelle organization;regulation of protein modification process;response to biotic stimulus;response to chemical stimulus;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
P10619,CTSA,Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain;Lysosomal protective protein 20 kDa chain],10,20.6,30.15,31.92,31.18,30.82,31.18,31.37,30.59,30.2,31.13,31.05,31.44,31.23,31.68,31.07,-0.92,0.85,0.1,-0.25,0.1,0.3,-0.48,-0.87,0.06,-0.02,0.37,0.16,0.61,cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;lipid metabolic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein transport;proteolysis;small molecule metabolic process;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P07858,CTSB,Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain;Cathepsin B heavy chain],18,53.1,33.56,36.1,34.16,34.27,33.78,34.79,33.76,34.25,34.49,33.99,35.12,32.88,35.04,34.32,-0.76,1.78,-0.17,-0.05,-0.54,0.47,-0.56,-0.07,0.16,-0.33,0.8,-1.45,0.72,biological regulation;cellular component disassembly;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;proteolysis;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoplasmic membrane-bounded vesicle;extracellular space;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle;vesicle,,,,,,,,,,
P53634,CTSC,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain);Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain);Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)],14,28.9,29.79,32.75,31.65,32.21,31.23,31.55,31.3,31.34,31.52,31.44,30.74,30.34,31.23,31.32,-1.53,1.44,0.34,0.9,-0.08,0.23,-0.02,0.03,0.2,0.13,-0.57,-0.97,-0.08,aging;biological regulation;cell killing;developmental process;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to chemical stimulus;response to stimulus,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
P07339,CTSD,Cathepsin D (EC 3.4.23.5) [Cleaved into: Cathepsin D light chain;Cathepsin D heavy chain],25,55.8,34.3,34.61,34.71,33.31,33.29,34.56,33.16,33.69,33.68,34.91,34,33.9,34.39,34.04,0.27,0.57,0.67,-0.73,-0.75,0.52,-0.88,-0.35,-0.36,0.87,-0.04,-0.14,0.35,cell death;cellular component assembly;cellular component disassembly;cellular component organization;cellular process;death;extracellular matrix organization;extracellular structure organization;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;organelle assembly;organelle organization;primary metabolic process;protein metabolic process;proteolysis;vacuole organization,cell part;cytoplasmic membrane-bounded vesicle;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle;vesicle,,,,,,,,,,
P09668,CTSH,Pro-cathepsin H [Cleaved into: Cathepsin H mini chain;Cathepsin H (EC 3.4.22.16);Cathepsin H heavy chain;Cathepsin H light chain],5,16.4,26.4,31.31,30.48,24.72,,24.83,,26.17,26.12,,,,,27.15,-0.75,4.16,3.33,-2.43, ,-2.31, ,-0.97,-1.03, , , , ,anatomical structure development;anatomical structure morphogenesis;biological regulation;catabolic process;cell killing;cellular metabolic process;cellular process;developmental process;homeostatic process;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis;regulation of protein stability;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;signal transduction,cell part;cytoplasmic membrane-bounded vesicle;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole;vesicle,,,,,,,,,,
P07711,CTSL,Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L1 heavy chain;Cathepsin L1 light chain],8,32.1,27.39,30.11,30.68,29.21,29.34,29.49,29.34,28.14,28.98,28.25,28.82,27.91,29.68,29.03,-1.64,1.09,1.65,0.18,0.32,0.46,0.31,-0.89,-0.05,-0.77,-0.21,-1.11,0.66,biological regulation;cell death;cellular component disassembly;cellular component organization;cellular process;death;extracellular matrix organization;extracellular structure organization;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;proteolysis;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P25774,CTSS,Cathepsin S (EC 3.4.22.27),10,38.1,28.58,31.87,32.12,25.53,,,23.7,,27.66,30.42,,,,28.55,0.03,3.32,3.56,-3.03, , ,-4.85, ,-0.9,1.87, , , ,biological regulation;cellular process;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;extracellular region;membrane,,,,,,,,,,
Q9UBR2,CTSZ,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),9,25.7,29.66,31.48,29.78,29.2,30.48,31.64,29.86,30.51,31.22,30.64,30.78,29.02,31.66,30.46,-0.8,1.02,-0.68,-1.26,0.03,1.19,-0.6,0.05,0.77,0.18,0.33,-1.44,1.2,anatomical structure morphogenesis;biological regulation;cellular metabolic process;cellular process;developmental process;hormone metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein maturation;protein metabolic process;proteolysis,cell part;endoplasmic reticulum;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole,,,,,,,,,,
Q14247,CTTN,Src substrate cortactin (Amplaxin) (Oncogene EMS1),29,52.7,31.83,31.18,32.17,32.1,31.94,31.69,32.26,32.17,31.98,32.08,32.69,32.29,30.91,31.94,-0.12,-0.76,0.22,0.16,-0.01,-0.26,0.32,0.22,0.03,0.13,0.75,0.35,-1.03,,cell cortex;cell part;cell projection;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;organelle,,,,,,,,,,
Q9P2B4,CTTNBP2NL,CTTNBP2 N-terminal-like protein,9,14.4,25.89,,24.25,26.36,,24.73,25.52,25.76,27.02,24.68,24.11,,24.9,25.32,0.57, ,-1.07,1.04, ,-0.59,0.2,0.44,1.7,-0.64,-1.21, ,-0.42,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q13616,CUL1,Cullin-1 (CUL-1),16,25.1,29.74,28.5,29.18,28.49,28.02,28.6,29.09,29.04,28.32,27.89,29.5,29.11,27.46,28.69,1.06,-0.19,0.49,-0.19,-0.67,-0.09,0.4,0.36,-0.37,-0.8,0.81,0.42,-1.23,anatomical structure morphogenesis;biological regulation;catabolic process;cell proliferation;cellular metabolic process;cellular process;developmental process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q13617,CUL2,Cullin-2 (CUL-2),14,22.6,29.61,29.11,27.48,28.81,29.19,28.43,28.92,29.91,27.66,26.99,28.34,28.88,28.14,28.58,1.04,0.54,-1.09,0.24,0.62,-0.15,0.35,1.34,-0.92,-1.58,-0.24,0.31,-0.44,biological regulation;catabolic process;cellular metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q13618,CUL3,Cullin-3 (CUL-3),14,19.9,30.28,29.73,29.24,29.14,29.01,29.8,30.29,29.6,30.18,28.93,29.84,29.52,29.26,29.6,0.68,0.13,-0.37,-0.46,-0.59,0.2,0.69,0,0.58,-0.68,0.24,-0.08,-0.34,anatomical structure morphogenesis;biological regulation;catabolic process;cell division;cell morphogenesis;cell motility;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular metabolic process;cellular process;cytokinesis;cytoskeleton organization;developmental process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;response to stimulus;signal transduction;vesicle organization,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q13619,CUL4A,Cullin-4A (CUL-4A),17,23.5,28.36,28.08,26.9,27.88,28.96,27.97,29.51,28.46,28.42,28.7,28.12,28.41,27.35,28.24,0.12,-0.16,-1.34,-0.35,0.72,-0.27,1.27,0.22,0.18,0.46,-0.12,0.17,-0.89,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to DNA damage stimulus;response to stimulus;response to stress,cell part;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q13620,CUL4B,Cullin-4B (CUL-4B),35,43.5,29.59,31.22,30.42,31.68,29,30.57,30.69,29.86,30.5,29.21,30.62,31.58,30.01,30.38,-0.8,0.84,0.04,1.3,-1.38,0.19,0.31,-0.52,0.12,-1.17,0.23,1.2,-0.37,biological regulation;catabolic process;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q93034,CUL5,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),17,26,29.89,29.38,28.35,28.38,27.22,28.37,28.75,28.67,28.62,28.25,29.29,27.51,28.16,28.53,1.36,0.85,-0.18,-0.15,-1.31,-0.15,0.22,0.15,0.09,-0.27,0.76,-1.01,-0.36,biological regulation;catabolic process;cell proliferation;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;homeostatic process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;response to abiotic stimulus;response to osmotic stress;response to stimulus;response to stress;viral reproduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;ubiquitin ligase complex,,,,,,,,,,
O60888,CUTA,Protein CutA (Acetylcholinesterase-associated protein) (Brain acetylcholinesterase putative membrane anchor),3,38.5,30.26,29.63,29.46,29.59,28,27.83,28.47,28.97,27.8,26.99,28.87,30.61,27.19,28.74,1.51,0.89,0.72,0.84,-0.75,-0.91,-0.27,0.23,-0.94,-1.75,0.13,1.86,-1.56,localization;response to chemical stimulus;response to stimulus,cell part;membrane,,,,,,,,,,
P39880,CUX1,Homeobox protein cut-like 1 (CCAAT displacement protein) (CDP) (Homeobox protein cux-1),14,13.3,27.25,27.01,26.79,27.43,26.95,27.38,25.35,25.41,27.43,26.61,23.18,26.5,27.59,26.53,0.72,0.48,0.26,0.9,0.42,0.85,-1.18,-1.12,0.9,0.09,-3.35,-0.03,1.06,anatomical structure development;biological regulation;biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transport;vesicle-mediated transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,Homeobox,,,,,,,,,
Q9P013,CWC15,Spliceosome-associated protein CWC15 homolog,6,30.1,28.78,28.08,26.8,28.08,28.8,29.02,27.58,28.14,28.39,27.77,27.13,,28.65,28.1,0.68,-0.02,-1.3,-0.02,0.69,0.92,-0.52,0.04,0.29,-0.33,-0.98, ,0.54,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9HCG8,CWC22,Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb),8,8.6,25.42,24.3,24.94,24.71,24.94,25.82,25.7,25.64,26.57,26,25.07,,25.09,25.35,0.07,-1.05,-0.41,-0.64,-0.41,0.47,0.35,0.29,1.22,0.65,-0.28, ,-0.26,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9NXE8,CWC25,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),2,5,21.94,23.97,24.51,23.52,,19.69,,19.55,,21.41,20.04,,,21.83,0.11,2.14,2.68,1.69, ,-2.14, ,-2.28, ,-0.42,-1.78, , ,,,,,,,,,,,,
Q6UX04,CWC27,Peptidyl-prolyl cis-trans isomerase CWC27 homolog (PPIase CWC27) (EC 5.2.1.8) (Antigen NY-CO-10) (Serologically defined colon cancer antigen 10),4,23.1,23.64,26.05,24.33,24.8,23.3,27.26,26.72,25.96,25.73,27.23,26.53,27.58,24.35,25.65,-2.01,0.4,-1.33,-0.85,-2.36,1.61,1.06,0.31,0.08,1.58,0.88,1.92,-1.3,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q69YN2,CWF19L1,CWF19-like protein 1,6,12.5,26.7,25.88,27.45,,26.51,26.34,26.73,26.54,26.2,26.01,,26.34,26.14,26.44,0.26,-0.56,1.01, ,0.07,-0.09,0.29,0.1,-0.24,-0.43, ,-0.1,-0.3,metabolic process,,,,,,,,,,,
P78310,CXADR,Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR),7,24.1,26.88,27.07,25.02,28.57,28.58,28.07,27.91,27.77,27.3,27.91,24.95,27.52,,27.3,-0.42,-0.22,-2.28,1.27,1.28,0.78,0.62,0.47,0,0.62,-2.35,0.23, ,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cell development;cell junction organization;cell motility;cellular component movement;cellular component organization;cellular process;coagulation;cytoskeleton organization;developmental process;establishment of localization;homeostatic process;immune system process;interspecies interaction between organisms;locomotion;mitochondrion organization;multicellular organismal process;multi-organism process;organelle organization;regulation of body fluid levels;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;transport,cell body;cell part;cell projection;cytoplasmic membrane-bounded vesicle;extracellular region;extracellular space;filopodium;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;site of polarized growth;synapse;vesicle,,,,,,,,,,
P42830,CXCL5,C-X-C motif chemokine 5 (ENA-78(1-78)) (Epithelial-derived neutrophil-activating protein 78) (Neutrophil-activating peptide ENA-78) (Small-inducible cytokine B5) [Cleaved into: ENA-78(8-78);ENA-78(9-78)],4,43,,26.65,24.58,27.73,,25.54,25.33,,,29.64,25.35,,25.27,26.26, ,0.39,-1.69,1.47, ,-0.72,-0.93, , ,3.38,-0.91, ,-0.99,biological regulation;cell communication;cell-cell signaling;cellular process;immune system process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling,extracellular region;extracellular space,,,,,,,,,,
P80162,CXCL6,"C-X-C motif chemokine 6 (Chemokine alpha 3) (CKA-3) (Granulocyte chemotactic protein 2) (GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1;Small-inducible cytokine B6, N-processed variant 2;Small-inducible cytokine B6, N-processed variant 3]",2,21.2,,26.85,,26.73,,26.87,,,25.31,25.83,,24.22,27.73,26.22, ,0.63, ,0.5, ,0.65, , ,-0.91,-0.39, ,-2,1.51,biological regulation;cell communication;cell-cell signaling;cellular process;immune system process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;signaling,extracellular region;extracellular space,,,,,,,,,,
P00167,CYB5A,Cytochrome b5 (Microsomal cytochrome b5 type A) (MCB5),8,82.7,31.95,31.53,31.21,30.65,29.81,30.43,30.07,29.54,30.45,31.75,30.44,28.35,30.78,30.54,1.41,1,0.67,0.12,-0.72,-0.1,-0.47,-1,-0.08,1.21,-0.09,-2.19,0.24,cellular ketone metabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;organic acid metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;membrane,,,,,,,,,,
O43169,CYB5B,Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform),12,75.3,31.04,30.31,30.24,29.79,30.57,31.18,30.56,29.99,31.27,31.56,31.68,30.43,30.98,30.74,0.3,-0.43,-0.5,-0.95,-0.17,0.44,-0.18,-0.75,0.53,0.82,0.94,-0.3,0.24,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process,cell part;membrane,,,,,,,,,,
Q9UHQ9,CYB5R1,NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2),14,42.3,31.72,31.92,31.76,30.61,29.47,31.26,30.45,30.58,30.96,31.6,31.97,31.73,32,31.23,0.49,0.68,0.53,-0.62,-1.76,0.03,-0.79,-0.65,-0.27,0.36,0.73,0.5,0.77,alcohol metabolic process;biosynthetic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6BCY4,CYB5R2,NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2),6,28.3,25.76,28.43,27.27,28.39,28.19,28.24,27.8,28.9,27.58,26.8,28.42,26.57,25.35,27.52,-1.75,0.91,-0.24,0.87,0.67,0.73,0.28,1.39,0.07,-0.72,0.9,-0.94,-2.17,alcohol metabolic process;biosynthetic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
P00387,CYB5R3,NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form;NADH-cytochrome b5 reductase 3 soluble form],25,81.3,33.03,34.49,32.66,33.77,33.08,34.2,33.82,33.41,34.58,34.36,34.36,34.15,34.56,33.88,-0.85,0.61,-1.22,-0.11,-0.8,0.32,-0.07,-0.47,0.7,0.47,0.48,0.26,0.68,alcohol metabolic process;biosynthetic process;blood circulation;cellular ketone metabolic process;cellular metabolic process;cellular process;circulatory system process;lipid metabolic process;metabolic process;multicellular organismal process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
P04839,CYBB,Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome),10,18.2,25.69,29.58,30.3,24.23,25.46,26.36,25.22,27.25,25.41,23.56,26.15,25.45,27.69,26.33,-0.64,3.24,3.96,-2.1,-0.88,0.03,-1.11,0.92,-0.93,-2.78,-0.18,-0.89,1.35,biosynthetic process;cellular component organization;cellular metabolic process;cellular process;generation of precursor metabolites and energy;immune system process;interspecies interaction between organisms;metabolic process;multi-organism process;organelle organization;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;protein complex,,,,,,,,,,
P08574,CYC1,"Cytochrome c1, heme protein, mitochondrial (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)",11,39.4,31.56,31.59,30.15,31.05,31.24,31.31,31.21,30.87,31.61,31.84,31.08,30.77,31.79,31.24,0.33,0.35,-1.09,-0.19,0,0.07,-0.03,-0.36,0.38,0.6,-0.15,-0.47,0.55,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P99999,CYCS,Cytochrome c,14,70.3,32.23,32.12,33.31,32.29,33.12,33.17,32.84,32.57,33.26,33.19,32.05,32.27,33.2,32.74,-0.51,-0.62,0.57,-0.45,0.38,0.43,0.1,-0.17,0.53,0.45,-0.69,-0.47,0.46,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
Q7L576,CYFIP1,Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1),30,26.4,31.4,30.94,31.51,30.91,30.9,30.65,31.04,30.76,31.09,30.86,30.55,30.92,30.65,30.94,0.47,0,0.58,-0.03,-0.03,-0.29,0.1,-0.18,0.15,-0.08,-0.38,-0.02,-0.29,biological regulation;cell growth;cellular component assembly;cellular component organization;cellular process;developmental process;growth,cell part;cell projection;macromolecular complex;neuron projection;protein complex;synapse,,,,,,,,,,
Q8WWM9,CYGB,Cytoglobin (Histoglobin) (HGb) (Stellate cell activation-associated protein),3,16.3,,23.99,,,26.86,26.75,27.96,25.38,26.57,,26.78,25.94,25.28,26.17, ,-2.18, , ,0.69,0.58,1.79,-0.78,0.4, ,0.61,-0.22,-0.89,response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell body;cell part;cell projection;cytoplasm;neuron projection;neuronal cell body,,,,,,,,,,
Q6ZMK1,CYHR1,Cysteine and histidine-rich protein 1,4,13.4,26.84,,25.83,,25.15,26.47,,,25.04,24.44,,26.12,25.89,25.72,1.12, ,0.1, ,-0.57,0.74, , ,-0.68,-1.28, ,0.4,0.17,,cell part;nuclear envelope,,,,,,,,,,
Q02318,CYP27A1,"Sterol 26-hydroxylase, mitochondrial (EC 1.14.13.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)",11,27.5,27.73,29.79,29.41,28.96,27.18,28.22,27.9,27.78,29.2,27.01,24.16,,26.02,27.78,-0.05,2.01,1.63,1.18,-0.6,0.44,0.12,0,1.42,-0.77,-3.62, ,-1.76,alcohol metabolic process;biosynthetic process;cellular ketone metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;membrane,,,,,,,,,,
Q96SQ9,CYP2S1,Cytochrome P450 2S1 (EC 1.14.14.1) (CYPIIS1),13,25.2,30.09,27.22,25.29,28.06,29.8,28.02,29.8,29.93,25.75,24.27,31.49,28.07,29.49,28.25,1.84,-1.03,-2.96,-0.19,1.55,-0.23,1.55,1.68,-2.5,-3.99,3.24,-0.19,1.23,cellular metabolic process;cellular process;metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;membrane,,,,,,,,,,
Q16850,CYP51A1,Lanosterol 14-alpha demethylase (LDM) (EC 1.14.13.70) (CYPLI) (Cytochrome P450 51A1) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase),18,45,28.18,27.66,29.27,31.01,30.91,31.19,31.8,31.53,31.65,31.66,29.55,31.24,31.15,30.52,-2.34,-2.86,-1.26,0.49,0.39,0.67,1.27,1,1.13,1.13,-0.97,0.72,0.63,alcohol metabolic process;biosynthetic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;membrane,,,,,,,,,,
O00622,CYR61,Protein CYR61 (CCN family member 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein GIG1),9,31.4,25.09,30.57,,29.19,27.89,27.98,27.8,27.22,30.35,28.32,26.65,,28.41,28.13,-3.04,2.44, ,1.05,-0.25,-0.16,-0.34,-0.91,2.22,0.19,-1.48, ,0.28,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell death;cell differentiation;cell motility;cell proliferation;cellular component movement;cellular component organization;cellular metabolic process;cellular process;death;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;metabolic process;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to stimulus,extracellular region,,,,,,,,,,
P98082,DAB2,Disabled homolog 2 (DOC-2) (Differentially-expressed protein 2),23,47,24.47,30.62,30.39,31.34,26.81,28.41,28.37,26.93,28.94,26.35,29.18,32.93,28.52,28.71,-4.24,1.91,1.68,2.62,-1.9,-0.3,-0.34,-1.78,0.23,-2.37,0.47,4.21,-0.2,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell death;cell differentiation;cell morphogenesis;cell proliferation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular metabolic process;cellular process;death;developmental process;embryo development;endocytosis;establishment of localization;excretion;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;organelle organization;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;protein transport;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;signal transduction;transport;vesicle organization;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
P61803,DAD1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (EC 2.4.99.18) (Defender against cell death 1) (DAD-1),4,37.6,30.06,30.37,,29.26,29.72,31.2,28.37,28.85,31.11,29.75,30.36,29.05,30.83,29.91,0.15,0.46, ,-0.65,-0.19,1.29,-1.54,-1.06,1.2,-0.16,0.45,-0.86,0.92,anatomical structure development;biological regulation;carbohydrate metabolic process;cell death;cellular metabolic process;cellular process;death;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;response to chemical stimulus;response to drug;response to external stimulus;response to extracellular stimulus;response to stimulus,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q14118,DAG1,Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG);Beta-dystroglycan (Beta-DG)],5,6.3,25.53,24.55,26.63,27.29,24.79,26.49,26.65,24.92,27.31,26.93,24.44,27.23,26.05,26.06,-0.53,-1.51,0.57,1.22,-1.27,0.43,0.59,-1.14,1.25,0.86,-1.62,1.17,-0.01,anatomical structure morphogenesis;biological regulation;cellular component organization;cellular process;cytoskeleton organization;developmental maturation;developmental process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;nuclear transport;nucleocytoplasmic transport;organelle organization;primary metabolic process;protein metabolic process;protein targeting;protein transport;proteolysis;transport,cell part;cell projection;cytoplasm;cytoskeleton;dystrophin-associated glycoprotein complex;extracellular space;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleoplasm;organelle;plasma membrane;protein complex,,,,,,,,,,
Q8NCG7,DAGLB,Sn1-specific diacylglycerol lipase beta (DGL-beta) (EC 3.1.1.-) (KCCR13L),4,8.6,27.4,24.8,,25.93,26.72,26.19,26.42,26.65,27.2,27.26,27.19,28.75,26.16,26.72,0.68,-1.93, ,-0.79,0,-0.53,-0.3,-0.07,0.48,0.53,0.47,2.03,-0.56,catabolic process;cell activation;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;membrane;plasma membrane,,,,,,,,,,
Q3LXA3,DAK,Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase);FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)],6,12.7,28.08,27.34,28.01,26.19,26.08,25.94,24.79,25.19,23.98,23.82,25.69,26.83,,25.99,2.08,1.34,2.01,0.19,0.08,-0.06,-1.2,-0.8,-2.01,-2.17,-0.3,0.84, ,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;immune system process;metabolic process;primary metabolic process;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P51397,DAP,Death-associated protein 1 (DAP-1),2,18.6,20.59,20.02,19.27,22.63,20.34,,21.92,23.04,19.94,19.94,,,,20.85,-0.26,-0.83,-1.58,1.77,-0.52, ,1.07,2.19,-0.92,-0.91, , , ,autophagy;biological regulation;catabolic process;cell communication;cellular metabolic process;cellular process;metabolic process;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress,,,,,,,,,,,
P51398,DAP3,"28S ribosomal protein S29, mitochondrial (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein)",14,44.3,29.76,29.29,29.33,30.82,30.94,31.73,30.94,30.03,30.79,30.87,29.33,31.2,31.51,30.5,-0.74,-1.22,-1.18,0.32,0.44,1.23,0.44,-0.48,0.29,0.36,-1.17,0.7,1.01,cellular component organization;cellular process;mitochondrion organization;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleolus;organelle;ribonucleoprotein complex;ribosome;small ribosomal subunit,,,,,,,,,,
P53355,DAPK1,Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1),9,7.6,23.1,26.66,24.54,27.24,28.15,28.9,28.23,27.77,26.53,28,27.28,28.47,28.4,27.17,-4.07,-0.51,-2.64,0.07,0.97,1.72,1.05,0.6,-0.64,0.82,0.11,1.3,1.22,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of translation;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,+,,,,,,,,
O43293,DAPK3,Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase),4,11,27.4,26.82,26.47,27.86,27.48,26.45,27.52,26.84,29.41,24.64,26.25,28.44,27,27.12,0.28,-0.3,-0.66,0.74,0.36,-0.67,0.4,-0.29,2.29,-2.48,-0.87,1.32,-0.12,biological regulation;biosynthetic process;cell death;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;cytokinesis;death;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of translation;response to chemical stimulus;response to stimulus;RNA metabolic process;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,+,,,,,,,,
P14868,DARS,"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein)",39,73.5,33.46,33.49,32.81,32.95,32.93,32.37,33.02,32.6,32.29,32.67,33,32.75,32.2,32.81,0.65,0.68,0,0.14,0.12,-0.44,0.21,-0.21,-0.52,-0.14,0.19,-0.06,-0.61,amine metabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
Q6PI48,DARS2,"Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)",21,36.4,29.84,30.58,28.88,29.39,29.65,29.97,29.3,29.56,29.13,29.07,29.29,28.86,29.82,29.49,0.35,1.09,-0.61,-0.1,0.16,0.48,-0.19,0.07,-0.35,-0.41,-0.2,-0.63,0.33,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q5IRN2,DAZAP1/MEF2D,DAZAP1/MEF2D fusion protein,8,22.9,29.66,30.11,29.85,29.83,29.74,30.91,30.55,29.9,31.17,30.94,29.18,29.51,28.48,29.99,-0.33,0.13,-0.14,-0.15,-0.25,0.92,0.56,-0.09,1.18,0.95,-0.81,-0.47,-1.51,,,,,,,,,,,,
P07108,DBI,Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP),8,83.9,31.7,31.27,32,31.79,31.39,30.65,31.33,31.81,29.77,31.21,30.9,32.07,28.95,31.14,0.56,0.13,0.86,0.65,0.25,-0.49,0.19,0.67,-1.37,0.06,-0.25,0.93,-2.19,anatomical structure development;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;glycerol ether metabolic process;lipid metabolic process;metabolic process;molting cycle;multicellular organismal process;primary metabolic process;small molecule metabolic process;transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),27,42.8,32.26,31.23,31.9,31.92,30.4,31.48,32.12,31.39,32.5,32.45,32.04,31.22,32.03,31.76,0.5,-0.53,0.14,0.16,-1.37,-0.28,0.35,-0.37,0.73,0.68,0.27,-0.55,0.26,biological regulation;cell communication;cell proliferation;cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cell projection;cytoplasm;membrane;neuron projection;plasma membrane,,,,,,,,,,
Q9UJU6,DBNL,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),20,52.1,30.12,31.09,31.53,31.12,30.49,30.15,30.84,30.86,29.52,29.86,31.27,30.26,29.59,30.52,-0.39,0.57,1.02,0.6,-0.03,-0.36,0.33,0.35,-1,-0.66,0.75,-0.25,-0.92,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;endocytosis;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell cortex;cell part;cell projection;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9UK59,DBR1,Lariat debranching enzyme (EC 3.1.-.-),6,11.9,28.59,26.25,24.6,27.06,25.28,26.39,26.29,,25.2,25.56,25.87,26.07,25.1,26.02,2.57,0.23,-1.42,1.04,-0.74,0.37,0.27, ,-0.82,-0.46,-0.15,0.05,-0.93,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P11182,DBT,"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)",15,37.8,30.84,30.47,29.9,28.71,27.78,29.86,28.48,29.5,29.26,30.35,29.71,28.93,30.2,29.54,1.3,0.93,0.37,-0.83,-1.76,0.32,-1.05,-0.03,-0.28,0.81,0.18,-0.61,0.66,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;tricarboxylic acid cycle enzyme complex,,,,,,,,,,
E7EVM5,DCAF13,DDB1- and CUL4-associated factor 13,3,21.2,25.37,22.46,21.28,25.03,27.09,26.04,22.14,23.24,26.13,27.32,,24.65,26.03,24.73,0.64,-2.27,-3.45,0.3,2.35,1.3,-2.59,-1.49,1.4,2.59, ,-0.09,1.3,,,,,,,,,,,,
Q58WW2,DCAF6,DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),5,10.1,24.33,23.31,,21.94,25.54,24.75,25.05,24.44,24.19,22.18,23.52,25.78,25.27,24.19,0.14,-0.88, ,-2.25,1.35,0.56,0.86,0.25,0,-2.01,-0.67,1.59,1.08,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
P61962,DCAF7,DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog),6,19.3,28.44,27.55,26.9,25.87,25.14,26.67,25.21,24.4,27.58,26.35,,26.47,26.85,26.45,1.99,1.1,0.45,-0.58,-1.31,0.21,-1.24,-2.06,1.12,-0.1, ,0.02,0.39,cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal development;multicellular organismal process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q5TAQ9,DCAF8,DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A),7,17.3,24.77,26.73,25.09,24.73,24.03,26.73,26.75,25.15,25.62,24.7,26.97,24.4,25.31,25.46,-0.69,1.27,-0.37,-0.73,-1.43,1.27,1.29,-0.32,0.16,-0.76,1.5,-1.06,-0.15,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
P81605,DCD,Dermcidin (EC 3.4.-.-) (Preproteolysin) [Cleaved into: Survival-promoting peptide;DCD-1],2,15.5,21.78,23.13,23.78,22.94,22.14,23.76,24.51,23.13,22.75,23.18,23.38,25.1,26.31,23.53,-1.75,-0.4,0.25,-0.59,-1.39,0.23,0.98,-0.4,-0.78,-0.35,-0.15,1.56,2.78,cell killing;killing of cells of other organism;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;proteolysis;response to biotic stimulus;response to stimulus;response to stress,extracellular region,,,,,,,,,,
Q9UHG0,DCDC2,Doublecortin domain-containing protein 2 (Protein RU2S),7,24.8,24.44,23.85,,,,,24.17,20.68,26.81,27.66,26.06,,23.74,24.68,-0.23,-0.83, , , , ,-0.5,-4,2.13,2.98,1.39, ,-0.94,anatomical structure morphogenesis;biological regulation;cell motility;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;developmental process;locomotion;response to stimulus;response to stress;signal transduction,,,,,,,,,,,
P07585,DCN,Decorin (Bone proteoglycan II) (PG-S2) (PG40),5,17.5,,29.76,27.97,28.36,27.93,,26.52,,25.66,25.52,27.49,,25.34,27.17, ,2.59,0.8,1.18,0.76, ,-0.65, ,-1.52,-1.65,0.31, ,-1.83,aging;amine metabolic process;anatomical structure development;anatomical structure morphogenesis;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;peptidyl-amino acid modification;polysaccharide metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;sulfur compound metabolic process,cell part;extracellular space,,,,,,,,,,
Q9NPI6,DCP1A,mRNA-decapping enzyme 1A (EC 3.-.-.-) (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF),2,5.1,25.03,25.77,26.23,25.84,25.58,25.34,25.69,26.08,25.4,25.15,,25.04,,25.56,-0.53,0.21,0.67,0.28,0.02,-0.21,0.13,0.52,-0.16,-0.41, ,-0.52, ,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q96C86,DCPS,m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS),8,25.5,29.8,28.45,28.62,27.57,28.4,28.22,26.9,27.57,28.79,26.45,25.06,27.48,27.94,27.79,2.01,0.66,0.83,-0.22,0.61,0.43,-0.89,-0.22,1,-1.34,-2.73,-0.31,0.15,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P32321,DCTD,Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase),5,28.7,25.25,27.06,25.46,27.41,26.93,25.32,28.27,27.46,26.16,22.22,27.08,29.01,25.23,26.37,-1.13,0.68,-0.91,1.04,0.56,-1.06,1.9,1.09,-0.21,-4.16,0.7,2.64,-1.15,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q14203,DCTN1,Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued),45,52,29.97,31.29,30.88,31.87,31.23,30.8,32.05,31.91,31.35,30.88,32.13,32.15,30.85,31.33,-1.36,-0.04,-0.46,0.53,-0.1,-0.53,0.71,0.58,0.01,-0.46,0.79,0.82,-0.49,anatomical structure development;biological regulation;cell death;cellular component organization;cellular metabolic process;cellular process;death;developmental process;establishment of localization;immune system process;macromolecule metabolic process;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;primary metabolic process;protein metabolic process;regulation of protein modification process;transport,cell leading edge;cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
Q13561,DCTN2,Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (p50 dynamitin),25,61.8,31.03,31.5,31.1,31.8,31.72,31.22,31.9,31.85,30.86,30.8,32.31,31.21,31.25,31.43,-0.39,0.08,-0.32,0.37,0.29,-0.21,0.47,0.43,-0.57,-0.63,0.88,-0.22,-0.18,cell proliferation;cellular component organization;cellular process;cytoskeleton organization;immune system process;mitosis;nuclear division;organelle fission;organelle organization,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;microtubule organizing center;organelle;protein complex;site of polarized growth;vesicle,,,,,,,,,,
O75935,DCTN3,Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22),6,32.3,26.39,28.59,27.27,28.88,28.09,28.63,28.06,28.61,26.72,25.11,29.34,27.73,27.38,27.75,-1.36,0.83,-0.48,1.12,0.33,0.88,0.31,0.85,-1.04,-2.64,1.59,-0.03,-0.37,cellular component organization;cellular process;cytokinesis;immune system process;mitosis;nuclear division;organelle fission;organelle organization,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;microtubule organizing center;midbody;organelle;protein complex,,,,,,,,,,
Q9UJW0,DCTN4,Dynactin subunit 4 (Dyn4) (Dynactin subunit p62),14,40.4,27.3,28.61,28.44,28.59,28.29,28.77,29.93,29.38,28.83,29.02,29.77,29.22,28.42,28.81,-1.51,-0.21,-0.37,-0.23,-0.52,-0.04,1.11,0.57,0.02,0.2,0.96,0.4,-0.39,immune system process,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
Q9H773,DCTPP1,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein),6,45.3,28.78,27.28,27.31,27.48,27.27,,27.09,27.86,,,25.97,24.35,,27.04,1.74,0.24,0.27,0.43,0.22, ,0.05,0.82, , ,-1.07,-2.7, ,catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q96GG9,DCUN1D1,DCN1-like protein 1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene),9,37.5,29.86,28.44,28.77,28.07,26.37,25.65,27.45,27.18,25.49,27.93,27.27,27.32,24.94,27.29,2.57,1.15,1.48,0.78,-0.92,-1.64,0.17,-0.11,-1.8,0.64,-0.02,0.04,-2.35,,cell part;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q9BTE7,DCUN1D5,DCN1-like protein 5 (DCUN1 domain-containing protein 5) (Defective in cullin neddylation protein 1-like protein 5),4,27.6,27.25,26.29,,25.85,25.91,25.64,25.81,25.08,23.61,,,25.37,24.96,25.58,1.67,0.72, ,0.27,0.33,0.06,0.23,-0.5,-1.96, , ,-0.21,-0.62,,,,,,,,,,,,
Q7Z4W1,DCXR,L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Sperm surface protein P34H),5,31.2,28.19,28.82,28.33,28.34,28.12,28.87,27.57,28.08,28.45,28.32,26.85,28.1,28.01,28.16,0.03,0.66,0.18,0.19,-0.04,0.71,-0.59,-0.08,0.29,0.16,-1.31,-0.06,-0.15,alcohol metabolic process;carbohydrate metabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,brush border;cell part;cell projection;macromolecular complex;membrane;microvillus;protein complex,,,,,,,,,,
O94760,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)",10,45.6,29.41,30.08,28.82,28.47,27.28,26.09,30.94,29.56,25.57,28.31,28.38,31.72,25.94,28.51,0.91,1.57,0.31,-0.03,-1.22,-2.42,2.43,1.06,-2.93,-0.2,-0.13,3.21,-2.57,amine metabolic process;biological regulation;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O95865,DDAH2,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 (DDAH-2) (Dimethylarginine dimethylaminohydrolase 2) (EC 3.5.3.18) (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein)",11,68.8,31.1,29.77,28.73,28,28.32,25.34,28.39,29.45,27.54,25.82,29.57,28.53,24.3,28.07,3.04,1.7,0.66,-0.07,0.26,-2.73,0.32,1.38,-0.53,-2.25,1.51,0.46,-3.76,amine metabolic process;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q16531,DDB1,DNA damage-binding protein 1 (DDB p127 subunit) (DNA damage-binding protein a) (DDBa) (Damage-specific DNA-binding protein 1) (HBV X-associated protein 1) (XAP-1) (UV-damaged DNA-binding factor) (UV-damaged DNA-binding protein 1) (UV-DDB 1) (XPE-binding factor) (XPE-BF) (Xeroderma pigmentosum group E-complementing protein) (XPCe),53,48.5,32.72,32.66,32.07,32.4,33.1,33.37,32.85,32.83,32.91,32.02,32.11,32.33,32.59,32.61,0.11,0.05,-0.54,-0.22,0.49,0.75,0.23,0.22,0.3,-0.59,-0.5,-0.28,-0.02,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;response to stimulus;signal transduction,cell part;cytoplasm;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q5TDH0,DDI2,Protein DDI1 homolog 2,6,20.1,28.33,26.77,26.82,26.94,24.55,25.29,25.56,26.12,,24.84,26.34,25.75,,26.12,2.21,0.65,0.7,0.82,-1.57,-0.83,-0.56,0, ,-1.28,0.22,-0.37, ,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,,,,,,,,,,,
P39656,DDOST,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (EC 2.4.99.18),18,50.7,33.41,34.06,33.53,32.61,33.44,34.21,33.28,32.82,33.83,33.57,33.41,33.35,34.14,33.51,-0.1,0.55,0.02,-0.91,-0.07,0.7,-0.23,-0.69,0.32,0.05,-0.11,-0.16,0.63,biosynthetic process;carbohydrate metabolic process;cell activation;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein targeting;protein transport;response to chemical stimulus;response to stimulus;response to stress;translation;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q96HY6,DDRGK1,DDRGK domain-containing protein 1,11,57.3,30.33,29.44,29.94,29.27,29.66,30.07,29.22,29.37,30.06,29.52,30.22,28.62,30.31,29.69,0.64,-0.26,0.24,-0.43,-0.03,0.38,-0.47,-0.33,0.37,-0.18,0.53,-1.07,0.61,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P30046,DDT,D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II),8,66.9,30.03,30.4,31.02,31.09,30.02,29.66,30.72,30.01,28.44,28.95,31.88,30.75,27.61,30.04,-0.01,0.36,0.98,1.04,-0.02,-0.38,0.68,-0.04,-1.61,-1.1,1.83,0.71,-2.43,biosynthetic process;cellular metabolic process;cellular process;metabolic process;pigment metabolic process;secondary metabolic process,cell part;cytoplasm,,,,,,,,,,
Q92499,DDX1,ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB),39,57.8,32.39,31.99,32.19,32.61,32.37,32.56,32.68,32.21,32.65,32.03,32.29,32.58,32.15,32.36,0.03,-0.37,-0.17,0.24,0.01,0.19,0.32,-0.15,0.29,-0.33,-0.07,0.22,-0.21,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA geometric change;DNA metabolic process;DNA repair;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;ribonucleoprotein complex assembly;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;ribonucleoprotein complex,Other TF domain,,,,,,,,,
Q13206,DDX10,Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10),5,11.8,24.65,24.06,25.38,24.05,24.46,25.79,26.09,24.43,26.45,27.1,25.64,27.24,25.32,25.44,-0.78,-1.37,-0.06,-1.38,-0.98,0.36,0.65,-1,1.01,1.66,0.2,1.8,-0.12,,,,,,,,,,,,
Q92841,DDX17,Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (RNA-dependent helicase p72),34,46.1,33.78,33.02,32.75,32.79,33.39,33.45,32.76,32.95,33.39,32.93,32.15,32.16,33.23,32.98,0.8,0.04,-0.23,-0.19,0.41,0.47,-0.22,-0.03,0.41,-0.06,-0.83,-0.82,0.25,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,,,,,,,,,,
Q9NVP1,DDX18,ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb),21,40.9,31.52,30.15,29.99,30.05,31.67,30.78,30.8,30.24,31.44,31.16,28.32,29.75,30.55,30.49,1.03,-0.35,-0.5,-0.45,1.18,0.28,0.31,-0.25,0.94,0.66,-2.17,-0.74,0.05,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9NUU7,DDX19A,ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A),13,23.9,29.16,28.94,28.57,29.76,28.19,26.78,28.24,28.6,26.19,26.44,27.68,28.93,24.97,27.88,1.28,1.06,0.69,1.88,0.31,-1.1,0.36,0.72,-1.7,-1.45,-0.2,1.05,-2.91,biological regulation;establishment of localization;nucleobase-containing compound transport;protein transport;response to chemical stimulus;response to stimulus;transport,cell part;cytoplasm;macromolecular complex;membrane;nuclear pore;protein complex,,,,,,,,,,
Q9UHI6,DDX20,Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3),5,6.9,26.28,25.9,26.4,26.34,27.48,27.85,27.89,28.03,25.72,,25.06,26.05,27.29,26.69,-0.41,-0.79,-0.29,-0.35,0.79,1.16,1.2,1.34,-0.98, ,-1.63,-0.65,0.6,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;ribonucleoprotein complex;spliceosomal complex;transcriptional repressor complex,,,,,,,,,,
Q9NR30,DDX21,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),57,56.2,32.7,31.7,32.21,32.95,32.82,32.8,32.52,32.18,32.7,33.64,31.14,32.03,32.29,32.44,0.27,-0.74,-0.23,0.51,0.38,0.36,0.09,-0.26,0.27,1.2,-1.29,-0.41,-0.15,multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9BUQ8,DDX23,Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD),25,31.1,30.91,30.07,29.63,30.26,31.05,31.02,29.9,29.73,30.5,30.66,28.7,29.08,30.21,30.13,0.78,-0.06,-0.5,0.13,0.92,0.89,-0.24,-0.4,0.37,0.53,-1.44,-1.06,0.08,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleoplasm;organelle;plasma membrane;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9GZR7,DDX24,ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24),21,29.4,30.55,29.77,30.46,29.98,29.09,29.38,28.63,28.56,29.78,29.1,28.97,29.6,28.18,29.39,1.16,0.38,1.07,0.59,-0.3,-0.01,-0.76,-0.83,0.39,-0.29,-0.42,0.22,-1.21,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q96GQ7,DDX27,Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27),22,28.6,30.51,29.67,29.37,29.92,30.71,30.73,29.63,29.7,30.73,30.85,28.99,30.11,30.39,30.1,0.41,-0.43,-0.73,-0.18,0.61,0.63,-0.48,-0.4,0.63,0.75,-1.11,0.01,0.29,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NUL7,DDX28,Probable ATP-dependent RNA helicase DDX28 (EC 3.6.4.13) (Mitochondrial DEAD box protein 28),3,7.2,24.79,,,24.86,26.12,25.14,26,26.31,24.45,26.82,,23.76,24.72,25.3,-0.51, , ,-0.44,0.82,-0.15,0.7,1.01,-0.85,1.52, ,-1.54,-0.58,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O00148,DDX39A,ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49),9,23.9,28.64,28.61,30.07,28.35,29.34,27.53,28.52,27.63,29.03,29.33,,28.65,27.01,28.56,0.08,0.05,1.51,-0.21,0.78,-1.03,-0.04,-0.93,0.47,0.77, ,0.09,-1.55,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q13838,DDX39B,Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein),36,66.1,33.95,33.85,33.61,33.46,33.75,34.06,33.91,33.66,34.42,34.2,32.97,33.08,34.01,33.76,0.19,0.09,-0.16,-0.3,-0.01,0.3,0.15,-0.1,0.66,0.44,-0.8,-0.68,0.24,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;transport,cell part;cytoplasm;macromolecular complex;protein complex;ribonucleoprotein complex;spliceosomal complex;transcription export complex,,,,,,,,,,
O00571,DDX3X,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)",44,63.1,32.13,32.25,31.98,33.14,32.89,32.04,33.42,33.09,32.38,32.52,32.84,33.29,32.09,32.62,-0.49,-0.37,-0.64,0.52,0.27,-0.58,0.8,0.47,-0.24,-0.1,0.22,0.67,-0.53,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome segregation;immune system process;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle assembly;primary metabolic process;regulation of translation;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to osmotic stress;response to stimulus;response to stress;ribonucleoprotein complex assembly;ribosome assembly;RNA metabolic process;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;ribonucleoprotein complex,Other TF domain,,,,,,,,,
Q9NQI0,DDX4,Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog),42,45,31.88,31,30.96,30.47,31.26,31.33,30.83,30.57,31.03,31.28,30.26,29.99,31.33,30.94,0.94,0.06,0.02,-0.47,0.32,0.39,-0.11,-0.36,0.09,0.34,-0.67,-0.95,0.39,biological regulation;cell motility;cellular component movement;cellular process;developmental process;locomotion;multicellular organismal development;multicellular organismal process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q9UJV9,DDX41,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) (DEAD box protein abstrakt homolog),7,12.4,27.32,26.38,25.97,27.34,27.83,27.48,27.29,26.89,28.01,27.92,25.74,28.17,,27.19,0.13,-0.81,-1.23,0.14,0.64,0.28,0.09,-0.31,0.81,0.73,-1.45,0.97, ,biological regulation;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal development;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q86XP3,DDX42,ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125),25,42,30.34,29.74,29.67,29.97,30.3,30.04,30.07,30.2,30.77,30.25,29.43,29.56,29.45,29.98,0.36,-0.24,-0.31,-0.01,0.32,0.06,0.09,0.21,0.79,0.26,-0.55,-0.43,-0.53,localization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H0S4,DDX47,Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47),17,43.3,30.55,28.81,27.61,29.67,30.31,29.59,28.11,29.32,28.74,26.35,27.37,28.61,28.62,28.74,1.81,0.07,-1.13,0.93,1.56,0.85,-0.64,0.58,0,-2.39,-1.37,-0.13,-0.13,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9Y6V7,DDX49,Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49),4,10.6,26.42,28.89,27.14,28.93,25.29,24.56,26.43,25.59,28.09,28.29,24.42,23.89,24.35,26.33,0.09,2.56,0.81,2.6,-1.04,-1.77,0.1,-0.74,1.76,1.96,-1.91,-2.44,-1.98,,,,,,,,,,,,
P17844,DDX5,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),51,59.4,33.95,33.32,33.73,33.9,33.99,33.92,33.76,33.41,34.16,33.92,32.93,33.31,33.53,33.68,0.27,-0.36,0.05,0.22,0.31,0.24,0.08,-0.27,0.48,0.24,-0.75,-0.37,-0.15,biological regulation;biosynthetic process;cell growth;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;growth;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;rhythmic process;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q8N8A6,DDX51,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),8,15.8,25.58,25.41,27.11,26.37,25.88,25.95,25.94,26.93,26.11,24.88,,26.37,19.91,25.54,0.05,-0.13,1.57,0.83,0.34,0.42,0.4,1.39,0.57,-0.66, ,0.83,-5.63,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9Y2R4,DDX52,Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52),11,24.9,27.44,26.87,25.47,27.78,28.12,27.75,28.62,28.16,29.7,27.39,,23.27,27.36,27.33,0.11,-0.46,-1.86,0.45,0.79,0.42,1.29,0.83,2.37,0.06, ,-4.06,0.04,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8TDD1,DDX54,ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54),15,24,27.13,28.05,24.9,28.51,29.17,29.1,27.67,27.85,28.37,28.7,26.16,28.09,27.86,27.81,-0.68,0.24,-2.91,0.7,1.36,1.29,-0.15,0.04,0.56,0.89,-1.65,0.28,0.04,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;signal transduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9NY93,DDX56,Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56),7,20.7,28.49,27.35,26.36,28.89,28.61,28.72,28.8,28.84,28.77,28.73,28.24,27.53,28.41,28.29,0.2,-0.93,-1.93,0.6,0.33,0.43,0.52,0.55,0.49,0.44,-0.05,-0.75,0.12,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O95786,DDX58,Probable ATP-dependent RNA helicase DDX58 (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),32,35.6,28.27,27.75,32.59,30.51,26.03,24.32,28.04,27.81,25.49,28.36,28.17,28.67,,28,0.27,-0.26,4.59,2.51,-1.97,-3.68,0.04,-0.19,-2.51,0.36,0.17,0.67, ,biological regulation;detection of stimulus;immune system process;interspecies interaction between organisms;multi-organism process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P26196,DDX6,Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK),19,52,31.41,30.76,30.57,30.87,31.07,30.15,30.61,30.65,30.31,30.72,30.47,30.56,29.77,30.61,0.8,0.15,-0.04,0.26,0.46,-0.46,0,0.04,-0.3,0.11,-0.14,-0.05,-0.84,catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;RNAi effector complex,,,,,,,,,,
Q8IY21,DDX60,Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60),8,6.7,23.37,25.58,28.85,27.18,26.2,23.84,22.98,24.71,24.78,25.51,,23.73,,25.16,-1.79,0.42,3.69,2.02,1.05,-1.32,-2.18,-0.45,-0.38,0.35, ,-1.43, ,immune system process;multi-organism process;response to biotic stimulus;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
Q16698,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial (EC 1.3.1.34) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH])",17,54.3,31.47,32.07,32.62,31.92,32.14,32.28,31.32,31.41,32.3,32.25,32.09,32.76,32.11,32.06,-0.59,0.02,0.57,-0.14,0.08,0.23,-0.73,-0.65,0.24,0.2,0.03,0.7,0.05,catabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecular complex assembly;metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NUI1,DECR2,"Peroxisomal 2,4-dienoyl-CoA reductase (pDCR) (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2)",4,17.1,26.7,25.13,,25.23,25.77,27.13,23.99,,26.44,25.2,,25.18,27.92,25.87,0.83,-0.74, ,-0.64,-0.1,1.26,-1.88, ,0.57,-0.66, ,-0.68,2.05,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle,,,,,,,,,,
O15121,DEGS1,Sphingolipid delta(4)-desaturase DES1 (EC 1.14.-.-) (Cell migration-inducing gene 15 protein) (Degenerative spermatocyte homolog 1) (Membrane lipid desaturase),4,26,29.28,28.6,28.21,28.24,26.83,28.32,27.72,26.87,29.16,29.36,28.31,29.14,29.21,28.4,0.88,0.2,-0.2,-0.17,-1.58,-0.08,-0.68,-1.54,0.76,0.96,-0.1,0.74,0.81,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
P35659,DEK,Protein DEK,26,53.6,32.68,30.98,31.25,30.66,31.57,31.97,31.02,30.83,31.24,31.39,29.22,29.62,30.86,31.02,1.65,-0.05,0.23,-0.36,0.54,0.95,0,-0.2,0.22,0.37,-1.8,-1.4,-0.16,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of DNA metabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,SAP-domain,,,,,,,,,
Q5VZ89,DENND4C,DENN domain-containing protein 4C,11,12.3,24.56,,25.28,24.36,25.35,25.68,24.22,25.47,25.69,,24.4,,,25,-0.44, ,0.28,-0.64,0.35,0.68,-0.78,0.47,0.69, ,-0.61, , ,cellular component organization;cellular localization;cellular membrane organization;cellular process;establishment of localization;localization;membrane organization;plasma membrane organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;retromer complex;vesicle,,,,,,,,,,
O43583,DENR,Density-regulated protein (DRP) (Protein DRP1) (Smooth muscle cell-associated protein 3) (SMAP-3),8,34.3,28.63,28.71,28.17,27.28,26.74,26.27,28.22,27,26.07,27.46,28.23,29.86,25.28,27.53,1.09,1.18,0.64,-0.26,-0.79,-1.26,0.69,-0.54,-1.46,-0.07,0.69,2.32,-2.25,,,,,,,,,,,,
Q8TB45,DEPTOR,DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6),5,13.7,27.07,22.02,24.46,22.26,,22.92,23.62,21.72,22.8,23.06,27.8,25.83,22.27,23.82,3.25,-1.8,0.64,-1.56, ,-0.9,-0.2,-2.1,-1.02,-0.76,3.98,2.01,-1.55,biological regulation;cellular component organization;cellular process;regulation of protein modification process;response to stimulus;signal transduction,cell part;intracellular,,,,,,,,,,
Q9Y315,DERA,Putative deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase),9,37.7,29.7,29.24,28.75,29.37,28.73,28.26,29.25,28.48,26.73,28.9,27.67,26.64,26.8,28.35,1.35,0.89,0.4,1.03,0.38,-0.09,0.9,0.13,-1.62,0.55,-0.68,-1.7,-1.55,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q9BUN8,DERL1,Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1),3,17.9,29.89,29.63,26.67,29.24,28.3,29.21,25.23,28.34,28.93,28.89,27.9,27.7,28.83,28.37,1.52,1.26,-1.69,0.88,-0.06,0.84,-3.13,-0.03,0.56,0.52,-0.47,-0.67,0.46,biological regulation;catabolic process;cellular metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9GZP9,DERL2,Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa),3,18.4,25.45,27.79,27.03,27.61,26.9,27.13,,26.63,27.15,27.46,27.93,27.87,28.12,27.25,-1.8,0.53,-0.23,0.35,-0.36,-0.13, ,-0.63,-0.11,0.2,0.68,0.62,0.87,biological regulation;catabolic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P17661,DES,Desmin,56,85.7,27.16,34.49,35.14,28.92,29.78,28.02,29.05,30.67,26.75,28.49,33.02,27.66,30.54,29.98,-2.82,4.51,5.16,-1.05,-0.19,-1.96,-0.93,0.69,-3.22,-1.49,3.04,-2.31,0.57,biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex;synapse,,,,,,,,,,
O00273,DFFA,DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD),6,26.9,28.34,26.25,25.74,28.03,25.97,25.11,24.25,24.01,,,26.02,27.12,23.76,25.87,2.47,0.37,-0.13,2.16,0.1,-0.76,-1.63,-1.86, , ,0.15,1.24,-2.11,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;signal transduction,cell part;cytosol;nucleoplasm,,,,,,,,,,
O60443,DFNA5,Non-syndromic hearing impairment protein 5 (Inversely correlated with estrogen receptor expression 1) (ICERE-1),15,29.4,24.54,29.17,28.49,30.39,28.64,27.34,30.86,29.77,27.82,26.36,30.12,31.98,27.74,28.71,-4.17,0.46,-0.22,1.68,-0.07,-1.37,2.16,1.06,-0.89,-2.35,1.41,3.27,-0.97,biological regulation;cell death;cell differentiation;cellular process;death;developmental process;multicellular organismal process;neurological system process,cell part;cytoplasm,,,,,,,,,,
P23743,DGKA,Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha),6,12.3,27.53,26.87,27.58,25.88,21.93,25.29,27.18,23.62,26.18,26.12,27.47,26.97,25.55,26.01,1.52,0.86,1.57,-0.13,-4.09,-0.73,1.16,-2.39,0.17,0.11,1.46,0.96,-0.47,biological regulation;cell activation;cellular process;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q15392,DHCR24,Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1),17,31.6,31.04,31.51,29.87,32.39,31.56,32.28,31.86,33.12,32.24,31.82,32.05,30.24,32.94,31.76,-0.72,-0.25,-1.89,0.63,-0.2,0.51,0.1,1.36,0.48,0.05,0.29,-1.52,1.17,alcohol metabolic process;anatomical structure development;biological regulation;biosynthetic process;catabolic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;lipid metabolic process;localization;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein maturation;protein metabolic process;regulation of cell cycle;response to chemical stimulus;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9UBM7,DHCR7,7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Putative sterol reductase SR-2) (Sterol Delta(7)-reductase),11,21.7,27.54,29.85,26.36,30.05,29.35,30.61,29.39,29.62,30.4,29.89,28.9,28.1,29.74,29.21,-1.68,0.63,-2.85,0.84,0.14,1.39,0.17,0.4,1.18,0.67,-0.32,-1.11,0.52,alcohol metabolic process;anatomical structure development;biological regulation;biosynthetic process;cell differentiation;cellular process;developmental process;growth;lipid metabolic process;metabolic process;multicellular organismal process;post-embryonic development;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q02127,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",5,17.2,26.32,26.41,26.81,26.46,27.55,27.1,25.72,24.99,27.44,26.57,25.54,,24.14,26.25,0.07,0.15,0.55,0.2,1.3,0.85,-0.54,-1.26,1.19,0.31,-0.71, ,-2.12,biological regulation;biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;heterocycle metabolic process;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;regulation of body fluid levels;regulation of organelle organization;response to chemical stimulus;response to drug;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;secretion;small molecule metabolic process;transport,cell body;cell part;membrane;neuronal cell body,,,,,,,,,,
Q96LJ7,DHRS1,Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-),7,29.4,29.75,28.95,,26.61,26.52,27.82,27.92,28.91,27.25,28.9,29.53,27.49,,28.15,1.6,0.8, ,-1.54,-1.63,-0.33,-0.23,0.76,-0.9,0.75,1.38,-0.66, ,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O75911,DHRS3,Short-chain dehydrogenase/reductase 3 (EC 1.1.1.300) (DD83.1) (Retinal short-chain dehydrogenase/reductase 1) (retSDR1),9,30.1,28.45,29.75,28.47,28.09,29.26,28.99,29.44,27.34,27.34,28.97,29.09,30.2,30.13,28.89,-0.43,0.86,-0.42,-0.79,0.37,0.11,0.55,-1.54,-1.54,0.08,0.21,1.31,1.24,biological regulation;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;hormone metabolic process;lipid metabolic process;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;small molecule metabolic process;vitamin metabolic process,cell part;membrane,,,,,,,,,,
Q9BTZ2,DHRS4,Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase) (CR) (PHCR) (NADPH-dependent retinol dehydrogenase/reductase) (NRDR) (humNRDR) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (SCAD-SRL) (Short-chain dehydrogenase/reductase family member 4),7,26.1,29.15,28.2,28.68,29.02,29.11,28.51,28.9,29.35,29.98,27.71,28.01,28.87,27.85,28.72,0.43,-0.52,-0.04,0.3,0.39,-0.21,0.18,0.63,1.26,-1.01,-0.71,0.15,-0.87,alcohol metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecular complex assembly;metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9Y394,DHRS7,Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4),11,39.2,28.78,31.27,30.6,30.49,29.95,30.92,30.53,30.32,30.92,30.64,30.83,31.65,31,30.61,-1.83,0.66,-0.01,-0.12,-0.66,0.31,-0.08,-0.28,0.31,0.03,0.23,1.04,0.39,,,,,,,,,,,,
Q6IAN0,DHRS7B,Dehydrogenase/reductase SDR family member 7B (EC 1.1.-.-),11,32.3,28.18,28.08,26.47,27.59,27.83,28.25,,27.19,27.84,29.46,27.81,24.78,28.44,27.66,0.52,0.42,-1.19,-0.07,0.17,0.59, ,-0.47,0.18,1.8,0.15,-2.88,0.78,,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle,,,,,,,,,,
Q9BPW9,DHRS9,Dehydrogenase/reductase SDR family member 9 (EC 1.1.-.-) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),4,20,27.59,25.57,28.91,25.32,,25.66,,,26.56,,25.44,,,26.44,1.15,-0.87,2.47,-1.12, ,-0.77, , ,0.12, ,-0.99, , ,biological regulation;biosynthetic process;cell differentiation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;hormone metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part,,,,,,,,,,
Q96HY7,DHTKD1,"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)",6,11.1,26.97,27.93,29.8,28.12,24.82,29.75,23.08,25.21,30.23,29.01,29.88,29.79,30.32,28.07,-1.1,-0.14,1.73,0.05,-3.25,1.68,-4.99,-2.86,2.16,0.94,1.81,1.72,2.25,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;cofactor metabolic process;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O43143,DHX15,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15),43,49.8,32.37,32.58,31.97,32.23,32.83,32.89,32.42,32.32,32.76,32.81,31.82,32.23,32.57,32.45,-0.08,0.13,-0.48,-0.21,0.38,0.44,-0.03,-0.13,0.32,0.37,-0.62,-0.22,0.13,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O60231,DHX16,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),11,11.1,27.64,27.15,26.49,26.57,26.45,27.26,27.68,26.62,26.68,26.98,24.79,27.55,27.47,26.87,0.77,0.28,-0.38,-0.3,-0.42,0.39,0.81,-0.25,-0.19,0.11,-2.08,0.68,0.6,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q7Z478,DHX29,ATP-dependent RNA helicase DHX29 (EC 3.6.4.13) (DEAH box protein 29) (Nucleic acid helicase DDXx),10,9.9,26.64,27.81,26.3,27.87,27.77,26.99,28.53,29.02,28.26,27.4,28.53,28.57,27.89,27.81,-1.18,-0.01,-1.52,0.06,-0.05,-0.82,0.72,1.21,0.44,-0.41,0.72,0.76,0.08,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q7L2E3,DHX30,Putative ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30),18,20.8,28.08,28.04,26.54,29.43,30.41,29.42,29.85,28.99,28.83,29.16,28.58,27.67,29.76,28.83,-0.75,-0.78,-2.29,0.6,1.58,0.59,1.02,0.16,0.01,0.34,-0.25,-1.16,0.93,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9H2U1,DHX36,Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE),13,15.3,28.55,27.46,27.93,28.25,26.23,26.76,28.25,28.36,27.64,26.17,27.87,28.75,25.56,27.52,1.03,-0.06,0.41,0.73,-1.29,-0.76,0.73,0.83,0.12,-1.36,0.35,1.23,-1.96,multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q14562,DHX8,ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1),5,5.2,27.22,25.11,26.36,26.71,26.21,26.45,26.16,26.16,27.16,26.38,25.79,27.04,26.67,26.42,0.81,-1.31,-0.06,0.29,-0.21,0.04,-0.26,-0.26,0.75,-0.04,-0.62,0.63,0.26,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q08211,DHX9,ATP-dependent RNA helicase A (RHA) (EC 3.6.4.13) (DEAH box protein 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II),82,60.4,34.95,34.08,34.24,34.16,34.58,34.85,34.23,33.92,34.82,34.84,33.2,34.04,34.23,34.32,0.63,-0.23,-0.08,-0.16,0.26,0.53,-0.08,-0.4,0.5,0.52,-1.12,-0.28,-0.09,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to heat;response to stimulus;response to stress;rhythmic process;RNA metabolic process;RNA processing;RNA splicing,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleolus;nucleoplasm;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9NR28,DIABLO,"Diablo homolog, mitochondrial (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac)",12,65.1,31.99,32.31,31.15,32.17,31.33,32.15,31.16,30.97,31.45,30.89,31.51,28.22,31.73,31.31,0.68,1,-0.16,0.86,0.02,0.84,-0.15,-0.34,0.14,-0.42,0.2,-3.09,0.42,biological regulation,cell part;cytosol;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
O60610,DIAPH1,Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1),30,29.7,31.85,30.14,30.93,30.44,29.71,28.46,30.51,30.08,29.04,29.71,30.64,30.43,29.6,30.12,1.74,0.02,0.81,0.32,-0.4,-1.66,0.39,-0.04,-1.08,-0.41,0.52,0.31,-0.52,biological regulation;cellular component assembly;cellular component organization;cellular localization;cellular macromolecular complex assembly;cellular process;cytoskeleton organization;localization;macromolecular complex assembly;multicellular organismal process;neurological system process;organelle organization;protein complex assembly;protein polymerization;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;cell projection;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;organelle,,,,,,,,,,
Q9BTC0,DIDO1,Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1),15,10.6,27.17,24.58,26.99,26.56,27.19,27.87,26.87,24.86,26.67,27.87,27.84,,26.59,26.75,0.41,-2.18,0.24,-0.2,0.44,1.11,0.11,-1.89,-0.09,1.11,1.09, ,-0.17,biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UNQ2,DIMT1,"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)",7,31.3,,26.21,27.27,28.07,29.02,28.37,28.31,26.54,29.12,28.28,26.75,28.3,28.54,27.9, ,-1.69,-0.63,0.17,1.12,0.48,0.41,-1.36,1.22,0.38,-1.15,0.4,0.65,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;rRNA processing;small molecule metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9P265,DIP2B,Disco-interacting protein 2 homolog B (DIP2 homolog B),8,7.5,27.66,25.77,24.69,25.75,,25.97,24.22,24.62,25.9,25.26,26.48,25.49,25.15,25.58,2.08,0.19,-0.89,0.17, ,0.39,-1.36,-0.96,0.32,-0.32,0.9,-0.09,-0.43,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y2L1,DIS3,Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44),18,23.2,29.65,29.35,28.67,29.44,29.91,29.08,29.09,28.5,29.64,29,28.74,28.84,29.8,29.21,0.44,0.14,-0.54,0.23,0.7,-0.12,-0.12,-0.71,0.43,-0.21,-0.47,-0.37,0.6,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O60832,DKC1,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),27,45.7,30.99,30.83,30.88,30.76,31.12,30.87,30.26,30.22,31.45,31.4,30.02,29.21,30.51,30.65,0.33,0.17,0.23,0.1,0.47,0.21,-0.4,-0.43,0.79,0.75,-0.63,-1.44,-0.14,biological regulation;biosynthetic process;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA replication;homeostatic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;rRNA processing;telomere organization,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;ribonucleoprotein complex;telomerase holoenzyme complex,,,,,,,,,,
Q86T81,DKFZp451M2318,Putative uncharacterized protein DKFZp451M2318,4,10.3,23.51,23.54,,27.71,25.36,21.7,,25.43,,24.46,,23.73,25.97,24.6,-1.09,-1.06, ,3.11,0.76,-2.9, ,0.83, ,-0.14, ,-0.88,1.37,,cell part;membrane,,,,,,,,,,
Q8TCJ8,DKFZp564C172,Putative uncharacterized protein DKFZp564C172,6,21.5,27.87,25.96,27.49,28.53,28.61,28.09,29.42,27.81,27.21,28.52,27.91,29.02,28.54,28.08,-0.21,-2.11,-0.59,0.46,0.53,0.01,1.35,-0.27,-0.87,0.45,-0.16,0.95,0.46,,,,,,,,,,,,
Q5JV90,DKFZp564P1772,Putative uncharacterized protein DKFZp564P1772,11,15.3,27.34,26.41,23.18,27.16,26.12,26.44,24.75,25.12,25.97,26.85,24.66,,25.05,25.75,1.58,0.66,-2.58,1.41,0.36,0.69,-1.01,-0.63,0.22,1.1,-1.09, ,-0.7,,,,,,,,,,,,
Q658N3,DKFZp666G145,"Down-regulator of transcription 1, TBP-binding (Negative cofactor 2), isoform CRA_a (Putative uncharacterized protein DKFZp666G145) (cDNA FLJ32979 fis, clone TESTI2017775, highly similar to TATA-BINDING PROTEIN-ASSOCIATED PHOSPHOPROTEIN)",4,25,27.34,27.66,27.69,25.42,27.27,26.85,25.84,25.83,26.93,25.23,25.49,27.91,26.21,26.59,0.75,1.07,1.1,-1.17,0.68,0.26,-0.75,-0.76,0.34,-1.36,-1.1,1.32,-0.38,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q658W7,DKFZp666L2010,Putative uncharacterized protein DKFZp666L2010 (Fragment),5,6.6,26.22,23.87,26.55,26.09,25.92,26.27,25.92,25.55,27.37,26.39,26.05,26.15,26.41,26.06,0.16,-2.19,0.5,0.03,-0.14,0.21,-0.13,-0.51,1.31,0.33,-0.01,0.09,0.35,,,,,,,,,,,,
Q7Z3D7,DKFZp686E2459,Putative uncharacterized protein DKFZp686E2459,15,19.8,28.05,27.76,27.66,27.52,27.94,28.79,27.55,27.09,29,27.12,27.53,28.79,27.7,27.88,0.17,-0.13,-0.23,-0.36,0.05,0.91,-0.33,-0.8,1.11,-0.77,-0.36,0.9,-0.18,,cell part;intracellular,,,,,,,,,,
Q5HYL3,DKFZp686H16220,Putative uncharacterized protein DKFZp686H16220,2,40.3,28.28,27.99,26.96,29.4,28.37,26.8,29.63,28.73,27.5,,26.6,29.82,28.53,28.22,0.06,-0.23,-1.25,1.19,0.15,-1.41,1.41,0.51,-0.72, ,-1.62,1.6,0.32,,,,,,,,,,,,
Q68DI6,DKFZp781H1925,Putative uncharacterized protein DKFZp781H1925,8,11.2,27.21,23.27,,24.68,23.29,,22.97,26.87,26.29,24.48,,23.68,,24.75,2.46,-1.48, ,-0.07,-1.46, ,-1.78,2.12,1.54,-0.27, ,-1.07, ,,,,,,,,,,,,
P09622,DLD,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",21,50.3,31.96,32.78,32.25,31.9,32.36,32.54,31.68,31.99,31.85,32.01,32.09,31.52,31.84,32.06,-0.1,0.72,0.19,-0.16,0.3,0.48,-0.38,-0.07,-0.21,-0.05,0.03,-0.54,-0.22,amine metabolic process;anatomical structure morphogenesis;biological regulation;catabolic process;cell maturation;cellular amino acid metabolic process;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental maturation;developmental process;generation of precursor metabolites and energy;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q12959,DLG1,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg),20,30.6,29.86,28.25,28.44,28.56,28.36,28.3,28.59,28,28.83,30.02,29.07,29.26,29.04,28.81,1.04,-0.56,-0.37,-0.25,-0.45,-0.51,-0.22,-0.82,0.01,1.21,0.26,0.44,0.23,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell communication;cell junction organization;cell proliferation;cell recognition;cell-cell signaling;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;cytokine production;cytoskeleton organization;developmental process;establishment or maintenance of cell polarity;homeostatic process;immune system process;interspecies interaction between organisms;localization;locomotion;macromolecule metabolic process;membrane organization;metabolic process;multicellular organismal process;multi-organism process;muscle contraction;organelle organization;plasma membrane organization;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;signaling,cell part;cytosol;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;synapse,,,+,,,,,,,
Q9Y2H0,DLGAP4,Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4),9,24.3,27.59,26.07,28.04,25.38,26.28,26.36,23.51,24.69,24.99,26.37,24.28,24.58,,25.68,1.91,0.39,2.36,-0.3,0.6,0.68,-2.17,-0.99,-0.68,0.69,-1.4,-1.1, ,cell communication;cell-cell signaling;cellular process;signaling,cell part;membrane;synapse,,,,,,,,,,
P36957,DLST,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)",26,53,30.85,32.33,31.88,32.3,32.14,32.49,32.45,32.39,32.82,33.19,33.22,33.39,33.51,32.54,-1.68,-0.21,-0.65,-0.24,-0.39,-0.05,-0.09,-0.14,0.29,0.66,0.69,0.85,0.97,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;oxoglutarate dehydrogenase complex;protein complex,,,,,,,,,,
P31689,DNAJA1,DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2),19,56.4,30.92,29.88,31.6,30.96,31.22,30.07,30.76,31.38,29.3,29.48,30.19,30.25,30.22,30.48,0.44,-0.6,1.12,0.48,0.75,-0.41,0.28,0.9,-1.18,-1,-0.29,-0.23,-0.26,biological regulation;cell motility;cellular component movement;cellular metabolic process;cellular process;detection of stimulus;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein folding;protein metabolic process;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to heat;response to stimulus;response to stress;signal transduction,cell part;membrane,,,,,,,,,,
O60884,DNAJA2,DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14),15,32.3,30.57,30.01,29.18,30.02,29.02,28.91,30.21,29.43,29.25,29.96,29.14,29.32,25.84,29.3,1.28,0.71,-0.11,0.72,-0.27,-0.39,0.91,0.13,-0.05,0.67,-0.16,0.02,-3.46,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to abiotic stimulus;response to heat;response to stimulus;response to stress,cell part;membrane,,,,,,,,,,
Q96EY1,DNAJA3,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",11,26.4,29.99,29.59,28.38,28.77,29.34,29.31,28.68,29.22,29.06,29.69,27.69,28.42,29.43,29.05,0.95,0.55,-0.66,-0.28,0.29,0.27,-0.36,0.18,0.02,0.65,-1.36,-0.62,0.39,aging;biological regulation;biosynthetic process;cell activation;cell death;cell differentiation;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;DNA metabolic process;DNA replication;embryo development;immune system process;localization;macromolecule metabolic process;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process;regulation of protein stability;response to abiotic stimulus;response to chemical stimulus;response to heat;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;synapse,,,,,,,,,,
P25685,DNAJB1,DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1),21,58.5,31.11,28.93,29.68,29.82,28.99,28.88,30.22,29.69,28.8,28.45,30.05,29.39,28.25,29.41,1.71,-0.48,0.28,0.42,-0.42,-0.52,0.81,0.29,-0.6,-0.95,0.64,-0.01,-1.16,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9UBS4,DNAJB11,DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4),19,42.2,32.44,31.55,31.32,31.58,31.71,31.92,31.58,31.24,32.14,31.93,31.8,29.54,31.94,31.59,0.85,-0.04,-0.27,-0.01,0.12,0.33,-0.01,-0.35,0.55,0.33,0.21,-2.05,0.35,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process;RNA metabolic process;RNA modification,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NXW2,DNAJB12,DnaJ homolog subfamily B member 12,5,14.1,21.87,,23.49,26.54,,28.23,23.21,21.82,23.02,24.13,23.23,24.99,25.64,24.2,-2.33, ,-0.71,2.34, ,4.04,-0.98,-2.38,-1.18,-0.06,-0.97,0.79,1.44,,cell part,,,,,,,,,,
Q9UDY4,DNAJB4,DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein),6,22.6,27.14,28.38,24.7,30.02,26.52,26.7,27.39,26.72,25.59,,27.79,28.69,27.48,27.26,-0.12,1.12,-2.56,2.76,-0.74,-0.56,0.13,-0.54,-1.67, ,0.53,1.43,0.22,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to abiotic stimulus;response to chemical stimulus;response to heat;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O75190,DNAJB6,DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1),8,32.9,29.01,26.95,26.56,26.59,26.74,26.95,26.57,25.62,27.41,23.77,26.78,26.29,25.43,26.51,2.5,0.44,0.04,0.08,0.22,0.44,0.06,-0.89,0.9,-2.74,0.27,-0.22,-1.08,biological adhesion;biological regulation;cell adhesion;cellular component organization;cellular localization;cellular metabolic process;cellular process;cytoskeleton organization;localization;macromolecule metabolic process;metabolic process;organelle organization;primary metabolic process;protein folding;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96KC8,DNAJC1,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),16,31.4,27.49,30.46,28.55,30.52,28.14,28.83,28.3,28.42,28.34,28.34,28.84,30.61,29.26,28.93,-1.44,1.53,-0.38,1.59,-0.79,-0.1,-0.63,-0.51,-0.59,-0.59,-0.09,1.68,0.33,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of translation;regulation of transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8IXB1,DNAJC10,DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr),21,26.6,29.97,29.96,29.93,29.64,30.61,31.1,30.16,29.93,31.39,31.44,29.99,29.93,30.96,30.38,-0.42,-0.42,-0.45,-0.75,0.23,0.72,-0.23,-0.46,1,1.05,-0.4,-0.45,0.57,biological regulation;catabolic process;cell death;cellular homeostasis;cellular metabolic process;cellular process;death;glycerol ether metabolic process;homeostatic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;small molecule metabolic process,cell part;extracellular region;macromolecular complex;protein complex,,,,,,,,,,
Q9NVH1,DNAJC11,DnaJ homolog subfamily C member 11,18,38.7,30.24,30,30.39,29.52,29.62,30.13,29.78,30.03,29.91,30.82,30.43,29.85,30.11,30.06,0.18,-0.06,0.33,-0.54,-0.44,0.07,-0.29,-0.04,-0.16,0.75,0.37,-0.22,0.04,,cell part;membrane,,,,,,,,,,
O75165,DNAJC13,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),45,24.9,30.97,31.17,30.61,31.04,30.88,30.66,30.95,31.07,30.91,30.54,31.09,31.07,30.82,30.91,0.07,0.27,-0.3,0.13,-0.02,-0.24,0.04,0.16,0,-0.37,0.18,0.16,-0.08,,,,,,,,,,,,
Q96DA6,DNAJC19,Mitochondrial import inner membrane translocase subunit TIM14 (DnaJ homolog subfamily C member 19),4,42.2,26.37,26.94,28.41,26.42,,27.1,27.15,,27.54,27.88,26.84,24.49,27.53,26.97,-0.6,-0.04,1.44,-0.55, ,0.13,0.18, ,0.57,0.91,-0.13,-2.48,0.56,anatomical structure development;cellular metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein folding;protein metabolic process;protein targeting;protein transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q5F1R6,DNAJC21,DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3),4,14.5,24.52,,25.88,23.93,21.66,,23.58,,,24.42,23.7,26.16,,24.23,0.29, ,1.65,-0.3,-2.57, ,-0.66, , ,0.19,-0.53,1.93, ,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,C2H2-type,,,,,,,,,
Q13217,DNAJC3,"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)",33,57.3,30.49,31.15,31.2,30.98,31.67,32.19,31.3,31.04,32.09,32.19,31.15,31.11,32.14,31.44,-0.94,-0.29,-0.24,-0.46,0.23,0.75,-0.14,-0.39,0.65,0.75,-0.29,-0.32,0.7,biological regulation;cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;regulation of protein modification process;response to biotic stimulus;response to stimulus;response to stress,cell part,,,,,,,,,,
Q9H3Z4,DNAJC5,DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP),9,72.7,27.77,28.75,29.2,26.45,,28.67,28.21,28.41,28.69,28.88,28.45,23.75,28.24,27.96,-0.19,0.8,1.24,-1.51, ,0.72,0.26,0.46,0.73,0.93,0.49,-4.2,0.28,biological regulation;cell death;cellular process;death;establishment of localization;neurotransmitter transport;secretion;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q99615,DNAJC7,DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2),11,38.6,26.13,26.24,27.83,29.08,28.68,27.17,28.36,28.46,26.76,26.3,28.65,27.22,26.61,27.5,-1.37,-1.26,0.33,1.58,1.18,-0.33,0.86,0.96,-0.74,-1.2,1.15,-0.28,-0.89,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75937,DNAJC8,DnaJ homolog subfamily C member 8 (Splicing protein spf31),7,30,28.91,29.23,29.07,28.83,28.93,28.98,29.41,28.67,29.48,28.33,27.03,28.05,27.73,28.66,0.25,0.56,0.4,0.16,0.27,0.31,0.74,0,0.81,-0.33,-1.64,-0.61,-0.93,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;nucleoplasm,,,,,,,,,,
Q8WXX5,DNAJC9,DnaJ homolog subfamily C member 9 (DnaJ protein SB73),6,22.3,27.88,27.56,27.02,28.73,28.79,28.1,28.98,29.23,26.63,25.33,25.53,27.79,26.41,27.54,0.35,0.02,-0.51,1.19,1.25,0.56,1.44,1.69,-0.91,-2.21,-2,0.25,-1.12,behavior;behavioral interaction between organisms;multi-organism process;response to stimulus,,,,,,,,,,,
O00429,DNM1L,Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),35,56.4,31.41,31.06,30.56,31.51,30.72,30.14,31.79,31.59,29.73,30.08,31.07,31.38,30.39,30.88,0.53,0.18,-0.32,0.63,-0.16,-0.74,0.91,0.72,-1.15,-0.8,0.19,0.5,-0.48,anatomical structure morphogenesis;biological regulation;catabolic process;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;macromolecular complex assembly;membrane organization;metabolic process;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle fission;organelle organization;primary metabolic process;protein complex assembly;protein polymerization;regulation of organelle organization;regulation of transport;small molecule metabolic process,cell part;cytosol;endomembrane system;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microbody;organelle;peroxisome;protein complex,,,,,,,,,,
P50570,DNM2,Dynamin-2 (EC 3.6.5.5),37,46.6,32.31,31.89,32.36,31.66,31.07,30.99,31.94,32.09,30.63,31.1,32.38,32.72,30.82,31.69,0.62,0.2,0.68,-0.03,-0.62,-0.7,0.25,0.4,-1.06,-0.59,0.69,1.03,-0.87,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;establishment of localization;Golgi vesicle transport;immune system process;ion transport;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;nitrogen compound metabolic process;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;membrane;midbody;plasma membrane;protein complex,,,,,,,,,,
Q6XZF7,DNMBP,Dynamin-binding protein (Scaffold protein Tuba),8,6.2,,24.67,21.47,26.76,24.84,25.34,26.06,25.11,25.29,24.52,25.33,28.54,26.79,25.39, ,-0.73,-3.92,1.36,-0.55,-0.06,0.67,-0.28,-0.1,-0.88,-0.06,3.15,1.39,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle;synapse,,,,,,,,,,
P26358,DNMT1,DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT),21,15.5,30.53,27.12,29.21,28.07,28.67,27.94,28.5,28.47,26.91,27.65,25.62,28.29,26.83,27.99,2.55,-0.87,1.22,0.08,0.68,-0.05,0.52,0.49,-1.07,-0.33,-2.37,0.3,-1.16,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;gene silencing;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q9ULA0,DNPEP,Aspartyl aminopeptidase (EC 3.4.11.21),16,37.5,31.06,30.1,30.32,29.02,28.72,27.89,28.53,28.83,26.98,28.65,29.27,28.4,27.39,28.86,2.2,1.25,1.46,0.16,-0.14,-0.97,-0.33,-0.03,-1.88,-0.21,0.41,-0.46,-1.47,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm,,,,,,,,,,
O43598,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein RCL),5,34.5,27.85,28.1,27.5,28.12,27.24,26.15,27.15,27,26.99,24.93,27.73,27.83,25.71,27.1,0.75,1,0.4,1.02,0.14,-0.95,0.05,-0.1,-0.11,-2.17,0.63,0.73,-1.39,biological regulation;catabolic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q5QJE6,DNTTIP2,Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2),8,13.1,27.29,24.93,27.73,27.88,28.18,27.58,28.18,26.58,27.69,29.01,26.11,27.62,27.8,27.43,-0.14,-2.5,0.31,0.45,0.75,0.15,0.75,-0.85,0.26,1.58,-1.32,0.19,0.37,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8N1I0,DOCK4,Dedicator of cytokinesis protein 4,5,6.7,,25.56,26.5,,,26.87,26.33,25.85,,26.38,28.57,23.22,27.7,26.33, ,-0.77,0.16, , ,0.54,0,-0.48, ,0.05,2.24,-3.11,1.36,biological regulation;cell motility;cellular component movement;cellular process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cell projection;cytosol;endomembrane system;membrane;microvillus,,,,,,,,,,
Q9H7D0,DOCK5,Dedicator of cytokinesis protein 5,11,8.3,24.71,24.24,,25.77,,22.2,25.13,,,20.96,27.42,27.75,26.54,24.97,-0.25,-0.73, ,0.8, ,-2.77,0.16, , ,-4.01,2.45,2.78,1.57,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm,,,,,,,,,,
Q96HP0,DOCK6,Dedicator of cytokinesis protein 6,15,9.7,27.14,,,25.8,27.74,24.84,25.21,26.29,28.38,27.02,26.5,,26.77,26.57,0.57, , ,-0.77,1.17,-1.73,-1.36,-0.28,1.81,0.45,-0.07, ,0.2,biological regulation;cellular process;coagulation;multicellular organismal process;regulation of body fluid levels;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q96N67,DOCK7,Dedicator of cytokinesis protein 7,42,24,29.55,29.27,28.64,30.65,29.1,28.68,29.61,29.15,28.49,29.8,28.62,30.34,28.77,29.28,0.27,-0.01,-0.64,1.37,-0.18,-0.6,0.33,-0.14,-0.79,0.52,-0.66,1.06,-0.51,anatomical structure morphogenesis;biological regulation;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment or maintenance of cell polarity;organelle organization;pigmentation;regulation of protein modification process;response to stimulus;signal transduction,basal part of cell;cell part;cell projection;neuron projection;site of polarized growth,,,,,,,,,,
Q9BU89,DOHH,Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1),4,20.2,25.61,26.9,25.26,27.75,25.14,24.57,26.74,25.22,24.25,,25.91,26,,25.76,-0.15,1.14,-0.49,1.99,-0.62,-1.19,0.98,-0.54,-1.51, ,0.15,0.24, ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q92785,DPF2,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",13,30.2,28.6,27.18,27.06,26.9,27.95,28.51,27.87,27.21,27.97,27.62,27.17,29.22,28.78,27.85,0.75,-0.67,-0.79,-0.95,0.1,0.66,0.02,-0.64,0.12,-0.23,-0.68,1.37,0.93,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,C2H2-type,,,,,,,,,
O60762,DPM1,Dolichol-phosphate mannosyltransferase (EC 2.4.1.83) (Dolichol-phosphate mannose synthase) (DPM synthase) (Dolichyl-phosphate beta-D-mannosyltransferase) (Mannose-P-dolichol synthase) (MPD synthase),17,56.2,29.36,30.7,30.22,30.33,30.66,30.63,30.19,30.37,30.78,30.65,30.44,30,30.99,30.41,-1.05,0.29,-0.19,-0.08,0.25,0.22,-0.22,-0.04,0.37,0.24,0.03,-0.41,0.58,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein lipidation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;macromolecular complex;mannosyltransferase complex;membrane;protein complex,,,,,,,,,,
Q9NY33,DPP3,Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III),24,49.4,32.1,31.02,30.43,30.57,29.65,29.4,30.66,30.7,29.18,29.14,31.16,30.73,28.66,30.26,1.84,0.76,0.17,0.31,-0.61,-0.86,0.4,0.44,-1.08,-1.12,0.9,0.47,-1.6,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P27487,DPP4,Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form);Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)],35,39,26.28,31.43,33.58,29,30.18,29.7,30.03,29.61,31.43,31.86,31.15,30.44,29.67,30.33,-4.06,1.09,3.25,-1.33,-0.16,-0.64,-0.3,-0.73,1.1,1.52,0.82,0.1,-0.67,biological adhesion;biological regulation;cell activation;cell adhesion;cell motility;cellular component movement;cellular process;immune system process;locomotion;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to chemical stimulus;response to stimulus;response to stress,cell part;cell projection;cell surface;cytoplasmic membrane-bounded vesicle;extracellular organelle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9UHL4,DPP7,Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase),15,36.4,28.4,31.58,30.84,26.9,28.1,28.37,26.79,27.44,27.46,28,29.33,27.91,28.59,28.44,-0.04,3.14,2.4,-1.54,-0.34,-0.07,-1.65,-1,-0.98,-0.44,0.89,-0.53,0.15,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasmic membrane-bounded vesicle;cytosol;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole;vesicle,,,,,,,,,,
Q2PZI1,DPY19L1,Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1),3,7.6,,28.6,26.07,28.67,27.91,26.58,28.91,27.81,29.28,26.48,27.52,27.44,28.42,27.81, ,0.79,-1.74,0.87,0.11,-1.23,1.11,0,1.48,-1.32,-0.29,-0.37,0.61,,cell part,,,,,,,,,,
Q9C005,DPY30,Protein dpy-30 homolog (Dpy-30-like protein) (Dpy-30L),9,89.9,31.38,30,29.69,30.1,31.12,30.84,30.4,30.49,30.61,30.36,29.65,30.54,30.65,30.45,0.93,-0.45,-0.76,-0.35,0.67,0.39,-0.05,0.04,0.16,-0.09,-0.8,0.1,0.2,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;endosome transport;establishment of localization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;RNA metabolic process;small molecule metabolic process;transport;vesicle-mediated transport,cell part;chromatin remodeling complex;Golgi apparatus;histone methyltransferase complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q16555,DPYSL2,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),26,53.2,26.9,33.26,32.04,33.3,32.25,32,32.8,33.06,31.19,29.65,33.29,33.08,31.4,31.86,-4.96,1.39,0.18,1.44,0.39,0.13,0.93,1.19,-0.67,-2.21,1.43,1.21,-0.46,anatomical structure development;biological regulation;catabolic process;cellular aromatic compound metabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;developmental process;establishment of localization;heterocycle metabolic process;locomotion;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;organelle organization;primary metabolic process;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to stimulus;signal transduction;small molecule metabolic process;transport;vesicle-mediated transport,cell body;cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;neuron projection;neuronal cell body;organelle;protein complex;site of polarized growth,,,,,,,,,,
Q14195,DPYSL3,Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1),47,74.7,32.88,32.68,32.97,32.5,34.8,34.05,35.3,34.5,33.52,28.94,34.83,32.96,33.37,33.33,-0.45,-0.66,-0.36,-0.83,1.47,0.72,1.97,1.16,0.19,-4.39,1.5,-0.37,0.04,biological regulation;catabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;heterocycle metabolic process;locomotion;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;organelle organization;primary metabolic process;protein complex assembly;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;small molecule metabolic process,cell body;cell part;cell projection;cytosol;extracellular space;macromolecular complex;protein complex;site of polarized growth,,,,,,,,,,
Q14919,DRAP1,Dr1-associated corepressor (Dr1-associated protein 1) (Negative co-factor 2-alpha) (NC2-alpha),3,22.2,27.68,27.45,27.25,27.85,26.93,28.21,28.03,28.65,27.96,26.33,27.15,29.01,27.62,27.7,-0.02,-0.26,-0.45,0.15,-0.77,0.51,0.32,0.95,0.26,-1.37,-0.55,1.31,-0.08,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q9Y295,DRG1,Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3),11,36.8,30.49,29.79,30.08,30.31,29.58,29.28,29.93,30.65,29.16,29.24,30.38,30.28,29.87,29.93,0.56,-0.13,0.15,0.39,-0.35,-0.65,0,0.73,-0.77,-0.69,0.46,0.35,-0.05,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;polysome;ribonucleoprotein complex,,,,,,,,,,
P55039,DRG2,Developmentally-regulated GTP-binding protein 2 (DRG-2),5,17.8,24.94,26.02,26.23,26.84,26.58,26.55,27.65,27.16,24.91,25.94,25.83,27.29,,26.33,-1.39,-0.3,-0.1,0.51,0.25,0.22,1.32,0.83,-1.41,-0.39,-0.5,0.96, ,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q02487,DSC2,Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III),7,10.5,28.93,25.84,27.83,25.2,25.42,24.56,22.56,,23.11,27.17,24.04,24.06,,25.34,3.59,0.5,2.49,-0.14,0.09,-0.78,-2.78, ,-2.23,1.83,-1.29,-1.28, ,biological adhesion;cell adhesion;cellular process,cell part;membrane;plasma membrane,,,,,,,,,,
O14972,DSCR3,Down syndrome critical region protein 3 (Down syndrome critical region protein A),3,17.3,25.27,27.17,26.14,27.49,25.77,25.64,27.4,26.6,24.09,25.16,27.4,27.07,25.68,26.22,-0.95,0.95,-0.08,1.27,-0.45,-0.58,1.18,0.38,-2.13,-1.06,1.18,0.85,-0.54,establishment of localization;transport;vacuolar transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;retromer complex,,,,,,,,,,
Q14126,DSG2,Desmoglein-2 (Cadherin family member 5) (HDGC),39,40.3,32.82,29.91,31.89,30.51,31.68,30.97,31.17,31.13,31.51,31.9,31.28,32.1,31.09,31.38,1.44,-1.47,0.51,-0.87,0.3,-0.42,-0.22,-0.25,0.13,0.52,-0.1,0.72,-0.29,biological adhesion;cell adhesion;cellular component disassembly;cellular component organization;cellular process,cell part;membrane;plasma membrane,,,,,,,,,,
P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),174,60.7,35.71,31.71,34.12,30.35,31.41,30.37,31.91,32.21,30.97,33.4,32.1,29.49,30.94,31.9,3.81,-0.19,2.22,-1.55,-0.48,-1.53,0.01,0.31,-0.93,1.5,0.2,-2.41,-0.96,anatomical structure development;anatomical structure morphogenesis;biological adhesion;cell adhesion;cell differentiation;cell junction organization;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;localization;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;plasma membrane;protein complex,,,,,,,,,,
Q03001,DST,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),36,5.8,,,23.74,,,23.38,23.86,24.41,27.78,,28.57,,,25.29, , ,-1.55, , ,-1.91,-1.43,-0.88,2.49, ,3.28, , ,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell motility;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;establishment or maintenance of cell polarity;extracellular matrix organization;extracellular structure organization;locomotion;organelle organization;regulation of cell cycle;regulation of organelle organization;response to stimulus;response to stress;signal transduction;transport,cell cortex;cell leading edge;cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;nuclear envelope;nucleus;organelle;protein complex;vesicle,,,,,,,,,,
P60981,DSTN,Destrin (Actin-depolymerizing factor) (ADF),12,51.5,31.99,31.07,31.9,32.25,30.21,30.41,31.59,30.96,30.54,29.91,30.61,31.81,29.52,30.98,1.01,0.09,0.92,1.26,-0.78,-0.57,0.6,-0.02,-0.44,-1.07,-0.38,0.83,-1.46,biological regulation;cellular component disassembly;cellular component movement;cellular component organization;cellular process;cytokinesis;cytoskeleton organization;organelle organization;protein depolymerization;regulation of organelle organization,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q8TEA8,DTD1,D-tyrosyl-tRNA(Tyr) deacylase 1 (EC 3.1.-.-) (Histidyl-tRNA synthase-related),6,41.1,26.86,25.7,27.16,26.85,26.22,26.95,27.77,27.32,27.07,25.34,30.1,27.27,26.34,26.99,-0.14,-1.3,0.17,-0.15,-0.78,-0.04,0.78,0.32,0.07,-1.65,3.1,0.27,-0.66,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8TDB6,DTX3L,E3 ubiquitin-protein ligase DTX3L (EC 6.3.2.-) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (Rhysin-2) (Rhysin2),20,28.5,29.44,28.37,30.35,28.89,27.2,26.91,27.61,28.86,,27.58,27.25,28.65,,28.28,1.15,0.09,2.06,0.61,-1.08,-1.37,-0.68,0.58, ,-0.71,-1.03,0.37, ,cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA repair;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P23919,DTYMK,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),16,62.7,27.5,29.81,28.92,30.17,29.91,29.28,29.76,28.61,29.04,28.99,29.71,29.14,28.72,29.2,-1.7,0.61,-0.28,0.98,0.72,0.08,0.56,-0.58,-0.15,-0.21,0.52,-0.05,-0.48,biosynthetic process;cell cycle;cell differentiation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9UNI6,DUSP12,Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity tyrosine phosphatase YVH1),2,9.1,25.79,24.79,25.13,25.65,24.58,24.59,25.83,26.19,,23.61,,25.81,,25.2,0.59,-0.41,-0.06,0.45,-0.62,-0.61,0.63,0.99, ,-1.58, ,0.61, ,biological regulation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,+,,,,,,,
Q9BVJ7,DUSP23,Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3) (VH1-like phosphatase Z),9,68,30.06,27.99,28.22,29.13,26.73,26.94,28.11,27.59,26.04,25.36,28.95,27.34,26.54,27.62,2.44,0.37,0.6,1.52,-0.89,-0.68,0.5,-0.03,-1.57,-2.26,1.34,-0.27,-1.07,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P51452,DUSP3,Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR),7,44.9,28.58,29.09,30.21,29.58,29.48,28.06,29.11,29.93,28.27,28.03,29.83,29.84,27.74,29.06,-0.47,0.03,1.15,0.52,0.42,-1,0.05,0.87,-0.78,-1.03,0.77,0.78,-1.32,biological regulation;cellular process;immune system process;regulation of cell cycle;regulation of mitotic cell cycle;response to stimulus;response to stress;signal transduction,cell part;cytosol;nucleoplasm,,,+,,,,,,,
P33316,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase)",8,59.1,27.84,27.91,27.64,28.66,28.73,27.83,28.28,28.24,27.88,27.02,,27.9,26.96,27.91,-0.07,0,-0.27,0.76,0.82,-0.08,0.37,0.33,-0.03,-0.89, ,-0.01,-0.95,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleoplasm;organelle,,,,,,,,,,
Q14204,DYNC1H1,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",236,52,34.58,34.85,34.34,35.01,34.11,34.44,35.14,34.91,34.41,34.56,35.44,35.12,34.76,34.74,-0.17,0.1,-0.4,0.27,-0.63,-0.3,0.4,0.17,-0.33,-0.19,0.69,0.38,0.01,cell death;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular process;cytoskeleton organization;death;establishment of localization;immune system process;macromolecular complex assembly;organelle organization;ribonucleoprotein complex assembly;transport,cell part;centrosome;cytosol;extracellular organelle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex;vesicle,,,,,,,,,,
Q13409,DYNC1I2,"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)",18,42.2,29.9,29.85,30.23,30.35,30.2,29.12,30.52,31.24,29.41,30.01,31.01,31.96,29.46,30.25,-0.35,-0.4,-0.02,0.1,-0.05,-1.13,0.27,0.99,-0.84,-0.24,0.76,1.71,-0.79,cellular component movement;cellular process;establishment of localization;immune system process;interspecies interaction between organisms;multi-organism process;transport,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex;vesicle,,,,,,,,,,
Q9Y6G9,DYNC1LI1,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",15,34.6,28.63,29.51,29.93,30.01,28.22,28.94,29.58,29.16,29.1,29.34,29.78,30.69,28.78,29.36,-0.73,0.15,0.57,0.65,-1.14,-0.42,0.22,-0.2,-0.26,-0.02,0.42,1.33,-0.57,biological regulation;cell division;cellular component organization;cellular process;establishment of localization;interspecies interaction between organisms;mitosis;multi-organism process;nuclear division;organelle fission;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle;transport,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;microtubule organizing center;organelle;plasma membrane;protein complex,,,,,,,,,,
O43237,DYNC1LI2,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)",8,20.9,28.68,28.9,28.2,29.26,29.1,28.03,29.35,29.46,27.67,27,29.96,30.1,27.82,28.73,-0.05,0.17,-0.54,0.53,0.37,-0.7,0.62,0.73,-1.06,-1.73,1.23,1.37,-0.91,cellular component organization;cellular localization;cellular process;cytoskeleton organization;establishment of localization;immune system process;localization;organelle localization;organelle organization;transport,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P63167,DYNLL1,"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (DLC8) (Dynein light chain LC8-type 1) (Protein inhibitor of neuronal nitric oxide synthase) (PIN)",6,59.6,31.24,30.92,31,31.03,30.95,30.35,31.18,31.11,30.94,30.93,30.91,30.82,29.09,30.81,0.43,0.11,0.2,0.23,0.14,-0.45,0.37,0.3,0.13,0.12,0.11,0.02,-1.72,anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;developmental process;establishment of localization;immune system process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process;transport,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;microtubule organizing center;mitochondrion;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q96FJ2,DYNLL2,"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b) (DLC8b) (Dynein light chain LC8-type 2)",3,33.7,28.07,28.06,28.79,27.28,27.11,27.72,26.79,27.91,25.55,27.91,27.94,26.1,27.43,27.43,0.64,0.62,1.35,-0.15,-0.32,0.28,-0.64,0.48,-1.89,0.47,0.51,-1.33,-0.01,cell recognition;cellular process;establishment of localization;immune system process;transport,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9NP97,DYNLRB1,"Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)",7,76,30.1,29.73,29.98,29.9,29.85,29.73,29.71,30.26,28.84,29.29,30.43,30.33,30.25,29.88,0.23,-0.15,0.1,0.02,-0.03,-0.15,-0.17,0.39,-1.04,-0.59,0.55,0.45,0.38,behavior;cellular component movement;cellular process;establishment of localization;multicellular organismal process;response to abiotic stimulus;response to stimulus;transport,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P63172,DYNLT1,Dynein light chain Tctex-type 1 (Protein CW-1) (T-complex testis-specific protein 1 homolog),4,58.4,29.67,29.17,28.6,29.94,29,29.1,29.65,28.83,28.93,28.97,27.61,28.85,28.23,28.96,0.71,0.21,-0.37,0.97,0.04,0.13,0.68,-0.13,-0.04,0,-1.36,-0.11,-0.74,anatomical structure morphogenesis;biological regulation;cell division;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment of localization;interspecies interaction between organisms;locomotion;mitosis;multi-organism process;nuclear division;organelle fission;organelle organization;protein transport;regulation of organelle organization;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
O75923,DYSF,Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1),27,21.3,,19.25,25.36,,24.2,25.21,,27.26,31.75,,25.7,24,27.86,25.62, ,-6.37,-0.26, ,-1.42,-0.41, ,1.64,6.13, ,0.08,-1.62,2.24,cellular component organization;cellular membrane organization;cellular process;membrane fusion;membrane organization;organelle fusion;organelle organization;plasma membrane organization;vesicle organization,cell part;cell projection;membrane;plasma membrane,,,,,,,,,,
Q5JPH6,EARS2,"Probable glutamate--tRNA ligase, mitochondrial (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS)",6,17.4,27.45,28.18,25.57,28.37,28.88,27.99,27.73,27.96,28.4,26.8,27.73,27.3,26.94,27.64,-0.19,0.54,-2.06,0.73,1.24,0.36,0.09,0.32,0.76,-0.84,0.1,-0.34,-0.7,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q99848,EBNA1BP2,Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40),12,37.9,29.61,28.89,27.42,29.21,29.88,29.44,29.08,28.63,29.43,29.41,28.76,28.6,29.09,29.04,0.58,-0.15,-1.62,0.18,0.84,0.41,0.04,-0.4,0.4,0.37,-0.28,-0.43,0.06,cellular process;ribosome biogenesis,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q15125,EBP,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein)",3,16.5,29.08,30.56,28.7,30.29,30.5,31.21,31.09,30.91,31.53,31.63,29.57,30.99,30.41,30.5,-1.42,0.06,-1.8,-0.21,0,0.71,0.59,0.42,1.03,1.14,-0.93,0.49,-0.09,alcohol metabolic process;anatomical structure development;biosynthetic process;developmental process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P42892,ECE1,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),19,35,31.35,25.93,29.57,29.35,30.04,30.65,30.2,29.62,30.7,31.91,29.89,28.27,29.81,29.79,1.56,-3.86,-0.22,-0.44,0.24,0.86,0.41,-0.17,0.9,2.12,0.09,-1.52,0.02,anatomical structure development;anatomical structure morphogenesis;biological regulation;catabolic process;cellular metabolic process;cellular process;developmental process;endocrine process;hormone metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q13011,ECH1,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-)",17,50.6,31.8,29.78,32.03,30.77,29.82,31.24,30.44,29.9,30.7,31.5,30.19,29.94,29.98,30.62,1.18,-0.84,1.41,0.14,-0.8,0.62,-0.18,-0.73,0.08,0.88,-0.43,-0.68,-0.64,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;microbody;mitochondrion;organelle;peroxisome,,,,,,,,,,
Q9NTX5,ECHDC1,Ethylmalonyl-CoA decarboxylase (EC 4.1.1.94) (Enoyl-CoA hydratase domain-containing protein 1) (Methylmalonyl-CoA decarboxylase) (MMCD) (EC 4.1.1.41),9,39.8,27.8,29.22,28.84,29.18,27.64,29.64,29.26,28.62,27.76,29.25,29.76,28.85,29.14,28.84,-1.04,0.38,0,0.34,-1.2,0.79,0.42,-0.23,-1.08,0.41,0.91,0.01,0.3,,cell part;cytosol,,,,,,,,,,
P30084,ECHS1,"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)",16,53.8,32.44,32.52,32.51,32.14,31.95,33.02,32.13,32.68,32.72,34.09,32.38,31.24,32.9,32.52,-0.07,0.01,-0.01,-0.37,-0.57,0.51,-0.39,0.16,0.2,1.58,-0.14,-1.28,0.38,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P42126,ECI1,"Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)",11,38.2,31.89,31.59,31.68,29.98,30.47,30.9,30.35,30.6,30.17,32.13,31.2,30.18,31.26,30.95,0.94,0.63,0.72,-0.97,-0.49,-0.06,-0.6,-0.35,-0.79,1.18,0.24,-0.77,0.31,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
O75521,ECI2,"Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)",15,50.4,29.13,29.77,28.73,29.82,29.54,30.23,28.76,29.65,30.43,30.08,30.01,30.65,30.03,29.76,-0.62,0.02,-1.03,0.06,-0.22,0.47,-0.99,-0.11,0.67,0.32,0.25,0.89,0.28,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q5VYK3,ECM29,Proteasome-associated protein ECM29 homolog (Ecm29),35,24.2,28.15,31.18,29.91,32.06,30.94,30.09,31.19,30.88,29.87,29.94,30.25,32.3,29.45,30.48,-2.33,0.7,-0.57,1.59,0.46,-0.39,0.71,0.4,-0.61,-0.54,-0.23,1.83,-1.02,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;centrosome;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;proteasome complex;protein complex;vesicle,,,,,,,,,,
Q9BQ95,ECSIT,"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)",3,12.1,25.18,23.73,24.56,25.48,26.01,27.08,26.36,26.52,,26.7,26.8,27.67,27.28,26.12,-0.93,-2.39,-1.55,-0.63,-0.11,0.97,0.25,0.4, ,0.59,0.69,1.56,1.16,anatomical structure formation involved in morphogenesis;biological regulation;cellular process;developmental process;immune system process;response to stimulus;response to stress;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex;transcription factor complex,,,,,,,,,,
Q9H8V3,ECT2,Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene),3,14.8,26.82,26.41,26.04,23.52,25.6,25.6,26.36,25.85,23.5,23.75,24.99,,,25.31,1.51,1.1,0.73,-1.79,0.29,0.29,1.05,0.53,-1.81,-1.57,-0.32, , ,anatomical structure morphogenesis;biological regulation;cell junction organization;cell morphogenesis;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;cytokinesis;developmental process;establishment of localization;macromolecular complex assembly;protein complex assembly;protein transport;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;midbody;nucleus;organelle;protein complex,,,,,,,,,,
Q96F86,EDC3,Enhancer of mRNA-decapping protein 3 (LSM16 homolog) (YjeF N-terminal domain-containing protein 2) (YjeF_N2) (hYjeF_N2) (YjeF domain-containing protein 1),4,9.6,25,25.57,25.42,26.38,25.57,25.45,25.76,25.96,24.86,23.71,24.45,25.58,24.15,25.22,-0.22,0.35,0.2,1.16,0.35,0.23,0.54,0.74,-0.36,-1.51,-0.77,0.36,-1.07,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex,,,,,,,,,,
Q6P2E9,EDC4,Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls),18,18.8,29.64,29.18,27.15,29.69,29.51,28.45,28.91,28.93,28.38,28.15,27.57,28.57,28.33,28.65,0.99,0.53,-1.5,1.03,0.86,-0.2,0.26,0.28,-0.28,-0.5,-1.08,-0.08,-0.33,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q9BZQ6,EDEM3,"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)",11,14.4,28.93,27.31,25.22,28.33,28.2,28.32,26.94,25.76,28.84,27.35,27.02,27.72,28.69,27.59,1.34,-0.28,-2.37,0.74,0.62,0.73,-0.64,-1.83,1.26,-0.24,-0.57,0.14,1.1,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;membrane,,,,,,,,,,
O60869,EDF1,Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1),7,41,29.64,28.32,29.62,29.78,28.52,28.85,30.25,29.8,28.15,29.64,29.38,28.63,28.14,29.13,0.51,-0.81,0.48,0.65,-0.61,-0.28,1.11,0.67,-0.99,0.51,0.25,-0.5,-0.99,biological regulation;biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,Other TF domain,,,,,,,,,
Q15075,EEA1,Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2),69,49.6,31.81,32.23,31.74,31.99,31.76,32.63,31.83,31.74,32.62,31.82,32.05,32.02,32.15,32.03,-0.22,0.2,-0.29,-0.04,-0.27,0.59,-0.2,-0.29,0.59,-0.21,0.02,-0.01,0.12,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane fusion;membrane organization;organelle fusion;organelle organization;transport;vesicle organization;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,C2H2-type,,,,,,,,,
Q6IPT9,EEF1A1,Elongation factor 1-alpha,44,78.4,36.9,36.27,35.99,36.8,35.95,35.28,36.43,36.58,35.4,35.77,36.22,36.29,35.5,36.11,0.8,0.16,-0.12,0.69,-0.15,-0.83,0.33,0.48,-0.71,-0.34,0.12,0.18,-0.6,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
P24534,EEF1B2,Elongation factor 1-beta (EF-1-beta),17,80.4,31.35,31.35,31.17,30.84,31.52,30.82,31.26,31.25,30.99,31.25,31.02,29.62,31.31,31.06,0.29,0.29,0.11,-0.22,0.46,-0.24,0.2,0.19,-0.06,0.2,-0.04,-1.44,0.25,,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P29692,EEF1D,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),37,88.3,33.95,33.58,33.65,34.14,33.95,33.43,33.97,33.94,33.48,33.35,34.2,32.95,33.85,33.73,0.23,-0.15,-0.08,0.41,0.22,-0.29,0.24,0.22,-0.25,-0.38,0.48,-0.78,0.12,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;translational elongation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,Other TF domain,,,,,,,,,
O43324,EEF1E1,Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18),8,54,30.56,29.88,30.29,29.63,30.49,30.4,30.53,30.65,29.74,30.27,30.75,30.78,29.51,30.27,0.29,-0.39,0.02,-0.64,0.22,0.13,0.26,0.38,-0.53,0.01,0.48,0.52,-0.76,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P26641,EEF1G,Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma),42,60,34.11,34.13,34.03,34.07,34.27,34.13,34.22,34.53,33.38,33.31,34.42,33.5,34.2,34.02,0.09,0.1,0.01,0.05,0.25,0.1,0.19,0.5,-0.64,-0.71,0.4,-0.53,0.18,multi-organism process;response to biotic stimulus;response to stimulus,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P13639,EEF2,Elongation factor 2 (EF-2),87,78.2,35.72,35.28,34.94,36.27,35.41,34.63,35.99,36.07,34.34,34.74,35.75,35.54,34.06,35.29,0.43,0,-0.35,0.98,0.12,-0.65,0.71,0.79,-0.95,-0.55,0.46,0.25,-1.23,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;translational elongation,cell part;cytosol;macromolecular complex;polysome;ribonucleoprotein complex,,,,,,,,,,
P57772,EEFSEC,"Selenocysteine-specific elongation factor (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific)",5,13.3,26.5,25.75,26.75,25.49,28.86,25.38,26.3,25.07,24.45,25.72,26.21,27.12,24.79,26.03,0.47,-0.28,0.72,-0.54,2.83,-0.65,0.27,-0.96,-1.58,-0.31,0.18,1.09,-1.24,biological regulation;biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;regulation of translation;translational elongation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q12805,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1 (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3) (FIBL-3),9,24.3,23.96,30.01,27.13,29.64,27.12,28.88,27.41,26.34,29.87,24.25,26.04,26.2,26.9,27.21,-3.25,2.79,-0.09,2.43,-0.09,1.66,0.19,-0.87,2.66,-2.96,-1.17,-1.01,-0.31,biological regulation;cellular component organization;cellular metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,extracellular matrix;extracellular space;proteinaceous extracellular matrix,,,,,,,,,,
Q9BUP0,EFHD1,EF-hand domain-containing protein D1 (EF-hand domain-containing protein 1) (Swiprosin-2),7,36,28.22,25.91,27.3,26.43,23.77,,23.01,,,,21.42,,,25.15,3.07,0.76,2.15,1.28,-1.38, ,-2.14, , , ,-3.73, , ,cellular component organization;cellular process,cell part;membrane,,,,,,,,,,
Q96C19,EFHD2,EF-hand domain-containing protein D2 (Swiprosin-1),17,52.5,30.8,31.04,31.2,30.19,30.74,29.43,31.2,31.29,31.13,31.29,30.68,29.75,29.26,30.61,0.18,0.42,0.58,-0.42,0.13,-1.18,0.59,0.68,0.51,0.67,0.06,-0.87,-1.36,,cell part,,,,,,,,,,
P98172,EFNB1,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2),4,17.1,,26.92,26.4,27.31,27,27.63,27.74,27.62,28.64,,,25.85,,27.24, ,-0.31,-0.84,0.08,-0.24,0.39,0.51,0.38,1.41, , ,-1.38, ,biological adhesion;biological regulation;cell adhesion;cell communication;cell motility;cell-cell signaling;cellular component movement;cellular process;developmental process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signaling,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;synapse,,,,,,,,,,
P52799,EFNB2,Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L),3,12.9,,,,25.56,25.85,25.25,26.77,25.85,27.41,24.47,,26.54,25.81,25.95, , , ,-0.39,-0.09,-0.7,0.82,-0.09,1.46,-1.48, ,0.59,-0.14,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell communication;cell differentiation;cell motility;cell-cell signaling;cellular component movement;cellular process;developmental process;interspecies interaction between organisms;locomotion;multi-organism process;response to stimulus;signal transduction;signaling,cell part,,,,,,,,,,
Q14156,EFR3A,Protein EFR3 homolog A (Protein EFR3-like),5,7.5,25.8,26.33,24.86,,,25.28,25.51,,25.65,26.92,,26.67,25.88,25.88,-0.08,0.46,-1.02, , ,-0.6,-0.37, ,-0.22,1.04, ,0.79,0,,cell part;intracellular;membrane;plasma membrane,,,,,,,,,,
Q7Z2Z2,EFTUD1,Elongation factor Tu GTP-binding domain-containing protein 1 (Elongation factor-like 1) (Protein FAM42A),8,7.4,25.34,27.83,27.65,26.99,27.02,23.74,28.38,27.8,26.61,26.61,28.06,29.38,24.88,26.95,-1.6,0.88,0.7,0.05,0.07,-3.2,1.43,0.86,-0.33,-0.33,1.12,2.44,-2.07,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;organelle assembly;ribonucleoprotein complex assembly;ribosome assembly,,,,,,,,,,,
K7EJ81,EFTUD2,116 kDa U5 small nuclear ribonucleoprotein component,42,54.6,32.66,32.34,32.18,32.22,32.64,32.74,32.54,32.06,32.85,32.41,31.33,32.2,32.24,32.34,0.32,0,-0.16,-0.12,0.3,0.4,0.2,-0.28,0.52,0.07,-1.01,-0.14,-0.1,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
P00533,EGFR,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),20,20.2,28.55,30.09,27.6,28.85,29.41,30.3,29.56,28.22,30.19,28.03,31.32,27.95,30.88,29.3,-0.76,0.79,-1.7,-0.46,0.11,0.99,0.26,-1.09,0.88,-1.27,2.01,-1.36,1.58,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell motility;cell proliferation;cellular component movement;cellular localization;cellular metabolic process;cellular process;developmental process;immune system process;localization;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;molting cycle;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of DNA metabolic process;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoplasmic membrane-bounded vesicle;endosome;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex;vesicle,,+,,,,,,,,
Q8NDI1,EHBP1,EH domain-binding protein 1,6,8.4,25.14,22.19,,,25.62,25.73,25.44,25.88,24.2,25.9,25.61,26.22,24.79,25.16,-0.02,-2.97, , ,0.46,0.57,0.28,0.73,-0.95,0.74,0.45,1.07,-0.36,,cell part;cytoplasm;membrane,,,,,,,,,,
Q8N3D4,EHBP1L1,EH domain-binding protein 1-like protein 1,4,5.4,25.18,24.53,25.99,24.16,,24.53,24.69,,,25.19,25.77,24.75,24.7,24.95,0.23,-0.42,1.04,-0.79, ,-0.41,-0.25, , ,0.24,0.82,-0.2,-0.25,,,,,,,,,,,,
Q9H4M9,EHD1,EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin),32,67,30.98,31.85,31.16,31.97,31.75,30.54,32.04,32.28,30.89,31.26,31.89,32.52,31.1,31.56,-0.57,0.29,-0.4,0.42,0.19,-1.02,0.48,0.72,-0.67,-0.29,0.34,0.96,-0.46,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;endocytosis;endosome transport;establishment of localization;heterocycle metabolic process;homeostatic process;macromolecular complex assembly;membrane invagination;membrane organization;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;protein transport;regulation of body fluid levels;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9NZN4,EHD2,EH domain-containing protein 2 (PAST homolog 2),27,55.6,29.68,32.59,29.22,31.76,30.18,30.98,30.64,29.92,30.72,28.46,30.71,29.92,31.58,30.49,-0.81,2.1,-1.27,1.27,-0.31,0.49,0.15,-0.57,0.23,-2.03,0.22,-0.57,1.09,biological regulation;catabolic process;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;cytoskeleton organization;endocytosis;endosome transport;establishment of localization;heterocycle metabolic process;localization;membrane invagination;membrane organization;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;plasma membrane organization;primary metabolic process;regulation of body fluid levels;small molecule metabolic process;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9H223,EHD4,EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4),20,45.7,29.61,31.11,30.64,30.65,30.73,28.84,30.91,31.17,30.82,30.79,30.76,28.8,29.05,30.3,-0.69,0.81,0.34,0.36,0.43,-1.46,0.62,0.87,0.52,0.49,0.46,-1.5,-1.25,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;endocytosis;endosome transport;establishment of localization;heterocycle metabolic process;macromolecular complex assembly;membrane invagination;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;small molecule metabolic process;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9NZC4,EHF,ETS homologous factor (hEHF) (ETS domain-containing transcription factor) (Epithelium-specific Ets transcription factor 3) (ESE-3),4,21.7,27.6,,26.56,25.02,,,27.53,,27.86,27.96,25.63,,,26.88,0.72, ,-0.32,-1.86, , ,0.65, ,0.98,1.08,-1.25, , ,biological regulation;biosynthetic process;cell differentiation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q08426,EHHADH,"Peroxisomal bifunctional enzyme (PBE) (PBFE) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8);3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]",19,35.8,30.15,27.07,29.27,26.79,26.49,27.09,26.14,26.38,27.4,30.17,28.48,29.05,28.6,27.93,2.22,-0.86,1.34,-1.14,-1.44,-0.83,-1.79,-1.55,-0.52,2.24,0.55,1.12,0.67,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;organic acid metabolic process;primary metabolic process;protein acylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;microbody;mitochondrion;nucleus;organelle;peroxisome,,,,,,,,,,
O14681,EI24,Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein),4,10.6,26.95,26.53,26.98,26.51,26.27,27.48,26.8,26.33,27.27,28.16,26.97,26.86,27.24,26.95,0,-0.42,0.03,-0.44,-0.68,0.53,-0.15,-0.62,0.32,1.21,0.02,-0.09,0.3,autophagy;biological regulation;catabolic process;cell death;cellular metabolic process;cellular process;death;metabolic process;response to chemical stimulus;response to drug;response to stimulus,cell part;membrane,,,,,,,,,,
P41567,EIF1,Eukaryotic translation initiation factor 1 (eIF1) (A121) (Protein translation factor SUI1 homolog) (Sui1iso1),10,81.4,31.73,29.57,30.58,30.99,30.77,29.59,31.11,30.7,28.79,30.42,30.5,31.59,29.84,30.48,1.25,-0.9,0.1,0.51,0.29,-0.89,0.64,0.23,-1.68,-0.05,0.03,1.11,-0.63,biological regulation;regulation of translation;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
P47813,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal (eIF-1A X isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C)",8,63.2,28.96,28.35,29.54,29.07,30.32,27.97,29.29,29.27,28.16,28.69,26.49,28.41,27.79,28.64,0.32,-0.29,0.9,0.43,1.68,-0.66,0.65,0.63,-0.48,0.05,-2.15,-0.23,-0.85,cellular process;translational initiation,cell part;cytosol,,,,,,,,,,
Q9BY44,EIF2A,Eukaryotic translation initiation factor 2A (eIF-2A) (65 kDa eukaryotic translation initiation factor 2A),21,44.6,31.22,29.61,30.65,30.82,30.36,30.58,31.44,31.41,30.58,30.94,30.77,31.41,30.21,30.77,0.45,-1.16,-0.12,0.05,-0.41,-0.19,0.67,0.64,-0.19,0.18,0,0.64,-0.56,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;organelle assembly;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of translation;response to stimulus;ribonucleoprotein complex assembly;ribosome assembly;signal transduction,cell part;macromolecular complex;protein complex,,,,,,,,,,
P19525,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)",14,22.7,29.53,29.86,30.59,31.33,29.43,29.24,29.72,30.71,28.89,29.72,29.51,29.11,28.74,29.72,-0.19,0.14,0.87,1.61,-0.29,-0.48,0,0.99,-0.83,0,-0.22,-0.61,-0.98,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of translation;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;translation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q14232,EIF2B1,Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha),9,26.7,26.91,26.76,28.26,27.29,26.05,27.56,28.59,28.73,24.84,26.42,28.05,28.28,25.78,27.2,-0.28,-0.44,1.06,0.09,-1.14,0.37,1.4,1.53,-2.35,-0.77,0.86,1.08,-1.42,anatomical structure development;biological regulation;cell development;cellular process;developmental process;regulation of translation;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to heat;response to stimulus;response to stress;translational initiation,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9BPX4,EIF2B2,"Eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa",10,31.3,28.42,28.23,25.85,28.76,27.94,26.51,28.2,28.9,25.79,27.76,28.2,26.42,25.15,27.39,1.02,0.83,-1.54,1.36,0.55,-0.89,0.8,1.51,-1.6,0.37,0.81,-0.98,-2.24,,,,,,,,,,,,
Q9NR50,EIF2B3,Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma),8,26.2,27.91,27.83,26.71,28.28,26.42,25.18,27.7,27.76,25.54,26.32,27.26,25.67,26.22,26.83,1.08,1,-0.12,1.45,-0.41,-1.65,0.87,0.93,-1.29,-0.51,0.43,-1.16,-0.61,anatomical structure development;biological regulation;cell development;cellular process;developmental process;regulation of translation;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to heat;response to stimulus;response to stress;translational initiation,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q9UI10,EIF2B4,Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta),8,23.1,26.77,27.13,27.62,27.98,27.95,27.87,27.44,28.44,26.77,27.4,29.06,27.28,27.33,27.62,-0.85,-0.49,0.01,0.36,0.33,0.25,-0.18,0.82,-0.85,-0.22,1.45,-0.34,-0.29,anatomical structure development;biological regulation;cell development;cellular process;developmental process;regulation of translation;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to heat;response to stimulus;response to stress;rhythmic process;translational initiation,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q13144,EIF2B5,Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon),8,15.7,27.44,27.44,27.18,27.86,26.85,27.5,27.87,28.44,27.11,26.55,27.58,26.37,26.82,27.31,0.13,0.13,-0.13,0.55,-0.46,0.19,0.56,1.13,-0.19,-0.76,0.28,-0.94,-0.49,anatomical structure development;biological regulation;cell development;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to heat;response to stimulus;response to stress;rhythmic process;RNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P05198,EIF2S1,Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha),29,67.6,31.88,32.64,32.65,32.91,33.02,32.7,33.06,33.2,31.81,32.28,33.14,32.91,32.09,32.64,-0.76,0,0.01,0.28,0.39,0.06,0.42,0.56,-0.82,-0.36,0.5,0.27,-0.55,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of translation;response to stimulus;response to stress,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;polysome;protein complex;ribonucleoprotein complex,,,,,,,,,,
P20042,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta),36,71.2,31.53,31.78,32.75,32.29,31.07,30.8,31.62,31.14,30.5,31.22,31.82,32.82,31.15,31.58,-0.05,0.21,1.17,0.71,-0.51,-0.78,0.04,-0.44,-1.07,-0.36,0.25,1.25,-0.42,,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P41091,EIF2S3,Eukaryotic translation initiation factor 2 subunit 3 (Eukaryotic translation initiation factor 2 subunit gamma X) (eIF-2-gamma X) (eIF-2gX),24,54.7,32.03,32.49,32.42,32.92,32.99,32.34,33.05,32.89,32.07,32.31,32.58,32.22,32.43,32.52,-0.49,-0.03,-0.1,0.4,0.47,-0.18,0.53,0.37,-0.45,-0.2,0.06,-0.3,-0.09,,cell part;cytosol,,,,,,,,,,
Q14152,EIF3A,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185),79,55.4,33.43,32.75,32.92,33.25,33.51,32.94,33.65,33.42,33.06,32.88,33.33,33.3,33.03,33.19,0.24,-0.44,-0.27,0.06,0.32,-0.25,0.46,0.23,-0.13,-0.31,0.14,0.11,-0.16,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
P55884,EIF3B,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),45,61.2,32.4,31.81,32.21,32.46,32.48,31.65,32.45,32.75,31.7,31.66,32.26,32.45,32.03,32.18,0.22,-0.36,0.03,0.29,0.3,-0.53,0.27,0.57,-0.47,-0.52,0.09,0.27,-0.15,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly,cell part;cytosol;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q99613,EIF3C,Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110),44,46.9,32.49,31.82,32.47,32.3,32.15,32.04,32.78,32.1,31.81,32.32,32.5,32.73,31.97,32.27,0.22,-0.45,0.21,0.03,-0.12,-0.23,0.51,-0.17,-0.46,0.05,0.23,0.46,-0.3,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly;translational initiation,cell part;cytosol;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
O15371,EIF3D,Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66),27,43.7,31.21,31.04,30.74,31.47,31.84,31,31.74,31.73,30.76,31.09,31.69,30.99,30.94,31.25,-0.04,-0.21,-0.51,0.22,0.59,-0.25,0.49,0.48,-0.49,-0.16,0.44,-0.26,-0.31,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly;translational initiation,cell part;cytosol;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
P60228,EIF3E,Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48),25,48.5,32.17,31.43,31.23,32.31,32.05,31.28,32.14,32.18,31.32,31.19,31.74,31.28,30.97,31.64,0.53,-0.21,-0.41,0.67,0.41,-0.35,0.51,0.54,-0.31,-0.45,0.1,-0.36,-0.67,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ribonucleoprotein complex,,,,,,,,,,
O00303,EIF3F,Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47),18,62.2,31.68,31.31,31.25,32.01,32.29,31.34,32.06,32.24,31.33,30.47,31.24,32.41,31.31,31.61,0.07,-0.3,-0.36,0.4,0.68,-0.27,0.45,0.63,-0.28,-1.14,-0.37,0.8,-0.3,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;regulation of translation;ribonucleoprotein complex assembly,cell part;cytosol;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
O75821,EIF3G,Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44),15,50.9,30.71,30.46,30.76,30.9,30.83,30.17,30.59,30.46,30.23,30.21,30.74,31.7,30.32,30.62,0.09,-0.16,0.14,0.28,0.21,-0.45,-0.03,-0.16,-0.39,-0.41,0.12,1.08,-0.3,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly;translational initiation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q6IB98,EIF3H,Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3 gamma) (eIF3 p40 subunit),15,41.2,30.96,30.44,30.31,30.99,30.34,29.48,30.64,30.29,30,29.91,30.21,29.73,29.26,30.2,0.76,0.24,0.11,0.8,0.14,-0.71,0.45,0.09,-0.19,-0.28,0.01,-0.47,-0.94,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly,cell part;cytoplasm;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q13347,EIF3I,Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (TGF-beta receptor-interacting protein 1) (TRIP-1) (eIF-3-beta) (eIF3 p36),18,58.8,31.13,30.99,30.48,31.69,31.96,31.16,31.92,31.48,31.01,30.81,30.41,31.04,30.73,31.14,-0.01,-0.15,-0.65,0.56,0.82,0.02,0.78,0.34,-0.13,-0.33,-0.73,-0.1,-0.41,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly,cell part;cytosol;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
O75822,EIF3J,Eukaryotic translation initiation factor 3 subunit J (eIF3j) (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35),19,65.1,30.21,30.4,31.49,30.83,29.01,28.7,30.6,29.96,28.77,29.76,30.07,30.36,26.98,29.78,0.43,0.62,1.71,1.05,-0.77,-1.08,0.82,0.18,-1.01,-0.02,0.29,0.58,-2.79,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly;translational initiation,cell part;cytosol;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9UBQ5,EIF3K,Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28),9,58.6,31.19,30.79,31.04,30.59,30.96,29.51,30.06,29.92,30.15,30.26,30.14,30.78,30.15,30.43,0.76,0.36,0.61,0.17,0.54,-0.92,-0.37,-0.5,-0.28,-0.16,-0.29,0.35,-0.28,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly;translational initiation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9Y262,EIF3L,Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein),30,55.8,31.88,31.57,31.48,31.81,32.05,31.49,32.33,32.33,31.55,31.56,31.93,31.55,31.92,31.8,0.08,-0.24,-0.32,0.01,0.25,-0.31,0.53,0.53,-0.26,-0.24,0.13,-0.26,0.11,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly;translational initiation,cell part;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q7L2H7,EIF3M,Eukaryotic translation initiation factor 3 subunit M (eIF3m) (Fetal lung protein B5) (hFL-B5) (PCI domain-containing protein 1),19,59.1,31.7,31.3,31.56,31.62,31.26,31.66,32.18,32,31.35,31.27,31.9,32.43,31.45,31.67,0.03,-0.36,-0.11,-0.05,-0.4,-0.01,0.51,0.33,-0.32,-0.4,0.23,0.77,-0.22,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly;translational initiation,cell part;macromolecular complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
P60842,EIF4A1,Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1),50,82.8,34.53,34.48,34.26,35.44,35.56,34.81,35.23,35.5,34,34.02,34.52,34.76,33.87,34.69,-0.16,-0.21,-0.43,0.75,0.87,0.12,0.54,0.81,-0.69,-0.68,-0.17,0.07,-0.82,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;signal transduction;translational initiation,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q14240,EIF4A2,Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2),13,31,31.75,30.34,30.86,27.82,25.99,28.09,30.39,30.37,28.63,29.6,30.22,29.83,28.97,29.45,2.3,0.89,1.41,-1.63,-3.46,-1.36,0.94,0.92,-0.82,0.15,0.77,0.38,-0.48,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to chemical stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P38919,EIF4A3,"Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic initiation factor 4A-like NUK-34) (Eukaryotic translation initiation factor 4A isoform 3) (Nuclear matrix protein 265) (NMP 265) (hNMP 265) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]",29,60.8,33.12,32.51,32.24,32.11,32.45,32.68,32.11,32.06,32.92,32.37,31.1,31.34,32.22,32.25,0.87,0.27,0,-0.14,0.2,0.43,-0.14,-0.19,0.68,0.12,-1.15,-0.91,-0.03,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;primary metabolic process;regulation of translation;response to chemical stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;rRNA processing;signal transduction;transport,cell part;cytosol;macromolecular complex;protein complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P23588,EIF4B,Eukaryotic translation initiation factor 4B (eIF-4B),28,50.2,31.77,30.26,30.31,30.66,29.97,29.2,30.43,31.39,29.94,29.58,30.46,29.65,28.62,30.17,1.6,0.09,0.14,0.48,-0.2,-0.97,0.26,1.22,-0.24,-0.59,0.29,-0.52,-1.55,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P06730,EIF4E,Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein),12,47.5,30.14,30.88,30.98,30.82,31.32,30.67,31.6,31.1,30.62,31.12,31.75,31.87,29.84,30.98,-0.84,-0.1,0,-0.15,0.35,-0.31,0.62,0.12,-0.36,0.14,0.77,0.89,-1.14,anatomical structure development;biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of translation;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;signal transduction;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;ribonucleoprotein complex;RNAi effector complex,,,,,,,,,,
O60573,EIF4E2,Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (mRNA cap-binding protein type 3),6,27.8,26.36,26.71,27.28,26.54,27.51,26.73,27.76,25.65,27.25,26.87,27.45,27.39,26.3,26.91,-0.55,-0.19,0.38,-0.37,0.6,-0.18,0.85,-1.26,0.34,-0.03,0.54,0.48,-0.61,biological regulation;cellular process;regulation of translation;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q13541,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) (eIF4E-binding protein 1) (Phosphorylated heat- and acid-stable protein regulated by insulin 1) (PHAS-I),7,78.8,,23.69,24.87,23.22,24.22,24.1,24.48,23.97,,,24.58,27.6,22.77,24.35, ,-0.66,0.52,-1.13,-0.13,-0.25,0.13,-0.38, , ,0.23,3.25,-1.58,anatomical structure development;biological regulation;cellular process;developmental process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of translation;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;translational initiation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),83,53,33.65,32.3,33.15,33.62,33.45,32.71,33.78,33.82,32.75,32.69,33.48,33.15,32.87,33.19,0.46,-0.89,-0.04,0.43,0.26,-0.48,0.59,0.63,-0.43,-0.49,0.3,-0.03,-0.32,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P78344,EIF4G2,Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Death-associated protein 5) (DAP-5) (p97),36,45.8,31.25,30.23,30.81,31.32,31.39,30.77,31.59,31.37,30.44,30.77,30.99,31.62,31.24,31.06,0.19,-0.83,-0.25,0.26,0.33,-0.29,0.53,0.31,-0.62,-0.29,-0.07,0.56,0.17,biological regulation;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of translation;response to chemical stimulus;response to stimulus;RNA metabolic process;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
O43432,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII),16,10.4,28.02,27.72,27.87,28.31,27.45,27.41,27.48,27.36,26.28,25.8,27.77,27.69,26.45,27.35,0.67,0.36,0.52,0.96,0.09,0.06,0.13,0.01,-1.08,-1.55,0.41,0.34,-0.91,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to chemical stimulus;response to stimulus;RNA metabolic process;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q15056,EIF4H,Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein),14,55.3,32.16,30.95,30.66,32.09,30.75,30.31,32.08,32.03,30.39,30.5,31.46,31.99,29.37,31.13,1.03,-0.19,-0.48,0.96,-0.38,-0.82,0.94,0.9,-0.74,-0.63,0.32,0.86,-1.76,biological regulation;developmental process;growth;interspecies interaction between organisms;multi-organism process;regulation of translation;reproduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P55010,EIF5,Eukaryotic translation initiation factor 5 (eIF-5),15,32.7,30.18,29.71,29.64,30.4,29.47,28.32,30.34,29.4,29.36,29.47,30.24,31.05,28.6,29.71,0.47,0.01,-0.07,0.7,-0.24,-1.38,0.64,-0.31,-0.35,-0.24,0.53,1.35,-1.11,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA metabolic process,cell part;cytosol,,,,,,,,,,
P63241,EIF5A,Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D),12,70.1,32.66,32.84,32.13,33.22,31.73,30.99,32.71,33.12,30.82,30.56,32.43,32.45,30.25,31.99,0.67,0.84,0.14,1.23,-0.26,-1,0.72,1.12,-1.17,-1.43,0.44,0.46,-1.75,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;protein targeting;protein transport;regulation of translation;small molecule metabolic process;transport,cell part;cytosol;macromolecular complex;membrane;nuclear pore;protein complex,,,,,,,,,,
O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),61,46.9,31.57,31.13,31.72,31.5,31.27,30.37,31.12,31.16,30.18,30.82,31.2,29.33,30.22,30.89,0.68,0.24,0.83,0.6,0.38,-0.52,0.23,0.27,-0.71,-0.07,0.31,-1.57,-0.68,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;regulation of translation;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P56537,EIF6,Eukaryotic translation initiation factor 6 (eIF-6) (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP)),13,53.1,31.51,31.04,30.14,31.52,31.11,30.51,31.21,30.92,30.64,30.47,30.87,30.19,29.82,30.77,0.74,0.28,-0.63,0.75,0.35,-0.26,0.45,0.15,-0.13,-0.29,0.11,-0.58,-0.94,cellular component assembly;cellular component organization;cellular localization;cellular macromolecular complex assembly;cellular process;establishment of localization;localization;macromolecular complex assembly;nuclear transport;nucleocytoplasmic transport;organelle assembly;ribonucleoprotein complex assembly;ribosomal large subunit biogenesis;ribosomal subunit export from nucleus;ribosome assembly;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9BQ52,ELAC2,Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Heredity prostate cancer protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2),11,17.7,28.85,26.82,28.55,28.63,29.32,28.79,28.78,29.11,28.05,29.43,29.32,28.52,29.26,28.72,0.12,-1.91,-0.18,-0.09,0.59,0.06,0.05,0.39,-0.68,0.7,0.59,-0.2,0.54,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q15717,ELAVL1,ELAV-like protein 1 (Hu-antigen R) (HuR),26,67.2,32.86,32.7,32.46,32.5,33.07,33.13,32.51,32.52,32.97,33.04,32.05,31.59,33.29,32.67,0.19,0.03,-0.21,-0.17,0.4,0.47,-0.16,-0.15,0.3,0.37,-0.61,-1.07,0.62,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA metabolic process,cell part;cytosol;nucleoplasm,,,,,,,,,,
Q96JJ3,ELMO2,Engulfment and cell motility protein 2 (Protein ced-12 homolog A) (hCed-12A),9,16,25.35,27.56,27.98,27.03,26.25,25.82,28.04,28.43,28.26,25.86,28.26,26.5,26.03,27.03,-1.68,0.54,0.95,0,-0.78,-1.21,1.01,1.41,1.23,-1.17,1.23,-0.53,-1,cell death;cell motility;cellular component movement;cellular process;death;immune system process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8IZ81,ELMOD2,ELMO domain-containing protein 2,9,46.4,27.52,28.59,29.17,27.26,28.36,28.86,26.7,28.09,28,27.03,28.84,23.95,29.23,27.82,-0.29,0.77,1.36,-0.55,0.54,1.04,-1.12,0.28,0.19,-0.78,1.03,-3.87,1.41,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;immune system process;membrane invagination;membrane organization;multi-organism process;response to biotic stimulus;response to stimulus;response to stress;transport;vesicle-mediated transport,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9BW60,ELOVL1,Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1),2,9.9,29.81,29.41,28.87,30.04,29.26,28.84,30.13,29.5,30.11,29.48,29.38,29.91,29.96,29.59,0.22,-0.18,-0.72,0.45,-0.34,-0.75,0.54,-0.09,0.52,-0.12,-0.21,0.32,0.37,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
E2QRH7,ELOVL5,Elongation of very long chain fatty acids protein 5,2,13.8,,26.45,,27.47,,26.85,28,28.41,27.72,,27.32,,29.71,27.74, ,-1.29, ,-0.27, ,-0.89,0.25,0.67,-0.02, ,-0.42, ,1.97,,cell part,,,,,,,,,,
Q9H9T3,ELP3,Elongator complex protein 3 (hELP3) (EC 2.3.1.48),3,8.4,23.09,23.83,24.15,25.65,25.1,,26.22,26.67,23.28,,26.18,26.82,25.09,25.1,-2.01,-1.27,-0.95,0.55,0, ,1.12,1.58,-1.82, ,1.08,1.72,0,"biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;RNA metabolic process;transcription elongation, DNA-dependent","cell part;cytoplasm;DNA-directed RNA polymerase II, holoenzyme;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;transcription elongation factor complex",,,,,,,,,,
Q8N766,EMC1,ER membrane protein complex subunit 1,26,35.9,30.24,31.52,30.65,31.35,31.9,31.71,31.22,31.58,31.56,31.55,32,31.69,31.87,31.45,-1.2,0.07,-0.8,-0.1,0.45,0.26,-0.23,0.13,0.11,0.1,0.55,0.24,0.42,,macromolecular complex;protein complex,,,,,,,,,,
Q5UCC4,EMC10,ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1),4,11.8,26.23,28.18,,28.57,29.21,28.17,28.39,28.77,28.6,28.2,26.28,28.09,28.53,28.1,-1.87,0.08, ,0.46,1.11,0.06,0.29,0.67,0.49,0.1,-1.82,-0.01,0.43,,extracellular region;macromolecular complex;protein complex,,,,,,,,,,
Q15006,EMC2,ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35),11,38,26.64,28.73,27.46,27.89,29.3,29.12,27.85,28.57,29.04,28.47,28.23,28.19,28.8,28.33,-1.69,0.4,-0.87,-0.44,0.97,0.8,-0.48,0.24,0.71,0.14,-0.1,-0.14,0.47,,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
Q9P0I2,EMC3,ER membrane protein complex subunit 3 (Transmembrane protein 111),10,32.2,26.79,28.87,28.75,29.19,29.11,29.42,28.4,25.63,29.34,29.45,29.43,27.71,29.5,28.58,-1.8,0.29,0.17,0.6,0.53,0.83,-0.18,-2.95,0.76,0.87,0.84,-0.88,0.92,,macromolecular complex;protein complex,,,,,,,,,,
Q5J8M3,EMC4,ER membrane protein complex subunit 4 (Cell proliferation-inducing gene 17 protein) (Transmembrane protein 85),5,59,26.45,28.4,25.64,27.99,24.11,27.35,25.69,23.92,26.9,27.04,27.01,25.68,27.54,26.44,0.01,1.96,-0.8,1.55,-2.33,0.91,-0.75,-2.52,0.46,0.6,0.57,-0.76,1.1,cell death;cellular process;death,macromolecular complex;protein complex,,,,,,,,,,
Q9NPA0,EMC7,ER membrane protein complex subunit 7,9,46.7,28.94,30.18,29.35,30.09,29.94,30,29.85,28.63,30.49,30.22,29.87,29.83,30.27,29.82,-0.88,0.36,-0.47,0.27,0.12,0.18,0.03,-1.19,0.67,0.4,0.05,0.01,0.45,,macromolecular complex;protein complex,,,,,,,,,,
O43402,EMC8,ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B),4,23.3,,28.21,,27.3,29.39,29,26.25,25.83,28.42,28.01,26.37,27.41,27.09,27.57, ,0.64, ,-0.27,1.82,1.43,-1.32,-1.74,0.85,0.44,-1.2,-0.16,-0.48,,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
P50402,EMD,Emerin,14,53.1,29.73,31.05,29.26,30.48,30.09,30.75,30.24,30.42,30.85,31.02,30.3,28.82,30.25,30.25,-0.52,0.8,-0.99,0.23,-0.16,0.5,-0.01,0.17,0.6,0.77,0.05,-1.43,0,anatomical structure development;biological regulation;cell differentiation;cellular component disassembly;cellular component organization;cellular membrane organization;cellular process;developmental process;membrane organization;multicellular organismal process;muscle contraction;regulation of transport;response to chemical stimulus;response to stimulus,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q92979,EMG1,Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine-N1-)-methyltransferase NEP1) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1),9,38.9,28.32,26.53,27.05,28.16,29.27,28.99,28.78,28.38,28.31,28.78,27.26,26.67,27.25,27.98,0.34,-1.45,-0.93,0.18,1.29,1.01,0.8,0.4,0.32,0.8,-0.73,-1.31,-0.73,cellular process;ribosomal small subunit biogenesis,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O95834,EML2,Echinoderm microtubule-associated protein-like 2 (EMAP-2) (HuEMAP-2),14,30.4,30.62,28.5,27.82,27.49,27.6,27.14,27.69,28.01,,28.27,28.3,28.34,,28.16,2.46,0.33,-0.34,-0.67,-0.56,-1.02,-0.47,-0.16, ,0.11,0.14,0.18, ,metabolic process;multicellular organismal process;neurological system process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q32P44,EML3,Echinoderm microtubule-associated protein-like 3 (EMAP-3),7,11.2,24.22,27.71,26.14,26.72,,24.57,27.11,27.17,23.7,,26.86,25.48,24.81,25.86,-1.64,1.84,0.27,0.86, ,-1.29,1.25,1.31,-2.16, ,1,-0.39,-1.06,,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9HC35,EML4,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),18,21.1,30.74,29.5,30.26,28.56,26.12,27.26,28.39,26.79,25.53,25.61,27.81,27.63,26.92,27.78,2.96,1.72,2.48,0.78,-1.65,-0.52,0.61,-0.99,-2.25,-2.17,0.03,-0.15,-0.86,cellular component organization;cellular process;mitosis;nuclear division;organelle fission;organelle organization,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q8N8S7,ENAH,Protein enabled homolog,15,37,26.81,28.05,27.75,29.76,28.15,27.83,28.18,28.99,27.11,27.67,29.35,29.15,28.47,28.25,-1.44,-0.2,-0.5,1.51,-0.1,-0.42,-0.07,0.74,-1.14,-0.58,1.1,0.9,0.22,anatomical structure formation involved in morphogenesis;biological regulation;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment of localization;immune system process;locomotion;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;transport,cell part;cell projection;cytosol;filopodium;membrane;plasma membrane;synapse,,,,,,,,,,
O94919,ENDOD1,Endonuclease domain-containing 1 protein (EC 3.1.30.-),13,32.4,31.25,28.69,29.77,27.7,27.73,28.57,27.94,28.95,29.07,27.37,27.7,28.64,28.44,28.6,2.65,0.09,1.17,-0.9,-0.87,-0.03,-0.67,0.35,0.47,-1.23,-0.91,0.04,-0.16,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,extracellular region,,,,,,,,,,
Q14249,ENDOG,"Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-)",5,23.2,24.12,27.37,23.88,26.73,28.21,27.81,28.21,26.92,27.94,28.62,26.48,26.23,28.08,26.97,-2.85,0.4,-3.09,-0.24,1.24,0.84,1.24,-0.05,0.97,1.65,-0.49,-0.74,1.11,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;embryo development;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P06733,ENO1,Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein),52,85.3,37.09,36.9,36.67,36.41,35.7,35.32,36.27,36.37,35.1,35.39,36.11,36.78,34.7,36.06,1.03,0.84,0.61,0.35,-0.36,-0.74,0.21,0.31,-0.97,-0.67,0.04,0.72,-1.36,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;RNA metabolic process;small molecule metabolic process,cell part;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;vesicle,Other TF domain,,,,,,,,,
Q9UHY7,ENOPH1,"Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)",4,22.4,27.96,28.02,28.32,28.41,27.06,26.46,28.36,28.36,26.42,26.65,27.29,29.29,,27.72,0.25,0.31,0.6,0.69,-0.66,-1.25,0.65,0.64,-1.3,-1.07,-0.43,1.57, ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,+,,,,,,,
Q9Y6X5,ENPP4,Bis(5'-adenosyl)-triphosphatase ENPP4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4),7,17.7,27.9,28.28,29.9,26.25,27.28,29.41,27.49,28.32,27.43,28.34,27.71,27.35,28.58,28.02,-0.11,0.26,1.88,-1.77,-0.74,1.39,-0.53,0.3,-0.59,0.32,-0.3,-0.66,0.56,biological regulation;coagulation;multicellular organismal process;regulation of body fluid levels,cell part;membrane;plasma membrane,,,,,,,,,,
Q9UJA9,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-),3,6.7,25.06,25.7,25.55,25.09,,27.11,24.54,,,,25.3,,,25.48,-0.42,0.22,0.07,-0.39, ,1.63,-0.94, , , ,-0.18, , ,cell communication;cellular process,cell part;extracellular region;membrane;plasma membrane,,,,,,,,,,
O43768,ENSA,Alpha-endosulfine (ARPP-19e),4,29.1,27.62,27.13,28.79,26.6,26.86,25.63,26.76,27.45,25.2,26.37,27.05,28.5,23.41,26.72,0.9,0.41,2.07,-0.12,0.14,-1.09,0.04,0.73,-1.52,-0.35,0.33,1.78,-3.31,cell division;cellular component organization;cellular process;establishment of localization;mitosis;nuclear division;organelle fission;organelle organization;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;transport,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
Q9NPA8,ENY2,Enhancer of yellow 2 transcription factor homolog,4,40.6,28.25,27.55,26.85,28.21,28.54,28.48,26.89,27.94,27.68,27.91,,27.64,26.68,27.72,0.53,-0.17,-0.87,0.49,0.82,0.76,-0.83,0.23,-0.04,0.19, ,-0.08,-1.04,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;establishment of localization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;RNA metabolic process;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q5NDL2,EOGT,EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase),4,10.4,23.69,26.77,24.18,26.61,28.57,29.01,28.09,27.74,28.49,28.16,27.82,26.93,29.64,27.36,-3.67,-0.59,-3.18,-0.75,1.21,1.65,0.73,0.38,1.13,0.8,0.46,-0.43,2.28,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part,,,,,,,,,,
Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),29,46.1,31.26,27.5,30.04,25.6,24.49,26.04,,,27.7,26.69,25.41,,25.31,27,4.26,0.49,3.04,-1.41,-2.52,-0.96, , ,0.7,-0.32,-1.59, ,-1.7,cell communication;cell-cell signaling;cellular component organization;cellular process;cytoskeleton organization;organelle organization;signaling,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),38,46.6,28.64,30.12,29.82,29.71,30.96,30.35,30.33,30.26,30.98,30.91,28.85,28.96,29.47,29.95,-1.31,0.17,-0.13,-0.24,1.01,0.4,0.38,0.31,1.03,0.96,-1.1,-0.99,-0.48,cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9Y2J2,EPB41L3,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",11,16.5,,28.66,28.74,26.04,,21.13,,,,27.41,22.05,25.23,,25.61, ,3.06,3.13,0.44, ,-4.48, , , ,1.8,-3.56,-0.38, ,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell junction organization;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular localization;cellular membrane organization;cellular process;cytoskeleton organization;developmental process;localization;membrane organization;organelle organization;plasma membrane organization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9HCM4,EPB41L5,Band 4.1-like protein 5,14,29.1,27.31,24.68,26.08,26.32,28.74,29.32,28.17,27.15,29.72,29.13,26.98,25.97,27.84,27.49,-0.18,-2.81,-1.41,-1.17,1.24,1.83,0.68,-0.34,2.23,1.64,-0.51,-1.52,0.34,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell growth;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;embryo development;growth;multicellular organismal process;organelle organization;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P16422,EPCAM,Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326),11,35,29.05,28.32,29.51,27.06,26.46,27.95,23.26,25.84,22.27,30.25,25.52,,,26.86,2.19,1.45,2.65,0.19,-0.4,1.09,-3.6,-1.03,-4.59,3.39,-1.34, , ,anatomical structure development;biological regulation;developmental process,cell part;cell surface,,,,,,,,,,
Q9UM22,EPDR1,Mammalian ependymin-related protein 1 (MERP-1) (Upregulated in colorectal cancer gene 1 protein),6,24.1,27.45,28.89,25.82,28.39,26.01,26.85,28.42,28.19,29.33,27.56,31.17,30.24,31.07,28.41,-0.96,0.47,-2.59,-0.02,-2.4,-1.56,0.01,-0.23,0.92,-0.86,2.76,1.82,2.65,biological adhesion;cell adhesion;cellular process,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
P29317,EPHA2,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),23,23.4,28.4,27.54,28.41,29.64,30.89,30.22,30.62,29.47,30.69,31.42,30.41,29.37,31.31,29.88,-1.48,-2.33,-1.46,-0.24,1.01,0.34,0.74,-0.4,0.81,1.55,0.54,-0.51,1.43,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell development;cell differentiation;cell morphogenesis;cell motility;cell proliferation;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;developmental process;locomotion;multicellular organismal process;response to chemical stimulus;response to DNA damage stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;tissue remodeling,cell part,,+,,,,,,,,
P29323,EPHB2,Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3),11,12.6,24.18,25.21,,28.08,28.47,28.58,27.01,26.29,28.5,27.6,27.66,27.19,27.88,27.22,-3.04,-2.01, ,0.86,1.25,1.35,-0.21,-0.93,1.28,0.37,0.44,-0.03,0.66,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;behavior;biological regulation;cell recognition;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;developmental process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;response to chemical stimulus;response to external stimulus;response to stimulus,cell body;cell part;cell projection;neuron projection;neuronal cell body,,+,,,,,,,,
P07099,EPHX1,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase),28,66.8,31.9,32.05,32.48,31.58,31.55,32.42,31.89,31.3,32,32.9,32.59,33.36,33.27,32.25,-0.35,-0.2,0.22,-0.67,-0.7,0.17,-0.37,-0.95,-0.26,0.65,0.33,1.11,1.02,catabolic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular process;metabolic process;response to chemical stimulus;response to stimulus,cell part;membrane,,,,,,,,,,
G3V134,EPHX2,"Epoxide hydrolase 2, cytoplasmic",2,6.1,24.13,24.14,,24.29,,,24.31,24.46,,,24.83,24.42,24.58,24.4,-0.26,-0.25, ,-0.1, , ,-0.09,0.07, , ,0.43,0.02,0.18,biological regulation;catabolic process;cellular aromatic compound metabolic process;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;drug metabolic process;homeostatic process;lipid metabolic process;metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;response to stress;secondary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microbody;nucleolus;organelle;peroxisome,,,,,,,,,,
Q9Y6I3,EPN1,Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1),13,24.9,27.61,28.91,28.19,28.74,28.51,28.23,27.5,28.3,28.78,28.92,28.07,25.26,26.97,28,-0.39,0.91,0.19,0.74,0.51,0.23,-0.5,0.3,0.78,0.92,0.07,-2.74,-1.03,anatomical structure development;biological regulation;cellular component organization;cellular membrane organization;cellular process;developmental process;embryo development;endocytosis;establishment of localization;membrane invagination;membrane organization;multi-organism process;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O95208,EPN2,Epsin-2 (EPS-15-interacting protein 2),6,19.8,26.6,27.04,26.28,26.71,22.18,26.18,26.67,25.78,27.46,27.86,26.43,27.88,26.47,26.43,0.18,0.61,-0.14,0.28,-4.25,-0.25,0.24,-0.65,1.03,1.43,0.01,1.46,0.05,anatomical structure development;biological regulation;cellular component organization;cellular membrane organization;cellular process;developmental process;embryo development;endocytosis;establishment of localization;membrane invagination;membrane organization;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
P58107,EPPK1,Epiplakin (450 kDa epidermal antigen),91,47.9,34.14,30.15,32.44,28.88,29.47,26.1,28.19,29.26,26.75,29.98,30.19,31.91,31.11,29.89,4.25,0.26,2.55,-1.01,-0.42,-3.79,-1.7,-0.63,-3.14,0.09,0.3,2.02,1.22,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P07814,EPRS,Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS);Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)],73,57.7,32.45,32.82,33.04,33.05,32.93,32.65,33.29,33.15,32.87,33.36,32.54,32.18,32.76,32.85,-0.4,-0.03,0.19,0.2,0.08,-0.2,0.44,0.3,0.01,0.5,-0.32,-0.67,-0.1,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;regulation of translation;response to chemical stimulus;response to stimulus;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P42566,EPS15,Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p),17,24.9,27.89,28.59,28.37,28,26.65,27.35,28.85,27.28,27.53,27.48,28.68,28.32,27.89,27.91,-0.02,0.67,0.46,0.09,-1.26,-0.57,0.93,-0.63,-0.39,-0.44,0.77,0.41,-0.02,biological regulation;cell proliferation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular process;endocytosis;endosome transport;establishment of localization;macromolecular complex assembly;membrane invagination;membrane organization;organelle organization;protein complex assembly;protein transport;response to stimulus;signal transduction;transport;vesicle organization;vesicle-mediated transport,AP-type membrane coat adaptor complex;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9UBC2,EPS15L1,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),24,39.9,29.06,28.72,28.67,29.3,27.78,28.01,28.86,27.95,29.18,29.54,29.74,29.83,28.1,28.83,0.24,-0.11,-0.15,0.48,-1.05,-0.81,0.04,-0.88,0.35,0.71,0.91,1,-0.73,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q12929,EPS8,Epidermal growth factor receptor kinase substrate 8,18,27.6,26.06,26.63,26.05,29.05,27.19,26.13,28.33,27.48,27.17,29.03,27.71,29.17,25.02,27.31,-1.25,-0.68,-1.26,1.74,-0.12,-1.18,1.02,0.17,-0.14,1.72,0.4,1.86,-2.29,behavior;biological regulation;cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;locomotion;multicellular organismal process;organelle organization;regulation of organelle organization;response to chemical stimulus;response to stimulus;signal transduction,cell cortex;cell part;cell projection;macromolecular complex;microvillus;protein complex;receptor complex;site of polarized growth,,,,+,,,,,,
Q8TE68,EPS8L1,Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1),20,39.2,30.48,25.19,25.69,21.98,24.04,21.97,26.5,24.35,,27.62,24.74,25.68,25.86,25.34,5.14,-0.15,0.35,-3.36,-1.3,-3.37,1.16,-0.99, ,2.28,-0.6,0.33,0.52,,cell part;cytoplasm,,,,,,,,,,
Q9H6S3,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2),26,43.4,30.85,26.61,29.32,26.66,27.76,26.84,29.19,29.94,27.19,30.39,29.68,28.36,25.62,28.34,2.51,-1.73,0.98,-1.68,-0.58,-1.5,0.85,1.6,-1.15,2.06,1.34,0.02,-2.72,,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q9C0D9,EPT1,Ethanolaminephosphotransferase 1 (hEPT1) (EC 2.7.8.1) (Selenoprotein I) (SelI),3,8.3,27.8,24.93,25.82,25.81,27.2,26.45,25.45,26.74,26.53,28.38,,,27.13,26.57,1.23,-1.64,-0.74,-0.76,0.64,-0.12,-1.12,0.17,-0.03,1.81, , ,0.56,alcohol metabolic process;amine metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
O75616,ERAL1,"GTPase Era, mitochondrial (H-ERA) (hERA) (Conserved ERA-like GTPase) (CEGA) (ERA-W) (ERA-like protein 1)",5,16.2,26.9,,25.92,26.44,26.24,26.97,24.88,,,,,21.59,25.13,25.51,1.4, ,0.42,0.93,0.73,1.46,-0.63, , , , ,-3.92,-0.38,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;membrane,,,,,,,,,,
Q9NZ08,ERAP1,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator),35,40.1,29.22,32.27,31.43,31.22,32.08,30.93,31.81,30.82,31.24,30.63,29.53,29.78,29.89,30.83,-1.61,1.43,0.6,0.39,1.25,0.09,0.97,-0.02,0.41,-0.21,-1.3,-1.06,-0.94,anatomical structure formation involved in morphogenesis;biological regulation;cell differentiation;cellular process;developmental process;immune system process;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;proteolysis;response to biotic stimulus;response to stimulus,cell part;cytosol;extracellular region;membrane,,,,,,,,,,
Q6P179,ERAP2,Endoplasmic reticulum aminopeptidase 2 (EC 3.4.11.-) (Leukocyte-derived arginine aminopeptidase) (L-RAP),20,25,27.73,29.95,29.99,29.58,,25.24,,29.82,31.11,31.04,29.92,31.65,30.56,29.69,-1.96,0.26,0.3,-0.11, ,-4.45, ,0.13,1.42,1.35,0.24,1.96,0.87,biological regulation;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;membrane,,,,,,,,,,
P04626,ERBB2,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),17,17.9,29.88,25.25,24.64,,24.77,25.68,,,24.94,26.14,,22.77,,25.51,4.37,-0.26,-0.86, ,-0.73,0.17, , ,-0.57,0.63, ,-2.74, ,anatomical structure development;biological regulation;biosynthetic process;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of translation;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex;receptor complex,,+,,,,,,,,
Q96RT1,ERBB2IP,Protein LAP2 (Densin-180-like protein) (Erbb2-interacting protein) (Erbin),11,10.7,24.6,27.86,25.21,27.62,27.33,26.57,26.74,25.99,26.53,25.25,25.56,26.14,25.87,26.25,-1.65,1.6,-1.05,1.37,1.08,0.31,0.49,-0.26,0.28,-1,-0.69,-0.11,-0.38,biological adhesion;biological regulation;cell adhesion;cell cycle;cell growth;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;establishment or maintenance of cell polarity;growth;localization;organelle organization;protein targeting;protein transport;response to stimulus;signal transduction;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q8IUD2,ERC1,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),17,17.3,28.81,26.36,27.82,28.83,27.99,29.37,28.5,28.88,27.48,28.71,29.36,27.39,28.88,28.34,0.47,-1.97,-0.51,0.49,-0.35,1.03,0.16,0.55,-0.86,0.37,1.02,-0.94,0.55,biological regulation;cellular metabolic process;cellular process;developmental process;endosome transport;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal development;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
P18074,ERCC2,TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein),2,8.9,24.13,24.16,,25.41,,,26.55,,25.46,,25.84,25.43,,25.28,-1.16,-1.12, ,0.12, , ,1.27, ,0.17, ,0.56,0.15, ,"aging;anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;catabolic process;cell death;cell differentiation;cell division;cell maturation;cell proliferation;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome segregation;death;developmental maturation;developmental process;DNA metabolic process;DNA repair;embryo development;extracellular matrix organization;extracellular structure organization;growth;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;molting cycle;mRNA metabolic process;mRNA processing;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;post-embryonic development;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;RNA processing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;cytoplasm;macromolecular complex;protein complex;SSL2-core TFIIH complex;transcription factor complex,Other TF domain,,,,,,,,,
P19447,ERCC3,TFIIH basal transcription factor complex helicase XPB subunit (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein),8,13.9,26.39,27.88,26.35,25.21,26.78,27.01,26.53,26.97,27.33,27.84,27.06,27.19,27.64,26.94,-0.54,0.94,-0.59,-1.72,-0.16,0.07,-0.41,0.03,0.39,0.91,0.12,0.25,0.7,"biological regulation;biosynthetic process;catabolic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA geometric change;DNA metabolic process;DNA repair;interspecies interaction between organisms;localization;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;RNA processing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;protein complex;SSL2-core TFIIH complex;transcription factor complex,Other TF domain,,,,,,,,,
Q969X5,ERGIC1,Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32),14,72.2,31.62,32.79,30.38,31.98,32.02,32.78,32.4,32.38,32.74,32,32.7,31.46,32.84,32.16,-0.54,0.63,-1.78,-0.18,-0.14,0.62,0.24,0.22,0.58,-0.16,0.54,-0.7,0.68,cellular process;establishment of localization;Golgi vesicle transport;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q96RQ1,ERGIC2,Endoplasmic reticulum-Golgi intermediate compartment protein 2,6,17,29.14,29.16,27.84,28.09,28.18,27.69,28.01,27.7,28.23,27.08,28.47,,27.22,28.07,1.07,1.09,-0.23,0.03,0.11,-0.38,-0.05,-0.37,0.16,-0.99,0.41, ,-0.85,cellular process;establishment of localization;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
A6PVJ3,ERGIC3,ERGIC and golgi 3 (Fragment),4,15.4,28.21,26.89,25.85,26.85,25.67,,25.7,,26.3,23.85,,,,26.17,2.05,0.73,-0.31,0.69,-0.5, ,-0.47, ,0.14,-2.31, , , ,,,,,,,,,,,,
P84090,ERH,Enhancer of rudimentary homolog,8,59.6,32.33,32.09,32.67,32.05,32.96,33.36,31.84,32.16,32.49,32.42,31.19,31.81,32.62,32.31,0.02,-0.22,0.37,-0.26,0.65,1.06,-0.47,-0.15,0.18,0.11,-1.12,-0.5,0.31,cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;primary metabolic process;small molecule metabolic process,cell part;midbody,,,,,,,,,,
Q8IV48,ERI1,3'-5' exoribonuclease 1 (EC 3.1.-.-) (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-end-specific exoribonuclease) (Histone mRNA 3'-exonuclease 1) (Protein 3'hExo) (HEXO),2,7.2,26.63,26.25,,26.21,,25.14,26.32,25.29,27.03,,25.74,25,25.5,25.91,0.72,0.34, ,0.3, ,-0.77,0.41,-0.62,1.12, ,-0.17,-0.91,-0.41,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;gene silencing;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,SAP-domain,,,,,,,,,
O43414,ERI3,ERI1 exoribonuclease 3 (EC 3.1.-.-) (Prion interactor 1) (Prion protein-interacting protein),2,23.4,26.61,25.44,,25.83,,24.77,25.11,,23.85,,,25.3,,25.27,1.33,0.17, ,0.56, ,-0.51,-0.16, ,-1.42, , ,0.03, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;intracellular,,,,,,,,,,
Q96DZ1,ERLEC1,Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein),9,28.2,28.39,29.83,28.29,28.96,27.74,29.22,28.33,28.07,28.77,28.49,28.33,28.56,28.32,28.56,-0.17,1.27,-0.27,0.4,-0.82,0.66,-0.23,-0.49,0.21,-0.07,-0.23,0,-0.24,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part,,,,,,,,,,
O75477,ERLIN1,Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1) (Protein KE04) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1) (SPFH domain-containing protein 1),10,32.9,29.3,30.06,29.41,30.62,29.59,30.11,30.17,30.26,30.09,29.87,29.73,29.59,30.74,29.96,-0.66,0.1,-0.56,0.65,-0.38,0.14,0.2,0.3,0.12,-0.09,-0.23,-0.37,0.78,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
O94905,ERLIN2,Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2),20,59.3,31.4,32.12,31.69,31.57,31.44,31.94,31.21,31.23,31.51,32.52,31.81,31.03,32.07,31.66,-0.26,0.46,0.03,-0.09,-0.21,0.29,-0.45,-0.43,-0.15,0.86,0.15,-0.63,0.41,catabolic process;cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q7Z2K6,ERMP1,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),22,25.2,31.03,29.62,32.34,28.96,29.04,29.92,29.77,29.33,31.79,31.39,29.51,28.85,30.01,30.12,0.91,-0.5,2.22,-1.17,-1.08,-0.2,-0.35,-0.79,1.67,1.27,-0.61,-1.27,-0.11,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;membrane,,,,,,,,,,
Q96HE7,ERO1L,ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Oxidoreductin-1-L-alpha),34,69.7,34.41,34.14,33.79,32.91,32.9,33.19,32.36,32.29,33.2,34.62,32.82,32.38,33.54,33.27,1.14,0.87,0.52,-0.36,-0.37,-0.08,-0.91,-0.99,-0.07,1.35,-0.45,-0.9,0.27,biological regulation;cell death;cell differentiation;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;death;developmental process;establishment of localization;generation of precursor metabolites and energy;homeostatic process;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein folding;protein metabolic process;protein modification process;response to abiotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;membrane,,,,,,,,,,
Q86YB8,ERO1LB,ERO1-like protein beta (ERO1-L-beta) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta),4,10.3,27.72,27.93,28.82,28.62,22.68,25.82,22.49,28.93,26.79,25.94,28.94,23.23,27.89,26.6,1.12,1.33,2.22,2.02,-3.92,-0.78,-4.11,2.33,0.19,-0.66,2.34,-3.37,1.29,cellular metabolic process;cellular process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P30040,ERP29,Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31),20,67.4,32.76,33.55,33.24,32.83,33.3,33.58,32.72,32.81,33.24,33.41,32.84,32.63,33.17,33.08,-0.32,0.47,0.15,-0.25,0.22,0.49,-0.37,-0.27,0.16,0.33,-0.24,-0.45,0.09,cellular process;establishment of localization;protein transport;secretion;transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9BS26,ERP44,Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4),30,59.4,31.78,33.58,33.07,32.23,32.35,32.61,32.47,32.41,32.42,32.79,32.65,31.77,33.11,32.56,-0.78,1.03,0.51,-0.33,-0.21,0.05,-0.08,-0.15,-0.14,0.24,0.09,-0.79,0.55,biological regulation;cellular homeostasis;cellular metabolic process;cellular process;homeostatic process;macromolecule metabolic process;metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;cell surface;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P10768,ESD,S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56),12,58.5,29.63,30.92,31.79,30.59,29.83,29.11,30.32,30.46,28.9,28.81,30.36,29.71,27.36,29.83,-0.2,1.09,1.96,0.76,0,-0.72,0.49,0.63,-0.93,-1.03,0.53,-0.12,-2.47,catabolic process;cellular aldehyde metabolic process;cellular metabolic process;cellular process;metabolic process;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;vesicle,,,,,,,,,,
Q9H501,ESF1,ESF1 homolog (ABT1-associated protein),15,18.3,27.21,25.81,26.19,25.32,,24.44,21.67,,26.52,26.88,22.62,25.31,,25.2,2.01,0.62,1,0.12, ,-0.76,-3.53, ,1.32,1.68,-2.58,0.12, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q6NXG1,ESRP1,Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A),18,22.7,31.23,29.89,29.03,29.33,29.79,29.82,29.11,,29.8,29.85,28.55,28.88,30.06,29.61,1.62,0.28,-0.59,-0.28,0.18,0.21,-0.51, ,0.19,0.23,-1.06,-0.73,0.45,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9BSJ8,ESYT1,Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein),57,51.3,32.98,32.65,32.49,32.85,33.72,34.02,33.37,33.25,33.8,33.95,33.6,33.06,34.03,33.37,-0.39,-0.72,-0.87,-0.52,0.35,0.65,0,-0.12,0.43,0.59,0.24,-0.31,0.67,,cell part,,,,,,,,,,
A0FGR8,ESYT2,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),43,52.8,32.5,31.23,31.14,30.37,30.46,30.96,31.05,30.11,32.05,31.95,31.35,30.5,32.02,31.21,1.3,0.02,-0.07,-0.84,-0.75,-0.25,-0.15,-1.1,0.84,0.74,0.15,-0.71,0.81,,cell part;membrane;plasma membrane,,,,,,,,,,
P62495,ETF1,Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Protein Cl1) (TB3-1),15,38.7,31.38,30.98,30.82,31.48,30.41,29.72,31.38,31.33,29.64,30.01,31.27,31.79,30.04,30.79,0.59,0.19,0.03,0.69,-0.38,-1.07,0.59,0.54,-1.15,-0.78,0.48,1,-0.75,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;regulation of translation;RNA catabolic process;RNA metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P13804,ETFA,"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)",23,71.8,30.73,32.44,32.16,32.07,32.3,32.8,32.15,31.95,32.51,32.8,32.72,32.59,33.03,32.33,-1.6,0.11,-0.17,-0.25,-0.02,0.48,-0.18,-0.38,0.18,0.47,0.39,0.26,0.71,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P38117,ETFB,Electron transfer flavoprotein subunit beta (Beta-ETF),23,67.8,30.42,31.82,31.73,31.57,31.69,32.43,31.05,31.24,31.8,32.15,32.29,31.24,32.52,31.69,-1.27,0.13,0.04,-0.12,0,0.74,-0.64,-0.45,0.12,0.46,0.6,-0.45,0.83,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q16134,ETFDH,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",12,21.4,26.34,27.22,28.97,26.79,26.62,27.26,27.24,26.4,28.3,28.61,28.57,27.7,28.83,27.6,-1.27,-0.39,1.37,-0.82,-0.98,-0.34,-0.37,-1.2,0.7,1,0.96,0.1,1.23,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part,,,,,,,,,,
O95571,ETHE1,"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)",20,86.6,31.1,30.59,31.23,29.51,29.65,30.85,29.38,29.91,30.84,32.62,30.33,29.26,30.24,30.43,0.67,0.16,0.81,-0.91,-0.78,0.43,-1.04,-0.52,0.42,2.2,-0.09,-1.16,-0.18,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q92817,EVPL,Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210),17,12.1,29.18,29.02,28.48,26.6,28.36,28.81,28.31,28.51,28.29,25.81,,,29.23,28.24,0.94,0.78,0.24,-1.64,0.12,0.57,0.08,0.27,0.05,-2.43, , ,1,cell differentiation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q01844,EWSR1,RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein),7,11.5,30.72,30.53,31,30.54,30.95,31.53,30.52,29.98,32.06,31.08,29.6,28.83,30.64,30.61,0.11,-0.09,0.38,-0.07,0.34,0.91,-0.1,-0.63,1.45,0.47,-1.01,-1.78,0.02,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9NVH0,EXD2,Exonuclease 3'-5' domain-containing protein 2 (Exonuclease 3'-5' domain-like-containing protein 2),6,16.1,27.16,27.21,,26.53,28.87,27.82,28.19,26.47,27.77,27.09,26.6,28.5,27.68,27.49,-0.33,-0.28, ,-0.96,1.38,0.33,0.7,-1.02,0.28,-0.4,-0.89,1.01,0.19,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,,,,,,,,,,,
Q9NV70,EXOC1,Exocyst complex component 1 (Exocyst complex component Sec3),12,18.5,26.48,26.38,27.13,26.39,26.35,24.3,27.12,25.92,26.16,27.08,26.86,27.36,27.28,26.52,-0.05,-0.14,0.61,-0.13,-0.17,-2.22,0.6,-0.61,-0.37,0.55,0.34,0.83,0.76,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;exocytosis;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein metabolic process;protein transport;secretion;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
O60645,EXOC3,Exocyst complex component 3 (Exocyst complex component Sec6),15,26.8,27.21,27.88,28.46,28.46,26.33,30.7,27.8,27.34,26.68,27.63,28.58,27.21,26.64,27.76,-0.56,0.11,0.7,0.69,-1.43,2.94,0.04,-0.42,-1.08,-0.13,0.82,-0.55,-1.13,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;exocytosis;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein metabolic process;protein transport;secretion;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q96A65,EXOC4,Exocyst complex component 4 (Exocyst complex component Sec8),23,27.6,28.87,28.96,29.66,28.86,27.9,28.93,29.83,29.22,28.91,28.98,30.03,30.32,28.99,29.19,-0.32,-0.23,0.47,-0.33,-1.29,-0.26,0.64,0.03,-0.28,-0.21,0.84,1.13,-0.2,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;membrane docking;membrane organization;metabolic process;primary metabolic process;protein metabolic process;protein transport;transport,cell part;cytoplasm;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
O00471,EXOC5,Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10),12,20.1,26.47,27.49,28.19,26.91,27.95,27.84,28.08,28.74,28.11,28.91,28.98,27.8,28.19,27.97,-1.5,-0.48,0.22,-1.07,-0.02,-0.13,0.1,0.77,0.13,0.93,1.01,-0.18,0.22,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;exocytosis;Golgi vesicle transport;macromolecule metabolic process;membrane docking;membrane organization;metabolic process;primary metabolic process;protein metabolic process;protein transport;secretion;transport;vesicle-mediated transport,cell part;cytosol,,,,,,,,,,
Q9Y2D4,EXOC6B,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),8,11.1,26.21,26.39,23.89,27.67,26.6,26.24,28.15,28.19,25.47,27.9,29.28,26.97,26.42,26.88,-0.66,-0.48,-2.99,0.79,-0.27,-0.64,1.28,1.32,-1.41,1.02,2.4,0.09,-0.46,cellular process;establishment of localization;membrane docking;protein transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9UPT5,EXOC7,Exocyst complex component 7 (Exocyst complex component Exo70),13,25.6,27.4,27.57,27.51,27.92,28.05,26.83,28.82,29.01,27.34,28.14,29.34,30.13,27.24,28.1,-0.7,-0.53,-0.59,-0.18,-0.05,-1.27,0.72,0.91,-0.76,0.04,1.24,2.03,-0.86,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;exocytosis;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein metabolic process;protein transport;secretion;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q8IYI6,EXOC8,Exocyst complex component 8 (Exocyst complex 84 kDa subunit),7,12.4,26.06,27.1,28.37,27.68,25.94,25.32,28.05,27.82,27.3,28.61,29.49,30.08,28.08,27.68,-1.62,-0.59,0.68,0,-1.75,-2.37,0.37,0.13,-0.38,0.93,1.8,2.4,0.4,cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;exocytosis;localization;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein metabolic process;protein transport;secretion;transport;vesicle-mediated transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;site of polarized growth,,,,,,,,,,
Q9Y2C4,EXOG,"Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)",3,9.2,23.21,24.85,,25,24.6,25.71,25.23,25.42,26.03,25.02,27.58,25.37,26.66,25.39,-2.18,-0.54, ,-0.39,-0.79,0.32,-0.16,0.03,0.64,-0.37,2.19,-0.02,1.27,,cell part;membrane,,,,,,,,,,
Q9Y3B2,EXOSC1,Exosome complex component CSL4 (Exosome component 1),3,22.9,27.06,27.18,25.95,26.25,28.01,27.93,27.04,27.1,27.66,27.35,24.67,25.51,26.7,26.8,0.26,0.38,-0.85,-0.55,1.21,1.13,0.24,0.3,0.86,0.55,-2.13,-1.29,-0.1,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q01780,EXOSC10,Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),19,29.6,27.94,27.22,29.31,29.31,30.32,29.54,29.6,28.31,29.72,29.76,27.35,28.75,28.65,28.91,-0.96,-1.69,0.4,0.4,1.42,0.64,0.69,-0.6,0.82,0.85,-1.55,-0.16,-0.26,"biological regulation;catabolic process;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of gene expression, epigenetic;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing",cell part;cytoplasm;exosome (RNase complex);intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q13868,EXOSC2,Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4),7,29,28.13,27.73,26.47,28.63,29.15,29.06,28.29,28.08,28.3,28.32,26.81,27.66,29.19,28.14,-0.01,-0.41,-1.67,0.49,1.01,0.92,0.15,-0.06,0.16,0.18,-1.33,-0.48,1.05,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleus;organelle;protein complex,,,,,,,,,,
Q9NQT5,EXOSC3,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),4,13.8,27.16,27.42,28.9,27.6,28.47,28.74,27.85,27.33,28.3,27.79,32.5,22.58,28.02,27.9,-0.74,-0.47,1,-0.3,0.58,0.84,-0.05,-0.57,0.4,-0.11,4.61,-5.32,0.12,catabolic process;cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA modification;DNA recombination;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q9NPD3,EXOSC4,Exosome complex component RRP41 (Exosome component 4) (Ribosomal RNA-processing protein 41) (p12A),6,20,26.3,26.25,25.93,27.56,28.28,27.93,26.71,27.14,27.43,27.34,23.4,26.02,26.92,26.71,-0.41,-0.45,-0.78,0.85,1.58,1.22,0,0.44,0.72,0.63,-3.31,-0.69,0.21,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA modification;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q9NQT4,EXOSC5,Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B),3,21.7,25.95,24.9,,27.06,26.64,28,27.52,25.27,28.13,27.87,25.25,25.48,25.73,26.48,-0.54,-1.58, ,0.57,0.16,1.52,1.04,-1.21,1.65,1.38,-1.23,-1,-0.76,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA modification;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q5RKV6,EXOSC6,Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog) (hMtr3) (p11),5,27.2,25.12,25.92,25.33,27.51,28.7,28.15,26.46,26.99,26.95,27.24,24.76,,26.68,26.65,-1.54,-0.73,-1.32,0.86,2.05,1.5,-0.19,0.34,0.3,0.59,-1.89, ,0.03,catabolic process;cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA modification;DNA recombination;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q15024,EXOSC7,Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8),5,23.4,26.22,26.78,,27.47,27.19,,25.96,26.34,27.25,,,23.55,,26.34,-0.13,0.43, ,1.13,0.84, ,-0.39,-0.01,0.91, , ,-2.8, ,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q96B26,EXOSC8,Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9),3,12.3,26.61,26.42,27.26,27.13,25.37,27.92,27.35,,26.79,,,,,26.86,-0.25,-0.44,0.41,0.27,-1.48,1.06,0.49, ,-0.07, , , , ,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleus;organelle;protein complex,,,,,,,,,,
Q06265,EXOSC9,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),5,14.6,26.5,26.82,26.95,27.51,28.45,28.05,28.05,25.71,28.32,28.4,27.21,28.71,27.88,27.58,-1.09,-0.77,-0.63,-0.07,0.87,0.47,0.47,-1.87,0.74,0.82,-0.37,1.13,0.3,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;exosome (RNase complex);intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleus;organelle;protein complex,,,,,,,,,,
Q9UBQ6,EXTL2,"Exostosin-like 2 (EC 2.4.1.223) (Alpha-1,4-N-acetylhexosaminyltransferase EXTL2) (Alpha-GalNAcT EXTL2) (EXT-related protein 2) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) [Cleaved into: Processed exostosin-like 2]",4,15.1,24.08,25.09,24.66,27.32,,28.27,24.94,24.56,27.22,,25.97,25.34,27.93,25.94,-1.86,-0.86,-1.29,1.37, ,2.32,-1,-1.38,1.28, ,0.02,-0.6,1.99,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;endoplasmic reticulum;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P15311,EZR,Ezrin (Cytovillin) (Villin-2) (p81),86,86.2,35.14,34.32,35.79,35,35.29,34.77,35.84,36.04,34.38,35.22,35.79,36.17,34.53,35.25,-0.11,-0.93,0.54,-0.25,0.03,-0.48,0.59,0.79,-0.87,-0.04,0.53,0.92,-0.72,biological adhesion;biological regulation;cell adhesion;cell differentiation;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment or maintenance of cell polarity;locomotion;membrane docking;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus,apical part of cell;cell part;cell projection;cytoskeleton;cytosol;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;microvillus;nucleolus;organelle;protein complex,,,,,,,,,,
Q9Y624,F11R,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321),13,51,30.65,30.3,30.01,28.1,29.87,28.73,29.62,29.31,29.37,31.31,28.91,28.22,29.03,29.49,1.15,0.8,0.52,-1.39,0.37,-0.77,0.13,-0.18,-0.13,1.82,-0.59,-1.28,-0.47,biological adhesion;biological regulation;cell adhesion;cell differentiation;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;coagulation;developmental process;immune system process;interspecies interaction between organisms;locomotion;multicellular organismal process;multi-organism process;regulation of body fluid levels;response to stimulus;response to stress;signal transduction,cell part;membrane;plasma membrane,,,,,,,,,,
P13726,F3,Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142),6,25.4,28.34,26.99,29.22,24.02,,,23.77,25.17,25.99,31.17,23.73,25.89,24.16,26.22,2.12,0.77,3,-2.2, , ,-2.46,-1.05,-0.24,4.94,-2.49,-0.33,-2.06,biological regulation;macromolecule metabolic process;metabolic process;primary metabolic process;protein maturation;protein metabolic process;response to stimulus,cell part;extracellular matrix;extracellular space,,,,,,,,,,
Q01469,FABP5,"Fatty acid-binding protein, epidermal (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein 5) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP)",12,85.9,31,31.54,32.88,30.46,29.96,27.42,30.06,30.38,29.39,28.33,28.39,29.45,,29.94,1.06,1.6,2.94,0.52,0.03,-2.51,0.12,0.44,-0.55,-1.61,-1.55,-0.49, ,alcohol metabolic process;amine metabolic process;anatomical structure development;biosynthetic process;carbohydrate metabolic process;carbohydrate transport;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process;transport,cell part;cytoplasm,,,,,,,,,,
Q13158,FADD,Protein FADD (FAS-associated death domain protein) (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity),4,31.7,26.58,26.61,25.8,28.01,24.47,,28.19,27.23,24.49,,25.62,,,26.33,0.25,0.28,-0.53,1.67,-1.86, ,1.85,0.89,-1.84, ,-0.71, , ,biological regulation;cell death;cellular component assembly;cellular component organization;cellular process;death;immune system process;interspecies interaction between organisms;macromolecular complex assembly;multi-organism process;protein complex assembly;response to abiotic stimulus;response to biotic stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell body;cell part;cell projection;cytosol;death-inducing signaling complex;macromolecular complex;neuron projection;protein complex,,,,,,,,,,
O60427,FADS1,Fatty acid desaturase 1 (EC 1.14.19.-) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase),14,32.9,,,,29.81,29.04,29.07,27.78,28.26,29.31,27.12,26.85,28.42,26.19,28.19, , , ,1.63,0.85,0.89,-0.41,0.07,1.13,-1.06,-1.33,0.23,-2,aging;biological regulation;biosynthetic process;cell communication;cell-cell signaling;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;generation of precursor metabolites and energy;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;signaling;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
O95864,FADS2,Fatty acid desaturase 2 (EC 1.14.19.-) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase),21,42.8,26.03,28.95,27.51,32.91,32.6,32.07,32.48,32,31.46,31.22,29.72,32.3,31.22,30.81,-4.77,-1.85,-3.3,2.1,1.79,1.27,1.67,1.19,0.65,0.42,-1.08,1.5,0.41,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9UNN5,FAF1,FAS-associated factor 1 (hFAF1) (UBX domain-containing protein 12) (UBX domain-containing protein 3A),6,9.8,27.15,26.97,26.62,25.71,27.31,26.34,27.12,26.85,26.7,25.35,25.34,25.2,25.19,26.3,0.85,0.67,0.33,-0.58,1.01,0.04,0.82,0.56,0.41,-0.95,-0.95,-1.09,-1.11,biological regulation;catabolic process;cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of transport,cell part;cytosol;death-inducing signaling complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear envelope;nucleus;organelle;protein complex,,,,,,,,,,
Q96CS3,FAF2,FAS-associated factor 2 (Protein ETEA) (UBX domain-containing protein 3B) (UBX domain-containing protein 8),15,42,31.19,31.13,30.72,30.99,31.14,31.96,31.17,31.15,31.97,31.57,31.02,30.16,32.1,31.25,-0.06,-0.13,-0.53,-0.27,-0.11,0.71,-0.08,-0.1,0.72,0.32,-0.23,-1.09,0.85,response to chemical stimulus;response to stimulus;response to stress,cell part;lipid particle;macromolecular complex;protein complex,,,,,,,,,,
P16930,FAH,Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase),16,47.7,27.46,31.79,29.6,32.11,30.86,31.14,30.19,31.32,30.22,27.66,31.11,31.72,29.35,30.35,-2.89,1.44,-0.75,1.76,0.51,0.79,-0.16,0.97,-0.13,-2.69,0.76,1.37,-0.99,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q6P587,FAHD1,"Acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (YisK-like protein)",11,58,29.16,29.7,30.2,29.18,27.79,29.56,29.38,28.87,30.64,30.51,29.95,30,29.32,29.56,-0.4,0.15,0.65,-0.38,-1.77,0,-0.18,-0.69,1.08,0.95,0.4,0.44,-0.24,,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96GK7,FAHD2A,Fumarylacetoacetate hydrolase domain-containing protein 2A (EC 3.-.-.-),8,40.8,28.81,29.74,29.32,29.77,29.07,29.86,29.26,30.06,29.85,30.15,29.97,28.68,30.11,29.59,-0.78,0.15,-0.27,0.19,-0.52,0.27,-0.32,0.47,0.26,0.56,0.38,-0.91,0.52,,,,,,,,,,,,
Q9NUU6,FAM105A,Inactive ubiquitin thioesterase FAM105A,6,14,25.02,25.13,26.39,27.25,27.77,29.98,29.18,28.99,27.34,,28.4,27.41,29.86,27.73,-2.71,-2.6,-1.34,-0.47,0.04,2.25,1.46,1.26,-0.39, ,0.68,-0.32,2.13,,,,,,,,,,,,
C9J6N5,FAM107B,Protein FAM107B (Fragment),3,31.2,28.25,23.37,27.76,22.08,25.44,,,,25.32,28.24,,23.36,,25.48,2.78,-2.11,2.28,-3.39,-0.04, , , ,-0.16,2.76, ,-2.12, ,,,,,,,,,,,,
Q8IWE2,FAM114A1,Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1),16,37.1,28.01,30.54,30.37,31.38,29.56,30.12,30.32,30.08,29.54,26.54,30.83,31.47,29.65,29.88,-1.87,0.67,0.49,1.5,-0.32,0.24,0.44,0.2,-0.33,-3.33,0.95,1.59,-0.23,,cell part;cytoplasm,,,,,,,,,,
Q9NRY5,FAM114A2,Protein FAM114A2,9,20.4,24.04,27.5,28.47,25.85,24.82,26.27,28.17,26.84,27.9,26.91,27.76,29.14,26.05,26.9,-2.86,0.6,1.57,-1.05,-2.08,-0.63,1.27,-0.06,1,0.01,0.86,2.24,-0.85,,,,,,,,,,,,
Q9Y4C2,FAM115A,Protein FAM115A,7,9.7,,23.73,24.42,28.42,26.66,26.21,26.1,26.68,,23.69,26.65,27.89,24.67,25.92, ,-2.19,-1.5,2.5,0.74,0.29,0.18,0.76, ,-2.23,0.72,1.97,-1.25,,,,,,,,,,,,
Q9NZB2,FAM120A,Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A),31,40.1,29.56,30.88,30.95,30.83,31.13,30.68,31.75,31.25,31.12,30.79,31.29,30.38,31.05,30.9,-1.34,-0.02,0.05,-0.06,0.24,-0.22,0.85,0.36,0.23,-0.11,0.39,-0.51,0.15,,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
A6ZKI3,FAM127A,Protein FAM127A (Mammalian retrotransposon derived protein 8C),4,39.8,25.48,26.11,,27.32,25.26,25.53,27.07,27.23,24.48,24.15,26.62,27.26,26.29,26.07,-0.59,0.04, ,1.25,-0.8,-0.53,1,1.16,-1.59,-1.91,0.55,1.19,0.22,,,,,,,,,,,,
Q9BZQ8,FAM129A,Protein Niban (Cell growth-inhibiting gene 39 protein) (Protein FAM129A),15,20,30.09,28.32,28.09,26.1,27.72,26.32,27.24,28.31,26.75,28.63,27.69,27.69,,27.74,2.34,0.57,0.34,-1.65,-0.02,-1.43,-0.51,0.56,-0.99,0.89,-0.05,-0.05, ,biological regulation;cellular process;regulation of protein modification process;regulation of translation;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q96TA1,FAM129B,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),39,68.2,32.28,31.84,31.49,32.12,32.13,31.43,32.72,32.6,31.54,32.26,33.28,32.65,32.32,32.21,0.07,-0.36,-0.72,-0.08,-0.07,-0.77,0.52,0.4,-0.66,0.05,1.07,0.45,0.11,biological regulation,cell part;cytosol,,,,,,,,,,
Q8NC44,FAM134A,Protein FAM134A,8,27.8,25.44,25.82,24.75,22.34,25.25,25.6,23.53,24.32,24.99,,26.71,26.34,26.29,25.11,0.33,0.7,-0.37,-2.78,0.14,0.48,-1.58,-0.8,-0.13, ,1.6,1.23,1.17,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q86VR2,FAM134C,Protein FAM134C,10,34.8,28.24,27.3,26.06,27.1,28.34,28.54,28.06,28.32,28.63,27.5,29.42,29.13,29.26,28.15,0.1,-0.84,-2.08,-1.05,0.19,0.39,-0.09,0.17,0.49,-0.65,1.27,0.99,1.11,,cell part,,,,,,,,,,
Q96C01,FAM136A,Protein FAM136A,5,23.2,28.2,29.02,27.66,27.58,28.22,28.29,28.35,28.35,28.37,29.65,28.04,26.37,27.98,28.16,0.04,0.86,-0.5,-0.58,0.06,0.13,0.19,0.19,0.21,1.49,-0.12,-1.79,-0.18,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q5W0V3,FAM160B1,Protein FAM160B1,3,5,27.51,27.12,27.77,27.32,23.86,25.08,25.65,25.93,25.81,25.51,26.71,26.59,24.81,26.13,1.38,0.99,1.64,1.19,-2.26,-1.05,-0.47,-0.2,-0.32,-0.62,0.58,0.47,-1.32,,,,,,,,,,,,
Q96A26,FAM162A,Protein FAM162A (E2-induced gene 5 protein) (Growth and transformation-dependent protein) (HGTD-P),10,46.5,31.22,32.02,30.54,29.71,30.14,30.66,28.4,30.21,30.47,30.01,30.42,29.29,30.52,30.28,0.94,1.74,0.26,-0.56,-0.14,0.38,-1.88,-0.06,0.19,-0.27,0.15,-0.98,0.24,biological regulation;cell death;cellular process;death;regulation of organelle organization;response to chemical stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q15018,FAM175B,BRISC complex subunit Abro1 (Abraxas brother protein 1) (Protein FAM175B),4,17.1,26.44,26.27,25.41,27.05,27.53,,27.33,27.18,25.94,,26.95,28.06,25.56,26.7,-0.26,-0.44,-1.3,0.35,0.83, ,0.62,0.48,-0.77, ,0.25,1.36,-1.14,,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q8N128,FAM177A1,Protein FAM177A1,8,36.6,27.08,24.55,27.15,26.99,29.42,28.61,26.41,29.64,26.38,27.36,28.61,28.55,28.48,27.63,-0.55,-3.08,-0.49,-0.64,1.79,0.98,-1.22,2.01,-1.25,-0.27,0.98,0.91,0.85,,,,,,,,,,,,
C9JLW8,FAM195B,Protein FAM195B,4,48.9,26.19,27.11,26.43,27.97,27.84,27.49,28.18,28.06,26.54,24.92,27.54,27.74,27.55,27.2,-1,-0.09,-0.77,0.78,0.64,0.29,0.98,0.87,-0.66,-2.27,0.34,0.54,0.35,,,,,,,,,,,,
Q9BTY7,FAM203A,Protein FAM203A (Brain protein 16),3,15.1,26.58,25.87,25.34,27.93,27.16,24.72,26.72,27.75,24.28,25.81,27.64,27.72,25.14,26.36,0.22,-0.49,-1.02,1.57,0.81,-1.64,0.36,1.39,-2.08,-0.55,1.28,1.36,-1.22,,,,,,,,,,,,
O75063,FAM20B,Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Protein FAM20B) (Xylose kinase),4,13.4,,25.82,,27.39,,26.81,,26.17,24.98,26.2,26.61,23.41,27.74,26.12, ,-0.3, ,1.26, ,0.68, ,0.04,-1.14,0.07,0.49,-2.71,1.61,,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q96ND0,FAM210A,Protein FAM210A,4,21.6,25.49,25.75,25.83,24.47,25.06,27.31,26.11,24.27,26.51,29.51,25.27,25.99,,25.96,-0.47,-0.22,-0.13,-1.49,-0.91,1.34,0.15,-1.69,0.54,3.55,-0.7,0.02, ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9BRX8,FAM213A,Redox-regulatory protein FAM213A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM),9,41.7,30.3,30.12,29.68,27.45,26.83,28.33,27.87,27.91,27.77,33.61,27.08,26.69,27.57,28.55,1.75,1.56,1.13,-1.11,-1.73,-0.23,-0.68,-0.65,-0.79,5.06,-1.47,-1.86,-0.99,biological regulation;metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8TBF2,FAM213B,Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Protein FAM213B),4,24.7,28.8,28.43,26.66,28.67,29.32,29.21,28.47,28.63,28.08,28.03,26.83,,27.82,28.25,0.56,0.18,-1.58,0.42,1.08,0.97,0.22,0.38,-0.16,-0.22,-1.42, ,-0.43,cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q641Q2,FAM21A,WASH complex subunit FAM21A,26,29.6,27.29,27.47,28.62,28.25,28.76,26.72,28.49,28.52,27.98,26.79,29.06,30.37,27.43,28.13,-0.85,-0.66,0.48,0.12,0.62,-1.42,0.36,0.39,-0.16,-1.35,0.92,2.23,-0.71,cellular process;endosome transport;establishment of localization;transport;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q92520,FAM3C,Protein FAM3C (Interleukin-like EMT inducer),9,44.1,29.85,29.16,29.47,29.7,27.44,29.04,28.69,28.27,28.21,29.52,27.66,26.18,28.58,28.6,1.26,0.56,0.87,1.1,-1.16,0.44,0.09,-0.33,-0.39,0.93,-0.94,-2.42,-0.01,developmental process;multicellular organismal development;multicellular organismal process,cell part;cytoplasmic membrane-bounded vesicle;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9H0Q0,FAM49A,Protein FAM49A,2,10.2,21.96,22.83,25.75,,23.38,,,22.43,20.58,,22.77,,,22.81,-0.86,0.02,2.93, ,0.57, , ,-0.39,-2.24, ,-0.04, , ,,cell part;intracellular,,,,,,,,,,
Q9NUQ9,FAM49B,Protein FAM49B (L1),14,43.2,31.19,31.21,30.82,29.93,29.71,29.68,29.66,30,29.88,29.94,29.63,30.5,29.32,30.11,1.08,1.1,0.7,-0.18,-0.4,-0.43,-0.45,-0.12,-0.24,-0.17,-0.48,0.38,-0.79,,cell part;cell projection;cilium,,,,,,,,,,
Q14320,FAM50A,Protein FAM50A (Protein HXC-26) (Protein XAP-5),4,15.3,27.57,28.34,28.12,27.99,27.19,25.95,28.8,26.91,28.55,26.11,27.86,28.39,28.19,27.69,-0.12,0.65,0.43,0.3,-0.5,-1.74,1.11,-0.78,0.86,-1.58,0.17,0.69,0.5,multicellular organismal process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q6ZS17,FAM65A,Protein FAM65A,10,7.6,24.09,25.06,24.93,26.19,28.16,25.85,27.29,27.05,25.98,,27.78,28.03,26.64,26.42,-2.33,-1.36,-1.49,-0.23,1.74,-0.57,0.87,0.63,-0.44, ,1.36,1.6,0.22,,cell part;cytoplasm,,,,,,,,,,
Q7L4E1,FAM73B,Protein FAM73B,3,7.1,21.15,21.78,,22.34,25.25,25.64,23.21,23.96,,,24.88,25.6,23.95,23.78,-2.63,-2, ,-1.44,1.48,1.87,-0.57,0.19, , ,1.1,1.83,0.17,,cell part,,,,,,,,,,
Q6ZRV2,FAM83H,Protein FAM83H,37,33.6,29.4,25.68,26.13,26.78,26.78,24.65,26.64,26.45,24.65,27.87,25.67,26.75,24.98,26.34,3.06,-0.66,-0.21,0.44,0.44,-1.69,0.3,0.11,-1.69,1.53,-0.67,0.41,-1.36,anatomical structure development;developmental process,,,,,,,,,,,
Q658Y4,FAM91A1,Protein FAM91A1,9,18.5,27.38,26.62,,27,25.36,27.08,24.49,26.44,25.44,26.43,26.68,26.09,26.66,26.31,1.07,0.32, ,0.7,-0.94,0.78,-1.81,0.13,-0.87,0.12,0.38,-0.22,0.36,,,,,,,,,,,,
Q9H5X1,FAM96A,MIP18 family protein FAM96A,2,22.5,23.5,25.62,24.75,24.52,25,,24.71,24.91,,22.39,,,,24.42,-0.92,1.19,0.32,0.09,0.58, ,0.29,0.48, ,-2.03, , , ,cellular process;chromosome segregation,cell part;cytoplasm,,,,,,,,,,
Q9Y3D0,FAM96B,Mitotic spindle-associated MMXD complex subunit MIP18 (MSS19-interacting protein of 18 kDa) (Protein FAM96B),3,31.1,26.48,26.11,26.93,27.03,27.68,26.01,27.16,27.4,23.1,22.31,27.14,27.68,25.01,26.16,0.33,-0.04,0.78,0.87,1.52,-0.14,1,1.24,-3.06,-3.85,0.98,1.52,-1.15,cellular process;chromosome segregation;metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q8NCA5,FAM98A,Protein FAM98A,5,14.5,27.95,28.63,27.35,29.45,29.47,28.68,29.37,29.06,29.03,28.97,29.86,28.79,28.76,28.87,-0.92,-0.25,-1.53,0.58,0.59,-0.19,0.5,0.18,0.15,0.1,0.98,-0.08,-0.12,,,,,,,,,,,,
Q52LJ0,FAM98B,Protein FAM98B,8,25.9,29.88,29.7,30.16,29.44,28.86,29.3,29.36,27.18,28.99,27.75,27.59,28.38,28.1,28.82,1.05,0.88,1.33,0.62,0.04,0.48,0.53,-1.64,0.17,-1.07,-1.23,-0.44,-0.72,,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9NVI1,FANCI,Fanconi anemia group I protein (Protein FACI),7,8.9,26.5,,24.98,,26.3,21.82,25.15,25.89,22.69,24.42,20.97,23.33,25.4,24.31,2.19, ,0.66, ,1.98,-2.49,0.84,1.58,-1.63,0.11,-3.34,-0.99,1.09,biological regulation;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;membrane;nucleoplasm;plasma membrane,,,,,,,,,,
Q12884,FAP,Seprase (EC 3.4.21.-) (170 kDa melanoma membrane-bound gelatinase) (Fibroblast activation protein alpha) (Integral membrane serine protease),7,11.7,24.93,29.19,26.98,27.91,29.45,29.77,26.7,27.48,28.01,28.43,26.54,,29.38,27.9,-2.97,1.29,-0.92,0.01,1.55,1.87,-1.19,-0.42,0.11,0.53,-1.35, ,1.48,biological regulation;cell motility;cellular component movement;cellular process;locomotion;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cell projection;extracellular space,,,,,,,,,,
Q8WVX9,FAR1,Fatty acyl-CoA reductase 1 (EC 1.2.1.n2) (Male sterility domain-containing protein 2),6,14.4,,,26.52,26.41,28.45,27.98,27.09,28.03,27.59,28.61,25.48,26.99,27.69,27.35, , ,-0.83,-0.94,1.11,0.63,-0.26,0.68,0.24,1.26,-1.87,-0.36,0.34,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle,,,,,,,,,,
Q9Y4F1,FARP1,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",18,23.2,25.43,26.21,26.69,26.13,25.66,27.03,,26.89,28.27,30.36,25.92,27.06,28.27,26.99,-1.57,-0.78,-0.3,-0.86,-1.34,0.04, ,-0.1,1.27,3.37,-1.07,0.07,1.27,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;developmental process,cell part;cell projection;cytoskeleton;cytosol;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;organelle;synapse,,,,,,,,,,
O95363,FARS2,"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)",3,9.5,26.1,,24.68,25.04,26.67,,25.77,25.46,25.46,,,24.09,25.06,25.37,0.73, ,-0.69,-0.33,1.3, ,0.4,0.09,0.09, , ,-1.28,-0.31,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;RNA processing;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process;tRNA processing,cell part,,,,,,,,,,
Q9Y285,FARSA,Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS),22,50.4,30.95,30.99,29.81,30.93,30.67,29.84,30.45,31.03,29.67,30.16,30.23,29.19,29.42,30.26,0.69,0.74,-0.45,0.67,0.41,-0.42,0.2,0.77,-0.59,-0.1,-0.03,-1.07,-0.84,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
Q9NSD9,FARSB,Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS),25,40.7,31.56,31.15,31.48,31.3,31.03,30.2,31.23,31.44,30.43,31.21,31.27,30.87,30.34,31.04,0.52,0.11,0.44,0.26,-0.01,-0.84,0.19,0.4,-0.61,0.17,0.23,-0.17,-0.7,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
P25445,FAS,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),8,35.7,27.02,27.85,28.06,27.42,26.7,28.01,27.73,27.84,27.91,29.44,28.88,25.99,28.5,27.8,-0.77,0.05,0.27,-0.38,-1.09,0.21,-0.07,0.05,0.11,1.64,1.08,-1.8,0.7,anatomical structure development;biological regulation;cell death;cellular component assembly;cellular component organization;cellular process;death;developmental process;immune system process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;protein complex assembly;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress,cell part;cytosol;death-inducing signaling complex;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P49327,FASN,Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38);[Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39);3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41);3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100);3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59);Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39);Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)],126,60.1,31.91,33.48,32.86,36.14,35.6,34.51,36.22,36,34.22,34.41,34.75,35.75,33.91,34.6,-2.69,-1.11,-1.74,1.54,1,-0.09,1.62,1.41,-0.38,-0.18,0.16,1.15,-0.69,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;energy reserve metabolic process;generation of precursor metabolites and energy;glycerol ether metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytoplasmic membrane-bounded vesicle;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9NYY8,FASTKD2,FAST kinase domain-containing protein 2,6,11.1,28.21,24.7,26.65,26.44,27.12,26.69,27.34,26.06,25.22,27.25,,27.46,24.28,26.45,1.76,-1.75,0.19,-0.01,0.67,0.24,0.89,-0.39,-1.23,0.8, ,1.01,-2.17,cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q7L8L6,FASTKD5,FAST kinase domain-containing protein 5,4,8.2,27.51,26.01,25.58,27.04,26.33,26.07,25.92,27.18,27.07,23.52,25.7,26.63,26.01,26.2,1.31,-0.18,-0.62,0.84,0.13,-0.13,-0.28,0.98,0.87,-2.68,-0.5,0.44,-0.19,cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P62861,FAU,40S ribosomal protein S30,3,20.3,30.2,28.18,30.52,30.89,31.61,30.61,31.27,31.7,30.57,31.13,31.21,31.64,30.86,30.8,-0.6,-2.62,-0.27,0.09,0.82,-0.19,0.47,0.9,-0.23,0.33,0.41,0.84,0.06,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P22087,FBL,rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen),20,72.7,33.03,31.34,32.29,31.49,32.67,32.57,31.96,31.84,32.48,32.08,31.04,31.84,32.47,32.08,0.95,-0.75,0.21,-0.6,0.59,0.48,-0.12,-0.24,0.4,-0.01,-1.05,-0.24,0.39,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing;tRNA metabolic process;tRNA processing,cell part;macromolecular complex;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
Q8WUP2,FBLIM1,Filamin-binding LIM protein 1 (FBLP-1) (Migfilin) (Mitogen-inducible 2-interacting protein) (MIG2-interacting protein),5,25,26.45,26.21,26.08,28.3,27.4,28.05,28.16,28.47,26.42,,28.18,25.51,26.04,27.11,-0.66,-0.89,-1.03,1.2,0.29,0.94,1.06,1.37,-0.69, ,1.07,-1.59,-1.06,biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process,cell cortex;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P23142,FBLN1,Fibulin-1 (FIBL-1),3,7.1,23.18,27.61,25,26.87,25.57,27.74,24.64,25.28,27.79,26.4,25.72,,29,26.23,-3.05,1.37,-1.23,0.64,-0.66,1.5,-1.6,-0.95,1.56,0.17,-0.51, ,2.77,cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization;interspecies interaction between organisms;multi-organism process,extracellular matrix;extracellular space;proteinaceous extracellular matrix,,,,,,,,,,
Q2TU34,FBP1,"Fructose-1,6-bisphosphatase 1 (Growth-inhibiting protein 17) (cDNA FLJ75786, highly similar to Homo sapiens fructose-1,6-bisphosphatase 1 (FBP1), mRNA)",16,51.2,22.3,30.97,30.32,24.22,,,25.74,24.97,,,,27.7,24.74,26.37,-4.07,4.6,3.95,-2.15, , ,-0.63,-1.4, , , ,1.33,-1.63,carbohydrate metabolic process;metabolic process;primary metabolic process,,,,,,,,,,,
Q9UK22,FBXO2,F-box only protein 2,6,27.4,29.75,28.49,26.01,26.73,,26.04,28.21,28.03,25.91,25.92,28.99,26.58,26.09,27.23,2.52,1.26,-1.22,-0.5, ,-1.18,0.98,0.8,-1.32,-1.31,1.76,-0.65,-1.14,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process,cell part;cell projection;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q8NEZ5,FBXO22,F-box only protein 22 (F-box protein FBX22p44),2,7.5,,24.5,22.76,,25.03,26.96,24.91,25.81,25.5,,,,24.69,25.02, ,-0.51,-2.26, ,0.01,1.94,-0.11,0.79,0.48, , , ,-0.33,biological regulation;catabolic process;cell communication;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;nuclear transport;nucleocytoplasmic transport;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NVF7,FBXO28,F-box only protein 28,2,6.5,,,,23.47,24.71,22.61,,23.77,24.47,25.79,,,24.23,24.15, , , ,-0.68,0.56,-1.54, ,-0.38,0.32,1.64, , ,0.08,,,,,,,,,,,,
Q9Y3I1,FBXO7,F-box only protein 7,3,19.3,23.92,25.42,,26.14,26.33,,27.28,27.23,25.16,25.67,23.61,26.58,23.3,25.51,-1.6,-0.09, ,0.63,0.82, ,1.77,1.72,-0.36,0.15,-1.9,1.07,-2.21,biological regulation;catabolic process;cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein stability,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
P55899,FCGRT,IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor),6,17.3,23.92,28.93,28.97,26.36,24.27,26.28,25.17,24.86,26.64,26.71,27.36,28.72,26.69,26.53,-2.61,2.4,2.44,-0.17,-2.26,-0.25,-1.36,-1.67,0.11,0.18,0.83,2.19,0.16,cellular process;establishment of localization;immune system process;response to stimulus;transport;vesicle-mediated transport,cell part;macromolecular complex;MHC protein complex;protein complex,,,,,,,,,,
Q0JRZ9,FCHO2,FCH domain only protein 2,8,16.4,28.26,26.04,25.11,26.55,26.57,24.37,23.97,,,25.88,26.3,,24.87,25.79,2.47,0.25,-0.69,0.76,0.78,-1.42,-1.83, , ,0.09,0.51, ,-0.92,cellular component assembly;cellular component organization;cellular localization;cellular macromolecular complex assembly;cellular membrane organization;cellular process;endocytosis;establishment of localization;localization;macromolecular complex assembly;membrane invagination;membrane organization;organelle organization;plasma membrane organization;protein complex assembly;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
P37268,FDFT1,Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase),29,59,26.5,30.43,28.52,32.24,31.78,31.74,31.93,31.64,32.21,31.85,28.16,30.03,30.41,30.57,-4.07,-0.14,-2.06,1.66,1.21,1.17,1.36,1.07,1.64,1.28,-2.41,-0.55,-0.16,alcohol metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P14324,FDPS,"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)",13,43.1,30.42,30.76,30.37,32.32,31.5,31.6,32.89,32.15,31.47,31.02,31.73,32.37,30.07,31.44,-1.02,-0.67,-1.06,0.88,0.07,0.16,1.45,0.71,0.03,-0.42,0.29,0.94,-1.37,alcohol metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;interspecies interaction between organisms;lipid metabolic process;metabolic process;multi-organism process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P10109,FDX1,"Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1) (Hepatoredoxin)",4,18.5,26.29,24.95,26.56,24.36,,26.21,24.5,,25.93,,,,27.12,25.74,0.56,-0.79,0.82,-1.38, ,0.47,-1.24, ,0.2, , , ,1.38,alcohol metabolic process;biological regulation;biosynthetic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P22570,FDXR,"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)",20,42,29.12,29.22,30.45,29.85,30.94,31.53,31.19,30.72,31.56,31.34,30.84,30.76,31.86,30.72,-1.6,-1.5,-0.27,-0.87,0.22,0.8,0.47,0,0.84,0.62,0.12,0.03,1.14,alcohol metabolic process;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;generation of precursor metabolites and energy;heterocycle metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P22830,FECH,"Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)",13,41.8,25.37,29.14,27.49,29.3,29.1,30.49,29.95,30.23,31.18,29.95,29.54,30.61,30.82,29.47,-4.11,-0.33,-1.99,-0.18,-0.37,1.02,0.48,0.76,1.7,0.48,0.06,1.14,1.34,alcohol metabolic process;biological regulation;biosynthetic process;cell differentiation;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;detection of stimulus;developmental process;generation of precursor metabolites and energy;heterocycle metabolic process;homeostatic process;lipid metabolic process;macromolecular complex assembly;metabolic process;multicellular organismal process;nitrogen compound metabolic process;pigment metabolic process;primary metabolic process;regulation of protein modification process;response to abiotic stimulus;response to external stimulus;response to stimulus;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P39748,FEN1,Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1),13,39.5,30.5,29.79,30.4,30.52,31,30.42,30.88,30.89,31.1,29.88,28.77,30.22,29.81,30.32,0.18,-0.53,0.08,0.2,0.67,0.1,0.56,0.57,0.78,-0.44,-1.56,-0.1,-0.51,behavior;biological regulation;biosynthetic process;catabolic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mitotic cell cycle;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;signal transduction;telomere organization,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q96AC1,FERMT2,Fermitin family homolog 2 (Kindlin-2) (Mitogen-inducible gene 2 protein) (MIG-2) (Pleckstrin homology domain-containing family C member 1) (PH domain-containing family C member 1),21,40.9,28.84,30.58,30.1,31.54,29.41,31.39,30.27,31.05,29.62,28.59,29.77,30.51,29.16,30.07,-1.23,0.51,0.04,1.48,-0.65,1.33,0.21,0.99,-0.45,-1.48,-0.29,0.44,-0.9,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell morphogenesis;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular localization;cellular membrane organization;cellular process;cytoskeleton organization;developmental process;localization;macromolecular complex assembly;membrane organization;organelle organization;protein complex assembly;response to stimulus;signal transduction,cell cortex;cell part;cell surface;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q96M96,FGD4,"FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6)",9,17.1,27.9,25.03,24.06,26.42,27.8,27.55,27.19,26.23,27.84,26.23,27.87,23.45,25.8,26.41,1.49,-1.38,-2.35,0,1.39,1.14,0.78,-0.18,1.42,-0.18,1.45,-2.96,-0.62,biological regulation;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;organelle organization;response to stimulus;signal transduction,cell part;cell projection;cytoskeleton;cytosol;filopodium;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P09038,FGF2,Fibroblast growth factor 2 (FGF-2) (Basic fibroblast growth factor) (bFGF) (Heparin-binding growth factor 2) (HBGF-2),5,29.7,,29.48,27.24,29.99,,28.7,27.25,24.81,26.1,27.01,27.38,23.15,27.96,27.19, ,2.29,0.05,2.8, ,1.51,0.06,-2.38,-1.09,-0.17,0.19,-4.04,0.77,amine metabolic process;anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell communication;cell death;cell development;cell differentiation;cell motility;cell-cell signaling;cellular component movement;cellular homeostasis;cellular ion homeostasis;cellular lipid metabolic process;cellular metabolic process;cellular process;death;developmental process;establishment of localization;homeostatic process;hormone metabolic process;immune system process;ion transport;lipid metabolic process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nuclear transport;nucleocytoplasmic transport;phosphorus metabolic process;polysaccharide metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein targeting;protein transport;regulation of cell cycle;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;signaling;transport,cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q14512,FGFBP1,Fibroblast growth factor-binding protein 1 (FGF-BP) (FGF-BP1) (FGF-binding protein 1) (FGFBP-1) (17 kDa heparin-binding growth factor-binding protein) (17 kDa HBGF-binding protein) (HBp17),4,27.8,29.42,27.94,,,27.08,,24.68,,25.31,29.67,25.27,,25.4,26.85,2.57,1.09, , ,0.23, ,-2.17, ,-1.53,2.83,-1.57, ,-1.45,biological regulation;cell communication;cell-cell signaling;cellular process;response to stimulus;signal transduction;signaling,cell part;cell surface;extracellular space;membrane;plasma membrane,,,,,,,,,,
O95684,FGFR1OP,FGFR1 oncogene partner,3,15,27.3,,26.81,26.22,26.7,25.9,24.67,26.78,25.42,,,,,26.23,1.08, ,0.58,-0.01,0.48,-0.32,-1.56,0.55,-0.8, , , , ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
P07954,FH,"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)",29,63.8,32.09,31.98,32.38,32.23,32.73,32.92,32.36,32.38,32.82,32.63,32.23,32.35,32.34,32.42,-0.33,-0.44,-0.04,-0.18,0.32,0.5,-0.06,-0.04,0.4,0.21,-0.18,-0.07,-0.08,biological regulation;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;homeostatic process;metabolic process;organic acid metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;tricarboxylic acid cycle enzyme complex,,,,,,,,,,
Q13642,FHL1,Four and a half LIM domains protein 1 (FHL-1) (Skeletal muscle LIM-protein 1) (SLIM) (SLIM-1),4,27.7,27.78,26.72,28.78,24.61,28.33,28.43,29.29,28.76,28.95,26.18,28.69,,27.59,27.84,-0.06,-1.12,0.93,-3.24,0.49,0.58,1.45,0.92,1.11,-1.66,0.85, ,-0.25,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell differentiation;cellular process;developmental process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of transport,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q14192,FHL2,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),5,21.9,28.57,28.29,28.88,29.09,26.82,27.24,27.69,27.36,27.83,27.36,28.17,,26.36,27.8,0.77,0.48,1.07,1.29,-0.99,-0.57,-0.11,-0.44,0.02,-0.45,0.37, ,-1.45,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cell development;cell differentiation;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
Q4L180,FILIP1L,Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1) (DOC-1),10,16.5,26.52,27.04,17.4,27.75,23.41,26.04,20.62,25.2,27.54,23.27,23.45,28.25,,24.71,1.81,2.33,-7.31,3.04,-1.3,1.33,-4.08,0.49,2.84,-1.44,-1.26,3.54, ,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
Q6UN15,FIP1L1,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),17,35.9,29.42,26.62,28.85,28.53,28.29,28.21,28.07,28.29,28.71,28.86,27.46,28.22,27.75,28.25,1.17,-1.63,0.6,0.28,0.03,-0.04,-0.19,0.04,0.46,0.61,-0.8,-0.03,-0.5,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mRNA cleavage factor complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9Y3D6,FIS1,Mitochondrial fission 1 protein (FIS1 homolog) (hFis1) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11),7,42.8,29.91,29.87,30.87,29.66,29.74,30.01,29.83,29.18,30.29,29.51,29.86,30.46,30.02,29.94,-0.03,-0.07,0.93,-0.28,-0.2,0.07,-0.11,-0.76,0.35,-0.43,-0.08,0.52,0.08,anatomical structure morphogenesis;autophagy;biological regulation;catabolic process;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;macromolecular complex assembly;metabolic process;mitochondrion organization;organelle fission;organelle organization;protein complex assembly;protein targeting;protein transport;regulation of organelle organization;response to stimulus;signal transduction;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q96AY3,FKBP10,Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (65 kDa FK506-binding protein) (65 kDa FKBP) (FKBP-65) (FK506-binding protein 10) (FKBP-10) (Immunophilin FKBP65) (Rotamase),32,56.2,29.68,33.76,31.37,33.19,32.42,33.38,32.17,32.26,33.94,31.12,32.13,31.96,32.66,32.31,-2.63,1.45,-0.94,0.88,0.11,1.07,-0.14,-0.05,1.63,-1.2,-0.18,-0.35,0.35,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;membrane,,,,,,,,,,
Q9NYL4,FKBP11,Peptidyl-prolyl cis-trans isomerase FKBP11 (PPIase FKBP11) (EC 5.2.1.8) (19 kDa FK506-binding protein) (19 kDa FKBP) (FKBP-19) (FK506-binding protein 11) (FKBP-11) (Rotamase),3,32.2,25.99,30.89,29.1,30.05,30.46,31.13,30.11,30.25,31.42,29.05,29.69,30.39,30.23,29.9,-3.92,0.99,-0.8,0.15,0.55,1.23,0.21,0.34,1.52,-0.86,-0.22,0.48,0.32,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;membrane,,,,,,,,,,
Q9NWM8,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),2,12.3,,26.35,24.22,27.3,24.89,26.54,24.33,24.57,27,26.31,22.4,27.34,27.3,25.71, ,0.64,-1.5,1.59,-0.82,0.83,-1.38,-1.14,1.28,0.6,-3.32,1.63,1.59,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process,cell part;membrane,,,,,,,,,,
Q5T1M5,FKBP15,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),18,22.4,25.13,28.41,29.85,27.92,27.6,27.71,27.46,28.87,25.77,27.66,27.49,28.13,26.06,27.54,-2.42,0.86,2.31,0.37,0.05,0.17,-0.08,1.33,-1.77,0.12,-0.05,0.58,-1.48,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;establishment of localization;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;primary metabolic process;protein folding;protein metabolic process;transport;vesicle-mediated transport,cell part;cell projection;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;organelle;protein complex;site of polarized growth,,,,,,,,,,
P62942,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase),6,83.3,29.96,30.88,30.8,30.85,29.69,30.13,31.14,30.85,30.26,28.55,30.9,30.32,28.36,30.21,-0.25,0.68,0.59,0.65,-0.52,-0.08,0.93,0.64,0.05,-1.65,0.69,0.12,-1.85,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;catabolic process;cell activation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein maturation;protein metabolic process;regulation of protein modification process;regulation of transport;response to stimulus;signal transduction,cell part;cell projection;cytosol;membrane;neuron projection,,,,,,,,,,
P26885,FKBP2,Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase),9,65.5,30.97,31.38,29.91,30.64,30.78,30.67,30.17,30.33,30.84,30.53,30.3,30.93,30.66,30.62,0.34,0.76,-0.71,0.02,0.16,0.04,-0.45,-0.3,0.21,-0.09,-0.32,0.31,0.04,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q00688,FKBP3,Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase),16,46,31.44,31.28,31.39,31.62,31.24,31.01,31.62,31.66,30.66,31.56,31.1,31.19,30.15,31.23,0.22,0.05,0.16,0.4,0.02,-0.21,0.4,0.44,-0.56,0.34,-0.12,-0.03,-1.07,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q02790,FKBP4,"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]",36,71.2,33.74,32.16,32.2,32.48,31.85,31.04,32.32,32.34,30.86,30.98,31.31,31.54,29.99,31.76,1.99,0.41,0.45,0.73,0.09,-0.72,0.56,0.58,-0.89,-0.77,-0.45,-0.21,-1.76,anatomical structure development;biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;developmental process;establishment of localization;ion transport;localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;regulation of organelle organization;response to stimulus;signal transduction;transport,cell body;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;neuronal cell body;nucleus;organelle;protein complex;site of polarized growth,,,,,,,,,,
Q13451,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5) (FKBP-5) (FKBP54) (p54) (HSP90-binding immunophilin) (Rotamase),34,69.6,29.22,30.58,31.09,31.84,31.69,32.07,31.53,32.47,32.27,27.26,31.61,30.74,31.43,31.06,-1.84,-0.48,0.02,0.78,0.62,1.01,0.47,1.41,1.21,-3.8,0.55,-0.32,0.37,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9Y680,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7 (PPIase FKBP7) (EC 5.2.1.8) (23 kDa FK506-binding protein) (23 kDa FKBP) (FKBP-23) (FK506-binding protein 7) (FKBP-7) (Rotamase),8,37.1,,28.44,24.99,27.9,,26.92,,26.14,28.82,25.07,,,26.69,26.87, ,1.57,-1.88,1.03, ,0.05, ,-0.74,1.95,-1.81, , ,-0.18,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q14318,FKBP8,Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase),7,30.3,29.32,29.77,29.31,29.67,29.93,30.97,29.45,29.08,30.23,29.93,29.93,29.26,29.66,29.73,-0.41,0.03,-0.42,-0.07,0.2,1.24,-0.28,-0.65,0.5,0.2,0.2,-0.47,-0.07,biological regulation;cell death;cellular metabolic process;cellular process;death;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein folding;protein metabolic process;response to stimulus;signal transduction,cell part;membrane;mitochondrial envelope,,,,,,,,,,
O95302,FKBP9,Peptidyl-prolyl cis-trans isomerase FKBP9 (PPIase FKBP9) (EC 5.2.1.8) (63 kDa FK506-binding protein) (63 kDa FKBP) (FKBP-63) (FK506-binding protein 9) (FKBP-9) (Rotamase),16,31.8,30.25,31.67,30.8,31.1,29.83,29.57,29.74,28.75,31.33,31.14,30.94,30.27,30.78,30.48,-0.23,1.2,0.33,0.62,-0.65,-0.9,-0.73,-1.72,0.85,0.67,0.46,-0.21,0.31,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8NFF5,FLAD1,FAD synthase (EC 2.7.7.2) (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region;FAD synthase region],10,34.8,29.2,28.05,27.65,25.44,24.96,24.64,26.43,27.66,24.58,27.61,26.41,24.93,26.93,26.5,2.7,1.55,1.15,-1.06,-1.54,-1.86,-0.07,1.16,-1.92,1.11,-0.09,-1.57,0.43,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;prosthetic group metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
Q13045,FLII,Protein flightless-1 homolog,37,34.6,30.71,31.88,31.5,31.38,31.65,30.58,32.83,32.51,30.26,31.6,32.46,32.34,31.33,31.62,-0.9,0.26,-0.12,-0.23,0.03,-1.04,1.21,0.9,-1.36,-0.02,0.84,0.72,-0.29,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;muscle contraction;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
Q8TEP9,FLJ00144,FLJ00144 protein (Fragment),2,11.8,,,,26.9,,27.44,27.81,,27.86,27.73,27.97,,27.41,27.59, , , ,-0.69, ,-0.15,0.22, ,0.27,0.14,0.38, ,-0.18,,,,,,,,,,,,
Q6ZNJ9,FLJ00319,FLJ00319 protein (Fragment),8,21.1,26.74,28.62,28.36,27.59,26.56,28.27,27.53,27.8,27.29,26.25,28.3,28.8,26.98,27.62,-0.89,1,0.73,-0.03,-1.06,0.65,-0.1,0.18,-0.33,-1.37,0.68,1.18,-0.64,,,,,,,,,,,,
O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),193,73.8,28.53,28.71,28.34,29.04,29.04,,28.64,28.52,29.98,,27.84,30.27,29.77,28.97,-0.44,-0.26,-0.63,0.06,0.07, ,-0.34,-0.45,1.01, ,-1.13,1.3,0.79,anatomical structure development;biological regulation;cell differentiation;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization;response to chemical stimulus;response to stimulus;signal transduction,cell cortex;cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q14315,FLNC,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),164,69.2,29.94,34.89,34.06,35.54,35.2,35.21,36.11,35.89,33.72,30.21,36.27,35.95,35.92,34.53,-4.59,0.35,-0.48,1.01,0.67,0.68,1.58,1.36,-0.81,-4.32,1.74,1.42,1.39,anatomical structure development;cell development;cell junction organization;cellular component assembly;cellular component organization;cellular process;developmental process,cell part;cytoplasm;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
O75955,FLOT1,Flotillin-1,25,66.5,32.56,31.43,31.61,31.13,31.91,32.27,31.94,31.53,32.03,30.22,31.65,31.19,31.99,31.65,0.91,-0.22,-0.04,-0.52,0.26,0.62,0.28,-0.12,0.38,-1.44,0,-0.46,0.34,anatomical structure morphogenesis;biological regulation;cellular component morphogenesis;cellular component organization;cellular localization;cellular membrane organization;cellular process;developmental process;localization;membrane organization;plasma membrane organization,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
Q14254,FLOT2,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),29,64.3,32.17,31.17,31.78,30.99,32,31.73,31.45,31.39,31.74,31.46,31.7,31.88,31.9,31.64,0.53,-0.48,0.14,-0.65,0.36,0.09,-0.19,-0.25,0.09,-0.19,0.05,0.24,0.26,anatomical structure development;biological adhesion;cell adhesion;cellular process;developmental process,cell part;cell surface;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
Q96PY5,FMNL2,Formin-like protein 2 (Formin homology 2 domain-containing protein 2),8,9.9,25.63,25.93,26.45,24.66,26.63,27.84,27.59,25.55,28.55,27.72,24.69,26.03,27.36,26.51,-0.87,-0.58,-0.06,-1.85,0.12,1.33,1.08,-0.96,2.04,1.21,-1.82,-0.48,0.85,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cytoplasm,,,,,,,,,,
Q06787,FMR1,Fragile X mental retardation protein 1 (FMRP) (Protein FMR-1),8,13.9,28.84,28.3,28.84,28.29,27.38,27.9,27.13,28.64,27.55,27.56,25.68,26.92,26.41,27.65,1.19,0.65,1.19,0.64,-0.27,0.25,-0.52,0.99,-0.1,-0.09,-1.96,-0.73,-1.24,anatomical structure development;biological regulation;developmental process;establishment of localization;nucleobase-containing compound transport;regulation of translation;transport,cell part;cell projection;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;nucleolus;nucleoplasm;organelle;protein complex;ribonucleoprotein complex;synapse,,,,,,,,,,
P02751,FN1,Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin;Ugl-Y1;Ugl-Y2;Ugl-Y3],150,68.9,,31.06,26.17,31.46,32.41,32.83,30.7,31.58,32.44,27.54,30.84,25.59,32.51,30.43, ,0.63,-4.26,1.03,1.98,2.4,0.27,1.15,2.01,-2.89,0.41,-4.84,2.08,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell junction organization;cell morphogenesis;cell motility;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;extracellular matrix organization;extracellular structure organization;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;extracellular matrix;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;proteinaceous extracellular matrix,,,,,,,,,,
Q9HA64,FN3KRP,Ketosamine-3-kinase (EC 2.7.1.-) (Fructosamine-3-kinase-related protein) (FN3K-RP) (FN3K-related protein),3,9.2,27.5,24.85,26.8,26.28,25.58,26.02,26.56,26.72,,24.73,27.39,28.53,24.63,26.3,1.2,-1.45,0.5,-0.02,-0.72,-0.28,0.27,0.42, ,-1.57,1.09,2.23,-1.67,,,,,,,,,,,,
Q5T0N5,FNBP1L,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),5,14.8,26.29,24.75,,25.12,,,25.22,,24.16,24.81,24.98,,,25.05,1.24,-0.3, ,0.07, , ,0.17, ,-0.88,-0.24,-0.07, , ,autophagy;biological regulation;catabolic process;cellular component movement;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;establishment of localization;localization;membrane invagination;membrane organization;metabolic process;organelle localization;organelle organization;transport;vesicle organization;vesicle-mediated transport,cell cortex;cell part;cytoplasmic membrane-bounded vesicle;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9Y2H6,FNDC3A,Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts),17,20.1,29.47,29.72,29.64,29.29,28.54,29.62,29.94,28.71,30.21,29.26,28.31,28.14,29.34,29.25,0.23,0.47,0.39,0.04,-0.7,0.38,0.69,-0.53,0.96,0.01,-0.93,-1.1,0.09,anatomical structure development;biological adhesion;cell adhesion;cell development;cellular process;developmental process,cell part;cytoplasmic membrane-bounded vesicle;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q53EP0,FNDC3B,Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37),26,21.7,29.97,29.73,29.65,30.5,29.44,30.26,29.97,29.29,30.66,31.11,28.97,29.01,30.36,29.92,0.06,-0.19,-0.26,0.58,-0.48,0.35,0.05,-0.63,0.74,1.19,-0.94,-0.91,0.45,biological regulation,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P49354,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha),6,17.2,28.22,28.59,27.54,28.28,27.98,25.71,27.11,28.42,26.32,25.9,28.02,29.55,27.1,27.6,0.62,1,-0.06,0.68,0.39,-1.88,-0.49,0.82,-1.27,-1.7,0.42,1.95,-0.5,biological regulation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P15407,FOSL1,Fos-related antigen 1 (FRA-1),2,6.3,24.93,,23.85,18.92,21.95,21.84,22.19,22.81,22.18,23.72,22.75,,22.88,22.55,2.38, ,1.31,-3.63,-0.6,-0.71,-0.36,0.26,-0.37,1.17,0.2, ,0.33,anatomical structure development;behavior;biological regulation;biosynthetic process;cell communication;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoplasm organization;developmental process;embryo development;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;nucleus;organelle,bZIP,,,,,,,,,
P15408,FOSL2,Fos-related antigen 2 (FRA-2),12,41.8,28.81,28.32,29.18,27.96,,28.34,26.29,,29.34,28.42,,26.3,27.6,28.06,0.75,0.26,1.12,-0.09, ,0.29,-1.76, ,1.28,0.36, ,-1.76,-0.46,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,bZIP,,,,,,,,,
P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),11,17.7,27.19,27.04,25.94,26.82,27.29,26.99,,27.8,27.54,26.18,25.72,,26.93,26.86,0.33,0.19,-0.92,-0.04,0.44,0.13, ,0.94,0.68,-0.68,-1.14, ,0.07,anatomical structure development;biological regulation;cell differentiation;cellular process;developmental process;embryo development,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;transcription factor complex,Forkhead,,,,,,,,,
Q96CU9,FOXRED1,FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-),6,18.2,26.84,26.33,24.47,25.6,27.74,26.93,28.04,26.76,27.26,26.79,23.84,,26.77,26.45,0.4,-0.12,-1.98,-0.85,1.29,0.48,1.6,0.32,0.81,0.34,-2.61, ,0.32,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q14331,FRG1,Protein FRG1 (FSHD region gene 1 protein),3,31,26.85,25.71,,25.95,27.01,26.01,25.91,,26.31,,,26.35,,26.26,0.58,-0.55, ,-0.31,0.74,-0.25,-0.36, ,0.05, , ,0.09, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q96NE9,FRMD6,FERM domain-containing protein 6 (Willin),5,12.1,26.26,26.16,,27.78,,24.75,27.3,26.42,26.65,24.39,26.95,25.63,27.56,26.35,-0.09,-0.19, ,1.43, ,-1.6,0.95,0.07,0.3,-1.96,0.6,-0.72,1.21,biological regulation;cellular localization;cellular process;localization,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
Q9BZ67,FRMD8,FERM domain-containing protein 8,7,23.5,28.25,27.34,23.6,26.81,23.99,24.94,27.12,,26.45,25.08,27.21,24.25,26.33,25.95,2.3,1.39,-2.35,0.86,-1.96,-1.01,1.17, ,0.5,-0.87,1.26,-1.7,0.38,,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O94915,FRYL,Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein),17,6.6,,25.7,19.66,27.21,27.27,25.81,28.03,27,25.63,26.07,27.4,27.81,27.21,26.23, ,-0.53,-6.57,0.98,1.04,-0.43,1.8,0.76,-0.61,-0.16,1.17,1.58,0.97,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,,,,,,,,,,,
Q16658,FSCN1,Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55),29,63.3,29.01,32.39,31.04,32.95,32.38,32.47,32.47,33.17,31.92,30.36,33.31,32.73,31.83,32,-2.99,0.39,-0.97,0.95,0.38,0.47,0.46,1.17,-0.08,-1.64,1.31,0.73,-0.17,cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;locomotion;organelle organization,cell part;cell projection;cytosol;filopodium,,,,,,,,,,
Q12841,FSTL1,Follistatin-related protein 1 (Follistatin-like protein 1),8,27.3,25.39,28.95,26.84,28.93,,25.98,26.89,,28.94,26.21,25.4,27.5,28.23,27.21,-1.82,1.74,-0.37,1.73, ,-1.23,-0.32, ,1.73,-0.99,-1.81,0.3,1.03,biological regulation;cellular process;response to stimulus;signal transduction,extracellular space,,,,,,,,,,
P02794,FTH1,Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein),13,57.9,31.63,31.36,31.56,31.87,30.15,31.24,30.82,31.33,30.48,32.31,31.67,32.26,31.31,31.38,0.25,-0.02,0.18,0.49,-1.24,-0.14,-0.56,-0.05,-0.91,0.92,0.29,0.88,-0.08,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;Golgi vesicle transport;immune system process;ion transport;membrane organization;response to stimulus;transmembrane transport;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P02792,FTL,Ferritin light chain (Ferritin L subunit),6,37.7,27.44,30.38,29.25,29.7,29.03,28.48,29.99,29.19,28.91,26.64,29.34,31.47,29.59,29.18,-1.75,1.2,0.06,0.51,-0.15,-0.7,0.8,0.01,-0.28,-2.55,0.16,2.28,0.4,biological regulation;cell death;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular process;death;establishment of localization;Golgi vesicle transport;homeostatic process;ion transport;membrane organization;transmembrane transport;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q9C0B1,FTO,Alpha-ketoglutarate-dependent dioxygenase FTO (EC 1.14.11.-) (Fat mass and obesity-associated protein),4,10.1,26.07,26.73,26.34,26.2,26.51,26.57,26.84,26.88,26.79,24.11,25.82,25.63,26.65,26.24,-0.17,0.49,0.1,-0.04,0.28,0.33,0.6,0.64,0.55,-2.13,-0.42,-0.61,0.41,"anatomical structure development;biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA modification;homeostatic process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;regulation of gene expression, epigenetic;RNA metabolic process;RNA modification;small molecule metabolic process",cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8IY81,FTSJ3,pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),18,26.9,28.75,28.84,27.91,29.42,30.32,30.7,29.64,29.4,30.15,30.43,29.44,30.44,29.25,29.59,-0.84,-0.75,-1.68,-0.18,0.73,1.11,0.04,-0.2,0.56,0.84,-0.15,0.85,-0.34,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;rRNA processing;small molecule metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8N1G2,FTSJD2,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (EC 2.1.1.57) (Cap1 2'O-ribose methyltransferase 1) (MTr1) (hMTr1) (FtsJ methyltransferase domain-containing protein 2) (Interferon-stimulated gene 95 kDa protein) (ISG95),7,12.6,27.73,26.69,27.05,26.67,24.93,23.64,25.59,24.72,24.65,26.16,24.85,23.98,,25.56,2.17,1.14,1.49,1.11,-0.63,-1.91,0.04,-0.83,-0.91,0.6,-0.7,-1.57, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96AE4,FUBP1,Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V),33,53.6,32.66,32.02,32.64,32.28,32.69,32.65,32.31,32.16,33.08,32.15,31.72,31.26,32.41,32.31,0.35,-0.29,0.33,-0.03,0.38,0.34,0,-0.15,0.77,-0.16,-0.59,-1.05,0.1,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q96I24,FUBP3,Far upstream element-binding protein 3 (FUSE-binding protein 3),23,49.3,31.49,31.47,31.05,31.16,31.62,31.34,30.99,30.91,31.39,30.7,29.93,30.22,30.32,30.97,0.52,0.5,0.08,0.2,0.65,0.37,0.02,-0.06,0.42,-0.27,-1.03,-0.75,-0.65,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
P04066,FUCA1,Tissue alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucosidase I) (Alpha-L-fucoside fucohydrolase 1) (Alpha-L-fucosidase 1),18,40.8,30.4,30.79,30.79,27.28,28.84,30.69,28.27,29.75,31.93,32.75,30.86,29.8,30.94,30.24,0.16,0.55,0.56,-2.96,-1.4,0.45,-1.97,-0.49,1.7,2.51,0.62,-0.44,0.7,alcohol metabolic process;amine metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q9BTY2,FUCA2,Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2),9,22.5,30.23,29.33,30.53,27.3,27.11,28.67,29.75,29.71,29.2,29.92,28.79,28.26,29.04,29.06,1.17,0.27,1.47,-1.77,-1.96,-0.4,0.69,0.65,0.13,0.85,-0.28,-0.8,-0.03,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,extracellular region,,,,,,,,,,
Q9BYC5,FUT8,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)",3,7.8,22.88,27.31,,27.42,25.5,26.06,,25.9,24.44,25.2,,,,25.59,-2.71,1.72, ,1.84,-0.09,0.48, ,0.31,-1.15,-0.39, , , ,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell motility;cellular component movement;cellular metabolic process;cellular process;developmental process;embryo development;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;response to stimulus;signal transduction;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q16595,FXN,"Frataxin, mitochondrial (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Cleaved into: Frataxin intermediate form (i-FXN);Frataxin(56-210) (m56-FXN);Frataxin(78-210) (d-FXN) (m78-FXN);Frataxin mature form (Frataxin(81-210)) (m81-FXN)]",4,38.5,25.58,26.86,27.16,27.34,27.01,28,25.71,27.51,28.3,28.58,27.08,26.29,27.87,27.18,-1.59,-0.32,-0.02,0.16,-0.17,0.82,-1.46,0.33,1.13,1.41,-0.09,-0.89,0.69,behavior;biological regulation;biosynthetic process;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cellular respiration;cofactor metabolic process;developmental process;embryo development;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;homeostatic process;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;mitochondrion organization;multicellular organismal process;neurological system process;nitrogen compound metabolic process;organelle organization;oxidative phosphorylation;phosphorus metabolic process;pigment metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein modification process;regulation of organelle organization;response to chemical stimulus;response to drug;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;transport,cell part;cytosol,,,,,,,,,,
P51114,FXR1,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),25,47.7,31.81,30.51,29.96,30.51,31.13,30.6,31.23,30.91,30.7,29.96,30.27,30.07,30,30.59,1.22,-0.08,-0.63,-0.08,0.54,0.01,0.64,0.32,0.12,-0.63,-0.32,-0.52,-0.59,anatomical structure development;biological regulation;cell death;cell differentiation;cellular process;death;developmental process;regulation of translation,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;polysome;ribonucleoprotein complex,,,,,,,,,,
P51116,FXR2,Fragile X mental retardation syndrome-related protein 2,10,25,28.6,28.37,27.33,28.41,26.4,27.32,27.5,27.94,28.11,27.86,27.99,26.54,27.52,27.68,0.92,0.69,-0.35,0.73,-1.28,-0.37,-0.18,0.26,0.42,0.18,0.3,-1.14,-0.17,,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q96QD9,FYTTD1,UAP56-interacting factor (Forty-two-three domain-containing protein 1) (Protein 40-2-3),10,34.6,29.38,28.32,28.89,28.61,27.39,27.06,27.75,28.53,27.95,28.67,27.17,26.99,27.46,28.01,1.37,0.3,0.88,0.6,-0.62,-0.95,-0.26,0.52,-0.07,0.66,-0.85,-1.02,-0.55,establishment of localization;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;transport,cell part,,,,,,,,,,
Q13283,G3BP1,Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1),31,65.2,32.36,31.76,31.93,32.87,33.23,32.45,32.99,33,32.53,32.6,32.33,32.06,32.27,32.49,-0.13,-0.73,-0.56,0.38,0.74,-0.04,0.5,0.51,0.04,0.11,-0.16,-0.43,-0.22,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;signal transduction;transport,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;ribonucleoprotein complex,,,,,,,,,,
Q9UN86,G3BP2,Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2),19,48.3,30.08,29.64,30.89,31.02,31.14,31.08,30.92,31.32,30.25,30.67,31.02,30.06,30.94,30.7,-0.61,-1.05,0.2,0.32,0.44,0.39,0.23,0.63,-0.45,-0.03,0.33,-0.63,0.24,biological regulation;cellular process;establishment of localization;nucleobase-containing compound transport;regulation of transport;response to stimulus;signal transduction;transport,cell part;cytosol,,,,,,,,,,
P11413,G6PD,Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49),38,68.3,27.05,29.52,28,30.99,28.74,28.89,30.03,28.52,28.87,28.34,29.95,30.63,28.04,29.04,-2,0.48,-1.05,1.94,-0.3,-0.16,0.99,-0.53,-0.17,-0.7,0.91,1.59,-1,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;cell maturation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytokine production;developmental maturation;developmental process;heterocycle metabolic process;lipid metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
P11413,G6PD,Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49),38,68.3,27.05,29.52,28,30.99,28.74,28.89,30.03,28.52,28.87,28.34,29.95,30.63,28.04,29.04,-2,0.48,-1.05,1.94,-0.3,-0.16,0.99,-0.53,-0.17,-0.7,0.91,1.59,-1,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;cell maturation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytokine production;developmental maturation;developmental process;heterocycle metabolic process;lipid metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
P10253,GAA,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase;70 kDa lysosomal alpha-glucosidase],29,36.3,28.3,33.52,31.69,28.82,30.08,30.44,29.54,30.86,30.39,31.32,30.46,29.51,30.23,30.4,-2.1,3.12,1.3,-1.58,-0.32,0.05,-0.85,0.47,-0.01,0.92,0.06,-0.89,-0.16,alcohol metabolic process;anatomical structure morphogenesis;behavior;biological regulation;carbohydrate metabolic process;catabolic process;cellular component organization;cellular homeostasis;cellular metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;homeostatic process;macromolecule metabolic process;metabolic process;multicellular organismal process;muscle contraction;neurological system process;oligosaccharide metabolic process;organelle organization;polysaccharide metabolic process;primary metabolic process;response to stimulus;small molecule metabolic process;vacuole organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole,,,,,,,,,,
P60520,GABARAPL2,Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (General protein transport factor p16) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16) (MAP1 light chain 3-related protein),2,21.6,24.84,24.55,,26.41,24.9,,27.13,27.05,26.08,,,24.73,,25.71,-0.87,-1.16, ,0.69,-0.81, ,1.42,1.34,0.37, , ,-0.99, ,autophagy;biological regulation;catabolic process;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;metabolic process;protein transport;transport;vesicle-mediated transport,cell part;cytosol;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q8TAE8,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1 (CKII beta-associating protein) (CR6-interacting factor 1) (CRIF1) (Papillomavirus L2-interacting nuclear protein 1) (PLINP) (PLINP-1) (p53-responsive gene 6 protein),6,31.1,25.81,26.69,27.81,27.85,27.25,27.9,27.64,26.71,27.93,28.11,26.38,26.54,28.32,27.3,-1.5,-0.61,0.51,0.55,-0.05,0.6,0.34,-0.59,0.63,0.8,-0.93,-0.76,1.01,cell cycle;cellular process;interspecies interaction between organisms;multi-organism process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
O14976,GAK,Cyclin-G-associated kinase (EC 2.7.11.1),15,20.7,27.41,28.2,28.47,28.67,25.91,26.56,27.63,28.17,27.36,26.89,28.37,27.59,26.67,27.53,-0.12,0.67,0.94,1.14,-1.62,-0.97,0.1,0.64,-0.17,-0.64,0.84,0.06,-0.86,cell cycle;cellular process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,+,,,,,,,,
P54803,GALC,Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase),4,7.6,26.19,27.25,25.05,26.28,26.76,26.22,24.32,26.6,26.66,25.67,24.85,27.61,27.34,26.22,-0.03,1.03,-1.16,0.07,0.54,0,-1.9,0.38,0.45,-0.54,-1.36,1.4,1.12,carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q14376,GALE,UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-galactose 4-epimerase),9,32.2,29.85,29.53,28.97,28.69,28.06,27.76,28.95,29.75,26.43,28.16,27.64,27.88,26.41,28.31,1.54,1.22,0.66,0.38,-0.25,-0.56,0.64,1.43,-1.88,-0.15,-0.68,-0.44,-1.9,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P51570,GALK1,Galactokinase (EC 2.7.1.6) (Galactose kinase),9,25,28.41,28.83,29.6,29.59,27.51,27.76,28.76,29.35,28.03,27,29.26,29.01,27.26,28.49,-0.08,0.34,1.11,1.1,-0.98,-0.73,0.27,0.86,-0.46,-1.49,0.77,0.52,-1.22,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q01415,GALK2,N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2),2,5.3,23.26,26.58,,25.88,,24.47,24.45,24.92,24.26,,25.21,26.61,,25.07,-1.81,1.51, ,0.81, ,-0.6,-0.62,-0.15,-0.81, ,0.14,1.54, ,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q96C23,GALM,Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase),7,25.1,27.59,27.37,29.88,27.01,21.39,24.4,24.61,25.11,24.77,25.69,23.59,,,25.58,2.01,1.79,4.3,1.43,-4.19,-1.18,-0.97,-0.47,-0.82,0.11,-2, , ,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q05BM8,GALNT1,GALNT1 protein,8,21.2,26.98,28.47,26.53,28.44,,27.98,26.56,24.76,26.48,28.12,27.24,27.78,27.73,27.26,-0.28,1.22,-0.73,1.18, ,0.73,-0.69,-2.5,-0.77,0.87,-0.01,0.53,0.47,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q10471,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],25,50.6,29.91,30.72,30.49,31.2,30.08,31.52,30.75,29.55,30.98,30.91,31.03,30.38,31.95,30.73,-0.82,-0.01,-0.23,0.47,-0.65,0.79,0.02,-1.18,0.25,0.19,0.3,-0.35,1.23,biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;extracellular region;membrane,,,,,,,,,,
Q14435,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3),12,25.4,31.01,26.09,29.17,24.14,,25.76,,,27.11,29.51,,,,27.54,3.47,-1.45,1.63,-3.4, ,-1.78, , ,-0.43,1.97, , , ,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q8N4A0,GALNT4,Polypeptide N-acetylgalactosaminyltransferase 4 (EC 2.4.1.41) (Polypeptide GalNAc transferase 4) (GalNAc-T4) (pp-GaNTase 4) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4),9,18.3,28.43,28.37,27.71,25.28,26.84,25.55,25.28,25.13,26.34,28.22,24.18,24.84,23.71,26.15,2.29,2.22,1.56,-0.87,0.7,-0.6,-0.86,-1.01,0.2,2.07,-1.97,-1.3,-2.43,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q86SF2,GALNT7,N-acetylgalactosaminyltransferase 7 (EC 2.4.1.-) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7),8,22.9,27.68,27,26.28,26.62,27.47,28.3,28.62,27.55,29.42,29.21,27.59,26.86,28,27.74,-0.06,-0.74,-1.46,-1.12,-0.27,0.56,0.88,-0.19,1.68,1.48,-0.15,-0.87,0.26,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q14697,GANAB,Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha),70,64.3,35.18,35.72,34.74,35.2,35.37,35.68,35.05,34.89,35.71,35.54,34.89,34.95,35.73,35.28,-0.1,0.43,-0.54,-0.08,0.09,0.4,-0.23,-0.39,0.43,0.25,-0.39,-0.33,0.44,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P04406,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),46,94,37.91,37.73,37.32,37.34,36.76,36.53,36.98,37.07,36.08,35.81,36.94,37.01,35.84,36.87,1.04,0.86,0.45,0.47,-0.11,-0.34,0.11,0.2,-0.79,-1.06,0.07,0.14,-1.03,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell death;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;death;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;regulation of protein stability;regulation of translation;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;cytoskeleton;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;lipid particle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;ribonucleoprotein complex;vesicle,,,,,,,,,,
Q14C86,GAPVD1,GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6),16,14.9,26.3,27.06,26.89,27.6,27.02,24.99,27.22,28.17,,,28.02,27.49,25.08,26.89,-0.59,0.17,0,0.71,0.12,-1.9,0.33,1.27, , ,1.12,0.59,-1.81,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;regulation of transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9NY12,GAR1,H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1),8,33.7,29.09,28.99,27.68,28.99,27.8,28.17,26.65,27.02,28.21,28.02,27.39,22.54,27.32,27.53,1.56,1.47,0.15,1.46,0.27,0.64,-0.88,-0.51,0.68,0.49,-0.14,-4.99,-0.21,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;rRNA processing,cell part;macromolecular complex;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
P41250,GARS,Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (AP-4-A synthetase) (Glycyl-tRNA synthetase) (GlyRS),34,49.5,31.61,32.49,31.12,33.11,31.82,31.81,31.83,32.27,31.3,31.48,32.24,31.99,31.6,31.9,-0.29,0.59,-0.78,1.21,-0.08,-0.09,-0.07,0.37,-0.6,-0.42,0.34,0.09,-0.3,amine metabolic process;biosynthetic process;cell death;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P22102,GART,Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase);Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase);Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)],31,40.8,31.14,30.94,30.93,31.84,31.45,29.67,31.47,31.94,29.17,29.05,30.56,31.68,28.85,30.67,0.47,0.27,0.26,1.17,0.78,-1,0.8,1.27,-1.5,-1.62,-0.1,1.01,-1.81,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;one-carbon metabolic process;pigment metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q86YP4,GATAD2A,Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A),9,23.4,28.49,,25.44,26.93,28.03,,25.47,,25.69,25.97,,,,26.58,1.91, ,-1.14,0.36,1.46, ,-1.11, ,-0.89,-0.6, , , ,"anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;DNA metabolic process;DNA modification;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;regulation of gene expression, epigenetic;RNA metabolic process;small molecule metabolic process",cell part;chromatin remodeling complex;macromolecular complex;protein complex;transcriptional repressor complex,,,,,,,,,,
Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),14,32.2,28.85,25.05,28.66,27.96,27.43,26.55,27.22,27.28,27.62,23.36,25.98,,,26.91,1.95,-1.85,1.75,1.06,0.52,-0.35,0.31,0.38,0.71,-3.54,-0.93, , ,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43716,GATC,"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-) (Protein 15E1.2)",3,31.6,25.9,21.87,,24.6,26.79,26.59,24.55,25.29,,26.04,26.26,26.69,27.53,25.64,0.25,-3.78, ,-1.04,1.14,0.94,-1.1,-0.36, ,0.39,0.61,1.04,1.89,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitochondrial translation;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;organic acid metabolic process;primary metabolic process;protein metabolic process;regulation of translation;RNA metabolic process;small molecule metabolic process;translation;tRNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
J3KQG4,GBA,Glucosylceramidase,11,27.2,29.68,30.09,29.79,29.63,29.68,30.88,29.36,30.36,30.25,30.28,31.52,30.58,31.02,30.24,-0.56,-0.15,-0.45,-0.61,-0.56,0.64,-0.88,0.12,0.01,0.04,1.28,0.34,0.78,carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;membrane,,,,,,,,,,
O75323,GBAS,Protein NipSnap homolog 2 (NipSnap2) (Glioblastoma-amplified sequence),8,34.3,28.7,30.39,29.89,28.28,29.34,28.65,28.82,28.85,29.65,29.45,29.76,26.89,30.16,29.14,-0.44,1.25,0.75,-0.86,0.2,-0.49,-0.32,-0.29,0.51,0.31,0.62,-2.25,1.02,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;generation of precursor metabolites and energy;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q04446,GBE1,"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)",29,45,30.69,32.58,30.71,31.85,31.02,30.1,31.2,31.71,30.47,27.55,31.99,30.65,31.16,30.9,-0.21,1.68,-0.19,0.95,0.12,-0.79,0.3,0.81,-0.43,-3.34,1.09,-0.25,0.26,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q92538,GBF1,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1),34,27.1,28.56,29.63,29.41,30.57,30.69,30.44,30.56,30.66,30.77,29.63,30.76,30.16,30.93,30.21,-1.65,-0.58,-0.8,0.36,0.47,0.23,0.35,0.45,0.56,-0.58,0.55,-0.06,0.72,biological regulation;cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;interspecies interaction between organisms;multi-organism process;organelle organization;transport;vesicle organization;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;organelle;peroxisome,,,,,,,,,,
P32456,GBP2,Interferon-induced guanylate-binding protein 2 (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2),9,17.3,28.5,27.99,30.27,27.53,,,26.04,25.34,25.94,27.45,24.31,26.04,,26.94,1.56,1.05,3.33,0.59, , ,-0.9,-1.6,-1,0.51,-2.63,-0.9, ,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
P28676,GCA,Grancalcin,8,47.9,29.32,28.36,28.9,26.45,26,25.56,27.84,27.49,24.52,24.45,25.78,28.88,24.92,26.81,2.51,1.55,2.09,-0.36,-0.8,-1.24,1.04,0.68,-2.28,-2.36,-1.03,2.08,-1.88,cellular component organization;cellular membrane organization;cellular process;membrane fusion;membrane organization,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q8IWJ2,GCC2,GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4) (RanBP2L4) (Renal carcinoma antigen NY-REN-53),16,11.3,26.51,27.76,29.04,27.93,29.32,26.51,26.28,26.42,27.72,29.05,26.89,27.45,26.83,27.52,-1,0.24,1.52,0.42,1.8,-1,-1.24,-1.1,0.2,1.54,-0.62,-0.07,-0.69,biological regulation;cellular component organization;cellular localization;cellular process;cytoskeleton organization;endosome transport;establishment of localization;Golgi organization;Golgi vesicle transport;localization;microtubule organizing center organization;organelle organization;protein targeting;protein transport;regulation of transport;transport;vacuolar transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q92947,GCDH,"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)",8,29.5,30.18,29.15,30.07,28.69,29.24,28.88,29.11,28.33,29.13,29.59,29.38,28.57,29.32,29.2,0.98,-0.05,0.87,-0.51,0.04,-0.32,-0.09,-0.88,-0.07,0.38,0.17,-0.63,0.12,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P16383,GCFC2,GC-rich sequence DNA-binding factor 2 (GC-rich sequence DNA-binding factor) (Transcription factor 9) (TCF-9),5,7.6,23.19,23.99,25.39,23.45,,,25.58,24.83,25.59,23.76,23.55,28.97,,24.83,-1.64,-0.84,0.56,-1.38, , ,0.75,0,0.76,-1.07,-1.27,4.14, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
P48506,GCLC,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),5,9.3,27.77,24.72,26.54,25.76,,,24.59,24.44,,26.84,25.89,26.11,,25.85,1.92,-1.13,0.69,-0.09, , ,-1.26,-1.41, ,0.99,0.04,0.26, ,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular homeostasis;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;homeostatic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to heat;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process;vitamin metabolic process;xenobiotic metabolic process,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P48507,GCLM,Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit),7,34.7,29.75,28.81,27.77,30.19,28.25,27.53,27.78,27.49,26.66,25.63,28.25,29.63,25.37,27.93,1.82,0.88,-0.16,2.26,0.32,-0.4,-0.15,-0.44,-1.28,-2.3,0.32,1.7,-2.56,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q92616,GCN1L1,Translational activator GCN1 (HsGCN1) (GCN1-like protein 1),84,37.6,32.35,32.49,31.64,32.58,32.07,31.26,32.8,32.58,31.14,31.69,32.58,33.16,31.02,32.1,0.25,0.38,-0.47,0.48,-0.03,-0.84,0.69,0.47,-0.96,-0.42,0.47,1.06,-1.08,biological regulation;regulation of translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P23434,GCSH,"Glycine cleavage system H protein, mitochondrial",2,24,26.76,26.04,27.19,25.8,25.22,26.54,25.91,25.7,26.84,26.92,,26.18,,26.28,0.47,-0.24,0.91,-0.48,-1.06,0.26,-0.37,-0.58,0.55,0.64, ,-0.11, ,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;glycine cleavage complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
Q8TB36,GDAP1,Ganglioside-induced differentiation-associated protein 1 (GDAP1),3,12.6,23.94,24.45,24.78,25.67,25.73,25.8,25.59,26.23,26.33,24.33,25.69,25.81,27.86,25.55,-1.62,-1.1,-0.77,0.12,0.18,0.24,0.04,0.67,0.78,-1.22,0.13,0.26,2.31,cellular component organization;cellular process;establishment of localization;mitochondrion organization;organelle fission;organelle organization;protein targeting;protein transport;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;transport,cell part,,,,,,,,,,
Q9NXN4,GDAP2,Ganglioside-induced differentiation-associated protein 2,3,9.1,24.44,25.35,24.82,26.42,25.02,26.41,24.66,25.19,25.74,25.4,25.12,25.44,26.78,25.45,-1,-0.09,-0.62,0.97,-0.43,0.96,-0.78,-0.26,0.3,-0.05,-0.33,-0.01,1.34,response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus,,,,,,,,,,,
P31150,GDI1,Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4),20,51.7,29.71,31.75,30.77,31.3,30.28,28.65,30.55,30.83,28.68,28.15,31.23,31.52,29.13,30.2,-0.49,1.56,0.57,1.1,0.08,-1.55,0.36,0.63,-1.51,-2.05,1.04,1.33,-1.07,biological regulation;cellular process;establishment of localization;protein transport;response to chemical stimulus;response to stimulus;signal transduction;transport,cell part;cell projection;cytosol;macromolecular complex;midbody;neuron projection;protein complex,,,,,,,,,,
P50395,GDI2,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),44,87.4,34.32,33.55,34.07,33.64,32.97,32.3,33.55,33.66,32.3,32.1,33.57,33.91,31.48,33.18,1.13,0.36,0.88,0.46,-0.22,-0.89,0.36,0.47,-0.89,-1.08,0.39,0.72,-1.71,biological regulation;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport,cell part;cell surface;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8TEQ6,GEMIN5,Gem-associated protein 5 (Gemin5),9,8,24.58,28.62,26.03,25.86,28.72,26.83,26.8,27.82,,,25.42,,,26.74,-2.16,1.88,-0.72,-0.88,1.98,0.09,0.05,1.08, , ,-1.32, , ,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;ribonucleoprotein complex assembly;RNA metabolic process,cell part;cytosol;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q7L5D6,GET4,Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35),5,25.7,28.32,27.31,27.43,27.57,26.91,27.25,27.75,27.43,27.78,24.86,27.97,27.97,25.96,27.27,1.05,0.04,0.16,0.3,-0.36,-0.02,0.48,0.16,0.51,-2.41,0.7,0.7,-1.31,cellular localization;cellular process;establishment of localization;localization;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q969S9,GFM2,"Ribosome-releasing factor 2, mitochondrial (RRF2mt) (Elongation factor G 2, mitochondrial) (EF-G2mt) (mEF-G 2) (Elongation factor G2) (hEFG2)",6,11.2,24.54,26.89,,26.15,26.92,27.75,25.87,25.83,27.39,27.97,25.82,26.49,25.92,26.46,-1.92,0.43, ,-0.32,0.46,1.29,-0.59,-0.64,0.93,1.51,-0.64,0.02,-0.55,biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitochondrial translation;mitochondrion organization;organelle organization;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q06210,GFPT1,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1),32,48.2,32.43,32.13,31.52,32.16,30.79,30.55,31.54,32.2,30.35,30.27,31.69,31.87,28.73,31.25,1.19,0.88,0.27,0.91,-0.46,-0.7,0.29,0.95,-0.9,-0.98,0.44,0.62,-2.52,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein complex assembly;protein glycosylation;protein metabolic process;protein modification process;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
O94808,GFPT2,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2),17,30.4,,29.47,28.28,31.2,28.55,28.94,30.41,29.58,27.61,24.44,29.87,30.62,26.96,28.83, ,0.64,-0.55,2.37,-0.28,0.12,1.58,0.75,-1.21,-4.39,1.04,1.8,-1.87,alcohol metabolic process;amine metabolic process;biosynthetic process;carbohydrate metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9UJY4,GGA2,"ADP-ribosylation factor-binding protein GGA2 (Gamma-adaptin-related protein 2) (Golgi-localized, gamma ear-containing, ARF-binding protein 2) (VHS domain and ear domain of gamma-adaptin) (Vear)",4,6.2,24.74,26.16,25.72,23.98,,24.69,25.29,,25.12,24.86,25.23,26.24,,25.2,-0.46,0.96,0.52,-1.23, ,-0.51,0.09, ,-0.09,-0.35,0.03,1.04, ,cellular process;establishment of localization;protein transport;transport;vesicle-mediated transport,AP-type membrane coat adaptor complex;cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
Q9NZ52,GGA3,"ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3)",2,8.4,24.28,25.07,23.82,,,,,25.68,,24.53,25.85,26.62,,25.12,-0.85,-0.05,-1.3, , , , ,0.56, ,-0.59,0.73,1.5, ,cellular process;establishment of localization;protein transport;transport;vesicle-mediated transport,AP-type membrane coat adaptor complex;cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
O75223,GGCT,Gamma-glutamylcyclotransferase (EC 2.3.2.4) (Cytochrome c-releasing factor 21),5,33.5,27.75,26.08,,26.89,25.56,,,26.59,,26.34,25.44,,,26.38,1.37,-0.3, ,0.51,-0.82, , ,0.21, ,-0.04,-0.94, , ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;mitochondrion organization;nitrogen compound metabolic process;organelle organization;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
P38435,GGCX,Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase),9,12,27.27,27.64,26.71,28.1,26.97,28.46,28.01,27.76,29.58,28.06,27.67,27.75,28.29,27.87,-0.6,-0.22,-1.16,0.23,-0.89,0.6,0.15,-0.11,1.71,0.19,-0.2,-0.12,0.42,biological regulation;cellular metabolic process;cellular process;coagulation;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;regulation of body fluid levels,cell part;membrane,,,,,,,,,,
Q92820,GGH,Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase),19,52.5,29.96,31.83,31.52,31.58,31.71,32.58,31.54,31.31,33.09,31.76,31.68,31.93,32.53,31.77,-1.81,0.06,-0.25,-0.19,-0.06,0.81,-0.23,-0.47,1.32,-0.01,-0.09,0.16,0.76,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole;vesicle,,,,,,,,,,
Q8N2G8,GHDC,GH3 domain-containing protein,5,16.5,25.18,26.75,,25.21,24.89,24.38,,25.02,25.56,27.29,,23.92,25.77,25.4,-0.21,1.35, ,-0.19,-0.51,-1.02, ,-0.38,0.16,1.9, ,-1.48,0.38,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nuclear envelope;organelle,,,,,,,,,,
O75420,GIGYF1,PERQ amino acid-rich with GYF domain-containing protein 1 (GRB10-interacting GYF protein 1),5,5.5,25.28,27,,28.7,28.14,29,,23.51,,29.03,,,,27.24,-1.96,-0.23, ,1.46,0.91,1.76, ,-3.72, ,1.79, , , ,biological regulation;cellular process;response to stimulus;signal transduction,,,,,,,,,,,
Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),17,17.6,26.9,28.16,26.02,28.61,27.99,27.57,27.91,28.71,27.69,19.29,28.13,25.96,26.61,26.89,0.01,1.27,-0.87,1.72,1.1,0.68,1.02,1.82,0.8,-7.6,1.24,-0.93,-0.28,behavior;biological regulation;cell death;cell differentiation;cellular metabolic process;cellular process;death;developmental process;growth;homeostatic process;macromolecule metabolic process;metabolic process;multicellular organismal movement;multicellular organismal process;neurological system process;post-embryonic development;primary metabolic process;protein metabolic process;regulation of translation;response to stimulus;signal transduction,,,,,,,,,,,
Q9NUV9,GIMAP4,GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4),6,26.1,23.87,26.21,29.53,,25.65,25.06,25.68,,26.05,25.62,25.28,25.9,26.31,25.92,-2.06,0.29,3.61, ,-0.27,-0.86,-0.24, ,0.12,-0.3,-0.65,-0.02,0.39,,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O14908,GIPC1,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Tax interaction protein 2) (TIP-2),10,28.2,29.87,27.65,29.12,29.6,30.42,29.46,30.46,30.2,28.91,30.14,30.31,29.29,27.39,29.45,0.42,-1.79,-0.33,0.15,0.97,0.01,1.01,0.76,-0.54,0.69,0.86,-0.16,-2.06,biological regulation;cell communication;cell motility;cell-cell signaling;cellular component movement;cellular process;establishment of localization;locomotion;protein targeting;protein transport;regulation of protein stability;response to stimulus;secretion;signal transduction;signaling;transport,brush border;cell cortex;cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;organelle;vesicle,,,,,,,,,,
Q9Y2X7,GIT1,ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1),11,21.2,28.6,28.38,25.34,28.63,29.23,28.21,29.18,29.23,27.57,27.54,30.04,,25.93,28.16,0.45,0.22,-2.81,0.47,1.07,0.05,1.02,1.08,-0.59,-0.62,1.89, ,-2.23,biological regulation,cell part;cytoplasm,,,,,,,,,,
P32189,GK,Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase),10,22.1,25.42,30.31,28.29,29.61,25.64,28.75,26.14,23.64,26.15,,,27.47,26.48,27.08,-1.66,3.23,1.2,2.53,-1.44,1.67,-0.94,-3.44,-0.93, , ,0.39,-0.6,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;phosphorus metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;membrane,,,,,,,,,,
P06280,GLA,Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase),8,20.8,26.05,27.39,26.16,26.57,25.18,28.63,26.15,25.21,26.02,26.42,26.29,25.52,28.22,26.45,-0.4,0.94,-0.29,0.12,-1.27,2.18,-0.29,-1.24,-0.42,-0.03,-0.16,-0.93,1.77,biological regulation;carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;oligosaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P16278,GLB1,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1),17,34.2,31.34,32.96,31.05,31.21,30.83,31.93,31.48,31.5,31.77,31.76,31.66,31.47,31.63,31.58,-0.25,1.38,-0.53,-0.37,-0.76,0.35,-0.1,-0.09,0.18,0.18,0.07,-0.11,0.05,alcohol metabolic process;amine metabolic process;carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part,,,,,,,,,,
P23378,GLDC,"Glycine dehydrogenase [decarboxylating], mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase)",18,28.5,26.07,25.61,28.87,,24.4,,25.74,,,32.09,26.39,,,27.03,-0.95,-1.42,1.85, ,-2.63, ,-1.28, , ,5.07,-0.63, , ,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q92896,GLG1,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),41,34.6,29.83,30.95,28.27,31.34,30.81,32.05,30.74,29.86,31.96,30.74,30.01,30.42,31.12,30.62,-0.79,0.33,-2.35,0.72,0.19,1.43,0.12,-0.76,1.33,0.12,-0.62,-0.21,0.5,anatomical structure morphogenesis;biological regulation;developmental process,cell part;extracellular matrix;membrane,,,,,,,,,,
Q9H4G4,GLIPR2,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),5,40.9,27.59,28.27,29.13,25.65,28.38,29.36,27.82,27.26,29.77,,26.76,,28.42,28.04,-0.45,0.23,1.09,-2.39,0.35,1.32,-0.22,-0.78,1.73, ,-1.28, ,0.38,,cell part;extracellular region;membrane,,,,,,,,,,
Q92990,GLMN,Glomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein),5,14.4,26.09,26.1,26.44,27.15,26,25.16,27.32,26.85,25.26,24.35,26.03,26.73,26.39,26.14,-0.06,-0.05,0.3,1.01,-0.14,-0.98,1.18,0.71,-0.88,-1.79,-0.12,0.58,0.24,"biological regulation;cell differentiation;cellular process;developmental process;regulation of gene expression, epigenetic;regulation of transport",cell part;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q04760,GLO1,Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase),11,67.9,31.97,31.28,30.57,30.97,29.94,29.64,30.98,30.93,29.17,28.1,30.93,31.43,28.75,30.36,1.61,0.92,0.21,0.62,-0.42,-0.72,0.62,0.57,-1.19,-2.26,0.57,1.07,-1.61,amine metabolic process;biological regulation;carbohydrate metabolic process;cellular aldehyde metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytoplasm,,,,,,,,,,
Q9HC38,GLOD4,Glyoxalase domain-containing protein 4,11,43.8,30.33,30.44,30.51,29.53,28.82,28.58,29.53,30.28,28.57,28.51,29.41,29.68,27.4,29.35,0.97,1.08,1.15,0.18,-0.53,-0.77,0.18,0.93,-0.78,-0.84,0.06,0.33,-1.96,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P35754,GLRX,Glutaredoxin-1 (Thioltransferase-1) (TTase-1),5,58.5,24.81,30.12,29.92,31.97,25.53,25.96,25.86,26.74,25.25,27.8,29,28.11,25.9,27.46,-2.65,2.66,2.46,4.51,-1.93,-1.5,-1.6,-0.72,-2.21,0.34,1.54,0.65,-1.57,biological regulation;cellular homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;generation of precursor metabolites and energy;homeostatic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
O76003,GLRX3,Glutaredoxin-3 (PKC-interacting cousin of thioredoxin) (PICOT) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2),17,57.9,31.19,30.13,31.25,30.84,29.23,29.39,31.59,31.03,30.05,29.68,30.95,31.85,28.75,30.46,0.73,-0.32,0.8,0.39,-1.23,-1.07,1.13,0.58,-0.41,-0.78,0.5,1.39,-1.71,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell cortex;cell part,,,,,,,,,,
Q86SX6,GLRX5,"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)",7,38.2,25.6,29.34,28.58,28.46,29.36,29.97,28.97,28.69,29.79,30.04,27.83,28.66,28.77,28.77,-3.18,0.57,-0.19,-0.32,0.59,1.2,0.2,-0.09,1.02,1.27,-0.94,-0.11,-0.01,anatomical structure development;biological regulation;cellular homeostasis;cellular process;developmental process;homeostatic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
O94925,GLS,"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase)",7,8.9,31.01,31.18,31.58,32.08,32.44,33.49,33.08,32.69,32.65,35.46,33.87,32.8,34,32.79,-1.78,-1.61,-1.21,-0.72,-0.36,0.7,0.28,-0.11,-0.15,2.67,1.08,0.01,1.2,amine metabolic process;behavior;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;metabolic process;multicellular organismal process;neurological system process;neurotransmitter transport;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;response to stimulus;secretion;small molecule metabolic process;transport,cell part;cytosol,,,,,,,,,,
O94925,GLS,"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase)",7,8.9,31.01,31.18,31.58,32.08,32.44,33.49,33.08,32.69,32.65,35.46,33.87,32.8,34,32.79,-1.78,-1.61,-1.21,-0.72,-0.36,0.7,0.28,-0.11,-0.15,2.67,1.08,0.01,1.2,amine metabolic process;behavior;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;metabolic process;multicellular organismal process;neurological system process;neurotransmitter transport;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;response to stimulus;secretion;small molecule metabolic process;transport,cell part;cytosol,,,,,,,,,,
Q68CQ7,GLT8D1,Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-),8,27.2,24.28,28.82,24.12,28.85,27.03,27.56,26.83,27.11,29.47,27.2,25.73,27.59,26.47,27.01,-2.72,1.81,-2.89,1.85,0.02,0.55,-0.18,0.1,2.46,0.2,-1.27,0.59,-0.53,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NZD2,GLTP,Glycolipid transfer protein (GLTP),5,20.5,28.15,27.75,28.21,27.73,,25.76,27.66,27.56,25.81,22.86,28.51,29.9,25.92,27.15,1,0.6,1.06,0.58, ,-1.39,0.51,0.41,-1.34,-4.29,1.36,2.75,-1.23,establishment of localization;lipid transport;transport,cell part;cytoplasm;membrane,,,,,,,,,,
P00367,GLUD1,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)",43,63.3,33.22,33.56,33.25,33.09,33.41,33.99,33.13,33.1,34.12,34.04,33.4,32.36,34.19,33.45,-0.23,0.11,-0.2,-0.37,-0.04,0.54,-0.32,-0.35,0.67,0.59,-0.05,-1.09,0.74,amine metabolic process;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of transport;small molecule metabolic process,cell part,,,,,,,,,,
P15104,GLUL,Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase),11,31.1,23.76,31.01,29.76,27.49,25.43,26.14,29,28.82,26.32,,25.59,26.94,24.53,27.06,-3.3,3.94,2.7,0.42,-1.63,-0.93,1.93,1.76,-0.75, ,-1.48,-0.13,-2.53,amine metabolic process;biological regulation;biosynthetic process;catabolic process;cell proliferation;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;metabolic process;neurotransmitter transport;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;regulation of transport;response to chemical stimulus;response to stimulus;small molecule metabolic process;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
Q49A26,GLYR1,Putative oxidoreductase GLYR1 (EC 1.-.-.-) (3-hydroxyisobutyrate dehydrogenase-like protein) (Cytokine-like nuclear factor N-PAC) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60) (Nuclear protein of 60 kDa),12,23.5,29.86,29.16,28.51,29.39,29.57,29.82,29.44,28.96,29.55,29.53,27.63,27.21,29.06,29.05,0.81,0.11,-0.54,0.33,0.52,0.77,0.39,-0.1,0.5,0.48,-1.43,-1.85,0.01,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O60547,GMDS,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)",12,39.5,31.08,27.78,29.46,26.35,22.91,27.39,27.73,27.64,27.45,27.58,27.02,,,27.49,3.59,0.29,1.97,-1.14,-4.58,-0.1,0.24,0.15,-0.05,0.09,-0.47, , ,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
P60983,GMFB,Glia maturation factor beta (GMF-beta),9,66.9,29.46,28.67,27.78,28.39,27.02,26.6,27.29,25.78,23.81,26.15,27.74,29.3,,27.33,2.13,1.34,0.45,1.06,-0.31,-0.74,-0.05,-1.56,-3.52,-1.18,0.41,1.97, ,anatomical structure development;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;intracellular,,,,,,,,,,
Q96IJ6,GMPPA,Mannose-1-phosphate guanyltransferase alpha (EC 2.7.7.13) (GDP-mannose pyrophosphorylase A) (GTP-mannose-1-phosphate guanylyltransferase alpha),12,37.6,28.61,29.74,29.3,29.94,29.39,28.61,29.3,29.76,28.46,27.61,29.22,30.13,26.75,28.99,-0.37,0.75,0.32,0.95,0.41,-0.38,0.32,0.78,-0.53,-1.38,0.23,1.15,-2.24,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,,,,,,,,,,,
Q9Y5P6,GMPPB,Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta),10,35.3,29.59,29.92,29.11,29.98,29.5,28.83,29.81,29.8,28.92,28.22,29.51,29.46,28.19,29.3,0.3,0.63,-0.19,0.69,0.21,-0.47,0.52,0.5,-0.38,-1.07,0.21,0.16,-1.11,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9P2T1,GMPR2,GMP reductase 2 (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2),4,13.7,28.4,28.01,25.51,27.69,26.85,24.67,27.06,27.4,24.04,,26.84,,24.91,26.49,1.91,1.52,-0.98,1.2,0.36,-1.82,0.57,0.91,-2.45, ,0.35, ,-1.58,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;purine-containing compound salvage;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P49915,GMPS,GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase),30,58,33.01,31.33,30.85,31.35,31.41,31.75,31.78,31.62,31.99,30.17,29.77,30.98,31.17,31.32,1.69,0.01,-0.47,0.03,0.09,0.43,0.46,0.3,0.67,-1.15,-1.55,-0.34,-0.15,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;organic acid metabolic process;pigment metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P29992,GNA11,Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Guanine nucleotide-binding protein G(y) subunit alpha),16,49.3,29.59,29.96,29.36,30.16,30.47,31.05,29.78,29.87,30.05,30.4,31.09,29.71,30.95,30.19,-0.6,-0.23,-0.82,-0.02,0.28,0.86,-0.41,-0.32,-0.14,0.21,0.9,-0.48,0.77,anatomical structure development;biological regulation;cell activation;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;homeostatic process;pigmentation;response to stimulus;signal transduction,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q14344,GNA13,Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13),9,28.7,27.83,28.9,27.69,27.71,28.5,29.6,28.48,27.95,29.57,29.09,28.52,28.47,29.18,28.58,-0.75,0.32,-0.88,-0.87,-0.07,1.02,-0.1,-0.63,1,0.52,-0.06,-0.11,0.61,anatomical structure morphogenesis;biological regulation;cell activation;cell differentiation;cellular component movement;cellular process;developmental process;embryo development;multicellular organismal process;response to stimulus;signal transduction,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P63096,GNAI1,Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein),4,16.1,28.87,26.8,25.86,27.62,27.29,28.37,27.36,27.03,28.07,28.79,27.28,26.21,27.24,27.45,1.42,-0.64,-1.58,0.17,-0.15,0.92,-0.08,-0.41,0.62,1.34,-0.16,-1.24,-0.21,biological regulation;cell activation;cell communication;cell cycle;cell division;cell-cell signaling;cellular process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;signaling,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;midbody;nucleus;organelle;protein complex,,,,,,,,,,
P04899,GNAI2,Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein),23,65.6,31.71,32.82,33.26,32.86,33.06,33.25,32.7,32.62,34.45,32.71,32.69,32.67,33.62,32.96,-1.25,-0.13,0.31,-0.09,0.1,0.29,-0.26,-0.34,1.5,-0.24,-0.27,-0.29,0.67,biological regulation;cell activation;cell communication;cell cycle;cell division;cell proliferation;cell-cell signaling;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;signal transduction;signaling,cell part;centrosome;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;midbody;nucleus;organelle;protein complex,,,,,,,,,,
P08754,GNAI3,Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3),10,20.9,29.81,28.99,29.38,28.79,27.39,28.36,28.55,27.55,28.35,29.53,28.7,,28.59,28.67,1.15,0.32,0.71,0.12,-1.28,-0.3,-0.11,-1.12,-0.31,0.87,0.04, ,-0.08,biological regulation;cell activation;cell communication;cell cycle;cell division;cell-cell signaling;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane fusion;membrane organization;organelle fusion;organelle organization;response to stimulus;signal transduction;signaling;transport;vesicle organization,cell part;centrosome;cytoplasm;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;midbody;organelle;protein complex;vesicle,,,,,,,,,,
P50148,GNAQ,Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q),4,15,28.51,27.9,26.77,27.47,26.6,27.93,25.26,,28.37,28.76,29.79,26.52,29.62,27.79,0.72,0.11,-1.02,-0.32,-1.19,0.14,-2.53, ,0.58,0.97,2,-1.28,1.82,anatomical structure development;anatomical structure morphogenesis;behavior;biological regulation;cell activation;cell development;cell maturation;cellular homeostasis;cellular ion homeostasis;cellular process;developmental maturation;developmental process;homeostatic process;pigmentation;post-embryonic development;regulation of protein modification process;regulation of protein stability;regulation of transport;response to stimulus;signal transduction,cell part;cytoplasm;macromolecular complex;membrane;protein complex,,,,,,,,,,
P63092,GNAS,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein),11,36.7,28.66,28.85,26.76,28.18,28.63,29.23,26.89,28.1,28.9,28.24,28.5,27.27,28.48,28.21,0.45,0.64,-1.45,-0.03,0.42,1.02,-1.32,-0.11,0.7,0.04,0.29,-0.93,0.28,biological regulation;cellular metabolic process;cellular process;coagulation;energy reserve metabolic process;establishment of localization;fluid transport;generation of precursor metabolites and energy;metabolic process;multicellular organismal process;neurological system process;regulation of body fluid levels;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transmembrane transport;transport,cell part;cytoplasm;macromolecular complex;membrane;protein complex,,,,,,,,,,
P62873,GNB1,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1),15,47.9,32.96,32.79,32.67,32.88,33.13,33.56,32.85,32.72,33.66,33.22,32.44,32.31,32.89,32.93,0.03,-0.14,-0.26,-0.05,0.2,0.63,-0.08,-0.21,0.73,0.29,-0.49,-0.62,-0.04,anatomical structure development;biological regulation;cell activation;cell communication;cell death;cell proliferation;cell-cell signaling;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;death;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;homeostatic process;metabolic process;multicellular organismal process;neurological system process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;signaling,cell body;cell part;cell projection;macromolecular complex;membrane;neuron projection;photoreceptor inner segment;protein complex,,,,,,,,,,
P62879,GNB2,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2),9,33.2,31.08,31.04,30.78,31.44,31.55,32,31.6,31.32,32.19,31.47,31,32.21,31.26,31.46,-0.38,-0.42,-0.68,-0.02,0.1,0.55,0.15,-0.14,0.73,0.01,-0.46,0.75,-0.2,biological regulation;cell communication;cell-cell signaling;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;signaling,cell body;cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P63244,GNB2L1,Guanine nucleotide-binding protein subunit beta-2-like 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Receptor of activated protein kinase C 1) (RACK1),28,77.6,33.66,33.94,33.83,34.35,34.22,33.68,34.32,34.51,33.97,34.1,34.06,33.77,33.1,33.96,-0.3,-0.02,-0.14,0.39,0.26,-0.28,0.36,0.55,0.01,0.14,0.1,-0.19,-0.87,anatomical structure morphogenesis;biological regulation;cell cycle;cellular process;developmental process;interspecies interaction between organisms;multi-organism process;regulation of cell cycle;regulation of protein modification process;regulation of translation;regulation of transport;rhythmic process,cell body;cell part;cell projection;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;midbody;neuron projection;neuronal cell body;nucleus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9HAV0,GNB4,Guanine nucleotide-binding protein subunit beta-4 (Transducin beta chain 4),4,13.8,,26.66,27.44,28.1,28.35,28.8,28.34,28.49,29.4,25.51,26.82,26.98,28.56,27.79, ,-1.12,-0.35,0.32,0.56,1.01,0.56,0.7,1.62,-2.28,-0.97,-0.81,0.77,cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;membrane;plasma membrane,,,,,,,,,,
Q9Y223,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase);N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)],4,7.7,,25.09,25.91,26.11,25.91,25.39,25.81,25.82,25.33,27.13,26.29,26.61,,25.95, ,-0.86,-0.04,0.17,-0.03,-0.56,-0.14,-0.12,-0.61,1.19,0.34,0.66, ,alcohol metabolic process;biological adhesion;biosynthetic process;carbohydrate metabolic process;cell adhesion;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;organic acid metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm;cytosol,,,,,,,,,,
P50151,GNG10,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10,2,51.5,,26.77,26.18,25.99,24.2,25.76,,,27.68,25.29,24.39,24.54,,25.64, ,1.13,0.54,0.34,-1.44,0.12, , ,2.04,-0.35,-1.25,-1.11, ,biological regulation;cell communication;cell-cell signaling;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;signaling,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9UBI6,GNG12,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12,12,87.5,29.94,29.78,28.08,31.03,30.7,29.53,30.5,30.69,30.8,28.64,29.2,27.37,29.58,29.68,0.26,0.1,-1.6,1.35,1.02,-0.15,0.82,1.01,1.12,-1.04,-0.48,-2.31,-0.1,biological regulation;cell communication;cell-cell signaling;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;signaling;small molecule metabolic process,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P63218,GNG5,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5,6,91.2,27.85,27.1,29.35,27.1,23.71,26.69,22.52,23.21,27.92,28.75,,,26.17,26.4,1.46,0.7,2.96,0.7,-2.68,0.29,-3.87,-3.19,1.52,2.35, , ,-0.23,biological regulation;cell communication;cell-cell signaling;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;signaling,cell part;macromolecular complex;protein complex,,,,,,,,,,
P36915,GNL1,Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1),11,25.3,30.67,28.29,26.91,28.23,26.8,26.45,27.41,28.62,23.66,24.91,28.23,27.36,24.91,27.11,3.56,1.18,-0.21,1.12,-0.31,-0.67,0.3,1.51,-3.45,-2.2,1.12,0.25,-2.2,biological regulation;cellular process;immune system process;response to DNA damage stimulus;response to stimulus;response to stress;ribosome biogenesis;signal transduction,cell part;cytosol;extracellular space,,,,,,,,,,
Q13823,GNL2,Nucleolar GTP-binding protein 2 (Autoantigen NGP-1),6,8.2,26.57,27.18,26.11,28.25,28.31,26.62,25.5,25.16,27.33,28.35,,24.98,26.11,26.7,-0.14,0.48,-0.59,1.54,1.6,-0.09,-1.21,-1.55,0.62,1.65, ,-1.72,-0.59,cellular process;ribosome biogenesis,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9BVP2,GNL3,Guanine nucleotide-binding protein-like 3 (E2-induced gene 3 protein) (Novel nucleolar protein 47) (NNP47) (Nucleolar GTP-binding protein 3) (Nucleostemin),13,33.5,30.07,28.92,28.99,29.63,30.29,30.18,29.06,29.18,29.94,30.11,28.3,29.21,29.25,29.47,0.6,-0.55,-0.48,0.16,0.81,0.71,-0.41,-0.29,0.47,0.64,-1.17,-0.27,-0.22,biological regulation;cell proliferation;cellular process;ribosome biogenesis,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
D6RAY7,GNPDA1,Glucosamine-6-phosphate isomerase 1 (Fragment),9,53.2,29.44,30.56,30.25,29.2,28.69,26.9,29.09,30.08,28.73,26.52,29.62,29.78,28.93,29.06,0.38,1.5,1.19,0.13,-0.38,-2.16,0.03,1.02,-0.33,-2.54,0.56,0.72,-0.13,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q96EK6,GNPNAT1,Glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase),6,57.1,28.12,27.05,25.46,28.59,26.87,25.81,26.58,27.58,26.3,24.96,26.7,26.04,25.44,26.58,1.55,0.48,-1.12,2.01,0.29,-0.77,0.01,1,-0.27,-1.61,0.12,-0.53,-1.14,alcohol metabolic process;anatomical structure development;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9UJJ9,GNPTG,N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma),3,15.1,27.43,25.99,,26.22,,25.87,26.86,27.46,26.38,24.9,25.7,24.61,26.33,26.16,1.27,-0.17, ,0.06, ,-0.29,0.7,1.3,0.23,-1.26,-0.46,-1.55,0.17,,cell part;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P15586,GNS,N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S),15,33.5,30.73,32.38,31.94,31.72,31.03,31.78,31.38,30.76,31.89,31.79,31.74,32.23,31.81,31.63,-0.9,0.75,0.31,0.09,-0.6,0.16,-0.24,-0.87,0.26,0.16,0.11,0.6,0.18,amine metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;sulfur compound metabolic process,cell part,,,,,,,,,,
Q08379,GOLGA2,Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95),26,38.9,29.76,29.91,29.94,29.29,29.68,29.91,29.31,28.78,30.79,30.11,29.59,29.18,29.98,29.71,0.06,0.2,0.23,-0.41,-0.03,0.2,-0.4,-0.93,1.08,0.4,-0.12,-0.53,0.27,cell cycle;cellular process;mitotic cell cycle,cell part;membrane,,,,,,,,,,
Q08378,GOLGA3,Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160),22,19.9,28.32,28.9,26.82,29.14,28.93,28.06,28.52,28.58,29.52,28.41,29.52,28.23,28.41,28.57,-0.25,0.34,-1.75,0.58,0.36,-0.51,-0.05,0.02,0.96,-0.16,0.95,-0.34,-0.15,cellular process;establishment of localization;Golgi vesicle transport;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
Q13439,GOLGA4,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),38,22.6,28.44,29.82,29.22,28.86,30.14,29.28,28.25,28.2,30.28,29.84,28.29,28.07,28.52,29.02,-0.58,0.8,0.2,-0.16,1.13,0.27,-0.77,-0.82,1.26,0.83,-0.73,-0.94,-0.5,cellular process;establishment of localization;Golgi vesicle transport;protein targeting;protein transport;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8TBA6,GOLGA5,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),17,31.8,26.48,27.6,28.18,27.1,27.05,28.31,27.17,26.88,29.95,28.17,27.72,25.59,28.55,27.6,-1.11,0.01,0.59,-0.5,-0.55,0.72,-0.42,-0.72,2.36,0.57,0.12,-2.01,0.95,cellular component organization;cellular process;establishment of localization;Golgi organization;Golgi vesicle transport;organelle organization;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q7Z5G4,GOLGA7,Golgin subfamily A member 7 (Golgi complex-associated protein of 16 kDa),2,20.6,26.55,26,24.37,26.07,26.72,26.68,26.24,26.04,27.08,26.27,27.16,26.48,26.72,26.34,0.21,-0.34,-1.97,-0.27,0.39,0.34,-0.1,-0.3,0.75,-0.07,0.83,0.15,0.38,,cell part;membrane,,,,,,,,,,
Q14789,GOLGB1,Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein) (GCP372) (Giantin) (Macrogolgin),97,35.8,32.36,31.81,31.34,30.89,30.23,31.58,30.61,29.96,32.18,31.37,30.91,31,30.48,31.13,1.23,0.68,0.2,-0.24,-0.9,0.45,-0.53,-1.17,1.05,0.24,-0.22,-0.13,-0.66,cellular component organization;cellular process;Golgi organization;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O00461,GOLIM4,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",24,37.6,29.82,27.35,26.98,29.93,29.03,28.67,27.31,27.29,28.02,27.02,27.46,24.67,28.47,27.85,1.97,-0.49,-0.87,2.09,1.18,0.82,-0.54,-0.56,0.17,-0.83,-0.39,-3.18,0.62,establishment of localization;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;vesicle,,,,,,,,,,
Q8NBJ4,GOLM1,Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2),14,36.1,25.46,27.7,29.04,29.03,28.05,29.01,28.95,26.94,28.52,28.77,29.33,28.69,29.23,28.36,-2.9,-0.67,0.68,0.66,-0.32,0.65,0.59,-1.42,0.15,0.41,0.97,0.33,0.87,,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9H4A6,GOLPH3,Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor) (MIDAS),5,26.2,28.67,28.4,28.06,28.17,28.15,26.79,28.5,28.22,28.73,26.49,25.86,27.63,27.95,27.82,0.86,0.58,0.24,0.35,0.33,-1.03,0.68,0.4,0.91,-1.33,-1.96,-0.18,0.13,biological regulation;cell proliferation;regulation of organelle organization,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
Q9Y3E0,GOLT1B,Vesicle transport protein GOT1B (Germ cell tumor 2) (Golgi transport 1 homolog B) (Putative NF-kappa-B-activating protein 470) (hGOT1a),4,26.8,27.33,28.42,22.81,26.97,28.66,28.82,25.56,28.39,27.42,23.86,27.33,24.75,27.57,26.76,0.57,1.66,-3.95,0.21,1.9,2.06,-1.21,1.63,0.66,-2.91,0.57,-2.01,0.81,biological regulation;cellular process;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9HD26,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (Fused in glioblastoma) (PDZ protein interacting specifically with TC10) (PIST),7,18.1,28.09,28.76,28.22,29.61,24.01,29.14,27.88,27.73,30.27,28.59,27.1,28.8,28.97,28.24,-0.15,0.51,-0.03,1.37,-4.23,0.9,-0.37,-0.51,2.03,0.34,-1.15,0.56,0.73,biological regulation;cellular component assembly;cellular component organization;cellular process;establishment of localization;Golgi vesicle transport;localization;macromolecular complex assembly;nucleus organization;organelle organization;protein complex assembly;protein transport;regulation of transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
Q9H8Y8,GORASP2,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),11,35.3,28.81,28.51,25.98,27.95,28.23,28.75,26.29,28.46,28.57,25.7,27.32,27.06,28.28,27.68,1.12,0.82,-1.7,0.27,0.54,1.07,-1.4,0.77,0.89,-1.98,-0.36,-0.63,0.59,cell cycle;cellular component organization;cellular process;mitotic cell cycle;organelle organization,cell part;membrane,,,,,,,,,,
O95249,GOSR1,Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28),7,35.9,26.59,27.76,28.05,27.96,28.87,26.31,28.69,29.2,29.28,29.23,25.62,24.46,27.63,27.66,-1.08,0.1,0.38,0.29,1.2,-1.35,1.03,1.53,1.61,1.57,-2.05,-3.21,-0.04,cellular process;endosome transport;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
O14653,GOSR2,Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin),3,21,26.56,28.92,27.45,28.46,29.02,29.55,28.21,27.13,29.66,28.19,29.56,28.36,29.75,28.52,-1.97,0.4,-1.07,-0.07,0.49,1.03,-0.32,-1.4,1.13,-0.33,1.04,-0.17,1.22,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;membrane fusion;membrane organization;metabolic process;primary metabolic process;protein metabolic process;protein transport;regulation of protein modification process;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
P17174,GOT1,"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)",15,55.2,31.08,30.71,29.71,30.78,30.89,29.61,31.36,31.76,28.76,30.15,31,31.34,28.49,30.43,0.64,0.28,-0.72,0.35,0.45,-0.82,0.93,1.33,-1.68,-0.29,0.56,0.91,-1.94,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;homeostatic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
P00505,GOT2,"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)",36,88.1,33.29,33.31,33.03,33.44,34.61,34.46,33.74,33.75,34.5,34.98,34.57,33.19,34.95,33.99,-0.69,-0.67,-0.96,-0.55,0.63,0.48,-0.25,-0.24,0.52,0.99,0.58,-0.8,0.96,alcohol metabolic process;amine metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;heterocycle metabolic process;lipid transport;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;organic acid transport;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process;transport,cell part;membrane;plasma membrane,,,,,,,,,,
O43292,GPAA1,Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (hGAA1),5,22.3,28.48,26.52,26.76,27.13,,27.37,27.68,26.31,28.46,27.81,28.61,27.64,28.36,27.59,0.89,-1.08,-0.84,-0.47, ,-0.22,0.08,-1.28,0.86,0.22,1.02,0.04,0.77,biological regulation;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein complex assembly;protein lipidation;protein metabolic process;protein modification process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q5T3I0,GPATCH4,G patch domain-containing protein 4,5,12.8,24.9,19.62,26.73,23.6,24.68,24.24,25.7,24.51,25.28,27.22,23.17,26.26,22.33,24.48,0.42,-4.86,2.25,-0.88,0.2,-0.24,1.22,0.03,0.8,2.74,-1.31,1.78,-2.15,,,,,,,,,,,,
Q9UKJ3,GPATCH8,G patch domain-containing protein 8,12,9.6,25.16,22.88,23.9,25.11,23.87,23.52,,22.13,,25.18,,19.34,,23.46,1.71,-0.58,0.45,1.65,0.42,0.06, ,-1.32, ,1.73, ,-4.11, ,,,C2H2-type,,,,,,,,,
P35052,GPC1,Glypican-1 [Cleaved into: Secreted glypican-1],3,8.1,25.34,25.47,26,27.53,27.51,26.69,26.05,28.1,26.38,25.82,,,28.27,26.65,-1.31,-1.18,-0.66,0.88,0.86,0.04,-0.6,1.45,-0.27,-0.83, , ,1.62,amine metabolic process;anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell differentiation;cellular component assembly;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;developmental process;lipid metabolic process;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;sulfur compound metabolic process,cell part;endosome;extracellular matrix;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;organelle;proteinaceous extracellular matrix,,,,,,,,,,
Q8N335,GPD1L,Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1-L) (EC 1.1.1.8),7,25.1,27.31,28.78,27.22,,,,26.24,26.27,,,26.45,24.97,,26.75,0.56,2.03,0.48, , , ,-0.5,-0.48, , ,-0.3,-1.78, ,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;glycerol ether metabolic process;heterocycle metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;regulation of protein modification process;regulation of transport;small molecule metabolic process,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P43304,GPD2,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (mtGPD)",46,68.8,33.61,33.12,33.63,31.75,32.06,31.98,31.32,31.42,32.02,32.57,31.16,30.45,31.52,32.05,1.56,1.07,1.59,-0.3,0.01,-0.07,-0.73,-0.62,-0.02,0.53,-0.89,-1.6,-0.53,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;phosphorus metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
P06744,GPI,Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36),37,61.1,34.95,34.7,34.66,34.25,33.32,32.79,33.57,34,32.2,32.51,33.51,33.74,31.97,33.55,1.4,1.15,1.11,0.69,-0.23,-0.76,0.02,0.45,-1.35,-1.04,-0.04,0.19,-1.59,alcohol metabolic process;anatomical structure formation involved in morphogenesis;behavior;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular aldehyde metabolic process;cellular metabolic process;cellular process;developmental process;generation of precursor metabolites and energy;immune system process;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;regulation of body fluid levels;response to stimulus;small molecule metabolic process,cell part;cell projection;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;nucleus;organelle;plasma membrane,,,,,,,,,,
Q92917,GPKOW,G patch domain and KOW motifs-containing protein (G patch domain-containing protein 5) (Protein MOS2 homolog) (Protein T54),7,20.2,27.24,,27.29,25.87,24.37,26.9,25.73,,26.39,27.83,26.83,26.8,26.47,26.52,0.72, ,0.77,-0.65,-2.15,0.38,-0.79, ,-0.13,1.31,0.31,0.28,-0.05,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NPR9,GPR108,Protein GPR108 (Lung seven transmembrane receptor 2),4,7.9,26.43,26.48,,25.65,26.07,24.81,26.01,25.16,26.69,25.56,25.08,25.85,,25.8,0.63,0.68, ,-0.15,0.27,-0.99,0.21,-0.64,0.89,-0.24,-0.72,0.05, ,,cell part,,,,,,,,,,
Q86V85,GPR180,Integral membrane protein GPR180 (Intimal thickness-related receptor),4,8.9,25.01,26.01,26.38,25.66,24.85,25.11,26.41,,27.58,27.09,24.97,24.3,25.22,25.72,-0.7,0.29,0.66,-0.06,-0.86,-0.61,0.69, ,1.86,1.37,-0.74,-1.41,-0.5,biological regulation;cellular process;response to chemical stimulus;response to stimulus;signal transduction,cell part,,,,,,,,,,
O43194,GPR39,G-protein coupled receptor 39,5,35.3,,,28.1,28.33,29.28,30.95,28.34,28.59,29.71,,,,29.72,29.13, , ,-1.03,-0.8,0.15,1.82,-0.79,-0.54,0.58, , , ,0.59,,cell part,,,,,,,,,,
A6NKF9,GPR89C,Putative Golgi pH regulator C (Protein GPR89C),2,7.8,25.58,25,,25.02,25.01,26.98,,,25.05,,26.54,25.97,27.07,25.8,-0.22,-0.8, ,-0.79,-0.79,1.18, , ,-0.75, ,0.74,0.17,1.27,,cell part,,,,,,,,,,
Q8NFJ5,GPRC5A,Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Orphan G-protein-coupling receptor PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1),8,28.3,27.66,26.38,28.55,27.35,28.84,27.46,29.78,29.8,24.83,28.71,30.46,29.52,30.12,28.42,-0.76,-2.04,0.13,-1.07,0.42,-0.96,1.36,1.38,-3.59,0.29,2.04,1.1,1.7,,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q13098,GPS1,COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH),11,29.5,28.59,29.49,29.25,29.49,29.84,29.11,29.87,29.37,29.54,28.72,29.58,29.96,28.36,29.32,-0.73,0.17,-0.07,0.17,0.52,-0.21,0.55,0.05,0.22,-0.6,0.26,0.64,-0.96,biological regulation;cell cycle;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of protein modification process;response to stimulus;response to stress;signal transduction,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q8TD30,GPT2,Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),9,23.3,29.72,29.21,,27.54,27.72,26.22,26.02,26.53,27.56,28.41,,,28.33,27.73,2,1.48, ,-0.19,-0.01,-1.51,-1.7,-1.2,-0.17,0.69, , ,0.61,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P07203,GPX1,Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase),16,76.4,31.88,33.42,32.84,32.14,31.97,32.18,32.87,32.55,32.13,32.54,32.98,33.13,32.8,32.57,-0.69,0.85,0.27,-0.43,-0.6,-0.39,0.3,-0.02,-0.44,-0.03,0.41,0.56,0.23,"amine metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;catabolic process;cell development;cell differentiation;cell motility;cell proliferation;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component movement;cellular component organization;cellular homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;developmental process;glycerol ether metabolic process;growth;heterocycle metabolic process;homeostatic process;interspecies interaction between organisms;lipid metabolic process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;mitochondrion organization;multicellular organismal process;multi-organism process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;organic acid metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;protein modification process;regulation of gene expression, epigenetic;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process",cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P36969,GPX4,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)",7,50.3,29.66,29.8,30.22,28.35,27.5,26.9,28.69,27.86,28.52,28.49,29.04,28.11,26.58,28.44,1.22,1.36,1.79,-0.09,-0.94,-1.54,0.25,-0.58,0.08,0.05,0.6,-0.33,-1.86,cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96SL4,GPX7,Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9) (CL683),2,26.7,25.35,25.9,26.16,27.08,,25.69,25.77,26.01,25.94,,,,25.93,25.98,-0.63,-0.09,0.18,1.1, ,-0.29,-0.21,0.03,-0.04, , , ,-0.05,response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,extracellular region,,,,,,,,,,
Q8TED1,GPX8,Probable glutathione peroxidase 8 (GPx-8) (GSHPx-8) (EC 1.11.1.9),9,53.6,26.85,30.2,28.97,31.07,30.27,31.33,30.67,30.02,31.57,30.29,29.82,29.31,30.88,30.1,-3.24,0.11,-1.12,0.97,0.18,1.23,0.57,-0.08,1.47,0.19,-0.27,-0.79,0.78,response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part,,,,,,,,,,
Q96CP6,GRAMD1A,GRAM domain-containing protein 1A,14,24.7,26.61,28.71,26.59,27.42,24.77,29.58,27.58,29.69,28.22,26.17,29.43,30,30.03,28.06,-1.45,0.65,-1.47,-0.64,-3.29,1.51,-0.48,1.62,0.15,-1.89,1.37,1.94,1.97,,cell part,,,,,,,,,,
Q8IYS0,GRAMD1C,GRAM domain-containing protein 1C,2,5,25.54,25.23,25.46,25.95,26.11,26.15,25.35,25.24,26.23,26.34,24.4,25.44,25.66,25.62,-0.09,-0.39,-0.16,0.33,0.49,0.53,-0.27,-0.38,0.61,0.72,-1.22,-0.18,0.03,,cell part,,,,,,,,,,
Q96HH9,GRAMD3,GRAM domain-containing protein 3 (HCV NS3-transactivated protein 2),8,28.5,29.3,27.03,28.63,26.93,,,24.56,26.47,,29.59,26.76,,25.13,27.16,2.14,-0.12,1.48,-0.23, , ,-2.6,-0.68, ,2.43,-0.39, ,-2.02,,cell part;macromolecular complex;protein complex,,,,,,,,,,
P62993,GRB2,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2),13,57.1,29.38,30.12,30.55,29.58,28.01,28.34,28.44,28.67,28,27.62,28.76,28.94,27.43,28.76,0.62,1.36,1.79,0.82,-0.74,-0.41,-0.31,-0.09,-0.76,-1.14,0,0.19,-1.32,aging;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell activation;cell communication;cell motility;cell-cell signaling;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;endocytosis;establishment of localization;immune system process;interspecies interaction between organisms;locomotion;macromolecular complex assembly;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;multicellular organismal process;multi-organism process;protein complex assembly;regulation of organelle organization;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;signaling;transport;vesicle-mediated transport,cell part;cytosol;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,+,,,,,,
Q14451,GRB7,Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein),4,11.8,27.78,26.23,24.95,,24.59,,24,24.24,,,23.53,24.47,,24.97,2.81,1.25,-0.03, ,-0.38, ,-0.97,-0.73, , ,-1.44,-0.51, ,biological regulation;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular process;coagulation;immune system process;locomotion;macromolecular complex assembly;multicellular organismal process;regulation of body fluid levels;regulation of translation;response to stimulus;ribonucleoprotein complex assembly;signal transduction,cell part;cell projection;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;ribonucleoprotein complex,,,,+,,,,,,
Q9UBQ7,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81),11,44.8,30.67,31.08,30.75,30.67,30.22,30.33,30.27,30.64,29.66,30.23,30.63,30.66,30.09,30.45,0.22,0.63,0.29,0.21,-0.24,-0.13,-0.19,0.18,-0.8,-0.22,0.18,0.21,-0.36,cellular aldehyde metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;excretion;macromolecular complex assembly;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;protein complex assembly;secretion;small molecule metabolic process;transport,cell part,,,,,,,,,,
P28799,GRN,Granulins (Proepithelin) (PEPI) [Cleaved into: Acrogranin;Paragranulin;Granulin-1 (Granulin G);Granulin-2 (Granulin F);Granulin-3 (Granulin B);Granulin-4 (Granulin A);Granulin-5 (Granulin C);Granulin-6 (Granulin D);Granulin-7 (Granulin E)],2,5.8,25.62,25.66,26.63,,,27.56,24.91,24.37,25.55,27.16,27.36,,24.47,25.93,-0.31,-0.27,0.7, , ,1.63,-1.02,-1.55,-0.38,1.23,1.43, ,-1.46,biological regulation;cell death;cellular process;death;developmental process;response to stimulus;signal transduction,cell part;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9HAV7,GRPEL1,"GrpE protein homolog 1, mitochondrial (HMGE) (Mt-GrpE#1)",11,49.3,29.61,32.09,31.11,31.74,32.16,32.02,31.48,31.31,31.97,32.04,30.93,31.23,31.25,31.46,-1.84,0.64,-0.35,0.28,0.7,0.56,0.02,-0.15,0.51,0.59,-0.53,-0.23,-0.2,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;protein targeting;protein transport;transmembrane transport;transport,cell part,,,,,,,,,,
Q12849,GRSF1,G-rich sequence factor 1 (GRSF-1),11,47,29.37,28.97,28.46,29.88,30.25,30.56,30.04,29.09,29.87,30.91,29.71,30.29,30.31,29.82,-0.45,-0.86,-1.36,0.06,0.43,0.74,0.22,-0.73,0.04,1.09,-0.12,0.46,0.49,anatomical structure morphogenesis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P57764,GSDMD,Gasdermin-D (Gasdermin domain-containing protein 1),5,16.1,27.89,26.29,27.5,27.88,24.8,22.1,25.09,26.43,26.97,24.01,25.92,26.56,,25.95,1.94,0.34,1.55,1.93,-1.15,-3.85,-0.86,0.47,1.02,-1.94,-0.03,0.6, ,cell communication;cellular process;response to external stimulus;response to extracellular stimulus;response to stimulus,,,,,,,,,,,
P49840,GSK3A,Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1),5,18.2,26.84,26.11,,26.39,,,26.54,24.12,23.79,,24.69,24.55,26.29,25.48,1.36,0.63, ,0.91, , ,1.06,-1.36,-1.69, ,-0.79,-0.92,0.81,anatomical structure development;anatomical structure morphogenesis;biological regulation;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;immune system process;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,+,,,,,,,,
P49841,GSK3B,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),8,26.4,27.82,25.38,,26.15,,,26.23,24.96,24.69,24.28,25.04,,,25.57,2.25,-0.19, ,0.58, , ,0.66,-0.61,-0.88,-1.29,-0.53, , ,"anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;carbohydrate metabolic process;cell differentiation;cell morphogenesis;cell motility;cellular component morphogenesis;cellular component movement;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;energy reserve metabolic process;establishment of localization;establishment or maintenance of cell polarity;generation of precursor metabolites and energy;immune system process;localization;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;peptidyl-amino acid modification;phosphorus metabolic process;polysaccharide metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein targeting;protein transport;regulation of DNA metabolic process;regulation of gene expression, epigenetic;regulation of protein modification process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;rhythmic process;signal transduction;syncytium formation;transport",cell body;cell part;cell projection;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;neuron projection;neuronal cell body;nucleus;organelle;plasma membrane;protein complex;ribonucleoprotein complex;site of polarized growth,,+,,,,,,,,
P06396,GSN,Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin),33,47,33.11,32.51,33.06,31.37,30.51,30.12,31.52,31.83,31.25,30.03,32.33,30.02,30.02,31.36,1.75,1.15,1.7,0.01,-0.85,-1.24,0.16,0.47,-0.11,-1.33,0.97,-1.34,-1.34,aging;anatomical structure development;anatomical structure morphogenesis;biological regulation;cell development;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component organization;cellular macromolecular complex assembly;cellular process;cytoskeleton organization;developmental process;establishment of localization;growth;macromolecular complex assembly;organelle organization;protein complex assembly;protein polymerization;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cytoskeleton;cytosol;extracellular organelle;extracellular space;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P15170,GSPT1,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog),19,30.8,31.51,30.83,30.58,31.56,29.43,28.93,31.05,31.07,29.51,29.99,30.99,31.67,28.21,30.41,1.09,0.42,0.17,1.15,-0.98,-1.48,0.64,0.66,-0.9,-0.42,0.58,1.26,-2.2,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;RNA catabolic process;RNA metabolic process;small molecule metabolic process,cell part;intracellular,,,,,,,,,,
P00390,GSR,"Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)",15,39.5,32.67,31.72,33.89,31.66,30.51,30.33,31.24,30.68,30.42,31.77,31.26,31.01,28.72,31.22,1.44,0.5,2.67,0.44,-0.71,-0.89,0.01,-0.54,-0.8,0.55,0.04,-0.21,-2.5,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular homeostasis;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;homeostatic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P48637,GSS,Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase),16,33.1,30.53,30.08,30.07,29.92,28.66,27.83,29.05,29.33,28.09,27.18,29.26,29.6,24.57,28.78,1.75,1.3,1.29,1.13,-0.12,-0.95,0.27,0.54,-0.69,-1.6,0.48,0.81,-4.21,aging;anatomical structure development;cellular metabolic process;cellular process;developmental process;metabolic process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q9Y2Q3,GSTK1,Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13),15,66.4,32.75,31.91,33.39,31.23,31.61,32.12,31.53,31.71,31.68,32.36,32.16,31.91,32.76,32.09,0.67,-0.18,1.31,-0.86,-0.48,0.03,-0.56,-0.38,-0.4,0.27,0.08,-0.17,0.67,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle;peroxisome,,,,,,,,,,
P09488,GSTM1,Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4),5,22.5,29.01,28.81,28.4,26.14,25.19,27.22,26.97,26.83,25.14,27.21,,28.69,,27.24,1.78,1.57,1.16,-1.09,-2.05,-0.01,-0.27,-0.41,-2.1,-0.03, ,1.45, ,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
P28161,GSTM2,Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST class-mu 2) (GSTM2-2),12,59.2,30.08,28.63,28.45,28.86,24.39,27.54,27.61,26.3,,24.74,27.94,29.44,26.24,27.52,2.56,1.11,0.93,1.34,-3.13,0.03,0.1,-1.22, ,-2.78,0.42,1.92,-1.28,amine metabolic process;biological regulation;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P21266,GSTM3,Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3),9,43.6,27.94,30.43,29.24,30.08,25.62,26.02,28.92,29.14,26.92,28.15,30.56,31.71,25.31,28.46,-0.52,1.97,0.78,1.61,-2.85,-2.45,0.45,0.68,-1.54,-0.31,2.09,3.24,-3.15,amine metabolic process;anatomical structure development;catabolic process;cell development;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytoplasm,,,,,,,,,,
P78417,GSTO1,Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R),17,46.5,30.95,31.82,32.76,32.7,31.43,31.11,31.52,32.13,30.94,29.66,32.36,32.25,29.38,31.46,-0.51,0.35,1.3,1.23,-0.03,-0.35,0.06,0.66,-0.52,-1.8,0.9,0.78,-2.08,biological regulation;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;vitamin metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
P09211,GSTP1,Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1),19,73.8,,29.82,,29.34,,29.44,28.94,29.78,,,,,29.12,29.41, ,0.41, ,-0.07, ,0.03,-0.46,0.37, , , , ,-0.28,amine metabolic process;anatomical structure development;biological regulation;cell proliferation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;localization;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;regulation of protein modification process;response to biotic stimulus;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
A6NED0,GSTZ1,Glutathione transferase zeta 1 (Maleylacetoacetate isomerase),3,20.7,25.51,26.2,25.15,25.94,26.09,25.46,25.91,25.72,27.13,27.48,27.01,27.73,25.66,26.23,-0.72,-0.03,-1.08,-0.3,-0.14,-0.77,-0.33,-0.51,0.9,1.25,0.78,1.5,-0.57,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P29083,GTF2E1,General transcription factor IIE subunit 1 (General transcription factor IIE 56 kDa subunit) (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha),5,16.8,26.84,25.21,26.13,25.82,25.89,25.53,24.32,26.01,20.11,24.05,24.63,25.36,26.03,25.07,1.77,0.14,1.06,0.75,0.82,0.46,-0.75,0.94,-4.96,-1.02,-0.44,0.29,0.95,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;nucleoplasm,,,,,,,,,,
P29084,GTF2E2,Transcription initiation factor IIE subunit beta (TFIIE-beta) (General transcription factor IIE subunit 2),2,7.2,26.9,,25.86,25.33,26.64,26.37,24.19,25.91,26.96,25.43,,24.75,26.84,25.92,0.97, ,-0.06,-0.6,0.72,0.45,-1.73,-0.02,1.03,-0.49, ,-1.18,0.91,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;cytoplasm;macromolecular complex;nucleoplasm;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
P35269,GTF2F1,General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74),19,39.8,29.07,28.38,28.58,28.31,28.61,28.34,29.07,28.93,28.91,28.7,27.21,27.4,28.21,28.44,0.63,-0.06,0.14,-0.13,0.17,-0.1,0.63,0.49,0.48,0.26,-1.23,-1.04,-0.23,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
P13984,GTF2F2,General transcription factor IIF subunit 2 (EC 3.6.4.12) (ATP-dependent helicase GTF2F2) (General transcription factor IIF 30 kDa subunit) (Transcription initiation factor IIF subunit beta) (TFIIF-beta) (Transcription initiation factor RAP30),9,40.6,27.97,25.51,27.58,27.82,29.06,29.13,28.68,28.79,28.79,27.04,28.15,22.5,29.33,27.72,0.26,-2.21,-0.14,0.1,1.34,1.41,0.96,1.07,1.07,-0.68,0.43,-5.22,1.61,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
Q92759,GTF2H4,General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit),4,13.6,28.46,28.2,25.81,24.16,26.26,26.71,26.08,25.75,27.01,25.42,,,26.13,26.36,2.1,1.83,-0.55,-2.2,-0.1,0.35,-0.28,-0.61,0.65,-0.94, , ,-0.23,"biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
P78347,GTF2I,General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135) (SRF-Phox1-interacting protein) (SPIN) (Williams-Beuren syndrome chromosomal region 6 protein),48,57,32.31,30.67,31.93,31.43,31.47,31.52,31.34,30.98,31.76,31.25,30.5,30.9,31.27,31.33,0.98,-0.66,0.6,0.1,0.13,0.19,0.01,-0.35,0.43,-0.08,-0.84,-0.44,-0.07,"biological regulation;biosynthetic process;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell body;cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;neuronal cell body;nucleus;organelle,Other TF domain,,,,,,,,,
Q12789,GTF3C1,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),15,8.6,27.84,25.45,27.02,27.01,28.07,28.35,27.86,27.04,27.63,27.61,22.61,25.62,25.51,26.74,1.1,-1.29,0.28,0.27,1.33,1.61,1.12,0.3,0.89,0.87,-4.13,-1.12,-1.23,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase III promoter,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;ribonucleoprotein complex;transcription factor complex,,,,,,,,,,
Q8WUA4,GTF3C2,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),6,11.9,27.59,25.85,27.67,25.87,26.28,26.75,27.08,26.01,26.41,27.32,,25.09,24.52,26.37,1.22,-0.52,1.3,-0.5,-0.09,0.38,0.71,-0.37,0.04,0.95, ,-1.28,-1.85,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase III promoter,cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q9Y5Q9,GTF3C3,General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit) (TFIIIC 102 kDa subunit) (TFIIIC102) (Transcription factor IIIC subunit gamma) (TF3C-gamma),8,10.7,28.69,26.41,26.56,26.75,27.74,27.51,27.3,27.28,27.45,27.34,,27.28,26.48,27.23,1.45,-0.82,-0.67,-0.48,0.51,0.28,0.07,0.05,0.22,0.11, ,0.04,-0.75,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase III promoter,cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q9UKN8,GTF3C4,General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta),10,17.9,26.72,24.68,27.23,25.11,26.2,25.96,25.67,24.06,24.56,29.06,27.52,25.7,27.84,26.18,0.55,-1.5,1.05,-1.07,0.02,-0.22,-0.51,-2.11,-1.62,2.88,1.34,-0.48,1.67,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase III promoter;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q9Y5Q8,GTF3C5,General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon),9,21.6,28.14,26.45,25.88,27.87,29.21,27.76,26.82,27.55,26.74,27.05,26.93,28.23,27.58,27.4,0.74,-0.95,-1.52,0.46,1.81,0.36,-0.58,0.15,-0.66,-0.35,-0.47,0.83,0.18,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase III promoter,cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
O00178,GTPBP1,GTP-binding protein 1 (G-protein 1) (GP-1) (GP1),4,7.5,25.96,26.21,,26.91,26.51,25.65,27.04,26.08,26.64,,28.71,26.83,,26.65,-0.69,-0.44, ,0.26,-0.15,-1.01,0.38,-0.58,-0.02, ,2.06,0.17, ,biological regulation;cellular process;immune system process;response to stimulus;signal transduction,cell part;cytosol;exosome (RNase complex);macromolecular complex;protein complex,,,,,,,,,,
A4D1E9,GTPBP10,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),5,18.6,26.24,25.02,24.93,25.59,26.68,27.2,26.6,26.63,,25.31,,25.98,25.73,25.99,0.25,-0.98,-1.07,-0.4,0.69,1.21,0.6,0.64, ,-0.69, ,-0.01,-0.26,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;ribosome biogenesis;small molecule metabolic process,cell part;chromosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
Q9BZE4,GTPBP4,Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB),30,47.3,31.26,29.87,30.27,30.87,31.17,31.22,30.67,30.72,30.99,31.15,29.47,30.8,30.81,30.71,0.54,-0.84,-0.44,0.15,0.46,0.5,-0.04,0.01,0.27,0.44,-1.24,0.09,0.09,biological regulation;cellular process;regulation of cell cycle;regulation of DNA metabolic process;regulation of protein modification process;regulation of protein stability;ribosome biogenesis,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
O43824,GTPBP6,Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like),4,16.1,23.8,23.47,,26.24,25.41,24.61,24.37,24.83,25.42,27.07,23.76,25.74,25.39,25.01,-1.21,-1.54, ,1.23,0.4,-0.4,-0.64,-0.18,0.41,2.06,-1.25,0.73,0.38,,,,,,,,,,,,
Q16774,GUK1,Guanylate kinase (EC 2.7.4.8) (GMP kinase),4,36.1,28.08,28.47,27.77,28.45,28.23,27.76,27.85,28.33,27.97,28.42,29.17,28.79,29.47,28.37,-0.29,0.1,-0.6,0.09,-0.13,-0.61,-0.51,-0.04,-0.4,0.05,0.81,0.42,1.11,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;drug metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9UBP9,GULP1,PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP),5,17.2,25.36,26.15,25.62,25.84,26.41,23.78,,25.62,24.65,27.58,25.22,,,25.62,-0.26,0.53,0,0.22,0.79,-1.84, ,-0.01,-0.98,1.96,-0.4, , ,cell death;cellular component organization;cellular membrane organization;cellular process;death;establishment of localization;lipid transport;membrane invagination;membrane organization;transport,cell part;cytoplasm,,,,,,,,,,
P08236,GUSB,Beta-glucuronidase (EC 3.2.1.31) (Beta-G1),4,10.1,26.06,26.47,25.12,,24.16,,,,23,24.92,,,24.01,24.82,1.24,1.64,0.3, ,-0.66, , , ,-1.82,0.1, , ,-0.81,amine metabolic process;carbohydrate metabolic process;catabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P46976,GYG1,Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186),11,30.6,29.83,29.22,29.78,28.99,27.8,27.94,28.73,28.7,26.07,27.27,30.78,28.97,29.45,28.73,1.09,0.49,1.04,0.26,-0.93,-0.79,0,-0.03,-2.66,-1.47,2.05,0.24,0.72,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P13807,GYS1,"Glycogen [starch] synthase, muscle (EC 2.4.1.11)",25,48.1,30.87,31.78,28.85,30.95,27.97,30.2,29.45,30.22,26.3,29,30.9,30.45,30.3,29.79,1.08,2,-0.94,1.16,-1.82,0.41,-0.34,0.43,-3.49,-0.79,1.11,0.66,0.52,alcohol metabolic process;anatomical structure development;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q71UI9,H2AFV,Histone H2A.V (H2A.F/Z),4,46.9,32.69,32.37,31.75,31.5,31.87,32.58,31.6,31.73,32.63,31.59,30.32,29.78,31.52,31.69,1,0.68,0.07,-0.18,0.18,0.9,-0.09,0.04,0.94,-0.1,-1.36,-1.91,-0.17,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
P16104,H2AFX,Histone H2AX (H2a/x) (Histone H2A.X),3,23.1,31.23,31.35,30.02,30.82,31.71,32.26,31.17,30.88,31.92,31.81,30.8,31.27,31.11,31.26,-0.03,0.09,-1.23,-0.44,0.45,1,-0.08,-0.38,0.66,0.56,-0.46,0.02,-0.15,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;macromolecular complex assembly;macromolecule metabolic process;meiosis;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;chromosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear chromosome;nucleoplasm;nucleosome;nucleus;organelle,,,,,,,,,,
O75367,H2AFY,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205),20,53.6,33.49,33.08,33.28,32.43,32.81,33.28,32.94,32.58,33.42,33.69,31.59,32.19,32.5,32.87,0.63,0.21,0.41,-0.44,-0.06,0.42,0.07,-0.28,0.55,0.82,-1.28,-0.67,-0.37,"biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization;regulation of gene expression, epigenetic",cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear chromosome;nucleosome;organelle,,,,,,,,,,
Q9P0M6,H2AFY2,Core histone macro-H2A.2 (Histone macroH2A2) (mH2A2),11,38.4,30.63,30.88,29.69,29.88,30.14,29.78,28.82,28.89,29.95,30.13,27.8,27.77,28.66,29.46,1.17,1.41,0.23,0.42,0.67,0.32,-0.64,-0.58,0.48,0.67,-1.66,-1.69,-0.8,"biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization;regulation of gene expression, epigenetic",cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear chromosome;nucleosome;organelle,,,,,,,,,,
P84243,H3F3A,Histone H3.3,20,67.4,35.18,34.75,34.99,34.77,34.64,35.18,34.14,33.81,35.02,35.43,31.62,30.41,32.87,34.06,1.12,0.68,0.92,0.71,0.58,1.12,0.08,-0.25,0.95,1.37,-2.44,-3.65,-1.19,anatomical structure development;biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;coagulation;developmental process;macromolecular complex assembly;multicellular organismal process;organelle organization;regulation of body fluid levels;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;extracellular region;macromolecular complex;nucleoplasm;nucleosome,,,,,,,,,,
O95479,H6PD,GDH/6PGL endoplasmic bifunctional protein [Includes: Glucose 1-dehydrogenase (EC 1.1.1.47) (Hexose-6-phosphate dehydrogenase);6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)],33,45,31.64,32.12,32.16,31.57,30.76,32.29,30.37,31.14,31.87,29.71,30.21,30.57,31.76,31.24,0.4,0.88,0.92,0.32,-0.48,1.05,-0.87,-0.1,0.63,-1.53,-1.04,-0.68,0.52,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q5JVS0,HABP4,Intracellular hyaluronan-binding protein 4 (IHABP-4) (IHABP4) (Ki-1/57 intracellular antigen),3,18.2,,22.5,,21.04,,23.08,24.01,23.32,23.19,23.21,24.03,25.69,,23.34, ,-0.84, ,-2.3, ,-0.27,0.66,-0.02,-0.15,-0.13,0.69,2.35, ,biological regulation;biosynthetic process;cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;exocytosis;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to external stimulus;response to stimulus;RNA metabolic process;secretion;transport;vesicle-mediated transport,cell part;cytosol;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UJ83,HACL1,2-hydroxyacyl-CoA lyase 1 (EC 4.1.-.-) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),8,18.9,23.32,27.68,27.01,27.67,26.44,26.6,25.89,24.43,29.33,27.91,27.35,27.23,26.89,26.75,-3.43,0.93,0.26,0.92,-0.31,-0.15,-0.86,-2.32,2.58,1.16,0.6,0.48,0.14,catabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecular complex assembly;metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part,,,,,,,,,,
Q16836,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)",14,56.1,32.21,32.35,31.53,31.07,31.28,32.03,31.61,31.61,32.45,32.97,31.17,31.22,31.24,31.75,0.46,0.6,-0.22,-0.68,-0.47,0.28,-0.13,-0.14,0.7,1.22,-0.58,-0.53,-0.5,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P40939,HADHA,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17);Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]",49,62.9,33.83,34,34.59,33.75,33.82,34.09,33.99,33.85,34.9,34.81,34.54,33.86,35.01,34.23,-0.41,-0.24,0.35,-0.48,-0.41,-0.14,-0.24,-0.38,0.67,0.58,0.3,-0.38,0.77,biosynthetic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;protein complex,,,,,,,,,,
P55084,HADHB,"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]",39,71.9,33.4,33.45,34.33,33.06,33.14,33.55,33.25,32.84,34.2,34.43,34.29,33.02,34.46,33.65,-0.25,-0.2,0.68,-0.58,-0.51,-0.1,-0.39,-0.81,0.55,0.78,0.64,-0.63,0.81,biosynthetic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q16775,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)",5,25.5,27.32,29.43,26.21,27.41,27.38,26.89,28.29,28.28,26.35,26.7,28.33,25.99,25.94,27.27,0.05,2.16,-1.06,0.14,0.11,-0.38,1.02,1.01,-0.92,-0.57,1.06,-1.28,-1.33,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytoplasm,,,,,,,,,,
P12081,HARS,"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)",23,40.3,30.79,31.09,30.82,31.86,30.35,30.43,31.56,31.52,29.62,30.27,31.39,31.06,30.19,30.84,-0.06,0.25,-0.02,1.02,-0.49,-0.41,0.72,0.68,-1.22,-0.57,0.55,0.22,-0.66,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
P49590,HARS2,"Probable histidine--tRNA ligase, mitochondrial (EC 6.1.1.21) (Histidine--tRNA ligase-like) (Histidyl-tRNA synthetase) (HisRS)",6,12.5,25.35,25.98,29.11,27,27.04,27.63,25.65,26.45,27.21,27,26.04,25.28,27.98,26.75,-1.4,-0.77,2.36,0.25,0.29,0.89,-1.1,-0.3,0.46,0.26,-0.7,-1.47,1.24,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
O14929,HAT1,Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1),10,28.2,29.56,26.12,28.49,29.41,29.82,29.19,29.7,28.98,29.17,28.51,27.09,29.4,29.05,28.81,0.75,-2.69,-0.31,0.61,1.02,0.38,0.89,0.17,0.36,-0.3,-1.72,0.6,0.24,"biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA packaging;gene silencing;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of gene expression, epigenetic;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus",cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleoplasm;nucleus;organelle,,,,,,,,,,
O00165,HAX1,HCLS1-associated protein X-1 (HS1-associating protein X-1) (HAX-1) (HS1-binding protein 1) (HSP1BP-1),7,31.9,26.78,28.44,27.12,26.87,26.44,27.29,24.72,26.45,23.84,25.77,25.48,25.01,25.44,26.13,0.65,2.31,1,0.74,0.32,1.16,-1.41,0.32,-2.28,-0.35,-0.65,-1.12,-0.69,biological regulation;cellular component organization;cellular process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to stimulus,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytoskeleton;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nuclear envelope;organelle;protein complex;transcription factor complex;vesicle,,,,,,,,,,
P69905,HBA1;HBA2,Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain),8,83.8,31.5,32.26,34.84,29.9,30.17,32.53,30.82,31.09,30.25,27.79,32.1,31,32.16,31.26,0.24,1,3.58,-1.36,-1.1,1.27,-0.44,-0.18,-1.01,-3.47,0.84,-0.27,0.9,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;establishment of localization;gas transport;ion transport;macromolecular complex assembly;metabolic process;protein complex assembly;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;transport,cell part;extracellular region;macromolecular complex;protein complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P68871,HBB,Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7],12,94.6,31.06,31.6,34.38,27.03,24.54,28.86,26.72,27.24,26.42,25.96,27.89,21.63,29.1,27.88,3.18,3.72,6.5,-0.85,-3.34,0.98,-1.16,-0.64,-1.46,-1.92,0.01,-6.24,1.22,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;circulatory system process;coagulation;establishment of localization;ion transport;macromolecular complex assembly;metabolic process;multicellular organismal process;protein complex assembly;regulation of body fluid levels;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;transport,cell part;extracellular region;macromolecular complex;protein complex,,,,,,,,,,
Q9Y450,HBS1L,HBS1-like protein (ERFS),13,29.5,27.65,27.93,27.65,28.7,22.01,27.26,28.27,27.63,26.62,27.35,28.51,29.23,26.52,27.33,0.32,0.59,0.32,1.37,-5.32,-0.07,0.93,0.29,-0.71,0.02,1.18,1.89,-0.81,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein metabolic process;response to stimulus;signal transduction;small molecule metabolic process;translation,,,,,,,,,,,
P53701,HCCS,Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase),7,26.5,25.14,28.1,25.89,27.74,27.73,28.24,27.62,25.01,28.68,28.57,27.87,,29.02,27.47,-2.33,0.64,-1.58,0.27,0.26,0.77,0.15,-2.46,1.21,1.1,0.4, ,1.55,anatomical structure morphogenesis;developmental process;metabolic process,cell part;membrane,,,,,,,,,,
P51610,HCFC1,Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1;HCF N-terminal chain 2;HCF N-terminal chain 3;HCF N-terminal chain 4;HCF N-terminal chain 5;HCF N-terminal chain 6;HCF C-terminal chain 1;HCF C-terminal chain 2;HCF C-terminal chain 3;HCF C-terminal chain 4;HCF C-terminal chain 5;HCF C-terminal chain 6],26,18.9,30.44,29.92,29.98,30.01,30.48,29.96,29.84,29.81,30.63,29.56,28.88,27.98,29.93,29.8,0.64,0.12,0.18,0.21,0.68,0.16,0.03,0.01,0.83,-0.25,-0.92,-1.82,0.13,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;regulation of cell cycle;regulation of protein stability;RNA metabolic process;transcription from RNA polymerase II promoter,cell body;cell part;chromatin remodeling complex;histone methyltransferase complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;neuronal cell body;organelle;protein complex,,,,,,,,,,
Q08ET0,hCG_39985,"Cell proliferation-inducing protein 47 (HCG39985, isoform CRA_a) (cDNA, FLJ94101, Homo sapiens ATP synthase, H+ transporting, mitochondrial F0complex, subunit b, isoform 1 (ATP5F1), mRNA)",19,53.1,31.76,32.37,32.06,31.79,32.64,32.58,32.34,32.31,32.57,33.17,32.73,31.92,32.98,32.4,-0.64,-0.03,-0.34,-0.61,0.24,0.17,-0.06,-0.1,0.16,0.77,0.33,-0.48,0.58,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q13547,HDAC1,Histone deacetylase 1 (HD1) (EC 3.5.1.98),6,21.6,28.33,27.69,27.59,27.23,26.85,27.02,26.5,27.45,28.64,27.77,,,27.93,27.55,0.78,0.14,0.05,-0.31,-0.7,-0.52,-1.04,-0.09,1.09,0.22, , ,0.38,"anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell cycle;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;coagulation;developmental process;histone modification;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mitotic cell cycle;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;regulation of body fluid levels;regulation of cell cycle;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;chromatin remodeling complex;cytosol;macromolecular complex;protein complex;transcriptional repressor complex,,,,,,,,,,
Q92769,HDAC2,Histone deacetylase 2 (HD2) (EC 3.5.1.98),23,52.2,32.18,30.53,30.67,30.6,31.68,31.28,31,30.31,31,31.13,30.17,29.77,30.35,30.82,1.36,-0.29,-0.15,-0.22,0.85,0.46,0.18,-0.52,0.18,0.31,-0.65,-1.05,-0.47,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;coagulation;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;regulation of body fluid levels;regulation of cell cycle;regulation of protein modification process;response to stimulus;RNA metabolic process;signal transduction,cell part;chromatin remodeling complex;cytoplasm;histone methyltransferase complex;macromolecular complex;PcG protein complex;protein complex;transcription factor complex;transcriptional repressor complex,,,,,,,,,,
Q8WUI4,HDAC7,Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a),8,14,30.61,30.64,28.08,31.22,31.04,30.26,31.04,31.63,30.03,29.32,30.81,25.38,24.42,29.58,1.03,1.07,-1.5,1.64,1.47,0.68,1.47,2.06,0.46,-0.26,1.23,-4.19,-5.15,biological regulation;biosynthetic process;cell differentiation;cell junction organization;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;response to stimulus;RNA metabolic process;signal transduction,cell part;chromatin remodeling complex;cytoplasm;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P51858,HDGF,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),30,80.8,34.33,33.47,34.01,32.05,31.97,32.52,32.48,32.39,32.93,32.46,31.54,32.35,31.96,32.65,1.68,0.82,1.36,-0.6,-0.68,-0.13,-0.17,-0.26,0.27,-0.19,-1.11,-0.3,-0.69,biological regulation;cell proliferation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;regulation of protein modification process,cell part;cytoplasm;extracellular space;macromolecular complex;protein complex;transcriptional repressor complex,Other TF domain,,,,,,,,,
Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),23,36.4,30.25,29.58,29.46,29.51,29.18,29.98,30.03,29.39,30.29,29.53,29.23,28.54,29.73,29.59,0.66,-0.01,-0.13,-0.08,-0.41,0.39,0.44,-0.2,0.7,-0.06,-0.36,-1.05,0.14,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y3E1,HDGFRP3,Hepatoma-derived growth factor-related protein 3 (HRP-3) (Hepatoma-derived growth factor 2) (HDGF-2),2,18.2,25.76,27.45,26.17,26.53,26.73,26.95,27.1,25.63,28.34,,,26.62,26.09,26.67,-0.91,0.78,-0.5,-0.14,0.06,0.28,0.43,-1.04,1.67, , ,-0.06,-0.58,cell proliferation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q08623,HDHD1,Pseudouridine-5'-monophosphatase (5'-PsiMPase) (EC 3.1.3.n6) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1),3,28.8,27.73,26.81,27.36,27.86,,24.28,25.56,,,25.56,,26.55,,26.46,1.26,0.35,0.9,1.39, ,-2.19,-0.9, , ,-0.9, ,0.09, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;phosphorus metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q9H0R4,HDHD2,Haloacid dehalogenase-like hydrolase domain-containing protein 2,3,29.6,27.52,27.25,25.27,27.16,26.13,26.46,25.61,26.35,25.33,24.45,27.04,26.67,,26.27,1.25,0.98,-1,0.89,-0.14,0.19,-0.66,0.08,-0.94,-1.82,0.77,0.4, ,,,,,,,,,,,,
Q9BSH5,HDHD3,Haloacid dehalogenase-like hydrolase domain-containing protein 3,6,32.3,25.83,28.98,25.72,24.89,23.11,25.3,26.59,,23.56,27.89,28.79,25.5,25.6,25.98,-0.15,3,-0.26,-1.09,-2.87,-0.68,0.61, ,-2.42,1.91,2.81,-0.48,-0.38,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q00341,HDLBP,Vigilin (High density lipoprotein-binding protein) (HDL-binding protein),65,53.9,32.37,33.04,32.55,33.3,33.09,33.05,33.43,33.02,33.98,32.56,32.9,32.82,33.09,33.02,-0.64,0.02,-0.46,0.28,0.07,0.04,0.41,0.01,0.96,-0.45,-0.12,-0.2,0.07,alcohol metabolic process;establishment of localization;lipid metabolic process;lipid transport;metabolic process;primary metabolic process;small molecule metabolic process;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
B2RWN5,HEATR1,HEAT repeat containing 1,32,18.6,30.16,29.4,29.36,29.74,29.75,29.84,30.32,30.13,30.69,30.72,29.38,29.42,29.34,29.86,0.29,-0.46,-0.5,-0.12,-0.11,-0.03,0.46,0.26,0.82,0.86,-0.49,-0.45,-0.53,,,,,,,,,,,,
Q86Y56,HEATR2,HEAT repeat-containing protein 2,9,14.9,27.24,26.24,25.84,27.35,26.99,26.07,27.04,26.44,,25.59,,25.92,,26.47,0.77,-0.23,-0.64,0.88,0.52,-0.4,0.56,-0.03, ,-0.88, ,-0.55, ,,cell part;cytoplasm,,,,,,,,,,
Q7Z4Q2,HEATR3,HEAT repeat-containing protein 3,5,8.8,26.46,25.55,27.02,26.82,27.49,27.39,26.86,27.74,27.36,26.26,25.56,27.09,25.51,26.7,-0.24,-1.15,0.32,0.12,0.79,0.69,0.16,1.04,0.66,-0.44,-1.14,0.39,-1.19,,,,,,,,,,,,
Q9NRV9,HEBP1,Heme-binding protein 1 (p22HBP),9,41.3,30.68,29.51,27.95,29.35,26.37,26.65,28.12,28.21,26.47,28.04,28.45,27.2,26.63,27.97,2.7,1.54,-0.03,1.38,-1.6,-1.32,0.15,0.23,-1.5,0.07,0.47,-0.77,-1.34,rhythmic process,cell part;cytosol;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9Y5Z4,HEBP2,Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL),13,53.2,30.65,29.44,30.98,27.81,27.89,27.18,29.05,27.92,27.64,26.4,27.9,27.3,25.63,28.14,2.52,1.3,2.85,-0.33,-0.25,-0.96,0.91,-0.22,-0.5,-1.74,-0.24,-0.84,-2.5,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9ULT8,HECTD1,E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),12,5,25.97,25.74,24.71,27.83,26.03,,25.84,25.74,,23.38,25.32,26.59,,25.72,0.26,0.02,-1.01,2.12,0.32, ,0.12,0.03, ,-2.34,-0.4,0.88, ,anatomical structure formation involved in morphogenesis;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q5T447,HECTD3,E3 ubiquitin-protein ligase HECTD3 (EC 6.3.2.-) (HECT domain-containing protein 3),6,12.5,24.9,25.85,24.74,25.77,25.5,25.14,26.99,28.08,24.21,25.61,26.56,26.26,25.77,25.8,-0.9,0.05,-1.06,-0.03,-0.3,-0.66,1.19,2.28,-1.59,-0.19,0.76,0.46,-0.03,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9ULI3,HEG1,Protein HEG homolog 1,8,7.5,,26.66,23.29,28.9,25.63,28.12,28.06,27.3,27,25.46,28.63,26.23,28.19,26.96, ,-0.3,-3.67,1.95,-1.32,1.17,1.11,0.34,0.05,-1.49,1.67,-0.73,1.23,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell differentiation;cell junction organization;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular process;circulatory system process;developmental process;embryo development;growth;multicellular organismal process;post-embryonic development;regulation of body fluid levels,cell part;extracellular region,,,,,,,,,,
Q5GLZ8,HERC4,Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4),12,16.1,26.72,28.13,28.08,28.57,25.36,25.46,28.37,28.73,25.91,26.24,27.44,29.35,25.96,27.26,-0.54,0.88,0.83,1.31,-1.89,-1.8,1.11,1.48,-1.34,-1.02,0.18,2.09,-1.29,cell differentiation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P06865,HEXA,Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha),20,41.6,28.85,32.83,31.18,30.8,30.64,30.95,30.89,30.73,30.87,31.3,31.06,30.84,30.71,30.9,-2.05,1.94,0.29,-0.1,-0.26,0.05,0,-0.17,-0.02,0.4,0.17,-0.05,-0.19,amine metabolic process;anatomical structure development;anatomical structure morphogenesis;behavior;carbohydrate metabolic process;catabolic process;cell death;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;death;developmental process;lipid metabolic process;localization;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;organelle organization;polysaccharide metabolic process;primary metabolic process;reproduction;response to stimulus;sulfur compound metabolic process;vacuole organization,cell part;membrane,,,,,,,,,,
P07686,HEXB,Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B;Beta-hexosaminidase subunit beta chain A],28,46,29.59,33.81,32.83,32.33,32.19,32.6,32.4,32.07,32.39,33.02,32.26,32.11,32.72,32.33,-2.74,1.48,0.49,0,-0.15,0.27,0.06,-0.26,0.06,0.69,-0.07,-0.23,0.39,amine metabolic process;anatomical structure development;behavior;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell death;cell motility;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular lipid metabolic process;cellular metabolic process;cellular process;death;developmental process;homeostatic process;lipid metabolic process;localization;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;oligosaccharide metabolic process;organelle organization;polysaccharide metabolic process;primary metabolic process;protein metabolic process;response to stimulus;sulfur compound metabolic process;vacuole organization,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
O94992,HEXIM1,Protein HEXIM1 (Cardiac lineage protein 1) (Estrogen down-regulated gene 1 protein) (Hexamethylene bis-acetamide-inducible protein 1) (Menage a quatre protein 1),6,21.2,29.03,27.38,25.85,28.62,28.03,28.15,27.61,26.87,27.19,26.8,27.26,24.07,26.78,27.2,1.83,0.18,-1.35,1.42,0.83,0.95,0.41,-0.34,-0.01,-0.4,0.06,-3.14,-0.42,anatomical structure development;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of protein modification process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O14964,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110),7,12.1,28.55,29.42,28.9,29.85,28.89,24.76,29.01,29.2,29.15,28.08,28.98,29.34,27.48,28.58,-0.03,0.83,0.31,1.26,0.3,-3.83,0.43,0.62,0.56,-0.5,0.4,0.75,-1.1,biological regulation;cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;response to stimulus;signal transduction;transport;vacuolar transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q96QV1,HHIP,Hedgehog-interacting protein (HHIP) (HIP),4,7.6,22.92,,26.06,,25.24,26.81,25.72,,28.9,,,25.56,,25.89,-2.97, ,0.17, ,-0.65,0.93,-0.16, ,3.01, , ,-0.33, ,anatomical structure morphogenesis;biological regulation;carbohydrate metabolic process;cell proliferation;cellular process;developmental process;metabolic process;multicellular organismal process;primary metabolic process;response to stimulus;signal transduction,cell part;cell surface;cytoplasm;extracellular region,,,,,,,,,,
P31937,HIBADH,"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)",16,48.8,30.49,30.99,31.81,30.64,30.8,31.29,30.5,30.88,31.2,31.43,30.96,31.76,31.53,31.1,-0.61,-0.11,0.71,-0.46,-0.29,0.2,-0.6,-0.21,0.1,0.33,-0.14,0.66,0.43,alcohol metabolic process;amine metabolic process;carbohydrate metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q6NVY1,HIBCH,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)",18,50.3,32.07,30.56,32.14,29.23,29.03,30.12,29.68,29.28,30.65,31.32,28.98,29.49,29.83,30.19,1.89,0.37,1.96,-0.95,-1.15,-0.06,-0.5,-0.9,0.47,1.14,-1.21,-0.69,-0.35,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q9Y241,HIGD1A,"HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a)",4,53,23.05,24.35,,24.06,28.42,,24.62,25.23,24.83,26.49,,,,25.13,-2.08,-0.78, ,-1.07,3.28, ,-0.51,0.1,-0.3,1.36, , , ,biological regulation;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;response to stimulus;response to stress,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
P49773,HINT1,Histidine triad nucleotide-binding protein 1 (EC 3.-.-.-) (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1),9,83.3,32.62,31.94,32.03,31.94,31.98,30.83,31.82,32.13,30.04,30.59,32.27,30.33,27.93,31.27,1.35,0.67,0.76,0.67,0.72,-0.44,0.56,0.87,-1.22,-0.68,1,-0.93,-3.33,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;chromatin remodeling complex;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9BX68,HINT2,"Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3) (HIT-17kDa) (PKCI-1-related HIT protein)",4,52.3,28.47,28.84,29.1,28.84,29.86,29.27,29.22,28.92,28.28,29.3,29.32,28.02,29.31,28.98,-0.51,-0.14,0.12,-0.14,0.88,0.28,0.24,-0.06,-0.7,0.32,0.34,-0.96,0.33,biosynthetic process;cell death;cellular process;death;lipid metabolic process;metabolic process;primary metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NQE9,HINT3,Histidine triad nucleotide-binding protein 3 (HINT-3) (EC 3.-.-.-),4,27.5,28.86,27.79,25.7,24.97,26.59,26.77,25.48,26.76,26.92,26.74,,27.52,27.04,26.76,2.09,1.03,-1.06,-1.79,-0.17,0.01,-1.28,-0.01,0.16,-0.02, ,0.76,0.27,metabolic process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
O00291,HIP1,Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I),14,19.7,26.11,27.85,28.57,29.04,27.53,26.03,28.31,27.03,28.89,27.52,27.41,28.3,26.8,27.65,-1.54,0.21,0.92,1.39,-0.12,-1.61,0.67,-0.62,1.25,-0.12,-0.24,0.65,-0.84,biological regulation;biosynthetic process;cell differentiation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;endocytosis;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein complex assembly;regulation of transport;RNA metabolic process;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytoskeleton;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;vesicle,,,,,,,,,,
O75146,HIP1R,Huntingtin-interacting protein 1-related protein (HIP1-related protein) (Huntingtin-interacting protein 12) (HIP-12),4,5.3,25.19,24.06,24.59,25.65,27.6,25.99,26.82,26.88,27.26,28.8,27.14,,26.21,26.35,-1.16,-2.29,-1.76,-0.7,1.25,-0.36,0.47,0.53,0.91,2.45,0.79, ,-0.14,cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
P16401,HIST1H1B,Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3),20,40.7,33.8,34.29,33.54,33.52,34.2,34.16,33.83,33.59,34.36,34.39,32.07,32.54,32.53,33.6,0.2,0.68,-0.06,-0.08,0.6,0.56,0.23,-0.01,0.76,0.79,-1.54,-1.06,-1.07,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;macromolecular complex;nucleosome,,,,,,,,,,
P16403,HIST1H1C,Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1),3,9.9,27.78,27.83,28.69,27.21,25.68,27.02,27.58,27.16,27.65,,,,,27.4,0.38,0.43,1.29,-0.19,-1.72,-0.38,0.18,-0.24,0.25, , , , ,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
Q4VB24,HIST1H1E,"Histone cluster 1, H1e",14,28.3,33.66,33.52,33.34,33.09,33.84,33.85,33.22,31.29,34.09,33.41,31.03,,31.43,32.98,0.68,0.54,0.36,0.11,0.86,0.87,0.23,-1.69,1.11,0.43,-1.95, ,-1.56,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
P62807,HIST1H2BC,Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l),17,83.3,36.39,35.78,35.95,35.87,36.45,36.33,35.92,35.77,36.59,36.37,34.7,35.24,35.54,35.91,0.48,-0.14,0.03,-0.05,0.54,0.42,0,-0.14,0.67,0.45,-1.21,-0.68,-0.37,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;multi-organism process;organelle organization;response to biotic stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
P62805,HIST1H4A,Histone H4,23,71.8,37.01,36.98,36.26,36.68,37.21,37.22,36.78,36.87,36.96,36.71,35.04,36.12,36.45,36.64,0.37,0.34,-0.37,0.04,0.58,0.58,0.14,0.24,0.32,0.08,-1.6,-0.52,-0.19,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;homeostatic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to stimulus;signal transduction;telomere organization,cell part;cytoskeleton;extracellular region;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;nucleosome;organelle,,,,,,,,,,
Q8IUE6,HIST2H2AB,Histone H2A type 2-B,2,10.8,30.7,30.24,30.56,30.25,30.45,31.02,30.38,30.15,31.23,31.08,27.41,,23.43,29.74,0.96,0.5,0.82,0.51,0.71,1.28,0.64,0.41,1.49,1.33,-2.33, ,-6.31,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
Q16777,HIST2H2AC,Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q),16,75.2,36.31,36,35.88,35.82,36.36,36.41,35.8,35.46,36.37,36.33,34.81,34.33,35.97,35.84,0.47,0.17,0.04,-0.02,0.53,0.58,-0.03,-0.37,0.54,0.5,-1.02,-1.5,0.13,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
Q16778,HIST2H2BE,Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q),3,9.5,32.43,29.65,32.68,31.97,33.83,34.33,32.25,32.69,33.13,31.99,31.05,28.91,32.62,32.12,0.31,-2.47,0.56,-0.15,1.71,2.21,0.13,0.57,1.01,-0.13,-1.07,-3.21,0.51,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;multi-organism process;organelle organization;response to biotic stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
Q5TEC6,HIST2H3PS2,Histone H3,3,24.3,34.38,32.9,32.35,32.5,32.79,33.34,33.58,33.14,32.93,32.9,31.68,26.5,33.25,32.48,1.9,0.42,-0.13,0.02,0.31,0.86,1.1,0.65,0.45,0.42,-0.8,-5.98,0.77,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;macromolecular complex;nucleosome,,,,,,,,,,
P19367,HK1,Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I),52,47,32.53,33.43,32.59,33.34,32.58,33.61,32.57,32.25,33.5,32.72,33.46,32.9,33.86,33.03,-0.49,0.4,-0.44,0.31,-0.45,0.58,-0.45,-0.78,0.48,-0.31,0.43,-0.12,0.83,alcohol metabolic process;biological regulation;carbohydrate metabolic process;carbohydrate transport;catabolic process;cellular homeostasis;cellular metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;homeostatic process;metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
P52789,HK2,Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Muscle form hexokinase),26,32.9,31.27,30.84,31.12,30.33,28.73,29.55,29.9,30.2,30.48,30.76,31.03,31.51,30.27,30.46,0.81,0.38,0.66,-0.13,-1.73,-0.91,-0.56,-0.26,0.02,0.3,0.58,1.05,-0.19,alcohol metabolic process;biological regulation;carbohydrate metabolic process;carbohydrate transport;catabolic process;cellular component organization;cellular homeostasis;cellular metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;homeostatic process;metabolic process;mitochondrion organization;multicellular organismal process;organelle organization;primary metabolic process;regulation of body fluid levels;regulation of transport;secretion;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;membrane,,,,,,,,,,
Q2TB90,HKDC1,Putative hexokinase HKDC1 (EC 2.7.1.1) (Hexokinase domain-containing protein 1),25,32.2,25.64,27.52,28.06,,25.7,26.61,25.52,26.7,26.5,32.02,27.63,25.55,25.5,26.91,-1.27,0.6,1.14, ,-1.21,-0.3,-1.39,-0.21,-0.41,5.11,0.71,-1.37,-1.42,alcohol metabolic process;biological regulation;carbohydrate metabolic process;catabolic process;cellular homeostasis;cellular metabolic process;cellular process;generation of precursor metabolites and energy;homeostatic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
A1Z1D7,HLA-A,MHC class I antigen,2,8.2,27.52,26.7,30.38,27.85,,25.89,25.19,,,27.41,,,,27.28,0.25,-0.57,3.1,0.57, ,-1.39,-2.09, , ,0.13, , , ,immune system process;response to stimulus,cell part;macromolecular complex;MHC protein complex;protein complex,,,,,,,,,,
E5FQ49,HLA-A,MHC class I antigen,14,32.9,31.32,30.82,28.75,28.79,25.82,25.4,25.51,29.97,27.27,,25.31,29.44,,28.03,3.28,2.78,0.72,0.76,-2.22,-2.63,-2.53,1.93,-0.77, ,-2.73,1.4, ,immune system process;response to stimulus,cell part;macromolecular complex;MHC protein complex;protein complex,,,,,,,,,,
A7L858,HLA-A,MHC class I antigen (Fragment),2,7.3,27.72,25.33,22.42,29.05,22.24,26.39,20.36,24.45,27.08,23.52,,,,24.86,2.86,0.47,-2.44,4.2,-2.61,1.53,-4.5,-0.41,2.22,-1.33, , , ,immune system process;response to stimulus,cell part;macromolecular complex;MHC protein complex;protein complex,,,,,,,,,,
B2DFW8,HLA-A,MHC class I antigen (Fragment),4,13.6,,,30.25,19.9,28.24,26.77,27.83,20.03,29.15,,23.17,,,25.67, , ,4.58,-5.76,2.57,1.1,2.16,-5.64,3.48, ,-2.5, , ,immune system process;response to stimulus,cell part;macromolecular complex;MHC protein complex;protein complex,,,,,,,,,,
Q70Q11,HLA-B,MHC class I antigen,2,6.6,26.74,27.27,,25.42,27.56,,,26.36,,,27.63,28.67,,27.09,-0.35,0.17, ,-1.67,0.47, , ,-0.74, , ,0.54,1.58, ,immune system process;response to stimulus,cell part;macromolecular complex;MHC protein complex;protein complex,,,,,,,,,,
Q14527,HLTF,Helicase-like transcription factor (EC 3.6.4.-) (EC 6.3.2.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3),6,9.9,27.42,23.24,26.61,23.77,,23.92,19.81,,24.23,,,22,,23.88,3.54,-0.63,2.73,-0.1, ,0.05,-4.07, ,0.35, , ,-1.88, ,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8TCT9,HM13,Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase),11,26,30.39,31.21,30.96,30.48,30.59,31.15,30.83,30.85,31.48,31.84,31.83,30.28,31.59,31.04,-0.65,0.18,-0.08,-0.56,-0.45,0.11,-0.21,-0.18,0.44,0.81,0.79,-0.76,0.56,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cell surface;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9NP66,HMG20A,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1),4,15.3,25.86,,24.14,24.22,25.44,26.31,,23.75,25,26.51,,,,25.15,0.71, ,-1.02,-0.93,0.28,1.15, ,-1.4,-0.16,1.36, , , ,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,HMG-box,,,,,,,,,
Q9P0W2,HMG20B,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related (SMARCE1-related protein) (BRCA2-associated factor 35) (HMG box-containing protein 20B) (HMG domain-containing protein 2) (HMG domain-containing protein HMGX2) (Sox-like transcriptional factor) (Structural DNA-binding protein BRAF35),3,11.9,30.63,27.54,30.93,27.16,30.97,28.56,30.78,31.59,27.95,27.87,31.61,,,29.6,1.03,-2.06,1.33,-2.44,1.37,-1.04,1.18,1.99,-1.65,-1.73,2.01, , ,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;coagulation;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of body fluid levels;regulation of protein modification process;RNA metabolic process,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,HMG-box,,,,,,,,,
P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),10,57,26.13,,,25.16,20.97,19.84,27.69,20.99,,25.83,,20.3,,23.36,2.77, , ,1.8,-2.4,-3.53,4.33,-2.37, ,2.46, ,-3.06, ,"aging;biological regulation;biosynthetic process;cellular component assembly;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA geometric change;DNA metabolic process;DNA repair;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein complex assembly;regulation of gene expression, epigenetic;response to biotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process",cell part;cytosol;macromolecular complex;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
P09429,HMGB1,High mobility group protein B1 (High mobility group protein 1) (HMG-1),23,69.3,34.03,32.72,33.94,33.09,33.39,33.73,33.74,33.35,33.55,33.07,31.8,30.77,32.16,33.03,1,-0.31,0.91,0.06,0.37,0.7,0.72,0.33,0.53,0.05,-1.23,-2.25,-0.87,anatomical structure development;biological regulation;catabolic process;cell activation;cell motility;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA ligation;DNA metabolic process;DNA recombination;immune system process;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress,cell part;cell projection;cell surface;chromosome;cytoplasm;extracellular space;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;nucleoplasm;organelle,HMG-box,,,,,,,,,
O15347,HMGB3,High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4),10,39,29.28,28.53,28.5,28.19,29.91,27.55,29,27.46,29.44,29.24,27.44,28.6,28.56,28.59,0.69,-0.06,-0.09,-0.4,1.32,-1.04,0.41,-1.13,0.85,0.65,-1.15,0.01,-0.03,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA recombination;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;chromosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,HMG-box,,,,,,,,,
P35914,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)",12,41.3,30.21,31.1,31.33,30.28,29.99,30.81,30.04,30.35,31.09,31.54,30.57,30.86,31.05,30.71,-0.5,0.4,0.62,-0.43,-0.72,0.1,-0.67,-0.36,0.38,0.84,-0.14,0.15,0.34,amine metabolic process;anatomical structure development;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone body metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;embryo development;lipid metabolic process;macromolecular complex assembly;metabolic process;mitochondrion organization;nitrogen compound metabolic process;organelle organization;organic acid metabolic process;primary metabolic process;protein complex assembly;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle;peroxisome,,,,,,,,,,
P05114,HMGN1,Non-histone chromosomal protein HMG-14 (High mobility group nucleosome-binding domain-containing protein 1),9,50,27.89,27.93,28.66,26.9,25.05,26.15,26.59,25.71,26.78,27.06,25.83,27.82,24.94,26.72,1.18,1.22,1.94,0.19,-1.67,-0.57,-0.12,-1.01,0.06,0.34,-0.89,1.11,-1.78,anatomical structure morphogenesis;biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q15651,HMGN3,High mobility group nucleosome-binding domain-containing protein 3 (Thyroid receptor-interacting protein 7) (TR-interacting protein 7) (TRIP-7),4,38.4,26.87,25.04,24.36,25.3,25.75,27.41,23.64,26.6,24.61,23.96,,,26.08,25.42,1.45,-0.38,-1.06,-0.12,0.33,1.99,-1.78,1.18,-0.81,-1.46, , ,0.66,biological regulation;cellular component organization;cellular process;chromatin modification;chromatin organization;chromosome organization;organelle organization;regulation of transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O00479,HMGN4,High mobility group nucleosome-binding domain-containing protein 4 (Non-histone chromosomal protein HMG-17-like 3) (Non-histone chromosomal protein),3,31.1,24.85,24.51,24.52,23.1,24.36,23.56,24.2,24.95,25.23,24.19,,,,24.35,0.5,0.16,0.17,-1.25,0.02,-0.79,-0.15,0.61,0.89,-0.16, , , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P82970,HMGN5,High mobility group nucleosome-binding domain-containing protein 5 (Nucleosome-binding protein 1),7,28.4,28.07,26.05,27.25,29.07,26.1,26.16,26.8,19.94,26.98,25.55,26.66,25.28,24.31,26.02,2.05,0.03,1.23,3.06,0.08,0.14,0.78,-6.08,0.97,-0.47,0.64,-0.74,-1.7,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,Other TF domain,,,,,,,,,
P09601,HMOX1,Heme oxygenase 1 (HO-1) (EC 1.14.99.3),9,42.4,24.34,27.43,28.41,29.54,26.84,27.51,24.6,,27.27,24.33,24.96,27.35,28.42,26.75,-2.41,0.68,1.66,2.79,0.09,0.76,-2.14, ,0.52,-2.42,-1.79,0.6,1.67,anatomical structure formation involved in morphogenesis;biological regulation;catabolic process;cell communication;cell death;cell proliferation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;death;developmental process;establishment of localization;excretion;heterocycle metabolic process;homeostatic process;macromolecular complex assembly;metabolic process;multicellular organismal process;muscle adaptation;nitrogen compound metabolic process;pigment metabolic process;protein complex assembly;regulation of transport;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;secretion;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;nucleus;organelle,,,,,,,,,,
P30519,HMOX2,Heme oxygenase 2 (HO-2) (EC 1.14.99.3),22,66.5,30.23,31.17,30.62,31.37,32.18,31.7,32.43,31.45,31.64,32.24,32.17,31.88,32.73,31.68,-1.45,-0.51,-1.06,-0.3,0.5,0.02,0.75,-0.23,-0.03,0.56,0.49,0.2,1.05,biological regulation;catabolic process;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;establishment of localization;heterocycle metabolic process;homeostatic process;metabolic process;nitrogen compound metabolic process;pigment metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;transmembrane transport;transport,cell part;membrane;plasma membrane,,,,,,,,,,
Q9UK76,HN1,Hematological and neurological expressed 1 protein (Androgen-regulated protein 2),11,84.4,28.62,27.84,27.94,29.43,29.8,25.42,31.5,30.9,25.48,28.96,30.28,32.36,26.94,28.88,-0.27,-1.04,-0.94,0.54,0.92,-3.46,2.62,2.02,-3.4,0.07,1.4,3.48,-1.94,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H910,HN1L,Hematological and neurological expressed 1-like protein (HN1-like protein),7,59.5,29.49,28.65,28.54,29.04,29.01,27.26,29.9,29.81,27.28,28.57,29.12,28.56,27.16,28.65,0.84,0.01,-0.1,0.4,0.36,-1.39,1.25,1.16,-1.36,-0.08,0.48,-0.09,-1.49,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P50135,HNMT,Histamine N-methyltransferase (HMT) (EC 2.1.1.8),3,15.4,26.11,25.84,28.4,25.69,,,21.18,,20.23,,,23.57,,24.43,1.68,1.4,3.97,1.26, , ,-3.25, ,-4.2, , ,-0.86, ,anatomical structure development;developmental process;multicellular organismal process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to osmotic stress;response to stimulus;response to stress,cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;nucleus;organelle,,,,,,,,,,
Q13151,HNRNPA0,Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0),12,43.6,32.14,31.8,32.4,31.61,30.2,31.09,31.67,29.6,32.02,32.14,31.67,29.61,31.06,31.31,0.83,0.49,1.09,0.3,-1.11,-0.21,0.36,-1.71,0.71,0.83,0.36,-1.7,-0.25,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex,,,,,,,,,,
P09651,HNRNPA1,Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1),40,73.7,34.25,33.63,33.74,33.58,34.74,34.53,34.5,33.83,34.96,34.3,33.5,33.72,34.4,34.13,0.12,-0.5,-0.39,-0.55,0.61,0.4,0.37,-0.3,0.83,0.17,-0.63,-0.41,0.27,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P22626,HNRNPA2B1,Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1),38,75.6,35.13,35.07,35.3,35.2,35.67,35.97,35.43,35.22,36.05,35.97,34.4,34.11,35.32,35.29,-0.16,-0.22,0,-0.1,0.37,0.67,0.14,-0.08,0.76,0.67,-0.89,-1.19,0.02,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P51991,HNRNPA3,Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3),31,48.7,34.31,33.51,34.49,33.44,34.26,34.34,33.52,33.5,34.69,34.01,32.91,33.07,33.52,33.81,0.5,-0.31,0.68,-0.38,0.45,0.53,-0.3,-0.31,0.88,0.19,-0.91,-0.74,-0.29,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q99729,HNRNPAB,Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1),16,38.6,32.3,31.92,31.96,31.78,32.5,32.05,31.65,31.65,32.22,33.1,30.65,31.69,31.99,31.96,0.34,-0.04,0.01,-0.18,0.55,0.09,-0.31,-0.31,0.26,1.14,-1.31,-0.27,0.03,anatomical structure morphogenesis;biological regulation;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular process;developmental process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),35,79.2,34.13,34.25,34.21,33.89,34.6,34.62,33.98,33.84,34.53,34.66,33.26,33.96,33.94,34.14,-0.02,0.1,0.07,-0.25,0.45,0.48,-0.16,-0.3,0.39,0.51,-0.88,-0.18,-0.2,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q14103,HNRNPD,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),31,74.8,33.46,33.2,33.47,32.95,33.34,33.5,32.81,32.71,33.75,33.47,32.28,32.92,33.27,33.16,0.3,0.04,0.31,-0.22,0.18,0.33,-0.36,-0.45,0.59,0.31,-0.89,-0.24,0.1,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex,Other TF domain,,,,,,,,,
O14979,HNRNPDL,Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1),20,63.1,23.29,24.9,25.21,26.81,26.39,26.79,26.14,26.15,26.85,26.1,24.92,25.56,26.42,25.81,-2.52,-0.91,-0.6,1,0.58,0.98,0.33,0.34,1.04,0.29,-0.89,-0.25,0.61,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
O14979,HNRNPDL,Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1),20,63.1,23.29,24.9,25.21,26.81,26.39,26.79,26.14,26.15,26.85,26.1,24.92,25.56,26.42,25.81,-2.52,-0.91,-0.6,1,0.58,0.98,0.33,0.34,1.04,0.29,-0.89,-0.25,0.61,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
P52597,HNRNPF,"Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]",24,63.6,33.33,32.49,32.95,32.46,32.84,32.67,32.34,32.54,32.82,33.39,31.1,29.82,30.77,32.27,1.06,0.22,0.68,0.19,0.57,0.4,0.06,0.27,0.55,1.12,-1.17,-2.45,-1.51,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P31943,HNRNPH1,"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]",32,68.6,33.67,33.43,33.1,33.55,33.66,33.92,33.26,33.23,33.82,33.12,32.75,31.9,33.14,33.27,0.4,0.16,-0.17,0.28,0.38,0.65,-0.01,-0.04,0.54,-0.15,-0.52,-1.37,-0.14,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P55795,HNRNPH2,"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]",8,22.7,29.9,30.68,29.62,30.28,30.35,30.54,30.11,29.54,30.93,30.65,29.65,29.64,28.96,30.07,-0.17,0.61,-0.44,0.21,0.29,0.48,0.05,-0.52,0.87,0.58,-0.42,-0.43,-1.11,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;ribonucleoprotein complex,,,,,,,,,,
P31942,HNRNPH3,Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9),18,60.4,31.6,32.19,31.37,31.73,32.03,31.95,30.98,30.99,31.46,30.84,30.73,30.5,30.78,31.32,0.28,0.87,0.05,0.41,0.71,0.63,-0.34,-0.33,0.14,-0.48,-0.58,-0.82,-0.54,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
P61978,HNRNPK,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),45,72.7,34.85,34.33,34.1,34.43,34.42,34.91,34.4,34.09,34.84,34.53,33.72,33.41,33.97,34.31,0.54,0.03,-0.21,0.12,0.11,0.61,0.09,-0.22,0.53,0.22,-0.59,-0.9,-0.33,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of transport;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;cell projection;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
P14866,HNRNPL,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),40,65.4,34.18,33.66,34.09,33.66,33.71,33.83,33.66,33,34.35,34.48,32.66,33.28,33.3,33.68,0.5,-0.02,0.41,-0.02,0.03,0.15,-0.02,-0.68,0.67,0.8,-1.02,-0.4,-0.38,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q8WVV9,HNRNPLL,Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) (Stromal RNA-regulating factor),15,44.5,29.28,27.9,29.19,28.38,,28.23,27.25,,26.38,27.19,27.58,25.43,28.06,27.72,1.56,0.18,1.48,0.66, ,0.51,-0.46, ,-1.34,-0.52,-0.14,-2.28,0.35,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
P52272,HNRNPM,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),67,81.9,34.47,33.52,34.51,34.3,34.92,34.72,34.35,34.05,34.78,34.46,33.34,34.13,34.51,34.31,0.16,-0.79,0.19,-0.01,0.61,0.41,0.03,-0.26,0.46,0.15,-0.97,-0.18,0.2,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O43390,HNRNPR,Heterogeneous nuclear ribonucleoprotein R (hnRNP R),30,42,32.1,32.54,32.53,32.34,33.04,33.21,32.82,32.35,33.08,32.72,31.58,31.97,32.41,32.51,-0.41,0.02,0.01,-0.18,0.52,0.69,0.31,-0.16,0.57,0.21,-0.93,-0.55,-0.11,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q00839,HNRNPU,Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (Scaffold attachment factor A) (SAF-A) (p120) (pp120),60,52.4,35.05,33.94,34.76,34.58,35.23,35.01,34.58,34.45,34.99,35.13,33.7,33.81,34.28,34.58,0.47,-0.64,0.18,0,0.66,0.43,0,-0.13,0.41,0.56,-0.88,-0.77,-0.29,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cell surface;macromolecular complex;nucleoplasm;protein complex;ribonucleoprotein complex;spliceosomal complex,SAP-domain,,,,,,,,,
Q9BUJ2,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5),36,48.9,32.72,31.23,31.32,31.37,31.22,31.56,30.6,30.87,32.07,31.12,30.18,30.27,30.73,31.17,1.55,0.05,0.14,0.19,0.05,0.39,-0.57,-0.3,0.9,-0.06,-0.99,-0.9,-0.44,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex,SAP-domain,,,,,,,,,
Q1KMD3,HNRNPUL2,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),56,59,33.28,33.2,33.21,32.36,32.35,32.99,32.65,32.22,33.67,33.38,31.67,31.98,32.32,32.72,0.56,0.49,0.5,-0.36,-0.36,0.28,-0.06,-0.49,0.95,0.67,-1.04,-0.73,-0.39,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,SAP-domain,,,,,,,,,
Q9NSC1,HOMER3,Homer-3B protein,6,23.4,25.74,26.84,26.27,27.1,27.65,23.83,27.03,28.43,25.57,28.4,28.21,25.46,28.78,26.87,-1.13,-0.03,-0.6,0.23,0.78,-3.04,0.16,1.56,-1.3,1.53,1.34,-1.41,1.91,biological regulation;cellular process;establishment of localization;protein targeting;protein transport;response to stimulus;signal transduction;transport,basal part of cell;cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q9UJC3,HOOK1,Protein Hook homolog 1 (h-hook1) (hHK1),8,16.8,28.32,24.71,27.38,23.84,,,24.22,24.97,,27.5,23.41,26.18,,25.61,2.7,-0.91,1.77,-1.77, , ,-1.4,-0.64, ,1.89,-2.21,0.56, ,anatomical structure development;cell development;cellular component organization;cellular process;cytoskeleton organization;developmental process;endosome organization;endosome transport;establishment of localization;multicellular organismal development;multicellular organismal process;organelle organization;protein transport;transport;vacuolar transport;vacuole organization;vesicle-mediated transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q86VS8,HOOK3,Protein Hook homolog 3 (h-hook3) (hHK3),12,20.3,26.7,27.56,27.01,28.88,27.11,27.31,27.38,26.56,27.72,24.92,28.43,27.78,27.65,27.31,-0.6,0.26,-0.3,1.57,-0.2,0,0.07,-0.74,0.41,-2.39,1.13,0.47,0.34,biological regulation;cellular component organization;cellular localization;cellular process;cytoskeleton organization;developmental process;endosome organization;endosome transport;establishment of localization;localization;organelle localization;organelle organization;protein transport;transport;vacuolar transport;vacuole organization;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
P20719,HOXA5,Homeobox protein Hox-A5 (Homeobox protein Hox-1C),2,11.9,,,,24.44,25.72,25.48,25.95,25.65,24.98,,23.08,,,25.04, , , ,-0.6,0.68,0.44,0.91,0.61,-0.06, ,-1.97, , ,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell communication;cell differentiation;cell maturation;cell motility;cell-cell signaling;cellular component movement;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental maturation;developmental process;growth;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;signaling,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Homeobox,,,,,,,,,
Q5SSJ5,HP1BP3,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),35,59.7,33.05,31.52,32.41,31.25,31.15,31.3,31.23,30.96,32.41,31.74,30.3,30.42,31.25,31.46,1.59,0.06,0.95,-0.21,-0.31,-0.16,-0.23,-0.5,0.95,0.28,-1.17,-1.04,-0.21,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleosome;nucleus;organelle,,,,,,,,,,
P37235,HPCAL1,Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3),8,36.8,28.99,29.37,28.97,29.54,26.87,28.16,28.13,28.18,29.38,28.44,28.78,29.71,28.24,28.68,0.32,0.69,0.29,0.87,-1.8,-0.51,-0.55,-0.49,0.7,-0.23,0.11,1.03,-0.43,,,,,,,,,,,,
P00492,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8),8,44,30.64,30.31,30.33,30.66,28.83,28.87,30.56,30.72,28.72,27.72,28.88,30.95,28.23,29.65,0.99,0.67,0.68,1.01,-0.82,-0.78,0.91,1.07,-0.92,-1.93,-0.76,1.3,-1.42,alcohol metabolic process;amine metabolic process;anatomical structure development;anatomical structure morphogenesis;behavior;biological regulation;biosynthetic process;catabolic process;cell activation;cell death;cell development;cell differentiation;cell proliferation;cellular aromatic compound metabolic process;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;heterocycle metabolic process;immune system process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;pigment metabolic process;primary metabolic process;protein complex assembly;purine-containing compound salvage;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P52758,HRSP12,Ribonuclease UK114 (EC 3.1.-.-) (14.5 kDa translational inhibitor protein) (p14.5) (Heat-responsive protein 12) (UK114 antigen homolog),2,22.8,27.24,28.03,26.77,26.84,27.59,28.22,26.48,28.03,27.03,27.12,28.18,26.7,27.82,27.39,-0.15,0.65,-0.62,-0.55,0.2,0.83,-0.91,0.64,-0.36,-0.27,0.79,-0.69,0.43,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q53T59,HS1BP3,HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3),4,16.1,,24.35,24.68,,,,26.57,25.2,25.06,,25.36,26.6,25.11,25.37, ,-1.02,-0.68, , , ,1.2,-0.17,-0.31, ,-0.01,1.23,-0.25,cell communication;cellular process,,,,,,,,,,,
Q7LGA3,HS2ST1,Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2OST) (EC 2.8.2.-),5,15.4,26.03,29.43,28,28.55,26.51,28.19,27.06,26.58,27.91,27.7,26.77,28.14,27.8,27.59,-1.56,1.84,0.41,0.96,-1.08,0.6,-0.53,-1.01,0.32,0.11,-0.82,0.55,0.21,amine metabolic process;biosynthetic process;carbohydrate metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
O75506,HSBP1,Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13),7,90.8,29.77,28.7,28.26,30.25,28.03,29.32,29.89,29.22,29.73,28.39,29.07,31.1,29.56,29.33,0.44,-0.63,-1.07,0.92,-1.3,-0.01,0.56,-0.11,0.4,-0.94,-0.26,1.77,0.23,biological regulation;multicellular organismal process;muscle contraction,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P28845,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1 (EC 1.1.1.146) (11-beta-hydroxysteroid dehydrogenase 1) (11-DH) (11-beta-HSD1),12,31.5,25.21,31.84,27.84,33.58,27.66,30.53,23.29,25.69,30.12,26.2,27.82,27.27,27.83,28.07,-2.86,3.77,-0.22,5.51,-0.41,2.46,-4.78,-2.38,2.06,-1.87,-0.25,-0.8,-0.24,anatomical structure development;biological regulation;biosynthetic process;cellular metabolic process;cellular process;developmental process;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q99714,HSD17B10,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH),20,83.1,32.29,33.45,32.69,32.85,32.98,34.12,32.62,32.46,32.7,33.09,33.73,33.63,33.89,33.11,-0.82,0.34,-0.42,-0.27,-0.13,1,-0.5,-0.66,-0.42,-0.02,0.62,0.51,0.77,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;RNA processing;small molecule metabolic process;tRNA metabolic process;tRNA processing,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q8NBQ5,HSD17B11,Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Cutaneous T-cell lymphoma-associated antigen HD-CL-03) (CTCL-associated antigen HD-CL-03) (Dehydrogenase/reductase SDR family member 8) (Retinal short-chain dehydrogenase/reductase 2) (retSDR2),14,56.2,30.02,30.38,30.43,29.21,29.55,30.56,30.9,30.31,29.43,28.11,31.33,29.13,30.8,30.01,0,0.37,0.41,-0.8,-0.47,0.55,0.89,0.3,-0.59,-1.91,1.31,-0.88,0.79,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular process;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process,cell part;extracellular region;lipid particle,,,,,,,,,,
Q53GQ0,HSD17B12,Estradiol 17-beta-dehydrogenase 12 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (EC 1.3.1.-),18,52,32.01,32.21,30.9,31.73,31.81,32.07,32.4,31.81,32.17,32.78,32.21,32.09,32.86,32.08,-0.07,0.13,-1.18,-0.36,-0.27,-0.01,0.32,-0.27,0.09,0.7,0.13,0.01,0.78,biological regulation;biosynthetic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;extracellular matrix organization;extracellular structure organization;glycerol ether metabolic process;hormone metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;extracellular matrix;membrane,,,,,,,,,,
P56937,HSD17B7,3-keto-steroid reductase (EC 1.1.1.270) (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62),5,17.3,25.42,25.88,25.73,26.14,26.64,27.11,26.87,27.9,27.89,27.19,26.16,26.58,26.1,26.58,-1.17,-0.71,-0.86,-0.44,0.05,0.53,0.29,1.31,1.31,0.61,-0.42,-0.01,-0.49,alcohol metabolic process;biological regulation;biosynthetic process;cellular metabolic process;cellular process;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane;plasma membrane,,,,,,,,,,
Q3SXM5,HSDL1,Inactive hydroxysteroid dehydrogenase-like protein 1,2,20.4,25.75,25.07,,,24.61,27.35,,24.57,27.79,27.27,27.91,23.47,26.98,26.08,-0.33,-1.01, , ,-1.47,1.27, ,-1.51,1.71,1.2,1.83,-2.61,0.9,metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6YN16,HSDL2,Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-),17,48.1,27.91,29.34,28.26,28.67,28.97,29.46,28.11,28.34,29,30.2,29.47,28.98,29.24,28.92,-1.01,0.42,-0.66,-0.24,0.05,0.54,-0.81,-0.58,0.08,1.28,0.55,0.07,0.32,,cell part;intracellular membrane-bounded organelle;intracellular organelle;microbody;mitochondrion;organelle;peroxisome,,,,,,,,,,
P07900,HSP90AA1,Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Renal carcinoma antigen NY-REN-38),59,57.5,35.5,34.47,35.12,34.71,35.05,34.59,35.28,35.36,34.28,34.61,34.98,35.27,34.63,34.91,0.59,-0.44,0.2,-0.2,0.14,-0.32,0.37,0.45,-0.63,-0.3,0.07,0.36,-0.28,biological regulation;cell death;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular metabolic process;cellular process;death;establishment of localization;immune system process;locomotion;macromolecular complex assembly;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;multicellular organismal process;muscle contraction;nitrogen compound metabolic process;organelle organization;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein targeting;protein transport;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to heat;response to osmotic stress;response to stimulus;response to stress;transport,cell body;cell part;cell projection;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;extracellular matrix;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;neuronal cell body;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
P08238,HSP90AB1,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84),85,73.9,36.72,36.04,36.48,36.51,36.28,36.13,36.73,36.71,35.69,36.13,36.4,36.84,35.69,36.33,0.38,-0.3,0.15,0.18,-0.06,-0.21,0.4,0.38,-0.65,-0.21,0.06,0.51,-0.64,anatomical structure development;biological regulation;cellular component organization;cellular metabolic process;cellular process;developmental process;immune system process;locomotion;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to osmotic stress;response to stimulus;response to stress;signal transduction,cell part;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle;vesicle,,,,,,,,,,
Q58FF8,HSP90AB2P,Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b) (Heat shock protein 90Bb),3,8.1,31.18,30.94,30.26,31.75,31.14,29.81,31.5,31.64,30.08,30.36,31.71,31.88,30.74,31,0.18,-0.06,-0.74,0.75,0.14,-1.19,0.5,0.64,-0.92,-0.64,0.71,0.88,-0.25,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
Q58FF6,HSP90AB4P,Putative heat shock protein HSP 90-beta 4,2,6.1,29.03,28.75,25.01,29.76,,,29.53,25.45,27.5,26.02,28.15,30.19,25,27.67,1.36,1.08,-2.66,2.09, , ,1.86,-2.22,-0.17,-1.66,0.48,2.52,-2.67,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
P14625,HSP90B1,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),103,82.6,37.73,37.57,37.45,36.72,36.57,36.71,36.39,36.13,36.66,37.3,36.45,35.99,36.58,36.79,0.95,0.79,0.66,-0.07,-0.22,-0.08,-0.4,-0.66,-0.13,0.52,-0.34,-0.8,-0.21,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;establishment of localization;immune system process;macromolecule metabolic process;metabolic process;organelle organization;primary metabolic process;protein folding;protein metabolic process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;midbody;organelle;vesicle,,,,,,,,,,
O43301,HSPA12A,Heat shock 70 kDa protein 12A,6,11.3,27.99,27.85,24.1,24.85,28.15,29.23,27.62,27.7,25.8,29.16,27.5,27.56,26.67,27.25,0.74,0.61,-3.14,-2.39,0.91,1.98,0.38,0.46,-1.45,1.92,0.25,0.31,-0.57,,,,,,,,,,,,
P48723,HSPA13,Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein),8,16.6,28.95,28.72,28.98,29.41,29.46,30.22,29.56,28.8,29.46,29.21,28.65,29.36,29.42,29.25,-0.3,-0.53,-0.27,0.17,0.22,0.98,0.31,-0.45,0.21,-0.04,-0.6,0.12,0.18,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q0VDF9,HSPA14,Heat shock 70 kDa protein 14 (HSP70-like protein 1) (Heat shock protein HSP60),6,14.3,28.1,27.06,27.59,27.42,27.24,25.4,26.4,27.59,25.29,25.94,26.87,27.63,25.27,26.75,1.34,0.3,0.83,0.67,0.49,-1.36,-0.35,0.83,-1.46,-0.81,0.12,0.88,-1.49,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytosol,,,,,,,,,,
P08107,HSPA1A,Heat shock 70 kDa protein 1A/1B (Heat shock 70 kDa protein 1/2) (HSP70-1/HSP70-2) (HSP70.1/HSP70.2),46,65.4,35.93,34.44,35.7,33.84,33.85,33.42,33.92,33.91,33,33.82,33.92,34.22,32.86,34.06,1.86,0.38,1.64,-0.23,-0.21,-0.64,-0.14,-0.16,-1.06,-0.25,-0.14,0.16,-1.2,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex,,,,,,,,,,
P54652,HSPA2,Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 2),9,19.9,30.52,28.46,27.52,28.87,25.68,25.62,26.68,27.12,25.21,25.8,25.81,28.38,26.41,27.08,3.44,1.37,0.44,1.79,-1.41,-1.46,-0.41,0.03,-1.87,-1.28,-1.27,1.29,-0.67,anatomical structure development;biological regulation;cell development;cellular component disassembly;cellular component organization;cellular process;chromosome organization;developmental process;meiosis;organelle organization;regulation of cell cycle;regulation of protein modification process;response to chemical stimulus;response to stimulus;response to stress,cell part;cell surface;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P34932,HSPA4,Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2),56,69.5,33.75,33.15,33.07,32.94,31.93,31.96,32.84,32.61,31.82,32.1,33.1,33.25,31.74,32.64,1.12,0.52,0.43,0.31,-0.7,-0.67,0.2,-0.03,-0.82,-0.53,0.46,0.61,-0.9,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular process;establishment of localization;macromolecular complex assembly;membrane organization;mitochondrion organization;organelle organization;protein complex assembly;protein targeting;protein transport;response to chemical stimulus;response to stimulus;response to stress;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P11021,HSPA5,78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP),86,74.9,36.81,37.17,36.89,36.85,37.05,37.15,36.35,36.46,36.72,36.95,36.16,36.24,36.83,36.74,0.07,0.43,0.15,0.11,0.31,0.41,-0.39,-0.28,-0.02,0.21,-0.58,-0.5,0.09,anatomical structure development;biological regulation;catabolic process;cell activation;cell communication;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to biotic stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;midbody;nucleus;organelle;protein complex;vesicle,,,,,,,,,,
P11142,HSPA8,Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8),64,73.1,36.29,35.87,36.6,36.52,36.81,36.29,36.89,36.95,36.19,36.29,36.76,36.42,36.4,36.48,-0.2,-0.61,0.12,0.04,0.33,-0.19,0.41,0.47,-0.29,-0.19,0.27,-0.07,-0.09,biological regulation;biosynthetic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;Golgi vesicle transport;interspecies interaction between organisms;macromolecule metabolic process;membrane organization;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;neurotransmitter transport;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of cell cycle;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;secretion;transport;vesicle-mediated transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;plasma membrane;protein complex;ribonucleoprotein complex;spliceosomal complex;vesicle,,,,,,,,,,
P38646,HSPA9,"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (MOT) (Peptide-binding protein 74) (PBP74)",76,75.3,35.21,35.14,35.32,34.86,34.96,35.11,34.85,34.81,35.07,35.74,34.59,34.75,35.2,35.05,0.16,0.1,0.27,-0.18,-0.09,0.06,-0.2,-0.23,0.02,0.69,-0.46,-0.3,0.15,biological regulation;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;nuclear transport;nucleocytoplasmic transport;primary metabolic process;protein folding;protein metabolic process;protein targeting;protein transport;transport,cell part;cell surface;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P04792,HSPB1,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),28,96.1,35.49,34.46,34.32,34.19,33.55,32.83,33.41,33.88,31.9,32.11,34.14,34.03,32.77,33.62,1.87,0.84,0.7,0.57,-0.07,-0.79,-0.21,0.26,-1.73,-1.51,0.52,0.41,-0.85,biological regulation;cell death;cellular component movement;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;cell surface;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;proteasome complex;protein complex,,,,,,,,,,
Q9Y547,HSPB11,Heat shock protein beta-11 (Hspb11) (Placental protein 25) (PP25),4,36.1,25.01,25.62,24.95,26.19,,25.84,27.49,26.64,,,24.21,27.01,,25.88,-0.87,-0.27,-0.94,0.31, ,-0.04,1.61,0.75, , ,-1.67,1.13, ,biological adhesion;cell adhesion;cellular process;response to stimulus;response to stress,cell part;cell projection;cilium;macromolecular complex;protein complex,,,,,,,,,,
Q9UJY1,HSPB8,Heat shock protein beta-8 (HspB8) (Alpha-crystallin C chain) (E2-induced gene 1 protein) (Protein kinase H11) (Small stress protein-like protein HSP22),8,39.8,28.37,27.18,21.68,28.16,26.09,27.3,29.42,29.31,27.19,25.22,29.07,26.76,25.5,27.02,1.35,0.16,-5.34,1.14,-0.93,0.28,2.4,2.29,0.17,-1.8,2.05,-0.26,-1.52,cell death;cellular process;death;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q9NZL4,HSPBP1,Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-binding protein 2) (HspBP2) (Hsp70-interacting protein 1) (Hsp70-interacting protein 2),7,24,28.77,27.8,28.16,28.62,27.51,25.87,27.88,28.24,26.28,26.65,26.25,28.36,23.88,27.25,1.52,0.55,0.91,1.37,0.26,-1.39,0.62,0.99,-0.97,-0.6,-1,1.1,-3.37,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process,,,,,,,,,,,
P10809,HSPD1,"60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)",76,90.1,36.58,36.22,36.73,35.81,36.03,36.37,35.96,35.65,36.29,36.58,35.69,35.65,36.31,36.14,0.44,0.07,0.59,-0.34,-0.11,0.22,-0.19,-0.5,0.15,0.44,-0.45,-0.49,0.17,biological regulation;cell activation;cell proliferation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytokine production;DNA metabolic process;DNA recombination;immune system process;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein folding;protein maturation;protein metabolic process;regulation of protein stability;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;endosome;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;receptor complex;vesicle,,,,,,,,,,
P61604,HSPE1,"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10) (Early-pregnancy factor) (EPF)",22,91.2,34.69,34.47,35.22,33.67,34.38,34.87,33.88,33.6,34.55,35.06,34.3,34.29,34.55,34.43,0.26,0.04,0.79,-0.75,-0.04,0.45,-0.55,-0.82,0.12,0.64,-0.12,-0.14,0.12,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P98160,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin;LG3 peptide],69,24.4,29.41,32.11,29.1,32.07,31.28,32.33,31.63,30.64,31.26,33.63,30.79,26.86,33.45,31.12,-1.71,0.99,-2.02,0.95,0.16,1.21,0.51,-0.48,0.14,2.51,-0.33,-4.26,2.33,amine metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell differentiation;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;developmental process;extracellular matrix organization;extracellular structure organization;lipid metabolic process;localization;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;sulfur compound metabolic process,cell part;extracellular organelle;extracellular space;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q92598,HSPH1,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein),53,66.2,31.9,30.75,32.57,32.71,32.48,31.44,33.38,32.89,31.14,31.85,32.65,33.47,31.61,32.22,-0.32,-1.47,0.35,0.49,0.26,-0.78,1.16,0.67,-1.07,-0.37,0.44,1.25,-0.61,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;cytoplasm;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9BUP3,HTATIP2,Oxidoreductase HTATIP2 (EC 1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2),11,47.8,25.9,29.11,30.25,28.28,27.17,27.15,28.73,27.03,27.37,29.13,30.14,28.44,28.61,28.26,-2.35,0.85,1.99,0.02,-1.08,-1.1,0.48,-1.22,-0.89,0.88,1.89,0.18,0.36,anatomical structure formation involved in morphogenesis;biological regulation;cell death;cell differentiation;cellular process;death;developmental process;establishment of localization;interspecies interaction between organisms;multi-organism process;nuclear transport;nucleocytoplasmic transport;transport,cell part;cytoplasm;nuclear envelope,,,,,,,,,,
O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),41,50.3,30.19,29.14,30.7,28.63,29.53,29.88,29.85,29.74,29.23,30.35,29.63,30.1,28.58,29.66,0.53,-0.52,1.05,-1.03,-0.13,0.23,0.19,0.09,-0.43,0.7,-0.03,0.45,-1.08,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43464,HTRA2,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)",8,28,27.9,28.67,26.7,27.43,29.28,28.87,27.42,28.85,28.5,27.71,28.47,26.53,28.94,28.1,-0.2,0.57,-1.4,-0.67,1.18,0.77,-0.68,0.75,0.4,-0.38,0.37,-1.57,0.85,anatomical structure development;behavior;biological regulation;cell development;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;macromolecule metabolic process;metabolic process;mitochondrion organization;multicellular organismal process;organelle organization;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;response to chemical stimulus;response to stimulus;response to stress,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex;receptor complex,,,,,,,,,,
Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",83,28.2,31.78,31.98,30.19,31.67,30.91,30.91,32.38,32.4,30.53,30.31,32.3,32.85,30.56,31.44,0.34,0.53,-1.26,0.23,-0.53,-0.54,0.93,0.96,-0.91,-1.14,0.85,1.41,-0.88,cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA repair;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y4L1,HYOU1,Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170),72,69.8,34.81,34.71,34.22,34.13,34.66,35.09,34.26,34.03,34.88,35.09,34.01,33.64,34.77,34.48,0.33,0.22,-0.27,-0.35,0.17,0.6,-0.23,-0.45,0.4,0.6,-0.48,-0.84,0.29,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;regulation of protein modification process,cell part,,,,,,,,,,
Q9NX55,HYPK,Huntingtin-interacting protein K (Huntingtin yeast partner K),2,22.5,27.2,27.3,,28.17,26.88,27.29,28.49,28.73,26.89,27.41,27.32,28.19,26.93,27.57,-0.36,-0.27, ,0.61,-0.69,-0.27,0.92,1.17,-0.68,-0.16,-0.25,0.62,-0.64,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q2TAA2,IAH1,Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-),4,33.3,25.8,27.84,28.07,27.89,29.22,29.19,28.73,29.28,27.7,27.87,28.7,30.28,27.61,28.32,-2.52,-0.49,-0.25,-0.43,0.9,0.87,0.41,0.96,-0.62,-0.45,0.38,1.96,-0.72,catabolic process;lipid metabolic process;metabolic process;primary metabolic process,,,,,,,,,,,
P41252,IARS,"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)",49,43.3,31.03,32.42,31.96,32.76,32.18,32.32,32.91,32.74,32.13,32.41,32.8,33.09,32.28,32.39,-1.36,0.04,-0.43,0.37,-0.2,-0.06,0.52,0.35,-0.25,0.02,0.41,0.7,-0.11,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of translation;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NSE4,IARS2,"Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)",35,38.1,30.31,32.04,32.08,31.67,31.91,31.75,31.77,31.43,32.08,32.82,32.14,31.21,32.24,31.8,-1.49,0.23,0.27,-0.13,0.1,-0.06,-0.03,-0.37,0.28,1.01,0.33,-0.59,0.44,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of translation;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
Q5T440,IBA57,"Putative transferase CAF17, mitochondrial (EC 2.1.-.-) (Iron-sulfur cluster assembly factor homolog)",3,13.2,26.8,27.65,23.93,24.58,27.43,26.26,26.54,25.62,26.15,26.48,24.68,26.89,25.82,26.06,0.74,1.59,-2.13,-1.49,1.36,0.2,0.48,-0.44,0.09,0.42,-1.39,0.82,-0.25,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;pigment metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P05362,ICAM1,Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54),26,43.4,31.68,32.48,31.67,31.78,31.53,32.05,31.99,31.7,32.81,30.7,34.05,32.15,33.66,32.17,-0.49,0.31,-0.5,-0.4,-0.65,-0.12,-0.18,-0.47,0.63,-1.48,1.88,-0.03,1.49,aging;biological adhesion;biological regulation;cell activation;cell adhesion;cell communication;cell motility;cellular component movement;cellular homeostasis;cellular process;developmental process;homeostatic process;immune system process;interspecies interaction between organisms;locomotion;membrane docking;multi-organism process;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;rhythmic process;signal transduction,cell part;extracellular space,,,,,,,,,,
Q14197,ICT1,"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (Digestion substraction 1) (DS-1) (Immature colon carcinoma transcript 1 protein)",6,29.2,21.09,25.84,24.04,26.85,27.9,27.67,28.13,26.6,28.66,29.75,26.85,28.07,27.54,26.84,-5.75,-1.01,-2.81,0,1.05,0.82,1.28,-0.25,1.82,2.9,0,1.23,0.7,cellular component disassembly;cellular component organization;cellular process,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P14735,IDE,Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin),26,28.9,28.07,29.24,28.38,30.15,29.39,28.58,30.91,30.94,29.01,29.87,30.58,31.44,27.85,29.57,-1.5,-0.33,-1.19,0.58,-0.18,-0.99,1.34,1.37,-0.56,0.3,1.01,1.87,-1.72,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular homeostasis;cellular metabolic process;cellular process;homeostatic process;hormone metabolic process;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;peptide metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell part;cell surface;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microbody;mitochondrion;nucleus;organelle;peroxisome;plasma membrane;proteasome complex;protein complex,,,,,,,,,,
O75874,IDH1,Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase),27,57.2,33.3,33.3,33.49,33.01,31.4,31.25,32.02,32.55,30.43,30.82,32.64,33.45,30.91,32.2,1.1,1.1,1.29,0.81,-0.8,-0.94,-0.18,0.35,-1.77,-1.38,0.45,1.25,-1.28,amine metabolic process;anatomical structure development;carbohydrate metabolic process;catabolic process;cellular aldehyde metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;heterocycle metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P48735,IDH2,"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)",37,63.3,35.72,35.21,33.84,33.02,33.27,33.16,33.14,33.31,33.6,34.05,32.57,32.78,33.13,33.6,2.12,1.62,0.24,-0.58,-0.33,-0.44,-0.46,-0.29,0,0.45,-1.03,-0.82,-0.47,carbohydrate metabolic process;catabolic process;cellular aldehyde metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P50213,IDH3A,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)",18,53.8,29.47,32.64,30.33,30.96,31.52,31.78,31.04,31.01,31.82,32.23,31.47,30.12,31.75,31.24,-1.77,1.4,-0.91,-0.29,0.28,0.53,-0.2,-0.23,0.58,0.99,0.23,-1.12,0.51,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
O43837,IDH3B,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",18,50.1,29,31.88,30.16,30.55,31.02,31.47,30.24,29.94,30.55,31.28,30.88,30.21,31.35,30.66,-1.65,1.22,-0.49,-0.1,0.36,0.81,-0.42,-0.72,-0.11,0.62,0.22,-0.44,0.69,catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P51553,IDH3G,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)",8,39.7,25.81,30.24,28.47,29.46,29.36,29.35,28.95,28.47,29.72,30.03,28.8,28.99,29.57,29.02,-3.2,1.22,-0.55,0.44,0.34,0.33,-0.06,-0.55,0.7,1.02,-0.21,-0.03,0.55,carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q13907,IDI1,Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1),9,56.8,27.58,27.14,28.7,30.39,30.04,29.15,30.37,30.44,28.59,28.94,29.49,31.02,28.11,29.23,-1.64,-2.09,-0.53,1.16,0.81,-0.08,1.14,1.21,-0.64,-0.29,0.27,1.79,-1.12,alcohol metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;microbody;mitochondrion;organelle;peroxisome,,,,,,,,,,
P35475,IDUA,Alpha-L-iduronidase (EC 3.2.1.76),4,10.2,24.73,27.22,,,,27.54,,24.85,,25.19,25.91,,25.35,25.83,-1.1,1.39, , , ,1.71, ,-0.98, ,-0.64,0.09, ,-0.48,amine metabolic process;anatomical structure morphogenesis;biological regulation;carbohydrate metabolic process;catabolic process;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;developmental process;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;oligosaccharide metabolic process;organelle organization;polysaccharide metabolic process;primary metabolic process;sulfur compound metabolic process;vacuole organization,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9Y5U9,IER3IP1,Immediate early response 3-interacting protein 1,2,34.1,26.72,28.81,27.74,29.28,27.39,29.39,27.97,26.59,28.3,28,29.42,28.45,29.78,28.3,-1.58,0.52,-0.55,0.99,-0.9,1.1,-0.32,-1.71,0,-0.29,1.12,0.16,1.48,biological regulation,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
D3DUZ3,IFI16,"Interferon, gamma-inducible protein 16, isoform CRA_a (Interferon, gamma-inducible protein 16, isoform CRA_b)",34,51.8,32.05,31.65,32.8,31.81,31.37,31.91,31.35,30.87,31.49,30.65,30.1,30.72,31.36,31.39,0.66,0.25,1.41,0.41,-0.03,0.51,-0.04,-0.52,0.09,-0.75,-1.29,-0.67,-0.03,,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P13284,IFI30,Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30) (Legumaturain),5,30,27.71,32.26,30.89,25.28,,,19.42,,,25.26,,24.87,,26.53,1.18,5.74,4.36,-1.24, , ,-7.11, , ,-1.27, ,-1.66, ,biological regulation;cellular process;immune system process;regulation of protein stability;response to chemical stimulus;response to stimulus;signal transduction,cell part;extracellular region;membrane;plasma membrane,,,,,,,,,,
P80217,IFI35,Interferon-induced 35 kDa protein (IFP 35) (Ifi-35),13,44.8,28.98,28.69,29.73,30.28,26.86,24.34,27.44,28.97,23.88,24.46,26.5,28.61,,27.4,1.58,1.3,2.34,2.88,-0.53,-3.05,0.04,1.57,-3.51,-2.93,-0.9,1.21, ,biological regulation;cellular process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P09914,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1 (IFIT-1) (Interferon-induced 56 kDa protein) (IFI-56K) (P56),25,56.3,26.59,29.78,33.32,31.33,,23.09,27.21,28.31,28.31,26.76,26.69,26.67,25.74,27.82,-1.23,1.96,5.5,3.51, ,-4.73,-0.6,0.5,0.49,-1.06,-1.13,-1.15,-2.07,biological regulation;cellular process;establishment of localization;immune system process;interspecies interaction between organisms;multi-organism process;protein transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cytosol,,,,,,,,,,
P09913,IFIT2,Interferon-induced protein with tetratricopeptide repeats 2 (IFIT-2) (ISG-54 K) (Interferon-induced 54 kDa protein) (IFI-54K) (P54),15,37.5,24.99,27.85,31.69,26.95,23.32,23.91,,,27.28,25.78,27.06,22.24,25.22,26.03,-1.03,1.82,5.66,0.92,-2.71,-2.12, , ,1.26,-0.25,1.03,-3.78,-0.81,biological regulation;cellular component organization;cellular process;immune system process;mitochondrion organization;multi-organism process;organelle organization;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O14879,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3 (IFIT-3) (CIG49) (ISG-60) (Interferon-induced 60 kDa protein) (IFI-60K) (Interferon-induced protein with tetratricopeptide repeats 4) (IFIT-4) (Retinoic acid-induced gene G protein) (P60) (RIG-G),24,64.3,26.45,29.45,33.1,30.61,26.22,,,26.92,,,24.56,27.25,24.92,27.72,-1.27,1.73,5.38,2.89,-1.5, , ,-0.8, , ,-3.16,-0.47,-2.8,biological regulation;cellular process;immune system process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q13325,IFIT5,Interferon-induced protein with tetratricopeptide repeats 5 (IFIT-5) (Interferon-induced 58 kDa protein) (Retinoic acid- and interferon-inducible 58 kDa protein) (P58),8,27,27.31,27.75,27.48,28.88,26.64,25.93,26.71,27.38,,24.96,,25.54,,26.86,0.45,0.89,0.62,2.03,-0.21,-0.93,-0.15,0.52, ,-1.9, ,-1.32, ,immune system process;multi-organism process;response to biotic stimulus;response to stimulus;response to stress,apical part of cell;cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q6IBB0,IFITM2,IFITM2 protein (Interferon induced transmembrane protein 2 (1-8D)),3,36.4,26.85,26.18,,28.14,27.95,,27.35,,27.39,26.7,29.42,30.7,,27.85,-1,-1.67, ,0.29,0.09, ,-0.5, ,-0.47,-1.15,1.57,2.85, ,response to biotic stimulus;response to stimulus,cell part,,,,,,,,,,
Q01628,IFITM3,Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Interferon-inducible protein 1-8U),4,48.9,28.72,29.31,31.1,31.02,28.94,31.28,31.08,29.98,31.3,30.98,31.77,31.89,31.84,30.71,-1.98,-1.4,0.4,0.31,-1.77,0.57,0.37,-0.73,0.59,0.27,1.06,1.19,1.13,biological regulation;cellular process;immune system process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;membrane;plasma membrane,,,,,,,,,,
Q9BW83,IFT27,Intraflagellar transport protein 27 homolog (Putative GTP-binding protein RAY-like) (Rab-like protein 4),3,18.1,24.54,24.61,24.42,25.92,,25.75,25.11,25.77,,,26.31,26.12,24.49,25.3,-0.76,-0.69,-0.89,0.62, ,0.45,-0.2,0.46, , ,1.01,0.81,-0.82,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cell projection;cilium;macromolecular complex;protein complex,,,,,,,,,,
P78318,IGBP1,Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4) (Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16),5,20.9,24.81,26.47,22.04,26.16,26.91,26.33,26.42,28.05,25,,27.27,27.03,,26.04,-1.23,0.42,-4,0.11,0.87,0.29,0.37,2.01,-1.05, ,1.22,0.98, ,biological regulation;cell activation;cellular process;immune system process;regulation of protein modification process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoplasm,,,,,,,,,,
Q9Y6M1,IGF2BP2,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),26,52.7,32.55,30.61,29.56,31.01,31.14,31.14,31.41,31.2,31.27,30.29,31.08,29.28,30.92,30.88,1.67,-0.27,-1.32,0.13,0.26,0.26,0.53,0.32,0.39,-0.6,0.2,-1.6,0.04,anatomical structure morphogenesis;biological regulation;developmental process;macromolecule metabolic process;metabolic process;regulation of translation,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O00425,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer) (hKOC) (VICKZ family member 3),14,31.4,30.45,28.43,30.03,28.69,28.53,28.9,29.04,28.6,29.14,30.67,28.9,28.28,29.47,29.16,1.29,-0.73,0.87,-0.47,-0.63,-0.26,-0.12,-0.56,-0.03,1.5,-0.27,-0.88,0.3,anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;regulation of translation;translation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P22692,IGFBP4,Insulin-like growth factor-binding protein 4 (IBP-4) (IGF-binding protein 4) (IGFBP-4),5,41.1,24.82,29.53,28.42,29.21,28.26,28.64,27.57,28.5,28.75,,28.07,28.71,28.2,28.22,-3.4,1.3,0.2,0.99,0.03,0.42,-0.65,0.28,0.52, ,-0.15,0.49,-0.02,anatomical structure development;biological regulation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;response to stimulus;response to stress;signal transduction,extracellular region;extracellular space,,,,,,,,,,
Q16270,IGFBP7,Insulin-like growth factor-binding protein 7 (IBP-7) (IGF-binding protein 7) (IGFBP-7) (IGFBP-rP1) (MAC25 protein) (PGI2-stimulating factor) (Prostacyclin-stimulating factor) (Tumor-derived adhesion factor) (TAF),6,34.4,27.18,29.94,25.3,30.57,27.03,29.78,27.74,25.77,31.58,30.14,28.69,26.16,29.64,28.43,-1.24,1.51,-3.12,2.15,-1.39,1.35,-0.68,-2.65,3.15,1.71,0.27,-2.27,1.22,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cellular process;developmental process,extracellular space,,,,,,,,,,
Q969P0,IGSF8,Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316),3,9.3,26.97,26.46,23.57,,,,22.15,23.71,24.63,25.62,22.45,,,24.45,2.52,2.02,-0.88, , , ,-2.3,-0.73,0.19,1.18,-2, , ,anatomical structure development;cell proliferation;cellular component movement;cellular process;developmental process,cell part;membrane;plasma membrane,,,,,,,,,,
Q70UQ0,IKBIP,Inhibitor of nuclear factor kappa-B kinase-interacting protein (I kappa-B kinase-interacting protein) (IKBKB-interacting protein) (IKK-interacting protein),18,41.1,29.5,32.32,31.27,32.28,32.34,32.87,32.28,31.88,33.14,31.8,32.83,31.45,33.19,32.09,-2.59,0.23,-0.82,0.2,0.25,0.78,0.19,-0.21,1.05,-0.29,0.74,-0.64,1.1,biological regulation;response to abiotic stimulus;response to stimulus,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q70UQ0,IKBIP,Inhibitor of nuclear factor kappa-B kinase-interacting protein (I kappa-B kinase-interacting protein) (IKBKB-interacting protein) (IKK-interacting protein),18,41.1,29.5,32.32,31.27,32.28,32.34,32.87,32.28,31.88,33.14,31.8,32.83,31.45,33.19,32.09,-2.59,0.23,-0.82,0.2,0.25,0.78,0.19,-0.21,1.05,-0.29,0.74,-0.64,1.1,biological regulation;response to abiotic stimulus;response to stimulus,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O14920,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB),4,6.9,,23.96,24.65,23.96,25.26,,25.97,24.47,,,25.9,24.08,24.15,24.71, ,-0.75,-0.06,-0.75,0.55, ,1.26,-0.25, , ,1.19,-0.63,-0.57,biological regulation;cellular process;homeostatic process;immune system process;multi-organism process;regulation of transport;response to biotic stimulus;response to stimulus;response to stress;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;receptor complex,,+,,,,,,,,
D3DWY2,IKBKG,"Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, isoform CRA_a",4,20.1,23.13,26.58,26.11,27.21,,,26.01,27.13,27,,27.29,25.34,,26.2,-3.07,0.38,-0.09,1.01, , ,-0.18,0.93,0.8, ,1.09,-0.86, ,,,,,,,,,,,,
Q14116,IL18,Interleukin-18 (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma),8,27,27.64,27.02,27.75,28.7,22.28,19.29,27.5,24.73,,27.69,29.24,30.73,26.42,26.58,1.06,0.44,1.17,2.11,-4.31,-7.29,0.92,-1.85, ,1.11,2.66,4.15,-0.16,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;behavior;biological regulation;cell communication;cell differentiation;cell-cell signaling;cellular process;circulatory system process;detection of stimulus;developmental process;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;signaling;sleep,cell part;cytosol;extracellular region;extracellular space,,,,,,,,,,
Q9NPH3,IL1RAP,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3),5,8.8,26.56,25.82,25.39,27.09,26.61,24.25,,26.56,,25.21,,24.97,,25.83,0.73,-0.01,-0.44,1.26,0.78,-1.58, ,0.73, ,-0.62, ,-0.86, ,cellular component assembly;cellular component organization;immune system process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;response to stimulus;response to stress,cell part;extracellular region,,,,,,,,,,
Q96RQ9,IL4I1,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (Protein Fig-1) (hFIG1),20,35.4,32.01,31.98,31.09,27.18,,25.85,22.7,27.63,23.64,29.88,21.01,,25.53,27.14,4.87,4.84,3.95,0.04, ,-1.29,-4.43,0.5,-3.5,2.74,-6.12, ,-1.6,,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole,,,,,,,,,,
Q12905,ILF2,Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa),27,65.1,33.44,32.86,33.06,32.68,33.91,33.97,33.34,33.34,33.7,33.26,32.56,33.03,33.71,33.3,0.14,-0.44,-0.24,-0.62,0.61,0.68,0.04,0.04,0.41,-0.04,-0.74,-0.27,0.42,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,Other TF domain,,,,,,,,,
Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),60,62.4,34.09,33.98,33.96,33.85,34.06,34.15,33.72,33.52,34.27,34.24,33.03,32.51,32.79,33.71,0.38,0.28,0.25,0.15,0.35,0.45,0.01,-0.18,0.56,0.53,-0.68,-1.19,-0.91,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of translation;response to biotic stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleolus;nucleus;organelle;ribonucleoprotein complex,Other TF domain,,,,,,,,,
Q13418,ILK,Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK),13,36.1,29.35,29.83,29.54,30.67,31.41,30.51,31.33,31.38,30.32,28.91,30.85,30.63,29.96,30.36,-1.01,-0.53,-0.82,0.31,1.05,0.15,0.96,1.02,-0.04,-1.45,0.48,0.27,-0.4,aging;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell morphogenesis;cell proliferation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;developmental process;establishment or maintenance of cell polarity;extracellular matrix organization;extracellular structure organization;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;response to stimulus;signal transduction,cell body;cell part;cell projection;cytosol;macromolecular complex;membrane;neuronal cell body;plasma membrane;protein complex,,+,,,,,,,,
Q9H0C8,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP) (EC 3.1.3.16),5,15.3,26.58,26.32,26.21,26.93,27.26,25.56,,,26.41,25.14,,,24.67,26.12,0.46,0.2,0.09,0.81,1.14,-0.56, , ,0.29,-0.98, , ,-1.44,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of cell cycle,cell part;cytoplasm,,,,,,,,,,
A1L0T0,ILVBL,Acetolactate synthase-like protein (EC 2.2.1.-) (IlvB-like protein),21,53.3,32.13,30.93,29.52,30.05,29.59,30.5,30.09,29.67,31.5,31.04,30.61,30.48,31.17,30.56,1.57,0.37,-1.04,-0.51,-0.97,-0.06,-0.47,-0.89,0.93,0.48,0.05,-0.08,0.61,metabolic process,cell part,,,,,,,,,,
Q16891,IMMT,Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89),60,69.7,32.82,33.53,33.37,32.94,32.92,33.76,32.95,32.54,33.73,33.9,33.37,32.29,33.68,33.22,-0.39,0.32,0.15,-0.27,-0.29,0.54,-0.27,-0.68,0.51,0.69,0.16,-0.92,0.46,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;homeostatic process;response to abiotic stimulus;response to stimulus;response to stress,cell part;membrane,,,,,,,,,,
Q9NV31,IMP3,U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3) (BRMS2),6,40.8,27.96,27.51,25.76,28.34,28.93,27.73,28.15,27.29,28.8,29.19,25.98,27.52,28.19,27.8,0.17,-0.29,-2.03,0.55,1.13,-0.06,0.35,-0.5,1,1.4,-1.81,-0.28,0.39,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q96G21,IMP4,U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4) (Brix domain-containing protein 4),5,37.8,27.12,24.71,24.98,26.5,26.87,27.27,23.23,26.66,27.16,27.49,,,,26.2,0.93,-1.49,-1.21,0.3,0.67,1.07,-2.97,0.46,0.96,1.29, , , ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P29218,IMPA1,Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1),7,24.2,28.45,28.69,29.26,28.79,29.54,29.57,30.14,30.7,28.84,27.77,30.19,31.03,27.44,29.26,-0.81,-0.58,0,-0.47,0.28,0.31,0.88,1.44,-0.43,-1.49,0.93,1.77,-1.82,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;phosphorus metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,+,,,,,,,
Q9NX62,IMPAD1,Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (EC 3.1.3.7) (Golgi 3-prime phosphoadenosine 5-prime phosphate 3-prime phosphatase) (Golgi-resident PAP phosphatase) (gPAPP) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3),8,24,28.98,29.06,28.15,29.4,28.86,29.57,29.47,27.64,29.74,29.04,28.73,28.77,29.4,28.99,-0.01,0.07,-0.83,0.42,-0.13,0.59,0.48,-1.35,0.75,0.06,-0.25,-0.22,0.41,alcohol metabolic process;amine metabolic process;anatomical structure development;anatomical structure morphogenesis;biosynthetic process;carbohydrate metabolic process;cell development;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;phosphorus metabolic process;polysaccharide metabolic process;post-embryonic development;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P12268,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (IMPDH-II),27,53.9,32.25,31.95,31.35,32.33,31.76,30.91,32.1,32.33,31.03,31.47,30.98,31.62,29.93,31.54,0.71,0.41,-0.19,0.79,0.22,-0.63,0.56,0.79,-0.51,-0.07,-0.56,0.08,-1.61,anatomical structure development;biosynthetic process;cell activation;cell proliferation;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;immune system process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;nucleus;organelle,,,,,,,,,,
Q8NI35,INADL,InaD-like protein (Inadl protein) (hINADL) (Pals1-associated tight junction protein) (Protein associated to tight junctions),20,16.2,28.12,,23.86,,24.03,,,25.18,23.37,29.69,25.37,25.72,26.1,25.72,2.4, ,-1.85, ,-1.68, , ,-0.54,-2.34,3.97,-0.34,0,0.38,biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;response to stimulus;signal transduction,cell part;membrane;plasma membrane,,,,,,,,,,
Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),39,41.6,30.77,29.47,29.1,30.23,31.21,30.23,30.74,31.35,30.59,30.91,31.79,31.19,31.22,30.68,0.09,-1.21,-1.58,-0.44,0.53,-0.44,0.06,0.67,-0.09,0.23,1.11,0.51,0.55,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O15357,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",15,16.5,29.41,27.01,29.28,27.36,26.35,24.94,27.6,26.99,25.34,27.47,28.57,28.51,26.83,27.36,2.06,-0.35,1.92,0,-1.01,-2.42,0.24,-0.37,-2.02,0.11,1.21,1.16,-0.53,alcohol metabolic process;anatomical structure development;biological adhesion;biological regulation;biosynthetic process;carbohydrate metabolic process;cell adhesion;cellular component organization;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;endocytosis;establishment of localization;lipid metabolic process;membrane invagination;membrane organization;metabolic process;organelle organization;phosphorus metabolic process;post-embryonic development;primary metabolic process;regulation of DNA metabolic process;regulation of protein modification process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cell projection;cytoskeleton;cytosol;filopodium;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q8N201,INTS1,Integrator complex subunit 1 (Int1),18,11.1,28.42,27.59,28.39,27.32,28.12,29.68,27.56,26.24,28.32,27.17,24.34,26.56,27.44,27.47,0.95,0.11,0.92,-0.15,0.65,2.2,0.09,-1.23,0.85,-0.31,-3.13,-0.91,-0.04,biological regulation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9NVR2,INTS10,Integrator complex subunit 10 (Int10),6,9.3,24.71,24.85,24.09,26.33,25.09,,24.33,,26.41,24.66,,,,25.06,-0.35,-0.2,-0.97,1.27,0.03, ,-0.73, ,1.35,-0.4, , , ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q68E01,INTS3,Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A),11,12.2,28.48,27.13,28.23,26.57,27.66,28.17,28.01,26.91,27.71,27.25,25.75,25.59,25.07,27.12,1.36,0.01,1.11,-0.55,0.54,1.05,0.89,-0.21,0.59,0.14,-1.37,-1.53,-2.05,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q96HW7,INTS4,Integrator complex subunit 4 (Int4),4,5.4,26.38,25.69,26.05,25.05,25.3,26.76,24.94,24.88,25.48,25.46,,,26.19,25.65,0.72,0.04,0.39,-0.6,-0.35,1.11,-0.71,-0.78,-0.17,-0.19, , ,0.54,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q6P9B9,INTS5,Integrator complex subunit 5 (Int5),5,7,27.61,26.21,26.83,26.75,28.02,27.45,27.02,27.58,28.25,26.9,,25.46,,27.1,0.51,-0.89,-0.27,-0.35,0.92,0.35,-0.08,0.48,1.16,-0.2, ,-1.63, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9UL03,INTS6,Integrator complex subunit 6 (Int6) (DBI-1) (Protein DDX26) (Protein deleted in cancer 1) (DICE1),6,8.1,27.43,25.06,24.35,26.11,27.12,26.69,25.44,23.7,26.03,25.09,,24.39,26.58,25.67,1.77,-0.6,-1.31,0.44,1.46,1.02,-0.23,-1.97,0.36,-0.58, ,-1.27,0.91,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q8TEX9,IPO4,Importin-4 (Imp4) (Importin-4b) (Imp4b) (Ran-binding protein 4) (RanBP4),16,19,30.36,29.53,29.16,29.63,28.89,27.41,29.34,29.49,27.04,28.38,29.02,29.5,25.96,28.75,1.61,0.78,0.41,0.88,0.15,-1.34,0.6,0.75,-1.71,-0.37,0.27,0.76,-2.79,establishment of localization;protein transport;transport,cell part;cytoplasm;macromolecular complex;nuclear pore;protein complex,,,,,,,,,,
O00410,IPO5,Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5),40,47.2,31.9,32.37,32.48,32.98,32.64,32.48,33.39,33.27,32.37,32.22,33.39,33.87,32.67,32.77,-0.87,-0.4,-0.29,0.21,-0.13,-0.29,0.62,0.5,-0.4,-0.55,0.61,1.1,-0.1,establishment of localization;interspecies interaction between organisms;multi-organism process;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;transport,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;nucleolus;organelle;protein complex,,,,,,,,,,
O95373,IPO7,Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7),24,29.7,31.45,30.88,30.65,31.73,31.58,30.54,32.34,31.77,30.64,30.52,31.49,32.22,30.08,31.22,0.23,-0.34,-0.58,0.51,0.36,-0.68,1.12,0.55,-0.58,-0.71,0.27,1,-1.15,biological regulation;cellular process;establishment of localization;interspecies interaction between organisms;multi-organism process;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;response to stimulus;signal transduction;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;organelle;protein complex,,,,,,,,,,
O15397,IPO8,Importin-8 (Imp8) (Ran-binding protein 8) (RanBP8),6,7.7,27.51,26.85,29.32,27.92,28.62,28.03,28.34,28.41,26.81,27.51,29.16,30.28,27.13,28.14,-0.64,-1.29,1.18,-0.22,0.47,-0.12,0.19,0.26,-1.33,-0.63,1.01,2.13,-1.02,biological regulation;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport,cell part;cytoplasm;macromolecular complex;nuclear pore;protein complex,,,,,,,,,,
Q96P70,IPO9,Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9),18,25.6,31,29.6,28.83,30.25,29.85,29.24,30.82,30.36,29.09,27.1,29.41,30.46,27.21,29.48,1.52,0.12,-0.65,0.78,0.38,-0.24,1.34,0.88,-0.39,-2.38,-0.07,0.98,-2.27,establishment of localization;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;transport,cell part;cytoplasm;macromolecular complex;nuclear pore;protein complex,,,,,,,,,,
P46940,IQGAP1,Ras GTPase-activating-like protein IQGAP1 (p195),121,70.5,35.64,35,34.57,34.74,34.51,34.3,35.02,34.93,34.76,34.93,35.09,34.89,34.48,34.84,0.8,0.16,-0.27,-0.09,-0.32,-0.54,0.19,0.1,-0.08,0.1,0.26,0.06,-0.36,anatomical structure development;biological regulation;cell development;cellular metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell leading edge;cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;midbody;neuron projection;nucleus;organelle;plasma membrane;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q86VI3,IQGAP3,Ras GTPase-activating-like protein IQGAP3,7,6,27.22,27.9,,28.77,26.07,29.29,28.94,26.13,27.83,27.6,,25.64,,27.54,-0.32,0.36, ,1.23,-1.47,1.75,1.4,-1.41,0.3,0.06, ,-1.9, ,biological regulation;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoplasm,,,,,,,,,,
Q6DN90,IQSEC1,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein),4,6.1,23.11,24.46,,24.78,,,23.66,23.75,,,23.97,24.86,,24.08,-0.98,0.37, ,0.69, , ,-0.42,-0.34, , ,-0.11,0.78, ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q7Z5L9,IRF2BP2,Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2),13,41.7,28.85,25.12,28.56,27.53,,26.69,27.08,27.49,28.23,28.02,25.38,,25.51,27.13,1.72,-2.01,1.43,0.39, ,-0.44,-0.06,0.36,1.1,0.89,-1.75, ,-1.62,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H1B7,IRF2BPL,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),17,24,29.17,27.91,27.76,26.38,27.18,27.91,27.32,24.25,28.33,28.3,25.93,26.59,27.02,27.23,1.94,0.68,0.53,-0.85,-0.06,0.68,0.09,-2.99,1.09,1.07,-1.31,-0.65,-0.21,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q00978,IRF9,Interferon regulatory factor 9 (IRF-9) (IFN-alpha-responsive transcription factor subunit) (ISGF3 p48 subunit) (Interferon-stimulated gene factor 3 gamma) (ISGF-3 gamma) (Transcriptional regulator ISGF3 subunit gamma),4,9.7,25.44,25.68,21.36,22.8,24.52,,22.5,22.98,23.27,21.38,,,,23.33,2.12,2.35,-1.97,-0.53,1.19, ,-0.82,-0.34,-0.06,-1.95, , , ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter,cell part;cytosol;nucleoplasm,Other TF domain,,,,,,,,,
Q8WZA9,IRGQ,Immunity-related GTPase family Q protein,4,10.8,27.78,25.28,26.15,26.96,26.42,,26.02,26.74,,26.37,24.89,24.93,25.23,26.07,1.71,-0.79,0.08,0.89,0.35, ,-0.05,0.67, ,0.3,-1.18,-1.14,-0.84,,,,,,,,,,,,
Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),19,19.2,,26.29,,26.99,,27.93,27.46,27.52,28.63,24.58,27.69,27.35,27.38,27.18, ,-0.89, ,-0.19, ,0.75,0.28,0.34,1.45,-2.61,0.51,0.17,0.2,alcohol metabolic process;anatomical structure development;biological regulation;carbohydrate metabolic process;cell proliferation;cellular metabolic process;cellular process;developmental process;homeostatic process;immune system process;metabolic process;primary metabolic process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q86U28,ISCA2,"Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1)",3,28.6,25.13,27.27,,25.85,25.9,27.92,25.97,,26.08,25.44,26.53,,25.76,26.19,-1.05,1.09, ,-0.33,-0.29,1.74,-0.22, ,-0.11,-0.74,0.35, ,-0.43,biosynthetic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9H1K1,ISCU,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)",4,26.3,27.71,25.98,26.72,25.87,,,26.32,,26.48,27.34,26.01,26.71,26.15,26.53,1.18,-0.55,0.19,-0.66, , ,-0.21, ,-0.05,0.81,-0.52,0.19,-0.38,biosynthetic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;nitrogen compound metabolic process;nitrogen cycle metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P05161,ISG15,Ubiquitin-like protein ISG15 (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP),11,63,27.9,30.33,33.18,32.79,27.15,26.7,29.33,28.9,28.23,29.39,29.57,30.56,,29.5,-1.61,0.83,3.68,3.29,-2.35,-2.8,-0.17,-0.6,-1.27,-0.11,0.06,1.06, ,biological regulation;catabolic process;cell communication;cell-cell signaling;cellular metabolic process;cellular process;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction;signaling,cell part;cytosol;extracellular space,,,,,,,,,,
Q96AZ6,ISG20,Interferon-stimulated gene 20 kDa protein (EC 3.1.13.1) (Estrogen-regulated transcript 45 protein) (Promyelocytic leukemia nuclear body-associated protein ISG20),6,37,27.21,28.4,29.67,,25.12,,26.98,26.04,26.08,25.83,25.09,,,26.71,0.5,1.69,2.96, ,-1.6, ,0.27,-0.67,-0.63,-0.88,-1.63, , ,biological regulation;catabolic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;immune system process;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;signal transduction,cell part,,,,,,,,,,
Q96CN7,ISOC1,Isochorismatase domain-containing protein 1,5,30.5,29.81,28.94,28.48,28.39,28.11,27.04,26.61,27.87,27.73,26.77,27.18,29,26.64,27.89,1.92,1.05,0.6,0.5,0.22,-0.85,-1.28,-0.02,-0.16,-1.12,-0.71,1.11,-1.25,,cell part;intracellular membrane-bounded organelle;intracellular organelle;microbody;organelle;peroxisome,,,,,,,,,,
Q96AB3,ISOC2,"Isochorismatase domain-containing protein 2, mitochondrial",10,76.1,31.43,29.91,30.15,29.41,29.23,30.76,30.15,30.96,30.86,29.96,29.78,29.34,30.14,30.16,1.27,-0.25,-0.01,-0.75,-0.93,0.6,-0.01,0.8,0.7,-0.2,-0.37,-0.81,-0.02,biological regulation;regulation of protein stability,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P53990,IST1,IST1 homolog (hIST1) (Putative MAPK-activating protein PM28),6,16.1,28.62,29.12,29.48,29.22,26.6,28,29.63,27.04,28.02,28.48,28.91,24.96,28.13,28.17,0.45,0.95,1.31,1.05,-1.57,-0.17,1.46,-1.13,-0.15,0.31,0.74,-3.21,-0.04,abscission;biological regulation;cellular process;cytokinesis;developmental process;localization,cell part;centrosome;cytoplasmic membrane-bounded vesicle;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle;vesicle,,,,,,,,,,
Q9ULR0,ISY1,Pre-mRNA-splicing factor ISY1 homolog,4,19.3,26.71,25.43,27.51,26.67,28.27,27.69,25.93,27.09,28.1,27.19,26.86,27.04,27.41,27.07,-0.36,-1.64,0.44,-0.4,1.2,0.62,-1.14,0.02,1.03,0.12,-0.21,-0.03,0.34,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
G3V1R9,ISYNA1,"Inositol-3-phosphate synthase 1 (Myo-inositol 1-phosphate synthase A1, isoform CRA_d)",11,43.4,30.9,,26.33,24.36,,24.44,26.18,25.45,24.57,26.01,,22.11,24.5,25.48,5.42, ,0.84,-1.13, ,-1.05,0.69,-0.03,-0.91,0.53, ,-3.38,-0.98,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q96J02,ITCH,E3 ubiquitin-protein ligase Itchy homolog (Itch) (EC 6.3.2.-) (Atrophin-1-interacting protein 4) (AIP4) (NFE2-associated polypeptide 1) (NAPP1),7,10.1,27.18,26.33,,27.45,27.36,25.48,28.18,26.96,27.03,25.6,26.41,27.11,,26.83,0.35,-0.49, ,0.62,0.53,-1.35,1.35,0.13,0.2,-1.22,-0.41,0.28, ,biological regulation;cell death;cellular metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of protein modification process;response to biotic stimulus;response to stimulus;response to stress;signal transduction,cell cortex;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
Q8TB96,ITFG1,T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1),5,13.6,27.24,25.36,26.81,24.59,,26.4,26.5,,27.28,27.4,26.75,26.53,27.76,26.6,0.64,-1.25,0.21,-2.02, ,-0.2,-0.1, ,0.68,0.79,0.15,-0.08,1.16,,cell part;extracellular region,,,,,,,,,,
P17301,ITGA2,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b),28,31.8,28.27,29.77,29.88,31.42,31.57,32.02,30.7,30.25,31.6,32.52,30.63,27.79,31.19,30.58,-2.31,-0.82,-0.7,0.83,0.99,1.43,0.12,-0.34,1.01,1.94,0.04,-2.79,0.6,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cellular process;coagulation;developmental process;interspecies interaction between organisms;locomotion;multicellular organismal process;multi-organism process;regulation of body fluid levels;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,basal part of cell;cell part;cell surface;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
P26006,ITGA3,Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain;Integrin alpha-3 light chain],23,24.3,31.28,29.97,29.9,31.83,33,33.41,32.29,32.85,32.91,33.2,33.39,30.51,33.39,32.15,-0.86,-2.18,-2.25,-0.32,0.85,1.26,0.15,0.7,0.76,1.05,1.24,-1.64,1.25,behavior;biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular process;coagulation;immune system process;locomotion;multicellular organismal process;neurological system process;regulation of body fluid levels;response to stimulus;signal transduction,cell part;cell surface;macromolecular complex;protein complex;receptor complex;synapse,,,,,,,,,,
P08648,ITGA5,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain;Integrin alpha-5 light chain],18,21.2,29.26,31.42,29.5,31.67,30.37,30.43,29.51,28.62,31.54,27.99,29.95,32,29.67,30.15,-0.89,1.27,-0.65,1.52,0.22,0.28,-0.63,-1.53,1.39,-2.16,-0.2,1.85,-0.48,anatomical structure formation involved in morphogenesis;behavior;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;coagulation;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;interspecies interaction between organisms;locomotion;multicellular organismal process;multi-organism process;neurological system process;regulation of body fluid levels;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cell projection;macromolecular complex;protein complex;receptor complex;synapse,,,,,,,,,,
P23229,ITGA6,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain;Integrin alpha-6 light chain],27,31.5,30.22,27.46,28.67,24.48,29.78,26.27,30.57,29.34,28.22,31.93,29.19,28.38,29.04,28.73,1.49,-1.27,-0.07,-4.25,1.04,-2.46,1.84,0.6,-0.52,3.19,0.45,-0.36,0.31,biological adhesion;biological regulation;cell adhesion;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;coagulation;extracellular matrix organization;extracellular structure organization;immune system process;locomotion;multicellular organismal process;regulation of body fluid levels;response to stimulus;signal transduction,cell part;macromolecular complex;membrane;plasma membrane;protein complex;receptor complex,,,,,,,,,,
P06756,ITGAV,Integrin alpha-V (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain;Integrin alpha-V light chain],40,42.2,31.04,32.34,32.11,32.33,32.46,32.73,32.91,31.81,33.46,32.75,33.03,31.48,33.22,32.44,-1.4,-0.1,-0.33,-0.1,0.02,0.29,0.48,-0.63,1.02,0.31,0.6,-0.95,0.79,anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular component organization;cellular membrane organization;cellular process;coagulation;developmental process;endocytosis;establishment of localization;extracellular matrix organization;extracellular structure organization;immune system process;interspecies interaction between organisms;locomotion;membrane invagination;membrane organization;multicellular organismal process;multi-organism process;regulation of body fluid levels;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;receptor complex;vesicle,,,,,,,,,,
P20702,ITGAX,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)",8,9.7,25.67,29,27.17,25.66,25.89,,,26.34,26.34,,,,,26.58,-0.91,2.42,0.59,-0.92,-0.69, , ,-0.25,-0.24, , , , ,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular process;coagulation;developmental process;immune system process;locomotion;multicellular organismal process;multi-organism process;regulation of body fluid levels;response to biotic stimulus;response to stimulus;response to stress;signal transduction,cell part;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
P05556,ITGB1,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),30,34.6,32.67,33.03,33.28,33.27,33.46,33.57,33.06,33.04,33.76,34.18,33,33.01,33.79,33.32,-0.64,-0.28,-0.04,-0.05,0.14,0.25,-0.26,-0.27,0.45,0.86,-0.32,-0.31,0.47,biological adhesion;biological regulation;cell activation;cell adhesion;cell communication;cell differentiation;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular process;coagulation;cytoskeleton organization;developmental process;embryo development;establishment of localization;extracellular matrix organization;extracellular structure organization;homeostatic process;immune system process;interspecies interaction between organisms;locomotion;membrane organization;multicellular organismal process;multi-organism process;organelle organization;protein transport;regulation of body fluid levels;regulation of cell cycle;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cell projection;cell surface;cytoplasm;cytoplasmic membrane-bounded vesicle;filopodium;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;receptor complex;synapse;vesicle,,,,,,,,,,
P05106,ITGB3,Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61),5,8.4,,29.16,25.84,28.54,25.69,28.9,27.96,27.72,28.18,27.68,28.65,22.91,28.65,27.49, ,1.67,-1.65,1.05,-1.81,1.41,0.47,0.23,0.69,0.18,1.16,-4.58,1.16,anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;developmental process;establishment of localization;exocytosis;extracellular matrix organization;extracellular structure organization;immune system process;interspecies interaction between organisms;locomotion;multi-organism process;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex;receptor complex;vesicle,,,,,,,,,,
P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),44,30,29.94,30.75,29.18,27.78,31.03,27.74,31.99,31.21,27.87,32.12,31.35,31.27,31.19,30.26,-0.32,0.49,-1.09,-2.48,0.77,-2.53,1.73,0.94,-2.4,1.86,1.08,1.01,0.93,biological adhesion;biological regulation;cell adhesion;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;multicellular organismal development;multicellular organismal process;response to stimulus;response to stress;signal transduction,cell leading edge;cell part;cell surface;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
P18084,ITGB5,Integrin beta-5,18,30.7,26.75,30.09,28.56,31.3,30.71,31.78,30.66,30.69,31.02,29.2,31.25,30.78,31.12,30.3,-3.55,-0.21,-1.74,1,0.41,1.48,0.36,0.39,0.72,-1.1,0.95,0.48,0.82,biological adhesion;biological regulation;cell adhesion;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;multicellular organismal development;multicellular organismal process;muscle contraction;response to stimulus;signal transduction,cell leading edge;cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;receptor complex;vesicle,,,,,,,,,,
C9JA97,ITGB6,Integrin beta,6,10.7,30.66,30.97,29.6,30.99,31.5,,30.88,31.02,31.38,31.34,30.24,31.44,,30.91,-0.25,0.06,-1.31,0.08,0.59, ,-0.04,0.11,0.47,0.43,-0.67,0.53, ,biological adhesion;biological regulation;cell adhesion;cellular process;developmental process;multicellular organismal development;multicellular organismal process;response to stimulus;signal transduction,cell part;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
P26012,ITGB8,Integrin beta-8,9,16.6,28.43,28,29.11,25.18,30.56,29.27,30.39,28.56,30.13,31.31,30.21,27.4,30.04,29.12,-0.69,-1.12,-0.02,-3.94,1.44,0.15,1.27,-0.57,1.01,2.19,1.09,-1.72,0.92,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;signal transduction,cell part;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
Q9Y287,ITM2B,"Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2);BRI2 intracellular domain (BRI2 ICD);BRI2C, soluble form;Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)]",3,18,28.65,26.72,28.21,25.9,25.66,,24.96,,25.38,27.94,24.41,,,26.43,2.22,0.29,1.78,-0.52,-0.76, ,-1.47, ,-1.04,1.52,-2.01, , ,anatomical structure development;biological regulation;cell death;cellular process;death;developmental process,cell part;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9NQX7,ITM2C,Integral membrane protein 2C (Cerebral protein 14) (Transmembrane protein BRI3) [Cleaved into: CT-BRI3],2,18.3,27.56,25.31,,25.7,25.17,24.73,23.06,,,24.95,,,,25.21,2.35,0.1, ,0.49,-0.05,-0.48,-2.15, , ,-0.26, , , ,biological regulation;cell differentiation;cellular process;developmental process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole,,,,,,,,,,
Q9BY32,ITPA,Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.19) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (Putative oncogene protein hlc14-06-p),4,27.8,30.11,29.13,28.78,28.36,27.39,26.35,29.57,27.13,27.88,28.83,29.07,29.76,26.6,28.38,1.73,0.75,0.39,-0.03,-0.99,-2.03,1.18,-1.25,-0.5,0.45,0.69,1.38,-1.78,catabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q13572,ITPK1,"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)",6,25.4,25.46,24.53,,24.89,27.38,24.79,29.46,29.42,,,27.64,29.71,25.81,26.91,-1.45,-2.38, ,-2.02,0.47,-2.12,2.55,2.51, , ,0.73,2.8,-1.1,biological regulation;cellular process;coagulation;metabolic process;multicellular organismal process;regulation of body fluid levels;response to stimulus;signal transduction,cell part;cytosol,,,+,,,,,,,
Q14571,ITPR2,"Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)",10,5.6,26.35,27.43,26.67,26.96,26.16,28.07,27.03,26.66,27.56,25.4,27.2,27.02,27.2,26.9,-0.55,0.53,-0.23,0.06,-0.74,1.17,0.13,-0.24,0.66,-1.5,0.3,0.12,0.3,biological regulation;cell activation;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;immune system process;metabolic process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell cortex;cell part;membrane;plasma membrane,,,,,,,,,,
Q14573,ITPR3,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",79,34.3,32.52,30.85,31.87,30.3,31.99,31.94,32.65,32.16,32.69,33.13,33.08,30.41,32.64,32.02,0.5,-1.17,-0.14,-1.71,-0.03,-0.08,0.63,0.14,0.67,1.11,1.06,-1.6,0.62,biological regulation;cell activation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;energy reserve metabolic process;establishment of localization;generation of precursor metabolites and energy;homeostatic process;immune system process;ion transport;macromolecular complex assembly;metabolic process;multicellular organismal process;neurological system process;protein complex assembly;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transport,apical part of cell;brush border;cell body;cell part;cell projection;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;neuronal cell body;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q8IWB1,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein (Protein DANGER)",10,18.5,25.7,26.42,28.54,28.92,28.94,29.6,28.39,27.41,29.82,27.26,29.26,29.31,30.56,28.47,-2.78,-2.05,0.07,0.45,0.47,1.13,-0.09,-1.06,1.35,-1.21,0.79,0.84,2.08,,cell part;membrane;plasma membrane,,,,,,,,,,
Q15811,ITSN1,Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17),17,14.2,28.64,29.65,27.51,29.33,29,30.22,29.95,29.55,29.11,30.1,30.39,30.53,31.46,29.65,-1.01,0,-2.13,-0.32,-0.65,0.57,0.3,-0.1,-0.54,0.45,0.74,0.88,1.81,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;organelle;plasma membrane;synapse;vesicle,,,,,,,,,,
Q9NZM3,ITSN2,Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein),5,5.7,26.1,25.93,26.63,24.76,23.24,22.98,25.33,25.03,25.13,26.6,24.16,,24.51,25.03,1.07,0.89,1.6,-0.27,-1.79,-2.05,0.29,0,0.1,1.56,-0.87, ,-0.52,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;transport;vesicle-mediated transport,cell part;cytoplasm,,,,+,,,,,,
P26440,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4)",9,22.5,27.75,29.64,29.36,28.83,29.95,30.55,29.65,29.34,30.41,30.49,31.27,,30.67,29.83,-2.08,-0.19,-0.46,-0.99,0.12,0.72,-0.17,-0.49,0.59,0.66,1.45, ,0.85,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),27,34.1,28.83,27.17,29.05,27.67,27.67,27.72,27.64,27.57,27.97,27.61,26.5,27.96,27.23,27.74,1.09,-0.56,1.31,-0.07,-0.07,-0.02,-0.1,-0.17,0.24,-0.13,-1.24,0.22,-0.51,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8N5M9,JAGN1,Protein jagunal homolog 1,4,14.8,26.48,28.52,27.29,28.45,27.72,26.62,20.93,27.89,22.76,24.69,28.24,25.06,28.5,26.4,0.08,2.12,0.89,2.06,1.32,0.22,-5.46,1.5,-3.63,-1.71,1.85,-1.33,2.1,,cell part;membrane,,,,,,,,,,
P23458,JAK1,Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1),5,5.7,27.49,25.67,26.42,26.47,25.85,26.43,25.32,25.36,25.87,26.63,,,,26.15,1.34,-0.48,0.27,0.32,-0.3,0.28,-0.83,-0.8,-0.28,0.48, , , ,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoskeleton;cytosol;endomembrane system;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,+,,,,,,,,
Q6NYC1,JMJD6,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR),2,6.3,25.99,26.32,26.6,27.08,26.83,27.12,25.84,26.19,27.15,25.41,,26.56,25.84,26.41,-0.41,-0.09,0.19,0.67,0.42,0.71,-0.57,-0.22,0.74,-1, ,0.15,-0.57,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cell activation;cell death;cell development;cell differentiation;cell recognition;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;nucleoplasm;organelle;plasma membrane,,,,,,,,,,
P17275,JUNB,Transcription factor jun-B,9,31.1,28.26,,28.62,23.24,,26.54,,,24.26,27.71,,25.83,,26.35,1.91, ,2.27,-3.11, ,0.19, , ,-2.09,1.36, ,-0.52, ,"anatomical structure development;biological regulation;biosynthetic process;cell differentiation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;nucleoplasm,bZIP,,,,,,,,,
P17535,JUND,Transcription factor jun-D,6,29.1,26.61,,,28.27,26.75,27.31,27.39,27.3,27.87,26.2,25.03,27.6,26.11,26.95,-0.34, , ,1.32,-0.19,0.36,0.44,0.35,0.92,-0.75,-1.92,0.65,-0.84,aging;anatomical structure development;biological regulation;biosynthetic process;cell development;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;rhythmic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,bZIP,,,,,,,,,
P14923,JUP,Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3),29,41.6,33.65,31.15,32.2,30.57,32.42,32.38,32.03,31.93,32.48,33.08,31.85,31.5,32.56,32.14,1.51,-0.99,0.06,-1.56,0.28,0.24,-0.11,-0.21,0.34,0.94,-0.28,-0.64,0.42,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell development;cell junction organization;cell morphogenesis;cell motility;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;detection of stimulus;developmental process;locomotion;macromolecular complex assembly;organelle organization;protein complex assembly;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q63ZY3,KANK2,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),13,22.4,28.18,28.11,25.66,27.82,27.84,27.96,26.33,26.89,27.56,24.84,25.12,24.16,26.62,26.7,1.48,1.41,-1.04,1.12,1.14,1.26,-0.37,0.19,0.86,-1.86,-1.58,-2.54,-0.08,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q7Z3B3,KANSL1,KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog),4,5.6,19.86,20.66,20.49,23.77,22.97,21.08,22.55,21.49,20.83,22.62,,,,21.63,-1.77,-0.97,-1.14,2.13,1.34,-0.55,0.92,-0.14,-0.8,0.99, , , ,cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process,cell part;histone methyltransferase complex;macromolecular complex;protein complex,,,,,,,,,,
Q15046,KARS,Lysine--tRNA ligase (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS),35,52.8,31.89,32.04,31.9,32.61,32.21,32.16,32.23,32.13,31.68,31.72,32.33,31.34,32.29,32.04,-0.15,0,-0.14,0.57,0.17,0.12,0.18,0.09,-0.36,-0.32,0.28,-0.7,0.25,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;RNA processing;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process;tRNA processing,cell part;cytoskeleton;cytosol;extracellular region;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q8NC54,KCT2,Keratinocyte-associated transmembrane protein 2,3,19.4,26.96,27.13,28.33,24.73,25.76,25.15,25.16,24.7,23.08,26.27,24.62,23.4,23.21,25.27,1.69,1.87,3.06,-0.54,0.49,-0.12,-0.11,-0.57,-2.19,1,-0.65,-1.87,-2.06,,cell part,,,,,,,,,,
Q6UW63,KDELC1,KDEL motif-containing protein 1 (Endoplasmic reticulum resident protein 58) (ER protein 58) (ERp58),4,7.6,,27.28,26.33,27.88,27.68,27.92,26.93,27.9,27.75,25.19,25.92,20.08,,26.44, ,0.84,-0.11,1.44,1.23,1.48,0.49,1.46,1.31,-1.25,-0.52,-6.36, ,,cell part,,,,,,,,,,
Q7Z4H8,KDELC2,KDEL motif-containing protein 2,13,30.2,27.29,30.38,29.2,30.17,29.17,29.53,29.12,28.59,28.21,27.97,27.07,29.05,29.31,28.85,-1.56,1.53,0.35,1.32,0.32,0.68,0.27,-0.26,-0.65,-0.88,-1.78,0.2,0.46,,cell part,,,,,,,,,,
O60341,KDM1A,Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),21,37.9,30.45,29.53,29.25,29.54,29.19,29.72,28.7,28.52,29.54,29.73,27.09,28.57,28.9,29.13,1.32,0.4,0.12,0.41,0.06,0.58,-0.44,-0.61,0.4,0.6,-2.04,-0.56,-0.24,anatomical structure development;biological regulation;biosynthetic process;cell development;cell differentiation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;developmental process;embryo development;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of body fluid levels;regulation of organelle organization;regulation of protein modification process;RNA metabolic process,cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q9Y2K7,KDM2A,Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A),13,12.1,27.56,25.5,23.55,26.12,24.23,25.95,25.5,24.94,26.98,25.49,,24.89,,25.52,2.04,-0.02,-1.97,0.6,-1.29,0.43,-0.02,-0.58,1.46,-0.03, ,-0.63, ,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;RNA metabolic process;small molecule metabolic process,cell part;nucleoplasm,Other TF domain,,,,,,,,,
Q7LBC6,KDM3B,Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA),10,10.5,28.06,25.32,26.28,25.59,,25.02,22.9,21.89,26,25.37,25.62,23.38,21.55,24.75,3.31,0.57,1.53,0.84, ,0.27,-1.84,-2.86,1.25,0.62,0.88,-1.37,-3.2,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q06136,KDSR,3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1),5,32.5,27.18,28.92,29.19,26.17,23.69,26.17,25.15,20.92,25.49,27.89,28.17,27.95,26.94,26.45,0.73,2.47,2.74,-0.28,-2.76,-0.28,-1.3,-5.53,-0.96,1.44,1.72,1.51,0.49,amine metabolic process;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;extracellular space;membrane,,,,,,,,,,
Q14145,KEAP1,Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19),5,8.8,25.25,24.97,25.79,27.9,27.36,25.3,26.29,27.26,,25.74,25.16,,,26.1,-0.85,-1.13,-0.31,1.8,1.26,-0.8,0.19,1.16, ,-0.36,-0.94, , ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;RNA metabolic process,cell part;centrosome;cytoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;midbody;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q07666,KHDRBS1,"KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein) (Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)",11,28.4,32.48,31.78,32.01,31.71,30.08,32.08,31.65,30.87,32.43,32.43,31.2,31.53,32.12,31.72,0.76,0.06,0.29,-0.01,-1.64,0.36,-0.07,-0.85,0.71,0.71,-0.52,-0.19,0.4,biological regulation;biosynthetic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of translation;regulation of transport;response to stimulus;RNA metabolic process;RNA processing;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,+,,,,,,
O75525,KHDRBS3,"KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein T-Star) (Sam68-like mammalian protein 2) (SLM-2) (Sam68-like phosphotyrosine protein)",5,18.1,28.01,27.26,26.48,26.71,26.93,27.95,27.77,27.68,28.54,28.47,28.31,25.1,,27.43,0.58,-0.17,-0.96,-0.73,-0.51,0.52,0.34,0.25,1.1,1.03,0.88,-2.33, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q92945,KHSRP,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),44,65.1,33.38,32.55,32.17,32.42,32.94,32.94,32.5,32.59,33.2,32.34,31.37,31.41,32.22,32.46,0.91,0.09,-0.29,-0.04,0.48,0.47,0.03,0.12,0.74,-0.12,-1.09,-1.06,-0.25,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;ribonucleoprotein complex,Other TF domain,,,,,,,,,
Q15397,KIAA0020,Pumilio domain-containing protein KIAA0020 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8) (HLA-HA8),15,26.1,28.81,28.74,28.48,28.98,29.99,29.8,29.13,28.36,30.22,30.25,28.3,28.39,29.89,29.18,-0.37,-0.44,-0.7,-0.2,0.81,0.62,-0.05,-0.82,1.04,1.07,-0.88,-0.79,0.71,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q12768,KIAA0196,WASH complex subunit strumpellin,17,17.4,28.94,28.69,28.65,29.2,27.88,27.74,28.84,28.28,27.89,26.58,28.75,29.09,28.08,28.35,0.58,0.33,0.29,0.85,-0.47,-0.61,0.49,-0.08,-0.46,-1.77,0.4,0.73,-0.27,cell death;cellular process;death;endosome transport;establishment of localization;transport;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q8IZA0,KIAA0319L,Dyslexia-associated protein KIAA0319-like protein,6,5.5,25.87,25.57,25.33,24.56,,26.25,24.08,,26.87,27.49,23.92,,24.11,25.41,0.47,0.16,-0.08,-0.84, ,0.84,-1.32, ,1.47,2.08,-1.49, ,-1.29,,cell part,,,,,,,,,,
O15091,KIAA0391,Mitochondrial ribonuclease P protein 3 (Mitochondrial RNase P protein 3),5,14.5,27.53,26.06,26.68,26.08,26.53,26.88,26.19,25.76,26.57,27.67,,25.49,26.34,26.48,1.05,-0.42,0.19,-0.4,0.04,0.4,-0.3,-0.72,0.09,1.19, ,-0.99,-0.14,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q2M389,KIAA1033,WASH complex subunit 7,10,9.7,28.19,28.15,28.03,28.78,26.31,27.32,28.46,28.78,27.31,26.62,29.16,29.16,26.2,27.88,0.31,0.27,0.14,0.89,-1.57,-0.56,0.58,0.9,-0.57,-1.26,1.28,1.27,-1.69,cellular process;endosome transport;establishment of localization;transport;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q5T5P2,KIAA1217,Sickle tail protein homolog,43,27.3,31.27,29.73,29.47,27.52,29.64,29.04,28.83,28.35,28.03,29.13,25.65,28.84,28.15,28.74,2.53,0.99,0.73,-1.22,0.89,0.3,0.09,-0.39,-0.72,0.39,-3.09,0.1,-0.6,anatomical structure development;developmental process,cell part;cytoplasm,,,,,,,,,,
Q96EK5,KIAA1279,KIF1-binding protein,10,28.7,25.46,27.52,25.84,28.09,27.01,25.94,28.24,28.44,26.16,25.42,27.11,29.09,26.48,26.99,-1.53,0.54,-1.14,1.1,0.03,-1.05,1.25,1.46,-0.82,-1.57,0.13,2.11,-0.51,anatomical structure development;cell differentiation;cellular process;developmental process;establishment of localization;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q69YN4,KIAA1429,Protein virilizer homolog,21,16.9,28.18,27.01,25.45,27.36,28.6,28.12,26.66,25.95,27.83,27.09,28.59,24.28,27.56,27.13,1.05,-0.12,-1.68,0.23,1.47,0.99,-0.47,-1.18,0.7,-0.04,1.46,-2.85,0.43,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9P260,KIAA1468,LisH domain and HEAT repeat-containing protein KIAA1468,11,15.6,26.59,25.71,28.37,25.07,24.58,24.26,24.38,24.92,19.68,21.81,26.08,26.39,20.82,24.51,2.08,1.2,3.86,0.56,0.07,-0.25,-0.13,0.4,-4.83,-2.71,1.56,1.88,-3.69,,,,,,,,,,,,
A0MZ66,KIAA1598,Shootin-1,19,38.2,30.23,27.58,30.1,25.72,25.21,23.5,29.67,28.55,22.46,28.76,29.64,29.43,27.85,27.59,2.63,-0.01,2.5,-1.87,-2.38,-4.09,2.08,0.96,-5.13,1.17,2.05,1.84,0.26,locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cell projection;neuron projection,,,,,,,,,,
Q8N163,KIAA1967,DBIRD complex subunit KIAA1967 (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (p30 DBC),37,45.8,32.2,31.65,32.4,31.72,32.56,32.5,32.23,31.89,32.52,32.29,30.92,31.82,31.76,32.04,0.17,-0.39,0.37,-0.31,0.53,0.46,0.19,-0.15,0.49,0.25,-1.12,-0.22,-0.28,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitochondrion organization;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9ULH0,KIDINS220,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),14,11.2,25.22,22.99,24.93,26.38,27.64,27.52,26.73,24.62,28.39,27.38,25.72,,28.04,26.3,-1.07,-3.31,-1.36,0.09,1.34,1.22,0.43,-1.67,2.09,1.08,-0.57, ,1.74,anatomical structure morphogenesis;biological regulation;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
O43896,KIF1C,Kinesin-like protein KIF1C,6,9.4,,24.23,24.32,24.67,25.2,25.21,25.88,26.08,24.73,25.81,26.39,25.27,,25.25, ,-1.03,-0.93,-0.58,-0.05,-0.04,0.63,0.83,-0.52,0.56,1.14,0.01, ,cellular component movement;cellular process;establishment of localization;Golgi vesicle transport;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q7Z4S6,KIF21A,Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62),8,8.9,26.02,24.79,25.01,25.78,24.84,23.3,25.46,25.85,23.34,25.75,24.78,24.61,23.25,24.83,1.19,-0.04,0.18,0.95,0.01,-1.53,0.63,1.02,-1.49,0.93,-0.05,-0.22,-1.58,cellular component movement;cellular process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q02241,KIF23,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),7,13.4,22.12,,26.6,22.47,27.6,23.04,24.23,23.65,,23.98,,,23.24,24.1,-1.99, ,2.5,-1.63,3.5,-1.06,0.12,-0.45, ,-0.13, , ,-0.86,biological regulation;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular process;coagulation;cytokinesis;immune system process;macromolecular complex assembly;multicellular organismal process;protein complex assembly;regulation of body fluid levels,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;midbody;nucleoplasm;organelle;protein complex,,,,,,,,,,
O00139,KIF2A,Kinesin-like protein KIF2A (Kinesin-2) (hK2),7,10.8,27.27,28.45,26.97,28.4,27.18,28.22,28.88,28.4,27.16,28.79,28.54,28.28,27.53,28.01,-0.73,0.44,-1.03,0.39,-0.82,0.22,0.87,0.4,-0.85,0.79,0.53,0.28,-0.48,anatomical structure development;biological regulation;cell differentiation;cell division;cellular component movement;cellular component organization;cellular process;coagulation;cytoskeleton organization;developmental process;immune system process;mitosis;multicellular organismal process;nuclear division;organelle fission;organelle organization;regulation of body fluid levels,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P33176,KIF5B,Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC),50,55.8,32.43,32.2,32.31,32.53,31.85,31.61,32.63,32.47,30.46,31.6,32.59,32.41,31.5,32.05,0.39,0.15,0.26,0.48,-0.19,-0.43,0.58,0.42,-1.58,-0.45,0.54,0.36,-0.54,biological regulation;cellular component disassembly;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular localization;cellular metabolic process;cellular process;cytoplasm organization;cytoskeleton-dependent intracellular transport;establishment of localization;homeostatic process;localization;macromolecule metabolic process;metabolic process;organelle localization;primary metabolic process;protein metabolic process;regulation of transport;transport,cell part;cell projection;macromolecular complex;neuron projection;organelle;protein complex;vesicle,,,,,,,,,,
Q07866,KLC1,Kinesin light chain 1 (KLC 1),28,49.7,30.42,30.34,30.33,30.94,29.44,29.81,30.6,30.23,29.01,29.65,30.94,30.95,29.98,30.2,0.22,0.13,0.13,0.74,-0.76,-0.39,0.4,0.02,-1.19,-0.55,0.74,0.74,-0.22,biological regulation;cellular component disassembly;cellular component movement;cellular component organization;cellular process;coagulation;immune system process;interspecies interaction between organisms;multicellular organismal process;multi-organism process;regulation of body fluid levels,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q9H0B6,KLC2,Kinesin light chain 2 (KLC 2),9,20.9,,26.21,,25.81,25.82,25.23,24.64,27.76,,26.9,27.25,26.38,,26.22, ,-0.02, ,-0.42,-0.4,-0.99,-1.58,1.54, ,0.68,1.03,0.16, ,biological regulation;cellular component movement;cellular process;coagulation;cytoskeleton-dependent intracellular transport;establishment of localization;immune system process;multicellular organismal process;regulation of body fluid levels;transport,cell part;cell projection;cytosol;macromolecular complex;neuron projection;protein complex,,,,,,,,,,
Q9NSK0,KLC4,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),10,19.9,26.26,25.74,25.95,,,,26.21,25.43,23.78,,25.81,24.24,,25.43,0.83,0.32,0.52, , , ,0.78,0,-1.65, ,0.38,-1.19, ,,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
P52294,KPNA1,Importin subunit alpha-5 (Karyopherin subunit alpha-1) (Nucleoprotein interactor 1) (NPI-1) (RAG cohort protein 2) (SRP1-beta),4,11.3,27.83,26.68,26.53,27.13,27.48,26.49,27.25,27.7,26.79,26.46,27.02,27.02,26.71,27.01,0.82,-0.32,-0.47,0.13,0.47,-0.52,0.25,0.69,-0.21,-0.55,0.01,0.01,-0.3,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;regulation of DNA metabolic process;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;transport,cell part;cell projection;cytosol;macromolecular complex;neuron projection;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
P52292,KPNA2,Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha),15,31.4,30.35,27.53,29.94,30.37,31.2,29.26,31.79,31.03,28.73,29.86,29.54,30.22,29.36,29.94,0.41,-2.4,0.01,0.43,1.27,-0.68,1.85,1.09,-1.21,-0.08,-0.4,0.28,-0.57,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;regulation of DNA metabolic process;response to chemical stimulus;response to stimulus;signal transduction;transport,cell part;cytosol;nucleoplasm,,,,,,,,,,
O00505,KPNA3,Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma),9,20.7,27.98,29.15,28.43,29.37,27.96,28.18,29.09,29.06,28.9,27.84,28.69,28.03,28.17,28.53,-0.55,0.62,-0.1,0.84,-0.57,-0.34,0.57,0.53,0.37,-0.69,0.16,-0.49,-0.36,biological regulation;cellular component assembly;cellular component organization;cellular process;establishment of localization;interspecies interaction between organisms;locomotion;macromolecular complex assembly;multi-organism process;nuclear transport;nucleocytoplasmic transport;protein complex assembly;protein targeting;protein transport;response to chemical stimulus;response to stimulus;signal transduction;transport,cell part;cytosol;macromolecular complex;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
O00629,KPNA4,Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4),14,40.7,31.74,30.55,30.97,31.36,31.3,30.73,31.58,31.46,31.02,30.84,31.3,31.2,30.72,31.14,0.61,-0.59,-0.17,0.23,0.16,-0.41,0.45,0.32,-0.11,-0.3,0.16,0.06,-0.41,biological regulation;cellular process;establishment of localization;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;response to chemical stimulus;response to stimulus;signal transduction;transport,cell part;cytosol;nucleoplasm,,,,,,,,,,
O60684,KPNA6,Importin subunit alpha-7 (Karyopherin subunit alpha-6),17,34.7,31.19,30.96,30.22,31.19,30.45,30.27,31.13,31,30.65,30.34,31,31.21,30.27,30.76,0.43,0.2,-0.54,0.43,-0.31,-0.49,0.37,0.24,-0.11,-0.42,0.24,0.45,-0.49,establishment of localization;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q14974,KPNB1,Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97),48,57,33.67,33.98,33.46,34.24,34.05,33.35,34.21,33.93,33.74,33.62,33.66,34.01,32.85,33.75,-0.08,0.23,-0.29,0.48,0.3,-0.4,0.46,0.18,-0.02,-0.13,-0.09,0.26,-0.9,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transport,cell part;cytosol;macromolecular complex;membrane;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
P01116,KRAS,"GTPase KRas (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]",10,44.6,27.76,25.91,28.54,25.68,26.73,27.88,,25.14,,26.02,25.77,,26.89,26.63,1.13,-0.72,1.91,-0.96,0.1,1.25, ,-1.49, ,-0.61,-0.86, ,0.26,behavior;behavioral interaction between organisms;biological regulation;cell motility;cellular component movement;cellular metabolic process;cellular process;coagulation;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
P01116,KRAS,"GTPase KRas (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]",10,44.6,27.76,25.91,28.54,25.68,26.73,27.88,,25.14,,26.02,25.77,,26.89,26.63,1.13,-0.72,1.91,-0.96,0.1,1.25, ,-1.49, ,-0.61,-0.86, ,0.26,behavior;behavioral interaction between organisms;biological regulation;cell motility;cellular component movement;cellular metabolic process;cellular process;coagulation;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
Q8N9T8,KRI1,Protein KRI1 homolog,15,30.1,29.38,25.05,27.48,27.26,24.52,27.43,26.85,,27.4,,26.36,26.5,26.42,26.79,2.59,-1.74,0.69,0.48,-2.26,0.64,0.07, ,0.62, ,-0.43,-0.28,-0.37,,,,,,,,,,,,
Q13601,KRR1,KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1) (Rip-1),9,23.4,29.95,28.79,28.82,29.39,27.14,27.75,27.14,27.32,28.59,29,26.89,26.9,29.86,28.27,1.67,0.51,0.55,1.12,-1.13,-0.52,-1.13,-0.95,0.32,0.73,-1.38,-1.37,1.59,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
H6VRG2,KRT1,Keratin 1,14,21.4,29.04,29.45,23.51,28.44,28.96,26.32,29.25,28.71,26.99,28.74,28.98,29.07,30.74,28.32,0.72,1.12,-4.81,0.12,0.64,-2,0.93,0.38,-1.33,0.41,0.66,0.74,2.42,,cell part;macromolecular complex;protein complex,,,,,,,,,,
P08730,Krt13,"Keratin, type I cytoskeletal 13 (47 kDa cytokeratin) (Cytokeratin-13) (CK-13) (Keratin-13) (K13)",3,5.3,28.44,26.73,30.41,29.05,28.13,31.53,32.39,28.78,27,31.36,32.36,28.5,30.48,29.63,-1.18,-2.9,0.78,-0.58,-1.5,1.91,2.76,-0.85,-2.63,1.74,2.73,-1.13,0.85,,,,,,,,,,,,
P13646,KRT13,"Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)",17,44.5,32.97,29.16,26.26,24.58,25.27,27.25,23.76,26.29,,,27.02,,28.77,27.13,5.84,2.03,-0.87,-2.55,-1.87,0.12,-3.37,-0.84, , ,-0.12, ,1.64,anatomical structure development;anatomical structure morphogenesis;cell communication;cellular process;developmental process;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus,cell part;extracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",24,61.4,34.13,26.78,27.05,28.01,27.78,25.75,26,26.32,23.98,25.61,27.66,27.98,25.65,27.13,7,-0.35,-0.08,0.88,0.65,-1.38,-1.13,-0.81,-3.15,-1.52,0.53,0.85,-1.48,anatomical structure development;developmental process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P08779,KRT16,"Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)",23,57.3,33.23,31.57,31.01,27.01,25.67,28.7,24.35,27.74,19.29,29.87,27.78,25.3,28.81,27.72,5.51,3.86,3.29,-0.71,-2.05,0.98,-3.37,0.02,-8.43,2.15,0.06,-2.42,1.1,anatomical structure development;cell proliferation;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q04695,KRT17,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",51,82.2,35.63,32.49,37.16,27.65,32.51,29.74,29.27,31.18,28.1,29.37,29.04,23.37,28.74,30.33,5.3,2.16,6.83,-2.68,2.18,-0.59,-1.06,0.85,-2.22,-0.96,-1.29,-6.95,-1.58,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization;regulation of translation,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
P05784,Krt18,"Keratin, type I cytoskeletal 18 (Cytokeratin endo B) (Keratin D) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",3,16.1,25.77,23.9,25.8,,,27.02,,23.11,23.95,24.31,30.34,31.53,29.28,26.5,-0.73,-2.6,-0.7, , ,0.52, ,-3.39,-2.55,-2.2,3.84,5.03,2.78,,,,,,,,,,,,
P35908,KRT2,"Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2)",3,5.2,24.59,23.09,23.66,24.37,,25.91,26.69,26.13,,25.41,26.44,27.53,27.12,25.54,-0.95,-2.45,-1.88,-1.17, ,0.36,1.15,0.59, ,-0.13,0.89,1.99,1.58,cell activation;cell motility;cell proliferation;cellular component movement;cellular process;developmental process;locomotion,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9C075,KRT23,"Keratin, type I cytoskeletal 23 (Cytokeratin-23) (CK-23) (Keratin-23) (K23)",7,19.9,25.81,,25.44,,26.01,25.67,24.73,25.72,,29.15,25.01,,,25.94,-0.13, ,-0.51, ,0.07,-0.27,-1.22,-0.22, ,3.2,-0.93, , ,,cell part;macromolecular complex;protein complex,,,,,,,,,,
O76013,KRT36,"Keratin, type I cuticular Ha6 (Hair keratin, type I Ha6) (Keratin-36) (K36)",3,6,28.33,26.09,,,27.2,27.15,27.88,28.83,26.67,28.27,29.06,,21.85,27.13,1.2,-1.04, , ,0.06,0.02,0.75,1.69,-0.46,1.14,1.93, ,-5.28,biological regulation,cell part;macromolecular complex;protein complex,,,,,,,,,,
P19013,KRT4,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",30,61,33.21,27.09,28.32,27.26,26.94,26.31,23.35,25.05,,26.37,27.34,,26.36,27.05,6.15,0.03,1.27,0.21,-0.11,-0.75,-3.71,-2.01, ,-0.68,0.29, ,-0.69,biological regulation;cell differentiation;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization,cell part;macromolecular complex;protein complex,,,,,,,,,,
P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",47,48.8,34.32,32.86,36.78,27.6,24.5,25.81,26.02,25.19,26.26,31.74,27.12,24.18,27.24,28.43,5.89,4.43,8.35,-0.83,-3.94,-2.62,-2.41,-3.25,-2.17,3.31,-1.31,-4.25,-1.19,anatomical structure development;cell junction organization;cellular component assembly;cellular component organization;cellular process;developmental process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;plasma membrane;protein complex,,,,,,,,,,
P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",66,69.7,35.8,34.61,36.15,29.92,34.48,33.87,35.5,35.32,29.39,35.26,34.23,28.26,34.07,33.6,2.2,1.01,2.55,-3.69,0.88,0.27,1.9,1.72,-4.22,1.65,0.62,-5.35,0.47,anatomical structure development;biological regulation;cell differentiation;cellular process;developmental process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",8,7.7,32.68,30.51,32.54,30.4,29.32,30.62,32.66,32.26,30.44,33.85,32.88,28.06,27.71,31.07,1.61,-0.56,1.47,-0.67,-1.75,-0.45,1.59,1.19,-0.63,2.78,1.81,-3.02,-3.36,biological regulation;cellular component organization;cellular process;cytoskeleton organization;interspecies interaction between organisms;multi-organism process;organelle organization;regulation of translation,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9DCV7,Krt7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Type-II keratin Kb7)",4,7.9,28.42,27.7,,26.9,22.29,26.4,28.25,26.78,26.73,27.4,29.1,24.71,25,26.64,1.78,1.06, ,0.26,-4.35,-0.24,1.61,0.14,0.09,0.76,2.46,-1.93,-1.64,,,,,,,,,,,,
Q6KB66,KRT80,"Keratin, type II cytoskeletal 80 (Cytokeratin-80) (CK-80) (Keratin-80) (K80) (Type-II keratin Kb20)",9,22.3,28.39,27.59,26.45,,26.95,27.01,27.52,28.17,26.04,28.69,28.52,27.8,28.86,27.66,0.72,-0.07,-1.22, ,-0.72,-0.66,-0.14,0.5,-1.63,1.03,0.85,0.14,1.19,,cell part;macromolecular complex;protein complex,,,,,,,,,,
P78385,KRT83,"Keratin, type II cuticular Hb3 (Hair keratin K2.10) (Keratin-83) (K83) (Type II hair keratin Hb3) (Type-II keratin Kb23)",11,18.1,24.09,26.37,24.78,,22.58,25.33,24.54,24.02,,27.39,29.72,,22.03,25.09,-0.99,1.29,-0.31, ,-2.51,0.24,-0.54,-1.07, ,2.31,4.63, ,-3.05,anatomical structure development;developmental process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P35527,KRT9,"Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)",6,15.1,25.33,24.22,25.17,24.17,,25.68,27.38,24.67,24.24,28.07,26.56,28.49,28.98,26.08,-0.75,-1.86,-0.91,-1.91, ,-0.4,1.3,-1.41,-1.84,1.99,0.48,2.41,2.9,anatomical structure development;cellular component organization;cellular process;cytoskeleton organization;developmental process;multicellular organismal process;organelle organization,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q8IVT5,KSR1,Kinase suppressor of Ras 1,5,10.8,27.02,,,26.66,25.96,25.54,25.41,25.75,26,,,,,26.05,0.97, , ,0.61,-0.08,-0.51,-0.64,-0.3,-0.05, , , , ,biological regulation;cellular process;response to stimulus;signal transduction,cell part;intracellular;membrane,,+,,,,,,,,
Q86UP2,KTN1,Kinectin (CG-1 antigen) (Kinesin receptor),98,66,32.73,33.12,32.55,32.75,33.2,33.65,33.18,33.45,33.64,33.52,32.99,32.7,33.56,33.16,-0.43,-0.04,-0.61,-0.4,0.04,0.5,0.02,0.29,0.49,0.36,-0.17,-0.46,0.4,cellular component movement;cellular process,cell part;membrane,,,,,,,,,,
P32004,L1CAM,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171),6,5.3,26.41,24.62,27.53,23.05,,21.78,25.26,25.48,,26.44,26.17,26.64,25.55,25.36,1.05,-0.74,2.17,-2.31, ,-3.58,-0.09,0.12, ,1.08,0.81,1.29,0.19,biological adhesion;biological regulation;cell adhesion;cell death;cell motility;cellular component movement;cellular process;coagulation;death;immune system process;locomotion;multicellular organismal process;regulation of body fluid levels;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;membrane;plasma membrane,,,,,,,,,,
Q9H9P8,L2HGDH,"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2) (Duranin)",7,20.2,28.58,28.25,,26.92,28.12,26.89,26.96,27.75,27.76,27.43,26.61,26.82,27.15,27.44,1.15,0.81, ,-0.51,0.69,-0.55,-0.48,0.32,0.32,-0.01,-0.83,-0.62,-0.29,cellular ketone metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q96EM0,L3HYPDH,Trans-L-3-hydroxyproline dehydratase (EC 4.2.1.77) (Trans-3-hydroxy-l-proline dehydratase),4,14.4,,25.99,,27.34,25.45,25.37,25.07,25.44,25.08,,24.1,26.63,,25.61, ,0.38, ,1.73,-0.15,-0.24,-0.54,-0.16,-0.53, ,-1.51,1.02, ,,,,,,,,,,,,
P83111,LACTB,"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)",23,39.1,29.24,30.66,31.1,29.19,30.09,31.05,29.41,30.18,31.52,31.23,30.7,29.38,31.39,30.4,-1.16,0.27,0.7,-1.21,-0.31,0.66,-0.99,-0.21,1.13,0.83,0.3,-1.01,1,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q53H82,LACTB2,Beta-lactamase-like protein 2 (EC 3.-.-.-),10,40.6,30.4,28.31,29.42,28.48,27.06,27.14,28.24,27.63,26.86,28.71,28.5,26.96,26.21,27.99,2.41,0.31,1.42,0.48,-0.93,-0.85,0.25,-0.37,-1.13,0.72,0.51,-1.03,-1.79,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q16787,LAMA3,Laminin subunit alpha-3 (Epiligrin 170 kDa subunit) (E170) (Epiligrin subunit alpha) (Kalinin subunit alpha) (Laminin-5 subunit alpha) (Laminin-6 subunit alpha) (Laminin-7 subunit alpha) (Nicein subunit alpha),90,28.6,34.34,30.54,34.11,28.02,29.27,28.45,28.04,28.02,27.88,33.76,28.48,28.07,29.29,29.87,4.47,0.67,4.24,-1.85,-0.6,-1.42,-1.83,-1.85,-1.98,3.9,-1.38,-1.79,-0.58,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization,laminin complex;macromolecular complex;protein complex,,,,,,,,,,
Q16363,LAMA4,Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha),21,16.9,22.55,29.04,,29.39,28.37,28.72,28.07,28.44,28.57,,27.02,27.82,28.82,27.89,-5.34,1.15, ,1.5,0.48,0.83,0.18,0.54,0.68, ,-0.87,-0.07,0.92,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cell differentiation;cellular process;developmental process,extracellular organelle;laminin complex;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
O15230,LAMA5,Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha),43,15.8,30.22,29.64,23.76,26.63,30.93,31.77,29.64,29.52,29.87,31.51,27.9,27.68,31.14,29.25,0.97,0.39,-5.48,-2.62,1.68,2.53,0.4,0.27,0.62,2.26,-1.35,-1.57,1.9,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell differentiation;cell junction organization;cell morphogenesis;cell motility;cell proliferation;cell recognition;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;embryo development;establishment of localization;locomotion;molting cycle;multicellular organismal process;organelle organization;response to stimulus;signal transduction,extracellular space;laminin complex;macromolecular complex;protein complex,,,,,,,,,,
P07942,LAMB1,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),32,22.1,26.84,29.49,28.89,30.72,30.86,31.23,29.82,29.64,31.78,31.66,29.14,28.77,31.24,30.01,-3.17,-0.52,-1.12,0.72,0.86,1.22,-0.18,-0.36,1.77,1.66,-0.87,-1.23,1.23,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell morphogenesis;cell motility;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;developmental process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;extracellular organelle;extracellular space;laminin complex;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P55268,LAMB2,Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta),31,24.4,29.07,30.45,26.75,29.93,28.86,30.29,29.73,29.47,28.63,29.78,27.98,28.21,30.37,29.2,-0.12,1.26,-2.44,0.74,-0.34,1.09,0.54,0.28,-0.56,0.59,-1.21,-0.99,1.17,anatomical structure development;biological adhesion;cell adhesion;cell development;cell growth;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;growth;locomotion;multicellular organismal process;neurological system process;response to chemical stimulus;response to external stimulus;response to stimulus,laminin complex;macromolecular complex;protein complex;synapse,,,,,,,,,,
Q13751,LAMB3,Laminin subunit beta-3 (Epiligrin subunit bata) (Kalinin B1 chain) (Kalinin subunit beta) (Laminin B1k chain) (Laminin-5 subunit beta) (Nicein subunit beta),44,42.7,32.83,29.18,30.18,25.7,28.02,29.56,27.46,28.68,30,32.94,26.3,,27.24,29.01,3.82,0.17,1.17,-3.31,-0.98,0.55,-1.55,-0.33,0.99,3.93,-2.71, ,-1.77,anatomical structure development;biological adhesion;cell adhesion;cell differentiation;cell junction organization;cellular component assembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization,extracellular region;laminin complex;macromolecular complex;protein complex,,,,,,,,,,
P11047,LAMC1,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),44,28.1,31.75,31.12,30.42,31.61,31.64,32.31,31.15,31.22,31.86,33.65,29.24,30.05,31.93,31.38,0.37,-0.26,-0.96,0.23,0.26,0.92,-0.23,-0.16,0.48,2.27,-2.14,-1.33,0.55,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell morphogenesis;cell motility;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecular complex assembly;protein complex assembly;response to chemical stimulus;response to external stimulus;response to stimulus,extracellular organelle;extracellular space;laminin complex;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
Q13753,LAMC2,Laminin subunit gamma-2 (Cell-scattering factor 140 kDa subunit) (CSF 140 kDa subunit) (Epiligrin subunit gamma) (Kalinin subunit gamma) (Kalinin/nicein/epiligrin 100 kDa subunit) (Ladsin 140 kDa subunit) (Laminin B2t chain) (Laminin-5 subunit gamma) (Large adhesive scatter factor 140 kDa subunit) (Nicein subunit gamma),36,35.1,32.24,29.11,29.91,27.97,27.61,29.03,27.77,29.11,30.68,32.51,28.14,22.32,28.49,28.84,3.4,0.27,1.07,-0.87,-1.23,0.19,-1.07,0.27,1.84,3.68,-0.7,-6.52,-0.34,anatomical structure development;biological adhesion;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization,extracellular region;laminin complex;macromolecular complex;protein complex,,,,,,,,,,
P11279,LAMP1,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),9,18.5,31.18,32.88,32.08,32.08,32.23,33.03,31.89,31.85,32.37,32.55,32.42,31.97,32.91,32.26,-1.09,0.62,-0.18,-0.19,-0.03,0.76,-0.37,-0.42,0.1,0.29,0.16,-0.29,0.64,autophagy;catabolic process;cell death;cellular metabolic process;cellular process;death;metabolic process,cell body;cell part;cell projection;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;neuron projection;neuronal cell body;organelle;plasma membrane;vacuole;vesicle,,,,,,,,,,
P13473,LAMP2,Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (CD antigen CD107b),6,14.6,30.18,30.55,28.94,29.88,30.11,30.67,28.5,29.28,28.78,28.66,30.29,29.27,29.93,29.62,0.56,0.93,-0.67,0.26,0.49,1.05,-1.12,-0.34,-0.84,-0.96,0.67,-0.35,0.31,cell activation;cellular process;establishment of localization;exocytosis;secretion;transport;vesicle-mediated transport,cell part;membrane;plasma membrane,,,,,,,,,,
Q6IAA8,LAMTOR1,Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho),10,76.4,28.75,29.11,28.51,29.26,30.24,29.36,29.05,29.54,30.08,30.57,29.86,29.95,29.75,29.54,-0.79,-0.43,-1.03,-0.28,0.69,-0.18,-0.5,0,0.54,1.03,0.32,0.41,0.21,biological regulation;cell growth;cellular component organization;cellular localization;cellular process;endosome organization;growth;homeostatic process;localization;organelle localization;organelle organization;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;vacuole organization,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vacuole,,,,,,,,,,
Q9Y2Q5,LAMTOR2,Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (Roadblock domain-containing protein 3),5,49.6,28.08,29.23,28.45,28.44,27.79,28.5,26.86,28.24,28.9,28.05,28.02,28.15,28.46,28.24,-0.16,0.99,0.2,0.19,-0.45,0.25,-1.38,-0.01,0.66,-0.19,-0.22,-0.09,0.22,biological regulation;cell growth;cellular localization;cellular metabolic process;cellular process;growth;localization;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9UHA4,LAMTOR3,Ragulator complex protein LAMTOR3 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3) (MEK-binding partner 1) (Mp1) (Mitogen-activated protein kinase kinase 1-interacting protein 1) (Mitogen-activated protein kinase scaffold protein 1),3,49.2,28.99,29.9,29.9,29.35,29.82,30.61,29.86,29.63,29.58,30.3,30.58,30.6,30.76,29.99,-1.01,-0.09,-0.09,-0.64,-0.17,0.62,-0.13,-0.36,-0.41,0.3,0.59,0.61,0.77,biological regulation;cellular localization;cellular process;localization;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;macromolecular complex;protein complex,,,,,,,,,,
O43504,LAMTOR5,Ragulator complex protein LAMTOR5 (Hepatitis B virus X-interacting protein) (HBV X-interacting protein) (HBX-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5),5,96.7,29.79,30.45,29.87,30.28,29.77,30.14,29.94,29.95,30.14,30.13,29.88,30.54,30.08,30.07,-0.29,0.37,-0.2,0.21,-0.3,0.07,-0.13,-0.13,0.07,0.05,-0.19,0.47,0,biological regulation;cellular component organization;cellular process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;organelle;protein complex;vacuole,,,,,,,,,,
Q6FHH6,LANCL1,LANCL1 protein (Fragment),8,20.1,29.33,28.13,28.03,28.12,27.69,25.35,27.92,27.46,25.03,24.12,27.62,26.6,,27.12,2.22,1.01,0.92,1,0.57,-1.77,0.81,0.34,-2.09,-2.99,0.5,-0.52, ,metabolic process,,,,,,,,,,,
Q9NS86,LANCL2,LanC-like protein 2 (Testis-specific adriamycin sensitivity protein),3,9.3,25.77,25.15,25.19,26.34,,,26.22,,,23.84,27.7,25.61,,25.73,0.05,-0.57,-0.54,0.61, , ,0.49, , ,-1.89,1.97,-0.12, ,biological regulation;metabolic process,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P28838,LAP3,Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase),39,76,32.06,33.11,34.54,32.61,32.16,31.82,31.28,32.05,30.41,31.78,31.67,32.97,31.77,32.17,-0.12,0.94,2.37,0.44,-0.01,-0.35,-0.89,-0.12,-1.76,-0.39,-0.51,0.8,-0.4,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),34,39.5,30.14,29.01,29.16,30.03,30.25,29.66,30.59,30.74,27.7,28.43,29.33,29.96,27.72,29.44,0.7,-0.43,-0.28,0.59,0.81,0.22,1.15,1.3,-1.74,-1.01,-0.11,0.52,-1.72,biological regulation,,,,,,,,,,,
Q71RC2,LARP4,La-related protein 4 (La ribonucleoprotein domain family member 4),12,19,29.35,27.96,24.94,27.84,29.14,28.64,28.46,27.84,26.69,25.74,29.02,27.28,28.7,27.82,1.54,0.15,-2.88,0.02,1.32,0.83,0.65,0.02,-1.12,-2.07,1.2,-0.53,0.88,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization,,,,,,,,,,,
Q92615,LARP4B,La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5),10,16.1,27.99,26.98,28.13,27.25,26.34,27.05,28.34,26.58,27.65,27.15,26.83,27.66,,27.33,0.66,-0.35,0.8,-0.08,-0.99,-0.28,1.01,-0.75,0.32,-0.18,-0.5,0.33, ,biological regulation;regulation of translation,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q4G0J3,LARP7,La-related protein 7 (La ribonucleoprotein domain family member 7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),16,23.2,28.96,28.22,27.07,27.36,25.05,27.6,26.4,26.5,27.59,27.51,25.84,25.57,26.88,26.97,2,1.25,0.1,0.39,-1.91,0.64,-0.57,-0.47,0.63,0.54,-1.13,-1.39,-0.08,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
F5H698,LARS,"Leucine--tRNA ligase, cytoplasmic",47,41.3,30.91,31.94,31.08,32.14,31.49,31.69,32.07,31.66,31.56,31.61,31.76,32.28,31.72,31.69,-0.77,0.25,-0.61,0.45,-0.2,0.01,0.39,-0.03,-0.13,-0.07,0.08,0.6,0.04,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of translation;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytoplasm,,,,,,,,,,
Q15031,LARS2,"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)",6,8.9,26.31,24.99,,28.41,26.44,28.14,29.53,26.16,28.82,28.61,24.88,27.15,27.69,27.26,-0.95,-2.27, ,1.15,-0.82,0.88,2.27,-1.1,1.55,1.34,-2.38,-0.11,0.43,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of translation;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
Q9Y4W2,LAS1L,Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog),19,31.9,28.52,28.82,28.81,28.18,29.44,29.87,28.6,28.28,28.31,29.02,28.28,29.57,29.43,28.86,-0.34,-0.04,-0.05,-0.68,0.58,1.02,-0.25,-0.58,-0.54,0.16,-0.57,0.71,0.57,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;histone methyltransferase complex;macromolecular complex;protein complex,,,,,,,,,,
Q14847,LASP1,LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50),17,46,31.06,29.32,31.8,31.62,29.7,27.14,29.95,29.87,29.26,28.72,30.41,32.48,28.4,29.98,1.08,-0.66,1.82,1.64,-0.27,-2.84,-0.03,-0.11,-0.72,-1.26,0.43,2.5,-1.58,,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,+,,,,,,
Q14739,LBR,Lamin-B receptor (Integral nuclear envelope inner membrane protein) (LMN2R),18,28.9,28.98,29,29.01,30.32,29.76,30.68,30.19,30.52,30.99,31.43,28.99,28.27,30.48,29.89,-0.91,-0.89,-0.88,0.42,-0.13,0.78,0.29,0.63,1.1,1.54,-0.91,-1.63,0.59,alcohol metabolic process;biosynthetic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9UIC8,LCMT1,Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1),4,19.6,27.26,27.03,25.28,25.67,21.01,21.41,25.38,21.7,,,24.95,26.32,,24.6,2.66,2.43,0.68,1.07,-3.6,-3.19,0.78,-2.9, , ,0.35,1.71, ,biological regulation;regulation of cell cycle;regulation of mitotic cell cycle,,,,,,,,,,,
P80188,LCN2,Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin LCN2) (p25),10,61.6,29.37,29.21,33.13,28.68,25.24,,,24.32,,33.27,25.32,22.71,,27.92,1.46,1.3,5.22,0.77,-2.68, , ,-3.6, ,5.36,-2.6,-5.21, ,biological regulation;cell communication;cell death;cellular component assembly;cellular component organization;cellular process;death;establishment of localization;immune system process;ion transport;macromolecular complex assembly;multi-organism process;protein complex assembly;response to biotic stimulus;response to chemical stimulus;response to drug;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;siderophore transport;transport,cell part;cytoplasm;cytosol;extracellular region;extracellular space,,,,,,,,,,
P00338,LDHA,L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59),43,88.9,35.97,36.09,35.61,36.16,34.88,34.65,35.64,35.71,34.44,34.77,35.3,35.72,34.38,35.33,0.63,0.76,0.27,0.83,-0.45,-0.68,0.31,0.38,-0.9,-0.56,-0.03,0.38,-0.95,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cell communication;cellular ketone metabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;organic acid metabolic process;primary metabolic process;response to external stimulus;response to extracellular stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P07195,LDHB,L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46),28,68,34.07,33.83,33.76,34.34,33.51,33.59,33.95,34.22,33.03,34,34.04,34.42,32.61,33.8,0.27,0.03,-0.04,0.54,-0.29,-0.2,0.15,0.42,-0.77,0.2,0.24,0.63,-1.18,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;generation of precursor metabolites and energy;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P01130,LDLR,Low-density lipoprotein receptor (LDL receptor),20,35.8,29.86,27.85,29.16,31.84,30.62,29.64,30.6,30.67,30.52,31.37,28.81,30.18,30.13,30.09,-0.24,-2.24,-0.94,1.75,0.52,-0.45,0.5,0.58,0.42,1.27,-1.29,0.09,0.03,alcohol metabolic process;biological regulation;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;establishment of localization;homeostatic process;interspecies interaction between organisms;lipid metabolic process;lipid transport;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;primary metabolic process;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;membrane;organelle;vacuole,,,,,,,,,,
Q8NC56,LEMD2,LEM domain-containing protein 2 (hLEM2),21,43.7,31.41,30.15,29.14,29.99,29.61,30.27,30.01,29.59,30.56,30.11,30.32,29.5,30.43,30.08,1.32,0.06,-0.94,-0.1,-0.47,0.18,-0.07,-0.49,0.48,0.02,0.24,-0.58,0.34,biological regulation;cell differentiation;cellular process;developmental process,cell part,,,,,,,,,,
Q9Y2U8,LEMD3,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),19,28.4,29.97,27.86,28.68,28.19,28.77,28.17,28.27,26.99,28.58,30.37,28.09,29.37,28.95,28.63,1.33,-0.78,0.05,-0.45,0.13,-0.46,-0.36,-1.65,-0.05,1.74,-0.55,0.73,0.31,biological regulation;cell differentiation;cellular process;developmental process;regulation of cell cycle,cell part,,,,,,,,,,
Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),19,33.5,27.26,26.63,25.84,26.8,25.72,26.91,26.24,27.06,27.28,27.15,25.51,26.46,25.84,26.52,0.75,0.12,-0.68,0.29,-0.79,0.4,-0.28,0.54,0.76,0.64,-1.01,-0.06,-0.67,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to stimulus;RNA metabolic process;RNA processing;signal transduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;transcription elongation factor complex,,,,,,,,,,
Q32P28,LEPRE1,Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1),26,45,28.32,32.74,29.85,33.03,31.15,32.18,31.36,30.81,32.46,31.07,30.85,29.85,31.41,31.16,-2.84,1.58,-1.31,1.87,-0.01,1.02,0.2,-0.35,1.3,-0.09,-0.31,-1.31,0.25,biological regulation;cell growth;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization;growth,cell part;extracellular matrix;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;proteinaceous extracellular matrix,,,,,,,,,,
Q8IVL6,LEPREL2,Prolyl 3-hydroxylase 3 (EC 1.14.11.7) (Leprecan-like protein 2) (Protein B),13,24.2,26.8,29.91,28.95,30.14,29.12,29.78,26.5,28.69,30.02,26.7,28.44,25.63,28.71,28.41,-1.62,1.5,0.54,1.72,0.7,1.37,-1.91,0.28,1.61,-1.71,0.02,-2.79,0.3,biological regulation;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization,cell part,,,,,,,,,,
Q92791,LEPREL4,Synaptonemal complex protein SC65 (Leprecan-like protein 4) (Nucleolar autoantigen No55),10,26.1,,29.43,26.22,29.43,28.09,28.38,23.55,27.54,27.52,,24.71,24.32,26.07,26.84, ,2.59,-0.62,2.59,1.25,1.54,-3.29,0.7,0.67, ,-2.13,-2.52,-0.77,cellular component assembly;cellular component organization;cellular process;chromosome organization;organelle organization,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O95202,LETM1,"LETM1 and EF-hand domain-containing protein 1, mitochondrial (Leucine zipper-EF-hand-containing transmembrane protein 1)",35,48.3,31.76,32.72,32.32,32.01,31.84,31.99,32.1,31.53,32.28,33.3,32.78,32.86,32.84,32.33,-0.57,0.39,-0.01,-0.33,-0.49,-0.34,-0.23,-0.81,-0.05,0.96,0.45,0.53,0.51,cellular component organization;cellular membrane organization;cellular process;membrane organization;mitochondrion organization;organelle organization,cell part;membrane,,,,,,,,,,
P09382,LGALS1,Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1),18,94.1,31.99,35.38,34.52,35.96,33.57,34.27,34.6,34.27,35.81,34.27,34.79,34.71,33.81,34.46,-2.47,0.92,0.06,1.5,-0.89,-0.19,0.14,-0.18,1.36,-0.18,0.33,0.25,-0.65,biological regulation;cell activation;cell death;cell differentiation;cellular homeostasis;cellular process;death;developmental process;homeostatic process;immune system process;multicellular organismal process;response to chemical stimulus;response to drug;response to stimulus;response to stress,cell part;cell surface;cytoplasm;extracellular matrix;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;proteinaceous extracellular matrix,,,,,,,,,,
P17931,LGALS3,Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen),13,74.4,34.1,32.25,33.34,31.26,30.85,30.63,31.71,31.72,32.1,33.59,31.66,28.74,30.46,31.72,2.38,0.53,1.61,-0.47,-0.88,-1.09,-0.02,0,0.37,1.87,-0.06,-2.99,-1.26,anatomical structure development;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;extracellular matrix;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;proteinaceous extracellular matrix;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q08380,LGALS3BP,Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K),23,43.8,32.85,32.87,32.87,32.45,31.92,31.9,31.14,31.69,31.85,31.96,30.93,31.6,31.61,31.97,0.88,0.89,0.89,0.48,-0.05,-0.07,-0.83,-0.28,-0.12,-0.01,-1.04,-0.38,-0.36,biological adhesion;biological regulation;cell adhesion;cellular process;response to stimulus;response to stress;signal transduction,cell part;extracellular matrix;extracellular organelle;extracellular space;membrane;organelle;proteinaceous extracellular matrix;vesicle,,,,,,,,,,
O00214,LGALS8,Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1),8,26.6,27.24,27.39,26.21,27.96,28.46,28.53,26.73,27.16,28.69,27.5,29.11,30.39,28.59,28,-0.76,-0.6,-1.79,-0.03,0.47,0.53,-1.26,-0.84,0.69,-0.5,1.12,2.39,0.59,biological regulation;cell activation;cell differentiation;cellular process;developmental process;immune system process,cell part;cytoplasm;extracellular space,,,,,,,,,,
Q99538,LGMN,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)",2,19.7,24.3,26.15,25.72,25.33,26.72,28.39,24.1,24.69,27.97,26.39,25.18,27,26.06,26,-1.7,0.15,-0.28,-0.67,0.72,2.39,-1.9,-1.31,1.97,0.39,-0.82,1,0.06,biological regulation;cellular process;immune system process;lipid metabolic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to chemical stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;vitamin metabolic process,apical part of cell;cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q6ZUX7,LHFPL2,Lipoma HMGIC fusion partner-like 2 protein,2,11.8,,,24.26,,27.31,27.36,27.02,,27.72,,26.02,26.86,27.94,26.81, , ,-2.55, ,0.5,0.55,0.21, ,0.91, ,-0.79,0.05,1.13,,cell part,,,,,,,,,,
Q9H008,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (hLHPP) (EC 3.1.3.-) (EC 3.6.1.1),6,31.9,29.63,27.29,26.66,25.55,24.81,,,24.3,,23.53,24.22,24.53,24.87,25.54,4.09,1.75,1.12,0.01,-0.73, , ,-1.24, ,-2.01,-1.32,-1.01,-0.67,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,+,,,,,,,
P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),13,20.2,27.9,,25.5,25.05,26.56,,,25.24,24.35,,,24.52,,25.59,2.31, ,-0.09,-0.53,0.97, , ,-0.35,-1.24, , ,-1.06, ,anatomical structure morphogenesis;biological regulation;biosynthetic process;cell cycle;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;developmental process;DNA ligation;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress;telomere organization,cell part;chromosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleoplasm;organelle,,,,,,,,,,
P49916,LIG3,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),13,14.2,28.64,27.42,26.08,28.44,28.51,28.31,28.58,28.12,28.88,27.88,27.72,26.4,28.58,27.97,0.68,-0.55,-1.89,0.47,0.55,0.34,0.61,0.16,0.92,-0.09,-0.25,-1.56,0.61,biological regulation;cell division;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA ligation;DNA metabolic process;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of DNA metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),57,69.6,30.66,31.64,31.89,32.79,32.62,32.57,32.59,32.49,32.16,32.46,32.79,32.46,33.15,32.33,-1.67,-0.69,-0.44,0.46,0.29,0.24,0.26,0.16,-0.17,0.13,0.46,0.13,0.82,biological regulation;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q9UPQ0,LIMCH1,LIM and calponin homology domains-containing protein 1,14,15.6,25.55,22.98,,26.47,,,24.35,21.75,21.03,23.78,25.67,,22.65,23.8,1.75,-0.82, ,2.67, , ,0.54,-2.05,-2.77,-0.03,1.87, ,-1.15,cellular component organization;cellular process;cytoskeleton organization;organelle organization,,,,,,,,,,,
P48059,LIMS1,LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48),8,24.5,29.28,28.62,27.55,29.28,30.13,29.34,30.51,30.18,29.25,27.8,30.03,28.63,29.29,29.22,0.06,-0.6,-1.67,0.06,0.91,0.12,1.29,0.96,0.03,-1.42,0.8,-0.59,0.06,aging;biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;developmental process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q9NUP9,LIN7C,Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3),12,59.9,28.63,28.84,29.09,28.63,28.35,30.64,28.57,29.63,28.89,31.16,28.84,27.44,29.76,29.11,-0.49,-0.27,-0.02,-0.48,-0.76,1.53,-0.54,0.51,-0.23,2.05,-0.28,-1.68,0.65,biological regulation;cellular process;establishment of localization;exocytosis;neurotransmitter transport;protein transport;secretion;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
P38571,LIPA,Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase),6,33.3,25.53,28.39,30.02,29.9,30.1,30.53,29.5,30.19,30.07,29.76,28.39,29.92,30.06,29.41,-3.89,-1.02,0.6,0.49,0.69,1.12,0.08,0.78,0.65,0.35,-1.02,0.51,0.65,anatomical structure development;anatomical structure morphogenesis;biological regulation;catabolic process;cell morphogenesis;cell proliferation;cellular component morphogenesis;cellular component organization;cellular process;cytokine production;developmental process;homeostatic process;lipid metabolic process;metabolic process;multicellular organismal process;primary metabolic process;response to stimulus;response to stress;tissue remodeling,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q6P1M3,LLGL2,Lethal(2) giant larvae protein homolog 2 (HGL),13,19.1,29.11,26.64,28.84,25.3,,,26.32,26.27,26.13,29.07,23.01,,,26.74,2.36,-0.11,2.09,-1.44, , ,-0.42,-0.47,-0.61,2.33,-3.73, , ,biological regulation;cell cycle;cell division;cellular process;establishment of localization;exocytosis;secretion;transport;vesicle-mediated transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9BRT6,LLPH,Protein LLP homolog (Protein LAPS18-like),2,21.7,26.18,,,26.76,25.5,25.92,26.64,25.64,27.01,27,,25.27,25.93,26.18,0, , ,0.57,-0.69,-0.27,0.46,-0.55,0.82,0.82, ,-0.91,-0.26,,,,,,,,,,,,
P49257,LMAN1,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),26,55.7,32.96,33.88,32.77,32.98,32.38,33.39,32.27,32.23,33.54,32.32,32.46,32.88,33.1,32.86,0.1,1.02,-0.09,0.12,-0.48,0.53,-0.59,-0.63,0.69,-0.54,-0.4,0.02,0.24,biological regulation;carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;coagulation;establishment of localization;Golgi organization;Golgi vesicle transport;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process;protein transport;regulation of body fluid levels;regulation of organelle organization;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9H0V9,LMAN2L,VIP36-like protein (Lectin mannose-binding 2-like) (LMAN2-like protein),6,20.7,27.44,25.41,27.31,26.65,26.74,27.89,27.34,26.76,26.83,27.3,28.29,29.31,28.85,27.39,0.04,-1.99,-0.08,-0.74,-0.65,0.49,-0.05,-0.63,-0.57,-0.09,0.9,1.92,1.45,cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;protein transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q9NZU5,LMCD1,LIM and cysteine-rich domains protein 1 (Dyxin),6,41.2,27.24,27.83,28.58,30.58,,,23.75,25.8,,,,28.92,,27.53,-0.29,0.3,1.05,3.05, , ,-3.78,-1.72, , , ,1.4, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96S06,LMF1,Lipase maturation factor 1 (Transmembrane protein 112),2,8.9,26.11,26.36,22.96,,22.71,25.89,26.31,26.7,25.64,26.21,26.35,25.88,25.12,25.52,0.59,0.84,-2.56, ,-2.81,0.37,0.79,1.18,0.11,0.69,0.83,0.36,-0.4,biological regulation;carbohydrate metabolic process;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;primary metabolic process;protein glycosylation;protein maturation;protein metabolic process;protein modification process;protein transport;secretion;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9BU23,LMF2,Lipase maturation factor 2 (Transmembrane protein 112B) (Transmembrane protein 153),5,11.6,22.91,27.67,24.07,28.11,25.64,28.54,27.42,28.04,29.27,28.75,28.52,27.94,27.15,27.23,-4.33,0.44,-3.16,0.88,-1.59,1.31,0.18,0.81,2.04,1.51,1.28,0.71,-0.09,,cell part;membrane,,,,,,,,,,
P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],117,92.2,30.16,28.2,29.43,29.88,30.74,29.84,30.96,30.4,30.34,29.72,30.17,,29.9,29.98,0.19,-1.78,-0.55,-0.09,0.76,-0.14,0.98,0.42,0.36,-0.26,0.2, ,-0.08,anatomical structure development;biological regulation;cell development;cellular component disassembly;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;establishment of localization;establishment or maintenance of cell polarity;localization;macromolecule metabolic process;membrane organization;metabolic process;nuclear transport;nucleocytoplasmic transport;organelle organization;primary metabolic process;protein metabolic process;protein targeting;protein transport;regulation of protein modification process;response to chemical stimulus;response to stimulus;response to stress;transport,cell part;cytosol;macromolecular complex;nuclear envelope;nucleoplasm;protein complex,,,,,,,,,,
P20700,LMNB1,Lamin-B1,71,79.7,34.36,33.83,33.91,33.07,33.66,33.69,32.88,32.92,33.95,33.86,31.05,30.98,32.04,33.09,1.27,0.74,0.82,-0.02,0.57,0.6,-0.21,-0.17,0.86,0.76,-2.05,-2.11,-1.05,cellular component disassembly;cellular component organization;cellular process,cell part;macromolecular complex;membrane;nuclear envelope;nucleoplasm;protein complex,,,,,,,,,,
Q03252,LMNB2,Lamin-B2,54,70.5,32.55,32.79,32.29,31.84,32.99,33.08,32.58,32.41,33.38,32.78,31.23,29.34,32.02,32.25,0.3,0.54,0.04,-0.41,0.73,0.83,0.33,0.15,1.12,0.53,-1.02,-2.91,-0.23,,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),36,36.9,28.56,26.6,29.52,27.45,27.15,27.5,27.12,27.79,27.44,28.7,26.58,25.36,26.8,27.43,1.13,-0.83,2.09,0.02,-0.28,0.08,-0.31,0.36,0.01,1.27,-0.85,-2.06,-0.63,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q9C0E8,LNP,Protein lunapark,13,51.8,29.86,29.57,29.36,28.79,28.24,29.76,28.38,28.6,30.16,29.33,30.08,28.66,29.4,29.24,0.61,0.32,0.11,-0.46,-1,0.52,-0.86,-0.65,0.92,0.09,0.83,-0.59,0.15,anatomical structure development;anatomical structure morphogenesis;biological regulation;coagulation;developmental process;multicellular organismal process;regulation of body fluid levels,cell part,,,,,,,,,,
Q9UIQ6,LNPEP,"Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form]",25,26,28.95,29.23,28.53,29.41,28.82,29.39,29.21,29.67,30.31,30,29.71,29.46,30.6,29.48,-0.54,-0.25,-0.95,-0.08,-0.67,-0.09,-0.28,0.19,0.83,0.52,0.23,-0.02,1.11,catabolic process;cell communication;cell-cell signaling;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;multi-organism process;primary metabolic process;protein catabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;signaling,cell part;cytosol;extracellular region;membrane,,,,,,,,,,
K7EJE8,LONP1,"Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)",44,61.6,32.27,33.24,31.94,31.77,32.13,32.95,32.33,31.75,32.69,32.79,32.06,32.61,32.69,32.4,-0.13,0.84,-0.46,-0.63,-0.27,0.55,-0.07,-0.65,0.29,0.39,-0.34,0.21,0.29,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of DNA metabolic process;regulation of organelle organization;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part,,,,,,,,,,
Q86WA8,LONP2,"Lon protease homolog 2, peroxisomal (EC 3.4.21.-) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease)",5,9.9,24.36,25.4,,25.42,23.44,,26.25,24.84,24.6,27.24,26.53,25.14,25.98,25.38,-1.02,0.02, ,0.04,-1.94, ,0.87,-0.54,-0.78,1.86,1.15,-0.24,0.6,biological regulation;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein targeting;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;transport,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y4K0,LOXL2,Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14),8,14,25.73,28.69,23.86,29.68,26.34,25.52,25.27,25.92,28.34,25.5,23.15,,25.3,26.11,-0.38,2.58,-2.25,3.58,0.23,-0.59,-0.83,-0.18,2.23,-0.6,-2.96, ,-0.81,aging;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;biosynthetic process;cell adhesion;cell morphogenesis;cell motility;cell proliferation;cellular component morphogenesis;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;extracellular matrix organization;extracellular structure organization;histone modification;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;chromosome;extracellular space;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q8NF37,LPCAT1,Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3),9,22.8,26.53,28.39,28.62,28.16,28.58,28.43,28.2,27.01,28.97,29.81,28.69,27.96,30.06,28.42,-1.89,-0.03,0.2,-0.25,0.16,0.01,-0.21,-1.4,0.56,1.39,0.27,-0.46,1.65,anatomical structure development;biological regulation;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;glycerol ether metabolic process;homeostatic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q7L5N7,LPCAT2,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1),11,21.5,26.98,29.04,26.55,28.27,27.81,27.59,27.66,27.53,29.15,27.55,29.07,27.28,29.36,27.99,-1.01,1.05,-1.44,0.28,-0.18,-0.39,-0.33,-0.46,1.16,-0.44,1.09,-0.71,1.37,alcohol metabolic process;amine metabolic process;biosynthetic process;cellular component organization;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;membrane organization;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q6P1A2,LPCAT3,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),4,12.3,29.39,27.78,28.08,27.02,26.79,25.47,27.05,27.19,27.96,27.84,28.24,28.94,27.6,27.64,1.75,0.13,0.44,-0.62,-0.85,-2.18,-0.59,-0.46,0.32,0.2,0.6,1.29,-0.05,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;membrane,,,,,,,,,,
Q643R3,LPCAT4,Lysophospholipid acyltransferase LPCAT4 (EC 2.3.1.25) (1-acylglycerol-3-phosphate O-acyltransferase 7) (1-AGP acyltransferase 7) (1-AGPAT 7) (Acyltransferase-like 3) (Lysophosphatidylcholine acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase 2) (Plasmalogen synthase),5,17.1,,24.69,,25.72,27.35,26.84,27.43,27.04,26.8,28.66,25.31,24.94,28.06,26.62, ,-1.93, ,-0.9,0.72,0.22,0.81,0.41,0.18,2.04,-1.31,-1.68,1.43,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q92604,LPGAT1,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-),4,10.3,22.8,25.96,27.04,25.93,25.18,27.4,26.6,25.09,27.4,26.84,,23.87,27.32,25.95,-3.15,0.01,1.09,-0.03,-0.78,1.45,0.65,-0.86,1.44,0.89, ,-2.08,1.37,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q14693,LPIN1,Phosphatidate phosphatase LPIN1 (EC 3.1.3.4) (Lipin-1),8,10.8,,25.05,26.14,25.71,23.5,,26.55,26.32,23.39,24.91,27.32,26.38,,25.53, ,-0.48,0.61,0.18,-2.03, ,1.03,0.79,-2.14,-0.62,1.79,0.86, ,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process,cell part;cytosol;membrane,,,,,,,,,,
Q93052,LPP,Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma),10,36.5,29.83,29.23,27.74,29.01,27.25,,28.9,28.5,27.28,28.46,27.97,30.43,,28.6,1.23,0.63,-0.86,0.41,-1.35, ,0.3,-0.1,-1.32,-0.15,-0.63,1.83, ,biological adhesion;cell adhesion;cellular process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P50851,LRBA,Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein),22,12.9,29.35,26.93,25.98,24.29,27.34,25.55,28.65,28.61,26.5,28.56,28.72,27.2,24.3,27.07,2.28,-0.15,-1.1,-2.78,0.26,-1.53,1.57,1.53,-0.58,1.49,1.65,0.12,-2.78,,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole;vesicle,,,,,,,,,,
Q9Y2L9,LRCH1,Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81),7,16.2,25.93,26.62,25.13,25.32,22.36,25.7,24.05,23.57,24.56,26.24,23.61,24.74,24.09,24.76,1.16,1.86,0.36,0.56,-2.4,0.94,-0.71,-1.2,-0.2,1.48,-1.15,-0.03,-0.67,,,,,,,,,,,,
O75427,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein),7,18.3,26.27,24.28,26.45,25.35,26.65,22.56,26.57,25.67,22.81,26.62,25.86,26.73,,25.49,0.78,-1.2,0.97,-0.13,1.16,-2.93,1.09,0.19,-2.67,1.14,0.38,1.24, ,anatomical structure development;developmental process,cell part,,,,,,,,,,
Q07954,LRP1,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85);Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515);Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],74,19.3,31.63,33.23,31.4,32.86,28.01,32.03,30.17,30.19,32.19,28.14,31.11,30.93,31.76,31.05,0.58,2.18,0.35,1.81,-3.04,0.98,-0.88,-0.86,1.14,-2.91,0.06,-0.12,0.71,alcohol metabolic process;anatomical structure morphogenesis;biological regulation;cellular component organization;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular process;detection of stimulus;developmental process;endocytosis;establishment of localization;lipid metabolic process;membrane invagination;membrane organization;metabolic process;primary metabolic process;regulation of organelle organization;regulation of transport;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;small molecule metabolic process;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q7Z4F1,LRP10,Low-density lipoprotein receptor-related protein 10 (LRP-10),2,12.6,,,,26.53,26.45,27.23,25.18,,26.17,25.5,25.26,25.58,26.75,26.07, , , ,0.46,0.38,1.16,-0.9, ,0.1,-0.57,-0.81,-0.5,0.68,anatomical structure development;developmental process;establishment of localization;lipid metabolic process;lipid transport;metabolic process;primary metabolic process;transport,cell part,,,,,,,,,,
P30533,LRPAP1,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),24,48.5,31.42,31.84,31.73,31.37,30.68,30.57,30.27,29.95,30.51,30.63,30.82,28.72,30.41,30.69,0.73,1.15,1.04,0.68,0,-0.11,-0.41,-0.73,-0.18,-0.06,0.14,-1.97,-0.28,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cell surface;endoplasmic reticulum;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
P42704,LRPPRC,"Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (GP130)",106,70.5,34.61,34.19,33.99,34.01,34.1,34.83,34.64,33.95,34.66,35.15,33.55,33.93,34.93,34.35,0.26,-0.16,-0.37,-0.34,-0.25,0.48,0.29,-0.4,0.31,0.8,-0.81,-0.42,0.58,biological regulation;biosynthetic process;cellular component movement;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;primary metabolic process;RNA metabolic process;transport,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nuclear chromosome;nucleoplasm;organelle;protein complex,Other TF domain,,,,,,,,,
Q9BTT6,LRRC1,Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein),3,8.8,27.01,26.12,,24.88,25.06,,25.95,25.67,27.69,26.21,25.8,25.3,26.53,26.02,0.99,0.1, ,-1.14,-0.96, ,-0.07,-0.35,1.67,0.19,-0.22,-0.72,0.51,,cell part;cytoplasm;membrane,,,,,,,,,,
Q15048,LRRC14,Leucine-rich repeat-containing protein 14,3,8.6,22.91,23.1,22.33,23.42,22.74,23.22,24.32,23.97,23.72,21.65,25.23,23.32,,23.33,-0.42,-0.23,-1,0.09,-0.58,-0.1,0.99,0.64,0.4,-1.68,1.9,-0.01, ,,,,,,,,,,,,
Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),29,26.9,30.12,26.58,27.92,27.27,24.76,25.02,27.68,23.53,26.64,28.04,27.41,29.25,26.33,26.96,3.15,-0.39,0.96,0.31,-2.21,-1.94,0.72,-3.44,-0.33,1.08,0.45,2.28,-0.64,biological regulation;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;cytoskeleton organization;heterocycle metabolic process;locomotion;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organelle organization;organic acid metabolic process;regulation of body fluid levels;small molecule metabolic process,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H9A6,LRRC40,Leucine-rich repeat-containing protein 40,9,14.6,27.63,27.82,26.26,28.57,27.21,26.25,28.57,28.75,27.32,25.69,26.07,30.3,26.3,27.44,0.19,0.38,-1.18,1.13,-0.23,-1.19,1.13,1.3,-0.12,-1.75,-1.37,2.86,-1.14,,,,,,,,,,,,
Q8N1G4,LRRC47,Leucine-rich repeat-containing protein 47,24,45.8,31.2,30.97,29.97,31.09,29.88,29.28,30.24,30.5,29.06,29.58,30.37,29.93,29.64,30.13,1.06,0.84,-0.16,0.96,-0.25,-0.86,0.11,0.37,-1.08,-0.55,0.24,-0.2,-0.49,,,,,,,,,,,,
Q8N9N7,LRRC57,Leucine-rich repeat-containing protein 57,3,20.9,24.9,24.27,25.76,24.86,25.35,25.19,,26.12,,24.29,,,,25.09,-0.19,-0.82,0.67,-0.23,0.26,0.1, ,1.03, ,-0.8, , , ,,,,,,,,,,,,
Q96AG4,LRRC59,Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34) (p34),24,53.4,32.78,32.91,33.3,33.34,33.69,33.74,33.71,33.37,34.39,34.45,33.19,33.82,34.22,33.61,-0.83,-0.69,-0.31,-0.26,0.08,0.13,0.1,-0.24,0.78,0.84,-0.42,0.21,0.61,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nuclear envelope;organelle,,,,,,,,,,
Q8IWT6,LRRC8A,Leucine-rich repeat-containing protein 8A,15,18.5,24.84,26.25,26.94,27,29.05,29.2,29.5,28.89,29.36,27.56,28.57,26.68,30.17,28,-3.16,-1.75,-1.06,-1,1.05,1.2,1.5,0.89,1.36,-0.44,0.57,-1.32,2.16,cell activation;cell differentiation;cellular process;developmental process;immune system process,cell part,,,,,,,,,,
Q6NSJ5,LRRC8E,Leucine-rich repeat-containing protein 8E,4,7.5,26.46,25.33,27.06,25.15,24.44,,27.28,,26.52,25.46,25.19,,25.61,25.85,0.61,-0.52,1.21,-0.7,-1.41, ,1.43, ,0.67,-0.39,-0.66, ,-0.24,,cell part,,,,,,,,,,
Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),40,54.8,29.72,30.07,31.28,29.51,29.61,28.78,31.26,31.54,28.06,30.4,31.42,31.36,30.08,30.24,-0.52,-0.17,1.05,-0.73,-0.63,-1.46,1.02,1.3,-2.18,0.16,1.19,1.12,-0.16,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,DNA binding region,,,,,,,,,
Q9Y608,LRRFIP2,Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2),11,16.9,26.6,26.83,24.89,27.65,27.3,24.86,27.77,27.2,23.56,25.73,27.23,28.32,22.4,26.18,0.42,0.65,-1.29,1.47,1.12,-1.32,1.59,1.02,-2.62,-0.45,1.05,2.14,-3.78,biological regulation;cellular process;response to stimulus;signal transduction,,,,,,,,,,,
Q9UFC0,LRWD1,Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein),8,15.3,27.75,26.35,25.9,26.61,26.48,26.8,26.39,,26.35,24.85,23.91,,26.38,26.16,1.59,0.19,-0.26,0.45,0.32,0.64,0.23, ,0.19,-1.31,-2.25, ,0.22,cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;macromolecular complex;origin recognition complex;protein complex,,,,,,,,,,
Q9H089,LSG1,Large subunit GTPase 1 homolog (hLsg1) (EC 3.6.1.-),15,20.7,29.57,28.21,28.71,28.19,28.17,28.52,27.36,26.73,28.65,27.73,27.56,27.15,27.46,28,1.57,0.21,0.71,0.19,0.17,0.52,-0.64,-1.27,0.65,-0.27,-0.44,-0.85,-0.54,cellular process;establishment of localization;nuclear transport;nucleocytoplasmic transport;protein transport;ribosome biogenesis;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O15116,LSM1,U6 snRNA-associated Sm-like protein LSm1 (Cancer-associated Sm-like) (Small nuclear ribonuclear CaSm),4,48.9,27.57,27.55,27.63,28.6,28.26,26.95,28.36,28.01,26.21,25.94,27.26,28.35,26.69,27.49,0.08,0.06,0.14,1.11,0.76,-0.54,0.87,0.52,-1.28,-1.55,-0.23,0.86,-0.8,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q3MHD2,LSM12,Protein LSM12 homolog,4,19,23.18,22.84,22.86,25.2,24.08,24.01,24.08,24.96,25.27,22.15,,,,23.86,-0.68,-1.02,-1,1.34,0.22,0.15,0.22,1.1,1.41,-1.71, , , ,,,,,,,,,,,,
Q8ND56,LSM14A,Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A),9,25.3,27.09,27.05,27.44,26.94,23.33,24.43,27.24,24.29,26.16,27.52,27.3,28.71,25.23,26.36,0.73,0.69,1.08,0.58,-3.04,-1.93,0.88,-2.07,-0.21,1.16,0.93,2.34,-1.13,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;developmental process;macromolecular complex assembly;multicellular organismal development;multicellular organismal process;regulation of translation;ribonucleoprotein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex,,,,,,,,,,
Q9Y333,LSM2,U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (Small nuclear ribonuclear protein D homolog) (snRNP core Sm-like protein Sm-x5),8,82.1,30.93,30.04,29.52,29.93,30.74,30.06,30.63,30.13,30.97,30.19,29.02,29.9,30.07,30.16,0.77,-0.13,-0.65,-0.23,0.57,-0.1,0.47,-0.03,0.81,0.02,-1.14,-0.26,-0.09,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62310,LSM3,U6 snRNA-associated Sm-like protein LSm3,4,41.2,29.31,29.24,25.55,28.14,29.33,28.03,28.03,29.11,29.07,27.53,28.36,27.86,27.06,28.2,1.1,1.04,-2.65,-0.06,1.13,-0.17,-0.17,0.91,0.87,-0.67,0.16,-0.34,-1.14,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9Y4Z0,LSM4,U6 snRNA-associated Sm-like protein LSm4 (Glycine-rich protein) (GRP),6,35.3,30,29.4,29.07,28.72,27.62,27.52,28.82,26.46,29.3,28.19,26.1,27.1,27.19,28.11,1.89,1.29,0.95,0.61,-0.5,-0.59,0.7,-1.65,1.19,0.07,-2.01,-1.02,-0.93,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9Y4Y9,LSM5,U6 snRNA-associated Sm-like protein LSm5,3,57.1,27.83,27.03,27.9,26.69,27.73,28.2,,26.43,27.63,,27.31,26.93,,27.37,0.47,-0.34,0.53,-0.67,0.36,0.83, ,-0.94,0.27, ,-0.06,-0.44, ,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62312,LSM6,U6 snRNA-associated Sm-like protein LSm6,5,55,29.33,29.42,28.75,28.14,28.53,28.5,28.07,27.68,28.76,29.31,26.63,,27.78,28.41,0.92,1.01,0.34,-0.27,0.12,0.09,-0.34,-0.73,0.36,0.9,-1.78, ,-0.63,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;rRNA processing;tRNA metabolic process;tRNA processing,cell part;cytosol;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P09960,LTA4H,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase),34,63.3,33.01,33.33,33.19,31.64,30.43,29.94,31.61,31.6,30.18,30.42,31.4,32.07,29.49,31.41,1.6,1.92,1.78,0.23,-0.98,-1.47,0.2,0.19,-1.23,-0.99,-0.01,0.66,-1.92,biosynthetic process;catabolic process;cellular alkene metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O94822,LTN1,E3 ubiquitin-protein ligase listerin (EC 6.3.2.-) (RING finger protein 160) (Zinc finger protein 294),4,8.6,25.68,24.75,,25.69,,,27.38,,,24.53,25.28,25.5,,25.54,0.14,-0.8, ,0.14, , ,1.84, , ,-1.02,-0.26,-0.04, ,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,,,,,,,,,,,
Q9NQ29,LUC7L,Putative RNA-binding protein Luc7-like 1 (Putative SR protein LUC7B1) (SR+89),4,12.9,27.74,27.37,26.89,27.75,28.7,27.89,27.67,27.81,27.58,27.44,27.76,27.98,27.57,27.7,0.04,-0.34,-0.81,0.05,0.99,0.19,-0.04,0.1,-0.13,-0.26,0.06,0.28,-0.13,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y383,LUC7L2,Putative RNA-binding protein Luc7-like 2,15,32.1,29.86,29.04,29.42,29.09,28.18,28.72,28.43,28.45,29.03,28.69,26.5,26.23,26.42,28.31,1.54,0.72,1.11,0.77,-0.13,0.41,0.12,0.14,0.72,0.37,-1.81,-2.08,-1.89,,cell part,,,,,,,,,,
O95232,LUC7L3,Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1),17,38.9,30.54,28.69,28.11,29.11,29.13,29.89,29.37,29.41,29.47,28.92,28.43,28.75,29.14,29.15,1.39,-0.46,-1.04,-0.04,-0.02,0.74,0.22,0.26,0.32,-0.23,-0.72,-0.4,-0.01,cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P51884,LUM,Lumican (Keratan sulfate proteoglycan lumican) (KSPG lumican),7,26,22.49,29.76,26.67,29.8,,,,,24.11,,27.08,,26.58,26.64,-4.15,3.12,0.03,3.15, , , , ,-2.53, ,0.44, ,-0.06,amine metabolic process;anatomical structure development;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular component organization;cellular metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;sulfur compound metabolic process,cell part;extracellular space,,,,,,,,,,
Q86V48,LUZP1,Leucine zipper protein 1,28,31.5,28.05,28.74,29.26,29.92,29.87,29.32,29.74,29.13,31.34,29.7,30.35,28.78,29.93,29.55,-1.5,-0.81,-0.29,0.37,0.32,-0.23,0.19,-0.42,1.79,0.15,0.8,-0.77,0.38,anatomical structure development;anatomical structure morphogenesis;developmental process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BS40,LXN,Latexin (Endogenous carboxypeptidase inhibitor) (ECI) (Protein MUM) (Tissue carboxypeptidase inhibitor) (TCI),6,39.2,28.16,30.87,30.42,28.85,27.76,28.14,27.8,28.65,25.63,24.49,28.23,30.02,26.29,28.1,0.06,2.77,2.31,0.75,-0.34,0.04,-0.3,0.55,-2.47,-3.61,0.13,1.92,-1.81,detection of stimulus;response to abiotic stimulus;response to external stimulus;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
Q9NX58,LYAR,Cell growth-regulating nucleolar protein,2,11.1,,,25.35,,,25.69,26.72,,27.96,27.53,24.98,24.51,21.18,25.49, , ,-0.14, , ,0.2,1.23, ,2.47,2.04,-0.51,-0.98,-4.31,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P07948,LYN,Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn),12,28.1,28.03,29.24,26.36,27.13,,24.4,,,25.82,26.6,,25.59,25.5,26.52,1.51,2.72,-0.16,0.61, ,-2.12, , ,-0.7,0.08, ,-0.93,-1.02,amine transport;anatomical structure development;biological regulation;cell activation;cell communication;cell development;cell differentiation;cell motility;cellular component disassembly;cellular component movement;cellular component organization;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;homeostatic process;hormone transport;immune system process;interspecies interaction between organisms;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein transport;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to heat;response to stimulus;response to stress;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;receptor complex,,+,,,,,,,,
O75608,LYPLA1,Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I),5,46,29.84,29.74,29.35,30.27,28.98,29.41,29.24,29.09,28.86,29.14,29.55,30.08,28.96,29.42,0.41,0.32,-0.08,0.84,-0.44,-0.02,-0.18,-0.33,-0.57,-0.28,0.13,0.66,-0.46,biological regulation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q5VWZ2,LYPLAL1,Lysophospholipase-like protein 1 (EC 3.1.2.-),3,14.9,,25.41,31.04,25.56,,26.48,24.95,27.66,27.26,,25.46,25.45,26.78,26.6, ,-1.19,4.44,-1.05, ,-0.13,-1.66,1.05,0.66, ,-1.15,-1.15,0.17,,cell part;cytoplasm,,,,,,,,,,
Q9HD34,LYRM4,LYR motif-containing protein 4,4,37.4,28.42,26.96,27.7,26.21,26.91,28.25,28.07,27.05,28.05,28.27,26.5,26.89,28.35,27.51,0.91,-0.55,0.19,-1.3,-0.6,0.74,0.56,-0.46,0.54,0.76,-1.01,-0.62,0.84,metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8WZA0,LZIC,Protein LZIC (Leucine zipper and CTNNBIP1 domain-containing protein) (Leucine zipper and ICAT homologous domain-containing protein),3,18.4,24.49,22.38,24.48,22.6,21.61,,,22.44,22.41,,22.57,25.95,21.33,23.03,1.47,-0.65,1.45,-0.42,-1.41, , ,-0.59,-0.62, ,-0.45,2.92,-1.7,anatomical structure development;developmental process;response to abiotic stimulus;response to stimulus,,,,,,,,,,,
Q9NQ48,LZTFL1,Leucine zipper transcription factor-like protein 1,7,27.8,27.79,28.1,26.97,27.67,,,26.63,26.82,,27.72,26.51,27.45,28.15,27.38,0.41,0.72,-0.41,0.29, , ,-0.75,-0.56, ,0.34,-0.87,0.07,0.77,,,,,,,,,,,,
P20645,M6PR,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),9,38.7,29.83,30.43,29.21,29.87,29.49,29.61,29.97,29.52,29.49,29.68,29.2,25.35,28.82,29.27,0.57,1.17,-0.05,0.6,0.22,0.34,0.71,0.25,0.22,0.42,-0.07,-3.92,-0.45,cellular component organization;cellular membrane organization;cellular process;endocytosis;endosome transport;establishment of localization;membrane invagination;membrane organization;transport;vacuolar transport;vesicle-mediated transport,cell part;cell surface;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9UPN3,MACF1,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",186,29.1,32.26,32.7,31.72,32.44,33.29,33.24,33.54,32.91,32.97,33.2,33.77,33.21,33.77,33,-0.74,-0.3,-1.28,-0.56,0.29,0.24,0.54,-0.09,-0.03,0.2,0.77,0.21,0.77,anatomical structure formation involved in morphogenesis;biological regulation;cellular component movement;cellular process;developmental process;establishment of localization;establishment or maintenance of cell polarity;Golgi vesicle transport;protein targeting;protein transport;regulation of cell cycle;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;cytoskeleton;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9BQ69,MACROD1,O-acetyl-ADP-ribose deacetylase MACROD1 (EC 3.2.2.-) (EC 3.5.1.-) (MACRO domain-containing protein 1) (Protein LRP16) ([Protein ADP-ribosylglutamate] hydrolase),4,16.9,28.44,27.31,27.04,25.54,,28.32,24.95,25.4,25.67,26.31,27.61,,27.05,26.69,1.75,0.62,0.34,-1.16, ,1.63,-1.74,-1.29,-1.03,-0.38,0.92, ,0.35,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9Y6D9,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181),8,14.3,27.96,27.34,26.24,27.7,27.17,27.01,27.38,26.41,27.86,28.11,,,27.33,27.32,0.64,0.02,-1.08,0.38,-0.15,-0.3,0.06,-0.91,0.54,0.79, , ,0.01,biological regulation;cell cycle;cell division;cellular process;mitotic cell cycle;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization,cell part;centrosome;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;microtubule organizing center;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
Q9ULX9,MAFF,Transcription factor MafF (U-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog F),3,26.2,27.91,26.19,24.34,26.58,25.95,24.76,26.92,26.69,26.84,26.37,25.92,,26,26.21,1.71,-0.02,-1.87,0.38,-0.26,-1.44,0.72,0.49,0.63,0.16,-0.29, ,-0.21,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;developmental process;embryo development;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of body fluid levels;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;nucleoplasm,bZIP,,,,,,,,,
O60675,MAFK,Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit),3,27.1,25.81,26.4,,25.62,28.09,27.36,28.38,27.83,,26.26,27.21,25.93,28.07,27,-1.19,-0.6, ,-1.38,1.09,0.37,1.38,0.83, ,-0.74,0.22,-1.07,1.08,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of body fluid levels;RNA metabolic process,cell part;nucleoplasm,bZIP,,,,,,,,,
Q9Y5V3,MAGED1,Melanoma-associated antigen D1 (MAGE tumor antigen CCF) (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog),5,13,23.85,24.39,,27.36,26.46,26.43,25.9,26.23,25.76,,25.13,28.14,25.66,25.94,-2.09,-1.54, ,1.42,0.52,0.49,-0.04,0.29,-0.18, ,-0.81,2.2,-0.27,biological regulation;cellular process;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytoplasm;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9UNF1,MAGED2,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),14,35.5,27.36,27.1,25.82,28.67,27.85,27.45,28.21,29.06,27.94,25.95,28.21,28.23,26.5,27.57,-0.2,-0.46,-1.75,1.1,0.28,-0.11,0.64,1.5,0.37,-1.62,0.64,0.67,-1.06,,,,,,,,,,,,
Q5TCQ9,MAGI3,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3)",5,6.4,26.03,26.56,,23.03,,20.24,24.46,,23.01,23.73,23.88,24.72,22.5,23.82,2.21,2.74, ,-0.78, ,-3.58,0.64, ,-0.8,-0.09,0.06,0.91,-1.31,biological regulation;cell death;cellular process;death;interspecies interaction between organisms;multi-organism process;regulation of protein modification process;response to stimulus;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P61326,MAGOH,Protein mago nashi homolog,18,73.3,31.17,30.85,30.74,30.53,31.74,31.19,30.89,30.68,30.9,30.61,29.7,29.55,30.29,30.68,0.49,0.17,0.06,-0.14,1.06,0.51,0.21,0,0.22,-0.07,-0.98,-1.12,-0.39,"biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9H0U3,MAGT1,Magnesium transporter protein 1 (MagT1) (Implantation-associated protein) (IAP),8,23.3,30.32,30.46,28.95,29.78,29.73,29.78,28.65,29.57,29.89,30.55,27.48,26.1,29.55,29.29,1.03,1.17,-0.34,0.49,0.44,0.49,-0.64,0.27,0.6,1.26,-1.82,-3.2,0.26,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9BXY0,MAK16,Protein MAK16 homolog (NNP78) (Protein RBM13),12,49.3,28.9,28.61,30.54,28.43,29.18,28.98,28,27.02,28.53,28.63,27.82,28.08,28.56,28.56,0.34,0.05,1.98,-0.14,0.62,0.42,-0.56,-1.54,-0.03,0.07,-0.74,-0.48,0,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q969L2,MAL2,Protein MAL2,2,18.2,28.99,28.23,24.91,26.8,28.41,28.11,28.07,28.44,29.01,28.93,28.88,23.65,28.4,27.76,1.23,0.47,-2.85,-0.96,0.66,0.35,0.31,0.69,1.25,1.17,1.13,-4.11,0.65,,cell part;endomembrane system,,,,,,,,,,
Q9UDY8,MALT1,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),4,8,24.91,25.81,25.52,26.63,,23.62,27.98,25.57,,26.95,26.73,27.11,,26.08,-1.18,-0.28,-0.57,0.55, ,-2.47,1.9,-0.51, ,0.87,0.65,1.03, ,biological regulation;cell activation;cell differentiation;cell proliferation;cellular component assembly;cellular component organization;cellular process;developmental process;establishment of localization;immune system process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multi-organism process;nuclear transport;nucleocytoplasmic transport;primary metabolic process;protein complex assembly;protein metabolic process;proteolysis;regulation of protein modification process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
O60476,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",4,8.3,25.33,25.95,,26.77,24.79,26.56,25.6,24.39,26.9,25.27,,,27.06,25.86,-0.54,0.09, ,0.91,-1.08,0.7,-0.26,-1.47,1.04,-0.59, , ,1.2,anatomical structure development;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q9UKM7,MAN1B1,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)",7,14.7,25.57,27.19,23.94,27.35,23.5,31.25,26.74,24.22,24.43,26.03,27.69,26.53,27.2,26.28,-0.71,0.91,-2.34,1.07,-2.78,4.97,0.46,-2.06,-1.85,-0.25,1.41,0.25,0.92,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;membrane,,,,,,,,,,
Q16706,MAN2A1,"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",21,24.3,27.17,28.59,27.73,30.1,29.3,29.28,29.78,29.43,29.99,30.79,29.48,29.4,30.58,29.36,-2.19,-0.76,-1.62,0.75,-0.06,-0.07,0.42,0.08,0.63,1.44,0.12,0.05,1.22,alcohol metabolic process;anatomical structure development;carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;mitochondrion organization;multicellular organismal process;oligosaccharide metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process;vacuole organization,cell part;membrane,,,,,,,,,,
E9PCD7,MAN2B2,Epididymis-specific alpha-mannosidase,8,9.9,27.68,27.91,27.49,27.57,26.41,27.29,25.99,27.64,27.98,26.58,28.55,26.95,27.69,27.36,0.31,0.55,0.13,0.21,-0.96,-0.07,-1.38,0.27,0.62,-0.79,1.19,-0.41,0.33,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
O00462,MANBA,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),5,7.1,27.24,27.12,26.67,24.48,24.25,25.64,,24.14,25.7,26.89,,24.88,24.48,25.59,1.65,1.54,1.08,-1.11,-1.34,0.05, ,-1.45,0.11,1.3, ,-0.71,-1.11,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
P55145,MANF,Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET),16,56.6,30.51,31.92,31.19,31.95,32.59,32.8,32.29,32.04,32.87,32.24,31.69,29.31,33.22,31.89,-1.39,0.03,-0.7,0.05,0.7,0.91,0.4,0.14,0.98,0.34,-0.21,-2.58,1.32,biological regulation;circulatory system process;multicellular organismal process;response to chemical stimulus;response to stimulus;response to stress,cell part;extracellular space,,,,,,,,,,
P21397,MAOA,Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A),15,35.3,25.67,30.7,29.47,32.87,30.76,32.16,31.01,30.77,29.47,,31.5,27.44,31.8,30.3,-4.63,0.39,-0.83,2.57,0.46,1.85,0.71,0.47,-0.83, ,1.2,-2.86,1.5,alcohol metabolic process;amine metabolic process;behavior;biological regulation;biosynthetic process;catabolic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;metabolic process;neurotransmitter metabolic process;neurotransmitter transport;nitrogen compound metabolic process;response to stimulus;secretion;small molecule metabolic process;transport;xenobiotic metabolic process,cell part;membrane,,,,,,,,,,
P27338,MAOB,Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),20,37.9,24.85,29.93,31.71,30.14,30.39,29.53,29.69,29.41,26.33,26.62,29.78,23.54,30.87,28.68,-3.83,1.26,3.03,1.46,1.71,0.85,1.02,0.73,-2.35,-2.05,1.11,-5.13,2.2,biological regulation;cellular metabolic process;cellular process;metabolic process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process;xenobiotic metabolic process,cell part;membrane,,,,,,,,,,
P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],18,11.2,24.66,27.76,24.47,27.01,27.71,,27.95,29.79,23.12,22.59,28.32,26.37,29.7,26.62,-1.96,1.14,-2.15,0.39,1.09, ,1.33,3.17,-3.5,-4.03,1.69,-0.25,3.08,cellular component organization;cellular process;cytoskeleton organization;multicellular organismal process;neurological system process;organelle organization,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],120,53.8,27.92,28.93,26.09,31.46,31.9,31,32.19,32.2,31.02,30.07,33.06,32.79,32.26,30.84,-2.92,-1.91,-4.75,0.62,1.06,0.16,1.35,1.37,0.18,-0.77,2.22,1.95,1.43,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;establishment or maintenance of cell polarity;organelle organization;regulation of transport;transport,cell part;cell projection;cytosol;macromolecular complex;membrane;neuron projection;plasma membrane;protein complex;synapse,,,,,,,,,,
H3BTL1,MAP1LC3B,"Microtubule-associated protein 1 light chain 3 beta, isoform CRA_f (Microtubule-associated proteins 1A/1B light chain 3B)",4,49.3,26.5,26.53,28.02,28.8,29.25,28.39,29.9,29.7,28.89,28,30.18,29.94,29.84,28.77,-2.26,-2.23,-0.74,0.04,0.48,-0.38,1.13,0.94,0.13,-0.76,1.42,1.17,1.07,,,,,,,,,,,,
Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],25,33.1,30.55,30.7,29.27,28.17,28.67,27.33,28.62,29.27,27.65,26.28,29.29,27.73,28.35,28.61,1.94,2.1,0.67,-0.43,0.07,-1.28,0.01,0.67,-0.96,-2.33,0.69,-0.88,-0.26,anatomical structure development;anatomical structure morphogenesis;catabolic process;cellular component morphogenesis;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;DNA metabolic process;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;transport,cell body;cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;neuronal cell body;nucleus;organelle;protein complex;synapse,,,,,,,,,,
P11137,MAP2,Microtubule-associated protein 2 (MAP-2),23,14.8,23.63,,26.32,28.85,,,27.1,27.77,,,29.15,26.29,27.96,27.13,-3.51, ,-0.81,1.72, , ,-0.03,0.64, , ,2.02,-0.84,0.82,anatomical structure development;anatomical structure morphogenesis;cell development;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;response to chemical stimulus;response to stimulus,cell body;cell part;cytoplasm;macromolecular complex;neuronal cell body;protein complex,,,,,,,,,,
Q02750,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1),6,15.1,28.66,29.67,29.37,29.28,27.45,29.05,29.59,29.68,27.82,27.98,30.16,29.12,26.71,28.81,-0.15,0.85,0.56,0.47,-1.36,0.24,0.78,0.87,-0.99,-0.83,1.35,0.31,-2.1,aging;anatomical structure development;biological regulation;cell differentiation;cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular localization;cellular metabolic process;cellular process;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;Golgi organization;immune system process;localization;locomotion;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nuclear division;organelle fission;organelle inheritance;organelle localization;organelle organization;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;transport,cell cortex;cell part;cytosol;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;mitochondrion;nucleus;organelle;plasma membrane,,+,,,,,,,,
P36507,MAP2K2,Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2),11,37,29.86,30.65,30.14,30.54,29.84,29.49,30.16,30.33,28.99,28.89,30.56,28.31,28.8,29.74,0.12,0.91,0.4,0.81,0.1,-0.25,0.43,0.59,-0.75,-0.84,0.83,-1.42,-0.93,biological regulation;cellular metabolic process;cellular process;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell cortex;cell part;cytosol;endoplasmic reticulum;endosome;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microbody;mitochondrion;nucleus;organelle;protein complex,,+,,,,,,,,
P46734,MAP2K3,Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2),3,16.4,27.54,26.16,27.24,25.97,26.09,25.4,26.36,26.91,25.87,25.55,25.47,25.91,24.65,26.09,1.45,0.07,1.16,-0.12,0.01,-0.69,0.27,0.83,-0.22,-0.53,-0.62,-0.17,-1.43,biological regulation;cellular process;immune system process;multicellular organismal process;muscle contraction;response to stimulus;response to stress;signal transduction,cell part;cytosol;nucleoplasm,,+,,,,,,,,
O43318,MAP3K7,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1),7,13.3,23.92,23.32,23.15,24.45,,25.1,,,,22.93,24.39,25.33,23.63,24.02,-0.1,-0.71,-0.87,0.43, ,1.08, , , ,-1.09,0.36,1.3,-0.39,anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cell death;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;death;developmental process;histone modification;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein acylation;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,+,,,,,,,,
P27816,MAP4,Microtubule-associated protein 4 (MAP-4),63,26.7,31.95,31.8,32.46,32.72,32.41,31.86,32.24,32.63,31.74,31.46,32.43,32.81,32.07,32.2,-0.25,-0.4,0.26,0.52,0.21,-0.34,0.04,0.43,-0.46,-0.74,0.23,0.61,-0.12,cell division;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;organelle organization,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
E7EN19,MAP4K4,Mitogen-activated protein kinase kinase kinase kinase 4,25,23.6,28.39,29.01,29.02,30.17,30.43,29.96,31.1,30.73,30.12,29.17,30.88,30.45,30.28,29.98,-1.59,-0.96,-0.96,0.19,0.45,-0.02,1.12,0.75,0.14,-0.8,0.9,0.47,0.3,,,,,,,,,,,,
Q9Y4K4,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5),8,10.3,25.59,26.43,25.77,27.12,26.21,25.43,27.23,27.43,25.56,26.73,26.68,26.74,22.94,26.14,-0.55,0.29,-0.38,0.98,0.06,-0.71,1.08,1.29,-0.58,0.59,0.53,0.59,-3.2,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process,cell part;cytoplasm;membrane;plasma membrane,,+,,,,,,,,
Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),21,28,26.68,26.98,27.65,28.79,28.06,26.97,28.89,29.21,27.15,27.24,28.16,28.57,26.89,27.79,-1.11,-0.8,-0.14,1,0.27,-0.81,1.1,1.42,-0.64,-0.55,0.37,0.78,-0.9,,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P28482,MAPK1,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),20,53.3,29.93,30.27,30.92,30.52,28.67,27.95,31.1,30.98,28.28,28.44,30.72,29.86,25.83,29.5,0.44,0.78,1.42,1.02,-0.83,-1.55,1.6,1.48,-1.22,-1.06,1.22,0.37,-3.66,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell activation;cell communication;cell cycle;cell death;cell proliferation;cell-cell signaling;cellular aromatic compound metabolic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;endocytosis;establishment of localization;heterocycle metabolic process;immune system process;interspecies interaction between organisms;locomotion;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;multi-organism process;neurological system process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleocytoplasmic transport;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein targeting;protein transport;regulation of organelle organization;regulation of protein modification process;regulation of translation;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;signaling;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cell projection;cytoskeleton;cytosol;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;mitochondrion;nucleoplasm;organelle;pseudopodium,Other TF domain,+,,,,,,,,
Q16539,MAPK14,Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a),10,28.3,26.27,27.07,26.78,27.97,26.16,,26.66,25.45,24.72,,26.52,28.24,23.78,26.33,-0.06,0.74,0.45,1.64,-0.17, ,0.33,-0.88,-1.61, ,0.19,1.91,-2.55,aging;alcohol metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;carbohydrate metabolic process;cell activation;cell death;cell differentiation;cell morphogenesis;cellular component morphogenesis;cellular component movement;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;lipid metabolic process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleoplasm;organelle,,+,,,,,,,,
P27361,MAPK3,Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1),8,30.6,27.85,27.49,28.54,25.33,25.24,,26.36,25.94,,,,26.31,,26.63,1.21,0.85,1.9,-1.3,-1.39, ,-0.27,-0.69, , , ,-0.32, ,"anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell activation;cell cycle;cell death;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;endocytosis;establishment of localization;immune system process;interspecies interaction between organisms;locomotion;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;multi-organism process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent;transport;vesicle-mediated transport",cell part;cell projection;cytoskeleton;cytosol;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleoplasm;organelle;pseudopodium,,+,,,,,,,,
P49137,MAPKAPK2,MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1),6,18,25.89,27.41,27.16,27.56,25.89,24.45,26.46,26.31,,25.12,27.28,,24.62,26.2,-0.3,1.21,0.97,1.36,-0.31,-1.74,0.27,0.11, ,-1.07,1.08, ,-1.58,anatomical structure development;biological regulation;cellular alkene metabolic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;endocytosis;establishment of localization;immune system process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of protein modification process;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cytosol;nucleoplasm,,+,,,,,,,,
Q15691,MAPRE1,Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1),19,76.9,31.15,30.69,31.25,31.14,31.42,30.27,31.08,31.23,29.51,30.01,30.89,31.03,29.76,30.72,0.43,-0.04,0.52,0.42,0.69,-0.45,0.36,0.5,-1.22,-0.72,0.16,0.31,-0.97,biological regulation;cell division;cell proliferation;cellular component organization;cellular localization;cellular process;localization;mitosis;nuclear division;organelle fission;organelle organization;regulation of organelle organization,cell part;centrosome;cytoskeleton;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
Q15555,MAPRE2,Microtubule-associated protein RP/EB family member 2 (APC-binding protein EB2) (End-binding protein 2) (EB2),3,18.7,,25.93,23.32,26.33,22.7,25.23,29.16,27.48,26.42,,25.57,28.98,,26.11, ,-0.18,-2.79,0.22,-3.41,-0.88,3.05,1.36,0.31, ,-0.54,2.87, ,biological regulation;cell division;cell proliferation;cellular component organization;cellular process;mitosis;nuclear division;organelle fission;organelle organization;response to stimulus;signal transduction,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9NX47,MARCH5,E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (Mitochondrial ubiquitin ligase) (MITOL) (RING finger protein 153),5,23.7,26.83,27.28,25.93,27.86,27.81,28.37,25.7,25.3,27.65,27.75,,27.26,27.94,27.14,-0.32,0.14,-1.21,0.72,0.67,1.23,-1.44,-1.84,0.51,0.61, ,0.12,0.8,biological regulation;cellular localization;cellular metabolic process;cellular process;localization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of organelle organization,cell part;membrane,,,,,,,,,,
P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",20,71.1,27.97,29.78,30.91,30.52,24.6,28.69,28.56,27.74,28.76,27.49,28.59,29.91,28.34,28.6,-0.64,1.18,2.31,1.92,-4.01,0.08,-0.04,-0.87,0.16,-1.12,-0.02,1.31,-0.26,biological regulation;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;regulation of transport;small molecule metabolic process,cell cortex;cell part;centrosome;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;nucleus;organelle;plasma membrane,,,,,,,,,,
P49006,MARCKSL1,MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS),10,75.9,23.85,23.4,27.46,23.78,24.77,24.56,26.94,23.07,26.19,28.24,26.52,27.6,25.29,25.51,-1.67,-2.11,1.95,-1.73,-0.74,-0.96,1.43,-2.45,0.68,2.72,1.01,2.09,-0.22,biological regulation,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
P56192,MARS,"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)",31,39,32.32,31.61,31.15,31.98,31.83,31.79,32.16,32.02,31.73,32.04,31.95,31.74,31.49,31.83,0.49,-0.22,-0.68,0.15,0,-0.04,0.33,0.19,-0.1,0.21,0.12,-0.09,-0.34,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96GW9,MARS2,"Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS)",3,7.1,31.13,27.13,24.32,31.97,26.31,25.96,24.83,26,25.29,27.07,25.35,26.93,26.82,26.86,4.27,0.27,-2.53,5.12,-0.55,-0.9,-2.03,-0.85,-1.56,0.22,-1.5,0.08,-0.04,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
P31153,MAT2A,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),20,47.1,32.29,30.98,30.9,31.94,32.01,31.77,32.11,32.48,31.67,30.7,31.81,31.81,30.92,31.64,0.65,-0.67,-0.74,0.29,0.36,0.12,0.47,0.84,0.03,-0.94,0.16,0.16,-0.73,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;one-carbon metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q9NZL9,MAT2B,Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase),13,44,31.2,30.45,29.17,30.27,30.11,30.44,30.73,30.47,30.56,30.24,30.43,29.88,29.51,30.27,0.94,0.19,-1.1,0,-0.16,0.17,0.46,0.2,0.3,-0.03,0.17,-0.39,-0.76,amine metabolic process;biosynthetic process;carbohydrate metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;one-carbon metabolic process;organic acid metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
P43243,MATR3,Matrin-3,57,64.5,33.67,33,33.14,33.18,33.81,33.72,33.33,33.04,33.77,33.65,32.53,32.77,33.32,33.3,0.37,-0.3,-0.16,-0.13,0.51,0.42,0.02,-0.27,0.47,0.34,-0.77,-0.53,0.01,,cell part;membrane,,,,,,,,,,
Q7Z434,MAVS,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),15,47,29.04,29.33,29.53,28.79,28.88,29.29,30.22,28.88,30.3,30.56,30.64,30.39,30.33,29.71,-0.67,-0.38,-0.18,-0.91,-0.82,-0.42,0.52,-0.83,0.6,0.85,0.93,0.69,0.62,biological regulation;cellular process;immune system process;interspecies interaction between organisms;multi-organism process;regulation of protein modification process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle,,,,,,,,,,
Q9UIS9,MBD1,Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1),6,19.1,24.52,23.18,,24.62,24.15,23.49,24.28,,24.39,25.05,24.49,25.85,23.4,24.31,0.21,-1.13, ,0.31,-0.16,-0.82,-0.03, ,0.08,0.74,0.18,1.54,-0.92,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;cytoplasm,Other TF domain,,,,,,,,,
Q9UBB5,MBD2,Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2),9,24.1,28.57,26.13,28.17,25.98,27.71,27.66,27.01,25.65,27.14,28.07,,19.99,27.16,26.6,1.96,-0.47,1.56,-0.62,1.11,1.05,0.41,-0.95,0.53,1.47, ,-6.61,0.56,behavior;biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;response to stimulus;RNA metabolic process,cell part;chromatin remodeling complex;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,Other TF domain,,,,,,,,,
Q9NR56,MBNL1,Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein),9,32.5,29.77,29.46,30.12,29.07,29.93,29.64,29.77,29.82,29.95,28.48,28.93,27.71,29.54,29.4,0.37,0.06,0.72,-0.33,0.53,0.24,0.37,0.42,0.56,-0.92,-0.47,-1.69,0.14,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell differentiation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q6ZNC8,MBOAT1,Lysophospholipid acyltransferase 1 (LPLAT 1) (EC 2.3.1.-) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 1) (O-acyltransferase domain-containing protein 1),5,8.5,27.09,21.05,22.67,23.33,24.53,23.97,23.72,23.76,24.81,,,,,23.88,3.21,-2.83,-1.21,-0.55,0.65,0.09,-0.16,-0.12,0.93, , , , ,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;membrane,,,,,,,,,,
Q96N66,MBOAT7,Lysophospholipid acyltransferase 7 (LPLAT 7) (EC 2.3.1.-) (1-acylglycerophosphatidylinositol O-acyltransferase) (EC 2.3.1.n4) (Bladder and breast carcinoma-overexpressed gene 1 protein) (Leukocyte receptor cluster member 4) (Lysophosphatidylinositol acyltransferase) (LPIAT) (Lyso-PI acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7) (h-mboa-7),8,20.7,29.67,28.91,28.14,28.84,28.71,30.06,29.44,29.26,29.84,28.84,31.05,29.77,30.41,29.46,0.21,-0.54,-1.32,-0.62,-0.75,0.6,-0.02,-0.2,0.39,-0.61,1.6,0.31,0.96,anatomical structure development;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q8IVS2,MCAT,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyl CoA:ACP acyltransferase) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase)",5,15.6,26.68,27.17,28.32,27.34,26.12,27.3,26.21,25.59,26.71,28.73,26.81,26.59,27.3,26.99,-0.31,0.18,1.33,0.35,-0.87,0.31,-0.78,-1.4,-0.28,1.74,-0.18,-0.4,0.31,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96RQ3,MCCC1,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)",11,23.5,29.18,29.27,28.6,27.65,28.38,29.07,27.97,29.01,28.96,29.58,30,29.1,29.62,28.95,0.22,0.32,-0.35,-1.31,-0.57,0.12,-0.98,0.05,0.01,0.63,1.05,0.14,0.67,amine metabolic process;catabolic process;cellular amide metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;vitamin metabolic process,cell part;membrane,,,,,,,,,,
Q9HCC0,MCCC2,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)",16,35.2,28.88,30.58,29.86,29,29.89,29.95,30.08,30.19,30.21,30.9,30.09,29.92,30.02,29.97,-1.09,0.61,-0.1,-0.97,-0.08,-0.02,0.11,0.22,0.24,0.94,0.12,-0.04,0.06,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q8NI22,MCFD2,Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein),5,68.5,29.66,31.56,30.69,31.05,29.71,31.04,31.25,29.75,32.11,31.23,31.38,32.18,31.29,30.99,-1.33,0.56,-0.3,0.06,-1.28,0.04,0.26,-1.24,1.12,0.24,0.39,1.19,0.3,carbohydrate metabolic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P49736,MCM2,DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28),34,37.6,29.57,27.13,29.02,29.81,31.5,30.23,30.34,30.63,29.52,28.85,21.51,29.58,29.1,28.98,0.59,-1.85,0.04,0.83,2.52,1.24,1.36,1.64,0.54,-0.14,-7.47,0.59,0.11,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;DNA geometric change;DNA metabolic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;macromolecular complex;nucleoplasm;origin recognition complex;protein complex,,,,,,,,,,
P33991,MCM4,DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21),17,22.8,29.44,26.8,30.49,29.68,30.44,29.78,30.72,29.84,30.06,29.82,,28.36,28.83,29.52,-0.08,-2.72,0.97,0.16,0.92,0.26,1.2,0.32,0.54,0.29, ,-1.16,-0.69,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA geometric change;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q14566,MCM6,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),23,30.6,29.82,26.21,29.89,30.1,30.98,30.72,31.03,31.09,30.2,30.38,25.15,28.7,29.75,29.54,0.28,-3.33,0.35,0.56,1.44,1.19,1.49,1.55,0.66,0.84,-4.39,-0.84,0.21,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA geometric change;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P33993,MCM7,DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3),22,36.4,28.82,26.65,30.28,29.3,31.41,30.89,30.08,30.9,29.51,28.77,24.9,29.25,29.45,29.25,-0.42,-2.59,1.03,0.05,2.16,1.64,0.83,1.65,0.26,-0.48,-4.35,0.01,0.21,biological regulation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA geometric change;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to endogenous stimulus;response to stimulus;response to stress,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q9BTE3,MCMBP,Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein),17,26.2,29.86,27.68,28.6,29.59,29.53,29.55,29.89,29.88,29.26,26.22,27.19,28.66,28.04,28.76,1.1,-1.09,-0.16,0.83,0.77,0.78,1.12,1.11,0.49,-2.55,-1.58,-0.11,-0.72,biosynthetic process;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9ULC4,MCTS1,Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies),8,62.4,30.15,30.4,30.13,30.33,29.18,29.15,30.49,30.47,29.34,29.03,30.35,30.95,29.53,29.96,0.18,0.43,0.17,0.37,-0.78,-0.81,0.53,0.51,-0.62,-0.93,0.39,0.99,-0.43,biological regulation;biosynthetic process;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;cytoplasm,,,,,,,,,,
Q8NE86,MCU,"Calcium uniporter protein, mitochondrial (Coiled-coil domain-containing protein 109A)",14,48,30.32,30.55,28.1,29.2,30.21,29.79,29.65,29.49,29.9,31.14,30.29,33.86,30.23,30.21,0.11,0.34,-2.11,-1.01,0,-0.42,-0.56,-0.72,-0.31,0.93,0.08,3.65,0.02,biological regulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;macromolecular complex assembly;protein complex assembly;regulation of transport;response to stimulus;signal transduction;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q14676,MDC1,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),15,15.2,27.1,22.9,25.36,,25.56,,24.41,,25.76,23.87,,,,25,2.11,-2.1,0.37, ,0.57, ,-0.58, ,0.77,-1.13, , , ,biological regulation;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;response to DNA damage stimulus;response to stimulus;response to stress,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
P40925,MDH1,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (EC 1.1.1.96)",20,58.1,32.56,32.86,32.96,32.73,31.2,30.99,32.09,32.31,30.94,30.55,32.41,32.68,30.22,31.88,0.67,0.97,1.07,0.84,-0.69,-0.9,0.2,0.43,-0.94,-1.33,0.52,0.8,-1.66,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle,,,,,,,,,,
P40926,MDH2,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",34,80.7,35.2,35.32,35.42,34.41,34.9,35.46,34.69,35.06,35.19,35.61,35.26,34.93,35.46,35.15,0.05,0.17,0.27,-0.73,-0.25,0.31,-0.46,-0.08,0.04,0.47,0.11,-0.22,0.31,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;protein acylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9NU22,MDN1,Midasin (MIDAS-containing protein),24,6.2,27.5,24.99,27.69,26.77,27.87,23.66,27.3,26.02,27.37,28.07,28.95,27.6,28.25,27.08,0.42,-2.09,0.61,-0.32,0.79,-3.43,0.22,-1.06,0.29,0.99,1.87,0.52,1.17,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,,,,,,,,,,
P48163,ME1,NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1),13,33.4,,28.23,25.35,29.85,28,28.49,29.16,28.8,26.49,27.42,29.84,30.5,25.9,28.17, ,0.06,-2.82,1.68,-0.17,0.32,0.99,0.63,-1.68,-0.75,1.67,2.34,-2.27,biosynthetic process;carbohydrate metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;lipid metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P23368,ME2,"NAD-dependent malic enzyme, mitochondrial (NAD-ME) (EC 1.1.1.38) (Malic enzyme 2)",27,53.9,30.81,32.07,31.1,31.42,32.06,31.77,31.93,31.12,31.12,32.16,31.87,31.23,32.06,31.59,-0.79,0.47,-0.49,-0.18,0.47,0.18,0.34,-0.47,-0.48,0.56,0.27,-0.36,0.47,cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P51608,MECP2,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),12,34.5,28.65,29.54,27.36,26,,24.46,25.78,25.96,27.47,25.92,26.25,,26.21,26.69,1.96,2.85,0.67,-0.69, ,-2.23,-0.91,-0.73,0.78,-0.77,-0.44, ,-0.48,"alcohol metabolic process;amine metabolic process;amine transport;anatomical structure development;behavior;behavioral interaction between organisms;biological regulation;biosynthetic process;carbohydrate metabolic process;cell maturation;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental maturation;developmental process;embryo development;establishment of localization;gene silencing;generation of precursor metabolites and energy;histone modification;homeostatic process;hormone metabolic process;lipid metabolic process;localization;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;organic acid metabolic process;pathogenesis;peptidyl-amino acid modification;post-embryonic development;primary metabolic process;protein acylation;protein alkylation;protein metabolic process;protein modification process;regulation of gene expression, epigenetic;regulation of organelle organization;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;secretion;small molecule metabolic process;transport",cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q9BV79,MECR,"Trans-2-enoyl-CoA reductase, mitochondrial (EC 1.3.1.38) (Nuclear receptor-binding factor 1) (HsNrbf-1) (NRBF-1)",2,7.4,25.74,26.05,,,,25.43,,,25.85,25.84,24.46,24.78,25.19,25.42,0.32,0.63, , , ,0.01, , ,0.43,0.42,-0.96,-0.64,-0.23,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q15648,MED1,Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A),9,8.9,27.05,24.7,,25.66,26.93,25.61,25.59,25.52,27.24,25.64,24.77,24.8,26.19,25.81,1.24,-1.11, ,-0.15,1.12,-0.2,-0.22,-0.29,1.43,-0.17,-1.04,-1.01,0.39,"alcohol metabolic process;amine metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell development;cell differentiation;cell morphogenesis;cell proliferation;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component morphogenesis;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA replication;establishment of localization;hormone metabolic process;lipid metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of body fluid levels;regulation of cell cycle;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process;secretion;signal transduction;small molecule metabolic process;transcription from RNA polymerase II promoter;transcription initiation, DNA-dependent;transport",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,Other TF domain,,,,,,,,,
Q96RN5,MED15,Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein),6,13,27.65,24.34,25.66,26.27,26.88,26.42,26.59,25.85,,26.13,,25.46,24.8,26.01,1.65,-1.66,-0.34,0.27,0.87,0.42,0.58,-0.16, ,0.13, ,-0.55,-1.2,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent",cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q9Y2X0,MED16,Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16) (Thyroid hormone receptor-associated protein 5) (Thyroid hormone receptor-associated protein complex 95 kDa component) (Trap95) (Vitamin D3 receptor-interacting protein complex 92 kDa component) (DRIP92),6,8.8,27.54,25.09,,25.85,26.69,26.64,26.67,27.44,26.88,26.17,25.26,26.27,25.86,26.37,1.17,-1.27, ,-0.51,0.33,0.28,0.31,1.07,0.52,-0.2,-1.1,-0.09,-0.51,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9ULK4,MED23,Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component) (ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3) (CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog) (hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component) (DRIP130),9,8.5,27.33,25.23,25.53,26.3,26.69,27.03,25.8,25.57,26.79,25.63,24.75,23.81,25.69,25.86,1.47,-0.63,-0.33,0.44,0.83,1.17,-0.06,-0.28,0.94,-0.23,-1.11,-2.05,-0.17,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
O75448,MED24,Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component) (ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4) (CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component) (Trap100) (hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component) (DRIP100),7,9.9,26.26,24.57,24.02,25.59,25.15,24.76,,,24.84,,23.71,,25.28,24.91,1.35,-0.34,-0.88,0.68,0.24,-0.15, , ,-0.07, ,-1.2, ,0.37,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex,,,,,,,,,,
Q14814,MEF2D,Myocyte-specific enhancer factor 2D,3,6.4,25.17,24.45,25.48,24.47,,24.88,,23.78,25.59,,,,25.45,24.91,0.27,-0.46,0.57,-0.44, ,-0.03, ,-1.13,0.68, , , ,0.54,anatomical structure development;biological regulation;cell death;cell differentiation;cellular process;death;developmental process;multicellular organismal process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,MADS-box domain,,,,,,,,,
Q9Y316,MEMO1,Protein MEMO1 (C21orf19-like protein) (Hepatitis C virus NS5A-transactivated protein 7) (HCV NS5A-transactivated protein 7) (Mediator of ErbB2-driven cell motility 1) (Mediator of cell motility 1) (Memo-1),4,24.5,27.31,27.4,,28.07,27.4,24.28,28.39,28.53,24.34,25.24,27.91,27.95,26.81,26.97,0.34,0.43, ,1.1,0.43,-2.69,1.42,1.56,-2.63,-1.73,0.94,0.98,-0.16,biological regulation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q7L2J0,MEPCE,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog),9,23.7,28.06,27.04,28.58,26.24,25.65,27.2,25.82,,26.79,27.27,,24.12,24.08,26.44,1.62,0.6,2.14,-0.2,-0.79,0.76,-0.62, ,0.35,0.83, ,-2.32,-2.36,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification,,,,,,,,,,,
Q14696,MESDC2,LDLR chaperone MESD (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61),11,38.9,29.98,32.19,31.57,31.64,30.43,30.86,32.8,30.09,32.57,32.6,32.57,33.46,31.62,31.72,-1.74,0.47,-0.15,-0.08,-1.29,-0.86,1.08,-1.63,0.85,0.88,0.85,1.73,-0.1,anatomical structure development;biological regulation;cellular localization;cellular metabolic process;cellular process;developmental process;localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to stimulus;signal transduction,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q5EB52,MEST,Mesoderm-specific transcript homolog protein (EC 3.-.-.-) (Paternally-expressed gene 1 protein),5,28.7,27.17,29.66,25.29,29.47,23.96,26.8,25.89,28.08,,23.94,27.52,30.95,27.59,27.19,-0.03,2.46,-1.9,2.28,-3.23,-0.39,-1.31,0.89, ,-3.25,0.32,3.76,0.4,anatomical structure development;biological regulation;developmental process;metabolic process;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P08581,MET,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),16,16.6,28.11,25.31,28.37,,28.51,26.78,27.99,27.19,26.54,30.1,29.27,26.83,25.42,27.54,0.57,-2.22,0.84, ,0.98,-0.76,0.45,-0.34,-1,2.56,1.74,-0.7,-2.11,anatomical structure development;anatomical structure morphogenesis;behavior;biological regulation;cell communication;cell differentiation;cell motility;cell proliferation;cell-cell signaling;cellular component movement;cellular metabolic process;cellular process;developmental process;homeostatic process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;signaling,cell part;extracellular region,,+,,,,,,,,
P53582,METAP1,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1),7,28.9,29.14,29.04,28.27,29.46,29.33,28.79,29.14,29.78,28.3,29.44,28.97,28.38,27.92,28.92,0.22,0.12,-0.65,0.54,0.41,-0.13,0.21,0.86,-0.62,0.52,0.04,-0.54,-1,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;proteolysis;regulation of translation,cell part;cytoplasm,,,,,,,,,,
P50579,METAP2,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M),16,39.3,30.24,28.52,29.92,28.62,29.67,27.95,28.84,29.47,27.35,27.57,28.83,28.87,28.34,28.78,1.46,-0.27,1.14,-0.16,0.88,-0.84,0.06,0.69,-1.43,-1.21,0.05,0.09,-0.45,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein maturation;protein metabolic process;protein modification process;proteolysis,cell part;cytoplasm,,,,,,,,,,
Q9UBP6,METTL1,tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase),3,13.4,24.2,23.44,,25.37,25.64,25.28,26.49,24.7,28.08,24.49,25.58,21.71,24.45,24.95,-0.76,-1.52, ,0.42,0.68,0.33,1.54,-0.25,3.13,-0.46,0.63,-3.24,-0.5,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8N6R0,METTL13,Methyltransferase-like protein 13 (EC 2.1.1.-),3,7.7,25.12,24.86,22.88,25.47,26,,25.1,,,25.64,23.3,24.46,,24.76,0.36,0.1,-1.88,0.71,1.24, ,0.34, , ,0.88,-1.46,-0.3, ,,,,,,,,,,,,
Q9HCE5,METTL14,Methyltransferase-like protein 14 (EC 2.1.1.-),4,11.8,26.39,25.88,28.47,25.94,,,23.69,24.95,25.39,25.1,20.93,26.48,,25.32,1.07,0.56,3.15,0.61, , ,-1.63,-0.37,0.06,-0.22,-4.39,1.16, ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q86U44,METTL3,N6-adenosine-methyltransferase 70 kDa subunit (MT-A70) (EC 2.1.1.62) (Methyltransferase-like protein 3),7,18.3,26.45,24.56,,23.93,27.51,27.34,24.62,24.58,27.27,,23.78,,25.34,25.54,0.91,-0.98, ,-1.61,1.97,1.8,-0.92,-0.96,1.73, ,-1.76, ,-0.2,macromolecule metabolic process;metabolic process,cell part;nucleoplasm,,,,,,,,,,
Q9H8H3,METTL7A,Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B),9,35.2,27.64,30.71,30.82,30.65,26.13,28.53,28.42,29.1,29.69,25.22,26.9,28,28.27,28.47,-0.83,2.24,2.35,2.19,-2.33,0.06,-0.05,0.64,1.22,-3.25,-1.57,-0.47,-0.2,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;membrane;organelle,,,,,,,,,,
P55081,MFAP1,Microfibrillar-associated protein 1,18,40.5,27.39,27.43,27.95,26.5,28.08,27.18,28.01,26.15,28.47,29.1,26.71,27.92,25.46,27.41,-0.02,0.02,0.54,-0.91,0.67,-0.23,0.6,-1.26,1.06,1.69,-0.7,0.51,-1.95,cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization,,,,,,,,,,,
Q9GZY8,MFF,Mitochondrial fission factor,11,62.5,29.53,29.28,26.03,29.96,28.8,29.89,28.56,28.3,29.62,28.01,29.53,29.45,29.65,28.97,0.56,0.31,-2.94,0.99,-0.17,0.92,-0.41,-0.67,0.65,-0.96,0.56,0.48,0.68,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;developmental process;establishment of localization;macromolecular complex assembly;mitochondrion organization;organelle fission;organelle organization;protein complex assembly;protein targeting;protein transport;regulation of organelle organization;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle;peroxisome,,,,,,,,,,
Q08431,MFGE8,Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form;Medin],13,56.1,32.07,30,30.68,29.81,29.86,30.92,27.58,29.41,29.63,30.44,28.51,29.65,30.58,29.93,2.13,0.07,0.75,-0.13,-0.07,0.98,-2.35,-0.52,-0.3,0.5,-1.42,-0.29,0.65,anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell recognition;cellular component organization;cellular membrane organization;cellular process;developmental process;interspecies interaction between organisms;membrane invagination;membrane organization;multi-organism process;regulation of transport,cell part;extracellular organelle;extracellular space;organelle;vesicle,,,,,,,,,,
P08582,MFI2,Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228),16,29.5,26.11,30.63,26.79,28.84,27.92,26.52,28.63,30.27,25.71,28.96,31.22,27.9,25.26,28.06,-1.95,2.57,-1.27,0.79,-0.14,-1.54,0.57,2.21,-2.35,0.9,3.16,-0.16,-2.79,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;transport,cell part;extracellular region,,,,,,,,,,
Q8IWA4,MFN1,Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1),20,31.7,30.59,28.13,28.11,28.49,28.49,28.51,27.27,26.26,29.17,28.02,26.38,22.19,28.09,27.67,2.92,0.46,0.44,0.82,0.82,0.84,-0.4,-1.41,1.5,0.36,-1.29,-5.48,0.42,cellular component organization;cellular membrane organization;cellular process;membrane fusion;membrane organization;mitochondrion organization;organelle fusion;organelle organization,cell part;membrane,,,,,,,,,,
O95140,MFN2,Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2),10,16.9,28.06,28.25,25.63,29.11,28.58,29.41,27.25,27.95,27.83,26.6,27.76,26.01,28.68,27.78,0.28,0.47,-2.15,1.33,0.81,1.63,-0.53,0.17,0.05,-1.18,-0.02,-1.77,0.9,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cellular component organization;cellular localization;cellular membrane organization;cellular process;coagulation;developmental process;establishment of localization;localization;membrane fusion;membrane organization;mitochondrion organization;multicellular organismal process;organelle fusion;organelle localization;organelle organization;protein targeting;protein transport;regulation of body fluid levels;transport,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9H3U5,MFSD1,Major facilitator superfamily domain-containing protein 1 (Smooth muscle cell-associated protein 4) (SMAP-4),3,26.9,25.42,27.87,26.37,25.96,24.1,28.3,22.87,24.28,22.61,24.05,27.53,27.67,27.37,25.72,-0.31,2.14,0.65,0.24,-1.62,2.58,-2.85,-1.44,-3.11,-1.68,1.81,1.95,1.65,cellular process;establishment of localization;transmembrane transport;transport,cell part,,,,,,,,,,
Q14728,MFSD10,Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein),2,6.2,26.71,28.28,26.31,27.31,27.58,28.15,27.27,26.83,27.76,27.96,29.04,27.8,28.93,27.69,-0.98,0.59,-1.38,-0.37,-0.11,0.47,-0.42,-0.85,0.07,0.27,1.35,0.12,1.24,cell death;cellular process;death;establishment of localization;transmembrane transport;transport,cell part,,,,,,,,,,
P26572,MGAT1,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)",7,17.8,26.85,27.58,24.83,28.71,27.57,28.01,26.05,26.18,27.95,26.56,26.76,27.08,28.79,27.15,-0.3,0.43,-2.32,1.56,0.43,0.86,-1.1,-0.96,0.8,-0.59,-0.39,-0.07,1.64,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q10469,MGAT2,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",5,15.9,27.08,28.83,26.58,29.17,27.83,28.81,27.24,28.29,28.64,27.69,27.79,28.34,29.07,28.1,-1.02,0.72,-1.53,1.06,-0.28,0.71,-0.86,0.19,0.54,-0.42,-0.31,0.24,0.96,biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q9UQ53,MGAT4B,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",2,5.1,27.17,26.14,,26.09,,,,23.79,23.89,,,25.99,25.11,25.45,1.72,0.69, ,0.63, , , ,-1.67,-1.56, , ,0.53,-0.34,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
O60502,MGEA5,Bifunctional protein NCOAT (Meningioma-expressed antigen 5) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) [Includes: Protein O-GlcNAcase (EC 3.2.1.169) (Glycoside hydrolase O-GlcNAcase) (Hexosaminidase C) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (O-GlcNAcase) (OGA);Histone acetyltransferase (HAT) (EC 2.3.1.48)],9,14.7,28.5,27.63,28.35,27.74,27.3,24.86,26.32,25.82,24.06,24.73,27.14,27.17,,26.64,1.86,1,1.72,1.11,0.66,-1.77,-0.32,-0.81,-2.57,-1.91,0.51,0.53, ,aging;alcohol metabolic process;biological regulation;carbohydrate metabolic process;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;establishment of localization;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein targeting;protein transport;regulation of DNA metabolic process;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q99685,MGLL,Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL),10,47.9,29.27,26.79,27.44,26.31,26.3,24.63,25.84,27.35,28.06,30.07,26.24,,26.54,27.07,2.2,-0.28,0.37,-0.76,-0.77,-2.44,-1.23,0.28,0.99,3,-0.83, ,-0.53,biological regulation;biosynthetic process;catabolic process;cell activation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to stimulus;response to stress;small molecule metabolic process,cell part;membrane;plasma membrane;synapse,,,,,,,,,,
Q9BQP7,MGME1,Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-),3,10.8,26.86,25.71,,25.85,,,26.77,25.63,26.31,25.9,,,,26.15,0.71,-0.44, ,-0.3, , ,0.62,-0.52,0.16,-0.25, , , ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P16455,MGMT,Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase),3,23.2,27.4,25.97,23.92,26.98,25.04,26.02,,25.69,25.35,,,26.85,,25.91,1.48,0.06,-1.99,1.07,-0.88,0.11, ,-0.22,-0.57, , ,0.94, ,biological regulation;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA ligation;DNA metabolic process;DNA modification;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of DNA metabolic process;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;nucleoplasm,,,,,,,,,,
P10620,MGST1,Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I),10,38.7,28.22,30.25,30.76,31.34,29.53,31.59,31.27,30.27,32.24,31.23,31.84,32.48,32.01,31,-2.78,-0.75,-0.24,0.34,-1.47,0.59,0.27,-0.73,1.24,0.22,0.84,1.48,1.01,amine metabolic process;cell differentiation;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;protein complex assembly;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,apical part of cell;cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;nucleus;organelle,,,,,,,,,,
Q99735,MGST2,Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Microsomal GST-II),2,20.8,29.02,29.34,27.68,28.46,28.91,29.45,27.75,28.78,30.33,29.74,29.94,24.8,29.82,28.77,0.25,0.57,-1.09,-0.31,0.14,0.67,-1.02,0.01,1.56,0.96,1.17,-3.97,1.05,amine metabolic process;biological regulation;biosynthetic process;cellular alkene metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;membrane;nuclear envelope;plasma membrane,,,,,,,,,,
O14880,MGST3,Microsomal glutathione S-transferase 3 (Microsomal GST-3) (EC 2.5.1.18) (Microsomal GST-III),5,34.2,30.04,29.62,29.33,27.63,27.54,28.01,27.28,28.43,30.91,30.19,28.7,30.44,29.21,29.03,1.01,0.6,0.31,-1.4,-1.48,-1.01,-1.74,-0.6,1.89,1.16,-0.33,1.42,0.19,biological regulation;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process;xenobiotic metabolic process,cell part;membrane;nuclear envelope,,,,,,,,,,
Q5JRA6,MIA3,Melanoma inhibitory activity protein 3 (C219-reactive peptide) (D320) (Transport and Golgi organization protein 1),36,25.1,29.06,29.2,29.43,29.5,28.34,29.64,29.08,26.64,29.88,29.53,28.57,29.48,29.65,29.08,-0.02,0.13,0.35,0.43,-0.74,0.56,0.01,-2.43,0.8,0.45,-0.51,0.41,0.57,biological regulation;cellular process;establishment of localization;exocytosis;protein transport;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q8TDZ2,MICAL1,Protein-methionine sulfoxide oxidase MICAL1 (EC 1.14.13.-) (Molecule interacting with CasL protein 1) (MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains),8,10.9,,26.12,24.66,26.55,24.35,24.77,26.35,27.03,25.91,,27.54,27.02,25.26,25.96, ,0.16,-1.3,0.59,-1.61,-1.19,0.39,1.07,-0.05, ,1.58,1.06,-0.7,biological regulation;cellular component disassembly;cellular component organization;cellular process;cytoskeleton organization;organelle organization;protein depolymerization;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
O94851,MICAL2,Protein-methionine sulfoxide oxidase MICAL2 (EC 1.14.13.-) (Molecule interacting with CasL protein 2) (MICAL-2),14,16.8,26.31,26.7,24.31,29.05,29.41,28.86,28.64,29.42,30.87,28.82,29.56,27.74,30.28,28.46,-2.15,-1.76,-4.15,0.59,0.95,0.4,0.18,0.96,2.41,0.36,1.1,-0.72,1.82,cellular component disassembly;cellular component organization;cellular process;cytoskeleton organization;organelle organization;protein depolymerization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q8N3F8,MICALL1,MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13),5,8.7,25.65,25.86,,26,23.97,23.81,22.58,23.89,21.6,22.66,24.2,25.19,21.68,23.92,1.72,1.93, ,2.07,0.05,-0.12,-1.34,-0.04,-2.32,-1.27,0.28,1.27,-2.24,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9BPX6,MICU1,"Calcium uptake protein 1, mitochondrial (Atopy-related autoantigen CALC) (ara CALC) (Calcium-binding atopy-related autoantigen 1) (allergen Hom s 4)",5,14.1,27.45,27.45,26.67,26.7,27.32,25.94,28.21,26.73,27.66,28.29,28.01,26.57,27.43,27.26,0.19,0.18,-0.6,-0.57,0.05,-1.33,0.95,-0.53,0.4,1.02,0.75,-0.69,0.17,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;response to stimulus;response to stress;transmembrane transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q8IYU8,MICU2,"Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1)",7,24.9,26.4,27.42,27.23,27.54,25.33,27.35,28.59,27.07,28.49,28.9,26.65,26.12,28.03,27.32,-0.92,0.1,-0.09,0.22,-1.99,0.04,1.28,-0.24,1.17,1.58,-0.66,-1.2,0.71,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
Q9BRT3,MIEN1,Migration and invasion enhancer 1 (HBV X-transactivated gene 4 protein) (HBV XAg-transactivated protein 4) (Protein C35),4,45.2,29.11,27.86,24.05,26.75,25.75,25.59,26.6,26.32,25.96,26.07,26.46,26.3,,26.4,2.71,1.46,-2.35,0.35,-0.65,-0.81,0.19,-0.08,-0.44,-0.33,0.06,-0.1, ,biological regulation;cell death;cellular homeostasis;cellular process;death;homeostatic process,cell part;cytosol,,,,,,,,,,
Q8N108,MIER1,Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (hMi-er1),3,14.6,25.77,25.19,26.8,23.66,,,25.11,,24.35,25.29,,25.66,,25.23,0.54,-0.04,1.57,-1.57, , ,-0.12, ,-0.88,0.06, ,0.43, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;macromolecular complex;protein complex;transcriptional repressor complex,,,,,,,,,,
P14174,MIF,Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase),6,80.9,33.58,33.9,33.62,33.53,32.2,31.55,32.99,32.94,31.9,31.63,32.25,34.09,29.35,32.58,1,1.32,1.04,0.95,-0.38,-1.03,0.41,0.36,-0.67,-0.95,-0.33,1.51,-3.23,aging;biological regulation;biosynthetic process;cell proliferation;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;immune system process;lipid metabolic process;macromolecular complex assembly;metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;regulation of cell cycle;regulation of protein modification process;regulation of transport;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cell surface;cytoplasm;extracellular region;extracellular space,,,,,,,,,,
Q8IUF8,MINA,Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA (EC 1.14.11.-) (60S ribosomal protein L27a histidine hydroxylase) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) (Mineral dust-induced gene protein) (Nucleolar protein 52) (Ribosomal oxygenase MINA) (ROX),4,11.4,26.93,,22.62,,,23.43,23.48,23.09,,22.94,,,23.83,23.76,3.17, ,-1.14, , ,-0.33,-0.28,-0.67, ,-0.82, , ,0.07,cellular process;ribosome biogenesis,cell part;cytoplasm;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;transcription factor complex,,,,,,,,,,
Q9UNW1,MINPP1,"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)",5,12.1,26.03,28.6,24.99,29.11,28.02,28.46,28.57,26.9,29.21,26.91,28.2,27.98,29.11,27.85,-1.82,0.75,-2.86,1.26,0.16,0.61,0.72,-0.95,1.35,-0.95,0.34,0.13,1.25,anatomical structure development;cellular metabolic process;cellular process;developmental process;metabolic process;phosphorus metabolic process,cell part,,,+,,,,,,,
Q99797,MIPEP,Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59),11,23.1,28.97,29.4,29.01,29.29,29.98,29.81,29.48,29.1,29.6,29.54,28.23,28.2,27.99,29.12,-0.15,0.27,-0.11,0.17,0.85,0.69,0.36,-0.03,0.48,0.42,-0.89,-0.93,-1.13,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),20,36.4,27.74,26.35,27.49,27.54,27.25,26.35,28.76,27.01,,29.98,27.01,25.52,25.71,27.23,0.52,-0.88,0.27,0.31,0.03,-0.87,1.53,-0.21, ,2.76,-0.22,-1.71,-1.52,,,,,,,,,,,,
P46013,MKI67,Antigen KI-67,23,11.2,28.53,22.56,28.18,27.46,27.99,26.67,28.61,28.29,27.38,28.22,,26.92,24.88,27.14,1.39,-4.58,1.03,0.32,0.85,-0.47,1.47,1.15,0.24,1.08, ,-0.22,-2.26,cell proliferation;cellular process;meiosis,cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9BYG3,MKI67IP,MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar phosphoprotein Nopp34) (Nucleolar protein interacting with the FHA domain of pKI-67) (hNIFK),12,38.9,29.15,28.26,27.4,29.36,29.41,28.99,28.77,29.08,29.02,29.45,26.66,29.44,28.6,28.74,0.41,-0.47,-1.33,0.62,0.67,0.25,0.03,0.34,0.28,0.71,-2.08,0.7,-0.13,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process,cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nuclear chromosome;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q14165,MLEC,Malectin,21,53.1,31.69,32.01,31.11,31.26,31.02,31.39,31.46,31.02,32.15,32.18,31.66,31.41,31.77,31.55,0.14,0.46,-0.44,-0.29,-0.53,-0.16,-0.09,-0.53,0.6,0.62,0.11,-0.14,0.22,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q03111,MLLT1,Protein ENL (YEATS domain-containing protein 1),5,11.1,26.2,25.67,,25.5,25.81,26.38,,,,,25.37,,26.1,25.86,0.34,-0.19, ,-0.36,-0.05,0.52, , , , ,-0.49, ,0.24,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein modification process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),50,34.6,30.86,27.97,29.69,27.83,29.51,29.08,29.72,29.82,29.97,30.02,29.24,29.7,29.44,29.45,1.41,-1.48,0.24,-1.62,0.06,-0.37,0.27,0.37,0.52,0.56,-0.21,0.25,-0.01,biological adhesion;biological regulation;cell adhesion;cell communication;cell junction organization;cell-cell signaling;cellular component assembly;cellular component organization;cellular process;response to stimulus;signal transduction;signaling,apical part of cell;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q96EY8,MMAB,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial (EC 2.5.1.17) (Cob(I)alamin adenosyltransferase) (Methylmalonic aciduria type B protein)",7,49.7,27.7,28.3,25.69,28.25,27.35,29.48,28.32,28.06,29.05,29.69,27.46,28.13,29.12,28.2,-0.5,0.1,-2.51,0.05,-0.85,1.28,0.12,-0.14,0.85,1.49,-0.74,-0.07,0.92,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P08473,MME,Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10),17,24.3,25.44,28.44,,29.98,,,26.76,25.77,29,,,24.21,23.11,26.59,-1.15,1.85, ,3.39, , ,0.17,-0.82,2.41, , ,-2.38,-3.48,aging;amine metabolic process;anatomical structure development;biological regulation;cellular amide metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;hormone metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis;response to abiotic stimulus;response to chemical stimulus;response to stimulus;response to stress;small molecule metabolic process,brush border;cell part;cell projection;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;organelle;vesicle,,,,,,,,,,
Q8N4V1,MMGT1,Membrane magnesium transporter 1 (ER membrane protein complex subunit 5) (Transmembrane protein 32),2,26.7,26.29,28.84,27.9,28.31,27.85,28.34,27.09,28.15,28.53,28.89,28.23,24.79,29.18,27.88,-1.58,0.97,0.02,0.43,-0.03,0.46,-0.79,0.27,0.66,1.02,0.35,-3.09,1.3,,cell part;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
P50281,MMP14,Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP),21,33.8,27.29,30.39,29.44,31.12,31.54,31.57,30.65,29.52,31.53,31.21,30.02,26.08,31.15,30.12,-2.82,0.27,-0.68,1,1.43,1.46,0.53,-0.6,1.42,1.09,-0.09,-4.04,1.03,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell motility;cell proliferation;cellular component disassembly;cellular component movement;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein maturation;protein metabolic process;proteolysis;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to oxidative stress;response to stimulus;response to stress;rhythmic process;tissue remodeling,cell part;cytoplasmic membrane-bounded vesicle;extracellular matrix;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P51511,MMP15,Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2),6,15.5,20.74,,,,,24.24,25.9,25.24,22.59,28.03,25.85,27.94,23.74,24.92,-4.18, , , , ,-0.68,0.98,0.32,-2.33,3.11,0.93,3.02,-1.18,cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;protein modification process;proteolysis;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;extracellular matrix,,,,,,,,,,
Q96T76,MMS19,MMS19 nucleotide excision repair protein homolog (hMMS19) (MET18 homolog) (MMS19-like protein),16,25.1,28.47,29.11,27.29,30.24,28.79,28.65,28.9,29.89,28.58,27.86,29.17,29.71,27.15,28.76,-0.29,0.36,-1.47,1.49,0.04,-0.11,0.15,1.13,-0.17,-0.9,0.41,0.96,-1.6,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome segregation;cofactor metabolic process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
P41218,MNDA,Myeloid cell nuclear differentiation antigen,10,30,,27.99,30.66,,26.94,24.08,25.08,22.95,,21.82,,,,25.65, ,2.35,5.01, ,1.3,-1.56,-0.57,-2.69, ,-3.83, , , ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q9BRT2,MNF1,Mitochondrial nucleoid factor 1 (Breast cancer-associated protein SGA-81M) (Mitochondrial protein M19),5,34.1,25.79,27.07,27.04,27.33,26.85,27.91,27.29,26.64,27.2,28.14,27.91,27.22,28.04,27.26,-1.48,-0.19,-0.22,0.06,-0.42,0.65,0.02,-0.62,-0.06,0.88,0.65,-0.04,0.77,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H8S9,MOB1A,MOB kinase activator 1A (Mob1 alpha) (Mob1A) (Mob1 homolog 1B) (Mps one binder kinase activator-like 1B),5,24.1,28.32,28.38,28.48,28.3,27.35,24.69,28.79,29.11,25.88,24.88,28.2,27.82,24.97,27.32,1,1.06,1.16,0.98,0.03,-2.64,1.47,1.79,-1.44,-2.44,0.88,0.5,-2.35,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q9Y3A3,MOB4,MOB-like protein phocein (2C4D) (Class II mMOB1) (Mob1 homolog 3) (Mob3) (Mps one binder kinase activator-like 3) (Preimplantation protein 3),6,41.5,29.42,29.36,30.64,29.74,30.75,29.03,30.36,30.33,29.79,30.54,30.05,31.25,30.56,30.14,-0.72,-0.78,0.5,-0.41,0.61,-1.12,0.22,0.19,-0.35,0.4,-0.09,1.11,0.42,establishment of localization;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q13724,MOGS,Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Processing A-glucosidase I),34,56.6,31.95,32.65,30.18,32.38,32.11,32.68,31.69,31.59,33.19,32.15,32.18,31.91,32.48,32.09,-0.13,0.56,-1.91,0.3,0.02,0.59,-0.4,-0.5,1.1,0.07,0.09,-0.18,0.39,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q9Y6X9,MORC2,MORC family CW-type zinc finger protein 2 (Zinc finger CW-type coiled-coil domain protein 1),10,11,26.98,26.36,,25.25,26.6,25.06,,,26.19,,26.34,,,26.11,0.87,0.25, ,-0.86,0.49,-1.05, , ,0.08, ,0.23, , ,,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8NHP6,MOSPD2,Motile sperm domain-containing protein 2,8,20.3,20.87,26.32,26.4,27.93,26.08,26.92,27.53,27.97,28.19,26.44,24.58,28.62,27.61,26.57,-5.7,-0.26,-0.17,1.36,-0.49,0.34,0.96,1.4,1.62,-0.14,-1.99,2.04,1.03,,cell part,,,,,,,,,,
Q9HCE1,MOV10,Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein),11,16.7,28.05,28.38,27.67,29.51,27.96,28.26,27.84,28.83,27.37,26.27,27.53,28.52,28.12,28.03,0.03,0.36,-0.36,1.48,-0.07,0.24,-0.18,0.81,-0.66,-1.75,-0.49,0.49,0.1,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;signal transduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex,,,,,,,,,,
P56378,MP68,6.8 kDa mitochondrial proteolipid,3,32.8,27.71,26.59,26.39,27.79,27.88,27.42,27.44,27.32,28.25,28.14,27.33,28.36,28.58,27.63,0.08,-1.04,-1.24,0.16,0.25,-0.21,-0.19,-0.31,0.62,0.51,-0.3,0.73,0.95,,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
O95563,MPC2,Mitochondrial pyruvate carrier 2 (Brain protein 44),5,48.6,29,28.16,27.92,27,26.58,27.95,26.84,27.18,28.42,28.3,27.73,25.65,27.95,27.59,1.41,0.57,0.33,-0.59,-1.01,0.36,-0.75,-0.41,0.83,0.71,0.14,-1.94,0.36,cellular ketone metabolic process;cellular metabolic process;cellular process;establishment of localization;ion transport;metabolic process;organic acid metabolic process;organic acid transport;small molecule metabolic process;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
J3KSI4,MPDU1,Mannose-P-dolichol utilization defect 1 protein,4,38.5,28.18,29.14,29.66,29.47,28.68,29.47,29.7,29.08,29.46,29.22,29.31,29.64,30.07,29.31,-1.14,-0.18,0.35,0.16,-0.63,0.15,0.38,-0.23,0.14,-0.1,0,0.32,0.75,,,,,,,,,,,,
A2IDA3,MPG,DNA-3-methyladenine glycosylase (N-methylpurine-DNA glycosylase) (Fragment),3,14.3,25.6,25.25,,27.11,27.3,26.11,26.79,25.99,27.48,,23.63,25.23,25.19,25.97,-0.37,-0.72, ,1.14,1.33,0.14,0.82,0.02,1.51, ,-2.34,-0.74,-0.78,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,,,,,,,,,,,
O00566,MPHOSPH10,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),11,23.6,28.34,26.3,27.71,28.11,28.13,27.27,28.02,27.3,29.04,27.97,,26.44,27.42,27.67,0.67,-1.37,0.04,0.44,0.46,-0.4,0.35,-0.37,1.37,0.3, ,-1.23,-0.26,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;rRNA processing,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
Q99549,MPHOSPH8,M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3),9,10.3,24.38,24.86,,26.64,,25.8,25.96,25.88,26.18,24.39,,,24.42,25.39,-1.01,-0.52, ,1.25, ,0.41,0.57,0.49,0.79,-1, , ,-0.97,biological regulation;biosynthetic process;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of DNA metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;nucleosome;organelle;plasma membrane,,,,,,,,,,
P34949,MPI,Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI),8,28.6,26.51,30.06,29.48,28.73,24.83,,26.91,27.2,,26.5,25.99,27.46,24.41,27.1,-0.58,2.96,2.38,1.63,-2.27, ,-0.19,0.1, ,-0.59,-1.11,0.36,-2.69,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q8N3R9,MPP5,MAGUK p55 subfamily member 5,13,28,26.24,26.52,26.5,27.57,24.27,27.21,26.98,26.56,26.6,28.63,26.23,27.08,27.32,26.75,-0.51,-0.23,-0.25,0.82,-2.48,0.46,0.23,-0.18,-0.15,1.88,-0.52,0.33,0.57,anatomical structure formation involved in morphogenesis;cell junction organization;cellular component assembly;cellular component organization;cellular localization;cellular membrane organization;cellular process;developmental process;establishment of localization;localization;membrane organization;plasma membrane organization,cell part;cytoplasm;endomembrane system;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9NZW5,MPP6,MAGUK p55 subfamily member 6 (Veli-associated MAGUK 1) (VAM-1),7,19.6,25.86,26.75,,30.01,27.58,27.25,28.33,27.77,27.67,25.48,26.62,27.1,28.73,27.43,-1.57,-0.68, ,2.58,0.15,-0.18,0.9,0.34,0.24,-1.95,-0.81,-0.33,1.3,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;membrane;plasma membrane,,,,,,,,,,
Q5T2T1,MPP7,MAGUK p55 subfamily member 7,10,22.6,29.64,27.36,28.05,,25.42,25.54,,,,25.8,,,25.83,26.8,2.83,0.55,1.24, ,-1.39,-1.27, , , ,-1.01, , ,-0.97,biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;establishment or maintenance of cell polarity;localization,cell part;macromolecular complex;protein complex,,,,+,,,,,,
Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),43,54.4,28.62,29.08,29.25,29.86,31.15,31.03,30.91,30.23,31.53,30.96,30.74,28.32,30.93,30.2,-1.58,-1.12,-0.95,-0.34,0.94,0.83,0.71,0.03,1.33,0.76,0.54,-1.88,0.73,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P25325,MPST,3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2),9,41.4,32.12,28.45,28.71,30.03,29.76,28.73,29.12,29.69,29.32,29.57,29.3,28.52,29.73,29.47,2.66,-1.02,-0.75,0.57,0.29,-0.73,-0.35,0.22,-0.15,0.1,-0.17,-0.94,0.26,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process;sulfur compound metabolic process,cell part;cell projection;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;neuron projection;organelle;synapse,,,,,,,,,,
O95297,MPZL1,Myelin protein zero-like protein 1 (Protein zero-related),7,25.5,27.21,27.83,26.83,28.82,27.49,27.82,28.34,27.96,28.8,26.69,29.21,,30.16,28.1,-0.88,-0.27,-1.26,0.72,-0.61,-0.28,0.24,-0.14,0.7,-1.41,1.11, ,2.07,biological regulation;cell communication;cell-cell signaling;cellular process;response to stimulus;signal transduction;signaling,cell part,,,,,,,,,,
Q9UBG0,MRC2,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),25,22.6,25.55,31.47,25.31,30.49,30.3,31.58,30.44,29.88,31.69,24.33,29.72,30.37,30.31,29.34,-3.79,2.13,-4.03,1.15,0.96,2.24,1.1,0.54,2.34,-5.01,0.38,1.03,0.97,cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;transport;vesicle-mediated transport,cell part,,,,,,,,,,
P49959,MRE11A,Double-strand break repair protein MRE11A (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),25,38,31.51,29.78,30.29,28.92,29.59,29.85,29.44,29.4,30.43,29.41,28.84,28.66,29.75,29.68,1.83,0.1,0.6,-0.76,-0.09,0.16,-0.24,-0.28,0.75,-0.27,-0.85,-1.02,0.07,biological regulation;biosynthetic process;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA geometric change;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q9NV56,MRGBP,MRG/MORF4L-binding protein (MRG-binding protein),2,13.7,26.4,25.37,,24.95,26.19,24.65,23,24.67,24.07,,,,23.49,24.75,1.64,0.62, ,0.19,1.44,-0.1,-1.75,-0.08,-0.69, , , ,-1.26,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9BV20,MRI1,Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein),3,14.3,25.83,28.38,,26.76,,,25.78,25.67,24.29,,27.85,28.44,24.26,26.36,-0.53,2.02, ,0.39, , ,-0.58,-0.69,-2.07, ,1.49,2.08,-2.1,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BYD6,MRPL1,"39S ribosomal protein L1, mitochondrial (L1mt) (MRP-L1)",12,42.2,29.05,28.16,28.84,29.15,28.48,30.17,29.57,28.75,30.18,30.86,29.12,28.25,29.91,29.27,-0.22,-1.11,-0.42,-0.12,-0.79,0.9,0.3,-0.52,0.91,1.59,-0.14,-1.02,0.64,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex,,,,,,,,,,
Q7Z7H8,MRPL10,"39S ribosomal protein L10, mitochondrial (L10mt) (MRP-L10) (39S ribosomal protein L8, mitochondrial) (L8mt) (MRP-L8)",5,29.7,25.32,26.23,25.05,27.05,27.44,28.28,27.45,25.58,28.08,29.08,27.24,27.95,27.44,27.09,-1.77,-0.86,-2.04,-0.04,0.35,1.19,0.36,-1.51,0.99,1.99,0.14,0.86,0.35,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;ribosome biogenesis;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q9Y3B7,MRPL11,"39S ribosomal protein L11, mitochondrial (L11mt) (MRP-L11)",8,49,26.91,29.13,27.68,29.49,30.37,29.23,29.53,29.72,29.86,29.01,28.41,28.5,29.7,29.04,-2.13,0.09,-1.36,0.45,1.33,0.19,0.49,0.68,0.82,-0.03,-0.63,-0.55,0.66,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P52815,MRPL12,"39S ribosomal protein L12, mitochondrial (L12mt) (MRP-L12) (5c5-2)",15,43.4,30.59,30.78,30.01,30.95,31.6,31.96,30.62,31.23,31.42,32.16,30.89,29.74,31.5,31.03,-0.44,-0.25,-1.02,-0.08,0.56,0.93,-0.41,0.19,0.38,1.12,-0.14,-1.29,0.46,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;RNA metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q9BYD1,MRPL13,"39S ribosomal protein L13, mitochondrial (L13mt) (MRP-L13)",11,71.3,29.45,29.12,28.64,29.49,30.77,30.57,29.84,30.28,30.67,30.28,30.09,29.54,29.4,29.86,-0.41,-0.73,-1.21,-0.37,0.91,0.71,-0.01,0.42,0.82,0.43,0.23,-0.32,-0.46,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q6P1L8,MRPL14,"39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14) (39S ribosomal protein L32, mitochondrial) (L32mt) (MRP-L32)",6,46.2,26.46,26.86,23.8,27.97,29.11,28.45,28.75,28.14,29.12,28.72,28.09,28.46,28.45,27.87,-1.41,-1.01,-4.07,0.09,1.23,0.57,0.88,0.26,1.24,0.84,0.22,0.59,0.57,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9P015,MRPL15,"39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15)",17,55.7,27.8,29.21,28.18,29.59,30.17,30.22,29.46,30.04,30.35,30.44,28.59,28.41,30.02,29.42,-1.62,-0.21,-1.25,0.17,0.75,0.8,0.04,0.61,0.92,1.02,-0.83,-1.01,0.6,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex,,,,,,,,,,
Q9NX20,MRPL16,"39S ribosomal protein L16, mitochondrial (L16mt) (MRP-L16)",9,33.5,26.85,27.33,27.12,28.6,29.27,29.76,27.94,29.12,29.11,30.09,28.96,29.41,29.68,28.71,-1.86,-1.38,-1.59,-0.12,0.55,1.05,-0.77,0.41,0.4,1.38,0.25,0.7,0.96,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9NRX2,MRPL17,"39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17) (LYST-interacting protein 2)",6,31.4,25.76,27.2,28.14,27.79,29.76,29.58,29.25,28.1,29.29,29.08,26.62,28.94,29.68,28.4,-2.64,-1.2,-0.25,-0.61,1.36,1.19,0.85,-0.29,0.89,0.68,-1.77,0.54,1.28,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9H0U6,MRPL18,"39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18)",6,34.1,27.07,27.87,26.63,28.07,29.33,28.76,28.54,28.53,28.63,28.22,24.42,25.04,28.03,27.63,-0.56,0.24,-0.99,0.45,1.71,1.13,0.91,0.9,1,0.59,-3.2,-2.59,0.4,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein metabolic process;translation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P49406,MRPL19,"39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) (39S ribosomal protein L15, mitochondrial) (L15mt) (MRP-L15)",7,28.2,28.41,28.65,27.79,28.84,29.33,29.24,29.98,29.11,29.74,28.75,28.82,29.67,27.79,28.93,-0.53,-0.28,-1.14,-0.09,0.4,0.31,1.04,0.18,0.81,-0.18,-0.11,0.74,-1.14,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q5T653,MRPL2,"39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2)",7,23.9,25.61,27.35,27.38,27.64,28.33,28.92,28.23,27.52,29.41,29.03,27.39,28.62,28.65,28.01,-2.4,-0.66,-0.63,-0.37,0.32,0.92,0.23,-0.49,1.4,1.02,-0.61,0.61,0.64,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9BYC9,MRPL20,"39S ribosomal protein L20, mitochondrial (L20mt) (MRP-L20)",4,21.5,26.25,26.41,,27.41,28.52,28.32,27.39,27.9,27.62,27.85,26.36,28.33,28.26,27.55,-1.3,-1.14, ,-0.14,0.97,0.77,-0.16,0.35,0.07,0.3,-1.19,0.78,0.71,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q7Z2W9,MRPL21,"39S ribosomal protein L21, mitochondrial (L21mt) (MRP-L21)",7,35.1,26.94,27.53,24.46,28.08,29.54,29.42,27.78,28.81,28.27,28.06,26.69,26.45,28.05,27.7,-0.75,-0.16,-3.24,0.38,1.84,1.72,0.08,1.11,0.57,0.36,-1.01,-1.25,0.35,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9NWU5,MRPL22,"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22) (39S ribosomal protein L25, mitochondrial) (L25mt) (MRP-L25)",11,46.6,29.04,28.52,27.27,28.4,28.69,29.02,28.9,28.14,29.34,29.73,27.92,28.55,29.5,28.69,0.35,-0.17,-1.43,-0.29,-0.01,0.32,0.21,-0.55,0.65,1.03,-0.77,-0.14,0.8,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex,,,,,,,,,,
Q16540,MRPL23,"39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23) (L23 mitochondrial-related protein) (Ribosomal protein L23-like)",8,67.3,27.63,27.65,26.66,29.06,29.38,29.77,29.6,28.94,29.36,29.9,29.44,30.21,29.55,29.01,-1.38,-1.36,-2.36,0.05,0.37,0.76,0.59,-0.07,0.35,0.89,0.43,1.2,0.54,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q96A35,MRPL24,"39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24)",10,47.2,27.46,28.7,26.07,29.03,29.52,30.14,29.55,28.84,29.89,29.62,29.11,30.14,29.95,29.08,-1.62,-0.38,-3.01,-0.05,0.44,1.06,0.48,-0.24,0.81,0.54,0.04,1.06,0.87,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9P0M9,MRPL27,"39S ribosomal protein L27, mitochondrial (L27mt) (MRP-L27)",4,47.3,26.92,28.1,28.32,28.69,30.2,30,29.21,29.09,29.69,30.02,29.04,28.43,29.79,29.04,-2.12,-0.94,-0.72,-0.34,1.17,0.96,0.17,0.05,0.66,0.98,0,-0.61,0.75,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q13084,MRPL28,"39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28) (Melanoma antigen p15) (Melanoma-associated antigen recognized by T-lymphocytes)",5,20,27.38,27.25,26.55,27.95,27.54,27.75,27.84,27.29,28.66,27.61,26.9,26.07,28.06,27.45,-0.06,-0.2,-0.9,0.5,0.09,0.3,0.39,-0.16,1.21,0.16,-0.55,-1.38,0.61,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P09001,MRPL3,"39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3)",10,39.1,29.96,28.45,29.08,29.4,30.38,30.45,29.81,29.8,30.03,30.35,29.13,29.25,29.85,29.69,0.27,-1.24,-0.61,-0.29,0.69,0.77,0.13,0.11,0.34,0.67,-0.56,-0.43,0.16,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q9BQ48,MRPL34,"39S ribosomal protein L34, mitochondrial (L34mt) (MRP-L34)",2,14.1,,,,25.77,27.52,27.63,26.39,27.61,27.69,27.22,26.5,26.45,27.62,27.04, , , ,-1.27,0.48,0.59,-0.65,0.57,0.64,0.18,-0.54,-0.59,0.58,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9BZE1,MRPL37,"39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) (39S ribosomal protein L2, mitochondrial) (L2mt) (MRP-L2)",14,37.6,27.85,29.13,,29.15,30.03,29.46,28.93,29.38,29.93,29.18,28.67,29.32,28.85,29.16,-1.31,-0.03, ,0,0.88,0.31,-0.23,0.22,0.78,0.02,-0.48,0.16,-0.31,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q96DV4,MRPL38,"39S ribosomal protein L38, mitochondrial (L38mt) (MRP-L38)",12,34.5,27.29,28.57,25.79,29.19,29.46,30.13,29.6,29.06,29.94,29.38,28.36,29.07,29.02,28.83,-1.55,-0.26,-3.05,0.36,0.62,1.3,0.77,0.23,1.1,0.54,-0.48,0.24,0.18,,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9NYK5,MRPL39,"39S ribosomal protein L39, mitochondrial (L39mt) (MRP-L39) (39S ribosomal protein L5, mitochondrial) (L5mt) (MRP-L5)",12,37.3,28.84,28.47,27.81,29.21,29.67,29.69,28.9,29.47,29.86,30.06,28.18,28.74,29.34,29.1,-0.26,-0.62,-1.29,0.11,0.58,0.59,-0.2,0.37,0.77,0.96,-0.91,-0.35,0.25,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9BYD3,MRPL4,"39S ribosomal protein L4, mitochondrial (L4mt) (MRP-L4)",10,49,28.92,29.1,27.34,30.08,30.89,30.9,30.11,30.49,30.45,29.68,28.55,30.12,30.57,29.78,-0.86,-0.68,-2.44,0.3,1.11,1.11,0.32,0.7,0.66,-0.11,-1.24,0.34,0.78,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9NQ50,MRPL40,"39S ribosomal protein L40, mitochondrial (L40mt) (MRP-L40) (Nuclear localization signal-containing protein deleted in velocardiofacial syndrome) (Up-regulated in metastasis)",5,37,,26.33,26.55,27.53,28.16,28.05,27.7,27.65,27.85,27.49,25.29,26.9,27.19,27.22, ,-0.89,-0.67,0.31,0.93,0.83,0.48,0.42,0.62,0.26,-1.94,-0.33,-0.03,anatomical structure morphogenesis;developmental process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q8IXM3,MRPL41,"39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) (39S ribosomal protein L27 homolog) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog)",7,40.9,25.73,27.72,27.95,28.18,29.63,30.02,29.15,29.26,29.52,30.87,28.71,30.8,28.53,28.93,-3.19,-1.21,-0.98,-0.75,0.7,1.09,0.22,0.33,0.59,1.94,-0.22,1.87,-0.4,biosynthetic process;cell cycle;cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q8N983,MRPL43,"39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Mitochondrial ribosomal protein bMRP36a)",6,40.9,25.12,27.88,27.74,29.25,30.8,30.02,27.83,29.86,28.67,29.69,29.18,28.53,30.12,28.82,-3.7,-0.94,-1.08,0.43,1.98,1.2,-0.99,1.04,-0.15,0.87,0.35,-0.29,1.3,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9H9J2,MRPL44,"39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-)",14,40.7,28.23,28.85,28,29.12,30.04,30.15,29.42,29.26,30.03,30.21,28.43,28.62,29.66,29.23,-1,-0.38,-1.23,-0.11,0.81,0.92,0.19,0.03,0.79,0.98,-0.8,-0.61,0.42,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9BRJ2,MRPL45,"39S ribosomal protein L45, mitochondrial (L45mt) (MRP-L45)",11,31.9,28.09,27.42,28.35,28.5,29.74,30.1,29.24,28.98,28.86,29.44,28.56,28.6,29.23,28.85,-0.77,-1.43,-0.51,-0.35,0.89,1.25,0.39,0.13,0.01,0.58,-0.3,-0.25,0.37,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9H2W6,MRPL46,"39S ribosomal protein L46, mitochondrial (L46mt) (MRP-L46) (P2ECSL)",9,36.9,29.21,29.73,28.42,29.9,28.6,29.95,29.56,29.12,30.24,30.58,29.24,28.82,29.78,29.47,-0.26,0.26,-1.06,0.43,-0.87,0.47,0.08,-0.35,0.77,1.11,-0.24,-0.65,0.31,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q9HD33,MRPL47,"39S ribosomal protein L47, mitochondrial (L47mt) (MRP-L47) (Nasopharyngeal carcinoma metastasis-related protein 1)",12,40.4,27.51,27.71,27.66,28.54,29.55,29.72,29.14,29.47,29.99,29.99,28.53,28.63,29.35,28.91,-1.4,-1.19,-1.25,-0.37,0.65,0.81,0.24,0.56,1.08,1.09,-0.38,-0.28,0.44,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q96GC5,MRPL48,"39S ribosomal protein L48, mitochondrial (L48mt) (MRP-L48)",6,53.1,27.78,27.57,27.78,28.17,28.4,28.67,27.63,27.83,28.83,29.31,28.32,27.81,29.19,28.25,-0.47,-0.68,-0.47,-0.08,0.15,0.41,-0.62,-0.42,0.58,1.05,0.07,-0.44,0.94,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q13405,MRPL49,"39S ribosomal protein L49, mitochondrial (L49mt) (MRP-L49) (Neighbor of FAU) (NOF) (Protein NOF1)",6,38.6,27.14,28.02,26.05,28.2,28.57,29.53,28.67,28.48,28.8,29.83,27.75,28.14,28.91,28.32,-1.18,-0.3,-2.27,-0.11,0.25,1.21,0.35,0.16,0.49,1.52,-0.56,-0.17,0.6,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q8N5N7,MRPL50,"39S ribosomal protein L50, mitochondrial (L50mt) (MRP-L50)",7,54.4,26.7,27.95,28,28.87,30.31,30.38,29.5,29.59,30.09,30.11,28.22,27.49,29.3,28.96,-2.26,-1.01,-0.96,-0.09,1.35,1.42,0.54,0.62,1.13,1.14,-0.74,-1.47,0.34,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q4U2R6,MRPL51,"39S ribosomal protein L51, mitochondrial (L51mt) (MRP-L51) (bMRP-64) (bMRP64)",2,17.2,23.42,25.41,,25.78,27.56,25.95,26.41,25.95,26.74,27.14,24.5,25.53,25.84,25.85,-2.43,-0.44, ,-0.07,1.71,0.1,0.55,0.1,0.89,1.29,-1.35,-0.32,-0.02,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q96EL3,MRPL53,"39S ribosomal protein L53, mitochondrial (L53mt) (MRP-L53)",3,36.6,24.77,26.08,20.3,26.73,26.81,27.22,26.48,21.03,27.02,27.65,26.07,22.7,26.53,25.34,-0.57,0.74,-5.03,1.39,1.47,1.88,1.15,-4.31,1.68,2.31,0.74,-2.64,1.19,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q7Z7F7,MRPL55,"39S ribosomal protein L55, mitochondrial (L55mt) (MRP-L55)",5,31.2,,24.84,,26.48,27.98,27.65,26.47,26.32,27.56,27.12,25.81,26.42,27.72,26.76, ,-1.92, ,-0.28,1.22,0.89,-0.29,-0.44,0.79,0.36,-0.95,-0.34,0.96,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q9BYD2,MRPL9,"39S ribosomal protein L9, mitochondrial (L9mt) (MRP-L9)",9,26.2,27.51,27.35,,28.82,28.31,28.97,28.59,29.12,29.05,28.66,26.92,27.89,28.51,28.31,-0.8,-0.96, ,0.52,0,0.66,0.28,0.81,0.74,0.36,-1.39,-0.42,0.21,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P82664,MRPS10,"28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt)",5,36.9,25.35,26.56,25.73,27.75,26.85,28.78,28.53,28.24,28.24,28.65,27.19,26.43,28.61,27.45,-2.11,-0.89,-1.72,0.29,-0.6,1.32,1.08,0.79,0.79,1.2,-0.26,-1.03,1.15,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P82912,MRPS11,"28S ribosomal protein S11, mitochondrial (MRP-S11) (S11mt) (Cervical cancer proto-oncogene 2 protein) (HCC-2)",2,14.5,,25.2,,25.34,26.49,26.93,27.71,27.91,28.09,28.93,25.83,,26.23,26.87, ,-1.67, ,-1.53,-0.38,0.07,0.84,1.04,1.22,2.06,-1.03, ,-0.63,biosynthetic process;cellular metabolic process;cellular process;detection of stimulus;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
O60783,MRPS14,"28S ribosomal protein S14, mitochondrial (MRP-S14) (S14mt)",2,21.9,26.09,27.15,,28.41,28.39,28.41,28.19,28.54,28.13,28.53,,27.14,29.08,28.01,-1.92,-0.85, ,0.4,0.38,0.41,0.18,0.53,0.12,0.53, ,-0.86,1.08,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P82914,MRPS15,"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt)",6,25.7,26.58,28.35,28.31,27.51,27.18,29.4,28.95,28.35,29.06,30.4,25.89,25.21,28.72,27.99,-1.41,0.36,0.32,-0.48,-0.82,1.41,0.96,0.36,1.07,2.41,-2.1,-2.78,0.72,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;membrane;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y3D3,MRPS16,"28S ribosomal protein S16, mitochondrial (MRP-S16) (S16mt)",6,54.7,26.91,27.77,26.7,28.97,29.38,29.51,27.82,28.83,28.65,29.19,27.8,26.92,28.28,28.21,-1.29,-0.44,-1.51,0.76,1.17,1.3,-0.38,0.62,0.44,0.98,-0.41,-1.29,0.07,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y2R5,MRPS17,"28S ribosomal protein S17, mitochondrial (MRP-S17) (S17mt)",4,44.6,25.43,26.63,27.06,28.18,28.11,28.56,27.69,27.49,28.53,29.38,26.92,28.46,29.19,27.82,-2.39,-1.19,-0.76,0.36,0.29,0.74,-0.13,-0.33,0.71,1.57,-0.89,0.65,1.37,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9NVS2,MRPS18A,"28S ribosomal protein S18a, mitochondrial (MRP-S18-a) (Mrps18a) (S18mt-a) (28S ribosomal protein S18-3, mitochondrial) (MRP-S18-3)",2,16.8,24.38,25.83,24.79,27.44,25.59,27.17,27.38,26.68,28.66,29.05,25.27,27.58,27,26.68,-2.3,-0.85,-1.88,0.76,-1.08,0.49,0.7,0,1.98,2.37,-1.41,0.9,0.32,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y676,MRPS18B,"28S ribosomal protein S18b, mitochondrial (MRP-S18-b) (Mrps18-b) (S18mt-b) (28S ribosomal protein S18-2, mitochondrial) (MRP-S18-2)",7,30.6,24.78,27.07,26.27,27.03,28.92,29.14,28.04,28.77,28.98,29.85,28.34,26.23,28.95,27.87,-3.09,-0.8,-1.61,-0.85,1.04,1.26,0.17,0.9,1.11,1.97,0.47,-1.64,1.07,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y3D5,MRPS18C,"28S ribosomal protein S18c, mitochondrial (MRP-S18-c) (Mrps18-c) (S18mt-c) (28S ribosomal protein S18-1, mitochondrial) (MRP-S18-1)",2,15.9,,24.36,,26.03,,,25.94,,27.79,27.52,24.94,26.79,27.51,26.36, ,-2, ,-0.33, , ,-0.42, ,1.43,1.16,-1.42,0.43,1.15,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y399,MRPS2,"28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt)",9,29.7,27.98,29.02,29.26,29.6,29.55,29.84,29.02,28.54,28.81,28.81,27.81,28.63,29.31,28.94,-0.96,0.08,0.33,0.67,0.62,0.91,0.08,-0.39,-0.13,-0.13,-1.13,-0.31,0.38,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P82921,MRPS21,"28S ribosomal protein S21, mitochondrial (MRP-S21) (S21mt)",4,40.2,25.87,24.7,,27.48,28.27,28.47,28.72,27.53,28.22,26.21,,24.39,27.43,27.03,-1.16,-2.32, ,0.45,1.25,1.45,1.69,0.5,1.19,-0.82, ,-2.64,0.4,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P82650,MRPS22,"28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt)",13,35.1,28.73,29.61,28.39,30.01,30.27,30.35,30.05,29.65,30.07,29.87,29.21,29.61,30.46,29.71,-0.99,-0.1,-1.33,0.3,0.56,0.64,0.33,-0.06,0.36,0.15,-0.51,-0.1,0.75,,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y3D9,MRPS23,"28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt)",10,45.3,26.3,28.24,27.97,28.91,30.37,30.01,29.91,29.89,29.73,30.61,28.61,29.72,29.9,29.25,-2.95,-1.01,-1.27,-0.33,1.13,0.77,0.67,0.65,0.48,1.37,-0.63,0.47,0.66,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q96EL2,MRPS24,"28S ribosomal protein S24, mitochondrial (MRP-S24) (S24mt) (bMRP-47) (bMRP47)",2,16.8,25.98,26.66,25.09,27.25,27.01,27.57,27.29,26.51,27.85,25.56,27.13,,27.99,26.82,-0.84,-0.16,-1.73,0.42,0.18,0.74,0.47,-0.31,1.03,-1.27,0.31, ,1.16,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P82663,MRPS25,"28S ribosomal protein S25, mitochondrial (MRP-S25) (S25mt)",9,45.7,25.54,24.82,27.89,28.71,28.64,29.44,29.38,28.4,29.29,29.65,26.66,27.38,27.55,27.95,-2.41,-3.13,-0.06,0.76,0.69,1.49,1.43,0.45,1.34,1.7,-1.29,-0.57,-0.4,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9BYN8,MRPS26,"28S ribosomal protein S26, mitochondrial (MRP-S26) (S26mt) (28S ribosomal protein S13, mitochondrial) (MRP-S13) (S13mt)",5,28.3,26.44,26.99,27.84,27.06,28.16,28.39,27.96,28.14,28.29,29.24,,21.49,27.6,27.3,-0.86,-0.31,0.54,-0.24,0.86,1.09,0.66,0.84,0.99,1.94, ,-5.81,0.3,biosynthetic process;cellular metabolic process;cellular process;detection of stimulus;metabolic process;peptide metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y2Q9,MRPS28,"28S ribosomal protein S28, mitochondrial (MRP-S28) (S28mt) (28S ribosomal protein S35, mitochondrial) (MRP-S35) (S35mt)",4,18.2,23.77,27.56,,25.19,28.6,28.62,27.98,28.05,27.52,28,27.68,,27.82,27.34,-3.58,0.21, ,-2.16,1.26,1.27,0.64,0.7,0.18,0.65,0.34, ,0.47,,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9NP92,MRPS30,"28S ribosomal protein S30, mitochondrial (MRP-S30) (S30mt) (Programmed cell death protein 9)",6,18.9,27.07,28.37,27.14,28.14,27.46,28.45,29.45,24.17,29.41,29.54,28.79,29.03,28.29,28.1,-1.04,0.27,-0.96,0.04,-0.64,0.35,1.35,-3.93,1.31,1.43,0.69,0.93,0.19,biosynthetic process;cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q92665,MRPS31,"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt) (Imogen 38)",9,32.7,26.2,28.72,26.7,29.57,29.55,29.77,29.79,29.05,29.61,29.71,28.13,29.94,29.39,28.93,-2.73,-0.21,-2.24,0.64,0.62,0.84,0.86,0.12,0.67,0.77,-0.8,1.01,0.45,,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y291,MRPS33,"28S ribosomal protein S33, mitochondrial (MRP-S33) (S33mt)",4,44.3,,25.63,,26.04,25.32,27.44,26.08,26.1,26.51,27.07,26.43,,26.09,26.27, ,-0.64, ,-0.23,-0.95,1.17,-0.19,-0.17,0.24,0.8,0.16, ,-0.18,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P82930,MRPS34,"28S ribosomal protein S34, mitochondrial (MRP-S34) (S34mt)",9,40.8,25.54,28.2,27.24,29.04,29.76,29.86,29.64,29.44,29.67,29.72,28.61,29.27,29.91,28.92,-3.38,-0.71,-1.68,0.12,0.84,0.95,0.73,0.52,0.76,0.81,-0.3,0.35,0.99,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P82673,MRPS35,"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt) (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt)",9,37.3,27.19,28.23,27.24,28.67,29.2,29.66,28.07,28.89,28.54,28.99,28.12,28.9,29.34,28.54,-1.35,-0.31,-1.3,0.13,0.66,1.12,-0.47,0.35,0,0.45,-0.43,0.36,0.79,biosynthetic process;cellular metabolic process;cellular process;detection of stimulus;metabolic process;peptide metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P82909,MRPS36,"28S ribosomal protein S36, mitochondrial (MRP-S36) (S36mt)",6,64.1,28.75,29.86,27.36,29.09,29.68,29.73,30,29.73,29.77,29.67,30.34,27.74,29.2,29.3,-0.55,0.56,-1.94,-0.22,0.38,0.43,0.7,0.43,0.47,0.36,1.04,-1.56,-0.11,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P82675,MRPS5,"28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt)",7,17.9,27.17,26.57,28.09,27.08,28.26,28.3,27.68,27.41,28.21,29.81,27.66,29.58,28.01,27.99,-0.82,-1.41,0.11,-0.91,0.28,0.32,-0.31,-0.58,0.22,1.82,-0.33,1.59,0.02,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P82932,MRPS6,"28S ribosomal protein S6, mitochondrial (MRP-S6) (S6mt)",5,36.8,26.89,27.73,27.35,27.85,28.47,28.82,28.03,27.06,30.33,29.15,27.75,26.66,27.49,27.97,-1.08,-0.24,-0.62,-0.12,0.5,0.85,0.06,-0.9,2.37,1.18,-0.21,-1.31,-0.48,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q9Y2R9,MRPS7,"28S ribosomal protein S7, mitochondrial (MRP-S7) (S7mt) (bMRP-27a) (bMRP27a)",10,51.2,27.9,28.54,24.79,29.84,30.75,30.34,29.75,29.74,29.61,30.92,29.46,30.32,30.69,29.43,-1.53,-0.89,-4.64,0.41,1.31,0.91,0.31,0.3,0.17,1.49,0.03,0.88,1.25,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P82933,MRPS9,"28S ribosomal protein S9, mitochondrial (MRP-S9) (S9mt)",11,35.6,27.45,28.16,27.09,29.1,29.01,29.36,29.73,29.78,29.48,29.26,28.6,28.64,29.37,28.85,-1.4,-0.69,-1.76,0.25,0.16,0.51,0.88,0.93,0.63,0.41,-0.25,-0.2,0.52,biosynthetic process;cellular metabolic process;cellular process;detection of stimulus;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;translation,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q96E11,MRRF,"Ribosome-recycling factor, mitochondrial (RRF) (Ribosome-releasing factor, mitochondrial)",5,30.5,26.19,28.62,24.82,27.88,27.68,27.1,27.81,27.66,27.39,28.6,29.16,27.9,26.5,27.49,-1.3,1.13,-2.67,0.4,0.2,-0.39,0.33,0.18,-0.1,1.11,1.68,0.42,-0.99,biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9UKD2,MRTO4,mRNA turnover protein 4 homolog,9,36.4,28.49,28.24,27.39,29.43,29.91,29.85,28.99,29.05,29.46,29.28,27.88,27.88,28.61,28.8,-0.32,-0.57,-1.41,0.63,1.1,1.04,0.19,0.25,0.65,0.48,-0.93,-0.92,-0.2,cellular process;ribosome biogenesis,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
P43246,MSH2,DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2),16,19.3,30.14,28.1,28.38,28.56,28.44,28.94,28.2,28.25,28.81,26.55,,27.66,27.7,28.31,1.83,-0.22,0.07,0.25,0.13,0.63,-0.11,-0.06,0.5,-1.76, ,-0.65,-0.61,anatomical structure development;biological regulation;cell activation;cell development;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;developmental process;DNA metabolic process;DNA recombination;DNA repair;embryo development;generation of precursor metabolites and energy;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mismatch repair complex;nuclear chromosome;organelle;protein complex,,,,,,,,,,
P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),22,23.3,30.52,28.15,28.63,28.21,28.21,28.22,28.11,27.91,28.29,25.49,27.22,27.59,27.72,28.02,2.5,0.13,0.61,0.18,0.19,0.19,0.09,-0.11,0.26,-2.53,-0.8,-0.43,-0.3,biological regulation;cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;DNA repair;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mismatch repair complex;nuclear chromosome;organelle;protein complex,,,,,,,,,,
Q96DH6,MSI2,RNA-binding protein Musashi homolog 2 (Musashi-2),4,19.5,25.29,26.46,25.03,25.81,,24.79,27.01,,25.79,26.28,27.11,27.94,26.17,26.15,-0.86,0.31,-1.13,-0.34, ,-1.36,0.86, ,-0.37,0.13,0.96,1.79,0.01,anatomical structure development;cell development;cellular process;developmental process,cell part;cytoplasm;macromolecular complex;polysome;ribonucleoprotein complex,,,,,,,,,,
Q13421,MSLN,"Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF);Mesothelin, cleaved form]",20,47.1,32.28,31.32,30.12,28.31,27.87,28.39,28.85,29.73,26.04,28.4,30.08,29.23,30.64,29.33,2.95,1.99,0.79,-1.02,-1.46,-0.93,-0.48,0.4,-3.29,-0.93,0.76,-0.1,1.31,anatomical structure development;biological adhesion;cell adhesion;cellular process;developmental process,cell part;cell surface;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q15800,MSMO1,Methylsterol monooxygenase 1 (EC 1.14.13.72) (C-4 methylsterol oxidase),4,15,26.33,26.72,26.16,29.06,28.56,29.19,29.41,29.31,29.84,29.46,27.94,28.69,27.62,28.33,-2,-1.61,-2.17,0.73,0.23,0.86,1.08,0.98,1.51,1.13,-0.39,0.36,-0.71,alcohol metabolic process;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane;plasma membrane,,,,,,,,,,
P26038,MSN,Moesin (Membrane-organizing extension spike protein),62,66.2,32.73,33.84,33.78,33.89,33.47,32.89,33.8,33.86,33.28,32.37,33.84,33.98,31.74,33.34,-0.62,0.49,0.44,0.55,0.13,-0.45,0.45,0.52,-0.06,-0.97,0.5,0.63,-1.61,biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular process;immune system process;locomotion;membrane docking,apical part of cell;cell part;cell projection;cytoplasm;cytoskeleton;extracellular organelle;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microvillus;nucleolus;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9UJ68,MSRA,Mitochondrial peptide methionine sulfoxide reductase (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase) (Protein-methionine-S-oxide reductase) (PMSR),2,17.8,25.69,26.94,23.83,26.59,,26.78,,26.16,25.52,25.91,27.1,25.76,26.24,26.05,-0.35,0.89,-2.22,0.54, ,0.74, ,0.11,-0.53,-0.14,1.05,-0.28,0.19,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9Y3D2,MSRB2,"Methionine-R-sulfoxide reductase B2, mitochondrial (MsrB2) (EC 1.8.4.-)",3,18.7,24.46,27.2,26.37,26.57,26.94,28.62,27.33,26.54,28.07,26.81,25.21,27.72,27.41,26.87,-2.41,0.34,-0.5,-0.3,0.07,1.75,0.46,-0.32,1.21,-0.05,-1.66,0.86,0.54,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9P289,MST4,Serine/threonine-protein kinase MST4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 4) (MST-4) (Mst3 and SOK1-related kinase) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK),10,37.5,25.44,,26.22,24.31,24.39,26.77,28.87,28.57,24.44,27.06,29.6,32.11,26.16,26.99,-1.56, ,-0.77,-2.68,-2.61,-0.23,1.88,1.57,-2.56,0.07,2.6,5.12,-0.84,biological regulation;cellular component disassembly;cellular component organization;cellular process,cell part;cytosol;membrane,,+,,,,,,,,
P02795,MT2A,Metallothionein-2 (MT-2) (Metallothionein-2A) (Metallothionein-II) (MT-II),3,65.6,25.37,27.67,27.87,29.1,20.26,22.53,25.84,26.22,25.46,,25.8,,,25.61,-0.24,2.06,2.26,3.49,-5.35,-3.08,0.23,0.61,-0.15, ,0.19, , ,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;homeostatic process;response to chemical stimulus;response to drug;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q13330,MTA1,Metastasis-associated protein MTA1,10,18.6,27.96,27.06,25.49,27.61,27.93,27.87,27.46,27.58,28.21,26.61,24.86,27.85,27.72,27.25,0.71,-0.19,-1.76,0.37,0.68,0.62,0.21,0.33,0.96,-0.64,-2.38,0.6,0.48,biological regulation;cellular component organization;cellular process;organelle organization;response to stimulus;signal transduction;vesicle organization,cell part;chromatin remodeling complex;cytoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;transcriptional repressor complex,,,,,,,,,,
O94776,MTA2,Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex),20,34,31.26,29.79,30.3,30.39,30.98,30.72,30.69,30.07,31.03,30.59,28.83,29.81,30.42,30.38,0.89,-0.58,-0.08,0.01,0.6,0.34,0.31,-0.3,0.66,0.22,-1.55,-0.56,0.05,"biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;DNA metabolic process;DNA modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;regulation of gene expression, epigenetic;small molecule metabolic process",cell part;chromatin remodeling complex;macromolecular complex;protein complex;transcription factor complex;transcriptional repressor complex,,,,,,,,,,
Q9BTC8,MTA3,Metastasis-associated protein MTA3,7,13.8,27.96,26.7,25.88,26.24,27.57,27.15,26.3,27.44,26.29,27.15,,26.18,25.41,26.69,1.27,0.01,-0.81,-0.45,0.88,0.46,-0.39,0.76,-0.4,0.46, ,-0.51,-1.28,biological regulation;regulation of cell cycle;regulation of mitotic cell cycle,cell part;chromatin remodeling complex;cohesin complex;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;transcriptional repressor complex,,,,,,,,,,
Q13126,MTAP,S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase),14,61.1,29.39,29.98,30.89,30.22,29.35,28.81,30.14,30.43,28.18,28.83,28.77,30.31,27.88,29.48,-0.08,0.51,1.42,0.75,-0.13,-0.67,0.66,0.96,-1.3,-0.65,-0.7,0.83,-1.59,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;organic acid metabolic process;primary metabolic process;purine-containing compound salvage;response to chemical stimulus;response to endogenous stimulus;response to stimulus;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P03928,MT-ATP8,ATP synthase protein 8 (A6L) (F-ATPase subunit 8),3,48.5,26.88,27.75,28.71,27.59,28.6,27.88,27.41,28.57,26.01,27.62,26.76,,27.57,27.61,-0.73,0.14,1.09,-0.02,0.98,0.27,-0.2,0.96,-1.61,0.01,-0.85, ,-0.05,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;heterocycle metabolic process;hydrogen transport;ion transport;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9NZJ7,MTCH1,Mitochondrial carrier homolog 1 (Presenilin-associated protein),10,31.9,29.02,29.53,28.12,28.49,28.75,28.27,27.71,28.94,25.5,29.32,28.19,27.65,29.07,28.35,0.67,1.18,-0.23,0.14,0.4,-0.08,-0.64,0.59,-2.85,0.97,-0.16,-0.7,0.72,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane organization;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9Y6C9,MTCH2,Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein),12,48.8,31.45,32.2,31.95,31.12,31.51,32.21,31.86,31.9,32.32,32.67,32.02,31.29,32.16,31.9,-0.45,0.3,0.05,-0.78,-0.39,0.31,-0.04,0,0.42,0.78,0.12,-0.61,0.27,establishment of localization;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
P00403,MT-CO2,Cytochrome c oxidase subunit 2 (Cytochrome c oxidase polypeptide II),8,32.3,31.15,31.94,29.71,31.95,31.98,32.45,31.98,31.89,32.38,32.27,30.69,31.32,31.98,31.67,-0.52,0.27,-1.96,0.28,0.31,0.78,0.31,0.22,0.71,0.61,-0.98,-0.35,0.31,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q86UE4,MTDH,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),29,43.3,31.63,31,30.68,31.11,31.16,31.48,31.5,30.96,31.76,31.65,31.56,31.49,31.77,31.36,0.26,-0.36,-0.69,-0.26,-0.2,0.11,0.13,-0.4,0.4,0.28,0.19,0.12,0.4,biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;response to biotic stimulus;response to chemical stimulus;response to stimulus;signal transduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q9H019,MTFR1L,Mitochondrial fission regulator 1-like,6,21.8,25.98,26.72,26.02,26.18,27.33,26.5,25.87,25.9,27.77,25.76,25.9,,26.19,26.34,-0.36,0.38,-0.33,-0.16,0.99,0.16,-0.47,-0.44,1.43,-0.58,-0.45, ,-0.15,,,,,,,,,,,,
P11586,MTHFD1,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5);Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9);Formyltetrahydrofolate synthetase (EC 6.3.4.3)]",30,37,31.46,31.57,31.55,32.38,32.1,31.11,32.27,32.43,30.35,31.68,32.02,32.08,30.61,31.66,-0.2,-0.09,-0.12,0.71,0.44,-0.55,0.61,0.76,-1.31,0.02,0.35,0.41,-1.05,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;one-carbon metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;vitamin metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6UB35,MTHFD1L,"Monofunctional C1-tetrahydrofolate synthase, mitochondrial (EC 6.3.4.3) (Formyltetrahydrofolate synthetase)",33,33.9,29.49,29.76,29.95,30.88,31.12,31.72,31.02,30.67,30.67,30.93,31.36,29.86,31.82,30.71,-1.22,-0.95,-0.76,0.17,0.4,1.01,0.31,-0.04,-0.04,0.22,0.65,-0.85,1.11,biosynthetic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;one-carbon metabolic process;organic acid metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P13995,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15);Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]",9,36.9,29.6,29.99,27.83,29.45,29.04,29.25,29.12,28.39,29.79,30.38,27.71,25.78,30.03,28.95,0.65,1.04,-1.12,0.5,0.09,0.3,0.17,-0.56,0.84,1.43,-1.24,-3.17,1.08,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;one-carbon metabolic process;response to abiotic stimulus;response to heat;response to stimulus;response to stress;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P46199,MTIF2,"Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt))",8,16,26.92,27.62,27.35,25.92,26.95,26.88,25.22,27.88,26.81,27.69,26.84,24.69,26.23,26.69,0.22,0.93,0.66,-0.77,0.26,0.19,-1.47,1.19,0.12,0.99,0.15,-2.01,-0.46,biological regulation;catabolic process;cellular component assembly;cellular component disassembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;regulation of translation;ribonucleoprotein complex assembly;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9H2K0,MTIF3,"Translation initiation factor IF-3, mitochondrial (IF-3(Mt)) (IF-3Mt) (IF3(mt)) (IF3mt)",4,14.7,27.38,26.78,28.07,27.3,,25.13,27.76,,26.78,27.47,27.39,28.4,25.95,27.13,0.26,-0.35,0.94,0.17, ,-2,0.63, ,-0.35,0.34,0.26,1.27,-1.18,biological regulation;cellular component assembly;cellular component disassembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of translation;ribonucleoprotein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9C0I1,MTMR12,Myotubularin-related protein 12 (Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit) (3-PAP) (3-phosphatase adapter protein),3,6.8,24,21.91,,21.55,22.1,22.8,,,,,24.95,25.86,23.27,23.3,0.69,-1.39, ,-1.75,-1.21,-0.51, , , , ,1.65,2.56,-0.04,,cell part;cytoplasm,,,,,,,,,,
Q9Y217,MTMR6,Myotubularin-related protein 6 (EC 3.1.3.-),5,10.3,,,25.9,24.91,,26.38,27.61,26.6,,,26.03,27.38,25.89,26.34, , ,-0.43,-1.43, ,0.04,1.28,0.26, , ,-0.31,1.04,-0.45,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;nuclear envelope,,,+,,,,,,,
P42345,MTOR,Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1),13,6.8,28.72,28.53,26.45,27.81,28.32,27.7,28.46,28.74,27.42,27.01,28.97,29.28,27.34,28.06,0.66,0.48,-1.6,-0.25,0.26,-0.36,0.4,0.68,-0.64,-1.05,0.91,1.22,-0.72,anatomical structure development;biological regulation;catabolic process;cell communication;cell development;cell growth;cellular component organization;cellular metabolic process;cellular process;developmental process;growth;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein catabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;regulation of protein modification process;regulation of translation;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;signal transduction,cell part;endomembrane system;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;membrane;organelle;phosphatidylinositol 3-kinase complex;protein complex;vacuole,,+,,,,,,,,
Q9NVV4,MTPAP,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",3,6.4,26.1,24.66,26.42,24.26,,26.34,22.46,25.58,,26.33,26.43,25.74,25.89,25.47,0.63,-0.81,0.95,-1.21, ,0.86,-3.01,0.1, ,0.86,0.96,0.27,0.41,biosynthetic process;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle;plasma membrane,,,,,,,,,,
P58546,MTPN,Myotrophin (Protein V-1),6,46.6,30.58,30.39,30.58,30.4,29.94,28.32,29.68,30.56,27.9,27.79,29.97,30.85,27.92,29.61,0.98,0.79,0.97,0.8,0.33,-1.29,0.07,0.95,-1.71,-1.82,0.37,1.25,-1.69,alcohol metabolic process;amine metabolic process;anatomical structure development;anatomical structure morphogenesis;biological regulation;cell differentiation;cell growth;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;growth;metabolic process;nitrogen compound metabolic process;regulation of translation;small molecule metabolic process,cell part;cell projection;cytosol;F-actin capping protein complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;nucleus;organelle;protein complex,,,,,,,,,,
Q99707,MTR,Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS),10,10.1,21.31,27.13,26.44,28.68,27.7,22.57,26.05,27.95,23.67,,25,25.8,,25.66,-4.35,1.46,0.78,3.01,2.04,-3.1,0.39,2.29,-1.99, ,-0.66,0.13, ,amine metabolic process;anatomical structure development;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;one-carbon metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q13505,MTX1,Metaxin-1 (Mitochondrial outer membrane import complex protein 1),8,34.7,30.18,30.02,30.05,29.52,30.33,29.83,30.14,29.13,30.23,30.18,29.52,29.88,29.71,29.9,0.27,0.12,0.15,-0.38,0.43,-0.07,0.24,-0.77,0.33,0.28,-0.38,-0.02,-0.19,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
O75431,MTX2,Metaxin-2 (Mitochondrial outer membrane import complex protein 2),8,43.3,29.37,30.32,29.57,29.72,27.93,29.3,29.15,27.98,30.36,30.72,29.7,27.3,28.69,29.24,0.13,1.08,0.33,0.48,-1.31,0.06,-0.09,-1.26,1.12,1.48,0.46,-1.94,-0.55,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;membrane,,,,,,,,,,
P15941,MUC1,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha);Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],9,73.1,32.58,31.57,31.46,28.19,27.9,,23.79,27.39,,32.65,25.74,,,29.03,3.55,2.54,2.43,-0.84,-1.13, ,-5.24,-1.64, ,3.62,-3.29, , ,biological regulation;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cell surface;extracellular region,,,,,,,,,,
Q9H3R2,MUC13,Mucin-13 (MUC-13) (Down-regulated in colon cancer 1),2,8.6,27.9,27.3,27.33,23.22,27.46,29.29,27.2,28.37,26.57,28.34,28.67,28.24,27.22,27.47,0.43,-0.17,-0.14,-4.25,-0.01,1.82,-0.27,0.9,-0.9,0.86,1.2,0.77,-0.25,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;extracellular region,,,,,,,,,,
P22033,MUT,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)",19,28.5,29.04,30.49,29.58,29.54,29.52,29.64,29.2,30.12,30.59,30.26,29.58,29.89,30.76,29.86,-0.82,0.63,-0.28,-0.32,-0.35,-0.22,-0.67,0.26,0.73,0.4,-0.28,0.03,0.9,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;post-embryonic development;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part,,,,,,,,,,
Q96EY5,MVB12A,Multivesicular body subunit 12A (CIN85/CD2AP family-binding protein) (ESCRT-I complex subunit MVB12A) (Protein FAM125A),2,24.8,24.93,24.54,,24.36,24.74,,25,,24.78,,25.17,24.65,24.99,24.8,0.13,-0.26, ,-0.43,-0.06, ,0.2, ,-0.01, ,0.37,-0.14,0.19,establishment of localization;protein transport;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;nucleus;organelle,,,,,,,,,,
P53602,MVD,Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase),11,35.8,26.25,27.73,26.48,30.14,28.3,27.46,29.89,30.05,28.17,27.9,28.98,30.18,,28.46,-2.21,-0.73,-1.99,1.68,-0.16,-1,1.43,1.59,-0.29,-0.56,0.52,1.72, ,alcohol metabolic process;biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q03426,MVK,Mevalonate kinase (MK) (EC 2.7.1.36),4,18.3,25.11,,,24.94,25.22,,27.9,27.17,,25.35,,27.85,,26.22,-1.1, , ,-1.28,-1, ,1.68,0.95, ,-0.87, ,1.63, ,alcohol metabolic process;biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;isopentenyl diphosphate metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q14764,MVP,Major vault protein (MVP) (Lung resistance-related protein),66,75.5,34.25,33.5,33.51,33.89,33.2,33.07,33.85,34.29,33.18,33.77,34.85,34.22,34.02,33.82,0.44,-0.32,-0.3,0.08,-0.62,-0.75,0.04,0.47,-0.63,-0.04,1.04,0.4,0.2,biological regulation;establishment of localization;nucleobase-containing compound transport;protein transport;regulation of protein modification process;transport,cell part;cytoskeleton;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;nucleus;organelle;protein complex;ribonucleoprotein complex;vesicle,,,,,,,,,,
P20591,MX1,"Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed]",51,66.9,30.07,31.32,34.86,34.65,30.84,28.41,29.07,32.21,26.62,30.2,29.41,30.16,27.84,30.43,-0.37,0.88,4.42,4.22,0.41,-2.03,-1.36,1.77,-3.81,-0.23,-1.03,-0.28,-2.6,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;immune system process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
P20592,MX2,Interferon-induced GTP-binding protein Mx2 (Interferon-regulated resistance GTP-binding protein MxB) (Myxovirus resistance protein 2) (p78-related protein),23,35.7,26,29.34,32.13,30.72,23.13,,25.51,27.11,23.24,22.92,25.87,,,26.6,-0.59,2.74,5.53,4.12,-3.46, ,-1.08,0.51,-3.36,-3.68,-0.73, , ,biological regulation;cellular process;establishment of localization;nucleobase-containing compound transport;protein transport;regulation of cell cycle;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;transport,cell part;cytosol;macromolecular complex;nuclear pore;protein complex,,,,,,,,,,
Q9NR99,MXRA5,Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican),22,10.1,,31.18,26.92,26.91,,25.12,,26.13,23.71,,,26.75,27.47,26.77, ,4.41,0.14,0.14, ,-1.65, ,-0.64,-3.06, , ,-0.02,0.7,,extracellular region,,,,,,,,,,
P84157,MXRA7,Matrix-remodeling-associated protein 7 (Transmembrane anchor protein 1),10,35.3,28.91,30.28,30.55,30.37,28.97,29.1,30.08,28.25,29.92,29.26,30.28,31.57,27.26,29.6,-0.69,0.68,0.95,0.77,-0.63,-0.5,0.48,-1.35,0.32,-0.34,0.68,1.97,-2.34,,cell part,,,,,,,,,,
P84157,MXRA7,Matrix-remodeling-associated protein 7 (Transmembrane anchor protein 1),10,35.3,28.91,30.28,30.55,30.37,28.97,29.1,30.08,28.25,29.92,29.26,30.28,31.57,27.26,29.6,-0.69,0.68,0.95,0.77,-0.63,-0.5,0.48,-1.35,0.32,-0.34,0.68,1.97,-2.34,,cell part,,,,,,,,,,
Q96S97,MYADM,Myeloid-associated differentiation marker (Protein SB135),2,19.7,22.91,,22.13,25.8,,24.62,24.72,25.69,25.06,23.91,,,,24.36,-1.45, ,-2.23,1.45, ,0.26,0.37,1.34,0.71,-0.45, , , ,,cell part,,,,,,,,,,
Q9BQG0,MYBBP1A,Myb-binding protein 1A,43,34,31.05,30.91,30.28,31.29,31.83,31.8,31.64,30.8,31.98,31.75,30.48,31.37,31.37,31.27,-0.23,-0.36,-0.99,0.02,0.56,0.52,0.37,-0.48,0.71,0.48,-0.79,0.1,0.1,biological regulation;biosynthetic process;cell communication;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;regulation of cell cycle;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;RNA metabolic process;signal transduction;transport,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleocytoplasmic shuttling complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q99417,MYCBP,C-Myc-binding protein (Associate of Myc 1) (AMY-1),6,72.8,29.96,28.15,29.34,28.43,28.92,28.21,29.41,29.44,27.39,29.15,27.78,26.13,28.24,28.5,1.46,-0.36,0.84,-0.07,0.42,-0.3,0.91,0.94,-1.11,0.64,-0.72,-2.37,-0.27,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9P2K5,MYEF2,Myelin expression factor 2 (MEF-2) (MyEF-2) (MST156),13,29.7,29.42,27.44,27.06,24.77,28.28,27.68,28.49,27.69,29.05,29.57,27.6,24.54,27.02,27.59,1.83,-0.15,-0.53,-2.81,0.7,0.1,0.9,0.1,1.46,1.98,0.01,-3.04,-0.57,biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P35580,MYH10,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)",89,44.8,33.08,33.06,32.78,32.74,31.81,31.51,32.54,32.52,31.29,32.2,31.4,32.53,30.54,32.15,0.92,0.91,0.62,0.58,-0.35,-0.64,0.39,0.37,-0.86,0.04,-0.75,0.38,-1.62,biological regulation;cellular component movement;cellular process;cytokinesis;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell cortex;cell part;macromolecular complex;midbody;protein complex,,,,,,,,,,
Q7Z406,MYH14,"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)",111,57.9,34.08,30.52,33.5,29.65,30.01,30.14,30.63,30.62,30.03,29.8,30.83,30.8,29.51,30.78,3.31,-0.25,2.72,-1.13,-0.77,-0.64,-0.15,-0.15,-0.75,-0.98,0.05,0.02,-1.27,biological regulation;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;macromolecular complex;protein complex,,,,,,,,,,
P05976,MYL1,"Myosin light chain 1/3, skeletal muscle isoform (MLC1/MLC3) (MLC1F/MLC3F) (Myosin light chain alkali 1/2) (Myosin light chain A1/A2)",2,11.4,,31.29,28.01,31.53,31.31,30.72,30.56,31.62,29.81,28.48,31.95,,30.44,30.52, ,0.77,-2.51,1.01,0.79,0.2,0.05,1.1,-0.71,-2.04,1.43, ,-0.08,anatomical structure development;cellular component movement;cellular process;developmental process;multicellular organismal process;muscle contraction,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P19105,MYL12A,"Myosin regulatory light chain 12A (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)",18,72.5,33.1,33.31,32.89,33.73,32.76,33.21,34.02,33.74,32.85,32.8,34.25,34.62,33.28,33.43,-0.32,-0.12,-0.54,0.3,-0.67,-0.21,0.59,0.31,-0.58,-0.63,0.83,1.2,-0.15,biological regulation;establishment of localization;protein targeting;protein transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
P60660,MYL6,Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6),15,81.4,34.65,34.45,34.19,34.75,34.34,34.31,34.97,34.95,34.21,34.31,35.14,35.1,34.34,34.59,0.06,-0.14,-0.4,0.15,-0.25,-0.28,0.37,0.36,-0.39,-0.28,0.54,0.5,-0.25,anatomical structure development;cellular component movement;cellular process;developmental process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P14649,MYL6B,Myosin light chain 6B (Myosin light chain 1 slow-twitch muscle A isoform) (MLC1sa) (Smooth muscle and nonmuscle myosin light chain alkali 6B),2,13.7,21.31,23.79,26.44,21.39,,20.12,26.67,,26.8,,21.74,24.76,27.77,24.08,-2.77,-0.29,2.36,-2.69, ,-3.96,2.59, ,2.72, ,-2.34,0.69,3.69,anatomical structure development;cellular component movement;cellular process;developmental process,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P24844,MYL9,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",5,39,27.88,25.58,27.59,29.16,,,,25.9,,,,28.91,24.74,27.11,0.77,-1.53,0.48,2.05, , , ,-1.21, , , ,1.8,-2.37,biological regulation;locomotion;multicellular organismal process;muscle contraction;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q15746,MYLK,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",26,16.5,27.76,30.61,28.76,30.68,29.06,29.35,28.51,29.5,30.15,28.47,29.57,30.74,30.5,29.51,-1.75,1.1,-0.75,1.17,-0.45,-0.17,-1,-0.02,0.64,-1.04,0.06,1.23,0.98,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component organization;cellular process;developmental process;multicellular organismal process;muscle contraction;regulation of transport;response to abiotic stimulus;response to osmotic stress;response to stimulus;response to stress,cell part;cell projection;cytosol;membrane;plasma membrane,,+,,,,,,,,
Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),24,15.9,29.2,25.92,28.7,26.33,26.77,27.3,27.44,27.54,27.22,27.6,28,29.5,27.77,27.64,1.56,-1.72,1.07,-1.31,-0.87,-0.34,-0.19,-0.09,-0.42,-0.04,0.36,1.86,0.13,biological regulation;cell motility;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;DNA metabolic process;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
O43795,MYO1B,Unconventional myosin-Ib (MYH-1c) (Myosin I alpha) (MMI-alpha) (MMIa),42,42.9,31.5,31.8,31.53,31.4,31.86,31.76,30.53,31.28,32.8,32.96,30.73,31.75,31.91,31.68,-0.17,0.12,-0.14,-0.28,0.18,0.08,-1.14,-0.4,1.12,1.28,-0.95,0.07,0.23,cellular component assembly;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;organelle organization,brush border;cell part;cell projection;cytoplasm;filopodium;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
O00159,MYO1C,Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb),62,54.6,32.01,33.01,32.52,32.62,33.24,33.23,33.75,33.26,34.02,33.44,33.47,33.48,34.18,33.25,-1.24,-0.24,-0.73,-0.63,-0.01,-0.02,0.5,0.01,0.78,0.19,0.22,0.23,0.93,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;immune system process;membrane organization;nucleobase-containing compound transport;protein targeting;protein transport;regulation of transport;response to stimulus;response to stress;transport,brush border;cell part;cell projection;cytosol;extracellular organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microvillus;nuclear pore;nucleolus;nucleoplasm;organelle;protein complex;vesicle,,,,,,,,,,
Q12965,MYO1E,Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E),13,12.3,28.52,28.5,28.89,28.54,27.32,26.76,28.4,29.2,28.39,29,28.77,27.19,27.56,28.23,0.29,0.26,0.65,0.3,-0.91,-1.48,0.16,0.97,0.15,0.77,0.54,-1.04,-0.67,anatomical structure development;biological regulation;cell development;cell differentiation;cellular component movement;cellular component organization;cellular membrane organization;cellular process;developmental process;embryo development;endocytosis;establishment of localization;extracellular matrix organization;extracellular structure organization;membrane invagination;membrane organization;multicellular organismal process;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasm;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
Q9Y4I1,MYO5A,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)",10,6.8,,25.3,25.78,24.53,,21.63,26.48,27.43,24.62,22,27.65,25.93,27.14,25.32, ,-0.01,0.46,-0.79, ,-3.69,1.16,2.11,-0.7,-3.32,2.34,0.62,1.82,anatomical structure morphogenesis;biological regulation;biosynthetic process;cell communication;cell differentiation;cell-cell signaling;cellular component movement;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;growth;hormone transport;lipid metabolic process;localization;locomotion;macromolecule metabolic process;membrane organization;metabolic process;molting cycle;multicellular organismal process;neurological system process;organelle localization;organic acid metabolic process;peptide transport;pigment metabolic process;plasma membrane organization;primary metabolic process;protein metabolic process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secondary metabolic process;secretion;signaling;small molecule metabolic process;transport;vesicle-mediated transport,cell body;cell part;cell projection;cilium;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;neuronal cell body;organelle;protein complex;site of polarized growth;vesicle,,,,,,,,,,
Q9ULV0,MYO5B,Unconventional myosin-Vb,12,8.9,28.11,27.65,27.31,,24,,25.54,26.08,,27.45,25.81,25.87,,26.43,1.68,1.23,0.88, ,-2.43, ,-0.88,-0.34, ,1.02,-0.61,-0.55, ,cellular process;establishment of localization;fluid transport;protein transport;transmembrane transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9UM54,MYO6,Unconventional myosin-VI (Unconventional myosin-6),45,38.4,32.97,30.58,31.66,29.65,29.65,28.34,30.77,31.41,31.11,31.73,30.04,27.49,29.43,30.37,2.6,0.21,1.28,-0.72,-0.72,-2.03,0.4,1.03,0.74,1.35,-0.33,-2.88,-0.94,anatomical structure development;anatomical structure morphogenesis;behavior;biological regulation;cell communication;cell differentiation;cell-cell signaling;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular process;developmental process;endocytosis;establishment of localization;membrane invagination;membrane organization;multicellular organismal process;neurological system process;protein targeting;protein transport;regulation of transport;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;secretion;signal transduction;signaling;transport;vesicle-mediated transport,"cell body;cell cortex;cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;DNA-directed RNA polymerase II, holoenzyme;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;neuronal cell body;organelle;plasma membrane;protein complex;vesicle",,,,,,,,,,
Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),18,11.4,,27.36,25.15,27.29,,,24.78,25.67,,,24.89,27.87,,26.14, ,1.21,-1,1.14, , ,-1.36,-0.47, , ,-1.25,1.73, ,biological regulation;cellular component movement;cellular process;response to stimulus;signal transduction,cell cortex;cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q9NZM1,MYOF,Myoferlin (Fer-1-like protein 3),139,64.2,34.16,34.15,33.57,32.71,34.69,34.35,34.74,34.12,35.3,36.24,34.27,33.71,35.24,34.4,-0.24,-0.26,-0.84,-1.69,0.29,-0.05,0.33,-0.28,0.9,1.84,-0.14,-0.7,0.83,biological regulation;blood circulation;cellular component organization;cellular membrane organization;cellular process;circulatory system process;membrane organization;multicellular organismal process;muscle contraction;plasma membrane organization;response to abiotic stimulus;response to heat;response to stimulus;response to stress,cell part;extracellular organelle;intracellular organelle;membrane;nuclear envelope;organelle;vesicle,,,,,,,,,,
Q9Y2G1,MYRF,Myelin regulatory factor (Myelin gene regulatory factor),6,9.7,22.32,23.53,22.21,24.77,26.8,26.66,26.93,25.75,,,,26.94,24.34,25.03,-2.71,-1.49,-2.81,-0.25,1.78,1.64,1.91,0.72, , , ,1.92,-0.68,biological regulation;biosynthetic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;plasma membrane organization;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q6P582,MZT2A,Mitotic-spindle organizing protein 2A (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2A),3,23.8,,24.94,,25.75,25.87,25.17,,,,24.99,25.09,24.28,,25.16, ,-0.22, ,0.6,0.71,0.02, , , ,-0.17,-0.07,-0.88, ,,cell part;centrosome;gamma-tubulin complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P41227,NAA10,N-alpha-acetyltransferase 10 (EC 2.3.1.-) (EC 2.3.1.88) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (NatA catalytic subunit),11,51.1,26.74,27.16,27.94,28.38,28.31,26.51,28.96,27.99,26.44,27.1,27.73,26.92,26.1,27.41,-0.66,-0.24,0.54,0.97,0.9,-0.9,1.55,0.58,-0.97,-0.31,0.32,-0.48,-1.3,cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA packaging;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein acylation;protein metabolic process;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BXJ9,NAA15,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100)",27,28.4,30.06,29.8,29.97,30.76,30.65,29.6,30.81,30.97,29.18,28.95,30.22,30.49,29.4,30.07,-0.01,-0.26,-0.09,0.69,0.58,-0.46,0.74,0.91,-0.89,-1.11,0.15,0.43,-0.67,anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein acylation;protein metabolic process;protein modification process;RNA metabolic process,cell part;cytoplasm;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q14CX7,NAA25,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",11,13.5,28.27,27.41,25.36,27.77,25.49,26.09,28.56,26.04,23.08,23.93,25.78,27.48,26.02,26.25,2.02,1.16,-0.89,1.51,-0.76,-0.16,2.31,-0.21,-3.17,-2.33,-0.48,1.23,-0.23,,cell part;cytoplasm,,,,,,,,,,
Q5VZE5,NAA35,"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)",3,6.1,24.75,24.03,,25.43,26.26,,24.03,25.76,24.9,24.65,25.6,26.71,22.06,24.92,-0.18,-0.89, ,0.51,1.33, ,-0.9,0.83,-0.02,-0.28,0.68,1.79,-2.87,cell proliferation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O95777,NAA38,"N-alpha-acetyltransferase 38, NatC auxiliary subunit (U6 snRNA-associated Sm-like protein LSm8)",5,64.2,29.59,29.31,29.47,27.24,29.27,29.25,28.17,28,29.06,28.54,27.74,28.16,29.74,28.73,0.86,0.58,0.73,-1.49,0.53,0.51,-0.56,-0.73,0.33,-0.19,-1,-0.58,1.01,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9GZZ1,NAA50,N-alpha-acetyltransferase 50 (EC 2.3.1.-) (N-acetyltransferase 13) (N-acetyltransferase 5) (hNAT5) (N-acetyltransferase san homolog) (hSAN) (NatE catalytic subunit),9,48.8,29.6,27.88,28.72,29.73,28.82,27.96,29.74,29.61,27.6,28.07,29.09,29.64,27.53,28.77,0.83,-0.89,-0.05,0.96,0.05,-0.81,0.97,0.84,-1.17,-0.7,0.32,0.87,-1.24,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein acylation;protein metabolic process;protein modification process,cell part;cytoplasm,,,,,,,,,,
Q13765,NACA,Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC) (allergen Hom s 2),10,86.8,31.94,31.53,32.61,32.41,32.4,31.49,33.03,31.77,31.34,31.84,32.16,32.99,31.54,32.08,-0.14,-0.55,0.53,0.33,0.32,-0.59,0.95,-0.31,-0.74,-0.24,0.08,0.91,-0.54,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;growth;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein transport;RNA metabolic process;translation;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,DNA binding region,,,,,,,,,
Q96RE7,NACC1,Nucleus accumbens-associated protein 1 (NAC-1) (BTB/POZ domain-containing protein 14B),6,14,27.65,26.87,26.12,27.47,27.5,27.03,26.75,26.72,26.96,25.79,27.43,25.26,26.56,26.78,0.87,0.1,-0.66,0.7,0.72,0.25,-0.03,-0.06,0.19,-0.99,0.65,-1.52,-0.22,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process,cell part;cytoplasm,,,,,,,,,,
Q4G0N4,NADK2,"NAD kinase 2, mitochondrial (EC 2.7.1.23) (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)",5,15.6,27.66,28.22,24.44,26.95,26.43,27.04,26.65,27.41,27.41,27.22,29.16,26.35,28.05,27.15,0.5,1.07,-2.72,-0.2,-0.72,-0.12,-0.51,0.26,0.26,0.07,2.01,-0.81,0.9,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6IA69,NADSYN1,Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase),2,17.4,25.64,24.82,22.9,23.67,,,23.64,23.53,,22.89,23.05,24.05,,23.8,1.84,1.02,-0.9,-0.13, , ,-0.16,-0.27, ,-0.91,-0.75,0.25, ,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
Q13564,NAE1,"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)",17,48.5,30.36,29.55,28.53,29.22,29.25,29.96,30.29,29.56,29.42,29.06,30.01,30.17,29.87,29.63,0.72,-0.08,-1.1,-0.42,-0.38,0.32,0.65,-0.08,-0.22,-0.57,0.38,0.54,0.24,biological regulation;biosynthetic process;cell cycle;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;DNA metabolic process;DNA replication;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of cell cycle;regulation of mitotic cell cycle;response to stimulus;signal transduction,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q96HR8,NAF1,H/ACA ribonucleoprotein complex non-core subunit NAF1 (hNAF1),2,8.2,25.34,,,24.94,25.31,24.22,24.97,24.89,24.82,24.43,,,,24.86,0.47, , ,0.07,0.44,-0.64,0.1,0.02,-0.04,-0.44, , , ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribosome biogenesis;RNA metabolic process;RNA modification;RNA processing;rRNA processing,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
P17050,NAGA,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),8,27.5,27.78,30.35,29.38,28.35,27.67,29.06,28.74,26.66,28.74,28.54,27.43,28.51,28.38,28.43,-0.65,1.92,0.95,-0.08,-0.76,0.63,0.31,-1.77,0.31,0.11,-1,0.08,-0.05,carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;oligosaccharide metabolic process;primary metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q9UJ70,NAGK,N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase),18,56.7,30.22,31.26,32.24,30.52,29.2,29.6,29.92,30.09,29.05,27.6,30.39,30.22,28.4,29.9,0.32,1.36,2.34,0.62,-0.7,-0.3,0.02,0.19,-0.85,-2.3,0.49,0.32,-1.5,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
P54802,NAGLU,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form;Alpha-N-acetylglucosaminidase 77 kDa form],6,14,25.2,28.09,25.2,27.19,26.98,27.75,27.23,28.02,28.45,27.54,27.61,27.87,27.95,27.31,-2.11,0.77,-2.12,-0.13,-0.33,0.44,-0.08,0.7,1.14,0.23,0.3,0.56,0.64,amine metabolic process;anatomical structure development;anatomical structure morphogenesis;behavior;carbohydrate metabolic process;catabolic process;cell development;cellular component organization;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organelle organization;polysaccharide metabolic process;primary metabolic process;response to stimulus;rhythmic process;small molecule metabolic process;vacuole organization,cell part,,,,,,,,,,
P43490,NAMPT,Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin),42,79,34.6,35.43,34.82,35.23,32.27,33.54,33.2,32.71,31.95,31.96,33.76,34.44,32.31,33.56,1.05,1.87,1.27,1.67,-1.28,-0.01,-0.35,-0.84,-1.61,-1.6,0.21,0.88,-1.25,biological regulation;biosynthetic process;cell communication;cell-cell signaling;cellular amide metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to stimulus;signal transduction;signaling;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
Q9NR45,NANS,Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase),18,49,29.41,30.95,30.97,29.7,29.24,30.11,29.77,29.74,30.57,29.35,29.98,30.03,29.86,29.98,-0.57,0.97,1,-0.28,-0.74,0.14,-0.21,-0.24,0.59,-0.62,0,0.06,-0.11,biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process,cell part;cytoplasm;cytosol,,,,,,,,,,
F8W020,NAP1L1,Nucleosome assembly protein 1-like 1 (Fragment),10,55.1,31.21,30.33,31.34,31.59,31,30.2,31.97,31.46,30.16,30.45,31.96,32.6,29.96,31.1,0.12,-0.76,0.24,0.49,-0.09,-0.9,0.87,0.37,-0.93,-0.64,0.86,1.51,-1.14,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q99733,NAP1L4,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),13,40.5,30.59,29.99,31.24,31.32,30.55,30.16,30.94,31.56,29.58,29.93,31.3,29.54,23.29,30,0.59,-0.01,1.24,1.32,0.55,0.16,0.94,1.56,-0.42,-0.07,1.3,-0.46,-6.71,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P54920,NAPA,Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha),21,71.9,30.65,31.09,32.09,31.26,31.2,30.69,30.26,31.14,31.21,30.76,31.6,30.91,30.83,31.05,-0.41,0.03,1.03,0.2,0.15,-0.36,-0.79,0.09,0.15,-0.29,0.55,-0.14,-0.22,anatomical structure development;biological regulation;cell communication;cell differentiation;cell-cell signaling;cellular component disassembly;cellular component organization;cellular membrane organization;cellular process;developmental process;establishment of localization;Golgi vesicle transport;localization;membrane fusion;membrane organization;protein transport;regulation of transport;signaling;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q99747,NAPG,Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma),8,28.8,28.45,28.28,27.56,27.92,27.01,26.76,27.7,27.42,26.69,27.25,26.37,25.95,27.31,27.28,1.17,1,0.28,0.64,-0.27,-0.52,0.42,0.14,-0.59,-0.03,-0.91,-1.34,0.02,biological regulation;cellular component assembly;cellular component organization;cellular membrane organization;cellular process;establishment of localization;Golgi vesicle transport;macromolecular complex assembly;membrane fusion;membrane organization;protein complex assembly;protein transport;regulation of protein stability;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q6XQN6,NAPRT1,Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21) (FHA-HIT-interacting protein) (Nicotinate phosphoribosyltransferase domain-containing protein 1),13,31.4,30.36,26.72,27.27,26.07,,25.59,,26.96,,25.43,,26.64,24.6,26.63,3.73,0.09,0.64,-0.56, ,-1.03, ,0.34, ,-1.2, ,0.01,-2.02,biosynthetic process;cellular amide metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;vitamin metabolic process,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43776,NARS,"Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)",31,51.8,32.55,32.36,31.46,31.96,31.69,30.81,32.13,32.28,30.82,31.15,32.51,32.66,30.35,31.75,0.8,0.61,-0.29,0.21,-0.06,-0.94,0.38,0.53,-0.92,-0.6,0.77,0.91,-1.4,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96I59,NARS2,"Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)",4,11.7,27.23,26.99,25.61,26.84,26.04,27.05,26.21,26.4,27.38,26.59,25.42,,26.27,26.5,0.73,0.49,-0.89,0.34,-0.46,0.54,-0.29,-0.11,0.87,0.09,-1.08, ,-0.23,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P49321,NASP,Nuclear autoantigenic sperm protein (NASP),32,55.8,32.12,30.43,31.19,30.65,30.99,30.95,31,30.55,30.88,30.82,28.02,29.97,29.63,30.55,1.56,-0.12,0.64,0.09,0.43,0.4,0.45,0,0.33,0.27,-2.53,-0.58,-0.93,anatomical structure development;biosynthetic process;cell cycle;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA replication;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein transport;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P18440,NAT1,Arylamine N-acetyltransferase 1 (EC 2.3.1.5) (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase) (MNAT) (N-acetyltransferase type 1) (NAT-1),5,20.8,25,25.34,22.52,26.27,,,23.89,24.49,,,,21.3,,24.12,0.88,1.23,-1.6,2.15, , ,-0.22,0.38, , , ,-2.82, ,cellular metabolic process;cellular process;metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q9H0A0,NAT10,N-acetyltransferase 10 (EC 2.3.1.-),31,32.1,29.27,30.2,29.28,30.34,31.23,31.14,30.1,29.36,31.15,31.2,29.39,29.79,30.8,30.25,-0.98,-0.05,-0.97,0.09,0.98,0.89,-0.15,-0.89,0.9,0.95,-0.86,-0.46,0.55,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,,,,,,,,,,
Q8WUY8,NAT14,N-acetyltransferase 14 (EC 2.3.1.-) (K562 cell-derived leucine-zipper-like protein 1),2,7.8,26.47,26.59,25.91,26.63,,25.3,25.85,24.78,26.67,27.42,,26.24,24.96,26.07,0.4,0.51,-0.17,0.55, ,-0.77,-0.22,-1.29,0.6,1.34, ,0.17,-1.12,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent",cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),23,18.1,24.92,24.28,22.95,28.06,28.49,31.45,30.74,29.38,30.96,20.48,28.92,27.93,28.42,27.46,-2.54,-3.18,-4.51,0.6,1.03,3.99,3.28,1.92,3.5,-6.98,1.46,0.47,0.96,cell motility;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;locomotion;organelle organization,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
A2RRP1,NBAS,Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein),27,13.8,29,29.22,29.04,29.03,29.46,30.03,28.86,29,30.33,29.34,29.9,28.96,30.62,29.45,-0.44,-0.22,-0.4,-0.41,0.02,0.58,-0.58,-0.44,0.88,-0.11,0.45,-0.49,1.17,,cell part;cytoplasm,,,,,,,,,,
Q3LIE1,Nbla04300,Putative uncharacterized protein Nbla04300 (Fragment),5,6.7,28.62,28.25,,27.69,,,,27.45,27.83,,27.31,23.49,28.14,27.35,1.27,0.91, ,0.34, , , ,0.1,0.49, ,-0.04,-3.86,0.79,cellular process;establishment of localization;transport;vesicle-mediated transport,cell part,,,,,,,,,,
O60934,NBN,Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1),14,20.4,28.02,24.78,26.94,25.23,26.16,26.66,26.71,27.08,25.95,27.35,26.32,26.95,27.06,26.56,1.46,-1.78,0.38,-1.33,-0.4,0.11,0.16,0.53,-0.6,0.8,-0.24,0.39,0.51,biological regulation;cell activation;cell death;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;death;developmental process;DNA geometric change;DNA metabolic process;DNA recombination;DNA repair;growth;homeostatic process;immune system process;macromolecule metabolic process;meiosis;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;regulation of mitotic cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;telomere organization,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q15021,NCAPD2,Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog),16,14.6,23.16,25.21,,29.1,28.93,27.48,29.14,28.83,26,24.68,25.85,28.78,25.46,26.88,-3.73,-1.68, ,2.21,2.05,0.6,2.25,1.94,-0.89,-2.21,-1.04,1.9,-1.42,cell cycle;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA packaging;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q15003,NCAPH,Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog),5,7.4,,,23.78,26.2,25.67,25.19,27.2,23.52,23.66,25.32,22.69,27.32,24.35,24.99, , ,-1.21,1.21,0.68,0.2,2.21,-1.47,-1.33,0.33,-2.3,2.33,-0.64,cell cycle;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA packaging;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;condensin complex;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q09161,NCBP1,Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit),17,26.6,29.07,28.32,29.23,28.77,29.25,29.59,30.14,29.04,30.21,30.84,29.66,31.41,29.49,29.62,-0.55,-1.3,-0.38,-0.85,-0.37,-0.03,0.52,-0.57,0.6,1.22,0.04,1.79,-0.13,"biological regulation;biosynthetic process;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;gene silencing;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of translation;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription termination, DNA-dependent;transport",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ribonucleoprotein complex,,,,,,,,,,
P52298,NCBP2,Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (Cell proliferation-inducing gene 55 protein) (NCBP 20 kDa subunit) (CBP20) (NCBP-interacting protein 1) (NIP1),3,34,25.52,26.21,25.24,26.31,23.64,26.28,26.11,25.5,26.58,22.61,25.52,23.77,25.99,25.33,0.19,0.88,-0.09,0.98,-1.69,0.95,0.79,0.17,1.25,-2.72,0.2,-1.56,0.66,"biological regulation;biosynthetic process;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;gene silencing;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of translation;regulation of transport;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription termination, DNA-dependent;transport",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q9UBB6,NCDN,Neurochondrin,4,6.3,24.8,26.57,22.94,26.98,,27.48,24.77,27.54,,,26.11,24.89,23.78,25.58,-0.79,0.99,-2.65,1.4, ,1.9,-0.82,1.95, , ,0.52,-0.69,-1.81,biological regulation;cellular component organization;cellular process;homeostatic process,cell body;cell part;cell projection;cytosol;neuron projection;neuronal cell body,,,,,,,,,,
Q6PIU2,NCEH1,Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Arylacetamide deacetylase-like 1),16,48.5,31.85,31.09,31.22,31.72,32.53,32.1,32.31,32.6,32.32,33.74,33.12,32.07,33.14,32.3,-0.44,-1.2,-1.07,-0.57,0.24,-0.2,0.02,0.31,0.02,1.45,0.83,-0.22,0.84,catabolic process;lipid metabolic process;metabolic process;primary metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P16333,NCK1,Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) (SH2/SH3 adaptor protein NCK-alpha),12,52,29.11,26.77,26.06,27.91,25.84,25.01,26.49,27.73,25.19,,25.46,25.33,26.3,26.43,2.67,0.34,-0.37,1.47,-0.59,-1.42,0.06,1.29,-1.24, ,-0.97,-1.1,-0.13,biological regulation;cell activation;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular process;cytoskeleton organization;immune system process;locomotion;macromolecular complex assembly;organelle organization;protein complex assembly;regulation of organelle organization;regulation of translation;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9Y2A7,NCKAP1,Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1),20,19.9,30.11,29.62,29.65,30.02,28.42,29.24,30.38,29.34,29.42,29.66,29.78,30.35,29.3,29.64,0.47,-0.02,0.02,0.39,-1.22,-0.4,0.74,-0.3,-0.22,0.02,0.14,0.71,-0.34,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell death;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;death;developmental process;embryo development;establishment or maintenance of cell polarity;immune system process;localization;locomotion;organelle organization;regulation of protein stability;response to stimulus;response to stress,cell part;cytosol,,,,,,,,,,
P19338,NCL,Nucleolin (Protein C23),65,67.5,35.26,34.24,34.78,34.24,34.53,34.41,33.86,33.98,34.32,34.19,32.81,33.36,34.36,34.18,1.08,0.06,0.6,0.06,0.35,0.23,-0.32,-0.2,0.14,0.01,-1.37,-0.82,0.18,anatomical structure formation involved in morphogenesis;developmental process,cell cortex;cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;ribonucleoprotein complex,,,,,,,,,,
Q969V3,NCLN,Nicalin (Nicastrin-like protein),19,37,30.98,31.03,30.73,31.22,31.74,31.87,31.32,31.52,31.83,32.03,31.5,30,32.23,31.38,-0.41,-0.36,-0.65,-0.17,0.35,0.48,-0.07,0.14,0.45,0.64,0.12,-1.38,0.84,biological regulation;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9HCD5,NCOA5,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),13,24.2,28.69,26.88,25.5,27.97,28.5,28.8,27.55,27.86,29.31,27.15,26.2,,28.37,27.73,0.96,-0.85,-2.23,0.24,0.77,1.07,-0.19,0.13,1.58,-0.58,-1.54, ,0.64,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8NI08,NCOA7,Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1),9,15.6,27.02,23.96,26.9,23.92,20.39,,25.47,,24.25,22.36,23.33,26.79,,24.44,2.58,-0.47,2.46,-0.52,-4.05, ,1.03, ,-0.19,-2.08,-1.11,2.35, ,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75376,NCOR1,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),9,5.6,25.34,22.08,26.8,23.84,24.42,24.6,,23.36,23.69,24.12,,24.37,,24.26,1.08,-2.19,2.54,-0.42,0.16,0.34, ,-0.9,-0.57,-0.14, ,0.11, ,"anatomical structure development;biological regulation;biosynthetic process;cell activation;cell differentiation;cellular component assembly;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;cytoskeleton organization;developmental process;homeostatic process;immune system process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle assembly;organelle organization;primary metabolic process;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to stimulus;rhythmic process;RNA metabolic process;signal transduction;small molecule metabolic process;transcription initiation, DNA-dependent",cell part;cytoplasm;macromolecular complex;protein complex;transcription factor complex;transcriptional repressor complex,Other TF domain,,,,,,,,,
Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",28,16.8,27.54,24.07,24.95,27.74,27.79,27.11,27.08,25.9,27.29,24.64,28.21,28.37,25.92,26.66,0.87,-2.59,-1.71,1.08,1.12,0.45,0.42,-0.76,0.63,-2.03,1.55,1.71,-0.74,"biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process;transcription initiation, DNA-dependent",cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;transcriptional repressor complex,Other TF domain,,,,,,,,,
P62166,NCS1,Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein),5,40.5,,26.99,25.58,25.45,,25.93,25.38,28.05,28.02,27.02,28.57,23.18,29.28,26.68, ,0.32,-1.1,-1.23, ,-0.75,-1.29,1.37,1.35,0.34,1.9,-3.5,2.6,biological regulation;cellular process;regulation of transport;response to stimulus;signal transduction,cell part;cell projection;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;organelle;plasma membrane;vesicle,,,,,,,,,,
Q92542,NCSTN,Nicastrin,7,11,29.26,29.4,29.02,29.09,29.62,29.91,29.24,29.46,29.24,30.12,29.81,30.2,30.58,29.61,-0.36,-0.22,-0.59,-0.52,0.01,0.3,-0.38,-0.15,-0.37,0.51,0.2,0.59,0.97,biological regulation;catabolic process;cell activation;cell proliferation;cellular metabolic process;cellular process;homeostatic process;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis;response to stimulus;signal transduction,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
G3XA81,NDC1,"Nucleoporin NDC1 (Transmembrane protein 48, isoform CRA_a)",8,23.6,27.81,25.37,26.24,26.61,27.07,26.72,27.22,24.84,26.83,26.19,,25.95,25.11,26.33,1.48,-0.96,-0.09,0.28,0.75,0.39,0.89,-1.49,0.5,-0.14, ,-0.38,-1.22,,cell part,,,,,,,,,,
Q9GZM8,NDEL1,Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1),5,23,24.45,26.03,24.53,26.31,25.95,25,25.25,25.74,25.33,24.65,25.56,24.52,24.63,25.23,-0.78,0.81,-0.7,1.08,0.72,-0.22,0.02,0.51,0.1,-0.58,0.33,-0.7,-0.6,anatomical structure morphogenesis;biological regulation;cell cycle;cell motility;cell proliferation;cellular component disassembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular localization;cellular membrane organization;cellular process;chromosome segregation;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;localization;locomotion;membrane organization;mitotic cell cycle;organelle localization;organelle organization;transport,cell body;cell leading edge;cell part;cell projection;centrosome;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;microtubule organizing center;neuron projection;nuclear envelope;organelle;protein complex,,,,,,,,,,
Q9UGV2,NDRG3,Protein NDRG3 (N-myc downstream-regulated gene 3 protein),8,32.5,28.85,27.13,28.2,28.53,28.83,28.28,28.64,28.68,26.94,27.41,29.85,31.06,27.81,28.48,0.37,-1.35,-0.28,0.05,0.35,-0.2,0.17,0.2,-1.54,-1.07,1.38,2.58,-0.67,biological regulation;cell differentiation;cellular process;developmental process;multicellular organismal process,cell part;cytoplasm,,,,,,,,,,
Q9ULP0,NDRG4,Protein NDRG4 (Brain development-related molecule 1) (N-myc downstream-regulated gene 4 protein) (Vascular smooth muscle cell-associated protein 8) (SMAP-8),6,20.8,24.61,,25.25,27.8,25.79,26.44,28.96,26.7,28.54,27.28,29.36,28.85,23.87,26.95,-2.34, ,-1.7,0.85,-1.16,-0.52,2.01,-0.25,1.59,0.32,2.41,1.89,-3.09,cell differentiation;cell growth;cellular process;developmental process;growth;response to stimulus;response to stress,cell part;cytoplasm;cytosol,,,,,,,,,,
O95299,NDUFA10,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)",11,31.9,30.46,30.12,30.45,30,31.06,31.35,30.63,31.11,29.15,31.42,30.28,30.07,31.46,30.58,-0.12,-0.46,-0.13,-0.58,0.48,0.77,0.04,0.53,-1.44,0.84,-0.3,-0.51,0.87,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
Q86Y39,NDUFA11,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 (Complex I-B14.7) (CI-B14.7) (NADH-ubiquinone oxidoreductase subunit B14.7),7,51.1,28.55,28.42,,28.16,29.66,28.33,29.52,29.12,25.31,27.81,25.9,29.04,27.54,28.11,0.44,0.31, ,0.05,1.55,0.22,1.4,1.01,-2.81,-0.3,-2.21,0.93,-0.58,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
Q9UI09,NDUFA12,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 (13 kDa differentiation-associated protein) (Complex I-B17.2) (CI-B17.2) (CIB17.2) (NADH-ubiquinone oxidoreductase subunit B17.2),9,54.5,28.04,27.93,28.57,28.28,29.45,29.32,28.71,29.04,,29.27,28.09,28.83,29.17,28.73,-0.68,-0.79,-0.16,-0.45,0.73,0.6,-0.02,0.32, ,0.55,-0.63,0.1,0.45,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;multicellular organismal process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
Q9P0J0,NDUFA13,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein) (GRIM-19) (Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit),8,49.3,29.69,29.52,28.15,30.09,30.92,30.59,30.76,30.51,29.71,30.52,30.02,30.82,31,30.18,-0.49,-0.66,-2.03,-0.08,0.75,0.41,0.59,0.34,-0.47,0.34,-0.15,0.64,0.82,biological regulation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;metabolic process;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;regulation of translation;small molecule metabolic process;transport,cell part;macromolecular complex;NADH dehydrogenase complex;nucleoplasm;protein complex,,,,,,,,,,
O43678,NDUFA2,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit),6,67.7,28.51,28.25,27.67,28.67,30.19,30.83,29.79,30.28,27.12,28.3,28.98,29.12,29.79,29.04,-0.53,-0.79,-1.37,-0.36,1.15,1.79,0.75,1.25,-1.92,-0.74,-0.06,0.09,0.75,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O00483,NDUFA4,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit),4,49.4,27.28,27.98,29,28.48,28.89,29.82,29.5,29.66,29.53,29.99,27.54,27.84,28.26,28.75,-1.47,-0.77,0.25,-0.27,0.14,1.07,0.75,0.91,0.78,1.24,-1.21,-0.91,-0.49,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex;respiratory chain complex IV,,,,,,,,,,
Q16718,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit),6,66.4,29.93,30.03,30.63,30.2,30.52,30.92,31.09,30.68,30.11,30.9,30.11,31.39,30.62,30.55,-0.62,-0.51,0.08,-0.35,-0.03,0.37,0.54,0.13,-0.44,0.35,-0.43,0.84,0.07,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
P56556,NDUFA6,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (LYR motif-containing protein 6) (NADH-ubiquinone oxidoreductase B14 subunit),5,38.3,28.95,28.68,28.77,29.11,30.03,29.5,29.58,29.33,27.61,29.55,28.54,29.12,28.77,29.04,-0.09,-0.36,-0.28,0.07,0.99,0.46,0.54,0.29,-1.43,0.51,-0.5,0.07,-0.27,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O95182,NDUFA7,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a),4,35.4,28.49,28.98,28.35,28.03,28.42,28.96,29.19,29.14,26.4,29.01,28.77,27.14,26.56,28.27,0.23,0.71,0.08,-0.23,0.15,0.7,0.93,0.87,-1.87,0.75,0.5,-1.12,-1.7,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
P51970,NDUFA8,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (Complex I-PGIV) (CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit),9,48.8,29.52,30.22,30,30.29,30.4,30.82,30.71,30.6,30.44,30.73,29.52,30.66,30.42,30.33,-0.81,-0.11,-0.33,-0.05,0.07,0.49,0.38,0.27,0.11,0.4,-0.82,0.32,0.08,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
Q16795,NDUFA9,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)",15,50.3,31.02,30.34,30.19,30.71,31.01,31.25,31.03,31.03,28.61,30.96,30.35,30.45,31.32,30.64,0.38,-0.3,-0.44,0.08,0.37,0.61,0.39,0.4,-2.02,0.32,-0.29,-0.18,0.68,cellular metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;ion transport;metabolic process;small molecule metabolic process;transport,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O14561,NDUFAB1,"Acyl carrier protein, mitochondrial (ACP) (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)",7,27.6,30.14,30.87,30.37,30.14,31.08,30.2,30.31,30.16,30.19,29.69,29.93,28.91,28.93,30.07,0.07,0.79,0.3,0.07,1.01,0.13,0.24,0.09,0.12,-0.38,-0.14,-1.16,-1.14,cellular metabolic process;cellular process;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
Q8N183,NDUFAF2,"Mimitin, mitochondrial (B17.2-like) (B17.2L) (Myc-induced mitochondrial protein) (MMTN) (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2) (NDUFA12-like protein)",9,57.4,23.91,27.51,24.84,27.89,28.93,29.02,26.45,27.71,27.45,28.48,28.19,27.58,28.1,27.39,-3.48,0.12,-2.55,0.49,1.54,1.63,-0.94,0.32,0.06,1.09,0.8,0.19,0.71,,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9BU61,NDUFAF3,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,3,19,27.28,27.09,,26.19,29.05,29.44,26.9,29.43,28.83,,26.84,,28.49,27.95,-0.67,-0.86, ,-1.77,1.1,1.49,-1.05,1.47,0.88, ,-1.12, ,0.53,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein complex biogenesis,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9P032,NDUFAF4,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa),6,37.7,27.91,28.15,28.76,28.25,27.67,28.47,28,27.63,28.1,29.52,27.82,27.91,28.81,28.23,-0.32,-0.08,0.53,0.02,-0.56,0.24,-0.23,-0.6,-0.13,1.29,-0.41,-0.32,0.58,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein complex biogenesis,cell part;membrane,,,,,,,,,,
Q5TEU4,NDUFAF5,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7, mitochondrial) (EC 2.1.1.-)",3,16.9,24.06,25.45,,24.41,23.12,,,23.77,23.99,25.9,,,,24.39,-0.32,1.06, ,0.02,-1.26, , ,-0.62,-0.4,1.52, , , ,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein complex biogenesis,cell part,,,,,,,,,,
Q7L592,NDUFAF7,"NADH dehydrogenase [ubiquinone] complex I, assembly factor 7 (Protein midA homolog, mitochondrial)",5,19.8,24.56,26.91,23.42,25.43,26.49,27.52,26.22,26.68,27.97,27.39,25.4,25.52,26.6,26.16,-1.6,0.75,-2.74,-0.73,0.33,1.36,0.06,0.52,1.8,1.22,-0.76,-0.65,0.44,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein complex biogenesis,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O75438,NDUFB1,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 (Complex I-MNLL) (CI-MNLL) (NADH-ubiquinone oxidoreductase MNLL subunit),4,36.2,28.32,28.17,28.43,27.65,28.96,29.31,28.89,28.63,28.5,28.36,27.79,28.03,29.35,28.49,-0.17,-0.33,-0.06,-0.84,0.47,0.82,0.4,0.14,0.01,-0.13,-0.7,-0.46,0.85,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O96000,NDUFB10,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW) (CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit),12,48.3,30.4,30.6,30.39,30.85,31.59,31.76,31.72,30.84,30.55,31.25,30.04,31.5,31.21,30.98,-0.58,-0.38,-0.58,-0.12,0.62,0.78,0.74,-0.14,-0.43,0.27,-0.94,0.53,0.23,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
Q9NX14,NDUFB11,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 17.3) (Np17.3) (p17.3)",3,32,26.87,27.66,28.49,28.15,28.2,29.09,28.79,26.69,28.14,29.72,28.7,30.35,28.92,28.44,-1.58,-0.78,0.04,-0.3,-0.24,0.64,0.35,-1.75,-0.3,1.27,0.26,1.91,0.47,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
H7C5B8,NDUFB2,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (Fragment)",2,19.2,24.84,26.05,25.73,25.78,25.94,27.27,26.31,26.23,,26.47,,,,26.07,-1.23,-0.02,-0.34,-0.29,-0.13,1.2,0.24,0.16, ,0.4, , , ,,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O43676,NDUFB3,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit),4,31.6,28.35,28.57,28.88,28.56,29.14,29.35,29.59,28.75,26.48,29.17,29.22,27.99,29.83,28.76,-0.41,-0.19,0.12,-0.2,0.38,0.59,0.83,-0.01,-2.28,0.41,0.46,-0.77,1.07,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O95168,NDUFB4,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (Complex I-B15) (CI-B15) (NADH-ubiquinone oxidoreductase B15 subunit),8,49.6,29.62,29.33,29.75,29.78,30.91,30.97,30.62,30,29.19,31.07,29.64,29.88,30.87,30.12,-0.51,-0.79,-0.37,-0.35,0.78,0.84,0.5,-0.12,-0.94,0.94,-0.49,-0.25,0.75,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O43674,NDUFB5,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)",10,37,26.31,25.68,25.88,26.77,28.55,28.33,26.62,27.54,26.46,27.84,25.24,,27.76,26.92,-0.6,-1.24,-1.04,-0.14,1.63,1.42,-0.29,0.62,-0.45,0.93,-1.67, ,0.84,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O95139,NDUFB6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 (Complex I-B17) (CI-B17) (NADH-ubiquinone oxidoreductase B17 subunit),6,45.3,26.47,26.84,28.09,28.2,27.92,29.45,28.24,27.97,28.41,28.37,26.35,28.49,28.35,27.94,-1.47,-1.09,0.15,0.27,-0.01,1.52,0.31,0.03,0.48,0.44,-1.59,0.55,0.42,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;NADH dehydrogenase complex;nucleus;organelle;protein complex,,,,,,,,,,
P17568,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18) (CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit),4,40.1,25.91,26.32,25.4,26.05,25.17,27.16,26.6,26.15,24.63,27.59,26.64,27.36,26.35,26.26,-0.35,0.06,-0.86,-0.21,-1.09,0.9,0.35,-0.11,-1.63,1.34,0.38,1.11,0.1,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O95169,NDUFB8,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)",8,59.4,27.87,28.12,22.64,28.6,30.35,30.08,29.13,28.85,27.3,28.57,28.69,28.83,30.16,28.4,-0.53,-0.28,-5.76,0.21,1.95,1.68,0.73,0.45,-1.1,0.17,0.3,0.43,1.76,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;NADH dehydrogenase complex;organelle;protein complex,,,,,,,,,,
Q9Y6M9,NDUFB9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (LYR motif-containing protein 3) (NADH-ubiquinone oxidoreductase B22 subunit),9,61.5,29.5,28.83,27.54,29.45,29.89,30.46,27.69,26.33,,30.35,29.01,28.28,30.78,29.01,0.49,-0.18,-1.47,0.44,0.88,1.45,-1.32,-2.68, ,1.34,0,-0.73,1.77,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;multicellular organismal process;neurological system process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O95298,NDUFC2,NADH dehydrogenase [ubiquinone] 1 subunit C2 (Complex I-B14.5b) (CI-B14.5b) (Human lung cancer oncogene 1 protein) (HLC-1) (NADH-ubiquinone oxidoreductase subunit B14.5b),6,37.5,25.88,26.84,27.81,26.54,29.28,28.35,27.76,28.13,26.88,28.09,27.6,,27.67,27.57,-1.69,-0.73,0.24,-1.03,1.71,0.78,0.19,0.56,-0.69,0.52,0.03, ,0.1,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
P28331,NDUFS1,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-75kD) (CI-75kD)",32,53.6,31.97,31.31,31.22,31.65,32.26,32.2,32.66,32.23,30.87,32.48,31.97,32.05,32.34,31.94,0.03,-0.63,-0.72,-0.29,0.32,0.26,0.72,0.29,-1.07,0.54,0.03,0.11,0.4,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;generation of precursor metabolites and energy;heterocycle metabolic process;homeostatic process;metabolic process;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O75489,NDUFS3,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)",18,48.1,30.84,30.97,30.47,30.77,31.42,31.63,31.49,31.13,30.01,31.14,30.55,30.91,31.93,31.02,-0.18,-0.05,-0.55,-0.25,0.4,0.61,0.47,0.11,-1.01,0.12,-0.47,-0.11,0.91,biological regulation;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O43181,NDUFS4,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)",5,25.7,29.1,29.18,28.9,29.56,28.44,28.97,29.74,27.98,27.6,30.08,29.03,30.02,29,29.05,0.05,0.14,-0.14,0.52,-0.6,-0.08,0.69,-1.06,-1.44,1.04,-0.02,0.97,-0.05,anatomical structure development;biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;developmental process;generation of precursor metabolites and energy;macromolecular complex assembly;metabolic process;protein complex assembly;protein complex biogenesis;regulation of protein modification process;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O43920,NDUFS5,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa) (CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit),7,50.9,28.57,28.93,28.32,29.3,29.45,30.2,29.58,29.57,29.15,29.92,29.4,28.71,30,29.31,-0.74,-0.39,-1,-0.02,0.13,0.89,0.26,0.25,-0.16,0.61,0.09,-0.61,0.68,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;generation of precursor metabolites and energy;macromolecular complex assembly;metabolic process;protein complex assembly;protein complex biogenesis;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O75380,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)",2,18.5,26.08,,26.43,26.81,,26.65,27.18,27.22,25.38,27.29,,,27.2,26.69,-0.61, ,-0.26,0.11, ,-0.04,0.49,0.53,-1.31,0.6, , ,0.51,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O75251,NDUFS7,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",6,21.6,28.2,27.67,28.73,28.52,32.16,30.51,31.98,29.17,28.85,30.41,29.11,29.13,30.22,29.59,-1.39,-1.92,-0.86,-1.07,2.57,0.92,2.39,-0.42,-0.74,0.82,-0.48,-0.46,0.63,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;generation of precursor metabolites and energy;macromolecular complex assembly;metabolic process;protein complex assembly;protein complex biogenesis;small molecule metabolic process,cell body;cell part;cell projection;macromolecular complex;membrane;NADH dehydrogenase complex;neuron projection;neuronal cell body;protein complex,,,,,,,,,,
O00217,NDUFS8,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)",8,44.6,28.93,29.09,26.91,29.26,29.1,29.13,29.32,28.82,28.55,28.59,27.83,28.12,29.18,28.68,0.25,0.41,-1.77,0.58,0.42,0.45,0.64,0.14,-0.13,-0.09,-0.85,-0.56,0.5,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;generation of precursor metabolites and energy;macromolecular complex assembly;metabolic process;protein complex assembly;protein complex biogenesis;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
P49821,NDUFV1,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)",20,54.9,30.18,30.17,30.09,30.35,29.5,31.42,30.54,30.37,28.82,31.1,29.89,30.88,30.91,30.32,-0.15,-0.15,-0.23,0.02,-0.82,1.09,0.22,0.05,-1.5,0.78,-0.43,0.55,0.58,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
P19404,NDUFV2,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (NADH-ubiquinone oxidoreductase 24 kDa subunit)",12,58.2,30.09,30.16,28.46,29.89,30.43,31.03,30.98,30.11,28.95,31.03,30.44,31.26,31.23,30.31,-0.22,-0.15,-1.85,-0.42,0.11,0.72,0.66,-0.2,-1.36,0.72,0.13,0.94,0.92,anatomical structure development;cellular metabolic process;cellular process;developmental process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;NADH dehydrogenase complex;protein complex,,,,,,,,,,
O76041,NEBL,Nebulette (Actin-binding Z-disk protein),2,10,25.34,24.72,,25.44,25.96,24.59,21.09,25.61,24.52,22.82,25.86,,,24.59,0.74,0.13, ,0.84,1.36,-0.01,-3.5,1.01,-0.08,-1.78,1.27, , ,cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part,,,,,,,,,,
Q9NVZ3,NECAP2,Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2),4,23.6,26.56,26.42,28.58,28.09,25.95,,27.62,28.39,26.68,,28.06,27.92,,27.43,-0.87,-1,1.15,0.66,-1.48, ,0.2,0.96,-0.75, ,0.64,0.49, ,cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q8NHV4,NEDD1,Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1),3,9.1,25.48,25.26,23.67,24.89,25.73,27.44,23.84,23.28,,23.89,26.05,25.77,22.74,24.84,0.64,0.43,-1.17,0.06,0.89,2.6,-1,-1.55, ,-0.95,1.21,0.94,-2.1,cell division;cellular component organization;cellular process;mitosis;nuclear division;organelle fission;organelle organization,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle,,,,,,,,,,
Q96PU5,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like (EC 6.3.2.-) (NEDD4.2) (Nedd4-2),12,15.8,26.78,25.94,26.25,27.48,27.3,25.51,28.91,28.9,27.48,26.43,28.34,28.65,26.82,27.29,-0.51,-1.35,-1.04,0.19,0.01,-1.78,1.62,1.61,0.18,-0.86,1.05,1.36,-0.47,"biological regulation;biosynthetic process;catabolic process;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;excretion;homeostatic process;interspecies interaction between organisms;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to osmotic stress;response to stimulus;response to stress;RNA metabolic process;secretion;signal transduction;transcription initiation, DNA-dependent;transmembrane transport;transport",cell part;cytosol;nucleoplasm,,,,,,,,,,
E9PL57,NEDD8-MDP1,Protein NEDD8-MDP1 (Fragment),4,20.6,28.58,27.78,28.86,27.31,28.3,28.16,28.56,30.02,27.2,28.41,29.61,31.7,28.16,28.67,-0.08,-0.88,0.2,-1.35,-0.37,-0.51,-0.11,1.36,-1.47,-0.26,0.94,3.04,-0.51,cellular metabolic process;cellular process;metabolic process;phosphorus metabolic process,,,,,,,,,,,
Q8TDX7,NEK7,Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),7,34.1,28.17,28.2,28.04,29.45,26.95,25.5,22.63,27.99,,24.77,26.64,28.47,25.77,26.88,1.29,1.32,1.16,2.57,0.07,-1.38,-4.25,1.1, ,-2.11,-0.25,1.58,-1.11,biological regulation;cellular component assembly;cellular component organization;cellular process;cytokinesis;cytoskeleton organization;organelle assembly;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex,,+,,,,,,,,
Q9H3P2,NELFA,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein),8,24.6,28.91,26.92,27.78,26.38,27.47,27.74,27.59,27.57,26.94,26.34,24.59,24.33,26.69,26.87,2.05,0.05,0.91,-0.48,0.61,0.88,0.72,0.7,0.07,-0.53,-2.27,-2.53,-0.18,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
Q8WX92,NELFB,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),6,16.9,28.33,27.29,25.98,26.28,26.79,27.07,25.64,25.94,27.79,,,,27.25,26.84,1.49,0.45,-0.86,-0.56,-0.05,0.24,-1.19,-0.9,0.96, , , ,0.42,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;cytoplasm;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
Q8IXH7,NELFCD,Negative elongation factor C/D (NELF-C/D) (TH1-like protein),7,14.8,29.1,27.82,27.19,26.6,27.34,28.41,26.53,26.41,27.92,27.28,26.66,25.7,27.71,27.28,1.81,0.53,-0.09,-0.68,0.06,1.13,-0.75,-0.87,0.63,0,-0.62,-1.59,0.43,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
P18615,NELFE,Negative elongation factor E (NELF-E) (RNA-binding protein RD),11,35.7,27.94,25.85,25.11,26.05,26.56,25.87,26.6,25.98,24.56,,,24.7,25,25.84,2.11,0.01,-0.72,0.21,0.72,0.03,0.76,0.14,-1.28, , ,-1.14,-0.84,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex;transcription elongation factor complex,,,,,,,,,,
O60524,NEMF,Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1),12,15.5,26.59,23.66,24.73,26.49,27.23,23.71,26.56,27.59,24.09,24.63,26.79,26.76,24.92,25.67,0.92,-2.01,-0.94,0.81,1.56,-1.96,0.88,1.92,-1.58,-1.04,1.12,1.09,-0.75,establishment of localization;nuclear transport;nucleocytoplasmic transport;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UMX5,NENF,Neudesin (Cell immortalization-related protein 2) (Neuron-derived neurotrophic factor) (Secreted protein of unknown function) (SPUF protein),9,60.5,25.61,29.4,30.17,29.35,30.18,29.71,28.72,29.39,28.72,27.95,29.98,28.43,30.62,29.1,-3.49,0.31,1.08,0.25,1.08,0.62,-0.37,0.3,-0.37,-1.14,0.88,-0.67,1.53,biological regulation,extracellular space,,,,,,,,,,
P48681,NES,Nestin,12,12.5,,24.64,24.69,,26.5,25.48,,,23.04,25.34,,26.87,,25.22, ,-0.59,-0.53, ,1.27,0.26, , ,-2.18,0.12, ,1.65, ,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell proliferation;cellular component morphogenesis;cellular component organization;cellular process;developmental process;regulation of organelle organization,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q99519,NEU1,Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1),3,10.8,23.32,25.31,25.56,26.43,27.5,26.97,26.55,26.94,27.09,26.95,26.64,27.4,27.78,26.5,-3.18,-1.18,-0.94,-0.06,1.01,0.47,0.06,0.44,0.6,0.45,0.14,0.91,1.29,cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q0ZGT2,NEXN,Nexilin (F-actin-binding protein) (Nelin),13,20.3,,25.76,,27.96,26.01,27.61,,,25.76,26.41,22.28,24.23,25.06,25.67, ,0.08, ,2.28,0.33,1.93, , ,0.08,0.73,-3.39,-1.44,-0.61,biological regulation;regulation of organelle organization,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P35240,NF2,Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin),10,15.5,,26.29,24.45,27.12,27.75,27.09,27.72,28.18,29.33,29.51,27.34,27.48,28.47,27.56, ,-1.27,-3.11,-0.44,0.19,-0.47,0.16,0.62,1.77,1.95,-0.22,-0.08,0.91,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell differentiation;cell junction organization;cell proliferation;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization;regulation of DNA metabolic process;regulation of organelle organization;regulation of protein modification process,cell part;cell projection;cytoskeleton;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle;plasma membrane,,,,,,,,,,
O00712,NFIB,Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein),6,26,26.92,25.91,26.45,26.34,25.87,27.22,27.13,26.34,27.48,27.04,,25.15,,26.53,0.39,-0.62,-0.08,-0.19,-0.66,0.69,0.6,-0.19,0.94,0.51, ,-1.38, ,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell differentiation;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA replication;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cell projection;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;nucleolus;nucleus;organelle,CTF/NF-I family,,,,,,,,,
P08651,NFIC,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),10,29.6,27.96,27.08,,27.49,28.22,28.4,27.47,28.1,26.82,,26.63,,26.73,27.49,0.47,-0.41, ,0,0.73,0.91,-0.02,0.61,-0.67, ,-0.86, ,-0.76,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,CTF/NF-I family,,,,,,,,,
P19838,NFKB1,Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit],11,12.5,28.63,28.77,28.65,28.09,28.34,27.54,28.73,28.58,27.65,27.38,27.12,25.09,26.06,27.74,0.89,1.03,0.91,0.35,0.6,-0.2,0.99,0.84,-0.09,-0.36,-0.62,-2.65,-1.68,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;proteolysis;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter,cell part;cytosol;I-kappaB/NF-kappaB complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleoplasm;organelle;protein complex,Other TF domain,,,,,,,,,
Q00653,NFKB2,Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit],13,19.6,29.28,28.83,28.34,27.61,28.62,28.53,28.77,29.15,28.28,28.55,29.36,27.01,27.01,28.41,0.87,0.42,-0.07,-0.8,0.21,0.12,0.36,0.74,-0.13,0.14,0.95,-1.4,-1.4,anatomical structure development;biological regulation;biosynthetic process;cell activation;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;cytosol;I-kappaB/NF-kappaB complex;macromolecular complex;nucleoplasm;protein complex,Other TF domain,,,,,,,,,
Q9Y697,NFS1,"Cysteine desulfurase, mitochondrial (EC 2.8.1.7)",10,30,29.95,28.06,28.52,27.71,28.19,27.72,29.56,30.06,29.29,29.55,29.55,27.97,29.95,28.93,1.02,-0.87,-0.41,-1.22,-0.73,-1.21,0.63,1.13,0.36,0.62,0.63,-0.96,1.02,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;prosthetic group metabolic process;protein complex assembly;protein metabolic process;protein modification process;small molecule metabolic process;sulfur compound metabolic process;vitamin metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UMS0,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)",8,45.7,26.23,28.17,27.63,29.45,29.37,29.9,29.23,28.8,29.56,30.16,29.35,27.42,29.7,28.84,-2.62,-0.68,-1.21,0.6,0.52,1.06,0.38,-0.04,0.72,1.32,0.51,-1.42,0.86,biosynthetic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;mitochondrion;nucleus;organelle,,,,,,,,,,
Q13952,NFYC,Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC) (Transactivator HSM-1/2),3,17.8,,25.99,25.64,25.99,26.62,,24.93,,25.52,26.39,,24.94,25.73,25.75, ,0.24,-0.11,0.24,0.87, ,-0.82, ,-0.23,0.64, ,-0.81,-0.02,biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;RNA metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
Q8NEJ9,NGDN,Neuroguidin (EIF4E-binding protein),6,26.7,27.19,27.36,27.18,28.19,29.05,29.18,28.35,27.75,28.7,28.19,26.72,26.99,28.11,27.92,-0.73,-0.56,-0.74,0.27,1.13,1.26,0.43,-0.17,0.78,0.28,-1.2,-0.93,0.19,biological regulation;regulation of translation,cell part;cell projection;cytoplasm;filopodium;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;nucleus;organelle,,,,,,,,,,
Q8NBF2,NHLRC2,NHL repeat-containing protein 2,6,11.6,28.59,26.67,,26.31,26.29,24.43,26.34,26.97,,23.59,26.46,26.84,,26.25,2.34,0.42, ,0.06,0.04,-1.82,0.09,0.72, ,-2.66,0.21,0.59, ,,,,,,,,,,,,
Q9NX24,NHP2,H/ACA ribonucleoprotein complex subunit 2 (Nucleolar protein family A member 2) (snoRNP protein NHP2),7,38.6,29.16,28.97,27.87,28.71,28.69,28.56,27.28,28.33,28.85,28.31,27.69,25.79,28.67,28.22,0.94,0.75,-0.35,0.49,0.47,0.34,-0.94,0.11,0.63,0.09,-0.54,-2.43,0.45,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
P55769,NHP2L1,"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (OTK27) (SNU13 homolog) (hSNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]",6,46.9,32.07,30.84,31.83,31.19,31.34,31.32,30.95,30.51,31.78,31.54,29.67,29.69,30.6,31.03,1.04,-0.18,0.8,0.17,0.31,0.3,-0.08,-0.52,0.75,0.51,-1.35,-1.34,-0.42,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribosome biogenesis;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q14112,NID2,Nidogen-2 (NID-2) (Osteonidogen),23,25.1,25.78,29.56,,29.18,30.02,31.6,29.01,29.58,29.2,32.61,27.39,,30.59,29.5,-3.72,0.05, ,-0.32,0.51,2.1,-0.49,0.08,-0.3,3.11,-2.12, ,1.09,biological adhesion;cell adhesion;cellular process,cell part;cell surface,,,,,,,,,,
Q9GZT8,NIF3L1,NIF3-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein),8,29.5,29.44,28.75,28.94,27.47,28.07,25.94,27.36,27.79,26.96,27.01,24.59,27.23,,27.46,1.98,1.29,1.47,0,0.61,-1.52,-0.1,0.33,-0.51,-0.45,-2.87,-0.23, ,biological regulation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9Y221,NIP7,60S ribosome subunit biogenesis protein NIP7 homolog (KD93),5,40,29.88,28.47,28.32,28.9,30,29.23,29.54,29.13,29.93,29.59,28.22,28.76,29.24,29.17,0.71,-0.7,-0.85,-0.27,0.83,0.06,0.37,-0.04,0.76,0.42,-0.95,-0.41,0.07,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;organelle assembly;ribonucleoprotein complex assembly;ribosome assembly,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),16,7,26.98,26.21,26.68,26,24.09,26.51,26.94,26.37,27.94,27.3,25.93,27.99,26.86,26.6,0.38,-0.39,0.08,-0.6,-2.51,-0.09,0.34,-0.23,1.34,0.7,-0.67,1.39,0.26,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell cycle;cell differentiation;cellular localization;cellular process;cytokinesis;developmental process;growth;localization;mitotic cell cycle;multicellular organismal process;neurological system process;regulation of organelle organization;regulation of protein modification process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q9BPW8,NIPSNAP1,Protein NipSnap homolog 1 (NipSnap1),13,48.6,31.56,31.44,31.29,31.39,31.29,31.67,31.16,31.2,32.12,32.16,31.7,30.96,32.17,31.55,0.02,-0.11,-0.25,-0.15,-0.26,0.12,-0.39,-0.34,0.57,0.61,0.15,-0.59,0.62,multicellular organismal process;neurological system process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9UFN0,NIPSNAP3A,Protein NipSnap homolog 3A (NipSnap3A) (Protein NipSnap homolog 4) (NipSnap4) (Target for Salmonella secreted protein C) (TassC),12,53.8,28.1,31.29,30.07,30.2,30.66,30.89,30.47,30.34,31.62,30.39,31.85,31.11,31.28,30.64,-2.53,0.66,-0.57,-0.44,0.03,0.26,-0.17,-0.29,0.98,-0.25,1.21,0.47,0.64,,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q86X76,NIT1,Nitrilase homolog 1 (EC 3.5.-.-),8,38.1,29.16,28.33,27.41,27.4,27.12,25.78,27.6,27.4,26.96,25.04,27.4,28.2,,27.32,1.84,1.01,0.1,0.09,-0.19,-1.53,0.29,0.08,-0.36,-2.28,0.08,0.88, ,metabolic process;nitrogen compound metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NQR4,NIT2,Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2),15,73.6,31.31,30.5,30.23,30.19,28.39,29.74,30.08,29.67,28.85,29.45,29.48,30.71,28.38,29.77,1.55,0.73,0.46,0.43,-1.37,-0.03,0.31,-0.1,-0.92,-0.32,-0.29,0.94,-1.39,metabolic process;nitrogen compound metabolic process,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;mitochondrion;organelle,,,,,,,,,,
Q9NYR9,NKIRAS2,NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2),2,17,26.19,25.01,27.26,24.81,25.7,24.44,24.77,24.87,25.19,25.69,24.21,24.91,24.29,25.18,1.01,-0.17,2.08,-0.37,0.52,-0.74,-0.41,-0.31,0.01,0.51,-0.97,-0.27,-0.89,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm;membrane,,,,,,,,,,
Q9NVX2,NLE1,Notchless protein homolog 1,5,14,24.35,24.03,,25.69,27.3,25.63,25.66,25.86,24.82,27.63,23.95,,25.04,25.45,-1.1,-1.42, ,0.24,1.85,0.18,0.21,0.41,-0.63,2.18,-1.5, ,-0.41,biological regulation;cell differentiation;cellular process;developmental process;response to stimulus;signal transduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9BYT8,NLN,"Neurolysin, mitochondrial (EC 3.4.24.16) (Angiotensin-binding protein) (Microsomal endopeptidase) (MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase)",14,24.4,26.34,28.49,26.87,29.1,28.41,28.3,28.43,27.69,28.37,29.36,28.75,29.76,28.99,28.37,-2.03,0.11,-1.5,0.73,0.04,-0.08,0.06,-0.68,0,0.98,0.38,1.38,0.62,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part,,,,,,,,,,
P22392,NME2,Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2),25,92.1,33.75,33.96,34.39,34.2,33.92,33.54,34.08,34.31,33.25,33.23,33.97,34.12,32.79,33.81,-0.06,0.15,0.59,0.39,0.11,-0.27,0.27,0.5,-0.56,-0.58,0.16,0.31,-1.02,biological adhesion;biological regulation;biosynthetic process;cell adhesion;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q13232,NME3,Nucleoside diphosphate kinase 3 (NDK 3) (NDP kinase 3) (EC 2.7.4.6) (DR-nm23) (Nucleoside diphosphate kinase C) (NDPKC) (nm23-H3),7,56.2,27.97,28.49,28.61,26.51,27.49,28.86,27.73,27.58,28.89,28.59,28.91,27.67,28.9,28.17,-0.2,0.33,0.44,-1.66,-0.68,0.69,-0.44,-0.59,0.72,0.42,0.74,-0.5,0.73,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P30419,NMT1,Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1),14,38.5,29.41,28.88,30.79,29.9,29.36,28.38,30.66,30.31,29.31,30.34,30.36,31.07,28.97,29.83,-0.42,-0.95,0.96,0.08,-0.46,-1.44,0.83,0.49,-0.52,0.51,0.53,1.25,-0.86,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein acylation;protein lipidation;protein metabolic process;protein modification process,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
O60551,NMT2,Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase),3,8.6,24.01,24.26,,,,,25.55,25.82,24.37,23.48,24.75,24.67,,24.61,-0.61,-0.36, , , , ,0.94,1.2,-0.24,-1.14,0.13,0.06, ,cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein acylation;protein lipidation;protein maturation;protein metabolic process;protein modification process,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P40261,NNMT,Nicotinamide N-methyltransferase (EC 2.1.1.1),19,58,32.48,33.35,32.32,34.2,32.15,32.41,32.17,33.07,32.04,33.54,32.94,33.19,31.68,32.73,-0.25,0.61,-0.41,1.46,-0.58,-0.32,-0.57,0.34,-0.69,0.81,0.21,0.46,-1.06,anatomical structure morphogenesis;cellular metabolic process;cellular process;developmental process;metabolic process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q13423,NNT,"NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)",28,29.5,31.65,32.19,32.59,30.76,31.32,31.52,31.49,31.01,32.42,32.92,32.2,30.92,32.06,31.77,-0.12,0.42,0.81,-1.02,-0.45,-0.25,-0.28,-0.76,0.64,1.14,0.42,-0.85,0.28,catabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q9H6W3,NO66,Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 (EC 1.14.11.-) (EC 1.14.11.27) (60S ribosomal protein L8 histidine hydroxylase) (Histone lysine demethylase NO66) (Myc-associated protein with JmjC domain) (Nucleolar protein 66) (hsNO66) (Ribosomal oxygenase NO66) (ROX),5,11.9,26.59,25.26,,26.54,26.82,26.55,26.63,25.79,26.83,26.15,25.49,,26.72,26.31,0.29,-1.04, ,0.24,0.51,0.24,0.32,-0.52,0.53,-0.16,-0.82, ,0.41,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;nucleus;organelle,,,,,,,,,,
Q9ULX3,NOB1,RNA-binding protein NOB1 (Phosphorylation regulatory protein HP-10) (Protein ART-4),2,6.3,24.93,24.69,25.89,25.93,25.92,,26.07,,25.18,25.7,24.58,25.22,24.89,25.36,-0.43,-0.68,0.53,0.56,0.55, ,0.71, ,-0.18,0.34,-0.79,-0.14,-0.48,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y3T9,NOC2L,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),15,21,29.17,28.73,28.52,29.96,30.07,30.08,29.27,28.88,30.36,30.64,28.11,28.69,29.31,29.37,-0.2,-0.63,-0.85,0.59,0.71,0.71,-0.1,-0.49,0.99,1.27,-1.26,-0.68,-0.06,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;primary metabolic process;regulation of organelle organization;regulation of protein modification process;response to abiotic stimulus;response to stimulus;RNA metabolic process;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q8WTT2,NOC3L,Nucleolar complex protein 3 homolog (NOC3 protein homolog) (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein),14,24.1,27.11,27.9,27.88,28.81,29.29,30.44,29.71,28.21,29.62,30.46,29.39,29.69,29.33,29.06,-1.95,-1.16,-1.19,-0.25,0.22,1.37,0.65,-0.86,0.56,1.4,0.32,0.63,0.26,cell differentiation;cellular process;developmental process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9BVI4,NOC4L,Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein),8,22.1,27.66,27.09,27.32,28.34,28.66,28.69,27.99,27.62,28.46,28.37,26.97,27.14,28.2,27.89,-0.22,-0.8,-0.57,0.46,0.78,0.81,0.1,-0.27,0.58,0.49,-0.91,-0.75,0.32,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q9BSC4,NOL10,Nucleolar protein 10,3,6.1,26.55,26.02,26.74,26.27,26.38,26.49,27.1,25.64,27.72,26.88,25,24.99,27.29,26.39,0.16,-0.37,0.35,-0.12,-0.01,0.1,0.71,-0.75,1.33,0.49,-1.39,-1.4,0.9,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9H8H0,NOL11,Nucleolar protein 11,14,26.6,29.33,28.43,28.59,28.02,29.62,31.33,28.48,28.12,30.81,29.53,27.81,29.22,28.57,29.07,0.26,-0.63,-0.47,-1.05,0.55,2.26,-0.59,-0.95,1.75,0.47,-1.26,0.16,-0.49,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9H6R4,NOL6,Nucleolar protein 6 (Nucleolar RNA-associated protein) (Nrap),13,17.9,28.58,27.58,27.62,28.27,28.61,29.06,28.22,27.9,29.52,29.37,26.24,28.18,28.86,28.31,0.27,-0.73,-0.69,-0.04,0.3,0.75,-0.09,-0.41,1.21,1.06,-2.07,-0.13,0.55,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;nuclear chromosome;nucleolus;organelle,,,,,,,,,,
Q9UMY1,NOL7,Nucleolar protein 7 (Nucleolar protein of 27 kDa),3,12.8,27.89,26.53,26.33,27.61,28.18,27.98,27.88,27.84,28.15,27.62,26.21,27.02,27.91,27.47,0.41,-0.94,-1.14,0.14,0.71,0.51,0.41,0.37,0.68,0.14,-1.27,-0.46,0.43,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
Q76FK4,NOL8,Nucleolar protein 8 (Nucleolar protein Nop132),6,6.3,26.99,27.16,,28.08,28.58,28.69,28.26,28.62,28.44,27.3,27.93,28.59,,28.06,-1.07,-0.9, ,0.03,0.52,0.63,0.21,0.56,0.38,-0.76,-0.13,0.53, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q5SY16,NOL9,Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9),7,15,27.69,27.78,26.89,28.62,28.03,28.33,27.79,26.65,28.43,28.98,26.78,27.68,28.39,27.85,-0.16,-0.07,-0.96,0.77,0.18,0.48,-0.06,-1.2,0.58,1.13,-1.07,-0.17,0.54,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),20,25.3,30.11,28.42,29.58,30.12,30.14,28.99,28.72,29.43,29.21,29.44,27.95,28.72,27.75,29.12,0.99,-0.7,0.45,1,1.02,-0.13,-0.41,0.31,0.09,0.32,-1.17,-0.4,-1.37,cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;nucleus organization;organelle fission;organelle organization;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q5JPE7,NOMO2,Nodal modulator 2 (pM5 protein 2),42,47.6,32.36,32.08,31.77,32.5,32.19,32.22,32.28,32.02,32.72,32.73,31.97,31.95,32.84,32.28,0.08,-0.2,-0.51,0.22,-0.09,-0.06,0,-0.26,0.44,0.45,-0.31,-0.33,0.56,,cell part;membrane,,,,,,,,,,
Q15233,NONO,"Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (55 kDa nuclear protein) (DNA-binding p52/p100 complex, 52 kDa subunit) (NMT55) (p54(nrb)) (p54nrb)",51,78.3,33.84,33.03,33.38,33.64,33.99,33.89,33.29,33.11,33.83,33.78,32.24,31.4,32.55,33.23,0.61,-0.2,0.15,0.41,0.77,0.67,0.06,-0.12,0.6,0.55,-0.98,-1.83,-0.68,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,Other TF domain,,,,,,,,,
Q9NPE3,NOP10,H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10),4,70.3,28.93,25.55,29.14,28.76,28.9,28.73,27.96,28.13,28.92,29.44,27.48,28.28,28.28,28.35,0.59,-2.8,0.79,0.41,0.55,0.38,-0.38,-0.21,0.57,1.1,-0.87,-0.07,-0.06,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
P78316,NOP14,Nucleolar protein 14 (Nucleolar complex protein 14),7,10.5,27.14,26.06,26.73,26.33,26.57,,25.77,27.33,26.22,26.1,,25.03,26.82,26.37,0.76,-0.32,0.36,-0.04,0.2, ,-0.6,0.95,-0.15,-0.27, ,-1.34,0.45,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;Noc complex;nucleolus;organelle;preribosome;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9Y3C1,NOP16,Nucleolar protein 16 (HBV pre-S2 trans-regulated protein 3),4,30.9,27.95,25.77,27.97,27.18,28.5,27.7,28.62,27.61,28.37,28.48,26.8,26.62,27.49,27.62,0.33,-1.85,0.35,-0.44,0.88,0.08,1,-0.01,0.75,0.86,-0.82,-1,-0.13,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P46087,NOP2,Putative ribosomal RNA methyltransferase NOP2 (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),31,37.7,31.28,29.84,29.84,30.81,31.61,31.25,31.16,30.57,31.2,31.62,29.69,30.08,31.29,30.79,0.5,-0.95,-0.95,0.02,0.82,0.47,0.37,-0.22,0.42,0.83,-1.1,-0.71,0.5,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O00567,NOP56,Nucleolar protein 56 (Nucleolar protein 5A),36,60.3,32.96,31.43,31.8,31.4,31.6,31.62,31.31,30.95,31.83,31.89,31.43,30.44,31.62,31.56,1.4,-0.13,0.24,-0.16,0.04,0.07,-0.25,-0.61,0.27,0.33,-0.13,-1.12,0.06,cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
Q9Y2X3,NOP58,Nucleolar protein 58 (Nucleolar protein 5),30,60.7,33.06,31.51,32.15,31.57,31.18,31.21,31.41,30.95,32.11,31.98,30.64,30.82,31.18,31.52,1.53,-0.01,0.63,0.05,-0.34,-0.31,-0.12,-0.57,0.59,0.46,-0.88,-0.7,-0.34,cell growth;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;growth;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;RNA metabolic process;RNA processing;rRNA processing;transport,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
Q86U38,NOP9,Nucleolar protein 9,9,18.2,27.81,27.93,27.43,25.9,27.43,28.19,26.57,26.75,28,28.24,27.71,24.85,28.09,27.3,0.51,0.63,0.13,-1.4,0.13,0.89,-0.73,-0.55,0.7,0.94,0.41,-2.45,0.79,,,,,,,,,,,,
Q9Y314,NOSIP,Nitric oxide synthase-interacting protein (eNOS-interacting protein),7,28.9,28.56,24.94,27.22,27.75,26.28,25.32,27.49,27.3,25.75,24.98,24.52,24.21,,26.19,2.36,-1.26,1.03,1.55,0.08,-0.87,1.3,1.11,-0.44,-1.21,-1.67,-1.98, ,biological regulation;metabolic process;nitrogen compound metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q04721,NOTCH2,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation;Notch 2 intracellular domain],14,6.8,25.83,27.81,26.75,28.93,29.2,29.25,28.62,28.72,29.19,25.57,28.72,29.02,30.1,28.29,-2.45,-0.48,-1.53,0.65,0.92,0.96,0.33,0.44,0.9,-2.71,0.43,0.73,1.81,"anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell growth;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;establishment of localization;growth;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein transport;regulation of cell cycle;response to stimulus;response to stress;RNA metabolic process;secretion;signal transduction;tissue remodeling;transcription initiation, DNA-dependent;transport",cell part;cell surface;extracellular region;membrane;nucleoplasm,,,,,,,,,,
O15118,NPC1,Niemann-Pick C1 protein,12,11.8,29.32,29.65,29.21,29.25,29.56,30.45,29.92,30.57,30.16,30.24,30.05,28.85,31.59,29.91,-0.59,-0.26,-0.7,-0.66,-0.35,0.54,0.01,0.66,0.25,0.34,0.15,-1.06,1.68,alcohol metabolic process;autophagy;behavior;biological regulation;carbohydrate metabolic process;catabolic process;cellular component organization;cellular ketone metabolic process;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;establishment of localization;homeostatic process;lipid metabolic process;lipid transport;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;organic acid metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process;transport;vacuolar transport;vesicle-mediated transport,cell part;endoplasmic reticulum;extracellular region;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;nuclear envelope;organelle;vacuole;vesicle,,,,,,,,,,
P61916,NPC2,Epididymal secretory protein E1 (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein),8,55.4,29.8,30.48,31.7,30.02,29.08,31.56,30.23,29.76,29.56,30.43,30.13,29.93,30.13,30.21,-0.41,0.26,1.48,-0.19,-1.14,1.34,0.01,-0.46,-0.66,0.21,-0.09,-0.29,-0.09,alcohol metabolic process;biological regulation;establishment of localization;homeostatic process;lipid metabolic process;lipid transport;metabolic process;multi-organism process;primary metabolic process;response to biotic stimulus;response to stimulus;small molecule metabolic process;transport,cell part;endoplasmic reticulum;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q8NDH3,NPEPL1,Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1),5,20.9,27.43,27.59,25.07,26.3,,,,23.15,26.2,,26.83,,25.21,25.97,1.46,1.61,-0.91,0.33, , , ,-2.82,0.23, ,0.86, ,-0.76,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm,,,,,,,,,,
P55786,NPEPPS,Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S),36,46.2,33,32.99,32.6,32.59,31.88,31.82,32.9,32.76,30.89,31.88,32.85,32.96,30.57,32.29,0.71,0.71,0.32,0.3,-0.41,-0.46,0.61,0.48,-1.39,-0.41,0.57,0.68,-1.71,cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;response to chemical stimulus;response to stimulus;response to stress,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BXD5,NPL,N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase),8,33.1,,28.85,28.99,,22.63,,,23.8,25.59,,26.26,25.8,25.03,25.87, ,2.98,3.12, ,-3.24, , ,-2.07,-0.28, ,0.39,-0.07,-0.84,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q8TAT6,NPLOC4,Nuclear protein localization protein 4 homolog (Protein NPL4),15,25.8,28.95,28.89,29.83,29.4,28,28.57,29.77,29.14,29.37,29.09,30.15,30.33,28.34,29.22,-0.27,-0.33,0.62,0.18,-1.22,-0.64,0.56,-0.08,0.16,-0.13,0.93,1.11,-0.88,catabolic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;Golgi organization;macromolecule metabolic process;membrane fusion;membrane organization;metabolic process;organelle organization;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
E5RI98,NPM1,Nucleophosmin (Fragment),2,18,27.03,23.76,23.87,23.85,26.67,25.73,24.76,24.8,25.21,25.61,,24.11,25.18,25.05,1.98,-1.29,-1.18,-1.2,1.62,0.69,-0.29,-0.25,0.16,0.57, ,-0.94,0.13,,,,,,,,,,,,
P06748,NPM1,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),35,89.8,35.3,33.72,33.77,34.34,35.63,35.25,34.42,34.46,35.12,35.36,33.09,33.68,34.68,34.53,0.78,-0.81,-0.75,-0.18,1.11,0.73,-0.11,-0.06,0.59,0.83,-1.44,-0.85,0.16,aging;biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA repair;establishment of localization;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;microtubule organizing center organization;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;organelle assembly;organelle organization;primary metabolic process;protein complex assembly;protein transport;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of translation;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;ribonucleoprotein complex assembly;ribosome assembly;signal transduction;transport;viral reproduction,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleolus;nucleoplasm;organelle;ribonucleoprotein complex,,,,,,,,,,
O75607,NPM3,Nucleoplasmin-3,2,17.4,26.95,27.02,25.65,28.15,28.63,28.17,27.2,28.65,27.88,27.65,25.35,,27.87,27.43,-0.47,-0.41,-1.78,0.72,1.2,0.74,-0.23,1.22,0.45,0.22,-2.08, ,0.44,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9Y639,NPTN,Neuroplastin (Stromal cell-derived receptor 1) (SDR-1),8,35.8,29.17,30.02,29.87,29.87,28.65,29.43,29,28.92,29.37,28.91,30.03,29.57,30.05,29.45,-0.28,0.57,0.42,0.42,-0.8,-0.02,-0.45,-0.53,-0.08,-0.54,0.58,0.12,0.6,biological adhesion;biological regulation;cell adhesion;cellular homeostasis;cellular ion homeostasis;cellular process;homeostatic process;regulation of protein modification process,cell part;membrane;plasma membrane,,,,,,,,,,
P15559,NQO1,NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1),10,44.6,30.92,30.52,26.76,31.5,30.1,30.87,31.71,31.72,30.27,26.88,32.32,32.44,29.58,30.43,0.49,0.09,-3.67,1.08,-0.33,0.44,1.28,1.29,-0.16,-3.55,1.89,2.01,-0.85,aging;biological regulation;biosynthetic process;cell communication;cell-cell signaling;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;metabolic process;nitrogen compound metabolic process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;signaling;small molecule metabolic process;xenobiotic metabolic process,cell body;cell part;cytosol;neuronal cell body,,,,,,,,,,
P16083,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.99.2) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2),2,15.5,27.53,27.47,27.39,27.37,,25.28,,,,25.22,25.58,,,26.55,0.98,0.92,0.84,0.83, ,-1.27, , , ,-1.33,-0.97, , ,behavior;multicellular organismal process;neurological system process;response to stimulus,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P01111,NRAS,GTPase NRas (Transforming protein N-Ras),6,29.1,28.53,28.15,30,28.55,29.01,29.1,29.37,28.92,29.59,29.74,29.63,30.2,29.59,29.26,-0.73,-1.11,0.74,-0.71,-0.25,-0.16,0.11,-0.34,0.33,0.48,0.37,0.94,0.33,behavior;biological regulation;cell differentiation;cell motility;cellular component movement;cellular component organization;cellular metabolic process;cellular process;coagulation;cytoskeleton organization;developmental process;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;membrane;plasma membrane,,,,,,,,,,
Q9UHY1,NRBP1,Nuclear receptor-binding protein,9,25.2,29.42,29.24,28.76,29.67,29.22,27,29.5,29.35,27.4,27.56,28.83,29.07,26.95,28.61,0.8,0.63,0.15,1.05,0.61,-1.61,0.89,0.74,-1.21,-1.05,0.21,0.45,-1.67,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent;transport;vesicle-mediated transport",cell cortex;cell part;cell projection;endomembrane system;membrane;nucleoplasm,,+,,,,,,,,
O43847,NRD1,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C),16,16.8,28.7,28.41,28.69,29.53,29.02,28.25,29.71,29.57,27.06,27.11,28.61,30.1,26.38,28.55,0.15,-0.14,0.14,0.98,0.47,-0.3,1.16,1.02,-1.49,-1.44,0.06,1.55,-2.17,biological regulation;cell motility;cell proliferation;cellular component movement;cellular component organization;cellular process;locomotion;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cell surface;cytosol,,,,,,,,,,
O14786,NRP1,Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304),7,20,23.53,26.53,,27.25,28.62,26.92,26.66,27.59,29.12,24.75,26.23,27.11,27.59,26.83,-3.3,-0.29, ,0.43,1.79,0.1,-0.17,0.77,2.29,-2.08,-0.6,0.29,0.76,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell communication;cell motility;cell recognition;cell-cell signaling;cellular component movement;cellular component organization;cellular process;developmental process;locomotion;multicellular organismal process;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;signaling,cell body;cell part;cell surface;cytosol;extracellular region;intracellular organelle;macromolecular complex;membrane;neuronal cell body;organelle;plasma membrane;protein complex;receptor complex;site of polarized growth;vesicle,,,,,,,,,,
O95478,NSA2,Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1),4,19.6,27.7,,26.2,28.08,27.2,27.4,27.09,,28.04,27.9,25.88,27.7,26.68,27.26,0.44, ,-1.06,0.82,-0.06,0.14,-0.17, ,0.78,0.64,-1.38,0.44,-0.58,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q15738,NSDHL,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (EC 1.1.1.170) (Protein H105e3)",24,68.1,29.31,32.43,30.32,31.75,31.87,32.14,31.77,31.92,32.5,32.76,31.88,31.43,32.37,31.73,-2.42,0.7,-1.4,0.02,0.15,0.41,0.04,0.19,0.77,1.03,0.16,-0.3,0.65,alcohol metabolic process;anatomical structure development;biological regulation;biosynthetic process;cellular process;developmental process;lipid metabolic process;metabolic process;molting cycle;multicellular organismal process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process,cell part;lipid particle;membrane,,,,,,,,,,
P46459,NSF,Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF),36,49,31.43,31.67,31.64,31.62,31.1,31.5,31.24,31.33,31.75,31.26,32.15,31.15,32.04,31.53,-0.1,0.14,0.11,0.09,-0.43,-0.02,-0.29,-0.2,0.22,-0.27,0.62,-0.38,0.51,biological regulation;cell communication;cell-cell signaling;cellular component organization;cellular membrane organization;cellular process;establishment of localization;exocytosis;ion transport;membrane fusion;membrane organization;protein transport;secretion;signaling;transport;vesicle-mediated transport,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q9UNZ2,NSFL1C,NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47),18,54.6,30.75,30.29,28.86,30.26,30.53,29.8,30.47,30.67,28,28.86,31.16,31.08,29.87,30.05,0.71,0.24,-1.19,0.22,0.48,-0.24,0.42,0.63,-2.05,-1.19,1.12,1.03,-0.18,,cell part;chromosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q08J23,NSUN2,tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4),28,53.8,30.66,29.92,31.6,30.46,30.44,30.26,29.84,29.38,30.13,30.19,28.79,30.35,29.8,30.14,0.52,-0.22,1.46,0.32,0.3,0.12,-0.3,-0.76,-0.01,0.05,-1.35,0.21,-0.35,cell division;cellular component organization;cellular process;mitosis;nuclear division;organelle fission;organelle organization,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q96P11,NSUN5,Putative methyltransferase NSUN5 (EC 2.1.1.-) (NOL1-related protein) (NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein),6,16.1,25.81,23.6,25.23,25.32,24.95,24.89,24.21,24.08,25.35,24.81,22.11,24.34,24.4,24.55,1.27,-0.95,0.68,0.77,0.4,0.35,-0.34,-0.46,0.81,0.26,-2.44,-0.2,-0.15,,,,,,,,,,,,
P49902,NT5C2,Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II),7,15.2,27.89,26.87,27.21,27.16,26.23,,26.86,28.15,25.13,25.58,27.83,25.76,,26.79,1.1,0.08,0.43,0.37,-0.56, ,0.08,1.36,-1.66,-1.21,1.04,-1.03, ,catabolic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;drug metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,+,,,,,,,
Q9H0P0,NT5C3A,Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I) (Uridine 5'-monophosphate hydrolase 1) (p36),10,36.3,27.8,26.34,29.51,28.06,23.91,25.48,26.84,27.01,26.01,26.96,25.89,26.92,25.27,26.62,1.18,-0.28,2.89,1.45,-2.7,-1.13,0.22,0.39,-0.6,0.35,-0.73,0.3,-1.34,catabolic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,+,,,,,,,
Q5TFE4,NT5DC1,5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-),8,24.8,29.28,28.22,27.36,28.38,25.65,26.72,28.43,26.96,27.41,26.32,27.74,29.86,26.73,27.62,1.66,0.59,-0.26,0.76,-1.97,-0.9,0.81,-0.66,-0.21,-1.3,0.12,2.24,-0.89,,,,,,,,,,,,
Q9H857,NT5DC2,5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-),9,18.8,24.69,24.94,,27.22,27.98,29.04,25.92,27.19,28.56,26.93,24.79,26.77,28.39,26.87,-2.18,-1.93, ,0.35,1.12,2.17,-0.95,0.32,1.69,0.06,-2.08,-0.1,1.52,,,,,,,,,,,,
Q86UY8,NT5DC3,5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-) (GRP94-neighboring nucleotidase),6,12,27.95,25.27,24.83,,25.48,24.77,25.28,25.25,26.78,28.47,24.99,,27.35,26.04,1.91,-0.77,-1.21, ,-0.56,-1.27,-0.76,-0.79,0.74,2.43,-1.05, ,1.31,,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6NZX3,NT5E,"5'-nucleotidase, ecto (CD73)",25,46.7,27.8,31.67,31.81,31.68,32.28,31.63,31.96,31.32,32.15,32.89,31.84,29.23,32.25,31.42,-3.62,0.24,0.39,0.26,0.86,0.21,0.53,-0.11,0.73,1.47,0.42,-2.19,0.83,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q9BV86,NTMT1,"N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (N-terminal RCC1 methyltransferase) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A) [Cleaved into: N-terminal Xaa-Pro-Lys N-methyltransferase 1, N-terminally processed]",5,27.8,26.89,27.16,25.43,28.02,26.35,25.67,28.13,26.77,24.96,23.97,26.97,27.86,22.79,26.23,0.67,0.93,-0.8,1.8,0.12,-0.56,1.9,0.54,-1.27,-2.26,0.74,1.63,-3.44,cellular component organization;cellular metabolic process;cellular process;chromosome segregation;cytoskeleton organization;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BSD7,NTPCR,Cancer-related nucleoside-triphosphatase (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase),7,39.5,27.06,26.2,29.1,28.12,26.56,26.97,27.2,27.47,24.85,28.48,25.54,26.1,25.11,26.83,0.23,-0.63,2.27,1.29,-0.26,0.14,0.37,0.64,-1.98,1.66,-1.29,-0.73,-1.71,,,,,,,,,,,,
P53384,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1 (Nucleotide-binding protein 1) (NBP 1),2,11.7,26.5,25.07,26.69,26.11,,25.83,25.54,24.84,,24.61,25.56,27.1,25.88,25.79,0.7,-0.72,0.9,0.32, ,0.04,-0.26,-0.96, ,-1.18,-0.23,1.31,0.08,biological regulation;biosynthetic process;cell growth;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;cofactor metabolic process;growth;homeostatic process;metabolic process;small molecule metabolic process,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q9Y5Y2,NUBP2,Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2) (NBP 2),2,9.2,24.79,26.01,,24.55,23,,25.56,24.85,,,,23.77,,24.65,0.15,1.36, ,-0.1,-1.65, ,0.91,0.2, , , ,-0.87, ,metabolic process;small molecule metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
Q8TB37,NUBPL,Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1),2,16.1,24.73,24.65,,24.54,26.77,26.8,25.57,25.25,25.24,25.13,25.91,26.67,24.43,25.47,-0.74,-0.82, ,-0.93,1.29,1.32,0.1,-0.22,-0.24,-0.34,0.43,1.19,-1.04,anatomical structure morphogenesis;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular macromolecular complex assembly;cellular process;developmental process;macromolecular complex assembly;mitochondrion organization;organelle organization;protein complex assembly;protein complex biogenesis,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q02818,NUCB1,Nucleobindin-1 (CALNUC),35,61.6,32.02,31.89,31.5,31.62,30.47,31.41,30.64,30.6,31.18,31.92,30.6,29.8,30.58,31.1,0.92,0.79,0.4,0.53,-0.62,0.31,-0.46,-0.49,0.09,0.83,-0.49,-1.29,-0.52,,cell part;cytoskeleton;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P80303,NUCB2,Nucleobindin-2 (DNA-binding protein NEFA) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1],22,45.5,31.01,32.72,31.62,31.84,31.16,31.66,31.39,31.77,32.56,30.96,31.64,32.53,31.73,31.74,-0.72,0.98,-0.12,0.1,-0.58,-0.07,-0.35,0.03,0.82,-0.78,-0.09,0.79,-0.01,,cell part;cytosol;endoplasmic reticulum;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9Y266,NUDC,Nuclear migration protein nudC (Nuclear distribution protein C homolog),21,57.1,30.5,30.85,31.34,31.75,31.16,30.38,31.52,31.27,30.21,29.9,30.84,30.73,28.54,30.69,-0.19,0.15,0.65,1.06,0.47,-0.31,0.83,0.58,-0.48,-0.79,0.15,0.03,-2.15,cell cycle;cell proliferation;cellular component organization;cellular process;cytokinesis;developmental process;mitosis;mitotic cell cycle;multicellular organismal development;multicellular organismal process;nuclear division;organelle fission;organelle organization,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q96RS6,NUDCD1,NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66),10,25.1,30.2,28.6,28.79,29.1,28.08,28.5,28.86,28.82,27.89,25.99,26.88,27.77,26.99,28.19,2.01,0.41,0.6,0.91,-0.11,0.31,0.67,0.63,-0.3,-2.2,-1.31,-0.42,-1.2,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8IVD9,NUDCD3,NudC domain-containing protein 3,3,8.3,,26.36,19.11,19.77,24.52,24.28,26.75,26.9,18.02,18.43,24.35,26.96,,23.22, ,3.14,-4.11,-3.46,1.3,1.06,3.53,3.68,-5.2,-4.79,1.13,3.73, ,,,,,,,,,,,,
Q9BRJ7,NUDT16L1,Protein syndesmos (NUDT16-like protein 1),5,36.9,26.35,25.99,,25.83,27.06,27.23,26.38,26.5,,26,,27.48,25.36,26.42,-0.07,-0.43, ,-0.59,0.64,0.81,-0.04,0.08, ,-0.41, ,1.06,-1.06,,cell part;cytoplasm,,,,,,,,,,
A8MXV4,NUDT19,"Nucleoside diphosphate-linked moiety X motif 19, mitochondrial (Nudix motif 19) (EC 3.6.1.-)",8,25.6,27.78,28.72,27.86,28.45,27.9,27.24,26.58,28.64,26.27,27.95,28.25,29.12,28.77,27.96,-0.18,0.76,-0.1,0.48,-0.07,-0.72,-1.39,0.67,-1.69,-0.01,0.28,1.16,0.81,,cell part;intracellular membrane-bounded organelle;intracellular organelle;microbody;mitochondrion;organelle;peroxisome,,,,,,,,,,
O43809,NUDT21,Cleavage and polyadenylation specificity factor subunit 5 (Cleavage and polyadenylation specificity factor 25 kDa subunit) (CFIm25) (CPSF 25 kDa subunit) (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21) (Pre-mRNA cleavage factor Im 25 kDa subunit),12,51.5,31.77,31.02,30.74,30.83,31.8,31.73,31.29,31.27,31.02,31.51,30.27,31.05,31.48,31.21,0.56,-0.2,-0.47,-0.38,0.58,0.52,0.07,0.06,-0.19,0.29,-0.94,-0.16,0.27,"biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent",cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;mRNA cleavage factor complex;organelle;protein complex,,,,,,,,,,
Q9NZJ9,NUDT4,"Diphosphoinositol polyphosphate phosphohydrolase 2 (DIPP-2) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 2) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 4) (Nudix motif 4)",3,27.4,26.05,25.15,,26.43,22.51,23.42,23.67,24.65,,,26.74,20.8,,24.38,1.67,0.77, ,2.05,-1.87,-0.96,-0.71,0.27, , ,2.36,-3.58, ,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;regulation of transport;response to stimulus;signal transduction;small molecule metabolic process;transport,cell part;cytosol,,,,,,,,,,
Q9UKK9,NUDT5,ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5) (YSA1H),14,69.4,30.54,29.91,30.36,30.39,29.82,28.96,30.46,29.94,29.54,28.79,29.85,31.46,27.74,29.83,0.71,0.09,0.53,0.56,-0.01,-0.87,0.63,0.11,-0.29,-1.04,0.02,1.63,-2.09,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9BW91,NUDT9,"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)",6,21.3,27.47,28.21,28.31,28.01,28.53,29.01,28.84,29.16,27.92,28.16,28.4,28.17,28.88,28.39,-0.92,-0.18,-0.08,-0.38,0.14,0.62,0.45,0.77,-0.47,-0.23,0.01,-0.22,0.49,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q7Z417,NUFIP2,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),21,39,30.23,26.59,28.84,28.94,29.17,27.54,28.65,28.34,28.56,28.77,27.57,27.72,26.59,28.27,1.96,-1.68,0.57,0.67,0.9,-0.73,0.38,0.07,0.29,0.5,-0.7,-0.55,-1.68,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q14980,NUMA1,Nuclear mitotic apparatus protein 1 (NuMA protein) (SP-H antigen),104,57.3,33.56,31.77,33.88,32.32,32.66,32.97,31.9,31.92,33.03,31.85,28.91,30.11,30.7,31.97,1.59,-0.2,1.91,0.35,0.69,1.01,-0.06,-0.04,1.06,-0.12,-3.06,-1.86,-1.26,cell differentiation;cell division;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment of localization;nucleus organization;organelle organization,apical part of cell;cell part;chromosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,,,,,,,,,,
P49757,NUMB,Protein numb homolog (h-Numb) (Protein S171),10,24.7,26.77,28.45,26.25,28.71,28.22,28.95,27.9,28.21,28.62,28.2,28.29,,27.17,27.98,-1.21,0.47,-1.72,0.73,0.24,0.97,-0.08,0.24,0.64,0.22,0.32, ,-0.81,anatomical structure development;biological regulation;cell differentiation;cell division;cell junction organization;cellular component organization;cellular process;developmental process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,apical part of cell;cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y6R0,NUMBL,Numb-like protein (Numb-related protein) (Numb-R),5,8.8,25.62,24.97,23.73,,25.54,24.91,27.06,25.7,,23.57,,26.28,22.7,25.01,0.61,-0.04,-1.28, ,0.54,-0.1,2.05,0.7, ,-1.44, ,1.27,-2.31,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell division;cell junction organization;cellular component morphogenesis;cellular component organization;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoplasm,,,,,,,,,,
P57740,NUP107,Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107),20,29.1,29.82,29.21,30.19,28.97,30.01,29.56,29.83,29.35,30.14,30.02,28.35,28.47,29.2,29.47,0.35,-0.26,0.72,-0.5,0.54,0.09,0.36,-0.12,0.67,0.55,-1.12,-1,-0.27,biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;macromolecular complex assembly;metabolic process;mitotic cell cycle;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;nucleus organization;organelle organization;primary metabolic process;protein complex assembly;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q8WUM0,NUP133,Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133),24,26.6,30.35,29.54,29.54,29.87,30.42,30.54,30.08,29.69,30.05,29.49,28.92,29.37,30.07,29.84,0.51,-0.3,-0.3,0.03,0.58,0.7,0.24,-0.15,0.21,-0.35,-0.93,-0.47,0.23,anatomical structure development;biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cellular component organization;cellular process;developmental process;establishment of localization;metabolic process;mitotic cell cycle;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;nucleus organization;organelle organization;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;organelle;protein complex,,,,,,,,,,
P49790,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),30,25.8,31.05,27.97,29.75,28.95,29.29,29.12,29.2,28.65,28.66,28.62,27.89,27.59,28.44,28.86,2.19,-0.89,0.89,0.09,0.43,0.26,0.34,-0.21,-0.2,-0.24,-0.97,-1.27,-0.42,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;interspecies interaction between organisms;locomotion;macromolecular complex assembly;metabolic process;multi-organism process;nucleobase-containing compound transport;nucleus organization;organelle organization;primary metabolic process;protein complex assembly;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;nucleoplasm;organelle,,,,,,,,,,
O75694,NUP155,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),31,27.2,31.66,31,31.31,31.01,31.21,31.15,30.99,30.85,31.39,31.45,29.7,30.8,31.16,31.05,0.61,-0.06,0.26,-0.05,0.15,0.1,-0.07,-0.2,0.34,0.4,-1.35,-0.25,0.11,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane organization;metabolic process;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;nuclear envelope;nuclear pore;protein complex,,,,,,,,,,
Q12769,NUP160,Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160),22,18.3,30.06,29.37,28.99,28.84,30.64,30.12,29.2,29.12,30.13,28.94,27.91,29.48,29.01,29.37,0.7,0,-0.38,-0.53,1.27,0.75,-0.16,-0.25,0.76,-0.43,-1.46,0.11,-0.36,biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cellular process;establishment of localization;metabolic process;mitotic cell cycle;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q5SRE5,NUP188,Nucleoporin NUP188 homolog (hNup188),14,9.7,28.25,27.23,26.91,26.25,28.07,27.91,26.96,27.31,27.84,27.83,26.99,26.3,28.17,27.38,0.86,-0.16,-0.48,-1.14,0.69,0.52,-0.43,-0.07,0.46,0.44,-0.4,-1.08,0.79,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;nuclear envelope;nuclear pore;protein complex,,,,,,,,,,
Q92621,NUP205,Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205),31,16.9,30.8,30.56,30.5,30.04,31.08,30.78,29.99,29.79,30.88,30.12,29.63,29.65,29.91,30.29,0.51,0.28,0.22,-0.25,0.79,0.49,-0.3,-0.5,0.59,-0.17,-0.66,-0.64,-0.37,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;macromolecular complex assembly;metabolic process;nucleobase-containing compound transport;nucleus organization;organelle organization;primary metabolic process;protein complex assembly;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;nuclear pore;protein complex,,,,,,,,,,
Q8TEM1,NUP210,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),27,19.6,31.81,29.46,30.2,25.45,30.44,28.91,29.88,29.78,27.02,30.5,26.39,26.16,,28.83,2.98,0.62,1.36,-3.38,1.61,0.08,1.04,0.95,-1.81,1.67,-2.45,-2.68, ,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;nuclear envelope;nuclear pore;protein complex,,,,,,,,,,
P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),25,17.4,29.3,29.11,29.2,29.11,28.99,28.91,29.14,28.55,29.9,29.38,26.61,29.27,27.89,28.87,0.43,0.23,0.33,0.23,0.12,0.03,0.27,-0.33,1.03,0.51,-2.27,0.39,-0.99,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;regulation of cell cycle;regulation of transport;response to chemical stimulus;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;macromolecular complex;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
Q8NFH5,NUP35,Nucleoporin NUP53 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin Nup35),10,53.7,28.32,25.1,26.69,27.14,26.83,28.03,26.61,26.62,28.82,,,27.18,,27.13,1.18,-2.04,-0.44,0.01,-0.3,0.9,-0.52,-0.51,1.68, , ,0.05, ,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nuclear pore;organelle;plasma membrane;protein complex,,,,,,,,,,
Q8NFH4,NUP37,Nucleoporin Nup37 (p37) (Nup107-160 subcomplex subunit Nup37),8,29.4,27.84,27.15,27.79,27.78,28.04,27.45,27.34,27.15,28.14,28.28,24.14,22.94,26.15,26.94,0.9,0.21,0.86,0.84,1.11,0.51,0.4,0.21,1.2,1.34,-2.79,-4,-0.79,biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cell division;cellular component organization;cellular process;chromosome segregation;establishment of localization;metabolic process;mitosis;mitotic cell cycle;nuclear division;nucleobase-containing compound transport;organelle fission;organelle organization;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q8NFH3,NUP43,Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43) (p42),6,17.1,29.08,29.04,26.16,28.79,28.41,28.94,26.1,27.99,27.8,26.18,28.07,25.54,25.78,27.53,1.55,1.52,-1.37,1.26,0.88,1.41,-1.43,0.46,0.28,-1.35,0.54,-1.99,-1.75,biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cell division;cellular component organization;cellular process;chromosome segregation;establishment of localization;metabolic process;mitosis;mitotic cell cycle;nuclear division;nucleobase-containing compound transport;organelle fission;organelle organization;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9UKX7,NUP50,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),7,21.8,27.46,27.66,28.56,28.3,26.13,28.13,28.23,27.13,27.51,28.96,25.55,28.06,27.04,27.59,-0.13,0.07,0.97,0.71,-1.46,0.53,0.63,-0.46,-0.09,1.37,-2.04,0.47,-0.56,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
Q7Z3B4,NUP54,Nucleoporin p54 (54 kDa nucleoporin),15,41.6,30.42,30.36,30.05,29.7,29.58,29.74,30.03,29,29.75,29.79,28.56,28.49,28.62,29.55,0.87,0.81,0.5,0.16,0.03,0.19,0.49,-0.55,0.21,0.24,-0.98,-1.05,-0.92,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein targeting;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytoplasm;macromolecular complex;membrane;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
P37198,NUP62,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),10,23.6,30.22,29.42,29.57,29.31,29.54,29.96,29.91,30.27,29.92,29.27,28.08,27.12,29.54,29.39,0.82,0.03,0.18,-0.09,0.15,0.56,0.51,0.88,0.53,-0.12,-1.31,-2.28,0.14,biological regulation;biosynthetic process;carbohydrate metabolic process;carbohydrate transport;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytoplasm;macromolecular complex;membrane;nuclear pore;nucleocytoplasmic shuttling complex;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9BW27,NUP85,Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup75) (Nucleoporin Nup85) (Pericentrin-1),16,29.9,29.61,29.62,29.4,29.04,28.99,29.57,29.09,28.45,29.57,29.42,28.74,29.16,29.03,29.21,0.4,0.41,0.2,-0.17,-0.22,0.36,-0.11,-0.76,0.36,0.21,-0.47,-0.05,-0.17,biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;establishment of localization;immune system process;locomotion;metabolic process;mitotic cell cycle;nucleobase-containing compound transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q99567,NUP88,Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88),15,24,28.75,28.64,28.27,28.12,29.06,28.91,28.39,28.94,28.73,28.54,26.4,27.34,27.77,28.3,0.46,0.34,-0.03,-0.18,0.77,0.61,0.1,0.64,0.43,0.24,-1.9,-0.96,-0.53,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;macromolecular complex;nuclear pore;protein complex,,,,,,,,,,
Q8N1F7,NUP93,Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93),35,47.6,31.84,31.37,30.87,31.3,31.73,31.37,31.88,30.76,31.67,31.52,30.63,31.24,31.28,31.34,0.5,0.03,-0.47,-0.04,0.38,0.02,0.53,-0.58,0.33,0.18,-0.71,-0.11,-0.07,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;macromolecular complex assembly;metabolic process;nucleobase-containing compound transport;nucleus organization;organelle organization;primary metabolic process;protein complex assembly;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;nuclear pore;protein complex,,,,,,,,,,
P52948,NUP98,Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98);Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],40,28.1,30.73,30.1,30.5,30.03,30.8,30.68,30.3,29.58,30.7,30.55,28.82,28.99,30.5,30.18,0.55,-0.08,0.32,-0.15,0.62,0.51,0.12,-0.6,0.53,0.38,-1.35,-1.19,0.33,biological regulation;biosynthetic process;carbohydrate metabolic process;carbohydrate transport;cell cycle;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;establishment of localization;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mitotic cell cycle;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleus organization;organelle organization;primary metabolic process;protein complex assembly;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;macromolecular complex;membrane;nucleoplasm;protein complex,,,,,,,,,,
Q9BVL2,NUPL1,Nucleoporin p58/p45 (Nucleoporin-like protein 1),7,21.4,27.56,27.49,28.12,26.1,28.03,27.83,27.32,28.13,27.57,27.33,25.76,25.5,27.4,27.24,0.32,0.25,0.87,-1.14,0.79,0.59,0.08,0.89,0.33,0.09,-1.48,-1.74,0.15,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nucleobase-containing compound transport;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;macromolecular complex;membrane;nuclear envelope;nuclear pore;protein complex,,,,,,,,,,
P61970,NUTF2,Nuclear transport factor 2 (NTF-2) (Placental protein 15) (PP15),6,76.4,30.86,30.32,29.76,30.99,27.34,27.87,30.29,29.48,29.02,28.87,30.86,31.02,26.61,29.48,1.38,0.84,0.27,1.51,-2.15,-1.62,0.8,-0.01,-0.46,-0.61,1.37,1.54,-2.87,establishment of localization;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;transport,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;organelle;protein complex,,,,,,,,,,
O15381,NVL,Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein),4,8.3,26.5,26.6,23.98,24.39,,23.15,24.53,,,23.67,,,,24.69,1.81,1.91,-0.71,-0.3, ,-1.54,-0.16, , ,-1.02, , , ,,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9UBU9,NXF1,Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP),16,39.1,29.07,28.42,29.03,28.96,29.25,29.17,28.92,28.96,29.6,29.4,27.22,27.61,28.1,28.75,0.33,-0.33,0.28,0.22,0.5,0.42,0.17,0.21,0.85,0.65,-1.53,-1.14,-0.64,establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;transport,cell part;cytosol;macromolecular complex;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
Q6DKJ4,NXN,Nucleoredoxin (EC 1.8.1.8),7,21.8,27.71,27.48,26.77,29.02,27.28,26.72,29.07,28.86,27.14,24.9,27.65,28.85,25.18,27.43,0.28,0.05,-0.66,1.59,-0.15,-0.71,1.64,1.42,-0.29,-2.53,0.22,1.42,-2.26,anatomical structure development;biological regulation;cell differentiation;cellular process;developmental process;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P29728,OAS2,2'-5'-oligoadenylate synthase 2 ((2-5')oligo(A) synthase 2) (2-5A synthase 2) (EC 2.7.7.84) (p69 OAS / p71 OAS) (p69OAS / p71OAS),18,28.1,26.14,28.89,31.93,30.45,,,26.27,28.34,28.04,28,25.02,23.46,,27.66,-1.52,1.24,4.28,2.8, , ,-1.38,0.69,0.38,0.35,-2.63,-4.19, ,biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein acylation;protein glycosylation;protein lipidation;protein metabolic process;protein modification process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;cytoplasm;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9Y6K5,OAS3,2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (p100 OAS) (p100OAS),28,29.1,28.43,30.87,31.82,31.63,29.13,25.42,29.88,30.04,25.84,28.95,26.47,28.98,24.52,28.61,-0.18,2.25,3.21,3.01,0.52,-3.19,1.27,1.42,-2.77,0.34,-2.14,0.37,-4.09,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
I1YDD2,OASLd,2'-5'-oligoadenylate synthetase-like transcript variant 4,6,23.2,23.82,25.36,26.55,28.59,,,,23.57,,,,25.54,25.59,25.57,-1.76,-0.21,0.97,3.02, , , ,-2, , , ,-0.04,0.01,biological regulation;cellular process;immune system process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P04181,OAT,"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form;Ornithine aminotransferase, renal form]",29,66.1,32.97,32.08,30.87,32.46,33.07,33.6,32.92,32.92,34.29,31.65,32.74,31.92,34.1,32.74,0.24,-0.66,-1.87,-0.28,0.34,0.86,0.18,0.18,1.55,-1.09,0.01,-0.82,1.36,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecular complex assembly;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part,,,,,,,,,,
Q9NX40,OCIAD1,OCIA domain-containing protein 1 (Ovarian carcinoma immunoreactive antigen),12,53.1,29.17,31.12,30.52,30.75,30.83,30.88,30.76,30.72,30.53,31.33,30.67,29.81,30.65,30.59,-1.43,0.53,-0.07,0.16,0.23,0.29,0.17,0.12,-0.07,0.73,0.08,-0.79,0.06,,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q56VL3,OCIAD2,OCIA domain-containing protein 2 (Ovarian carcinoma immunoreactive antigen-like protein),11,74.7,26.82,29.34,29,29.1,31.63,31.1,31.33,30.59,31.86,30.95,30.84,28.95,30.55,30.16,-3.34,-0.82,-1.16,-1.06,1.48,0.94,1.17,0.43,1.7,0.79,0.68,-1.21,0.39,,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q01968,OCRL,Inositol polyphosphate 5-phosphatase OCRL-1 (EC 3.1.3.36) (Lowe oculocerebrorenal syndrome protein),6,9.1,26.51,24.61,25.7,26.06,,24.07,25.62,26.72,24.67,22.97,26.93,27.03,25.59,25.54,0.97,-0.93,0.16,0.52, ,-1.47,0.08,1.18,-0.87,-2.57,1.39,1.49,0.05,anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;embryo development;lipid metabolic process;metabolic process;phosphorus metabolic process;primary metabolic process;response to stimulus;signal transduction,cell part;cell projection;cilium;cytoplasmic membrane-bounded vesicle;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;vesicle,,,+,,,,,,,
Q5SWX8,ODR4,Protein odr-4 homolog (hODR-4) (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1),8,21.8,27.92,27.94,28.35,27.83,27.65,27.64,27.34,28.25,28.24,28.68,28.9,29.28,29.16,28.24,-0.32,-0.31,0.11,-0.41,-0.6,-0.61,-0.9,0.01,0,0.43,0.66,1.04,0.91,,cell part,,,,,,,,,,
Q02218,OGDH,"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)",60,56.7,31.74,32.78,32.97,32.1,32.39,33.09,32.53,32.12,33.16,33.72,33.16,33.14,33.35,32.79,-1.05,-0.01,0.18,-0.69,-0.4,0.3,-0.25,-0.67,0.37,0.94,0.37,0.35,0.56,alcohol metabolic process;amine metabolic process;anatomical structure development;carbohydrate metabolic process;catabolic process;cell development;cell motility;cellular amino acid metabolic process;cellular component movement;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;generation of precursor metabolites and energy;heterocycle metabolic process;locomotion;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;membrane;oxoglutarate dehydrogenase complex;protein complex,,,,,,,,,,
Q9NZT2,OGFR,Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor),13,32.9,29.13,28.49,29.69,28.87,28.28,26.68,28.18,28.08,26.13,26.25,25.67,28.1,26.99,27.73,1.4,0.75,1.95,1.13,0.54,-1.05,0.45,0.35,-1.61,-1.48,-2.06,0.37,-0.74,biological regulation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
O15294,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),14,16.6,29.15,27.8,29.46,28.55,27.73,28.37,28.98,28.52,28.11,28.97,27.05,28.03,26.89,28.28,0.87,-0.48,1.18,0.27,-0.55,0.09,0.71,0.24,-0.17,0.69,-1.22,-0.25,-1.39,biological regulation;carbohydrate metabolic process;cell communication;cell death;cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;death;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein alkylation;protein glycosylation;protein metabolic process;protein modification process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell part;centrosome;cytosol;histone methyltransferase complex;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;mitochondrion;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9NTK5,OLA1,Obg-like ATPase 1 (DNA damage-regulated overexpressed in cancer 45) (DOC45) (GTP-binding protein 9),21,59.8,32.56,31,31.17,31.61,31.1,30.03,31.29,30.73,29.91,30.52,31.37,32.4,30.69,31.11,1.46,-0.11,0.06,0.5,-0.01,-1.07,0.19,-0.38,-1.19,-0.59,0.27,1.29,-0.42,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O60313,OPA1,"Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1) [Cleaved into: Dynamin-like 120 kDa protein, form S1]",41,45.9,32.35,31.85,31.9,31.21,30.87,31.62,30.76,30.27,31.8,31.78,30.75,31.89,31.56,31.43,0.92,0.42,0.47,-0.23,-0.56,0.19,-0.67,-1.16,0.37,0.35,-0.68,0.46,0.12,aging;anatomical structure formation involved in morphogenesis;biological regulation;cell death;cellular component movement;cellular component organization;cellular membrane organization;cellular process;cytoskeleton-dependent intracellular transport;death;developmental process;establishment of localization;membrane fusion;membrane organization;mitochondrion organization;multicellular organismal process;neurological system process;organelle fission;organelle fusion;organelle organization;regulation of organelle organization;response to stimulus;response to stress;transport,cell part;cell projection;membrane;neuron projection,,,,,,,,,,
Q96CV9,OPTN,Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP),12,24.4,26.94,27.07,27.69,28.24,,,27.19,27.33,24.69,22.6,26.91,23.74,,26.24,0.7,0.83,1.45,2, , ,0.95,1.09,-1.55,-3.64,0.67,-2.5, ,biological regulation;cell death;cellular component organization;cellular process;death;establishment of localization;Golgi organization;Golgi vesicle transport;organelle organization;protein targeting;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;membrane;nucleoplasm,,,,,,,,,,
Q9UBD5,ORC3,Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo),7,14.6,27.6,24.57,26.57,26.93,26.45,27.16,27.26,27.54,27.45,27.15,,26.59,27,26.86,0.75,-2.29,-0.29,0.08,-0.4,0.3,0.41,0.68,0.6,0.3, ,-0.27,0.14,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;macromolecular complex;nucleoplasm;origin recognition complex;protein complex,,,,,,,,,,
O43929,ORC4,Origin recognition complex subunit 4,2,13.7,26.08,,26.18,25.4,25.21,25.83,24.27,,,25.89,,25.64,24.31,25.42,0.66, ,0.76,-0.02,-0.21,0.4,-1.15, , ,0.47, ,0.21,-1.11,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;macromolecular complex;nucleoplasm;origin recognition complex;protein complex,,,,,,,,,,
O43913,ORC5,Origin recognition complex subunit 5,3,10.8,26.13,24.12,,25.33,25.48,25.26,26.74,23.66,24.34,25.08,23.88,25.53,24.71,25.02,1.11,-0.9, ,0.31,0.46,0.24,1.72,-1.36,-0.68,0.05,-1.14,0.5,-0.31,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;cytoplasm;macromolecular complex;nucleoplasm;origin recognition complex;protein complex,,,,,,,,,,
Q8N138,ORMDL3,ORM1-like protein 3,2,16.1,29.28,26.92,27.72,26.91,27.34,27.1,26.82,26.45,26.52,27.31,26.42,,26.9,27.14,2.14,-0.22,0.58,-0.23,0.2,-0.04,-0.33,-0.69,-0.62,0.17,-0.72, ,-0.24,cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q13438,OS9,Protein OS-9 (Amplified in osteosarcoma 9),16,34.2,29.67,28.79,25.92,28.02,27.76,28.47,27.81,27.76,28.27,28.26,28.72,27.67,29.52,28.2,1.47,0.59,-2.28,-0.18,-0.44,0.26,-0.39,-0.45,0.07,0.06,0.52,-0.53,1.32,biological regulation;catabolic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein targeting;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;response to stimulus;response to stress;transport,cell part;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
P22059,OSBP,Oxysterol-binding protein 1,23,36.8,30.01,29.75,28.88,29.8,28.99,27.69,29.91,29.64,29.39,28.04,29.62,30.01,25.46,29.02,1,0.74,-0.13,0.79,-0.03,-1.33,0.9,0.63,0.37,-0.98,0.6,0.99,-3.55,establishment of localization;lipid transport;transport,cell part;membrane,,,,,,,,,,
Q9BXB4,OSBPL11,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),7,11.6,27,27.14,27.83,27.14,26.68,23.63,27.02,27.25,26.19,27.49,27.56,26.53,26.18,26.74,0.26,0.4,1.09,0.4,-0.06,-3.11,0.28,0.51,-0.55,0.74,0.82,-0.21,-0.56,biological regulation;cell differentiation;cellular process;developmental process;establishment of localization;lipid transport;transport,,,,,,,,,,,
Q9H1P3,OSBPL2,Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2),2,8.3,22.39,23.13,23.16,24.48,27.97,27.61,23.81,25.88,24.63,23.46,26.49,28.24,27.84,25.32,-2.92,-2.18,-2.16,-0.83,2.66,2.3,-1.51,0.57,-0.69,-1.86,1.18,2.92,2.53,establishment of localization;lipid transport;transport,,,,,,,,,,,
Q9H4L5,OSBPL3,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),19,29.9,27.82,25.58,27.53,27.27,28.23,27.89,29.46,29.05,29.74,27.93,30.72,29.47,28.84,28.43,-0.6,-2.85,-0.89,-1.15,-0.2,-0.53,1.04,0.63,1.31,-0.5,2.29,1.04,0.41,establishment of localization;lipid transport;transport,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),18,30.7,30.12,29.22,29.73,28.93,29,28.98,28.84,28.23,30.48,29.88,28.73,28.99,29.89,29.31,0.81,-0.09,0.42,-0.38,-0.31,-0.33,-0.46,-1.08,1.17,0.57,-0.58,-0.32,0.58,biological regulation;cell differentiation;cellular process;developmental process;establishment of localization;lipid transport;transport,,,,,,,,,,,
Q96SU4,OSBPL9,Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9),4,6.1,26.49,26.45,27.21,26.86,26.47,26.51,27.65,26.98,26.4,26.35,26.67,26.85,25.53,26.65,-0.16,-0.2,0.56,0.21,-0.18,-0.14,1.01,0.33,-0.25,-0.3,0.02,0.2,-1.12,establishment of localization;lipid transport;transport,,,,,,,,,,,
Q9NPF4,OSGEP,Probable tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP (hOSGEP) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP),3,12.8,26.94,26.44,27.95,,,26.33,25.87,26.28,,26.33,26.42,25.19,,26.42,0.53,0.02,1.54, , ,-0.08,-0.55,-0.14, ,-0.09,0,-1.22, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,,,,,,,,,,,
Q9H4B0,OSGEPL1,Probable tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1 (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1),2,9.9,26.12,24.49,24.66,25.95,,25.52,24.31,,25.07,26.08,,,24.86,25.23,0.89,-0.74,-0.57,0.72, ,0.29,-0.92, ,-0.15,0.85, , ,-0.37,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NRP0,OSTC,Oligosaccharyltransferase complex subunit OSTC (Hydrophobic protein HSF-28),4,17.4,29.6,29.34,28.33,29.39,27.16,29.98,28.38,28.42,30.14,29.71,29.26,29.66,30.67,29.23,0.37,0.11,-0.9,0.15,-2.07,0.75,-0.85,-0.81,0.91,0.47,0.02,0.42,1.44,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q92882,OSTF1,Osteoclast-stimulating factor 1,9,52.3,28.68,29.77,30.34,29.49,27.48,27.5,28.72,29.03,28.19,27.1,28.03,27.63,25.12,28.24,0.44,1.53,2.1,1.25,-0.75,-0.74,0.49,0.79,-0.04,-1.13,-0.21,-0.61,-3.11,biological regulation;cellular process;multicellular organismal process;response to stimulus;signal transduction,cell part;cytoplasm;intracellular,,,,,,,,,,
Q86WC4,OSTM1,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit),2,7.2,24.41,24.95,25.46,25.71,25.25,25.95,25.29,25.07,25.31,26.28,26.93,23.07,25.89,25.35,-0.94,-0.4,0.11,0.36,-0.11,0.6,-0.06,-0.29,-0.04,0.93,1.58,-2.28,0.54,cell differentiation;cellular process;developmental process;establishment of localization;ion transport;transmembrane transport;transport,cell part;cytosol;membrane,,,,,,,,,,
Q96FW1,OTUB1,Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1),11,53.1,31.4,31.6,30.68,31.34,31.14,30.6,31.07,31.43,30.38,29.78,30.87,31.92,29.64,30.91,0.49,0.69,-0.23,0.43,0.23,-0.31,0.16,0.51,-0.53,-1.13,-0.04,1.01,-1.27,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;regulation of DNA metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
Q01804,OTUD4,OTU domain-containing protein 4 (HIV-1-induced protein HIN-1),8,9.5,26.2,24.89,,23.73,,23.91,,25.31,25.69,26.77,24.01,,,25.06,1.13,-0.18, ,-1.34, ,-1.15, ,0.25,0.63,1.71,-1.05, , ,,,,,,,,,,,,
Q6GQQ9,OTUD7B,OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne),3,7.7,24.41,,,24.77,,,25.03,23.92,23.8,23.42,,,24.22,24.22,0.19, , ,0.54, , ,0.81,-0.3,-0.43,-0.8, , ,-0.01,biological regulation;cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;response to stimulus,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8WZ82,OVCA2,Ovarian cancer-associated gene 2 protein,5,39.6,26.93,28.24,27.46,27.8,25.45,27.6,28.42,27.37,28.1,28.13,28.63,29.18,27.83,27.78,-0.85,0.46,-0.32,0.02,-2.33,-0.18,0.64,-0.41,0.32,0.35,0.85,1.4,0.05,response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus,cell part;cytoplasm,,,,,,,,,,
Q15070,OXA1L,Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein) (OXA1-like protein),3,6.6,25.35,26.12,28.24,27.36,26.61,,26.81,26.89,26.29,27.86,27.49,,26.5,26.86,-1.52,-0.75,1.37,0.5,-0.25, ,-0.06,0.02,-0.58,1,0.63, ,-0.37,biological regulation;cellular component assembly;cellular component organization;cellular localization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;localization;macromolecular complex assembly;metabolic process;protein complex assembly;protein complex biogenesis,cell part;macromolecular complex;protein complex,,,,,,,,,,
P55809,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)",14,29.2,28.85,29.35,30.94,30.46,30.72,31.15,30.58,30.09,31.15,30.31,30.17,29.07,30.75,30.28,-1.43,-0.92,0.66,0.19,0.45,0.88,0.31,-0.18,0.87,0.03,-0.11,-1.21,0.48,anatomical structure development;biological regulation;catabolic process;cellular homeostasis;cellular ketone body metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;homeostatic process;lipid metabolic process;metabolic process;primary metabolic process;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part,,,,,,,,,,
Q9NWU1,OXSM,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)",4,16.2,25.76,27.2,26.46,25.57,26.25,25.99,26.14,25.8,25.34,27.14,26.49,25.89,27.03,26.24,-0.48,0.97,0.22,-0.66,0.01,-0.24,-0.1,-0.44,-0.9,0.91,0.26,-0.35,0.79,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O95747,OXSR1,Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein),15,37,29.8,30.45,29.15,29.79,27.3,28.19,29.06,29.05,28.67,28.05,29.68,29.5,26.77,28.88,0.92,1.57,0.27,0.91,-1.58,-0.69,0.18,0.17,-0.22,-0.83,0.8,0.62,-2.11,biological regulation;cellular process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction,cell part;cytoplasm,,+,,,,,,,,
P13674,P4HA1,"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)",46,67.4,31.84,34.79,31.85,33.84,32.22,32.67,31.63,32.08,32.52,31.15,31.31,31.85,32.44,32.32,-0.48,2.47,-0.47,1.51,-0.1,0.35,-0.69,-0.25,0.2,-1.17,-1.01,-0.47,0.12,amine metabolic process;cellular amino acid metabolic process;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;heterocycle metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
O15460,P4HA2,"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)",34,60.7,30.79,33.99,30.91,33.6,32.63,33.14,31.78,32.18,32.78,31.48,31.53,32.13,32.52,32.27,-1.48,1.72,-1.35,1.33,0.37,0.88,-0.48,-0.08,0.51,-0.79,-0.74,-0.14,0.26,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;small molecule metabolic process,cell part,,,,,,,,,,
P07237,P4HB,Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55),83,91.7,35.39,37.3,36.43,36.39,36.71,36.95,36.49,36.24,37.31,37.15,36.7,36.67,36.99,36.67,-1.28,0.62,-0.24,-0.28,0.04,0.28,-0.18,-0.43,0.64,0.48,0.03,0,0.32,amine metabolic process;biological regulation;cellular amino acid metabolic process;cellular component organization;cellular homeostasis;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;glycerol ether metabolic process;heterocycle metabolic process;homeostatic process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cell surface;cytoplasmic membrane-bounded vesicle;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9NXG6,P4HTM,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.-) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),3,10,,24.84,,24.1,25.21,25.17,25.5,25.14,25.14,24.8,26.48,26.93,26.37,25.43, ,-0.58, ,-1.33,-0.22,-0.25,0.08,-0.29,-0.28,-0.63,1.06,1.51,0.94,,cell part;membrane,,,,,,,,,,
Q9UQ80,PA2G4,Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1),36,67.3,33.7,33.02,33.31,33.38,33.22,32.72,33.53,33.34,32.16,32.98,32.59,32.5,32.58,33,0.7,0.02,0.3,0.38,0.22,-0.28,0.53,0.33,-0.84,-0.02,-0.41,-0.51,-0.42,biological regulation;biosynthetic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of translation;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q9BRP4,PAAF1,Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71),3,8.8,,27.39,,27.34,25.16,,25.77,26.01,24.55,,26.41,26.09,26.65,26.15, ,1.24, ,1.19,-0.99, ,-0.38,-0.14,-1.6, ,0.26,-0.07,0.5,interspecies interaction between organisms;multi-organism process,cell part;macromolecular complex;proteasome complex;protein complex,,,,,,,,,,
P11940,PABPC1,Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1),47,67.1,34.11,33.85,33.93,34.19,34.28,33.84,34.47,34.43,33.57,34.07,34.02,33.78,34.04,34.04,0.06,-0.2,-0.12,0.15,0.24,-0.21,0.42,0.39,-0.48,0.03,-0.03,-0.27,0,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;gene silencing;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;translational initiation,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q13310,PABPC4,Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP),19,32.2,31.47,31.47,31.86,31.38,31.75,31.13,31.73,31.65,31.04,31.7,31.55,31.77,31.46,31.54,-0.07,-0.06,0.33,-0.15,0.21,-0.41,0.19,0.12,-0.49,0.17,0.01,0.23,-0.08,biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;regulation of body fluid levels;RNA catabolic process;RNA metabolic process;RNA processing;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q86U42,PABPN1,Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1),12,61.5,29.63,29.32,29.33,29.47,30.25,30.28,29.19,30.34,30.56,29.63,27.2,27.37,28.54,29.32,0.31,0,0.02,0.15,0.94,0.97,-0.12,1.02,1.24,0.31,-2.11,-1.95,-0.78,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal process;multi-organism process;muscle contraction;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;cytoplasm;macromolecular complex;nucleoplasm;ribonucleoprotein complex,,,,,,,,,,
Q6VY07,PACS1,Phosphofurin acidic cluster sorting protein 1 (PACS-1),11,15.4,27.63,27.74,28.02,28.2,27.61,27.11,28.76,28.79,25.97,26.05,28.92,28.95,27.29,27.77,-0.14,-0.03,0.24,0.43,-0.16,-0.66,0.99,1.02,-1.8,-1.72,1.15,1.18,-0.48,biological regulation;cellular process;establishment of localization;Golgi vesicle transport;interspecies interaction between organisms;multi-organism process;protein targeting;protein transport;transport;vesicle-mediated transport;viral reproduction,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9UNF0,PACSIN2,Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II),18,55.3,29.38,30.03,30.09,30.52,29.75,28.94,31.2,31.06,29.26,29.61,31.13,30.43,29.92,30.1,-0.72,-0.07,-0.01,0.42,-0.35,-1.16,1.1,0.96,-0.84,-0.49,1.03,0.33,-0.18,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;developmental process;endocytosis;establishment of localization;membrane invagination;membrane organization;organelle organization;regulation of transport;transport;vesicle-mediated transport,cell part;cytoplasm;cytoskeleton;cytosol;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8N7H5,PAF1,RNA polymerase II-associated factor 1 homolog (hPAF1) (Pancreatic differentiation protein 2),12,27.7,28.55,27.32,28.25,28.56,28.83,29.11,28.55,28.75,28.31,28.58,28.08,28.37,28.34,28.43,0.12,-1.11,-0.18,0.13,0.4,0.68,0.12,0.32,-0.12,0.15,-0.36,-0.06,-0.09,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to biotic stimulus;response to chemical stimulus;response to stimulus;RNA metabolic process;RNA processing;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex;transcription elongation factor complex,,,,,,,,,,
P43034,PAFAH1B1,Platelet-activating factor acetylhydrolase IB subunit alpha (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha),16,40,30.25,30.82,30.83,30.5,29.81,29.63,30.55,30.55,29.47,29.62,31.33,30.4,29,30.21,0.03,0.61,0.61,0.29,-0.4,-0.58,0.34,0.34,-0.74,-0.59,1.12,0.19,-1.21,alcohol metabolic process;amine metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;behavior;biological regulation;catabolic process;cell communication;cell differentiation;cell division;cell motility;cell proliferation;cell-cell signaling;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular lipid metabolic process;cellular localization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;establishment of localization;lipid metabolic process;localization;locomotion;membrane organization;metabolic process;microtubule organizing center organization;mitosis;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nuclear division;organelle fission;organelle localization;organelle organization;primary metabolic process;protein transport;regulation of cell cycle;regulation of mitotic cell cycle;response to stimulus;secretion;signaling;small molecule metabolic process;transport,cell body;cell cortex;cell leading edge;cell part;cell projection;centrosome;cilium;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;microtubule organizing center;neuronal cell body;nuclear envelope;organelle;protein complex;site of polarized growth;vesicle,,,,,,,,,,
P68402,PAFAH1B2,Platelet-activating factor acetylhydrolase IB subunit beta (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta),8,56.8,31.94,31.45,30.03,31.68,30.27,29.48,31.11,30.99,29.65,28.38,30.73,31.83,28.63,30.47,1.47,0.98,-0.44,1.2,-0.21,-1,0.63,0.52,-0.83,-2.09,0.26,1.36,-1.85,anatomical structure development;biological regulation;catabolic process;developmental process;lipid metabolic process;metabolic process;multicellular organismal process;primary metabolic process,cell part;cytoplasm;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle;plasma membrane,,,,,,,,,,
Q15102,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma),9,58.4,30.64,29.22,30.14,29.48,28.34,28.29,28.55,29.65,27.82,28.54,28.75,29.37,28.17,29,1.64,0.22,1.15,0.49,-0.65,-0.71,-0.45,0.65,-1.18,-0.46,-0.25,0.37,-0.82,anatomical structure development;catabolic process;developmental process;lipid metabolic process;metabolic process;multicellular organismal process;primary metabolic process,cell part;cytosol,,,,,,,,,,
P22234,PAICS,Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase);Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)],22,51.1,31.91,32.51,31.47,32.58,31.48,30.44,32.18,31.71,30.6,31.03,31.35,33.28,29.68,31.56,0.36,0.95,-0.08,1.02,-0.07,-1.11,0.62,0.15,-0.96,-0.52,-0.21,1.72,-1.87,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;pigment metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9H074,PAIP1,Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1),10,28.2,28.62,28.5,27.7,28.61,28.05,26.64,28.52,29.03,27.14,26.86,27.26,28.8,,27.98,0.64,0.52,-0.28,0.63,0.07,-1.33,0.55,1.05,-0.84,-1.11,-0.72,0.82, ,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;translational initiation,cell part;cytosol,,,,,,,,,,
Q13153,PAK1,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),9,17.8,26.81,27.86,27.28,25.72,,,26.11,23.82,,,25.06,26.39,24.58,25.96,0.85,1.9,1.32,-0.24, , ,0.15,-2.14, , ,-0.9,0.43,-1.38,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell death;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;cytoskeleton organization;death;developmental process;establishment of localization;exocytosis;immune system process;localization;locomotion;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;multicellular organismal process;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;organelle;plasma membrane;protein complex;site of polarized growth,,+,,,,,,,,
Q9NWT1,PAK1IP1,p21-activated protein kinase-interacting protein 1 (PAK/PLC-interacting protein 1) (hPIP1) (PAK1-interacting protein 1) (WD repeat-containing protein 84),7,17.1,28.33,25.24,27.01,27.05,,,26.14,25.87,27.47,28.11,,25.07,,26.7,1.63,-1.46,0.31,0.35, , ,-0.56,-0.82,0.77,1.41, ,-1.63, ,biological regulation,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q13177,PAK2,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],26,58.4,31.18,30.48,30.56,31.2,29.99,28.92,30.75,30.51,29.1,28.97,30.48,30.88,28.18,30.09,1.09,0.39,0.47,1.11,-0.1,-1.17,0.65,0.42,-0.99,-1.12,0.38,0.79,-1.91,biological regulation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;immune system process;interspecies interaction between organisms;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;viral reproduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,+,,,,,,,,
O96013,PAK4,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),9,17.8,20.63,18.54,,25.79,19.45,26.71,27.36,25.25,20.95,,25.38,27.55,,23.76,-3.13,-5.23, ,2.03,-4.31,2.95,3.59,1.49,-2.81, ,1.62,3.79, ,biological regulation;cell cycle;cell death;cell growth;cell motility;cell proliferation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;death;growth;locomotion;organelle organization;response to stimulus;signal transduction,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,+,,,,,,,,
Q8WX93,PALLD,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),28,38.2,26.92,27.51,27.62,30.04,30.66,29.77,29.96,30.63,30.62,30.49,29.86,30.65,30.43,29.63,-2.71,-2.12,-2.01,0.41,1.03,0.14,0.34,1,1,0.87,0.23,1.02,0.81,cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cell projection;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9NVE7,PANK4,Pantothenate kinase 4 (hPanK4) (EC 2.7.1.33) (Pantothenic acid kinase 4),5,6.6,26.44,26.35,25,26.15,24.13,,25.94,25.99,,24.68,24.33,26.57,,25.56,0.88,0.8,-0.56,0.59,-1.42, ,0.38,0.43, ,-0.88,-1.22,1.01, ,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q96RD7,PANX1,Pannexin-1,2,7.3,26.54,26.12,25.45,27.73,25.08,26.34,26.18,25.2,26.77,25.6,,24.73,26.66,26.03,0.51,0.08,-0.58,1.69,-0.96,0.31,0.15,-0.84,0.74,-0.43, ,-1.3,0.63,biological regulation;cell communication;cell-cell signaling;cellular component assembly;cellular component organization;cellular process;immune system process;macromolecular complex assembly;protein complex assembly;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;signal transduction;signaling,bleb;cell part;cell projection;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
P51003,PAPOLA,Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha),9,17.3,28.82,26.41,28.25,27.8,28.53,27.87,29.1,28.6,28.52,27.24,25.45,28.01,26.67,27.79,1.03,-1.38,0.46,0.01,0.74,0.08,1.31,0.81,0.73,-0.55,-2.34,0.22,-1.12,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent",cell part;cytoplasm;nucleoplasm,,,,,,,,,,
O43252,PAPSS1,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT);Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],19,37.5,29.99,29.9,30.8,30.77,29.96,29.72,30.47,30.52,30.42,29.33,28.86,30.58,28.05,29.95,0.04,-0.05,0.85,0.81,0,-0.23,0.52,0.57,0.47,-0.62,-1.09,0.63,-1.9,anatomical structure development;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
O95340,PAPSS2,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT);Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],28,50.3,26.96,31.55,29.71,33.25,28.73,29.07,30.06,29.82,30.38,27.13,30.53,32.1,29.2,29.88,-2.92,1.67,-0.17,3.37,-1.15,-0.82,0.17,-0.07,0.49,-2.75,0.65,2.22,-0.68,anatomical structure development;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;developmental process;heterocycle metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;regulation of body fluid levels;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),18,24.2,28.52,25.83,27.57,26.84,28.24,27.14,28.24,28.32,27.01,28.3,27.61,26.66,27.29,27.51,1.02,-1.68,0.07,-0.67,0.73,-0.37,0.74,0.82,-0.5,0.8,0.1,-0.84,-0.22,anatomical structure morphogenesis;biological regulation;cell cycle;cell division;cell junction organization;cell motility;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular localization;cellular process;cytoskeleton organization;developmental process;establishment of localization;establishment or maintenance of cell polarity;localization;locomotion;macromolecular complex assembly;organelle localization;organelle organization;protein complex assembly;protein targeting;protein transport;regulation of protein modification process;response to stimulus;signal transduction;transport,apical part of cell;cell body;cell cortex;cell part;cytosol;endomembrane system;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;neuronal cell body;organelle;plasma membrane;site of polarized growth,,,,,,,,,,
Q9BYG5,PARD6B,Partitioning defective 6 homolog beta (PAR-6 beta) (PAR-6B),8,29.8,30.14,27.36,27.79,24.5,26.19,24.17,26.86,26.31,,29.51,27.89,,,27.07,3.06,0.29,0.72,-2.57,-0.89,-2.9,-0.21,-0.76, ,2.44,0.82, , ,anatomical structure morphogenesis;biological regulation;cell cycle;cell division;cell junction organization;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;developmental process;establishment or maintenance of cell polarity;macromolecular complex assembly;protein complex assembly,apical part of cell;cell cortex;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q99497,PARK7,Protein DJ-1 (EC 3.4.-.-) (Oncogene DJ1) (Parkinson disease protein 7),23,96.8,32.84,33.05,32.53,33.08,31.59,31.87,32.5,32.5,31.5,31.24,32.39,32.64,31.03,32.21,0.63,0.83,0.32,0.87,-0.63,-0.34,0.29,0.28,-0.71,-0.97,0.18,0.43,-1.18,amine transport;autophagy;behavior;biological regulation;catabolic process;cell death;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;death;establishment of localization;homeostatic process;macromolecule metabolic process;metabolic process;mitochondrion organization;multicellular organismal process;neurotransmitter transport;organelle organization;primary metabolic process;protein metabolic process;proteolysis;regulation of protein stability;regulation of transport;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
O95453,PARN,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease),15,23.7,29.92,27.19,27.82,27.35,27.46,27.24,27.41,26.03,28.69,28.3,27.4,26.47,26.22,27.5,2.42,-0.3,0.32,-0.15,-0.04,-0.26,-0.09,-1.47,1.19,0.8,-0.1,-1.03,-1.28,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA modification;RNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,,,,,,,,,,
P09874,PARP1,Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1),48,48.3,33.22,32.17,32.51,32.33,33.02,32.49,32.6,32.07,33.05,32.24,30.38,30.66,31.81,32.2,1.03,-0.02,0.31,0.14,0.82,0.3,0.41,-0.13,0.86,0.04,-1.82,-1.54,-0.39,"biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;detection of stimulus;DNA metabolic process;DNA repair;homeostatic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein maturation;protein metabolic process;protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;telomere organization;transcription initiation, DNA-dependent",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear envelope;nucleolus;organelle;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
Q460N5,PARP14,Poly [ADP-ribose] polymerase 14 (PARP-14) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2),17,12.3,29.67,28.73,29.93,29.42,27.53,22.27,26.41,28.8,25.88,28.04,25.18,24.52,,27.2,2.48,1.53,2.73,2.22,0.33,-4.93,-0.79,1.6,-1.32,0.85,-2.02,-2.68, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9UKK3,PARP4,Poly [ADP-ribose] polymerase 4 (PARP-4) (EC 2.4.2.30) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Vault poly(ADP-ribose) polymerase) (VPARP),30,22.7,29.73,29.33,29.54,29.78,29.48,29.18,30.59,31.19,29.16,30.8,30.99,31.16,29.57,30.04,-0.31,-0.71,-0.5,-0.26,-0.56,-0.85,0.55,1.15,-0.88,0.76,0.95,1.12,-0.47,cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;DNA metabolic process;DNA repair;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to stimulus;response to stress;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q8IXQ6,PARP9,Poly [ADP-ribose] polymerase 9 (PARP-9) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 9) (ARTD9) (B aggressive lymphoma protein),18,31.8,30.21,29.2,31.13,29.95,27.56,26.5,31.85,28.88,,27.65,27.28,27.4,27.9,28.79,1.42,0.41,2.33,1.16,-1.24,-2.29,3.06,0.09, ,-1.14,-1.51,-1.39,-0.89,biological regulation;cell motility;cellular component movement;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q7L3T8,PARS2,"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)",5,9.1,26.77,26.83,25.77,23.93,,24.45,,,25.58,26.04,,23.84,25.39,25.4,1.37,1.43,0.37,-1.48, ,-0.95, , ,0.17,0.64, ,-1.56,-0.01,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
Q9NVD7,PARVA,Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2),14,34.7,28.85,29.95,29.52,30.36,29.56,30.21,30.63,30.76,29.83,29.16,30.95,30.79,30.08,30.05,-1.2,-0.1,-0.53,0.31,-0.49,0.16,0.58,0.72,-0.22,-0.89,0.9,0.74,0.03,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cell morphogenesis;cell motility;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;developmental process;establishment or maintenance of cell polarity;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9HBI1,PARVB,Beta-parvin (Affixin),2,8.9,,20.39,21.82,20.81,,,26.44,22.58,21.85,,25.25,,24.76,22.99, ,-2.6,-1.17,-2.18, , ,3.46,-0.41,-1.14, ,2.26, ,1.78,biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;establishment or maintenance of cell polarity;organelle organization,cell part;cell projection;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q96IZ0,PAWR,PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein) (Par-4),8,25.6,28.51,26.16,25.73,27.58,26.16,24.98,25.79,24.47,24.89,26.08,27.44,28.76,25.73,26.33,2.18,-0.17,-0.6,1.25,-0.17,-1.35,-0.53,-1.85,-1.44,-0.25,1.11,2.43,-0.6,biological regulation;biosynthetic process;cell death;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q06710,PAX8,Paired box protein Pax-8,11,39.6,30.63,25.12,27.58,25.39,29.16,28.38,27.54,28.5,28.98,29.29,28.28,,29.31,28.18,2.45,-3.06,-0.6,-2.79,0.98,0.2,-0.64,0.32,0.8,1.1,0.1, ,1.13,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process,cell part;nucleoplasm,Other TF domain,,,,,,,,,
Q9Y5B6,PAXBP1,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),10,18.2,27.3,24.1,25.71,25.98,25.85,25.93,25.58,,25.32,26.29,,,24.84,25.69,1.61,-1.59,0.02,0.29,0.16,0.24,-0.11, ,-0.37,0.6, , ,-0.85,anatomical structure development;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q9BVG4,PBDC1,Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1),9,48.9,28.55,28.6,26.02,29.82,28.38,27.48,28.66,29.65,26.66,26.97,28.21,29.21,27.41,28.12,0.42,0.47,-2.1,1.7,0.25,-0.64,0.53,1.52,-1.46,-1.16,0.09,1.09,-0.72,,,,,,,,,,,,
Q86U86,PBRM1,Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D),20,18.3,29.3,27.97,26.17,28.11,28.9,28.46,27.92,27.08,29.31,29.54,28.48,29.15,27.07,28.27,1.03,-0.3,-2.1,-0.16,0.64,0.2,-0.34,-1.19,1.04,1.27,0.21,0.89,-1.2,anatomical structure development;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;macromolecule metabolic process;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;RNA metabolic process,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nuclear chromosome;organelle;protein complex,HMG-box,,,,,,,,,
P40424,PBX1,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),3,25.2,27.13,26.79,,27.64,24.47,25.57,25.04,,,,,25.17,,25.97,1.16,0.81, ,1.67,-1.51,-0.4,-0.93, , , , ,-0.8, ,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;lipid metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;transcription factor complex,Homeobox,,,,,,,,,
Q96AQ6,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1 (Hematopoietic PBX-interacting protein),26,34,31,30.67,30.92,29.57,28.66,30.23,29.36,27.82,29.65,29.53,30.31,29.85,30.98,29.89,1.11,0.78,1.03,-0.32,-1.23,0.34,-0.53,-2.07,-0.24,-0.36,0.42,-0.04,1.09,biological regulation;cell differentiation;cellular process;developmental process;multicellular organismal development;multicellular organismal process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P11498,PC,"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)",28,34.6,29.01,29.72,28.19,30.17,29.7,30.38,30.3,29.92,30.67,31.24,30.02,29.69,31.45,30.03,-1.02,-0.31,-1.85,0.13,-0.34,0.35,0.27,-0.12,0.63,1.21,-0.02,-0.35,1.42,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P61457,PCBD1,Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD),10,73.1,30.98,27.75,28.96,26.85,28.72,26.7,29.46,30.04,26.89,29.43,29.46,29.44,25.73,28.49,2.49,-0.74,0.46,-1.64,0.22,-1.79,0.97,1.55,-1.6,0.93,0.96,0.95,-2.76,amine metabolic process;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q15365,PCBP1,Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3),15,66.3,32.67,32.63,32.36,32.92,32.69,31.9,32.71,32.77,32.51,31.81,32.38,33.33,31.29,32.46,0.21,0.17,-0.1,0.46,0.23,-0.56,0.25,0.31,0.05,-0.65,-0.08,0.87,-1.17,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;nucleoplasm;ribonucleoprotein complex,,,,,,,,,,
Q15366,PCBP2,Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2),21,66.8,33.15,32.49,32.09,32.78,32.11,31.94,32.6,32.24,32.33,31.42,31.41,33.21,29.2,32.07,1.08,0.41,0.02,0.71,0.04,-0.14,0.53,0.17,0.26,-0.66,-0.67,1.13,-2.88,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;response to biotic stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex,,,,,,,,,,
P05165,PCCA,"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)",19,35.8,28.61,29.75,28.57,27.47,28.95,29.51,29.39,28.99,29.09,30.97,29.31,28.15,27.99,28.98,-0.37,0.77,-0.41,-1.51,-0.03,0.53,0.41,0.01,0.1,1.99,0.33,-0.84,-0.99,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
P05166,PCCB,"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)",11,31.2,28.7,29.53,28.31,27.84,27.1,28.72,28.25,27.75,28.06,30.19,29.31,26.41,27.97,28.32,0.38,1.22,-0.01,-0.48,-1.22,0.4,-0.07,-0.57,-0.26,1.87,0.99,-1.9,-0.35,catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q08174,PCDH1,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),8,10.9,27.68,23.44,27.25,23.16,29.21,26.86,27,26.06,28.19,27.57,26.06,,26.48,26.58,1.1,-3.14,0.67,-3.42,2.63,0.29,0.42,-0.52,1.61,0.99,-0.52, ,-0.1,anatomical structure development;biological adhesion;cell adhesion;cell communication;cell-cell signaling;cellular process;developmental process;signaling,cell part,,,,,,,,,,
Q5JVF3,PCID2,PCI domain-containing protein 2 (CSN12-like protein),2,6.6,25.58,25.8,23.61,26.72,26.08,26.16,26.85,25.56,26.26,24.82,26.04,,26.21,25.81,-0.23,-0.01,-2.19,0.91,0.27,0.35,1.04,-0.25,0.46,-0.99,0.23, ,0.4,anatomical structure development;biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;RNA metabolic process,,,,,,,,,,,
Q9H4Z3,PCIF1,Phosphorylated CTD-interacting factor 1,9,16.9,27.61,24.73,25.28,27.24,25.75,24.23,23.63,26.22,25.53,24.36,,25.6,23.2,25.28,2.33,-0.55,-0.01,1.96,0.47,-1.05,-1.65,0.94,0.25,-0.92, ,0.31,-2.08,biological regulation,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q16822,PCK2,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32) (Phosphoenolpyruvate carboxylase)",30,49.7,31.63,32.11,30.46,32.09,30.07,31.36,30.04,30.94,31.66,31.96,29.17,28.55,30.32,30.8,0.84,1.31,-0.34,1.29,-0.73,0.57,-0.76,0.14,0.86,1.16,-1.63,-2.25,-0.47,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),22,12.8,27.85,27.11,27.76,26.43,28.78,27.78,26.79,26.79,25.61,26.56,27.5,26.82,27.38,27.17,0.68,-0.06,0.6,-0.73,1.62,0.61,-0.38,-0.38,-1.56,-0.6,0.33,-0.34,0.22,anatomical structure formation involved in morphogenesis;biological regulation;cellular component assembly;cellular component organization;cellular localization;cellular process;cytoskeleton organization;developmental process;localization;microtubule organizing center organization;organelle localization;organelle organization,cell part;cytosol;membrane,,,,,,,,,,
P22061,PCMT1,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),13,68.3,32.05,30.79,30.44,31.26,30.49,29.25,30.73,30.59,30.09,29.27,31.08,31.35,29,30.49,1.56,0.3,-0.05,0.76,0,-1.24,0.24,0.1,-0.4,-1.22,0.59,0.86,-1.49,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P12004,PCNA,Proliferating cell nuclear antigen (PCNA) (Cyclin),14,62.8,30.94,29.5,29.95,31.26,31.85,31.83,31.48,31.54,30.95,30.44,28.9,31.39,30.36,30.8,0.14,-1.3,-0.85,0.46,1.05,1.03,0.68,0.74,0.15,-0.36,-1.9,0.59,-0.44,anatomical structure development;biological regulation;biosynthetic process;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;developmental process;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of DNA metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;telomere organization,cell part;cytoplasm;cytoskeleton;DNA replication factor C complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q8WW12,PCNP,PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein),9,58.4,28.75,27.29,28.31,27.47,27.76,27.49,27.43,28.06,27.5,26.83,27.15,21.01,,27.09,1.66,0.2,1.23,0.39,0.67,0.4,0.34,0.98,0.41,-0.26,0.06,-6.08, ,catabolic process;cell cycle;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UHG3,PCYOX1,Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase),19,46.1,32.14,32.27,30.89,30.91,31.46,32.17,31.3,31.4,31.71,31.4,32.21,30.47,33.46,31.68,0.46,0.59,-0.79,-0.76,-0.22,0.49,-0.37,-0.27,0.03,-0.28,0.54,-1.21,1.78,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;membrane;organelle;plasma membrane;vacuole,,,,,,,,,,
Q8NBM8,PCYOX1L,Prenylcysteine oxidase-like (EC 1.8.3.-),3,8.7,,25.95,,25.73,26.42,27.59,26.11,27.29,26.75,23.16,24.34,25.28,27.38,26, ,-0.05, ,-0.27,0.42,1.6,0.11,1.29,0.75,-2.84,-1.66,-0.72,1.38,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,extracellular region,,,,,,,,,,
P49585,PCYT1A,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),18,55.6,30.27,29.47,26.47,29.25,27.75,27.97,28.75,29.36,28.92,26.4,28.08,27.38,29.73,28.45,1.82,1.02,-1.97,0.8,-0.69,-0.48,0.3,0.91,0.48,-2.05,-0.37,-1.07,1.29,response to abiotic stimulus;response to stimulus,cell part;cytosol;membrane,,,,,,,,,,
Q13442,PDAP1,28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1),10,36.5,29.25,29.52,29.44,30.01,29.34,28.67,30.18,29.98,28.2,28.54,29.82,31.15,28.35,29.42,-0.17,0.1,0.02,0.59,-0.08,-0.75,0.76,0.56,-1.22,-0.88,0.4,1.73,-1.07,biological regulation;cell proliferation;cellular process;response to stimulus;signal transduction,,,,,,,,,,,
Q9BUL8,PDCD10,Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15),9,42.9,30.84,29.75,30.59,29.95,30.65,30.07,30.68,31.14,28.68,30.02,30.98,30.82,30.02,30.32,0.52,-0.57,0.27,-0.37,0.32,-0.25,0.36,0.82,-1.65,-0.3,0.66,0.49,-0.3,anatomical structure formation involved in morphogenesis;biological regulation;cell death;cellular process;death;developmental process;regulation of protein modification process,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q14690,PDCD11,Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11),32,22.2,29.75,29.07,28.83,29.62,30.49,30.59,29.98,29.33,30.95,31.04,27.9,29.81,30.14,29.81,-0.05,-0.73,-0.98,-0.19,0.68,0.78,0.18,-0.48,1.14,1.23,-1.9,0,0.33,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,,,,,,,,,,
Q53EL6,PDCD4,Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a),9,26.6,27.76,28.36,24.64,26.32,25.9,25.77,25.81,25.58,26.72,,25.5,,25.42,26.16,1.6,2.2,-1.52,0.16,-0.26,-0.39,-0.35,-0.58,0.55, ,-0.66, ,-0.74,aging;biological regulation;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of protein modification process;RNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O14737,PDCD5,Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19),13,72.8,30.57,30.6,30.34,31.15,30.84,30.2,31.49,31.41,30.17,29.32,30.44,31.59,29.66,30.6,-0.03,0.01,-0.26,0.55,0.24,-0.4,0.89,0.81,-0.43,-1.28,-0.16,0.99,-0.94,biological regulation;cell death;cellular process;death,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75340,PDCD6,Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2),9,40.3,30.82,30.83,30.08,29.67,30.11,29.63,30.05,30.3,28.72,29.4,30.32,30.32,28.87,29.93,0.89,0.9,0.15,-0.26,0.18,-0.3,0.12,0.37,-1.22,-0.53,0.38,0.39,-1.07,biological regulation;cellular process;establishment of localization;protein transport;response to chemical stimulus;response to stimulus;response to stress;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;vesicle,,,,,,,,,,
Q8WUM4,PDCD6IP,Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95),46,59.3,31.38,32.28,32.43,32.53,31.78,31.35,32.75,32.79,30.6,30.8,32.84,33.05,31.05,31.97,-0.59,0.31,0.46,0.55,-0.2,-0.63,0.78,0.82,-1.37,-1.17,0.87,1.08,-0.92,cell cycle;cell death;cell division;cellular process;death;establishment of localization;interspecies interaction between organisms;multi-organism process;protein transport;transport,cell part;cytoplasm;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle;vesicle,,,,,,,,,,
Q13371,PDCL,Phosducin-like protein (PHLP),2,8.3,24.86,24.21,23.89,25.33,,,25.6,25.11,24.97,,24.26,24.15,23.42,24.58,0.28,-0.37,-0.69,0.75, , ,1.02,0.53,0.39, ,-0.32,-0.43,-1.16,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein folding;protein metabolic process;response to stimulus;signal transduction,,,,,,,,,,,
Q9H2J4,PDCL3,Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1) (VIAF-1),10,58.6,27.65,25.61,26.5,27.95,26.99,24.7,28.03,27.32,,24.46,26.69,27.07,23.34,26.36,1.29,-0.75,0.14,1.59,0.64,-1.66,1.67,0.96, ,-1.9,0.33,0.71,-3.02,cell death;cellular process;death;interspecies interaction between organisms;multi-organism process,cell part;cytoplasm,,,,,,,,,,
Q8NB37,PDDC1,Parkinson disease 7 domain-containing protein 1,4,24.2,27,25.97,27.84,26.87,25.63,25.69,27.69,27.52,25.84,26.73,27.85,28.81,26.62,26.93,0.07,-0.96,0.91,-0.05,-1.3,-1.24,0.76,0.59,-1.08,-0.2,0.92,1.89,-0.31,,extracellular region,,,,,,,,,,
Q6L8Q7,PDE12,"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-)",9,26,27.33,28.62,28.24,29.01,28.94,28.5,29.15,29.34,28.36,28.51,28.6,28.18,28.52,28.56,-1.23,0.06,-0.33,0.45,0.38,-0.06,0.58,0.77,-0.2,-0.05,0.04,-0.38,-0.04,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q14432,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A)",3,5,26.17,22.63,,23.58,23.37,22.97,22.97,23.35,,,,23.86,,23.61,2.56,-0.98, ,-0.04,-0.24,-0.64,-0.65,-0.26, , , ,0.24, ,biological regulation;catabolic process;cell maturation;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;coagulation;developmental maturation;developmental process;heterocycle metabolic process;lipid metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;regulation of body fluid levels;regulation of cell cycle;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P08559,PDHA1,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",26,60.3,31.27,32.18,31.57,31.75,31.16,31.4,31.44,30.82,32.09,32,31.72,31,32.28,31.59,-0.32,0.58,-0.02,0.16,-0.43,-0.19,-0.15,-0.77,0.5,0.41,0.13,-0.59,0.69,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;generation of precursor metabolites and energy;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;pyruvate dehydrogenase complex,,,,,,,,,,
P11177,PDHB,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)",16,49.3,31.85,32.73,32.52,32.2,32.65,33.05,32.67,32.26,33.05,33.01,32.43,32.58,32.92,32.61,-0.76,0.12,-0.09,-0.4,0.04,0.44,0.06,-0.35,0.44,0.4,-0.18,-0.03,0.31,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;pyruvate dehydrogenase complex,,,,,,,,,,
E9PB14,PDHX,"Pyruvate dehydrogenase protein X component, mitochondrial",10,20.8,28.6,29.27,29.14,28.64,28.64,29.17,28.72,28.86,28.86,30.48,29.69,28.78,29.53,29.11,-0.51,0.17,0.03,-0.46,-0.47,0.06,-0.39,-0.24,-0.25,1.37,0.59,-0.32,0.42,,,,,,,,,,,,
P30101,PDIA3,Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60),62,85.4,36.4,36.95,36.31,36.17,35.99,36.65,35.68,35.74,36.53,36.41,35.66,35.07,36.14,36.13,0.27,0.82,0.18,0.03,-0.14,0.52,-0.45,-0.39,0.4,0.28,-0.47,-1.06,0.01,biological regulation;carbohydrate metabolic process;cellular homeostasis;cellular metabolic process;cellular process;establishment of localization;glycerol ether metabolic process;homeostatic process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;nuclear transport;nucleocytoplasmic transport;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein targeting;protein transport;response to stimulus;signal transduction;small molecule metabolic process;transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P13667,PDIA4,Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72),59,71.6,35.47,35.59,35.26,35.3,35.1,35.74,34.91,34.67,35.9,36,34.62,33.85,34.8,35.17,0.3,0.42,0.09,0.13,-0.07,0.57,-0.26,-0.5,0.73,0.83,-0.55,-1.32,-0.37,biological regulation;cellular homeostasis;cellular metabolic process;cellular process;establishment of localization;glycerol ether metabolic process;homeostatic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;protein transport;secretion;small molecule metabolic process;transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q14554,PDIA5,Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein),14,32.6,31,31.48,30.06,30.89,29.81,30.95,30.14,29.3,31.82,30.03,30.11,28.34,30.85,30.37,0.63,1.11,-0.31,0.52,-0.56,0.58,-0.23,-1.07,1.45,-0.34,-0.26,-2.02,0.48,biological regulation;cellular homeostasis;cellular process;glycerol ether metabolic process;homeostatic process;metabolic process;regulation of protein modification process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q15084,PDIA6,Protein disulfide-isomerase A6 (EC 5.3.4.1) (Endoplasmic reticulum protein 5) (ER protein 5) (ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7),45,65.9,34.76,35.18,34.96,34.86,35.02,35.58,34.81,34.62,35.43,35.58,34.65,34.91,35.43,35.06,-0.3,0.12,-0.1,-0.2,-0.04,0.51,-0.25,-0.44,0.37,0.52,-0.41,-0.15,0.37,biological regulation;cellular homeostasis;cellular process;glycerol ether metabolic process;homeostatic process;metabolic process;regulation of protein modification process;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
O00151,PDLIM1,PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36),19,77.5,31.12,31.41,32.23,31.03,29.98,28.93,29.88,31.1,30.7,30.63,30.53,30.19,28.33,30.47,0.65,0.95,1.77,0.56,-0.48,-1.54,-0.58,0.63,0.24,0.16,0.06,-0.28,-2.13,biological regulation;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;transcription factor complex,,,,,,,,,,
P50479,PDLIM4,PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein),10,35.2,27.83,29.54,28.07,30.52,30.01,29.92,30.18,30.48,31.6,29.83,30.47,30.07,30.51,29.93,-2.09,-0.39,-1.86,0.59,0.09,-0.01,0.25,0.55,1.68,-0.09,0.54,0.15,0.59,,,,,,,,,,,,
Q96HC4,PDLIM5,PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein),18,48,29.88,30.07,30.77,31.88,30.59,30.4,31.82,31.33,30.29,28.87,31.28,30.93,29.42,30.58,-0.7,-0.51,0.19,1.3,0.01,-0.18,1.24,0.75,-0.29,-1.71,0.7,0.36,-1.16,biological regulation,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9NR12,PDLIM7,PDZ and LIM domain protein 7 (LIM mineralization protein) (LMP) (Protein enigma),18,49.7,28.32,29.63,29.72,31.35,30.63,30.24,30.54,30.62,31.49,30.5,30.52,31.1,29.98,30.36,-2.03,-0.73,-0.64,0.99,0.27,-0.11,0.19,0.26,1.14,0.14,0.16,0.74,-0.38,biological regulation;cell differentiation;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;developmental process;endocytosis;establishment of localization;membrane invagination;membrane organization;multicellular organismal development;multicellular organismal process;organelle organization;transport;vesicle-mediated transport,cell part;cell projection;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9P0J1,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1)",13,30.7,29.85,29.73,28.83,27.9,29.47,29.36,28.79,28.28,30.08,30.54,28.42,28.22,29.75,29.17,0.68,0.55,-0.34,-1.27,0.3,0.19,-0.38,-0.89,0.91,1.37,-0.75,-0.95,0.58,biological regulation;cellular ketone metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part,,,+,,,,,,,
O15530,PDPK1,3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1),6,14.6,24.55,26.26,,24.86,25.53,25.45,25.69,26.77,24.11,24.76,26.92,25.03,24.1,25.34,-0.79,0.92, ,-0.47,0.19,0.11,0.36,1.43,-1.22,-0.58,1.58,-0.31,-1.23,anatomical structure development;biological regulation;biosynthetic process;cell activation;cell communication;cell development;cell junction organization;cell-cell signaling;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to osmotic stress;response to stimulus;response to stress;RNA metabolic process;signal transduction;signaling,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleoplasm;organelle;plasma membrane;vesicle,,+,,,,,,,,
Q8NCN5,PDPR,"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)",16,21.5,28.82,28.95,26.96,27.68,28.76,29.12,28.39,27.47,29.45,28.84,28.03,26.41,29.8,28.36,0.46,0.59,-1.4,-0.67,0.4,0.76,0.03,-0.89,1.09,0.48,-0.33,-1.95,1.44,amine metabolic process;biological regulation;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q29RF7,PDS5A,Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112),21,19.1,28.84,28.44,29.06,28.7,29.69,29.25,29,29,29.14,28.51,26.74,28.9,28.3,28.74,0.11,-0.3,0.32,-0.04,0.95,0.52,0.26,0.26,0.4,-0.23,-2,0.16,-0.44,biological regulation;cell cycle;cellular component organization;cellular process;cytokinesis;mitosis;mitotic cell cycle;nuclear division;organelle fission;organelle organization;regulation of DNA metabolic process,cell part;cytosol;membrane;nucleoplasm;plasma membrane,,,,,,,,,,
Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),31,27.4,29.8,28.6,29.57,29.15,30.61,30.39,29.96,29.42,30.19,29.37,27.88,29.65,28.78,29.49,0.31,-0.89,0.08,-0.34,1.12,0.9,0.47,-0.07,0.7,-0.12,-1.61,0.16,-0.71,biological regulation;cell cycle;cell proliferation;cellular component organization;cellular process;chromosome organization;cytokinesis;mitotic cell cycle;organelle organization,cell part;cytosol;nucleoplasm,,,,,,,,,,
Q86YH6,PDSS2,Decaprenyl-diphosphate synthase subunit 2 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 2) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2),3,13.5,25.82,24.41,,24.62,,25.24,,,24.39,,26.18,24.69,25.42,25.1,0.72,-0.68, ,-0.47, ,0.14, , ,-0.7, ,1.08,-0.4,0.32,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;lipid metabolic process;macromolecular complex assembly;metabolic process;multicellular organismal process;primary metabolic process;protein complex assembly;regulation of body fluid levels;small molecule metabolic process,cell part,,,,,,,,,,
Q6P996,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-),29,48.6,30.7,30.56,30.12,30.18,30.25,29.9,30.12,29.91,31.21,30.7,29.13,28.83,30.52,30.16,0.54,0.39,-0.04,0.02,0.09,-0.26,-0.04,-0.26,1.05,0.54,-1.04,-1.33,0.36,cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;small molecule metabolic process,,,,,,,,,,,
O00764,PDXK,Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase),14,51.3,32.01,31.22,30.65,30.9,29.21,28.6,29.76,30.53,26.96,29.31,29.65,29.31,27.77,29.68,2.32,1.54,0.97,1.22,-0.48,-1.08,0.08,0.85,-2.72,-0.37,-0.03,-0.37,-1.92,biosynthetic process;cell proliferation;cellular metabolic compound salvage;cellular metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8NEN9,PDZD8,PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104),8,9.5,25.61,23.72,,25.24,23.84,24.15,25.38,25.27,25.7,26.31,22.22,,26.74,24.93,0.69,-1.2, ,0.31,-1.09,-0.78,0.45,0.34,0.78,1.38,-2.71, ,1.82,biological regulation;cellular component organization;cellular process;cytoskeleton organization;interspecies interaction between organisms;multi-organism process;organelle organization;response to stimulus;signal transduction,,,,,,,,,,,
Q15121,PEA15,Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes) (PED),12,84.6,29.52,30.21,30.59,30.27,28.04,27.86,30,29.51,27.81,27.71,31.07,31.82,27.62,29.39,0.13,0.82,1.2,0.88,-1.35,-1.52,0.62,0.12,-1.57,-1.67,1.68,2.43,-1.77,biological regulation;carbohydrate transport;cell death;cellular process;death;establishment of localization;regulation of transport;response to chemical stimulus;response to stimulus;transport,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9H792,PEAK1,Pseudopodium-enriched atypical kinase 1 (EC 2.7.10.2) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),13,9.6,,25.29,25.36,26.6,,24.49,25.33,,26.52,24.35,25.29,27.62,25.36,25.62, ,-0.33,-0.26,0.98, ,-1.13,-0.29, ,0.9,-1.27,-0.33,2,-0.26,anatomical structure morphogenesis;biological adhesion;cell adhesion;cell morphogenesis;cell motility;cellular component morphogenesis;cellular component movement;cellular component organization;cellular metabolic process;cellular process;developmental process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,+,,,,,,,,
P30086,PEBP1,Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)],12,76.5,32.38,32.17,31.27,31.53,29.91,29.13,30.91,30.92,29.01,29.98,31.12,32.32,28.65,30.72,1.66,1.45,0.55,0.81,-0.8,-1.59,0.2,0.2,-1.7,-0.73,0.41,1.61,-2.06,,cell part;cytoplasm,,,,,,,,,,
Q9BY49,PECR,"Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) (2,4-dienoyl-CoA reductase-related protein) (DCR-RP) (HPDHase) (pVI-ARL)",6,29,25.84,27.59,27.42,26.85,26.29,26.41,24.91,,26.33,28.66,26.33,26.02,26.97,26.63,-0.8,0.95,0.79,0.21,-0.35,-0.23,-1.73, ,-0.3,2.02,-0.3,-0.62,0.34,alcohol metabolic process;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;organelle,,,,,,,,,,
Q9UBV8,PEF1,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),4,15.1,27.28,28.09,26.49,26.84,27.49,26.88,26.88,28.16,25.51,,24.09,26.62,23.87,26.52,0.76,1.57,-0.03,0.32,0.98,0.37,0.36,1.64,-1.01, ,-2.43,0.1,-2.65,response to chemical stimulus;response to stimulus,cell part;cytoplasm;membrane,,,,,,,,,,
Q86TG7,PEG10,Retrotransposon-derived protein PEG10 (Embryonal carcinoma differentiation-regulated protein) (Mammalian retrotransposon-derived protein 2) (Myelin expression factor 3-like protein 1) (MEF3-like protein 1) (Paternally expressed gene 10 protein) (Retrotransposon gag domain-containing protein 3) (Retrotransposon-derived gag-like polyprotein) (Ty3/Gypsy-like protein),2,9.5,22.3,,,23.77,25.99,23.78,24.17,26.1,22.98,,25.71,25.65,22.9,24.34,-2.03, , ,-0.56,1.65,-0.56,-0.17,1.77,-1.36, ,1.37,1.32,-1.44,anatomical structure development;biological regulation;cell death;cell differentiation;cellular process;death;developmental process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BRX2,PELO,Protein pelota homolog (EC 3.1.-.-),3,8.6,,27.29,24.44,28.26,24.89,27.04,27,27.57,27.56,23.19,24.71,29.04,,26.45, ,0.84,-2.01,1.81,-1.57,0.59,0.54,1.12,1.11,-3.26,-1.74,2.58, ,cell cycle;cell division;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8IZL8,PELP1,"Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)",20,28.4,28.64,29.17,29.01,28.49,29.2,29.42,28.58,27.76,29.64,28.73,28,27.77,28.76,28.7,-0.07,0.47,0.31,-0.21,0.49,0.72,-0.13,-0.94,0.93,0.02,-0.71,-0.94,0.05,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;histone methyltransferase complex;macromolecular complex;protein complex,,,,,,,,,,
P12955,PEPD,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase),14,30.8,30.81,30.23,30.36,29.73,27.52,29.1,29.93,28.97,28.54,27.45,30.11,30.23,28.18,29.32,1.49,0.91,1.04,0.41,-1.8,-0.22,0.61,-0.35,-0.78,-1.87,0.79,0.91,-1.14,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process,,,,,,,,,,,
O00541,PES1,Pescadillo homolog,21,32.7,29.86,28.98,28.49,30.55,31.07,30.94,30.37,29.89,30.74,30.89,29.51,28.16,30.12,29.97,-0.11,-0.98,-1.48,0.58,1.1,0.97,0.41,-0.08,0.77,0.92,-0.46,-1.81,0.15,biological regulation;cell proliferation;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleus organization;organelle organization;primary metabolic process;regulation of cell cycle;RNA metabolic process;RNA processing;rRNA processing,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;preribosome;protein complex;ribonucleoprotein complex,,,,,,,,,,
D6RDU9,PET112,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",2,9.2,21.6,,22.19,,23.26,23.24,23.02,23.74,22.32,26,23.04,,23.53,23.19,-1.59, ,-1, ,0.07,0.04,-0.17,0.55,-0.88,2.8,-0.15, ,0.33,,,,,,,,,,,,
O43933,PEX1,Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1),5,8.2,,,25.19,,24.93,24.12,24.82,22.74,,26.62,,23.87,,24.61, , ,0.58, ,0.32,-0.49,0.2,-1.87, ,2, ,-0.74, ,cellular localization;cellular process;establishment of localization;localization;organelle localization;protein targeting;protein transport;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;nucleus;organelle,,,,,,,,,,
O96011,PEX11B,Peroxisomal membrane protein 11B (Peroxin-11B) (Peroxisomal biogenesis factor 11B) (Protein PEX11 homolog beta) (PEX11-beta),6,23.2,27.95,26.19,28.68,27.07,25.58,27.43,25.91,26.35,27.9,28.13,27.62,26.09,26.55,27.03,0.91,-0.84,1.65,0.04,-1.46,0.4,-1.12,-0.69,0.86,1.1,0.59,-0.95,-0.48,biological regulation;cellular component assembly;cellular component organization;cellular process;macromolecular complex assembly;organelle fission;organelle organization;protein complex assembly;response to stimulus;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
O75381,PEX14,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),14,70.7,28.82,28.31,29.23,28.82,28.73,29.54,28.91,28.51,29.13,28.62,29.81,27.84,30.03,28.95,-0.13,-0.63,0.28,-0.13,-0.21,0.6,-0.04,-0.43,0.18,-0.33,0.87,-1.11,1.08,biological regulation;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;macromolecular complex assembly;organelle organization;protein complex assembly;protein transport;transmembrane transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microbody;nucleus;organelle;protein complex,,,,,,,,,,
P56589,PEX3,Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3),6,27.9,27.66,26.59,25.53,25.97,26.46,27.19,27.44,26.51,28.01,25.83,,,28.48,26.88,0.78,-0.29,-1.35,-0.91,-0.42,0.31,0.57,-0.37,1.13,-1.05, , ,1.61,cellular process;establishment of localization;protein targeting;protein transport;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
O60925,PFDN1,Prefoldin subunit 1,4,27.9,27.41,28.29,28.51,28.67,26.82,28.48,29.34,29.88,27.18,27.7,28.72,29.62,27.55,28.32,-0.92,-0.03,0.19,0.35,-1.5,0.16,1.02,1.56,-1.14,-0.62,0.4,1.3,-0.77,anatomical structure development;cell activation;cell cycle;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;immune system process;macromolecule metabolic process;metabolic process;organelle organization;primary metabolic process;protein folding;protein metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9UHV9,PFDN2,Prefoldin subunit 2,6,47.4,29,29.7,29.8,29.12,29.07,29.12,29.29,29.87,27.9,28.88,29.3,29.87,28.51,29.19,-0.18,0.52,0.62,-0.07,-0.12,-0.07,0.1,0.69,-1.29,-0.31,0.11,0.68,-0.68,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
Q9NQP4,PFDN4,Prefoldin subunit 4 (Protein C-1),3,22.4,26.95,27.68,26.85,27.41,27.85,26.43,28.23,28.56,27.65,26.25,26.05,28.48,26.74,27.32,-0.37,0.36,-0.47,0.09,0.53,-0.89,0.91,1.24,0.33,-1.07,-1.27,1.16,-0.58,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
Q99471,PFDN5,Prefoldin subunit 5 (C-Myc-binding protein Mm-1) (Myc modulator 1),7,48.7,28.64,29.14,29.39,28.5,28.1,27.58,28.81,28.29,27.53,28.86,27.69,28.25,26.37,28.24,0.39,0.89,1.15,0.26,-0.14,-0.66,0.57,0.05,-0.71,0.62,-0.55,0.01,-1.87,anatomical structure development;biological regulation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
O15212,PFDN6,Prefoldin subunit 6 (Protein Ke2),10,69.8,29.03,30.93,29.77,30.63,29.11,28.85,29.52,30.24,27.71,29.04,29.58,29.43,28.02,29.37,-0.34,1.56,0.4,1.26,-0.26,-0.53,0.15,0.86,-1.67,-0.33,0.2,0.05,-1.36,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P17858,PFKL,"6-phosphofructokinase, liver type (EC 2.7.1.11) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphofructokinase 1) (Phosphohexokinase)",27,40.9,32.64,32.36,31.41,31.39,30.1,29.09,30.66,31.09,29.58,28.09,30.57,31.18,27.06,30.4,2.24,1.96,1.01,0.99,-0.3,-1.31,0.26,0.69,-0.82,-2.31,0.17,0.78,-3.34,alcohol metabolic process;biological regulation;carbohydrate metabolic process;catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;generation of precursor metabolites and energy;macromolecular complex assembly;metabolic process;primary metabolic process;protein complex assembly;regulation of transport;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P08237,PFKM,"6-phosphofructokinase, muscle type (EC 2.7.1.11) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphofructokinase-M) (Phosphofructokinase 1) (Phosphohexokinase)",16,26.2,29.51,29.95,29.8,30.19,28.48,28.75,29.75,29.92,27.59,24.51,29.45,30.69,,29.05,0.46,0.9,0.75,1.14,-0.57,-0.3,0.7,0.87,-1.46,-4.54,0.4,1.64, ,alcohol metabolic process;biological regulation;carbohydrate metabolic process;catabolic process;cellular component assembly;cellular component organization;cellular homeostasis;cellular metabolic process;cellular process;generation of precursor metabolites and energy;homeostatic process;macromolecular complex assembly;metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q01813,PFKP,"6-phosphofructokinase type C (EC 2.7.1.11) (6-phosphofructokinase, platelet type) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphofructokinase 1) (Phosphohexokinase)",40,48,33.88,33.08,31.82,33.33,32.78,31.81,33.22,33.28,32.31,31.82,32.62,33.14,30.77,32.6,1.27,0.47,-0.79,0.73,0.18,-0.8,0.62,0.67,-0.29,-0.79,0.02,0.54,-1.83,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P07737,PFN1,Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I),15,92.1,34.42,34.85,35.09,34.98,34.41,33.71,34.53,34.79,33.45,33.58,34.18,35.2,32.94,34.32,0.1,0.53,0.77,0.66,0.09,-0.61,0.21,0.47,-0.87,-0.73,-0.14,0.88,-1.37,anatomical structure formation involved in morphogenesis;biological regulation;cell activation;cell death;cellular component organization;cellular process;cytoskeleton organization;death;developmental process;establishment of localization;exocytosis;organelle organization;regulation of DNA metabolic process;regulation of organelle organization;response to chemical stimulus;response to stimulus;secretion;transport;vesicle-mediated transport,cell part;cell projection;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;nucleus;organelle;synapse,,,,,,,,,,
P35080,PFN2,Profilin-2 (Profilin II),7,78,30.23,29.93,28.83,30.66,29.83,29.18,30.52,30.9,28.83,29.2,30.23,29.33,29,29.74,0.48,0.19,-0.92,0.92,0.09,-0.57,0.77,1.15,-0.91,-0.54,0.49,-0.41,-0.74,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization;regulation of transport,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P18669,PGAM1,Phosphoglycerate mutase 1 (EC 3.1.3.13) (EC 5.4.2.1) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B),23,71.3,32.62,33.72,32.72,33.76,32.45,31.84,33.19,33.43,31.72,31.06,33.19,33.84,30.68,32.63,-0.01,1.09,0.09,1.13,-0.18,-0.79,0.56,0.8,-0.92,-1.57,0.56,1.2,-1.95,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q96HS1,PGAM5,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Bcl-XL-binding protein v68) (Phosphoglycerate mutase family member 5)",13,55.7,29.52,30.22,28.94,29.79,31.26,31.12,30.46,29.99,31.01,31.57,29.91,28.33,30.53,30.2,-0.69,0.02,-1.26,-0.41,1.05,0.91,0.26,-0.22,0.81,1.37,-0.29,-1.87,0.33,,cell part;membrane,,,+,,,,,,,
P52209,PGD,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)",27,64.7,31.74,32.78,33.08,32.16,31.42,30.88,32.37,32,30.73,31.41,32.02,32.76,29.63,31.77,-0.03,1.01,1.31,0.4,-0.35,-0.89,0.6,0.24,-1.04,-0.36,0.25,0.99,-2.14,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P00558,PGK1,Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2),48,95.7,35.72,36.35,35.73,35.71,34.08,34.1,34.67,34.84,33.43,33.5,34.87,35.38,33.5,34.76,0.96,1.59,0.97,0.95,-0.68,-0.66,-0.09,0.08,-1.33,-1.26,0.11,0.62,-1.26,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
O95336,PGLS,6-phosphogluconolactonase (6PGL) (EC 3.1.1.31),15,79.5,31.32,31.18,31.13,31.02,30.02,29.76,30.5,31.31,29.75,30.03,30.35,31.31,28.3,30.46,0.86,0.72,0.67,0.56,-0.44,-0.7,0.04,0.85,-0.71,-0.44,-0.12,0.85,-2.16,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P36871,PGM1,Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1),35,77.8,32.91,33.27,32.1,32.83,30.44,29.61,31.03,31.87,30.18,29.36,31.94,32.19,29.63,31.34,1.58,1.93,0.77,1.5,-0.9,-1.72,-0.3,0.53,-1.15,-1.97,0.6,0.85,-1.71,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q96G03,PGM2,Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7),28,42.5,30.75,32.54,32,31.6,30.63,31.5,31.71,31.71,30.95,28.66,32.03,31.86,30.71,31.28,-0.53,1.26,0.71,0.32,-0.65,0.22,0.43,0.43,-0.33,-2.62,0.75,0.58,-0.57,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q6PCE3,PGM2L1,"Glucose 1,6-bisphosphate synthase (EC 2.7.1.106) (PMMLP) (Phosphoglucomutase-2-like 1)",12,26.8,30.2,26.88,28,26.47,25.27,26.29,27.49,26.91,28.08,27.88,29.19,28.02,25.95,27.43,2.77,-0.56,0.56,-0.96,-2.16,-1.14,0.05,-0.52,0.64,0.45,1.76,0.59,-1.49,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
O95394,PGM3,Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3),22,46.9,29.57,31.15,30.16,31.2,29.79,29.72,30.1,30.52,29.91,28.33,30.39,30.12,28.55,29.96,-0.39,1.19,0.2,1.24,-0.17,-0.24,0.14,0.56,-0.05,-1.63,0.43,0.16,-1.42,alcohol metabolic process;anatomical structure development;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q15124,PGM5,Phosphoglucomutase-like protein 5 (Aciculin) (Phosphoglucomutase-related protein) (PGM-RP),2,6.5,21.9,21.61,21.99,20.26,,23.34,,,22.49,21.55,20.4,,,21.69,0.21,-0.08,0.3,-1.43, ,1.65, , ,0.8,-0.14,-1.3, , ,alcohol metabolic process;biological adhesion;carbohydrate metabolic process;cell adhesion;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;dystrophin-associated glycoprotein complex;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
A6NDG6,PGP,Phosphoglycolate phosphatase (PGP) (PGPase) (EC 3.1.3.18),5,24,26.78,26.57,24.74,28.52,25.88,25.22,26.75,27.07,24.78,24.15,27.28,27.79,25.74,26.25,0.53,0.32,-1.51,2.26,-0.37,-1.03,0.5,0.82,-1.47,-2.11,1.03,1.54,-0.51,carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;phosphorus metabolic process;primary metabolic process,,,,,,,,,,,
O00264,PGRMC1,Membrane-associated progesterone receptor component 1 (mPR),21,70.3,32.02,32.58,31.86,31.88,31.34,31.54,31.13,31.75,32,32.3,31.52,31.82,31.9,31.82,0.2,0.76,0.04,0.06,-0.48,-0.28,-0.69,-0.07,0.18,0.48,-0.3,0,0.08,locomotion;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cell surface;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
O15173,PGRMC2,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),11,48.9,30.62,30.71,29.74,30.56,29.97,30.71,30.01,29.68,30.59,30.1,30.49,29.54,31.15,30.3,0.32,0.41,-0.55,0.26,-0.33,0.41,-0.29,-0.62,0.29,-0.2,0.2,-0.76,0.85,,cell part,,,,,,,,,,
Q8IZ21,PHACTR4,Phosphatase and actin regulator 4,7,12.1,24.81,23.84,25.95,23.56,23.66,,23.28,,,21.52,23.33,23.4,,23.71,1.11,0.13,2.25,-0.15,-0.04, ,-0.43, , ,-2.18,-0.37,-0.3, ,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell motility;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;locomotion;organelle organization;regulation of cell cycle;response to stimulus;signal transduction,cell part;cell projection;cytoplasm,,,,,,,,,,
P35232,PHB,Prohibitin,35,97.1,34.08,34.04,33.14,33.65,33.64,34,33.68,33.63,34.18,34.29,33.58,33.67,34.09,33.82,0.26,0.22,-0.68,-0.17,-0.18,0.18,-0.14,-0.19,0.36,0.47,-0.24,-0.15,0.27,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA replication;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to stimulus;signal transduction,cell part;membrane;nucleoplasm,,,,,,,,,,
Q99623,PHB2,Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity),26,74.6,34.21,34.33,33.85,33.85,34.82,34.54,34.17,34.15,34.64,34.41,34.1,33.29,34.74,34.24,-0.03,0.09,-0.39,-0.39,0.58,0.3,-0.06,-0.09,0.4,0.17,-0.14,-0.95,0.5,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q8IXK0,PHC2,Polyhomeotic-like protein 2 (hPH2) (Early development regulatory protein 2),4,14.2,24.69,25.63,24.16,27.6,,26.31,25.92,23.3,26.91,24.38,23.29,24.72,26.46,25.28,-0.59,0.35,-1.12,2.32, ,1.03,0.64,-1.98,1.63,-0.9,-1.99,-0.56,1.18,developmental process;multicellular organismal development;multicellular organismal process,cell part;macromolecular complex;PcG protein complex;protein complex,,,,,,,,,,
Q96BD5,PHF21A,PHD finger protein 21A (BHC80a) (BRAF35-HDAC complex protein BHC80),2,5.7,28.55,27.14,,25.63,29.08,28.69,29.34,29.79,27.92,27.92,30.57,,30.8,28.68,-0.12,-1.53, ,-3.04,0.4,0.02,0.67,1.11,-0.75,-0.76,1.89, ,2.12,behavior;behavioral interaction between organisms;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;coagulation;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of body fluid levels;response to stimulus;RNA metabolic process,cell part;chromatin remodeling complex;macromolecular complex;protein complex,Other TF domain,,,,,,,,,
Q92576,PHF3,PHD finger protein 3,10,6.3,26.92,26.3,27.86,26.15,22.9,24.97,23.33,23.47,24.43,24,23.32,26.34,24.91,24.99,1.92,1.31,2.87,1.16,-2.09,-0.02,-1.66,-1.53,-0.56,-1,-1.67,1.35,-0.08,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q7RTV0,PHF5A,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),6,48.2,29.08,27.54,29.34,26.42,27.54,28.51,27.37,27.05,28.64,27.95,25.06,,25.98,27.54,1.54,0,1.8,-1.12,0,0.97,-0.17,-0.49,1.1,0.4,-2.48, ,-1.56,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
Q8IWS0,PHF6,PHD finger protein 6 (PHD-like zinc finger protein),7,27.5,26.15,25,25.64,25.46,26.4,26.37,25.43,25.81,23.88,24.59,25.95,25.08,26.4,25.55,0.6,-0.55,0.09,-0.09,0.85,0.82,-0.12,0.26,-1.67,-0.96,0.4,-0.47,0.85,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8WWQ0,PHIP,PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),21,14.7,30.09,25.85,27.4,26.09,26.33,25.4,23.73,25.59,26.59,28.07,22.2,25.69,23.79,25.91,4.18,-0.06,1.49,0.18,0.42,-0.51,-2.18,-0.33,0.68,2.16,-3.71,-0.22,-2.12,biological regulation;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;nuclear transport;nucleocytoplasmic transport;organelle organization;protein targeting;protein transport;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q86UU1,PHLDB1,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),11,10.4,26.26,,24.9,26.45,,25.71,27.03,24.99,25.27,25.99,25.3,25.27,25.95,25.74,0.52, ,-0.84,0.71, ,-0.03,1.29,-0.75,-0.47,0.25,-0.44,-0.46,0.22,,,,,,,,,,,,
Q86SQ0,PHLDB2,Pleckstrin homology-like domain family B member 2 (Protein LL5-beta),13,15.5,27.41,27.38,26.32,28.09,24.83,24.64,27.3,25.87,26.45,23.8,28.39,26.3,26.29,26.39,1.02,0.99,-0.07,1.7,-1.56,-1.75,0.91,-0.52,0.06,-2.59,2,-0.09,-0.1,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9NRX4,PHPT1,14 kDa phosphohistidine phosphatase (EC 3.1.3.-) (Phosphohistidine phosphatase 1) (Protein janus-A homolog),4,53.6,28.7,28.09,29.12,28.38,26.24,27.37,28.88,28.31,27.18,27.31,29.45,30.22,26.37,28.13,0.58,-0.03,1,0.25,-1.88,-0.75,0.75,0.19,-0.95,-0.81,1.32,2.1,-1.76,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of organelle organization;regulation of transport,cell part;cytosol,,,+,,,,,,,
Q9BTU6,PI4K2A,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),20,47.6,27.2,31.2,28.42,28.77,31.54,29.56,29.61,29.64,29.38,28.74,29.68,30.04,29.73,29.5,-2.3,1.7,-1.07,-0.73,2.04,0.06,0.11,0.14,-0.12,-0.76,0.18,0.54,0.23,biosynthetic process;cell activation;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;exocytosis;immune system process;lipid metabolic process;metabolic process;primary metabolic process;secretion;small molecule metabolic process;transport;vesicle-mediated transport,cell body;cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;neuron projection;neuronal cell body;organelle;protein complex;site of polarized growth;vesicle,,,,,,,,,,
P42356,PI4KA,Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67),12,6.6,25.77,26.93,26.01,27.07,24.76,26.83,26.26,,27.28,27.53,25.58,25.46,26.87,26.36,-0.59,0.57,-0.36,0.71,-1.6,0.47,-0.1, ,0.91,1.17,-0.78,-0.91,0.51,biological regulation;biosynthetic process;cell communication;cell-cell signaling;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;signal transduction;signaling;small molecule metabolic process,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q13492,PICALM,Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein),16,36.7,29.99,30.55,31.13,30.56,30.32,30.63,30.95,30.21,31.09,30.97,30.78,31.22,30.95,30.72,-0.73,-0.17,0.41,-0.16,-0.4,-0.09,0.24,-0.51,0.37,0.26,0.06,0.5,0.23,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular metabolic process;cellular process;developmental process;endocytosis;endosome transport;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;organelle organization;protein complex assembly;regulation of transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex;vesicle,,,,,,,,,,
Q92508,PIEZO1,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),23,11.9,,26.38,25.91,28.17,26.89,27.61,28.44,28.09,28.15,27.84,29.34,27.12,28.53,27.71, ,-1.33,-1.79,0.46,-0.82,-0.1,0.73,0.39,0.45,0.13,1.63,-0.58,0.83,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;detection of stimulus;homeostatic process;response to abiotic stimulus;response to external stimulus;response to stimulus,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q5H8A4,PIGG,GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G),5,13.4,28.24,27.18,24.8,27.11,26.15,27.55,26.34,26.04,26.29,28.04,26.08,25.02,27.98,26.68,1.56,0.5,-1.88,0.43,-0.53,0.87,-0.34,-0.63,-0.39,1.36,-0.6,-1.66,1.3,cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein lipidation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q92643,PIGK,GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (GPI8 homolog) (hGPI8) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),13,35.9,29.01,26.57,28.17,26.08,26.1,27.88,26.24,26.73,27.45,28.9,27.81,26.73,28.22,27.38,1.63,-0.81,0.79,-1.3,-1.28,0.5,-1.14,-0.64,0.07,1.52,0.44,-0.64,0.85,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein lipidation;protein metabolic process;protein modification process;proteolysis,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9BRB3,PIGQ,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (EC 2.4.1.198) (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein) (PIG-Q),3,7.6,25.52,25.12,,24.8,25.02,26.44,,22.97,24.19,25.03,24.11,23.08,24.08,24.58,0.94,0.54, ,0.22,0.45,1.86, ,-1.61,-0.38,0.45,-0.47,-1.5,-0.49,carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein lipidation;protein metabolic process;protein modification process,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q96S52,PIGS,GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein),17,46.5,31.58,27.85,28.91,29.2,29.71,30.09,29.59,28.93,30.07,30.2,28.89,28.54,29.85,29.49,2.08,-1.64,-0.58,-0.29,0.22,0.6,0.1,-0.56,0.58,0.7,-0.61,-0.96,0.36,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein lipidation;protein metabolic process;protein modification process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q969N2,PIGT,GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein),9,20.6,29.22,28.44,26.91,27.82,27.75,28.68,27.66,28.2,28.94,28.79,27.37,25.63,29.18,28.05,1.17,0.39,-1.13,-0.23,-0.29,0.63,-0.38,0.16,0.9,0.75,-0.68,-2.41,1.13,cell death;cell differentiation;cellular metabolic process;cellular process;death;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein lipidation;protein metabolic process;protein modification process,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
Q9NWS0,PIH1D1,PIH1 domain-containing protein 1 (Nucleolar protein 17 homolog),2,8.3,26.87,,,25.23,25.52,26.71,,26.48,24.52,26.11,,,,25.92,0.95, , ,-0.69,-0.4,0.79, ,0.56,-1.4,0.19, , , ,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P27986,PIK3R1,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),4,10.2,25.17,25.65,23.49,27.07,26.85,24.73,27.1,26.83,24.58,,27.35,,,25.88,-0.71,-0.23,-2.4,1.19,0.96,-1.15,1.22,0.94,-1.3, ,1.46, , ,biological regulation;biosynthetic process;cell activation;cell differentiation;cell motility;cellular component movement;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;immune system process;interspecies interaction between organisms;lipid metabolic process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nuclear transport;nucleocytoplasmic transport;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein targeting;protein transport;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transport,cell part;macromolecular complex;membrane;phosphatidylinositol 3-kinase complex;plasma membrane;protein complex,,,,+,,,,,,
Q13526,PIN1,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1),6,76.7,27.79,27.7,25.69,28.28,27.21,26.5,28.82,29.32,26.77,26.02,28.58,27.92,,27.55,0.24,0.15,-1.86,0.73,-0.34,-1.05,1.27,1.77,-0.78,-1.53,1.03,0.37, ,biological regulation;cell cycle;cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoplasm;midbody;nucleoplasm,,,,,,,,,,
Q9Y237,PIN4,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (hPar14) (Parvulin-17) (Par17) (hPar17) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Peptidyl-prolyl cis/trans isomerase EPVH) (hEPVH) (Rotamase Pin4),2,32.1,27.47,25.58,,27.82,25.97,28.11,26.92,27.86,25.64,,27.36,,21.49,26.42,1.05,-0.84, ,1.4,-0.45,1.69,0.5,1.44,-0.78, ,0.94, ,-4.94,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;preribosome;ribonucleoprotein complex,DNA binding region,,,,,,,,,
P48426,PIP4K2A,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIP5KIII) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(4)P-5-kinase B isoform) (PtdIns(4)P-5-kinase C isoform) (PtdIns(5)P-4-kinase isoform 2-alpha),6,17.2,27.12,28.27,28.46,27.36,26.88,26.35,26.54,25.36,27.99,26.99,27.22,27.03,25.81,27.03,0.09,1.24,1.43,0.33,-0.14,-0.68,-0.49,-1.67,0.96,-0.04,0.19,0,-1.21,anatomical structure development;biosynthetic process;cell development;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P78356,PIP4K2B,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta),4,13.5,25.44,27.09,26.93,27.46,23.45,26.03,26.87,27.19,26.27,26.27,27.6,28.12,24.04,26.36,-0.92,0.72,0.56,1.09,-2.92,-0.34,0.51,0.82,-0.1,-0.1,1.23,1.75,-2.33,biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q8TBX8,PIP4K2C,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma),10,37,29.96,27.59,27.25,26.55,26.38,26.57,26.29,27.71,26.87,26.74,26.75,25.41,24.68,26.83,3.13,0.77,0.42,-0.27,-0.45,-0.26,-0.53,0.88,0.04,-0.09,-0.07,-1.42,-2.14,cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;phosphorus metabolic process;primary metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
O00625,PIR,"Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase)",8,39,25.04,24.3,,25.9,27.64,28.66,30.58,30.59,27.03,25.69,30,25.9,,27.39,-2.35,-3.1, ,-1.49,0.25,1.26,3.18,3.19,-0.36,-1.7,2.61,-1.5, ,biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UG56,PISD,Phosphatidylserine decarboxylase proenzyme (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase alpha chain;Phosphatidylserine decarboxylase beta chain],4,10.2,24.62,26.59,24.92,25.76,22.79,26.72,,25.86,25.5,28.31,25.89,,27.04,25.82,-1.2,0.77,-0.89,-0.06,-3.03,0.9, ,0.05,-0.32,2.49,0.08, ,1.22,alcohol metabolic process;amine metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q00169,PITPNA,Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha),6,21.9,27.03,28.11,27.91,28.37,26.5,26.14,28.15,24.59,25.82,25.45,28.09,27.49,27.27,26.99,0.03,1.12,0.91,1.38,-0.49,-0.86,1.16,-2.4,-1.17,-1.54,1.09,0.49,0.27,lipid metabolic process;locomotion;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cytoplasm,,,,,,,,,,
P48739,PITPNB,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta),10,49.1,29.6,29.01,29.68,30.17,28.56,27.69,29.82,29.55,28.48,29.29,29.02,28.76,24.56,28.78,0.81,0.23,0.9,1.38,-0.22,-1.09,1.03,0.77,-0.31,0.51,0.23,-0.03,-4.22,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;embryo development;establishment of localization;lipid metabolic process;lipid transport;metabolic process;primary metabolic process;small molecule metabolic process;transport,cell part;membrane,,,,,,,,,,
O00562,PITPNM1,"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)",7,8.1,26.06,24.54,26.85,22.9,25.37,,25.99,,25.5,27.43,,25.14,25.59,25.54,0.53,-1,1.31,-2.64,-0.16, ,0.45, ,-0.03,1.89, ,-0.39,0.05,anatomical structure development;biological regulation;cellular process;detection of stimulus;developmental process;establishment of localization;lipid metabolic process;metabolic process;primary metabolic process;protein transport;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;transport,cell part;lipid particle;membrane;midbody,,,,,,,,,,
Q5JRX3,PITRM1,"Presequence protease, mitochondrial (hPreP) (EC 3.4.24.-) (Pitrilysin metalloproteinase 1) (Metalloprotease 1) (hMP1)",44,48.6,31.6,30.67,32.01,31.84,31.34,32.51,32.53,31.26,32.21,33.13,32.45,32.02,32.72,32.02,-0.42,-1.35,-0.01,-0.19,-0.68,0.49,0.51,-0.76,0.19,1.11,0.42,0,0.7,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q13563,PKD2,Polycystin-2 (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321),5,6,24.42,28.28,,27.11,,26.68,25.13,24.4,26.46,,24.49,,27.02,26,-1.58,2.28, ,1.12, ,0.68,-0.87,-1.6,0.46, ,-1.51, ,1.02,anatomical structure development;anatomical structure morphogenesis;biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;detection of stimulus;developmental process;establishment of localization;homeostatic process;ion transport;microtubule organizing center organization;multicellular organismal process;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to osmotic stress;response to oxidative stress;response to stimulus;response to stress;signal transduction;transport,cell part;cell projection;cilium;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P14618,PKM,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58),66,89.5,35.53,37.29,36.35,36.82,35.83,35.36,36.31,36.41,35.14,35.71,36.81,36.6,34.86,36.08,-0.55,1.22,0.27,0.74,-0.24,-0.72,0.23,0.33,-0.94,-0.37,0.73,0.52,-1.22,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cell death;cellular metabolic process;cellular process;death;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
Q16512,PKN1,Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N),9,12.4,26.66,26.66,27.64,26.89,27.33,26.91,28.28,27.49,25.26,,27.53,26.68,,27.03,-0.37,-0.37,0.61,-0.14,0.3,-0.12,1.25,0.46,-1.77, ,0.5,-0.35, ,biological regulation;biosynthetic process;cell motility;cellular component movement;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to abiotic stimulus;response to osmotic stress;response to stimulus;response to stress;RNA metabolic process,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;midbody;nucleus;organelle;plasma membrane;vesicle,,+,,,,,,,,
Q16513,PKN2,Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2),19,27.4,29.19,27.24,26.03,27.72,27.75,26.17,27.23,27.43,26.88,29.32,28.24,27.31,27.14,27.51,1.68,-0.27,-1.48,0.21,0.24,-1.34,-0.28,-0.08,-0.63,1.81,0.72,-0.21,-0.37,biological adhesion;biological regulation;biosynthetic process;cell adhesion;cell cycle;cell death;cell division;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to stimulus;RNA metabolic process;signal transduction,cell part;cell projection;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;midbody;nucleus;organelle,,+,,,,,,,,
Q99959,PKP2,Plakophilin-2,41,52.6,31.9,28.32,29.14,30.11,29.98,29.46,29.73,30.37,30.25,30.09,30.3,29.13,29.77,29.89,2.01,-1.57,-0.75,0.22,0.09,-0.42,-0.16,0.48,0.37,0.2,0.41,-0.76,-0.12,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;developmental process;homeostatic process;organelle organization;regulation of transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9Y446,PKP3,Plakophilin-3,31,42.5,31.56,26.77,29.79,26.45,28.43,27.05,27.59,27.73,27.6,26.06,27.15,26.74,27.76,27.74,3.81,-0.98,2.04,-1.29,0.69,-0.69,-0.15,-0.01,-0.15,-1.69,-0.6,-1.01,0.02,biological adhesion;cell adhesion;cellular process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8NCC3,PLA2G15,Group XV phospholipase A2 (EC 2.3.1.-) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2),5,16,25.87,27.54,24.85,27.93,27.27,29.18,25.57,25.6,28.18,26.98,28.92,28.34,29.97,27.4,-1.53,0.14,-2.56,0.53,-0.13,1.78,-1.83,-1.8,0.78,-0.42,1.52,0.94,2.57,alcohol metabolic process;amine metabolic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;mitochondrion;organelle;vacuole,,,,,,,,,,
P47712,PLA2G4A,Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase);Lysophospholipase (EC 3.1.1.5)],10,17.4,25.83,26.86,26.37,29.07,24.69,,25.26,26.82,,26.58,23.74,29,24.44,26.24,-0.41,0.62,0.13,2.82,-1.55, ,-0.99,0.58, ,0.33,-2.51,2.76,-1.8,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;catabolic process;cell activation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;lipid metabolic process;lipid transport;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;organic acid transport;primary metabolic process;response to chemical stimulus;response to stimulus;secretion;small molecule metabolic process;transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q9Y263,PLAA,Phospholipase A-2-activating protein (PLA2P) (PLAP),18,33.5,29.51,30.26,29.64,30.28,28.92,28.54,30.83,29.83,29.44,28.02,29.74,29.89,28.51,29.49,0.02,0.76,0.15,0.78,-0.57,-0.95,1.33,0.34,-0.05,-1.47,0.25,0.4,-0.98,biological regulation;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;response to stress;signal transduction,extracellular organelle;organelle;vesicle,,,,,,,,,,
E7ESF4,PLAT,Tissue-type plasminogen activator chain A,8,20.6,,25.11,29.3,28.04,28.17,27.8,28,28.16,27.95,25.9,28.24,,28.04,27.7, ,-2.59,1.6,0.34,0.47,0.1,0.3,0.46,0.25,-1.8,0.54, ,0.34,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,extracellular region,,,,,,,,,,
E7ESM2,PLAU,Urokinase-type plasminogen activator chain B,7,26.6,26.73,27.12,,25.04,29.44,28.44,29.17,28.91,30.19,30.97,28.86,,28.98,28.53,-1.8,-1.41, ,-3.49,0.91,-0.09,0.64,0.37,1.66,2.44,0.33, ,0.45,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,,,,,,,,,,,
Q03405,PLAUR,Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87),2,11.6,27.18,28.99,28.37,27.5,27.02,26.57,,,26.23,26.72,,,,27.32,-0.14,1.67,1.05,0.17,-0.3,-0.75, , ,-1.09,-0.61, , , ,biological regulation;cellular component movement;cellular metabolic process;cellular process;coagulation;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;primary metabolic process;protein lipidation;protein metabolic process;protein modification process;regulation of body fluid levels;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cell surface;extracellular region;membrane;plasma membrane,,,,,,,,,,
Q6P4A8,PLBD1,Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1),6,11.9,29.15,28.42,28.82,24.28,,,,25.47,,25.42,25.84,,26.93,26.79,2.36,1.63,2.03,-2.51, , , ,-1.32, ,-1.37,-0.95, ,0.14,biosynthetic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;cytosol;extracellular region,,,,,,,,,,
Q8NHP8,PLBD2,Putative phospholipase B-like 2 (EC 3.1.1.-) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative phospholipase B-like 2 32 kDa form;Putative phospholipase B-like 2 45 kDa form],14,23.6,28.99,30.89,29.91,30.37,30.13,30.51,29.91,30.01,30.8,29.4,29.96,30.67,31.14,30.21,-1.21,0.68,-0.29,0.16,-0.08,0.3,-0.3,-0.19,0.59,-0.81,-0.24,0.46,0.93,catabolic process;lipid metabolic process;metabolic process;primary metabolic process,cell part,,,,,,,,,,
Q01970,PLCB3,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3)",6,6.9,27.62,27.19,25.08,27.88,26.91,25.05,28.19,26.85,27.11,26.3,27.64,26.14,25.1,26.7,0.92,0.49,-1.61,1.18,0.22,-1.65,1.49,0.15,0.41,-0.4,0.94,-0.56,-1.6,biological regulation;catabolic process;cell communication;cell-cell signaling;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;signal transduction;signaling,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q15147,PLCB4,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4)",6,7.7,23.45,,22.12,,,25.76,25.9,,25.77,27.64,26,,28.48,25.64,-2.19, ,-3.52, , ,0.12,0.26, ,0.13,2,0.36, ,2.84,biological regulation;catabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to stimulus;signal transduction,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P19174,PLCG1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)",6,6.5,26.5,24.97,25.01,27.01,25.48,24.91,27.97,22.33,26.23,25.52,24.6,26.79,,25.61,0.89,-0.64,-0.6,1.4,-0.13,-0.7,2.36,-3.28,0.62,-0.09,-1.01,1.18, ,biological regulation;catabolic process;cell motility;cellular component movement;cellular lipid metabolic process;cellular metabolic process;cellular process;coagulation;developmental process;embryo development;immune system process;interspecies interaction between organisms;lipid metabolic process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;cell projection;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q13393,PLD1,Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1),6,9,24.78,24.79,,,25.4,25.33,27.4,23.69,26.53,26.32,25.8,25.83,24.03,25.45,-0.66,-0.65, , ,-0.05,-0.11,1.95,-1.76,1.09,0.87,0.36,0.38,-1.41,biological regulation;biosynthetic process;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;locomotion;metabolic process;multi-organism process;organic acid metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8IV08,PLD3,Phospholipase D3 (PLD 3) (EC 3.1.4.4) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3),11,25.5,29.89,30.24,30.08,29.8,29.24,29.63,28.3,28.63,29.08,29.77,28.97,28.84,28.75,29.32,0.56,0.92,0.75,0.47,-0.09,0.31,-1.03,-0.7,-0.24,0.45,-0.35,-0.49,-0.57,biosynthetic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),23,23.1,28.04,25.23,25.62,26.86,28.54,29.6,29.31,28.1,28.47,26.66,29.02,28.19,29.81,27.96,0.08,-2.73,-2.34,-1.09,0.58,1.65,1.36,0.14,0.51,-1.3,1.07,0.23,1.85,,cell part;cytoplasm,,,,,,,,,,
Q9Y2H5,PLEKHA6,Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3),8,8.1,,,25.92,,24.47,24.05,24.23,24.9,,26.69,24.73,,,25, , ,0.92, ,-0.52,-0.95,-0.77,-0.1, ,1.7,-0.27, , ,,,,,,,,,,,,
Q9ULL1,PLEKHG1,Pleckstrin homology domain-containing family G member 1,4,5.3,25.94,24.84,,25.54,26.3,25.91,25.18,25.34,,26.91,25.5,,26.13,25.76,0.18,-0.92, ,-0.22,0.54,0.15,-0.58,-0.42, ,1.15,-0.26, ,0.37,biological regulation,cell part;intracellular,,,,,,,,,,
Q9HBL7,PLGRKT,Plasminogen receptor (KT) (Plg-R(KT)),5,27.2,24.84,27.23,28.97,26.79,27.03,28.35,25.69,25.05,29.36,25.62,26.96,26.81,28.28,27,-2.16,0.24,1.97,-0.21,0.03,1.35,-1.31,-1.95,2.37,-1.38,-0.04,-0.19,1.28,biological regulation;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q99541,PLIN2,Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP),17,55.6,26.95,30.47,29.79,24.88,25.64,25.7,,,,,25.03,26.65,,26.89,0.06,3.58,2.9,-2.01,-1.24,-1.19, , , , ,-1.86,-0.24, ,cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;lipid metabolic process;lipid transport;localization;metabolic process;organic acid transport;primary metabolic process;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process;transport,cell part;endoplasmic reticulum;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
O60664,PLIN3,Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17),32,84.3,32.29,32.11,32.64,32.53,31.69,31.04,32.35,32.27,31.54,31,32.76,33.49,30.52,32.02,0.27,0.09,0.62,0.52,-0.33,-0.98,0.33,0.25,-0.48,-1.01,0.74,1.47,-1.5,cellular process;establishment of localization;transport;vesicle-mediated transport,cell part;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;membrane;organelle,,,,,,,,,,
Q02809,PLOD1,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)",37,52.4,30.99,33.64,30.83,33.24,32.28,32.98,31.43,31.82,33.39,31.68,31.44,32.28,32.26,32.17,-1.18,1.47,-1.34,1.07,0.1,0.81,-0.74,-0.36,1.21,-0.49,-0.73,0.11,0.08,amine metabolic process;anatomical structure development;biosynthetic process;cellular amino acid metabolic process;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to stimulus;response to stress;small molecule metabolic process,cell part;membrane,,,,,,,,,,
O00469,PLOD2,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2)",49,61.9,33.02,35.67,32.31,35.54,34.68,35.43,34.41,34.61,35.59,34.85,35.87,34.69,36.52,34.86,-1.84,0.81,-2.55,0.67,-0.19,0.57,-0.45,-0.25,0.72,-0.01,1.01,-0.17,1.66,cellular component organization;cellular metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to stimulus;response to stress,cell part;membrane,,,,,,,,,,
O60568,PLOD3,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3)",40,58.1,31.93,33.26,31.99,33.17,32.72,32.81,32.5,32.04,32.45,32.4,32.26,31.78,33.16,32.5,-0.57,0.76,-0.51,0.67,0.22,0.31,0.01,-0.45,-0.05,-0.09,-0.24,-0.72,0.66,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell morphogenesis;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;circulatory system process;developmental process;embryo development;extracellular matrix organization;extracellular structure organization;localization;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;membrane,,,,,,,,,,
O43660,PLRG1,Pleiotropic regulator 1,11,30,29.6,28.52,29.73,29.39,29.95,29.93,29.62,29.47,30.69,29.56,28.42,23.85,28.88,29.05,0.55,-0.52,0.68,0.35,0.9,0.88,0.57,0.42,1.65,0.52,-0.63,-5.2,-0.16,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q14651,PLS1,Plastin-1 (Intestine-specific plastin) (I-plastin),11,24.5,30.14,29.24,28.14,25.38,,25.89,28.31,27.88,26.69,29.17,26.3,27.18,,27.66,2.48,1.58,0.48,-2.29, ,-1.78,0.64,0.22,-0.98,1.5,-1.36,-0.48, ,,cell part;cytoplasm,,,,,,,,,,
P13797,PLS3,Plastin-3 (T-plastin),38,60.5,32.63,33.06,33.11,32.65,31.94,31.38,32.58,32.57,31.5,31.83,32.74,33.6,31.13,32.36,0.27,0.7,0.74,0.28,-0.42,-0.98,0.22,0.21,-0.86,-0.53,0.37,1.24,-1.23,,cell part;cytoplasm,,,,,,,,,,
Q6UX71,PLXDC2,Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein),6,17.6,25.27,27.32,25.77,27.84,,25.09,25.17,,,,25.55,17.4,25.48,24.99,0.28,2.33,0.78,2.86, ,0.1,0.18, , , ,0.56,-7.59,0.49,,cell part,,,,,,,,,,
O15031,PLXNB2,Plexin-B2 (MM1),41,28.1,30.59,31.01,30.05,30.97,31.33,32.02,31.28,30.39,31.35,31.37,30.99,30.52,31.42,31.02,-0.43,-0.01,-0.97,-0.05,0.3,1,0.25,-0.63,0.33,0.35,-0.04,-0.5,0.4,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;cell proliferation;developmental process;regulation of protein modification process,cell part;intracellular,,,,,,,,,,
P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),54,63.5,31.12,32.3,32.57,31.59,32.6,32.62,32.01,32.62,33.62,33.02,32.68,27.93,32.39,32.08,-0.96,0.22,0.49,-0.5,0.52,0.53,-0.07,0.54,1.54,0.93,0.6,-4.15,0.31,aging;anatomical structure morphogenesis;biological regulation;biosynthetic process;catabolic process;cell differentiation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;immune system process;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;nucleus organization;organelle organization;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;protein targeting;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of DNA metabolic process;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of protein stability;regulation of translation;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;signal transduction;transport,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;nucleus;organelle,Other TF domain,,,,,,,,,
O15305,PMM2,Phosphomannomutase 2 (PMM 2) (EC 5.4.2.8),9,41.1,29.67,28.77,28.93,29.3,27.1,27.12,28.49,29.17,27.01,27.44,28.85,27.77,20.23,27.68,1.99,1.09,1.25,1.62,-0.58,-0.56,0.81,1.49,-0.67,-0.24,1.17,0.09,-7.45,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell body;cell part;cytosol;neuronal cell body,,,,,,,,,,
Q10713,PMPCA,Mitochondrial-processing peptidase subunit alpha (EC 3.4.24.64) (Alpha-MPP) (P-55),20,37,29.21,30.34,30.44,30.02,30.85,31.4,30.77,30.34,31.28,31.78,30.35,30.1,31.11,30.62,-1.41,-0.27,-0.17,-0.6,0.23,0.79,0.15,-0.27,0.66,1.17,-0.26,-0.52,0.49,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;proteolysis;transport,cell part;membrane,,,,,,,,,,
O75439,PMPCB,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP) (P-52),18,40.5,28.83,30.15,29.79,30.06,31.21,31.21,30.38,29.86,30.53,30.47,31.56,28.39,31.41,30.3,-1.47,-0.15,-0.51,-0.24,0.92,0.91,0.08,-0.44,0.24,0.18,1.26,-1.91,1.12,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;proteolysis;transport,cell part;membrane,,,,,,,,,,
Q15126,PMVK,Phosphomevalonate kinase (PMKase) (hPMK) (EC 2.7.4.2),3,13,26.5,26.06,26.2,27.43,25.05,25.62,24.85,25.71,,24.48,25.55,27.8,24.99,25.85,0.65,0.21,0.35,1.58,-0.81,-0.23,-1,-0.14, ,-1.38,-0.3,1.95,-0.87,alcohol metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;isopentenyl diphosphate metabolic process;lipid metabolic process;metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;microbody;organelle;peroxisome,,,,,,,,,,
Q8N490,PNKD,Probable hydrolase PNKD (EC 3.-.-.-) (Myofibrillogenesis regulator 1) (MR-1) (Paroxysmal nonkinesiogenic dyskinesia protein) (Trans-activated by hepatitis C virus core protein 2),3,6,,24.95,27.01,25.06,,,24.76,,26.06,26.43,,24.88,,25.59, ,-0.64,1.42,-0.53, , ,-0.83, ,0.47,0.83, ,-0.71, ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;peptide metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
Q96T60,PNKP,Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase);Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)],8,22.2,28.88,22.44,28.38,23.27,26.62,26.61,26.2,26.29,26.65,26.83,23.49,24.64,25.88,25.86,3.02,-3.42,2.52,-2.59,0.76,0.75,0.34,0.43,0.79,0.97,-2.37,-1.22,0.02,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;detection of stimulus;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,+,,,,,,,
Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),39,46.9,32.23,31.2,31.81,31.24,30.98,30.94,31.18,30.56,31.66,31.65,30.26,31.05,30.59,31.18,1.05,0.02,0.63,0.06,-0.2,-0.24,0,-0.62,0.48,0.47,-0.92,-0.13,-0.59,biological adhesion;biological regulation;biosynthetic process;cell adhesion;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;membrane;plasma membrane;protein complex;ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
Q9NRX1,PNO1,RNA-binding protein PNO1,2,26.5,25.97,25.65,,27.33,26.89,27.06,27.71,25.62,26.22,27.85,25.97,26.49,26.76,26.63,-0.66,-0.98, ,0.71,0.26,0.43,1.09,-1.01,-0.41,1.23,-0.66,-0.14,0.14,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P00491,PNP,Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase),21,79.2,30.64,31.61,31.32,32.91,32.71,31.75,33.23,32.82,31.59,31.14,33.24,33.1,31.44,32.11,-1.47,-0.5,-0.8,0.79,0.59,-0.37,1.11,0.7,-0.52,-0.98,1.12,0.98,-0.67,biological regulation;biosynthetic process;catabolic process;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;establishment of localization;heterocycle metabolic process;immune system process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;protein transport;purine-containing compound salvage;response to chemical stimulus;response to drug;response to stimulus;secretion;small molecule metabolic process;transport,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q96AD5,PNPLA2,Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2) (Desnutrin) (IPLA2-zeta) (Pigment epithelium-derived factor) (TTS2.2) (Transport-secretion protein 2) (TTS2),4,10.7,18.93,,,22.15,21.81,23.19,25.25,23.43,21.95,20.74,,,,22.18,-3.25, , ,-0.03,-0.37,1.01,3.07,1.25,-0.23,-1.44, , , ,biological regulation;biosynthetic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;glycerol ether metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;lipid particle;membrane;plasma membrane,,,,,,,,,,
P41247,PNPLA4,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Protein GS2),2,15.1,24.6,26.58,26.62,25.97,26.54,26.52,28.56,25.1,26.88,25.84,26.9,,,26.37,-1.77,0.2,0.25,-0.4,0.17,0.15,2.18,-1.27,0.5,-0.53,0.53, , ,catabolic process;lipid metabolic process;metabolic process;primary metabolic process,,,,,,,,,,,
Q8IY17,PNPLA6,Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6),20,19.7,28.96,29.4,28.27,28.68,29.13,30.26,29.4,29.45,30.1,29.49,30.66,28.93,30.96,29.51,-0.56,-0.12,-1.24,-0.83,-0.38,0.75,-0.11,-0.07,0.58,-0.02,1.14,-0.59,1.45,alcohol metabolic process;amine metabolic process;catabolic process;cell death;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9NVS9,PNPO,Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase),8,39.1,28.31,28.13,26.88,27.41,27.75,27.47,26.42,28.89,25.42,,30.24,25.78,25.75,27.37,0.94,0.76,-0.49,0.03,0.38,0.1,-0.95,1.52,-1.95, ,2.87,-1.59,-1.62,biosynthetic process;cellular metabolic process;cellular process;heterocycle metabolic process;metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
Q8TCS8,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)",23,34.1,30.11,30.59,31.22,31.26,30.8,30.65,30.87,30.5,30.8,31.71,29.97,30.31,30.98,30.75,-0.64,-0.16,0.47,0.51,0.05,-0.1,0.12,-0.25,0.05,0.96,-0.78,-0.44,0.23,anatomical structure morphogenesis;biological regulation;catabolic process;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mitochondrion organization;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;organelle organization;primary metabolic process;protein complex assembly;regulation of cell cycle;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;RNA processing;transport,cell part;exosome (RNase complex);macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
O00592,PODXL,Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1),6,18.2,29.66,29.61,31.5,27.22,28.06,28.16,28.67,26.44,25.96,29.84,30.08,31.2,30.86,29.02,0.64,0.59,2.48,-1.8,-0.96,-0.86,-0.35,-2.58,-3.06,0.82,1.06,2.18,1.83,anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell development;cell motility;cellular component movement;cellular process;developmental process;immune system process;locomotion,cell part;cell projection;cytoplasm;filopodium,,,,,,,,,,
Q8WVV4,POF1B,Protein POF1B (Premature ovarian failure protein 1B),8,19,27.98,,30.39,25.21,25.19,25.17,25.54,24.53,25.46,,,27.4,25.3,26.22,1.76, ,4.17,-1,-1.02,-1.05,-0.67,-1.69,-0.76, , ,1.19,-0.92,,,,,,,,,,,,
Q9H488,POFUT1,GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1),10,32.2,30.45,30.9,30.86,31.07,30.5,31.54,30.48,30.23,31.08,30.49,30.56,30.62,31.66,30.8,-0.36,0.1,0.05,0.27,-0.3,0.74,-0.32,-0.57,0.28,-0.32,-0.25,-0.19,0.86,alcohol metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;response to stimulus;signal transduction;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9Y2G5,POFUT2,GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2),16,39.6,27.3,29.92,27.3,29.36,28.95,29.26,28.6,27.53,29.78,27.14,29.11,29.52,30.96,28.83,-1.53,1.1,-1.52,0.54,0.13,0.43,-0.23,-1.3,0.96,-1.69,0.28,0.7,2.13,alcohol metabolic process;anatomical structure formation involved in morphogenesis;biological regulation;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;metabolic process;primary metabolic process;regulation of transport;small molecule metabolic process,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q8NBL1,POGLUT1,Protein O-glucosyltransferase 1 (EC 2.4.1.-) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein),7,16.1,29.01,29.87,28.18,27.64,27.93,29.35,28.14,29.65,28.59,27.28,29.22,27.63,29.67,28.63,0.38,1.24,-0.45,-0.99,-0.7,0.72,-0.49,1.03,-0.04,-1.35,0.59,-1,1.05,anatomical structure development;biological regulation;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;response to stimulus;signal transduction,cell part,,,,,,,,,,
Q7Z3K3,POGZ,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),13,13.5,27.63,26.46,25.5,26.38,27.85,27.36,,24.61,27.59,26.41,,,25.18,26.5,1.13,-0.04,-1,-0.12,1.36,0.86, ,-1.89,1.09,-0.09, , ,-1.31,cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromosome organization;macromolecular complex assembly;organelle assembly;organelle organization;protein complex assembly,cell part;cytoplasm,C2H2-type,,,,,,,,,
P06746,POLB,DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-),3,18.1,27.14,25.1,25.86,23.78,,,23.63,,,26.09,,,25.8,25.34,1.8,-0.24,0.52,-1.56, , ,-1.72, , ,0.75, , ,0.45,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;DNA metabolic process;DNA repair;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;macromolecular complex;nucleoplasm;protein complex,DNA binding region,,,,,,,,,
P28340,POLD1,DNA polymerase delta catalytic subunit (EC 2.7.7.7) (DNA polymerase subunit delta p125),10,11.7,27.79,25.2,26.38,25.04,27.42,25.3,26.81,26.4,26.27,25.45,25.46,24.5,25.16,25.94,1.86,-0.74,0.44,-0.89,1.48,-0.64,0.87,0.47,0.34,-0.49,-0.48,-1.43,-0.78,biological regulation;biosynthetic process;catabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;small molecule metabolic process;telomere organization,cell part;DNA polymerase complex;macromolecular complex;nucleoplasm;nucleotide-excision repair complex;protein complex,,,,,,,,,,
Q9Y2S7,POLDIP2,Polymerase delta-interacting protein 2 (38 kDa DNA polymerase delta interaction protein) (p38),16,54.9,30.56,29.59,27.96,29.53,30.2,29.97,29.91,29.68,30.1,30.34,29.1,27.64,29.94,29.58,0.99,0.02,-1.61,-0.05,0.62,0.39,0.33,0.1,0.53,0.76,-0.48,-1.94,0.36,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BY77,POLDIP3,Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR),12,35.6,28.34,27.4,29.01,28.22,29.18,29.16,29.03,27.67,29.49,29.93,28.03,29.56,28.94,28.77,-0.42,-1.37,0.24,-0.54,0.41,0.39,0.26,-1.1,0.73,1.16,-0.73,0.79,0.18,biological regulation;regulation of translation,cell part;cytoplasm,,,,,,,,,,
Q9NRF9,POLE3,DNA polymerase epsilon subunit 3 (EC 2.7.7.7) (Arsenic-transactivated protein) (AsTP) (Chromatin accessibility complex 17 kDa protein) (CHRAC-17) (HuCHRAC17) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17),6,30.6,26.03,26.24,27.29,26.54,28.13,,27.31,27.66,26.8,26.44,,26.68,26.28,26.86,-0.83,-0.61,0.43,-0.31,1.27, ,0.46,0.81,-0.05,-0.41, ,-0.17,-0.57,biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA replication;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process,cell part;DNA polymerase complex;macromolecular complex;protein complex,,,,,,,,,,
O95602,POLR1A,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),17,13.4,28.1,28.06,27.29,27.81,28.85,28.29,27.37,28.21,28.63,28.38,26.59,28.73,28.44,28.06,0.04,0,-0.77,-0.25,0.79,0.23,-0.69,0.15,0.57,0.32,-1.47,0.67,0.39,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;nucleoplasm;protein complex;RNA polymerase complex,,,,,,,,,,
Q9H9Y6,POLR1B,DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135),6,6.5,24.11,25.83,23.88,26.35,25.49,25.12,26.15,,27.36,26.93,,24.44,25.74,25.58,-1.47,0.25,-1.7,0.77,-0.09,-0.47,0.57, ,1.78,1.35, ,-1.14,0.16,"biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleus organization;organelle organization;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;protein complex;RNA polymerase complex,,,,,,,,,,
O15160,POLR1C,DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPA39) (RPC40),7,23.1,29.05,28.44,27.96,28.72,29.17,29.23,29.21,29.1,28.68,29.19,28.86,28.81,28.97,28.88,0.17,-0.44,-0.91,-0.16,0.29,0.36,0.33,0.22,-0.19,0.31,-0.01,-0.07,0.09,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;nucleoplasm;protein complex;RNA polymerase complex,,,,,,,,,,
Q9Y2S0,POLR1D,DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) (RNA polymerase I 16 kDa subunit) (RPA16) (RPC16) (hRPA19),2,18.8,26.88,26.11,27.6,26.72,27.46,26.68,27.51,23.6,26.86,28.24,26.17,25.66,26.69,26.63,0.25,-0.52,0.97,0.09,0.83,0.05,0.88,-3.03,0.23,1.61,-0.46,-0.97,0.06,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;nucleoplasm;protein complex;RNA polymerase complex,,,,,,,,,,
P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),28,22,29.46,28.73,29.72,28.68,29.42,28.97,28.96,28.11,29.67,28.74,28.64,28.74,29.04,28.99,0.47,-0.26,0.73,-0.31,0.43,-0.02,-0.03,-0.88,0.68,-0.25,-0.35,-0.25,0.05,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;RNA polymerase complex,,,,,,,,,,
P30876,POLR2B,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2),22,21.2,30.44,29.57,28.64,30.18,30.7,30.6,30.13,30.16,30.11,30.5,29.23,30.35,29.99,30.05,0.39,-0.47,-1.41,0.14,0.66,0.56,0.09,0.12,0.06,0.45,-0.82,0.3,-0.06,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;RNA polymerase complex,,,,,,,,,,
O15514,POLR2D,DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16),5,50,25.55,25.23,24.73,25.26,26.77,26.74,25.82,24.46,26.55,26.79,26.31,26.53,26.56,25.95,-0.39,-0.72,-1.21,-0.69,0.83,0.79,-0.13,-1.49,0.61,0.84,0.36,0.58,0.61,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;RNA polymerase complex,,,,,,,,,,
P19388,POLR2E,"DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4)",5,24.8,29.52,26.76,26.96,28,28.5,28.11,28.34,26.81,27.47,27.97,27.16,28.4,29.16,27.94,1.58,-1.18,-0.97,0.07,0.57,0.17,0.41,-1.12,-0.47,0.03,-0.78,0.47,1.22,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;protein complex;RNA polymerase complex,,,,,,,,,,
P62487,POLR2G,DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) (DNA-directed RNA polymerase II subunit G) (RNA polymerase II 19 kDa subunit) (RPB19),4,30.2,27.75,26.76,28.64,27.06,27.41,27.85,27.47,27.36,27.05,28.49,28.01,27.83,26.42,27.55,0.2,-0.79,1.09,-0.48,-0.13,0.31,-0.08,-0.18,-0.49,0.94,0.46,0.28,-1.13,"biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;RNA polymerase complex,,,,,,,,,,
P52434,POLR2H,"DNA-directed RNA polymerases I, II, and III subunit RPABC3 (RNA polymerases I, II, and III subunit ABC3) (DNA-directed RNA polymerase II subunit H) (DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide) (RPB17) (RPB8 homolog) (hRPB8)",8,45.6,29.7,28.57,28.13,27.75,27.25,28.14,28.74,27.45,28.05,28.91,27.47,27.16,27.11,28.03,1.67,0.54,0.09,-0.28,-0.79,0.11,0.71,-0.58,0.02,0.87,-0.56,-0.87,-0.92,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;RNA polymerase complex,,,,,,,,,,
Q9GZM3,POLR2J2,DNA-directed RNA polymerase II subunit RPB11-b1 (RNA polymerase II subunit B11-b1) (RPB11b1) (DNA-directed RNA polymerase II subunit J2),3,22.6,25,25.1,,26.05,26.98,26.56,,26.92,,23.87,25.92,26.11,25.95,25.85,-0.85,-0.75, ,0.2,1.14,0.72, ,1.07, ,-1.97,0.08,0.27,0.1,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P62875,POLR2L,"DNA-directed RNA polymerases I, II, and III subunit RPABC5 (RNA polymerases I, II, and III subunit ABC5) (DNA-directed RNA polymerase III subunit L) (RNA polymerase II 7.6 kDa subunit) (RPB7.6) (RPB10 homolog)",2,29.9,,26.42,27.54,,28.88,27.51,27.2,26.93,27.17,27.32,26.99,24.2,28.26,27.13, ,-0.71,0.41, ,1.75,0.38,0.07,-0.2,0.04,0.19,-0.14,-2.93,1.14,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;protein complex;RNA polymerase complex,,,,,,,,,,
P05423,POLR3D,DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog),3,7.4,25.64,25.38,25.7,23.14,22.53,25.99,27.63,24.52,27.46,27.99,26.72,27.97,26.93,25.97,-0.33,-0.59,-0.27,-2.83,-3.44,0.02,1.66,-1.44,1.49,2.03,0.75,2,0.96,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to stimulus;response to stress;RNA metabolic process;transcription elongation, DNA-dependent;transcription termination, DNA-dependent",cell part;macromolecular complex;nucleoplasm;protein complex;RNA polymerase complex,,,,,,,,,,
H3BNJ0,POLR3E,DNA-directed RNA polymerase III subunit RPC5 (Fragment),2,13.3,,,,,23.05,,24.91,24.31,23.57,,24.77,26.64,21.96,24.17, , , , ,-1.13, ,0.73,0.14,-0.6, ,0.6,2.47,-2.21,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
F5H827,POMGNT1,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1",3,7.8,23.32,22.01,,,,,,,24.95,24.79,24.15,24.98,23.67,23.98,-0.66,-1.97, , , , , , ,0.97,0.81,0.17,1,-0.31,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q15165,PON2,Serum paraoxonase/arylesterase 2 (PON 2) (EC 3.1.1.2) (EC 3.1.1.81) (Aromatic esterase 2) (A-esterase 2) (Serum aryldialkylphosphatase 2),14,60.6,31.2,32.16,32.45,32.13,31.43,31.97,32.16,31.15,32.83,32.98,32.49,31.83,33.08,32.14,-0.94,0.01,0.3,-0.01,-0.71,-0.17,0.01,-0.99,0.69,0.84,0.35,-0.32,0.94,catabolic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular process;metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;mitochondrion;nucleus;organelle;plasma membrane;vacuole,,,,,,,,,,
Q99575,POP1,Ribonucleases P/MRP protein subunit POP1 (hPOP1) (EC 3.1.26.5),13,14.9,28.1,25.27,26.87,29.23,29.28,28.62,29.59,29.42,29.53,29.29,27.87,29.18,29.36,28.58,-0.49,-3.31,-1.72,0.64,0.7,0.04,1,0.83,0.95,0.7,-0.72,0.59,0.78,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;macromolecular complex;ribonuclease P complex;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
O95707,POP4,Ribonuclease P protein subunit p29 (hPOP4) (EC 3.1.26.5),3,15,24.96,24.87,25.06,26.33,25.68,27.2,25.55,24.32,25.98,25.53,25.02,26.69,26.61,25.68,-0.72,-0.81,-0.62,0.65,0,1.52,-0.13,-1.35,0.3,-0.15,-0.66,1.01,0.93,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing;tRNA metabolic process;tRNA processing,cell part;macromolecular complex;ribonuclease P complex;ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
P16435,POR,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),34,52.4,33.02,32.34,33.56,31.57,31.62,31.89,31.87,31.92,31.85,32.66,32.37,31.64,32.28,32.2,0.82,0.14,1.36,-0.63,-0.58,-0.31,-0.33,-0.28,-0.35,0.46,0.17,-0.56,0.08,amine metabolic process;biological regulation;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;one-carbon metabolic process;organic acid metabolic process;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;secondary metabolic process;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q15063,POSTN,Periostin (PN) (Osteoblast-specific factor 2) (OSF-2),24,43.7,25.13,27.95,26,32.46,27.48,30.1,29.52,25.21,,27.37,28.81,29.46,29.74,28.27,-3.14,-0.32,-2.27,4.19,-0.78,1.83,1.25,-3.06, ,-0.9,0.54,1.19,1.47,anatomical structure development;biological adhesion;biological regulation;cell adhesion;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization,cell part;extracellular matrix;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle;proteinaceous extracellular matrix,,,,,,,,,,
Q15181,PPA1,Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase),23,76.5,32.85,33.82,33.64,32.98,31.62,32.29,33.59,33.32,32,32.61,34.08,34.98,32.35,33.09,-0.24,0.73,0.55,-0.1,-1.47,-0.79,0.5,0.23,-1.08,-0.48,0.99,1.9,-0.74,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
Q9H2U2,PPA2,"Inorganic pyrophosphatase 2, mitochondrial (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2)",16,60.2,31.92,32.14,31.87,30.56,30.61,31.6,31.44,30.93,32.1,32.81,31.92,31.55,31.69,31.63,0.29,0.52,0.24,-1.07,-1.02,-0.02,-0.18,-0.7,0.47,1.18,0.3,-0.07,0.06,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
Q9NQ55,PPAN,Suppressor of SWI4 1 homolog (Ssf-1) (Brix domain-containing protein 3) (Peter Pan homolog),6,14.8,27.89,27.03,27.63,28.34,28.81,28.66,28.61,28.03,28.88,28.57,25.61,28.31,28.39,28.06,-0.17,-1.03,-0.42,0.28,0.75,0.6,0.56,-0.03,0.82,0.51,-2.45,0.25,0.33,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q06203,PPAT,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT),7,15.1,27.24,24.53,23.1,25.59,24.7,21.59,23.25,22.4,,25.94,21.77,26.63,,24.25,2.99,0.28,-1.15,1.35,0.45,-2.66,-0.99,-1.85, ,1.69,-2.48,2.38, ,amine metabolic process;anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;heterocycle metabolic process;macromolecular complex assembly;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;pigment metabolic process;primary metabolic process;protein complex assembly;regulation of body fluid levels;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;secretion;small molecule metabolic process;transport,cell part;cytosol,,,,,,,,,,
Q9HAB8,PPCS,Phosphopantothenate--cysteine ligase (EC 6.3.2.5) (Phosphopantothenoylcysteine synthetase) (PPC synthetase),8,24.4,29.43,29.65,28.2,28.48,26.71,24.78,28.76,28.47,26.33,26.64,28.32,28.32,25.7,27.67,1.75,1.97,0.53,0.8,-0.97,-2.89,1.08,0.79,-1.34,-1.04,0.64,0.65,-1.98,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
Q13136,PPFIA1,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),12,13.5,26.84,27.03,27.29,27.21,25.03,26.43,27.68,26.94,27.44,26.4,27.27,27.23,26.67,26.88,-0.04,0.15,0.41,0.33,-1.85,-0.45,0.8,0.06,0.56,-0.48,0.39,0.35,-0.22,biological adhesion;cell adhesion;cellular process,cell part;cytoplasm,,,,,,,,,,
Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),35,33.5,29.33,29.26,28.69,29.93,29.6,29.65,29.46,28.65,29.97,30.69,29.9,28.88,30.2,29.55,-0.22,-0.3,-0.87,0.37,0.05,0.09,-0.09,-0.9,0.42,1.13,0.35,-0.67,0.65,biological adhesion;cell adhesion;cellular process,cell part;membrane;plasma membrane,,,,,,,,,,
Q05CN4,PPFIBP1,PPFIBP1 protein (Fragment),2,7.5,26.69,26.38,,27.05,27.36,28.18,27.32,26.26,26.37,27.97,,26.9,27.78,27.11,-0.42,-0.74, ,-0.06,0.25,1.07,0.2,-0.85,-0.74,0.85, ,-0.22,0.66,,,,,,,,,,,,
Q8NEY8,PPHLN1,Periphilin-1 (Gastric cancer antigen Ga50),8,15,26.56,25.89,25.25,25.2,27.87,27.7,28.14,27.15,27.82,27.41,25.65,22.17,26.91,26.44,0.12,-0.55,-1.19,-1.24,1.42,1.26,1.7,0.71,1.38,0.97,-0.79,-4.27,0.47,developmental process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P62937,PPIA,"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",20,95.2,34.78,35.07,35.64,35.59,35.07,34.49,35.19,35.39,34.33,34.16,34.91,35.82,33.74,34.94,-0.15,0.13,0.7,0.65,0.14,-0.45,0.26,0.46,-0.61,-0.78,-0.02,0.89,-1.2,biological regulation;biosynthetic process;cell activation;cell motility;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;establishment of localization;exocytosis;immune system process;interspecies interaction between organisms;locomotion;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein folding;protein metabolic process;regulation of transport;secretion;transport;vesicle-mediated transport,cell part;cytosol;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P23284,PPIB,Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP),28,71.8,34.85,35.98,35.15,35.74,35.73,36.04,35.26,35.19,36.01,35.68,35.37,34.4,35.89,35.48,-0.63,0.49,-0.33,0.26,0.24,0.56,-0.22,-0.3,0.53,0.2,-0.12,-1.08,0.4,cellular component organization;cellular metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P45877,PPIC,Peptidyl-prolyl cis-trans isomerase C (PPIase C) (EC 5.2.1.8) (Cyclophilin C) (Rotamase C),4,14.6,29.37,30.18,29.29,30.46,29.69,29.7,29.17,29.84,30.06,30.48,29.25,29.74,30.06,29.79,-0.42,0.39,-0.5,0.67,-0.1,-0.09,-0.62,0.05,0.26,0.69,-0.54,-0.05,0.27,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification process;response to stimulus;signal transduction,cell part;cytoplasm,,,,,,,,,,
Q08752,PPID,Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D),5,18.4,26.11,,24.52,26.8,22.82,24.99,27.03,25.33,21.8,26.59,25.33,,,25.13,0.98, ,-0.61,1.66,-2.31,-0.14,1.9,0.2,-3.33,1.46,0.2, , ,biological regulation;cell death;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;death;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;organelle organization;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein transport;regulation of transport;response to abiotic stimulus;response to stimulus;transport,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q9UNP9,PPIE,Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E),6,42.9,27.31,28.98,26.26,26.43,28.1,26.67,24.82,26.66,27.12,26.42,25.65,25.23,25.28,26.53,0.77,2.45,-0.27,-0.1,1.57,0.14,-1.71,0.13,0.59,-0.12,-0.89,-1.31,-1.25,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein folding;protein metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P30405,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Mitochondrial cyclophilin) (CyP-M) (Rotamase F)",12,64.7,28.88,31.36,30.84,30.87,30.98,31.08,30.42,30.59,30.94,31.35,30.13,30.92,30.9,30.71,-1.84,0.64,0.13,0.16,0.27,0.37,-0.3,-0.12,0.22,0.64,-0.58,0.21,0.19,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;organelle organization;primary metabolic process;protein folding;protein metabolic process;regulation of organelle organization;regulation of transport;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;membrane,,,,,,,,,,
Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),18,21.9,28.18,25.97,27.7,27.12,26.19,26.32,,26.74,27.76,24.47,23.69,25.66,23.65,26.12,2.06,-0.15,1.58,1,0.07,0.2, ,0.62,1.64,-1.65,-2.43,-0.46,-2.47,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
O43447,PPIH,Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP),4,32.6,28.35,28.08,28.44,27.25,27.2,27.73,28.26,27.57,28.32,27.68,28,27.42,27.01,27.79,0.55,0.29,0.64,-0.54,-0.59,-0.06,0.47,-0.22,0.53,-0.11,0.2,-0.37,-0.78,biological regulation;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9Y3C6,PPIL1,Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1),4,30.1,28.43,28.97,28.09,28.85,28.14,27.12,29.31,28.39,28.57,28.31,27.64,,28.45,28.36,0.07,0.62,-0.27,0.49,-0.22,-1.24,0.95,0.04,0.22,-0.04,-0.71, ,0.09,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9H2H8,PPIL3,Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin J) (CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3),6,41.6,26.64,27.64,27.52,27.29,27.91,26.65,26.69,27.31,26.16,26.22,26.18,26.21,25.56,26.77,-0.12,0.87,0.75,0.52,1.14,-0.12,-0.08,0.54,-0.61,-0.55,-0.59,-0.56,-1.2,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q8WUA2,PPIL4,Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4),2,6.8,27.49,26.74,26.15,26.64,23.26,26.49,27.21,23.68,26.72,25.23,27.86,27.54,25.54,26.2,1.29,0.54,-0.05,0.44,-2.94,0.29,1.01,-2.52,0.52,-0.96,1.67,1.35,-0.66,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O60437,PPL,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),132,65.5,34.34,32.94,33.5,29.22,28.75,28.97,29.14,29.68,28.47,34.03,29.69,27.77,28.53,30.39,3.95,2.55,3.11,-1.16,-1.63,-1.42,-1.25,-0.71,-1.91,3.64,-0.69,-2.62,-1.85,developmental process,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle;plasma membrane,,,,,,,,,,
P35813,PPM1A,Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA),3,6.5,25.77,25.23,23.27,25.43,25.7,24.87,25.71,25.03,25.45,25.54,24.53,25.49,,25.17,0.6,0.06,-1.9,0.26,0.53,-0.3,0.54,-0.14,0.28,0.37,-0.64,0.32, ,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein acylation;protein dephosphorylation;protein lipidation;protein metabolic process;protein modification process;regulation of cell cycle;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;cytosol;membrane;nucleoplasm,,,+,,,,,,,
O75688,PPM1B,Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta),9,20,29.39,29.19,27.75,29.77,28.65,27.69,27.6,28.72,27.12,26.7,27.67,27.26,,28.13,1.26,1.07,-0.38,1.65,0.53,-0.43,-0.53,0.59,-1,-1.43,-0.46,-0.86, ,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein acylation;protein dephosphorylation;protein lipidation;protein metabolic process;protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytosol;membrane,,,+,,,,,,,
P49593,PPM1F,Protein phosphatase 1F (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase) (CaM-kinase phosphatase) (CaMKPase) (Partner of PIX 2) (Protein fem-2 homolog) (hFem-2),10,33.2,24.67,27.79,27.41,28.06,27.87,26.59,29.16,28.92,27.35,27.11,29.7,30.03,25.2,27.68,-3.01,0.11,-0.28,0.38,0.19,-1.09,1.48,1.23,-0.33,-0.57,2.01,2.35,-2.48,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to drug;response to stimulus,cell part;cytosol;macromolecular complex;protein complex,,,+,,,,,,,
O15355,PPM1G,Protein phosphatase 1G (EC 3.1.3.16) (Protein phosphatase 1C) (Protein phosphatase 2C isoform gamma) (PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma),14,36.4,31.08,29.88,30.19,30.16,30.68,30.19,30.4,30.09,30.02,30.17,28.84,29.15,29.41,30.02,1.06,-0.14,0.17,0.14,0.66,0.17,0.38,0.07,0,0.15,-1.18,-0.87,-0.61,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of cell cycle,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,+,,,,,,,
Q9Y570,PPME1,Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89),9,27.7,29.39,28.32,28.26,29.54,27.54,27.72,28.1,28.66,27.25,27.42,29.05,29.51,26.91,28.28,1.11,0.03,-0.02,1.26,-0.75,-0.56,-0.18,0.38,-1.03,-0.86,0.77,1.23,-1.38,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;primary metabolic process;protein metabolic process;protein modification process;small molecule metabolic process,,,,,,,,,,,
P50336,PPOX,Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4),10,29.8,27.66,29.55,,26.41,28.54,27.81,27.86,28.39,28.17,28.72,28.56,28.03,28.86,28.21,-0.55,1.34, ,-1.8,0.32,-0.41,-0.35,0.18,-0.05,0.51,0.35,-0.18,0.65,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;pigment metabolic process;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process,cell part,,,,,,,,,,
P62136,PPP1CA,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16),26,77.6,33.15,32.76,32.54,32.83,32.6,32.93,32.91,32.9,33.19,32.68,32.47,33.22,32.35,32.81,0.34,-0.05,-0.27,0.02,-0.21,0.12,0.1,0.09,0.38,-0.13,-0.34,0.41,-0.46,anatomical structure development;anatomical structure morphogenesis;biological regulation;carbohydrate metabolic process;catabolic process;cell cycle;cell division;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;glycerol ether metabolic process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;phosphorus metabolic process;polysaccharide metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;response to stimulus;signal transduction;small molecule metabolic process,cell part;cell projection;cytosol;histone methyltransferase complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;nucleolus;organelle;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
P62140,PPP1CB,Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (EC 3.1.3.16) (EC 3.1.3.53),9,37.3,31.89,31.07,31.19,31.16,31.11,30.48,31.23,31.51,31.67,30.69,30.68,30.4,30.4,31.04,0.85,0.03,0.15,0.12,0.07,-0.56,0.19,0.48,0.63,-0.34,-0.36,-0.64,-0.64,biological regulation;carbohydrate metabolic process;catabolic process;cell division;cellular lipid metabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;glycerol ether metabolic process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;polysaccharide metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;response to stimulus;signal transduction;small molecule metabolic process,cell part;histone methyltransferase complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
P36873,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit),4,11.6,28.48,27.95,27.71,27.96,26.73,28.79,27.92,29.37,27.94,27.89,28.17,28.39,27.69,28.08,0.41,-0.13,-0.36,-0.12,-1.34,0.71,-0.16,1.29,-0.13,-0.19,0.09,0.31,-0.38,biological regulation;carbohydrate metabolic process;catabolic process;cell cycle;cell division;cellular lipid metabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;glycerol ether metabolic process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;mitotic cell cycle;phosphorus metabolic process;polysaccharide metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of transport;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytosol;histone methyltransferase complex;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;midbody;mitochondrion;nucleolus;organelle;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
Q96QC0,PPP1R10,Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) (PP1-binding protein of 114 kDa) (Phosphatase 1 nuclear targeting subunit) (Protein FB19) (p99),8,11.8,26.51,25.81,27.02,26.68,27.28,28.75,25.79,26.01,27.21,27.62,,26.61,27.5,26.9,-0.39,-1.09,0.12,-0.22,0.38,1.86,-1.11,-0.89,0.31,0.72, ,-0.29,0.6,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;RNA metabolic process;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),33,33.5,31.28,30.09,30.19,30.96,30.12,30.29,30.55,30.07,30.13,29.75,30.69,29.8,30,30.3,0.98,-0.21,-0.11,0.66,-0.18,-0.01,0.25,-0.23,-0.17,-0.55,0.39,-0.5,-0.3,biological regulation;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;microtubule organizing center organization;mitosis;nuclear division;organelle fission;organelle organization;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of transport,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;microtubule organizing center;nucleoplasm;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
Q9BZL4,PPP1R12C,Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa) (Protein phosphatase 1 myosin-binding subunit p85),9,13.8,23.84,24.76,25.58,24.29,26.9,27.34,22.17,25.74,,,27.59,26.95,25.62,25.53,-1.68,-0.77,0.06,-1.24,1.38,1.82,-3.36,0.21, , ,2.07,1.42,0.1,,cell part;cytoplasm,,,,,,,,,,
Q8WUF5,PPP1R13L,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),6,10.3,26.2,25.79,24.71,26.57,26.02,25.37,26.1,27.46,26.8,23.2,26.44,24.5,25.53,25.75,0.46,0.04,-1.03,0.83,0.27,-0.38,0.36,1.71,1.05,-2.54,0.7,-1.25,-0.22,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;growth;homeostatic process;macromolecule metabolic process;metabolic process;molting cycle;multicellular organismal process;muscle contraction;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;post-embryonic development;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q6NYC8,PPP1R18,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),18,38.5,26.87,27.19,28.99,28.29,29.57,28.8,29.11,28.45,29.72,27.88,29.79,28,29.59,28.63,-1.77,-1.45,0.35,-0.35,0.93,0.17,0.48,-0.18,1.09,-0.75,1.15,-0.64,0.95,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P41236,PPP1R2,Protein phosphatase inhibitor 2 (IPP-2),8,47.3,27.82,25.69,25.43,25.49,27.1,25.36,24.02,25.06,23.07,18.03,26.48,27.21,23.54,24.95,2.87,0.74,0.48,0.55,2.15,0.42,-0.93,0.11,-1.88,-6.92,1.53,2.27,-1.4,biological regulation;carbohydrate metabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process,,,,,,,,,,,
Q6ZMI0,PPP1R21,Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1),4,8.6,26.45,25.96,24.43,25.6,25.36,25.39,26.07,,,24.8,27.08,25.64,25.57,25.67,0.78,0.29,-1.23,-0.06,-0.31,-0.27,0.4, , ,-0.87,1.41,-0.03,-0.1,,,,,,,,,,,,
Q15435,PPP1R7,Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22),24,63.1,29.85,30.56,30.8,30.27,28.51,29.87,30.23,30.25,29.85,28.61,30.4,30.5,29.88,29.97,-0.12,0.59,0.83,0.31,-1.46,-0.09,0.26,0.29,-0.12,-1.36,0.44,0.53,-0.09,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q12972,PPP1R8,Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8) [Includes: Activator of RNA decay (EC 3.1.4.-) (ARD-1)],7,30.5,28.67,27.49,28.1,27.96,28.7,29.17,28.89,27.86,28.98,28.62,27.44,28.2,27.41,28.27,0.4,-0.78,-0.17,-0.31,0.43,0.9,0.62,-0.41,0.71,0.35,-0.82,-0.07,-0.86,biological regulation;biosynthetic process;catabolic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
Q96SB3,PPP1R9B,Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin),9,15.6,25.62,28.08,26.84,27.62,26.18,27.38,27.37,27.27,28.45,,22.96,,26.51,26.75,-1.13,1.32,0.09,0.86,-0.57,0.62,0.62,0.51,1.7, ,-3.79, ,-0.24,anatomical structure development;biological regulation;cell differentiation;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to chemical stimulus;response to stimulus;RNA metabolic process;RNA processing;RNA splicing,cell part;cell projection;cytoskeleton;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;nucleoplasm;organelle;protein complex;protein serine/threonine phosphatase complex;synapse,,,,,,,,,,
P67775,PPP2CA,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C),11,54.4,30.43,30.43,29.8,30.9,29.77,29.8,31.08,31.29,29.67,29.64,31,31.14,29.23,30.32,0.11,0.11,-0.52,0.58,-0.55,-0.52,0.76,0.97,-0.66,-0.68,0.68,0.82,-1.09,anatomical structure development;biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;lipid metabolic process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;meiosis;membrane organization;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein dephosphorylation;protein metabolic process;protein modification process;regulation of DNA metabolic process;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleus;organelle;plasma membrane;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
P30153,PPP2R1A,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha),38,66.6,33.08,32.71,32.99,33.14,32.59,32.69,32.97,32.9,32.08,32.55,33.52,33.38,32.38,32.84,0.23,-0.13,0.15,0.29,-0.26,-0.15,0.12,0.06,-0.76,-0.29,0.67,0.54,-0.46,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome segregation;lipid metabolic process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein dephosphorylation;protein metabolic process;protein modification process;regulation of DNA metabolic process;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
P30154,PPP2R1B,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta),4,12.8,24.94,25.93,26.58,27.32,26.47,26.25,26.98,28.37,25.48,25.73,26.24,27.87,25.76,26.46,-1.51,-0.52,0.12,0.87,0.01,-0.21,0.53,1.92,-0.98,-0.73,-0.22,1.42,-0.7,,,,,,,,,,,,
P63151,PPP2R2A,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha),11,30.9,29.15,29.74,29.28,30.33,30.13,29.01,30.88,30.2,27.94,27.1,30.61,30.56,27.97,29.45,-0.3,0.28,-0.17,0.87,0.68,-0.45,1.43,0.75,-1.52,-2.36,1.16,1.11,-1.49,biological regulation;catabolic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;response to chemical stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;signal transduction,cell part;cytosol;macromolecular complex;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
Q15257,PPP2R4,"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')",5,19.7,28.96,29.74,28.96,29.82,28.17,27.47,28.4,28.6,27.18,26.57,28.46,28.81,26.91,28.31,0.65,1.43,0.65,1.51,-0.14,-0.84,0.09,0.29,-1.13,-1.74,0.15,0.5,-1.4,biological regulation;catabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;protein folding;protein metabolic process;regulation of protein modification process;small molecule metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
Q13362,PPP2R5C,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29),4,7.5,27.27,26.7,24.13,26.24,27.15,26.54,28.39,28.18,26.22,25.58,29.13,26.36,27.37,26.87,0.4,-0.16,-2.74,-0.63,0.28,-0.33,1.52,1.32,-0.64,-1.28,2.27,-0.5,0.5,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
Q14738,PPP2R5D,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),16,36.7,26.63,28.21,27.6,29.39,29.54,28.84,29.41,29.77,27.59,27.46,29.26,29.62,27.83,28.55,-1.92,-0.34,-0.95,0.84,0.99,0.29,0.86,1.22,-0.96,-1.09,0.72,1.07,-0.72,alcohol metabolic process;anatomical structure development;biological regulation;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;immune system process;metabolic process;primary metabolic process;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
Q86XZ2,PPP2R5E,PPP2R5E protein (Fragment),7,16.6,26.98,27.59,26.4,27.31,24.44,26.31,26.92,26.11,26.61,26.94,28.34,27.5,25.95,26.72,0.26,0.87,-0.32,0.58,-2.28,-0.41,0.19,-0.62,-0.11,0.21,1.62,0.78,-0.77,biological regulation;cellular process;response to stimulus;signal transduction,cell part;macromolecular complex;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
Q08209,PPP3CA,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform),13,25,30.26,30.02,29.47,30.06,30.06,29.48,30.51,30.82,30.75,29.77,30.62,29.39,30.11,30.1,0.16,-0.08,-0.63,-0.04,-0.04,-0.62,0.4,0.71,0.65,-0.33,0.52,-0.71,0.01,anatomical structure development;biological regulation;cell activation;cell development;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;immune system process;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;nuclear transport;nucleocytoplasmic transport;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;protein targeting;protein transport;regulation of transport;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
P16298,PPP3CB,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform),3,7.9,,26.67,,26.31,25.74,24.27,26.79,26,24.46,24.43,23.46,26.2,23.98,25.3, ,1.37, ,1.01,0.44,-1.03,1.49,0.7,-0.84,-0.87,-1.84,0.9,-1.32,anatomical structure development;behavior;behavioral interaction between organisms;biological regulation;cell activation;cell differentiation;cell growth;cell proliferation;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;growth;homeostatic process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;neurological system process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;protein phosphorylation;regulation of transport;response to chemical stimulus;response to drug;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
P63098,PPP3R1,Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1),5,8,26.11,27.74,27.26,27.16,27.19,27.05,27.57,27.5,27.01,27.2,28.4,29.16,28.07,27.49,-1.39,0.25,-0.23,-0.34,-0.3,-0.44,0.07,0.01,-0.48,-0.29,0.9,1.67,0.57,,cell part;cytosol;macromolecular complex;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
P60510,PPP4C,Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X),7,24.1,28.46,27.57,28.15,28.55,29.06,28.18,29.19,29.55,29.32,28.31,26.98,27.71,27.82,28.37,0.08,-0.81,-0.23,0.17,0.69,-0.19,0.82,1.18,0.95,-0.06,-1.39,-0.66,-0.55,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of DNA metabolic process,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;nucleus;organelle;plasma membrane;protein complex;protein serine/threonine phosphatase complex,,,+,,,,,,,
Q9NY27,PPP4R2,Serine/threonine-protein phosphatase 4 regulatory subunit 2,8,29,28.09,27.63,28.45,27.45,29.22,28.63,28.95,28.51,29.08,27.94,26.08,27.47,27.89,28.11,-0.02,-0.48,0.35,-0.66,1.11,0.52,0.84,0.41,0.97,-0.16,-2.03,-0.64,-0.22,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification process;regulation of DNA metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
Q9BPW0,PPP5C,Serine/threonine-protein phosphatase (EC 3.1.3.16) (Fragment),10,26.7,28.91,27.74,28.04,28.64,27.59,26.39,28.99,28.68,26.42,26.53,27.96,28.65,,27.88,1.03,-0.14,0.16,0.76,-0.29,-1.49,1.11,0.8,-1.46,-1.35,0.08,0.77, ,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O00743,PPP6C,Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16),5,21,26.67,28.34,28.77,28.5,27.13,27.48,29.12,28.61,24.26,28.21,27.78,27.94,27.76,27.74,-1.07,0.6,1.04,0.76,-0.6,-0.25,1.38,0.87,-3.47,0.47,0.05,0.21,0.02,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process,cell part;cytosol,,,+,,,,,,,
Q5H9R7,PPP6R3,Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL),12,19.5,26.93,28.01,25.53,28.04,26.47,27.32,27.66,26.3,26.45,26.39,28.21,28.35,24.83,26.96,-0.03,1.05,-1.43,1.08,-0.49,0.36,0.7,-0.66,-0.51,-0.57,1.25,1.39,-2.13,biological regulation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P50897,PPT1,Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1),7,31.4,30.09,30.07,30.04,30.05,30.23,30.28,29.54,29.45,30.58,29.79,29.1,29.61,29.97,29.91,0.18,0.16,0.13,0.15,0.32,0.38,-0.37,-0.46,0.67,-0.12,-0.81,-0.3,0.06,anatomical structure development;behavior;biological regulation;catabolic process;cell development;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;cofactor transport;developmental process;DNA metabolic process;endocytosis;establishment of localization;homeostatic process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;neurological system process;neurotransmitter transport;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein catabolic process;protein metabolic process;protein modification process;protein transport;regulation of transport;response to stimulus;secretion;transport;vesicle-mediated transport,cell body;cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;extracellular region;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;neuron projection;neuronal cell body;nucleus;organelle;vacuole;vesicle,,,,,,,,,,
O60828,PQBP1,Polyglutamine-binding protein 1 (PQBP-1) (38 kDa nuclear protein containing a WW domain) (Npw38) (Polyglutamine tract-binding protein 1),4,46.7,27.85,23.6,26.9,26.59,26.55,24.03,25.77,26.54,25.61,26.23,,26.42,,26.01,1.84,-2.41,0.89,0.58,0.54,-1.98,-0.24,0.54,-0.4,0.22, ,0.41, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
O60831,PRAF2,PRA1 family protein 2,7,38.2,27.82,30.22,28.64,29.57,30.51,29.99,28.66,30.27,30.24,28.86,30.88,29.76,31.17,29.74,-1.92,0.48,-1.1,-0.16,0.77,0.25,-1.08,0.53,0.51,-0.88,1.14,0.02,1.43,amine transport;amino acid transport;establishment of localization;ion transport;organic acid transport;protein transport;transport,cell part;membrane,,,,,,,,,,
Q92733,PRCC,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),8,37,28.39,23.54,28.14,26.49,25.49,25.06,25.9,25.92,26.14,25.26,,,24.78,25.92,2.47,-2.38,2.22,0.57,-0.43,-0.86,-0.02,0,0.23,-0.66, , ,-1.14,biological regulation;cell cycle;cellular process;regulation of cell cycle;regulation of mitotic cell cycle,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P42785,PRCP,Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP),13,29.4,30.13,31.21,29.94,29.94,29.49,30.52,28.7,28.61,29.89,27.78,29.54,28.92,30.64,29.64,0.49,1.57,0.3,0.3,-0.15,0.88,-0.94,-1.03,0.25,-1.86,-0.1,-0.72,1,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to stimulus,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole,,,,,,,,,,
Q06830,PRDX1,Peroxiredoxin-1 (EC 1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2),28,79.9,34.62,34.84,34.46,34.93,34.56,34.32,35.1,34.72,34.05,34.21,35.48,34.87,33.92,34.62,0,0.22,-0.16,0.31,-0.06,-0.3,0.48,0.1,-0.58,-0.41,0.85,0.25,-0.7,anatomical structure development;biological regulation;catabolic process;cell killing;cell proliferation;cellular metabolic process;cellular process;developmental process;homeostatic process;immune system process;metabolic process;regulation of transport;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;nucleus;organelle;vesicle,,,,,,,,,,
P32119,PRDX2,Peroxiredoxin-2 (EC 1.11.1.15) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1),17,73.7,32.16,33.12,32.55,32.16,31.15,31.02,32.48,32.19,29.92,31.07,32.91,32.17,30.38,31.79,0.37,1.33,0.76,0.37,-0.64,-0.77,0.69,0.4,-1.87,-0.72,1.12,0.38,-1.41,biological regulation;catabolic process;cellular metabolic process;cellular process;metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;cytoplasm;cytosol,,,,,,,,,,
P30048,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.15) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog)",18,50.4,33.35,33.71,33.86,33.37,33.37,33.94,33.89,33.61,34.03,34.25,33.93,34.21,34.08,33.82,-0.47,-0.1,0.05,-0.45,-0.44,0.12,0.07,-0.2,0.22,0.43,0.11,0.39,0.26,anatomical structure development;biological regulation;catabolic process;cell differentiation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;developmental process;homeostatic process;metabolic process;mitochondrion organization;organelle organization;response to biotic stimulus;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q13162,PRDX4,Peroxiredoxin-4 (EC 1.11.1.15) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372),19,62,30.63,33.16,31.27,32.75,32.34,32.95,32.06,32.22,32.68,31.72,32.75,32.1,33.2,32.29,-1.66,0.86,-1.02,0.46,0.05,0.65,-0.23,-0.07,0.38,-0.58,0.46,-0.2,0.91,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P30044,PRDX5,"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)",16,79.6,33.8,33.49,33.35,32.25,31.72,32.34,32.46,32.2,32.94,33.16,32.92,33.15,32.31,32.78,1.02,0.72,0.58,-0.53,-1.06,-0.43,-0.32,-0.57,0.16,0.38,0.14,0.37,-0.46,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;microbody;mitochondrion;nucleus;organelle;peroxisome;vesicle,,,,,,,,,,
P30041,PRDX6,Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.-) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (EC 1.11.1.9) (Red blood cells page spot 12),29,88.4,34.74,34.3,33.38,34.08,32.49,32.34,33.05,33.51,32.04,31.39,33.43,34.26,31.26,33.1,1.64,1.2,0.28,0.98,-0.61,-0.76,-0.05,0.41,-1.06,-1.71,0.34,1.16,-1.84,catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole;vesicle,,,,,,,,,,
Q9HCU5,PREB,Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12),7,25.7,29.34,29.85,27.92,29.48,28.95,29.13,28.08,27.82,30.04,28.81,29.17,25.7,29.69,28.77,0.57,1.08,-0.85,0.72,0.18,0.36,-0.69,-0.94,1.27,0.05,0.4,-3.07,0.92,biological regulation;biosynthetic process;carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;regulation of protein modification process;RNA metabolic process;transport;vesicle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,Other TF domain,,,,,,,,,
P48147,PREP,Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme),25,43.5,32.29,29.67,29.31,29.51,28.01,27.05,29.26,28.49,27.35,26.71,29.01,30.05,25.52,28.63,3.65,1.04,0.68,0.87,-0.63,-1.59,0.63,-0.14,-1.28,-1.93,0.38,1.42,-3.11,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q13131,PRKAA1,5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26),12,25.4,29.34,27.97,28.36,27.81,27.6,26,27.99,28.54,26.72,27.51,27.91,27.61,22.15,27.35,1.99,0.62,1.01,0.46,0.26,-1.34,0.64,1.2,-0.63,0.16,0.56,0.26,-5.2,alcohol metabolic process;autophagy;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell communication;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;homeostatic process;lipid metabolic process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to starvation;response to stimulus;response to stress;rhythmic process;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,+,,,,,,,,
Q9Y478,PRKAB1,5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb),6,32.2,27.75,26.69,26.28,24.2,26.06,24.88,25.55,26.98,25.87,24.44,25.85,24.61,24.88,25.7,2.06,1,0.58,-1.49,0.36,-0.81,-0.15,1.28,0.18,-1.26,0.15,-1.09,-0.81,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular process;lipid metabolic process;macromolecular complex assembly;membrane organization;metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;regulation of cell cycle;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P17612,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11),9,22.7,28.18,29.08,30.01,29.03,27.9,27.6,28.47,28.54,28.14,27.91,28.37,27.89,27.12,28.33,-0.15,0.76,1.68,0.7,-0.42,-0.73,0.14,0.21,-0.18,-0.42,0.04,-0.43,-1.2,alcohol metabolic process;anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cell maturation;cellular homeostasis;cellular lipid metabolic process;cellular metabolic process;cellular process;coagulation;developmental maturation;developmental process;energy reserve metabolic process;establishment of localization;fluid transport;generation of precursor metabolites and energy;glycerol ether metabolic process;homeostatic process;immune system process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;regulation of cell cycle;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;mitochondrion;nucleus;organelle;plasma membrane;protein complex;synapse,,+,,,,,,,,
P10644,PRKAR1A,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1) [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed]",19,44.4,29.77,31.39,31.38,31.55,30.52,29.94,30.17,30.69,29.47,29.02,31.17,30.97,29.36,30.42,-0.64,0.97,0.96,1.13,0.11,-0.47,-0.25,0.28,-0.95,-1.39,0.76,0.56,-1.06,biological regulation;cellular metabolic process;cellular process;coagulation;energy reserve metabolic process;establishment of localization;fluid transport;generation of precursor metabolites and energy;immune system process;metabolic process;multicellular organismal process;regulation of body fluid levels;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P13861,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21,61.5,30.09,30.28,30.14,29.74,30.07,30.28,30.02,30.07,29.95,29.79,30.65,30.41,30.68,30.17,-0.08,0.11,-0.02,-0.43,-0.1,0.11,-0.15,-0.09,-0.22,-0.38,0.48,0.24,0.51,biological regulation;cellular metabolic process;cellular process;coagulation;energy reserve metabolic process;establishment of localization;fluid transport;generation of precursor metabolites and energy;immune system process;metabolic process;multicellular organismal process;regulation of body fluid levels;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;organelle;plasma membrane;protein complex,,,,,,,,,,
P17252,PRKCA,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),8,15,26.57,27.19,27.26,26.35,26.63,25.49,26.51,,25.21,,,27.79,25.18,26.42,0.15,0.77,0.84,-0.07,0.21,-0.92,0.09, ,-1.21, , ,1.37,-1.24,anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell communication;cell differentiation;cell junction organization;cell motility;cell-cell signaling;cellular component assembly;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;energy reserve metabolic process;generation of precursor metabolites and energy;homeostatic process;immune system process;locomotion;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;signaling;small molecule metabolic process,cell body;cell part;cell projection;cilium;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;neuronal cell body;nucleoplasm;organelle;plasma membrane,,+,,,,,,,,
Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],14,20.3,29.49,26.78,28.96,26.19,28.33,26.21,26.85,26.8,26.3,25.4,27.95,25.6,26.97,27.06,2.43,-0.28,1.9,-0.87,1.27,-0.85,-0.22,-0.26,-0.76,-1.67,0.89,-1.46,-0.1,aging;amine transport;amino acid transport;biological regulation;cell activation;cell communication;cell cycle;cell proliferation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytokine production;developmental process;establishment of localization;immune system process;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid transport;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;regulation of protein modification process;regulation of protein stability;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to heat;response to oxidative stress;response to starvation;response to stimulus;response to stress;RNA metabolic process;signal transduction;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleoplasm;organelle;plasma membrane,,+,,,,,,,,
Q969G5,PRKCDBP,Protein kinase C delta-binding protein (Cavin-3) (Serum deprivation response factor-related gene product that binds to C-kinase) (hSRBC),12,62.1,24.58,30.09,26.86,29.46,30.36,30.84,30.42,29.88,30.71,29.19,29.71,25.1,31.04,29.1,-4.51,0.99,-2.23,0.36,1.27,1.75,1.33,0.79,1.61,0.09,0.61,-3.99,1.94,,,,,,,,,,,,
P41743,PRKCI,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),10,32.2,30.12,27.08,28.23,28.32,27.16,26.77,29.18,28.8,26.9,28.9,28.5,28.96,26.15,28.08,2.04,-1,0.15,0.24,-0.92,-1.31,1.1,0.71,-1.18,0.82,0.41,0.87,-1.93,anatomical structure development;biological regulation;cell development;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;developmental process;establishment of localization;establishment or maintenance of cell polarity;locomotion;membrane organization;organelle organization;protein targeting;protein transport;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;signal transduction;transport;vesicle organization;vesicle-mediated transport,cell leading edge;cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;polarisome;protein complex,,+,,,,,,,,
K7ELL7,PRKCSH,Glucosidase 2 subunit beta,39,68.2,34.66,34.62,35.07,33.86,33.21,33.36,33.36,32.87,34.06,34.37,33.82,32.25,33.37,33.76,0.9,0.86,1.31,0.1,-0.55,-0.4,-0.4,-0.89,0.3,0.61,0.06,-1.51,-0.39,carbohydrate metabolic process;metabolic process;oligosaccharide metabolic process;primary metabolic process,,,,,,,,,,,
Q9BZL6,PRKD2,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),7,13.1,27.53,27.49,,25.32,26.68,25.36,25.61,24.97,,26.81,25,25.12,,25.99,1.54,1.5, ,-0.67,0.69,-0.63,-0.38,-1.02, ,0.82,-0.99,-0.87, ,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell death;cellular metabolic process;cellular process;death;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of DNA metabolic process;regulation of protein modification process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoplasm;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,+,,,,,,,,
P78527,PRKDC,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460),216,49.3,35.11,34.68,34.31,34.4,34.71,35.3,34.75,34.33,35.36,35.3,33.61,34.1,34.84,34.68,0.44,0,-0.37,-0.28,0.03,0.62,0.07,-0.35,0.69,0.62,-1.06,-0.58,0.16,anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;cell activation;cell death;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;death;developmental process;DNA metabolic process;DNA recombination;DNA repair;homeostatic process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein stability;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;telomere organization,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;transcription factor complex,,+,,,,,,,,
O75569,PRKRA,"Interferon-inducible double stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double stranded RNA-dependent activator)",11,37.1,29.41,29.09,28.87,29.04,29.09,28.48,29.18,29.15,28,28.17,29.24,28.63,27.05,28.72,0.69,0.37,0.14,0.31,0.37,-0.24,0.45,0.43,-0.73,-0.55,0.51,-0.09,-1.67,anatomical structure morphogenesis;biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing,cell part;cytosol,,,,,,,,,,
Q99873,PRMT1,Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) (Interferon receptor 1-bound protein 4),20,56.9,32.34,31.73,32.31,31.96,32.33,32.23,32.25,31.89,32.71,32.69,31.6,31.34,32.13,32.12,0.23,-0.39,0.19,-0.16,0.21,0.12,0.13,-0.22,0.59,0.58,-0.52,-0.78,0.02,biological regulation;cellular component organization;cellular process;developmental process;embryo development;response to stimulus;signal transduction,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleus;organelle;protein complex,,,,,,,,,,
O14744,PRMT5,"Protein arginine N-methyltransferase 5 (EC 2.1.1.-) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (EC 2.1.1.125) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]",16,28.4,30.07,29.67,29.3,30.18,30.09,30.04,30.42,30.83,29.28,29.41,30.16,30.4,28.76,29.89,0.18,-0.22,-0.59,0.29,0.2,0.15,0.53,0.94,-0.62,-0.48,0.26,0.5,-1.13,biological regulation;biosynthetic process;cell activation;cell proliferation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;ribonucleoprotein complex assembly;RNA metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9UNN8,PROCR,Endothelial protein C receptor (Activated protein C receptor) (APC receptor) (Endothelial cell protein C receptor) (CD antigen CD201),3,15.1,,27.7,27.85,27.67,28.68,29.75,27.47,27.62,28.5,26.12,28.64,31.06,29.72,28.4, ,-0.69,-0.55,-0.73,0.28,1.35,-0.93,-0.77,0.1,-2.28,0.24,2.66,1.32,biological regulation;coagulation;immune system process;multicellular organismal process;regulation of body fluid levels;response to stimulus,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;MHC protein complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
O94903,PROSC,Proline synthase co-transcribed bacterial homolog protein,5,20.7,27.82,28.42,28.81,28.45,27.3,27.49,28.43,28.41,27.36,27.55,29.1,28.2,26.73,28.01,-0.19,0.41,0.81,0.44,-0.7,-0.51,0.42,0.4,-0.65,-0.46,1.09,0.2,-1.27,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9UMS4,PRPF19,Pre-mRNA-processing factor 19 (Nuclear matrix protein 200) (PRP19/PSO4 homolog) (hPso4) (Senescence evasion factor),21,49.2,32.23,32.14,32.15,31.81,32.74,32.36,31.66,31.53,32.23,31.97,30.96,30.47,31.83,31.85,0.38,0.29,0.3,-0.05,0.89,0.51,-0.19,-0.32,0.37,0.12,-0.89,-1.39,-0.03,biological regulation;biosynthetic process;cell proliferation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;lipid metabolic process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;ribonucleoprotein complex assembly,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;lipid particle;macromolecular complex;organelle;protein complex;ribonucleoprotein complex;spliceosomal complex;ubiquitin ligase complex,,,,,,,,,,
O43395,PRPF3,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3) (hPrp3) (U4/U6 snRNP 90 kDa protein),20,35.9,29.44,28.9,30.13,29.41,29.53,28.78,29.57,27.14,28.96,29.22,28.27,26.51,28.17,28.77,0.67,0.13,1.36,0.64,0.76,0.01,0.8,-1.63,0.19,0.45,-0.51,-2.26,-0.6,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q8WWY3,PRPF31,U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31),9,24.9,29.77,28.61,28.91,28.69,29.46,29.26,29.05,27.87,29.07,28.29,27.53,28.75,27.76,28.69,1.08,-0.09,0.22,-0.01,0.76,0.57,0.36,-0.82,0.37,-0.4,-1.17,0.05,-0.93,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;histone methyltransferase complex;macromolecular complex;protein complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q8NAV1,PRPF38A,Pre-mRNA-splicing factor 38A,12,41.3,28.87,28.37,27.87,28.02,28.85,28.19,26.78,27.63,29.14,28.3,25.95,22.67,26.83,27.5,1.38,0.87,0.37,0.52,1.35,0.69,-0.72,0.13,1.65,0.8,-1.54,-4.82,-0.66,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q5VTL8,PRPF38B,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),9,12.3,27.25,27.5,26.17,25.64,,24,25.04,,26.76,25.7,,25.29,,25.93,1.32,1.57,0.24,-0.28, ,-1.92,-0.89, ,0.83,-0.23, ,-0.64, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O43172,PRPF4,U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog) (hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4),17,41.3,30.43,30,30.06,29.86,30.29,29.95,30.1,29.4,30.34,29.98,28.53,29.4,28.52,29.76,0.67,0.24,0.3,0.1,0.53,0.19,0.34,-0.35,0.58,0.22,-1.23,-0.36,-1.24,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),26,23.7,31.17,30.23,30,30.22,31.09,31.2,30.29,30.1,30.42,30.7,28.66,29.6,30.24,30.3,0.87,-0.07,-0.3,-0.08,0.79,0.89,-0.01,-0.2,0.12,0.4,-1.64,-0.7,-0.06,biological regulation;cell cycle;cell division;cell motility;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;locomotion;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part,,,,,,,,,,
Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),43,35.2,31.14,30.59,30.61,29.24,29.78,30.18,29.96,29.34,30.4,30.04,28.48,29.41,29.44,29.89,1.24,0.7,0.71,-0.65,-0.12,0.29,0.06,-0.55,0.51,0.15,-1.41,-0.49,-0.45,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;spliceosomal complex,,+,,,,,,,,
O94906,PRPF6,Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein),33,39.3,31.06,30.6,30.79,30.53,31.09,30.37,30.61,31.19,31.14,30.75,32.11,30.15,29.74,30.78,0.28,-0.18,0.01,-0.25,0.31,-0.41,-0.17,0.41,0.36,-0.03,1.33,-0.63,-1.04,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;localization;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q6P2Q9,PRPF8,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),101,47.3,33.37,32.87,32.57,32.83,33.01,33.32,33.01,32.65,33.7,33.31,31.72,32.25,32.6,32.86,0.51,0.01,-0.3,-0.03,0.15,0.46,0.15,-0.21,0.83,0.45,-1.14,-0.61,-0.26,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P60891,PRPS1,Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase I) (PRS-I),9,32.4,28.65,30.31,29.64,30.54,30.01,29.38,30.4,30.16,28.99,28.96,29.79,30.59,28.64,29.7,-1.05,0.61,-0.05,0.84,0.31,-0.32,0.7,0.46,-0.71,-0.73,0.09,0.9,-1.05,alcohol metabolic process;anatomical structure development;biosynthetic process;carbohydrate metabolic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;pigment metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q14558,PRPSAP1,Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39),4,15.4,25.14,26.58,26.08,27.39,26.42,27.2,26.71,27.61,24.99,,24.81,26.77,25.45,26.26,-1.12,0.32,-0.19,1.13,0.16,0.94,0.45,1.34,-1.27, ,-1.45,0.51,-0.81,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,macromolecular complex;protein complex,,,,,,,,,,
O60256,PRPSAP2,Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41),6,35.8,24.98,25.89,26.04,26.82,27.8,,27.64,27.78,,,26.38,25.9,,26.58,-1.6,-0.69,-0.54,0.24,1.21, ,1.05,1.2, , ,-0.2,-0.68, ,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,macromolecular complex;protein complex,,,,,,,,,,
Q96M27,PRRC1,Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1),4,14.2,29.14,29.36,28.51,29.55,28.36,29.33,28.87,29.1,29.9,28.6,29.47,30.26,29.27,29.21,-0.07,0.15,-0.7,0.34,-0.85,0.12,-0.33,-0.11,0.69,-0.61,0.26,1.05,0.06,,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),22,11.2,27.48,25.89,28.19,27.97,27.45,26.16,26.81,27.73,24,26.15,25.9,27.39,23.97,26.55,0.94,-0.65,1.64,1.42,0.91,-0.38,0.27,1.18,-2.55,-0.4,-0.64,0.84,-2.58,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q5JSZ5,PRRC2B,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),10,5.6,25.63,26.33,,24.9,,,24.73,26.02,22.13,24.78,26.4,25.69,,25.18,0.45,1.15, ,-0.28, , ,-0.45,0.84,-3.05,-0.39,1.22,0.51, ,,,,,,,,,,,,
Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),36,17.5,29.94,28.17,29.43,29.14,27.42,28.58,29.68,27.98,27.57,29.14,28.36,29.3,27.53,28.63,1.31,-0.46,0.79,0.51,-1.22,-0.05,1.04,-0.65,-1.07,0.51,-0.28,0.67,-1.1,,,,,,,,,,,,
Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),20,10,25.13,21.42,20.94,27.77,24.01,,24.85,25.89,26.4,25.59,27.98,26.58,25.54,25.17,-0.04,-3.76,-4.24,2.59,-1.16, ,-0.33,0.71,1.23,0.42,2.8,1.4,0.37,cell death;cellular process;death,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P07602,PSAP,Proactivator polypeptide [Cleaved into: Saposin-A (Protein A);Saposin-B-Val;Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator);Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2);Saposin-D (Component C) (Protein C)],19,31.5,33.7,34.96,35.39,33.08,30.84,32.66,33.52,31.37,33.87,35.01,34.21,34.73,33.57,33.61,0.09,1.35,1.78,-0.53,-2.77,-0.95,-0.09,-2.24,0.26,1.4,0.6,1.12,-0.04,biological regulation;cell activation;cell differentiation;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;growth;lipid metabolic process;lipid transport;metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;secretion;small molecule metabolic process;transport;vesicle-mediated transport,cell part;extracellular space;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9Y617,PSAT1,Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT),20,57.3,33.65,29.14,27.5,30.28,29.1,29.18,28.11,30.4,27.28,28.27,28.15,26.67,26.13,28.76,4.9,0.38,-1.26,1.52,0.34,0.42,-0.65,1.64,-1.48,-0.49,-0.61,-2.09,-2.62,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
P49768,PSEN1,Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit;Presenilin-1 CTF subunit;Presenilin-1 CTF12 (PS1-CTF12)],3,10.9,,21.87,,,,22.6,21.25,23.23,23.23,,25.01,26.16,24.57,23.49, ,-1.62, , , ,-0.89,-2.24,-0.26,-0.26, ,1.52,2.67,1.08,amine transport;amino acid transport;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;behavior;biological adhesion;biological regulation;carbohydrate metabolic process;catabolic process;cell activation;cell adhesion;cell death;cell development;cell differentiation;cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;death;developmental process;establishment of localization;growth;homeostatic process;immune system process;ion transport;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;molting cycle;multicellular organismal process;neurological system process;organelle assembly;organelle organization;organic acid transport;phosphorus metabolic process;post-embryonic development;primary metabolic process;protein glycosylation;protein maturation;protein metabolic process;protein modification process;protein phosphorylation;protein transport;proteolysis;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;transport;vacuole organization,cell body;cell cortex;cell part;cell projection;cell surface;centrosome;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;microtubule organizing center;neuron projection;neuronal cell body;organelle;protein complex;site of polarized growth;synapse;vesicle,,,,,,,,,,
P49810,PSEN2,Presenilin-2 (PS-2) (EC 3.4.23.-) (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit;Presenilin-2 CTF subunit],3,30.2,,22.28,24.35,22.31,,,,20.11,,20.03,20.7,23.83,20.53,21.77, ,0.51,2.58,0.54, , , ,-1.65, ,-1.74,-1.07,2.06,-1.24,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;behavior;biological regulation;catabolic process;cell activation;cell differentiation;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;developmental process;establishment of localization;growth;homeostatic process;immune system process;ion transport;locomotion;macromolecule metabolic process;metabolic process;molting cycle;multicellular organismal process;muscle contraction;neurological system process;primary metabolic process;protein maturation;protein metabolic process;protein transport;proteolysis;regulation of protein modification process;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell body;cell cortex;cell part;cell projection;cell surface;centrosome;cytosol;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;microtubule organizing center;neuron projection;neuronal cell body;organelle;protein complex;site of polarized growth;synapse,,,,,,,,,,
O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),21,40.4,29.92,29.44,29.97,29.25,30.79,30.37,30.86,30.18,30.49,29.43,29.35,30.54,29.03,29.97,-0.05,-0.53,0,-0.72,0.82,0.4,0.89,0.21,0.52,-0.54,-0.62,0.57,-0.94,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to heat;response to oxidative stress;response to stimulus;response to stress;ribonucleoprotein complex assembly;RNA metabolic process,cell part;cytosol;nucleoplasm,Other TF domain,,,,,,,,,
P25786,PSMA1,Proteasome subunit alpha type-1 (EC 3.4.25.1) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain),22,78.3,32.01,32.43,32.56,32.75,32.95,32.69,32.75,33.15,32.29,32.22,32.39,31.8,32.23,32.48,-0.47,-0.05,0.08,0.27,0.47,0.21,0.28,0.67,-0.19,-0.26,-0.09,-0.68,-0.24,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleoplasm;organelle;polysome;protein complex;ribonucleoprotein complex,,,,,,,,,,
P25787,PSMA2,Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3),10,49.6,30.99,31.44,31.44,31.93,31.85,31.18,31.68,32.14,31.24,31.28,31.13,31.35,31.35,31.46,-0.47,-0.02,-0.02,0.47,0.39,-0.28,0.21,0.68,-0.22,-0.18,-0.33,-0.11,-0.11,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to biotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
P25788,PSMA3,Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8),21,58.1,32.11,32.36,32.18,32.6,32.75,32.66,32.88,33.18,32.18,32.18,32.52,32.55,32.31,32.5,-0.38,-0.14,-0.32,0.1,0.26,0.17,0.38,0.68,-0.32,-0.32,0.03,0.05,-0.19,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P25789,PSMA4,Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L),16,66.3,30.77,31.81,31.82,31.62,31.81,31.42,31.61,31.8,30.98,31.58,31.96,31.3,31.2,31.51,-0.75,0.3,0.31,0.1,0.3,-0.1,0.09,0.28,-0.53,0.07,0.45,-0.22,-0.31,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
P28066,PSMA5,Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain),15,56.8,31.85,32.04,32.5,32.19,31.27,31.12,32.34,31.8,31.9,32.13,32.24,31.84,31.9,31.93,-0.08,0.1,0.57,0.26,-0.67,-0.81,0.41,-0.13,-0.03,0.2,0.31,-0.09,-0.03,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P60900,PSMA6,Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain),16,60.6,31.89,32.3,32.81,32.44,32.57,32.4,32.37,32.41,31.94,32.19,32.23,32.47,32.42,32.34,-0.45,-0.04,0.47,0.09,0.23,0.06,0.03,0.07,-0.4,-0.15,-0.11,0.13,0.08,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleoplasm;organelle;polysome;protein complex;ribonucleoprotein complex,,,,,,,,,,
O14818,PSMA7,Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7),21,64.1,31.57,32.34,32.65,32.55,32.75,32.48,32.45,32.53,32.49,32.25,32.69,31.68,32.44,32.37,-0.81,-0.03,0.27,0.18,0.37,0.11,0.07,0.16,0.12,-0.12,0.32,-0.69,0.06,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P20618,PSMB1,Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain),14,61.8,31.63,32.32,32.28,32.39,32.08,31.85,32.06,32.05,31.99,32.05,32.1,31.67,31.87,32.03,-0.4,0.29,0.26,0.37,0.06,-0.18,0.03,0.02,-0.04,0.02,0.07,-0.35,-0.15,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P40306,PSMB10,Proteasome subunit beta type-10 (EC 3.4.25.1) (Low molecular mass protein 10) (Macropain subunit MECl-1) (Multicatalytic endopeptidase complex subunit MECl-1) (Proteasome MECl-1) (Proteasome subunit beta-2i),7,29.3,28.94,29.02,29.23,26.7,,,24.59,,25.2,,27.55,25.67,25.75,26.96,1.98,2.06,2.27,-0.26, , ,-2.37, ,-1.76, ,0.59,-1.29,-1.21,anatomical structure morphogenesis;biological regulation;catabolic process;cell activation;cell death;cell morphogenesis;cell proliferation;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P49721,PSMB2,Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I),13,60.2,30.8,31.57,30.66,31.56,32.09,31.43,31.74,31.78,31.31,31.46,31.74,31.67,31.19,31.46,-0.66,0.1,-0.8,0.09,0.63,-0.03,0.27,0.32,-0.15,0,0.28,0.2,-0.27,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P49720,PSMB3,Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain),12,58,30.34,31.31,31.26,31.42,31.59,30.35,31.27,31.13,30.72,30.98,30.73,31.12,30.7,30.99,-0.66,0.31,0.27,0.43,0.6,-0.64,0.28,0.14,-0.27,-0.02,-0.26,0.12,-0.3,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P28070,PSMB4,Proteasome subunit beta type-4 (EC 3.4.25.1) (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3),9,44.7,29.29,30.44,30.17,30.15,31.13,30.32,30.51,31.26,30.2,30.52,29.91,30.68,29.73,30.33,-1.04,0.11,-0.16,-0.19,0.8,-0.01,0.18,0.93,-0.13,0.19,-0.42,0.35,-0.6,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P28074,PSMB5,Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit MB1) (Proteasome subunit X),13,43.7,29.6,31.63,29.66,32.57,31.91,32.12,32.26,32.65,31.95,31.27,32.09,29.79,30.86,31.41,-1.82,0.22,-1.75,1.16,0.5,0.71,0.84,1.23,0.54,-0.14,0.68,-1.62,-0.56,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P28072,PSMB6,Proteasome subunit beta type-6 (EC 3.4.25.1) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y),8,33.9,29.36,30.49,27.91,30.89,31.37,31.27,31.43,31.57,30.61,30.9,31.54,30.3,31.16,30.68,-1.32,-0.19,-2.77,0.21,0.69,0.6,0.75,0.89,-0.06,0.22,0.86,-0.38,0.48,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q99436,PSMB7,Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z),10,41.9,30.04,31,30.51,31.51,31.11,31.56,31.64,31.83,30.97,30.75,31.82,32.15,31.42,31.25,-1.21,-0.26,-0.74,0.25,-0.15,0.31,0.38,0.58,-0.28,-0.5,0.56,0.89,0.16,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P28062,PSMB8,Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein),13,54.4,31.31,31.56,32.45,30.47,29.26,29.28,30.02,29.23,29.65,30.88,29.01,30.04,28.38,30.12,1.19,1.45,2.33,0.35,-0.86,-0.84,-0.1,-0.89,-0.47,0.76,-1.11,-0.08,-1.74,biological regulation;catabolic process;cell death;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P28065,PSMB9,Proteasome subunit beta type-9 (EC 3.4.25.1) (Low molecular mass protein 2) (Macropain chain 7) (Multicatalytic endopeptidase complex chain 7) (Proteasome chain 7) (Proteasome subunit beta-1i) (Really interesting new gene 12 protein),4,20.9,29.27,28.78,29.05,28.55,,25.34,27.02,27.91,,25.47,25.81,,,27.47,1.8,1.32,1.58,1.08, ,-2.13,-0.44,0.45, ,-1.99,-1.66, , ,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P62191,PSMC1,26S protease regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1),28,67.7,31.16,31.64,31.66,32.33,31.87,32.16,32.45,32.11,31.77,31.94,32.08,32.49,32.1,31.98,-0.82,-0.35,-0.32,0.34,-0.11,0.18,0.47,0.13,-0.21,-0.04,0.09,0.51,0.12,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P35998,PSMC2,26S protease regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1),38,78.8,31.9,32.25,32.35,32.7,32.91,32.21,32.67,32.47,31.86,31.59,32.09,32.85,32,32.29,-0.4,-0.05,0.05,0.4,0.62,-0.09,0.37,0.17,-0.43,-0.7,-0.21,0.55,-0.3,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;viral reproduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleoplasm;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
P17980,PSMC3,26S protease regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1),28,61.3,31.63,31.58,32.26,31.7,32.16,31.8,32.2,32.07,31.44,31.91,31.93,31.78,32.15,31.89,-0.26,-0.31,0.36,-0.19,0.27,-0.09,0.31,0.17,-0.45,0.01,0.03,-0.11,0.25,anatomical structure development;biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;viral reproduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
P43686,PSMC4,26S protease regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7) (TBP-7),28,72.2,31.42,31.91,31.45,32.13,32.52,31.83,32.09,32.36,31.73,31.49,32.08,32,31.65,31.9,-0.48,0.01,-0.45,0.23,0.62,-0.07,0.19,0.47,-0.17,-0.41,0.18,0.1,-0.25,anatomical structure development;biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;viral reproduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleoplasm;organelle;protein complex,,,,,,,,,,
P62195,PSMC5,26S protease regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG),32,78.1,31.57,32.01,32.27,32.53,32.48,32.22,32.6,32.32,32.06,32.09,32.46,32.63,31.94,32.24,-0.67,-0.24,0.02,0.28,0.24,-0.02,0.36,0.07,-0.19,-0.16,0.21,0.39,-0.3,biological regulation;biosynthetic process;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter;viral reproduction,cell part;cytosol;intracellular organelle;macromolecular complex;nucleoplasm;organelle;proteasome complex;protein complex;vesicle,,,,,,,,,,
P62333,PSMC6,26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),22,67.6,31.65,31.67,31.42,31.95,32.15,31.74,32.01,31.98,31.72,31.19,31.7,31.75,31.49,31.72,-0.07,-0.06,-0.31,0.22,0.43,0.02,0.28,0.26,-0.01,-0.53,-0.02,0.02,-0.23,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;viral reproduction,cell part;cytosol;macromolecular complex;membrane;nucleoplasm;plasma membrane;protein complex,,,,,,,,,,
Q99460,PSMD1,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112),38,46.6,31.49,31.8,31.59,32.2,32.17,32.13,32.2,32.4,32.02,32.22,32.77,32.94,32.09,32.16,-0.67,-0.35,-0.57,0.04,0.01,-0.02,0.05,0.25,-0.14,0.06,0.62,0.78,-0.07,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O75832,PSMD10,26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK)),6,29.6,27.48,27.69,27.33,28.05,,,27.06,26.82,26.86,25.99,27.6,28.48,,27.34,0.14,0.35,-0.01,0.72, , ,-0.27,-0.52,-0.48,-1.35,0.27,1.14, ,biological regulation;catabolic process;cell death;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,,,,,,,,,,
O00231,PSMD11,26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5),26,54,32.14,32.5,32.3,32.92,32.8,32.55,32.93,33.08,32.33,32.49,32.68,32.51,32.57,32.6,-0.46,-0.1,-0.3,0.32,0.2,-0.05,0.33,0.48,-0.27,-0.11,0.08,-0.09,-0.03,biological regulation;catabolic process;cell death;cell differentiation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O00232,PSMD12,26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55),28,48.7,30.92,31.36,31.58,31.68,31.45,31.57,31.97,31.9,31.27,31.54,31.77,31.63,31.69,31.56,-0.64,-0.2,0.01,0.11,-0.11,0.01,0.41,0.33,-0.29,-0.02,0.21,0.06,0.12,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q9UNM6,PSMD13,26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5),26,72.3,31.16,31.67,31.51,32.04,32.47,32.29,32.52,32.34,31.96,31.77,32.58,32.05,32.12,32.04,-0.88,-0.37,-0.53,0.01,0.43,0.25,0.48,0.3,-0.07,-0.27,0.55,0.02,0.09,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O00487,PSMD14,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1),14,62.3,30.1,30.82,29.7,31.08,31.68,31.33,30.84,31.48,30.52,30.63,30.71,31.09,31.28,30.87,-0.77,-0.05,-1.16,0.21,0.81,0.46,-0.03,0.62,-0.35,-0.23,-0.16,0.22,0.42,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;DNA metabolic process;DNA recombination;DNA repair;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q13200,PSMD2,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2),52,58.1,32.88,33.09,32.76,33.22,33.05,33.2,33.51,33.56,32.75,32.34,33.21,33.08,32.71,33.03,-0.15,0.07,-0.27,0.19,0.02,0.17,0.48,0.54,-0.28,-0.69,0.18,0.05,-0.31,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O43242,PSMD3,26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58),33,60.1,31.56,31.94,31.52,32.73,32.28,32.44,32.96,33.03,32.59,32.2,32.6,32.32,31.55,32.29,-0.73,-0.34,-0.77,0.45,0,0.15,0.67,0.74,0.3,-0.08,0.32,0.03,-0.74,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P55036,PSMD4,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),13,52.3,30.54,30.67,29.88,31.26,31.01,31.29,31.76,31.2,31.04,31.01,30.94,30.85,30.87,30.95,-0.41,-0.27,-1.07,0.31,0.06,0.34,0.81,0.26,0.09,0.06,0,-0.1,-0.08,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q16401,PSMD5,26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B),17,44.3,30.48,31.1,30.54,30.61,30.19,29.9,30.01,30.58,28.88,28.53,30.25,30.88,29.16,30.09,0.39,1.01,0.46,0.52,0.11,-0.18,-0.08,0.49,-1.2,-1.56,0.16,0.8,-0.92,biological regulation;catabolic process;cell death;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q15008,PSMD6,26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A),24,55.3,30.84,31.26,30.93,31.82,31.61,32.43,32.02,31.83,31.26,31.06,32,31.36,32.1,31.58,-0.74,-0.31,-0.65,0.24,0.03,0.85,0.44,0.25,-0.32,-0.52,0.43,-0.22,0.52,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P51665,PSMD7,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),19,68.8,29.46,30.49,30.68,30.63,31.53,31.31,31.25,31.23,30.64,30.79,31.26,30.36,31.13,30.83,-1.37,-0.34,-0.14,-0.2,0.7,0.48,0.43,0.41,-0.19,-0.03,0.43,-0.47,0.3,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P48556,PSMD8,26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31),12,33.7,29.75,30.4,30.5,30.48,31.19,31.66,31.37,31.72,30.55,30.57,31.22,30.14,31.66,30.86,-1.11,-0.47,-0.36,-0.39,0.32,0.8,0.51,0.86,-0.31,-0.29,0.36,-0.72,0.8,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O00233,PSMD9,26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27),6,26.9,28.81,29.14,27.88,28.87,27.89,27.44,29.08,28.64,26.9,27.18,29.9,28.91,27.41,28.31,0.5,0.83,-0.44,0.56,-0.43,-0.87,0.77,0.33,-1.41,-1.13,1.59,0.6,-0.91,biological regulation;catabolic process;cell death;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;regulation of transport;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q06323,PSME1,Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein) (IGUP I-5111) (Proteasome activator 28 subunit alpha) (PA28a) (PA28alpha),21,75.1,34.19,33.17,34.4,32.59,30.95,31.09,32.03,31.99,31.29,31.49,31.84,32.34,29.77,32.09,2.1,1.08,2.32,0.5,-1.14,-1,-0.06,-0.1,-0.8,-0.6,-0.24,0.25,-2.32,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;proteasome complex;protein complex,,,,,,,,,,
Q9UL46,PSME2,Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta),17,68.6,33.9,32.82,33.01,32.1,32.03,31.55,31.67,32.35,30.92,30.94,31.86,31.75,29.24,31.86,2.04,0.96,1.16,0.24,0.18,-0.31,-0.19,0.49,-0.93,-0.92,0,-0.1,-2.62,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;proteasome complex;protein complex,,,,,,,,,,
P61289,PSME3,Proteasome activator complex subunit 3 (11S regulator complex subunit gamma) (REG-gamma) (Activator of multicatalytic protease subunit 3) (Ki nuclear autoantigen) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma),13,58.7,30.47,29.94,30.87,31.25,31.99,31.87,31.56,31.61,31.28,31.5,30.93,31.9,31.82,31.31,-0.83,-1.37,-0.44,-0.06,0.69,0.57,0.25,0.31,-0.02,0.19,-0.37,0.59,0.51,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;proteasome complex;protein complex,,,,,,,,,,
Q14997,PSME4,Proteasome activator complex subunit 4 (Proteasome activator PA200),8,6.6,27.02,26.44,25.67,26.88,26.13,26.22,26.52,27.07,26.35,26.33,26.77,27.92,24.56,26.45,0.57,-0.01,-0.79,0.43,-0.32,-0.23,0.07,0.62,-0.1,-0.12,0.32,1.47,-1.89,biological regulation;catabolic process;cell death;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;proteasome complex;protein complex,,,,,,,,,,
Q92530,PSMF1,Proteasome inhibitor PI31 subunit (hPI31),4,23.2,29.56,28.73,28.41,29.62,28.23,27.85,28.63,29.29,27.24,28.14,29.64,30,26.39,28.59,0.97,0.13,-0.19,1.02,-0.37,-0.74,0.04,0.7,-1.35,-0.46,1.05,1.41,-2.2,biological regulation;catabolic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O95456,PSMG1,Proteasome assembly chaperone 1 (PAC-1) (Chromosome 21 leucine-rich protein) (C21-LRP) (Down syndrome critical region protein 2),4,22.5,28.55,25.91,27.01,27.85,27.8,26.85,28.02,27.81,26.63,26.92,27.64,29.06,25.4,27.34,1.21,-1.43,-0.33,0.51,0.46,-0.5,0.68,0.47,-0.71,-0.42,0.3,1.71,-1.94,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q969U7,PSMG2,Proteasome assembly chaperone 2 (PAC-2) (Hepatocellular carcinoma-susceptibility protein 3) (Tumor necrosis factor superfamily member 5-induced protein 1),3,12.5,24.55,24.16,24.98,24.35,26.54,25.83,25.65,24.98,,,26.46,24.35,26.85,25.34,-0.79,-1.17,-0.35,-0.99,1.21,0.49,0.31,-0.36, , ,1.12,-0.98,1.52,biological regulation;cell death;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;death;macromolecular complex assembly;protein complex assembly;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BT73,PSMG3,Proteasome assembly chaperone 3 (PAC-3) (hPAC3),2,32,26.49,25.21,25.76,27.3,27.35,25.71,26.88,27.61,26.17,,,26.07,,26.45,0.04,-1.25,-0.69,0.85,0.89,-0.75,0.43,1.15,-0.29, , ,-0.38, ,,,,,,,,,,,,
Q8WXF1,PSPC1,Paraspeckle component 1 (Paraspeckle protein 1),28,51.6,32.29,30.67,31.13,31.07,31.64,31.18,30.43,30.5,30.98,31.3,29.51,29.02,30.71,30.8,1.49,-0.13,0.32,0.27,0.84,0.38,-0.37,-0.3,0.17,0.5,-1.29,-1.79,-0.09,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P78330,PSPH,Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase),4,25.7,27.54,26.98,26.15,29.02,27.6,27.63,26,27.4,26.54,28.53,,26.71,,27.28,0.26,-0.3,-1.13,1.74,0.31,0.35,-1.28,0.12,-0.74,1.25, ,-0.57, ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;small molecule metabolic process,cell part;cell projection;cytosol;neuron projection,,,+,,,,,,,
P26599,PTBP1,Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I),34,90,34.63,34.31,33.68,34.17,35.27,34.98,34.38,34.4,34.92,34.64,33.82,34.23,34.72,34.47,0.16,-0.16,-0.79,-0.3,0.79,0.51,-0.09,-0.08,0.45,0.16,-0.66,-0.24,0.25,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
O95758,PTBP3,Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1),6,23.2,28.69,28.51,27,28.18,29.02,28.45,29.04,29.53,29.27,29.24,27.33,28.41,28.32,28.54,0.15,-0.03,-1.54,-0.36,0.48,-0.09,0.51,0.99,0.73,0.71,-1.21,-0.12,-0.22,anatomical structure morphogenesis;biological regulation;cell maturation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental maturation;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96EY7,PTCD3,"Pentatricopeptide repeat domain-containing protein 3, mitochondrial (Transformation-related gene 15 protein) (TRG-15)",14,22.5,28.8,29.46,27.57,30.34,29.87,29.98,29.57,28.97,29.82,30.34,27.65,29.32,29.79,29.34,-0.55,0.11,-1.78,0.99,0.52,0.64,0.23,-0.37,0.48,1,-1.7,-0.02,0.44,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitochondrial translation;mitochondrion organization;organelle organization;primary metabolic process;protein metabolic process;regulation of translation;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P48651,PTDSS1,Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I),3,8,28.64,28.64,,28.76,28.26,28.64,26.85,28.21,28.75,28,29.21,29.35,29.15,28.54,0.1,0.1, ,0.22,-0.28,0.1,-1.69,-0.33,0.21,-0.54,0.67,0.82,0.61,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;membrane,,,,,,,,,,
Q9BVG9,PTDSS2,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),7,21.6,24.98,26.28,,27,25.41,27.36,27.63,26.06,27.3,28.23,28.76,24.81,28.31,26.84,-1.86,-0.57, ,0.15,-1.43,0.52,0.79,-0.78,0.46,1.39,1.91,-2.04,1.47,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,cell part;membrane,,,,,,,,,,
O14684,PTGES,Prostaglandin E synthase (EC 5.3.99.3) (Microsomal glutathione S-transferase 1-like 1) (MGST1-L1) (Microsomal prostaglandin E synthase 1) (MPGES-1) (p53-induced gene 12 protein),2,11.2,,29.19,24.33,23.97,28.27,28.75,28.23,29.69,,,29.5,27.85,29.99,27.98, ,1.21,-3.64,-4,0.3,0.77,0.25,1.72, , ,1.52,-0.13,2.01,biological regulation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9H7Z7,PTGES2,Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form],15,43,29.17,29.66,29.2,29.25,29.77,29.91,29.89,29.39,29.94,30.07,29.43,29.45,29.3,29.57,-0.4,0.09,-0.37,-0.32,0.2,0.34,0.32,-0.18,0.37,0.5,-0.14,-0.12,-0.28,biological regulation;biosynthetic process;cellular homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;homeostatic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;secretion;small molecule metabolic process;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
Q15185,PTGES3,Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23),14,83.1,32.78,31.97,31.65,32.26,30.36,30.28,31.66,31.31,30.68,30.02,30.82,31.89,29.76,31.19,1.6,0.78,0.46,1.07,-0.83,-0.9,0.48,0.12,-0.5,-1.17,-0.37,0.7,-1.43,biological regulation;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;homeostatic process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;organic acid metabolic process;primary metabolic process;protein folding;protein metabolic process;response to stimulus;signal transduction;small molecule metabolic process;telomere organization,cell part;cytosol;macromolecular complex;ribonucleoprotein complex;telomerase holoenzyme complex,,,,,,,,,,
Q4QQP8,PTGFRN,PTGFRN protein (Fragment),7,11.7,28.79,26.82,26.37,25.96,24.7,25.56,23.91,24.99,,,,,,25.89,2.9,0.93,0.48,0.08,-1.18,-0.33,-1.97,-0.9, , , , , ,,,,,,,,,,,,
Q16647,PTGIS,Prostacyclin synthase (EC 5.3.99.4) (Prostaglandin I2 synthase),30,55.8,26.19,32.62,33.02,30.26,29.12,31.05,32.73,32.24,29.44,24.34,34.63,34.81,34.91,31.18,-4.99,1.44,1.84,-0.93,-2.06,-0.13,1.55,1.06,-1.74,-6.84,3.45,3.62,3.73,biological regulation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;response to stress;small molecule metabolic process;xenobiotic metabolic process,cell part;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q14914,PTGR1,Prostaglandin reductase 1 (PRG-1) (EC 1.3.1.-) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (EC 1.3.1.74),12,45.3,30.03,31.47,30.43,30.56,29.61,28.09,29.86,31.26,28.24,27.96,30.19,30.24,27.32,29.64,0.4,1.84,0.79,0.92,-0.02,-1.55,0.22,1.62,-1.39,-1.67,0.55,0.6,-2.31,cellular alkene metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
P35354,PTGS2,Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2),3,6.5,27.3,25.45,,27.03,25.37,26.39,23.59,27.5,25.29,,,,,25.99,1.31,-0.54, ,1.04,-0.62,0.4,-2.4,1.51,-0.7, , , , ,anatomical structure development;anatomical structure formation involved in morphogenesis;behavior;biological regulation;cell differentiation;cellular component movement;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cytokine production;developmental process;growth;lipid metabolic process;metabolic process;molting cycle;multicellular organismal process;neurological system process;organic acid metabolic process;primary metabolic process;regulation of cell cycle;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;cell projection;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;nucleus;organelle;protein complex,,,,,,,,,,
Q05397,PTK2,Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK),18,19.8,28.8,28.7,28.34,29.23,28.37,26.3,28.74,29.72,26.82,26.58,28.4,28.72,27.23,28.15,0.65,0.55,0.19,1.08,0.23,-1.85,0.59,1.57,-1.33,-1.57,0.25,0.57,-0.92,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell activation;cell differentiation;cell motility;cellular component assembly;cellular component disassembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;embryo development;establishment of localization;establishment or maintenance of cell polarity;extracellular matrix organization;extracellular structure organization;homeostatic process;immune system process;locomotion;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of organelle organization;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell cortex;cell part;cell projection;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;nucleolus;nucleus;organelle;plasma membrane,,+,,,,,,,,
Q13308,PTK7,Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7),8,9.3,28.24,28.46,26.83,28.19,,28.73,26.13,,28,25.14,,27.3,25.65,27.27,0.97,1.2,-0.44,0.92, ,1.46,-1.13, ,0.73,-2.12, ,0.04,-1.62,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell communication;cell differentiation;cell motility;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment or maintenance of cell polarity;growth;locomotion;organelle organization;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;signal transduction,cell part,,+,,,,,,,,
Q12974,PTP4A2,Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2),3,27.9,28.3,27.68,29.16,28.56,28.94,26.85,27.67,26.07,28.07,27.94,27.41,27.45,,27.84,0.46,-0.16,1.32,0.72,1.09,-0.99,-0.17,-1.77,0.23,0.09,-0.43,-0.39, ,,cell part;cytoplasm;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,+,,,,,,,
Q9P035,PTPLAD1,Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein tyrosine phosphatase-like protein PTPLAD1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),16,37.8,31.01,31.25,29.95,30.52,30.22,31,30.53,30.63,30.84,31.6,31.09,29.61,30.63,30.68,0.32,0.57,-0.73,-0.16,-0.46,0.32,-0.16,-0.05,0.16,0.92,0.41,-1.08,-0.05,biological regulation;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;organic acid metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to stimulus;signal transduction;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P18031,PTPN1,Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B),28,66.4,30.93,31.69,31.28,31.77,31.36,32.22,31.93,31.77,32.54,31.86,33.13,31.8,33.24,31.96,-1.04,-0.27,-0.68,-0.2,-0.6,0.26,-0.04,-0.19,0.58,-0.1,1.16,-0.17,1.28,biological regulation;cell activation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;endoplasmic reticulum;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,+,,,,,,,
Q06124,PTPN11,Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3),16,39,29.74,29.86,28.08,29.4,28.23,27.29,28.64,29.25,28.31,28.16,28.38,29.73,24.64,28.44,1.3,1.42,-0.36,0.96,-0.21,-1.15,0.2,0.81,-0.12,-0.28,-0.06,1.29,-3.8,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell motility;cellular component movement;cellular lipid metabolic process;cellular metabolic process;cellular process;coagulation;developmental process;glycerol ether metabolic process;growth;homeostatic process;hormone metabolic process;immune system process;lipid metabolic process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;regulation of cell cycle;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,+,+,,,,,,
Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),17,27.6,26.33,27.55,27.25,27.4,25.46,26.7,27.67,27.39,26.39,22.33,27.75,23.53,26.34,26.32,0.02,1.23,0.94,1.08,-0.86,0.38,1.36,1.07,0.08,-3.98,1.43,-2.79,0.03,,cell part;cell projection;cytoplasm;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,+,,,,,,,
Q15678,PTPN14,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),11,11.7,25.72,,,26.9,27.87,25.92,27.21,26.95,26.33,25.55,,27.4,25.83,26.57,-0.85, , ,0.34,1.3,-0.65,0.64,0.38,-0.24,-1.01, ,0.83,-0.74,anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of transport;RNA metabolic process,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,+,,,,,,,
P17706,PTPN2,Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP),4,10.5,26.29,25.6,24.76,24.41,25.84,26.42,,25.65,25.41,25.85,,,,25.58,0.71,0.02,-0.82,-1.17,0.26,0.84, ,0.07,-0.17,0.27, , , ,biological regulation;cellular process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleoplasm;nucleus;organelle,,,+,,,,,,,
Q9H3S7,PTPN23,Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14),12,11.6,27.53,27.53,27.51,28.07,28.03,27.84,29.09,28.72,26.42,24.04,28.26,27.49,26.23,27.44,0.08,0.09,0.07,0.62,0.59,0.4,1.64,1.28,-1.03,-3.4,0.81,0.05,-1.21,anatomical structure morphogenesis;catabolic process;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;transport,cell part;cell projection;cilium;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle;vesicle,,,,,,,,,,
P10586,PTPRF,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR),13,9.7,27.79,28.74,27.26,26.16,26.17,28.55,,,26.14,24.17,,25.96,26.61,26.75,1.04,1.99,0.5,-0.59,-0.59,1.8, , ,-0.62,-2.58, ,-0.8,-0.15,biological adhesion;biological regulation;cell adhesion;cellular process;response to stimulus;signal transduction,cell part,,,+,,,,,,,
Q12913,PTPRJ,Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148),10,9.6,27.68,25.66,24.82,26.48,29.23,28.42,26.88,27.69,29.55,28.46,25.43,22.38,28.61,27.02,0.66,-1.36,-2.21,-0.54,2.21,1.4,-0.14,0.67,2.52,1.44,-1.59,-4.64,1.59,anatomical structure development;biological regulation;cell differentiation;cellular process;circulatory system process;coagulation;developmental process;locomotion;multicellular organismal process;regulation of body fluid levels;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cell surface,,,+,,,,,,,
Q15262,PTPRK,Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48),6,6.3,28.17,27.22,27.08,24.23,24.84,26.61,18.94,24.1,27.77,28.2,,,24.95,25.65,2.52,1.58,1.43,-1.41,-0.81,0.96,-6.71,-1.54,2.13,2.56, , ,-0.7,biological regulation;cell junction organization;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular localization;cellular process;localization;locomotion;regulation of cell cycle;response to abiotic stimulus;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction,cell body;cell part;cell projection;cell surface;cilium;neuron projection;neuronal cell body,,,+,,,,,,,
Q6NZI2,PTRF,Polymerase I and transcript release factor (Cavin-1),22,57,28.36,32.75,31.41,33.22,32.69,32.79,32.76,33.09,33.16,31.74,32.68,30.54,32.75,32.15,-3.79,0.6,-0.74,1.07,0.54,0.64,0.61,0.94,1.01,-0.41,0.53,-1.61,0.6,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleoplasm;organelle,,,,,,,,,,
Q86Y79,PTRH1,Probable peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29),2,12.6,28.26,27.17,,24.26,25.55,26.2,,,27.51,25.41,,,,26.34,1.93,0.83, ,-2.08,-0.79,-0.13, , ,1.18,-0.93, , , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9Y3E5,PTRH2,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",8,53.1,29.54,30.07,29.36,30.16,30.52,30.4,29.79,30,30.23,29.75,29.49,29.52,30.29,29.93,-0.39,0.14,-0.57,0.23,0.59,0.46,-0.14,0.07,0.3,-0.18,-0.44,-0.42,0.36,biological regulation;cell death;cellular process;death,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6GMV3,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1),4,57.9,28.28,27.4,28.61,26.91,26.54,27.28,27.35,28.43,26.58,27.92,29.06,25.99,27.28,27.51,0.77,-0.11,1.1,-0.6,-0.97,-0.23,-0.16,0.92,-0.93,0.41,1.55,-1.52,-0.23,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process,,,,,,,,,,,
A8MXQ1,PTTG1IP,Pituitary tumor-transforming gene 1 protein-interacting protein,3,21.4,26.16,25.73,27.42,27.25,28.39,,26.55,,25.7,29.02,,26.85,,27.01,-0.85,-1.28,0.41,0.25,1.38, ,-0.46, ,-1.3,2.01, ,-0.15, ,,,,,,,,,,,,
Q9UHX1,PUF60,Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor) (FBP-interacting repressor) (Ro-binding protein 1) (RoBP1) (Siah-binding protein 1) (Siah-BP1),22,62.5,31.85,30.49,30.9,30.85,31.3,31.17,30.65,30.71,31.21,31.15,30.26,30.98,30.99,30.96,0.88,-0.48,-0.06,-0.11,0.34,0.21,-0.31,-0.25,0.25,0.18,-0.7,0.01,0.03,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,Other TF domain,,,,,,,,,
Q14671,PUM1,Pumilio homolog 1 (HsPUM) (Pumilio-1),12,18.3,27.78,26.73,27.61,27.4,27.66,25.49,28.1,28.09,27.22,28.25,26.59,27.72,27.88,27.42,0.36,-0.69,0.19,-0.02,0.24,-1.93,0.67,0.66,-0.21,0.82,-0.83,0.29,0.45,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;Golgi vesicle transport;membrane organization;regulation of translation;transport;vesicle-mediated transport,cell part;cytosol,,,,,,,,,,
Q00577,PURA,Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha),10,40.4,28.95,29.38,28.5,28.35,29.22,28.48,28.67,28.32,28.89,28.5,29.57,29.98,28.73,28.89,0.06,0.49,-0.39,-0.53,0.33,-0.41,-0.22,-0.57,0,-0.39,0.68,1.09,-0.16,anatomical structure development;biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA geometric change;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell body;cell part;cell projection;cytoplasm;macromolecular complex;neuron projection;neuronal cell body;protein complex,Other TF domain,,,,,,,,,
Q96QR8,PURB,Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B),14,69.9,28.7,29.59,29.32,28.64,28.04,28.73,28.35,28.74,28.12,26.84,28.47,24.45,28.22,28.17,0.53,1.42,1.15,0.47,-0.13,0.56,0.18,0.56,-0.05,-1.33,0.3,-3.72,0.05,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;macromolecular complex;protein complex,Other TF domain,,,,,,,,,
Q9Y606,PUS1,"tRNA pseudouridine synthase A, mitochondrial (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)",8,25.4,29.25,28.06,28.35,28,23.72,28.18,28.09,25.41,28.51,27.69,26.06,26.26,27.21,27.29,1.95,0.77,1.06,0.71,-3.57,0.89,0.8,-1.88,1.22,0.4,-1.23,-1.03,-0.08,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleolus;nucleus;organelle;protein complex;transcription factor complex,,,,,,,,,,
P15151,PVR,Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155),5,17.4,27.66,27.26,27.1,28.79,28.05,28.64,28.42,27.02,28.16,27.74,27.86,23.88,29.09,27.67,0,-0.41,-0.56,1.12,0.38,0.97,0.75,-0.64,0.49,0.07,0.19,-3.78,1.42,biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process;interspecies interaction between organisms;multi-organism process,cell part;cell surface;cytoplasm;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q92692,PVRL2,Poliovirus receptor-related protein 2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin-2) (CD antigen CD112),10,27.5,29.33,29.58,28.26,29.62,29.44,30.16,29.4,28.84,29.97,29.41,29.36,28.78,30.84,29.46,-0.13,0.12,-1.2,0.16,-0.02,0.7,-0.06,-0.62,0.51,-0.05,-0.1,-0.68,1.38,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell development;cell junction organization;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment of localization;interspecies interaction between organisms;membrane fusion;membrane organization;mitochondrion organization;multi-organism process;nucleus organization;organelle organization,cell part;cell surface;membrane;plasma membrane,,,,,,,,,,
Q13610,PWP1,Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502),7,22.2,28.98,29.1,28.05,30.35,28.66,28.77,29.94,27.58,29.03,29.35,28.54,28.05,28.43,28.83,0.14,0.26,-0.78,1.52,-0.17,-0.06,1.11,-1.25,0.19,0.52,-0.3,-0.78,-0.4,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q15269,PWP2,Periodic tryptophan protein 2 homolog,14,14.8,28.39,27.6,26.72,28.48,29.57,29.19,28.73,28.1,29.17,29.1,29.84,28.21,27.48,28.51,-0.12,-0.91,-1.79,-0.02,1.07,0.68,0.23,-0.41,0.66,0.59,1.33,-0.29,-1.02,,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q92626,PXDN,Peroxidasin homolog (EC 1.11.1.7) (Melanoma-associated antigen MG50) (Vascular peroxidase 1) (p53-responsive gene 2 protein),31,29,29.55,30.22,28.75,31.22,30.18,31.36,29.4,29.66,31.77,31.01,28.67,28.77,30.82,30.11,-0.55,0.12,-1.35,1.12,0.08,1.25,-0.71,-0.45,1.66,0.9,-1.44,-1.34,0.71,catabolic process;cellular component organization;cellular metabolic process;cellular process;extracellular matrix organization;extracellular structure organization;immune system process;metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;endoplasmic reticulum;extracellular matrix;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;organelle;proteinaceous extracellular matrix,,,,,,,,,,
Q9NR77,PXMP2,Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane protein),2,12.5,22.09,23.37,,25.43,23.63,24.85,24.15,24.35,25.11,24.47,24.94,25.85,24.86,24.42,-2.34,-1.05, ,1,-0.8,0.43,-0.27,-0.08,0.68,0.04,0.51,1.42,0.44,,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microbody;mitochondrion;organelle;protein complex,,,,,,,,,,
P49023,PXN,Paxillin,15,32.8,28.73,28.38,27.52,28.75,28.41,26.6,28.98,29.01,26.39,,27.96,26.24,27.15,27.84,0.89,0.54,-0.33,0.9,0.57,-1.24,1.14,1.17,-1.46, ,0.12,-1.61,-0.69,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell junction organization;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;muscle contraction;organelle organization;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction,cell cortex;cell part;cell projection;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9ULZ3,PYCARD,Apoptosis-associated speck-like protein containing a CARD (hASC) (Caspase recruitment domain-containing protein 5) (PYD and CARD domain-containing protein) (Target of methylation-induced silencing 1),10,48.7,29.17,30.48,29.61,29.01,24.91,26.06,26.31,28.19,,,28.2,28.82,,28.08,1.09,2.4,1.53,0.94,-3.16,-2.02,-1.77,0.11, , ,0.12,0.74, ,biological regulation;cell activation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;immune system process;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;proteolysis;regulation of organelle organization;regulation of protein modification process;regulation of protein stability;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
P32322,PYCR1,"Pyrroline-5-carboxylate reductase 1, mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2)",12,46.4,29.43,31,28.44,30.97,29.99,31.41,29.39,29.71,32.9,31.1,29.44,28.65,30.64,30.24,-0.81,0.76,-1.8,0.74,-0.25,1.18,-0.85,-0.53,2.66,0.87,-0.8,-1.59,0.41,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part,,,,,,,,,,
Q96C36,PYCR2,Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2),10,37.2,28.38,28.81,29.23,29.03,29.6,30.36,28.66,28.7,29.68,29.46,29.72,27.31,30.34,29.18,-0.79,-0.36,0.05,-0.14,0.43,1.19,-0.52,-0.48,0.5,0.28,0.54,-1.86,1.16,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q53H96,PYCRL,Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (EC 1.5.1.2) (Pyrroline-5-carboxylate reductase-like protein),3,30.6,27.56,25.3,24.91,27.69,25.71,,25.42,,24.97,,24.94,,,25.81,1.75,-0.51,-0.91,1.88,-0.11, ,-0.39, ,-0.85, ,-0.87, , ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
P11216,PYGB,"Glycogen phosphorylase, brain form (EC 2.4.1.1)",52,58.4,33.5,32.34,32.6,32.16,31.63,31.67,33.4,33.54,32.23,31.84,33.05,32.18,31.96,32.47,1.04,-0.13,0.13,-0.31,-0.84,-0.8,0.93,1.07,-0.24,-0.63,0.58,-0.29,-0.51,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
P06737,PYGL,"Glycogen phosphorylase, liver form (EC 2.4.1.1)",33,39.9,30.48,31.76,31.82,30.84,30.77,29.47,31.45,31.44,30.06,31.99,31.23,32.54,29.32,31.01,-0.54,0.75,0.81,-0.17,-0.24,-1.54,0.43,0.43,-0.95,0.98,0.22,1.52,-1.7,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;heterocycle metabolic process;homeostatic process;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
P47897,QARS,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),44,60.6,32.24,32.11,31.65,32.53,32.31,32.05,32.41,32.45,31.65,32.28,32.45,32.05,32.36,32.2,0.04,-0.08,-0.54,0.33,0.12,-0.14,0.22,0.25,-0.55,0.08,0.26,-0.14,0.16,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
P09417,QDPR,Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase),6,41,29.35,30.17,29.24,29.31,28.62,27.51,28.7,29.3,27.52,28.85,29.47,28.01,26.81,28.68,0.67,1.49,0.56,0.63,-0.06,-1.17,0.02,0.62,-1.16,0.17,0.79,-0.68,-1.87,amine metabolic process;anatomical structure development;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;neuron projection;organelle,,,,,,,,,,
Q5XKP0,QIL1,Protein QIL1 (Protein P117),4,33.1,27.83,29.8,27.32,28.69,28.96,29.19,28.76,28.74,29.3,29.06,28.06,27.77,28.7,28.63,-0.8,1.18,-1.31,0.06,0.33,0.56,0.13,0.11,0.68,0.43,-0.57,-0.86,0.07,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96PU8,QKI,Protein quaking (Hqk) (HqkI),13,43.2,29.18,30.38,29.49,30.11,30.67,30.97,29.81,29.36,31.1,29.9,30.06,30.14,30.3,30.11,-0.93,0.26,-0.63,0,0.56,0.86,-0.3,-0.75,0.98,-0.22,-0.05,0.03,0.19,anatomical structure development;biological regulation;biosynthetic process;cell development;cell differentiation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;lipid metabolic process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;organic acid metabolic process;primary metabolic process;regulation of translation;RNA metabolic process;RNA processing;RNA splicing;small molecule metabolic process;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NXS2,QPCTL,Glutaminyl-peptide cyclotransferase-like protein (EC 2.3.2.5) (Golgi-resident glutaminyl-peptide cyclotransferase) (isoQC) (gQC),4,16.5,26.35,28.41,24.38,27.85,28.31,27.2,26.73,27.88,28.76,26.75,27.04,25.16,28.21,27.16,-0.8,1.26,-2.77,0.69,1.16,0.04,-0.43,0.72,1.6,-0.41,-0.12,-1.99,1.05,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein metabolic process;protein modification process;proteolysis,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q15274,QPRT,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase) (QPRTase),7,27.9,26.29,28.13,27.53,28.14,26.67,27.18,27.62,28.79,21.21,26.61,27.36,26.55,,26.84,-0.55,1.29,0.69,1.3,-0.17,0.34,0.78,1.95,-5.63,-0.23,0.52,-0.29, ,biosynthetic process;catabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process;vitamin metabolic process,cell part;cytosol,,,,,,,,,,
Q2TAL8,QRICH1,Glutamine-rich protein 1,4,7.2,27.63,26.84,26.24,26.3,25.54,27.73,26.35,25.85,27.24,25.62,25.45,27.21,26.8,26.52,1.11,0.32,-0.28,-0.22,-0.98,1.21,-0.18,-0.67,0.72,-0.9,-1.08,0.68,0.27,,,,,,,,,,,,
Q9H0R6,QRSL1,"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.-) (Glutaminyl-tRNA synthase-like protein 1)",5,12.1,27.57,25.27,24.98,27.13,27,26.99,25.02,26.93,,27.56,25.91,25.93,27.66,26.49,1.07,-1.22,-1.51,0.63,0.5,0.49,-1.47,0.43, ,1.07,-0.58,-0.57,1.16,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mitochondrial translation;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;organic acid metabolic process;primary metabolic process;protein metabolic process;RNA metabolic process;small molecule metabolic process;translation;tRNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
O00391,QSOX1,Sulfhydryl oxidase 1 (hQSOX) (EC 1.8.3.2) (Quiescin Q6),10,18.1,28.88,29.53,26.85,28.95,28.24,29.5,27.87,28.27,25.88,26.11,26.5,27.76,28.72,27.93,0.95,1.6,-1.07,1.02,0.31,1.57,-0.06,0.34,-2.05,-1.81,-1.43,-0.17,0.79,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part;extracellular space,,,,,,,,,,
Q6ZRP7,QSOX2,Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1),9,12.5,26.45,26.59,27.39,27.45,24.91,27.63,26.67,,27.32,26.65,26.68,27.91,27.55,26.93,-0.48,-0.34,0.46,0.51,-2.02,0.69,-0.26, ,0.39,-0.28,-0.26,0.98,0.62,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part;extracellular region;membrane;plasma membrane,,,,,,,,,,
Q9BXR0,QTRT1,Queuine tRNA-ribosyltransferase (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase),4,18.4,27.77,26.06,25.37,25.92,24.91,,,26.02,,25.5,24.98,,,25.82,1.95,0.24,-0.45,0.1,-0.9, , ,0.2, ,-0.32,-0.83, , ,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;small molecule metabolic process;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P61026,RAB10,Ras-related protein Rab-10,13,38.5,32.04,31.27,31.86,31.71,31.56,31.37,31.59,31.36,31.88,31.71,31.79,31.05,31.54,31.59,0.44,-0.33,0.26,0.12,-0.04,-0.23,0,-0.23,0.29,0.12,0.19,-0.55,-0.05,anatomical structure morphogenesis;biological regulation;cell differentiation;cellular component morphogenesis;cellular component organization;cellular localization;cellular membrane organization;cellular process;developmental process;endoplasmic reticulum organization;endosome transport;establishment of localization;establishment or maintenance of cell polarity;Golgi vesicle transport;localization;membrane organization;organelle organization;plasma membrane organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cilium;cytoplasmic membrane-bounded vesicle;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q15907,RAB11B,Ras-related protein Rab-11B (GTP-binding protein YPT3),23,77.1,31.86,31.88,32.69,31.78,32.56,33.1,32.09,32.14,32.16,32.74,33.28,30.82,33.6,32.36,-0.51,-0.48,0.33,-0.58,0.2,0.73,-0.27,-0.22,-0.2,0.38,0.92,-1.54,1.24,biological regulation;cell cycle;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane;vesicle,,,,,,,,,,
Q6WKZ4,RAB11FIP1,Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein),16,15,27.64,27.3,27.9,27.45,27.37,26.78,27.3,26.39,26.65,28.08,27.35,27.01,25.76,27.15,0.48,0.15,0.74,0.3,0.22,-0.37,0.15,-0.76,-0.51,0.93,0.19,-0.15,-1.39,establishment of localization;protein transport;transport,cell part;cytoplasm;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9BXF6,RAB11FIP5,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),11,30.8,26.82,26.71,27.22,26.12,25.99,27.49,27.37,26.75,27.75,27.03,29.21,28.58,29.68,27.44,-0.62,-0.73,-0.22,-1.32,-1.45,0.05,-0.07,-0.69,0.31,-0.41,1.77,1.14,2.24,establishment of localization;protein transport;transport,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;organelle,,,,,,,,,,
Q6IQ22,RAB12,Ras-related protein Rab-12,6,29.1,25.79,28.04,26.28,27.14,23.89,26.63,27.72,24.88,25.54,28.1,27.02,25.72,27.9,26.51,-0.72,1.53,-0.23,0.63,-2.62,0.12,1.21,-1.63,-0.97,1.59,0.51,-0.79,1.39,biological regulation;catabolic process;cellular metabolic process;cellular process;endosome transport;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein catabolic process;protein metabolic process;protein transport;response to stimulus;signal transduction;transport;vacuolar transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole,,,,,,,,,,
P51153,RAB13,Ras-related protein Rab-13 (Cell growth-inhibiting gene 4 protein),9,33.5,29.29,29.65,30.52,28.61,29.74,30.64,29.35,29.54,30.62,29.13,30.14,28.83,29.56,29.66,-0.38,-0.01,0.85,-1.05,0.08,0.98,-0.31,-0.12,0.95,-0.53,0.48,-0.83,-0.1,biological adhesion;biological regulation;cell adhesion;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane organization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P61106,RAB14,Ras-related protein Rab-14,18,74.9,32.27,32.53,32.51,32.24,32.3,32.27,32.63,32.36,32.84,32.7,32.25,32.4,32.21,32.42,-0.15,0.11,0.09,-0.19,-0.13,-0.15,0.2,-0.06,0.42,0.28,-0.18,-0.02,-0.22,biological regulation;cellular component organization;cellular membrane organization;cellular process;developmental process;embryo development;endosome transport;establishment of localization;Golgi vesicle transport;membrane organization;neurotransmitter transport;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;endoplasmic reticulum;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole;vesicle,,,,,,,,,,
Q9NP72,RAB18,Ras-related protein Rab-18,13,56.8,30.73,30.57,31.29,31.2,30.33,31.08,30.81,30.77,31.52,30.54,31.43,32.66,31.74,31.13,-0.39,-0.56,0.16,0.07,-0.8,-0.05,-0.32,-0.36,0.39,-0.59,0.31,1.53,0.61,anatomical structure development;biological regulation;cellular component organization;cellular membrane organization;cellular process;developmental process;endocytosis;establishment of localization;membrane invagination;membrane organization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;intracellular;membrane;plasma membrane,,,,,,,,,,
P62820,RAB1A,Ras-related protein Rab-1A (YPT1-related protein),21,67.8,33.01,33.26,33.48,32.93,33.15,33.64,33.17,33.19,33.51,33.51,33.29,33.73,33.65,33.35,-0.33,-0.09,0.13,-0.42,-0.19,0.29,-0.18,-0.16,0.16,0.16,-0.05,0.39,0.3,biological regulation;cell cycle;cellular process;establishment of localization;mitotic cell cycle;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9H0U4,RAB1B,Ras-related protein Rab-1B,8,40.3,28.96,30.04,27.62,29.4,31.08,29.9,29.47,30.01,29.78,30.23,30.16,29.87,29.01,29.66,-0.69,0.39,-2.04,-0.26,1.42,0.24,-0.19,0.35,0.12,0.58,0.5,0.22,-0.65,biological regulation;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9UL25,RAB21,Ras-related protein Rab-21,13,51.6,30.9,30.72,30.3,30.48,30.71,30.63,29.86,30.41,29.93,30.37,30.77,29.48,30.62,30.4,0.5,0.32,-0.1,0.09,0.31,0.23,-0.54,0.01,-0.47,-0.03,0.37,-0.92,0.22,biological regulation;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9ULC3,RAB23,Ras-related protein Rab-23,6,39.2,26.74,27.68,28.17,27.32,27.61,27.91,28.57,27.17,29.02,28.25,27.17,28.68,26.77,27.77,-1.04,-0.09,0.39,-0.45,-0.17,0.13,0.79,-0.6,1.24,0.48,-0.6,0.9,-1,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component organization;cellular process;developmental process;establishment of localization;organelle assembly;organelle organization;protein transport;regulation of transport;response to stimulus;response to stress;signal transduction;transport;vacuole organization,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vacuole;vesicle,,,,,,,,,,
Q969Q5,RAB24,Ras-related protein Rab-24,2,13.8,25.2,25.33,,24.57,24.85,25.59,24.72,23.71,25.61,25.39,24.55,24.77,,24.93,0.27,0.39, ,-0.36,-0.09,0.66,-0.21,-1.23,0.67,0.45,-0.39,-0.16, ,autophagy;biological regulation;catabolic process;cellular metabolic process;cellular process;establishment of localization;metabolic process;protein transport;response to stimulus;signal transduction;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;vacuole,,,,,,,,,,
P51159,RAB27A,Ras-related protein Rab-27A (Rab-27) (GTP-binding protein Ram),6,31.9,26.49,28.36,28.26,28.96,27.45,28.13,27.97,26.35,29.25,30.06,26.09,26.32,28.24,27.84,-1.35,0.51,0.42,1.12,-0.39,0.29,0.13,-1.49,1.41,2.22,-1.75,-1.52,0.4,biological regulation;cell activation;cell differentiation;cellular metabolic process;cellular process;coagulation;developmental process;establishment of localization;exocytosis;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;protein targeting;protein transport;regulation of body fluid levels;regulation of transport;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cilium;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;neuron projection;organelle;vacuole;vesicle,,,,,,,,,,
P61019,RAB2A,Ras-related protein Rab-2A,20,84,32.62,32.8,32.34,32.31,32.71,32.24,32.47,32.48,33.32,32.46,32.56,33.04,32.7,32.62,0,0.18,-0.28,-0.31,0.1,-0.38,-0.15,-0.14,0.7,-0.16,-0.06,0.42,0.08,biological regulation;cell cycle;cellular process;establishment of localization;Golgi vesicle transport;mitotic cell cycle;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q8WUD1,RAB2B,Ras-related protein Rab-2B,2,17.1,25.74,27.1,26.92,26.51,26.03,,26.6,26.76,27.96,27.3,27.03,,27.27,26.84,-1.1,0.26,0.09,-0.33,-0.81, ,-0.23,-0.08,1.12,0.46,0.19, ,0.43,biological regulation;cellular process;establishment of localization;protein transport;regulation of transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;membrane;plasma membrane,,,,,,,,,,
Q13636,RAB31,Ras-related protein Rab-31 (Ras-related protein Rab-22B),6,42.3,27.43,28.46,29.39,28.9,27.84,27.79,,26.82,27.49,26.68,28.24,29.68,28.41,28.09,-0.66,0.37,1.29,0.81,-0.25,-0.3, ,-1.27,-0.6,-1.41,0.15,1.58,0.32,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;establishment of localization;exocytosis;Golgi vesicle transport;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q13637,RAB32,Ras-related protein Rab-32,12,63.6,27.91,30.31,30.04,31.17,30.72,31.35,30.74,30.82,30.75,29.08,30.73,29.89,31.56,30.39,-2.48,-0.08,-0.35,0.78,0.33,0.96,0.35,0.43,0.36,-1.31,0.34,-0.5,1.17,biological regulation;cellular component organization;cellular process;establishment of localization;organelle organization;protein transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;vesicle,,,,,,,,,,
Q9BZG1,RAB34,Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah),7,35.9,30.51,29.31,29.59,29.34,27.53,29.03,29.7,28.59,29.98,29.08,28.52,30.01,29.47,29.28,1.23,0.03,0.31,0.06,-1.75,-0.25,0.42,-0.69,0.7,-0.2,-0.76,0.73,0.19,biological regulation;cellular component organization;cellular process;establishment of localization;organelle fusion;organelle organization;protein transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q15286,RAB35,Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C),9,50.8,26.01,27.82,28.84,26.91,28.73,28.89,28.14,28.32,29.81,28.15,28.35,26.73,28.69,28.11,-2.1,-0.29,0.73,-1.2,0.62,0.79,0.04,0.22,1.7,0.04,0.24,-1.38,0.59,biological regulation;cellular process;cytokinesis;endosome transport;establishment of localization;localization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle;vesicle,,,,,,,,,,
P20337,RAB3B,Ras-related protein Rab-3B,2,12.8,,,,,,26.03,25.68,24.63,25.84,,24.38,26.38,23.04,25.14, , , , , ,0.89,0.54,-0.51,0.7, ,-0.76,1.24,-2.1,biological regulation;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;protein transport;regulation of transport;response to stimulus;signal transduction;small molecule metabolic process;transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
O95716,RAB3D,Ras-related protein Rab-3D,8,38.8,29.53,28.95,28.95,27.96,30.05,30.04,29.88,29.47,30.02,29.55,28.5,29.04,30.19,29.39,0.13,-0.44,-0.44,-1.44,0.66,0.64,0.49,0.08,0.62,0.15,-0.89,-0.36,0.8,biological regulation;cellular metabolic process;cellular process;establishment of localization;exocytosis;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;protein transport;regulation of transport;response to stimulus;secretion;signal transduction;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane;vesicle,,,,,,,,,,
Q15042,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP),22,31,26.17,28.65,28.36,28.91,28.8,28.24,29.97,29.24,30.6,26.5,29.67,30.2,28.67,28.77,-2.6,-0.12,-0.41,0.14,0.04,-0.53,1.2,0.47,1.83,-2.26,0.9,1.43,-0.1,anatomical structure development;anatomical structure morphogenesis;developmental process,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
Q9H2M9,RAB3GAP2,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),22,20.4,27.43,29.55,29.76,30.49,29.32,29.15,29.72,29.97,28.95,28.91,30.55,29.68,29.61,29.47,-2.04,0.08,0.29,1.02,-0.15,-0.31,0.25,0.5,-0.52,-0.56,1.08,0.22,0.14,establishment of localization;protein transport;transport,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q86YS6,RAB43,Ras-related protein Rab-43 (Ras-related protein Rab-41),6,31.1,28.23,27.95,27.88,28.15,28.07,28.47,28.1,27.25,29.1,27.06,25.87,27.57,28.21,27.84,0.39,0.11,0.04,0.31,0.23,0.63,0.26,-0.59,1.27,-0.78,-1.97,-0.27,0.37,biological regulation;cellular component organization;cellular process;establishment of localization;Golgi organization;organelle organization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
P20338,RAB4A,Ras-related protein Rab-4A,5,29.1,27.03,27.13,21.19,27.14,25.61,26.67,25.48,25.98,26.05,26.18,26.35,26.98,26.44,26.02,1.02,1.11,-4.83,1.12,-0.41,0.65,-0.54,-0.04,0.03,0.16,0.34,0.96,0.42,biological regulation;cellular component organization;cellular membrane organization;cellular process;membrane organization;regulation of transport;response to stimulus;signal transduction,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P61018,RAB4B,Ras-related protein Rab-4B,6,33.8,28.34,26.92,27.13,26.44,25.23,27.24,22.88,25.84,26.32,24.59,27.45,26.57,27.28,26.33,2.02,0.59,0.81,0.11,-1.09,0.92,-3.44,-0.48,-0.01,-1.74,1.12,0.24,0.95,biological regulation;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;intracellular;membrane;plasma membrane,,,,,,,,,,
P20339,RAB5A,Ras-related protein Rab-5A,5,35.8,29.06,29.22,24.99,25.85,28.43,29.2,29.27,29.75,28.82,28.19,29.09,29.18,28.28,28.41,0.65,0.81,-3.42,-2.56,0.02,0.79,0.86,1.34,0.41,-0.22,0.68,0.77,-0.12,anatomical structure development;biological regulation;cell differentiation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;coagulation;developmental process;endocytosis;establishment of localization;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;multicellular organismal process;protein transport;regulation of body fluid levels;regulation of transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytoskeleton;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
P61020,RAB5B,Ras-related protein Rab-5B,5,23.3,30.03,29.76,29.91,28.72,29.39,29.54,29.2,29.66,29.74,29.86,29.12,29.69,30.14,29.6,0.43,0.16,0.31,-0.88,-0.21,-0.06,-0.39,0.06,0.15,0.26,-0.48,0.1,0.55,biological regulation;cellular component organization;cellular process;endosome organization;establishment of localization;organelle organization;protein transport;regulation of transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
P51148,RAB5C,Ras-related protein Rab-5C (L1880) (RAB5L),13,54.2,31.74,32.67,32.68,32.37,32.37,32.64,32.67,32.42,32.84,32.74,32.79,32.04,32.69,32.51,-0.77,0.16,0.17,-0.14,-0.15,0.13,0.16,-0.09,0.33,0.22,0.27,-0.48,0.18,biological regulation;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
P20340,RAB6A,Ras-related protein Rab-6A (Rab-6),21,59.6,32.86,32.74,32.68,32.59,32.45,32.9,32.75,32.33,32.91,32.53,32.73,32.24,32.97,32.67,0.2,0.07,0.01,-0.08,-0.22,0.23,0.08,-0.34,0.25,-0.14,0.06,-0.43,0.3,biological regulation;cellular component movement;cellular metabolic process;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;protein targeting;protein transport;response to stimulus;signal transduction;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q9NRW1,RAB6B,Ras-related protein Rab-6B,3,17.8,28.94,27.66,27.86,25.31,,,26.67,26.22,26.02,23.55,27.05,,26.38,26.57,2.37,1.1,1.3,-1.26, , ,0.1,-0.35,-0.55,-3.02,0.49, ,-0.18,biological regulation;cellular process;establishment of localization;Golgi vesicle transport;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
P51149,RAB7A,Ras-related protein Rab-7a,26,86,33.43,32.84,33.21,32.86,32.27,32.46,32.41,32.63,32.61,32.77,33.3,32.89,33.34,32.85,0.58,0,0.36,0.02,-0.57,-0.39,-0.44,-0.22,-0.24,-0.08,0.45,0.05,0.49,biological regulation;catabolic process;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;endosome transport;establishment of localization;homeostatic process;immune system process;macromolecule metabolic process;metabolic process;organelle fusion;organelle organization;primary metabolic process;protein catabolic process;protein metabolic process;protein targeting;protein transport;response to stimulus;signal transduction;transport;vacuolar transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q96AH8,RAB7B,Ras-related protein Rab-7b,3,20.1,28.75,30.38,24.81,29.57,,,,,27.2,,25.59,27.96,,27.75,1,2.63,-2.94,1.81, , , , ,-0.55, ,-2.16,0.21, ,biological regulation;cellular process;endosome transport;establishment of localization;Golgi vesicle transport;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole;vesicle,,,,,,,,,,
P61006,RAB8A,Ras-related protein Rab-8A (Oncogene c-mel),6,31.9,30.62,30.33,30.47,30.26,30.64,30.84,30.37,30.64,30.59,31.02,30.67,28.75,30.13,30.41,0.21,-0.08,0.06,-0.15,0.23,0.43,-0.04,0.23,0.18,0.61,0.26,-1.66,-0.28,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular membrane organization;cellular process;developmental process;establishment of localization;membrane docking;membrane fusion;membrane organization;organelle fusion;organelle organization;protein transport;regulation of transport;response to stimulus;signal transduction;transport;vesicle organization,cell body;cell part;cell projection;cilium;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;neuronal cell body;organelle;plasma membrane;vesicle,,,,,,,,,,
Q92930,RAB8B,Ras-related protein Rab-8B,4,22.7,26.81,29.72,27.58,28.99,28.7,28.28,28.36,28.89,29.19,24.95,29.2,28.04,27.8,28.19,-1.38,1.52,-0.62,0.79,0.5,0.09,0.17,0.7,1,-3.25,1.01,-0.16,-0.39,biological regulation;cell junction organization;cellular component organization;cellular process;establishment of localization;protein targeting;protein transport;regulation of transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;mitochondrion;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9UI14,RABAC1,Prenylated Rab acceptor protein 1 (PRA1 family protein 1),5,30.3,28.42,28.13,27.47,28.12,28.85,28.74,27.45,28.62,29.78,29.12,29.37,28.25,29.47,28.6,-0.18,-0.47,-1.13,-0.48,0.26,0.14,-1.15,0.02,1.18,0.52,0.77,-0.35,0.87,,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q15276,RABEP1,Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17),6,9.3,25.3,26.5,27.8,27.09,26.14,27.07,26.95,26.97,25.72,26.35,27.62,28.32,25.6,26.73,-1.43,-0.22,1.08,0.36,-0.58,0.34,0.22,0.24,-1,-0.37,0.89,1.59,-1.12,biological regulation;cell death;cellular component organization;cellular membrane organization;cellular process;death;endocytosis;establishment of localization;membrane fusion;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9Y3P9,RABGAP1,Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA),14,16.1,26.69,27.54,27.13,26.57,26.13,24.27,26.62,26.38,20.79,23.53,27.59,26.99,24.28,25.73,0.96,1.81,1.4,0.84,0.4,-1.46,0.89,0.65,-4.94,-2.2,1.86,1.26,-1.45,biological regulation;cell cycle;cellular process,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
Q92696,RABGGTA,Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha),14,28.4,28.49,28.95,28.77,28.25,27.26,26.11,29.48,30.29,24.84,25.87,29.49,29.08,25.35,27.86,0.63,1.08,0.91,0.39,-0.6,-1.75,1.62,2.42,-3.03,-2,1.63,1.21,-2.51,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein metabolic process;protein modification process,,,,,,,,,,,
P53611,RABGGTB,Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta),5,12.4,26.67,26.58,,25.57,25.45,,25.36,26.69,,,27.84,28.45,,26.57,0.1,0, ,-1.01,-1.12, ,-1.21,0.11, , ,1.26,1.87, ,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein metabolic process;protein modification process,,,,,,,,,,,
P47224,RABIF,Guanine nucleotide exchange factor MSS4 (Rab-interacting factor),2,22,25.39,25.73,25.62,26.41,26.6,26.59,26.34,28.01,,25.87,,28.19,,26.47,-1.08,-0.75,-0.85,-0.07,0.12,0.11,-0.13,1.53, ,-0.61, ,1.72, ,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane fusion;membrane organization;protein transport;response to stimulus;signal transduction;transport,,,,,,,,,,,
Q5HYI8,RABL3,Rab-like protein 3,6,24.6,27.88,28.26,31.39,25.71,25.07,23.25,21.9,24.2,23.82,,22.14,23.25,,25.17,2.71,3.09,6.22,0.54,-0.09,-1.92,-3.27,-0.97,-1.34, ,-3.03,-1.92, ,biological regulation;cellular process;response to stimulus;signal transduction,,,,,,,,,,,
Q3YEC7,RABL6,Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1),8,15.5,,25.91,23.22,27.17,24.66,,27.91,25.96,,,26.77,27.57,24.99,26.02, ,-0.11,-2.8,1.16,-1.35, ,1.89,-0.06, , ,0.75,1.56,-1.03,biological regulation;cellular process;response to stimulus;signal transduction,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
P63000,RAC1,Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1),10,64.9,32.23,32.35,32.54,32.4,32.14,32.3,32.24,32.68,32.27,32.21,32.4,31.52,32.18,32.27,-0.03,0.09,0.27,0.13,-0.13,0.04,-0.03,0.42,0,-0.06,0.13,-0.75,-0.09,anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell differentiation;cell junction organization;cell morphogenesis;cell motility;cell proliferation;cellular component assembly;cellular component morphogenesis;cellular component movement;cellular component organization;cellular localization;cellular macromolecular complex assembly;cellular membrane organization;cellular process;cytoskeleton organization;developmental process;homeostatic process;immune system process;localization;locomotion;macromolecular complex assembly;membrane invagination;membrane organization;organelle organization;protein complex assembly;protein polymerization;regulation of DNA metabolic process;regulation of organelle organization;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to osmotic stress;response to stimulus;response to stress;signal transduction;viral reproduction,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
P15153,RAC2,Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2),5,31.1,23.83,29.22,29.43,29.61,30.9,30.19,30.65,30.4,31,29.1,31.08,31.49,31.18,29.85,-6.03,-0.63,-0.42,-0.24,1.04,0.34,0.8,0.55,1.14,-0.75,1.23,1.64,1.33,biological regulation;cell activation;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;homeostatic process;locomotion;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytosol;membrane;nuclear envelope;plasma membrane,,,,,,,,,,
Q9NS91,RAD18,E3 ubiquitin-protein ligase RAD18 (EC 6.3.2.-) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73),4,10.3,24.1,24.96,25.9,23.55,25.16,24.82,24.83,25.32,23.45,25.51,24.32,,25.59,24.79,-0.69,0.17,1.1,-1.24,0.36,0.03,0.04,0.52,-1.34,0.72,-0.47, ,0.8,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;chromosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,SAP-domain,,,,,,,,,
O60216,RAD21,Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog),19,28.5,30.07,29.87,31.56,29.75,29.77,29.38,31.07,28.76,31.08,31.54,29.39,31.15,28.67,30.16,-0.09,-0.29,1.41,-0.41,-0.39,-0.78,0.91,-1.4,0.92,1.38,-0.76,0.99,-1.49,biological regulation;cell cycle;cell death;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome segregation;cytokinesis;death;DNA metabolic process;DNA recombination;DNA repair;localization;macromolecule metabolic process;metabolic process;mitosis;mitotic cell cycle;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cohesin complex;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P54725,RAD23A,UV excision repair protein RAD23 homolog A (HR23A) (hHR23A),8,30.4,27.58,27.67,29.27,28.11,27.45,27.65,28.41,28.95,27.27,26.5,27.76,28.57,27.65,27.91,-0.33,-0.24,1.36,0.2,-0.46,-0.26,0.5,1.04,-0.64,-1.41,-0.15,0.66,-0.26,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;proteasome complex;protein complex,,,,,,,,,,
P54727,RAD23B,UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58),14,44.7,29.2,31.22,30.71,30.96,30.56,30.58,30.85,30.88,30.06,29.74,31.11,29.98,30.3,30.47,-1.28,0.75,0.24,0.49,0.09,0.11,0.38,0.4,-0.41,-0.74,0.64,-0.5,-0.18,biological regulation;catabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cytoplasm;macromolecular complex;nucleoplasm;nucleotide-excision repair complex;proteasome complex;protein complex,,,,,,,,,,
Q92878,RAD50,DNA repair protein RAD50 (hRAD50) (EC 3.6.-.-),40,31.7,31.92,30.47,31,29.93,29.9,30.62,30.42,29.89,30.99,30.98,29.17,28.63,30.27,30.32,1.6,0.15,0.68,-0.39,-0.43,0.29,0.1,-0.43,0.67,0.66,-1.15,-1.69,-0.05,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA geometric change;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of DNA metabolic process;regulation of protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleus;organelle;protein complex,,,,,,,,,,
P78406,RAE1,mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41),12,46.7,30.2,29.86,29.45,30.1,29.98,30.33,29.55,28.94,30.38,29.83,28.33,28.06,29.84,29.6,0.59,0.26,-0.15,0.5,0.38,0.73,-0.06,-0.66,0.77,0.22,-1.27,-1.54,0.24,biological regulation;carbohydrate metabolic process;carbohydrate transport;cellular process;establishment of localization;metabolic process;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nuclear pore;organelle;protein complex,,,,,,,,,,
Q7Z5J4,RAI1,Retinoic acid-induced protein 1,7,6.5,25.84,25.52,26.38,,,,,,22.51,22.52,21.37,,25.89,24.29,1.55,1.23,2.09, , , , , ,-1.78,-1.77,-2.92, ,1.6,anatomical structure development;biological regulation;developmental process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),40,41.5,29.39,30.76,30.95,31.68,30.76,31.56,31.1,30.6,31.73,31.31,31.28,30.11,31.7,30.99,-1.61,-0.23,-0.04,0.69,-0.23,0.56,0.11,-0.39,0.74,0.31,0.28,-0.89,0.71,,cell cortex;cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P11233,RALA,Ras-related protein Ral-A,15,66.5,31.34,30.54,32.1,31.01,33.1,32.91,32.49,32.25,33.04,32.07,31.98,30.16,33.39,32.03,-0.69,-1.49,0.07,-1.02,1.07,0.88,0.46,0.22,1.01,0.04,-0.05,-1.87,1.36,biological regulation;cellular component organization;cellular localization;cellular membrane organization;cellular process;cytokinesis;cytoskeleton organization;establishment of localization;exocytosis;interspecies interaction between organisms;localization;locomotion;membrane organization;multi-organism process;organelle organization;regulation of transport;response to chemical stimulus;response to external stimulus;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;cell surface;membrane;midbody;plasma membrane,,,,,,,,,,
P11234,RALB,Ras-related protein Ral-B,8,27.2,28.04,27.36,28.73,26.66,28.76,28.78,28.02,28,28.42,28.23,27.38,26.71,28.64,27.98,0.06,-0.62,0.75,-1.32,0.78,0.8,0.05,0.02,0.44,0.26,-0.6,-1.27,0.67,biological regulation;cell death;cellular process;cytokinesis;death;regulation of transport;response to stimulus;signal transduction,cell part;membrane;midbody;plasma membrane,,,,,,,,,,
Q2PPJ7,RALGAPA2,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),12,7.7,28.6,25.44,28.92,23.45,23.53,25.67,25.34,25.24,24.07,27.23,26.55,26.91,25.64,25.89,2.71,-0.45,3.02,-2.44,-2.36,-0.22,-0.55,-0.66,-1.82,1.34,0.66,1.02,-0.26,biological regulation;cellular component organization;cellular membrane organization;cellular process;membrane organization;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q86X10,RALGAPB,Ral GTPase-activating protein subunit beta (p170),11,13.9,28.56,27.4,28.74,25.68,24.98,24.02,25.87,26.38,24.86,26.7,26.66,26.58,24.81,26.25,2.31,1.15,2.49,-0.57,-1.27,-2.23,-0.38,0.13,-1.39,0.45,0.41,0.33,-1.44,biological regulation;cellular component organization;cellular membrane organization;cellular process;membrane organization;response to stimulus;signal transduction,,,,,,,,,,,
Q9UKM9,RALY,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),22,75.6,32.35,30.93,31.76,31.34,31.99,32.35,31.67,31.63,32.01,31.63,31.09,30.09,31.89,31.6,0.76,-0.66,0.17,-0.25,0.39,0.76,0.08,0.03,0.41,0.04,-0.5,-1.51,0.29,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62826,RAN,GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein),21,57.4,33.22,33.03,33.09,33.78,33.16,32.21,33.49,33.68,32.94,32.74,32.71,32.8,31.84,32.98,0.25,0.06,0.11,0.81,0.18,-0.77,0.51,0.7,-0.04,-0.23,-0.27,-0.18,-1.14,biological regulation;cell division;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;DNA metabolic process;establishment of localization;localization;macromolecule metabolic process;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;organelle fission;organelle organization;primary metabolic process;protein targeting;protein transport;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;nucleoplasm;organelle;protein complex;vesicle,,,,,,,,,,
P43487,RANBP1,Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1),12,66.7,30.01,29.62,29.83,30.95,30.15,28.43,30.49,30.25,28.58,28.68,29.03,31.42,27.22,29.59,0.42,0.03,0.24,1.36,0.56,-1.16,0.9,0.66,-1.01,-0.91,-0.56,1.83,-2.37,biological regulation;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;response to stimulus;signal transduction;transport,cell part;centrosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nuclear envelope;organelle,,,,,,,,,,
Q6VN20,RANBP10,Ran-binding protein 10 (RanBP10),4,13.6,24.45,25.28,,24.8,26.63,24.42,26.09,24.56,26.77,24.88,24.48,26.61,,25.36,-0.91,-0.08, ,-0.56,1.27,-0.94,0.73,-0.8,1.41,-0.48,-0.88,1.25, ,cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],87,35.7,32.02,31.14,31.58,31.46,31.65,31.76,31.42,31.05,31.41,32.27,30.13,31.14,30.79,31.37,0.65,-0.23,0.21,0.09,0.28,0.39,0.04,-0.32,0.04,0.9,-1.24,-0.23,-0.58,biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;mitotic cell cycle;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;peptidyl-amino acid modification;primary metabolic process;protein folding;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein targeting;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;membrane,,,,,,,,,,
Q9H6Z4,RANBP3,Ran-binding protein 3 (RanBP3),19,45.5,30.71,29.71,29.76,29.75,29.49,29.95,30.12,29.91,30.19,28.89,29.94,28.78,29.91,29.78,0.93,-0.06,-0.02,-0.03,-0.29,0.18,0.34,0.13,0.41,-0.89,0.16,-1,0.13,establishment of localization;protein transport;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96S59,RANBP9,Ran-binding protein 9 (RanBP9) (BPM-L) (BPM90) (Ran-binding protein M) (RanBPM) (RanBP7),7,12.5,28.16,26.97,24.8,26.77,26.2,25.83,,29.03,23.64,,,,,26.42,1.73,0.55,-1.62,0.35,-0.23,-0.59, ,2.61,-2.79, , , , ,cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;locomotion;macromolecular complex assembly;organelle organization;protein complex assembly;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P46060,RANGAP1,Ran GTPase-activating protein 1 (RanGAP1),33,62.4,31.45,31.23,31.16,32.16,32.42,31.64,32.03,32.09,31.84,31.39,31.18,31.71,31.39,31.67,-0.21,-0.44,-0.51,0.49,0.75,-0.03,0.36,0.42,0.17,-0.28,-0.48,0.04,-0.27,biological regulation;cell cycle;cellular process;mitotic cell cycle;regulation of transport;response to stimulus;signal transduction,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;nuclear pore;organelle;protein complex,,,,,,,,,,
P62834,RAP1A,Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1),3,19.6,28.45,28.74,29.77,28.48,21.88,26.12,27.65,,28.72,29.07,28.05,29,27.02,27.75,0.7,1,2.03,0.73,-5.86,-1.63,-0.1, ,0.97,1.32,0.3,1.25,-0.72,biological regulation;cell activation;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of transport;response to stimulus;signal transduction,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P61224,RAP1B,Ras-related protein Rap-1b (GTP-binding protein smg p21B),12,57,31.77,31.69,32.3,31.35,31.68,31.84,31.24,31.25,31.99,31.87,31.65,31.72,32.45,31.75,0.02,-0.07,0.54,-0.4,-0.07,0.09,-0.52,-0.51,0.23,0.12,-0.11,-0.03,0.7,biological regulation;cell activation;cell proliferation;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;regulation of transport;response to stimulus;signal transduction,cell part;cytosol;lipid particle;membrane;plasma membrane,,,,,,,,,,
P52306,RAP1GDS1,Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein),15,27.3,28.94,29.38,28.01,30.35,28.84,27.47,30.2,30.06,27.56,27.69,30.47,30.76,28.13,29.07,-0.13,0.31,-1.06,1.28,-0.23,-1.6,1.13,0.99,-1.5,-1.37,1.41,1.7,-0.94,,,,,,,,,,,,
P61225,RAP2B,Ras-related protein Rap-2b,6,40.9,27.81,28.93,28.89,27.89,26.19,27.39,27.61,25.4,28.65,29.16,26.93,26.85,28.18,27.68,0.13,1.25,1.21,0.2,-1.49,-0.3,-0.08,-2.28,0.97,1.48,-0.76,-0.83,0.5,biological regulation;cellular process;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytosol;membrane,,,,,,,,,,
Q9Y3L5,RAP2C,Ras-related protein Rap-2c,3,21.9,26.55,27.62,27.45,25.65,27.86,27.86,,,27.91,27.33,27.8,26.88,27.99,27.35,-0.81,0.27,0.09,-1.71,0.51,0.51, , ,0.56,-0.02,0.45,-0.48,0.63,biological regulation;cellular process;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytosol;membrane,,,,,,,,,,
Q70E73,RAPH1,Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1),14,20.6,25.46,26.77,24.57,28.55,24.78,23.97,25.02,21.24,,,27.38,26.75,20.77,25.02,0.44,1.75,-0.45,3.53,-0.24,-1.06,0,-3.78, , ,2.35,1.73,-4.25,biological adhesion;biological regulation;cell adhesion;cell growth;cellular process;developmental process;growth;response to stimulus;signal transduction,cell part;cell projection;cytoplasm;cytoskeleton;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P49788,RARRES1,Retinoic acid receptor responder protein 1 (RAR-responsive protein TIG1) (Tazarotene-induced gene 1 protein),6,24.5,29.7,27.83,27.43,26.05,,28.89,24.8,26.35,,24.69,,27.3,26.93,27,2.71,0.83,0.43,-0.94, ,1.9,-2.2,-0.65, ,-2.31, ,0.3,-0.07,biological regulation,cell part,,,,,,,,,,
P54136,RARS,"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)",47,68,32.55,32.67,32.13,32.75,32.61,32.26,32.84,32.94,32.27,32.51,32.3,32.84,32.23,32.53,0.02,0.14,-0.4,0.22,0.08,-0.27,0.31,0.41,-0.26,-0.02,-0.23,0.3,-0.31,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
Q5T160,RARS2,"Probable arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)",8,15.7,27.32,29.1,29.41,29.49,28.43,28.79,28.47,28.74,28.19,28.64,28.68,24.63,29.06,28.38,-1.06,0.72,1.03,1.11,0.05,0.41,0.09,0.36,-0.19,0.26,0.3,-3.75,0.68,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
Q15283,RASA2,Ras GTPase-activating protein 2 (GTPase-activating protein 1m) (GAP1m),2,5.1,26.38,25.54,24.39,25.21,26.45,25.12,24.77,25.57,25.63,25.15,26.87,25.62,26.4,25.62,0.76,-0.09,-1.24,-0.42,0.83,-0.51,-0.85,-0.05,0.01,-0.48,1.25,0,0.78,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q8IY67,RAVER1,Ribonucleoprotein PTB-binding 1 (Protein raver-1),24,55.3,29.82,28.29,28.7,28.57,29.18,28.57,28.54,28.36,28.74,28.24,26.89,24.82,27.6,28.18,1.64,0.11,0.52,0.39,1,0.39,0.36,0.18,0.57,0.06,-1.29,-3.36,-0.57,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P06400,RB1,Retinoblastoma-associated protein (p105-Rb) (pRb) (Rb) (pp110),13,15.9,26.29,24.98,25.28,,,26.37,26.1,26.83,26.28,25.33,,,25.3,25.86,0.43,-0.88,-0.58, , ,0.5,0.23,0.97,0.42,-0.53, , ,-0.56,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell death;cell differentiation;cell division;cell maturation;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;cytoskeleton organization;death;developmental maturation;developmental process;interspecies interaction between organisms;localization;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;response to stimulus;RNA metabolic process;signal transduction,cell part;chromatin remodeling complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
Q09028,RBBP4,Histone-binding protein RBBP4 (Chromatin assembly factor 1 subunit C) (CAF-1 subunit C) (Chromatin assembly factor I p48 subunit) (CAF-I 48 kDa subunit) (CAF-I p48) (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4) (Retinoblastoma-binding protein p48),21,60,32.57,31.1,31.98,31.42,32.09,32.11,31.85,31.76,31.43,31.73,30.92,31.37,31.8,31.7,0.87,-0.6,0.28,-0.28,0.39,0.4,0.15,0.06,-0.27,0.03,-0.78,-0.34,0.1,biological regulation;biosynthetic process;cell cycle;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA replication;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;chromatin remodeling complex;histone methyltransferase complex;macromolecular complex;PcG protein complex;protein complex;transcriptional repressor complex,,,,,,,,,,
Q15291,RBBP5,Retinoblastoma-binding protein 5 (RBBP-5) (Retinoblastoma-binding protein RBQ-3),6,15.2,27.76,26.51,26.34,26.72,26.72,27.02,23.6,25.87,25.74,25.44,23.47,23.61,26.46,25.79,1.97,0.72,0.55,0.93,0.93,1.23,-2.19,0.08,-0.05,-0.35,-2.32,-2.18,0.67,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;small molecule metabolic process,cell part;chromatin remodeling complex;histone methyltransferase complex;macromolecular complex;protein complex,,,,,,,,,,
Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),19,12.1,26.49,25.31,26.07,25.62,25.12,21.18,20.55,,,,,,,24.33,2.16,0.97,1.74,1.28,0.79,-3.16,-3.78, , , , , , ,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleolus;organelle,,,,,,,,,,
Q16576,RBBP7,Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46),11,44,30.05,29.1,29.56,29.65,29.33,30.11,29.94,27.74,29.42,30.17,28.89,27.74,28.05,29.21,0.84,-0.11,0.35,0.44,0.12,0.9,0.73,-1.47,0.21,0.95,-0.32,-1.47,-1.16,biological regulation;biosynthetic process;cell proliferation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA replication;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to abiotic stimulus;response to heat;response to stimulus;response to stress;RNA metabolic process,cell part;chromatin remodeling complex;histone methyltransferase complex;macromolecular complex;PcG protein complex;protein complex;transcriptional repressor complex,,,,,,,,,,
O43251,RBFOX2,RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9) (Repressor of tamoxifen transcriptional activity),7,18.9,25.93,25.71,21.05,25.78,28.47,28.19,26.9,27.71,28.54,28.22,27.56,26.03,29.37,26.88,-0.95,-1.17,-5.83,-1.1,1.59,1.31,0.01,0.83,1.66,1.33,0.68,-0.86,2.49,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H477,RBKS,Ribokinase (EC 2.7.1.15),2,7,23.9,23.85,23.57,,,21.21,22.08,24,,22.51,22.51,25.6,,23.25,0.66,0.6,0.32, , ,-2.03,-1.17,0.75, ,-0.74,-0.73,2.35, ,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;heterocycle metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q9NTZ6,RBM12,RNA-binding protein 12 (RNA-binding motif protein 12) (SH3/WW domain anchor protein in the nucleus) (SWAN),11,11.1,29.76,29.01,29.34,28.77,28.85,29.4,28.64,28.23,29.43,28.1,27.22,28.86,28.44,28.77,0.99,0.24,0.57,0,0.08,0.63,-0.14,-0.55,0.66,-0.68,-1.55,0.09,-0.33,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8IXT5,RBM12B,RNA-binding protein 12B (RNA-binding motif protein 12B),14,20.1,28.03,27.67,28.07,27.97,27.63,28.55,27.26,26.56,28.53,27.93,27.49,27.12,27.32,27.7,0.33,-0.03,0.37,0.27,-0.07,0.85,-0.45,-1.15,0.83,0.23,-0.22,-0.58,-0.39,,,,,,,,,,,,
Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),32,45.4,31.64,30.75,31.02,31.05,31.39,31.16,30.88,30.54,31.4,31.52,30.51,26.88,30.57,30.72,0.92,0.03,0.31,0.34,0.68,0.44,0.16,-0.18,0.69,0.8,-0.2,-3.83,-0.15,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;macromolecular complex;protein complex;ribonucleoprotein complex;transcription factor complex,,,,,,,,,,
Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),19,25.4,29.04,28.28,27.08,28.2,26.89,28.42,27.67,27.69,28.62,27.8,25.32,26.94,27.34,27.64,1.4,0.64,-0.56,0.56,-0.74,0.78,0.04,0.05,0.99,0.16,-2.32,-0.7,-0.3,anatomical structure development;anatomical structure morphogenesis;biological regulation;developmental process;interspecies interaction between organisms;multicellular organismal process;multi-organism process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8NDT2,RBM15B,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),7,9,,25.43,25.7,25.42,25.23,25.61,,24.93,25.35,25.15,,,25.24,25.34, ,0.09,0.36,0.08,-0.11,0.27, ,-0.41,0.01,-0.19, , ,-0.1,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;nucleoplasm,,,,,,,,,,
Q96I25,RBM17,Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17),13,34.7,29.26,27.84,29.66,28.53,28.25,28.23,28.8,28.26,28.23,29.12,26.13,28.35,28.38,28.39,0.87,-0.55,1.27,0.14,-0.14,-0.15,0.41,-0.12,-0.16,0.73,-2.26,-0.04,-0.01,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9Y4C8,RBM19,Probable RNA-binding protein 19 (RNA-binding motif protein 19),5,8.1,25.91,26.23,25.65,25.47,27.22,26.2,25.39,24.72,27.08,26.38,25.15,26.43,26.58,26.03,-0.13,0.2,-0.38,-0.56,1.19,0.16,-0.64,-1.31,1.05,0.34,-0.88,0.4,0.55,biological regulation;developmental process;multicellular organismal development;multicellular organismal process,cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q9NW64,RBM22,Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) (Zinc finger CCCH domain-containing protein 16),5,10.5,27.86,27.51,26.41,26.69,25.81,26.3,26.39,24.84,27.53,25.83,,,25.92,26.46,1.4,1.04,-0.05,0.23,-0.65,-0.16,-0.08,-1.62,1.07,-0.63, , ,-0.54,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein transport;regulation of transport;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P49756,RBM25,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),27,31.9,31.27,30.62,30.06,30.02,31.36,31.02,30.34,30.56,30.73,31.48,29.69,30.65,30.74,30.66,0.61,-0.04,-0.6,-0.63,0.7,0.36,-0.31,-0.09,0.07,0.82,-0.97,-0.01,0.08,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm,,,,,,,,,,
Q5T8P6,RBM26,RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26),9,10.4,26.75,26.5,25.58,26.56,25.76,26.59,27,25.75,27.81,26.67,,24.62,24.65,26.19,0.56,0.31,-0.61,0.37,-0.43,0.41,0.81,-0.43,1.63,0.48, ,-1.56,-1.54,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,,,,,,,,,,,
Q9P2N5,RBM27,RNA-binding protein 27 (RNA-binding motif protein 27),11,14.5,28.19,27.18,26.01,26.38,,27.57,27.22,27.93,28.8,28.61,26.9,,26.96,27.43,0.76,-0.25,-1.42,-1.05, ,0.14,-0.21,0.5,1.36,1.18,-0.53, ,-0.47,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NW13,RBM28,RNA-binding protein 28 (RNA-binding motif protein 28),11,20.4,28.6,29.16,27.05,28.99,28.81,27.89,27.76,27,28.51,28.86,26.95,27.83,27.56,28.07,0.52,1.09,-1.03,0.91,0.74,-0.18,-0.31,-1.07,0.43,0.78,-1.12,-0.24,-0.52,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P98179,RBM3,Putative RNA-binding protein 3 (RNA-binding motif protein 3) (RNPL),8,66.9,31.41,28.91,30.73,31.92,32.68,32.01,32.51,32.03,32.12,31.37,30.69,32.4,31.98,31.6,-0.19,-2.69,-0.87,0.32,1.09,0.41,0.91,0.43,0.53,-0.22,-0.91,0.8,0.39,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;regulation of translation;response to abiotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;translation,cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;nucleus;organelle,,,,,,,,,,
Q96EV2,RBM33,RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33),9,10.5,27.33,25.98,26.09,22.47,26.84,26.53,25.93,26.49,24.44,26.43,25.29,25.52,24.98,25.72,1.61,0.26,0.37,-3.25,1.12,0.81,0.21,0.77,-1.27,0.71,-0.43,-0.19,-0.73,,,,,,,,,,,,
Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),25,49.4,32.12,30.96,30.9,30.94,31.01,30.82,30.9,30.92,31.49,30.73,29.35,30.14,30.4,30.82,1.3,0.14,0.08,0.12,0.19,0,0.08,0.1,0.66,-0.09,-1.47,-0.68,-0.42,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleoplasm;organelle,,,,,,,,,,
Q9BWF3,RBM4,RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a),15,45.3,30.78,30.03,30.31,30.61,31.05,30.94,30.14,30.82,30.83,30.54,29.88,29.9,30.37,30.47,0.31,-0.44,-0.17,0.13,0.57,0.46,-0.34,0.34,0.36,0.06,-0.6,-0.58,-0.11,biological regulation;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;regulation of transport;response to abiotic stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;signal transduction;translational initiation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q9BTD8,RBM42,RNA-binding protein 42 (RNA-binding motif protein 42),5,13.9,27.3,26.54,28.33,25.97,27.97,28.39,26.66,26.96,27.76,26.64,27.48,26.42,27.33,27.21,0.08,-0.68,1.12,-1.24,0.76,1.18,-0.55,-0.25,0.55,-0.57,0.27,-0.79,0.12,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8IUH3,RBM45,RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45),3,12.9,25.8,,23.52,25.45,25.9,,25.86,25.68,26.76,25.83,24.9,23.8,26.01,25.41,0.39, ,-1.89,0.04,0.49, ,0.45,0.27,1.35,0.42,-0.51,-1.61,0.6,anatomical structure development;cell differentiation;cellular process;developmental process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
A0AV96,RBM47,RNA-binding protein 47 (RNA-binding motif protein 47),10,29.3,27.76,27.48,28.29,25.93,25.77,26.73,27.94,27.83,25.73,29.33,27.88,28.09,27.45,27.4,0.36,0.07,0.89,-1.47,-1.64,-0.67,0.54,0.43,-1.67,1.93,0.48,0.69,0.05,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y580,RBM7,RNA-binding protein 7 (RNA-binding motif protein 7),7,35.7,28.21,25.54,26.67,24.5,26.09,26.58,24.64,24.29,26.92,26.61,,25.26,,25.94,2.28,-0.4,0.73,-1.44,0.15,0.64,-1.3,-1.64,0.99,0.67, ,-0.68, ,cellular process;meiosis,,,,,,,,,,,
Q9Y5S9,RBM8A,RNA-binding protein 8A (Binder of OVCA1-1) (BOV-1) (RNA-binding motif protein 8A) (RNA-binding protein Y14) (Ribonucleoprotein RBM8A),10,67.2,30.37,29.37,30.16,29.61,28.4,29.93,29.28,28.67,29.86,30.06,28.31,27.83,29.11,29.31,1.07,0.06,0.85,0.31,-0.9,0.62,-0.02,-0.63,0.55,0.76,-0.99,-1.47,-0.2,"biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q15434,RBMS2,"RNA-binding motif, single-stranded-interacting protein 2 (Suppressor of CDC2 with RNA-binding motif 3)",7,24.6,28.1,27.83,29.05,29.05,28.19,28.11,29.66,27.96,29.13,30.09,29.42,,27.93,28.71,-0.61,-0.88,0.34,0.34,-0.52,-0.6,0.95,-0.75,0.42,1.38,0.71, ,-0.78,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P38159,RBMX,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",47,71.6,32.77,32.12,32.16,32.28,32.85,32.54,32.56,32.3,33.06,32.57,31.45,32.12,32.38,32.4,0.38,-0.28,-0.24,-0.11,0.45,0.14,0.16,-0.1,0.67,0.17,-0.94,-0.27,-0.02,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;proteolysis;response to chemical stimulus;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;transcription from RNA polymerase II promoter,cell part;extracellular organelle;macromolecular complex;nucleoplasm;organelle;ribonucleoprotein complex;spliceosomal complex;vesicle,,,,,,,,,,
Q9Y388,RBMX2,"RNA-binding motif protein, X-linked 2",6,16.7,24.86,26.82,24.28,24.44,26.11,24.81,25.01,23.72,24.86,26.18,,24.07,22.46,24.8,0.05,2.02,-0.52,-0.36,1.31,0.01,0.21,-1.08,0.06,1.38, ,-0.73,-2.34,,,,,,,,,,,,
Q96E39,RBMXL1,"RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1)",5,9.9,27.4,26.95,25.07,26.56,25.69,27.04,25.27,26.07,27.54,26.35,27.34,26.05,27.37,26.51,0.88,0.44,-1.45,0.05,-0.83,0.53,-1.25,-0.45,1.03,-0.17,0.83,-0.47,0.85,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
P09455,RBP1,Retinol-binding protein 1 (Cellular retinol-binding protein) (CRBP) (Cellular retinol-binding protein I) (CRBP-I),14,77,32.87,30.56,29.43,26.05,29.43,28.66,29.23,30.16,29.81,27.07,28.31,26.79,24.76,28.7,4.17,1.85,0.73,-2.65,0.73,-0.04,0.53,1.46,1.11,-1.64,-0.39,-1.91,-3.94,biological regulation;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;hormone metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;signal transduction;small molecule metabolic process;vitamin metabolic process,cell body;cell part;cytosol,,,,,,,,,,
Q93062,RBPMS,RNA-binding protein with multiple splicing (RBP-MS) (Heart and RRM expressed sequence) (Hermes),8,57.3,29.26,28.46,28.95,28.4,28.25,28.26,28.6,29.25,27.73,28.53,29.06,27.21,28.06,28.46,0.8,0,0.49,-0.06,-0.22,-0.21,0.14,0.78,-0.73,0.06,0.6,-1.25,-0.4,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein modification process;regulation of transport;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P62877,RBX1,"E3 ubiquitin-protein ligase RBX1 (EC 6.3.2.-) (Protein ZYP) (RING finger protein 75) (RING-box protein 1) (Rbx1) (Regulator of cullins 1) [Cleaved into: E3 ubiquitin-protein ligase RBX1, N-terminally processed]",4,32.4,29.28,28.99,29.86,28.69,29.65,29.58,29.95,29.73,28.97,29.23,29.51,27.01,29.27,29.21,0.07,-0.22,0.65,-0.52,0.44,0.37,0.74,0.52,-0.24,0.02,0.3,-2.2,0.06,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
P18754,RCC1,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),18,47.3,31.23,30.8,30.91,30.49,30.81,30.25,29.24,29.68,30.15,31.28,28.6,28.28,29.39,30.09,1.14,0.71,0.83,0.41,0.73,0.16,-0.84,-0.4,0.07,1.2,-1.49,-1.8,-0.7,biological regulation;cell division;cellular component assembly;cellular component organization;cellular process;chromosome segregation;cytoskeleton organization;mitosis;nuclear division;organelle assembly;organelle fission;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization,cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nuclear chromosome;nucleoplasm;organelle,,,,,,,,,,
Q9P258,RCC2,Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa),20,42.3,32.91,30.22,30.75,29.97,30.69,30.06,30.3,30.3,29.82,30.39,28.27,27.88,28.81,30.03,2.88,0.19,0.72,-0.06,0.66,0.03,0.27,0.27,-0.21,0.36,-1.76,-2.15,-1.22,cell cycle;cell division;cellular component organization;cellular process;mitosis;mitotic cell cycle;nuclear division;organelle fission;organelle organization,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q9Y2P8,RCL1,RNA 3'-terminal phosphate cyclase-like protein,7,23.6,26.74,26.37,27.85,27.84,28.59,27.66,25.33,25.46,27.72,27.44,27.1,27.05,27.48,27.13,-0.38,-0.76,0.72,0.71,1.46,0.54,-1.79,-1.66,0.59,0.32,-0.02,-0.08,0.35,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribosome biogenesis;RNA metabolic process;RNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q15293,RCN1,Reticulocalbin-1,27,80.4,32.7,34.5,32.98,34.23,33.18,33.96,33.4,33.43,34.47,33.37,33.94,33.26,34.3,33.67,-0.97,0.83,-0.69,0.56,-0.49,0.29,-0.27,-0.24,0.8,-0.3,0.27,-0.41,0.63,anatomical structure development;developmental process;embryo development,cell part,,,,,,,,,,
Q14257,RCN2,Reticulocalbin-2 (Calcium-binding protein ERC-55) (E6-binding protein) (E6BP),15,64,28.38,31.81,28.93,31.11,30.73,31.53,30.63,30.8,31.04,30.2,31.19,30.67,31.71,30.67,-2.29,1.14,-1.74,0.44,0.06,0.86,-0.04,0.13,0.37,-0.47,0.51,0,1.04,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q96D15,RCN3,Reticulocalbin-3 (EF-hand calcium-binding protein RLP49),12,39.9,25.46,32.12,27.22,31.31,29.63,29.52,23.07,26.21,31.5,26.46,26.51,26.74,29.54,28.1,-2.64,4.02,-0.88,3.21,1.53,1.42,-5.03,-1.89,3.4,-1.64,-1.59,-1.36,1.44,,cell part,,,,,,,,,,
Q9UKL0,RCOR1,REST corepressor 1 (Protein CoREST),12,25.9,27.78,25.12,27.61,26.31,26.81,26.54,25.71,25.37,26.47,28.32,,,25.38,26.49,1.29,-1.37,1.12,-0.18,0.31,0.05,-0.78,-1.12,-0.02,1.82, , ,-1.11,biological regulation;cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;coagulation;histone modification;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;organelle organization;primary metabolic process;protein metabolic process;protein modification process;regulation of body fluid levels,cell part;macromolecular complex;protein complex;transcriptional repressor complex,,,,,,,,,,
Q6JBY9,RCSD1,CapZ-interacting protein (Protein kinase substrate CapZIP) (RCSD domain-containing protein 1),12,40.7,22.09,23.93,26.39,20.73,25.94,,26.41,27.56,,,25.83,,,24.86,-2.77,-0.93,1.53,-4.13,1.08, ,1.55,2.7, , ,0.97, , ,cellular process;multicellular organismal process;muscle contraction;response to abiotic stimulus;response to osmotic stress;response to stimulus;response to stress,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q8IZV5,RDH10,Retinol dehydrogenase 10 (EC 1.1.1.300),9,29,27.37,28.74,29.08,28.54,28.27,28.4,29.47,27.39,25.47,29.56,29.05,29.73,29.6,28.51,-1.14,0.23,0.57,0.03,-0.24,-0.11,0.95,-1.13,-3.05,1.05,0.53,1.22,1.09,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell development;cellular aldehyde metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;developmental process;embryo development;growth;hormone metabolic process;lipid metabolic process;metabolic process;multicellular organismal process;neurological system process;organic acid metabolic process;primary metabolic process;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;small molecule metabolic process;vitamin metabolic process,cell body;cell part;membrane,,,,,,,,,,
Q8TC12,RDH11,Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1),10,36.2,29.61,30.39,30.34,30.97,31.3,31.41,30.78,31.21,30.99,31.54,30.86,29.75,31.89,30.85,-1.24,-0.46,-0.51,0.12,0.45,0.56,-0.07,0.36,0.14,0.69,0.01,-1.1,1.04,biological regulation;cellular aldehyde metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;small molecule metabolic process;vitamin metabolic process,cell part;membrane;photoreceptor inner segment,,,,,,,,,,
Q8NBN7,RDH13,Retinol dehydrogenase 13 (EC 1.1.1.-),6,22.7,27.54,28.05,28.1,25.41,25.67,26.32,26.91,27.21,,27.57,27.96,25.44,26.07,26.86,0.69,1.19,1.25,-1.44,-1.18,-0.54,0.06,0.36, ,0.71,1.11,-1.42,-0.78,,,,,,,,,,,,
Q9HBH5,RDH14,Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2),8,30.1,28.48,28.35,28.68,28.15,28.58,29.26,27.55,27.21,29.17,28.39,29.26,29.03,29.92,28.62,-0.14,-0.27,0.06,-0.47,-0.03,0.65,-1.07,-1.41,0.56,-0.23,0.64,0.41,1.3,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P35241,RDX,Radixin,14,26.1,29.31,28.75,29.26,30.03,28.99,28.82,28.4,28.18,27.85,26.42,30.48,27.57,27.81,28.6,0.7,0.15,0.66,1.42,0.39,0.21,-0.2,-0.42,-0.75,-2.19,1.87,-1.03,-0.8,biological regulation;cellular component organization;regulation of organelle organization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P46063,RECQL,"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)",34,58.2,32.23,31.81,31.96,31.37,32.23,32.56,32.18,32.03,32.59,30.92,31.77,31.09,32.34,31.93,0.3,-0.12,0.03,-0.56,0.3,0.63,0.25,0.1,0.66,-1.01,-0.16,-0.84,0.41,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;DNA repair;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H6H4,REEP4,Receptor expression-enhancing protein 4,4,16,26.91,26.04,,25.16,26.47,25.47,25.64,26.05,,,26.07,25.61,26.2,25.96,0.95,0.08, ,-0.8,0.51,-0.49,-0.32,0.09, , ,0.11,-0.35,0.24,,cell part,,,,,,,,,,
Q00765,REEP5,Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2),10,37.8,30.78,30.68,30.59,30.79,30.21,31.14,30.02,30.31,31.19,31.23,31.24,29.86,30.75,30.68,0.1,0,-0.09,0.11,-0.47,0.46,-0.65,-0.37,0.52,0.55,0.57,-0.82,0.07,,cell part,,,,,,,,,,
Q2TAM5,RELA,RELA protein (Transcription factor p65),6,19.1,26.78,27.58,26.04,27.11,26.5,26.95,29.07,28.77,,24.41,28.68,27.62,24.32,26.99,-0.2,0.59,-0.95,0.12,-0.48,-0.04,2.09,1.79, ,-2.57,1.69,0.63,-2.67,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),13,25.9,27.99,26.07,26.59,27.25,27.23,23.89,28,27.82,27.02,25.96,28.83,26.91,24.77,26.79,1.2,-0.72,-0.21,0.45,0.44,-2.91,1.2,1.03,0.23,-0.83,2.03,0.12,-2.03,cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;transport;vesicle-mediated transport,cell part;membrane;plasma membrane,,,,,,,,,,
Q8NFH8,REPS2,RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2),4,8.3,24.92,23.77,23.99,23.02,24.33,26.75,26.94,26.75,25.88,24.93,28.87,27.29,26.98,25.72,-0.81,-1.96,-1.74,-2.7,-1.39,1.02,1.22,1.03,0.16,-0.79,3.14,1.57,1.25,biological regulation;cellular component assembly;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;macromolecular complex assembly;membrane invagination;membrane organization;protein complex assembly;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasm,,,,,,,,,,
O15258,RER1,Protein RER1,6,34.7,30.2,30.41,30.35,30.51,28.29,29.62,29.35,30.03,29.32,30.51,30.62,29.19,30.26,29.9,0.3,0.52,0.45,0.61,-1.61,-0.27,-0.55,0.13,-0.58,0.61,0.72,-0.7,0.37,cellular process;establishment of localization;Golgi vesicle transport;transport;vesicle-mediated transport,cell part,,,,,,,,,,
Q6NUM9,RETSAT,"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)",19,36.7,28.35,30.12,28.34,30.48,30.79,30.17,30.57,31.01,31.39,32.58,32.17,29.78,31.91,30.59,-2.24,-0.47,-2.25,-0.11,0.2,-0.42,-0.02,0.42,0.8,1.99,1.58,-0.81,1.32,biological regulation;cellular lipid metabolic process;cellular metabolic process;cellular process;hormone metabolic process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process;vitamin metabolic process,cell part;membrane,,,,,,,,,,
H0YGR4,REXO2,"Oligoribonuclease, mitochondrial (Fragment)",10,40.1,29.7,29.49,29.15,29.93,29.12,29.27,29.12,29.27,28.71,27.77,28.86,28.29,28.66,29.03,0.68,0.47,0.12,0.9,0.09,0.24,0.09,0.24,-0.32,-1.26,-0.17,-0.73,-0.36,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleolus;organelle;plasma membrane,,,,,,,,,,
P35251,RFC1,Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit),10,12.2,25.72,25.91,25.89,26.24,27.36,26.58,26.45,25.68,26.43,25.76,24.78,27.18,25.45,26.11,-0.39,-0.2,-0.22,0.13,1.25,0.47,0.34,-0.43,0.32,-0.35,-1.33,1.07,-0.66,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;telomere organization,cell part;DNA replication factor C complex;macromolecular complex;nucleoplasm;protein complex,Other TF domain,,,,,,,,,
P35250,RFC2,Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40),9,31.4,27.4,28.12,27.04,27.73,29.31,28.98,28.45,28.19,27.93,27.58,,,26.52,27.93,-0.53,0.18,-0.89,-0.2,1.38,1.05,0.51,0.26,0,-0.35, , ,-1.42,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;DNA replication factor C complex;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P40938,RFC3,Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38),4,13.4,25.43,24.78,27.2,25.54,27.14,26.92,26.9,26.71,26.84,27.2,,,26.34,26.46,-1.02,-1.68,0.74,-0.91,0.68,0.47,0.45,0.26,0.38,0.74, , ,-0.11,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;DNA replication factor C complex;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P35249,RFC4,Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37),8,35.3,29.14,28.82,28.24,29.33,27.86,28.96,29.37,29.16,29.2,28.73,26.52,28.42,29.08,28.68,0.46,0.14,-0.44,0.65,-0.82,0.28,0.69,0.48,0.52,0.05,-2.16,-0.26,0.4,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;telomere organization,cell part;DNA replication factor C complex;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P40937,RFC5,Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36),8,35.7,29.04,26.14,27.62,27.59,29.05,28.99,28.5,29.05,28.93,27.64,,28.58,27.89,28.25,0.79,-2.11,-0.64,-0.66,0.8,0.74,0.25,0.79,0.68,-0.61, ,0.33,-0.36,biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;DNA replication factor C complex;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q14699,RFTN1,Raftlin (Cell migration-inducing gene 2 protein) (Raft-linking protein),13,27.7,28.07,28.63,28.73,30,28.49,28.99,25.41,25.93,29.42,26.69,28.54,29.87,28.72,28.27,-0.2,0.36,0.46,1.73,0.22,0.72,-2.86,-2.34,1.15,-1.58,0.28,1.6,0.45,,cell part;membrane;plasma membrane,,,,,,,,,,
P48382,RFX5,DNA-binding protein RFX5 (Regulatory factor X 5),5,11.5,27.42,26.88,25.42,27.01,25.37,27.51,28.78,27.94,26.15,24.65,28.68,28.52,25.91,26.94,0.48,-0.06,-1.52,0.07,-1.57,0.57,1.84,0.99,-0.79,-2.3,1.74,1.58,-1.03,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
O43665,RGS10,Regulator of G-protein signaling 10 (RGS10),6,40.3,29.37,27.14,26.04,27.63,26.25,24.74,24.73,26.71,24.76,26.91,27.43,,,26.52,2.86,0.62,-0.48,1.12,-0.27,-1.78,-1.79,0.19,-1.76,0.39,0.91, , ,biological regulation,cell body;cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;neuronal cell body;nucleus;organelle;plasma membrane,,,,,,,,,,
Q15382,RHEB,GTP-binding protein Rheb (Ras homolog enriched in brain),10,32.6,29.73,28.83,28.92,29.72,29.77,29.05,29.71,29.82,28.87,27.88,29.95,29.24,28.03,29.19,0.53,-0.36,-0.28,0.53,0.57,-0.14,0.52,0.63,-0.32,-1.32,0.76,0.04,-1.16,biological regulation;cellular process;regulation of cell cycle;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell body;cell part;cell projection;cytosol;macromolecular complex;membrane;neuron projection;neuronal cell body;plasma membrane;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P61586,RHOA,Transforming protein RhoA (Rho cDNA clone 12) (h12),14,66.3,32.79,32.63,32.18,32.26,32.12,31.98,32.33,32.02,32.2,32.13,32.06,32.45,31.78,32.23,0.56,0.4,-0.05,0.03,-0.1,-0.24,0.11,-0.2,-0.03,-0.09,-0.16,0.22,-0.45,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell junction organization;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;developmental process;interspecies interaction between organisms;locomotion;multicellular organismal process;multi-organism process;organelle assembly;organelle organization;regulation of organelle organization;regulation of translation;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell cortex;cell part;cell projection;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;midbody;mitochondrion;neuron projection;nucleus;organelle;plasma membrane,,,,,,,,,,
P08134,RHOC,Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9),7,39.7,28.89,28.35,28.19,28.45,28.32,28.12,28.92,28.17,28.75,28.93,29.8,30.63,29.37,28.84,0.05,-0.48,-0.65,-0.38,-0.52,-0.72,0.09,-0.66,-0.09,0.09,0.96,1.79,0.53,biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;cytokinesis;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9HBH0,RHOF,Rho-related GTP-binding protein RhoF (Rho family GTPase Rif) (Rho in filopodia),7,39.8,28.67,27.22,28.98,,27.37,25.12,24.86,27.02,28.35,30,26.14,,,27.37,1.3,-0.16,1.61, ,0,-2.25,-2.52,-0.35,0.98,2.62,-1.24, , ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;response to stimulus;signal transduction,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P84095,RHOG,Rho-related GTP-binding protein RhoG,9,51.3,28.71,29.47,30,29.02,29.42,30.01,29.58,29.25,29.04,29.36,30.08,28.3,30,29.4,-0.69,0.07,0.6,-0.39,0.02,0.61,0.18,-0.16,-0.36,-0.04,0.68,-1.1,0.6,biological regulation;cell activation;cell motility;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;locomotion;organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q8IXI2,RHOT1,Mitochondrial Rho GTPase 1 (MIRO-1) (hMiro-1) (EC 3.6.5.-) (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1),6,11.4,27.54,27.71,27.56,26.94,27.56,28.04,28.43,27.22,29.1,29.3,28.29,28.38,28.22,28.02,-0.49,-0.31,-0.46,-1.09,-0.47,0.02,0.41,-0.8,1.07,1.28,0.27,0.36,0.19,biological regulation;catabolic process;cellular component movement;cellular homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;heterocycle metabolic process;homeostatic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process;transport,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q8IXI1,RHOT2,Mitochondrial Rho GTPase 2 (MIRO-2) (hMiro-2) (EC 3.6.5.-) (Ras homolog gene family member T2),13,29.6,29.09,29.38,29.61,29.66,30.23,30.24,29.69,28.96,30.46,30.63,29.87,29.74,30.36,29.84,-0.75,-0.46,-0.23,-0.19,0.39,0.4,-0.15,-0.88,0.62,0.79,0.03,-0.1,0.52,biological regulation;catabolic process;cellular component movement;cellular homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;heterocycle metabolic process;homeostatic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process;transport,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
Q8IUC4,RHPN2,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),22,41.7,30.82,27.01,28.74,22.66,26.76,27.21,28.24,28.01,,29.29,27.54,27.1,26.38,27.48,3.34,-0.47,1.26,-4.82,-0.73,-0.27,0.76,0.53, ,1.81,0.06,-0.38,-1.1,biological regulation;cellular process;response to stimulus;signal transduction,cell part,,,,,,,,,,
Q9NPQ8,RIC8A,Synembryn-A (Protein Ric-8A),15,36.6,26.54,28.59,28.18,28.75,28.43,27.19,29.67,29.32,28.85,27.57,28.64,29.5,27.95,28.4,-1.86,0.19,-0.22,0.35,0.03,-1.21,1.28,0.92,0.45,-0.83,0.24,1.1,-0.45,anatomical structure development;behavior;biological adhesion;biological regulation;cell adhesion;cell motility;cellular component movement;cellular component organization;cellular process;developmental process;embryo development;extracellular matrix organization;extracellular structure organization;locomotion;multicellular organismal process;neurological system process;response to abiotic stimulus;response to stimulus;signal transduction,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q5UIP0,RIF1,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog),23,12.5,28.84,24.89,28.86,25.82,25.42,26.02,26.74,26.14,24.42,26.9,22.38,26.25,24.73,25.95,2.88,-1.07,2.91,-0.14,-0.53,0.07,0.79,0.18,-1.54,0.95,-3.57,0.3,-1.23,biological regulation;cell cycle;cellular process;developmental process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q06587,RING1,E3 ubiquitin-protein ligase RING1 (EC 6.3.2.-) (Polycomb complex protein RING1) (RING finger protein 1) (Really interesting new gene 1 protein),2,9.2,26.73,25.7,27.58,25.61,24.55,26.35,26.09,26.29,26.89,26.74,,,,26.25,0.48,-0.55,1.32,-0.64,-1.7,0.1,-0.16,0.04,0.63,0.48, , , ,anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;RNA metabolic process,cell part;cytoplasm;macromolecular complex;PcG protein complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q6NUQ1,RINT1,RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1),9,13.9,27.05,26.81,27.35,26.7,27.04,27.56,27.83,27.32,28.21,28.45,28.06,27.08,28.28,27.52,-0.46,-0.71,-0.17,-0.82,-0.47,0.04,0.31,-0.2,0.69,0.93,0.54,-0.44,0.76,biological regulation;cell cycle;cellular process;establishment of localization;protein transport;regulation of cell cycle;response to DNA damage stimulus;response to stimulus;response to stress;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9BVS4,RIOK2,Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2),5,16.7,25.92,26.64,26.07,25.44,,,23.78,26.89,,,,24.93,,25.67,0.25,0.97,0.4,-0.23, , ,-1.88,1.22, , , ,-0.74, ,,,,+,,,,,,,,
O14730,RIOK3,Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog),3,8.5,23.98,24.23,23.26,23.42,,20.8,22.62,20.96,22.66,23.13,23.74,25.37,22.87,23.09,0.89,1.14,0.17,0.33, ,-2.29,-0.46,-2.13,-0.42,0.04,0.66,2.29,-0.22,cellular process;chromosome segregation,,,+,,,,,,,,
Q13546,RIPK1,Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) (Serine/threonine-protein kinase RIP),5,10.6,27.19,25.93,26.58,27.43,26.52,,27.01,27.69,26.51,,27.92,27.98,24.89,26.88,0.31,-0.95,-0.3,0.56,-0.35, ,0.13,0.81,-0.36, ,1.05,1.1,-1.99,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;immune system process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein catabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;death-inducing signaling complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex;receptor complex,,+,,,,,,,,
Q96DB5,RMDN1,Regulator of microtubule dynamics protein 1 (RMD-1) (hRMD-1) (Protein FAM82B),13,34.1,29.43,28.9,30.28,29.85,30.01,30.67,29.74,29.07,30.39,30.61,29.86,29.89,30.33,29.92,-0.49,-1.03,0.36,-0.08,0.08,0.75,-0.19,-0.85,0.46,0.68,-0.06,-0.04,0.4,,cell part;centrosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;mitochondrion;organelle;protein complex,,,,,,,,,,
Q96LZ7,RMDN2,Regulator of microtubule dynamics protein 2 (RMD-2) (hRMD-2) (Protein FAM82A1),3,9.5,,,27.15,23.76,,26.06,26.42,25.1,26.66,24.12,27.33,26.09,27.52,26.02, , ,1.13,-2.27, ,0.04,0.4,-0.92,0.64,-1.9,1.31,0.07,1.5,,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q96TC7,RMDN3,Regulator of microtubule dynamics protein 3 (RMD-3) (hRMD-3) (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51),13,31.9,28.86,29.36,29.44,29.26,29.16,29.43,29.28,28.84,29.53,30.03,30.15,29.77,29.86,29.46,-0.6,-0.09,-0.02,-0.2,-0.3,-0.03,-0.18,-0.62,0.07,0.58,0.69,0.32,0.4,biological regulation;cell death;cell differentiation;cellular homeostasis;cellular ion homeostasis;cellular process;death;developmental process;homeostatic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
Q9NWS8,RMND1,Required for meiotic nuclear division protein 1 homolog,5,28.9,26.72,24.94,26.29,26.74,24.72,27.13,26.52,25.43,26.37,27.56,27.77,27.05,27.27,26.5,0.22,-1.56,-0.21,0.24,-1.78,0.62,0.02,-1.07,-0.13,1.06,1.27,0.55,0.76,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9H871,RMND5A,Protein RMD5 homolog A,3,9.2,26.21,25.95,,25.96,24.31,,,24.94,25.24,22.35,,,24.31,24.91,1.3,1.04, ,1.05,-0.6, , ,0.03,0.34,-2.56, , ,-0.6,,,,,,,,,,,,
O75792,RNASEH2A,Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A),3,14.7,24.94,24.85,24.53,24.45,24.75,22.95,22.68,25.07,,,,25.65,,24.43,0.51,0.42,0.1,0.02,0.32,-1.48,-1.75,0.64, , , ,1.22, ,biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q8TDP1,RNASEH2C,Ribonuclease H2 subunit C (RNase H2 subunit C) (Aicardi-Goutieres syndrome 3 protein) (AGS3) (RNase H1 small subunit) (Ribonuclease HI subunit C),2,19.4,25.51,23.56,,,26.48,25.48,,24.23,23.44,,,,21.25,24.28,1.23,-0.72, , ,2.2,1.2, ,-0.05,-0.84, , , ,-3.03,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
O00584,RNASET2,Ribonuclease T2 (EC 3.1.27.-) (Ribonuclease 6),18,53.1,32.3,29.03,31.99,27.61,27.83,27.93,26.29,27.07,26.93,32.68,26.44,26.81,27.66,28.5,3.79,0.53,3.49,-0.9,-0.68,-0.58,-2.21,-1.44,-1.58,4.17,-2.06,-1.7,-0.85,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q5VTR2,RNF20,E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 6.3.2.-) (RING finger protein 20),11,13.5,27.99,,26.37,26.78,27.61,27.57,27.27,,26.08,27.43,21.33,24.95,27.65,26.46,1.54, ,-0.09,0.33,1.15,1.11,0.81, ,-0.38,0.97,-5.13,-1.51,1.2,biological regulation;catabolic process;cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of organelle organization;regulation of protein modification process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;ubiquitin conjugating enzyme complex;ubiquitin ligase complex,,,,,,,,,,
Q63HN8,RNF213,E3 ubiquitin-protein ligase RNF213 (EC 6.3.2.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213),60,14.2,30.67,29.82,31.63,30.09,28.91,29.87,30.03,30.29,28.33,29.79,29.25,27.78,27.8,29.56,1.11,0.27,2.07,0.53,-0.65,0.31,0.47,0.73,-1.22,0.23,-0.31,-1.78,-1.76,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm,,,,,,,,,,
Q96BH1,RNF25,E3 ubiquitin-protein ligase RNF25 (EC 6.3.2.-) (RING finger protein 25),2,6.1,25.22,24.83,24.13,25.79,24.35,24.57,24.93,24.47,24.92,,24.04,24.49,24.55,24.69,0.53,0.13,-0.56,1.1,-0.34,-0.12,0.24,-0.22,0.23, ,-0.65,-0.2,-0.14,biological regulation,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75150,RNF40,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 6.3.2.-) (95 kDa retinoblastoma-associated protein) (RBP95) (RING finger protein 40),6,8.1,27.12,25.89,26.6,26.79,,27.11,27.31,27.15,28.02,25.89,24.52,,25.56,26.54,0.58,-0.65,0.06,0.25, ,0.56,0.77,0.61,1.48,-0.65,-2.02, ,-0.99,catabolic process;cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;nucleus;organelle;plasma membrane;protein complex;ubiquitin conjugating enzyme complex;ubiquitin ligase complex,,,,,,,,,,
Q99942,RNF5,E3 ubiquitin-protein ligase RNF5 (EC 6.3.2.-) (Protein G16) (RING finger protein 5) (Ram1 homolog) (HsRma1),2,18.7,26.97,28,26.99,26.17,28.21,27.39,26.91,27.17,27.49,27.76,26.95,28.43,25.72,27.24,-0.27,0.76,-0.25,-1.07,0.96,0.15,-0.33,-0.07,0.25,0.51,-0.3,1.19,-1.53,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;membrane,,,,,,,,,,
Q9UBF6,RNF7,RING-box protein 2 (Rbx2) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein),2,27.4,25.98,22.34,21.72,,23.2,,21.86,21.97,,23.4,22.31,25.13,,23.1,2.88,-0.76,-1.38, ,0.1, ,-1.24,-1.13, ,0.3,-0.79,2.02, ,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to chemical stimulus;response to stimulus,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
P13489,RNH1,Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI),22,58.1,31.59,32.66,32.02,32.84,31.36,31.3,31.56,32.3,31.28,29.49,33.15,33.65,30.18,31.8,-0.21,0.86,0.22,1.04,-0.44,-0.49,-0.24,0.51,-0.52,-2.3,1.35,1.85,-1.62,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
O43148,RNMT,mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7)-)-methyltransferase) (mRNA cap methyltransferase) (hCMT1) (hMet) (hcm1p),9,16.4,29.31,27.8,28.77,26.9,28.69,28.68,27.07,27.74,28.56,29.04,26.63,27.54,28.27,28.08,1.23,-0.28,0.7,-1.17,0.61,0.6,-1.01,-0.34,0.48,0.96,-1.44,-0.54,0.19,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q9H4A4,RNPEP,Aminopeptidase B (AP-B) (EC 3.4.11.6) (Arginine aminopeptidase) (Arginyl aminopeptidase),23,47.8,31.42,31.42,30.9,30.8,30.22,29.71,30.97,31.06,29.4,29.17,31.23,31.95,27.88,30.47,0.95,0.95,0.43,0.33,-0.25,-0.76,0.5,0.59,-1.07,-1.3,0.76,1.47,-2.6,biosynthetic process;cellular alkene metabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process,cell part;extracellular region;extracellular space;membrane;plasma membrane,,,,,,,,,,
Q15287,RNPS1,RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2),10,34.9,30.73,29.99,30.43,30.05,30.92,30.71,30.2,29.29,30.22,30.77,27.37,29.39,30.52,30.05,0.69,-0.05,0.39,0.01,0.87,0.66,0.15,-0.75,0.17,0.72,-2.67,-0.65,0.47,"biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;cytosol;nucleoplasm,,,,,,,,,,
Q13464,ROCK1,"Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)",11,10.5,26.65,26.04,26.18,26.81,22.99,,26.81,25.59,26.38,25.92,25.46,27.24,25.12,25.93,0.72,0.11,0.24,0.87,-2.94, ,0.87,-0.34,0.45,-0.01,-0.47,1.3,-0.81,biological adhesion;biological regulation;cell adhesion;cellular component assembly;cellular component disassembly;cellular component organization;cellular process;cytoskeleton organization;locomotion;membrane docking;multicellular organismal process;muscle contraction;organelle organization;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,bleb;cell part;cell projection;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,+,,,,,,,,
O75116,ROCK2,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",14,11,27.91,27.82,29.04,28.37,28.19,27.68,28.75,28.65,28.03,29.3,29.28,28.83,26.24,28.31,-0.41,-0.5,0.72,0.06,-0.12,-0.63,0.44,0.33,-0.28,0.99,0.96,0.51,-2.07,anatomical structure formation involved in morphogenesis;biological regulation;cellular component organization;cellular process;cytokinesis;cytoskeleton organization;developmental process;locomotion;microtubule organizing center organization;multicellular organismal process;muscle contraction;organelle organization;regulation of cell cycle;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;nucleus;organelle;plasma membrane,,+,,,,,,,,
P60602,ROMO1,Reactive oxygen species modulator 1 (ROS modulator 1) (Epididymis tissue protein Li 175) (Glyrichin) (Mitochondrial targeting GxxxG motif protein) (MTGM) (Protein MGR2 homolog),2,32.2,27.21,27.9,28.23,27.45,25.8,26.17,26.63,26.28,26.86,27.36,,,,26.99,0.22,0.91,1.24,0.46,-1.19,-0.82,-0.36,-0.71,-0.13,0.37, , , ,aging;biological regulation;cellular process;developmental process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
P56715,RP1,Oxygen-regulated protein 1 (Retinitis pigmentosa 1 protein) (Retinitis pigmentosa RP1 protein),2,6.3,26.59,26.72,27.72,26.67,,26,25.67,25.18,27.45,27.24,24.89,,26.28,26.4,0.19,0.32,1.31,0.27, ,-0.4,-0.73,-1.22,1.05,0.83,-1.51, ,-0.12,anatomical structure development;biological regulation;cell development;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;detection of stimulus;developmental process;organelle organization;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cell projection;cilium;macromolecular complex;photoreceptor inner segment;protein complex,,,,,,,,,,
O75695,RP2,Protein XRP2,5,13.4,25.83,27.48,27.32,27.17,27.87,26.92,28.44,27.28,27.97,27.29,28,28.11,28.82,27.58,-1.74,-0.09,-0.26,-0.41,0.3,-0.66,0.86,-0.3,0.4,-0.29,0.42,0.53,1.25,anatomical structure morphogenesis;biosynthetic process;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;heterocycle metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;protein folding;protein metabolic process;protein transport;small molecule metabolic process;transport,cell part;cell projection;cilium;cytoplasm;membrane;plasma membrane,,,,,,,,,,
P27694,RPA1,"Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed]",16,27.1,30.7,30.87,30.3,29.17,29.67,30.18,29.63,29.57,30.41,29.1,28.26,29.47,30.17,29.81,0.89,1.06,0.49,-0.64,-0.14,0.37,-0.18,-0.24,0.6,-0.71,-1.55,-0.33,0.36,anatomical structure development;biological regulation;biosynthetic process;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;developmental process;DNA metabolic process;DNA recombination;DNA repair;DNA replication;embryo development;homeostatic process;macromolecular complex assembly;macromolecule metabolic process;meiosis;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P15927,RPA2,Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34),3,21.1,27.77,29.04,29.01,27.07,27.77,28.5,28.33,28.78,27.98,28.13,27.3,24.66,28.07,27.88,-0.1,1.17,1.14,-0.81,-0.11,0.62,0.45,0.9,0.1,0.25,-0.57,-3.22,0.19,biological regulation;biosynthetic process;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of DNA metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P35244,RPA3,Replication protein A 14 kDa subunit (RP-A p14) (Replication factor A protein 3) (RF-A protein 3),7,61.2,30,29.91,30.03,28.78,29.41,28.48,29.69,29.53,29.19,28.45,28.08,28.99,28.4,29.15,0.85,0.76,0.88,-0.37,0.26,-0.66,0.54,0.38,0.04,-0.7,-1.06,-0.16,-0.75,biological regulation;biosynthetic process;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;DNA replication;homeostatic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;cytoplasm;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q9H6T3,RPAP3,RNA polymerase II-associated protein 3,11,24.1,27.97,26.27,27.24,27.82,27.26,26.16,26.52,26.33,24.32,24.56,26.93,27.38,24.32,26.39,1.58,-0.12,0.85,1.43,0.87,-0.23,0.13,-0.06,-2.07,-1.83,0.54,0.98,-2.07,,,,,,,,,,,,
Q96AT9,RPE,Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase),6,49.7,28.88,27.96,27.56,28.17,27.05,25.21,27.05,26.68,24.59,,,26.4,24.51,26.73,2.15,1.23,0.82,1.43,0.31,-1.53,0.32,-0.05,-2.14, , ,-0.33,-2.22,alcohol metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9H7B2,RPF2,Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog),7,28.8,28.92,26.89,27.33,27.98,28.83,29.01,28.51,28.34,29.48,30.01,27.39,27.84,29.08,28.43,0.49,-1.54,-1.1,-0.45,0.4,0.57,0.07,-0.1,1.05,1.57,-1.04,-0.59,0.65,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P49247,RPIA,Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase),3,15.4,28.09,25.95,,26.55,27.33,26.67,26.98,27.95,,26.77,,,,27.04,1.05,-1.09, ,-0.49,0.29,-0.37,-0.05,0.91, ,-0.26, , , ,alcohol metabolic process;carbohydrate metabolic process;cellular metabolic process;cellular process;heterocycle metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P27635,RPL10,60S ribosomal protein L10 (Laminin receptor homolog) (Protein QM) (Tumor suppressor QM),21,65.9,32.06,31.77,32.48,33.21,33.28,32.82,32.9,33.26,32.56,32.53,32.94,33.27,32.45,32.73,-0.67,-0.96,-0.25,0.48,0.55,0.09,0.17,0.52,-0.18,-0.2,0.2,0.54,-0.29,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex,,,,,,,,,,
P62906,RPL10A,60S ribosomal protein L10a (CSA-19) (Neural precursor cell expressed developmentally down-regulated protein 6) (NEDD-6),20,63.1,33.25,33.03,33.16,33.88,34.03,33.88,34.19,34.08,33.93,34.12,33.45,33.33,33.63,33.69,-0.44,-0.66,-0.53,0.19,0.34,0.2,0.5,0.39,0.24,0.43,-0.24,-0.36,-0.06,anatomical structure morphogenesis;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex,,,,,,,,,,
P62913,RPL11,60S ribosomal protein L11 (CLL-associated antigen KW-12),18,73.6,31.68,31.31,32.19,32.67,32.93,31.51,31.85,32.5,31.8,32.33,31.53,31.09,31.41,31.91,-0.23,-0.6,0.28,0.76,1.03,-0.4,-0.06,0.59,-0.11,0.42,-0.38,-0.82,-0.5,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal large subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P30050,RPL12,60S ribosomal protein L12,13,72.7,32.01,31.95,31.06,32.62,32.46,32.25,32.39,32.45,32.14,32.18,31.78,32.44,32.21,32.15,-0.14,-0.2,-1.09,0.47,0.31,0.1,0.24,0.3,-0.01,0.03,-0.37,0.29,0.07,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P26373,RPL13,60S ribosomal protein L13 (Breast basic conserved protein 1),26,70.1,32.19,32.61,32.07,33.69,33.43,32.84,33.35,33.49,32.92,33.23,33.32,32.55,32.85,32.96,-0.77,-0.35,-0.9,0.72,0.46,-0.12,0.39,0.52,-0.04,0.27,0.36,-0.42,-0.12,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P40429,RPL13A,60S ribosomal protein L13a (23 kDa highly basic protein),25,69,31.53,31.83,31.84,32.89,33.18,32.68,33,33.01,32.28,32.44,32.2,32.45,32.56,32.45,-0.92,-0.62,-0.61,0.43,0.72,0.23,0.54,0.56,-0.17,-0.01,-0.26,0,0.11,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;regulation of translation;response to chemical stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q6IPH7,RPL14,RPL14 protein (Ribosomal protein L14 variant),16,51.4,31.12,32.24,31.56,33.09,33.28,32.35,33.62,33.2,32.36,33.03,32.96,32.19,33.18,32.63,-1.51,-0.39,-1.07,0.46,0.65,-0.28,0.99,0.57,-0.27,0.4,0.34,-0.44,0.55,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P61313,RPL15,60S ribosomal protein L15,20,54.9,31.54,31.65,31.59,32.51,32.31,32.6,33.07,32.8,32.45,32.1,32.51,33.2,32.49,32.37,-0.83,-0.72,-0.78,0.14,-0.06,0.23,0.7,0.43,0.08,-0.27,0.14,0.83,0.12,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P18621,RPL17,60S ribosomal protein L17 (60S ribosomal protein L23) (PD-1),17,74.9,32.5,32.23,32.83,33.15,33.21,32.85,33.67,33.57,33.34,32.95,32.9,32.59,33.13,32.99,-0.49,-0.76,-0.16,0.15,0.22,-0.15,0.68,0.58,0.34,-0.04,-0.1,-0.41,0.13,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
F8VWC5,RPL18,60S ribosomal protein L18,15,63.5,32.44,32.49,32.02,33.76,32.97,32.88,33.56,32.99,32.8,33.13,33.34,33.07,33.41,32.99,-0.55,-0.5,-0.97,0.78,-0.02,-0.11,0.57,0,-0.19,0.14,0.35,0.08,0.42,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q02543,RPL18A,60S ribosomal protein L18a,19,63.1,31.21,31.4,31.21,32.38,32.34,32.14,31.89,32.12,32.28,31.89,32.04,31.14,32.2,31.86,-0.65,-0.46,-0.65,0.51,0.47,0.28,0.03,0.25,0.41,0.03,0.18,-0.72,0.34,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P84098,RPL19,60S ribosomal protein L19,16,46.1,31.97,31.23,31.71,32.95,32.53,31.68,31.81,32.32,30.93,31.53,32.35,31.13,31.32,31.81,0.17,-0.58,-0.1,1.14,0.73,-0.12,0,0.52,-0.87,-0.27,0.54,-0.68,-0.48,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P46778,RPL21,60S ribosomal protein L21,11,52.5,32.16,31.74,30.72,33.26,32.95,32.19,32.87,33.08,32.4,32.38,32.55,31.02,32.18,32.27,-0.11,-0.53,-1.55,0.99,0.68,-0.08,0.6,0.81,0.13,0.11,0.28,-1.25,-0.09,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P35268,RPL22,60S ribosomal protein L22 (EBER-associated protein) (EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15),11,69.5,32.69,32.4,32.73,32.67,33.9,33.02,33.31,33.14,33.48,32.8,32.87,33.13,33.33,33.04,-0.35,-0.64,-0.31,-0.36,0.86,-0.02,0.27,0.1,0.45,-0.23,-0.16,0.09,0.3,biosynthetic process;catabolic process;cell activation;cell differentiation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q6P5R6,RPL22L1,60S ribosomal protein L22-like 1,4,39.7,25.86,,,28.47,28.64,27.95,25.26,27.37,26.39,25.93,,,,26.99,-1.12, , ,1.48,1.66,0.97,-1.72,0.39,-0.59,-1.05, , , ,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P62829,RPL23,60S ribosomal protein L23 (60S ribosomal protein L17),15,79.1,30.83,30.88,29.75,32.57,31.89,31.46,32.24,32.56,31.93,31.22,31.71,32.65,31.67,31.64,-0.81,-0.76,-1.89,0.92,0.25,-0.19,0.6,0.92,0.28,-0.42,0.07,1,0.03,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P62750,RPL23A,60S ribosomal protein L23a,16,59,32.67,31.85,32.5,33.22,32.73,32.38,33.14,33.24,32.64,32.19,32.48,32.15,32.33,32.58,0.09,-0.73,-0.08,0.64,0.15,-0.19,0.56,0.66,0.06,-0.38,-0.1,-0.42,-0.25,biosynthetic process;catabolic process;cell proliferation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
P83731,RPL24,60S ribosomal protein L24 (60S ribosomal protein L30),11,54.5,30.67,30.73,31.35,31.93,32.02,31.27,32.16,31.98,31.71,32.07,32.01,32.47,31.57,31.69,-1.02,-0.96,-0.33,0.25,0.33,-0.42,0.47,0.29,0.02,0.38,0.32,0.78,-0.11,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P61254,RPL26,60S ribosomal protein L26,17,62.1,32.27,32.22,32.36,33.2,33.48,33.09,33.46,33.64,32.74,32.71,32.95,29.68,32.18,32.61,-0.35,-0.4,-0.26,0.59,0.87,0.48,0.85,1.02,0.13,0.09,0.34,-2.94,-0.43,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal large subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q9UNX3,RPL26L1,60S ribosomal protein L26-like 1,3,12.4,26.86,25.41,24.55,26.69,23.03,25.41,24.55,25.4,25.47,24.5,,,,25.19,1.67,0.23,-0.64,1.5,-2.15,0.22,-0.64,0.22,0.28,-0.68, , , ,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;cytosol;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P61353,RPL27,60S ribosomal protein L27,9,52.9,32.37,32.5,31.46,33.65,33.86,33.47,33.32,33.9,33.09,33.08,33.07,31.39,33.26,32.96,-0.58,-0.46,-1.49,0.69,0.9,0.51,0.36,0.94,0.14,0.12,0.12,-1.56,0.3,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P46776,RPL27A,60S ribosomal protein L27a,10,52.7,31.78,32.16,31.57,33.22,33.19,32.51,32.86,32.66,32.52,32.63,32.79,32.39,33.36,32.59,-0.81,-0.43,-1.02,0.63,0.6,-0.08,0.27,0.07,-0.07,0.04,0.21,-0.2,0.77,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P46779,RPL28,60S ribosomal protein L28,15,66.4,30.82,30.98,30.31,32.02,32.12,31.43,31.53,32.54,31.66,31.45,30.52,30.24,31.14,31.29,-0.47,-0.31,-0.98,0.73,0.83,0.14,0.24,1.25,0.37,0.16,-0.77,-1.05,-0.15,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P47914,RPL29,60S ribosomal protein L29 (Cell surface heparin-binding protein HIP),7,30.8,29.76,29.5,29.92,31.04,30.04,29.91,29.77,30.38,29.54,29.2,29.82,,,29.9,-0.14,-0.4,0.02,1.14,0.15,0.02,-0.12,0.48,-0.36,-0.7,-0.08, , ,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P39023,RPL3,60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B),35,62,32.7,32.99,33.76,34.03,33.73,33.43,33.96,33.73,33.5,33.7,33.66,33.7,32.97,33.53,-0.83,-0.54,0.24,0.5,0.21,-0.1,0.43,0.2,-0.03,0.17,0.14,0.17,-0.56,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P62888,RPL30,60S ribosomal protein L30,12,80.9,32.2,32.18,31.76,33.08,32.55,32.54,32.61,32.67,32.46,32.36,32.45,32.39,32.15,32.42,-0.22,-0.23,-0.66,0.66,0.13,0.12,0.2,0.26,0.05,-0.05,0.03,-0.03,-0.26,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P62899,RPL31,60S ribosomal protein L31,13,64.8,32.1,31.76,32.15,33.08,32.78,32.37,32.73,33.22,32.55,32.54,32.63,33.4,32.07,32.57,-0.46,-0.81,-0.42,0.51,0.21,-0.2,0.16,0.66,-0.01,-0.03,0.07,0.83,-0.5,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P62910,RPL32,60S ribosomal protein L32,15,66.2,31.64,31.66,32.05,32.66,32.32,31.63,32.26,32.2,32.18,32.03,31.83,30.17,30.65,31.79,-0.15,-0.13,0.26,0.87,0.53,-0.16,0.47,0.41,0.39,0.24,0.04,-1.63,-1.14,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P49207,RPL34,60S ribosomal protein L34,9,47,30.79,30.63,30.1,31.84,31.22,31.04,31.37,31.57,31.59,30.68,31.34,,29.71,30.99,-0.2,-0.36,-0.89,0.85,0.23,0.05,0.38,0.58,0.6,-0.31,0.35, ,-1.28,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P42766,RPL35,60S ribosomal protein L35,11,55.3,29.83,30.31,30.2,31.67,32.21,30.98,31.16,31.8,30.78,31.13,31.37,,30.7,31.01,-1.18,-0.7,-0.81,0.66,1.2,-0.03,0.15,0.79,-0.23,0.11,0.35, ,-0.31,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P18077,RPL35A,60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein),14,71.8,30.95,30.68,29.77,32.15,32.3,31.68,31.62,31.79,31.37,31.38,31.34,30.56,31.42,31.31,-0.36,-0.62,-1.54,0.84,0.99,0.37,0.31,0.48,0.06,0.07,0.03,-0.75,0.11,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal large subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
Q9Y3U8,RPL36,60S ribosomal protein L36,12,47.6,31.33,31.17,31.54,32.38,32.7,32.35,32.57,32.73,32.54,32.29,31.14,32.26,32.58,32.12,-0.79,-0.95,-0.58,0.26,0.58,0.23,0.45,0.61,0.42,0.17,-0.98,0.14,0.46,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P83881,RPL36A,60S ribosomal protein L36a (60S ribosomal protein L44) (Cell growth-inhibiting gene 15 protein) (Cell migration-inducing gene 6 protein),9,49.1,27.5,26.61,28.72,29.67,28.21,24.93,28.14,28.22,28.68,28.43,26.8,29.36,,27.94,-0.44,-1.33,0.79,1.73,0.27,-3.01,0.2,0.29,0.74,0.49,-1.14,1.42, ,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P61927,RPL37,60S ribosomal protein L37 (G1.16),3,15.9,25.87,24.48,25.08,26.83,26.42,25.29,25.09,26.62,25.56,25.65,24.68,,,25.6,0.27,-1.11,-0.52,1.24,0.82,-0.31,-0.51,1.02,-0.03,0.05,-0.91, , ,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P61513,RPL37A,60S ribosomal protein L37a,9,68.5,27.76,29.01,28.7,30.39,29.24,29.31,29.77,29.39,29.87,30.28,29.41,27.42,28.89,29.19,-1.43,-0.17,-0.48,1.2,0.06,0.12,0.58,0.2,0.68,1.09,0.22,-1.77,-0.3,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P63173,RPL38,60S ribosomal protein L38,6,50,30.03,27.87,29.55,30.14,29.23,28.45,29.83,30.55,28.19,28.55,29.89,30.87,29.44,29.43,0.6,-1.56,0.12,0.71,-0.2,-0.98,0.4,1.12,-1.24,-0.88,0.46,1.44,0.01,anatomical structure morphogenesis;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P36578,RPL4,60S ribosomal protein L4 (60S ribosomal protein L1),41,60,33.78,33.82,33.72,35.15,34.76,34.28,34.83,34.64,34.52,34.49,34.46,35.01,34.27,34.44,-0.67,-0.62,-0.73,0.71,0.32,-0.16,0.39,0.2,0.08,0.05,0.01,0.57,-0.17,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P46777,RPL5,60S ribosomal protein L5,26,58.2,33.33,33.52,33.41,34.22,33.54,33.62,33.61,33.87,33.64,33.68,33.36,31.94,33.19,33.46,-0.12,0.07,-0.04,0.76,0.09,0.16,0.15,0.42,0.18,0.22,-0.1,-1.52,-0.26,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal large subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q02878,RPL6,60S ribosomal protein L6 (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107),30,62.2,33.12,33.3,32.94,34.3,34.33,34.03,34,34.34,33.88,33.42,33.6,33.72,32.93,33.68,-0.57,-0.39,-0.74,0.61,0.65,0.34,0.32,0.66,0.2,-0.26,-0.09,0.04,-0.76,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P18124,RPL7,60S ribosomal protein L7,28,68.5,33.69,34.04,33.71,34.59,34.36,34.26,34.62,34.6,34.24,34.57,34.32,33.17,34.26,34.19,-0.49,-0.14,-0.48,0.4,0.17,0.08,0.44,0.41,0.06,0.39,0.13,-1.02,0.07,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal large subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P62424,RPL7A,60S ribosomal protein L7a (PLA-X polypeptide) (Surfeit locus protein 3),27,62.4,33.21,33.09,33.17,34.48,34.01,33.82,34.2,34.32,33.99,34.26,34.13,32.49,33.83,33.77,-0.56,-0.68,-0.6,0.71,0.24,0.05,0.43,0.55,0.22,0.49,0.36,-1.28,0.06,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosome biogenesis;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q6DKI1,RPL7L1,60S ribosomal protein L7-like 1,10,45.1,29.27,28.05,28.74,29.65,29.63,29.54,29.45,29.48,29.69,30.07,28.62,29.34,29.58,29.31,-0.04,-1.27,-0.58,0.33,0.32,0.22,0.14,0.17,0.37,0.75,-0.69,0.03,0.26,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P62917,RPL8,60S ribosomal protein L8,18,51.4,31.82,32.16,32.45,33.21,33.36,33.15,33.38,33.52,33.31,33.48,33.02,,32.05,32.91,-1.09,-0.75,-0.46,0.3,0.45,0.24,0.47,0.61,0.4,0.57,0.11, ,-0.86,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P32969,RPL9,60S ribosomal protein L9,14,68.2,32.13,32.18,32.14,33.09,33.04,32.75,33.19,33.13,33.07,32.73,32.44,32.56,32.6,32.7,-0.56,-0.52,-0.56,0.39,0.35,0.05,0.49,0.43,0.38,0.03,-0.26,-0.14,-0.09,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
P05388,RPLP0,60S acidic ribosomal protein P0 (60S ribosomal protein L10E),27,74.1,33.56,33.92,33.67,34.32,33.38,33.48,34.1,33.4,34.08,33.89,33.71,34.32,33.59,33.8,-0.24,0.12,-0.13,0.52,-0.42,-0.32,0.29,-0.4,0.28,0.09,-0.1,0.52,-0.21,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosome biogenesis;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
P05386,RPLP1,60S acidic ribosomal protein P1,5,84.2,32.03,32.38,32.84,32.59,32.67,32.28,32.38,32.7,32.43,32.09,32.41,32.98,32.3,32.47,-0.44,-0.09,0.37,0.12,0.2,-0.19,-0.09,0.23,-0.04,-0.38,-0.05,0.51,-0.17,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P05387,RPLP2,60S acidic ribosomal protein P2 (Renal carcinoma antigen NY-REN-44),14,97.4,32.93,33.04,33.08,33.55,33.88,32.78,33.27,33.79,33.21,33.73,33.04,34.38,33.74,33.42,-0.48,-0.38,-0.34,0.14,0.46,-0.64,-0.15,0.37,-0.21,0.31,-0.38,0.96,0.33,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex,,,,,,,,,,
P04843,RPN1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1),54,74.5,34.81,34.94,34.68,34.37,34.43,35.06,34.48,34.18,35.33,34.89,34.33,34.36,34.98,34.68,0.13,0.26,0,-0.31,-0.25,0.38,-0.2,-0.5,0.65,0.21,-0.35,-0.32,0.3,biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein targeting;protein transport;translation;transport,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P04844,RPN2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II) (RPN-II) (Ribophorin-2),35,57.5,33.78,34.26,33.23,33.58,33.89,34.69,33.57,33.49,34.6,34.22,33.64,33.54,34.58,33.93,-0.15,0.34,-0.7,-0.35,-0.04,0.76,-0.36,-0.44,0.67,0.29,-0.29,-0.39,0.65,aging;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein targeting;protein transport;response to chemical stimulus;response to drug;response to stimulus;translation;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
P78346,RPP30,Ribonuclease P protein subunit p30 (RNaseP protein p30) (EC 3.1.26.5) (RNase P subunit 2),7,37.3,27.89,27.19,26.49,28.62,27.05,27.18,25.95,26.09,27.2,27.59,26.89,26.39,26.46,27,0.89,0.19,-0.51,1.62,0.06,0.18,-1.05,-0.91,0.2,0.59,-0.11,-0.61,-0.54,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;macromolecular complex;ribonuclease P complex;ribonucleoprotein complex,,,,,,,,,,
P78345,RPP38,Ribonuclease P protein subunit p38 (RNaseP protein p38) (EC 3.1.26.5),4,15.9,25.5,23.42,25.12,24.99,22.86,22.31,,,,,,23.09,,23.9,1.6,-0.48,1.22,1.09,-1.04,-1.59, , , , , ,-0.8, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;macromolecular complex;ribonuclease P complex;ribonucleoprotein complex,,,,,,,,,,
O75818,RPP40,Ribonuclease P protein subunit p40 (RNaseP protein p40) (EC 3.1.26.5) (RNase P subunit 1),5,20.3,27.47,24.84,25.52,26.88,25.11,27.62,26.08,26.87,27.18,26.79,26.3,24.5,26.23,26.26,1.21,-1.42,-0.74,0.62,-1.15,1.36,-0.18,0.61,0.92,0.52,0.04,-1.76,-0.03,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;macromolecular complex;ribonuclease P complex;ribonucleoprotein complex,,,,,,,,,,
Q96P16,RPRD1A,Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein),6,26.3,28.98,27.42,26.76,28.12,26.82,27.46,27.9,24.85,27.32,26.11,24.66,25.84,25.87,26.78,2.2,0.64,-0.02,1.35,0.05,0.68,1.12,-1.92,0.54,-0.67,-2.11,-0.94,-0.91,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process,"cell part;DNA-directed RNA polymerase II, holoenzyme;macromolecular complex;protein complex",,,,,,,,,,
Q9NQG5,RPRD1B,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),19,68.7,31.35,29.6,30.17,29,29.62,29.34,29.42,29.27,29.98,28.64,27.52,28.82,29.07,29.37,1.98,0.23,0.8,-0.37,0.26,-0.03,0.05,-0.1,0.61,-0.73,-1.85,-0.55,-0.3,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of cell cycle;RNA metabolic process,"cell part;DNA-directed RNA polymerase II, holoenzyme;macromolecular complex;protein complex",,,,,,,,,,
Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,16,19.1,28.29,24.38,26.96,24.87,25.64,27.33,25.71,24.75,25.07,26.19,,25.49,,25.88,2.41,-1.5,1.08,-1.01,-0.24,1.45,-0.17,-1.13,-0.81,0.31, ,-0.39, ,,"cell part;DNA-directed RNA polymerase II, holoenzyme;macromolecular complex;protein complex",,,,,,,,,,
P46783,RPS10,40S ribosomal protein S10,18,67.3,31.39,31.22,30.34,31.89,32.51,31.45,32.2,32.57,31.84,30.82,31.73,32.43,31.57,31.69,-0.3,-0.47,-1.35,0.2,0.82,-0.24,0.51,0.88,0.15,-0.87,0.04,0.74,-0.12,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62280,RPS11,40S ribosomal protein S11,19,72.2,32.13,31.99,32.27,33.15,32.24,32.71,33.1,33.02,32.22,32.85,32.78,30.3,32.51,32.41,-0.28,-0.41,-0.14,0.75,-0.16,0.3,0.69,0.61,-0.19,0.45,0.37,-2.1,0.1,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P25398,RPS12,40S ribosomal protein S12,14,84.8,32.66,32.89,33.42,33.28,32.92,32.91,33.33,33.07,32.96,32.98,32.89,33.24,32.26,32.98,-0.32,-0.09,0.44,0.29,-0.07,-0.08,0.35,0.08,-0.02,-0.01,-0.1,0.26,-0.72,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62277,RPS13,40S ribosomal protein S13,20,66.9,32.58,32.38,32.35,33.17,33.56,33.27,33.47,33.77,32.66,32.88,33.31,33.04,33.42,33.07,-0.48,-0.69,-0.71,0.1,0.5,0.2,0.4,0.7,-0.4,-0.18,0.25,-0.03,0.35,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62263,RPS14,40S ribosomal protein S14,11,42.4,31.75,31.31,31.47,32.55,32.61,32.57,32.32,32.64,31.96,31.68,32.28,32.6,32.3,32.16,-0.41,-0.84,-0.69,0.39,0.45,0.41,0.16,0.48,-0.2,-0.47,0.12,0.44,0.14,biological regulation;biosynthetic process;catabolic process;cell differentiation;cellular component assembly;cellular component disassembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62841,RPS15,40S ribosomal protein S15 (RIG protein),9,75.9,30.24,29.28,29,30.93,31.27,30.25,31.31,31.55,30.78,30.38,30.5,29.53,29.48,30.35,-0.1,-1.06,-1.35,0.58,0.92,-0.1,0.97,1.21,0.43,0.03,0.15,-0.81,-0.87,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;ribosomal small subunit biogenesis;ribosomal subunit export from nucleus;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62244,RPS15A,40S ribosomal protein S15a,14,78.5,32.16,32.59,32.38,33.18,33.31,32.85,33.21,33.38,32.96,32.64,31.99,31.7,33.06,32.72,-0.56,-0.13,-0.35,0.46,0.59,0.13,0.48,0.66,0.23,-0.08,-0.73,-1.03,0.33,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;regulation of cell cycle;response to biotic stimulus;response to stimulus;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62249,RPS16,40S ribosomal protein S16,16,61.6,33,33.14,32.82,33.95,34.17,33.34,33.9,34.26,33.41,33.35,33.88,33.61,33.51,33.57,-0.56,-0.43,-0.74,0.39,0.61,-0.23,0.34,0.7,-0.16,-0.21,0.32,0.04,-0.06,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal small subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P0CW22,RPS17L,40S ribosomal protein S17-like,15,77,31.67,31.75,32.21,32.25,32.53,32.1,32.61,32.61,31.79,31.35,32.76,32.32,32.02,32.15,-0.48,-0.4,0.06,0.1,0.37,-0.05,0.46,0.46,-0.37,-0.8,0.61,0.17,-0.13,biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P62269,RPS18,40S ribosomal protein S18 (Ke-3) (Ke3),26,75,32.93,32.95,32.75,34.1,33.68,33.29,33.77,33.78,32.98,32.83,33.27,33.23,33.15,33.29,-0.35,-0.34,-0.53,0.82,0.4,0,0.49,0.5,-0.31,-0.46,-0.02,-0.06,-0.13,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosome biogenesis;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P39019,RPS19,40S ribosomal protein S19,20,77.2,32.92,32.61,32.89,33.29,33.6,33.2,33.54,33.7,33.04,33.29,33.18,31.52,33.48,33.1,-0.18,-0.49,-0.21,0.19,0.51,0.11,0.45,0.6,-0.06,0.19,0.09,-1.58,0.38,biological regulation;biosynthetic process;catabolic process;cell differentiation;cell motility;cellular component assembly;cellular component disassembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;immune system process;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleus organization;organelle organization;primary metabolic process;protein complex assembly;protein targeting;protein transport;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P15880,RPS2,40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3),23,62.5,32.35,31.8,32.4,32.98,32.55,32.55,33.43,32.85,32.85,32.33,33.09,32.65,32.6,32.65,-0.3,-0.85,-0.25,0.33,-0.1,-0.1,0.79,0.21,0.2,-0.31,0.44,0,-0.05,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P60866,RPS20,40S ribosomal protein S20,9,45.4,32.18,32.08,31.84,32.64,33.61,32.83,32.95,33.06,32.34,32.14,32.53,29.52,32.8,32.35,-0.17,-0.27,-0.5,0.29,1.27,0.48,0.6,0.72,-0.01,-0.21,0.19,-2.82,0.45,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P63220,RPS21,40S ribosomal protein S21,11,77.8,31.92,32.07,32.37,32.57,32.54,31.86,32.68,32.8,32.26,32.11,32.19,32.52,31.55,32.26,-0.34,-0.19,0.1,0.31,0.27,-0.41,0.42,0.53,0,-0.16,-0.08,0.26,-0.71,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62266,RPS23,40S ribosomal protein S23,9,41.3,29.25,29.39,29.98,31.83,30.97,29.76,31.85,31.79,29.87,30.23,31.52,31.46,28.97,30.53,-1.27,-1.14,-0.55,1.3,0.44,-0.77,1.32,1.26,-0.65,-0.3,1,0.93,-1.56,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62847,RPS24,40S ribosomal protein S24,7,43.8,30.88,30.83,31.74,31.82,32.08,31.92,31.8,31.8,31.21,31.33,31.58,31.79,31.72,31.58,-0.69,-0.75,0.16,0.24,0.5,0.35,0.23,0.22,-0.37,-0.25,0.01,0.21,0.14,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;homeostatic process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62851,RPS25,40S ribosomal protein S25,14,54.4,32.65,32.65,32.63,33.58,33.19,32.64,33.18,33.51,32.83,32.92,32.87,33.32,32.83,32.98,-0.34,-0.34,-0.35,0.6,0.2,-0.34,0.19,0.52,-0.15,-0.06,-0.12,0.34,-0.16,biosynthetic process;catabolic process;cellular component assembly;cellular component disassembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62854,RPS26,40S ribosomal protein S26,5,34.8,29.51,30.09,29.29,31.26,30.65,30.56,31.08,31.22,30.83,30.33,30.59,30.39,28.99,30.37,-0.86,-0.27,-1.08,0.89,0.28,0.19,0.71,0.85,0.46,-0.03,0.22,0.02,-1.38,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62979,RPS27A,Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin;40S ribosomal protein S27a],16,71.2,33.77,33.76,33.97,33.65,34.37,33.9,33.7,33.47,33.71,33.81,33.37,34.18,33.87,33.81,-0.04,-0.05,0.16,-0.16,0.56,0.09,-0.11,-0.34,-0.1,0,-0.44,0.37,0.06,"biological regulation;biosynthetic process;catabolic process;cellular component assembly;cellular component disassembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;endosome transport;establishment of localization;immune system process;ion transport;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein phosphorylation;protein targeting;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to endogenous stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent;translational elongation;translational initiation;transmembrane transport;transport;vesicle-mediated transport",cell part;macromolecular complex;membrane;nucleoplasm;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
Q71UM5,RPS27L,40S ribosomal protein S27-like,8,48.8,31.02,29.47,31.95,31.31,31.35,30.85,31.55,31.74,30.71,30.18,30.85,30.48,31.17,30.97,0.05,-1.5,0.98,0.33,0.38,-0.12,0.58,0.77,-0.26,-0.79,-0.12,-0.49,0.2,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
P62857,RPS28,40S ribosomal protein S28,11,87,32.04,31.52,32.73,32.76,32.26,32.31,32.73,32.71,31.83,31.53,32.2,32.8,31.38,32.21,-0.18,-0.69,0.52,0.54,0.04,0.1,0.52,0.49,-0.38,-0.69,-0.01,0.58,-0.84,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal small subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62273,RPS29,40S ribosomal protein S29,4,60.7,28.97,29.31,28.96,29.51,30.88,30.4,29.51,29.99,29.15,28.23,29.37,25.23,29.91,29.19,-0.22,0.13,-0.23,0.33,1.69,1.21,0.33,0.81,-0.03,-0.96,0.18,-3.95,0.72,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P23396,RPS3,40S ribosomal protein S3,36,92.6,33.67,33.73,33.48,34.35,33.98,34.07,34.45,34.24,33.74,33.54,34.11,33.92,33.72,33.92,-0.25,-0.19,-0.45,0.43,0.06,0.15,0.53,0.32,-0.18,-0.38,0.18,-0.01,-0.2,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;regulation of DNA metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P61247,RPS3A,40S ribosomal protein S3a (v-fos transformation effector protein) (Fte-1),34,78,32.87,33.21,32.98,33.74,34,33.4,33.87,33.86,33.4,33.05,33.13,32.93,33,33.34,-0.47,-0.13,-0.36,0.4,0.66,0.06,0.53,0.51,0.06,-0.3,-0.21,-0.41,-0.34,biosynthetic process;catabolic process;cell differentiation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62701,RPS4X,"40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein)",41,84,33.28,33.53,33.36,34.28,33.87,33.52,34.13,34.06,33.75,33.92,33.69,33.57,33.58,33.73,-0.46,-0.2,-0.37,0.54,0.13,-0.21,0.39,0.33,0.02,0.19,-0.04,-0.16,-0.16,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;regulation of translation;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;polysome;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P46782,RPS5,"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]",16,63.2,31.47,31.33,31.02,31.97,32.07,30.76,31.65,31.81,31.57,31.3,30.71,30.67,29.99,31.26,0.22,0.07,-0.23,0.71,0.82,-0.5,0.4,0.55,0.31,0.04,-0.54,-0.58,-1.26,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;regulation of translation;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62753,RPS6,40S ribosomal protein S6 (Phosphoprotein NP33),31,56.2,32.37,32.23,32.85,33,33.41,32.38,33.35,33.55,32.78,32.82,32.49,33,32.59,32.83,-0.47,-0.6,0.02,0.17,0.58,-0.45,0.52,0.71,-0.05,-0.01,-0.34,0.17,-0.24,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;homeostatic process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;ribosomal small subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;signal transduction;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P51812,RPS6KA3,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),17,35.4,28.34,29.4,28.73,29.21,26.48,27.45,28.91,29.51,27.33,25.2,28.13,28.67,26.85,28.02,0.32,1.38,0.72,1.19,-1.54,-0.57,0.89,1.5,-0.69,-2.81,0.11,0.65,-1.17,anatomical structure development;biological regulation;cell communication;cell cycle;cell-cell signaling;cellular process;developmental process;immune system process;locomotion;regulation of translation;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction;signaling,cell part;cytosol;nucleoplasm,,+,,,,,,,,
P62081,RPS7,40S ribosomal protein S7,23,78.9,32.95,32.13,33.2,33.84,33.96,33.01,33.41,33.76,32.95,33.15,33.06,32.95,32.8,33.17,-0.22,-1.04,0.03,0.68,0.79,-0.16,0.25,0.59,-0.22,-0.01,-0.11,-0.21,-0.36,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;ribosomal small subunit biogenesis;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleolus;organelle;preribosome;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P62241,RPS8,40S ribosomal protein S8,24,65.4,32.52,32.76,31.97,33.54,33.26,33.08,33.63,33.28,33.3,33.29,32.76,32.71,32.74,32.99,-0.47,-0.23,-1.02,0.55,0.27,0.09,0.64,0.29,0.31,0.3,-0.22,-0.28,-0.25,biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;macromolecular complex;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P46781,RPS9,40S ribosomal protein S9,27,67.5,33.18,33.33,33.13,33.98,34.31,34.22,34.31,34.21,33.59,33.93,33.83,33.5,34.49,33.85,-0.66,-0.52,-0.72,0.13,0.46,0.37,0.46,0.36,-0.26,0.08,-0.01,-0.34,0.65,biological regulation;biosynthetic process;catabolic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA catabolic process;RNA metabolic process;translational elongation;translational initiation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
P08865,RPSA,40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4),28,79.2,33.67,34.09,33.69,34.36,34.62,34.17,34.39,34.76,33.96,33.66,33.89,34.39,34.12,34.14,-0.47,-0.05,-0.44,0.22,0.49,0.04,0.25,0.62,-0.18,-0.47,-0.24,0.25,-0.02,biological adhesion;biosynthetic process;catabolic process;cell adhesion;cellular component assembly;cellular component disassembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;ribonucleoprotein complex assembly;RNA catabolic process;RNA metabolic process;RNA processing;rRNA processing;translational elongation;translational initiation;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;preribosome;ribonucleoprotein complex;small ribosomal subunit,,,,,,,,,,
B5MDQ4,RQCD1,"Cell differentiation protein RCD1 homolog (RCD1 required for cell differentiation1 homolog (S. pombe), isoform CRA_a)",5,25.2,28.27,26.71,27.74,26.5,27.72,26.66,26.65,27.61,27.22,24.75,26.81,28.06,26.28,27,1.27,-0.29,0.74,-0.5,0.72,-0.34,-0.35,0.62,0.23,-2.25,-0.19,1.06,-0.72,,,,,,,,,,,,
Q7L523,RRAGA,Ras-related GTP-binding protein A (Rag A) (RagA) (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1),5,24.7,27.15,27.86,27.82,27.56,27.94,27.76,28.68,28.43,27.05,28.47,29.06,28.12,28.22,28.01,-0.86,-0.15,-0.19,-0.45,-0.07,-0.25,0.68,0.42,-0.96,0.46,1.05,0.11,0.21,biological regulation;cell death;cellular localization;cellular process;death;interspecies interaction between organisms;localization;multi-organism process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;nucleus;organelle;vacuole,,,,,,,,,,
Q9HB90,RRAGC,Ras-related GTP-binding protein C (Rag C) (RagC) (GTPase-interacting protein 2) (TIB929),12,34.8,27.97,28.24,29.13,27.3,28.3,28.28,28.62,28.81,28.05,28.87,29.83,29.97,29.15,28.66,-0.69,-0.42,0.47,-1.35,-0.35,-0.37,-0.04,0.15,-0.6,0.22,1.17,1.32,0.49,biological regulation;biosynthetic process;cell death;cell growth;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;growth;localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;nucleus;organelle;vacuole,,,,,,,,,,
P10301,RRAS,Ras-related protein R-Ras (p23),14,56,30.27,30.77,30.08,30.4,29.88,31,30.38,30.14,31.94,30.71,30.72,30.09,30.99,30.57,-0.3,0.2,-0.48,-0.17,-0.69,0.43,-0.18,-0.43,1.37,0.15,0.15,-0.48,0.42,biological regulation;cell communication;cell-cell signaling;cellular process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling,cell part;membrane;plasma membrane,,,,,,,,,,
P62070,RRAS2,Ras-related protein R-Ras2 (Ras-like protein TC21) (Teratocarcinoma oncogene),10,52.5,28.11,28.77,27.55,28.97,29.42,28.88,29.87,28.29,30.93,30.22,29.48,29.23,29.67,29.18,-1.07,-0.42,-1.63,-0.22,0.23,-0.3,0.69,-0.9,1.75,1.04,0.3,0.05,0.48,biological regulation;cellular process;response to stimulus;signal transduction,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9P2E9,RRBP1,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),101,54,,,26.72,,,27.89,27.54,26.53,28.93,28.36,,,27.35,27.62, , ,-0.9, , ,0.27,-0.08,-1.08,1.31,0.75, , ,-0.27,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein transport;response to stimulus;signal transduction;translation;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome,,,,,,,,,,
Q92766,RREB1,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),15,16.9,27.83,26.76,25.8,26.4,27,,26.6,26.19,26.98,23.07,26.89,22.13,26.95,26.05,1.78,0.71,-0.25,0.35,0.95, ,0.55,0.14,0.93,-2.98,0.84,-3.92,0.9,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;multicellular organismal development;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter,cell part;cytoplasm,C2H2-type,,,,,,,,,
E9PD78,RRM1,Ribonucleoside-diphosphate reductase (EC 1.17.4.1),15,31.1,25.09,27.71,27.64,29.8,28.98,25.36,29.05,29.31,24.98,22.99,27.27,30.12,22.84,27.01,-1.92,0.7,0.63,2.79,1.97,-1.65,2.04,2.3,-2.03,-4.02,0.26,3.11,-4.17,biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q7LG56,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B (EC 1.17.4.1) (TP53-inducible ribonucleotide reductase M2 B) (p53-inducible ribonucleotide reductase small subunit 2-like protein) (p53R2),3,11.7,27.2,25.22,26.51,24.16,24.73,24.96,25.28,25.83,22.73,25.41,26.85,27.13,23.36,25.34,1.87,-0.11,1.17,-1.18,-0.61,-0.38,-0.06,0.5,-2.61,0.07,1.52,1.8,-1.97,anatomical structure development;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;DNA replication;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
Q9NYV6,RRN3,RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA),3,7.1,24.09,22.09,24.1,21.61,18.74,,23.03,,22.89,23.85,24.25,25.93,22.71,23.03,1.07,-0.93,1.07,-1.41,-4.29, ,0, ,-0.14,0.82,1.23,2.9,-0.32,"biological regulation;biosynthetic process;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoplasm organization;developmental process;embryo development;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleus organization;organelle organization;primary metabolic process;ribosome biogenesis;RNA metabolic process;transcription initiation, DNA-dependent",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
P56182,RRP1,Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein),10,27.1,29.37,28.48,27.91,29.16,28.9,29.49,29.02,28.82,29.46,29.85,27.15,28.11,28.73,28.8,0.57,-0.32,-0.89,0.35,0.1,0.69,0.21,0.01,0.66,1.05,-1.65,-0.69,-0.07,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;preribosome;ribonucleoprotein complex,,,,,,,,,,
Q5JTH9,RRP12,RRP12-like protein,25,26.7,30.12,29.8,28.71,30.64,29.75,30.82,30.75,29.83,30.91,31.01,29.67,30.34,30.69,30.23,-0.12,-0.44,-1.52,0.4,-0.48,0.59,0.52,-0.4,0.68,0.78,-0.57,0.1,0.46,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q9Y3B9,RRP15,RRP15-like protein (Ribosomal RNA-processing protein 15),8,36.2,26.65,,23.18,27.04,27.12,27.78,25.11,24.35,24.79,27.98,26.04,25.53,27.38,26.08,0.57, ,-2.9,0.96,1.04,1.7,-0.97,-1.73,-1.29,1.9,-0.04,-0.55,1.3,,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
Q14684,RRP1B,Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B),9,11.4,25.83,,25.56,26.45,,25.28,25.66,,25.95,26.51,25.42,25.82,24.66,25.71,0.11, ,-0.15,0.74, ,-0.44,-0.05, ,0.24,0.8,-0.3,0.1,-1.06,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;preribosome;ribonucleoprotein complex,,,,,,,,,,
Q9Y3A4,RRP7A,Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14),4,18.9,26.22,25.5,,25.91,24.87,25.03,25.24,24.21,25.41,25.41,,,,25.31,0.91,0.19, ,0.6,-0.44,-0.28,-0.07,-1.1,0.1,0.1, , , ,,,,,,,,,,,,
O43159,RRP8,Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1) (Nucleomethylin),7,20.4,26.2,25.86,25.18,27.64,29.15,28.9,28.16,27.68,28.93,27.7,23.51,27.39,27.45,27.21,-1.01,-1.35,-2.03,0.43,1.94,1.69,0.95,0.47,1.72,0.49,-3.7,0.17,0.24,"biological regulation;biosynthetic process;cell communication;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;gene silencing;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of gene expression, epigenetic;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;RNA metabolic process;RNA processing;rRNA processing;signal transduction",cell part;chromatin remodeling complex;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;plasma membrane;protein complex,,,,,,,,,,
O43818,RRP9,U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K),10,20.2,27.57,25.53,,26.22,28.24,28.8,28.45,26.87,28.34,28.08,26.67,27.09,26.64,27.37,0.2,-1.84, ,-1.16,0.86,1.42,1.07,-0.5,0.97,0.7,-0.71,-0.29,-0.73,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,
Q15050,RRS1,Ribosome biogenesis regulatory protein homolog,8,29.6,29.1,27.97,27.69,29.61,28.87,28.24,28.57,27.91,29.4,29.76,27.14,28.73,28.14,28.55,0.55,-0.58,-0.86,1.06,0.32,-0.31,0.02,-0.64,0.85,1.21,-1.41,0.19,-0.41,cellular process;establishment of localization;ribosome biogenesis,cell part;chromosome;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nuclear chromosome;nucleolus;organelle,,,,,,,,,,
Q8WXG1,RSAD2,"Radical S-adenosyl methionine domain-containing protein 2 (Cytomegalovirus-induced gene 5 protein) (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)",3,11.1,28.73,29.22,28.83,29.37,30.93,30.49,30.25,29.58,30.16,30.17,29.11,31.13,30.16,29.85,-1.13,-0.64,-1.03,-0.49,1.08,0.64,0.39,-0.27,0.3,0.32,-0.75,1.27,0.3,biological regulation;cell activation;cell differentiation;cellular process;developmental process;immune system process;interspecies interaction between organisms;metabolic process;multicellular organismal process;multi-organism process;regulation of transport;response to biotic stimulus;response to stimulus;response to stress,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;membrane;organelle,,,,,,,,,,
Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),22,18.7,28.24,25.63,26.42,24.52,25.09,25.58,25.85,,26.56,26.65,25.98,27.13,26.16,26.15,2.09,-0.52,0.27,-1.63,-1.06,-0.57,-0.3, ,0.41,0.5,-0.17,0.98,0.01,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent",cell part;chromatin remodeling complex;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O76021,RSL1D1,Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1),25,52.8,30.5,30.07,29.75,31.54,32.04,32.21,31.12,31.24,31.7,31.83,30.29,31.6,31.82,31.21,-0.71,-1.13,-1.45,0.33,0.83,1.01,-0.09,0.03,0.49,0.62,-0.92,0.39,0.61,biological regulation;biosynthetic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;translation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q15404,RSU1,Ras suppressor protein 1 (RSP-1) (Rsu-1),14,61,29.34,28.95,29.16,30,28.43,29.17,30.15,30.92,29.45,28.08,30.03,30.26,28.73,29.44,-0.1,-0.49,-0.28,0.56,-1,-0.27,0.72,1.49,0.01,-1.36,0.59,0.82,-0.71,biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
O00442,RTCA,RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1) (RTC domain-containing protein 1),9,28.1,29.61,28.58,29.5,28.76,28.34,27.42,28.73,29.02,28.2,27.02,28.44,29.06,27.91,28.51,1.1,0.07,0.99,0.25,-0.17,-1.08,0.22,0.51,-0.31,-1.48,-0.07,0.56,-0.59,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;nucleoplasm,,,,,,,,,,
Q9Y3I0,RTCB,tRNA-splicing ligase RtcB homolog (EC 6.5.1.3),28,55.2,32.43,32.45,32.63,32.64,32.8,32.9,33.02,32.96,33.15,32.48,32.89,32.94,32.93,32.79,-0.36,-0.33,-0.16,-0.14,0.01,0.11,0.23,0.17,0.37,-0.31,0.1,0.16,0.14,anatomical structure development;anatomical structure morphogenesis;biological adhesion;cell adhesion;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;tRNA metabolic process;tRNA processing,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q92541,RTF1,RNA polymerase-associated protein RTF1 homolog,4,8.5,23.85,25,26.51,24.71,21.54,25.79,23.91,22.64,22.4,25.05,22.07,24.63,22.6,23.9,-0.05,1.1,2.62,0.81,-2.36,1.89,0.01,-1.26,-1.5,1.15,-1.83,0.73,-1.3,"biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;regulation of organelle organization;regulation of protein modification process;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process;transcription initiation, DNA-dependent",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;transcription elongation factor complex,Other TF domain,,,,,,,,,
Q16799,RTN1,Reticulon-1 (Neuroendocrine-specific protein),11,20.9,25.94,25.1,24.17,24.55,23.84,25.56,24.65,25.31,25.6,22.58,25.2,29.66,28,25.4,0.55,-0.3,-1.23,-0.85,-1.56,0.16,-0.74,-0.09,0.21,-2.82,-0.2,4.26,2.61,cell differentiation;cellular process;developmental process,cell part,,,,,,,,,,
O95197,RTN3,Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII),7,9.7,31.89,30.6,31.59,30.19,30.17,31.16,30.57,30.39,31,31.76,31.54,23.97,31.61,30.49,1.39,0.11,1.1,-0.3,-0.33,0.66,0.07,-0.11,0.51,1.26,1.04,-6.53,1.12,cell death;cellular component organization;cellular process;death;endoplasmic reticulum organization;establishment of localization;interspecies interaction between organisms;multi-organism process;organelle organization;response to stimulus;response to stress;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9NQC3,RTN4,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),2,25.1,32.61,32.67,30.99,33.42,32.85,32.97,32.89,33.24,33.44,33.3,34.35,34.61,35.27,33.28,-0.66,-0.61,-2.29,0.15,-0.43,-0.31,-0.39,-0.04,0.16,0.03,1.07,1.33,1.99,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell death;cell morphogenesis;cell motility;cell recognition;cellular component morphogenesis;cellular component movement;cellular component organization;cellular process;death;developmental process;endoplasmic reticulum organization;locomotion;organelle organization;response to stimulus;signal transduction,cell body;cell part;cell projection;membrane;neuronal cell body;nuclear envelope;plasma membrane,,,,,,,,,,
Q8WWV3,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein)",3,20,27.15,24.69,,25.65,24.84,26.57,24.87,24.49,26.34,24.57,,,,25.46,1.69,-0.77, ,0.19,-0.62,1.11,-0.6,-0.98,0.88,-0.89, , , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96T51,RUFY1,RUN and FYVE domain-containing protein 1 (FYVE-finger protein EIP1) (La-binding protein 1) (Rab4-interacting protein) (Zinc finger FYVE domain-containing protein 12),12,25.1,26.59,28.87,29.33,27.76,24.69,23.02,27.98,27.97,25.46,24.72,26.76,27.62,22.83,26.43,0.16,2.44,2.9,1.33,-1.74,-3.41,1.55,1.54,-0.97,-1.71,0.33,1.19,-3.61,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;regulation of transport;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q9Y265,RUVBL1,RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha),21,60.5,33.07,31.71,32.26,32.13,32.46,31.85,32.02,32.19,31.7,31.96,31.26,31.76,30.47,31.91,1.16,-0.2,0.35,0.22,0.55,-0.07,0.11,0.28,-0.21,0.05,-0.65,-0.15,-1.44,biological regulation;biosynthetic process;cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;histone modification;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;multicellular organismal process;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;chromatin remodeling complex;DNA helicase complex;Golgi apparatus;histone methyltransferase complex;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;organelle;protein complex,,,,,,,,,,
Q9Y230,RUVBL2,RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta),32,56.8,32.73,31.3,32.33,31.54,32.05,31.99,31.7,32.06,31.06,31.63,31.87,31.94,31.46,31.82,0.91,-0.52,0.51,-0.28,0.23,0.17,-0.12,0.24,-0.76,-0.19,0.05,0.12,-0.36,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein folding;protein metabolic process;protein modification process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;chromatin remodeling complex;cytoplasm;DNA helicase complex;histone methyltransferase complex;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9H446,RWDD1,RWD domain-containing protein 1 (DRG family-regulatory protein 2),3,51.4,25.69,25.23,25.8,27.06,27.72,24.48,27.13,27.64,26.01,24.52,26.43,27.14,,26.24,-0.55,-1.01,-0.44,0.82,1.49,-1.75,0.89,1.4,-0.23,-1.72,0.19,0.9, ,,,,,,,,,,,,
Q6NW29,RWDD4,RWD domain-containing protein 4 (Protein FAM28A),3,17.1,19.6,24.13,,22.95,25.3,23.41,21.22,24.16,24.67,22.26,,26.04,,23.37,-3.78,0.75, ,-0.42,1.93,0.03,-2.16,0.78,1.3,-1.11, ,2.67, ,,,,,,,,,,,,
P28702,RXRB,Retinoic acid receptor RXR-beta (Nuclear receptor subfamily 2 group B member 2) (Retinoid X receptor beta),6,22.2,27.33,24.72,,25.48,23.49,24.11,26.71,23.11,26.29,25.29,22.59,23.93,23.1,24.68,2.65,0.04, ,0.8,-1.19,-0.57,2.03,-1.57,1.61,0.61,-2.09,-0.75,-1.58,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent",cell part;nucleoplasm,NR C4-type,,,,,,,,,
P23297,S100A1,Protein S100-A1 (S-100 protein alpha chain) (S-100 protein subunit alpha) (S100 calcium-binding protein A1),3,45.7,31.93,30.97,31.11,27.08,,25.42,,24.73,24.64,30.08,,19.6,25.85,27.14,4.79,3.83,3.97,-0.06, ,-1.72, ,-2.41,-2.5,2.94, ,-7.54,-1.29,biological regulation;cellular process;response to stimulus;signal transduction,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P60903,S100A10,Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11),13,68,33.5,34.42,34.9,33.79,35.17,34.48,35.61,35.3,34.8,34.79,35.19,34.54,35.8,34.79,-1.29,-0.37,0.11,-1,0.38,-0.31,0.82,0.51,0.01,0,0.4,-0.25,1,biological regulation;cellular process;response to chemical stimulus;response to stimulus;signal transduction,cell part,,,,,,,,,,
P31949,S100A11,Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11),12,91.4,34.3,32.99,34.55,32.35,32.06,31.72,32.64,32.78,32.07,32.01,33.22,32.62,30.83,32.63,1.68,0.37,1.93,-0.28,-0.57,-0.91,0.01,0.15,-0.55,-0.62,0.59,0,-1.8,biological regulation;cellular process;regulation of DNA metabolic process;response to stimulus;signal transduction,cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q99584,S100A13,Protein S100-A13 (S100 calcium-binding protein A13),9,59.2,31.88,32.05,31.99,31.3,31.13,30.81,31.91,32.69,31.63,30.18,32.19,29.85,30.18,31.37,0.52,0.68,0.62,-0.07,-0.24,-0.56,0.54,1.32,0.26,-1.19,0.82,-1.52,-1.19,biological regulation;cell activation;cellular process;establishment of localization;exocytosis;immune system process;protein transport;response to abiotic stimulus;response to chemical stimulus;response to stimulus;secretion;transport;vesicle-mediated transport,cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9HCY8,S100A14,Protein S100-A14 (S100 calcium-binding protein A14) (S114),8,84.6,31.87,30.65,28.4,29,23.94,25.69,,24.79,25.44,28.99,,,,27.64,4.23,3.01,0.76,1.36,-3.7,-1.95, ,-2.85,-2.2,1.35, , , ,biological regulation;cell death;cellular process;death;homeostatic process;immune system process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q96FQ6,S100A16,Protein S100-A16 (Aging-associated gene 13 protein) (Protein S100-F) (S100 calcium-binding protein A16),6,58.3,31.22,29.87,28.67,29.71,30.26,29.2,29.69,30.1,28.73,28.69,29.97,27.76,28.1,29.38,1.84,0.49,-0.71,0.33,0.87,-0.18,0.31,0.71,-0.66,-0.69,0.59,-1.62,-1.28,response to chemical stimulus;response to stimulus,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle;plasma membrane,,,,,,,,,,
P06703,S100A6,Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6),11,94.4,33.14,34.3,34.6,34.55,34.94,33.33,33.3,34.87,34.73,33.74,34.68,33.52,33.61,34.1,-0.96,0.2,0.5,0.45,0.84,-0.77,-0.8,0.77,0.63,-0.36,0.58,-0.59,-0.49,anatomical structure morphogenesis;biological regulation;cellular component morphogenesis;cellular component organization;cellular process;developmental process;response to stimulus;signal transduction,cell part;cell projection;cytosol;nuclear envelope,,,,,,,,,,
P05109,S100A8,"Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A) [Cleaved into: Protein S100-A8, N-terminally processed]",11,60.2,28.54,30.03,33.16,27.54,25.17,,25.49,,,,24.47,22.66,26.49,27.06,1.48,2.96,6.1,0.47,-1.89, ,-1.57, , , ,-2.59,-4.4,-0.57,autophagy;biological adhesion;biological regulation;catabolic process;cell adhesion;cell motility;cellular component movement;cellular metabolic process;cellular process;cytokine production;immune system process;locomotion;metabolic process;multicellular organismal process;multi-organism process;regulation of organelle organization;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;extracellular region;extracellular space;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P06702,S100A9,Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9),7,68.4,29.84,31.24,33.85,28.04,26.35,26.13,27.82,26.86,27.13,27.39,26.99,20.37,27.77,27.68,2.16,3.56,6.18,0.37,-1.32,-1.55,0.15,-0.82,-0.55,-0.29,-0.68,-7.31,0.1,autophagy;biological adhesion;biological regulation;catabolic process;cell adhesion;cell communication;cell motility;cell-cell signaling;cellular component movement;cellular component organization;cellular metabolic process;cellular process;cytokine production;cytoskeleton organization;immune system process;locomotion;metabolic process;multicellular organismal process;multi-organism process;organelle organization;regulation of organelle organization;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signaling,cell part;cytoskeleton;cytosol;extracellular region;extracellular space;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9NTJ5,SACM1L,Phosphatidylinositide phosphatase SAC1 (EC 3.1.3.-) (Suppressor of actin mutations 1-like protein),18,34.9,30.3,31.09,30.63,30.24,30.7,30.64,30.7,30.61,30.92,31,30.81,30.79,31.01,30.73,-0.43,0.37,-0.1,-0.49,-0.02,-0.09,-0.03,-0.11,0.2,0.27,0.08,0.06,0.28,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;phosphorus metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,+,,,,,,,
Q9UBE0,SAE1,"SUMO-activating enzyme subunit 1 (Ubiquitin-like 1-activating enzyme E1A) [Cleaved into: SUMO-activating enzyme subunit 1, N-terminally processed]",16,57.5,31.2,30.3,29.66,29.8,30.29,30.59,30.1,30.54,29.38,28.84,29.94,29.78,30.73,30.09,1.11,0.21,-0.43,-0.29,0.2,0.5,0.01,0.45,-0.71,-1.24,-0.15,-0.3,0.64,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q15424,SAFB,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),43,47.1,30.66,30.21,30.69,29.74,30.37,30.65,30.36,29.12,30.73,32.06,29.64,31.16,30.04,30.42,0.24,-0.2,0.28,-0.68,-0.05,0.23,-0.06,-1.3,0.31,1.65,-0.78,0.74,-0.38,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;growth;hormone metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,SAP-domain,,,,,,,,,
Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),13,17.2,27.84,27.09,28.72,27.84,27.01,28.4,27.56,26.92,27.55,27.7,27.51,26.71,27.11,27.54,0.31,-0.45,1.19,0.3,-0.53,0.86,0.03,-0.61,0.02,0.16,-0.03,-0.83,-0.43,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,SAP-domain,,,,,,,,,
Q6SPF0,SAMD1,Atherin (Sterile alpha motif domain-containing protein 1) (SAM domain-containing protein 1),4,12.8,24.85,,22.63,21.59,24.17,23.84,22.53,22.75,23.16,,,,,23.19,1.66, ,-0.56,-1.6,0.98,0.65,-0.66,-0.44,-0.03, , , , ,,cell part;cytoplasm;extracellular region,,,,,,,,,,
Q5PRF9,SAMD4B,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),4,12,25.2,24.76,25.15,24.49,24.32,24.21,25.07,25.2,,,24.14,24.24,,24.68,0.52,0.08,0.47,-0.19,-0.35,-0.47,0.39,0.52, , ,-0.54,-0.44, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q5K651,SAMD9,Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9),24,18.7,27.15,29.1,30.79,30.1,24.09,24.05,28.84,27.76,,,28.28,30.15,25.92,27.84,-0.69,1.27,2.95,2.26,-3.75,-3.79,1,-0.08, , ,0.44,2.31,-1.92,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9Y512,SAMM50,Sorting and assembly machinery component 50 homolog (Transformation-related gene 3 protein) (TRG-3),20,47.1,30.89,31.34,30.84,30.87,30.58,31.06,31.19,30.75,31.55,31.68,31.32,30.91,31.2,31.09,-0.2,0.26,-0.25,-0.22,-0.51,-0.02,0.1,-0.34,0.46,0.59,0.23,-0.18,0.11,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;organelle organization;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
O00422,SAP18,Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (2HOR0202) (Cell growth-inhibiting gene 38 protein) (Sin3-associated polypeptide p18),9,47.1,29.57,29.18,29.11,28.89,28.8,29.03,28.63,28.52,29.24,29.35,27.63,26.11,27.52,28.58,0.99,0.6,0.53,0.31,0.21,0.45,0.05,-0.06,0.66,0.76,-0.95,-2.48,-1.06,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;chromatin remodeling complex;cytoplasm;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9NR31,SAR1A,GTP-binding protein SAR1a (COPII-associated small GTPase),11,61.6,30.8,31.69,31.4,31.75,31.21,31.3,32.05,31.72,31.22,31.18,31.84,31.86,32.68,31.59,-0.79,0.1,-0.2,0.15,-0.38,-0.29,0.46,0.12,-0.37,-0.41,0.25,0.27,1.09,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9Y6B6,SAR1B,GTP-binding protein SAR1b (GTP-binding protein B) (GTBPB),4,29.8,28.23,28.58,25.9,28.32,26.84,26.2,27.35,27.65,27.54,26.31,27.67,27.85,26.52,27.3,0.92,1.28,-1.4,1.01,-0.47,-1.11,0.04,0.35,0.23,-0.99,0.36,0.55,-0.78,carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;transport;vesicle organization,cell part;cytosol;membrane,,,,,,,,,,
Q9BW04,SARG,Specifically androgen-regulated gene protein,11,29.8,28.65,26.15,28.98,,25.83,,27.55,28.11,,28.92,24.93,,23.5,26.96,1.69,-0.81,2.02, ,-1.13, ,0.59,1.15, ,1.96,-2.02, ,-3.46,,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q6SZW1,SARM1,Sterile alpha and TIR motif-containing protein 1 (Sterile alpha and Armadillo repeat protein) (Sterile alpha motif domain-containing protein 2) (MyD88-5) (SAM domain-containing protein 2) (Tir-1 homolog),5,11.4,,25.9,25.84,25.04,,23.95,,,,,25.04,26.89,25.26,25.42, ,0.48,0.42,-0.38, ,-1.46, , , , ,-0.38,1.47,-0.16,biological regulation;cellular process;immune system process;response to stimulus;response to stress;signal transduction,cell part;cell projection;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;neuron projection;organelle;protein complex;synapse,,,,,,,,,,
P82979,SARNP,SAP domain-containing ribonucleoprotein (Cytokine-induced protein of 29 kDa) (Nuclear protein Hcc-1) (Proliferation-associated cytokine-inducible protein CIP29),12,53.3,30.94,30.06,30.41,30.4,31.47,31.05,30.26,30.43,31.08,30.67,29.61,28.24,29.6,30.32,0.61,-0.26,0.09,0.07,1.15,0.72,-0.06,0.11,0.76,0.35,-0.72,-2.08,-0.73,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,SAP-domain,,,,,,,,,
P49591,SARS,"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)",25,54.3,32.16,31.34,31.12,31.06,27.92,27.51,30.21,30.62,28.79,29.75,30.41,30.71,26,29.82,2.35,1.52,1.3,1.24,-1.9,-2.31,0.39,0.8,-1.03,-0.06,0.6,0.9,-3.81,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;RNA processing;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process;tRNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9NP81,SARS2,"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)",14,35.3,28.53,28.65,27.61,27.81,28.11,28.76,28.44,27.23,28.09,29.09,28.73,27.65,28.31,28.23,0.3,0.42,-0.62,-0.42,-0.12,0.53,0.21,-1,-0.15,0.86,0.5,-0.58,0.08,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
O43290,SART1,U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1),22,33.6,29.91,28.88,28.94,29.02,29.92,29.17,28.61,28.64,29.27,28.82,27.73,26,28.6,28.73,1.18,0.15,0.21,0.29,1.18,0.44,-0.12,-0.09,0.54,0.09,-1,-2.74,-0.13,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;regulation of cell cycle;ribonucleoprotein complex assembly,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q15020,SART3,Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3) (hSART-3) (Tat-interacting protein of 110 kDa) (Tip110),29,33.7,31.03,30.48,30.08,29.43,29.62,29.68,28.84,27.9,30.56,29.27,27.89,28.7,29.33,29.45,1.58,1.04,0.63,-0.02,0.17,0.23,-0.6,-1.55,1.11,-0.17,-1.56,-0.75,-0.12,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9Y3A5,SBDS,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),10,30,30.47,29.77,29.93,30.41,28.78,28.59,30.44,29.93,28.92,28.8,30.5,30.66,28.82,29.7,0.78,0.07,0.24,0.72,-0.92,-1.1,0.75,0.23,-0.77,-0.89,0.8,0.96,-0.88,anatomical structure development;biological regulation;cell motility;cell proliferation;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;immune system process;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle assembly;primary metabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;ribonucleoprotein complex assembly;ribosomal large subunit biogenesis;ribosome assembly;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",14,14.4,25.72,23.5,25.69,23.36,22.43,25.06,25.14,23.27,25.15,26.95,25.61,27.16,24.65,24.9,0.82,-1.4,0.79,-1.54,-2.47,0.16,0.25,-1.63,0.25,2.05,0.71,2.26,-0.25,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O95104,SCAF4,"Splicing factor, arginine/serine-rich 15 (CTD-binding SR-like protein RA4) (SR-related and CTD-associated factor 4)",7,12,28.4,26.73,27.45,27.38,27.65,26.92,26.4,27.29,27.81,27.39,,25.52,,27.18,1.23,-0.45,0.27,0.2,0.48,-0.26,-0.78,0.11,0.63,0.21, ,-1.65, ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UPN6,SCAF8,Protein SCAF8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) (SR-related and CTD-associated factor 8),9,10,28.09,27.45,27.71,28.1,26.75,28.04,27.5,27.56,28.36,27.22,25.19,27.34,27.66,27.46,0.63,-0.01,0.25,0.65,-0.71,0.58,0.04,0.1,0.9,-0.24,-2.27,-0.12,0.2,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O15126,SCAMP1,Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1),6,30.8,29.15,30.11,28.75,29.67,29.38,29.61,29.02,28.93,29.97,29.26,29.69,29.95,29.42,29.45,-0.3,0.65,-0.71,0.22,-0.08,0.15,-0.43,-0.52,0.51,-0.19,0.23,0.5,-0.04,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O15127,SCAMP2,Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2),6,15.8,27.75,30.33,30.21,29.24,29.41,29.53,29.11,29.08,29.22,30.33,30.25,27.65,30.44,29.43,-1.68,0.9,0.78,-0.19,-0.02,0.11,-0.31,-0.35,-0.21,0.9,0.83,-1.78,1.02,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
O14828,SCAMP3,Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3),10,42.7,30.3,30.31,29.84,29.67,30.28,30.13,30.2,29.91,29.05,29.59,30.77,30.43,30.1,30.04,0.26,0.27,-0.21,-0.38,0.24,0.09,0.15,-0.14,-1,-0.45,0.73,0.39,0.05,cellular process;establishment of localization;Golgi vesicle transport;protein transport;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q8WTV0,SCARB1,"Scavenger receptor class B member 1 (SRB1) (CD36 and LIMPII analogous 1) (CLA-1) (CD36 antigen-like 1) (Collagen type I receptor, thrombospondin receptor-like 1) (SR-BI) (CD antigen CD36)",6,14.8,24.32,23.65,,26.23,25.63,28.41,,,26.37,24.92,,26.04,24.49,25.56,-1.24,-1.91, ,0.67,0.07,2.85, , ,0.81,-0.65, ,0.47,-1.07,alcohol metabolic process;biological adhesion;biological regulation;biosynthetic process;carbohydrate transport;catabolic process;cell adhesion;cell motility;cell proliferation;cell recognition;cellular component movement;cellular component organization;cellular metabolic process;cellular process;detection of stimulus;establishment of localization;homeostatic process;hormone metabolic process;interspecies interaction between organisms;lipid metabolic process;lipid transport;lipopolysaccharide transport;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;multi-organism process;primary metabolic process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;small molecule metabolic process;transmembrane transport;transport,cell part;cell surface;cytoplasm,,,,,,,,,,
Q14108,SCARB2,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),16,37.2,30.92,32.01,31.3,32.2,31.83,32.82,30.96,31.22,31.84,31.53,32.16,31.36,32.14,31.71,-0.8,0.29,-0.41,0.48,0.12,1.1,-0.75,-0.49,0.12,-0.18,0.44,-0.35,0.42,biological adhesion;cell adhesion;cellular process;establishment of localization;protein targeting;protein transport;transport;vacuolar transport,cell part;membrane,,,,,,,,,,
Q8NBX0,SCCPDH,Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-),13,36.8,29.24,30.84,30.4,30.24,30.08,30.62,30.28,30.24,31.15,29.97,30.28,29.82,30.44,30.28,-1.04,0.56,0.12,-0.03,-0.2,0.34,0,-0.04,0.88,-0.3,0,-0.46,0.16,,cell part;intracellular membrane-bounded organelle;intracellular organelle;lipid particle;midbody;mitochondrion;organelle,,,,,,,,,,
O00767,SCD,Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase),9,25.3,26.36,24.5,27.24,30.85,26.21,26.02,29.38,26.67,29.19,29.34,27.03,29.67,,27.71,-1.34,-3.2,-0.47,3.15,-1.49,-1.69,1.68,-1.04,1.48,1.64,-0.68,1.96, ,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O95171,SCEL,Sciellin,35,53,27.29,26.84,31.28,23.87,27.21,26.6,27.58,25.94,25.08,31.93,,23.04,25.05,26.81,0.48,0.03,4.47,-2.94,0.4,-0.21,0.77,-0.87,-1.73,5.12, ,-3.77,-1.76,cell differentiation;cellular process;developmental process;embryo development,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q8WVM8,SCFD1,Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2),27,50.6,30.94,30.9,30.82,30.77,31.12,31.47,31.02,30.81,31.49,30.83,30.8,31.55,31.48,31.08,-0.14,-0.18,-0.26,-0.31,0.05,0.4,-0.06,-0.27,0.41,-0.25,-0.27,0.47,0.41,biological regulation;cellular process;establishment of localization;Golgi vesicle transport;membrane docking;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
Q8WU76,SCFD2,Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1),6,11.1,26.71,27.08,24.95,27.14,26.7,27.86,27,27.03,27.91,27.57,27.54,27.42,27.91,27.14,-0.43,-0.06,-2.19,0,-0.44,0.72,-0.14,-0.11,0.77,0.43,0.4,0.28,0.77,cellular process;establishment of localization;membrane docking;protein transport;transport,,,,,,,,,,,
O75880,SCO1,"Protein SCO1 homolog, mitochondrial",5,23.7,28.28,29.76,28.63,28.98,30.15,30.32,29.31,28.98,29.29,30.32,29.46,28.65,30.49,29.43,-1.15,0.33,-0.8,-0.46,0.72,0.89,-0.12,-0.46,-0.15,0.88,0.03,-0.78,1.06,biological regulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular macromolecular complex assembly;cellular metabolic process;cellular process;establishment of localization;generation of precursor metabolites and energy;homeostatic process;ion transport;macromolecular complex assembly;metabolic process;protein complex assembly;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
O43819,SCO2,"Protein SCO2 homolog, mitochondrial",4,19.2,25.87,24.48,22.37,24.58,25.84,25.49,26.83,26.42,26.63,27.45,25.2,,27.08,25.69,0.19,-1.21,-3.32,-1.1,0.15,-0.19,1.14,0.74,0.94,1.76,-0.49, ,1.4,biological regulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular macromolecular complex assembly;cellular metabolic process;cellular process;developmental process;embryo development;establishment of localization;generation of precursor metabolites and energy;homeostatic process;ion transport;macromolecular complex assembly;metabolic process;multicellular organismal process;protein complex assembly;response to stimulus;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9UIL1,SCOC,Short coiled-coil protein,2,16.5,27.23,26.4,,27.21,26.14,23.98,24.45,26.39,,,26.47,,,26.03,1.2,0.36, ,1.18,0.11,-2.05,-1.58,0.36, , ,0.43, , ,biological regulation,cell part;cytosol;membrane,,,,,,,,,,
A6NM69,SCP2,Non-specific lipid-transfer protein,19,34.4,32.67,33.13,33.66,32.56,32.81,33.03,32.44,32.74,33.32,33.37,32.83,32.24,32.68,32.88,-0.21,0.25,0.78,-0.32,-0.07,0.15,-0.45,-0.14,0.44,0.49,-0.06,-0.65,-0.21,biological regulation;biosynthetic process;catabolic process;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;hormone metabolic process;lipid metabolic process;lipid transport;localization;membrane organization;metabolic process;organelle organization;organic acid metabolic process;peroxisome organization;plasma membrane organization;primary metabolic process;regulation of transport;small molecule metabolic process;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;protein complex,,,,,,,,,,
Q9HB40,SCPEP1,Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1),7,19,28.08,29.83,29.59,27.39,28.59,28.54,26.17,27.73,29.75,26.1,28.41,26.35,29.34,28.14,-0.06,1.68,1.45,-0.75,0.45,0.4,-1.98,-0.41,1.6,-2.04,0.27,-1.8,1.2,biological regulation;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;hormone metabolic process;lipid metabolic process;macromolecule metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process;vitamin metabolic process,cell part;cytosol;extracellular region,,,,,,,,,,
Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),40,33.8,30.3,29.46,27.49,29.07,29.63,30.19,29.62,29.19,29.35,29.99,29.64,28.09,30.06,29.39,0.91,0.07,-1.9,-0.32,0.24,0.79,0.23,-0.2,-0.04,0.6,0.25,-1.3,0.67,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell death;cell motility;cell proliferation;cellular component movement;cellular component organization;cellular membrane organization;cellular process;death;developmental process;endocytosis;establishment of localization;establishment or maintenance of cell polarity;interspecies interaction between organisms;localization;locomotion;membrane invagination;membrane organization;multi-organism process;regulation of cell cycle;regulation of mitotic cell cycle;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q12765,SCRN1,Secernin-1,7,18.6,28.58,29.03,27.86,29.81,28.47,28.27,29.76,29.09,28.24,26.68,29.33,30.6,27,28.67,-0.09,0.36,-0.81,1.14,-0.2,-0.4,1.09,0.42,-0.43,-1.99,0.66,1.93,-1.67,cellular process;establishment of localization;exocytosis;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;secretion;transport;vesicle-mediated transport,cell part;cytoplasm;membrane,,,,,,,,,,
Q96KG9,SCYL1,N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase),10,22.1,28.99,28.91,28.13,29.11,27.91,27.09,28.68,28.23,28.1,26.87,28.38,29.53,27.1,28.23,0.76,0.68,-0.1,0.88,-0.32,-1.14,0.45,0,-0.14,-1.37,0.15,1.3,-1.13,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex,Other TF domain,+,,,,,,,,
Q6P3W7,SCYL2,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),5,7.8,26.3,26.43,27.28,27.45,26.39,26.56,25.88,25.56,25.38,25.69,26.88,26.01,25.58,26.26,0.04,0.16,1.02,1.19,0.13,0.29,-0.38,-0.7,-0.88,-0.57,0.62,-0.25,-0.68,biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endocytosis;endosome transport;establishment of localization;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;regulation of transport;transport;vacuolar transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,+,,,,,,,,
Q9NVU7,SDAD1,Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA),10,15.6,26.72,25.17,22.71,27.36,,25.61,26.63,,27.26,28.06,25.54,25.85,26.32,26.11,0.61,-0.94,-3.4,1.25, ,-0.5,0.52, ,1.15,1.95,-0.57,-0.27,0.2,cellular component organization;cellular localization;cellular process;cytoskeleton organization;establishment of localization;localization;nuclear transport;nucleocytoplasmic transport;organelle organization;protein transport;ribosomal large subunit biogenesis;ribosomal subunit export from nucleus;transport,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P31431,SDC4,Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein),4,35.4,28.96,29.1,27.08,28.76,24.33,26.18,26.38,22.96,27.21,29.61,26.32,25.01,23.45,26.57,2.39,2.54,0.52,2.19,-2.24,-0.38,-0.18,-3.6,0.65,3.04,-0.24,-1.56,-3.12,amine metabolic process;anatomical structure development;biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;detection of stimulus;developmental process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;regulation of organelle organization;regulation of protein modification process;response to abiotic stimulus;response to external stimulus;response to stimulus;signal transduction;sulfur compound metabolic process,cell part;cell surface;extracellular region,,,,,,,,,,
O00560,SDCBP,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),11,52.3,28.87,28.02,29.56,30.4,30.69,30.22,29.46,30.48,29.78,29.5,29.81,30.57,29.9,29.79,-0.92,-1.77,-0.23,0.61,0.9,0.43,-0.33,0.69,-0.01,-0.29,0.02,0.78,0.11,biological regulation;cell communication;cell-cell signaling;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;locomotion;organelle organization;protein targeting;protein transport;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction;signaling;transport,cell part;cytoplasmic membrane-bounded vesicle;cytoskeleton;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex;receptor complex;vesicle,,,,,,,,,,
Q99470,SDF2,Stromal cell-derived factor 2 (SDF-2),5,36,30.51,29.7,29.27,29.55,29.72,30.3,29.22,29.59,29.76,29.54,29.96,26.54,30.49,29.55,0.96,0.15,-0.28,0,0.17,0.75,-0.33,0.04,0.21,-0.01,0.41,-3.01,0.94,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;extracellular space;membrane,,,,,,,,,,
Q9BRK5,SDF4,45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4),21,56.6,30.18,31.71,30.54,31.91,30.8,31.46,30.97,30.91,31.74,31.3,30.98,30.87,31.23,31.12,-0.94,0.59,-0.58,0.79,-0.32,0.34,-0.15,-0.22,0.62,0.18,-0.14,-0.25,0.11,anatomical structure development;cell differentiation;cellular process;developmental process;establishment of localization;exocytosis;response to abiotic stimulus;response to chemical stimulus;response to stimulus;secretion;transport;vesicle-mediated transport,bleb;cell part;cell projection;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P31040,SDHA,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)",29,52.3,32.57,32.43,32.49,31.65,32.24,32.79,32.08,31.52,32.68,32.34,32.25,30.89,32.52,32.19,0.38,0.24,0.3,-0.54,0.05,0.6,-0.11,-0.67,0.49,0.16,0.07,-1.3,0.33,anatomical structure development;catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;developmental process;generation of precursor metabolites and energy;metabolic process;organic acid metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9NX18,SDHAF2,"Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (Succinate dehydrogenase subunit 5, mitochondrial) (hSDH5)",2,20.1,26.15,25.71,24.85,23.73,,,,,25.92,26.64,24.99,23.7,,25.21,0.93,0.5,-0.36,-1.48, , , , ,0.71,1.43,-0.22,-1.51, ,cellular metabolic process;cellular process;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,,,,,,,,,,
P21912,SDHB,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip)",18,52.2,31.96,31.74,32.69,31.49,31.54,31.95,31.81,31.21,32.17,31.94,30.62,31.08,31.85,31.7,0.26,0.04,1,-0.21,-0.15,0.25,0.11,-0.48,0.48,0.25,-1.08,-0.62,0.15,catabolic process;cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;generation of precursor metabolites and energy;metabolic process;organic acid metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q99643,SDHC,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL)",3,19.5,27.44,27.67,28.39,27.4,,27.65,26.01,26.1,28.14,27.92,27.44,,27.1,27.39,0.06,0.28,1.01,0.01, ,0.27,-1.38,-1.28,0.75,0.53,0.05, ,-0.29,catabolic process;cellular metabolic process;cellular process;cofactor metabolic process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
O14521,SDHD,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit)",2,6.7,25.9,25.65,27.82,25.07,25.48,26.52,24.98,24.46,,26.38,24.84,24.29,25.43,25.57,0.33,0.09,2.25,-0.5,-0.09,0.95,-0.59,-1.11, ,0.82,-0.73,-1.28,-0.14,catabolic process;cellular metabolic process;cellular process;cofactor metabolic process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
O95810,SDPR,Serum deprivation-response protein (Cavin-2) (PS-p68) (Phosphatidylserine-binding protein),13,33.6,26.29,28.81,28.23,29.56,28.61,27.91,26.88,27.5,27,27.06,28.16,29.45,28.2,27.97,-1.68,0.84,0.25,1.59,0.64,-0.06,-1.09,-0.48,-0.98,-0.91,0.19,1.48,0.22,,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q9NRG7,SDR39U1,Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1),3,17.1,26.78,27.16,,24.74,26.76,,26.71,26.3,27.43,26.76,,,,26.58,0.2,0.58, ,-1.84,0.18, ,0.13,-0.28,0.85,0.18, , , ,,,,,,,,,,,,
Q96GA7,SDSL,Serine dehydratase-like (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (Serine dehydratase 2) (SDH 2) (EC 4.3.1.17),2,18.6,24.31,27.44,26.75,26.66,24.13,,26.17,25.56,,24.4,26.31,27.07,,25.88,-1.57,1.56,0.87,0.78,-1.75, ,0.29,-0.32, ,-1.48,0.44,1.19, ,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
H0YNG3,SEC11A,Signal peptidase complex catalytic subunit SEC11A,10,31.9,29.82,30.25,28.16,29.9,30.7,30.3,29.98,29.98,30.46,29.94,29.92,29.42,30.38,29.94,-0.12,0.32,-1.78,-0.04,0.76,0.37,0.04,0.04,0.52,0,-0.02,-0.52,0.44,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis,cell part,,,,,,,,,,
Q9BY50,SEC11C,Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21),5,34,24.95,25.55,24.11,26.76,27.22,27.43,27.21,27.26,27.28,26.81,23.71,27.13,26.45,26.3,-1.34,-0.75,-2.19,0.46,0.92,1.13,0.92,0.96,0.98,0.51,-2.58,0.83,0.15,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein targeting;protein transport;proteolysis;regulation of transport;translation;transport,cell part;membrane,,,,,,,,,,
P55735,SEC13,Protein SEC13 homolog (SEC13-like protein 1) (SEC13-related protein),19,74.2,31.08,31.31,31.06,31.76,30.63,30.18,31.56,30.71,31.14,30.38,31.34,31.04,29.69,30.91,0.17,0.39,0.15,0.84,-0.28,-0.73,0.65,-0.21,0.22,-0.54,0.43,0.12,-1.22,carbohydrate metabolic process;cell cycle;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;mitotic cell cycle;nucleobase-containing compound transport;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;transport;vesicle organization,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
B3KRD8,SEC14L2,"SEC14-like 2 (S. cerevisiae), isoform CRA_c (SEC14-like protein 2) (cDNA FLJ34083 fis, clone FCBBF3004409, highly similar to SEC14-like protein 2)",12,36.5,29.17,28.43,25.44,29.33,29.44,28.77,29.98,30.12,28.08,26.23,30.46,26.15,27.63,28.4,0.76,0.03,-2.96,0.93,1.04,0.36,1.58,1.71,-0.32,-2.17,2.06,-2.25,-0.77,establishment of localization;transport,cell part,,,,,,,,,,
O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),25,20.2,28.33,28.89,28.45,29.16,28.83,27.62,29.26,29.15,28.17,28.21,30.09,28.23,28.68,28.7,-0.37,0.2,-0.25,0.46,0.13,-1.08,0.56,0.45,-0.53,-0.49,1.39,-0.47,-0.02,cellular component organization;cellular process;endoplasmic reticulum organization;establishment of localization;organelle organization;protein transport;transport;vesicle organization,cell part;cytosol;membrane,,,,,,,,,,
Q96IW7,SEC22A,Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2),3,14.2,27.14,25.76,,25.6,,27.33,,,23.94,26.98,26.37,27.18,27.34,26.4,0.74,-0.65, ,-0.81, ,0.92, , ,-2.46,0.58,-0.04,0.77,0.94,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
I1VE18,SEC22B,SEC22 vesicle trafficking protein B (Fragment),3,39.6,27.19,29.21,28.71,28.85,28.11,30.09,29.04,28.79,30.29,28.47,29.19,29.53,30.81,29.1,-1.91,0.11,-0.39,-0.25,-0.99,1,-0.06,-0.31,1.2,-0.63,0.09,0.43,1.71,establishment of localization;transport,cell part;membrane,,,,,,,,,,
O75396,SEC22B,Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1),17,52.6,31.93,33.05,32.19,32.65,32.21,33.17,31.72,31.99,32.79,31.91,32.71,32.69,33.3,32.49,-0.56,0.57,-0.3,0.17,-0.28,0.69,-0.77,-0.49,0.3,-0.58,0.22,0.2,0.82,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q15436,SEC23A,Protein transport protein Sec23A (SEC23-related protein A),32,50.8,30.18,32.01,30.62,32.24,32.25,31.52,32.13,32.36,32.35,30.37,31.73,31.32,31.58,31.59,-1.41,0.42,-0.97,0.65,0.66,-0.07,0.54,0.77,0.76,-1.22,0.14,-0.27,-0.01,carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;small molecule metabolic process;transport;vesicle organization,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q15437,SEC23B,Protein transport protein Sec23B (SEC23-related protein B),15,26.4,30.33,29.09,29.42,28.52,27.41,28.49,27.86,28.66,,28.71,27.51,28.29,,28.57,1.76,0.52,0.85,-0.05,-1.17,-0.08,-0.71,0.09, ,0.14,-1.06,-0.28, ,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9Y6Y8,SEC23IP,SEC23-interacting protein (p125),19,21.8,30.5,30.9,30.29,30.31,29.4,30.48,29.79,30.22,30.01,29.02,30.17,30.36,29.81,30.1,0.4,0.81,0.19,0.21,-0.7,0.38,-0.31,0.12,-0.08,-1.07,0.07,0.26,-0.28,cellular component organization;cellular process;establishment of localization;Golgi organization;organelle organization;protein transport;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O95486,SEC24A,Protein transport protein Sec24A (SEC24-related protein A),20,28.6,29.35,29.52,29.22,29.74,29.21,29.19,29.6,30.08,28.27,27.97,29.27,28.9,28.84,29.17,0.19,0.35,0.06,0.57,0.05,0.03,0.43,0.91,-0.9,-1.2,0.1,-0.27,-0.32,carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;small molecule metabolic process;transport;vesicle organization,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
O95487,SEC24B,Protein transport protein Sec24B (SEC24-related protein B),12,15.5,28.86,29.04,28.4,28.84,28.89,28.53,29.16,29.38,28.6,28.32,29.54,29.2,29.11,28.91,-0.06,0.13,-0.51,-0.07,-0.02,-0.38,0.25,0.47,-0.31,-0.59,0.63,0.28,0.19,carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;small molecule metabolic process;transport;vesicle organization,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
P53992,SEC24C,Protein transport protein Sec24C (SEC24-related protein C),18,21.1,30.25,31.09,30.88,30.81,30.39,30.38,31.15,31.2,30.57,29.6,31.31,30.88,30.18,30.67,-0.42,0.42,0.21,0.14,-0.28,-0.29,0.48,0.53,-0.09,-1.07,0.65,0.21,-0.49,carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;small molecule metabolic process;transport;vesicle organization,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
O94855,SEC24D,Protein transport protein Sec24D (SEC24-related protein D),25,30.8,30.28,31.44,30.56,31.49,30.76,30.34,31.36,31.5,31.17,29.12,30.97,31.33,29.55,30.76,-0.48,0.68,-0.2,0.73,0,-0.42,0.6,0.74,0.41,-1.64,0.21,0.57,-1.21,carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;small molecule metabolic process;transport;vesicle organization,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
O94979,SEC31A,Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein),42,39.5,30.99,31.5,31.55,32.29,32.2,31.48,32.07,32.51,30.89,29.88,32.35,31.65,31.92,31.64,-0.65,-0.13,-0.09,0.65,0.57,-0.16,0.43,0.87,-0.75,-1.75,0.72,0.01,0.28,biological regulation;carbohydrate metabolic process;cellular component organization;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein transport;regulation of protein modification process;response to chemical stimulus;response to stimulus;transport;vesicle organization,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
P61619,SEC61A1,Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1),13,27.7,29.66,30.7,29.34,30.67,28.47,30.8,29.87,29.07,30.9,30.81,29.91,27.73,29.24,29.78,-0.12,0.92,-0.45,0.89,-1.31,1.02,0.08,-0.71,1.12,1.03,0.13,-2.05,-0.54,establishment of localization;immune system process;protein targeting;protein transport;response to chemical stimulus;response to stimulus;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P60468,SEC61B,Protein transport protein Sec61 subunit beta,4,41.7,28.04,29.16,27.07,29.28,29.33,29.37,28.41,28.41,29.64,29.94,27.9,,28.5,28.76,-0.71,0.41,-1.68,0.52,0.58,0.62,-0.35,-0.35,0.89,1.19,-0.85, ,-0.25,biosynthetic process;catabolic process;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;translation;transport,cell part;endoplasmic reticulum Sec complex;macromolecular complex;protein complex,,,,,,,,,,
P60059,SEC61G,Protein transport protein Sec61 subunit gamma,5,48.5,28.61,29.41,31.33,29.27,29.79,30.79,30.3,29.21,31.35,31.57,30.38,30.83,31.22,30.31,-1.7,-0.91,1.02,-1.04,-0.52,0.48,-0.01,-1.11,1.04,1.25,0.07,0.52,0.91,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;translation;transport,cell part;membrane,,,,,,,,,,
Q99442,SEC62,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),15,32.1,29.29,29.32,29.02,28.62,28.29,28.24,28.59,27.62,28.38,29.06,28.5,23.77,28.69,28.26,1.03,1.06,0.76,0.36,0.03,-0.02,0.33,-0.64,0.12,0.8,0.24,-4.49,0.43,establishment of localization;protein targeting;protein transport;transport,cell part;cytoskeleton;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9UGP8,SEC63,Translocation protein SEC63 homolog,31,38.9,32.49,31.29,32.09,30.69,30.09,30.93,30.12,29.26,31.32,31.41,30.59,31.25,31.06,30.97,1.52,0.32,1.12,-0.28,-0.88,-0.04,-0.85,-1.71,0.35,0.44,-0.37,0.28,0.09,cellular process;establishment of localization;protein targeting;protein transport;transmembrane transport;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q96EE3,SEH1L,Nucleoporin SEH1 (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein),14,47.5,29.5,29,29.37,28.88,29.73,29.69,29.18,29.78,29.73,30.12,28.93,29.1,29.38,29.41,0.09,-0.41,-0.04,-0.54,0.31,0.27,-0.23,0.36,0.31,0.71,-0.48,-0.32,-0.03,biological regulation;carbohydrate metabolic process;carbohydrate transport;cell cycle;cell division;cellular component organization;cellular process;cytoskeleton organization;establishment of localization;metabolic process;mitotic cell cycle;nucleobase-containing compound transport;nucleus organization;organelle organization;primary metabolic process;protein transport;regulation of transport;response to chemical stimulus;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9UBV2,SEL1L,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),10,22.4,29.13,29.29,27.88,28.6,28.88,29.22,28.5,27.29,29.47,29.67,28.12,28,28.72,28.68,0.46,0.62,-0.79,-0.08,0.2,0.54,-0.17,-1.38,0.79,0.99,-0.56,-0.68,0.05,biological regulation;cellular process;response to stimulus;response to stress;signal transduction,cell part;membrane,,,,,,,,,,
Q68CR1,SEL1L3,Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3),6,7.8,,25.08,24.19,25.89,27.68,27.37,27.93,27.12,24.29,26.37,28.11,28.39,29.55,26.83, ,-1.75,-2.64,-0.94,0.85,0.54,1.09,0.29,-2.54,-0.46,1.28,1.56,2.72,,cell part,,,,,,,,,,
Q13228,SELENBP1,Selenium-binding protein 1 (56 kDa selenium-binding protein) (SBP56) (SP56),26,57,33.01,31.22,30.47,29.24,25.24,27.29,29.43,29.98,,23.8,29.74,29.92,25.29,28.72,4.29,2.5,1.75,0.53,-3.48,-1.43,0.71,1.26, ,-4.92,1.02,1.2,-3.43,establishment of localization;protein transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q8IZQ5,SELH,Selenoprotein H (SelH),4,26.2,27.1,28.19,26.62,27.69,25.51,27.73,27.61,25.5,28.01,27.13,25.28,25.65,26.97,26.84,0.26,1.34,-0.23,0.84,-1.33,0.88,0.76,-1.35,1.17,0.28,-1.57,-1.19,0.13,biological regulation;cellular homeostasis;cellular process;homeostatic process,,,,,,,,,,,
Q8WWX9,SELM,Selenoprotein M (SelM),5,31.7,24.65,28.41,26.85,28.47,26.01,28.21,26.95,26.95,28.99,,27.56,27.35,29.07,27.45,-2.8,0.95,-0.61,1.02,-1.44,0.75,-0.5,-0.5,1.53, ,0.1,-0.1,1.61,,cell part;cytoplasm;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P62341,SELT,Selenoprotein T (SelT),3,15.4,,26.12,,25.97,24.61,27.02,26.17,,25.88,27.6,27.49,,27.64,26.5, ,-0.38, ,-0.53,-1.89,0.52,-0.33, ,-0.62,1.1,0.99, ,1.14,biological regulation;biosynthetic process;cellular homeostasis;cellular metabolic process;cellular process;homeostatic process;macromolecule metabolic process;metabolic process;regulation of translation;translational elongation,,,,,,,,,,,
Q13214,SEMA3B,Semaphorin-3B (Sema A(V)) (Semaphorin-V) (Sema V),6,10.4,26.19,23.07,24.67,23.49,18.44,,22.84,,,25.11,,26.08,,23.74,2.45,-0.67,0.94,-0.25,-5.3, ,-0.89, , ,1.38, ,2.34, ,cell communication;cell-cell signaling;cellular process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signaling,cell part;endoplasmic reticulum;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q99985,SEMA3C,Semaphorin-3C (Semaphorin-E) (Sema E),5,8.1,25.7,24.68,24.58,26.35,24.86,26.11,,,27.42,26.74,26.01,25.15,25.68,25.75,-0.05,-1.07,-1.17,0.59,-0.89,0.35, , ,1.67,0.99,0.26,-0.61,-0.07,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;cell motility;cellular component movement;cellular process;developmental process;immune system process;locomotion;multicellular organismal process;post-embryonic development;response to chemical stimulus;response to drug;response to external stimulus;response to stimulus;tissue remodeling,cell part;extracellular space;membrane,,,,,,,,,,
Q9NPR2,SEMA4B,Semaphorin-4B,10,14.2,29.1,25.24,,24.7,25.43,25.68,,24.04,25.9,,,,,25.73,3.37,-0.49, ,-1.03,-0.3,-0.04, ,-1.69,0.17, , , , ,anatomical structure development;cell differentiation;cellular process;developmental process,cell part,,,,,,,,,,
Q9H4L4,SENP3,Sentrin-specific protease 3 (EC 3.4.22.68) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3),7,15.4,26.31,26.76,27.1,27.6,26.58,27.96,25.62,25.44,28.02,28.43,,,27.86,27.06,-0.75,-0.3,0.04,0.54,-0.48,0.89,-1.45,-1.62,0.95,1.37, , ,0.8,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;histone methyltransferase complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q9P0V9,Sep10,Septin-10,12,33.2,28.54,28.85,29.62,29.35,30.54,29.85,30.17,30.42,29.28,29.25,30.54,30.38,30.7,29.81,-1.26,-0.96,-0.19,-0.46,0.73,0.04,0.37,0.62,-0.53,-0.56,0.74,0.57,0.89,cell cycle;cell division;cellular process,cell part;macromolecular complex;protein complex;septin complex,,,,,,,,,,
Q9NVA2,Sep11,Septin-11,26,46.8,30.07,31.14,31.31,31.84,30.9,31.03,31.21,30.92,31.39,31.69,31.25,31.31,31.01,31.16,-1.09,-0.02,0.15,0.68,-0.26,-0.13,0.05,-0.24,0.23,0.53,0.09,0.15,-0.15,cell cycle;cell division;cellular component assembly;cellular component organization;cellular process;macromolecular complex assembly;protein complex assembly,cell part;cell projection;cytoplasm;macromolecular complex;neuron projection;protein complex;septin complex;synapse,,,,,,,,,,
Q15019,SEP2,Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5),31,81.7,31.79,32,32.37,32.47,32.88,32.65,32.58,32.88,31.91,31.75,32.65,33.1,33.06,32.47,-0.67,-0.47,-0.1,0,0.41,0.18,0.11,0.41,-0.56,-0.72,0.18,0.63,0.59,anatomical structure formation involved in morphogenesis;biological regulation;cell division;cellular component assembly;cellular component organization;cellular process;developmental process;mitosis;nuclear division;organelle fission;organelle organization;regulation of transport;response to stimulus;signal transduction,cell part;cell surface;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;midbody;nucleolus;organelle;protein complex;septin complex;synapse,,,,,,,,,,
Q14141,SEP6,Septin-6,5,15.2,25.23,27.86,28.66,27.71,28.34,27.63,25.65,28.55,24.88,26.15,25.3,26,28.73,26.98,-1.75,0.89,1.69,0.73,1.37,0.65,-1.33,1.57,-2.09,-0.82,-1.68,-0.98,1.76,cellular process;cytokinesis;interspecies interaction between organisms;multi-organism process,cell part;cytoplasm;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;midbody;organelle;protein complex;septin complex;vesicle,,,,,,,,,,
Q16181,SEP7,Septin-7 (CDC10 protein homolog),29,63.2,31.99,32.22,32.43,32.48,32.82,32.5,32.93,32.86,32.39,32.11,32.57,32.68,32.08,32.47,-0.47,-0.25,-0.04,0.01,0.35,0.04,0.47,0.39,-0.08,-0.35,0.1,0.21,-0.39,anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;cytokinesis;developmental process;macromolecular complex assembly;mitosis;nuclear division;organelle fission;organelle organization;protein complex assembly,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;midbody;nucleolus;organelle;plasma membrane;protein complex;septin complex;synapse,,,,,,,,,,
Q92599,SEP8,Septin-8,11,31.4,29.12,29.47,29.87,29.38,29.66,30.14,30.24,30.48,28.65,29.1,30.14,26.8,30.01,29.47,-0.34,0.01,0.4,-0.08,0.19,0.68,0.77,1.01,-0.82,-0.37,0.67,-2.66,0.54,cell cycle;cellular process,cell part;cytoplasm;macromolecular complex;protein complex;septin complex,,,,,,,,,,
Q9UHD8,SEP9,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),43,67.6,31.99,31.9,31.8,32.31,32.52,32.27,32.64,32.97,32.34,32.54,33.05,33.38,33.38,32.55,-0.56,-0.64,-0.75,-0.24,-0.03,-0.27,0.1,0.42,-0.2,0,0.5,0.83,0.83,cell cycle;cell division;cellular component assembly;cellular component organization;cellular process;macromolecular complex assembly;protein complex assembly,cell part;macromolecular complex;protein complex,,,,,,,,,,
P49903,SEPHS1,"Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1)",10,39.3,30.79,29.13,29.54,29.22,28.54,29.03,29.01,28.49,29.35,28.82,28.36,29.12,28.76,29.09,1.7,0.04,0.46,0.13,-0.55,-0.06,-0.08,-0.6,0.26,-0.27,-0.73,0.03,-0.33,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q99611,SEPHS2,"Selenide, water dikinase 2 (EC 2.7.9.3) (Selenium donor protein 2) (Selenophosphate synthase 2)",3,11.4,26.64,25.91,25.91,24.98,,,25.16,25.11,,,24.54,25.7,,25.49,1.14,0.42,0.42,-0.51, , ,-0.33,-0.39, , ,-0.96,0.21, ,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q8NC51,SERBP1,Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1),33,70.3,31.92,32.27,31.09,32.36,32.23,31.1,32.3,32.04,31.02,30.95,31.5,30.33,29.61,31.44,0.48,0.83,-0.35,0.92,0.79,-0.34,0.86,0.6,-0.42,-0.49,0.06,-1.11,-1.83,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P01009,SERPINA1,Alpha-1-antitrypsin (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) [Cleaved into: Short peptide from AAT (SPAAT)],16,43.3,31.66,28.13,31.08,26.24,,,27.14,24.95,25.1,24.99,,,25.5,27.2,4.46,0.93,3.88,-0.96, , ,-0.06,-2.25,-2.09,-2.21, , ,-1.7,biological regulation;cell activation;cellular process;establishment of localization;exocytosis;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;extracellular matrix;extracellular space;proteinaceous extracellular matrix,,,,,,,,,,
P30740,SERPINB1,Leukocyte elastase inhibitor (LEI) (Monocyte/neutrophil elastase inhibitor) (EI) (M/NEI) (Peptidase inhibitor 2) (PI-2) (Serpin B1),25,67.5,34.13,30.71,32.63,29.75,27.28,26.53,27.79,27.35,26.98,29.91,26.14,24.87,,28.67,5.46,2.04,3.96,1.08,-1.39,-2.14,-0.88,-1.33,-1.69,1.23,-2.54,-3.81, ,biological regulation,cell part;cytoplasm;extracellular space,,,,,,,,,,
P35237,SERPINB6,Serpin B6 (Cytoplasmic antiproteinase) (CAP) (Peptidase inhibitor 6) (PI-6) (Placental thrombin inhibitor),20,54.8,30.92,31.14,31.23,31.52,30.22,28.77,31.46,31.75,29.49,28.56,32.3,32.16,29.31,30.68,0.24,0.46,0.55,0.84,-0.46,-1.91,0.78,1.07,-1.19,-2.12,1.62,1.48,-1.37,biological regulation,cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex,,,,,,,,,,
P50452,SERPINB8,Serpin B8 (Cytoplasmic antiproteinase 2) (CAP-2) (CAP2) (Peptidase inhibitor 8) (PI-8),7,19.3,26.46,28.37,25.54,28.39,22.7,24.3,26.49,27.67,,23.45,27.86,26.46,25.04,26.06,0.39,2.31,-0.52,2.33,-3.36,-1.77,0.43,1.61, ,-2.61,1.8,0.4,-1.02,biological regulation,cell part;cytosol,,,,,,,,,,
P50453,SERPINB9,Serpin B9 (Cytoplasmic antiproteinase 3) (CAP-3) (CAP3) (Peptidase inhibitor 9) (PI-9),17,46.8,31.29,31.17,31.23,30,27.11,24.9,29.17,28.37,27.54,26.47,28.37,29.77,25.97,28.56,2.73,2.6,2.66,1.43,-1.46,-3.67,0.6,-0.2,-1.03,-2.1,-0.19,1.2,-2.59,biological regulation;cellular process;immune system process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P05121,SERPINE1,Plasminogen activator inhibitor 1 (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1),24,55,25.42,32.58,29.83,33.32,32.74,32.92,32.15,31.43,33.37,24.5,32.49,31.71,33.73,31.25,-5.83,1.33,-1.42,2.08,1.49,1.68,0.9,0.19,2.12,-6.74,1.24,0.46,2.49,"aging;anatomical structure formation involved in morphogenesis;biological regulation;biosynthetic process;cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;exocytosis;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;secretion;signal transduction;transcription initiation, DNA-dependent;transport;vesicle-mediated transport",cell part;extracellular matrix;extracellular space;membrane;plasma membrane,,,,,,,,,,
P07093,SERPINE2,Glia-derived nexin (GDN) (Peptidase inhibitor 7) (PI-7) (Protease nexin 1) (PN-1) (Protease nexin I) (Serpin E2),3,10.5,26.97,25.22,25.56,26.88,,24.41,,,23.87,24.75,22.56,,,25.03,1.94,0.19,0.53,1.86, ,-0.62, , ,-1.16,-0.28,-2.46, , ,anatomical structure development;anatomical structure morphogenesis;behavior;biological regulation;cellular component organization;cellular process;coagulation;detection of stimulus;developmental process;establishment of localization;multicellular organismal process;organelle organization;regulation of body fluid levels;regulation of transport;response to abiotic stimulus;response to external stimulus;response to stimulus;secretion;transport;vesicle organization,cell part;cytoplasmic membrane-bounded vesicle;cytosol;extracellular matrix;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;organelle;synapse;vesicle,,,,,,,,,,
P05155,SERPING1,Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1),8,25,29.61,30.01,27.93,29.03,25.74,28.3,28.37,27.8,27.51,,28.74,28.52,29.2,28.4,1.21,1.61,-0.47,0.63,-2.66,-0.1,-0.03,-0.59,-0.89, ,0.35,0.13,0.81,biological regulation;blood circulation;cell activation;cellular process;circulatory system process;establishment of localization;exocytosis;immune system process;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein metabolic process;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;extracellular space,,,,,,,,,,
P50454,SERPINH1,Serpin H1 (47 kDa heat shock protein) (Arsenic-transactivated protein 3) (AsTP3) (Cell proliferation-inducing gene 14 protein) (Collagen-binding protein) (Colligin) (Rheumatoid arthritis-related antigen RA-A47),41,70.1,34.42,36.6,35.35,36.47,35.31,35.81,35,34.85,35.86,34.67,34.77,35.58,35.59,35.41,-0.99,1.2,-0.05,1.06,-0.09,0.4,-0.41,-0.55,0.45,-0.73,-0.64,0.17,0.18,biological regulation;biosynthetic process;cellular component organization;cellular process;extracellular matrix organization;extracellular structure organization;macromolecule metabolic process;metabolic process;multicellular organismal process;primary metabolic process;protein maturation;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q01105,SET,Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I),14,59.6,26.09,,,,26.87,,,25.82,,,,,,26.26,-0.17, , , ,0.61, , ,-0.44, , , , , ,biological regulation;biosynthetic process;cellular component assembly;cellular component disassembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;DNA metabolic process;DNA replication;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;organelle organization;primary metabolic process;regulation of organelle organization;regulation of protein modification process;RNA metabolic process;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q86TU7,SETD3,Histone-lysine N-methyltransferase setd3 (EC 2.1.1.43) (SET domain-containing protein 3),8,17.2,26.16,27.47,26.68,28.35,26.14,26.5,27.88,28.51,26.34,27.47,26.66,26.44,25.4,26.92,-0.76,0.54,-0.25,1.43,-0.79,-0.42,0.96,1.58,-0.58,0.55,-0.26,-0.48,-1.53,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;RNA metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q15637,SF1,Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162),17,39.1,31.53,30.78,30.67,30.9,31.05,31.03,30.39,30.33,31.12,30.32,29.75,29.68,30.17,30.59,0.93,0.18,0.07,0.31,0.46,0.43,-0.2,-0.26,0.53,-0.27,-0.84,-0.91,-0.42,biological regulation;biosynthetic process;cell differentiation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex;ribosome;spliceosomal complex,,,,,,,,,,
Q15459,SF3A1,Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114),40,53.3,32.44,31.6,31.49,31.9,32.02,31.83,31.86,31.18,32.3,32.06,30.6,31.23,31.78,31.71,0.72,-0.11,-0.22,0.18,0.31,0.11,0.15,-0.54,0.59,0.34,-1.12,-0.49,0.07,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q15428,SF3A2,Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62),14,28,30.38,29.75,29.98,29.93,30.53,30.34,29.42,29.79,30.46,29.84,28.22,27.04,28.84,29.58,0.8,0.17,0.4,0.36,0.95,0.76,-0.16,0.21,0.88,0.26,-1.35,-2.54,-0.74,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O75533,SF3B1,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),67,60.1,33,31.82,32.02,32.16,32.62,32.74,32.43,31.96,33.11,32.39,31.28,31.56,32.61,32.28,0.71,-0.46,-0.26,-0.13,0.33,0.45,0.15,-0.33,0.82,0.11,-1,-0.72,0.32,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9Y3B4,SF3B14,Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit),4,31.2,29.17,28.67,28.07,28.8,28.51,28.95,28.7,27.88,29.37,29.03,27.06,28.64,27.87,28.52,0.65,0.16,-0.44,0.28,-0.01,0.44,0.18,-0.64,0.85,0.51,-1.46,0.12,-0.64,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),51,58.4,32.96,31.94,32,32.53,32.59,32.97,32.49,32.16,33.12,32.77,31.36,31.43,32.42,32.36,0.59,-0.42,-0.36,0.16,0.23,0.6,0.12,-0.21,0.75,0.4,-1,-0.94,0.06,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,SAP-domain,,,,,,,,,
Q15393,SF3B3,Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (STAF130) (Spliceosome-associated protein 130) (SAP 130),55,44.9,33.11,32.48,32.74,32.28,33.4,33.67,32.68,32.43,33.18,32.97,32.13,32.68,33.08,32.83,0.28,-0.35,-0.09,-0.55,0.57,0.84,-0.15,-0.4,0.34,0.14,-0.71,-0.16,0.25,cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q15427,SF3B4,Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49),5,14.9,30.24,29.09,30.11,28.74,28.95,30.06,29.59,29.23,30.24,30.1,29.11,29.75,29.69,29.61,0.64,-0.52,0.5,-0.87,-0.66,0.45,-0.02,-0.38,0.63,0.5,-0.5,0.14,0.08,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9BWJ5,SF3B5,Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit),5,59.3,29.83,29.3,29.94,28.71,30.77,29.57,28.99,29.01,29.99,30.12,27.76,21.56,28.55,28.78,1.06,0.52,1.16,-0.06,1.99,0.79,0.21,0.23,1.22,1.35,-1.02,-7.22,-0.22,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P31947,SFN,14-3-3 protein sigma (Epithelial cell marker protein 1) (Stratifin),14,61.7,31.6,31.2,31.36,31.11,30.26,28.11,30.68,31.13,29.86,31,29.85,25.27,26.51,29.84,1.76,1.36,1.52,1.27,0.42,-1.73,0.84,1.28,0.01,1.16,0.01,-4.57,-3.33,anatomical structure development;biological regulation;cell differentiation;cell proliferation;cellular component organization;cellular membrane organization;cellular process;developmental process;membrane organization;mitochondrion organization;organelle organization;regulation of cell cycle;regulation of protein modification process;regulation of transport;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
P23246,SFPQ,"Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein) (hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)",59,62.5,34.14,33.65,33.55,33.94,34.16,34.24,33.66,33.72,34.22,33.75,32.97,32.58,33.47,33.7,0.45,-0.04,-0.15,0.25,0.46,0.54,-0.04,0.02,0.53,0.05,-0.72,-1.11,-0.23,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm,Other TF domain,,,,,,,,,
Q12872,SFSWAP,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",7,20.5,25.97,23.72,,25.22,,24.52,25.03,23.5,25.04,24.3,,25.77,24.11,24.72,1.25,-1, ,0.5, ,-0.2,0.31,-1.22,0.32,-0.41, ,1.05,-0.61,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H9B4,SFXN1,Sideroflexin-1 (Tricarboxylate carrier protein) (TCC),20,67.4,31.13,32.21,31.29,31.86,33.25,33.01,31.77,31.68,32.86,32.24,32.18,30.83,32.81,32.09,-0.95,0.12,-0.8,-0.22,1.16,0.92,-0.31,-0.41,0.77,0.16,0.09,-1.26,0.72,biological regulation;cell differentiation;cellular process;developmental process;establishment of localization;homeostatic process;ion transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9BWM7,SFXN3,Sideroflexin-3,15,47.1,29.94,31.03,30.94,30.51,30.2,30.8,30.84,30.14,31.23,30.77,31.04,30.38,30.89,30.67,-0.73,0.36,0.27,-0.16,-0.47,0.13,0.17,-0.53,0.56,0.1,0.37,-0.29,0.22,biological regulation;homeostatic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
O95470,SGPL1,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),23,42.3,31.11,32.14,31.38,30.6,30.81,30.96,30.73,30.6,31.72,32.85,30.97,29.69,31.1,31.13,-0.02,1.01,0.26,-0.53,-0.32,-0.16,-0.39,-0.53,0.6,1.72,-0.16,-1.44,-0.03,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;catabolic process;cell differentiation;cell motility;cellular component movement;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;hormone metabolic process;lipid metabolic process;locomotion;metabolic process;multicellular organismal process;organic acid metabolic process;post-embryonic development;primary metabolic process;response to stimulus;rhythmic process;signal transduction;small molecule metabolic process,cell part,,,,,,,,,,
P51688,SGSH,N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase),9,21.3,27.38,28.8,27.07,26.71,28.9,27.07,25.83,23.99,24.57,,26.93,24.25,25.49,26.41,0.96,2.38,0.66,0.3,2.48,0.65,-0.59,-2.42,-1.85, ,0.52,-2.17,-0.92,amine metabolic process;carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
O43765,SGTA,Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP),11,37.1,28.43,29.33,29.28,30.02,29.15,28.97,30,30.08,28.42,28.24,29.32,30.67,28.13,29.23,-0.8,0.09,0.05,0.78,-0.08,-0.26,0.77,0.85,-0.81,-0.99,0.09,1.43,-1.11,interspecies interaction between organisms;multi-organism process,cell part;cytoplasm,,,,,,,,,,
Q9H788,SH2D4A,SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38),12,33.9,26.81,27.1,26.72,29.08,,23.97,26.28,25.79,25.62,24.21,26.39,29.96,22.29,26.19,0.63,0.91,0.53,2.9, ,-2.21,0.1,-0.39,-0.56,-1.97,0.2,3.77,-3.9,biological regulation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75368,SH3BGRL,SH3 domain-binding glutamic acid-rich-like protein,7,57,28.57,29.33,29.53,28.54,26.7,26.94,27.93,28.54,26.92,,28.22,27.56,25.6,27.86,0.71,1.47,1.67,0.67,-1.17,-0.93,0.07,0.67,-0.95, ,0.36,-0.31,-2.27,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,+,,,,,,
Q9UJC5,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2 (Fovea-associated SH3 domain-binding protein),2,13.1,26.72,24.13,25.35,24.87,24.36,24.54,25.51,26.67,,25.43,,,24.85,25.24,1.48,-1.11,0.11,-0.38,-0.88,-0.71,0.27,1.43, ,0.19, , ,-0.39,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H299,SH3BGRL3,SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1) (SH3BP-1),9,56.8,29.42,31.21,33.52,31.46,30.6,28.85,31.41,31.6,29.46,29.65,31.54,32.36,28.95,30.77,-1.35,0.43,2.75,0.68,-0.17,-1.92,0.64,0.83,-1.31,-1.12,0.77,1.59,-1.82,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9P0V3,SH3BP4,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),15,20.1,26.26,25.93,25.56,28.53,27.82,28.83,27.91,27.78,28.98,27.69,28.11,27.86,27.18,27.57,-1.32,-1.64,-2.01,0.96,0.25,1.26,0.33,0.2,1.41,0.12,0.53,0.29,-0.39,biological regulation;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;response to chemical stimulus;response to endogenous stimulus;response to stimulus;transport;vesicle-mediated transport,cell part;cytoplasm;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;vesicle,,,,,,,,,,
Q99961,SH3GL1,Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1),10,38.8,28.89,29.06,28.43,29.8,27.69,27.69,29.38,28.76,28.19,28.45,29.92,30.01,24.84,28.55,0.34,0.52,-0.12,1.26,-0.86,-0.86,0.84,0.21,-0.35,-0.1,1.37,1.46,-3.7,anatomical structure development;biological regulation;cellular component organization;cellular membrane organization;cellular process;developmental process;endocytosis;establishment of localization;membrane invagination;membrane organization;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cell projection;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9Y371,SH3GLB1,Endophilin-B1 (Bax-interacting factor 1) (Bif-1) (SH3 domain-containing GRB2-like protein B1),13,36.4,29.89,30.81,31.75,30.78,29.59,28.94,30.31,30.71,28.97,28.93,31.17,30.36,29.55,30.13,-0.25,0.67,1.61,0.64,-0.55,-1.19,0.18,0.58,-1.17,-1.21,1.03,0.23,-0.58,biological regulation;biosynthetic process;cell death;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;death;lipid metabolic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;small molecule metabolic process,cell part;cytoplasm;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9NR46,SH3GLB2,Endophilin-B2 (SH3 domain-containing GRB2-like protein B2),6,20.1,24.94,27.35,,25.59,27.25,25.68,27.29,28.56,22.86,24.71,28.78,22.96,,26,-1.06,1.35, ,-0.41,1.25,-0.32,1.29,2.57,-3.14,-1.29,2.78,-3.04, ,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96B97,SH3KBP1,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),17,37.1,22.87,27.25,27,28.52,28.47,27.49,29.11,29.18,27.48,22.68,30.04,30.9,28.09,27.62,-4.75,-0.37,-0.62,0.9,0.85,-0.13,1.49,1.56,-0.14,-4.94,2.41,3.27,0.47,biological regulation;cell communication;cell death;cell motility;cell-cell signaling;cellular component movement;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;death;endocytosis;establishment of localization;locomotion;membrane invagination;membrane organization;organelle organization;response to stimulus;signal transduction;signaling;transport;vesicle-mediated transport,cell part;cell projection;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;neuron projection;organelle;plasma membrane;synapse,,,,,,,,,,
A1X283,SH3PXD2B,SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),14,22.7,29.46,28.86,28.2,29.09,27.89,27.56,27.95,28.03,27.68,27.12,29.16,29.59,27.75,28.33,1.12,0.53,-0.14,0.75,-0.44,-0.77,-0.39,-0.3,-0.65,-1.21,0.83,1.26,-0.58,anatomical structure development;biological regulation;cell communication;cell differentiation;cellular component assembly;cellular component disassembly;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;localization;macromolecular complex assembly;membrane organization;metabolic process;protein complex assembly,cell part;cell projection;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
P29353,SHC1,SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1),4,16.5,27.01,27.6,23.75,27.62,25.86,26.25,26.16,26.18,25.02,,25.43,25.94,,26.07,0.94,1.53,-2.33,1.55,-0.22,0.18,0.09,0.1,-1.06, ,-0.65,-0.14, ,anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell motility;cellular component movement;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of DNA metabolic process;regulation of protein modification process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;macromolecular complex;protein complex,,,,+,,,,,,
Q8TBC3,SHKBP1,SH3KBP1-binding protein 1,5,12.7,28.05,24.9,25.12,26.97,27.41,26.82,25.67,27.38,27.62,25.43,25.75,27.22,27.21,26.58,1.47,-1.68,-1.46,0.39,0.83,0.24,-0.92,0.8,1.04,-1.16,-0.83,0.64,0.63,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,,,,,,,,,,,
P34896,SHMT1,"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)",6,21.6,29.44,27.61,27.54,27.36,26.97,25.1,28.71,28.99,25.58,27.71,26.65,24.29,,27.16,2.28,0.45,0.38,0.19,-0.19,-2.06,1.55,1.83,-1.58,0.55,-0.51,-2.88, ,amine metabolic process;biosynthetic process;catabolic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;one-carbon metabolic process;organic acid metabolic process;pigment metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process;vitamin metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P34897,SHMT2,"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)",40,77.8,32.93,33.36,32.23,33.29,33.52,34.19,32.92,32.77,34.1,33.76,32.22,32.31,33.42,33.16,-0.22,0.2,-0.93,0.14,0.37,1.03,-0.23,-0.38,0.94,0.6,-0.94,-0.85,0.27,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;one-carbon metabolic process;organic acid metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9UQ13,SHOC2,Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog),3,6.2,27.46,26.29,27.34,26.74,26.71,26.74,26.14,26.18,26.76,25.28,,26.22,26.95,26.57,0.89,-0.28,0.77,0.17,0.15,0.17,-0.42,-0.39,0.19,-1.28, ,-0.34,0.38,biological regulation;cellular process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
Q13796,SHROOM2,Protein Shroom2 (Apical-like protein) (Protein APXL),8,5.3,23.53,23.15,,23.65,25.88,24.89,22.6,25.11,25.37,,24.91,26.61,23.47,24.47,-0.94,-1.32, ,-0.82,1.41,0.42,-1.87,0.64,0.9, ,0.44,2.14,-1,anatomical structure development;anatomical structure morphogenesis;biological regulation;cell junction organization;cell motility;cellular component movement;cellular component organization;cellular process;developmental process;establishment of localization;localization;locomotion;organelle organization;pigment granule organization;pigmentation;regulation of organelle organization;response to external stimulus;response to stimulus;vesicle organization,cell body;cell cortex;cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;neuronal cell body;organelle;protein complex,,,,,,,,,,
Q9HAT2,SIAE,Sialate O-acetylesterase (EC 3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase),8,18,30.43,29.42,26.21,26.43,26.7,26.82,25.96,27.5,24.18,28.32,25.15,25.34,,26.87,3.56,2.55,-0.66,-0.44,-0.17,-0.05,-0.92,0.63,-2.69,1.45,-1.72,-1.53, ,,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q99720,SIGMAR1,Sigma non-opioid intracellular receptor 1 (Aging-associated gene 8 protein) (SR31747-binding protein) (SR-BP) (Sigma 1-type opioid receptor) (SIG-1R) (Sigma1-receptor) (Sigma1R) (hSigmaR1),4,23.8,25.97,26.88,,27.7,27.57,24.98,26.22,26.39,27.26,27.78,26.47,,28.74,26.9,-0.94,-0.02, ,0.8,0.67,-1.93,-0.69,-0.52,0.35,0.87,-0.44, ,1.84,alcohol metabolic process;anatomical structure development;biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular process;death;developmental process;establishment of localization;lipid metabolic process;lipid transport;metabolic process;primary metabolic process;small molecule metabolic process;transport,cell part;lipid particle;membrane;nuclear envelope;site of polarized growth,,,,,,,,,,
Q9H173,SIL1,Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP),9,27.1,26.59,29.04,26.42,28.98,29.09,28.44,28.15,27.94,29.37,27.75,27.18,27.11,28.94,28.08,-1.49,0.96,-1.65,0.9,1.02,0.36,0.07,-0.13,1.29,-0.33,-0.9,-0.96,0.86,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;protein transport;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q96ST3,SIN3A,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),13,13.5,27.42,27.39,25.94,26.47,24.74,27.45,26.55,26.75,28.33,27.4,23.86,24.8,26.84,26.46,0.96,0.93,-0.52,0.01,-1.72,1,0.09,0.29,1.87,0.95,-2.59,-1.66,0.39,aging;biological regulation;biosynthetic process;cellular homeostasis;cellular lipid metabolic process;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;developmental process;DNA metabolic process;DNA replication;embryo development;homeostatic process;immune system process;lipid metabolic process;localization;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of body fluid levels;response to chemical stimulus;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell part;chromatin remodeling complex;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nucleolus;organelle;protein complex;transcription factor complex;transcriptional repressor complex,,,,,,,,,,
O75182,SIN3B,Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b),8,7.7,27.31,,24.29,25.35,,,24.1,,24.24,24.3,24.22,23.54,,24.67,2.64, ,-0.38,0.68, , ,-0.56, ,-0.43,-0.37,-0.45,-1.13, ,anatomical structure development;biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process,cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),51,34.7,24.84,24.97,24.56,27.96,29.06,30.47,28.75,28.16,30.36,29.47,28.22,26.29,29.53,27.9,-3.05,-2.93,-3.33,0.06,1.16,2.58,0.85,0.27,2.46,1.58,0.32,-1.6,1.63,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;response to stimulus;signal transduction,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q9NXA8,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)",3,21.8,27.12,27.07,25.31,25.04,,,24.53,,25.46,,27.48,24.81,27.09,25.99,1.13,1.08,-0.68,-0.96, , ,-1.46, ,-0.53, ,1.49,-1.18,1.1,"biological regulation;cellular metabolic process;cellular process;gene silencing;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;regulation of gene expression, epigenetic",cell part,,,,,,,,,,
Q9NPK3,SKIV2L,DJ34F7.7 (Superkiller viralicidic activity 2 (S. cerevisiae homolog)-like (SKI2W)),13,14.7,26.86,28.67,27.99,28.6,28.72,27.55,29.36,29.48,27.48,27.82,28.96,28.97,27.81,28.33,-1.47,0.35,-0.34,0.27,0.39,-0.78,1.03,1.15,-0.85,-0.51,0.63,0.64,-0.52,,,,,,,,,,,,
P42285,SKIV2L2,Superkiller viralicidic activity 2-like 2 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2),25,30.3,29.8,29.38,29.06,30.21,30.53,30.43,30.68,30.3,30.85,30.58,28.88,29.32,29.98,30,-0.2,-0.62,-0.94,0.21,0.53,0.43,0.68,0.3,0.85,0.58,-1.12,-0.68,-0.02,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P63208,SKP1,S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B) (p19A) (p19skp1),11,69.3,31.89,30.8,31.54,31.14,30.19,30.47,32.17,31.36,31.36,30.95,31.39,31.63,29.37,31.1,0.79,-0.29,0.45,0.04,-0.91,-0.63,1.07,0.26,0.26,-0.14,0.29,0.53,-1.73,biological regulation;catabolic process;cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to stimulus;signal transduction;viral reproduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q9P270,SLAIN2,SLAIN motif-containing protein 2,8,22.4,23.28,,,25.56,26.34,,25.45,26.07,,25.53,,,25.19,25.35,-2.07, , ,0.22,1, ,0.1,0.73, ,0.19, , ,-0.16,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization,cell part;centrosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle,,,,,,,,,,
P55011,SLC12A2,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1),20,21.5,24.21,26.94,23.24,27.94,29.07,28.04,28.29,27.94,29.61,30.64,27.76,26.23,27.26,27.48,-3.27,-0.54,-4.23,0.47,1.6,0.57,0.81,0.46,2.14,3.17,0.29,-1.24,-0.21,anatomical structure morphogenesis;detection of stimulus;developmental process;establishment of localization;growth;ion transport;multicellular organismal process;neurological system process;response to abiotic stimulus;response to external stimulus;response to stimulus;transport,cell part,,,,,,,,,,
Q9UP95,SLC12A4,Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1),16,14.3,26.08,29.01,27,28.83,28.97,29.76,29.49,29.18,29.57,28.67,29.14,28.74,29.86,28.79,-2.72,0.22,-1.8,0.04,0.17,0.97,0.69,0.39,0.78,-0.12,0.35,-0.05,1.07,biological regulation;cellular homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;transport,cell part,,,,,,,,,,
Q9Y666,SLC12A7,Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4),23,27.6,29.51,27.34,30.63,26.75,27.97,27.43,26.45,27.12,27.35,32.29,26.8,26.86,28.03,28.04,1.47,-0.7,2.59,-1.29,-0.07,-0.61,-1.59,-0.92,-0.7,4.24,-1.24,-1.18,-0.01,biological regulation;cellular homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;transport,cell part,,,,,,,,,,
D6W5X3,SLC12A9,"Solute carrier family 12 (Potassium/chloride transporters), member 9, isoform CRA_d",6,11.5,25.11,26.55,26.66,25.75,25.7,27.29,26.9,26.21,26.65,26.14,27.55,26.5,27.97,26.54,-1.42,0.02,0.12,-0.79,-0.84,0.76,0.36,-0.33,0.11,-0.39,1.01,-0.04,1.44,cellular process;establishment of localization;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
O15427,SLC16A3,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),11,20.4,27.68,29.64,28.59,28.92,29.92,30.7,29.33,29.49,30.29,29.04,30.07,29.3,31.12,29.55,-1.86,0.09,-0.96,-0.62,0.38,1.15,-0.22,-0.06,0.74,-0.5,0.52,-0.25,1.58,biological regulation;cell motility;cellular component movement;cellular ketone metabolic process;cellular metabolic process;cellular process;coagulation;immune system process;locomotion;metabolic process;multicellular organismal process;organic acid metabolic process;regulation of body fluid levels;small molecule metabolic process,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9NRA2,SLC17A5,Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter),2,5.5,23.95,24.54,23.23,22.94,23.27,,,,,24.54,24.1,,25,23.95,0,0.59,-0.71,-1,-0.67, , , , ,0.59,0.15, ,1.05,amine transport;amino acid transport;carbohydrate transport;establishment of localization;organic acid transport;transport,cell part;membrane,,,,,,,,,,
Q15758,SLC1A5,Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5),7,16.5,30.5,29.11,28.59,30.07,29.7,29.82,28.71,29.31,29.63,28.23,27.43,28.82,29.12,29.16,1.34,-0.05,-0.56,0.91,0.55,0.66,-0.45,0.16,0.47,-0.93,-1.73,-0.34,-0.04,,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q8WUM9,SLC20A1,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),11,12.1,21.64,,23.17,26.03,26.66,26.18,28.64,28.32,27.95,24.55,29.34,28.96,28.49,26.66,-5.02, ,-3.49,-0.63,-0.01,-0.48,1.98,1.66,1.29,-2.11,2.68,2.3,1.82,biological regulation;cellular metabolic process;cellular process;metabolic process;phosphorus metabolic process,cell part,,,,,,,,,,
Q08357,SLC20A2,Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2),7,19.6,28.62,29.45,27.52,29.21,31.31,30.69,30.78,31.51,29.83,29.39,29.74,29.87,29.53,29.81,-1.19,-0.35,-2.28,-0.6,1.51,0.89,0.97,1.71,0.03,-0.41,-0.06,0.06,-0.27,interspecies interaction between organisms;multi-organism process,cell part,,,,,,,,,,
P53007,SLC25A1,"Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)",16,49.5,30.91,31.42,30.17,31.53,31.31,32.26,31.25,31.53,32.6,32.44,32.06,31.84,32.19,31.65,-0.74,-0.24,-1.49,-0.12,-0.34,0.6,-0.41,-0.13,0.95,0.78,0.4,0.19,0.54,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;establishment of localization;glycerol ether metabolic process;ion transport;lipid metabolic process;metabolic process;organic acid transport;primary metabolic process;small molecule metabolic process;transport,cell part;membrane,,,,,,,,,,
Q02978,SLC25A11,Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11),16,51.4,30.35,30.93,30.75,30.21,30.16,31.13,30.49,30.04,31.05,31.03,31.24,30.52,31.27,30.71,-0.35,0.22,0.04,-0.49,-0.55,0.43,-0.22,-0.66,0.34,0.32,0.54,-0.18,0.56,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
O75746,SLC25A12,Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12),18,35,31.78,30.14,30.1,29.27,30.02,30.31,30.03,29.46,31.84,29.78,30.79,29.98,30.79,30.33,1.45,-0.19,-0.23,-1.06,-0.31,-0.02,-0.3,-0.87,1.51,-0.55,0.46,-0.35,0.46,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;establishment of localization;metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process;transport,cell part;membrane,,,,,,,,,,
Q9UJS0,SLC25A13,Calcium-binding mitochondrial carrier protein Aralar2 (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13),35,64,33,31.68,32.85,31.67,32.17,32.76,31.94,32.01,32.47,32.91,32.12,32.34,32.64,32.35,0.64,-0.67,0.5,-0.68,-0.18,0.41,-0.41,-0.34,0.12,0.56,-0.23,-0.01,0.29,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process;transport,cell part;membrane,,,,,,,,,,
O43772,SLC25A20,Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (Solute carrier family 25 member 20),7,23.6,26.44,28.4,29.21,26.94,27.43,26.75,25.74,27.18,29.01,29.28,27.84,23.5,28.91,27.43,-1,0.96,1.77,-0.49,0,-0.68,-1.69,-0.25,1.58,1.85,0.41,-3.93,1.48,amine transport;amino acid transport;cellular lipid metabolic process;cellular metabolic process;cellular process;establishment of localization;ion transport;lipid metabolic process;lipid transport;metabolic process;organic acid transport;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
Q9H936,SLC25A22,Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22),12,47.7,30.34,29.03,28.67,29.22,29.85,30.39,29.61,29.54,30.17,30.74,30.45,29.9,30.2,29.86,0.48,-0.83,-1.18,-0.63,0,0.53,-0.24,-0.31,0.32,0.89,0.59,0.04,0.35,,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q6NUK1,SLC25A24,Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24),34,60.8,33.1,33.24,32.71,31.25,32.43,32.86,32,32.29,32.73,32.87,31.98,31.32,32.55,32.41,0.69,0.83,0.3,-1.16,0.02,0.45,-0.41,-0.12,0.32,0.46,-0.43,-1.09,0.14,cellular process;establishment of localization;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
Q00325,SLC25A3,"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)",24,51.2,34.33,34.28,32.79,33.55,34.07,34.39,33.79,33.67,34.62,34.76,33.95,33.62,34.41,34.02,0.31,0.26,-1.22,-0.47,0.05,0.38,-0.23,-0.35,0.6,0.74,-0.06,-0.4,0.39,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process,cell part;membrane,,,,,,,,,,
P12235,SLC25A4,"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)",6,19.8,29.8,29.74,29.17,29.57,29.13,29.29,29.33,29.46,30.05,29.76,30.7,30.91,30.59,29.81,0,-0.07,-0.64,-0.24,-0.68,-0.52,-0.48,-0.35,0.24,-0.04,0.9,1.1,0.78,biological regulation;cellular component organization;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;interspecies interaction between organisms;metabolic process;mitochondrion organization;multi-organism process;organelle organization;regulation of transport;small molecule metabolic process;viral reproduction,cell part;membrane,,,,,,,,,,
P05141,SLC25A5,"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]",13,27.9,32.04,31.8,32.14,31.87,32.79,32.74,32.54,32.13,32.73,33.05,32.21,32.56,32.78,32.41,-0.37,-0.61,-0.28,-0.54,0.38,0.33,0.13,-0.28,0.31,0.64,-0.21,0.15,0.37,biological regulation;cellular metabolic process;cellular process;chromosome segregation;energy reserve metabolic process;generation of precursor metabolites and energy;interspecies interaction between organisms;metabolic process;multi-organism process;regulation of transport;small molecule metabolic process;viral reproduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
P12236,SLC25A6,"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6)",34,64.8,33.64,34,33.4,34.31,34.13,34.67,34.16,34.2,34.74,34.87,34.28,33.95,34.62,34.23,-0.58,-0.23,-0.83,0.08,-0.1,0.44,-0.07,-0.03,0.51,0.64,0.05,-0.28,0.39,biological regulation;cell death;cellular metabolic process;cellular process;death;energy reserve metabolic process;establishment of localization;generation of precursor metabolites and energy;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein targeting;protein transport;regulation of transport;response to biotic stimulus;response to stimulus;small molecule metabolic process;transport,cell part;macromolecular complex;mitochondrial inner membrane presequence translocase complex;protein complex,,,,,,,,,,
P50443,SLC26A2,Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2),3,5.1,,20.92,,26.51,26.39,28.29,25.86,25.94,28.71,28.76,,,27.61,26.55, ,-5.63, ,-0.04,-0.17,1.73,-0.69,-0.62,2.15,2.2, , ,1.06,establishment of localization;ion transport;multicellular organismal process;transport,cell part,,,,,,,,,,
Q6PCB7,SLC27A1,Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.-) (Solute carrier family 27 member 1),9,18.4,29.02,28.58,26.26,26.38,,24.58,,,26.02,25.89,26.61,,25.04,26.49,2.54,2.09,-0.22,-0.11, ,-1.91, , ,-0.47,-0.6,0.12, ,-1.45,alcohol metabolic process;amine metabolic process;biological regulation;biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;lipid metabolic process;lipid transport;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;organic acid transport;primary metabolic process;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;endomembrane system;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q6P1M0,SLC27A4,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4),8,14.2,27.23,27.41,27.41,27.31,28.54,28.44,28.25,28.1,28.4,29.09,28.95,27.81,29.24,28.17,-0.94,-0.75,-0.76,-0.86,0.38,0.27,0.08,-0.07,0.23,0.92,0.78,-0.36,1.07,anatomical structure development;catabolic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;lipid metabolic process;lipid transport;metabolic process;organic acid metabolic process;organic acid transport;primary metabolic process;small molecule metabolic process;transmembrane transport;transport,cell part;cell projection;membrane;microvillus;plasma membrane,,,,,,,,,,
Q9UGQ3,SLC2A6,"Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6) (GLUT-6) (Glucose transporter type 9) (GLUT-9)",5,12.4,,,,27.12,28.2,,25.55,25.15,25.4,26.01,28.39,21.2,28.3,26.15, , , ,0.98,2.05, ,-0.6,-1,-0.75,-0.13,2.24,-4.95,2.16,,cell part;membrane;plasma membrane,,,,,,,,,,
Q9Y6M5,SLC30A1,Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1),9,30,27.5,28.36,29.74,27.42,25.2,26.86,22.89,25.99,24.59,28.42,27.56,28.66,27.81,27,0.5,1.36,2.74,0.42,-1.8,-0.14,-4.11,-1.01,-2.41,1.42,0.56,1.66,0.81,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;embryo development;establishment of localization;homeostatic process;ion transport;regulation of transport;response to chemical stimulus;response to stimulus;transmembrane transport;transport,cell part,,,,,,,,,,
Q8NEW0,SLC30A7,Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) (Znt-like transporter 2),6,16,28.45,29.01,29.55,28.72,28.77,30.67,28.69,28.94,29.13,28.94,29.82,29.29,28.27,29.1,-0.64,-0.09,0.45,-0.37,-0.32,1.58,-0.41,-0.16,0.04,-0.15,0.72,0.19,-0.83,biological regulation;cellular metabolic process;cellular process;establishment of localization;ion transport;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;transmembrane transport;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q6PML9,SLC30A9,Zinc transporter 9 (ZnT-9) (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9),5,11.4,25.76,28.25,24.88,27.15,26.76,27.02,27.5,27.6,28.17,26.08,25.35,25.77,26.86,26.7,-0.94,1.55,-1.82,0.44,0.05,0.31,0.8,0.9,1.47,-0.62,-1.36,-0.94,0.16,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;establishment of localization;ion transport;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transport,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O00400,SLC33A1,Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1),4,9.8,27.73,27.66,,27.11,27.69,28.89,25.92,25.5,28.26,27.76,27.49,26.46,29.17,27.47,0.26,0.19, ,-0.36,0.22,1.42,-1.55,-1.97,0.79,0.29,0.02,-1.01,1.69,cell death;cellular process;death;establishment of localization;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
O95436,SLC34A2,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),12,18.7,29.53,31.01,31.3,25.51,26.07,26.38,24.82,26.97,24.73,31.17,26.58,21.05,,27.09,2.44,3.92,4.21,-1.59,-1.02,-0.72,-2.27,-0.12,-2.37,4.08,-0.51,-6.04, ,aging;biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;embryo development;homeostatic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part,,,,,,,,,,
Q8TB61,SLC35B2,Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2),6,14.1,27.25,29.66,27.86,29.12,28.55,29.68,28.46,28.02,28.41,28.96,28.11,28.37,28.95,28.57,-1.32,1.09,-0.71,0.55,-0.02,1.11,-0.11,-0.55,-0.16,0.39,-0.46,-0.2,0.38,biological regulation;cellular process;establishment of localization;nucleobase-containing compound transport;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
Q96K37,SLC35E1,Solute carrier family 35 member E1,5,17.6,27.73,28.08,27.66,27.71,26.75,28.38,26.45,27.4,28.45,29.23,28.25,22.84,26.89,27.37,0.36,0.71,0.29,0.34,-0.62,1.01,-0.92,0.03,1.08,1.86,0.88,-4.53,-0.48,establishment of localization;transport,cell part,,,,,,,,,,
Q8N357,SLC35F6,Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog),2,11.2,23.32,24.16,23.65,24.28,23.07,23.66,21.95,,22.33,22.81,,,,23.25,0.07,0.91,0.4,1.04,-0.18,0.41,-1.3, ,-0.92,-0.44, , , ,biological regulation;establishment of localization;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9HBR0,SLC38A10,Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10),6,8.4,,,,25.43,24.51,23.48,25.85,22.62,26.25,,25.59,,26.22,24.99, , , ,0.43,-0.48,-1.51,0.86,-2.37,1.25, ,0.6, ,1.22,amine transport;amino acid transport;establishment of localization;ion transport;organic acid transport;transport,cell part,,,,,,,,,,
Q96QD8,SLC38A2,Sodium-coupled neutral amino acid transporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2),5,13.8,28.65,26.34,27.96,30.31,30,28.93,29.35,29.13,28.36,27.91,28.43,29.01,29.57,28.76,-0.11,-2.42,-0.81,1.54,1.24,0.16,0.59,0.37,-0.41,-0.86,-0.34,0.24,0.8,biological regulation;cellular process;establishment of localization;ion transport;neurotransmitter transport;secretion;transmembrane transport;transport,cell part;membrane;plasma membrane,,,,,,,,,,
H3BPK8,SLC38A7,Putative sodium-coupled neutral amino acid transporter 7,2,8.8,27.54,27.4,27.5,25.07,28.48,29.42,25.01,25.74,,27.82,,27.93,27.25,27.2,0.35,0.21,0.3,-2.13,1.29,2.22,-2.18,-1.46, ,0.63, ,0.73,0.05,establishment of localization;ion transport;transport,cell body;cell part;cell projection;neuron projection;neuronal cell body,,,,,,,,,,
Q9ULF5,SLC39A10,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),5,9.5,25.5,26.36,26.06,25.27,25.28,26.12,,,26.82,27.92,26.98,26.11,25.38,26.16,-0.67,0.2,-0.11,-0.89,-0.89,-0.05, , ,0.66,1.76,0.82,-0.06,-0.78,cellular process;establishment of localization;ion transport;transmembrane transport;transport,cell part,,,,,,,,,,
Q15043,SLC39A14,Zinc transporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),4,11.2,25.89,27.6,20.9,28.2,,26.68,18.41,,25.17,,25.61,27.22,25.77,25.15,0.75,2.46,-4.24,3.06, ,1.53,-6.73, ,0.02, ,0.47,2.07,0.62,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;ion transport;transmembrane transport;transport,cell part;cell projection;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q92504,SLC39A7,Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7),5,16.7,27.88,28.43,28.61,26.51,24.11,26.17,25.5,25.17,27.34,26.11,26.29,25.43,23.44,26.23,1.65,2.2,2.38,0.28,-2.12,-0.06,-0.73,-1.06,1.11,-0.12,0.06,-0.8,-2.79,cellular process;establishment of localization;ion transport;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
P08195,SLC3A2,4F2 cell-surface antigen heavy chain (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98),32,58,32.72,31.65,32.05,33,33.65,34.04,33.36,32.52,33.15,32.99,32.86,32.46,33.64,32.93,-0.21,-1.28,-0.88,0.07,0.72,1.11,0.43,-0.41,0.22,0.06,-0.07,-0.47,0.71,amine transport;amino acid transport;biological regulation;carbohydrate metabolic process;cell growth;cell motility;cellular component movement;cellular process;coagulation;establishment of localization;growth;immune system process;locomotion;metabolic process;multicellular organismal process;organic acid transport;primary metabolic process;regulation of body fluid levels;transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
D6R9S7,SLC41A3,Solute carrier family 41 member 3 (Fragment),2,20.4,25.99,26.16,25.95,25.33,24.17,26.75,25.94,24.94,26.73,27.23,25.5,,,25.88,0.11,0.28,0.07,-0.55,-1.71,0.87,0.05,-0.94,0.85,1.35,-0.38, , ,,,,,,,,,,,,
Q8WWI5,SLC44A1,Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92),4,8.7,26.17,27.82,24.54,27.34,26.36,28.79,26.48,26.14,28.18,,26.15,26.55,27.12,26.8,-0.63,1.02,-2.26,0.53,-0.44,1.99,-0.32,-0.66,1.38, ,-0.66,-0.26,0.32,alcohol metabolic process;amine metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane;plasma membrane,,,,,,,,,,
Q9BWU0,SLC4A1AP,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),14,19.3,26.84,25.93,27.9,26.97,25.91,26.59,26.49,27.14,27.67,27.11,27.21,28.16,26.84,26.98,-0.14,-1.05,0.92,-0.01,-1.08,-0.39,-0.49,0.16,0.69,0.13,0.23,1.17,-0.14,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P04920,SLC4A2,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2),8,11.2,22.74,25.18,27.19,25.47,24.73,25.36,26.37,,,27.43,25.08,27.65,27.5,25.88,-3.15,-0.7,1.3,-0.41,-1.15,-0.52,0.49, , ,1.55,-0.8,1.77,1.62,establishment of localization;ion transport;transport,cell part;membrane;plasma membrane,,,,,,,,,,
Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),21,18.8,28.65,28.84,23.85,27.77,27.49,27.45,26.23,27.09,29.04,28.26,25.41,26.45,27.23,27.21,1.44,1.63,-3.36,0.56,0.28,0.24,-0.98,-0.12,1.83,1.04,-1.8,-0.76,0.02,anatomical structure development;anatomical structure morphogenesis;cell death;cell development;cellular process;death;developmental process,cell part;cell projection;membrane;microvillus;plasma membrane,,,,,,,,,,
P30825,SLC7A1,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (ERR) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),4,11.3,27.44,25.72,24.42,26.66,27.34,27.99,25.75,27.06,27.68,28.4,27.35,27.64,26.18,26.9,0.54,-1.17,-2.47,-0.23,0.45,1.09,-1.15,0.17,0.79,1.5,0.46,0.75,-0.71,amine transport;amino acid transport;cellular process;establishment of localization;organic acid transport;transmembrane transport;transport,cell part,,,,,,,,,,
P52569,SLC7A2,Low affinity cationic amino acid transporter 2 (CAT-2) (CAT2) (Solute carrier family 7 member 2),7,13.4,28.13,28.18,28.03,25.93,27.27,27.72,26.61,28.68,26.77,27.02,29.75,28.63,26.19,27.61,0.52,0.57,0.42,-1.68,-0.34,0.12,-1,1.08,-0.84,-0.59,2.14,1.02,-1.42,amine metabolic process;biological regulation;biosynthetic process;cell activation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q01650,SLC7A5,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),4,11.2,26.63,25.87,25.56,26.92,28.37,28.63,27.33,27.14,27.08,26.69,27.7,26.81,28.07,27.14,-0.51,-1.27,-1.58,-0.22,1.24,1.49,0.19,0,-0.06,-0.45,0.56,-0.33,0.93,amine metabolic process;anatomical structure development;biological regulation;cell differentiation;cell motility;cellular amino acid metabolic process;cellular component movement;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;coagulation;developmental process;immune system process;locomotion;metabolic process;multicellular organismal process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of body fluid levels;small molecule metabolic process,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
P19634,SLC9A1,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",12,15.1,25.22,26.75,26.82,26.16,27.03,27.9,27.41,26.38,27.55,27.29,28.32,29.1,28.16,27.24,-2.02,-0.49,-0.42,-1.08,-0.21,0.66,0.18,-0.85,0.31,0.05,1.08,1.87,0.92,amine metabolic process;biological regulation;carbohydrate metabolic process;catabolic process;cell death;cell differentiation;cell growth;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular process;death;developmental process;establishment of localization;growth;homeostatic process;ion transport;macromolecular complex assembly;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;nitrogen compound metabolic process;organelle organization;polysaccharide metabolic process;primary metabolic process;protein complex assembly;response to abiotic stimulus;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process;transmembrane transport;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
O14745,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),26,79.3,31.15,30.72,31.94,30.52,29.97,30.31,31.35,31.51,28.84,30.14,31.28,33.11,29.9,30.83,0.32,-0.11,1.12,-0.31,-0.85,-0.52,0.53,0.68,-1.98,-0.68,0.46,2.28,-0.93,amine transport;amino acid transport;biological regulation;cell death;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular localization;cellular process;cytoskeleton organization;death;establishment of localization;homeostatic process;ion transport;localization;macromolecular complex assembly;multicellular organismal process;organelle organization;organic acid transport;peptide transport;protein complex assembly;regulation of protein modification process;regulation of transport;response to stimulus;secretion;signal transduction;transport,cell part;cell projection;centrosome;cytoplasm;cytoskeleton;endomembrane system;filopodium;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;organelle,,,,,,,,,,
Q15599,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF-2) (NHE3 kinase A regulatory protein E3KARP) (SRY-interacting protein 1) (SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2) (Tyrosine kinase activator protein 1) (TKA-1),7,25.2,29.49,29.38,27.3,27.85,29.16,27.62,27.71,27.79,26.83,28.12,28.26,25.89,27.42,27.91,1.58,1.47,-0.61,-0.06,1.25,-0.29,-0.2,-0.12,-1.08,0.21,0.35,-2.01,-0.49,biological regulation;cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;cytoplasm;endomembrane system;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q96T83,SLC9A7,Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7),2,7.4,,22.91,,23.72,26.6,25.12,25.48,,25.64,25,25.49,26.33,,25.14, ,-2.23, ,-1.42,1.46,-0.03,0.33, ,0.5,-0.14,0.35,1.19, ,biological regulation;homeostatic process,cell part;membrane,,,,,,,,,,
Q08AF3,SLFN5,Schlafen family member 5,12,16.5,29.03,27.29,29.29,28.85,29.01,29.17,28.78,28.98,29.59,29.58,28.71,28.24,28.85,28.88,0.15,-1.58,0.42,-0.02,0.13,0.29,-0.09,0.11,0.72,0.7,-0.16,-0.64,-0.02,cell differentiation;cellular process;developmental process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9GZT3,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",11,79.4,30.99,31,31.35,31.23,31.8,32.33,31.43,31.74,31.62,32.32,30.55,29.42,32.03,31.37,-0.38,-0.37,-0.02,-0.14,0.43,0.96,0.06,0.37,0.25,0.95,-0.82,-1.95,0.66,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9H2G2,SLK,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),22,23.9,27.2,28.59,30.14,28.37,29.17,29.35,29.38,28.73,28.12,29.15,30.11,31,28.93,29.1,-1.9,-0.5,1.04,-0.73,0.07,0.26,0.28,-0.36,-0.98,0.06,1.01,1.91,-0.16,cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;cytoplasm;membrane;plasma membrane,,+,,,,,,,,
Q14BN4,SLMAP,Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein),7,12.9,26.3,24.56,26.73,25.62,26.46,25.85,25.82,24.17,26.47,28.35,26.92,27.93,27.43,26.35,-0.06,-1.8,0.38,-0.73,0.11,-0.5,-0.54,-2.19,0.12,2,0.56,1.58,1.08,multicellular organismal process;muscle contraction,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;organelle;plasma membrane,,,,,,,,,,
Q9NWH9,SLTM,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),27,30.7,28.93,29.14,29.8,29.06,30.4,29.88,29.43,29.85,30.9,30.93,29.86,29.19,28.94,29.72,-0.79,-0.58,0.08,-0.66,0.68,0.16,-0.29,0.14,1.18,1.21,0.15,-0.53,-0.77,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,SAP-domain,,,,,,,,,
P84022,SMAD3,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3),3,8.5,26.55,26.84,24.58,,,26.26,26.38,27.7,,,,25.69,25.68,26.21,0.34,0.63,-1.62, , ,0.06,0.17,1.49, , , ,-0.52,-0.53,"anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell activation;cell development;cell differentiation;cell junction organization;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;establishment of localization;growth;immune system process;interspecies interaction between organisms;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mitochondrion organization;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein complex assembly;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;regulation of protein stability;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;signal transduction;transcription initiation, DNA-dependent;transport",cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex;receptor complex;transcription factor complex,Other TF domain,,,,,,,,,
Q13485,SMAD4,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),3,9.6,25.99,25.33,24.92,24.95,25.82,26.34,25.6,25.3,,25.58,25.95,24.23,26.34,25.53,0.47,-0.19,-0.61,-0.58,0.3,0.81,0.07,-0.23, ,0.05,0.42,-1.3,0.81,"anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell differentiation;cell proliferation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;growth;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;centrosome;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;organelle;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
O00193,SMAP,Small acidic protein,11,47,28.13,26.8,28.47,27.49,25.64,27.52,27.86,26.54,27.15,26.81,25.18,26.41,26.9,26.99,1.14,-0.19,1.48,0.5,-1.35,0.52,0.87,-0.45,0.16,-0.19,-1.82,-0.58,-0.09,,,,,,,,,,,,
Q8IYB5,SMAP1,Stromal membrane-associated protein 1,2,16.8,27.27,26.48,25.68,26.18,23.82,,25.79,26.36,,,25.65,,,25.9,1.37,0.57,-0.22,0.28,-2.08, ,-0.12,0.46, , ,-0.26, , ,biological regulation;regulation of transport,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
P28370,SMARCA1,Probable global transcription activator SNF2L1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA1) (Nucleosome-remodeling factor subunit SNF2L) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1),7,7,25.58,25.26,,27.43,25.62,26.63,25.96,26.62,27.61,26.9,24.6,24.85,24.6,25.97,-0.39,-0.71, ,1.46,-0.35,0.66,-0.01,0.65,1.64,0.93,-1.37,-1.12,-1.37,anatomical structure development;biological regulation;biosynthetic process;cell differentiation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;chromatin remodeling complex;macromolecular complex;protein complex,,,,,,,,,,
P51531,SMARCA2,Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2),6,5.7,26.86,24.58,27.62,26.42,27.58,26.74,26.15,25.52,27.04,25.88,24.35,25.2,26.46,26.18,0.68,-1.61,1.43,0.24,1.4,0.56,-0.03,-0.67,0.85,-0.31,-1.84,-0.98,0.27,anatomical structure development;biological regulation;cell differentiation;cellular component organization;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;organelle organization,cell part;chromatin remodeling complex;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,Other TF domain,,,,,,,,,
P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),37,24.4,31.37,29.4,30.23,30.15,30.16,29.86,29.92,28.98,29.83,30.3,28.12,28.04,28.83,29.63,1.74,-0.23,0.6,0.52,0.53,0.23,0.29,-0.65,0.2,0.67,-1.51,-1.59,-0.8,"anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell differentiation;cell morphogenesis;cellular component disassembly;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA modification;extracellular matrix organization;extracellular structure organization;gene silencing;growth;histone modification;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;regulation of cell cycle;regulation of gene expression, epigenetic;regulation of mitotic cell cycle;small molecule metabolic process",cell part;chromatin remodeling complex;macromolecular complex;protein complex,,,,,,,,,,
O60264,SMARCA5,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H),48,44.1,31.65,30.51,30.76,30.89,31.9,31.68,31.35,30.95,31.43,31.25,29.93,30.55,31.21,31.08,0.57,-0.57,-0.32,-0.19,0.82,0.6,0.27,-0.13,0.35,0.17,-1.15,-0.53,0.13,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA repair;embryo development;gene silencing;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of gene expression, epigenetic;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transcription initiation, DNA-dependent",cell part;chromatin remodeling complex;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q9H4L7,SMARCAD1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1),8,12.9,24.2,24.7,26.01,25.05,24.69,26.3,24.86,25.81,25.21,,,26.48,25.25,25.32,-1.13,-0.63,0.68,-0.27,-0.63,0.98,-0.47,0.49,-0.11, , ,1.15,-0.07,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;histone modification;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organelle organization;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;regulation of DNA metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q12824,SMARCB1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47) (Integrase interactor 1 protein) (SNF5 homolog) (hSNF5),6,22.1,29.1,27.16,28.42,27.5,28.49,28.43,27.02,27.38,27.61,28.53,27.44,29.1,27.35,27.96,1.14,-0.8,0.46,-0.47,0.53,0.47,-0.95,-0.58,-0.36,0.57,-0.52,1.14,-0.62,anatomical structure development;biological regulation;biosynthetic process;cell differentiation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA integration;DNA metabolic process;DNA repair;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;chromatin remodeling complex;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear chromosome;nucleolus;nucleoplasm;organelle;protein complex,DNA binding region,,,,,,,,,
Q92922,SMARCC1,SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1),19,21.7,28.6,26.23,29.22,28.26,28.76,27.54,28.12,27.57,29.26,28.64,25.32,27,26.88,27.8,0.8,-1.57,1.42,0.46,0.95,-0.26,0.32,-0.23,1.46,0.84,-2.48,-0.8,-0.92,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process;signal transduction,cell part;chromatin remodeling complex;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q8TAQ2,SMARCC2,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),35,35.3,31.25,30.11,29.96,30.08,30.18,30.24,29.45,29.41,30.96,29.42,28.64,29.82,28.97,29.88,1.36,0.23,0.08,0.2,0.3,0.36,-0.43,-0.47,1.08,-0.47,-1.25,-0.07,-0.92,anatomical structure development;biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;chromatin remodeling complex;macromolecular complex;protein complex,,,,,,,,,,
Q92925,SMARCD2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B),15,43,29.94,28.2,28.81,27.76,29.25,28.96,28.17,27.89,28.72,28.36,24.73,25.29,28.25,28.02,1.91,0.18,0.79,-0.27,1.23,0.93,0.15,-0.14,0.7,0.34,-3.3,-2.74,0.22,biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;chromatin remodeling complex;macromolecular complex;protein complex,,,,,,,,,,
Q969G3,SMARCE1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57),13,46.9,29.92,28.81,29.88,28.84,29.6,29.93,28.83,28.67,29.8,29.58,26.4,28.73,29.02,29.08,0.84,-0.27,0.8,-0.23,0.52,0.85,-0.25,-0.41,0.72,0.51,-2.68,-0.35,-0.06,anatomical structure development;biological regulation;cellular component disassembly;cellular component organization;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;organelle organization,cell part;chromatin remodeling complex;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear chromosome;organelle;protein complex;transcriptional repressor complex,HMG-box,,,,,,,,,
Q14683,SMC1A,Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Sb1.8),33,30.6,30.6,29.73,30.17,29.86,31.22,30.46,30.07,29.53,30.37,30.26,28.65,28.7,28.46,29.85,0.74,-0.12,0.32,0.01,1.37,0.61,0.22,-0.32,0.52,0.4,-1.2,-1.15,-1.39,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;cytokinesis;cytoskeleton organization;developmental process;DNA metabolic process;DNA packaging;DNA recombination;DNA repair;macromolecule metabolic process;meiosis;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;chromosome;cohesin complex;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nuclear chromosome;nucleoplasm;organelle;protein complex,,,,,,,,,,
O95347,SMC2,Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (hCAP-E) (XCAP-E homolog),20,19.2,25.93,27.59,26.29,29.85,30.34,28.42,30.18,29.7,27.17,27.79,26.03,29.27,28.9,28.27,-2.33,-0.68,-1.98,1.58,2.07,0.16,1.92,1.43,-1.1,-0.48,-2.23,1.01,0.64,cell cycle;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;chromosome segregation;DNA metabolic process;DNA packaging;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;chromosome;condensin complex;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear chromosome;organelle;protein complex,,,,,,,,,,
Q9UQE7,SMC3,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Basement membrane-associated chondroitin proteoglycan) (Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide) (hCAP),45,38.7,31.61,30.07,31.14,30.52,30.3,30.53,30.54,29.72,31.21,30.38,27.97,29.43,28.88,30.18,1.43,-0.11,0.97,0.34,0.12,0.35,0.36,-0.46,1.04,0.21,-2.21,-0.74,-1.3,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;cytokinesis;cytoskeleton organization;developmental process;DNA metabolic process;DNA repair;macromolecule metabolic process;meiosis;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;regulation of cell cycle;regulation of DNA metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cohesin complex;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
Q9NTJ3,SMC4,Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog),18,16.1,26.27,25.6,27.3,28.38,29.43,27.42,27.96,29.42,25.44,25.4,25.96,27.19,26.74,27.12,-0.85,-1.51,0.19,1.26,2.32,0.3,0.84,2.3,-1.67,-1.71,-1.15,0.07,-0.38,cell cycle;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;chromosome segregation;DNA metabolic process;DNA packaging;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;condensin complex;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
A6NHR9,SMCHD1,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1),12,8,28.5,29.16,28.17,30.01,28.24,28.55,27.48,27.63,27.84,28.18,28.14,28.27,28.05,28.33,0.18,0.84,-0.15,1.68,-0.08,0.23,-0.85,-0.69,-0.49,-0.15,-0.18,-0.05,-0.27,"biological regulation;cellular component organization;cellular process;chromosome organization;organelle organization;regulation of gene expression, epigenetic",cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;nuclear chromosome;organelle,,,,,,,,,,
Q9H4I9,SMDT1,"Single-pass membrane protein with aspartate-rich tail 1, mitochondrial",3,42.1,25.53,24.57,,,25.29,,24.45,,,25.85,25.31,23.59,26.14,25.09,0.44,-0.53, , ,0.2, ,-0.64, , ,0.76,0.22,-1.51,1.05,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6IN85,SMEK1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),15,24.1,28.18,27.39,28.48,27.47,27.44,28.12,27.84,27.7,28.5,28.05,26.2,27.51,27.4,27.71,0.47,-0.33,0.77,-0.24,-0.27,0.41,0.13,-0.02,0.78,0.33,-1.51,-0.21,-0.32,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
Q9H0W8,SMG9,Protein SMG9 (Protein smg-9 homolog),2,6.3,23.07,,,,24.86,,,25.45,22.57,23.79,24.76,23.45,24.13,24.01,-0.94, , , ,0.85, , ,1.44,-1.44,-0.22,0.75,-0.56,0.12,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;cytosol,,,,,,,,,,
Q8N5G0,SMIM20,Small integral membrane protein 20,2,34.3,25.79,26.97,25.93,26.17,26.76,27.44,26.51,26.25,27.43,26.67,27.18,26.77,26.72,26.66,-0.87,0.31,-0.73,-0.49,0.1,0.78,-0.15,-0.42,0.77,0.01,0.52,0.1,0.06,,cell part,,,,,,,,,,
Q9BQ49,SMIM7,Small integral membrane protein 7,2,25.3,,24.65,24.97,23.42,21.42,23.52,,21.99,22.45,,24.01,24.4,23.37,23.42, ,1.23,1.55,0,-2,0.1, ,-1.43,-0.97, ,0.59,0.98,-0.05,,cell part,,,,,,,,,,
Q16637,SMN1,Survival motor neuron protein (Component of gems 1) (Gemin-1),4,25.6,25.63,25.88,25.72,26.37,27.28,,27.16,27.08,26.01,26.16,,26.92,25.69,26.35,-0.73,-0.48,-0.63,0.02,0.92, ,0.81,0.73,-0.35,-0.2, ,0.57,-0.66,cell death;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process,cell part;cytosol;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O75940,SMNDC1,Survival of motor neuron-related-splicing factor 30 (30 kDa splicing factor SMNrp) (SMN-related protein) (Survival motor neuron domain-containing protein 1),5,34,29.47,27.58,27.99,27.96,27.78,28.08,28.06,28.15,28.82,26.77,26.23,26.74,27.51,27.78,1.69,-0.2,0.21,0.18,0,0.3,0.28,0.37,1.04,-1.01,-1.55,-1.04,-0.27,biological regulation;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
E9LUE8,SMPD1,Sphingomyelin phosphodiesterase 1 isoform 6 (EC 3.1.4.12),4,9.3,,24.34,,24.31,26.83,27.68,,25.42,25.16,26.86,27.72,24.81,28.15,26.13, ,-1.79, ,-1.82,0.7,1.55, ,-0.71,-0.97,0.73,1.59,-1.32,2.03,catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process,,,,,,,,,,,
Q9NXE4,SMPD4,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),10,15.4,28.42,27.88,28.64,28.48,25.8,27.81,28.63,27.76,29.02,28.5,27.01,28.38,28.87,28.09,0.33,-0.21,0.55,0.39,-2.29,-0.28,0.54,-0.34,0.92,0.4,-1.08,0.29,0.78,biosynthetic process;catabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P52788,SMS,Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase),13,39.9,27.67,29.24,28.11,29.89,28.65,28.64,28.85,30.04,24.75,28.17,29.45,28,27.55,28.39,-0.72,0.86,-0.28,1.51,0.27,0.26,0.47,1.65,-3.64,-0.22,1.06,-0.39,-0.84,amine metabolic process;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;cytosol,,,,,,,,,,
P53814,SMTN,Smoothelin,4,9.1,,21,22.56,,25.38,26.28,24.44,24.22,24.91,25.89,,,25.82,24.5, ,-3.5,-1.95, ,0.88,1.78,-0.06,-0.28,0.4,1.39, , ,1.32,anatomical structure development;developmental process;multicellular organismal process;muscle contraction,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q2TAY7,SMU1,WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog),18,41.5,30.3,30.1,30.09,30.39,31.04,31.14,30.23,30.03,31.04,30.47,28.58,29.82,30.4,30.28,0.02,-0.18,-0.19,0.11,0.76,0.86,-0.05,-0.25,0.76,0.19,-1.7,-0.46,0.12,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q6GMV2,SMYD5,SET and MYND domain-containing protein 5 (EC 2.1.1.-) (Protein NN8-4AG) (Retinoic acid-induced protein 15),2,5,25.89,25.77,,25.34,25.07,,25.04,25.67,24.75,,25.39,26.8,,25.53,0.37,0.25, ,-0.19,-0.45, ,-0.49,0.15,-0.78, ,-0.14,1.28, ,,,,,,,,,,,,
O00161,SNAP23,Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23),12,70.6,28.49,28.84,28.65,29.32,28.87,29.71,29.78,29.07,30.72,29.44,29.49,29.9,29.8,29.39,-0.9,-0.55,-0.74,-0.07,-0.52,0.32,0.39,-0.33,1.33,0.05,0.1,0.51,0.41,cellular component organization;cellular membrane organization;cellular process;establishment of localization;exocytosis;Golgi vesicle transport;membrane fusion;membrane organization;protein transport;secretion;transport;vesicle-mediated transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;neuron projection;nucleus;organelle;plasma membrane;synapse;vacuole;vesicle,,,,,,,,,,
O95721,SNAP29,Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29),5,21.3,26.37,28.99,26.84,28,25.03,26.46,26.85,27.45,25.37,24.2,27.19,26.65,25.34,26.52,-0.15,2.48,0.32,1.49,-1.49,-0.06,0.33,0.93,-1.15,-2.32,0.68,0.13,-1.18,cellular component organization;cellular membrane organization;cellular process;establishment of localization;exocytosis;membrane fusion;membrane organization;organelle fusion;organelle organization;protein transport;secretion;transport;vesicle-mediated transport,cell part;cell projection;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;nucleus;organelle;plasma membrane;protein complex;synapse,,,,,,,,,,
O95295,SNAPIN,SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein),4,44.1,26.95,26.01,,26.04,26.23,,26.47,26.03,25.79,,,25.63,,26.14,0.8,-0.13, ,-0.1,0.08, ,0.33,-0.11,-0.36, , ,-0.51, ,cellular component movement;cellular component organization;cellular membrane organization;cellular process;cytoskeleton-dependent intracellular transport;developmental maturation;developmental process;establishment of localization;exocytosis;interspecies interaction between organisms;membrane fusion;membrane organization;multi-organism process;organelle fusion;organelle organization;pigment granule organization;protein transport;secretion;transport;vesicle organization;vesicle-mediated transport,BLOC complex;cell part;cell projection;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;nucleolus;organelle;protein complex;vesicle,,,,,,,,,,
P37840,SNCA,Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP),2,32.4,,,26.22,23.79,,25.03,26.82,25.77,28.7,,23.65,,,25.71, , ,0.51,-1.92, ,-0.68,1.11,0.06,2.99, ,-2.06, , ,aging;alcohol metabolic process;amine metabolic process;amine transport;behavior;biological regulation;biosynthetic process;cell activation;cellular aromatic compound metabolic process;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;endocytosis;establishment of localization;extracellular matrix organization;extracellular structure organization;generation of precursor metabolites and energy;homeostatic process;immune system process;lipid metabolic process;macromolecule metabolic process;membrane invagination;membrane organization;metabolic process;mitochondrion organization;multicellular organismal process;neurotransmitter transport;nitrogen compound metabolic process;organelle organization;organic acid metabolic process;primary metabolic process;regulation of organelle organization;regulation of protein modification process;regulation of protein stability;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;transport;vesicle-mediated transport,cell cortex;cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytoskeleton;cytosol;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;neuron projection;nucleus;organelle;plasma membrane;ribonucleoprotein complex;ribosome;site of polarized growth;vesicle,,,,,,,,,,
O76070,SNCG,Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR),13,93.7,32.73,30.09,25.57,26.46,26.32,21.35,25.47,23.3,23.13,25.6,26.92,24.38,23.73,25.77,6.96,4.32,-0.2,0.69,0.55,-4.42,-0.3,-2.48,-2.64,-0.17,1.15,-1.39,-2.05,behavior;behavioral interaction between organisms;biological regulation;cell communication;cell-cell signaling;cellular component organization;cellular process;multicellular organismal process;multi-organism process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to drug;response to stimulus;response to stress;signaling,cell body;cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;neuronal cell body;organelle;plasma membrane,,,,,,,,,,
Q7KZF4,SND1,Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator),68,69.6,33.55,33.76,33.73,34.08,33.97,34.01,34.04,33.97,34.13,33.84,34.24,34.25,34.16,33.98,-0.43,-0.22,-0.25,0.1,-0.01,0.03,0.06,-0.01,0.15,-0.14,0.26,0.27,0.18,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;gene silencing;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoplasm;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;ribonucleoprotein complex;RNAi effector complex;vesicle,,,,,,,,,,
O75643,SNRNP200,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),90,48.5,33.2,32.8,32.52,32.57,33.13,33.52,33.08,32.43,33.54,33.19,31.65,32.04,32.83,32.81,0.39,0,-0.29,-0.24,0.32,0.71,0.27,-0.38,0.73,0.38,-1.16,-0.77,0.02,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q96DI7,SNRNP40,U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57),16,63.3,30.64,30.18,29.86,30.21,31.03,31.11,30.07,29.59,30.77,30.51,28.81,28.94,30.04,30.13,0.51,0.05,-0.27,0.07,0.89,0.97,-0.07,-0.55,0.63,0.38,-1.32,-1.2,-0.09,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;small nucleolar ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P08621,SNRNP70,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),31,61.6,32.27,31.6,31.26,31.68,31.74,31.51,31.39,31.27,32.25,31.67,30.07,29.85,31.2,31.37,0.91,0.24,-0.11,0.32,0.38,0.14,0.02,-0.1,0.88,0.3,-1.3,-1.52,-0.17,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P09012,SNRPA,U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A),14,45.4,30.85,30.64,30.94,30.84,29.74,31.35,30.99,30.44,31.55,30.88,30.24,28.32,30.97,30.6,0.25,0.05,0.34,0.24,-0.86,0.75,0.4,-0.16,0.95,0.29,-0.35,-2.28,0.38,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P09661,SNRPA1,U2 small nuclear ribonucleoprotein A' (U2 snRNP A'),22,56.9,31.52,30.57,31.31,30.71,31.46,31.45,31.2,31.05,32.08,31.89,30.44,31.45,31.11,31.25,0.27,-0.68,0.07,-0.54,0.22,0.2,-0.05,-0.2,0.83,0.64,-0.81,0.2,-0.14,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P08579,SNRPB2,U2 small nuclear ribonucleoprotein B'' (U2 snRNP B''),7,34.7,30.04,29.04,29.22,29.51,28.36,28.71,29.49,28.45,30.04,29.9,27.85,27.9,29.06,29.04,1,0,0.18,0.47,-0.68,-0.34,0.44,-0.59,1,0.86,-1.2,-1.15,0.02,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P09234,SNRPC,U1 small nuclear ribonucleoprotein C (U1 snRNP C) (U1-C) (U1C),5,25.2,29.69,29.3,29.84,29.9,29.42,29.83,29.29,28.71,30.07,29.75,28.35,28.61,29.72,29.42,0.26,-0.12,0.42,0.48,0,0.41,-0.13,-0.71,0.65,0.32,-1.08,-0.81,0.3,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;ribonucleoprotein complex assembly,cell part;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62314,SNRPD1,Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (Sm-D autoantigen) (snRNP core protein D1),7,64.7,32.01,31.41,31.06,31.96,32.31,32.6,31.98,31.91,32.09,32.23,31.31,28.58,32.13,31.66,0.35,-0.25,-0.6,0.3,0.65,0.94,0.32,0.25,0.43,0.57,-0.35,-3.08,0.47,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process,cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62316,SNRPD2,Small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2),11,74.6,31.6,31.38,31.75,31.15,31.06,31.62,31.27,31.02,31.81,31.8,29.83,31.41,31.06,31.29,0.31,0.09,0.46,-0.14,-0.23,0.33,-0.02,-0.26,0.52,0.51,-1.45,0.12,-0.23,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process,cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62318,SNRPD3,Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3),7,45,32.84,32.12,31.91,32.25,32.65,33,32.3,32.08,32.79,32.27,31.25,32.06,32.43,32.3,0.53,-0.18,-0.39,-0.05,0.35,0.7,-0.01,-0.22,0.49,-0.04,-1.05,-0.25,0.12,"biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent",cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62304,SNRPE,Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE),3,29.3,30.29,30.64,28.36,30.64,31.97,31.55,30.93,30.94,31.43,30.73,30.07,31.25,31.4,30.78,-0.5,-0.14,-2.43,-0.15,1.19,0.77,0.15,0.15,0.64,-0.05,-0.72,0.47,0.61,"biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent",cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62306,SNRPF,Small nuclear ribonucleoprotein F (snRNP-F) (Sm protein F) (Sm-F) (SmF),9,58.1,32.88,32.75,32.25,32.34,33.73,33.37,32.63,32.51,32.62,32.39,31.75,33.23,31.86,32.64,0.24,0.11,-0.39,-0.3,1.09,0.73,-0.01,-0.13,-0.02,-0.25,-0.89,0.59,-0.78,"biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent",cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P62308,SNRPG,Small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG),4,36.8,29.92,29.46,21.15,29.81,30.41,29.46,29.22,29.09,29.21,28.01,27.83,27.92,28.37,28.45,1.47,1.01,-7.3,1.36,1.96,1.01,0.77,0.64,0.76,-0.44,-0.62,-0.53,-0.08,"biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent",cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;small nuclear ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
J3QLE5,SNRPN,Small nuclear ribonucleoprotein-associated protein N (Fragment),9,39.1,31.77,31.89,31.36,32.01,32.07,32.13,31.57,31.56,32.03,31.81,30.32,31.63,31.63,31.68,0.09,0.21,-0.32,0.33,0.39,0.45,-0.1,-0.11,0.35,0.13,-1.36,-0.04,-0.04,response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;macromolecular complex;ribonucleoprotein complex;small nuclear ribonucleoprotein complex,,,,,,,,,,
Q13425,SNTB2,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),18,36.9,29.27,28.82,27.48,29.41,29.48,29.71,29.06,29.01,29.82,27.87,28.45,28.91,29.41,28.98,0.29,-0.15,-1.5,0.43,0.5,0.73,0.08,0.04,0.85,-1.11,-0.53,-0.07,0.43,,cell part;cytoplasm;dystrophin-associated glycoprotein complex;macromolecular complex;membrane;protein complex;synapse,,,,,,,,,,
Q13573,SNW1,SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein),18,40.9,30.01,28.73,29.62,29.26,30.51,30.52,30.35,29.36,30.22,30.2,28.94,28.32,29.67,29.67,0.34,-0.94,-0.05,-0.41,0.84,0.85,0.68,-0.31,0.55,0.53,-0.74,-1.35,0,"biological regulation;biosynthetic process;cell communication;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;signal transduction;transcription initiation, DNA-dependent",cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q13596,SNX1,Sorting nexin-1,24,49.4,29.8,30.08,30.43,30.61,30.09,29.34,30.55,30.05,29.27,29.8,30.23,31.22,29.39,30.07,-0.27,0.01,0.36,0.54,0.03,-0.72,0.48,-0.02,-0.8,-0.27,0.16,1.15,-0.67,biological regulation;cell communication;cellular component organization;cellular membrane organization;cellular process;endocytosis;endosome transport;establishment of localization;Golgi vesicle transport;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9UMY4,SNX12,Sorting nexin-12,5,17.9,26.59,28.22,28.04,28.12,26.98,27.54,28.05,28.3,27.06,25.72,28.34,27.65,25.78,27.42,-0.83,0.81,0.62,0.71,-0.43,0.13,0.64,0.88,-0.36,-1.69,0.93,0.23,-1.63,cell communication;cellular process;establishment of localization;protein transport;transport,cell part;membrane,,,,,,,,,,
Q15036,SNX17,Sorting nexin-17,7,22,,24.91,,26.22,26.62,25.83,26.94,25.56,,,24.33,25.41,25.05,25.65, ,-0.75, ,0.57,0.96,0.18,1.28,-0.09, , ,-1.32,-0.24,-0.61,alcohol metabolic process;biological regulation;catabolic process;cellular component organization;cellular membrane organization;cellular process;endocytosis;endosome transport;establishment of localization;lipid metabolic process;membrane invagination;membrane organization;metabolic process;primary metabolic process;protein transport;regulation of transport;response to stimulus;signal transduction;small molecule metabolic process;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q92543,SNX19,Sorting nexin-19,2,5.4,,23.74,,24.83,24.68,25.45,24.03,25.3,25.12,23.63,,24.17,24.98,24.59, ,-0.85, ,0.24,0.09,0.86,-0.56,0.7,0.53,-0.97, ,-0.42,0.39,cell communication;cellular process;establishment of localization;protein transport;transport,cell part;membrane,,,,,,,,,,
O60749,SNX2,Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9),26,48.9,31.83,30.92,32.12,30.62,30.06,29.51,30.71,30.99,30.38,29.87,31.19,30.75,29.86,30.68,1.15,0.24,1.45,-0.06,-0.62,-1.17,0.04,0.31,-0.3,-0.81,0.52,0.08,-0.82,cell communication;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q96L92,SNX27,Sorting nexin-27,5,13.3,27.36,27.54,25.92,27.19,25.42,22.15,25.94,27,25.35,24.18,23.22,25.73,24.71,25.52,1.84,2.03,0.4,1.67,-0.1,-3.37,0.42,1.48,-0.16,-1.33,-2.3,0.22,-0.81,biological regulation;cellular process;endosome transport;establishment of localization;protein transport;response to stimulus;signal transduction;transport;vacuolar transport;vesicle-mediated transport,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
O60493,SNX3,Sorting nexin-3 (Protein SDP3),16,77.8,30.39,30.4,31.43,31.02,30.67,29.73,30.56,30.69,29.81,29.01,30.68,30.86,30.19,30.42,-0.03,-0.02,1.01,0.6,0.25,-0.69,0.14,0.27,-0.61,-1.41,0.26,0.44,-0.23,cell communication;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O95219,SNX4,Sorting nexin-4,9,27.1,27.43,28.17,27.8,27.88,27.86,28.06,28.68,28.35,27.88,26.6,29.08,28.6,27.3,27.98,-0.55,0.2,-0.18,-0.09,-0.12,0.09,0.7,0.38,-0.1,-1.38,1.1,0.62,-0.68,cell communication;cellular component organization;cellular membrane organization;cellular process;endocytosis;endosome transport;establishment of localization;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9Y5X3,SNX5,Sorting nexin-5,17,47.8,30.63,29.24,30.24,28.87,28.72,27.58,28.84,29.71,27.06,28.09,28.03,29.21,25.98,28.63,2,0.61,1.6,0.24,0.09,-1.05,0.21,1.08,-1.57,-0.54,-0.6,0.58,-2.66,cell communication;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cell projection;membrane,,,,,,,,,,
Q9UNH7,SNX6,"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]",16,37.2,29.45,29.56,30.09,29.15,30.33,29.26,29.3,30.37,28.12,28.39,30.51,30.7,28.83,29.54,-0.1,0.02,0.55,-0.39,0.79,-0.29,-0.24,0.82,-1.42,-1.15,0.97,1.16,-0.72,biological regulation;cell communication;cellular process;endosome transport;establishment of localization;protein transport;regulation of protein modification process;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q9Y5X2,SNX8,Sorting nexin-8,7,17,25.46,25.7,27.51,26.96,27.56,27.43,26.73,28.2,27.23,25.84,27.55,27.9,26.83,26.99,-1.53,-1.29,0.51,-0.04,0.57,0.44,-0.26,1.21,0.24,-1.15,0.56,0.9,-0.17,cell communication;cellular process;endosome transport;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q9Y5X1,SNX9,Sorting nexin-9 (SH3 and PX domain-containing protein 1) (Protein SDP1) (SH3 and PX domain-containing protein 3A),17,38,29.82,30.03,30.38,29.47,28.77,28.35,29.48,30.01,28.69,29.69,29.38,28.86,28.15,29.31,0.51,0.71,1.07,0.16,-0.54,-0.96,0.17,0.7,-0.62,0.37,0.06,-0.45,-1.17,biological regulation;cell communication;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular process;endocytosis;establishment of localization;macromolecular complex assembly;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
P35610,SOAT1,Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1),7,17.1,27.63,27.68,29.34,27.96,28.17,28.51,27.24,27.79,28.04,30.29,27.72,29.35,28.54,28.33,-0.7,-0.65,1.01,-0.37,-0.16,0.18,-1.09,-0.54,-0.29,1.96,-0.61,1.02,0.21,alcohol metabolic process;biological regulation;cell differentiation;cellular component assembly;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;lipid metabolic process;lipid transport;localization;macromolecular complex assembly;metabolic process;multicellular organismal process;primary metabolic process;small molecule metabolic process;transport,cell part;membrane,,,,,,,,,,
P00441,SOD1,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1),17,92.2,33.03,32.17,33.36,32.38,30.24,30.42,32.41,31.67,31.41,31.72,32.81,32.74,30.51,31.91,1.11,0.25,1.45,0.47,-1.67,-1.5,0.5,-0.24,-0.5,-0.19,0.89,0.83,-1.41,aging;amine metabolic process;anatomical structure development;behavior;biological regulation;biosynthetic process;catabolic process;cell activation;cellular amino acid metabolic process;cellular component movement;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;cytoskeleton organization;cytoskeleton-dependent intracellular transport;developmental process;DNA metabolic process;DNA repair;establishment of localization;exocytosis;homeostatic process;immune system process;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;organic acid metabolic process;peptide metabolic process;phosphorus metabolic process;plasma membrane organization;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to heat;response to oxidative stress;response to stimulus;response to stress;rhythmic process;secretion;small molecule metabolic process;sulfur compound metabolic process;transport;vesicle-mediated transport,cell body;cell part;cytosol;extracellular matrix;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;microbody;neuronal cell body;nucleus;organelle;peroxisome;protein complex;vesicle,,,,,,,,,,
P04179,SOD2,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)",24,93.7,34.65,35.83,35.76,33.94,33.62,34.43,34.06,34.11,35.62,36.04,35.91,34.08,35.12,34.86,-0.21,0.98,0.9,-0.92,-1.24,-0.43,-0.79,-0.75,0.76,1.18,1.05,-0.78,0.26,amine metabolic process;anatomical structure development;behavior;biological regulation;biosynthetic process;cell development;cell differentiation;cellular amino acid metabolic process;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;circulatory system process;detection of stimulus;developmental process;generation of precursor metabolites and energy;homeostatic process;macromolecular complex assembly;metabolic process;mitochondrion organization;multicellular organismal process;nitrogen compound metabolic process;organelle organization;organic acid metabolic process;peptide metabolic process;post-embryonic development;primary metabolic process;protein complex assembly;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process;sulfur compound metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9Y4B5,SOGA2,Protein SOGA2 (Coiled-coil domain-containing protein 165),6,5.6,26.09,25.94,25.27,26.28,26.63,,26.83,26.97,25.93,24.94,27.18,27.85,,26.35,-0.26,-0.42,-1.08,-0.08,0.27, ,0.47,0.62,-0.42,-1.42,0.83,1.49, ,,,,,,,,,,,,
P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),47,25.6,30.82,29.25,30.04,29.85,30.4,29.93,30.22,29.7,30.59,30.53,28.41,29.77,29.57,29.93,0.89,-0.68,0.11,-0.08,0.47,0,0.29,-0.23,0.66,0.6,-1.52,-0.16,-0.36,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytokinesis;cytoskeleton organization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;RNA metabolic process;RNA processing;RNA splicing,cell part,,,,,,,,,,
O94875,SORBS2,Sorbin and SH3 domain-containing protein 2 (Arg/Abl-interacting protein 2) (ArgBP2) (Sorbin),22,34.5,28.33,25.42,,24.8,27.35,26.05,,24.57,27.23,30.76,26.63,,25.55,26.67,1.66,-1.25, ,-1.87,0.68,-0.62, ,-2.1,0.56,4.09,-0.04, ,-1.12,,cell part;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BT70,SORBS3,SORBS3 protein (Fragment),8,31,25.57,25.85,,27.31,25.78,26.19,26.77,27.65,25.78,,25.97,28.44,,26.53,-0.96,-0.68, ,0.78,-0.75,-0.34,0.24,1.12,-0.75, ,-0.56,1.91, ,,,,,,,,,,,,
Q00796,SORD,Sorbitol dehydrogenase (EC 1.1.1.14) (L-iditol 2-dehydrogenase),13,50.1,30.37,29.72,29.61,29.48,28.37,28.25,28.78,29.46,25.64,27.83,28.39,27.67,26.49,28.46,1.9,1.25,1.15,1.02,-0.1,-0.21,0.31,0.99,-2.82,-0.63,-0.08,-0.8,-1.98,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cell motility;cellular component movement;cellular metabolic process;cellular process;locomotion;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cell projection;cilium;extracellular space;membrane,,,,,,,,,,
Q92673,SORL1,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),13,8.7,28.02,28.82,24.56,24.95,26.71,,,24.77,,24.68,,26.22,,26.09,1.93,2.72,-1.53,-1.14,0.62, , ,-1.32, ,-1.41, ,0.13, ,alcohol metabolic process;cellular component organization;cellular membrane organization;cellular process;endocytosis;establishment of localization;lipid metabolic process;lipid transport;membrane invagination;membrane organization;metabolic process;primary metabolic process;small molecule metabolic process;transport;vesicle-mediated transport,cell part;macromolecular complex,,,,,,,,,,
Q99523,SORT1,Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3),8,13.7,27.35,27.77,22.26,25.29,22.77,24.81,24.99,25.75,25.01,29.12,,,25.17,25.48,1.87,2.29,-3.22,-0.19,-2.71,-0.67,-0.49,0.27,-0.47,3.64, , ,-0.31,biological regulation;carbohydrate transport;cell differentiation;cellular component organization;cellular membrane organization;cellular process;developmental process;endocytosis;endosome transport;establishment of localization;Golgi vesicle transport;membrane invagination;membrane organization;multicellular organismal process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;signal transduction;transport;vacuolar transport;vesicle organization;vesicle-mediated transport,cell body;cell part;cell projection;cell surface;cytoplasmic membrane-bounded vesicle;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;neuronal cell body;organelle;plasma membrane;vesicle,,,,,,,,,,
Q53LP3,SOWAHC,Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C),2,6.1,21.82,,,,23.8,23.6,22.29,22.68,,23.02,24.12,23.29,23.54,23.13,-1.31, , , ,0.67,0.48,-0.84,-0.45, ,-0.11,0.99,0.16,0.41,,,,,,,,,,,,
P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),16,17.7,27.8,29.8,29.55,29.27,28.25,28.02,27.15,27.27,28.25,27.38,26.41,28.01,27.94,28.09,-0.29,1.72,1.47,1.19,0.17,-0.06,-0.94,-0.81,0.16,-0.7,-1.67,-0.07,-0.14,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;homeostatic process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of transport;response to chemical stimulus;response to DNA damage stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;telomere organization,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,HMG-box,,,,,,,,,
Q07617,SPAG1,Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1),5,7.3,25.38,,26.24,24.63,27.02,25.72,26.96,25.76,26.4,28.22,26.13,26.38,26.58,26.28,-0.9, ,-0.05,-1.65,0.74,-0.57,0.67,-0.52,0.11,1.94,-0.16,0.09,0.29,,cell part;cytoplasm,,,,,,,,,,
O60271,SPAG9,C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1),23,22.9,27.08,28.4,28.95,28.24,27.77,27.28,29,29.24,26.8,26.83,29.1,29.95,25.63,28.02,-0.94,0.38,0.93,0.22,-0.25,-0.74,0.98,1.22,-1.22,-1.19,1.08,1.93,-2.39,biological regulation;cell differentiation;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;developmental process;endosome transport;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P09486,SPARC,SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine),14,50.8,25.24,32.09,29.45,32.72,31.28,32.06,30.54,31.04,31.63,25.85,30.38,30.72,31.6,30.35,-5.11,1.73,-0.9,2.37,0.93,1.7,0.19,0.69,1.27,-4.51,0.03,0.36,1.24,anatomical structure development;biological regulation;cell activation;cellular process;developmental process;establishment of localization;exocytosis;multicellular organismal process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;secretion;signal transduction;transport;vesicle-mediated transport,cell part;extracellular matrix;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;proteinaceous extracellular matrix,,,,,,,,,,
Q86XZ4,SPATS2,Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr),3,7.3,,24.28,,23.45,24.56,24.39,23.75,23.8,24.41,,24.13,26.68,23.9,24.34, ,-0.05, ,-0.89,0.23,0.05,-0.58,-0.54,0.08, ,-0.21,2.34,-0.44,,cell part;cytoplasm,,,,,,,,,,
Q9NUQ6,SPATS2L,SPATS2-like protein (DNA polymerase-transactivated protein 6) (Stress granule and nucleolar protein) (SGNP),14,32.3,28.72,28.8,29.92,29.9,28.79,27.91,30.47,30.17,28.61,28.85,29.75,29.06,28.93,29.22,-0.5,-0.42,0.7,0.67,-0.43,-1.31,1.25,0.94,-0.61,-0.37,0.53,-0.17,-0.29,,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9Y6A9,SPCS1,Signal peptidase complex subunit 1 (EC 3.4.-.-) (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit),2,21.2,27.47,27.64,,26.43,28.94,27.67,24.81,29.2,,,,,21.46,26.7,0.77,0.94, ,-0.27,2.24,0.97,-1.89,2.5, , , , ,-5.25,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein targeting;protein transport;proteolysis;regulation of transport;translation;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q15005,SPCS2,Signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit),16,75.2,30.44,30.77,29.85,30.6,30.65,31.07,30.35,30.48,31.28,30.62,30.69,29.75,30.43,30.54,-0.1,0.24,-0.68,0.06,0.11,0.53,-0.18,-0.05,0.74,0.08,0.16,-0.78,-0.11,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein targeting;protein transport;proteolysis;regulation of transport;translation;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
P61009,SPCS3,Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit),7,28.9,30.17,31.13,30.56,30.54,30.37,30.77,30.58,30.78,31.05,30.85,30.3,29.66,30.73,30.58,-0.41,0.56,-0.01,-0.04,-0.21,0.19,0.01,0.2,0.47,0.27,-0.28,-0.91,0.16,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein targeting;protein transport;proteolysis;regulation of transport;translation;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),17,21.6,27.69,26.14,28.01,27.48,27.15,27.42,26.59,26.61,29.24,29.23,26.08,27.52,27.19,27.41,0.28,-1.27,0.6,0.06,-0.27,0.01,-0.82,-0.81,1.83,1.82,-1.33,0.11,-0.22,biological adhesion;cell adhesion;cellular process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8N0X7,SPG20,Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1),10,22.2,26.13,27.75,28.68,29.57,28.72,28.07,29.48,29.96,28.75,27.64,29.23,30.09,28.64,28.67,-2.54,-0.92,0.01,0.9,0.05,-0.6,0.81,1.29,0.08,-1.03,0.56,1.42,-0.03,abscission;anatomical structure development;biological regulation;cell death;cell division;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;cytokinesis;death;developmental process;homeostatic process;multicellular organismal process;neurological system process;organelle organization,cell part;lipid particle;membrane;midbody;synapse,,,,,,,,,,
Q9UQ90,SPG7,Paraplegin (EC 3.4.24.-) (Spastic paraplegia 7 protein),3,6.3,25.95,25.93,,25.28,25.87,26.57,26.09,25.48,26.52,27.05,25.85,25.2,26.43,26.02,-0.07,-0.09, ,-0.74,-0.15,0.55,0.07,-0.53,0.5,1.03,-0.17,-0.82,0.41,anatomical structure development;catabolic process;cell death;cellular component movement;cellular component organization;cellular process;cytoskeleton-dependent intracellular transport;death;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;mitochondrion organization;organelle organization;primary metabolic process;protein catabolic process;protein metabolic process;proteolysis;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q9Y657,SPIN1,Spindlin-1 (Ovarian cancer-related protein),3,19.8,28.82,27.53,28.11,27.67,26.39,26.49,26.96,25.49,26.67,26.98,25.1,27.16,25.99,26.87,1.95,0.65,1.24,0.8,-0.49,-0.39,0.08,-1.38,-0.2,0.11,-1.78,0.28,-0.88,cell cycle;cellular process;developmental process;multicellular organismal development;multicellular organismal process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
H3BVD9,SPINT1,Kunitz-type protease inhibitor 1 (Fragment),15,29,29.52,27.88,29,26.64,28.69,29.27,29.1,27.67,30.65,31.88,27.67,28.2,29.41,28.89,0.63,-1.01,0.11,-2.25,-0.2,0.38,0.21,-1.22,1.76,2.99,-1.22,-0.69,0.52,,,,,,,,,,,,
Q9H2V7,SPNS1,Protein spinster homolog 1 (HSpin1) (Spinster-like protein 1),3,14.3,25.62,26,25.96,25.86,27.06,27.19,25.97,24.15,26.25,27.53,27.69,28.89,26.44,26.51,-0.89,-0.51,-0.55,-0.65,0.55,0.68,-0.54,-2.36,-0.26,1.02,1.18,2.38,-0.07,cellular process;establishment of localization;lipid transport;transmembrane transport;transport,cell part;membrane,,,,,,,,,,
Q9HCB6,SPON1,Spondin-1 (F-spondin) (Vascular smooth muscle cell growth-promoting factor),8,17,28.68,29.62,26.97,26.91,,22.86,,,26.61,30.23,,,,27.41,1.27,2.21,-0.44,-0.5, ,-4.55, , ,-0.8,2.82, , , ,biological adhesion;cell adhesion;cellular process,extracellular matrix;extracellular space;proteinaceous extracellular matrix,,,,,,,,,,
Q8TCT8,SPPL2A,Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2),2,15.3,24.9,27.75,27.59,28.34,27.86,28.01,27.82,,27.49,27.96,26.88,28.02,27.77,27.53,-2.63,0.22,0.06,0.81,0.33,0.48,0.29, ,-0.04,0.42,-0.65,0.49,0.24,biological regulation;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;membrane;plasma membrane,,,,,,,,,,
P35270,SPR,Sepiapterin reductase (SPR) (EC 1.1.1.153),14,61.3,30.28,29.35,29.07,28.53,28.43,29.11,29.08,29.48,28.03,27.94,29.85,29.59,28.64,29.03,1.25,0.32,0.04,-0.5,-0.6,0.08,0.05,0.45,-0.99,-1.09,0.82,0.56,-0.39,biological regulation;biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8WW59,SPRYD4,SPRY domain-containing protein 4,6,32.4,28.25,29.02,27.76,28.73,27.42,27.04,27.26,28.14,27.32,28.23,28.59,26.11,27.47,27.8,0.46,1.22,-0.04,0.93,-0.37,-0.76,-0.54,0.35,-0.47,0.44,0.8,-1.68,-0.32,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q5W111,SPRYD7,SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein) (CLL deletion region gene 6 protein),4,23,26.59,27.11,26.57,27.93,28.22,27,27.48,27.52,28.12,28.08,27.14,28.98,28.3,27.62,-1.03,-0.51,-1.05,0.31,0.6,-0.62,-0.13,-0.1,0.5,0.47,-0.48,1.36,0.68,,,,,,,,,,,,
Q13813,SPTAN1,"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)",254,77.3,34.25,35.04,34.7,35.51,35.91,35.89,36.03,35.97,36.13,36.18,35.99,35.14,36.26,35.62,-1.37,-0.57,-0.92,-0.1,0.3,0.27,0.42,0.35,0.52,0.57,0.37,-0.47,0.65,biological regulation;cellular component disassembly;cellular component organization;cellular process;locomotion;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",208,76.2,33.96,34.77,34.41,35.16,35.52,35.64,35.54,35.26,35.74,35.85,35.72,35.42,36.09,35.31,-1.36,-0.55,-0.9,-0.15,0.21,0.33,0.22,-0.06,0.43,0.53,0.41,0.11,0.77,biological regulation;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;cytokinesis;establishment of localization;Golgi vesicle transport;locomotion;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;nuclear transport;nucleocytoplasmic transport;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;protein targeting;protein transport;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;transport;vesicle-mediated transport,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
O15020,SPTBN2,"Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)",24,14.5,29.58,28.41,28.53,25.63,27.14,26.24,26.4,24.8,25.8,28.17,25.67,27.15,25.36,26.84,2.75,1.57,1.69,-1.21,0.3,-0.59,-0.43,-2.03,-1.03,1.33,-1.16,0.31,-1.47,anatomical structure morphogenesis;behavior;biological regulation;cell death;cellular component assembly;cellular component organization;cellular process;death;developmental process;establishment of localization;growth;immune system process;locomotion;multicellular organismal process;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to stimulus;transport;vesicle-mediated transport,cell body;cell part;cytosol;neuronal cell body,,,,,,,,,,
O15269,SPTLC1,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),15,32.3,28.43,29.14,29.42,29.66,29.27,30.36,30.09,29.83,30.3,30.13,29.98,30.34,30.47,29.8,-1.37,-0.66,-0.38,-0.14,-0.53,0.56,0.29,0.03,0.5,0.33,0.18,0.53,0.67,alcohol metabolic process;amine metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
O15270,SPTLC2,Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2),8,21.7,26.01,26.64,27.1,28.05,28.16,28.09,28.23,27.09,28.44,30.07,28.6,28.93,29.01,28.03,-2.02,-1.4,-0.93,0.01,0.13,0.05,0.2,-0.94,0.4,2.03,0.57,0.9,0.98,alcohol metabolic process;amine metabolic process;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
Q9NUV7,SPTLC3,Serine palmitoyltransferase 3 (EC 2.3.1.50) (Long chain base biosynthesis protein 2b) (LCB2b) (Long chain base biosynthesis protein 3) (LCB 3) (Serine-palmitoyl-CoA transferase 3) (SPT 3),4,7.2,28.52,29.06,29.05,29.71,26.14,28.52,28.6,28.15,29.41,28.21,28.85,,25.52,28.31,0.21,0.75,0.74,1.4,-2.18,0.21,0.29,-0.17,1.09,-0.1,0.54, ,-2.8,biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q14534,SQLE,Squalene monooxygenase (EC 1.14.13.132) (Squalene epoxidase) (SE),16,37.2,27.36,26.87,28.16,30.69,29.54,29.86,30.45,30.15,30.82,30.45,26.73,29.2,29.13,29.19,-1.83,-2.31,-1.02,1.51,0.35,0.68,1.26,0.96,1.64,1.26,-2.45,0.01,-0.06,alcohol metabolic process;biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular process;lipid metabolic process;metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q9Y6N5,SQRDL,"Sulfide:quinone oxidoreductase, mitochondrial (EC 1.-.-.-)",38,66.9,30.91,32.84,32.93,32.39,33.06,33.04,33.12,33.18,33.69,34.32,33.38,32.56,33.75,33.01,-2.1,-0.17,-0.09,-0.62,0.05,0.03,0.11,0.16,0.67,1.31,0.37,-0.45,0.74,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process,cell part;membrane,,,,,,,,,,
Q13501,SQSTM1,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),15,48.9,30.41,29.34,28.44,29.77,29.72,29.09,27.9,28.91,28.55,28.6,30.38,30.92,30.37,29.42,0.99,-0.07,-0.98,0.36,0.31,-0.33,-1.51,-0.51,-0.86,-0.82,0.96,1.5,0.96,autophagy;biological regulation;catabolic process;cell communication;cell differentiation;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;developmental process;endosome transport;establishment of localization;localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;endoplasmic reticulum;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;nucleoplasm;organelle;ribonucleoprotein complex;vacuole;vesicle,,,,,,,,,,
P12931,SRC,Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src),9,23.5,25.38,27.05,27.57,26.29,26.93,26.23,25.75,25,,28.29,28.03,,27.67,26.75,-1.37,0.31,0.82,-0.45,0.19,-0.51,-0.99,-1.75, ,1.55,1.28, ,0.92,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell cycle;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular membrane organization;cellular metabolic process;cellular process;circulatory system process;developmental process;homeostatic process;immune system process;interspecies interaction between organisms;locomotion;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;multicellular organismal process;multi-organism process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoskeleton;cytosol;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;lysosome;membrane;nucleus;organelle;vacuole,,+,,+,,,,,,
Q8WXA9,SREK1,"Splicing regulatory glutamine/lysine-rich protein 1 (Serine/arginine-rich-splicing regulatory protein 86) (SRrp86) (Splicing factor, arginine/serine-rich 12) (Splicing regulatory protein 508) (SRrp508)",5,16.1,26.9,27.12,26.08,26.63,26.79,27.08,27.23,,28.58,26.72,,26.06,25.29,26.77,0.13,0.35,-0.69,-0.14,0.01,0.31,0.46, ,1.81,-0.05, ,-0.71,-1.48,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleus;organelle;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q7Z6B7,SRGAP1,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),6,8.2,26.08,25.04,25.26,25.75,,24.82,,,,,27.47,26.16,25.46,25.75,0.33,-0.71,-0.5,-0.01, ,-0.93, , , , ,1.71,0.41,-0.3,biological regulation;cell motility;cellular component movement;cellular process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
O75044,SRGAP2,SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34),4,5.2,,22.31,22.7,,,,24.11,22.22,,23.41,24.85,25.62,,23.6, ,-1.29,-0.9, , , ,0.51,-1.39, ,-0.19,1.24,2.01, ,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell morphogenesis;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular process;developmental process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cell projection;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
P30626,SRI,Sorcin (22 kDa protein) (CP-22) (CP22) (V19),12,71.6,30.58,30.11,30.73,30.09,29.85,29.23,30.28,29.71,28.7,28.39,30.16,30.53,27.69,29.7,0.88,0.41,1.04,0.39,0.15,-0.47,0.58,0.02,-1,-1.3,0.46,0.83,-2.01,anatomical structure development;biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;establishment of localization;homeostatic process;ion transport;regulation of transport;response to stimulus;signal transduction;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
P19623,SRM,Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase),14,49,29,30.15,29.39,31.21,29.3,29.06,30.73,30.61,28.9,28.21,29.78,31.24,28.57,29.71,-0.7,0.44,-0.31,1.51,-0.4,-0.64,1.02,0.91,-0.81,-1.49,0.07,1.54,-1.13,amine metabolic process;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P37108,SRP14,Signal recognition particle 14 kDa protein (SRP14) (18 kDa Alu RNA-binding protein),6,36.8,30.03,29.12,29.7,30.08,30.3,30.61,30.2,30.19,30.39,30.32,29.7,30.04,30.21,30.07,-0.04,-0.95,-0.37,0.01,0.23,0.54,0.14,0.12,0.32,0.25,-0.37,-0.03,0.14,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;response to chemical stimulus;response to drug;response to stimulus;translation;transport,cell part;cytosol;macromolecular complex;ribonucleoprotein complex;signal recognition particle,,,,,,,,,,
P09132,SRP19,Signal recognition particle 19 kDa protein (SRP19),3,29.9,26.51,26.29,25.65,28.14,26.22,26.86,27.16,26.06,26.31,26.74,,25.21,26.49,26.47,0.04,-0.18,-0.82,1.67,-0.25,0.39,0.69,-0.41,-0.16,0.27, ,-1.26,0.02,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;response to chemical stimulus;response to drug;response to stimulus;translation;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;nucleolus;organelle;ribonucleoprotein complex;signal recognition particle,,,,,,,,,,
P61011,SRP54,Signal recognition particle 54 kDa protein (SRP54),20,43.8,30.09,30.5,30.35,30.75,29.48,28.91,30.85,30.12,30.2,29.9,30.2,30.64,29.09,30.08,0,0.42,0.27,0.66,-0.6,-1.17,0.76,0.04,0.12,-0.18,0.12,0.56,-0.99,biosynthetic process;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;heterocycle metabolic process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein transport;response to chemical stimulus;response to drug;response to stimulus;small molecule metabolic process;translation;transmembrane transport;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;signal recognition particle,,,,,,,,,,
Q9UHB9,SRP68,Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein),27,52.8,29.36,30.49,30.48,30.51,30.06,30.13,30.43,30.65,30.1,29.85,30.03,29.95,29.44,30.11,-0.75,0.38,0.37,0.39,-0.06,0.01,0.31,0.54,-0.01,-0.26,-0.08,-0.17,-0.67,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;response to chemical stimulus;response to drug;response to stimulus;translation;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex;ribosome;signal recognition particle,,,,,,,,,,
O76094,SRP72,Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein),20,43.2,30.42,30.96,31.07,31.1,30.6,30.86,31,30.89,31.05,30.67,30.82,31.32,30.6,30.87,-0.45,0.09,0.2,0.22,-0.27,-0.02,0.12,0.01,0.18,-0.2,-0.05,0.45,-0.28,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;response to chemical stimulus;response to drug;response to stimulus;translation;transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;plasma membrane;ribonucleoprotein complex;signal recognition particle,,,,,,,,,,
P49458,SRP9,Signal recognition particle 9 kDa protein (SRP9),7,69.8,29.94,30.57,30.73,30.56,29.95,30.14,30.05,29.65,30.74,29.91,28.47,29.17,29.06,29.92,0.02,0.65,0.81,0.64,0.04,0.22,0.13,-0.27,0.82,-0.01,-1.45,-0.75,-0.86,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;regulation of translation;translation;transport,cell part;cytosol;macromolecular complex;protein complex;receptor complex;ribonucleoprotein complex;signal recognition particle,,,,,,,,,,
Q96SB4,SRPK1,SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1),8,20.5,26.58,26.01,27.36,27.61,28.2,27.54,27.87,27.48,26.83,28.05,27.16,28.33,27.63,27.44,-0.86,-1.42,-0.08,0.17,0.77,0.11,0.44,0.04,-0.6,0.62,-0.28,0.9,0.19,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;chromosome segregation;DNA metabolic process;DNA packaging;immune system process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;cytoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
P78362,SRPK2,SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal;SRSF protein kinase 2 C-terminal],5,8,26.46,25.27,23.62,27.19,24.56,26.28,23.93,25.46,25.57,,24.7,25.23,,25.3,1.17,-0.03,-1.67,1.89,-0.74,0.98,-1.36,0.16,0.27, ,-0.6,-0.06, ,anatomical structure formation involved in morphogenesis;biological regulation;cell differentiation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;developmental process;immune system process;macromolecular complex assembly;nucleus organization;organelle organization;regulation of cell cycle;response to stimulus;response to stress;ribonucleoprotein complex assembly;signal transduction,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,+,,,,,,,,
P08240,SRPR,Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha),32,53.4,30.71,31.47,31.14,31.24,31.99,31.74,31.02,30.84,32.35,31.33,30.82,30.11,31.49,31.25,-0.54,0.22,-0.11,-0.01,0.74,0.49,-0.23,-0.4,1.1,0.08,-0.43,-1.14,0.25,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;regulation of protein modification process;translation;transport,cell part;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
Q9Y5M8,SRPRB,Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1),23,76.4,31.2,31.69,31.55,31.69,31.89,32.37,31.95,31.28,32.59,31.53,31.44,29.53,32.57,31.64,-0.43,0.05,-0.08,0.05,0.25,0.74,0.31,-0.36,0.96,-0.11,-0.2,-2.1,0.93,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;regulation of protein modification process;response to stimulus;signal transduction;translation;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),59,43.6,29.61,29.53,29.5,29.45,29.96,29.37,28.92,28.62,30.07,28.99,26.52,29.04,29.04,29.13,0.48,0.41,0.38,0.32,0.83,0.24,-0.2,-0.5,0.95,-0.13,-2.61,-0.08,-0.09,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;cytosol;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),147,50.6,32.44,31.1,30.92,31.68,32.03,31.22,31.41,31.28,31.85,31.09,30.78,31.13,31.36,31.41,1.03,-0.31,-0.49,0.27,0.62,-0.19,0,-0.13,0.44,-0.32,-0.63,-0.28,-0.05,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q9BXP5,SRRT,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),42,39,31.84,30.32,30.81,30.54,30.02,30.32,29.93,28.88,30.86,30.35,28.87,29.08,29.54,30.1,1.73,0.21,0.7,0.43,-0.08,0.21,-0.17,-1.23,0.76,0.25,-1.23,-1.02,-0.57,biological regulation;biosynthetic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;RNA metabolic process;RNA processing,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
Q07955,SRSF1,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",35,73.4,32.78,32.54,32,32.54,32.9,32.52,32.19,32.56,33.2,32.89,31.47,30.72,31.93,32.33,0.45,0.22,-0.32,0.22,0.58,0.19,-0.14,0.23,0.87,0.57,-0.86,-1.6,-0.4,"biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal process;muscle contraction;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent;transport",cell part;cytoplasm;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O75494,SRSF10,"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein) (SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats) (TASR) (TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein) (TLS-associated SR protein)",18,42.5,31,30.56,29.95,29.9,30.89,30.87,30.85,30.5,31.27,29.81,28.18,21.34,27.37,29.42,1.58,1.13,0.53,0.47,1.47,1.45,1.42,1.08,1.85,0.39,-1.24,-8.08,-2.05,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;establishment of localization;macromolecular complex assembly;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;ribonucleoprotein complex assembly;transport,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
Q05519,SRSF11,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",16,28.4,30.16,29.38,27.61,29.6,30.22,30.35,29.57,29.73,29.69,28.79,29.14,30.2,30.17,29.59,0.57,-0.21,-1.98,0.01,0.64,0.76,-0.01,0.14,0.1,-0.79,-0.45,0.62,0.59,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;nucleoplasm,,,,,,,,,,
Q01130,SRSF2,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",25,57.9,32.52,32.13,31.83,31.67,32.57,32.52,31.92,31.87,32.2,32.08,31.32,31.59,31.85,32.01,0.51,0.12,-0.17,-0.34,0.56,0.51,-0.08,-0.14,0.2,0.08,-0.68,-0.42,-0.15,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P84103,SRSF3,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)",17,65.9,33.41,32.98,32.43,33.31,34.09,33.64,32.81,33.35,33.47,32.5,31.95,32.99,32.95,33.07,0.34,-0.09,-0.64,0.24,1.02,0.58,-0.26,0.28,0.4,-0.56,-1.11,-0.08,-0.12,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;nucleoplasm,,,,,,,,,,
Q08170,SRSF4,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",20,32.4,29.25,28.61,29.05,28.66,27.43,27.37,27.05,27.41,28.22,28.5,26.35,,,27.99,1.26,0.62,1.06,0.67,-0.56,-0.62,-0.94,-0.58,0.23,0.51,-1.64, , ,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;nucleoplasm,,,,,,,,,,
Q13243,SRSF5,"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)",7,26.1,28.88,28.15,28.47,28.66,28.51,28.59,27.57,28.12,28.51,28.58,27.49,26.51,28.02,28.16,0.72,-0.01,0.31,0.5,0.35,0.43,-0.59,-0.03,0.36,0.42,-0.67,-1.64,-0.14,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of cell cycle;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent;transport",cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q13247,SRSF6,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",14,28.2,29.82,29.34,30.71,29.28,30.45,29.42,27.93,28.31,29.41,29.49,28.52,25.59,28.78,29.01,0.81,0.33,1.71,0.28,1.45,0.42,-1.07,-0.7,0.41,0.48,-0.48,-3.42,-0.22,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent;transport",cell part;nucleoplasm,,,,,,,,,,
Q16629,SRSF7,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)",22,57.1,32.92,32.09,31.93,31.91,32.83,32.86,32.04,32.37,33.01,32.31,31.02,31.39,32.32,32.23,0.69,-0.14,-0.3,-0.32,0.6,0.63,-0.19,0.14,0.78,0.08,-1.21,-0.84,0.09,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;nucleoplasm,,,,,,,,,,
Q13242,SRSF9,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",19,73.3,31.36,31.47,29.43,31.06,31.24,31.54,30.43,30.93,31.89,30.72,30.53,29.65,31.43,30.9,0.46,0.58,-1.47,0.16,0.35,0.64,-0.47,0.03,0.99,-0.18,-0.37,-1.24,0.53,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing;transcription termination, DNA-dependent;transport",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,,,,,,,,,
P05455,SSB,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),41,64.5,33.18,32.04,32.9,32.42,31.38,31.66,31.9,31.4,31.9,31.83,31.18,31.68,31.47,31.92,1.27,0.12,0.98,0.5,-0.54,-0.26,-0.02,-0.52,-0.02,-0.09,-0.74,-0.23,-0.44,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q04837,SSBP1,"Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) (PWP1-interacting protein 17)",17,75.7,31.14,32.3,32.66,31.53,32.47,32.15,31.88,31.49,32.34,32.38,31.97,28.46,32,31.75,-0.61,0.55,0.9,-0.22,0.72,0.4,0.13,-0.26,0.58,0.63,0.22,-3.29,0.25,anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),19,21.8,27.5,25.59,27.31,22.26,27.55,27.46,27.75,25.12,27.71,28.65,27.97,24.67,27.45,26.69,0.81,-1.1,0.62,-4.43,0.86,0.77,1.06,-1.57,1.02,1.96,1.28,-2.02,0.76,,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q8TE77,SSH3,Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L),13,25.8,27.35,25.51,23.53,24.45,25.76,26.3,25.61,27.53,25.24,,28.45,29.7,24.39,26.15,1.2,-0.64,-2.62,-1.71,-0.39,0.15,-0.54,1.38,-0.91, ,2.3,3.55,-1.76,biological regulation;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein dephosphorylation;protein metabolic process;protein modification process;regulation of organelle organization,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,+,,,,,,,
P43307,SSR1,Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha),6,30.4,31.39,31.82,31.22,31.64,31.49,31.9,31.41,30.8,32.01,31.12,31.52,31.31,32.54,31.55,-0.16,0.26,-0.33,0.09,-0.06,0.35,-0.14,-0.75,0.46,-0.43,-0.04,-0.24,0.99,biological regulation;biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;regulation of protein modification process;translation;transport,cell part;membrane,,,,,,,,,,
P51571,SSR4,Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta),9,43.4,32.23,32.75,31.77,32.57,33.33,33.19,32.65,32.64,33.33,33.28,31.91,32,33.58,32.71,-0.48,0.04,-0.94,-0.14,0.62,0.47,-0.06,-0.07,0.62,0.57,-0.8,-0.71,0.87,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;translation;transport,cell part;macromolecular complex;protein complex;Sec61 translocon complex,,,,,,,,,,
Q08945,SSRP1,FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160),35,46.8,31.88,30.85,30.98,30.94,31.96,31.79,31.4,31.68,31.71,30.75,29.76,30.31,30.84,31.14,0.74,-0.29,-0.16,-0.2,0.82,0.65,0.26,0.53,0.57,-0.39,-1.38,-0.84,-0.3,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transcription elongation, DNA-dependent",cell part;chromosome;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,HMG-box,,,,,,,,,
P30874,SSTR2,Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1),2,17.7,25.24,26.22,30.58,25.74,25.46,25.51,,27.28,26.09,26.23,,,,26.48,-1.24,-0.26,4.09,-0.75,-1.02,-0.98, ,0.8,-0.39,-0.26, , , ,anatomical structure development;biological regulation;cellular process;developmental process;digestion;multicellular organismal process;muscle contraction;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;signal transduction,cell part;cytoplasm,,,,,,,,,,
P50502,ST13,Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein),18,50.4,31.84,31.89,32.27,32.22,32,31.15,32.21,32.48,30.71,31.55,32.34,32.7,30.88,31.87,-0.02,0.02,0.41,0.36,0.14,-0.72,0.35,0.62,-1.15,-0.31,0.48,0.83,-0.98,biological regulation;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process,cell part;cytoplasm;cytosol;macromolecular complex;protein complex,,,,,,,,,,
Q1ET63,ST1A5,Phenol sulfotransferase 1A5*4,15,69.2,28.03,30.61,30.2,28.86,27.03,24.01,29.17,28.57,25.52,24.25,28.08,32.08,26.65,27.93,0.1,2.68,2.27,0.93,-0.9,-3.92,1.24,0.64,-2.4,-3.68,0.15,4.16,-1.28,,,,,,,,,,,,
Q11201,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (Alpha 2,3-ST 1) (Beta-galactoside alpha-2,3-sialyltransferase 1) (EC 2.4.99.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (SIATFL) (ST3Gal I) (ST3GalI) (ST3GalA.1) (ST3O) (Sialyltransferase 4A) (SIAT4-A)",5,20,27.55,26.44,25.27,26.77,27.81,27.87,27.71,27.13,27.86,26.12,28.28,27.86,28.61,27.33,0.22,-0.89,-2.06,-0.56,0.48,0.54,0.38,-0.2,0.53,-1.21,0.95,0.53,1.28,amine metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;phosphorus metabolic process;polysaccharide metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;protein phosphorylation;sulfur compound metabolic process,cell part;extracellular region;membrane,,,,,,,,,,
Q9UNP4,ST3GAL5,"Lactosylceramide alpha-2,3-sialyltransferase (EC 2.4.99.9) (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase) (Ganglioside GM3 synthase) (ST3Gal V) (ST3GalV) (Sialyltransferase 9)",5,15.4,,,,25.08,24.82,27.67,27.55,26.89,25.72,,27.42,27.8,28.2,26.8, , , ,-1.72,-1.97,0.88,0.76,0.09,-1.07, ,0.63,1,1.4,biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;membrane,,,,,,,,,,
Q9BQD2,STA6,"Signal transducer and activator of transcription 6, interleukin-4 induced",11,20,29.69,28.49,28.09,28.8,27.16,26.93,26.94,28.2,27.26,27.78,28.93,28.72,26.92,27.99,1.69,0.5,0.09,0.81,-0.83,-1.06,-1.06,0.21,-0.73,-0.21,0.94,0.72,-1.07,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8WVM7,STAG1,Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1),4,5.4,26.57,25.02,24.58,26.09,25.03,25.33,,24.6,,,,22.78,25.29,25.03,1.54,-0.01,-0.45,1.05,0,0.3, ,-0.43, , , ,-2.25,0.25,cell cycle;cellular component organization;cellular process;chromosome segregation;cytokinesis;mitosis;mitotic cell cycle;nuclear division;organelle fission;organelle organization,cell part;cytosol;nucleoplasm,,,,,,,,,,
Q8N3U4,STAG2,Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2),8,8.8,29.96,30.04,27.7,30.69,27.48,28.22,27.1,26.63,27.99,28.09,31.88,25.72,31.66,28.71,1.26,1.34,-1.01,1.98,-1.23,-0.48,-1.6,-2.08,-0.71,-0.61,3.17,-2.98,2.95,biological regulation;cell cycle;cellular component organization;cellular process;chromosome organization;cytokinesis;developmental process;meiosis;mitosis;mitotic cell cycle;nuclear division;organelle fission;organelle organization;regulation of cell cycle;regulation of DNA metabolic process,cell part;cytosol;nucleoplasm,,,,,,,,,,
Q92783,STAM,Signal transducing adapter molecule 1 (STAM-1),8,30.8,28.54,28.56,27.89,28.63,24.48,,28.29,27.38,27.86,27.81,27.43,30.03,27.13,27.84,0.7,0.72,0.05,0.8,-3.35, ,0.45,-0.46,0.03,-0.03,-0.4,2.19,-0.7,biological regulation;cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;membrane,,,,+,,,,,,
O75886,STAM2,Signal transducing adapter molecule 2 (STAM-2) (Hrs-binding protein),7,14.3,26.39,26.43,28.95,27.91,26.88,26.35,28.01,26.63,27.77,26.23,28.18,27.77,26.39,27.22,-0.83,-0.79,1.72,0.69,-0.35,-0.87,0.79,-0.59,0.55,-0.99,0.96,0.54,-0.83,biological regulation;cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
O95630,STAMBP,STAM-binding protein (EC 3.4.19.-) (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase),5,22,27.02,27.26,26.23,26.08,,,27.19,26.22,26.21,25.23,26.26,28.49,,26.62,0.4,0.64,-0.39,-0.54, , ,0.57,-0.4,-0.41,-1.39,-0.36,1.87, ,biological regulation;cellular metabolic process;cellular process;cytokinesis;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;response to stimulus;signal transduction,cell part;cytoplasm;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P49675,STAR,"Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1)",2,12.6,24.42,25.27,23.82,24.38,25.55,26.46,25.96,26.4,26.58,,,27.68,,25.65,-1.23,-0.38,-1.83,-1.27,-0.1,0.81,0.31,0.75,0.93, , ,2.03, ,alcohol metabolic process;anatomical structure development;behavior;biological regulation;biosynthetic process;cellular aromatic compound metabolic process;cellular homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;establishment of localization;heterocycle metabolic process;homeostatic process;hormone metabolic process;lipid metabolic process;lipid transport;macromolecule metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;protein metabolic process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;rhythmic process;secondary metabolic process;small molecule metabolic process;toxin metabolic process;transport;xenobiotic metabolic process,cell body;cell part;cell projection;cytosol;neuron projection;neuronal cell body,,,,,,,,,,
P42224,STAT1,Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84),40,54.4,32.15,32.51,34.02,33.81,31.24,30.39,31.42,32.25,30.48,29.63,31.22,32.33,28.8,31.56,0.59,0.96,2.46,2.25,-0.32,-1.17,-0.14,0.69,-1.08,-1.93,-0.34,0.78,-2.76,anatomical structure development;biological regulation;blood circulation;cell differentiation;cell proliferation;cellular process;circulatory system process;developmental process;immune system process;interspecies interaction between organisms;multicellular organismal process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cell projection;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;neuron projection;nucleolus;nucleoplasm;organelle,transcription factor STAT family,,,,,,,,,
P52630,STAT2,Signal transducer and activator of transcription 2 (p113),15,20.7,26.92,28.6,28.99,30.06,25.77,24.53,26.49,27.04,27.13,25.66,26.24,28.43,,27.15,-0.23,1.44,1.84,2.9,-1.38,-2.63,-0.67,-0.11,-0.02,-1.49,-0.91,1.27, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;immune system process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;cytosol;membrane;nucleoplasm;plasma membrane,transcription factor STAT family,,,,,,,,,
P40763,STAT3,Signal transducer and activator of transcription 3 (Acute-phase response factor),28,45.9,31.94,30.25,31.15,31.23,30.17,29.53,30.38,30.57,28.62,29.38,30.37,31.12,28.66,30.26,1.68,0,0.89,0.97,-0.09,-0.73,0.12,0.31,-1.64,-0.88,0.11,0.86,-1.6,behavior;biological regulation;cell differentiation;cell proliferation;cellular component movement;cellular metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;interspecies interaction between organisms;metabolic process;multicellular organismal process;multi-organism process;nuclear transport;nucleocytoplasmic transport;phosphorus metabolic process;protein targeting;protein transport;reproduction;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cytosol;membrane;nucleoplasm;plasma membrane,transcription factor STAT family,,,,,,,,,
O95793,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19,50.2,31.08,29.53,30.03,30.17,29.4,29.55,30.67,30.38,29.8,29.13,30.36,30.26,29.89,30.02,1.06,-0.49,0.01,0.15,-0.62,-0.47,0.66,0.36,-0.22,-0.89,0.34,0.25,-0.13,cellular localization;cellular process;localization,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9NUL3,STAU2,Double-stranded RNA-binding protein Staufen homolog 2,5,19,24.85,,25.18,24.69,24.68,,26.97,27.21,25.36,25.95,23.3,,,25.36,-0.51, ,-0.17,-0.66,-0.68, ,1.62,1.85,0.01,0.6,-2.05, , ,establishment of localization;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
O95210,STBD1,Starch-binding domain-containing protein 1 (Genethonin-1),7,24.6,26.7,27.65,24.59,26.25,25.84,26.73,,26.87,,26.44,26.42,,26.33,26.38,0.31,1.27,-1.79,-0.14,-0.54,0.35, ,0.49, ,0.06,0.04, ,-0.05,multicellular organismal process;muscle contraction,cell part,,,,,,,,,,
Q658P3,STEAP3,Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6) (hTSAP6) (pHyde) (hpHyde),3,8.2,27.75,26.86,24.49,25.9,25.32,,25.45,26.3,27.52,,,,,26.2,1.55,0.66,-1.71,-0.3,-0.88, ,-0.74,0.1,1.32, , , , ,biological regulation;cell cycle;cell death;cellular homeostasis;cellular ion homeostasis;cellular process;death;establishment of localization;homeostatic process;ion transport;protein transport;secretion;transmembrane transport;transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q13586,STIM1,Stromal interaction molecule 1,16,24.8,28.93,28.87,28.53,28.59,28.1,28.08,27.63,27.37,29.69,30.1,29.46,28.15,29.28,28.68,0.25,0.2,-0.15,-0.08,-0.58,-0.59,-1.05,-1.31,1.01,1.42,0.79,-0.52,0.6,biological regulation;coagulation;detection of stimulus;establishment of localization;ion transport;multicellular organismal process;regulation of body fluid levels;regulation of transport;response to chemical stimulus;response to stimulus;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
P31948,STIP1,Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521),49,63.7,33.46,32.77,32.58,33.17,33.15,32.64,33.16,33.48,31.91,32.21,33.08,32.81,32.55,32.84,0.61,-0.08,-0.27,0.33,0.31,-0.2,0.31,0.64,-0.93,-0.64,0.24,-0.03,-0.29,locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
O94804,STK10,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),12,16.6,22.77,27.47,28.15,27.52,25.86,,28.22,27.54,26.51,25.31,28.36,28.16,,26.9,-4.13,0.57,1.25,0.62,-1.04, ,1.32,0.64,-0.39,-1.59,1.46,1.27, ,biological adhesion;biological regulation;cell adhesion;cell cycle;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;membrane;plasma membrane,,+,,,,,,,,
Q8N1F8,STK11IP,Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1),6,7.8,,24.95,25.36,23.66,,,25.98,,25.83,27.35,27.1,27.46,22.89,25.62, ,-0.67,-0.26,-1.96, , ,0.36, ,0.21,1.73,1.48,1.84,-2.73,localization,cell part;cytoplasm,,,,,,,,,,
Q9Y6E0,STK24,Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N);Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)],17,34.5,30.11,29.34,30.41,29.45,29.35,29.15,28.95,29.3,27.53,29.67,29.44,30.17,28.23,29.32,0.79,0.02,1.09,0.13,0.04,-0.16,-0.36,-0.01,-1.78,0.35,0.12,0.86,-1.08,biological regulation;cellular component disassembly;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;cytosol;membrane;nucleoplasm,,+,,,,,,,,
Q13188,STK3,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N);Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],12,32,28.74,27.14,27.39,27.06,25.65,25.2,27.09,24.64,26.04,25.72,26.26,27.52,26.41,26.53,2.21,0.61,0.86,0.53,-0.88,-1.33,0.56,-1.89,-0.48,-0.81,-0.27,0.99,-0.12,biological regulation;cell death;cellular process;death;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q15208,STK38,Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1),4,11,26.49,27.77,25.46,27.26,27.69,,26.6,27.18,24.31,25.13,27.77,27.78,,26.68,-0.19,1.1,-1.22,0.58,1.02, ,-0.07,0.5,-2.37,-1.54,1.09,1.11, ,biological regulation;cellular process;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytoplasm;histone methyltransferase complex;macromolecular complex;membrane;plasma membrane;protein complex,,+,,,,,,,,
Q9UEW8,STK39,STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39),3,7.2,28.28,27.13,26.07,27.86,29.74,26.53,27.85,28.01,26.66,26.84,26.44,27.35,24.12,27.15,1.13,-0.01,-1.07,0.71,2.59,-0.61,0.71,0.86,-0.48,-0.31,-0.7,0.21,-3.03,biological regulation;regulation of transport;response to stimulus;response to stress,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q13043,STK4,Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N);Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)],3,10.5,24.4,27.03,26.95,25.94,25.59,25.23,25.34,25.51,25.67,25.69,26.73,27.37,26.2,25.97,-1.57,1.06,0.98,-0.04,-0.38,-0.74,-0.63,-0.46,-0.3,-0.29,0.76,1.4,0.22,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell death;cell differentiation;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;death;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;response to stimulus;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
P16949,STMN1,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),16,71.8,27.58,29.46,29.53,29.25,28.57,25.45,27.01,27.35,25.36,24.83,25.76,28.8,26.86,27.37,0.21,2.09,2.16,1.88,1.2,-1.92,-0.36,-0.02,-2.01,-2.54,-1.61,1.43,-0.51,anatomical structure morphogenesis;biological regulation;cellular component disassembly;cellular component morphogenesis;cellular component organization;cellular process;cytoskeleton organization;developmental process;multi-organism process;organelle organization;protein depolymerization;regulation of organelle organization;response to biotic stimulus;response to stimulus;signal transduction,cell part;cytosol;intracellular;macromolecular complex;membrane;protein complex,,,,,,,,,,
P27105,STOM,Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin),15,68.4,27.87,29.74,29.65,30.29,32.01,31.89,31.4,30.35,30.6,27.72,30.6,28.89,32.09,30.24,-2.37,-0.5,-0.59,0.06,1.77,1.65,1.16,0.11,0.36,-2.52,0.36,-1.35,1.86,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;cytoplasm;cytoplasmic membrane-bounded vesicle;cytoskeleton;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9UJZ1,STOML2,"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)",25,62.9,30.31,32.13,31.37,30.92,32.09,32.23,31.15,31.17,31.98,32.2,31.49,31.15,31.95,31.55,-1.24,0.58,-0.18,-0.63,0.54,0.68,-0.4,-0.38,0.43,0.65,-0.06,-0.4,0.41,biological regulation;biosynthetic process;cell activation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytokine production;establishment of localization;heterocycle metabolic process;homeostatic process;hydrogen transport;immune system process;ion transport;localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;protein complex assembly;protein maturation;protein metabolic process;regulation of DNA metabolic process;regulation of organelle organization;response to stimulus;signal transduction;small molecule metabolic process;transmembrane transport;transport,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9Y3F4,STRAP,Serine-threonine kinase receptor-associated protein (MAP activator with WD repeats) (UNR-interacting protein) (WD-40 repeat protein PT-WD),17,56,32.42,31.33,31.48,32.09,32.13,31.75,32.15,32.34,31.31,31.27,31.86,31.28,31.47,31.76,0.66,-0.43,-0.28,0.33,0.37,-0.01,0.39,0.58,-0.45,-0.49,0.1,-0.48,-0.29,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleus;organelle;plasma membrane;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q96SI9,STRBP,Spermatid perinuclear RNA-binding protein,6,9.4,28.52,28.14,,27.17,27.09,27.55,26.06,26.82,27.99,27.49,,,25.7,27.25,1.27,0.88, ,-0.08,-0.17,0.3,-1.2,-0.43,0.74,0.24, , ,-1.55,anatomical structure development;behavior;cell development;cellular component movement;cellular process;developmental process;multicellular organismal development;multicellular organismal process;response to abiotic stimulus;response to external stimulus;response to stimulus,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q5VSL9,STRIP1,Striatin-interacting protein 1 (Protein FAM40A),11,16.7,24.92,25.29,26.25,,,22.65,24.28,,,26.5,26.94,25.62,23.03,25.05,-0.13,0.24,1.2, , ,-2.41,-0.77, , ,1.44,1.89,0.57,-2.02,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43815,STRN,Striatin,14,31.8,30.08,29.25,29.61,29.17,29.08,28.6,29.58,29.7,28.81,29.47,29.47,29.73,29.14,29.36,0.72,-0.11,0.25,-0.19,-0.28,-0.76,0.22,0.34,-0.55,0.11,0.11,0.37,-0.22,anatomical structure development;behavior;biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;developmental process;response to stimulus;signal transduction,cell body;cell part;cytoplasm;membrane;neuronal cell body,,,,,,,,,,
Q13033,STRN3,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),9,16.2,28.8,28.24,27.48,28.02,26.87,26.61,28.58,28.36,28.04,28.84,28.85,28.27,27.1,28,0.8,0.24,-0.52,0.02,-1.14,-1.4,0.58,0.36,0.03,0.83,0.85,0.26,-0.91,biological regulation;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell body;cell part;cell projection;cytoplasm;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;neuronal cell body;nucleoplasm;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9NRL3,STRN4,Striatin-4 (Zinedin),3,6.8,26.44,24.77,,26.18,,25.27,25.98,26.39,24.38,,26.83,26.94,26.87,26.01,0.44,-1.24, ,0.18, ,-0.74,-0.02,0.39,-1.62, ,0.83,0.94,0.86,,cell part;cell projection;cytoplasm;membrane;neuron projection,,,,,,,,,,
P46977,STT3A,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1) (Transmembrane protein TMC),17,19.7,31.83,32.24,30.01,31.41,31.15,32.42,30.77,31.25,32.43,31.17,31.81,31.56,32.06,31.55,0.28,0.69,-1.54,-0.14,-0.4,0.88,-0.77,-0.3,0.88,-0.38,0.26,0.01,0.51,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q8TCJ2,STT3B,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),23,20.9,31.2,31.47,31.07,30.81,30.54,31.98,31.12,31.26,32.17,31.72,31.41,30.98,32.08,31.37,-0.17,0.1,-0.3,-0.55,-0.83,0.61,-0.25,-0.11,0.8,0.35,0.04,-0.39,0.71,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9UNE7,STUB1,E3 ubiquitin-protein ligase CHIP (EC 6.3.2.-) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (STIP1 homology and U box-containing protein 1),16,44.9,28.97,27.77,26.12,28.7,28.32,27.36,27.94,28.51,27.24,27.99,29.08,29.14,28.2,28.1,0.87,-0.33,-1.98,0.6,0.22,-0.74,-0.16,0.41,-0.86,-0.12,0.97,1.03,0.1,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;macromolecular complex;protein complex;ubiquitin conjugating enzyme complex;ubiquitin ligase complex,,,,,,,,,,
O60499,STX10,Syntaxin-10 (Syn10),3,20.4,26.37,26.34,25.27,26.94,,,,26.11,,,26.59,,26.32,26.28,0.09,0.07,-1.01,0.67, , , ,-0.16, , ,0.31, ,0.04,cellular process;endosome transport;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q86Y82,STX12,Syntaxin-12,15,50.7,27.96,29.93,30.06,29.82,29.84,29.88,29.9,30.29,29.95,30.05,30.68,30.05,31.37,29.98,-2.03,-0.05,0.07,-0.16,-0.14,-0.1,-0.08,0.31,-0.03,0.06,0.69,0.07,1.38,biological regulation;cellular process;establishment of localization;exocytosis;lipid transport;protein transport;regulation of protein stability;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
O14662,STX16,Syntaxin-16 (Syn16),6,36.4,27.45,28.11,,27.55,27.61,27.64,27.18,27.15,28.44,26.83,27.56,26.7,27.54,27.48,-0.03,0.63, ,0.07,0.13,0.16,-0.3,-0.33,0.96,-0.65,0.08,-0.78,0.06,cellular process;endosome transport;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;protein complex,,,,,,,,,,
Q9P2W9,STX18,Syntaxin-18 (Cell growth-inhibiting gene 9 protein),10,48.1,27.55,27.5,26.54,28.3,26.37,25.67,26.87,24.71,26.86,26.95,28.07,28.45,28.02,27.07,0.49,0.44,-0.53,1.24,-0.7,-1.4,-0.2,-2.36,-0.21,-0.12,1,1.39,0.96,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q13277,STX3,Syntaxin-3,4,15.5,26.35,25.02,25.87,24.92,27.41,27.55,28.29,27.6,27.91,29.11,27.76,25.68,25.24,26.82,-0.48,-1.8,-0.95,-1.91,0.59,0.73,1.47,0.77,1.09,2.28,0.94,-1.14,-1.58,cellular component organization;cellular membrane organization;cellular process;establishment of localization;exocytosis;membrane fusion;membrane organization;neurotransmitter transport;protein transport;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;organelle;protein complex;site of polarized growth;vacuole;vesicle,,,,,,,,,,
Q12846,STX4,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),12,44.1,28.86,29.03,27,26.91,26.67,27.83,27.42,27.44,28.14,28.22,26.7,26.12,27.72,27.54,1.32,1.49,-0.54,-0.63,-0.88,0.28,-0.13,-0.1,0.6,0.68,-0.85,-1.42,0.17,cell activation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;Golgi vesicle transport;membrane organization;neurotransmitter transport;protein transport;transport;vesicle-mediated transport,cell part;cell surface;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;vacuole;vesicle,,,,,,,,,,
Q13190,STX5,Syntaxin-5,8,38.6,29.22,27.84,28.25,29.16,27.35,28.84,28.85,28.41,29.83,28.19,28.29,29.51,28.68,28.65,0.57,-0.81,-0.4,0.51,-1.3,0.2,0.2,-0.24,1.18,-0.45,-0.36,0.86,0.03,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;Golgi vesicle transport;membrane fusion;membrane organization;organelle fusion;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
O43752,STX6,Syntaxin-6,7,23.9,27.25,28.35,26.64,25.67,27.96,25.85,26.35,27.33,28.07,,,27.89,,27.13,0.11,1.21,-0.49,-1.47,0.83,-1.28,-0.78,0.19,0.93, , ,0.75, ,cellular component organization;cellular membrane organization;cellular process;endosome organization;endosome transport;establishment of localization;Golgi vesicle transport;membrane fusion;membrane organization;organelle fusion;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
O15400,STX7,Syntaxin-7,13,52.7,28.99,28.73,29.4,29.3,28.29,27.94,29.23,29.18,28.71,28.85,29.01,25.55,28.16,28.57,0.42,0.16,0.84,0.74,-0.27,-0.63,0.66,0.62,0.15,0.28,0.45,-3.01,-0.4,cellular process;establishment of localization;exocytosis;Golgi vesicle transport;protein transport;secretion;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9UNK0,STX8,Syntaxin-8,7,41.9,25.72,27.03,26.71,26.14,27.93,27.16,25.99,27.17,25.62,26.48,26.67,26.66,27.46,26.67,-0.95,0.35,0.04,-0.53,1.25,0.49,-0.68,0.5,-1.05,-0.19,0,-0.01,0.79,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane fusion;membrane organization;organelle fusion;organelle organization;transport;vacuolar transport;vesicle organization;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
P61764,STXBP1,Syntaxin-binding protein 1 (MUNC18-1) (N-Sec1) (Protein unc-18 homolog 1) (Unc18-1) (Protein unc-18 homolog A) (Unc-18A) (p67),11,24.2,25.08,26.54,26.24,26.82,24.48,24.61,26.86,26.62,26.74,21.6,28.46,27.53,25.71,25.95,-0.87,0.59,0.3,0.87,-1.46,-1.34,0.91,0.67,0.8,-4.34,2.51,1.59,-0.24,biological adhesion;biological regulation;cell adhesion;cell communication;cell-cell signaling;cellular component organization;cellular metabolic process;cellular process;developmental maturation;developmental process;energy reserve metabolic process;establishment of localization;exocytosis;generation of precursor metabolites and energy;membrane docking;metabolic process;neurotransmitter transport;organelle organization;protein transport;regulation of protein stability;regulation of transport;secretion;signaling;small molecule metabolic process;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
Q15833,STXBP2,Syntaxin-binding protein 2 (Protein unc-18 homolog 2) (Unc18-2) (Protein unc-18 homolog B) (Unc-18B),23,46.1,30.38,30.14,30.32,29.15,29.53,28.62,29.69,30.17,29.91,29.77,32.23,30.55,29.8,30.02,0.36,0.12,0.3,-0.87,-0.49,-1.4,-0.33,0.15,-0.11,-0.25,2.21,0.53,-0.22,biological regulation;cell activation;cell killing;cellular process;establishment of localization;exocytosis;immune system process;membrane docking;protein transport;regulation of transport;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole;vesicle,,,,,,,,,,
O00186,STXBP3,Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C),13,21.5,29.84,30.24,29.21,28.97,28.6,29.3,29.2,28.38,29.57,30.05,29.92,29.65,29.45,29.41,0.43,0.83,-0.2,-0.45,-0.82,-0.12,-0.22,-1.03,0.16,0.64,0.51,0.23,0.03,biological adhesion;biological regulation;cell activation;cell adhesion;cellular component assembly;cellular component organization;cellular membrane organization;cellular process;establishment of localization;exocytosis;immune system process;macromolecular complex assembly;membrane docking;membrane organization;protein complex assembly;protein transport;regulation of transport;secretion;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
P53999,SUB1,Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14),14,74,32.27,30.73,31.92,30.7,30.12,30.16,30.31,30.29,30.16,30.51,28.95,30.79,30.15,30.54,1.72,0.18,1.38,0.16,-0.42,-0.39,-0.24,-0.25,-0.38,-0.03,-1.59,0.24,-0.39,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex;transcription factor complex,Other TF domain,,,,,,,,,
B7ZAF6,SUCLA2,"Succinate-CoA ligase, ADP-forming, beta subunit, isoform CRA_d (cDNA, FLJ79170, highly similar to Succinyl-CoA ligase (ADP-forming) beta-chain, mitochondrial (EC 6.2.1.5))",23,52.8,30.84,31.91,31.38,30.84,31.78,31.88,31.53,31.58,31.42,32.47,31.9,31.38,32.39,31.64,-0.79,0.27,-0.26,-0.8,0.14,0.24,-0.11,-0.06,-0.22,0.83,0.26,-0.26,0.75,,,,,,,,,,,,
Q6IAL5,SUCLG1,Putative uncharacterized protein tmp_locus_1 (SUCLG1 protein),11,40.8,31.39,31.35,31.34,30.69,31.09,31.47,31.01,31.05,31.18,31.23,30.77,30.64,30.59,31.06,0.33,0.29,0.28,-0.37,0.02,0.41,-0.05,-0.01,0.11,0.17,-0.29,-0.42,-0.48,cellular ketone metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;organic acid metabolic process;small molecule metabolic process,cell part;macromolecular complex;membrane;protein complex;tricarboxylic acid cycle enzyme complex,,,,,,,,,,
Q96I99,SUCLG2,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG)",25,53.7,30.8,31.11,32.24,30.62,31.3,32.03,30.74,31,31.41,31.55,31.62,31,31.35,31.29,-0.49,-0.18,0.95,-0.67,0.01,0.74,-0.55,-0.29,0.13,0.26,0.33,-0.29,0.07,catabolic process;cellular metabolic process;cellular process;cofactor metabolic process;metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q8IX01,SUGP2,"SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)",9,12.7,26.49,26.56,24.45,25.69,27.31,27.45,27.07,26.21,27.22,26.73,25.16,27.32,25.52,26.4,0.09,0.16,-1.95,-0.7,0.91,1.05,0.67,-0.19,0.82,0.33,-1.24,0.92,-0.88,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y2Z0,SUGT1,Suppressor of G2 allele of SKP1 homolog (Protein 40-6-3) (Sgt1),18,44.7,29.47,30.03,29.76,31.26,30.09,29.37,30.93,30.79,30.26,29.7,31.22,30.37,29.46,30.21,-0.74,-0.18,-0.45,1.05,-0.11,-0.84,0.72,0.58,0.05,-0.51,1.01,0.16,-0.74,biological regulation;cellular component organization;cellular process;immune system process;mitosis;nuclear division;organelle fission;organelle organization;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
P50225,SULT1A1,Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST),6,30.2,26.24,31.01,30.02,29.45,24.94,26.35,28.41,28.04,,,26.88,32.17,24.59,28.01,-1.77,3,2.01,1.44,-3.07,-1.66,0.4,0.03, , ,-1.13,4.16,-3.42,alcohol metabolic process;amine metabolic process;biological regulation;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;hormone metabolic process;lipid metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;secondary metabolic process;small molecule metabolic process;sulfur compound metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q8NBK3,SUMF1,Sulfatase-modifying factor 1 (EC 1.8.99.-) (C-alpha-formylglycine-generating enzyme 1),4,22.5,26.12,26.55,,27.7,25.3,27.77,25.3,,25.04,28.72,26.84,,27.59,26.69,-0.57,-0.14, ,1,-1.4,1.07,-1.39, ,-1.65,2.03,0.15, ,0.9,cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;small molecule metabolic process,cell part,,,,,,,,,,
Q8NBJ7,SUMF2,Sulfatase-modifying factor 2 (C-alpha-formylglycine-generating enzyme 2),13,43.5,28.93,31.77,29.65,31.05,31.05,31.72,30.18,30.62,31.18,31.38,31.15,31.3,31.44,30.88,-1.95,0.89,-1.23,0.17,0.17,0.85,-0.7,-0.26,0.3,0.5,0.27,0.43,0.56,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,cell part,,,,,,,,,,
P63165,SUMO1,Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1),6,49.5,29.39,28.15,29.58,27.76,28.61,28.85,28.43,28.72,29.24,28.84,28.04,24.34,29.01,28.38,1.01,-0.23,1.2,-0.62,0.23,0.47,0.05,0.34,0.86,0.46,-0.34,-4.04,0.63,anatomical structure development;biological regulation;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;localization;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleus organization;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cell projection;cytoplasm;macromolecular complex;membrane;neuron projection;nuclear pore;protein complex;synapse,,,,,,,,,,
P61956,SUMO2,Small ubiquitin-related modifier 2 (SUMO-2) (HSMT3) (SMT3 homolog 2) (SUMO-3) (Sentrin-2) (Ubiquitin-like protein SMT3A) (Smt3A),3,36.6,26.89,26.37,26.18,26.02,27.08,29.02,26.12,29.6,26.19,25,24.89,,,26.67,0.22,-0.3,-0.49,-0.65,0.41,2.35,-0.55,2.93,-0.47,-1.67,-1.78, , ,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part,,,,,,,,,,
O94901,SUN1,SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1),16,28,30.66,28.78,28.21,28.53,27.15,29.04,28.36,27.2,29.9,29.38,26.68,26.54,28.94,28.41,2.24,0.37,-0.2,0.12,-1.26,0.63,-0.05,-1.21,1.49,0.97,-1.73,-1.87,0.53,biological regulation;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;membrane organization;nucleus organization;organelle organization,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9UH99,SUN2,SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein) (Rab5IP) (Sad1/unc-84 protein-like 2),24,49.7,29.62,30.5,29.4,30.85,31.56,31.97,30.98,30.25,32.36,30.83,28.77,29.97,30.68,30.6,-0.98,-0.1,-1.2,0.26,0.96,1.37,0.39,-0.35,1.77,0.24,-1.82,-0.63,0.09,biological regulation;cellular component movement;cellular component organization;cellular localization;cellular membrane organization;cellular process;cytoskeleton organization;establishment of localization;localization;membrane organization;nucleus organization;organelle localization;organelle organization,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9Y5B9,SUPT16H,FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16),42,34.7,32.43,31.41,31.74,31.54,31.92,32.4,31.96,31.38,32.13,31.16,30.54,31.74,31.61,31.69,0.74,-0.28,0.05,-0.15,0.23,0.71,0.27,-0.31,0.44,-0.53,-1.15,0.05,-0.08,"biological regulation;biosynthetic process;cellular component disassembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;DNA metabolic process;DNA repair;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transcription elongation, DNA-dependent",cell part;chromosome;intracellular non-membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
O75486,SUPT3H,Transcription initiation protein SPT3 homolog (SPT3-like protein),2,7.6,22.21,22.22,24.4,22.84,20.85,24.34,25.2,23.55,24.5,25.62,22.63,24.45,23.86,23.59,-1.38,-1.37,0.82,-0.75,-2.74,0.75,1.61,-0.04,0.91,2.03,-0.96,0.86,0.27,"biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;RNA metabolic process;transcription from RNA polymerase II promoter;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
P63272,SUPT4H1,Transcription elongation factor SPT4 (hSPT4) (DRB sensitivity-inducing factor 14 kDa subunit) (DSIF p14) (DRB sensitivity-inducing factor small subunit) (DSIF small subunit),3,27.4,28.53,,,,28.59,26.07,27.19,26.8,,25.79,24.57,,27.63,26.9,1.63, , , ,1.69,-0.83,0.29,-0.1, ,-1.1,-2.32, ,0.73,"biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
O00267,SUPT5H,Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein),19,26.6,30.55,28.81,29.86,28.7,27.73,28.32,28.89,28.27,29.59,29.16,26.88,29.03,28.8,28.81,1.74,0,1.05,-0.12,-1.09,-0.5,0.08,-0.54,0.77,0.35,-1.93,0.22,-0.01,"biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to chemical stimulus;response to stimulus;RNA metabolic process;RNA processing;transcription elongation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
Q7KZ85,SUPT6H,Transcription elongation factor SPT6 (hSPT6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),32,26.1,30.68,27.37,28.74,29.3,29.42,30.29,29.62,27.72,28.62,28.37,28.54,29.19,29.59,29.03,1.64,-1.66,-0.3,0.26,0.39,1.25,0.59,-1.31,-0.41,-0.67,-0.5,0.15,0.56,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8IYB8,SUPV3L1,"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)",10,18.1,27.15,28.98,25.98,28.22,27.62,27.23,26.97,27.38,27.97,28.48,26.13,25.78,26.35,27.25,-0.1,1.73,-1.27,0.97,0.37,-0.02,-0.28,0.13,0.72,1.23,-1.12,-1.47,-0.9,anatomical structure morphogenesis;biological regulation;catabolic process;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA recombination;macromolecule metabolic process;metabolic process;mitochondrion organization;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing,cell part;exosome (RNase complex);intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q15526,SURF1,Surfeit locus protein 1,3,11.5,25.48,27.29,26.83,26.57,27.7,27.71,26.28,26.61,26.43,27.65,27.88,26.4,27.66,26.96,-1.48,0.33,-0.14,-0.39,0.74,0.75,-0.68,-0.35,-0.53,0.69,0.92,-0.56,0.7,biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;heterocycle metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;protein complex assembly;small molecule metabolic process,cell part,,,,,,,,,,
O15260,SURF4,Surfeit locus protein 4,6,38.4,29.79,32.17,30.45,31.33,31,31.8,31.22,31.09,32.24,31.43,31.57,31.39,32.36,31.37,-1.58,0.8,-0.92,-0.04,-0.37,0.43,-0.15,-0.28,0.86,0.05,0.2,0.01,0.99,biological regulation;cellular component organization;cellular process;Golgi organization;organelle organization;regulation of organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O95425,SVIL,Supervillin (Archvillin) (p205/p250),59,40.8,30.79,26.36,30.38,26.08,28.62,28.4,29.19,26.94,29.45,32.64,28.49,25.81,27.85,28.54,2.25,-2.18,1.84,-2.46,0.09,-0.14,0.65,-1.6,0.91,4.1,-0.05,-2.73,-0.69,anatomical structure development;cellular component organization;cellular process;cytoskeleton organization;developmental process;organelle organization,cell part;cell projection;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q9UH65,SWAP70,Switch-associated protein 70 (SWAP-70),11,25.5,26.94,27.1,27.8,26.88,28.32,27.06,29.21,28.85,26.75,26.88,27.11,26.66,26.7,27.4,-0.46,-0.31,0.39,-0.53,0.91,-0.34,1.81,1.45,-0.65,-0.52,-0.3,-0.74,-0.71,cell activation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q96A49,SYAP1,Synapse-associated protein 1,20,52,26.98,28.89,28.91,29.99,29.51,29.45,29.82,30.66,29.47,28.75,29.39,27.69,29.12,29.13,-2.15,-0.23,-0.22,0.87,0.38,0.32,0.7,1.53,0.35,-0.37,0.26,-1.44,0,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q92797,SYMPK,Symplekin,17,15.4,29.23,27.82,28.29,28.93,28.18,28.8,28.46,27.42,29.07,29.06,27.23,28.77,28.26,28.42,0.81,-0.61,-0.13,0.5,-0.25,0.37,0.03,-1,0.65,0.63,-1.19,0.35,-0.17,biological adhesion;biological regulation;cell adhesion;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein modification process;RNA metabolic process;RNA processing,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleoplasm;organelle;plasma membrane,,,,,,,,,,
O60506,SYNCRIP,"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)",42,63.2,34.25,33.73,33.39,33.73,34.25,33.74,34.09,33.74,34.17,33.71,33.44,33.69,33.36,33.79,0.46,-0.06,-0.4,-0.06,0.46,-0.05,0.3,-0.05,0.38,-0.08,-0.35,-0.1,-0.43,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to chemical stimulus;response to stimulus;RNA metabolic process;RNA processing;RNA splicing,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q8WXH0,SYNE2,Nesprin-2 (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),132,24.3,32.61,28.69,30.47,29.15,29.08,28.57,29.18,28.59,30.33,33.8,29.36,28.34,28.32,29.73,2.88,-1.04,0.74,-0.58,-0.65,-1.16,-0.55,-1.14,0.6,4.07,-0.37,-1.39,-1.41,biological regulation;cell motility;cellular component movement;cellular component organization;cellular localization;cellular membrane organization;cellular process;cytoskeleton organization;establishment of localization;establishment or maintenance of cell polarity;localization;locomotion;membrane organization;organelle localization;organelle organization,cell part;cytoskeleton;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleoplasm;organelle;protein complex,,,,,,,,,,
O43760,SYNGR2,Synaptogyrin-2 (Cellugyrin),4,16.5,28.33,27.57,27.07,23.7,25.4,25.98,24.71,26.73,25.6,27.98,25.98,,25.06,26.18,2.15,1.4,0.89,-2.47,-0.77,-0.19,-1.47,0.55,-0.57,1.8,-0.2, ,-1.11,establishment of localization;protein targeting;protein transport;transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
P57105,SYNJ2BP,Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25),6,40,28.06,28,28.91,28.99,29.25,29.67,29.37,28.82,30.79,31.19,28.66,29.29,30.67,29.36,-1.3,-1.36,-0.45,-0.37,-0.1,0.31,0.01,-0.54,1.43,1.83,-0.7,-0.07,1.31,biological regulation;cellular component organization;cellular localization;cellular process;localization;mitochondrion organization;organelle localization;organelle organization;regulation of transport,cell part;cell surface;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8N3V7,SYNPO,Synaptopodin,18,32.5,25.03,28.34,24.57,24.37,29.19,28.71,29.55,25.24,30.02,24.67,28.78,26.54,30.09,27.32,-2.29,1.03,-2.75,-2.94,1.88,1.39,2.24,-2.08,2.71,-2.65,1.47,-0.77,2.78,biological regulation;regulation of organelle organization,cell part;cell projection;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;neuron projection;organelle;plasma membrane,,,,,,,,,,
Q16563,SYPL1,Synaptophysin-like protein 1 (Pantophysin),5,19.6,30.14,29.94,30.01,29.87,29.12,30.01,29.28,29,30.65,29.92,30.2,29.8,30.67,29.89,0.25,0.05,0.12,-0.02,-0.78,0.12,-0.61,-0.89,0.75,0.02,0.3,-0.09,0.78,cell communication;cell-cell signaling;cellular process;signaling,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
O75410,TACC1,Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1),14,20.5,26.69,24.8,27.32,25.7,26.76,27.67,27.54,27.6,27.66,25.64,26.89,27.79,27.37,26.88,-0.19,-2.08,0.44,-1.18,-0.12,0.79,0.66,0.72,0.78,-1.24,0.01,0.91,0.49,anatomical structure development;biological regulation;cell cycle;cell differentiation;cell division;cellular component organization;cellular localization;cellular process;cytoskeleton organization;developmental process;localization;organelle localization;organelle organization,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleus;organelle,,,,,,,,,,
O95359,TACC2,Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1),16,7.7,27.05,20.06,22.6,21.02,27.33,24.55,27.32,27.85,22.04,20.82,27.22,,,24.35,2.7,-4.29,-1.75,-3.33,2.98,0.2,2.96,3.5,-2.31,-3.53,2.87, , ,anatomical structure development;biological regulation;cell differentiation;cellular component organization;cellular localization;cellular process;cytoskeleton organization;developmental process;localization;organelle localization;organelle organization,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleolus;organelle,,,,,,,,,,
Q9BSH4,TACO1,Translational activator of cytochrome c oxidase 1 (Coiled-coil domain-containing protein 44) (Translational activator of mitochondrially-encoded cytochrome c oxidase I),9,42.1,27.82,29.65,25.97,29.15,28.82,29.12,28.7,28.61,28.64,28.83,28.15,27.19,28.38,28.39,-0.56,1.26,-2.42,0.77,0.44,0.74,0.31,0.22,0.25,0.45,-0.24,-1.2,0,biological regulation;regulation of translation,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P09758,TACSTD2,Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1),10,33.1,30.9,29.75,30.46,26.72,27.66,26.3,,29.44,,,,,27.61,28.61,2.3,1.15,1.85,-1.88,-0.95,-2.31, ,0.84, , , , ,-1,anatomical structure morphogenesis;biological regulation;cell proliferation;cellular process;developmental process;multicellular organismal process;neurological system process;regulation of organelle organization;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q92804,TAF15,TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56),15,26.1,31.56,31.1,31.78,31.61,31.9,32.25,31.92,31.69,32.41,32.18,31.03,31.12,31.79,31.72,-0.16,-0.62,0.06,-0.11,0.18,0.54,0.21,-0.03,0.69,0.46,-0.69,-0.6,0.07,biological regulation,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P49848,TAF6,Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80),5,9.7,26.03,24.35,24.18,25.73,25.14,26.42,28.37,,26.49,23.85,,,,25.62,0.42,-1.27,-1.44,0.11,-0.48,0.8,2.75, ,0.87,-1.77, , , ,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent",cell part;cytoplasm;histone methyltransferase complex;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q9HBM6,TAF9B,Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7) (DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L),4,23.5,20.67,20.97,23.36,20.06,25.61,25.36,23.98,20.23,26.41,25.54,18.44,18.99,25.03,22.67,-2,-1.69,0.69,-2.6,2.95,2.7,1.31,-2.43,3.74,2.87,-4.23,-3.68,2.37,"biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to stimulus;RNA metabolic process;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex;transcription factor complex,,,,,,,,,,
Q01995,TAGLN,Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha) (SM22-alpha),20,88.1,31.79,32.22,30.65,33.59,30.03,29.12,31.88,31,28.3,28.56,30.61,33.05,29.41,30.78,1,1.43,-0.13,2.8,-0.76,-1.66,1.09,0.21,-2.48,-2.23,-0.17,2.26,-1.38,anatomical structure development;developmental process,cell part;cytoplasm,,,,,,,,,,
P37802,TAGLN2,Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog),27,98,34.89,34.26,34.27,34.53,33.93,33.41,34.29,34.42,33.56,32.62,34.67,34.17,32.76,33.98,0.91,0.27,0.29,0.55,-0.06,-0.58,0.31,0.43,-0.42,-1.36,0.69,0.19,-1.22,anatomical structure development;developmental process,,,,,,,,,,,
P37837,TALDO1,Transaldolase (EC 2.2.1.2),25,53.4,33.54,33.18,33.44,32.56,32.65,33.11,32.82,33.16,33.49,32.84,32.29,31.05,33.31,32.88,0.66,0.3,0.56,-0.32,-0.23,0.23,-0.06,0.28,0.61,-0.04,-0.59,-1.83,0.43,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular aldehyde metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;energy reserve metabolic process;generation of precursor metabolites and energy;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q96BW9,TAMM41,"Mitochondrial translocator assembly and maintenance protein 41 homolog (TAM41) (MMP37-like protein, mitochondrial)",5,16.6,26.83,27.77,25.06,27.33,26.32,28.16,26.69,26.14,28.43,28.21,25.7,27.96,28.08,27.13,-0.3,0.64,-2.07,0.2,-0.81,1.03,-0.44,-0.99,1.3,1.08,-1.43,0.83,0.95,cellular process;establishment of localization;protein targeting;protein transport;transmembrane transport;transport,cell part,,,,,,,,,,
Q7L7X3,TAOK1,Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1),5,6.7,26.73,26.8,26.84,26.92,27.76,27.03,27.18,27.24,26.1,26.66,26.48,25.2,26.69,26.74,-0.02,0.06,0.1,0.18,1.02,0.29,0.44,0.5,-0.64,-0.08,-0.26,-1.54,-0.05,biological regulation;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of cell cycle;regulation of organelle organization;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytosol,,+,,,,,,,,
Q03518,TAP1,Antigen peptide transporter 1 (APT1) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein),17,28.2,30.98,30.77,32.22,30.32,29,28.05,28.52,28.59,29.55,30.68,29.02,27.48,28.41,29.5,1.48,1.26,2.71,0.81,-0.51,-1.46,-0.99,-0.92,0.05,1.18,-0.48,-2.03,-1.1,biological regulation;establishment of localization;immune system process;interspecies interaction between organisms;multi-organism process;protein transport;response to stimulus;response to stress;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;plasma membrane;protein complex,,,,,,,,,,
Q03519,TAP2,Antigen peptide transporter 2 (APT2) (ATP-binding cassette sub-family B member 3) (Peptide supply factor 2) (Peptide transporter PSF2) (PSF-2) (Peptide transporter TAP2) (Peptide transporter involved in antigen processing 2) (Really interesting new gene 11 protein),18,30.5,31.49,31.02,32.78,30.25,29.16,28.85,28.8,28.77,29.9,30.85,29.52,28.33,29.36,29.93,1.56,1.09,2.86,0.32,-0.77,-1.08,-1.13,-1.16,-0.03,0.92,-0.4,-1.6,-0.57,biological regulation;establishment of localization;immune system process;interspecies interaction between organisms;multi-organism process;peptide transport;protein transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
O15533,TAPBP,Tapasin (TPN) (TPSN) (NGS-17) (TAP-associated protein) (TAP-binding protein),9,30.6,30.95,30.97,30.61,29.89,29.9,28.56,28.54,28.8,29.76,30.25,28.72,27.81,27.78,29.43,1.52,1.54,1.19,0.47,0.47,-0.86,-0.89,-0.62,0.33,0.83,-0.71,-1.61,-1.65,cellular component assembly;cellular component organization;cellular metabolic process;cellular process;establishment of localization;Golgi vesicle transport;immune system process;macromolecular complex assembly;metabolic process;peptide metabolic process;protein complex assembly;response to stimulus;response to stress;transport;vesicle-mediated transport,cell part;macromolecular complex;membrane;MHC class I peptide loading complex;protein complex,,,,,,,,,,
Q15633,TARBP2,RISC-loading complex subunit TARBP2 (TAR RNA-binding protein 2) (Trans-activation-responsive RNA-binding protein),2,9,26.01,25.15,25.38,26.63,26.21,25.78,25.19,24.21,22.83,24.75,25.43,25.78,24.29,25.2,0.81,-0.05,0.18,1.43,1.01,0.58,-0.02,-0.99,-2.37,-0.45,0.22,0.57,-0.91,biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein modification process;regulation of translation;response to chemical stimulus;response to stimulus;ribonucleoprotein complex assembly;RNA metabolic process;RNA processing,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;RNAi effector complex,,,,,,,,,,
Q13148,TARDBP,TAR DNA-binding protein 43 (TDP-43),15,32.9,31.37,31,31.02,30.69,31.29,31,30.63,30.58,30.88,29.95,29.66,29.78,29.66,30.58,0.8,0.42,0.44,0.11,0.71,0.43,0.05,0,0.3,-0.62,-0.92,-0.8,-0.91,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
P26639,TARS,"Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)",33,48.4,32.17,31.89,31.24,32.56,30.86,30.25,31.97,31.57,30.66,30.3,31.6,32.14,28.74,31.23,0.94,0.66,0.01,1.33,-0.37,-0.97,0.74,0.35,-0.57,-0.92,0.37,0.91,-2.48,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9BW92,TARS2,"Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like 1)",10,16,27.5,29,27.23,25.85,26.94,27.39,26.25,26.37,28.01,27.81,25.28,27.78,27.68,27.16,0.34,1.84,0.07,-1.31,-0.22,0.23,-0.91,-0.79,0.85,0.65,-1.88,0.62,0.52,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
Q6P1N9,TATDN1,Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein),6,26.3,28.3,27.44,25.09,27.67,25.43,,25.35,,,,25.11,,,26.34,1.96,1.1,-1.26,1.33,-0.91, ,-0.99, , , ,-1.23, , ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O14907,TAX1BP3,Tax1-binding protein 3 (Glutaminase-interacting protein 3) (Tax interaction protein 1) (TIP-1) (Tax-interacting protein 1),3,39.5,27.35,28.07,26.81,28.86,27.33,27.68,29.25,29.51,27.88,27.72,29.53,29.74,27.9,28.28,-0.93,-0.21,-1.47,0.58,-0.94,-0.6,0.97,1.23,-0.39,-0.56,1.25,1.46,-0.38,biological regulation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q4KMP7,TBC1D10B,TBC1 domain family member 10B (Rab27A-GAP-beta),5,11.5,25.24,26.28,25.21,25.31,,,24.96,24.47,24.89,,26.25,24.45,,25.23,0.01,1.05,-0.02,0.08, , ,-0.27,-0.76,-0.34, ,1.02,-0.78, ,,cell part;cytoplasm,,,,,,,,,,
Q9NVG8,TBC1D13,TBC1 domain family member 13,3,13.5,23.04,25.25,23.14,26,24.89,25.23,25.71,27.14,24.33,24.67,27.04,26.82,25.01,25.25,-2.21,0,-2.11,0.75,-0.36,-0.03,0.46,1.89,-0.92,-0.58,1.78,1.57,-0.24,biological regulation,cell part;intracellular,,,,,,,,,,
Q8TC07,TBC1D15,TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP),10,17.8,28.92,29.24,26.92,27.99,25.73,27.51,28.12,27.52,27.16,24.73,27.86,27.61,26.11,27.34,1.58,1.9,-0.42,0.65,-1.61,0.17,0.78,0.18,-0.18,-2.61,0.52,0.27,-1.23,,cell part;cytoplasm;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9BYX2,TBC1D2,TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1) (PARIS-1),11,14.3,,27.13,27.08,28.49,27.88,,29.27,29.53,27.62,25.84,28.76,29.64,27.64,28.08, ,-0.95,-1,0.41,-0.2, ,1.19,1.45,-0.46,-2.24,0.68,1.56,-0.44,,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle;vesicle,,,,,,,,,,
Q9NUY8,TBC1D23,TBC1 domain family member 23 (HCV non-structural protein 4A-transactivated protein 1),10,21.6,28.07,28.81,27.56,28.53,26.93,27.75,28.83,27.61,28.07,26.66,26.77,28.2,28.01,27.83,0.24,0.98,-0.27,0.69,-0.9,-0.08,1,-0.22,0.24,-1.17,-1.06,0.37,0.18,biological regulation,cell part;intracellular,,,,,,,,,,
Q9UPU7,TBC1D2B,TBC1 domain family member 2B,6,6.2,22.3,24.41,25.1,23.45,23.79,24.35,23.85,23.95,23.36,,25.76,27.17,23.14,24.22,-1.92,0.19,0.88,-0.77,-0.43,0.13,-0.37,-0.27,-0.86, ,1.54,2.95,-1.08,biological regulation,cell part;intracellular,,,,,,,,,,
Q92609,TBC1D5,TBC1 domain family member 5,10,15.6,23.46,25.61,25.73,24.07,,,26.73,25,25.3,25.96,25.71,25.89,23.61,25.19,-1.73,0.42,0.54,-1.12, , ,1.55,-0.18,0.11,0.78,0.52,0.7,-1.58,biological regulation,cell part;intracellular;macromolecular complex;protein complex;retromer complex,,,,,,,,,,
Q66K14,TBC1D9B,TBC1 domain family member 9B,13,13.7,27.23,27.34,26.92,25.67,25.02,,25.21,25.61,,,27.25,28.02,24.9,26.32,0.91,1.03,0.61,-0.65,-1.3, ,-1.1,-0.71, , ,0.93,1.7,-1.42,biological regulation,cell part;intracellular,,,,,,,,,,
O75347,TBCA,Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA),12,78.6,29.73,30.44,30.95,30.79,30.25,29.22,30.27,30.1,27.29,29.2,30.51,30.94,27.28,29.77,-0.03,0.68,1.19,1.03,0.48,-0.54,0.5,0.33,-2.48,-0.57,0.74,1.17,-2.48,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;protein complex,,,,,,,,,,
Q99426,TBCB,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),13,52,30.16,28.15,29.53,29.37,29.48,27.6,30.7,30.75,29.23,28.14,29.75,29.01,25.48,29.03,1.14,-0.88,0.51,0.34,0.45,-1.43,1.67,1.72,0.2,-0.88,0.73,-0.02,-3.55,anatomical structure development;cell differentiation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q15814,TBCC,Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC),6,21.7,26.19,24,23.44,26.17,,24.92,26.28,22.72,25.72,,25.81,25.88,22.68,24.89,1.3,-0.89,-1.45,1.28, ,0.03,1.39,-2.17,0.83, ,0.92,0.99,-2.22,anatomical structure morphogenesis;cell morphogenesis;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cell projection;cilium;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9BTW9,TBCD,Tubulin-specific chaperone D (Beta-tubulin cofactor D) (tfcD) (SSD-1) (Tubulin-folding cofactor D),11,14.2,27.23,26.31,24.46,27.69,27.58,26.89,29.12,28.91,27.13,24.77,29.3,30.25,24.39,27.23,0,-0.92,-2.77,0.45,0.34,-0.35,1.89,1.68,-0.1,-2.47,2.07,3.02,-2.84,biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;regulation of organelle organization,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q15813,TBCE,Tubulin-specific chaperone E (Tubulin-folding cofactor E),10,26.8,25.87,26.38,26.81,28.51,26.78,25.16,28.81,28.57,26.06,,27.91,29.47,23.07,26.95,-1.08,-0.57,-0.14,1.56,-0.17,-1.79,1.86,1.62,-0.89, ,0.96,2.52,-3.88,anatomical structure morphogenesis;behavior;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;developmental process;growth;macromolecule metabolic process;metabolic process;multicellular organismal process;muscle adaptation;organelle organization;post-embryonic development;primary metabolic process;protein folding;protein metabolic process;response to stimulus,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q9BZK7,TBL1XR1,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),16,39.1,31.5,29.24,29.54,29.48,30.11,29.34,27.97,28.81,29.61,29.54,23.98,27.55,28.01,28.82,2.68,0.42,0.71,0.66,1.29,0.52,-0.85,-0.01,0.78,0.72,-4.84,-1.27,-0.81,biological regulation;biosynthetic process;catabolic process;cellular component organization;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;lipid metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;macromolecular complex;protein complex;transcriptional repressor complex,,,,,,,,,,
Q9Y4P3,TBL2,Transducin beta-like protein 2 (WS beta-transducin repeats protein) (WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein),19,54,30.39,30.99,30.57,30.68,30.65,31.36,30.36,29.97,31.3,31.35,30.48,28.59,31.3,30.61,-0.22,0.38,-0.05,0.07,0.04,0.74,-0.26,-0.65,0.69,0.73,-0.13,-2.03,0.69,,,,,,,,,,,,
Q12788,TBL3,Transducin beta-like protein 3 (WD repeat-containing protein SAZD),22,37.4,29.51,28.82,30.32,28.92,30.56,29.85,29.81,29.2,29.97,29.46,28.5,28.23,29.32,29.42,0.09,-0.6,0.89,-0.5,1.14,0.43,0.38,-0.22,0.55,0.04,-0.92,-1.19,-0.1,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;rRNA processing;signal transduction,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;preribosome;ribonucleoprotein complex,,,,,,,,,,
Q969Z0,TBRG4,Protein TBRG4 (Cell cycle progression restoration protein 2) (Cell cycle progression protein 2) (FAST kinase domain-containing protein 4) (Transforming growth factor beta regulator 4),10,26.3,28.87,29.63,27.74,29.15,29.26,29.46,29.4,29.49,29.63,29.93,28.71,28.66,30.25,29.24,-0.37,0.39,-1.5,-0.1,0.01,0.22,0.15,0.24,0.38,0.68,-0.53,-0.58,1,biological regulation;cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
E7ENP0,TBXAS1,Thromboxane-A synthase,8,23.1,24.84,30.03,28.63,25.52,26.17,25.84,,,27.48,26.86,,27.26,25.95,26.86,-2.02,3.18,1.77,-1.34,-0.69,-1.02, , ,0.62,0.01, ,0.4,-0.91,,,,,,,,,,,,
P23193,TCEA1,Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o),13,46.2,30.3,28.42,29.44,29.4,29.42,29.37,29.39,29.19,29.18,29.11,26.63,26.59,28.72,28.86,1.44,-0.43,0.58,0.54,0.56,0.51,0.53,0.33,0.32,0.25,-2.23,-2.27,-0.14,"biological regulation;biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transcription elongation, DNA-dependent",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,Other TF domain,,,,,,,,,
Q969E4,TCEAL3,Transcription elongation factor A protein-like 3 (TCEA-like protein 3) (Transcription elongation factor S-II protein-like 3),9,41.5,27.01,27.96,27.94,27.58,21.29,,24.16,,24.76,,25.74,26.6,22.19,25.52,1.49,2.44,2.41,2.06,-4.24, ,-1.37, ,-0.76, ,0.22,1.08,-3.34,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q15369,TCEB1,Transcription elongation factor B polypeptide 1 (Elongin 15 kDa subunit) (Elongin-C) (EloC) (RNA polymerase II transcription factor SIII subunit C) (SIII p15),9,83.1,30.88,30.37,31.04,30.95,31.27,30.74,30.71,31.36,30.08,30.46,30.2,30.01,30.05,30.62,0.26,-0.26,0.42,0.33,0.65,0.11,0.08,0.73,-0.55,-0.17,-0.43,-0.61,-0.57,"biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q15370,TCEB2,Transcription elongation factor B polypeptide 2 (Elongin 18 kDa subunit) (Elongin-B) (EloB) (RNA polymerase II transcription factor SIII subunit B) (SIII p18),9,60.2,31.2,31.14,31.67,31.25,29.52,30.84,30.43,31.08,29.94,29.14,31.21,30.41,29.48,30.56,0.64,0.58,1.1,0.68,-1.04,0.28,-0.13,0.52,-0.62,-1.42,0.65,-0.15,-1.08,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q14241,TCEB3,Transcription elongation factor B polypeptide 3 (Elongin 110 kDa subunit) (Elongin-A) (EloA) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110),7,10.5,23.92,,25.75,,28.93,28.24,25.43,27.73,29.12,,25,25.84,24.96,26.49,-2.57, ,-0.74, ,2.43,1.75,-1.06,1.23,2.63, ,-1.49,-0.65,-1.53,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent",cell part;nucleoplasm,,,,,,,,,,
O14776,TCERG1,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),27,27.1,31.19,30,30.53,30.15,30.63,31.11,30.49,29.79,31.16,30.73,29.54,29.65,30.84,30.45,0.74,-0.45,0.08,-0.3,0.19,0.66,0.04,-0.66,0.71,0.28,-0.91,-0.79,0.4,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BQ70,TCF25,Transcription factor 25 (TCF-25) (Nuclear localized protein 1),4,11.2,,24.42,25.03,25.9,26.9,25.63,25.97,,25.69,26.57,26.36,26.7,26.27,25.95, ,-1.53,-0.92,-0.05,0.95,-0.32,0.03, ,-0.26,0.62,0.41,0.75,0.32,anatomical structure development;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;nucleolus;organelle,Other TF domain,,,,,,,,,
Q13488,TCIRG1,V-type proton ATPase 116 kDa subunit a isoform 3 (V-ATPase 116 kDa isoform a3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3),17,19.6,28.18,30.5,30.22,29.92,30.66,31.2,29.42,30.17,29.5,30.6,31.58,30.09,31.83,30.3,-2.12,0.2,-0.08,-0.38,0.36,0.9,-0.88,-0.12,-0.8,0.3,1.28,-0.21,1.54,biological regulation;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular process;establishment of localization;homeostatic process;hydrogen transport;interspecies interaction between organisms;ion transport;multi-organism process;organelle organization;protein transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;response to stress;signal transduction;transmembrane transport;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;protein complex,,,,,,,,,,
Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),37,29,29.83,28.7,29.27,29.1,28.83,27.62,28.99,29.01,28.86,28.7,26.85,28,28.31,28.62,1.21,0.08,0.65,0.48,0.21,-1,0.37,0.39,0.24,0.08,-1.77,-0.62,-0.31,anatomical structure development;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase I promoter,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P17987,TCP1,T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha),39,68.9,32.94,33.12,32.7,33.5,33.7,32.92,33.44,33.62,32.6,33.07,33.75,33.52,32.69,33.2,-0.26,-0.08,-0.5,0.3,0.5,-0.28,0.25,0.42,-0.6,-0.13,0.55,0.33,-0.5,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process,cell part;centrosome;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;nucleus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q86YL5,TDRP,Testis development-related protein (Protein INM01),2,21.1,26.86,25.85,,27.16,,,27.55,,25.87,,27.63,24.23,,26.45,0.4,-0.6, ,0.71, , ,1.1, ,-0.58, ,1.18,-2.22, ,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P28347,TEAD1,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),2,6.6,26.64,26.15,26.05,26.26,24.88,,26.84,25.49,26.28,23.41,,,,25.78,0.86,0.37,0.27,0.48,-0.9, ,1.07,-0.29,0.51,-2.37, , , ,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;nucleoplasm,Other TF domain,,,,,,,,,
Q9NZ01,TECR,"Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)",14,27.3,32.21,30.91,30.57,31.35,30.56,31.23,30.48,30.57,31.66,31.51,30.75,28.7,31.32,30.91,1.3,0,-0.34,0.45,-0.35,0.32,-0.43,-0.34,0.75,0.6,-0.16,-2.21,0.41,biosynthetic process;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;cofactor metabolic process;glycerol ether metabolic process;lipid metabolic process;metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part,,,,,,,,,,
Q96QE5,TEFM,"Transcription elongation factor, mitochondrial",2,8.1,25.07,,,25.57,,25.8,,,26.7,26.32,,24.57,27.3,25.91,-0.83, , ,-0.33, ,-0.1, , ,0.8,0.42, ,-1.34,1.39,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;mitochondrion organization;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;ribonucleoprotein complex,,,,,,,,,,
Q15554,TERF2,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),5,14.6,26.12,25.25,26.91,24.5,26.32,24.89,26.15,24.79,26.07,26.46,24.32,,24.99,25.56,0.56,-0.31,1.34,-1.07,0.76,-0.68,0.58,-0.78,0.5,0.89,-1.24, ,-0.57,aging;biological regulation;biosynthetic process;cell cycle;cellular component organization;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;DNA metabolic process;DNA replication;embryo development;homeostatic process;localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of DNA metabolic process;regulation of organelle organization;response to DNA damage stimulus;response to stimulus;response to stress;telomere organization,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;nucleus;organelle;telomere cap complex,,,,,,,,,,
Q9NXF1,TEX10,Testis-expressed sequence 10 protein,20,26.2,28.91,29.56,29.05,28.95,28.88,29.84,29.13,28.79,29.93,29.94,27.89,28.88,29.17,29.15,-0.24,0.41,-0.1,-0.2,-0.26,0.7,-0.02,-0.35,0.78,0.79,-1.26,-0.27,0.03,,cell part;cytoplasm;histone methyltransferase complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;protein complex,,,,,,,,,,
Q9Y6I9,TEX264,Testis-expressed sequence 264 protein (Putative secreted protein Zsig11),4,13.7,25.94,28.62,25.58,27.56,27.42,27.66,28.13,27.53,28.36,28.09,27.72,27.89,28.63,27.62,-1.68,0.99,-2.05,-0.07,-0.21,0.03,0.51,-0.09,0.74,0.46,0.09,0.27,1.01,,extracellular region,,,,,,,,,,
Q00059,TFAM,"Transcription factor A, mitochondrial (mtTFA) (Mitochondrial transcription factor 1) (MtTF1) (Transcription factor 6) (TCF-6) (Transcription factor 6-like 2)",10,30.1,29.99,30.43,29.06,29.57,30.27,30.74,29.92,30.34,30.49,29.77,29.12,29.47,29.61,29.91,0.08,0.52,-0.84,-0.33,0.36,0.83,0.02,0.43,0.58,-0.14,-0.79,-0.43,-0.3,"biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;transcription initiation, DNA-dependent",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,HMG-box,,,,,,,,,
Q8WVM0,TFB1M,"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (h-mtTFB) (h-mtTFB1) (hTFB1M) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)",10,44.2,28.13,24.65,,27.48,28.67,28.85,28.35,28.78,29.01,29.17,26.98,26.08,28.35,27.87,0.26,-3.23, ,-0.4,0.8,0.98,0.47,0.91,1.13,1.29,-0.89,-1.8,0.47,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;rRNA processing;small molecule metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,Other TF domain,,,,,,,,,
Q9H5Q4,TFB2M,"Dimethyladenosine transferase 2, mitochondrial (EC 2.1.1.-) (Hepatitis C virus NS5A-transactivated protein 5) (HCV NS5A-transactivated protein 5) (Mitochondrial 12S rRNA dimethylase 2) (Mitochondrial transcription factor B2) (h-mtTFB) (h-mtTFB2) (hTFB2M) (mtTFB2) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2)",5,14.9,27.23,26.7,27.85,27.42,26.49,26.67,27.19,27.13,27.87,26.8,25.3,,26.56,26.93,0.3,-0.24,0.92,0.49,-0.44,-0.26,0.25,0.19,0.94,-0.13,-1.64, ,-0.38,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription initiation, DNA-dependent",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q12800,TFCP2,Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF),5,17.1,28.02,26.25,25.57,26.87,25.34,25.7,27.26,26.61,25.42,26.19,25.82,26.17,24.82,26.16,1.87,0.09,-0.59,0.72,-0.82,-0.46,1.1,0.45,-0.74,0.04,-0.34,0.01,-1.33,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,DNA binding region,,,,,,,,,
Q92734,TFG,Protein TFG (TRK-fused gene protein),14,52.1,31.57,30.41,31.54,30.94,30.55,29.99,30.34,31.46,29.4,29.55,31.76,30.93,30.23,30.67,0.9,-0.26,0.87,0.28,-0.12,-0.68,-0.33,0.79,-1.26,-1.11,1.09,0.26,-0.44,biological regulation;cell death;cellular process;death,cell part;cytoplasm,,,,,,,,,,
Q9UBB9,TFIP11,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),10,15.3,27.9,26.11,28.63,26.09,26.81,27.19,,27.68,24.94,26.33,27.47,,,26.92,0.99,-0.8,1.71,-0.82,-0.11,0.28, ,0.77,-1.97,-0.59,0.56, , ,anatomical structure development;biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;extracellular matrix;macromolecular complex;proteinaceous extracellular matrix;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P48307,TFPI2,Tissue factor pathway inhibitor 2 (TFPI-2) (Placental protein 5) (PP5),12,52.2,23.57,27.9,22.27,30.13,28.31,30.05,28.28,27.65,31.63,28.01,29.09,,29.65,28.05,-4.47,-0.14,-5.77,2.08,0.26,2.01,0.23,-0.4,3.59,-0.04,1.04, ,1.61,biological regulation;coagulation;multicellular organismal process;regulation of body fluid levels,extracellular matrix;proteinaceous extracellular matrix,,,,,,,,,,
P02786,TFRC,"Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]",42,50.9,32.96,34.49,34.3,34.21,33.37,33.18,32.26,32.91,32.99,34.51,32.36,34.41,32.35,33.41,-0.45,1.08,0.89,0.81,-0.04,-0.23,-1.15,-0.49,-0.42,1.1,-1.05,1,-1.06,biological regulation;cell differentiation;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;establishment of localization;homeostatic process;interspecies interaction between organisms;ion transport;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein transport;proteolysis;transmembrane transport;transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;extracellular organelle;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
O43294,TGFB1I1,Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5),6,26.9,,24.98,23,28.76,26.18,24.62,25.64,26.72,25.97,,23.77,26.69,24.52,25.53, ,-0.55,-2.53,3.23,0.65,-0.91,0.11,1.19,0.44, ,-1.76,1.15,-1.01,anatomical structure morphogenesis;biological adhesion;biological regulation;biosynthetic process;catabolic process;cell adhesion;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;response to abiotic stimulus;response to heat;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription from RNA polymerase II promoter,cell part;cytoplasm;cytoskeleton;intracellular;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q15582,TGFBI,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP),17,31,25.26,30.71,27.93,31.3,30.88,31.28,28.08,30.89,28.97,27.76,25.72,29.26,30.29,29.1,-3.84,1.61,-1.17,2.2,1.78,2.17,-1.02,1.79,-0.13,-1.34,-3.38,0.16,1.19,anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell proliferation;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;multicellular organismal process;neurological system process;response to stimulus,cell part;extracellular matrix;extracellular organelle;extracellular space;membrane;organelle;plasma membrane;proteinaceous extracellular matrix;vesicle,,,,,,,,,,
P37173,TGFBR2,TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II),9,19.2,23.03,26.14,,27.15,28.09,28.38,26.98,24.87,27.41,,25.94,24.72,29.5,26.56,-3.54,-0.42, ,0.59,1.52,1.81,0.41,-1.69,0.85, ,-0.62,-1.85,2.94,aging;anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cell activation;cell death;cell differentiation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;death;developmental process;embryo development;endocytosis;establishment of localization;immune system process;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;peptidyl-amino acid modification;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;protein complex;receptor complex,,+,,,,,,,,
P21980,TGM2,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase-2) (TGase-2),52,65.8,33.76,33.94,33.92,34.08,35.34,35.53,35.88,36.33,34.4,34.54,36.86,32.83,34.88,34.79,-1.03,-0.85,-0.87,-0.71,0.55,0.74,1.09,1.54,-0.39,-0.25,2.07,-1.97,0.09,anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component organization;cellular homeostasis;cellular ion homeostasis;cellular membrane organization;cellular metabolic process;cellular process;developmental process;endocytosis;establishment of localization;homeostatic process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multicellular organismal process;peptidyl-amino acid modification;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;tissue remodeling;transport;vesicle-mediated transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle;plasma membrane,,,,,,,,,,
O43493,TGOLN2,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),17,38.9,27.15,28.03,29.81,27.77,26.59,26.62,26.99,25.01,26.93,27.17,27.14,28.17,27.86,27.33,-0.17,0.71,2.49,0.44,-0.74,-0.7,-0.33,-2.32,-0.4,-0.15,-0.19,0.84,0.53,,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane;vesicle,,,,,,,,,,
P07996,THBS1,Thrombospondin-1,25,21.4,28.07,29.98,30.55,28.53,31.22,31.23,30.32,30.78,31.64,31.64,29.73,26.21,31.45,30.1,-2.03,-0.12,0.45,-1.58,1.11,1.12,0.22,0.68,1.53,1.54,-0.38,-3.9,1.34,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell motility;cellular component movement;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of cell cycle;regulation of protein modification process;regulation of translation;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to heat;response to stimulus;response to stress;secretion;transport;vesicle-mediated transport,cell part;extracellular matrix;extracellular organelle;macromolecular complex;organelle;protein complex;vesicle,,,,,,,,,,
P35442,THBS2,Thrombospondin-2,7,8.8,,27.84,21.1,26.64,25.33,25.57,24.36,24.57,,23.95,25.95,25.56,23.04,24.9, ,2.94,-3.8,1.74,0.43,0.67,-0.54,-0.33, ,-0.95,1.05,0.66,-1.86,biological adhesion;biological regulation;cell adhesion;cellular process,extracellular region,,,,,,,,,,
Q8WUY1,THEM6,Protein THEM6 (Mesenchymal stem cell protein DSCD75) (Thioesterase superfamily member 6),7,43.8,29.34,27.87,26.6,28.04,27.91,27.8,26.51,26.1,26.06,28.85,27,24.79,27.82,27.28,2.06,0.59,-0.69,0.75,0.63,0.52,-0.77,-1.19,-1.22,1.56,-0.29,-2.49,0.54,,extracellular region,,,,,,,,,,
Q5TEJ8,THEMIS2,Protein THEMIS2 (Induced by contact to basement membrane 1 protein) (Protein ICB-1) (Thymocyte-expressed molecule involved in selection protein 2),10,20.8,26.05,28.69,27.59,25.77,,,,,24.68,,26.87,,26.44,26.58,-0.53,2.1,1.01,-0.82, , , , ,-1.9, ,0.29, ,-0.14,biological adhesion;cell adhesion;cellular process;response to stimulus;response to stress,,,,,,,,,,,
Q9NWX6,THG1L,Probable tRNA(His) guanylyltransferase (EC 2.7.7.79) (Interphase cytoplasmic foci protein 45) (tRNA-histidine guanylyltransferase),2,12.7,23.75,25.24,25.83,25.87,23.35,24.39,25.52,26.2,25.18,27.25,26.22,27.51,24.24,25.43,-1.68,-0.18,0.41,0.44,-2.07,-1.03,0.09,0.78,-0.25,1.82,0.79,2.08,-1.18,cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;RNA metabolic process;RNA modification;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96FV9,THOC1,THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) (p84N5) (hTREX84),12,22.7,29.38,28.64,29.16,28.49,29.96,29.59,29.32,28.72,29.29,29.83,28.81,29.62,28.86,29.21,0.17,-0.56,-0.04,-0.71,0.75,0.39,0.11,-0.49,0.09,0.62,-0.39,0.41,-0.35,biological regulation;biosynthetic process;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;RNA splicing;signal transduction;transport,cell part;cytoplasm;macromolecular complex;protein complex;THO complex,Other TF domain,,,,,,,,,
Q8NI27,THOC2,THO complex subunit 2 (Tho2) (hTREX120),18,13.8,28.94,27.77,27.15,28.12,28.21,29.45,28.85,27.47,29.4,29.14,26.31,25.4,29.34,28.12,0.82,-0.35,-0.97,0,0.09,1.33,0.73,-0.65,1.28,1.02,-1.81,-2.72,1.22,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;macromolecular complex;protein complex;THO complex,,,,,,,,,,
Q96J01,THOC3,THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45),4,10.3,27.59,27.38,27.35,28.09,28.52,27.43,26.19,27.24,27.89,27.18,25.91,27.29,27.57,27.36,0.23,0.02,0,0.74,1.17,0.08,-1.17,-0.11,0.53,-0.18,-1.45,-0.07,0.21,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;macromolecular complex;protein complex;transcription export complex,,,,,,,,,,
Q86W42,THOC6,THO complex subunit 6 homolog (Functional spliceosome-associated protein 35) (fSAP35) (WD repeat-containing protein 58),6,25.7,27.59,28.56,27,27.52,28.26,28.46,27.51,27.04,29.07,28.28,25.28,27.27,28.23,27.7,-0.11,0.86,-0.69,-0.18,0.56,0.76,-0.19,-0.66,1.37,0.58,-2.42,-0.42,0.53,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;macromolecular complex;protein complex;THO complex,,,,,,,,,,
Q6I9Y2,THOC7,THO complex subunit 7 homolog (Functional spliceosome-associated protein 24) (fSAP24) (Ngg1-interacting factor 3-like protein 1-binding protein 1) (NIF3L1-binding protein 1) (hTREX30),3,16.7,26.94,28.37,26.79,25.91,26.4,25.85,26.84,26.69,24.86,27.86,24.68,,,26.47,0.47,1.9,0.32,-0.57,-0.07,-0.62,0.37,0.22,-1.61,1.38,-1.79, , ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multi-organism process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transport,cell part;cytoplasm;macromolecular complex;protein complex;THO complex,,,,,,,,,,
P52888,THOP1,Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78),10,16.7,26.98,29.02,26.98,28.41,26.89,30.04,28.86,28.36,26.95,26.85,28.38,29.32,29.01,28.16,-1.18,0.86,-1.18,0.26,-1.27,1.88,0.7,0.2,-1.21,-1.3,0.22,1.16,0.86,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to stimulus;signal transduction,cell part;cytoplasm,,,,,,,,,,
Q7Z5U1,THRAP3,THRAP3 protein (Fragment),2,8,28.7,27.17,30.02,27.72,25.55,26.03,26.04,26.15,26.47,27.23,26.2,27.57,24.94,26.91,1.79,0.26,3.12,0.81,-1.35,-0.87,-0.87,-0.76,-0.43,0.33,-0.71,0.66,-1.96,,,,,,,,,,,,
Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),54,43.5,31.17,31.04,31.42,31.13,31.57,31.7,30.79,30.73,31.58,31.97,30.57,28.94,31.02,31.05,0.12,-0.01,0.37,0.09,0.53,0.65,-0.26,-0.32,0.53,0.92,-0.48,-2.11,-0.03,"biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA catabolic process;RNA metabolic process;RNA processing;RNA splicing;signal transduction;transcription initiation, DNA-dependent",cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9NXG2,THUMPD1,THUMP domain-containing protein 1,15,41.4,30.3,30.09,29.4,29.14,26.99,28.63,29.01,28.84,29.34,28.83,27.09,25.07,27.45,28.48,1.83,1.61,0.93,0.67,-1.49,0.16,0.53,0.37,0.86,0.35,-1.38,-3.41,-1.02,,,,,,,,,,,,
P04216,THY1,Thy-1 membrane glycoprotein (CDw90) (Thy-1 antigen) (CD antigen CD90),4,27.6,28.09,32.78,30.51,30.88,31.75,33.31,30.68,32.81,33.22,,32.91,29.76,33.32,31.67,-3.58,1.11,-1.16,-0.79,0.08,1.64,-0.99,1.14,1.55, ,1.24,-1.91,1.65,anatomical structure development;anatomical structure formation involved in morphogenesis;biological adhesion;biological regulation;cell adhesion;cell development;cell junction organization;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;developmental process;immune system process;organelle organization;regulation of protein modification process;regulation of transport;response to stimulus;signal transduction,cell part;cell projection;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;neuron projection;organelle;site of polarized growth,,,,,,,,,,
Q9P016,THYN1,Thymocyte nuclear protein 1 (Thymocyte protein Thy28),6,27.1,28.04,27.76,28.24,25.77,24.31,27.4,26.08,25.37,27.7,26.63,,26.07,,26.67,1.37,1.09,1.57,-0.9,-2.36,0.73,-0.59,-1.3,1.03,-0.04, ,-0.6, ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P31483,TIA1,Nucleolysin TIA-1 isoform p40 (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1) (TIA-1) (p40-TIA-1),6,23.5,28.06,26.29,27.53,26.35,25.28,27.3,26.62,24.91,26.76,26.73,24.27,26.57,,26.39,1.67,-0.11,1.14,-0.04,-1.11,0.91,0.23,-1.48,0.37,0.34,-2.12,0.18, ,biological regulation;cell death;cellular process;death;regulation of translation,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q01085,TIAL1,Nucleolysin TIAR (TIA-1-related protein),11,34,30.49,30.05,29.48,30.15,30.46,30.05,30.39,30.23,30.56,30.21,29.59,29.25,30.26,30.09,0.4,-0.04,-0.61,0.06,0.37,-0.04,0.3,0.14,0.47,0.12,-0.5,-0.84,0.17,anatomical structure development;biological regulation;cell death;cell development;cell division;cellular process;death;developmental process;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;lysosome;macromolecular complex;nucleus;organelle;ribonucleoprotein complex;vacuole,,,,,,,,,,
Q9NQ88,TIGAR,"Fructose-2,6-bisphosphatase TIGAR (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator)",3,13,26.39,25.29,,28.02,26.72,25.58,28.51,28.24,26.62,24.04,26.13,19.89,,25.95,0.44,-0.66, ,2.07,0.77,-0.36,2.56,2.29,0.67,-1.9,0.18,-6.06, ,,cell part;intracellular,,,,,,,,,,
P62072,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,2,23.3,28,27.61,26.64,27.95,27.32,28.36,27.33,24.12,27.34,27.78,27.09,27.29,28.37,27.32,0.68,0.28,-0.69,0.63,0,1.03,0.01,-3.2,0.02,0.46,-0.23,-0.03,1.04,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;multicellular organismal process;neurological system process;organelle organization;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;mitochondrial inner membrane presequence translocase complex;protein complex,,,,,,,,,,
Q9Y5J6,TIMM10B,Mitochondrial import inner membrane translocase subunit Tim10 B (Fracture callus protein 1) (FxC1) (Mitochondrial import inner membrane translocase subunit Tim9 B) (TIMM10B) (Tim10b),3,49.5,26.05,26.42,21.8,25.58,27.17,26.2,26.26,26.49,26,26.83,26.58,25.08,25.62,25.85,0.2,0.56,-4.05,-0.27,1.32,0.34,0.4,0.64,0.15,0.98,0.73,-0.77,-0.23,biological adhesion;cell adhesion;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9Y5L4,TIMM13,Mitochondrial import inner membrane translocase subunit Tim13,5,57.9,29.23,29.12,30.23,29.1,29.72,29.83,29.03,28.77,29.26,31.16,29.55,29.1,29.78,29.53,-0.3,-0.41,0.7,-0.43,0.2,0.3,-0.5,-0.76,-0.27,1.63,0.02,-0.43,0.25,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q99595,TIMM17A,Mitochondrial import inner membrane translocase subunit Tim17-A (Inner membrane preprotein translocase Tim17a),2,20,25.97,24.84,,25.42,27.41,26.05,27.17,26.78,26.68,26.84,,26.02,26.29,26.31,-0.35,-1.48, ,-0.9,1.09,-0.27,0.86,0.47,0.36,0.52, ,-0.29,-0.02,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;mitochondrial inner membrane presequence translocase complex;protein complex,,,,,,,,,,
Q9BVV7,TIMM21,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",3,9.7,26.55,21.66,24.73,23.32,27.62,27.27,26.39,26.19,26.14,27.26,26.41,27.53,25.65,25.9,0.65,-4.24,-1.17,-2.58,1.72,1.37,0.49,0.29,0.24,1.36,0.51,1.62,-0.25,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein complex biogenesis;protein metabolic process;protein targeting;protein transport;transmembrane transport;transport,cell part;macromolecular complex;mitochondrial inner membrane presequence translocase complex;protein complex,,,,,,,,,,
O14925,TIMM23,Mitochondrial import inner membrane translocase subunit Tim23,5,27.3,27.95,28,25.67,27.42,29.54,28.15,28.98,28.85,27.74,28.58,27.8,28.9,28.83,28.19,-0.24,-0.19,-2.51,-0.77,1.36,-0.03,0.79,0.67,-0.45,0.39,-0.39,0.72,0.65,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;mitochondrial inner membrane presequence translocase complex;protein complex,,,,,,,,,,
O43615,TIMM44,Mitochondrial import inner membrane translocase subunit TIM44,24,52.4,30.72,30.18,30.88,30.63,30.97,31.24,30.62,29.85,31.45,31.8,30.8,31.17,31.37,30.9,-0.17,-0.71,-0.02,-0.27,0.07,0.34,-0.28,-1.05,0.55,0.9,-0.1,0.27,0.47,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;membrane,,,,,,,,,,
Q3ZCQ8,TIMM50,Mitochondrial import inner membrane translocase subunit TIM50,11,34,30.1,29.66,28.92,29.85,30.9,30.25,29.67,29.9,30.69,29.52,29.4,29.41,30.35,29.89,0.21,-0.23,-0.97,-0.04,1.01,0.36,-0.22,0,0.8,-0.37,-0.5,-0.48,0.45,cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane organization;mitochondrion organization;organelle organization;protein targeting;protein transport;transport,cell part;macromolecular complex;mitochondrial inner membrane presequence translocase complex;protein complex,,,+,,,,,,,
O60220,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A (Deafness dystonia protein 1) (X-linked deafness dystonia protein),3,28.9,27.72,28.16,29.33,28.24,27.75,29.15,26.8,27.35,28.38,28.64,28.96,26.94,28.82,28.17,-0.46,-0.01,1.16,0.06,-0.42,0.98,-1.37,-0.82,0.21,0.46,0.79,-1.23,0.65,anatomical structure development;cellular metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;membrane,,,,,,,,,,
Q9Y5J9,TIMM8B,Mitochondrial import inner membrane translocase subunit Tim8 B (DDP-like protein) (Deafness dystonia protein 2),3,38.6,23.92,24.43,28.59,25.35,29.38,28.04,28.93,27.93,28.17,30.04,26.54,28.77,28.21,27.56,-3.64,-3.13,1.02,-2.21,1.82,0.48,1.37,0.37,0.61,2.48,-1.02,1.2,0.65,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9Y5J7,TIMM9,Mitochondrial import inner membrane translocase subunit Tim9,4,50.6,29.17,29.62,28.5,28.11,27.53,29.06,27.75,27.79,28.94,29.12,28.91,,28.7,28.6,0.57,1.02,-0.1,-0.49,-1.07,0.46,-0.85,-0.81,0.34,0.52,0.31, ,0.1,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;multicellular organismal process;neurological system process;organelle organization;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9NPL8,TIMMDC1,Translocase of inner mitochondrial membrane domain-containing protein 1 (Protein M5-14),6,41.7,27.15,27.76,27.98,27.18,26.35,27.94,27.09,25.28,27.91,27.68,25.93,26.87,25.61,26.98,0.17,0.78,1,0.2,-0.63,0.96,0.12,-1.7,0.93,0.7,-1.05,-0.11,-1.36,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P01033,TIMP1,Metalloproteinase inhibitor 1 (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1),9,83.9,26.88,32.57,30.24,32.34,30.91,32.13,29.58,30.9,28.57,,31.59,31.42,32.41,30.8,-3.92,1.78,-0.56,1.54,0.12,1.33,-1.21,0.11,-2.23, ,0.8,0.63,1.62,aging;biological regulation;cell activation;cell maturation;cellular component disassembly;cellular component organization;cellular process;developmental maturation;developmental process;establishment of localization;exocytosis;extracellular matrix organization;extracellular structure organization;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;transport;vesicle-mediated transport,cell part;extracellular region,,,,,,,,,,
P16035,TIMP2,Metalloproteinase inhibitor 2 (CSC-21K) (Tissue inhibitor of metalloproteinases 2) (TIMP-2),4,16.4,26.01,26.19,24.11,27.24,25.02,25.73,26.37,23.72,27.03,24.32,25.69,25.73,24.43,25.51,0.5,0.68,-1.39,1.73,-0.49,0.23,0.86,-1.79,1.52,-1.19,0.18,0.22,-1.08,aging;anatomical structure development;biological regulation;cellular component disassembly;cellular component organization;cellular process;developmental process;extracellular matrix organization;extracellular structure organization;regulation of cell cycle;regulation of mitotic cell cycle;response to chemical stimulus;response to drug;response to stimulus,cell body;cell part;cell surface;extracellular region;extracellular space;neuronal cell body;site of polarized growth,,,,,,,,,,
Q9GZM7,TINAGL1,Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP),10,29.8,25.46,27.22,26.4,23.2,27.55,28.77,28.62,28.39,29.27,31.18,28.92,,29.62,27.88,-2.43,-0.66,-1.48,-4.69,-0.33,0.89,0.74,0.51,1.39,3.3,1.04, ,1.73,cellular process;endosome transport;establishment of localization;immune system process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;response to stimulus;transport;vesicle-mediated transport,cell part;cytoplasm;extracellular space,,,,,,,,,,
O75663,TIPRL,TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein) (TIP),5,22.8,28.3,28.07,28.04,28.1,24.78,25.31,25.67,26.59,24.12,27.85,26.82,25.92,25.39,26.53,1.76,1.54,1.5,1.56,-1.75,-1.22,-0.86,0.05,-2.42,1.32,0.29,-0.61,-1.15,biological regulation;cellular process;regulation of cell cycle;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),38,33.1,28.42,29.64,29.42,29.81,30.7,30.08,30.99,30.06,30.54,30.86,29.14,28.79,28.47,29.76,-1.34,-0.13,-0.34,0.05,0.94,0.32,1.23,0.3,0.78,1.1,-0.63,-0.98,-1.29,anatomical structure formation involved in morphogenesis;biological regulation;cell junction organization;cellular component assembly;cellular component disassembly;cellular component organization;cellular homeostasis;cellular process;circulatory system process;developmental process;homeostatic process;multicellular organismal process;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to stimulus;signal transduction,apical part of cell;cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),55,49.6,30.37,28.21,30.12,28.91,30.5,29.55,31.23,29.91,30.01,29.93,29.62,29.92,29.51,29.83,0.54,-1.62,0.29,-0.92,0.67,-0.28,1.4,0.08,0.18,0.1,-0.21,0.09,-0.32,biological regulation;cellular component disassembly;cellular component organization;cellular process;response to stimulus;signal transduction,cell part;cytosol;membrane;nucleoplasm;plasma membrane,,,,,,,,,,
B4DZK7,TK2,"Thymidine kinase 2, mitochondrial (Thymidine kinase 2, mitochondrial, isoform CRA_a) (cDNA FLJ59102, highly similar to Thymidine kinase 2, mitochondrial (EC 2.7.1.21))",2,18.5,,24.84,,24.66,24.76,25.27,24.32,,25.9,25.06,24.38,,25.74,24.99, ,-0.15, ,-0.33,-0.23,0.28,-0.67, ,0.91,0.07,-0.61, ,0.75,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;heterocycle metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
P29401,TKT,Transketolase (TK) (EC 2.2.1.1),52,75,35.05,34.06,34.63,34.52,34.45,34.61,34.34,34.38,34.23,34.33,33.99,34.3,34.21,34.39,0.66,-0.33,0.24,0.13,0.05,0.22,-0.06,-0.01,-0.16,-0.06,-0.4,-0.09,-0.18,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular aldehyde metabolic process;cellular metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;microbody;nucleus;organelle;peroxisome,,,,,,,,,,
Q04726,TLE3,Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3) (ESG3),13,19,27.41,25.94,26.78,25.64,28.39,25.21,26.09,26.21,26.52,27.35,,26.87,25.4,26.49,0.93,-0.55,0.3,-0.85,1.91,-1.28,-0.4,-0.27,0.04,0.87, ,0.39,-1.08,anatomical structure morphogenesis;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction,cell part;nucleoplasm,,,,,,,,,,
Q9Y490,TLN1,Talin-1,176,74.2,33.6,35.47,35.49,36,35.12,35.13,35.58,35.85,34.94,33.32,35.63,36.06,34.44,35.13,-1.52,0.34,0.37,0.87,0,0.01,0.45,0.72,-0.19,-1.8,0.5,0.94,-0.68,biological adhesion;biological regulation;cell activation;cell adhesion;cell junction organization;cellular component assembly;cellular component movement;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;establishment of localization;exocytosis;locomotion;macromolecule metabolic process;metabolic process;multicellular organismal process;muscle contraction;organelle organization;primary metabolic process;protein metabolic process;regulation of protein modification process;response to chemical stimulus;response to external stimulus;response to stimulus;secretion;transport;vesicle-mediated transport,cell part;cell projection;cell surface;centrosome;cytoskeleton;cytosol;extracellular organelle;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;organelle;plasma membrane;vesicle,,,,,,,,,,
O60603,TLR2,Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282),9,15.8,28.8,27.19,28.48,23.58,24.21,,27.01,24.89,28.63,23.1,26.1,24.85,,26.08,2.72,1.11,2.4,-2.49,-1.87, ,0.93,-1.18,2.55,-2.98,0.03,-1.23, ,biological regulation;cellular metabolic process;cellular process;detection of stimulus;drug transport;establishment of localization;immune system process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cell surface;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
O15455,TLR3,Toll-like receptor 3 (CD antigen CD283),4,7.5,26.42,25.52,,26.72,,,,,,26.48,24.61,25.79,26.01,25.93,0.49,-0.42, ,0.79, , , , , ,0.54,-1.33,-0.14,0.07,biological regulation;cellular metabolic process;cellular process;detection of stimulus;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to osmotic stress;response to stimulus;response to stress;signal transduction,cell part;membrane,,,,,,,,,,
Q9NS93,TM7SF3,Transmembrane 7 superfamily member 3 (Seven span transmembrane protein),2,12.5,25.67,,,26.38,25.87,26.94,24.43,25.84,25.68,27.41,25.49,,26.92,26.06,-0.4, , ,0.32,-0.19,0.88,-1.64,-0.23,-0.39,1.35,-0.57, ,0.86,,cell part;membrane;plasma membrane,,,,,,,,,,
E9PSI1,TM9SF1,Transmembrane 9 superfamily member 1,7,11.7,28.35,29.29,28.25,28.51,28.92,29.42,28.03,28.72,29.22,28.21,30.42,29.67,29.22,28.94,-0.59,0.35,-0.69,-0.43,-0.02,0.48,-0.91,-0.23,0.28,-0.73,1.48,0.73,0.28,establishment of localization;protein transport;transport,cell part,,,,,,,,,,
Q99805,TM9SF2,Transmembrane 9 superfamily member 2 (p76),11,21.5,29.9,29.5,30.13,29.39,29.49,30.02,30.18,29.07,30.93,29.88,30.43,29.84,30.17,29.92,-0.02,-0.42,0.21,-0.52,-0.42,0.1,0.26,-0.85,1.01,-0.04,0.52,-0.08,0.25,establishment of localization;transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9HD45,TM9SF3,Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein),19,29.9,30.92,31.67,29.67,31.44,29.59,31.23,30.44,29.92,31.44,31.01,31.53,30.89,30.92,30.82,0.1,0.85,-1.15,0.62,-1.23,0.41,-0.38,-0.9,0.62,0.19,0.71,0.07,0.1,,cell part,,,,,,,,,,
Q92544,TM9SF4,Transmembrane 9 superfamily member 4,14,21.7,30.9,30.85,29.78,30.4,29.51,30.41,29.66,29.76,30.5,30.42,29.59,30.15,30.35,30.18,0.72,0.67,-0.39,0.23,-0.66,0.23,-0.52,-0.41,0.33,0.24,-0.58,-0.02,0.17,,cell part,,,,,,,,,,
F8W1G3,TMBIM6,Bax inhibitor 1 (Fragment),2,93.8,27.97,28.15,28.66,27.51,26.03,27.65,27.81,25.06,28.35,28.81,27.28,28.44,28.5,27.71,0.26,0.44,0.95,-0.2,-1.67,-0.06,0.1,-2.65,0.64,1.1,-0.43,0.73,0.79,,,,,,,,,,,,
O94876,TMCC1,Transmembrane and coiled-coil domains protein 1,5,11.9,25.46,24.53,27.19,23.58,22.65,23.82,25.12,22.51,24.65,25.65,24.82,25.48,24,24.57,0.88,-0.04,2.62,-0.99,-1.93,-0.76,0.54,-2.07,0.08,1.08,0.25,0.9,-0.57,,cell part,,,,,,,,,,
Q9ULS5,TMCC3,Transmembrane and coiled-coil domains protein 3,11,28.1,28.45,,25.47,24.3,,,24.81,25.33,27.04,26.75,25.48,25.36,25.41,25.84,2.61, ,-0.37,-1.54, , ,-1.03,-0.51,1.2,0.91,-0.36,-0.48,-0.43,,cell part,,,,,,,,,,
Q9UM00,TMCO1,Transmembrane and coiled-coil domain-containing protein 1 (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3),5,29,30.18,30.41,29.71,29.94,30.47,30.49,29.76,29.94,30.14,29.96,30.21,30.55,31.1,30.22,-0.04,0.19,-0.51,-0.28,0.25,0.27,-0.46,-0.28,-0.09,-0.26,-0.01,0.33,0.88,,cell part;membrane,,,,,,,,,,
Q13445,TMED1,Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1) (Tp24) (p24gamma1),4,18.9,28.25,28.38,25.67,26.9,27.52,27.41,27.89,27.69,27.89,27.18,26.95,28.05,27.4,27.48,0.77,0.91,-1.81,-0.58,0.05,-0.07,0.42,0.21,0.41,-0.3,-0.52,0.58,-0.07,biological regulation;cell communication;cell-cell signaling;cellular process;establishment of localization;protein transport;response to stimulus;signal transduction;signaling;transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
P49755,TMED10,Transmembrane emp24 domain-containing protein 10 (21 kDa transmembrane-trafficking protein) (S31III125) (S31I125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1) (p24delta1) (p24delta),15,47.5,32.59,33.34,31.85,32.72,32.84,32.73,32.23,32.86,32.94,32.25,32.66,31.36,32.9,32.56,0.03,0.78,-0.71,0.16,0.28,0.17,-0.33,0.3,0.39,-0.31,0.1,-1.2,0.34,anatomical structure development;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;developmental process;establishment of localization;exocytosis;Golgi organization;Golgi vesicle transport;macromolecular complex assembly;macromolecule metabolic process;metabolic process;organelle organization;protein complex assembly;protein transport;response to chemical stimulus;response to stimulus;secretion;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
Q15363,TMED2,Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1),10,54.4,30.07,31.23,29.73,29.7,28.14,28.47,28.78,27.07,30.34,30.6,29.19,24.95,25.02,28.71,1.36,2.51,1.02,0.99,-0.57,-0.24,0.07,-1.65,1.62,1.88,0.47,-3.76,-3.7,anatomical structure development;anatomical structure formation involved in morphogenesis;anatomical structure morphogenesis;biological regulation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;developmental process;establishment of localization;Golgi organization;growth;macromolecular complex assembly;multicellular organismal process;organelle organization;protein complex assembly;protein targeting;protein transport;transport;vesicle organization,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q7Z7H5,TMED4,Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3),10,50,29.88,30.52,29.75,28.81,29.64,29.79,28.89,28.58,29.38,30.46,29.04,27.73,30.18,29.44,0.44,1.09,0.31,-0.63,0.21,0.36,-0.55,-0.85,-0.05,1.03,-0.39,-1.71,0.75,biological regulation;establishment of localization;protein transport;transport,cell part;membrane,,,,,,,,,,
Q9Y3A6,TMED5,Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma-2) (p24gamma2) (p28),6,23.3,28.67,29.84,29.7,30.16,26.82,32,27.89,27.28,28.57,29,28.82,,27.52,28.85,-0.19,0.98,0.84,1.3,-2.03,3.14,-0.96,-1.58,-0.29,0.14,-0.03, ,-1.34,cellular component organization;cellular process;establishment of localization;Golgi organization;organelle organization;protein transport;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9Y3B3,TMED7,Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27),8,36.2,31.29,32.25,30.76,31.2,30.88,31.88,30.57,30.7,31.77,31.04,31.58,29.27,31.88,31.16,0.13,1.09,-0.4,0.04,-0.28,0.72,-0.59,-0.46,0.61,-0.12,0.42,-1.89,0.72,establishment of localization;protein transport;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9BVK6,TMED9,Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2) (p25),11,36.9,31.63,32.26,31.24,31.45,31.45,32.32,31.47,31.37,32.01,31.65,31.49,31.1,32.5,31.69,-0.06,0.57,-0.45,-0.24,-0.24,0.63,-0.22,-0.31,0.32,-0.03,-0.2,-0.59,0.81,biological regulation;cellular component organization;cellular process;establishment of localization;Golgi organization;organelle organization;protein transport;regulation of organelle organization;transport;vesicle organization,cell part;cytoplasmic membrane-bounded vesicle;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q9NUM4,TMEM106B,Transmembrane protein 106B,7,22,,26.19,27.73,28.16,27.71,28.71,,28.09,27.37,28.47,27.7,26.48,26.63,27.57, ,-1.37,0.16,0.59,0.14,1.14, ,0.52,-0.19,0.9,0.14,-1.09,-0.94,,cell part;membrane,,,,,,,,,,
Q9BVC6,TMEM109,Transmembrane protein 109 (Mitsugumin-23) (Mg23),6,15.2,30.62,30.54,26.35,30.4,29.57,30.59,29.54,29.18,30.41,29.97,30.2,29.53,30.63,29.81,0.81,0.73,-3.46,0.59,-0.24,0.78,-0.27,-0.63,0.6,0.16,0.39,-0.28,0.82,biological regulation;cellular process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoplasm;membrane,,,,,,,,,,
P17152,TMEM11,"Transmembrane protein 11, mitochondrial (Protein PM1) (Protein PMI)",5,26.6,28.22,28.95,27.51,28.33,28.63,29.16,28.24,27.24,29.59,29.76,27.29,26.63,28.47,28.31,-0.09,0.64,-0.8,0.02,0.33,0.85,-0.07,-1.07,1.28,1.45,-1.01,-1.68,0.16,cellular component organization;cellular process;mitochondrion organization;organelle organization,cell part,,,,,,,,,,
Q12893,TMEM115,Transmembrane protein 115 (Placental protein 6) (PP6) (Protein PL6),3,10.5,,22.86,23.46,21.96,,22.71,24.42,,24.22,25.71,25.16,26.78,,24.14, ,-1.29,-0.68,-2.18, ,-1.43,0.28, ,0.07,1.56,1.02,2.64, ,biological regulation,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H061,TMEM126A,Transmembrane protein 126A,3,28.7,28.3,27.92,25.14,27.76,27.87,26.98,26.31,26.37,28.28,25.55,27.74,27.61,27.86,27.21,1.09,0.71,-2.07,0.55,0.66,-0.23,-0.89,-0.83,1.07,-1.66,0.54,0.4,0.66,anatomical structure development;developmental process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q24JP5,TMEM132A,Transmembrane protein 132A (HSPA5-binding protein 1),8,10,33.72,31.06,27.67,28.21,27.81,27.38,28.17,27.69,27.85,23.14,28.04,28.18,28.11,28.23,5.48,2.83,-0.56,-0.03,-0.42,-0.86,-0.06,-0.54,-0.39,-5.1,-0.19,-0.05,-0.12,,cell part;membrane,,,,,,,,,,
Q6P9G4,TMEM154,Transmembrane protein 154,3,40.5,,,,25.8,,24.72,24.68,23.37,24.89,,26.26,28.59,26.57,25.61, , , ,0.19, ,-0.89,-0.93,-2.24,-0.72, ,0.65,2.98,0.96,,cell part,,,,,,,,,,
Q9HC07,TMEM165,Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL),8,22.8,29.66,30.67,30.2,30.46,29.23,31.01,29.97,29.84,30.63,30.97,29.87,31.02,31,30.35,-0.69,0.32,-0.15,0.11,-1.11,0.66,-0.38,-0.5,0.28,0.62,-0.47,0.67,0.65,biological regulation;carbohydrate metabolic process;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;establishment of localization;homeostatic process;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q86WV6,TMEM173,Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173),11,34.6,31.99,26.29,29.7,27.37,24.75,26.96,26.65,22.78,27.01,28.78,26.94,25.76,26.57,27.04,4.95,-0.75,2.66,0.33,-2.29,-0.08,-0.39,-4.26,-0.03,1.73,-0.11,-1.28,-0.47,biological regulation;cell death;cellular process;cytokine production;death;immune system process;multicellular organismal process;multi-organism process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
A5PLL7,TMEM189,Transmembrane protein 189,2,7.7,26.13,25.08,,25.13,25.52,25.61,24.97,26.1,27.4,26.69,27.07,26.01,26.55,26.02,0.11,-0.94, ,-0.9,-0.5,-0.41,-1.05,0.08,1.37,0.67,1.05,-0.02,0.53,,cell part;membrane,,,,,,,,,,
Q8IY95,TMEM192,Transmembrane protein 192,4,15.7,25.59,26.47,,27.08,27.13,27.92,26.5,26.91,27.41,27.82,28,27.83,27.92,27.21,-1.63,-0.74, ,-0.13,-0.08,0.71,-0.72,-0.3,0.2,0.61,0.78,0.61,0.7,,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
E9PBQ3,TMEM199,Transmembrane protein 199,2,7.7,26.91,27.7,24.7,26.09,26.46,24.81,,,,,25.5,,24.97,25.89,1.02,1.8,-1.19,0.2,0.56,-1.08, , , , ,-0.39, ,-0.92,,,,,,,,,,,,
Q9UHN6,TMEM2,Transmembrane protein 2,14,13.1,25.33,26.06,25.1,29.61,30.19,29.41,27.6,30.43,28.61,29.01,28.31,27.76,30.43,28.3,-2.96,-2.24,-3.19,1.31,1.9,1.11,-0.69,2.13,0.31,0.71,0.01,-0.54,2.14,developmental process;multicellular organismal development;multicellular organismal process,cell part,,,,,,,,,,
Q5SNT2,TMEM201,Transmembrane protein 201 (Spindle-associated membrane protein 1),5,8.9,26.16,24.63,26.42,25.33,24.16,24.46,23.49,23.69,24.02,25.48,24.93,23.33,25.24,24.72,1.44,-0.09,1.7,0.61,-0.56,-0.26,-1.22,-1.02,-0.7,0.76,0.21,-1.38,0.52,,cell part;membrane,,,,,,,,,,
Q6UW68,TMEM205,Transmembrane protein 205,7,38.8,31.21,30.41,29.06,29.6,28.45,29.59,28.77,29.45,29.89,29.18,30,24.81,29.03,29.19,2.02,1.22,-0.13,0.41,-0.74,0.4,-0.42,0.26,0.71,-0.01,0.81,-4.37,-0.16,,cell part,,,,,,,,,,
Q96SK2,TMEM209,Transmembrane protein 209,3,11.4,27.27,26.5,25.27,26.02,26.39,25.26,25.48,25.66,26.32,,,,24.93,25.91,1.36,0.59,-0.64,0.11,0.48,-0.65,-0.43,-0.26,0.41, , , ,-0.98,,cell part,,,,,,,,,,
Q6NUQ4,TMEM214,Transmembrane protein 214,20,32.8,28.17,30.69,29.79,30.97,30.53,31.46,29.73,29.87,32.36,30.94,30.27,29.42,31.71,30.45,-2.29,0.24,-0.67,0.51,0.08,1.01,-0.72,-0.58,1.9,0.48,-0.19,-1.03,1.25,,cell part;macromolecular complex;protein complex,,,,,,,,,,
A0PJW6,TMEM223,Transmembrane protein 223,2,15.8,23.79,25.95,23.7,24.57,26.51,26.44,26,,26.89,26.04,,,26.1,25.6,-1.81,0.35,-1.9,-1.03,0.91,0.84,0.4, ,1.29,0.44, , ,0.5,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96A57,TMEM230,Transmembrane protein 230,4,31.7,24.79,21.54,,22.76,25.04,25.46,,,24.58,24.94,25.48,26.17,24.53,24.53,0.26,-2.99, ,-1.77,0.51,0.93, , ,0.05,0.41,0.95,1.64,0,,cell part,,,,,,,,,,
Q9H330,TMEM245,Transmembrane protein 245 (Protein CG-2),10,13,27.2,28.95,26.94,29.03,27.92,29.02,28.36,28.41,29.23,29.48,29.44,26.63,28.96,28.43,-1.22,0.52,-1.49,0.6,-0.51,0.59,-0.07,-0.02,0.81,1.05,1.01,-1.8,0.54,,cell part,,,,,,,,,,
Q8N2U0,TMEM256,Transmembrane protein 256,3,90.2,27.17,27.99,,26.17,26.79,28.96,26.4,26.45,27.18,26.33,27.25,22.21,27.4,26.69,0.48,1.3, ,-0.52,0.1,2.27,-0.3,-0.24,0.48,-0.36,0.56,-4.48,0.71,,cell part,,,,,,,,,,
Q9NV96,TMEM30A,Cell cycle control protein 50A (Transmembrane protein 30A),3,11.4,25.77,27.44,26.88,27.01,27.11,26.98,26.81,27.22,27.69,27.53,25.05,26.25,25.61,26.72,-0.95,0.72,0.16,0.29,0.39,0.26,0.09,0.5,0.97,0.81,-1.67,-0.47,-1.11,biological regulation;regulation of transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P57088,TMEM33,Transmembrane protein 33 (Protein DB83),7,27,28.89,30.49,28.65,29.84,30.91,31.41,29.28,30.09,30.75,30.75,30.91,30.75,31.38,30.32,-1.42,0.17,-1.66,-0.47,0.59,1.09,-1.03,-0.23,0.44,0.43,0.6,0.43,1.07,,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q96HV5,TMEM41A,Transmembrane protein 41A,3,14.4,27.27,26.56,24.72,26.75,,26.62,,,25.16,27.11,25.82,27.25,27.07,26.43,0.84,0.12,-1.72,0.32, ,0.19, , ,-1.28,0.68,-0.61,0.82,0.64,,cell part,,,,,,,,,,
Q9BTV4,TMEM43,Transmembrane protein 43 (Protein LUMA),23,59.2,31.66,32.33,31.5,32.05,31.93,32.14,31.22,31.44,32.25,32,31.85,30.99,32.65,31.85,-0.19,0.48,-0.34,0.2,0.08,0.3,-0.62,-0.4,0.4,0.15,0,-0.86,0.8,,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q8N5G2,TMEM57,Macoilin (Transmembrane protein 57),3,5.6,24.12,24.76,24.79,24.51,,,25.57,,24.89,25.01,25.1,,,24.84,-0.72,-0.08,-0.06,-0.33, , ,0.72, ,0.04,0.16,0.26, , ,anatomical structure development;developmental process,cell part;cell projection;membrane;neuron projection;synapse,,,,,,,,,,
Q6PI78,TMEM65,Transmembrane protein 65,2,9.2,27.84,25.58,24.99,25.32,25.98,26.41,24.46,25.39,26.97,27.35,24.72,,26.35,25.95,1.9,-0.36,-0.96,-0.63,0.03,0.46,-1.49,-0.55,1.02,1.4,-1.22, ,0.4,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9BUB7,TMEM70,"Transmembrane protein 70, mitochondrial",4,36,27.58,28.15,27.21,28.43,27.77,27.57,27.39,26.19,28.54,27.68,27.87,27.93,26.45,27.6,-0.01,0.55,-0.39,0.83,0.18,-0.03,-0.2,-1.41,0.94,0.09,0.27,0.33,-1.15,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly,cell part;membrane,,,,,,,,,,
Q8NBN3,TMEM87A,Transmembrane protein 87A,7,15.6,26.9,26.64,26.86,27.03,26.34,26.74,26.59,26.42,27.61,25.57,,25.61,26.84,26.6,0.31,0.04,0.26,0.43,-0.25,0.14,-0.01,-0.18,1.02,-1.03, ,-0.98,0.24,,cell part,,,,,,,,,,
Q96K49,TMEM87B,Transmembrane protein 87B,6,15.5,26.34,27.08,27.71,27.27,24.72,28.02,28.54,26.5,28.75,28.73,28.8,28.03,28.41,27.61,-1.27,-0.53,0.1,-0.34,-2.89,0.41,0.94,-1.11,1.14,1.13,1.2,0.42,0.8,,cell part,,,,,,,,,,
Q5BJF2,TMEM97,Transmembrane protein 97 (Protein MAC30),2,12.1,25.54,25.22,,26.48,21.57,27.69,26.38,22.09,22.26,22.2,,,,24.38,1.16,0.84, ,2.1,-2.81,3.31,2,-2.29,-2.12,-2.18, , , ,biological regulation;homeostatic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;plasma membrane;vacuole,,,,,,,,,,
P82094,TMF1,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),19,20.4,25.76,28.63,27.57,28.65,27.64,27.6,27.28,27.67,28.32,28.21,27.78,27.2,29.09,27.8,-2.04,0.83,-0.23,0.85,-0.16,-0.2,-0.52,-0.13,0.52,0.41,-0.02,-0.6,1.29,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,Other TF domain,,,,,,,,,
Q9NVH6,TMLHE,"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)",5,15,25.56,27.81,23.94,25.43,,26.07,25.27,24.95,25.66,26.29,26.23,26.28,26.46,25.83,-0.27,1.98,-1.89,-0.4, ,0.24,-0.56,-0.88,-0.17,0.46,0.4,0.45,0.63,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;organic acid metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P28289,TMOD1,Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod),18,57.9,28.28,30.09,29.15,27.5,31.48,30.9,31.81,32.1,30.01,30.91,32.34,25.84,31.87,30.18,-1.9,-0.09,-1.02,-2.67,1.3,0.72,1.64,1.93,-0.16,0.73,2.16,-4.33,1.69,anatomical structure formation involved in morphogenesis;behavior;cellular component assembly;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;multicellular organismal process;organelle organization;response to stimulus,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9NYL9,TMOD3,Tropomodulin-3 (Ubiquitous tropomodulin) (U-Tmod),20,62.2,31.09,31.22,31.61,31.14,31.5,31.2,31.73,31.73,32.12,32.26,30.96,31.95,31.69,31.55,-0.46,-0.34,0.05,-0.42,-0.05,-0.35,0.18,0.17,0.56,0.7,-0.59,0.4,0.14,,cell part,,,,,,,,,,
P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",16,35,30.62,28.85,25.62,29.52,29.88,29.13,27.79,28.22,27.94,26.94,24.8,26.35,,27.97,2.65,0.88,-2.36,1.55,1.91,1.16,-0.18,0.25,-0.03,-1.03,-3.17,-1.62, ,biological regulation,cell part;membrane;nuclear envelope,,,,,,,,,,
P42167,TMPO,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",32,65,33.24,31.99,31.76,31.79,32.33,32.31,31.73,31.45,32.56,32.7,30.18,31.17,31.22,31.88,1.36,0.11,-0.12,-0.09,0.45,0.43,-0.15,-0.43,0.69,0.82,-1.7,-0.71,-0.66,,cell part;membrane;nuclear envelope,,,,,,,,,,
Q6ZT21,TMPPE,Transmembrane protein with metallophosphoesterase domain (EC 3.1.-.-),3,13.3,26.07,26.17,25.76,25.23,26.24,26.77,24.6,25.91,27.33,26.49,26.54,25.14,27.2,26.11,-0.04,0.06,-0.35,-0.88,0.13,0.65,-1.51,-0.2,1.22,0.38,0.43,-0.98,1.09,,cell part,,,,,,,,,,
P63313,TMSB10,Thymosin beta-10,6,72.7,21.23,27.02,24.68,26.54,32.19,28.33,25.64,32.19,,22.5,,,,26.7,-5.47,0.32,-2.02,-0.16,5.49,1.63,-1.06,5.49, ,-4.21, , , ,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P0CG35,TMSB15B,Thymosin beta-15B,2,31.1,,22.55,,23.17,23.67,21.6,23.16,23.46,,,22.65,25.06,20.95,22.92, ,-0.37, ,0.25,0.75,-1.31,0.24,0.54, , ,-0.27,2.14,-1.97,biological regulation;cellular component organization;cellular process;cytoskeleton organization;organelle organization;regulation of organelle organization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P62328,TMSB4X,Thymosin beta-4 (T beta-4) (Fx) [Cleaved into: Hematopoietic system regulatory peptide (Seraspenide)],7,86.4,26.62,28.87,29.59,28.94,32.11,31.3,27.07,33.3,24.12,23.47,26.77,26.65,22.99,27.83,-1.21,1.04,1.76,1.11,4.28,3.47,-0.76,5.47,-3.71,-4.36,-1.06,-1.18,-4.83,biological regulation;cell activation;cell differentiation;cellular component organization;cellular process;cytoskeleton organization;developmental process;establishment of localization;exocytosis;organelle organization;regulation of organelle organization;secretion;transport;vesicle-mediated transport,cell part;cytoskeleton;extracellular region;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9BVT8,TMUB1,Transmembrane and ubiquitin-like domain-containing protein 1 (Dendritic cell-derived ubiquitin-like protein) (DULP) (Hepatocyte odd protein shuttling protein) (Ubiquitin-like protein SB144),2,14.5,25.88,26.88,,26.06,25.12,27.15,26.02,26.76,27.06,,,,21.91,25.87,0.01,1.01, ,0.18,-0.75,1.28,0.15,0.88,1.19, , , ,-3.96,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H3N1,TMX1,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),19,36.8,30.52,31.16,31.05,31.12,30.13,31.16,31.24,30.74,31.78,31.51,30.65,29.54,31.62,30.94,-0.42,0.22,0.11,0.18,-0.82,0.22,0.3,-0.2,0.84,0.56,-0.29,-1.4,0.68,biological regulation;biosynthetic process;cell activation;cell proliferation;cellular homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;establishment of localization;generation of precursor metabolites and energy;Golgi vesicle transport;homeostatic process;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;membrane,,,,,,,,,,
Q9Y320,TMX2,Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14),7,28.7,28.08,28.86,28.36,29.36,28.41,29.01,28.08,27.48,28.76,28.02,28.81,29.06,28.61,28.53,-0.45,0.33,-0.17,0.83,-0.12,0.48,-0.46,-1.05,0.23,-0.52,0.28,0.53,0.08,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part,,,,,,,,,,
Q96JJ7,TMX3,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),20,41.4,30.78,31.42,30.99,31.88,31.83,32.08,31.57,30.86,32.15,31.97,31.57,31.55,32.12,31.6,-0.82,-0.17,-0.61,0.29,0.23,0.48,-0.03,-0.74,0.55,0.37,-0.02,-0.05,0.52,biological regulation;cellular homeostasis;cellular metabolic process;cellular process;glycerol ether metabolic process;homeostatic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;small molecule metabolic process,cell part;cell surface;membrane,,,,,,,,,,
Q9H1E5,TMX4,Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13),16,41,28.45,29.06,29.56,30.31,29.06,31.22,29.22,29.57,30.01,30.31,29.29,30.87,31.08,29.85,-1.4,-0.79,-0.28,0.47,-0.79,1.37,-0.63,-0.27,0.16,0.46,-0.56,1.03,1.24,biological regulation;cellular homeostasis;cellular metabolic process;cellular process;generation of precursor metabolites and energy;homeostatic process;metabolic process,cell part,,,,,,,,,,
P24821,TNC,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),32,21.1,26.54,28.61,23.79,25.02,30.39,32.19,27.68,31.47,30.26,28.29,29.61,22.95,30.75,28.27,-1.73,0.34,-4.48,-3.25,2.11,3.92,-0.6,3.19,1.99,0.02,1.33,-5.32,2.47,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell communication;cell-cell signaling;cellular component morphogenesis;cellular component organization;cellular process;developmental process;response to stimulus;response to stress;signaling,extracellular matrix;extracellular space;proteinaceous extracellular matrix,,,,,,,,,,
Q03169,TNFAIP2,Tumor necrosis factor alpha-induced protein 2 (TNF alpha-induced protein 2) (Primary response gene B94 protein),25,47.9,30.66,29.25,28.55,26.93,,26.73,24.49,24.5,26.28,30.25,23.83,25.74,26.59,26.98,3.68,2.27,1.57,-0.06, ,-0.25,-2.5,-2.49,-0.7,3.27,-3.15,-1.25,-0.39,anatomical structure formation involved in morphogenesis;cell differentiation;cellular process;developmental process;establishment of localization;exocytosis;secretion;transport;vesicle-mediated transport,cell part;extracellular space;macromolecular complex;protein complex,,,,,,,,,,
O14763,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262),6,18.7,26.84,27.22,23.63,25.38,26.53,26.8,27.87,26.99,27.7,26.52,26.79,26.37,28.08,26.67,0.17,0.55,-3.04,-1.29,-0.14,0.13,1.2,0.32,1.03,-0.15,0.12,-0.3,1.41,biological regulation;cell death;cellular process;death;regulation of protein modification process;response to abiotic stimulus;response to external stimulus;response to stimulus,cell part;membrane;plasma membrane,,,,,,,,,,
Q9UKE5,TNIK,TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1),8,6.1,,,,25.92,25.81,,26.93,26.66,,24.71,26.72,26.26,,26.15, , , ,-0.23,-0.33, ,0.79,0.52, ,-1.43,0.57,0.12, ,biological regulation;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of protein modification process;response to stimulus;signal transduction,cell part;cytoplasm;cytoskeleton;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,+,,,,,,,,
Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,92,61.4,31.74,30.51,30.06,30.74,31.82,32.09,31.75,32.44,31.25,30.57,32.52,31.54,31.73,31.44,0.3,-0.93,-1.38,-0.71,0.37,0.65,0.31,1,-0.2,-0.87,1.08,0.1,0.29,biological regulation;biosynthetic process;catabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;DNA replication;homeostatic process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;telomere organization,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;transcription factor complex,,,,,,,,,,
Q92973,TNPO1,Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein) (MIP),33,44,31.01,31.73,31.26,32.09,31.67,31.17,32.21,31.84,31.46,31.08,32.21,32.91,30.82,31.65,-0.64,0.08,-0.4,0.44,0.02,-0.48,0.56,0.19,-0.19,-0.57,0.56,1.26,-0.83,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;mRNA metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein transport;RNA metabolic process;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;nucleus;organelle;protein complex,,,,,,,,,,
O14787,TNPO2,Transportin-2 (Karyopherin beta-2b),12,20.1,29.68,28,28.2,27.53,25.57,24.49,27.28,26.8,25.63,27.08,27.4,26.95,24.08,26.82,2.85,1.18,1.38,0.71,-1.26,-2.33,0.46,-0.03,-1.19,0.26,0.58,0.13,-2.74,establishment of localization;protein transport;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nuclear pore;nucleus;organelle;protein complex,,,,,,,,,,
Q9Y5L0,TNPO3,Transportin-3 (Importin-12) (Imp12) (Transportin-SR) (TRN-SR),11,19,28.6,27.5,28.22,28.09,27.43,26.4,28.12,28.34,25.68,26.41,25.96,28.24,,27.42,1.18,0.08,0.81,0.67,0.02,-1.01,0.7,0.92,-1.74,-1.01,-1.45,0.82, ,establishment of localization;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;transport,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q0VG54,TNS1,TNS1 protein,21,20.3,28.39,27.74,26.17,27.89,25.85,27.77,25.6,26.02,27.85,24.27,,24.02,27.73,26.61,1.78,1.13,-0.44,1.29,-0.76,1.16,-1.01,-0.59,1.24,-2.34, ,-2.59,1.12,,,,,,,,,,,,
Q68CZ2,TNS3,Tensin-3 (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6),13,17.3,24.79,26.68,25.3,28.95,24.5,26,25.24,25.27,,,25.57,25.49,,25.78,-0.99,0.9,-0.48,3.17,-1.28,0.22,-0.54,-0.51, , ,-0.21,-0.29, ,anatomical structure development;biological regulation;cell motility;cellular component movement;cellular process;developmental process;locomotion,,,,,,,,,,,
Q8IZW8,TNS4,Tensin-4 (C-terminal tensin-like protein),12,23.4,29.97,,25.74,,23.9,,25.22,27.22,24.41,23.43,,,26.4,25.79,4.18, ,-0.05, ,-1.88, ,-0.57,1.43,-1.37,-2.36, , ,0.62,cell death;cellular process;death;localization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q96GM8,TOE1,Target of EGR1 protein 1,2,5.7,23.77,,,24.18,,24.98,,24.33,25.1,23.88,,,24.37,24.37,-0.61, , ,-0.2, ,0.61, ,-0.04,0.73,-0.49, , ,0,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9H0E2,TOLLIP,Toll-interacting protein,7,32.8,27.04,28.26,28.21,28.08,27.68,28.29,27.37,28.47,26.93,27.73,28.04,29,28.68,27.98,-0.95,0.28,0.23,0.09,-0.3,0.31,-0.62,0.49,-1.06,-0.25,0.06,1.02,0.7,biological regulation;cell activation;cell communication;cell-cell signaling;cellular metabolic process;cellular process;immune system process;metabolic process;phosphorus metabolic process;regulation of protein modification process;response to stimulus;response to stress;signal transduction;signaling,cell part;cytosol;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
O60784,TOM1,Target of Myb protein 1,10,27.2,27.57,28.82,26.82,28.74,26.84,25.73,27.45,27.98,26.58,28.39,28.56,28.79,,27.69,-0.12,1.13,-0.87,1.05,-0.85,-1.96,-0.23,0.29,-1.11,0.7,0.87,1.1, ,cellular component organization;cellular membrane organization;cellular process;endocytosis;endosome transport;establishment of localization;membrane invagination;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q6ZVM7,TOM1L2,TOM1-like protein 2 (Target of Myb-like protein 2),8,24.1,23.65,26.34,25.67,26.4,22.32,28.28,28.44,26.61,24.82,28.32,28.49,28.13,28.21,26.59,-2.94,-0.25,-0.92,-0.19,-4.27,1.69,1.85,0.02,-1.77,1.73,1.9,1.54,1.62,establishment of localization;protein transport;transport,cell part;intracellular,,,,,,,,,,
Q9NS69,TOMM22,Mitochondrial import receptor subunit TOM22 homolog (hTom22) (1C9-2) (Translocase of outer membrane 22 kDa subunit homolog),8,67.6,30.96,30.66,29.74,30.67,31.25,31.71,31.31,30.98,31.23,31.32,31.01,31.16,30.53,30.96,0,-0.31,-1.22,-0.29,0.29,0.75,0.34,0.02,0.27,0.36,0.04,0.2,-0.44,cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;mitochondrion organization;organelle organization;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q15785,TOMM34,Mitochondrial import receptor subunit TOM34 (hTom34) (Translocase of outer membrane 34 kDa subunit),12,46,29.41,28.44,29.66,29.84,30.23,29.98,30.16,30.32,28.97,29.18,30.95,29.9,27.67,29.59,-0.18,-1.16,0.06,0.25,0.64,0.39,0.57,0.72,-0.63,-0.41,1.35,0.3,-1.92,establishment of localization;protein targeting;protein transport;transport,cell part;membrane,,,,,,,,,,
O96008,TOMM40,Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5),12,40.2,30.56,29.87,29.86,30.67,31.53,31.5,30.57,30.62,30.34,30.78,31.26,30.29,31.54,30.72,-0.16,-0.85,-0.87,-0.05,0.81,0.78,-0.15,-0.11,-0.39,0.06,0.53,-0.43,0.82,cellular metabolic process;cellular process;establishment of localization;ion transport;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q8N4H5,TOMM5,Mitochondrial import receptor subunit TOM5 homolog,8,84.3,27.99,27.7,29.17,27.64,30,30.74,29.76,30.06,30.14,30.2,29.32,29.66,29.54,29.38,-1.39,-1.68,-0.2,-1.74,0.62,1.37,0.38,0.68,0.76,0.82,-0.06,0.29,0.17,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q96B49,TOMM6,Mitochondrial import receptor subunit TOM6 homolog (Overexpressed breast tumor protein) (Translocase of outer membrane 6 kDa subunit homolog),3,70.3,28.51,27.62,24.22,27.72,27.13,28.31,26.35,28.37,27.6,27.8,27.79,28.71,27.18,27.48,1.02,0.14,-3.26,0.24,-0.35,0.82,-1.14,0.88,0.11,0.32,0.3,1.22,-0.31,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;membrane,,,,,,,,,,
O94826,TOMM70A,Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit),25,49.8,32.05,31.06,31.65,30.83,31.42,31.42,30.88,30.45,31.22,31.56,30.74,30.25,31.27,31.14,0.91,-0.08,0.51,-0.31,0.28,0.28,-0.26,-0.69,0.09,0.42,-0.4,-0.89,0.14,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein targeting;protein transport;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
P11387,TOP1,DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I),41,49.3,33.13,31.88,32.7,32.25,32.29,32.46,32.08,31.48,32.58,33.15,31.06,31.28,31.94,32.18,0.95,-0.3,0.53,0.08,0.12,0.29,-0.09,-0.7,0.41,0.97,-1.12,-0.9,-0.24,biosynthetic process;cell death;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;chromosome segregation;death;DNA metabolic process;DNA replication;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;phosphorus metabolic process;primary metabolic process;response to chemical stimulus;response to drug;response to stimulus,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",43,28.7,30.95,26.8,28.72,27.38,30.42,28.5,29.73,28.93,28.87,28.56,,26.96,29.05,28.74,2.21,-1.94,-0.02,-1.36,1.68,-0.24,0.99,0.19,0.13,-0.18, ,-1.78,0.31,biological regulation;biosynthetic process;cell cycle;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;chromosome segregation;DNA ligation;DNA metabolic process;DNA packaging;DNA recombination;DNA repair;DNA replication;macromolecule metabolic process;metabolic process;mitotic cell cycle;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",63,44.1,31.93,31.26,31.61,31.4,31.7,32.2,31.75,31.11,32.24,31.87,29.67,30.9,31.49,31.47,0.46,-0.21,0.13,-0.07,0.23,0.72,0.28,-0.36,0.77,0.4,-1.8,-0.57,0.02,anatomical structure development;anatomical structure morphogenesis;biosynthetic process;cell motility;cellular component morphogenesis;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;chromosome segregation;developmental process;DNA metabolic process;DNA recombination;DNA replication;locomotion;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process,cell part;chromatin remodeling complex;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
O14656,TOR1A,Torsin-1A (Dystonia 1 protein) (Torsin family 1 member A),11,39.5,24.87,28.98,28,28.14,28.7,29.62,28.96,28.81,29.71,28.75,28.93,29.03,30.42,28.69,-3.82,0.29,-0.69,-0.55,0.01,0.93,0.27,0.12,1.03,0.07,0.24,0.34,1.74,cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;membrane,,,,,,,,,,
Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),26,50.8,31.54,31.6,31.37,30.99,30.82,31.21,30.64,30.42,31.34,31.22,30.65,30.14,31.07,31,0.54,0.6,0.37,-0.01,-0.19,0.21,-0.36,-0.58,0.34,0.22,-0.35,-0.87,0.07,cellular component organization;cellular localization;cellular membrane organization;cellular process;localization;membrane organization,cell part;membrane,,,,,,,,,,
Q8NFQ8,TOR1AIP2,Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1),15,47.4,28.87,30.17,29.12,30.08,29.85,30.64,30.64,29.51,30.57,30.67,30.74,31.33,31.22,30.26,-1.39,-0.09,-1.14,-0.19,-0.41,0.37,0.37,-0.75,0.31,0.41,0.48,1.07,0.96,,cell part;membrane,,,,,,,,,,
O14657,TOR1B,Torsin-1B (Torsin family 1 member B),6,20.8,26.62,27.38,28.86,28,28.99,28.25,27.63,27.84,27.74,28.41,26.14,27.86,29.12,27.91,-1.29,-0.53,0.95,0.09,1.08,0.34,-0.28,-0.07,-0.17,0.5,-1.77,-0.05,1.21,cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;response to chemical stimulus;response to stimulus;response to stress,cell part;nuclear envelope,,,,,,,,,,
Q5JU69,TOR2A,Torsin-2A (Torsin family 2 member A) (Torsin-related protein 1),2,8.1,24.04,27,25.26,26.42,24.87,26.22,26.89,,25.99,26.38,25.94,26.25,26.71,26,-1.95,1,-0.74,0.42,-1.13,0.23,0.89, ,-0.01,0.38,-0.06,0.26,0.71,cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process,cell part;extracellular region,,,,,,,,,,
Q9NXH8,TOR4A,Torsin-4A (Torsin family 4 member A),13,32.9,25.63,27.61,,27.55,27.38,24.71,27.62,25.84,25.36,28.03,27.13,25.69,27.5,26.67,-1.04,0.94, ,0.88,0.71,-1.96,0.95,-0.83,-1.31,1.36,0.46,-0.98,0.83,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part,,,,,,,,,,
Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),52,33.9,29.62,29.7,29.69,29.61,29.71,29.94,29.19,28,30.82,29.39,28.77,29.36,29.08,29.45,0.17,0.25,0.24,0.16,0.26,0.49,-0.27,-1.45,1.37,-0.06,-0.68,-0.09,-0.37,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nucleoplasm;organelle;protein complex,Other TF domain,,,,,,,,,
E9PN66,TP53I11,Tumor protein p53-inducible protein 11 (Fragment),4,59.7,30.54,28.59,27.83,28.33,26.53,,25.75,26.61,,24.08,28.82,,,27.45,3.09,1.14,0.38,0.88,-0.93, ,-1.7,-0.85, ,-3.38,1.37, , ,,,,,,,,,,,,
Q53FA7,TP53I3,Quinone oxidoreductase PIG3 (EC 1.-.-.-) (Tumor protein p53-inducible protein 3) (p53-induced gene 3 protein),9,35.2,28.63,27.02,29.49,29.7,28.33,27.6,29.1,29.85,28.04,26.03,30.01,30.31,28.54,28.67,-0.03,-1.65,0.82,1.03,-0.33,-1.06,0.44,1.18,-0.63,-2.63,1.35,1.65,-0.13,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,,,,,,,,,,,
Q96S44,TP53RK,TP53-regulating kinase (EC 2.7.11.1) (Nori-2) (p53-related protein kinase),3,19,26.87,25.68,25.24,26.19,24.66,24.38,25.44,25.75,,24.57,26.42,25.71,26.27,25.6,1.27,0.08,-0.36,0.59,-0.94,-1.22,-0.15,0.15, ,-1.03,0.83,0.11,0.67,biosynthetic process;carbohydrate metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular process;lipid metabolic process;macromolecule metabolic process;metabolic process;polysaccharide metabolic process;primary metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,+,,,,,,,,
Q13641,TPBG,Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1),7,18.6,29.47,30.7,28.65,30.41,29.9,29.94,28.88,29.36,29.2,28.11,28.94,29.39,29.92,29.45,0.02,1.25,-0.8,0.96,0.45,0.48,-0.57,-0.1,-0.25,-1.34,-0.51,-0.07,0.47,biological adhesion;cell adhesion;cellular process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P55327,TPD52,Tumor protein D52 (Protein N8),8,76.6,31.75,28.96,29.5,27.36,28.26,27.49,28.1,28.43,25.85,28.79,29.15,28.76,27.91,28.49,3.26,0.48,1.01,-1.13,-0.22,-0.99,-0.38,-0.06,-2.64,0.3,0.67,0.28,-0.57,anatomical structure morphogenesis;cell activation;cell differentiation;cellular process;developmental process;establishment of localization;immune system process;secretion;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q16890,TPD52L1,Tumor protein D53 (hD53) (Tumor protein D52-like 1),8,60,30.59,26.58,25.36,,24.71,,25.75,,26.45,24.98,27.17,27.26,25.34,26.42,4.17,0.16,-1.06, ,-1.7, ,-0.67, ,0.03,-1.44,0.75,0.84,-1.08,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein modification process,cell part,,,,,,,,,,
O43399,TPD52L2,Tumor protein D54 (hD54) (Tumor protein D52-like 2),21,86.4,31.73,31.63,31.79,31.43,31.11,30.56,31.74,31.27,31.14,30.74,32.62,31.64,31.27,31.44,0.29,0.2,0.35,-0.01,-0.33,-0.88,0.31,-0.17,-0.3,-0.7,1.19,0.21,-0.17,biological regulation,cell part,,,,,,,,,,
P60174,TPI1,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase),29,96,36.41,35.57,35.04,35.23,33.94,33.95,34.11,34.23,33.81,33.34,33.96,34.47,32.95,34.39,2.03,1.19,0.66,0.84,-0.45,-0.43,-0.28,-0.16,-0.58,-1.05,-0.42,0.09,-1.43,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular aldehyde metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;embryo development;generation of precursor metabolites and energy;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
P09493,TPM1,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),2,6.7,23.62,,,22.06,24.42,23.88,22.78,23.58,23.04,24.46,22.43,25.67,27.69,23.97,-0.35, , ,-1.91,0.46,-0.09,-1.19,-0.39,-0.93,0.5,-1.53,1.71,3.72,anatomical structure morphogenesis;biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;embryo development;multicellular organismal process;muscle contraction;organelle organization;regulation of organelle organization;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,bleb;cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P09493,TPM1,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),2,6.7,23.62,,,22.06,24.42,23.88,22.78,23.58,23.04,24.46,22.43,25.67,27.69,23.97,-0.35, , ,-1.91,0.46,-0.09,-1.19,-0.39,-0.93,0.5,-1.53,1.71,3.72,anatomical structure morphogenesis;biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;embryo development;multicellular organismal process;muscle contraction;organelle organization;regulation of organelle organization;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,bleb;cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P09493,TPM1,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),2,6.7,23.62,,,22.06,24.42,23.88,22.78,23.58,23.04,24.46,22.43,25.67,27.69,23.97,-0.35, , ,-1.91,0.46,-0.09,-1.19,-0.39,-0.93,0.5,-1.53,1.71,3.72,anatomical structure morphogenesis;biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;embryo development;multicellular organismal process;muscle contraction;organelle organization;regulation of organelle organization;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,bleb;cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P09493,TPM1,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),2,6.7,23.62,,,22.06,24.42,23.88,22.78,23.58,23.04,24.46,22.43,25.67,27.69,23.97,-0.35, , ,-1.91,0.46,-0.09,-1.19,-0.39,-0.93,0.5,-1.53,1.71,3.72,anatomical structure morphogenesis;biological regulation;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;embryo development;multicellular organismal process;muscle contraction;organelle organization;regulation of organelle organization;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,bleb;cell part;cell projection;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P07951,TPM2,Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2),26,57,31.9,33.16,32.26,33.9,32.68,33.31,33.23,32.9,33.53,32.12,33.23,33.01,33.78,33,-1.1,0.16,-0.74,0.9,-0.32,0.31,0.23,-0.1,0.53,-0.88,0.23,0.01,0.78,biological regulation;cellular component movement;cellular process,cell part;cytosol,,,,,,,,,,
P06753,TPM3,Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5),39,77.8,,,,,,26.1,,,28.43,27.64,,,,27.39, , , , , ,-1.29, , ,1.04,0.25, , , ,biological regulation;cellular component movement;cellular process,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;site of polarized growth,,,,,,,,,,
P67936,TPM4,Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4),3,9.2,33.04,33.83,33.32,33.58,33.09,32.96,32.94,32.81,33.35,32.84,33.14,32.61,32.81,33.1,-0.06,0.73,0.22,0.48,-0.01,-0.14,-0.16,-0.3,0.25,-0.26,0.03,-0.49,-0.3,cellular component movement;cellular process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
P67936,TPM4,Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4),3,9.2,33.04,33.83,33.32,33.58,33.09,32.96,32.94,32.81,33.35,32.84,33.14,32.61,32.81,33.1,-0.06,0.73,0.22,0.48,-0.01,-0.14,-0.16,-0.3,0.25,-0.26,0.03,-0.49,-0.3,cellular component movement;cellular process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
P51580,TPMT,Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase),8,31.8,27.81,26.45,28.19,27.22,25.63,,25.16,26.25,,25.1,,26.9,,26.52,1.29,-0.07,1.67,0.69,-0.9, ,-1.37,-0.27, ,-1.42, ,0.37, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
O14773,TPP1,Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I),8,22.6,30.68,33.23,33,30.74,32.24,30.69,30.93,31.49,30.77,31.24,31.71,30.7,31.5,31.46,-0.78,1.78,1.54,-0.71,0.78,-0.77,-0.52,0.03,-0.68,-0.22,0.25,-0.75,0.05,anatomical structure development;biological regulation;catabolic process;cell death;cellular component organization;cellular metabolic process;cellular process;death;developmental process;homeostatic process;lipid metabolic process;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;organelle organization;peptide metabolic process;primary metabolic process;protein catabolic process;protein metabolic process;proteolysis;regulation of protein modification process;vacuole organization,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle;vesicle,,,,,,,,,,
P29144,TPP2,Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II),32,29.9,29.6,31.01,31.01,31.14,29.57,30.41,30.86,30.98,29.84,29.98,30.88,30.8,29.52,30.43,-0.83,0.58,0.58,0.71,-0.87,-0.02,0.43,0.55,-0.59,-0.45,0.45,0.37,-0.91,cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P12270,TPR,Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein),97,41,33.37,32.5,32.73,32.59,33.23,33.19,32.79,32.17,33.3,32.87,31.57,32.13,32.78,32.71,0.66,-0.21,0.02,-0.12,0.52,0.48,0.08,-0.54,0.59,0.16,-1.14,-0.58,0.07,amine metabolic process;biological regulation;carbohydrate metabolic process;carbohydrate transport;cell division;cellular amino acid metabolic process;cellular component organization;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;nucleus organization;organelle fission;organelle organization;organic acid metabolic process;primary metabolic process;protein targeting;protein transport;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of translation;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to heat;response to stimulus;response to stress;RNA metabolic process;signal transduction;small molecule metabolic process;transmembrane transport;transport;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q9Y3C4,TPRKB,TP53RK-binding protein (PRPK-binding protein),3,24.2,27.07,26.99,27.67,25.86,25,25.34,,24.4,25.94,,25.88,24.43,25.08,25.79,1.28,1.2,1.88,0.08,-0.79,-0.45, ,-1.39,0.15, ,0.09,-1.36,-0.71,catabolic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein catabolic process;protein metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P13693,TPT1,Translationally-controlled tumor protein (TCTP) (Fortilin) (Histamine-releasing factor) (HRF) (p23),13,77.9,32.16,33.15,32.91,33.54,32.88,31.72,33.27,32.97,31.25,31.21,32.82,32.05,31.08,32.39,-0.22,0.76,0.52,1.15,0.5,-0.67,0.89,0.58,-1.13,-1.17,0.43,-0.34,-1.31,biological regulation;cellular homeostasis;cellular ion homeostasis;cellular process;developmental process;establishment of localization;homeostatic process;ion transport;multi-organism process;response to biotic stimulus;response to stimulus;transport,cell part;endosome;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleoplasm;organelle,,,,,,,,,,
Q9ULW0,TPX2,Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2) (DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Protein fls353) (Restricted expression proliferation-associated protein 100) (p100),6,13.6,27.67,25.07,28.49,26.19,26.71,,26.81,25.34,22.6,25.67,,24.4,23.48,25.67,2,-0.61,2.81,0.51,1.03, ,1.13,-0.34,-3.07,-0.01, ,-1.27,-2.2,biological regulation;cell death;cell division;cell proliferation;cellular component organization;cellular process;death;mitosis;nuclear division;organelle fission;organelle organization;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q13595,TRA2A,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),10,30.1,27.99,28.47,26.12,28.44,29.19,28.67,28.32,28.07,28.69,28.26,27.41,28.27,28.6,28.19,-0.2,0.28,-2.07,0.24,0.99,0.48,0.13,-0.12,0.5,0.07,-0.78,0.08,0.41,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H4I3,TRABD,TraB domain-containing protein (Protein TTG2),4,25,25.21,,25.61,,27.04,26.9,27.09,26.43,25.92,25.48,26.85,24.47,28,26.27,-1.06, ,-0.67, ,0.77,0.63,0.82,0.16,-0.36,-0.79,0.58,-1.8,1.73,,,,,,,,,,,,
Q15628,TRADD,Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain),2,11.9,24.55,26.74,26.68,26.58,25.69,24.09,26.71,,24.95,24.11,27.51,26.56,24.76,25.74,-1.19,1,0.94,0.83,-0.05,-1.66,0.96, ,-0.8,-1.63,1.77,0.82,-0.99,biological regulation;cellular process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;receptor complex,,,,,,,,,,
Q12933,TRAF2,TNF receptor-associated factor 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3),3,8.8,25.72,25.21,,25.22,,,25.74,25.04,23.35,,23.44,22.42,,24.52,1.2,0.69, ,0.71, , ,1.22,0.52,-1.17, ,-1.07,-2.09, ,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;immune system process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein catabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;macromolecular complex;protein complex;receptor complex,,,,,,,,,,
O14545,TRAFD1,TRAF-type zinc finger domain-containing protein 1 (Protein FLN29),3,6.4,22.73,22.99,21.63,23.14,22.13,22.47,21.62,22.95,,,23.5,24.86,,22.8,-0.08,0.19,-1.17,0.34,-0.67,-0.33,-1.18,0.14, , ,0.7,2.06, ,biological regulation;response to chemical stimulus;response to stimulus,,,,,,,,,,,
Q15629,TRAM1,Translocating chain-associated membrane protein 1,5,18.1,28.18,28.91,25.87,28.12,26.66,28.95,24.37,29.03,28.88,27.21,29.26,27.37,28.43,27.79,0.39,1.12,-1.92,0.33,-1.12,1.16,-3.42,1.24,1.09,-0.57,1.47,-0.42,0.64,biosynthetic process;cellular metabolic process;cellular process;establishment of localization;interspecies interaction between organisms;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein targeting;protein transport;translation;transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q15035,TRAM2,Translocating chain-associated membrane protein 2,3,8.4,20.15,24.72,20.09,23.57,23.52,24.75,22.43,22.77,27.14,24.1,26.72,24.99,24.09,23.77,-3.62,0.95,-3.68,-0.2,-0.26,0.97,-1.35,-1,3.37,0.33,2.95,1.22,0.31,biosynthetic process;establishment of localization;macromolecule metabolic process;metabolic process;multicellular organismal process;protein transport;transport,cell part,,,,,,,,,,
Q12931,TRAP1,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)",41,56.9,32.81,33.36,31.84,31.92,32.87,32.75,32.52,32.12,32.47,33.06,31.48,31.53,32.19,32.38,0.43,0.99,-0.54,-0.46,0.49,0.37,0.14,-0.26,0.09,0.68,-0.9,-0.85,-0.19,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q9Y5R8,TRAPPC1,Trafficking protein particle complex subunit 1 (BET5 homolog) (Multiple myeloma protein 2) (MUM-2),2,16.6,24.79,25.48,24.82,25.14,25.31,24.68,,25.31,,24.94,,25.18,25.63,25.13,-0.34,0.35,-0.31,0.01,0.18,-0.45, ,0.18, ,-0.18, ,0.05,0.5,cellular process;establishment of localization;Golgi vesicle transport;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9UL33,TRAPPC2L,Trafficking protein particle complex subunit 2-like protein,3,28.8,,,27.17,25.19,25.93,,26.27,26.58,,,26.57,27.43,,26.45, , ,0.72,-1.26,-0.52, ,-0.18,0.13, , ,0.12,0.98, ,cellular process;establishment of localization;Golgi vesicle transport;transport;vesicle-mediated transport,cell part;cytoplasm;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
P0DI82,TRAPPC2P1,Trafficking protein particle complex subunit 2 protein TRAPPC2P1 (MBP-1-interacting protein 2A) (MIP-2A),2,15.7,23.43,25.2,,,26.5,25.86,24.87,27.11,25.86,25.66,26.74,25.96,26,25.74,-2.31,-0.55, , ,0.75,0.12,-0.87,1.37,0.12,-0.09,0.99,0.21,0.26,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43617,TRAPPC3,Trafficking protein particle complex subunit 3 (BET3 homolog),7,31.1,29.62,31.17,31.55,30.33,30.68,29.27,29.35,30.45,28.08,29.24,29.78,30.68,28.89,29.93,-0.31,1.24,1.62,0.4,0.75,-0.66,-0.58,0.52,-1.85,-0.69,-0.15,0.75,-1.04,cellular process;establishment of localization;Golgi vesicle transport;transport;vesicle-mediated transport,cell part;cytosol;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q8IUR0,TRAPPC5,Trafficking protein particle complex subunit 5,2,9,25,25.06,25,26.34,25.73,24.22,25.3,24.69,24.42,24.07,24.94,24.83,24.86,24.96,0.04,0.1,0.04,1.38,0.78,-0.74,0.34,-0.27,-0.54,-0.89,-0.02,-0.13,-0.1,cellular process;establishment of localization;transport;vesicle-mediated transport,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
O43715,TRIAP1,TP53-regulated inhibitor of apoptosis 1 (Protein 15E1.1) (WF-1) (p53-inducible cell-survival factor) (p53CSV),3,38.2,25.31,26.13,24.83,25.25,25.5,26.14,25.4,,,26.45,,25.15,25.91,25.61,-0.3,0.53,-0.78,-0.36,-0.1,0.54,-0.21, , ,0.85, ,-0.46,0.3,biological regulation;cellular process;regulation of cell cycle;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
P19474,TRIM21,E3 ubiquitin-protein ligase TRIM21 (EC 6.3.2.-) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21),7,18.5,25.42,26.82,28.97,28.13,24.9,24.95,25.84,28.53,26.11,,26.54,25.77,,26.54,-1.12,0.28,2.42,1.59,-1.64,-1.59,-0.71,1.99,-0.44, ,0,-0.77, ,biological regulation;cell cycle;cellular component assembly;cellular component organization;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of cell cycle;regulation of protein modification process;regulation of protein stability,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
C9JWC5,TRIM22,E3 ubiquitin-protein ligase TRIM22 (Fragment),2,8.2,,24.36,25.52,26.03,24.3,,26.77,24.36,27.07,27.03,,,,25.68, ,-1.32,-0.16,0.35,-1.38, ,1.09,-1.33,1.39,1.35, , , ,,cell part;intracellular,,,,,,,,,,
Q14258,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25 (EC 6.3.2.19) (EC 6.3.2.n3) (Estrogen-responsive finger protein) (RING finger protein 147) (Tripartite motif-containing protein 25) (Ubiquitin/ISG15-conjugating enzyme TRIM25) (Zinc finger protein 147),19,30.5,30.71,30.34,30.86,30.74,29.87,29.26,30.34,30.76,29.96,30.12,30.3,29.49,29.01,30.14,0.57,0.21,0.73,0.61,-0.27,-0.87,0.2,0.62,-0.18,-0.02,0.17,-0.65,-1.13,biological regulation;immune system process;interspecies interaction between organisms;multi-organism process;response to biotic stimulus;response to stimulus;response to stress,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q12899,TRIM26,Tripartite motif-containing protein 26 (Acid finger protein) (AFP) (RING finger protein 95) (Zinc finger protein 173),4,9.6,24.5,,24.61,25.99,27.09,26.39,26.92,27.93,,21.49,26.76,27.1,26.4,25.93,-1.43, ,-1.31,0.07,1.17,0.46,0.99,2, ,-4.43,0.83,1.17,0.47,,cell part;cytoplasm,,,,,,,,,,
P14373,TRIM27,Zinc finger protein RFP (EC 6.3.2.-) (RING finger protein 76) (Ret finger protein) (Tripartite motif-containing protein 27),5,13.6,28.79,28.22,28.4,27.91,29.87,28.76,28.79,28.64,29.38,28.87,27.18,,19.8,27.88,0.9,0.34,0.52,0.02,1.99,0.88,0.9,0.76,1.5,0.98,-0.71, ,-8.08,"biological regulation;biosynthetic process;cell proliferation;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;protein transport;regulation of gene expression, epigenetic;regulation of protein modification process;regulation of transport;RNA metabolic process;secretion;transport",cell part;cytoplasm;membrane;nucleoplasm,Other TF domain,,,,,,,,,
Q13263,TRIM28,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),54,74.9,34.68,32.31,33.8,32.57,33.34,33.3,32.98,32.64,33.27,33.17,31.7,32.12,32.91,32.98,1.7,-0.68,0.81,-0.41,0.36,0.32,-0.01,-0.34,0.29,0.18,-1.28,-0.87,-0.07,"anatomical structure morphogenesis;biological regulation;biosynthetic process;cell morphogenesis;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein phosphorylation;regulation of DNA metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transcription initiation, DNA-dependent",cell part;nucleoplasm,,+,,,,,,,,
Q14134,TRIM29,Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein),30,47.5,31.84,27.93,31.47,28.6,23.58,,24.42,22.98,25.61,26.91,21.48,26.98,,26.53,5.31,1.4,4.94,2.08,-2.94, ,-2.11,-3.55,-0.92,0.39,-5.05,0.45, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;cytoplasm,,,,,,,,,,
Q13049,TRIM32,E3 ubiquitin-protein ligase TRIM32 (EC 6.3.2.-) (72 kDa Tat-interacting protein) (Tripartite motif-containing protein 32) (Zinc finger protein HT2A),5,10,25.56,27.04,,28.04,25.98,26.48,26.68,26.28,24.92,24.16,26.67,25.4,25.79,26.08,-0.52,0.95, ,1.96,-0.1,0.4,0.6,0.2,-1.17,-1.92,0.59,-0.69,-0.29,biological regulation;cell differentiation;cellular metabolic process;cellular process;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of cell cycle;response to abiotic stimulus;response to chemical stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
Q9UPN9,TRIM33,E3 ubiquitin-protein ligase TRIM33 (EC 6.3.2.-) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),6,6.5,28.92,25.59,28.24,26.74,26.46,28.09,24.26,27.1,24.71,27.88,24.57,26.48,27.09,26.63,2.29,-1.03,1.61,0.12,-0.16,1.47,-2.37,0.48,-1.92,1.26,-2.05,-0.15,0.46,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;nucleoplasm,Other TF domain,+,,,,,,,,
Q9C037,TRIM4,Tripartite motif-containing protein 4 (RING finger protein 87),5,20.7,,26.63,26.56,25.27,26.8,,23.93,27.33,27.4,24.63,26.87,26.35,25.94,26.15, ,0.47,0.4,-0.88,0.64, ,-2.23,1.17,1.25,-1.52,0.71,0.19,-0.22,cellular component assembly;cellular component organization;macromolecular complex assembly;protein complex assembly,cell part;cytoplasm;membrane;plasma membrane,,,,,,,,,,
Q9BRZ2,TRIM56,E3 ubiquitin-protein ligase TRIM56 (EC 6.3.2.-) (RING finger protein 109) (Tripartite motif-containing protein 56),6,7.4,26.14,25.42,,25.75,25.38,25.94,24.39,21.65,24.42,24.17,23.94,24.55,24.26,24.67,1.47,0.75, ,1.08,0.72,1.27,-0.28,-3.02,-0.24,-0.5,-0.73,-0.12,-0.4,cellular metabolic process;cellular process;cytokine production;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress,cell part;cytoplasm,,,,,,,,,,
Q9H2D6,TRIOBP,TRIO and F-actin-binding protein (Protein Tara) (Trio-associated repeat on actin),11,23.4,25.6,30.08,26.29,29.77,28.47,28.95,27.37,26.81,26.5,27.06,26.04,26.65,27.19,27.45,-1.84,2.64,-1.16,2.32,1.02,1.51,-0.08,-0.63,-0.94,-0.39,-1.4,-0.79,-0.26,biological regulation;cell division;cellular component organization;cellular metabolic process;cellular process;cytoskeleton organization;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;primary metabolic process;protein metabolic process;protein modification process;regulation of organelle organization,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;midbody;nucleus;organelle,,,,,,,,,,
Q15642,TRIP10,Cdc42-interacting protein 4 (Protein Felic) (Salt tolerant protein) (hSTP) (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10),12,29.2,28.78,27.35,27.55,27.81,25.28,,26.83,25.61,26.89,25.91,,26.38,,26.84,1.94,0.51,0.71,0.97,-1.56, ,-0.01,-1.23,0.05,-0.93, ,-0.46, ,biological regulation;cellular component organization;cellular membrane organization;cellular process;cytoskeleton organization;endocytosis;establishment of localization;membrane invagination;membrane organization;organelle organization;response to stimulus;signal transduction;transport;vesicle-mediated transport,cell cortex;cell part;cell projection;cytoskeleton;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q15643,TRIP11,Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230),22,15,27.74,29.15,28.14,29.45,28.63,28.66,28.06,27.4,29.49,29.46,27.65,28.1,28.71,28.51,-0.77,0.64,-0.37,0.94,0.12,0.15,-0.45,-1.11,0.98,0.95,-0.86,-0.41,0.19,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;Golgi vesicle transport;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA metabolic process;transcription from RNA polymerase II promoter;transport;vesicle-mediated transport,cell part;cytoskeleton;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,,,,,,,,,
Q14669,TRIP12,E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (E3 ubiquitin-protein ligase for Arf) (ULF) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),36,19.4,29.87,29.04,30.22,29.62,30.13,29.85,29.72,29.49,29.08,28.71,28.3,29.35,29.1,29.42,0.45,-0.38,0.8,0.2,0.71,0.43,0.3,0.07,-0.34,-0.71,-1.12,-0.08,-0.32,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;embryo development;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of DNA metabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
Q15645,TRIP13,Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein) (16E1-BP) (HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13),8,19,25.68,25.37,,28.2,28.63,27.48,27.59,28.11,26.37,,24.8,28.04,,27.03,-1.35,-1.65, ,1.17,1.61,0.45,0.57,1.08,-0.66, ,-2.23,1.02, ,anatomical structure development;biosynthetic process;cell development;cell maturation;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;developmental maturation;developmental process;DNA metabolic process;DNA recombination;DNA repair;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q15654,TRIP6,Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Opa-interacting protein 1) (OIP-1) (Zyxin-related protein 1) (ZRP-1),4,21.1,27.12,24.79,27.18,27.51,25.68,24.78,27.52,27.71,,,26.91,28.4,,26.76,0.36,-1.97,0.42,0.75,-1.08,-1.98,0.76,0.95, , ,0.15,1.64, ,biological regulation;biosynthetic process;cell junction organization;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of transport;RNA metabolic process,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NXH9,TRMT1,"tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)",6,17.5,28,26.93,25.4,27.47,27.14,24.86,25.14,25.97,26.81,25.02,25.66,26.61,28.09,26.39,1.61,0.53,-1,1.08,0.75,-1.53,-1.25,-0.42,0.42,-1.37,-0.73,0.22,1.7,,,,,,,,,,,,
Q7L0Y3,TRMT10C,Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (HBV pre-S2 trans-regulated protein 2) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (tRNA methyltransferase 10 homolog C),19,50.6,30.01,29.71,29.97,29.6,29.5,30.24,30.11,29.58,29.98,31.18,29.54,29.14,30.89,29.96,0.05,-0.25,0.01,-0.35,-0.46,0.28,0.16,-0.38,0.02,1.22,-0.41,-0.82,0.93,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9UI30,TRMT112,tRNA methyltransferase 112 homolog (TRM112-like protein),5,47.2,29.06,28.5,29.11,29.12,30.69,28.91,29.82,29.97,27.71,29.47,29.15,30.23,27.97,29.21,-0.14,-0.71,-0.1,-0.09,1.49,-0.3,0.61,0.76,-1.5,0.26,-0.06,1.02,-1.24,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;small molecule metabolic process,macromolecular complex;protein complex,,,,,,,,,,
Q7Z2T5,TRMT1L,TRMT1-like protein (EC 2.1.1.-),9,21.6,24.91,26.3,24.76,22.94,26.15,25.96,24.92,23.54,24.22,26.3,26.99,26.77,23.99,25.21,-0.3,1.09,-0.45,-2.27,0.94,0.75,-0.3,-1.67,-0.99,1.09,1.78,1.56,-1.22,behavior;multicellular organismal process;response to stimulus,,C2H2-type,,,,,,,,,
Q32P41,TRMT5,tRNA (guanine(37)-N1)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog),3,6.7,26.66,,25.04,25.54,,26.44,26.46,,26.61,25.97,24.12,,,25.86,0.8, ,-0.82,-0.31, ,0.59,0.61, ,0.75,0.11,-1.74, , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UJA5,TRMT6,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6),8,30.1,29.1,27.57,27.66,27.48,27.31,26.08,27.07,26.13,25.89,27.39,26.19,26.3,26.74,26.99,2.1,0.58,0.67,0.49,0.31,-0.91,0.08,-0.86,-1.11,0.4,-0.81,-0.69,-0.26,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA metabolic process;RNA processing;tRNA metabolic process;tRNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96FX7,TRMT61A,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A),6,30.4,28.29,26.14,27.47,25.52,26.99,21.38,27.05,25.15,24.12,26.53,26.55,26.65,27.69,26.12,2.17,0.02,1.35,-0.6,0.87,-4.74,0.93,-0.96,-1.99,0.41,0.43,0.53,1.57,,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;tRNA methyltransferase complex,,,,,,,,,,
Q96Q11,TRNT1,"CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)",9,27.8,29.2,28.69,29.01,28.39,27.39,28,27.74,28.28,28.72,28.4,28.04,27.7,27.68,28.25,0.95,0.44,0.76,0.14,-0.86,-0.25,-0.5,0.04,0.47,0.15,-0.21,-0.55,-0.57,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA metabolic process;RNA processing;transport;tRNA metabolic process;tRNA processing,cell part;centrosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;mitochondrion;organelle,,,,,,,,,,
P10155,TROVE2,60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (Ro 60 kDa autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2),16,35.9,31.29,30.44,29.51,30.7,30.54,30.55,30.58,30.59,30.89,29.7,30.29,29.98,30.53,30.43,0.86,0.01,-0.92,0.27,0.11,0.12,0.15,0.16,0.46,-0.73,-0.14,-0.45,0.1,anatomical structure morphogenesis;biosynthetic process;cellular component morphogenesis;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription from RNA polymerase III promoter,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q9Y4A5,TRRAP,Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog),15,5.5,27.03,24.26,27.19,23.56,26.58,26.23,26.08,23.44,27.42,27.31,,,25.69,25.89,1.14,-1.63,1.3,-2.33,0.69,0.34,0.19,-2.46,1.53,1.42, , ,-0.21,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of cell cycle;regulation of mitotic cell cycle;RNA metabolic process,cell part;macromolecular complex;protein complex;transcription factor complex,,+,,,,,,,,
F8W6R3,TSFM,"Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt)",12,50.2,29.13,29.18,30.04,28.78,28.71,29.27,28.48,28.97,30.62,29.97,29.1,29.91,30.45,29.43,-0.31,-0.25,0.61,-0.65,-0.72,-0.16,-0.95,-0.46,1.19,0.54,-0.34,0.48,1.02,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q99816,TSG101,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),10,32.9,27.33,27.09,26.31,27.16,27.5,27.22,28.09,28.63,26.25,27,28.74,28.95,27.06,27.49,-0.15,-0.4,-1.18,-0.33,0.01,-0.27,0.6,1.15,-1.23,-0.49,1.25,1.46,-0.43,biological regulation;catabolic process;cell differentiation;cell division;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;endosome transport;establishment of localization;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein modification process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;transport;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleolus;organelle;plasma membrane;protein complex,,,,,,,,,,
Q15631,TSN,Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO),9,44.8,30.57,30.53,28.8,30.31,29.12,28.44,30.05,29.76,29.27,29.05,28.95,30.52,27.17,29.43,1.14,1.11,-0.62,0.88,-0.31,-0.99,0.63,0.33,-0.15,-0.38,-0.48,1.1,-2.25,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA recombination;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q99598,TSNAX,Translin-associated protein X (Translin-associated factor X),13,58.3,30.26,29.43,27.38,29.06,28.5,27.82,29.01,28.62,28.46,27.89,29.28,28.95,27.03,28.59,1.67,0.84,-1.21,0.47,-0.09,-0.77,0.41,0.03,-0.13,-0.7,0.69,0.36,-1.56,cell differentiation;cellular process;developmental process;multicellular organismal development;multicellular organismal process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P30536,TSPO,Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR),4,43,30.06,29.51,29.46,29.72,28.62,28.4,28.77,28.5,30.25,29.67,29.65,29.09,29.7,29.34,0.72,0.17,0.12,0.38,-0.72,-0.94,-0.57,-0.84,0.91,0.34,0.31,-0.25,0.36,aging;anatomical structure development;anatomical structure morphogenesis;behavior;biological regulation;biosynthetic process;cell death;cell motility;cell proliferation;cellular component morphogenesis;cellular component movement;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;death;developmental process;establishment of localization;heterocycle metabolic process;ion transport;lipid metabolic process;locomotion;metabolic process;multicellular organismal process;nitrogen compound metabolic process;pigment metabolic process;primary metabolic process;protein targeting;protein transport;regulation of transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to osmotic stress;response to stimulus;response to stress;transport,cell part;membrane,,,,,,,,,,
Q9H0U9,TSPYL1,Testis-specific Y-encoded-like protein 1 (TSPY-like protein 1),2,7.1,28.31,26.64,30.03,28.93,,25.75,29.03,26.03,26.3,28.51,25.63,26.82,26.31,27.36,0.96,-0.72,2.67,1.57, ,-1.61,1.67,-1.33,-1.06,1.15,-1.73,-0.54,-1.05,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;chromatin organization;chromosome organization;macromolecular complex assembly;organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q2NL82,TSR1,Pre-rRNA-processing protein TSR1 homolog,10,14.8,28.62,27.17,27.63,27.98,29.11,26.2,27.84,27.92,27.09,27.82,25.33,27.93,27.33,27.53,1.08,-0.37,0.09,0.45,1.57,-1.33,0.3,0.38,-0.45,0.28,-2.2,0.39,-0.2,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;organelle assembly;ribonucleoprotein complex assembly;ribosome assembly,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q53HC9,TSSC1,Protein TSSC1 (Tumor-suppressing STF cDNA 1 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 1 protein),4,12.7,23.6,23.43,26.52,23.67,24.07,24,26.46,25.72,24.8,25.53,28.13,26.81,26.87,25.36,-1.76,-1.92,1.17,-1.68,-1.28,-1.36,1.1,0.37,-0.55,0.18,2.77,1.46,1.52,,,,,,,,,,,,
Q16762,TST,Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese),13,50.5,30.13,30.64,29.37,31.22,31.02,32.23,31.69,31.47,31.81,32.4,32.03,31.26,31.89,31.32,-1.19,-0.68,-1.94,-0.1,-0.3,0.91,0.37,0.15,0.49,1.08,0.71,-0.06,0.57,amine metabolic process;catabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound transport;organic acid metabolic process;primary metabolic process;small molecule metabolic process;sulfur compound metabolic process;transport,cell part;membrane;plasma membrane,,,,,,,,,,
Q13630,TSTA3,"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)",18,61.1,31.21,29.37,31.05,29.63,29.03,28.14,29.71,29.99,29.11,28.6,29.5,30.02,27.27,29.43,1.78,-0.06,1.62,0.2,-0.4,-1.3,0.28,0.56,-0.33,-0.84,0.07,0.58,-2.17,alcohol metabolic process;biological adhesion;biosynthetic process;carbohydrate metabolic process;cell adhesion;cell death;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;primary metabolic process;small molecule metabolic process,cell part;cytoplasm,,,,,,,,,,
Q8NFU3,TSTD1,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1,4,41.7,28.76,27.99,25.43,24.57,25.69,,25.29,27.02,,24.27,25.11,24.1,25.48,25.79,2.97,2.2,-0.36,-1.23,-0.1, ,-0.5,1.22, ,-1.52,-0.68,-1.7,-0.31,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q99614,TTC1,Tetratricopeptide repeat protein 1 (TPR repeat protein 1),4,17.8,28.37,27.91,27.13,28.4,,26.61,27.64,27.23,27.38,26.45,27.72,28.36,26.04,27.44,0.93,0.47,-0.31,0.96, ,-0.82,0.21,-0.2,-0.06,-0.99,0.29,0.92,-1.4,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;microbody;organelle,,,,,,,,,,
Q8NBP0,TTC13,Tetratricopeptide repeat protein 13 (TPR repeat protein 13),3,6.2,26.78,25.64,,25.89,,25.77,25.14,25.15,26.06,25.74,,26.12,25.97,25.83,0.96,-0.19, ,0.06, ,-0.06,-0.69,-0.68,0.24,-0.09, ,0.29,0.15,,,,,,,,,,,,
Q96AE7,TTC17,Tetratricopeptide repeat protein 17 (TPR repeat protein 17),6,7.3,29.16,27.35,27.91,27.52,27.1,27.4,27.21,26.81,27.87,27.98,27.74,25.97,28.43,27.57,1.58,-0.22,0.34,-0.05,-0.47,-0.17,-0.36,-0.76,0.3,0.4,0.17,-1.61,0.86,,,,,,,,,,,,
Q6DKK2,TTC19,"Tetratricopeptide repeat protein 19, mitochondrial (TPR repeat protein 19)",5,16.1,26.33,26.17,23.31,25.31,26.5,27.77,26.34,25.74,26.55,28.51,22.82,27.47,26.78,26.12,0.21,0.04,-2.81,-0.81,0.38,1.65,0.22,-0.38,0.42,2.39,-3.3,1.34,0.66,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;cytokinesis;macromolecular complex assembly;protein complex assembly;protein complex biogenesis,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;midbody;organelle,,,,,,,,,,
Q6PGP7,TTC37,Tetratricopeptide repeat protein 37 (TPR repeat protein 37) (SKI3 homolog) (Ski3) (Tricho-hepatic-enteric syndrome protein) (Thespin),15,12.5,27.09,28.72,28.78,28.82,27.54,28.73,29.28,29.35,27.93,28.03,29.31,29.53,28.63,28.6,-1.51,0.13,0.19,0.22,-1.06,0.14,0.68,0.75,-0.67,-0.56,0.71,0.93,0.03,,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
O95801,TTC4,Tetratricopeptide repeat protein 4 (TPR repeat protein 4),5,17.3,24.46,,23.64,,26.48,,25.73,26.57,,,23.72,26.06,22.62,24.91,-0.45, ,-1.27, ,1.57, ,0.82,1.66, , ,-1.19,1.15,-2.29,,,,,,,,,,,,
Q14166,TTLL12,Tubulin--tyrosine ligase-like protein 12,27,56.6,30.57,30.19,28.79,29.7,31.18,30.98,32.05,32.73,30.77,29.42,31.52,31.3,27.05,30.48,0.09,-0.29,-1.69,-0.79,0.7,0.5,1.57,2.25,0.28,-1.06,1.04,0.82,-3.43,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process,,,,,,,,,,,
Q9C0H2,TTYH3,Protein tweety homolog 3 (hTTY3),6,19.3,23.66,,20.37,26.88,29.94,29.74,25.87,28.09,26.45,26.62,23.69,24.61,23.8,25.81,-2.15, ,-5.44,1.07,4.13,3.93,0.06,2.28,0.64,0.81,-2.12,-1.2,-2.01,,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q71U36,TUBA1A,Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain),3,6.7,31.21,30.89,30.43,32.13,31.43,29.68,31.61,31.64,29.96,29.19,32.11,32.37,30.38,31,0.21,-0.11,-0.57,1.12,0.43,-1.32,0.61,0.64,-1.04,-1.82,1.11,1.37,-0.63,cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization;transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
P68363,TUBA1B,Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain),44,78,36.27,35.91,36.21,36.63,36.06,35.39,36.55,36.53,35.16,35.28,36.36,36.73,35.16,36.02,0.25,-0.11,0.19,0.61,0.04,-0.63,0.53,0.51,-0.86,-0.74,0.34,0.71,-0.86,cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cytoskeleton organization;cytoskeleton-dependent intracellular transport;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;organelle organization;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q9BQE3,TUBA1C,Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain),5,15.8,27.44,27.3,28.53,27.88,31.05,27.27,28.94,28.8,25.95,26.68,28.96,28.69,26.33,27.99,-0.55,-0.69,0.54,-0.11,3.07,-0.71,0.95,0.82,-2.04,-1.31,0.98,0.7,-1.65,cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;cytoskeleton-dependent intracellular transport;establishment of localization;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
P68366,TUBA4A,Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain),11,19.6,29.79,28.75,31.35,28.88,30.34,28.57,30.92,29.85,28.25,29.48,30.91,30.98,28.63,29.75,0.05,-0.99,1.61,-0.86,0.6,-1.18,1.17,0.1,-1.5,-0.27,1.16,1.23,-1.12,cell activation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;establishment of localization;exocytosis;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization;secretion;transport;vesicle-mediated transport,cell part;cytosol;extracellular region;macromolecular complex;protein complex,,,,,,,,,,
A6NHL2,TUBAL3,Tubulin alpha chain-like 3,2,7.9,28.25,26.99,,26.33,,,25.86,28.13,29.11,,,26.51,,27.31,0.94,-0.32, ,-0.98, , ,-1.45,0.82,1.8, , ,-0.8, ,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein polymerization,cell part;cytoplasm;macromolecular complex;protein complex,,,,,,,,,,
Q5JP53,TUBB,Tubulin beta chain,11,22.8,34.39,33.87,34.14,34.55,34.3,33.58,34.36,34.54,32.77,32.59,34.39,34.68,33.43,33.97,0.42,-0.1,0.17,0.58,0.33,-0.39,0.4,0.57,-1.2,-1.38,0.42,0.71,-0.54,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;protein complex assembly;protein polymerization,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
Q13885,TUBB2A,Tubulin beta-2A chain (Tubulin beta class IIa),7,19.6,29.37,30.1,30.21,31.5,30.1,29.33,30.78,31.5,28.55,28.77,31.91,31.97,29.89,30.31,-0.94,-0.21,-0.1,1.2,-0.2,-0.97,0.47,1.2,-1.76,-1.53,1.6,1.66,-0.42,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization,cell part;cytoplasm;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q13509,TUBB3,Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III),9,34.7,28.45,30.18,30.81,30.99,31.66,29.21,31.74,32.22,29.74,30.39,32.48,32.12,30.89,30.84,-2.39,-0.65,-0.02,0.16,0.82,-1.63,0.9,1.38,-1.09,-0.45,1.64,1.28,0.06,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;locomotion;macromolecular complex assembly;macromolecule metabolic process;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization;response to chemical stimulus;response to external stimulus;response to stimulus,cell part;cell projection;cytoplasm;macromolecular complex;membrane;neuron projection;plasma membrane;protein complex,,,,,,,,,,
P04350,TUBB4A,Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain),5,12.4,26.69,29.39,28.12,30.11,27.9,27.98,30.41,31.08,27.73,26.97,30.45,28.96,28.3,28.78,-2.08,0.61,-0.65,1.33,-0.88,-0.8,1.64,2.31,-1.05,-1.81,1.68,0.19,-0.48,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization,cell body;cell part;cell projection;cilium;cytosol;macromolecular complex;membrane;neuronal cell body;plasma membrane;protein complex,,,,,,,,,,
P68371,TUBB4B,Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain),39,71.2,36.35,36.3,36.54,36.96,36.4,35.92,36.68,36.82,35.23,35.5,36.57,36.91,35.09,36.25,0.1,0.05,0.29,0.7,0.15,-0.33,0.43,0.57,-1.03,-0.75,0.32,0.66,-1.16,biological regulation;cell killing;cellular component assembly;cellular component movement;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;immune system process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization;response to stimulus;response to stress,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9BUF5,TUBB6,Tubulin beta-6 chain (Tubulin beta class V),20,60.8,30.83,32.18,31.63,33.44,32.4,31.81,33.45,33.65,31.72,31.1,33.15,33.56,31.34,32.33,-1.5,-0.15,-0.7,1.12,0.07,-0.52,1.12,1.32,-0.61,-1.23,0.82,1.24,-0.99,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein complex assembly;protein folding;protein metabolic process;protein polymerization,cell part;cytoplasm;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
P23258,TUBG1,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),9,30.4,26.96,28.8,27.6,29.1,28.85,28.14,28.88,29.17,28.31,27.74,29.53,29.67,28.16,28.53,-1.57,0.26,-0.93,0.57,0.32,-0.4,0.35,0.64,-0.22,-0.79,1,1.13,-0.37,cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;cytoskeleton organization;macromolecular complex assembly;organelle organization;protein complex assembly;protein polymerization,apical part of cell;cell leading edge;cell part;centrosome;chromosome;cytosol;gamma-tubulin complex;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nuclear chromosome;organelle;protein complex,,,,,,,,,,
Q9BSJ2,TUBGCP2,Gamma-tubulin complex component 2 (GCP-2) (hGCP2) (Gamma-ring complex protein 103 kDa) (h103p) (hGrip103) (Spindle pole body protein Spc97 homolog) (hSpc97),9,11.2,25,25.91,,27.02,26.69,25.18,26.35,25.59,,24.66,25.84,25.05,25.47,25.7,-0.71,0.21, ,1.31,0.98,-0.53,0.64,-0.12, ,-1.04,0.13,-0.65,-0.23,cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;macromolecular complex assembly;organelle organization;protein complex assembly,cell part;centrosome;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;microtubule organizing center;nucleus;organelle;protein complex,,,,,,,,,,
P49411,TUFM,"Elongation factor Tu, mitochondrial (EF-Tu) (P43)",47,78.5,34.07,34.61,34,33.86,33.63,34.38,33.85,33.29,34.31,34.72,33.58,33.37,33.93,33.97,0.1,0.64,0.03,-0.11,-0.34,0.41,-0.12,-0.68,0.34,0.75,-0.38,-0.6,-0.04,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q13454,TUSC3,Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33),3,12.3,27.23,28.17,28.51,27.14,27,28.2,24.89,,28.96,26.97,27.58,24.66,28.18,27.29,-0.06,0.88,1.22,-0.15,-0.29,0.91,-2.4, ,1.66,-0.32,0.29,-2.64,0.89,biological regulation;carbohydrate metabolic process;cellular homeostasis;cellular metabolic process;cellular process;establishment of localization;homeostatic process;ion transport;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;organelle;protein complex,,,,,,,,,,
Q9NYZ1,TVP23B,Golgi apparatus membrane protein TVP23 homolog B,4,25.9,26.09,26.32,25.65,26.06,25.51,25.64,26.06,,26.64,26.82,26.1,,25.92,26.07,0.01,0.25,-0.42,-0.01,-0.56,-0.44,-0.01, ,0.57,0.74,0.02, ,-0.15,,cell part,,,,,,,,,,
Q12792,TWF1,Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9),18,49.4,31.03,30.51,30.84,30.79,30.52,30.48,31.18,31.24,30.52,30.41,31.34,30.51,30.28,30.74,0.29,-0.23,0.1,0.05,-0.23,-0.26,0.44,0.5,-0.22,-0.34,0.6,-0.23,-0.46,biological regulation;cellular component organization;regulation of organelle organization;regulation of protein modification process,cell part;cell projection;cytoskeleton;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q6IBS0,TWF2,Twinfilin-2 (A6-related protein) (hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein),25,72.5,31.19,32.18,32.1,32.05,31.19,30.39,31.69,31.86,31.23,30.65,31.38,30.63,29.25,31.21,-0.02,0.97,0.89,0.83,-0.03,-0.82,0.47,0.65,0.01,-0.56,0.17,-0.58,-1.97,biological regulation;cell communication;cellular component organization;cellular process;regulation of organelle organization;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus,cell part;cell projection;cytoskeleton;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;microvillus;organelle;site of polarized growth,,,,,,,,,,
Q3B726,TWISTNB,DNA-directed RNA polymerase I subunit RPA43 (Twist neighbor protein),4,20.1,25.97,24.19,25.63,25.77,27.05,27.4,25.78,26.59,25.19,,26.74,26.19,27.17,26.14,-0.17,-1.95,-0.51,-0.37,0.91,1.26,-0.36,0.45,-0.95, ,0.6,0.05,1.03,biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P40222,TXLNA,Alpha-taxilin,8,15.9,25.46,27.16,29.2,28.42,28.46,28.09,28.81,29.24,27.69,28.1,28.93,25.82,28.05,27.96,-2.5,-0.8,1.24,0.46,0.5,0.14,0.85,1.28,-0.26,0.14,0.98,-2.14,0.09,cell proliferation;cellular process;establishment of localization;exocytosis;secretion;transport;vesicle-mediated transport,cell part;cytoplasm;extracellular region,,,,,,,,,,
P10599,TXN,Thioredoxin (Trx) (ATL-derived factor) (ADF) (Surface-associated sulphydryl protein) (SASP),9,66.7,32.43,33.48,33.18,33.9,31.88,32.1,32.74,32.98,31.1,32.33,34.19,34.49,31.07,32.76,-0.33,0.72,0.43,1.14,-0.87,-0.66,-0.02,0.22,-1.66,-0.43,1.43,1.73,-1.69,biological regulation;biosynthetic process;cell communication;cell proliferation;cell-cell signaling;cellular component movement;cellular homeostasis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;drug metabolic process;generation of precursor metabolites and energy;glycerol ether metabolic process;homeostatic process;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;primary metabolic process;regulation of transport;response to abiotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;signaling;small molecule metabolic process,cell body;cell part;cell projection;cytosol;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;neuron projection;neuronal cell body;nucleoplasm;organelle,,,,,,,,,,
Q99757,TXN2,"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)",3,13.3,23.4,27.49,27.81,26.81,27.16,28.53,27.1,27.27,27.93,28.65,26.57,28.17,27.9,27.29,-3.89,0.2,0.52,-0.49,-0.13,1.24,-0.19,-0.02,0.64,1.35,-0.72,0.88,0.61,biological regulation;cell communication;cellular homeostasis;cellular metabolic process;cellular process;generation of precursor metabolites and energy;glycerol ether metabolic process;homeostatic process;metabolic process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to stimulus;response to stress;small molecule metabolic process,cell body;cell part;cell projection;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;neuron projection;neuronal cell body;nucleolus;organelle,,,,,,,,,,
O95881,TXNDC12,Thioredoxin domain-containing protein 12 (EC 1.8.4.2) (Endoplasmic reticulum resident protein 18) (ER protein 18) (ERp18) (Endoplasmic reticulum resident protein 19) (ER protein 19) (ERp19) (Thioredoxin-like protein p19) (hTLP19),11,54.7,30.81,31.7,31.42,30.92,31.4,31.84,31.07,31.12,31.57,31.79,31.22,30.83,31.58,31.33,-0.52,0.37,0.09,-0.41,0.07,0.51,-0.26,-0.21,0.24,0.46,-0.11,-0.5,0.25,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part,,,,,,,,,,
Q96J42,TXNDC15,Thioredoxin domain-containing protein 15,4,11.9,24.52,25.74,24.89,27.46,27.47,27.23,25.73,24.63,26.73,25.78,26.17,27.1,26.3,26.13,-1.61,-0.4,-1.25,1.32,1.33,1.09,-0.4,-1.5,0.6,-0.36,0.04,0.97,0.16,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part,,,,,,,,,,
Q9BRA2,TXNDC17,Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5),7,52.8,30.37,30.1,30.3,30.16,28.91,28.12,29.83,29.86,27.7,28.23,29.88,30.62,26.88,29.3,1.06,0.8,1,0.85,-0.4,-1.18,0.53,0.56,-1.61,-1.07,0.57,1.31,-2.42,biological regulation;cellular process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytosol,,,,,,,,,,
Q86UY0,TXNDC5,Protein BLOC1S5-TXNDC5 (TXNDC5 protein) (Thioredoxin domain-containing protein 5),31,71.4,32.88,34.08,33.09,33.73,33.8,33.98,33.15,33.33,33.85,33.21,32.95,32.13,33.79,33.38,-0.51,0.7,-0.29,0.34,0.42,0.6,-0.23,-0.05,0.46,-0.17,-0.43,-1.25,0.41,biological regulation;cellular homeostasis;cellular process;glycerol ether metabolic process;homeostatic process;metabolic process;small molecule metabolic process,,,,,,,,,,,
O14530,TXNDC9,Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4),5,26.1,26.23,25.55,27.63,27.89,27.2,26.12,27.35,27.67,25.25,26.22,27.35,26.97,26.06,26.73,-0.5,-1.18,0.9,1.16,0.47,-0.61,0.61,0.94,-1.48,-0.51,0.62,0.24,-0.67,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part;centrosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;midbody;nucleus;organelle,,,,,,,,,,
Q9H3M7,TXNIP,Thioredoxin-interacting protein (Thioredoxin-binding protein 2) (Vitamin D3 up-regulated protein 1),6,21.5,,28.24,27.27,27.89,24.46,26.47,25.72,24.82,26.49,24.49,,26.26,26.08,26.2, ,2.04,1.08,1.7,-1.74,0.27,-0.48,-1.38,0.29,-1.71, ,0.06,-0.12,biological regulation;biosynthetic process;cell cycle;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;response to abiotic stimulus;response to biotic stimulus;response to chemical stimulus;response to drug;response to endogenous stimulus;response to external stimulus;response to oxidative stress;response to stimulus;response to stress;RNA metabolic process;signal transduction;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43396,TXNL1,Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein),18,51.6,31.2,30.75,31.03,30.98,30.61,29.99,30.58,31.21,29.35,30.34,30.34,31.3,29.71,30.57,0.63,0.18,0.46,0.41,0.04,-0.58,0.01,0.64,-1.21,-0.23,-0.23,0.73,-0.86,biological regulation;cellular homeostasis;cellular metabolic process;cellular process;generation of precursor metabolites and energy;glycerol ether metabolic process;homeostatic process;metabolic process;small molecule metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;proteasome complex;protein complex,,,,,,,,,,
P83876,TXNL4A,Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD),5,33.8,27.91,,26.63,26.43,,25.5,,24.74,25.74,25.56,,,,26.07,1.84, ,0.56,0.36, ,-0.57, ,-1.33,-0.34,-0.51, , , ,cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular process;macromolecular complex assembly;mitosis;nuclear division;organelle fission;organelle organization;ribonucleoprotein complex assembly,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q16881,TXNRD1,"Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1)",33,66.4,32.83,32.34,31.26,33.89,32.86,32.24,34.05,33.73,31.37,31.61,33.78,34.56,31.75,32.79,0.04,-0.45,-1.53,1.1,0.07,-0.55,1.26,0.94,-1.42,-1.18,0.99,1.77,-1.04,amine metabolic process;anatomical structure development;anatomical structure formation involved in morphogenesis;biological regulation;catabolic process;cell proliferation;cellular amino acid metabolic process;cellular aromatic compound metabolic process;cellular component assembly;cellular component organization;cellular homeostasis;cellular ketone metabolic process;cellular lipid metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;developmental process;generation of precursor metabolites and energy;heterocycle metabolic process;homeostatic process;lipid metabolic process;macromolecular complex assembly;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;organic acid metabolic process;organometal metabolic process;peptide metabolic process;primary metabolic process;protein complex assembly;response to chemical stimulus;response to drug;response to oxidative stress;response to stimulus;response to stress;signal transduction;small molecule metabolic process;sulfur compound metabolic process,cell body;cell part;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;mitochondrion;neuronal cell body;nucleolus;organelle,,,,,,,,,,
Q17RE6,TXNRD2,TXNRD2 protein,10,34.1,29.03,29.45,28.93,28.16,28.59,30.02,27.73,28.89,30.02,29.93,29,29.46,29.29,29.12,-0.09,0.33,-0.19,-0.95,-0.52,0.91,-1.38,-0.23,0.9,0.81,-0.12,0.35,0.18,biological regulation;cellular homeostasis;cellular process;homeostatic process,cell part;cytoplasm,,,,,,,,,,
Q01081,U2AF1,Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit),9,34.2,31.37,31.12,30.76,31.17,31.02,31.65,30.87,30.3,31.76,31.2,30.13,30.53,30.88,30.98,0.39,0.14,-0.23,0.19,0.04,0.67,-0.11,-0.68,0.78,0.22,-0.85,-0.45,-0.11,"biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
P26368,U2AF2,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),19,43.9,31.97,31.35,32.33,31.93,31.79,31.91,31.51,31.55,32.11,31.9,31.07,32.27,31.98,31.82,0.15,-0.47,0.51,0.11,-0.03,0.09,-0.31,-0.27,0.29,0.08,-0.75,0.45,0.16,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription termination, DNA-dependent;transport",cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
O15042,U2SURP,U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140),25,27.1,30.11,29.11,30.26,29.98,30.26,30.55,29.8,29.95,29.53,29.12,28.84,28.1,28.9,29.58,0.53,-0.47,0.68,0.4,0.69,0.97,0.22,0.37,-0.05,-0.46,-0.74,-1.48,-0.68,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q16222,UAP1,UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1);UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)],19,43.8,27.65,30.12,29.36,31.73,30.46,29.22,30.81,31.07,28.93,21.72,30.1,31.66,29.69,29.42,-1.78,0.7,-0.07,2.31,1.04,-0.21,1.38,1.64,-0.5,-7.7,0.68,2.24,0.26,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;oligosaccharide metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
P22314,UBA1,Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1),64,58.1,34.58,35.18,34.17,34.74,34.14,34.4,34.66,34.69,34.11,33.25,34.5,35.04,34.31,34.44,0.13,0.74,-0.28,0.3,-0.31,-0.04,0.21,0.24,-0.33,-1.2,0.06,0.6,-0.13,cell death;cellular metabolic process;cellular process;death;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,,,,,,,,,,,
Q9UBT2,UBA2,SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B),22,57.8,31.85,30.31,30.47,30.73,29.37,30.6,30.31,28.88,30.37,29.83,29.88,30.3,30.19,30.24,1.61,0.07,0.24,0.49,-0.87,0.36,0.07,-1.36,0.13,-0.41,-0.35,0.06,-0.05,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8TBC4,UBA3,NEDD8-activating enzyme E1 catalytic subunit (EC 6.3.2.-) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),9,31.6,28.84,28.22,27.06,28.2,28.08,28.49,27.7,28.42,28.76,26.52,30.37,27.07,27.16,28.07,0.77,0.15,-1.01,0.13,0.01,0.43,-0.36,0.35,0.69,-1.55,2.3,-1,-0.91,biological regulation;cell cycle;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mitotic cell cycle;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;regulation of cell cycle,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9GZZ9,UBA5,Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1),5,21,25.91,27.19,,26.57,,,25.92,25.87,24.77,,25.1,25.83,,25.9,0.01,1.3, ,0.67, , ,0.02,-0.02,-1.12, ,-0.8,-0.06, ,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
A0AVT1,UBA6,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),21,23.1,30.7,30.74,30.75,30.72,30.32,29.54,30.12,30.39,29.6,28.9,30.66,30.85,30.63,30.3,0.4,0.44,0.45,0.42,0.01,-0.76,-0.18,0.09,-0.71,-1.4,0.36,0.55,0.33,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cytoplasm,,,,,,,,,,
P41226,UBA7,Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (D8) (Ubiquitin-activating enzyme E1 homolog),8,12.5,27.27,28.13,29.38,28.46,26.86,26.27,,26.58,,26.26,,23.06,25.58,26.78,0.48,1.35,2.59,1.68,0.08,-0.52, ,-0.21, ,-0.52, ,-3.72,-1.21,biological regulation;catabolic process;cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol,,,,,,,,,,
Q5T6F2,UBAP2,Ubiquitin-associated protein 2 (UBAP-2),3,7.2,26.05,24.77,24.16,26.36,27.4,25.25,27.11,27.53,24.38,,,25.62,,25.86,0.18,-1.09,-1.71,0.5,1.54,-0.62,1.25,1.67,-1.48, , ,-0.25, ,,,,,,,,,,,,
Q14157,UBAP2L,Ubiquitin-associated protein 2-like (Protein NICE-4),20,29.7,30.57,29.18,29.47,30.19,30.27,29.71,30.41,30.32,29.71,29.3,30.59,30.57,29.95,30.02,0.55,-0.84,-0.54,0.17,0.25,-0.31,0.39,0.3,-0.31,-0.72,0.57,0.55,-0.07,cell recognition;cellular process,,,,,,,,,,,
D6RAW0,UBE2D3,Ubiquitin-conjugating enzyme E2 D3 (Fragment),3,48.6,29.39,29.58,27.69,29.17,29.61,28.69,29.65,30.03,28.54,28.65,27.29,30.59,27.47,28.95,0.44,0.63,-1.26,0.22,0.66,-0.26,0.7,1.08,-0.41,-0.3,-1.66,1.64,-1.48,,,,,,,,,,,,
P51965,UBE2E1,Ubiquitin-conjugating enzyme E2 E1 (EC 6.3.2.19) (UbcH6) (Ubiquitin carrier protein E1) (Ubiquitin-protein ligase E1),4,44.9,28.03,26.45,27.21,26.98,26.92,,27.78,27.71,27.04,26.3,,27.05,,27.15,0.89,-0.7,0.07,-0.17,-0.23, ,0.63,0.57,-0.11,-0.85, ,-0.1, ,biological regulation;catabolic process;cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;ubiquitin ligase complex,,,,,,,,,,
P62253,UBE2G1,Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1),3,17.6,24.89,26.58,26.1,25.63,,,25.66,25.05,,25.16,23.78,,,25.36,-0.47,1.22,0.75,0.27, , ,0.3,-0.31, ,-0.19,-1.57, , ,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,,,,,,,,,,,
P62256,UBE2H,Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H),3,67.7,26.64,25.85,26.78,27.45,26.15,25.07,27.17,26.57,24.78,,25.66,28.34,,26.4,0.23,-0.55,0.38,1.04,-0.26,-1.33,0.77,0.17,-1.63, ,-0.75,1.93, ,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,,,,,,,,,,,
H3BQQ9,UBE2I,SUMO-conjugating enzyme UBC9 (Fragment),8,64.2,31.78,31.14,31.74,30.87,30.11,30.91,30.35,30.64,31.03,30.48,30,30.81,30.45,30.79,0.98,0.34,0.95,0.08,-0.69,0.12,-0.44,-0.15,0.24,-0.31,-0.79,0.01,-0.34,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cell projection;neuron projection;synapse,,,,,,,,,,
Q9Y385,UBE2J1,Ubiquitin-conjugating enzyme E2 J1 (EC 6.3.2.19) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e),8,32.4,28.15,27.12,25.32,26.45,27.23,27.86,27.69,27.27,28.14,26.71,27.55,25.92,28.11,27.19,0.96,-0.07,-1.88,-0.74,0.04,0.67,0.5,0.08,0.95,-0.48,0.35,-1.27,0.91,carbohydrate metabolic process;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein glycosylation;protein metabolic process;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;membrane,,,,,,,,,,
P61086,UBE2K,Ubiquitin-conjugating enzyme E2 K (EC 6.3.2.19) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),6,47.5,27.45,27.99,28.78,29.02,29.09,27.25,29.13,28.46,27.15,27.52,28.65,28.68,26.6,28.14,-0.69,-0.15,0.64,0.88,0.95,-0.89,0.99,0.33,-0.98,-0.61,0.51,0.54,-1.54,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cytoplasm,,,,,,,,,,
P68036,UBE2L3,Ubiquitin-conjugating enzyme E2 L3 (EC 6.3.2.19) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3),2,31.1,28.87,26.67,28.94,29.04,,20.45,28.32,27.6,22.93,21.7,28.79,29.56,26.3,26.6,2.27,0.08,2.35,2.44, ,-6.15,1.72,1,-3.67,-4.9,2.19,2.97,-0.29,biological regulation;biosynthetic process;catabolic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to endogenous stimulus;response to stimulus;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
O14933,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6 (EC 6.3.2.19) (Retinoic acid-induced gene B protein) (RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6),7,56.2,27.82,27.76,27.89,28.88,26.44,,,24.9,,,25.79,27.15,,27.08,0.74,0.68,0.81,1.8,-0.64, , ,-2.18, , ,-1.29,0.08, ,biological regulation;catabolic process;cellular metabolic process;cellular process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol,,,,,,,,,,
P61081,UBE2M,NEDD8-conjugating enzyme Ubc12 (EC 6.3.2.-) (NEDD8 carrier protein) (NEDD8 protein ligase) (Ubiquitin-conjugating enzyme E2 M),8,39.3,30.6,29.91,29.13,29.56,29.78,29.05,29.52,29.94,28.74,27.92,29.05,28.31,27.32,29.14,1.46,0.77,-0.01,0.42,0.64,-0.09,0.38,0.8,-0.4,-1.22,-0.09,-0.83,-1.82,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,,,,,,,,,,,
P61088,UBE2N,Ubiquitin-conjugating enzyme E2 N (EC 6.3.2.19) (Bendless-like ubiquitin-conjugating enzyme) (Ubc13) (UbcH13) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N),14,71.1,32.48,32.05,31.88,32.12,30.94,30.36,31.68,31.59,30.68,30.43,31.12,32.03,29.27,31.28,1.2,0.77,0.6,0.84,-0.34,-0.92,0.4,0.31,-0.6,-0.85,-0.15,0.75,-2.01,biological regulation;catabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA recombination;DNA repair;histone modification;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of DNA metabolic process;regulation of organelle organization;regulation of protein modification process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin conjugating enzyme complex;ubiquitin ligase complex,,,,,,,,,,
Q9C0C9,UBE2O,Ubiquitin-conjugating enzyme E2 O (EC 6.3.2.19) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),9,9.1,25.99,27.32,24.03,27.41,26.63,,26.76,27.15,,24.44,,28.26,,26.44,-0.45,0.87,-2.41,0.97,0.19, ,0.32,0.71, ,-2.01, ,1.82, ,,,,,,,,,,,,
Q13404,UBE2V1,Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A),13,76.9,31.48,31.17,30.72,31.55,30.83,30.03,31.64,31.13,28.78,28.62,31.39,30.74,28.84,30.53,0.94,0.64,0.19,1.02,0.3,-0.5,1.11,0.6,-1.75,-1.91,0.85,0.2,-1.69,biological regulation;cell differentiation;cellular metabolic process;cellular process;developmental process;immune system process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of DNA metabolic process;response to stimulus;response to stress;signal transduction,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin conjugating enzyme complex;ubiquitin ligase complex,,,,,,,,,,
Q15819,UBE2V2,Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein),4,32.4,27.34,28.69,27.43,27.92,28.91,26.3,27.39,29.23,26.36,26.82,27.18,26.05,,27.47,-0.13,1.22,-0.04,0.45,1.44,-1.17,-0.08,1.76,-1.11,-0.65,-0.29,-1.42, ,biological regulation;catabolic process;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of DNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin conjugating enzyme complex,,,,,,,,,,
Q9H832,UBE2Z,Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Uba6-specific E2 conjugating enzyme 1) (Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),5,21.5,27.05,27.32,27.35,27.53,,26.11,27.53,28.49,26.26,,27.69,27.09,,27.24,-0.2,0.07,0.11,0.29, ,-1.13,0.29,1.25,-0.98, ,0.45,-0.16, ,cell death;cellular process;death,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q05086,UBE3A,Ubiquitin-protein ligase E3A (EC 6.3.2.-) (E6AP ubiquitin-protein ligase) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),8,12.9,27.61,27.98,26.32,27.46,26.61,26.75,26.27,27.09,26.25,22.44,23.86,27.29,25.38,26.26,1.35,1.72,0.06,1.21,0.35,0.5,0.02,0.84,-0.01,-3.82,-2.4,1.04,-0.87,anatomical structure development;biological regulation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;developmental process;endocytosis;establishment of localization;growth;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;membrane invagination;membrane organization;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to stimulus;rhythmic process;signal transduction;transport;vesicle-mediated transport,cell part;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;proteasome complex;protein complex,,,,,,,,,,
Q15386,UBE3C,Ubiquitin-protein ligase E3C (EC 6.3.2.-) (HectH2),9,14.4,27.96,27.45,26.48,26.8,27.5,26.77,28.3,27.64,27.11,26.89,27.37,28.08,25.61,27.23,0.73,0.22,-0.75,-0.43,0.27,-0.45,1.07,0.41,-0.12,-0.34,0.14,0.86,-1.62,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;proteasome complex;protein complex,,,,,,,,,,
Q14139,UBE4A,Ubiquitin conjugation factor E4 A,12,16.8,29.38,28.23,30.1,27.45,29.04,29.52,27.6,29.71,29.31,28.26,28.73,28.97,30.08,28.95,0.43,-0.73,1.15,-1.5,0.09,0.57,-1.36,0.76,0.36,-0.69,-0.22,0.02,1.13,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cytoplasm;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
O95155,UBE4B,Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2),6,8.3,,23.19,26.93,25.99,22.85,23.27,25.06,25.14,26.59,,26.01,,,25, ,-1.81,1.93,0.99,-2.15,-1.74,0.05,0.14,1.58, ,1, , ,anatomical structure morphogenesis;biological regulation;cellular component organization;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;response to abiotic stimulus;response to stimulus;response to stress,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex;ubiquitin ligase complex,,,,,,,,,,
P11441,UBL4A,Ubiquitin-like protein 4A (Ubiquitin-like protein GDX),5,37.6,24.11,26.09,24.88,25.61,,,26.03,24.56,,25.09,24.45,25.58,,25.16,-1.04,0.94,-0.27,0.45, , ,0.87,-0.6, ,-0.06,-0.7,0.42, ,cellular localization;cellular metabolic process;cellular process;establishment of localization;localization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification process;transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q96S82,UBL7,Ubiquitin-like protein 7 (Bone marrow stromal cell ubiquitin-like protein) (BMSC-UbP) (Ubiquitin-like protein SB132),2,14.7,,24.44,24.83,25.32,,,25.49,26.45,,25.46,25.61,24.9,,25.31, ,-0.87,-0.49,0.01, , ,0.17,1.13, ,0.15,0.3,-0.41, ,,,,,,,,,,,,
Q8WVY7,UBLCP1,Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1),8,18.9,28.54,28.05,27.37,28.05,28.3,26.91,27.92,28.21,28.03,25.18,27.04,27.76,27.35,27.59,0.95,0.46,-0.23,0.46,0.7,-0.69,0.33,0.62,0.43,-2.41,-0.55,0.17,-0.24,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9UMX0,UBQLN1,Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1),14,26.5,30.33,30.28,29.74,31.15,30.57,30.54,30.89,30.99,30.67,30,30.64,31.27,30.5,30.58,-0.25,-0.31,-0.85,0.57,-0.01,-0.04,0.3,0.41,0.08,-0.58,0.06,0.68,-0.08,biological regulation;cellular process;regulation of protein modification process;response to chemical stimulus;response to stimulus;response to stress,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;proteasome complex;protein complex,,,,,,,,,,
Q9UHD9,UBQLN2,Ubiquilin-2 (Chap1) (DSK2 homolog) (Protein linking IAP with cytoskeleton 2) (PLIC-2) (hPLIC-2) (Ubiquitin-like product Chap1/Dsk2),3,10,27.03,27.6,26.96,28.63,27.82,27.03,27.73,29.16,26.9,26.3,27.73,28.16,26.3,27.49,-0.46,0.11,-0.53,1.14,0.34,-0.46,0.24,1.67,-0.59,-1.19,0.24,0.67,-1.19,cell death;cellular process;death,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1),57,12.6,30.81,30.68,29.7,30.68,29.4,29.52,31.34,30.98,29.38,29.37,31.62,30.92,29.93,30.33,0.47,0.34,-0.63,0.35,-0.93,-0.82,1.01,0.65,-0.95,-0.96,1.29,0.59,-0.4,interspecies interaction between organisms;multi-organism process,cell part;cytoplasm;cytoskeleton;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O95071,UBR5,"E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)",15,6.5,27.47,,22.68,25.64,27.17,27.52,23.72,24.75,26.46,26.08,25.83,24.56,26.62,25.71,1.76, ,-3.03,-0.07,1.46,1.82,-1.99,-0.96,0.75,0.37,0.13,-1.15,0.91,biological regulation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of DNA metabolic process;regulation of transport;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9HAC8,UBTD1,Ubiquitin domain-containing protein 1,3,10.6,24.7,25.19,20.2,25.97,26.06,27.3,26.01,24.11,25.95,23.71,,26.07,27.28,25.21,-0.51,-0.02,-5.01,0.76,0.85,2.08,0.79,-1.1,0.74,-1.5, ,0.86,2.07,,,,,,,,,,,,
P17480,UBTF,Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1) (UBF-1),15,23.1,30.19,28.15,29.4,29.06,29.69,30.17,28.83,28.38,29.76,30.15,27.57,28.09,28.08,29.04,1.15,-0.89,0.36,0.02,0.65,1.13,-0.21,-0.66,0.72,1.11,-1.47,-0.95,-0.96,"biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;growth;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;transcription elongation, DNA-dependent;transcription initiation, DNA-dependent;transcription termination, DNA-dependent",cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,HMG-box,,,,,,,,,
Q04323,UBXN1,UBX domain-containing protein 1 (SAPK substrate protein 1) (UBA/UBX 33.3 kDa protein),5,21.7,28.93,28.49,27.06,29.34,28.37,28.81,28.85,29.5,28.1,26.84,28.94,29.38,28.55,28.55,0.38,-0.06,-1.49,0.79,-0.18,0.25,0.3,0.95,-0.45,-1.71,0.39,0.83,0,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process,cell body;cell part;cell projection;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;neuron projection;neuronal cell body;nucleus;organelle;protein complex,,,,,,,,,,
Q92575,UBXN4,UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2),7,17.3,28.83,29.65,28.82,28.72,29.8,28.76,29.03,28.87,30.36,29.43,29.45,28.58,29.25,29.2,-0.37,0.45,-0.37,-0.48,0.6,-0.44,-0.16,-0.33,1.16,0.23,0.26,-0.62,0.05,response to chemical stimulus;response to stimulus;response to stress,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;nuclear envelope;nucleus;organelle,,,,,,,,,,
P09936,UCHL1,Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) (EC 3.4.19.12) (EC 6.-.-.-) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1),17,84.3,26.3,32.09,29.02,33.65,32.1,31.81,33.11,33.55,32.26,30.73,33.86,33.02,31.23,31.75,-5.45,0.35,-2.73,1.9,0.35,0.07,1.36,1.8,0.51,-1.02,2.11,1.27,-0.52,anatomical structure development;behavior;biological regulation;catabolic process;cell communication;cell death;cell development;cell proliferation;cellular component movement;cellular metabolic process;cellular process;cytoskeleton-dependent intracellular transport;death;developmental process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;response to stimulus;response to stress;transport,cell body;cell part;cell projection;cytoplasm;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;neuron projection;neuronal cell body;nucleus;organelle,,,,,,,,,,
P15374,UCHL3,Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3),8,43,28.93,28.54,27.87,28.99,28.35,27.98,28.41,28.2,27.68,26.25,29.25,29.17,25.8,28.11,0.82,0.43,-0.24,0.88,0.24,-0.13,0.3,0.09,-0.43,-1.86,1.14,1.06,-2.31,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q9Y5K5,UCHL5,Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5),10,37.7,28.76,29.77,27.9,29.5,29.38,28.3,28.67,29.44,28.28,28.95,28.25,28.84,27.84,28.76,0,1.01,-0.86,0.74,0.62,-0.46,-0.09,0.68,-0.48,0.19,-0.51,0.08,-0.92,anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA recombination;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction,cell part;chromatin remodeling complex;cytosol;DNA helicase complex;macromolecular complex;proteasome complex;protein complex,,,,,,,,,,
Q9BZX2,UCK2,Uridine-cytidine kinase 2 (UCK 2) (EC 2.7.1.48) (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2),4,20.7,26.84,25.04,25.12,26.3,25.07,,,25.26,25.18,,25.94,,25.68,25.6,1.23,-0.56,-0.49,0.7,-0.54, , ,-0.34,-0.42, ,0.34, ,0.08,behavior;biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;pyrimidine-containing compound salvage;response to chemical stimulus;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9Y3C8,UFC1,Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1),7,32.3,28.07,27.75,28.24,26.73,27.26,24.06,27.98,27.41,26.63,26.03,26.55,28.01,24.38,26.85,1.22,0.9,1.38,-0.12,0.4,-2.79,1.13,0.55,-0.22,-0.83,-0.3,1.16,-2.48,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,,,,,,,,,,,
Q92890,UFD1L,Ubiquitin fusion degradation protein 1 homolog (UB fusion protein 1),8,28.7,29.29,29.56,28.76,30.33,30.35,28.62,29.87,30,29.22,28.52,29.79,29.74,28.23,29.41,-0.12,0.16,-0.65,0.92,0.95,-0.78,0.46,0.59,-0.18,-0.89,0.38,0.33,-1.18,anatomical structure development;catabolic process;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O94874,UFL1,E3 UFM1-protein ligase 1 (EC 6.3.2.-) (LZAP-binding protein),34,44.5,32.19,31.89,31.41,31.42,31.81,32.18,31.57,31.49,32.21,31.71,31.9,31.98,32.51,31.87,0.33,0.02,-0.46,-0.44,-0.06,0.31,-0.3,-0.38,0.34,-0.16,0.03,0.11,0.64,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of protein modification process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P61960,UFM1,Ubiquitin-fold modifier 1,3,58.8,30.15,30.18,30.81,30.48,29.92,28.34,30.06,30.39,28.95,29.47,29.62,28.68,27.63,29.59,0.56,0.59,1.22,0.89,0.33,-1.25,0.47,0.8,-0.64,-0.12,0.02,-0.91,-1.96,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NUQ7,UFSP2,Ufm1-specific protease 2 (UfSP2) (EC 3.4.22.-),12,38,30.11,29.77,29.12,29.52,29.93,29.54,29.54,28.67,29.48,29.6,30.15,29.47,30.18,29.62,0.49,0.15,-0.5,-0.1,0.31,-0.09,-0.09,-0.95,-0.14,-0.02,0.53,-0.16,0.56,macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q16739,UGCG,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),4,12.4,25,27.67,,27.21,26.31,27.47,26.68,,29.07,27.97,25.07,25.88,26.26,26.78,-1.78,0.89, ,0.43,-0.47,0.69,-0.1, ,2.29,1.19,-1.72,-0.9,-0.52,anatomical structure development;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;developmental process;lipid metabolic process;metabolic process;primary metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
O60701,UGDH,UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22),35,68.2,30.54,33.02,32.48,32.39,31.52,30.63,31.79,31.15,31.16,31.42,31.63,32.14,29.6,31.5,-0.96,1.52,0.99,0.89,0.03,-0.87,0.29,-0.35,-0.33,-0.08,0.14,0.64,-1.9,alcohol metabolic process;amine metabolic process;anatomical structure morphogenesis;biosynthetic process;carbohydrate metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;organic acid metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q9NYU2,UGGT1,UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (hUGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1),62,49.8,33.48,33.59,33.43,33.08,33.16,33.81,33.24,33.05,33.89,33.49,32.98,32.71,33.99,33.38,0.1,0.22,0.05,-0.29,-0.21,0.43,-0.14,-0.32,0.51,0.11,-0.4,-0.67,0.61,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q9NYU1,UGGT2,UDP-glucose:glycoprotein glucosyltransferase 2 (UGT2) (hUGT2) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase 2) (UDP-glucose ceramide glucosyltransferase-like 1),9,7.7,25.89,28.26,,27.35,27.07,26.16,25.45,27.17,27.92,26.06,26.22,27.53,26.8,26.82,-0.94,1.44, ,0.53,0.24,-0.67,-1.37,0.35,1.09,-0.76,-0.6,0.71,-0.02,carbohydrate metabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;peptidyl-amino acid modification;primary metabolic process;protein folding;protein glycosylation;protein metabolic process;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q16851,UGP2,UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase),31,59.6,32.13,33.54,33.43,33.48,31.58,31.26,32.22,33.2,30.84,30.52,32.93,32.48,30.61,32.17,-0.04,1.37,1.26,1.31,-0.59,-0.91,0.05,1.03,-1.33,-1.65,0.76,0.31,-1.56,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;energy reserve metabolic process;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;organic acid metabolic process;phosphorus metabolic process;polysaccharide metabolic process;primary metabolic process;small molecule metabolic process;xenobiotic metabolic process,cell part;cytosol,,,,,,,,,,
Q96RL1,UIMC1,BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1),4,8.9,24.42,23.65,23.67,23.72,,22.93,24.04,23.39,24.35,22.96,,,,23.68,0.74,-0.03,-0.01,0.05, ,-0.75,0.36,-0.29,0.67,-0.72, , , ,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;DNA metabolic process;DNA repair;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;regulation of cell cycle;regulation of DNA metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P11172,UMPS,Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10);Orotidine 5'-phosphate decarboxylase (ODC) (EC 4.1.1.23) (OMPdecase)],14,39.8,31.01,29.26,30.25,29.98,28.57,27.63,29.55,29.96,26.79,29.38,29.03,29.22,27.06,29.05,1.96,0.21,1.19,0.92,-0.48,-1.42,0.5,0.91,-2.26,0.33,-0.02,0.17,-2,biological regulation;biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;heterocycle metabolic process;metabolic process;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;regulation of body fluid levels;response to chemical stimulus;response to drug;response to stimulus;secretion;small molecule metabolic process;transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H3U1,UNC45A,Protein unc-45 homolog A (Unc-45A) (GCUNC-45) (Smooth muscle cell-associated protein 1) (SMAP-1),21,28.5,29.97,29.33,30.12,30.28,30.16,28.84,30.3,29.8,29.79,28.67,30.31,30.12,28.43,29.7,0.27,-0.37,0.42,0.58,0.46,-0.86,0.6,0.1,0.09,-1.03,0.61,0.42,-1.27,anatomical structure development;cell differentiation;cellular metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9H1C4,UNC93B1,Protein unc-93 homolog B1 (Unc-93B1) (hUNC93B1),2,9.5,25.5,24.84,,24.49,25.52,25.23,25.85,25.42,24.85,26.6,26.02,26.41,24.61,25.45,0.05,-0.61, ,-0.95,0.07,-0.22,0.41,-0.02,-0.59,1.15,0.57,0.96,-0.83,biological regulation;cellular process;establishment of localization;immune system process;multi-organism process;protein transport;response to biotic stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole;vesicle,,,,,,,,,,
Q92900,UPF1,Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1),43,44.2,32.3,31.11,31.47,31.51,31.94,31.32,31.76,32.1,31.08,31.05,31.23,31.54,31.63,31.54,0.76,-0.43,-0.08,-0.03,0.4,-0.22,0.22,0.56,-0.47,-0.49,-0.32,0,0.09,"biological regulation;biosynthetic process;catabolic process;cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;DNA replication;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;regulation of gene expression, epigenetic;regulation of translation;response to DNA damage stimulus;response to stimulus;response to stress;RNA catabolic process;RNA metabolic process;transport",cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9HAU5,UPF2,Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (hUpf2),8,7.2,26.87,25.81,27.56,25.81,24.79,24.9,25.56,25.46,24.3,24.39,25.24,24.92,,25.47,1.41,0.35,2.09,0.34,-0.68,-0.56,0.09,-0.01,-1.17,-1.08,-0.22,-0.55, ,anatomical structure development;anatomical structure morphogenesis;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;establishment of localization;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;RNA catabolic process;RNA metabolic process;transport,cell part;cytosol;macromolecular complex;protein complex,,,,,,,,,,
O75841,UPK1B,Uroplakin-1b (UP1b) (Tetraspanin-20) (Tspan-20) (Uroplakin Ib) (UPIb),5,20.6,,26.55,25.17,25.14,25.75,25.42,27.97,28.82,21.52,,28.4,29.34,29.74,26.71, ,-0.16,-1.54,-1.57,-0.96,-1.29,1.26,2.11,-5.2, ,1.69,2.63,3.03,cell differentiation;cellular process;developmental process,cell part,,,,,,,,,,
Q9BT76,UPK3B,Uroplakin-3b (UP3b) (Uroplakin IIIb) (UPIIIb) (p35),5,14.1,24.92,28.15,,,25.76,,28.71,29.61,,,29.12,28.34,28.48,27.89,-2.96,0.27, , ,-2.12, ,0.82,1.72, , ,1.23,0.45,0.59,biological regulation,cell part;membrane;plasma membrane,,,,,,,,,,
Q16831,UPP1,Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3),3,9.7,25.84,28.26,27.28,26.21,27.04,26.75,24.96,,,,25.13,,,26.44,-0.6,1.82,0.85,-0.22,0.61,0.32,-1.47, , , ,-1.3, , ,biosynthetic process;catabolic process;cell communication;cellular aromatic compound metabolic process;cellular metabolic compound salvage;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleoside metabolic process;nucleotide metabolic process;primary metabolic process;pyrimidine-containing compound salvage;response to external stimulus;response to extracellular stimulus;response to starvation;response to stimulus;response to stress;small molecule metabolic process,cell part;cytosol,,,,,,,,,,
Q9NVA1,UQCC,Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog (Basic FGF-repressed Zic-binding protein) (bFGF-repressed Zic-binding protein) (bFZb),3,14.3,27.39,26.88,26.29,26.44,26.19,28.11,26.03,26.8,26.95,27.21,26.77,26.93,27.93,26.92,0.47,-0.04,-0.63,-0.48,-0.72,1.2,-0.89,-0.12,0.04,0.29,-0.15,0.01,1.01,,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle;vesicle,,,,,,,,,,
Q9UDW1,UQCR10,Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein),2,38.1,26.29,27.06,,26.68,28.42,29.04,25.61,27.01,27.64,27.55,28.43,27.24,28.51,27.46,-1.17,-0.39, ,-0.78,0.96,1.59,-1.84,-0.45,0.18,0.09,0.97,-0.22,1.05,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;macromolecular complex;membrane;protein complex;respiratory chain complex III,,,,,,,,,,
P14927,UQCRB,Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein),14,77.5,30.04,31.4,30.61,30.67,30.96,30.96,30.54,30.12,30.64,30.76,30.4,30.68,30.26,30.62,-0.58,0.78,0,0.05,0.34,0.34,-0.08,-0.5,0.02,0.14,-0.22,0.06,-0.36,cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;metabolic process;oxidative phosphorylation;phosphorus metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;respiratory chain complex III,,,,,,,,,,
P31930,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)",29,57.9,32.17,32.77,31.81,32.62,32.86,32.88,32.77,32.42,32.88,33.24,31.99,32.26,32.49,32.55,-0.38,0.22,-0.74,0.07,0.31,0.33,0.22,-0.13,0.33,0.69,-0.56,-0.29,-0.06,cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;metabolic process;oxidative phosphorylation;phosphorus metabolic process;response to chemical stimulus;response to stimulus;small molecule metabolic process,cell part;macromolecular complex;protein complex;respiratory chain complex III,,,,,,,,,,
P22695,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",26,62.3,32.44,33.26,32.09,32.68,33.76,33.77,33.19,32.8,33.78,33.94,32.96,33.51,33.76,33.23,-0.78,0.03,-1.13,-0.55,0.53,0.55,-0.03,-0.43,0.55,0.71,-0.27,0.28,0.53,cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;macromolecule metabolic process;metabolic process;oxidative phosphorylation;phosphorus metabolic process;primary metabolic process;protein metabolic process;proteolysis;small molecule metabolic process,cell part;macromolecular complex;membrane;protein complex;respiratory chain complex III,,,,,,,,,,
P47985,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 1.10.2.2) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 11 (Complex III subunit IX) (Ubiquinol-cytochrome c reductase 8 kDa protein)]",13,38,30.44,30.48,30.18,30.28,31.29,30.8,31.26,30.66,31.2,31.08,31.14,30.96,31.81,30.89,-0.45,-0.41,-0.71,-0.61,0.4,-0.09,0.37,-0.23,0.31,0.19,0.25,0.07,0.92,cellular metabolic process;cellular process;generation of precursor metabolites and energy;metabolic process;response to chemical stimulus;response to drug;response to endogenous stimulus;response to stimulus;small molecule metabolic process,cell part;macromolecular complex;protein complex;respiratory chain complex III,,,,,,,,,,
P07919,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)",5,64.8,27.58,27.88,,27.58,28.69,27.39,27.93,27.06,28.24,28.28,28.1,29.41,29.2,28.11,-0.53,-0.24, ,-0.54,0.58,-0.72,-0.18,-1.05,0.12,0.17,-0.01,1.3,1.09,cellular component assembly;cellular component organization;cellular metabolic process;cellular process;cellular respiration;generation of precursor metabolites and energy;macromolecular complex assembly;metabolic process;oxidative phosphorylation;phosphorus metabolic process;protein complex assembly;small molecule metabolic process,cell part;macromolecular complex;protein complex;respiratory chain complex III,,,,,,,,,,
O14949,UQCRQ,Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C),6,51.2,29.29,28.88,27.44,29.22,30.17,30.5,29.52,29.27,30.32,30.56,29.5,30.35,30.26,29.64,-0.35,-0.76,-2.19,-0.42,0.53,0.87,-0.12,-0.36,0.68,0.93,-0.14,0.71,0.62,anatomical structure development;cell development;cellular metabolic process;cellular process;developmental process;generation of precursor metabolites and energy;metabolic process;small molecule metabolic process,cell part;membrane,,,,,,,,,,
Q8TCY9,URGCP,Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein) (HBxAg up-regulated gene 4 protein),4,6.2,24.63,24.84,24.05,25.48,,23.33,,24.23,,,,24.57,24.33,24.43,0.19,0.41,-0.38,1.05, ,-1.1, ,-0.2, , , ,0.14,-0.1,cell cycle;cellular process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O94763,URI1,Unconventional prefoldin RPB5 interactor 1 (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein),3,12.2,26.76,24.44,23.81,25.74,25.27,25.01,26.13,24.13,25.91,24.84,24.16,25.16,,25.11,1.64,-0.68,-1.3,0.63,0.16,-0.1,1.02,-0.99,0.8,-0.27,-0.95,0.04, ,biological regulation;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;multi-organism process;primary metabolic process;protein folding;protein metabolic process;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to stimulus,cell part;cell projection;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;mitochondrion;neuron projection;organelle;protein complex;RNA polymerase complex,,,,,,,,,,
P06132,UROD,Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37),11,33.5,29.35,29.74,28.3,30.27,29.53,29.47,29.86,29.87,28.87,26.66,29.03,29.24,27.46,29.05,0.3,0.69,-0.75,1.22,0.48,0.42,0.81,0.82,-0.18,-2.39,-0.02,0.19,-1.59,biosynthetic process;cellular aromatic compound metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cofactor metabolic process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;pigment metabolic process;small molecule metabolic process,cell part;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9NZ43,USE1,Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31),7,24.7,28.68,27.68,27.98,28.04,25.39,28.34,26.64,25.38,27.57,27.27,27.61,25.39,28.76,27.29,1.4,0.39,0.7,0.75,-1.89,1.05,-0.65,-1.91,0.28,-0.02,0.33,-1.9,1.48,biological regulation;catabolic process;cellular component organization;cellular process;endoplasmic reticulum organization;establishment of localization;macromolecule metabolic process;metabolic process;organelle organization;primary metabolic process;protein catabolic process;protein metabolic process;protein transport;regulation of transport;secretion;transport;vacuolar transport;vesicle-mediated transport,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P22415,USF1,Upstream stimulatory factor 1 (Class B basic helix-loop-helix protein 11) (bHLHb11) (Major late transcription factor 1),2,10.3,26.29,25.78,26.13,,25.43,25.31,25.68,,,25.59,24.24,,25.51,25.55,0.74,0.23,0.58, ,-0.12,-0.24,0.13, , ,0.04,-1.31, ,-0.05,alcohol metabolic process;biological regulation;biosynthetic process;carbohydrate metabolic process;cell communication;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;RNA metabolic process;small molecule metabolic process,cell part;macromolecular complex;protein complex;transcription factor complex,bHLH,,,,,,,,,
Q96IX5,USMG5,Up-regulated during skeletal muscle growth protein 5 (Diabetes-associated protein in insulin-sensitive tissues) (HCV F-transactivated protein 2),3,44.8,29.67,30,29.98,30.05,30.3,30.57,30.13,30.42,30.3,30.78,30.63,26.17,31.47,30.04,-0.37,-0.04,-0.05,0.01,0.26,0.54,0.09,0.38,0.27,0.74,0.6,-3.87,1.44,,cell part;macromolecular complex;protein complex;proton-transporting two-sector ATPase complex,,,,,,,,,,
O60763,USO1,General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein),43,50.1,31.69,32.06,31.31,31.87,31.88,31.61,31.52,31.76,32.06,31.45,31.76,31.27,31.2,31.65,0.04,0.41,-0.34,0.22,0.23,-0.04,-0.13,0.11,0.41,-0.2,0.11,-0.38,-0.45,cell cycle;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane fusion;membrane organization;mitotic cell cycle;organelle fusion;organelle organization;protein transport;transport;vesicle organization,cell part;cytosol;membrane,,,,,,,,,,
Q14694,USP10,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),14,24.6,27.06,28.81,28.94,29.56,29.66,29.25,30.09,30.21,29.09,29.31,29.15,29.11,29.95,29.25,-2.19,-0.44,-0.3,0.32,0.41,0.01,0.84,0.96,-0.15,0.07,-0.1,-0.14,0.71,autophagy;biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction,cell part;cytoskeleton;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P54578,USP14,Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14),21,44.3,30.97,31.53,31.15,31.49,30.99,30.54,31.46,31.89,29.8,30.69,31.36,31.51,30.38,31.06,-0.09,0.48,0.09,0.43,-0.07,-0.52,0.41,0.84,-1.26,-0.37,0.3,0.45,-0.68,biological regulation;catabolic process;cell communication;cell-cell signaling;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;signaling,cell part;cell surface;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;proteasome complex;protein complex;synapse;vesicle,,,,,,,,,,
Q9Y4E8,USP15,Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4),18,21.3,28.91,28.5,29.37,29.65,27.67,27.19,28.81,29.1,27.99,25.01,28.87,29.74,26.22,28.23,0.67,0.27,1.14,1.41,-0.56,-1.04,0.58,0.86,-0.24,-3.22,0.63,1.51,-2.01,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein phosphorylation;proteolysis;proteolysis involved in cellular protein catabolic process;response to stimulus;signal transduction,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y5T5,USP16,Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-processing protease UBP-M) (Ubiquitin-specific-processing protease 16),6,7.5,24.57,,20.56,25.18,23.74,24.64,,24.76,21.58,22.78,25.16,24.34,24.5,23.8,0.77, ,-3.25,1.38,-0.06,0.84, ,0.96,-2.22,-1.02,1.36,0.54,0.7,biological regulation;biosynthetic process;catabolic process;cell division;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;protein complex assembly;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of translation;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UPU5,USP24,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),11,5.1,26.69,26.41,22.51,25.77,,,26.83,25.93,24.99,25.2,25.95,27.09,,25.73,0.95,0.67,-3.23,0.03, , ,1.09,0.19,-0.74,-0.54,0.21,1.35, ,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,,,,,,,,,,,
Q53GS9,USP39,U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K),18,33.6,30.75,29.86,29.33,29.92,29.66,30.37,29.85,29.22,30.47,29.91,29.23,30.18,29.33,29.85,0.89,0.01,-0.52,0.07,-0.19,0.52,0,-0.63,0.62,0.06,-0.62,0.33,-0.52,catabolic process;cell cycle;cell division;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process;ribonucleoprotein complex assembly,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q96K76,USP47,Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47),11,12.6,24.59,26.27,25.97,26.68,25.17,25.65,27.01,27.56,23.76,23.46,27.46,27.61,25.64,25.91,-1.32,0.36,0.06,0.77,-0.74,-0.26,1.1,1.65,-2.15,-2.45,1.55,1.7,-0.27,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of cell cycle;regulation of mitotic cell cycle;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to stimulus;response to stress,cell part;cytoplasm;macromolecular complex;protein complex;ubiquitin ligase complex,,,,,,,,,,
Q86UV5,USP48,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific-processing protease 48),5,8.5,25.42,24.97,,26.11,27.45,26.42,26.3,25.41,26.91,23.89,24.31,26.04,25.33,25.71,-0.29,-0.74, ,0.4,1.73,0.71,0.59,-0.31,1.19,-1.83,-1.4,0.33,-0.39,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
P45974,USP5,Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5),34,43.6,32.13,31.23,30.35,31.17,30.96,30.41,31.3,31.45,29.7,29.37,31.48,31.66,30.34,30.89,1.24,0.34,-0.53,0.29,0.07,-0.48,0.41,0.56,-1.18,-1.52,0.59,0.77,-0.55,biological regulation;catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;organelle;vacuole,,,,,,,,,,
Q93009,USP7,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),40,41.7,32.58,31.52,30.85,30.73,30.71,30.73,31,30.36,31.19,31.52,29.76,31.46,30.22,30.97,1.61,0.55,-0.12,-0.24,-0.26,-0.24,0.03,-0.61,0.22,0.54,-1.21,0.49,-0.75,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal development;multicellular organismal process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
P40818,USP8,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),6,5.2,23.06,25.46,26.63,26.49,25.27,,21.65,25.03,20.88,22.63,21.97,27.46,,24.23,-1.17,1.23,2.4,2.26,1.04, ,-2.58,0.8,-3.35,-1.6,-2.26,3.23, ,biological regulation;catabolic process;cell proliferation;cellular component organization;cellular metabolic process;cellular process;cytokinesis;endosome organization;macromolecule metabolic process;macromolecule modification;metabolic process;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to stimulus;signal transduction,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;midbody;nucleus;organelle,,,,,,,,,,
Q93008,USP9X,"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",48,21.1,29.98,30.47,29.9,30.83,30.5,30.09,31.35,31.42,29.25,28.87,31.16,31.61,29.58,30.38,-0.41,0.08,-0.48,0.45,0.12,-0.3,0.96,1.03,-1.13,-1.52,0.78,1.23,-0.81,"biological regulation;biosynthetic process;catabolic process;cell division;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome segregation;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;multicellular organismal process;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;proteolysis;proteolysis involved in cellular protein catabolic process;response to stimulus;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",apical part of cell;cell part;cytosol,,,,,,,,,,
Q9BVJ6,UTP14A,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),21,36.2,27.35,26.37,26.19,28.83,29.24,27.62,28.02,27.35,29.21,28.67,26.91,28.51,27.99,27.87,-0.51,-1.5,-1.67,0.97,1.38,-0.25,0.15,-0.52,1.34,0.8,-0.96,0.65,0.13,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;preribosome;ribonucleoprotein complex,,,,,,,,,,
Q8TED0,UTP15,U3 small nucleolar RNA-associated protein 15 homolog,10,23.4,27.9,27.81,28.11,28.36,29.19,28.49,28.57,28.77,29.06,28.76,27.19,27.82,28.49,28.35,-0.45,-0.54,-0.24,0.01,0.84,0.14,0.22,0.42,0.71,0.41,-1.16,-0.53,0.14,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9Y5J1,UTP18,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),10,25,26.62,27.62,26.3,27.64,29.13,28.82,27.77,27.95,28.48,29.18,24.18,27.06,27.75,27.58,-0.96,0.05,-1.28,0.06,1.56,1.24,0.19,0.37,0.91,1.6,-3.4,-0.52,0.17,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleus;organelle,,,,,,,,,,
O75691,UTP20,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),30,13.1,28.11,25.99,27.49,29.12,28.22,29.43,29.48,27.37,29.55,29.5,26.82,28.51,29.19,28.37,-0.26,-2.38,-0.88,0.75,-0.15,1.06,1.11,-1,1.19,1.14,-1.55,0.14,0.83,biological regulation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;preribosome;ribonucleoprotein complex,,,,,,,,,,
Q9NQZ2,UTP3,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (CRL1) (Disrupter of silencing SAS10) (UTP3 homolog),4,16.7,26.25,26.3,26.49,25.9,25.89,25.35,26.63,24.05,26.9,27.59,25.42,27.43,25.99,26.17,0.08,0.14,0.32,-0.27,-0.28,-0.82,0.46,-2.12,0.73,1.42,-0.75,1.26,-0.18,anatomical structure development;cellular component organization;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;organelle organization,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9NYH9,UTP6,U3 small nucleolar RNA-associated protein 6 homolog (Hepatocellular carcinoma-associated antigen 66) (Multiple hat domains protein),5,20.6,,,25.68,24.93,25.98,25.57,25.97,25.81,25.33,27.23,,21.93,26.26,25.47, , ,0.21,-0.54,0.51,0.1,0.49,0.34,-0.14,1.76, ,-3.54,0.79,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
P46939,UTRN,Utrophin (Dystrophin-related protein 1) (DRP-1),54,21.2,29.53,29.89,30.6,30.49,29.89,30.31,29.54,29.27,31.06,29.82,29.09,29.73,29.58,29.91,-0.38,-0.02,0.69,0.58,-0.02,0.4,-0.36,-0.64,1.16,-0.09,-0.82,-0.18,-0.32,anatomical structure development;biological regulation;developmental process;multicellular organismal process;muscle contraction;regulation of transport,cell part;cell projection;cytoplasm;cytoskeleton;dystrophin-associated glycoprotein complex;filopodium;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;synapse,,,,,,,,,,
Q8NBZ7,UXS1,UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1),4,20.6,26.27,25.89,,25.75,,27.5,25.22,,24.67,26.99,,,27.07,26.17,0.1,-0.28, ,-0.42, ,1.33,-0.95, ,-1.5,0.82, , ,0.9,alcohol metabolic process;biosynthetic process;carbohydrate metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;nucleotide-sugar metabolic process;primary metabolic process;small molecule metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q08AM6,VAC14,Protein VAC14 homolog (Tax1-binding protein 2),7,12.1,27.86,28.17,28.56,28.09,28,27.38,26.68,27.8,25.28,27.82,27.69,27.44,24.8,27.35,0.51,0.82,1.21,0.73,0.64,0.03,-0.67,0.44,-2.07,0.46,0.34,0.09,-2.56,biological regulation;biosynthetic process;cellular lipid metabolic process;cellular metabolic process;cellular process;interspecies interaction between organisms;lipid metabolic process;metabolic process;multi-organism process;primary metabolic process;response to stimulus;signal transduction;small molecule metabolic process,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q15836,VAMP3,Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3),7,61,28.73,28.28,27.2,29.44,28.45,28.07,28.61,29.51,27.35,28.66,29.9,29.37,28.56,28.62,0.11,-0.34,-1.42,0.81,-0.17,-0.56,-0.02,0.88,-1.28,0.04,1.27,0.75,-0.07,anatomical structure morphogenesis;biological adhesion;biological regulation;cell adhesion;cell morphogenesis;cellular component assembly;cellular component morphogenesis;cellular component organization;cellular membrane organization;cellular process;developmental process;endosome transport;establishment of localization;exocytosis;Golgi vesicle transport;macromolecular complex assembly;membrane docking;membrane fusion;membrane organization;protein complex assembly;protein transport;secretion;transport;vesicle-mediated transport,cell part;cell projection;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;organelle;plasma membrane;protein complex;synapse;vesicle,,,,,,,,,,
P51809,VAMP7,Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1) (Tetanus-insensitive VAMP) (Ti-VAMP),6,32,26.35,28.41,27.76,27.9,27.65,28.39,28.77,28,28.52,28.67,28.89,28.31,28.03,28.13,-1.78,0.28,-0.37,-0.23,-0.47,0.26,0.64,-0.12,0.39,0.54,0.76,0.18,-0.1,cell activation;cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;exocytosis;Golgi vesicle transport;immune system process;lipid transport;membrane fusion;membrane invagination;membrane organization;organelle fusion;organelle organization;protein transport;secretion;transport;vacuolar transport;vesicle organization;vesicle-mediated transport,apical part of cell;cell part;cell projection;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;organelle;plasma membrane;protein complex;synapse;vesicle,,,,,,,,,,
Q9BV40,VAMP8,Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB),11,59,29.88,29.17,30.27,28.92,29.83,29.58,30.21,30.47,30.3,30.49,30.06,26.19,23.77,29.16,0.71,0.01,1.1,-0.24,0.66,0.42,1.05,1.31,1.13,1.33,0.89,-2.98,-5.39,biological regulation;cellular component assembly;cellular component organization;cellular membrane organization;cellular process;establishment of localization;Golgi vesicle transport;macromolecular complex assembly;membrane fusion;membrane organization;organelle fusion;organelle organization;protein complex assembly;protein transport;regulation of transport;transport;vesicle organization;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;plasma membrane;protein complex,,,,,,,,,,
Q8TAA9,VANGL1,Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1),7,19.2,27.05,25.65,27.61,26.57,,24.55,,,,26.94,,25.33,24.91,26.08,0.97,-0.43,1.54,0.5, ,-1.53, , , ,0.86, ,-0.74,-1.17,developmental process;multicellular organismal development;multicellular organismal process,cell part,,,,,,,,,,
Q9P0L0,VAPA,Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33),28,75.5,32.87,33.01,33.13,32.63,32.49,33.27,32.69,32.01,33.1,32.94,32.74,32.93,32.82,32.82,0.05,0.19,0.31,-0.19,-0.33,0.46,-0.12,-0.81,0.28,0.12,-0.08,0.12,0,biological regulation;biosynthetic process;cell death;cellular component organization;cellular lipid metabolic process;cellular localization;cellular membrane organization;cellular metabolic process;cellular process;death;lipid metabolic process;localization;membrane fusion;membrane organization;metabolic process;primary metabolic process;small molecule metabolic process,cell part;macromolecular complex;membrane;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
O95292,VAPB,Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C),15,60.5,31.16,30.39,31.63,30.7,30.62,31.53,30.61,30.68,31.13,31.9,31.11,30.38,31.95,31.06,0.1,-0.67,0.57,-0.36,-0.44,0.47,-0.45,-0.38,0.07,0.84,0.05,-0.68,0.89,biological regulation;biosynthetic process;cell death;cellular homeostasis;cellular ion homeostasis;cellular lipid metabolic process;cellular metabolic process;cellular process;death;homeostatic process;interspecies interaction between organisms;lipid metabolic process;metabolic process;multi-organism process;primary metabolic process;regulation of protein modification process;small molecule metabolic process,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
P26640,VARS,Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS),43,46,32.75,32.76,32.28,32.68,32.33,32.11,32.97,32.49,32.66,32.65,32.42,32.43,32.05,32.51,0.24,0.26,-0.22,0.17,-0.17,-0.4,0.47,-0.01,0.15,0.14,-0.08,-0.08,-0.45,amine metabolic process;biological regulation;biosynthetic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;regulation of translation;RNA metabolic process;small molecule metabolic process;translational elongation;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q6EMK4,VASN,Vasorin (Protein slit-like 2),9,15.6,26.96,28.66,,29.65,26.29,29.16,24.57,24.24,24.91,,25.73,28.84,27.07,26.92,0.05,1.74, ,2.73,-0.63,2.25,-2.35,-2.68,-2, ,-1.19,1.92,0.16,,cell part;extracellular region,,,,,,,,,,
P50552,VASP,Vasodilator-stimulated phosphoprotein (VASP),21,50.3,31.73,31.01,32.12,30.96,31.2,30.47,31.31,31.56,31.31,31.06,30.96,30.81,30.68,31.17,0.56,-0.16,0.95,-0.2,0.03,-0.7,0.14,0.39,0.14,-0.11,-0.2,-0.36,-0.49,anatomical structure formation involved in morphogenesis;biological regulation;cell junction organization;cellular component assembly;cellular component organization;cellular process;cytoskeleton organization;developmental process;immune system process;locomotion;macromolecular complex assembly;organelle organization;protein complex assembly;response to chemical stimulus;response to external stimulus;response to stimulus;signal transduction,cell part;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane,,,,,,,,,,
Q99536,VAT1,Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-),21,59.5,31.26,32.62,32.99,31.84,31.52,31.65,31.67,31.93,31.46,32.56,33.41,33.11,32.33,32.18,-0.92,0.44,0.81,-0.34,-0.67,-0.53,-0.51,-0.25,-0.72,0.38,1.23,0.93,0.15,biological regulation;regulation of organelle organization,cell part;membrane,,,,,,,,,,
P52735,VAV2,Guanine nucleotide exchange factor VAV2 (VAV-2),7,9.9,27.39,26.36,27.19,26.22,26,26.36,28.22,27.7,23.53,26.16,28.63,28.15,23.17,26.54,0.85,-0.18,0.65,-0.32,-0.55,-0.18,1.67,1.15,-3.02,-0.39,2.08,1.6,-3.37,anatomical structure formation involved in morphogenesis;biological regulation;cell activation;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;developmental process;immune system process;locomotion;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;signal transduction,cell part;cytosol;membrane;plasma membrane,,,,,,,,,,
P61758,VBP1,Prefoldin subunit 3 (HIBBJ46) (Von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1),6,31.5,27.78,28.55,28.78,28.94,25.93,27.78,29.2,28.48,26.62,27.48,28.16,31.17,25.48,28.03,-0.24,0.52,0.75,0.92,-2.09,-0.25,1.17,0.45,-1.41,-0.55,0.14,3.14,-2.54,cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;primary metabolic process;protein folding;protein metabolic process,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;protein complex,,,,,,,,,,
P19320,VCAM1,Vascular cell adhesion protein 1 (V-CAM 1) (VCAM-1) (INCAM-100) (CD antigen CD106),21,34.4,28.72,32.53,31.87,32.33,25.89,28.83,,25.39,30.81,25.12,28.18,31.03,24.93,28.8,-0.08,3.73,3.07,3.52,-2.91,0.03, ,-3.42,2.01,-3.68,-0.62,2.23,-3.87,aging;anatomical structure development;biological adhesion;biological regulation;cell activation;cell adhesion;cell differentiation;cellular homeostasis;cellular process;developmental process;homeostatic process;immune system process;interspecies interaction between organisms;membrane docking;multi-organism process;response to abiotic stimulus;response to chemical stimulus;response to external stimulus;response to extracellular stimulus;response to stimulus;response to stress;signal transduction,apical part of cell;cell part;cell projection;extracellular space;filopodium;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microvillus;organelle;plasma membrane;protein complex,,,,,,,,,,
P18206,VCL,Vinculin (Metavinculin) (MV),85,76.4,34.29,33.81,33.2,34.57,33.5,33.12,34.43,34.57,33.17,33.45,34.12,34.6,32.37,33.78,0.5,0.03,-0.58,0.79,-0.29,-0.66,0.65,0.79,-0.62,-0.33,0.33,0.81,-1.41,anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell junction organization;cellular component assembly;cellular component movement;cellular component organization;cellular localization;cellular process;developmental process;establishment of localization;exocytosis;localization;multicellular organismal process;muscle contraction;secretion;transport;vesicle-mediated transport,cell part;cytoskeleton;cytosol;extracellular region;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
P55072,VCP,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP),89,89.6,34.07,34.89,34.47,35.17,35.14,35.15,35.4,35.14,35.26,35.04,35.4,35.32,35.35,35.06,-1,-0.17,-0.59,0.11,0.08,0.09,0.34,0.07,0.2,-0.03,0.34,0.25,0.29,biological regulation;biosynthetic process;carbohydrate metabolic process;catabolic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;establishment of localization;Golgi vesicle transport;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;peptidyl-amino acid modification;primary metabolic process;protein complex assembly;protein glycosylation;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress;signal transduction;transport;vesicle-mediated transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;proteasome complex;protein complex,,,,,,,,,,
P21796,VDAC1,Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM),28,95.4,33.64,34.81,34.25,34.06,34.22,34.74,34.25,34.36,34.68,35.11,34.48,34.27,34.67,34.43,-0.78,0.38,-0.18,-0.36,-0.2,0.31,-0.18,-0.07,0.25,0.69,0.05,-0.15,0.24,behavior;cell communication;cell death;cell-cell signaling;cellular process;death;interspecies interaction between organisms;multicellular organismal process;multi-organism process;neurological system process;response to stimulus;response to stress;signaling,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;protein complex,,,,,,,,,,
P45880,VDAC2,Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2),21,69,33.23,34.13,33.82,33.29,33.79,33.86,33.64,33.58,34.15,34.34,33.91,33.79,34.32,33.84,-0.61,0.3,-0.02,-0.54,-0.04,0.03,-0.2,-0.26,0.31,0.5,0.08,-0.04,0.49,biological regulation,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9Y277,VDAC3,Voltage-dependent anion-selective channel protein 3 (VDAC-3) (hVDAC3) (Outer mitochondrial membrane protein porin 3),12,45.9,32.26,32.54,32.92,32.12,32.98,33.3,32.52,32.59,32.63,33.34,32.61,32.31,33.4,32.73,-0.47,-0.19,0.19,-0.61,0.24,0.56,-0.22,-0.14,-0.11,0.61,-0.12,-0.42,0.67,cellular process;establishment of localization;nucleobase-containing compound transport;transmembrane transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q9HBM0,VEZT,Vezatin,3,5.8,24.99,24.48,25.25,24.24,24.18,25.56,26.18,24.58,25.56,26.75,26.4,27.38,26.35,25.53,-0.54,-1.05,-0.28,-1.29,-1.35,0.03,0.65,-0.95,0.03,1.22,0.86,1.85,0.82,biological adhesion;cell adhesion;cellular process;developmental process;embryo development,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;plasma membrane;protein complex;vesicle,,,,,,,,,,
Q9BQE4,VIMP,Selenoprotein S (SelS) (VCP-interacting membrane protein),4,27.3,27.52,25.95,26.57,,27.86,27.73,27.59,26.51,28,28.12,29.37,,29.43,27.7,-0.18,-1.75,-1.12, ,0.16,0.03,-0.1,-1.18,0.31,0.42,1.68, ,1.73,biological regulation;catabolic process;cellular homeostasis;cellular metabolic process;cellular process;establishment of localization;homeostatic process;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to endogenous stimulus;response to oxidative stress;response to stimulus;response to stress;signal transduction;transport,cell part;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9H9C1,VIPAS39,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),5,14.6,26.43,26.49,25.04,26.25,24.88,23.87,26.93,25.32,26.2,23.81,27.07,27.3,23.56,25.63,0.8,0.87,-0.59,0.62,-0.75,-1.76,1.3,-0.3,0.58,-1.82,1.44,1.67,-2.06,biological regulation;biosynthetic process;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;endosome transport;establishment of localization;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein transport;RNA metabolic process;transport;vacuolar transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q8N0U8,VKORC1L1,Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1),5,23.3,28.04,28.48,26.85,27.85,28,28.2,27.57,26.24,28.55,27.14,28.36,28.08,29.44,27.91,0.13,0.57,-1.06,-0.06,0.1,0.29,-0.34,-1.67,0.65,-0.77,0.45,0.17,1.53,,cell part,,,,,,,,,,
Q9H270,VPS11,Vacuolar protein sorting-associated protein 11 homolog (hVPS11) (RING finger protein 108),4,5.2,25.33,26.64,27.6,26.22,26.4,26.84,,26.67,24.64,25.77,27.06,26.18,25.75,26.26,-0.93,0.38,1.34,-0.04,0.14,0.59, ,0.41,-1.62,-0.49,0.8,-0.08,-0.51,cellular process;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
Q709C8,VPS13C,Vacuolar protein sorting-associated protein 13C,21,7,28.26,28.1,27.68,27.96,28.05,28.31,28.08,28.42,29.09,29.48,29.22,28.31,28.66,28.43,-0.18,-0.33,-0.75,-0.47,-0.38,-0.12,-0.35,-0.01,0.66,1.05,0.79,-0.12,0.23,,,,,,,,,,,,
Q9H269,VPS16,Vacuolar protein sorting-associated protein 16 homolog (hVPS16),7,10.7,26.52,27.53,28.12,27.68,26.99,27.14,28.58,27.66,27.65,27.22,28.45,29.12,28.36,27.77,-1.25,-0.24,0.35,-0.09,-0.78,-0.63,0.81,-0.11,-0.12,-0.55,0.68,1.35,0.59,establishment of localization;protein transport;transport,cell body;cell part;cell projection;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;neuron projection;neuronal cell body;organelle;protein complex,,,,,,,,,,
Q9P253,VPS18,Vacuolar protein sorting-associated protein 18 homolog (hVPS18),7,7.6,26.04,27.58,26.73,27.08,28.04,27.32,27.59,27.92,27.17,25.98,28.8,29.37,27.51,27.47,-1.43,0.11,-0.74,-0.39,0.56,-0.15,0.11,0.45,-0.3,-1.49,1.33,1.89,0.04,cellular component organization;cellular process;endosome organization;establishment of localization;organelle organization;protein transport;transport;vacuole organization;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
Q9BRG1,VPS25,Vacuolar protein-sorting-associated protein 25 (hVps25) (Dermal papilla-derived protein 9) (ELL-associated protein of 20 kDa) (ESCRT-II complex subunit VPS25),6,30.1,24.99,26.08,25.33,26.02,27.15,25.19,27.16,28.17,26.04,,25.02,25.95,23.66,25.9,-0.91,0.18,-0.56,0.12,1.25,-0.71,1.26,2.28,0.14, ,-0.88,0.06,-2.23,biological regulation;biosynthetic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;endosome transport;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein transport;RNA metabolic process;transport;vesicle-mediated transport,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;nucleoplasm;organelle,,,,,,,,,,
O75436,VPS26A,Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) (hVPS26),18,58.7,30.23,30.26,30.85,30.34,29.32,29.69,30.67,30.12,29.35,30.85,30.95,30.4,29.56,30.2,0.03,0.06,0.65,0.14,-0.87,-0.51,0.47,-0.08,-0.85,0.65,0.75,0.21,-0.64,cellular process;endosome transport;establishment of localization;transport;vacuolar transport;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;retromer complex;vesicle,,,,,,,,,,
Q4G0F5,VPS26B,Vacuolar protein sorting-associated protein 26B (Vesicle protein sorting 26B),3,12.2,26.96,27.13,,27.69,,24.84,,25.79,,,27.1,28.87,25.88,26.78,0.18,0.35, ,0.91, ,-1.94, ,-1, , ,0.31,2.08,-0.9,establishment of localization;protein transport;transport;vacuolar transport,cell part;cytosol;macromolecular complex;protein complex;retromer complex,,,,,,,,,,
Q9UK41,VPS28,Vacuolar protein sorting-associated protein 28 homolog (H-Vps28) (ESCRT-I complex subunit VPS28),6,36.7,28.36,26.56,27.81,27.8,26.66,25.43,28.18,27.72,26.21,24.81,27.92,28.18,26.71,27.1,1.25,-0.55,0.71,0.7,-0.44,-1.67,1.08,0.61,-0.9,-2.29,0.81,1.07,-0.39,biological regulation;catabolic process;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;endosome transport;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of protein modification process;transport;vesicle-mediated transport,cell part;cytosol;macromolecular complex;membrane;plasma membrane;protein complex,,,,,,,,,,
Q9UBQ0,VPS29,Vacuolar protein sorting-associated protein 29 (hVPS29) (EC 3.1.3.3) (PEP11 homolog) (Vesicle protein sorting 29),6,40.1,30.15,30.78,29.99,30.42,30.12,29.48,30.73,31.02,29.39,28.58,30.33,30.23,28.74,30,0.15,0.78,-0.01,0.42,0.12,-0.51,0.73,1.03,-0.6,-1.41,0.33,0.23,-1.26,establishment of localization;protein transport;transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q96AX1,VPS33A,Vacuolar protein sorting-associated protein 33A (hVPS33A),4,7.4,24.7,26.1,25.74,25.03,25.77,24.69,25.8,24.66,24.75,26.19,27.61,27.64,26.26,25.76,-1.07,0.34,-0.03,-0.73,0,-1.07,0.04,-1.1,-1.02,0.43,1.84,1.87,0.5,anatomical structure formation involved in morphogenesis;biological regulation;cell differentiation;cellular localization;cellular process;developmental process;establishment of localization;localization;membrane docking;organelle localization;protein transport;transport;vesicle-mediated transport,cell part;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9H267,VPS33B,Vacuolar protein sorting-associated protein 33B (hVPS33B),7,17,27.43,27.32,28.65,27.85,24.67,24.38,27.08,31.22,26.03,26.18,27.31,28.05,24.68,26.99,0.44,0.34,1.66,0.86,-2.32,-2.61,0.09,4.23,-0.96,-0.81,0.32,1.06,-2.31,cellular component organization;cellular localization;cellular membrane organization;cellular process;establishment of localization;localization;membrane docking;membrane fusion;membrane organization;organelle localization;organelle organization;protein transport;transport;vesicle organization;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;organelle;vacuole;vesicle,,,,,,,,,,
Q96QK1,VPS35,Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35),29,42.7,31.94,32.02,32.41,32.01,31.46,31.61,31.95,32.44,31.38,31.29,32.47,32.28,31.53,31.91,0.03,0.11,0.51,0.11,-0.45,-0.3,0.04,0.53,-0.53,-0.61,0.56,0.37,-0.37,cell death;cellular process;death;endosome transport;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q86VN1,VPS36,Vacuolar protein-sorting-associated protein 36 (ELL-associated protein of 45 kDa) (ESCRT-II complex subunit VPS36),4,13.5,24.28,25.36,25.76,,24.85,24.75,24.56,,24.38,,24.19,26.83,,25,-0.71,0.37,0.76, ,-0.14,-0.25,-0.44, ,-0.62, ,-0.81,1.84, ,biological regulation;biosynthetic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;endosome transport;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein transport;RNA metabolic process;transport;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;nucleus;organelle;vacuole,,,,,,,,,,
Q8NEZ2,VPS37A,Vacuolar protein sorting-associated protein 37A (hVps37A) (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1),6,22,25.09,24.55,27.1,26.4,,25.58,27.05,27.45,,25.89,27.55,27.5,25.82,26.36,-1.27,-1.81,0.74,0.03, ,-0.78,0.69,1.09, ,-0.47,1.18,1.14,-0.54,catabolic process;cell death;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;death;endosome transport;establishment of localization;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein maturation;protein metabolic process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;transport;vesicle-mediated transport,cell part;centrosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;microtubule organizing center;nucleus;organelle;protein complex,,,,,,,,,,
Q96JC1,VPS39,Vam6/Vps39-like protein (TRAP1-like protein) (hVam6p),5,7.1,,25.42,26.02,24.07,24.23,25.04,25.66,24.83,,25.66,26.61,27.6,26.86,25.64, ,-0.22,0.39,-1.57,-1.41,-0.59,0.02,-0.81, ,0.02,0.97,1.97,1.22,establishment of localization;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
P49754,VPS41,Vacuolar protein sorting-associated protein 41 homolog (S53),5,6.1,26.5,25.68,26.52,24.9,24.77,25.72,25.91,24.41,,25.74,26.54,26.72,24.75,25.68,0.82,0,0.84,-0.78,-0.91,0.04,0.23,-1.27, ,0.06,0.86,1.04,-0.93,cellular process;establishment of localization;Golgi vesicle transport;protein transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
Q9NRW7,VPS45,Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45),15,30.2,28.87,29.77,28.89,28.61,29.3,29.15,29.17,28.6,29.44,28.96,29.27,28.79,29.13,29.07,-0.2,0.7,-0.18,-0.46,0.23,0.07,0.09,-0.47,0.37,-0.12,0.2,-0.28,0.06,biological regulation;cellular process;coagulation;establishment of localization;membrane docking;multicellular organismal process;protein transport;regulation of body fluid levels;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q9UN37,VPS4A,Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4),9,23.6,26.95,28.32,28.93,28.78,28.57,27.35,29.36,29.58,27.64,27.74,29.27,29.16,26.99,28.36,-1.41,-0.03,0.57,0.42,0.22,-1.01,1,1.23,-0.72,-0.62,0.91,0.8,-1.37,cellular component organization;cellular membrane organization;cellular process;cytokinesis;endosome transport;establishment of localization;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;membrane;midbody,,,,,,,,,,
O75351,VPS4B,Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1),14,33.3,29.8,29.61,30.39,29.2,28.76,27.88,29.04,30.02,27.74,28.01,29.44,29.54,27.85,29.02,0.78,0.58,1.36,0.18,-0.26,-1.15,0.02,1,-1.28,-1.01,0.42,0.52,-1.17,cell cycle;cell division;cellular component organization;cellular membrane organization;cellular process;endosome organization;endosome transport;establishment of localization;ion transport;lipid transport;membrane organization;organelle organization;protein transport;response to chemical stimulus;response to stimulus;transport;vesicle-mediated transport,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;lysosome;membrane;nucleus;organelle;vacuole,,,,,,,,,,
Q9UID3,VPS51,Vacuolar protein sorting-associated protein 51 homolog (Another new gene 2 protein) (Protein fat-free homolog),7,13,26.95,25.2,26.41,26.45,,25.81,25.53,26.74,25.65,24.4,26.34,26.66,25.87,26,0.95,-0.8,0.41,0.45, ,-0.19,-0.47,0.74,-0.35,-1.6,0.34,0.65,-0.13,autophagy;catabolic process;cellular metabolic process;cellular process;endosome transport;establishment of localization;lipid transport;metabolic process;protein transport;transport;vesicle-mediated transport,cell part;macromolecular complex;protein complex,,,,,,,,,,
Q8N1B4,VPS52,Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein),5,11.2,26.94,27.73,27.12,27.36,25.85,26.25,26.95,27.56,26.26,26.89,26.77,28.39,,27.01,-0.07,0.73,0.11,0.36,-1.16,-0.76,-0.06,0.56,-0.75,-0.12,-0.23,1.39, ,establishment of localization;protein transport;transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
Q5VIR6,VPS53,Vacuolar protein sorting-associated protein 53 homolog,3,5,24.91,23.94,25.21,23.9,25.84,24.86,26.45,25.48,25.92,25.36,25.05,26.52,25.83,25.33,-0.42,-1.39,-0.11,-1.43,0.51,-0.46,1.12,0.15,0.59,0.03,-0.28,1.19,0.5,establishment of localization;protein transport;transport,cell part;macromolecular complex;membrane;protein complex,,,,,,,,,,
Q99986,VRK1,Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1),6,14.9,27.37,23.33,28.15,27.72,,24.19,27.52,25.66,27.86,28.11,,25.13,26.76,26.53,0.84,-3.2,1.62,1.19, ,-2.34,0.99,-0.87,1.33,1.59, ,-1.4,0.23,cell division;cellular component disassembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;Golgi organization;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;nucleoplasm;organelle,,+,,,,,,,,
Q86Y07,VRK2,Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2),5,15.2,26.36,24.98,25.28,26.85,28.38,27.72,27.65,27.24,28.03,27.59,25.78,27.04,26.13,26.85,-0.49,-1.87,-1.56,0,1.53,0.87,0.8,0.39,1.18,0.74,-1.07,0.19,-0.72,biological regulation;cellular metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;response to chemical stimulus;response to oxidative stress;response to stimulus;response to stress,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle,,+,,,,,,,,
Q9NP79,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog (Dopamine-responsive gene 1 protein) (DRG-1) (LYST-interacting protein 5) (LIP5) (SKD1-binding protein 1) (SBP1),8,28.7,29.63,29.15,29.54,29.37,28.74,27.92,29.02,28.95,26.5,27.18,29.13,28.68,27.34,28.55,1.08,0.6,0.99,0.82,0.19,-0.63,0.47,0.4,-2.05,-1.37,0.58,0.13,-1.21,cellular component organization;cellular membrane organization;cellular process;endosome transport;establishment of localization;membrane organization;protein transport;transport;vesicle-mediated transport,cell part;cytosol;membrane,,,,,,,,,,
Q96AJ9,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2),2,11.3,24.62,25.07,24.64,23.78,26.15,25.88,25.02,25.46,25.19,24.24,24.97,26.69,27.03,25.29,-0.67,-0.22,-0.65,-1.51,0.86,0.6,-0.27,0.17,-0.1,-1.04,-0.32,1.4,1.74,cellular process;endosome transport;establishment of localization;protein transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;vesicle,,,,,,,,,,
O00534,VWA5A,von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein),11,22,29.84,26.6,26.65,,26.92,,23.65,,25.28,25.66,,,,26.37,3.47,0.22,0.28, ,0.55, ,-2.72, ,-1.1,-0.71, , , ,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
A3KMH1,VWA8,von Willebrand factor A domain-containing protein 8,16,11.9,25.97,26.43,26.69,28.4,29.03,27.49,27.95,27.36,28.99,29.9,28.17,28.86,28.89,28.01,-2.04,-1.58,-1.32,0.39,1.02,-0.52,-0.06,-0.65,0.98,1.89,0.16,0.85,0.88,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;heterocycle metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound catabolic process;nucleobase-containing compound metabolic process;nucleobase-containing small molecule metabolic process;nucleotide metabolic process;primary metabolic process;small molecule metabolic process,cell part;extracellular region;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q96SY0,VWA9,von Willebrand factor A domain-containing protein 9,8,19.9,28.93,27.73,27.82,28.46,27.93,28.28,28.4,27.44,28.87,28.74,27.65,29.46,27.73,28.27,0.67,-0.54,-0.44,0.19,-0.34,0.02,0.14,-0.82,0.61,0.48,-0.61,1.2,-0.54,,,,,,,,,,,,
Q7Z5K2,WAPAL,Wings apart-like protein homolog (Friend of EBNA2 protein),7,7,,24.51,26.44,24.87,24.59,26.52,21.43,22.02,23.77,24.86,23.03,23.71,21.76,23.96, ,0.55,2.48,0.91,0.63,2.56,-2.53,-1.94,-0.19,0.9,-0.93,-0.25,-2.2,biological regulation;cell cycle;cellular component organization;cellular localization;cellular process;cytokinesis;interspecies interaction between organisms;localization;mitosis;mitotic cell cycle;multi-organism process;nuclear division;organelle fission;organelle organization;regulation of cell cycle;regulation of DNA metabolic process;regulation of organelle organization;response to chemical stimulus;response to stimulus,cell part;cohesin complex;cytoskeleton;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex,,,,,,,,,,
P23381,WARS,"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS;T2-TrpRS]",39,79.6,33.04,32.85,33.99,33.07,31.38,30.66,33.01,33.58,30.28,30.54,31.41,32.77,29.11,31.98,1.06,0.87,2.02,1.1,-0.6,-1.32,1.03,1.61,-1.7,-1.43,-0.57,0.79,-2.86,amine metabolic process;anatomical structure formation involved in morphogenesis;biological regulation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol,,,,,,,,,,
Q9UGM6,WARS2,"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)",6,26.3,27.99,27.17,26.65,25.45,26.36,25.92,23.77,,26.82,28.65,23.9,24.3,,26.09,1.9,1.08,0.56,-0.64,0.27,-0.17,-2.32, ,0.74,2.56,-2.19,-1.79, ,amine metabolic process;cell differentiation;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
Q9Y6W5,WASF2,Wiskott-Aldrich syndrome protein family member 2 (WASP family protein member 2) (Protein WAVE-2) (Verprolin homology domain-containing protein 2),7,10.8,27.61,27.34,27.55,26.76,26.27,,26.97,26.53,26.5,26.78,27.05,,,26.93,0.68,0.4,0.62,-0.18,-0.67, ,0.03,-0.4,-0.44,-0.16,0.11, , ,anatomical structure formation involved in morphogenesis;biological regulation;cell motility;cellular component assembly;cellular component movement;cellular component organization;cellular process;cytoskeleton organization;developmental process;immune system process;locomotion;organelle organization;response to stimulus;response to stress;signal transduction,cell part;cell projection;cytoskeleton;cytosol;endosome;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
C4AMC7,WASH3P,Putative WAS protein family homolog 3 (Protein FAM39DP),6,19.8,27.32,25.65,27.73,27.6,24.74,26.68,26.99,27.8,,27.43,26.71,28.37,27.26,27.02,0.29,-1.37,0.7,0.57,-2.29,-0.34,-0.03,0.78, ,0.41,-0.32,1.34,0.24,biological regulation;cellular component organization;cellular process;cytoskeleton organization;endosome transport;establishment of localization;organelle organization;regulation of organelle organization;transport;vesicle-mediated transport,cell part;cell projection;endosome;filopodium;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex,,,,,,,,,,
O00401,WASL,Neural Wiskott-Aldrich syndrome protein (N-WASP),5,19.6,26.85,24.88,26.1,25.05,,,25.81,26.04,25.82,,24.76,,,25.67,1.18,-0.78,0.44,-0.61, , ,0.14,0.38,0.16, ,-0.91, , ,biological regulation;biosynthetic process;cellular component assembly;cellular component movement;cellular component organization;cellular localization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;cytoskeleton organization;immune system process;localization;locomotion;macromolecular complex assembly;macromolecule metabolic process;membrane organization;metabolic process;multi-organism process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle localization;organelle organization;primary metabolic process;protein complex assembly;regulation of transport;response to biotic stimulus;response to chemical stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;small molecule metabolic process;vesicle organization,cell part;cell projection;cytoskeleton;cytosol;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q9Y2W2,WBP11,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),17,30.6,29.77,28.11,29.11,28.21,28.77,28.2,27.83,28.4,28.51,28.57,27.07,26.73,25.52,28.06,1.7,0.05,1.05,0.15,0.71,0.14,-0.24,0.34,0.45,0.51,-0.99,-1.33,-2.54,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;rRNA processing,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96I51,WBSCR16,Williams-Beuren syndrome chromosomal region 16 protein (RCC1-like G exchanging factor-like protein),3,8.8,,25.52,25.74,25.5,26.42,26.16,25.24,25.52,27.22,26.45,25.68,26.33,26.24,26, ,-0.48,-0.26,-0.5,0.41,0.16,-0.76,-0.48,1.22,0.45,-0.32,0.33,0.24,,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;organelle,,,,,,,,,,
Q8IWB7,WDFY1,WD repeat and FYVE domain-containing protein 1 (FENS-1) (Phosphoinositide-binding protein 1) (WD40- and FYVE domain-containing protein 1) (Zinc finger FYVE domain-containing protein 17),11,30.5,29.84,30.95,31.58,30.49,29.98,30.17,30.92,29.32,30.92,29.92,29.98,29,29.97,30.23,-0.39,0.72,1.35,0.26,-0.26,-0.07,0.68,-0.92,0.68,-0.31,-0.25,-1.23,-0.27,,cell part;cytosol;endosome;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75717,WDHD1,WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1),7,8.9,26.71,23.7,24.87,25.13,25.27,25.93,27.04,27.19,24.57,26.16,24.47,,26.91,25.66,1.05,-1.97,-0.79,-0.53,-0.39,0.27,1.37,1.53,-1.09,0.5,-1.19, ,1.25,biological regulation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin organization;chromosome organization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of organelle organization;RNA metabolic process;RNA processing,cell part;cytoplasm;nucleoplasm,HMG-box,,,,,,,,,
O75083,WDR1,WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1),38,67.7,33.04,33.49,33.22,33.51,32.89,32.47,33.69,33.92,32.4,32.42,34.03,34,31.85,33.15,-0.11,0.34,0.07,0.36,-0.26,-0.68,0.54,0.77,-0.74,-0.73,0.88,0.86,-1.3,cell activation;cellular process;establishment of localization;exocytosis;multicellular organismal process;neurological system process;secretion;transport;vesicle-mediated transport,cell part;cell projection;cytosol;extracellular region;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;organelle;protein complex,,,,,,,,,,
Q9BZH6,WDR11,WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15),17,17.1,28.44,28.31,27.75,28.56,28.36,28.03,27.9,28.69,28.77,27.63,28.27,28.91,28.2,28.29,0.15,0.01,-0.55,0.27,0.07,-0.26,-0.39,0.4,0.48,-0.66,-0.02,0.61,-0.09,,cell part;cell projection;cilium;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9GZL7,WDR12,Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12),9,29.1,30.5,28.89,28.8,29.47,28.95,29.88,29.03,28.37,29.51,29.57,27.47,28.54,28.62,29.05,1.46,-0.16,-0.25,0.42,-0.1,0.84,-0.01,-0.68,0.47,0.53,-1.58,-0.51,-0.43,biological regulation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;rRNA processing;signal transduction,cell part;macromolecular complex;nucleoplasm;preribosome;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9H1Z4,WDR13,WD repeat-containing protein 13,3,6.6,24.38,25.53,24.13,25.53,,,,25.64,24.6,24.58,25.64,24.83,,24.98,-0.6,0.54,-0.86,0.54, , , ,0.65,-0.38,-0.4,0.66,-0.15, ,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BV38,WDR18,WD repeat-containing protein 18,10,28.7,28.32,28.98,29.61,27.23,28.84,28.72,28.2,28.68,29.05,29.14,27.66,28.53,28.92,28.61,-0.29,0.37,1,-1.38,0.24,0.12,-0.4,0.08,0.45,0.53,-0.95,-0.07,0.32,developmental process;multicellular organismal development;multicellular organismal process,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
Q9H7D7,WDR26,WD repeat-containing protein 26 (CUL4- and DDB1-associated WDR protein 2) (Myocardial ischemic preconditioning up-regulated protein 2),9,13.6,26.43,26.77,25.38,27.14,27.32,25.52,25.72,26.19,27.8,25.53,,26.19,,26.36,0.06,0.41,-0.98,0.78,0.96,-0.85,-0.64,-0.17,1.44,-0.83, ,-0.17, ,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9UNX4,WDR3,WD repeat-containing protein 3,12,14.4,27.98,27.26,28.11,27.89,28.15,28.53,28.08,27.34,28.94,27.93,27.2,27.71,27.79,27.91,0.06,-0.65,0.19,-0.03,0.24,0.61,0.17,-0.58,1.02,0.02,-0.72,-0.21,-0.13,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q9C0J8,WDR33,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein WDC146),6,5.7,25.58,22.04,25.39,26.51,26.43,24.94,24.1,26.28,25.74,26.55,26.19,26.88,23.49,25.39,0.19,-3.36,-0.01,1.12,1.04,-0.45,-1.29,0.88,0.34,1.16,0.79,1.49,-1.9,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8NI36,WDR36,WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP),15,20.3,29.02,28.51,29.12,29.66,30.31,30.03,29.26,28.73,29.56,29.61,28.49,28.99,29.18,29.27,-0.25,-0.76,-0.15,0.4,1.04,0.76,-0.01,-0.54,0.3,0.34,-0.77,-0.27,-0.09,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to stimulus;RNA metabolic process;RNA processing;rRNA processing,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;preribosome;ribonucleoprotein complex,,,,,,,,,,
P57081,WDR4,tRNA (guanine-N(7)-)-methyltransferase subunit WDR4 (WD repeat-containing protein 4),2,12,26.05,,,25.64,25.35,,25.26,27.36,25.45,,,27.07,,26.03,0.03, , ,-0.39,-0.67, ,-0.77,1.33,-0.57, , ,1.05, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA modification;RNA processing;tRNA metabolic process;tRNA processing,cell part;cytoplasm;nucleoplasm,,,,,,,,,,
Q15061,WDR43,WD repeat-containing protein 43,12,24.2,29.4,29.17,30.78,29.19,29.93,30.1,28.78,29.32,29.55,29.73,26.94,29.17,29.21,29.33,0.08,-0.15,1.46,-0.14,0.6,0.77,-0.55,-0.01,0.22,0.4,-2.39,-0.16,-0.12,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q5JSH3,WDR44,WD repeat-containing protein 44 (Rabphilin-11),22,32.6,26.21,26.36,25.6,27.94,21.64,25.2,26.98,23.61,22.14,26.22,28.27,28.76,25.31,25.71,0.5,0.65,-0.11,2.23,-4.07,-0.51,1.27,-2.1,-3.57,0.51,2.56,3.05,-0.4,,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle,,,,,,,,,,
O15213,WDR46,WD repeat-containing protein 46 (WD repeat-containing protein BING4),7,19.7,27.32,26.71,25.48,28.29,28.35,28.08,27.34,27.01,27.74,27.76,27.5,27.56,26.98,27.39,-0.07,-0.68,-1.91,0.9,0.95,0.68,-0.05,-0.39,0.35,0.36,0.1,0.17,-0.41,,,,,,,,,,,,
Q8TAF3,WDR48,WD repeat-containing protein 48 (USP1-associated factor 1) (WD repeat endosomal protein) (p80),4,14.7,25.36,25.8,25.93,25.94,,23.67,,22.39,24.62,26.09,22.49,,22.58,24.49,0.87,1.31,1.44,1.46, ,-0.82, ,-2.1,0.14,1.61,-2, ,-1.91,cellular metabolic process;cellular process;interspecies interaction between organisms;macromolecule metabolic process;macromolecule modification;metabolic process;multi-organism process;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;intracellular membrane-bounded organelle;intracellular organelle;lysosome;nucleus;organelle;vacuole,,,,,,,,,,
P61964,WDR5,WD repeat-containing protein 5 (BMP2-induced 3-kb gene protein),7,28.4,29.51,28.91,28.87,28.66,29.86,29.49,28.74,28.13,29.51,29.07,26.96,25.86,26.31,28.45,1.06,0.45,0.42,0.21,1.41,1.04,0.28,-0.32,1.06,0.61,-1.5,-2.59,-2.14,anatomical structure development;biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;developmental process;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein alkylation;protein metabolic process;protein modification process;RNA metabolic process;small molecule metabolic process,cell part;chromatin remodeling complex;histone methyltransferase complex;macromolecular complex;protein complex,,,,,,,,,,
Q9H6Y2,WDR55,WD repeat-containing protein 55,4,19.3,26.62,24.8,,27.32,27.49,27.34,27.5,26.43,27.19,26.27,24.99,26.41,26.88,26.6,0.02,-1.8, ,0.72,0.89,0.74,0.9,-0.18,0.59,-0.34,-1.61,-0.2,0.27,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;rRNA processing,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9GZS3,WDR61,WD repeat-containing protein 61 (Meiotic recombination REC14 protein homolog) (SKI8 homolog) (Ski8),7,36.1,28.63,29.21,29.32,29.28,29.89,29.73,29.61,30.09,28.59,29.07,29.46,29.05,29.27,29.32,-0.69,-0.11,0,-0.05,0.57,0.41,0.28,0.76,-0.73,-0.25,0.13,-0.27,-0.05,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;one-carbon metabolic process;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;regulation of organelle organization;regulation of protein modification process;response to stimulus;RNA metabolic process;signal transduction;small molecule metabolic process,cell part;macromolecular complex;protein complex;transcription elongation factor complex,,,,,,,,,,
Q9NW82,WDR70,WD repeat-containing protein 70,5,8.6,27.48,24.63,26.32,26.12,25.93,25.98,25.74,24.77,27.07,26.51,23.2,,,25.79,1.68,-1.16,0.52,0.32,0.13,0.19,-0.05,-1.03,1.28,0.71,-2.6, , ,,,,,,,,,,,,
Q6RFH5,WDR74,WD repeat-containing protein 74 (NOP seven-associated protein 1),6,15.8,27.53,26.94,25.88,26.75,27.79,28.52,,20.74,27.27,25.7,22,,28.1,26.11,1.42,0.83,-0.23,0.64,1.68,2.41, ,-5.37,1.16,-0.41,-4.11, ,1.99,anatomical structure formation involved in morphogenesis;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8IWA0,WDR75,WD repeat-containing protein 75,14,21.4,28.02,26.25,26.98,27.54,28.67,28.9,28.24,28.08,29.32,28.41,27.28,27.45,27.94,27.93,0.09,-1.67,-0.95,-0.39,0.74,0.97,0.31,0.15,1.39,0.48,-0.65,-0.48,0.01,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BQA1,WDR77,Methylosome protein 50 (MEP-50) (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50),8,39.8,29.01,28.46,26.08,29.07,27.83,27.24,28.9,28.9,27.32,27.03,27.95,28.3,26.25,27.87,1.14,0.58,-1.79,1.2,-0.04,-0.63,1.02,1.03,-0.55,-0.84,0.08,0.43,-1.62,biological regulation;cell differentiation;cellular component assembly;cellular component organization;cellular macromolecular complex assembly;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;ribonucleoprotein complex assembly;RNA metabolic process,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q6UXN9,WDR82,WD repeat-containing protein 82 (Protein TMEM113) (Swd2),10,37.1,29.48,28.51,29.57,29.47,29.49,28.82,28.53,28.76,28.51,29.7,27.48,26.82,28.77,28.76,0.72,-0.26,0.81,0.71,0.73,0.06,-0.23,0,-0.25,0.94,-1.28,-1.94,0.01,cellular component organization;cellular metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;one-carbon metabolic process;organelle organization;primary metabolic process;protein alkylation;protein metabolic process;protein modification process;small molecule metabolic process,cell part;chromatin remodeling complex;histone methyltransferase complex;macromolecular complex;protein complex;protein serine/threonine phosphatase complex,,,,,,,,,,
O76024,WFS1,Wolframin,14,16.6,28.79,26.12,27.27,27.86,26.82,27.97,27.66,27.89,28.44,28.37,29.68,29.72,28.68,28.1,0.7,-1.98,-0.82,-0.24,-1.28,-0.13,-0.44,-0.2,0.34,0.27,1.58,1.62,0.58,anatomical structure development;biological regulation;catabolic process;cellular homeostasis;cellular ion homeostasis;cellular metabolic process;cellular process;developmental process;establishment of localization;homeostatic process;macromolecule metabolic process;metabolic process;multicellular organismal process;neurological system process;primary metabolic process;protein folding;protein maturation;protein metabolic process;protein transport;proteolysis;proteolysis involved in cellular protein catabolic process;regulation of body fluid levels;regulation of protein modification process;regulation of protein stability;regulation of transport;response to biotic stimulus;response to stimulus;response to stress;signal transduction;transport,cell part;cell projection;neuron projection,,,,,,,,,,
Q9BRP8,WIBG,Partner of Y14 and mago (Protein wibg homolog),4,28.6,28.01,26.82,27.09,27.11,26.75,26.82,27.8,28.86,26.56,27.26,27.23,27.5,25.88,27.21,0.81,-0.38,-0.12,-0.1,-0.46,-0.38,0.6,1.66,-0.64,0.05,0.02,0.29,-1.33,biological regulation;catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;nucleoplasm;organelle;protein complex,,,,,,,,,,
Q9Y4P8,WIPI2,WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2) (WIPI49-like protein 2),5,18.3,24.65,26.82,,26.19,25.88,,26.53,26.51,25.43,,27.41,25.93,,26.15,-1.5,0.67, ,0.04,-0.27, ,0.38,0.36,-0.72, ,1.26,-0.22, ,cellular component assembly;cellular component organization;cellular process;organelle assembly;organelle organization;vacuole organization,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
Q5T9L3,WLS,Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog) (EVI) (Putative NF-kappa-B-activating protein 373),3,18,27.56,25.14,27.97,27.16,22.88,27.59,24.86,,28.49,27.73,24.75,24.6,25.37,26.18,1.39,-1.03,1.8,0.98,-3.29,1.41,-1.31, ,2.32,1.55,-1.43,-1.57,-0.8,anatomical structure formation involved in morphogenesis;biological regulation;cellular process;developmental process;response to stimulus;signal transduction,cell part;membrane,,,,,,,,,,
Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),14,9.9,27.76,27.37,27.28,27.78,26.71,26.6,26.21,27.15,25.28,25.56,27.98,27.82,25.81,26.87,0.89,0.5,0.41,0.91,-0.16,-0.27,-0.66,0.28,-1.59,-1.31,1.1,0.95,-1.06,anatomical structure development;biological regulation;cell development;cellular process;developmental process;establishment of localization;ion transport;regulation of protein modification process;regulation of transport;response to stimulus;signal transduction;transport,cell part;cytoplasm,,+,,,,,,,,
O00755,WNT7A,Protein Wnt-7a,5,10.9,24.76,25.98,25.55,25.91,22.49,24.96,24.38,24.74,,28.71,,,,25.28,-0.52,0.7,0.27,0.63,-2.78,-0.32,-0.89,-0.54, ,3.44, , , ,anatomical structure development;anatomical structure morphogenesis;biological adhesion;biological regulation;cell activation;cell adhesion;cell development;cell differentiation;cell division;cell proliferation;cellular component organization;cellular process;developmental process;establishment of localization;establishment or maintenance of cell polarity;localization;neurotransmitter transport;response to chemical stimulus;response to endogenous stimulus;response to stimulus;secretion;signal transduction;transport,cell part;cell surface;extracellular matrix;extracellular space;proteinaceous extracellular matrix,,,,,,,,,,
O00258,WRB,Tail-anchored protein insertion receptor WRB (Congenital heart disease 5 protein) (Tryptophan-rich basic protein) (WRB),3,31.9,,24.98,24.21,25.58,,25.87,23.07,,24.61,24.92,21.72,23.98,25.81,24.47, ,0.5,-0.26,1.11, ,1.39,-1.41, ,0.14,0.45,-2.76,-0.5,1.33,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;nucleolus;organelle,,,,,,,,,,
Q14191,WRN,"Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)",3,5.9,24.52,22.03,25.72,,,,22.39,,22.12,24.52,19.31,22.97,21.52,22.79,1.74,-0.76,2.93, , , ,-0.4, ,-0.67,1.73,-3.48,0.18,-1.27,aging;biological regulation;biosynthetic process;cell communication;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;developmental process;DNA metabolic process;DNA recombination;DNA repair;establishment of localization;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to external stimulus;response to extracellular stimulus;response to oxidative stress;response to starvation;response to stimulus;response to stress;telomere organization;transport,cell part;centrosome;intracellular non-membrane-bounded organelle;intracellular organelle;microtubule organizing center;nucleolus;nucleoplasm;organelle,,,,,,,,,,
Q96S55,WRNIP1,ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),20,37.3,30.43,27.65,27.55,26.67,25.78,24.59,,22.99,26.78,23.3,,22.23,,25.8,4.63,1.86,1.76,0.88,-0.02,-1.2, ,-2.8,0.98,-2.5, ,-3.57, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;DNA replication;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of DNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;mitochondrion;nucleus;organelle,,,,,,,,,,
Q15007,WTAP,Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (hFL(2)D) (WT1-associated protein) (Wilms tumor 1-associating protein),7,20.5,27.42,25.77,27.32,26.25,,26.73,,,26.44,27.69,24.64,21.52,,25.98,1.45,-0.21,1.34,0.27, ,0.76, , ,0.46,1.71,-1.33,-4.45, ,cell cycle;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;membrane;nucleoplasm,,,,,,,,,,
Q6AWC2,WWC2,Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2),2,6.9,25.98,24.33,,23.77,24.24,,23.71,25.34,23.43,,,,24.16,24.37,1.61,-0.04, ,-0.6,-0.13, ,-0.66,0.97,-0.94, , , ,-0.21,,,,,,,,,,,,
Q9HCS7,XAB2,Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2),12,22.7,28,25.02,27.64,26.13,26.45,27.12,27.54,26.18,27.49,27.44,,26.17,25.79,26.75,1.25,-1.73,0.89,-0.61,-0.3,0.38,0.79,-0.57,0.74,0.7, ,-0.58,-0.96,anatomical structure development;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;nucleoplasm;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q01831,XPC,DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125),8,14.9,29.73,25.49,27.21,25.47,,27.77,28.74,23.56,29.36,30.45,25.68,,28.43,27.44,2.29,-1.96,-0.24,-1.97, ,0.33,1.3,-3.89,1.91,3.01,-1.77, ,0.99,biological regulation;catabolic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA metabolic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;regulation of cell cycle;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to stimulus;response to stress,cell part;cytoplasm;macromolecular complex;nucleoplasm;nucleotide-excision repair complex;protein complex,DNA binding region,,,,,,,,,
Q9NQW7,XPNPEP1,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",17,35.3,30.92,30.04,29.5,29.7,28.74,27.88,29.93,29.24,28.17,27.33,29.73,29.81,26.55,29.04,1.88,1,0.46,0.66,-0.3,-1.16,0.89,0.2,-0.87,-1.72,0.69,0.77,-2.5,catabolic process;cellular metabolic process;cellular process;macromolecule metabolic process;metabolic process;peptide metabolic process;primary metabolic process;protein metabolic process;proteolysis,cell part;cytoplasm;cytosol,,,,,,,,,,
O14980,XPO1,Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog),37,41.2,32.55,31.78,32.05,31.88,31.26,31.1,32.05,32.05,31.67,30.86,30.67,32.02,30.8,31.59,0.95,0.19,0.46,0.28,-0.33,-0.49,0.45,0.45,0.07,-0.73,-0.93,0.42,-0.8,biological regulation;cell cycle;cellular localization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;localization;macromolecule metabolic process;metabolic process;mitotic cell cycle;mRNA metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleobase-containing compound transport;nucleocytoplasmic transport;primary metabolic process;protein targeting;protein transport;regulation of cell cycle;regulation of organelle organization;regulation of transport;response to chemical stimulus;response to drug;response to stimulus;RNA metabolic process;signal transduction;transport,cell part;cytosol;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;nuclear envelope;nuclear pore;nucleolus;nucleoplasm;organelle;protein complex;ribonucleoprotein complex,,,,,,,,,,
Q9HAV4,XPO5,Exportin-5 (Exp5) (Ran-binding protein 21),10,11.9,27.63,27.78,26.63,27.12,26.52,26.26,27.93,26.49,25.91,26.3,,27,,26.87,0.76,0.91,-0.24,0.25,-0.35,-0.61,1.06,-0.38,-0.96,-0.57, ,0.13, ,biological regulation;cellular process;establishment of localization;gene silencing;macromolecule metabolic process;metabolic process;nuclear transport;nucleocytoplasmic transport;protein targeting;protein transport;transport,cell part;cytosol;macromolecular complex;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
Q9UIA9,XPO7,Exportin-7 (Exp7) (Ran-binding protein 16),13,15,28.9,28.92,28.61,28.03,25.2,26.8,28.3,27.48,25.14,26.92,27.94,28.86,,27.59,1.31,1.33,1.02,0.44,-2.39,-0.79,0.7,-0.11,-2.46,-0.67,0.35,1.27, ,establishment of localization;nucleobase-containing compound transport;transport,cell part;cytoplasm;macromolecular complex;nuclear pore;protein complex,,,,,,,,,,
O43592,XPOT,Exportin-T (Exportin(tRNA)) (tRNA exportin),16,19.3,29.74,29.53,27.02,29.3,26.24,25.09,27.76,27.42,27.38,23.51,27.57,27.06,,27.3,2.44,2.23,-0.28,2,-1.06,-2.21,0.46,0.12,0.08,-3.79,0.27,-0.24, ,establishment of localization;nuclear transport;nucleobase-containing compound transport;nucleocytoplasmic transport;protein transport;transport,cell part;cytoplasm;macromolecular complex;nuclear pore;nucleoplasm;protein complex,,,,,,,,,,
Q9UBH6,XPR1,Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor),9,18.4,26.28,27.12,,,28.1,26.12,24.7,26.98,27.3,25.07,24.81,26.34,26.18,26.27,0.01,0.85, , ,1.83,-0.15,-1.58,0.71,1.02,-1.2,-1.46,0.07,-0.1,multi-organism process;response to biotic stimulus;response to stimulus,cell part,,,,,,,,,,
P18887,XRCC1,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),5,11.8,27.12,25.86,26.86,26.84,27.01,27.21,25.4,25.6,27.11,27.05,25.64,25.35,26.77,26.45,0.67,-0.59,0.41,0.39,0.56,0.76,-1.05,-0.85,0.66,0.6,-0.81,-1.1,0.32,anatomical structure development;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA metabolic process;DNA repair;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to chemical stimulus;response to DNA damage stimulus;response to drug;response to stimulus;response to stress,cell part;nucleoplasm,,,,,,,,,,
Q13426,XRCC4,DNA repair protein XRCC4 (X-ray repair cross-complementing protein 4),5,24.2,25.54,26.02,25.51,25.63,26.55,26.41,27.03,25.73,27.55,26.06,,25.91,25.41,26.11,-0.57,-0.09,-0.6,-0.48,0.44,0.3,0.92,-0.38,1.43,-0.05, ,-0.21,-0.71,anatomical structure development;biological regulation;cell activation;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;DNA ligation;DNA metabolic process;DNA recombination;DNA repair;embryo development;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to chemical stimulus;response to DNA damage stimulus;response to stimulus;response to stress,cell part;cytosol;macromolecular complex;nucleoplasm;protein complex,,,,,,,,,,
P13010,XRCC5,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)),59,71.4,34.67,34.2,34.2,33.82,34.84,34.75,34.28,34.13,34.71,34.7,33.42,34.06,34.33,34.32,0.35,-0.12,-0.11,-0.5,0.52,0.44,-0.04,-0.19,0.39,0.39,-0.9,-0.25,0.02,biological regulation;biosynthetic process;cell differentiation;cell proliferation;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;developmental process;DNA metabolic process;DNA recombination;DNA repair;homeostatic process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;telomere organization,cell part;cytoplasm;macromolecular complex;nucleoplasm;protein complex;telomere cap complex,Other TF domain,,,,,,,,,
P12956,XRCC6,X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6),56,65.7,34.33,33.69,33.9,33.58,34.4,34.57,34.33,34.19,34.63,34.59,33.11,33.79,34.25,34.1,0.22,-0.42,-0.2,-0.52,0.29,0.47,0.22,0.09,0.52,0.49,-0.99,-0.32,0.14,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromosome organization;DNA ligation;DNA metabolic process;DNA recombination;DNA repair;homeostatic process;immune system process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organelle organization;primary metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;telomere organization,cell part;cytoplasm;macromolecular complex;membrane;protein complex;telomere cap complex;transcription factor complex,SAP-domain,,,,,,,,,
Q8IZH2,XRN1,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),7,5,27.23,26.08,27.11,26,26.23,25.2,27.18,26.12,27.36,27.08,26.88,27.58,26.4,26.65,0.58,-0.57,0.46,-0.65,-0.42,-1.45,0.52,-0.53,0.71,0.43,0.23,0.93,-0.25,catabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process,cell part;cytoskeleton;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;plasma membrane;ribonucleoprotein complex,,,,,,,,,,
Q9H0D6,XRN2,5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein),32,32,31.16,29.51,30.69,29.81,30.81,30.85,30.44,30.65,30.76,30.77,28.14,29.79,30.39,30.29,0.87,-0.77,0.4,-0.48,0.52,0.56,0.15,0.36,0.47,0.48,-2.15,-0.49,0.1,"biological regulation;biosynthetic process;catabolic process;cell growth;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;DNA metabolic process;growth;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA catabolic process;RNA metabolic process;RNA processing;transcription termination, DNA-dependent",cell part;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q8NBI6,XXYLT1,"Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)",4,14.8,27.69,26.7,,27.88,26.61,26.81,27.58,25.33,27.29,,,,27.68,27.06,0.63,-0.37, ,0.82,-0.46,-0.25,0.52,-1.73,0.22, , , ,0.61,,cell part;membrane,,,,,,,,,,
P46937,YAP1,Yorkie homolog (65 kDa Yes-associated protein) (YAP65),12,49.8,28.66,27.01,25.64,28.63,26.15,27.44,28.27,28.03,26.03,26.47,28.03,29.16,,27.46,1.2,-0.45,-1.82,1.17,-1.31,-0.02,0.81,0.57,-1.43,-0.99,0.57,1.7, ,"anatomical structure development;anatomical structure morphogenesis;biological regulation;biosynthetic process;cell differentiation;cell proliferation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;response to abiotic stimulus;response to DNA damage stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;transcription initiation, DNA-dependent",cell part;cytosol;macromolecular complex;nucleoplasm;protein complex;transcription factor complex,,,,,,,,,,
P54577,YARS,"Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]",33,60.8,31.54,31.78,30.53,32.23,31.19,30.96,31.42,31.43,30.17,30.29,31.45,31.71,29.18,31.07,0.48,0.71,-0.53,1.16,0.12,-0.11,0.35,0.36,-0.9,-0.78,0.38,0.65,-1.88,amine metabolic process;cell death;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;death;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part;cytosol;extracellular space;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9Y2Z4,YARS2,"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS)",12,36.1,28.56,28.98,26.71,28.01,28.56,29.16,28.72,27.42,29.11,29.97,28.76,29.02,28.4,28.57,-0.01,0.41,-1.86,-0.55,-0.01,0.59,0.15,-1.15,0.55,1.4,0.2,0.45,-0.17,amine metabolic process;cellular amino acid metabolic process;cellular ketone metabolic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;organic acid metabolic process;primary metabolic process;RNA metabolic process;small molecule metabolic process;tRNA aminoacylation for protein translation;tRNA metabolic process,cell part,,,,,,,,,,
P67809,YBX1,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),30,77.5,31.97,31.78,31.83,32.54,32.96,32.48,32.78,32.87,32.46,32.47,32.17,29.39,31.99,32.13,-0.16,-0.35,-0.3,0.41,0.83,0.35,0.65,0.74,0.33,0.34,0.04,-2.74,-0.14,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing;transcription from RNA polymerase II promoter,cell part;extracellular region;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleoplasm;organelle;protein complex;ribonucleoprotein complex;spliceosomal complex,Other TF domain,,,,,,,,,
P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),15,58.1,29.53,26.23,27.3,29.4,28.83,27.91,28.98,29.56,29.46,29.18,28.71,23.69,28.8,28.27,1.26,-2.04,-0.98,1.12,0.55,-0.37,0.7,1.29,1.19,0.9,0.43,-4.58,0.52,anatomical structure development;biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;embryo development;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;response to abiotic stimulus;response to chemical stimulus;response to osmotic stress;response to stimulus;response to stress;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleus;organelle;polysome;ribonucleoprotein complex,Other TF domain,,,,,,,,,
O95619,YEATS4,YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1),2,15.6,26.64,26.62,27.18,25.27,27.07,26.81,25.95,25.39,27.14,27.06,,25.56,,26.43,0.22,0.19,0.75,-1.15,0.64,0.39,-0.48,-1.04,0.71,0.64, ,-0.87, ,biological regulation;biosynthetic process;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;chromatin modification;chromatin organization;chromosome organization;histone modification;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nitrogen compound metabolic process;nuclear division;nucleobase-containing compound metabolic process;organelle fission;organelle organization;peptidyl-amino acid modification;primary metabolic process;protein acylation;protein metabolic process;protein modification process;RNA metabolic process,cell part;macromolecular complex;protein complex,,,,,,,,,,
P07947,YES1,Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes),17,36.5,28.75,28.61,28.22,27.92,29.57,29.22,28.53,27.55,29.44,29.26,28.41,29.11,29.15,28.75,0,-0.14,-0.53,-0.83,0.82,0.47,-0.22,-1.2,0.69,0.52,-0.34,0.37,0.4,biological regulation;carbohydrate transport;cell motility;cellular component movement;cellular metabolic process;cellular process;circulatory system process;coagulation;establishment of localization;immune system process;locomotion;macromolecule metabolic process;macromolecule modification;metabolic process;multicellular organismal process;phosphorus metabolic process;primary metabolic process;protein metabolic process;protein modification process;protein phosphorylation;regulation of body fluid levels;response to stimulus;response to stress;transport,cell part;cytosol;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;organelle;plasma membrane,,+,,,,,,,,
O95070,YIF1A,Protein YIF1A (54TMp) (YIP1-interacting factor homolog A),4,24.1,26.58,26.65,,26.54,25.22,,25.31,25,28.08,,27.22,,27.76,26.48,0.1,0.16, ,0.06,-1.27, ,-1.17,-1.49,1.59, ,0.74, ,1.28,biological regulation;cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;primary metabolic process;protein metabolic process;protein transport;regulation of protein modification process;transport;vesicle-mediated transport,cell part;centrosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;membrane;microtubule organizing center;organelle,,,,,,,,,,
Q5BJH7,YIF1B,Protein YIF1B (YIP1-interacting factor homolog B),6,34.7,28.36,26.67,26.57,29.37,28.09,29.41,28.72,28.02,29.1,26.09,28.55,27.23,30.02,28.17,0.19,-1.5,-1.6,1.2,-0.07,1.24,0.55,-0.15,0.93,-2.08,0.38,-0.94,1.85,,cell part,,,,,,,,,,
Q9Y548,YIPF1,Protein YIPF1 (YIP1 family member 1),2,8.3,23.77,23.99,25.05,24.41,,21.04,24.88,,24.57,26.46,24.47,27.71,,24.63,-0.86,-0.65,0.41,-0.23, ,-3.6,0.24, ,-0.06,1.83,-0.17,3.08, ,,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;organelle;vesicle,,,,,,,,,,
Q9GZM5,YIPF3,"Protein YIPF3 (Killer lineage protein 1) (Natural killer cell-specific antigen KLIP1) (YIP1 family member 3) [Cleaved into: Protein YIPF3, 36 kDa form III]",4,18.1,26.34,27.66,27.7,27.63,25.25,27.7,26.88,27.12,28.11,28.24,28.29,27.55,28.37,27.45,-1.11,0.21,0.25,0.18,-2.2,0.25,-0.57,-0.33,0.66,0.79,0.84,0.09,0.92,cell differentiation;cellular process;developmental process,cell part;cytoplasmic membrane-bounded vesicle;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;plasma membrane;vesicle,,,,,,,,,,
Q9BSR8,YIPF4,Protein YIPF4 (YIP1 family member 4),4,12.7,27.27,27.46,26.83,27.93,26.04,28.15,,26.71,28.03,28.32,27.12,27.29,27.37,27.38,-0.11,0.09,-0.54,0.55,-1.34,0.77, ,-0.67,0.65,0.95,-0.25,-0.09,-0.01,,cell part;endoplasmic reticulum;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
Q969M3,YIPF5,Protein YIPF5 (Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5) (Smooth muscle cell-associated protein 5) (SMAP-5) (YIP1 family member 5) (YPT-interacting protein 1 A),2,8.2,28.35,29.32,28.45,29.49,28.74,29.69,28.55,28.66,29.67,28.78,29.19,,29.02,28.99,-0.65,0.33,-0.54,0.49,-0.26,0.7,-0.44,-0.33,0.68,-0.21,0.2, ,0.03,biological regulation;cellular process;establishment of localization;protein transport;regulation of transport;transport;vesicle-mediated transport,cell part;cytoplasmic membrane-bounded vesicle;intracellular membrane-bounded organelle;intracellular organelle;membrane;organelle;vesicle,,,,,,,,,,
Q96EC8,YIPF6,Protein YIPF6 (YIP1 family member 6),3,9.3,25.32,27.42,,25.08,27.21,,25.12,25.49,26.61,27.29,26.94,,27.07,26.35,-1.04,1.06, ,-1.28,0.85, ,-1.24,-0.87,0.26,0.94,0.59, ,0.72,,cell part;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O15498,YKT6,Synaptobrevin homolog YKT6 (EC 2.3.1.-),9,52.9,29.01,29.19,28.23,29.35,27.43,28.18,28.2,27.69,27.1,27.48,29.59,29.64,27.13,28.32,0.68,0.87,-0.09,1.02,-0.89,-0.14,-0.12,-0.63,-1.22,-0.85,1.26,1.32,-1.2,cellular process;endosome transport;establishment of localization;Golgi vesicle transport;membrane docking;protein transport;transport;vesicle-mediated transport,cell part;cytosol;endoplasmic reticulum;endosome;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;protein complex,,,,,,,,,,
P49750,YLPM1,YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113),14,11.3,27.82,27.31,26.3,28.96,25.76,28.13,27.48,26.93,28.52,28.18,26.68,28.04,28.32,27.57,0.25,-0.26,-1.27,1.39,-1.81,0.56,-0.09,-0.64,0.95,0.61,-0.89,0.47,0.74,biological regulation;regulation of DNA metabolic process;regulation of organelle organization,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96TA2,YME1L1,ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1),13,24.2,28.47,27.96,28.02,29.41,28.75,29.32,29.26,28.95,29.61,29.54,28.1,29.21,28.89,28.88,-0.42,-0.92,-0.86,0.53,-0.14,0.44,0.37,0.06,0.73,0.66,-0.78,0.33,0,cell proliferation;cellular component organization;cellular process;macromolecule metabolic process;metabolic process;mitochondrion organization;organelle organization;primary metabolic process;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;membrane,,,,,,,,,,
P62699,YPEL5,Protein yippee-like 5,2,21.5,25.74,25.73,,25.53,26.96,26.64,26.19,26.48,24.97,,26.11,27.69,25.52,26.14,-0.4,-0.42, ,-0.61,0.82,0.49,0.05,0.34,-1.17, ,-0.04,1.55,-0.62,,,,,,,,,,,,
Q86U90,YRDC,"YrdC domain-containing protein, mitochondrial (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog) (hIRIP)",3,14.3,26.48,26.1,25.52,26.65,26.1,25.9,26.91,27.13,25.87,25.75,24.54,26.91,,26.16,0.33,-0.06,-0.63,0.5,-0.06,-0.26,0.75,0.98,-0.28,-0.41,-1.61,0.76, ,biological regulation;regulation of transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;membrane;mitochondrion;organelle,,,,,,,,,,
Q96MU7,YTHDC1,YTH domain-containing protein 1 (Putative splicing factor YT521),13,19.5,28.34,27.58,27.53,27.44,28.14,26.99,27.93,,28.5,29.43,25.58,28.97,,27.86,0.48,-0.28,-0.32,-0.42,0.28,-0.87,0.07, ,0.64,1.58,-2.28,1.12, ,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q9BYJ9,YTHDF1,YTH domain family protein 1 (Dermatomyositis associated with cancer putative autoantigen 1) (DACA-1),2,6.1,26.66,,25.49,26.3,,,25.93,26.86,25.34,,25.69,25.36,,25.95,0.71, ,-0.46,0.35, , ,-0.03,0.91,-0.62, ,-0.26,-0.6, ,,,,,,,,,,,,
Q9Y5A9,YTHDF2,YTH domain family protein 2 (CLL-associated antigen KW-14) (High-glucose-regulated protein 8) (Renal carcinoma antigen NY-REN-2),5,12.1,28.04,27.13,29.07,27.31,27.96,28.51,28.8,28.12,28.4,28.07,27.73,,26.25,27.95,0.09,-0.82,1.12,-0.64,0.01,0.56,0.85,0.17,0.45,0.12,-0.22, ,-1.7,immune system process;response to stimulus,,,,,,,,,,,
Q7Z739,YTHDF3,YTH domain family protein 3,12,27.2,29,28.12,28.55,29,27.19,28.74,29.1,28.87,28.23,28.53,29.01,27.81,28.52,28.51,0.49,-0.39,0.04,0.49,-1.33,0.23,0.58,0.35,-0.28,0.02,0.49,-0.71,0,,,,,,,,,,,,
P31946,YWHAB,"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]",18,72.8,33.36,32.6,33.24,32.68,32.55,31.85,32.7,32.94,32.05,31.7,33.2,32.75,31.21,32.53,0.83,0.08,0.72,0.15,0.03,-0.67,0.18,0.41,-0.48,-0.82,0.67,0.22,-1.31,biological regulation;cellular component assembly;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;immune system process;locomotion;macromolecular complex assembly;macromolecule metabolic process;macromolecule modification;membrane organization;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;phosphorus metabolic process;primary metabolic process;protein complex assembly;protein metabolic process;protein modification process;protein phosphorylation;protein targeting;protein transport;regulation of protein modification process;regulation of transport;response to chemical stimulus;response to endogenous stimulus;response to external stimulus;response to stimulus;response to stress;RNA metabolic process;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;organelle;protein complex;transcriptional repressor complex;vesicle,,,,,,,,,,
P62258,YWHAE,14-3-3 protein epsilon (14-3-3E),26,80,34.88,34.97,34.92,34.92,34.54,34.7,34.94,35.11,33.9,34.23,35.22,35.5,33.84,34.74,0.14,0.22,0.17,0.17,-0.2,-0.04,0.2,0.37,-0.84,-0.52,0.48,0.75,-0.91,anatomical structure development;biological regulation;cell motility;cellular component movement;cellular component organization;cellular membrane organization;cellular process;developmental process;establishment of localization;interspecies interaction between organisms;locomotion;membrane organization;multi-organism process;protein targeting;protein transport;regulation of protein modification process;response to stimulus;signal transduction;transport,cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;organelle;protein complex;vesicle,,,,,,,,,,
P61981,YWHAG,"14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]",24,91.1,33.93,32.95,33.95,32.83,32.58,32.08,33.1,33.36,32.14,31.94,33.67,32.74,31.68,32.84,1.09,0.1,1.11,-0.01,-0.27,-0.76,0.25,0.52,-0.7,-0.91,0.83,-0.1,-1.16,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane organization;protein targeting;protein transport;transport,cell part;cytosol;membrane,,,,,,,,,,
Q04917,YWHAH,14-3-3 protein eta (Protein AS1),17,67.9,31.34,31.55,32.58,31.84,31.33,30.9,32.25,32.46,30.98,31.59,32.19,31.09,30.05,31.55,-0.21,0,1.03,0.29,-0.22,-0.65,0.7,0.91,-0.57,0.04,0.64,-0.47,-1.5,biological regulation;catabolic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;establishment of localization;hormone metabolic process;lipid metabolic process;membrane organization;metabolic process;primary metabolic process;protein transport;regulation of transport;response to stimulus;signal transduction;transport,cell part;cytosol;membrane,,,,,,,,,,
P27348,YWHAQ,14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1),25,80.4,32.4,32.88,32.88,33.23,32.68,31.93,32.96,33.1,31.52,31.81,33.43,33.18,31.44,32.57,-0.18,0.31,0.31,0.66,0.11,-0.64,0.39,0.53,-1.05,-0.76,0.86,0.61,-1.14,biological regulation;cellular component organization;cellular membrane organization;cellular process;establishment of localization;membrane organization;protein targeting;protein transport;response to stimulus;signal transduction;transport,cell part;cytosol;macromolecular complex;membrane;protein complex,,,,,,,,,,
P63104,YWHAZ,14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1),32,80.4,36.04,34.92,34.73,35.01,34.46,34.22,34.92,35.09,34.07,33.86,34.74,34.57,33.69,34.64,1.4,0.28,0.09,0.37,-0.18,-0.42,0.28,0.45,-0.57,-0.78,0.09,-0.07,-0.95,amine transport;biological regulation;cell activation;cellular component organization;cellular membrane organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;hormone transport;macromolecule metabolic process;membrane organization;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein targeting;protein transport;RNA metabolic process;secretion;transport,cell leading edge;cell part;cytoplasmic membrane-bounded vesicle;cytosol;intracellular membrane-bounded organelle;intracellular organelle;macromolecular complex;membrane;mitochondrion;nucleoplasm;organelle;protein complex;vesicle,,,,,,,,,,
Q8N4Q0,ZADH2,Zinc-binding alcohol dehydrogenase domain-containing protein 2 (EC 1.-.-.-),2,6.6,26.28,25.67,,25.45,25.57,25.62,24.17,,26.24,24.03,,24.46,26.28,25.38,0.9,0.29, ,0.07,0.19,0.24,-1.21, ,0.86,-1.35, ,-0.91,0.9,,cell part;intracellular membrane-bounded organelle;intracellular organelle;microbody;mitochondrion;organelle;peroxisome,,,,,,,,,,
Q8IWT0,ZBTB8OS,Protein archease (Protein ZBTB8OS) (Zinc finger and BTB domain-containing opposite strand protein 8),3,22.2,25.45,25.3,23.58,26.15,26.24,25.37,23.8,25.95,25.15,,26.02,26.7,25.59,25.44,0.01,-0.14,-1.86,0.71,0.8,-0.07,-1.64,0.51,-0.29, ,0.58,1.25,0.15,,,,,,,,,,,,
O75152,ZC3H11A,Zinc finger CCCH domain-containing protein 11A,12,24.5,28.47,27.74,29.08,27.35,26.74,26.97,27.06,23.82,27.63,28.13,26.73,26.39,26.04,27.09,1.38,0.66,1.99,0.26,-0.35,-0.12,-0.03,-3.26,0.54,1.04,-0.36,-0.7,-1.05,,,,,,,,,,,,
Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,34,15.6,22.84,24.1,24.45,22.75,,22.43,,,,25.04,24.05,24.43,,23.76,-0.93,0.33,0.69,-1.01, ,-1.33, , , ,1.28,0.29,0.67, ,,,,,,,,,,,,
Q6PJT7,ZC3H14,Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2) (MSUT-2) (Renal carcinoma antigen NY-REN-37),9,17.7,29.56,24.99,24.93,25.42,28.09,28.72,28.11,26.88,26.58,25.98,26.91,26.8,26.67,26.89,2.67,-1.91,-1.97,-1.47,1.2,1.82,1.21,-0.02,-0.31,-0.92,0.01,-0.09,-0.23,,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8WU90,ZC3H15,Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4),16,37.3,30.13,28.29,29.89,29.34,27.55,27.58,28.93,27.96,28.18,28.34,29.4,29.12,27.7,28.65,1.48,-0.36,1.25,0.69,-1.1,-1.06,0.29,-0.69,-0.46,-0.3,0.75,0.47,-0.95,biological regulation;cellular process;response to chemical stimulus;response to stimulus;signal transduction,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q9UPT8,ZC3H4,Zinc finger CCCH domain-containing protein 4,10,12.4,27.71,26.89,28.44,26.96,27.4,27.8,28.11,26.16,28.06,28.68,27.38,28.3,27.02,27.61,0.1,-0.72,0.83,-0.65,-0.21,0.19,0.5,-1.45,0.45,1.07,-0.23,0.69,-0.59,,,,,,,,,,,,
Q9UGR2,ZC3H7B,Zinc finger CCCH domain-containing protein 7B (Rotavirus 'X'-associated non-structural protein) (RoXaN),6,6,25.36,25.47,,26.67,26.51,25.44,25.99,27.31,25.99,26.82,26.16,25.19,27.01,26.16,-0.8,-0.69, ,0.51,0.35,-0.72,-0.17,1.15,-0.17,0.66,0,-0.97,0.85,interspecies interaction between organisms;multi-organism process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
Q7Z2W4,ZC3HAV1,Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP),23,33.3,29.51,29.48,30.11,30.16,30.54,30,29.93,30.22,29.5,29.79,29.53,29.51,30,29.87,-0.36,-0.39,0.24,0.29,0.67,0.14,0.07,0.36,-0.37,-0.08,-0.34,-0.36,0.13,biological regulation;cellular process;immune system process;multi-organism process;response to biotic stimulus;response to chemical stimulus;response to stimulus;response to stress,cell part;cytoplasm;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;membrane;nucleus;organelle;plasma membrane,,,,,,,,,,
Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),16,39.7,26.84,25.58,,25.68,24.28,26.66,,,26.31,25.25,,,25.9,25.81,1.03,-0.23, ,-0.14,-1.54,0.84, , ,0.49,-0.56, , ,0.09,biological regulation;cell division;cellular component organization;cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;mitosis;nuclear division;organelle fission;organelle organization;primary metabolic process;protein metabolic process;protein modification by small protein conjugation or removal;protein modification process,cell part;membrane,,,,,,,,,,
Q9NP64,ZCCHC17,Nucleolar protein of 40 kDa (pNO40) (Pnn-interacting nucleolar protein) (Putative S1 RNA-binding domain protein) (PS1D protein) (Zinc finger CCHC domain-containing protein 17),2,10.6,23.45,23,23.55,22.69,,24.95,23.73,23.59,23.95,24.64,24.91,25.72,24.83,24.08,-0.63,-1.08,-0.53,-1.39, ,0.86,-0.35,-0.5,-0.14,0.56,0.82,1.64,0.74,,cell part;intracellular non-membrane-bounded organelle;intracellular organelle;macromolecular complex;nucleolus;organelle;ribonucleoprotein complex,,,,,,,,,,
Q6NZY4,ZCCHC8,Zinc finger CCHC domain-containing protein 8,16,33.2,28.7,27.51,29.69,28.03,27.03,27.06,27.95,26.57,28.24,29.34,28.52,29.55,27.18,28.1,0.6,-0.6,1.58,-0.07,-1.08,-1.04,-0.15,-1.54,0.14,1.23,0.42,1.44,-0.93,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;macromolecular complex;ribonucleoprotein complex;spliceosomal complex,,,,,,,,,,
Q8IUH4,ZDHHC13,Palmitoyltransferase ZDHHC13 (EC 2.3.1.-) (Huntingtin-interacting protein 14-related protein) (HIP14-related protein) (Huntingtin-interacting protein HIP3RP) (Putative MAPK-activating protein PM03) (Putative NF-kappa-B-activating protein 209) (Zinc finger DHHC domain-containing protein 13) (DHHC-13),2,5.8,25.86,26.96,26.91,26.72,25.97,26.79,26.37,25.44,27.13,28.13,26.59,25.8,26.82,26.58,-0.72,0.38,0.34,0.14,-0.61,0.22,-0.21,-1.14,0.55,1.55,0.01,-0.77,0.25,biological regulation,cell part;membrane,,,,,,,,,,
Q9NYG2,ZDHHC3,Palmitoyltransferase ZDHHC3 (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3) (Zinc finger protein 373),2,12.7,26.35,26.54,28.16,26.3,24.54,27.05,27.17,26.51,28.18,28.88,27.7,26.53,29.05,27.15,-0.8,-0.62,1.01,-0.85,-2.61,-0.1,0.02,-0.65,1.03,1.73,0.55,-0.62,1.9,cellular metabolic process;cellular process;establishment of localization;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein acylation;protein lipidation;protein metabolic process;protein modification process;protein targeting;protein transport;transport,cell part;membrane,,,,,,,,,,
Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),12,26,25.81,24.47,23.9,25.38,23.98,,,23.54,,25.98,22.3,24.91,,24.47,1.34,0,-0.58,0.91,-0.49, , ,-0.94, ,1.51,-2.18,0.43, ,cellular metabolic process;cellular process;macromolecule metabolic process;macromolecule modification;metabolic process;primary metabolic process;protein acylation;protein lipidation;protein metabolic process;protein modification process,cell part;membrane;plasma membrane,,,,,,,,,,
Q07352,ZFP36L1,"Zinc finger protein 36, C3H1 type-like 1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (Protein TIS11B)",8,15.6,27.4,26.82,25.55,25.76,24.52,26.5,25.68,25.89,27.1,,,,,26.14,1.27,0.68,-0.59,-0.38,-1.61,0.37,-0.45,-0.25,0.96, , , , ,biological regulation;catabolic process;cell activation;cell differentiation;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;developmental process;immune system process;macromolecule metabolic process;metabolic process;mRNA metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of translation;RNA catabolic process;RNA metabolic process,cell part;cytosol;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O95159,ZFPL1,Zinc finger protein-like 1 (Zinc finger protein MCG4),7,21.9,27.62,28.25,26.6,27.51,25.09,28.48,27.14,27.07,29.62,28.2,28.37,23.55,28.16,27.36,0.26,0.9,-0.76,0.15,-2.27,1.12,-0.22,-0.29,2.26,0.84,1.01,-3.8,0.8,biological regulation;cellular process;establishment of localization;transport;vesicle-mediated transport,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q96KR1,ZFR,Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog),19,16,29.73,29.2,29.93,29.5,29.93,29.87,29.14,29.25,29.77,29.77,28.59,27.09,29,29.29,0.44,-0.09,0.64,0.21,0.65,0.58,-0.15,-0.04,0.48,0.48,-0.7,-2.2,-0.29,developmental process;multicellular organismal development;multicellular organismal process,cell part;chromosome;cytoplasm;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
Q8N5A5,ZGPAT,Zinc finger CCCH-type with G patch domain-containing protein (G patch domain-containing protein 6) (Zinc finger CCCH domain-containing protein 9) (Zinc finger and G patch domain-containing protein),3,11,22.63,24.62,27.95,22.78,26.75,26.01,24.77,25.86,23.39,27.31,26.82,26.72,26.22,25.53,-2.9,-0.91,2.43,-2.74,1.23,0.48,-0.76,0.34,-2.13,1.78,1.29,1.19,0.69,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;regulation of protein modification process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,Other TF domain,,,,,,,,,
Q96NC0,ZMAT2,Zinc finger matrin-type protein 2,2,10.1,26.56,25.68,27.09,26.22,24.64,24.3,25.31,25.65,26.15,24.31,23.64,26.02,23.62,25.32,1.24,0.36,1.77,0.9,-0.68,-1.02,-0.01,0.32,0.83,-1.01,-1.68,0.7,-1.7,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O75844,ZMPSTE24,CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog),14,33.9,31.17,31.8,30.63,30.58,29.6,30.63,30.4,29.84,30.37,31.85,31.12,30.69,31.35,30.77,0.4,1.02,-0.14,-0.19,-1.17,-0.14,-0.37,-0.93,-0.4,1.08,0.35,-0.08,0.58,catabolic process;cellular component organization;cellular membrane organization;cellular metabolic process;cellular process;macromolecule metabolic process;membrane organization;metabolic process;primary metabolic process;protein maturation;protein metabolic process;proteolysis;proteolysis involved in cellular protein catabolic process,cell part;membrane,,,,,,,,,,
Q5VZL5,ZMYM4,Zinc finger MYM-type protein 4 (Zinc finger protein 262),9,6.9,25.92,24.83,24.81,25.1,,25.86,25.8,,26.51,26.28,,26.42,24.78,25.63,0.29,-0.81,-0.83,-0.53, ,0.23,0.16, ,0.88,0.65, ,0.79,-0.85,biological regulation;cellular component organization;cellular process;cytoskeleton organization;developmental process;multicellular organismal development;multicellular organismal process;organelle organization,,,,,,,,,,,
Q9UQR1,ZNF148,Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89),9,17.3,27.92,25.16,27.12,25.91,24.96,26.05,25.29,25.6,25,25.24,,23.95,24.13,25.53,2.39,-0.37,1.59,0.38,-0.56,0.52,-0.24,0.07,-0.53,-0.29, ,-1.57,-1.4,biological regulation;biosynthetic process;cellular component assembly;cellular component organization;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecular complex assembly;macromolecule metabolic process;metabolic process;multicellular organismal process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;protein complex assembly;response to stimulus;response to stress;RNA metabolic process;transcription from RNA polymerase II promoter,cell part;Golgi apparatus;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),50,67.8,31.52,32,30.96,29.25,32.5,31.23,32.86,32.95,32.9,32.96,32.6,29.14,31.18,31.7,-0.18,0.31,-0.74,-2.45,0.8,-0.46,1.16,1.26,1.2,1.26,0.91,-2.56,-0.52,,cell part;cytoplasm;cytoskeleton;intracellular non-membrane-bounded organelle;intracellular organelle;organelle,,,,,,,,,,
O43670,ZNF207,Zinc finger protein 207,8,16.4,30.37,29.44,29.72,29.9,30.35,30.07,29.85,30.02,30.11,29.66,28.04,24.03,28.79,29.26,1.11,0.18,0.46,0.64,1.09,0.81,0.6,0.76,0.85,0.4,-1.21,-5.22,-0.47,,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
O75312,ZNF259,Zinc finger protein ZPR1 (Zinc finger protein 259),10,37,27.47,27.66,28.17,27.32,27.27,26.19,28.17,26.36,,24.18,28.62,29.35,26,27.23,0.24,0.43,0.94,0.09,0.04,-1.04,0.94,-0.87, ,-3.05,1.39,2.12,-1.23,biological regulation;cell proliferation;cellular process;response to stimulus;signal transduction,cell part;cytoplasm;intracellular non-membrane-bounded organelle;intracellular organelle;nucleolus;organelle,,,,,,,,,,
Q5BKZ1,ZNF326,DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs and DBC1),14,29.7,29.98,28.89,29.65,29.52,29.73,29.33,30.06,28.75,30.43,31.15,28.89,29.59,28.55,29.58,0.4,-0.69,0.07,-0.06,0.15,-0.25,0.48,-0.83,0.86,1.57,-0.69,0.01,-1.03,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part,Other TF domain,,,,,,,,,
Q8TF68,ZNF384,Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein),4,11.8,28.5,25.51,27.08,26.44,26.81,27.18,,,25.05,25.85,,22.87,,26.14,2.36,-0.63,0.94,0.29,0.67,1.04, , ,-1.1,-0.29, ,-3.27, ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;establishment of localization;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nuclear transport;nucleobase-containing compound metabolic process;nucleocytoplasmic transport;primary metabolic process;regulation of transport;RNA metabolic process;transport,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
Q96ME7,ZNF512,Zinc finger protein 512,3,8.9,27.54,25,25.24,26.6,26.5,24.89,25.05,25.2,24.83,24.51,24.04,,,25.4,2.14,-0.4,-0.16,1.2,1.1,-0.51,-0.35,-0.2,-0.57,-0.89,-1.36, , ,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
Q14966,ZNF638,Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein),19,12.4,29.2,27.46,27.89,28.22,28.85,28.71,27.14,26.49,28.23,28.96,26.32,27.95,27.45,27.91,1.28,-0.45,-0.02,0.31,0.93,0.8,-0.77,-1.42,0.31,1.05,-1.59,0.04,-0.47,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;cytoplasm;nucleoplasm,Other TF domain,,,,,,,,,
Q2TB10,ZNF800,Zinc finger protein 800,2,23.1,24.43,23.81,24.29,23.22,,24.74,23.74,23.19,25.66,27.11,25.07,25.39,24.66,24.61,-0.18,-0.8,-0.32,-1.39, ,0.13,-0.86,-1.42,1.05,2.5,0.46,0.78,0.05,biological regulation;biosynthetic process;cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
Q96NB3,ZNF830,Zinc finger protein 830 (Coiled-coil domain-containing protein 16),2,14.7,23.76,,,,25.71,24.46,23.43,23.5,23.53,,,25.16,24.1,24.21,-0.44, , , ,1.51,0.26,-0.77,-0.71,-0.68, , ,0.95,-0.11,cell division;cellular component organization;cellular process;developmental process;growth;mitosis;nuclear division;organelle fission;organelle organization,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,C2H2-type,,,,,,,,,
O95218,ZRANB2,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",16,31.2,28.17,27.25,29.09,26.2,26.05,29.16,28.77,27.08,28.6,29,28.83,30.05,28.65,28.22,-0.05,-0.98,0.87,-2.03,-2.17,0.94,0.55,-1.14,0.37,0.78,0.61,1.82,0.42,cellular metabolic process;cellular nitrogen compound metabolic process;cellular process;macromolecule metabolic process;metabolic process;mRNA metabolic process;mRNA processing;nitrogen compound metabolic process;nucleobase-containing compound metabolic process;primary metabolic process;RNA metabolic process;RNA processing;RNA splicing,cell part;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,
O43264,ZW10,Centromere/kinetochore protein zw10 homolog,17,27.1,28.61,28.83,28.83,29.13,29.31,28.94,29.56,29.16,29.49,29.11,29.25,29.61,29.88,29.21,-0.6,-0.38,-0.38,-0.08,0.1,-0.27,0.35,-0.05,0.28,-0.1,0.04,0.4,0.67,biological regulation;cell division;cellular component assembly;cellular component organization;cellular localization;cellular process;cytoskeleton organization;establishment of localization;Golgi vesicle transport;localization;macromolecular complex assembly;meiosis;organelle organization;protein complex assembly;protein transport;regulation of cell cycle;regulation of mitotic cell cycle;transport;vesicle-mediated transport,cell part;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;intracellular non-membrane-bounded organelle;intracellular organelle;kinetochore;macromolecular complex;membrane;nucleus;organelle;protein complex,,,,,,,,,,
Q15942,ZYX,Zyxin (Zyxin-2),30,57,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological adhesion;biological regulation;cell adhesion;cell communication;cell-cell signaling;cellular process;interspecies interaction between organisms;multi-organism process;response to stimulus;signal transduction;signaling,cell part;cytoplasm;intracellular membrane-bounded organelle;intracellular organelle;nucleus;organelle,,,,,,,,,,